<SEC-DOCUMENT>0001280776-25-000012.txt : 20250807
<SEC-HEADER>0001280776-25-000012.hdr.sgml : 20250807
<ACCEPTANCE-DATETIME>20250807065803
ACCESSION NUMBER:		0001280776-25-000012
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250807
DATE AS OF CHANGE:		20250807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUNIC, INC.
		CENTRAL INDEX KEY:			0001280776
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				562358443
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36201
		FILM NUMBER:		251191474

	BUSINESS ADDRESS:	
		STREET 1:		1200 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 200
		CITY:			NEW YORK
		STATE:			X1
		ZIP:			10036
		BUSINESS PHONE:		(332) 255-9818

	MAIL ADDRESS:	
		STREET 1:		1200 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 200
		CITY:			NEW YORK
		STATE:			X1
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VITAL THERAPIES INC
		DATE OF NAME CHANGE:	20040219
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>vtl-20250630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:21259784-9322-473c-b39e-2847017b16ee,g:8411c107-5431-4a14-ae41-df3b5f39857c,d:3f98a63a9d28482ab81ca8a270389f57-->
<html xmlns:srt="http://fasb.org/srt/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:vtl="http://vitaltherapies.com/20250630" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2025" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vtl-20250630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-28">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" id="f-29">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-30">0001280776</ix:nonNumeric><ix:nonNumeric contextRef="c-78" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-310">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-324">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-329">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-330">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-331">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-385">http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-386">http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-138" name="vtl:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" id="f-491">P5D</ix:nonNumeric><ix:nonNumeric contextRef="c-138" name="vtl:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" id="f-492">P5D</ix:nonNumeric><ix:nonNumeric contextRef="c-190" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-575">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vtl-20250630.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="employee"><xbrli:measure>vtl:employee</xbrli:measure></xbrli:unit><xbrli:unit id="program"><xbrli:measure>vtl:program</xbrli:measure></xbrli:unit><xbrli:unit id="financialinstitution"><xbrli:measure>vtl:financialInstitution</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>vtl:lease</xbrli:measure></xbrli:unit><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:unit id="tranche"><xbrli:measure>vtl:tranche</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>vtl:vote</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>vtl:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vtl:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vtl:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:NewYorkCityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:GrafelfingGermanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:GrafelfingGermanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:NewYorkCityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:PlaneggGermanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-08</xbrli:startDate><xbrli:endDate>2024-01-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-08</xbrli:startDate><xbrli:endDate>2024-01-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-08</xbrli:startDate><xbrli:endDate>2024-01-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2022ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025AndMay2025FinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025AndMay2025FinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2024ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2024ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2024ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-09</xbrli:startDate><xbrli:endDate>2025-04-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PlacementAgencyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-09</xbrli:startDate><xbrli:endDate>2025-04-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PlacementAgencyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:OfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-09</xbrli:startDate><xbrli:endDate>2025-04-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesAWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesAWarrantAndSeriesBWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:VolumeWeightageAveragePriceTargetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-28</xbrli:startDate><xbrli:endDate>2025-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-28</xbrli:startDate><xbrli:endDate>2025-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PlacementAgencyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-28</xbrli:startDate><xbrli:endDate>2025-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-04</xbrli:startDate><xbrli:endDate>2024-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-08</xbrli:startDate><xbrli:endDate>2024-01-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-04</xbrli:startDate><xbrli:endDate>2024-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-04</xbrli:startDate><xbrli:endDate>2024-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-08</xbrli:startDate><xbrli:endDate>2024-01-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-04</xbrli:startDate><xbrli:endDate>2024-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-04</xbrli:startDate><xbrli:endDate>2024-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vtl:CommonStockAndPreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:CommonStockAndPreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityCapitalizationAxis">us-gaap:EquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityCapitalizationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:May2025PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:May2025SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:May2025SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:EmployeeStockOptionsforFutureGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:EmployeeStockOptionsforFutureGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-25</xbrli:startDate><xbrli:endDate>2021-04-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-28</xbrli:startDate><xbrli:endDate>2023-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-04</xbrli:startDate><xbrli:endDate>2025-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:IncentiveEmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:NonStatutoryEmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:NonStatutoryEmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtl:DuaneNashMDJDMBAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vtl:ExecutiveChairmanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-17</xbrli:startDate><xbrli:endDate>2023-10-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtl:DuaneNashMDJDMBAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vtl:ExecutiveChairmanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtl:DuaneNashMDJDMBAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vtl:ExecutiveChairmanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-29</xbrli:startDate><xbrli:endDate>2024-08-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesAWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-07</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3f98a63a9d28482ab81ca8a270389f57_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June 30, 2025</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Commission File Number:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36201</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Immunic, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.654%"><tr><td style="width:1.0%"/><td style="width:46.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.406%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">56-2358443</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">1200 Avenue of the Americas</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">Suite 200</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">New York,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">NY</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">10036</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">332</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">255-9818</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="padding-left:54pt;padding-right:54pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.976%"><tr><td style="width:1.0%"/><td style="width:35.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.114%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, $0.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">IMUX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:54pt;padding-right:54pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-19">Yes</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-21">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-22">&#9746;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">On July 31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">98,650,590</ix:nonFraction> shares of common stock, $0.0001 par value, were outstanding.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">IMMUNIC, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_10">PART I - FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_10">Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_10">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_13">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_16">Condensed Consolidated Statements of Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_19">Condensed Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_25">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_25">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_28">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_28">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_61">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_61">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_73">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_73">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_76">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_76">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_79">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_82">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_82">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_85">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_85">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_88">Unregistered Sales of Equity Securities</a> and Use of Proceeds</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_88">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_91">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_88">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_94">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_94">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_97">Other Information </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_97">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_100">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f98a63a9d28482ab81ca8a270389f57_100">46</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">IMMUNIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:73.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">55,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">35,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">4,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">3,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">59,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">39,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-37">612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-38">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-39">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-40">991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-41">61,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-42">40,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">7,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">7,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-45">18,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">12,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">1,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">27,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">22,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="f-51">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="f-52">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="f-53">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="f-54">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-55">27,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-56">22,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-57"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-58"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-59"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-60">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-61"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-62">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-63"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-64"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-65"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-66">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding as of June 30, 2025 and December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-69"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-70">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-71"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-72">500,000,000</ix:nonFraction></ix:nonFraction>  shares authorized as of June 30, 2025 and December 31, 2024, and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-73"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-74">98,650,590</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-75"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-76">90,150,869</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June 30, 2025 and December&#160;31, 2024, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-77">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-78">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-79">595,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-80">525,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-81">2,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-82">4,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-83">563,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-84">511,399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-85">33,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-86">18,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-87">61,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-88">40,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">IMMUNIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(In&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"/><td style="width:49.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.210%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br/>&#160;Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months<br/>&#160;Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-89">21,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-90">18,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-91">42,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-92">37,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-93">5,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-94">4,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-95">11,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-96">9,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-97">27,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-98">22,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-99">53,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-100">46,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-101">27,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-102">22,814</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-103">53,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-104">46,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-105">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-106">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-107">424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-108">2,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of the tranche rights</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:fixed-zero" scale="3" id="f-109">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:fixed-zero" scale="3" id="f-110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:fixed-zero" scale="3" id="f-111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:num-dot-decimal" scale="3" id="f-112">4,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other  income (expense), net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-113">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-114">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-115">1,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-116">1,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-117">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-118">1,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-119">1,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-120">4,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-121">26,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-122">21,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-123">52,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-124">50,964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-125"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-126">0.20</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-127"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-128">0.21</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-129"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-130">0.45</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-131"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-132">0.51</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding, basic and diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-133"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-134">132,175,202</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-135"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-136">101,272,580</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-137"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-138">116,844,985</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-139"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-140">99,607,158</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">IMMUNIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(In&#160;thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"/><td style="width:55.298%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br/>&#160;Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months<br/>&#160;Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-141">26,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-142">21,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-143">52,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-144">50,964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-145">1,399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-146">505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-147">1,684</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-148">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-149">28,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-150">21,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-151">53,977</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-152">50,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_19"></div><hr style="page-break-after:always"/><div style="min-height:36.72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:232%">IMMUNIC, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:232%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(In&#160;thousands,&#160;except&#160;share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.920%"><tr><td style="width:1.0%"/><td style="width:43.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.819%"/><td style="width:0.1%"/></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2025</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance at January 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-153">90,150,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-154">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-155">525,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-156">4,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-157">511,399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-158">18,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-159">25,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-160">25,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-161">2,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-162">2,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-163">285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-164">285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-165">90,150,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-166">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-167">527,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-168">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-169">536,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-170">5,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-171">26,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-172">26,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-173">1,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-174">1,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-175">1,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-176">1,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of  pre-funded warrants - May 2025 Offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-177">4,332</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-178">60,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-179">60,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock - April 2025 Offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-180">367</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-181">5,666,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-182">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-183">4,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-184">4,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of pre-funded warrants from January 2024 Financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-185">2,613,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:fixed-zero" scale="3" id="f-186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Shares issued in connection with the Company's employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-187">219,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-188">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-189">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-190">98,650,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-191">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-192">595,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-193">2,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-194">563,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-195">33,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:36.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36.72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.920%"><tr><td style="width:1.0%"/><td style="width:42.950%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.956%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.102%"/><td style="width:0.1%"/></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit)</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance at January 1, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-196">45,177,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-197">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-198">436,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-199">3,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-200">410,892</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-201">28,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">29,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">29,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-204">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-205">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-206">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-207">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock and pre-funded warrants - January 2024 Financing, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-208">4,037</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-209">44,751,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-210">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-211">52,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-212">52,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of tranche rights liability to equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="vtl:AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" format="ixt:num-dot-decimal" scale="3" id="f-213">28,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="vtl:AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" format="ixt:num-dot-decimal" scale="3" id="f-214">28,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock - At The Market Sales Agreement net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-215">6</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-216">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-217">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-218">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-219">90,079,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-220">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-221">519,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-222">4,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-223">440,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-224">83,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-225">21,380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-226">21,380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-227">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-228">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-229">505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-230">505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-59" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-231">90,079,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-232">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-233">521,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-234">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-235">461,856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-236">63,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:36.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_25"></div><hr style="page-break-after:always"/><div style="min-height:27.36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">IMMUNIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(In&#160;thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.622%"><tr><td style="width:1.0%"/><td style="width:79.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.221%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months<br/>&#160;Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">52,293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-238">50,964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="f-239">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="f-240">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign currency gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="f-241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-242">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-243">3,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-244">4,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" scale="3" id="f-245">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" scale="3" id="f-246">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of tranche rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vtl:GainLossFromChangeInFairValueOfTrancheRights" format="ixt:fixed-zero" scale="3" id="f-247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="vtl:GainLossFromChangeInFairValueOfTrancheRights" format="ixt:num-dot-decimal" scale="3" id="f-248">4,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fees expensed as part of January 2024 Financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:fixed-zero" scale="3" id="f-249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-250">1,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-251">429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-252">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-253">896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-254">2,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-255">3,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-256">4,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="f-257">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="f-258">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-259">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-260">350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-261">46,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-262">41,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-263">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-264">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-265">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-266">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from public offering of common stock through At The Market Sales Agreement, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-268">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from January 2024 Financing, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-270">74,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from shares issued in connection with the Company's employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="f-271">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" format="ixt:fixed-zero" scale="3" id="f-272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from May 2025 Offering, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-273">60,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from April 2025 Offering, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-275">4,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-277">65,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-278">74,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-279">592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-280">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-281">19,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-282">33,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-283">35,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-284">46,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-285">55,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-286">79,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of noncash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of tranche rights liability to equity upon increase in authorized shares</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vtl:ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" format="ixt:fixed-zero" scale="3" id="f-287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="vtl:ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" format="ixt:num-dot-decimal" scale="3" id="f-288">28,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:27.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">IMMUNIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_31"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="f-289" continuedAt="f-289-1" escape="true">Description of Business and Basis of Financial Statements</ix:nonNumeric></span></div><ix:continuation id="f-289-1" continuedAt="f-289-2"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Immunic, Inc. ("Immunic" or the "Company") is a biotechnology company developing a clinical pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The Company is headquartered in New York City with its main operations in Gr&#228;felfing near Munich, Germany. The Company had approximately <ix:nonFraction unitRef="employee" contextRef="c-70" decimals="-1" name="dei:EntityNumberOfEmployees" scale="0" id="f-290">90</ix:nonFraction> employees as of July 31, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is pursuing clinical development of orally administered, small molecule programs, each of which has unique features intended to directly address the unmet needs of patients with serious chronic inflammatory and autoimmune diseases. These include the vidofludimus calcium (IMU-838) program, which is in Phase 3 clinical development for patients with relapsing multiple sclerosis (&#8220;RMS&#8221;), and which has shown therapeutic activity in Phase 2 clinical trials in patients suffering from relapsing-remitting MS ("RRMS"), progressive MS (&#8220;PMS&#8221;) and moderate-to-severe ulcerative colitis (&#8220;UC&#8221;); the IMU-856 program, which is targeted to regenerate bowel epithelium and restore intestinal barrier function, which could potentially be applicable in numerous gastrointestinal diseases, such as celiac disease, inflammatory bowel disease ("IBD"), Graft-versus-Host-Disease ("GvHD") and possibly weight management; and the IMU-381 program, which is a next generation molecule being developed to specifically address the needs of gastrointestinal diseases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business, operating results, financial condition and growth prospects are subject to significant risks and uncertainties, including the failure of its clinical trials to meet their endpoints, failure to obtain regulatory approval and needing additional funding to continue and potentially complete the development and commercialization of the Company's <ix:nonFraction unitRef="program" contextRef="c-3" decimals="INF" name="vtl:NumberOfDevelopmentPrograms" format="ixt-sec:numwordsen" scale="0" id="f-291">three</ix:nonFraction> development programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Condition, Liquidity and Going Concern</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Immunic has no products approved for commercial sale and has not generated any revenue from product sales. It has never been profitable and has incurred operating losses in each year since inception in 2016.  The Company has an accumulated deficit of approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-292">563.7</ix:nonFraction>&#160;million as of June 30, 2025 and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-293">511.4</ix:nonFraction> million as of December 31, 2024.  Substantially all of Immunic's operating losses resulted from expenses incurred in connection with its research and development programs and from general and administrative costs associated with its operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Immunic expects to incur significant expenses and increasing operating losses for the foreseeable future as it initiates and continues the development of its product candidates and adds personnel necessary to advance its pipeline of product candidates. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Immunic expects that its operating losses will fluctuate significantly from quarter-to-quarter and year-to-year due to timing of development programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From inception through June 30, 2025, Immunic has raised net cash of approximately $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="6" id="f-294">496.3</ix:nonFraction> million from private and public offerings of preferred stock, common stock, pre-funded warrants and tranche rights. As of June 30, 2025, the Company had cash and cash equivalents of approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-295">55.3</ix:nonFraction> million. With these funds, the Company does not have adequate liquidity to fund its operations for at least twelve months from the issuance of these condensed consolidated financial statements included in this quarterly report without raising additional capital and such actions are not solely within the control of the Company. If the Company is unable to obtain additional capital, it would have a material adverse effect on the operations of the Company, its clinical development program, and the Company may have to cease operations altogether. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-296" continuedAt="f-296-1" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in conformity with United States generally accepted accounting principles ("U.S. GAAP") and include the accounts of Immunic and its wholly-owned subsidiaries, Immunic AG and Immunic Australia Pty Ltd.  All intercompany accounts and transactions have been eliminated in consolidation. Immunic manages its operations as a single reportable segment for the purposes of assessing performance and making operating decisions.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:24.75pt"><span><br/></span></div><ix:continuation id="f-296-1"><ix:continuation id="f-289-2"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Immunic has prepared the accompanying interim unaudited condensed consolidated financial statements in accordance with United States generally accepted accounting principles, (&#8220;US GAAP&#8221;), for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals which, in the opinion of management, are necessary to present fairly Immunic&#8217;s consolidated financial position, consolidated results of operations, consolidated statement of stockholders&#8217; equity (deficit) and consolidated cash flows for the periods and as of the dates presented. The Company&#8217;s fiscal year ends on December 31. The condensed consolidated balance sheet as of December 31, 2024 was derived from audited consolidated financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto included on the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the"SEC") on March 31, 2025. The nature of Immunic&#8217;s business is such that the results of any interim period may not be indicative of the results to be expected for the entire year or for corresponding interim periods in an any subsequent year.</span></div></ix:continuation></ix:continuation><div id="i3f98a63a9d28482ab81ca8a270389f57_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-297" continuedAt="f-297-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-297-1" continuedAt="f-297-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-298" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements. The most significant estimates in the Company&#8217;s financial statements and accompanying notes relate to stock-based compensation and the valuation of the tranche rights. Management believes its estimates to be reasonable under the circumstances. Actual results could differ materially from those estimates and assumptions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-299" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is United States (&#8220;U.S.&#8221;) dollars. Immunic AG is located in Germany with the Euro being its functional currency. Immunic Australia Pty Ltd.&#8217;s functional currency is the Australian dollar. All amounts in the financial statements where the functional currency is not the U.S. dollar are translated into U.S. dollar equivalents at exchange rates as follows:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; assets and liabilities at reporting period-end rates;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; income statement accounts at average exchange rates for the reporting period; and</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; components of equity at historical rates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from translation of the financial statements into U.S. dollars are recorded in stockholders&#8217; equity (deficit) as a component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses resulting from foreign currency transactions denominated in currencies other than the functional currency are reflected as general and administrative expenses in the Consolidated Statements of Operations. Foreign currency transaction gains and losses related to long-term intercompany loans that are payable in the foreseeable future are recorded in Other Income (Expense). The Consolidated Statements of Cash Flows were prepared by using the average exchange rate in effect during the reporting period which reasonably approximates the timing of the cash flows.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-300" continuedAt="f-300-1" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash on hand and deposits in banks located in the U.S. of approximately $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-301">47.9</ix:nonFraction>&#160;million, Germany of approximately $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-302">7.3</ix:nonFraction>&#160;million and Australia of approximately $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-303">0.1</ix:nonFraction>&#160;million as of June 30, 2025. The Company maintains cash and cash equivalent balances denominated in Euro and U.S. dollars with major financial institutions in the U.S. and Germany in excess of the deposit limits insured by the government. Management periodically reviews the credit </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-297-2" continuedAt="f-297-3"><ix:continuation id="f-300-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">standing of these financial institutions. The Company currently deposits its cash and cash equivalents with <ix:nonFraction unitRef="financialinstitution" contextRef="c-3" decimals="INF" name="vtl:NumberOfFinancialInstitutionsUsedForCashDeposits" format="ixt-sec:numwordsen" scale="0" id="f-304">two</ix:nonFraction> large financial institutions. Cash and cash equivalents in the U.S. are held at JP Morgan and are primarily held in a U.S. Government money market fund account earning interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-75" decimals="3" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-305">4.1</ix:nonFraction>% during the period ended June 30, 2025. Cash and cash equivalents in Germany are earning interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-76" decimals="3" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-306">1.6</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-77" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-307">3.25</ix:nonFraction>% during the period ended June 30, 2025.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-308" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Quoted prices in active markets for identical assets or liabilities. Level 1 assets consisted of money market funds for the periods presented. The Company had no Level 1 liabilities for the periods presented.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs other than observable quoted prices for the asset or liability, either directly or indirectly; these include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. The Company had no Level 2 assets or liabilities for the periods presented.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The Company had no Level 3 assets or liabilities for the periods presented.  The Company did have tranche rights that were at level 3 during the first quarter of 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximates fair value due to the short period of time to maturity.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-309" continuedAt="f-309-1" escape="true"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-309-1">Property and equipment is stated at cost. Depreciation is computed using the straight-line method based on the estimated service lives of the assets, which range from <span style="-sec-ix-hidden:f-310">three</span> to <ix:nonNumeric contextRef="c-79" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-311">thirteen years</ix:nonNumeric>.</ix:continuation> Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-312">43,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-313">31,000</ix:nonFraction> for the three months ended June 30, 2025 and 2024, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-314">86,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-315">57,000</ix:nonFraction> for the six months ended June 30, 2025 and 2024, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-316" continuedAt="f-316-1" escape="true"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-316-1">The Company records impairment losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets&#8217; carrying amount. Impaired assets are then recorded at their estimated fair value.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="INF" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt-sec:numwordsen" scale="0" id="f-317"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt-sec:numwordsen" scale="0" id="f-318">no</ix:nonFraction></ix:nonFraction> impairment losses during the six months ended June 30, 2025 and 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-319" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These costs primarily include external development expenses and internal personnel expenses for its development programs, vidofludimus calcium and IMU-856. Immunic has spent the majority of its research and development resources on vidofludimus calcium, the Company's lead development program, for clinical trials in MS and UC.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist of expenses incurred in research and development activities, which include clinical trials, contract research services, certain milestone payments, salaries and related employee benefits, allocated facility costs and other outsourced services. Research and development expenses are charged to operations as incurred.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into agreements with contract research organizations (&#8220;CROs&#8221;) to provide clinical trial services for individual studies and projects by executing individual work orders governed by a Master Service Arrangement (&#8220;MSA&#8221;). The MSAs and associated work orders provide for regular recurrent payments and payments upon the completion of certain milestones. The Company regularly assesses the timing of payments against actual costs incurred to ensure a proper accrual of related expenses in the appropriate accounting period.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:18pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-297-3" continuedAt="f-297-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementAccountingPolicy" id="f-320" escape="true"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain collaboration and license agreements may include payments to or from the Company of one or more of the following: non-refundable or partially refundable upfront or license fees; development, regulatory and commercial milestone payments; payment for manufacturing supply services; partial or complete reimbursement of research and development costs; and royalties on net sales of licensed products. The Company assesses whether such contracts are within the scope of Financial Accounting Standards Board (FASB) Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and ASU No. 2018-18, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2018-18"). ASU 2018-18, clarifies that certain elements of collaborative arrangements could qualify as transactions with customers in the scope of ASC 606.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Daiichi Sankyo Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company entered into an option and license agreement (the "Daiichi Sankyo Agreement") with Daiichi Sankyo Co., Ltd. ("Daiichi Sankyo") which granted the Company the right to license a group of compounds, designated by the Company as IMU-856, as a potential new oral treatment option for gastrointestinal diseases such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea and other barrier function associated diseases. During the option period, the Company performed agreed upon research and development activities for which it was reimbursed by Daiichi Sankyo up to a maximum agreed-upon limit. Such reimbursement was recorded as other income. There are no additional research and development reimbursements expected under this agreement.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#8217;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%">Ludwig-Maximilians-University Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:GovernmentAssistancePolicyTextBlock" id="f-321" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Government assistance</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Government assistance relating to research and development performed by Immunic Australia is recorded as a component of other (income) expense. This government assistance is recognized at a rate of <ix:nonFraction unitRef="number" contextRef="c-80" decimals="3" name="vtl:GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" scale="-2" id="f-322">43.5</ix:nonFraction>% of the qualified research and development expenditures which are incurred. We also receive government assistance from the German Government  for reimbursement of research and development expenses up to <ix:nonFraction unitRef="eur" contextRef="c-73" decimals="-5" name="vtl:GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" format="ixt:num-dot-decimal" scale="6" id="f-323">3.5</ix:nonFraction>&#160;million Euros per year.  We had recognized <span style="-sec-ix-hidden:f-324">expense</span> of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GovernmentAssistanceExpense" format="ixt:num-dot-decimal" scale="0" id="f-325">7,000</ix:nonFraction> and income of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GovernmentAssistanceAmount" format="ixt:num-dot-decimal" scale="0" id="f-326">3,000</ix:nonFraction> for the three months ended June 30, 2025 and 2024, respectively and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GovernmentAssistanceAmount" format="ixt:num-dot-decimal" scale="6" id="f-327">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GovernmentAssistanceAmount" format="ixt:num-dot-decimal" scale="0" id="f-328">39,000</ix:nonFraction> of <span style="-sec-ix-hidden:f-329"><span style="-sec-ix-hidden:f-330"><span style="-sec-ix-hidden:f-331">other income</span></span></span> related to research activities performed during the six months ended June 30, 2025 and 2024, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="f-332" escape="true"><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and related costs for personnel in executive, finance, business development and other support functions. Other general and administrative expenses include, but are not limited to, stock-based compensation, insurance costs, professional fees for legal, accounting and tax services, consulting, related facility costs and travel.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-333" continuedAt="f-333-1" escape="true"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the cost of employee and non-employee services received in exchange for equity awards based on the grant-date fair value of the award recognized generally as an expense (i) on a straight-line basis over the requisite service period for those awards whose vesting is based upon a service condition, and (ii) on an accelerated method for awards whose </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-297-4" continuedAt="f-297-5"><ix:continuation id="f-333-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">vesting is based upon a performance condition, but only to the extent it is probable that the performance condition will be met. Stock-based compensation is (i) estimated at the date of grant based on the award&#8217;s fair value for equity classified awards and (ii) based on the final measurement date for liability classified awards. Forfeitures are recorded in the period in which they occur.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock options using the Black-Scholes-Merton option-pricing model ("BSM"), which requires the use of estimates and subjective assumptions, including the risk-free interest rate, the expected dividend yield of the Company&#8217;s common stock, the expected volatility of the price of the Company&#8217;s common stock, and the expected term of the option. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. If factors change and different assumptions are used, the Company&#8217;s stock-based compensation expense could be materially different in the future.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-334" continuedAt="f-334-1" escape="true"><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases office space and office equipment. The underlying lease agreements have lease terms of less than <ix:nonNumeric contextRef="c-78" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="f-335">12</ix:nonNumeric> months and up to <ix:nonNumeric contextRef="c-79" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="f-336">60</ix:nonNumeric> months. Leases with terms of 12 months or less at inception are not included in the operating lease right of use asset and operating lease liability.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-334-1">The Company has <ix:nonFraction unitRef="lease" contextRef="c-3" decimals="INF" name="vtl:LesseeOperatingLeasesNumberOfExistingLeases" format="ixt-sec:numwordsen" id="f-337">three</ix:nonFraction> existing leases for office and laboratory space. At inception of a lease agreement, the Company determines whether an agreement represents a lease and at commencement each lease agreement is assessed as to classification as an operating or financing lease. The Company's leases have been classified as operating leases and an operating lease right-of-use asset and an operating lease liability have been recorded on the Company&#8217;s consolidated balance sheet. A right-of-use lease asset represents the Company&#8217;s right to use the underlying asset for the lease term and the lease obligation represents its commitment to make the lease payments arising from the lease. Right-of-use lease assets and obligations are recognized at the commencement date based on the present value of remaining lease payments over the lease term. As the Company&#8217;s leases do not provide an implicit rate, the Company has used an estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The right-of-use lease asset includes any lease payments made prior to commencement and excludes any lease incentives. The lease term used in estimating future lease payments may include options to extend when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or changes in expectations regarding the lease term. Variable lease costs such as common area costs and property taxes are expensed as incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-338" escape="true"><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Accumulated other comprehensive income (loss) has been reflected as a separate component of stockholders&#8217; equity in the accompanying Consolidated Balance Sheets and consists of foreign currency translation adjustments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-339" continuedAt="f-339-1" escape="true"><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to corporate income tax laws and regulations in the U.S., Germany and Australia. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment in their application.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes the asset and liability method of accounting for income taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the audited consolidated financial statements. Deferred income tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. Deferred taxes are reduced by a valuation allowance when, in the opinion of management, it is more likely than not some portion or the entire deferred tax asset will not be realized.  As of June 30, 2025 and December 31, 2024, respectively, the Company maintained a full valuation allowance against the balance of deferred tax assets.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-297-5" continuedAt="f-297-6"><ix:continuation id="f-339-1"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">It is the Company&#8217;s policy to provide for uncertain tax positions and the related interest and penalties based upon management&#8217;s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense.  The Company is subject to U.S. federal, New York, California, Texas, German and Australian income taxes. The Company is subject to U.S. federal or state income tax examination by tax authorities for tax returns filed for the years 2003 and forward due to the carryforward of NOLs. Tax years 2019 through 2023 are subject to audit by German and Australian tax authorities. The Company is not currently under examination by any tax jurisdictions.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityPolicyTextBlock" id="f-340" continuedAt="f-340-1" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants and Tranche Rights</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-340-1">The Company accounts for issued financial instruments either as a liability or equity in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (&#8220;ASC 480-10&#8221;) or ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock (&#8220;ASC 815-40&#8221;). If financial instruments do not meet liability classification under ASC 480-10, the Company considers the requirements of ASC 815-40 to determine whether the financial instruments should be classified as a liability or as equity. Liability-classified financial instruments are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the financial instruments after the issuance date is recorded in the Consolidated Statements of Operations as a gain or loss. If financial instruments do not require liability classification under ASC 815-40, the instrument is classified in permanent equity. Equity-classified financial instruments are accounted for based on allocated proceeds on the issuance date with no subsequent measurement after the issuance date.</ix:continuation>   </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-341" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of common shares and, if dilutive, common stock equivalents outstanding for the period determined using the treasury-stock method. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#8217;s net loss position. The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2025 includes <ix:nonFraction unitRef="shares" contextRef="c-81" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-342">8,580,507</ix:nonFraction> pre-funded warrants from the January 2024 Financing and <ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-343">86,666,667</ix:nonFraction> pre-funded warrants from the May 2025 Offering that remain unexercised as of June 30, 2025.  The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2024 includes <ix:nonFraction unitRef="shares" contextRef="c-83" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-344">11,193,564</ix:nonFraction> per-funded warrants from the January 2024 Financing that were unexercised as of June 30, 2024.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-345" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities, which are not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive, are as follows:</span></div><div style="margin-top:12pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:73.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-84" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-346">25,853,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-85" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-347">10,819,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Placement agent warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-86" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-348">283,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-87" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-350">26,136,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-351">10,819,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-352" continuedAt="f-352-1" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued and/or Adopted Accounting Standards</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The new guidance is expected to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information by requiring 1) consistent categories and greater disaggregation of information in the rate reconciliation and 2) income taxes paid disaggregated by jurisdiction. The guidance is effective on a prospective basis, although retrospective application and early adoption is permitted. The standard was adopted by the Company for the annual period starting January 1, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 2024, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures to improve the disclosures about a public entity&#8217;s expenses and provide more detailed information about the types of expenses in commonly presented expense captions such as inventory purchases, employee compensation, depreciation and intangible asset </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-352-1"><ix:continuation id="f-297-6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">amortization. The disclosure requirements must be applied retrospectively to all prior periods presented in the financial statements. The effective date for the standard is for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i3f98a63a9d28482ab81ca8a270389f57_37"></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-353" continuedAt="f-353-1" escape="true">Balance Sheet Details</ix:nonNumeric></span></div><ix:continuation id="f-353-1"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets and Prepaid Expenses</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="f-354" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Assets and Prepaid Expenses consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:74.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.255%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid clinical and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="vtl:PrepaidClinicalAndRelatedCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-355">2,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="vtl:PrepaidClinicalAndRelatedCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-356">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="3" id="f-357">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="3" id="f-358">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-359">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-360">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="f-361">861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="f-362">948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-363">4,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-364">3,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Payable</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-365" continuedAt="f-365-1" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounts Payable consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.474%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="vtl:ClinicalCostsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-366">7,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="vtl:ClinicalCostsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-367">7,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Legal and audit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="vtl:LegalAndAuditCostsPayableCurrent" scale="3" id="f-368">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="vtl:LegalAndAuditCostsPayableCurrent" scale="3" id="f-369">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableOtherCurrent" scale="3" id="f-370">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableOtherCurrent" scale="3" id="f-371">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-372">7,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-373">7,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses</span></div><ix:continuation id="f-365-1"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="vtl:AccruedClinicalCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-374">16,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="vtl:AccruedClinicalCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-375">12,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued legal and audit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="vtl:AccruedLegalAndAuditCostsCurrent" scale="3" id="f-376">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="vtl:AccruedLegalAndAuditCostsCurrent" scale="3" id="f-377">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="vtl:AccruedCompensationCurrent" format="ixt:num-dot-decimal" scale="3" id="f-378">1,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="vtl:AccruedCompensationCurrent" scale="3" id="f-379">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-380">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-381">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-382">18,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-383">12,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="f-384" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Liabilities consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.740%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-385"><span style="-sec-ix-hidden:f-386">Lease liabilities</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-387">774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-388">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="f-389">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="f-390">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-391">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-392">1,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_40"></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-393" continuedAt="f-393-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-393-1"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space under non-cancelable operating leases. The leases terminate on July 31, 2026 for the New York City office, December 31, 2025 for the Gr&#228;felfing, Germany office and November 30, 2028 for the research laboratory in Planegg, Germany.  These agreements include both lease (e.g., fixed rent) and non-lease components (e.g., common-area and other maintenance costs). The non-lease components are deemed to be executory costs and are therefore excluded from the minimum lease payments used to determine the present value of the operating lease obligation and related right-of-use asset. The New York City lease was extended on November 8, 2024 for an additional <ix:nonNumeric contextRef="c-88" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durmonth" id="f-394">12</ix:nonNumeric> months resulting in the new lease termination date of July 31, 2026. The New York City lease has a renewal option, but this was not included in calculating the right of use asset and liabilities. On April 7, 2020, the Company signed a <ix:nonNumeric contextRef="c-89" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-395">five year</ix:nonNumeric> lease for its facility in Gr&#228;felfing, Germany. On March 1, 2021 and August 1, 2022 the Company added additional lease space at the Gr&#228;felfing, Germany office. The lease term has expired, however, the Company is currently operating on a one-year monthly rolling lease and the Company needs to provide one-years notice to terminate the lease. Renewal options were not included in calculating the right of use asset and liabilities for this facility. In February 2023, the Company leased space in Germany for a research laboratory. The leases do not have concessions, leasehold improvement incentives or other build-out clauses. Further, the leases do not contain contingent rent provisions. There were net additions of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="vtl:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-396"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="vtl:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-397">448,000</ix:nonFraction></ix:nonFraction> related to the extension of the New York City lease and Gr&#228;felfing offices during the year ended December 31, 2024.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The leases do not provide an implicit rate and, due to the lack of a commercially salable product, the Company is generally considered unable to obtain commercial credit. Therefore, the Company estimated its incremental interest rate to be <ix:nonFraction unitRef="number" contextRef="c-88" decimals="2" name="vtl:OperatingLeaseIncrementalBorrowingRate" scale="-2" id="f-398">6</ix:nonFraction>% for the original leases and <ix:nonFraction unitRef="number" contextRef="c-92" decimals="2" name="vtl:OperatingLeaseIncrementalBorrowingRate" scale="-2" id="f-399">8</ix:nonFraction>% for the New York City extension and German laboratory, considering the quoted rates for the lowest investment-grade debt. Immunic used its estimated incremental borrowing rate and other information available at the lease commencement date in determining the present value of the lease payments.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Immunic&#8217;s operating lease costs and variable lease costs were $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="vtl:OperatingAndVariableLeasesCost" format="ixt:num-dot-decimal" scale="0" id="f-400">312,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="vtl:OperatingAndVariableLeasesCost" format="ixt:num-dot-decimal" scale="0" id="f-401">270,000</ix:nonFraction> for the three months ended June 30, 2025 and 2024, respectively and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vtl:OperatingAndVariableLeasesCost" format="ixt:num-dot-decimal" scale="0" id="f-402">591,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="vtl:OperatingAndVariableLeasesCost" format="ixt:num-dot-decimal" scale="0" id="f-403">527,000</ix:nonFraction> for the six months ended June 30, 2025 and 2024, respectively. Variable lease costs consist primarily of common area maintenance costs, insurance and taxes which are paid based upon actual costs incurred by the lessor.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-404" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the operating lease obligation are as follows as of June 30, 2025 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:85.106%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.945%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="f-405">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-406">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-407">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-408">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-409">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-410">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Present value of obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="f-411">979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-412" continuedAt="f-412-1" escape="true">Fair Value</ix:nonNumeric></span></div><ix:continuation id="f-412-1" continuedAt="f-412-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-413" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following fair value hierarchy tables present information about each major category of the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:50.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.240%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement at June 30, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-414">47,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-415">47,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-418">47,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-419">47,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:50.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.240%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement at Fair&#160;Value&#160;Measurement&#160;at&#160;December&#160;31,&#160;2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-422">14,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-423">14,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-425">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-426">14,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-427">14,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level&#160;1, Level&#160;2 or Level&#160;3 assets during the periods presented.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s money market funds which are included as a component of cash and cash equivalents on the Consolidated Balance Sheet, realized gains and losses are included in interest income on the Consolidated Statements of Operations. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our money market fund account is held in our bank in the U.S. and was earning interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-72" decimals="3" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-430">4.1</ix:nonFraction>% in a U.S. Government money market fund.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has cash balances in banks in excess of the maximum amount insured by the FDIC and other international agencies as of June 30, 2025. The Company has not historically experienced any credit losses with balances in excess of FDIC limits.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded tranche rights of $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="vtl:TrancheRightFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-431">23.6</ix:nonFraction>&#160;million at January 8, 2024 as a result of the January 2024 Financing (see note 6).  The fair value measurement of the tranche rights associated with the January 2024 Financing was classified as Level 3 under the fair value hierarchy.  The fair value of the tranche rights was determined using a Black Scholes Option Pricing Model. The inputs to this model included a risk-free rate range of <ix:nonFraction unitRef="number" contextRef="c-110" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-432">3.93</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-111" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-433">4.36</ix:nonFraction>%, a stock price volatility range of <ix:nonFraction unitRef="number" contextRef="c-110" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-434">105</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="c-111" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-435">115</ix:nonFraction>%, an expected dividend rate of <ix:nonFraction unitRef="number" contextRef="c-112" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-436">0</ix:nonFraction>% and remaining term of <ix:nonNumeric contextRef="c-110" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-437">1.81</ix:nonNumeric>-<ix:nonNumeric contextRef="c-111" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-438">4.81</ix:nonNumeric> years.  This liability was revalued on March 4, 2024, upon stockholder approval to increase its authorized shares of common stock from <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-439">130</ix:nonFraction>&#160;million to <ix:nonFraction unitRef="shares" contextRef="c-113" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-440">500</ix:nonFraction>&#160;million, which resulted in the reclassification of the tranche rights from a liability to equity.  This revaluation resulted in an increase in the tranche rights liability of $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="vtl:FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" format="ixt:num-dot-decimal" scale="6" id="f-441">4.8</ix:nonFraction>&#160;million using a Black Scholes Option Pricing Model. The inputs to this model as of the date of the reclassification included a risk-free rate range of <ix:nonFraction unitRef="number" contextRef="c-114" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-442">4.16</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-115" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-443">4.63</ix:nonFraction>%, a stock price volatility range of <ix:nonFraction unitRef="number" contextRef="c-114" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" format="ixt:num-dot-decimal" scale="-2" id="f-444">90</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-115" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-445">105</ix:nonFraction>%, an expected dividend rate of <ix:nonFraction unitRef="number" contextRef="c-116" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-446">0</ix:nonFraction>% and remaining term of <ix:nonNumeric contextRef="c-114" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-447">1.66</ix:nonNumeric>-<ix:nonNumeric contextRef="c-115" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-448">4.66</ix:nonNumeric> years. The inputs used in the determination of fair value of the liability are level 3 inputs. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-449" continuedAt="f-449-1" escape="true">A rollforward of the fair value of the tranche rights is as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-449-1"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"/><td style="width:66.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="0" id="f-450">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-117" name="vtl:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" id="f-451">Fair value as of January 8, 2024</ix:nonNumeric></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="0" id="f-452">23,600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value through March 4, 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-453">4,796</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to equity in March 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="0" sign="-" name="vtl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" format="ixt:num-dot-decimal" scale="0" id="f-454">28,396</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="0" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-412-2">The carrying amounts of other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximate their fair values due to their short-term nature. The fair value and book value of the money market funds presented in the table above are the same.</ix:continuation>  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-456" continuedAt="f-456-1" escape="true">Common Stock</ix:nonNumeric></span></div><ix:continuation id="f-456-1" continuedAt="f-456-2"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shelf Registration Statements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In December 2020, the Company filed a Prospectus Supplement to the shelf registration statement on Form S-3 filed on November 13, 2020 and declared effective on November 24, 2020 (the "2020 Shelf Registration Statement") for the offering, issuance and sale of up to a maximum aggregate offering price of $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="6" id="f-457">50.0</ix:nonFraction>&#160;million of common stock that may be issued and sold under an at-the-market sales agreement with SVB Leerink LLC (now Leerink Partners LLC) as agent ("December 2020 ATM"). The Company used the net proceeds from the December 2020 ATM to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The December 2020 ATM terminated in May 2024.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a Prospectus Supplement to the 2020 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="6" id="f-458">80.0</ix:nonFraction>&#160;million of common stock to be issued and sold under another at-the-market sales agreement ("May 2022 ATM") with Leerink Partners LLC (formerly SVB Leerink LLC) as agent. The 2020 Shelf Registration Statement expired in November 2023. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the Company filed a shelf registration statement on Form S-3 (the "2023 Shelf Registration Statement").  The 2023 Shelf Registration Statement permits the offering, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="6" id="f-459">250.0</ix:nonFraction>&#160;million of common stock, preferred stock, warrants, debt securities, and/or units in one or more offerings and in any combination of the foregoing. This registration statement was declared effective on May 31, 2024.  Unsold securities from the expired 2020 Shelf Registration Statement can continue to be sold under the 2023 Shelf Registration Statement.  As a result of the April 2025 Offering and May 2025 Offering, the amount available under the 2023 Shelf Registration Statement was reduced by $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="vtl:UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" format="ixt:num-dot-decimal" scale="6" id="f-460">70.1</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="vtl:UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" format="ixt:num-dot-decimal" scale="6" id="f-461">342.2</ix:nonFraction>&#160;million as of June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2024, we filed a Prospectus Supplement to the 2023 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="6" id="f-462">80.0</ix:nonFraction>&#160;million of common stock that may be issued and sold under an at-the-market sales agreement with Leerink Partners LLC as agent ("May 2024 ATM"), which rolls over the $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="6" id="f-463">80.0</ix:nonFraction>&#160;million of unsold common stock from the May 2022 ATM. We intend to use the net proceeds from the May 2024 ATM to continue to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The May 2024 ATM will terminate upon the earlier of (i) the issuance and sale of all of the shares through Leerink Partners LLC on the terms and subject to the conditions set forth in the May 2024 ATM or (ii) termination of the May 2024 ATM as otherwise permitted thereby. The May 2024 ATM may be terminated at any time by either party upon <ix:nonFraction unitRef="d" contextRef="c-124" decimals="INF" name="vtl:ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" format="ixt-sec:numwordsen" id="f-464">ten</ix:nonFraction> days&#8217; prior notice, or by Leerink Partners LLC at any time in certain circumstances, including the occurrence of a material adverse effect on us.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="vtl:SaleOfStockRemainingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-465">80.0</ix:nonFraction>&#160;million in capacity remains under the May 2024 ATM.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The Company has agreed to pay Leerink Partners LLC a commission equal to <ix:nonFraction unitRef="number" contextRef="c-125" decimals="3" name="vtl:SalesOfStockCommissionsPercentOfGrossProceeds" scale="-2" id="f-466">3.0</ix:nonFraction>% of the gross proceeds from the sales of common stock pursuant to the May 2024 ATM and has agreed to provide Leerink Partners LLC with customary indemnification and contribution rights.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any ATM activity during the three or six months ended June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June 30, 2024, we raised gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-467"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-468">0.2</ix:nonFraction></ix:nonFraction>&#160;million pursuant to the December 2020 ATM through the sale of <ix:nonFraction unitRef="shares" contextRef="c-127" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-469"><ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-470">150,000</ix:nonFraction></ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-471">1.31</ix:nonFraction> per share. The net proceeds from the December 2020 ATM were $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-472">0.2</ix:nonFraction>&#160;million after deducting sales agent commissions of $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:PaymentsForCommissions" format="ixt:num-dot-decimal" scale="0" id="f-473">6,000</ix:nonFraction>. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">April 2025 Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2025, Immunic entered into a securities purchase agreement with certain institutional and accredited investors relating to the issuance and sale of an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-129" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-474">5,666,667</ix:nonFraction> shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-130" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-475">0.0001</ix:nonFraction> per share. The purchase price per share was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-130" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-476">0.90</ix:nonFraction> for aggregate gross proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-477">5.1</ix:nonFraction>&#160;million. The offer and sale of the shares is referred to herein as the &#8220;April 2025 Offering.&#8221; The April 2025 Offering closed on April 10, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on April 9, 2025, the Company entered into a placement agency agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (the &#8220;Placement Agent&#8221;), relating to the April 2025 Offering. Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of <ix:nonFraction unitRef="number" contextRef="c-131" decimals="3" name="vtl:PlacementAgentAgreementBrokerageFeePercent" scale="-2" id="f-478">6.0</ix:nonFraction>% of the gross proceeds from the April 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-456-2" continuedAt="f-456-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">therewith. Additionally, upon the closing of the April 2025 Offering, the Company agreed to issue to the Placement Agent, or its designees, warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-132" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-479">283,334</ix:nonFraction> shares of common stock, representing <ix:nonFraction unitRef="number" contextRef="c-131" decimals="3" name="us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction" scale="-2" id="f-480">5.0</ix:nonFraction>% of the shares sold in the April 2025 Offering (the &#8220;Placement Agent Warrants&#8221;). The Placement Agent Warrants will be exercisable, in whole or in part, commencing 180 days from the date of the Placement Agency Agreement and expiring on the five year anniversary of the Placement Agency Agreement, at an initial exercise price per share of common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-132" decimals="3" name="us-gaap:SharePrice" scale="0" id="f-481">1.125</ix:nonFraction>, which is equal to <ix:nonFraction unitRef="number" contextRef="c-131" decimals="2" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="f-482">125</ix:nonFraction>% of the price per share to investors in the April 2025 Offering. The Placement Agent Warrants and the shares of common stock underlying the Placement Agent Warrants were offered pursuant to the exemptions from registration provided in Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds to the Company from the April 2025 Offering, after deducting commissions and the Company&#8217;s offering expenses, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="vtl:ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-483">4.7</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The April 2025 Shares were registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on the Company&#8217;s Registration Statement on Form S-3 (Registration No. 333-275717), previously filed with the SEC, and declared effective on May 31, 2024.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">May 2025 Equity Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2025, Immunic entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Leerink Partners LLC, issuance and sale of (i) pre-funded warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-134" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-484">86,666,667</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-134" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-485">0.0001</ix:nonFraction> (&#8220;Common Stock&#8221;) of the Company (the &#8220;Pre-Funded Warrants&#8221;), (ii) accompanying series A warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-135" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-486">86,666,667</ix:nonFraction> shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#8220;Series A Warrants&#8221;), and (iii) accompanying series B warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-136" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-487">86,666,667</ix:nonFraction> shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#8220;Series B Warrants&#8221;) (the &#8220;May 2025 Offering&#8221;). The price per Pre-Funded Warrant and accompanying Series A Warrant and Series B Warrant was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-488">0.7499</ix:nonFraction>. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-134" decimals="4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-489">0.0001</ix:nonFraction> per share and will expire when exercised in full. Each Series A Warrant is immediately exercisable for one share of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-490">0.75</ix:nonFraction> per share and will expire on December 31, 2025. Each Series B Warrant is exercisable on the earlier of (i) October 1, 2025, (ii) the first day following any <span style="-sec-ix-hidden:f-491">five</span> trading days during which the volume weighted average price for the Common Stock of the Company during such <span style="-sec-ix-hidden:f-492">five</span> trading day period is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-493">1.25</ix:nonFraction> or greater (the &#8220;VWAP Target&#8221;), or (iii) immediately prior to the consummation of a Fundamental Transaction (as defined in the Series B Warrants) for one share of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-494">0.75</ix:nonFraction> per share and will expire <ix:nonNumeric contextRef="c-136" name="vtl:ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" format="ixt-sec:durwordsen" id="f-495">five years</ix:nonNumeric> from the date of issuance. Each Series A Warrant and Series B Warrant will immediately expire in proportion to the extent that the corresponding Pre-Funded Warrant is exercised prior to September 30, 2025; provided that this term will not apply to the Series B Warrants immediately as of the date of achievement of the VWAP Target. The holder of the Pre-Funded Warrants and Series B Warrants may also satisfy its obligation to pay the exercise price through a &#8220;cashless exercise,&#8221; in which the holder receives the net value of such warrant in shares of Common Stock determined according to the formula set forth in the applicable warrant. Holders of Series A Warrants may, provided there is no effective registration statement or prospectus available which covers the warrants and shares of Common Stock issuable upon exercise of the Series A Warrants, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Series A Warrant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is prohibited from effecting an exercise of any Pre-Funded Warrants, Series A Warrants or Series B Warrants to the extent that such exercise would result in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding <ix:nonFraction unitRef="number" contextRef="c-139" decimals="4" name="vtl:OwnershipLimitationPercentage" scale="-2" id="f-496">4.99</ix:nonFraction>% (or <ix:nonFraction unitRef="number" contextRef="c-139" decimals="4" name="vtl:OwnershipLimitationPercentageUponElectionOfTheHolder" scale="-2" id="f-497">9.99</ix:nonFraction>% at election of the holder) of the total number of shares of Common Stock outstanding immediately after giving effect to the exercise (the &#8220;Beneficial Ownership Limitation&#8221;), which percentage may be increased or decreased at the holder&#8217;s election, not to exceed <ix:nonFraction unitRef="number" contextRef="c-140" decimals="4" name="vtl:OwnershipLimitationPercentage" scale="-2" id="f-498">19.99</ix:nonFraction>%. Any increase to the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. If a holder is not permitted to exercise a Series A Warrant or a Series B Warrant for Common Stock due to the Beneficial Ownership Limitation, then the holder may exercise such Series A Warrant or Series B Warrant for an equivalent number of Pre-Funded Warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The aggregate proceeds from the May 2025 Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-499">65</ix:nonFraction>&#160;million before deducting underwriting discounts and commissions and offering expenses payable by the Company in connection with the May 2025 Offering. The Company may receive up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-500">130</ix:nonFraction>&#160;million of additional gross proceeds if the Series A Warrants and Series B Warrants are exercised in full for cash.  Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of <ix:nonFraction unitRef="number" contextRef="c-141" decimals="3" name="vtl:PlacementAgentAgreementBrokerageFeePercent" scale="-2" id="f-501">6.0</ix:nonFraction>% of the gross proceeds from the May 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection therewith. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-456-3" continuedAt="f-456-4"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The May 2025 Offering was made pursuant to an effective registration statement on Form S-3 (Registration Statement No. 333-275717), as amended, previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on November 22, 2023, and declared effective by the SEC on May 31, 2024, as supplemented by the preliminary prospectus supplement, dated May 28, 2025, and a final prospectus supplement (the &#8220;Prospectus Supplement&#8221;) filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on May 30, 2025. The closing of the May 2025 Offering took place on  June 3, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement of up to $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="6" id="f-502">240</ix:nonFraction>&#160;million (the "January 2024 Financing")</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2024, Immunic entered into a Securities Purchase Agreement with select accredited investors, pursuant to which the Company agreed to issue and sell to the Investors in a <ix:nonFraction unitRef="tranche" contextRef="c-143" decimals="INF" name="vtl:SaleOfStockPrivatePlacementNumberOfTranche" format="ixt-sec:numwordsen" scale="0" id="f-503">three</ix:nonFraction>-tranche private placement shares of the Company&#8217;s common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-143" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-504">0.0001</ix:nonFraction> par value per share or in lieu thereof, pre-funded warrants to purchase shares of Common Stock. The Pre-Funded Warrants are exercisable immediately for $<ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-505">0.0001</ix:nonFraction> per share and until exercised in full.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first tranche, which closed on January 8, 2024, resulted in the purchase by the Investors of an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-506">80</ix:nonFraction>&#160;million of Common Stock (or pre-funded warrants) from the Company at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-146" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-507">1.43</ix:nonFraction> per share;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The second tranche is a conditional mandatory purchase by the Investors of an additional $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-508">80</ix:nonFraction>&#160;million of Common Stock (or pre-funded warrants) from the Company at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-148" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-509">1.716</ix:nonFraction> per share, equal to <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="vtl:SaleOfStockConsiderationReceivedPercentage" scale="-2" id="f-510">120</ix:nonFraction>% of the price paid in the first tranche and is subject to the satisfaction of <ix:nonFraction unitRef="tranche" contextRef="c-148" decimals="INF" name="vtl:SaleOfStockNumberOfTrancheConditions" format="ixt-sec:numwordsen" scale="0" id="f-511">three</ix:nonFraction> conditions:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">release by the Company of topline data from its Phase 2b clinical trial of vidofludimus calcium (IMU-838) in progressive multiple sclerosis, which data was announced on April 30, 2025;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the <ix:nonNumeric contextRef="c-147" name="vtl:ThresholdTradingDaysForWeightedAveragePriceCalculation" format="ixt-sec:durwordsen" id="f-512">10-day</ix:nonNumeric> volume-weighted average price of the Common Stock is at least $<ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" name="vtl:WeightedAveragePriceOfLast10Days" scale="0" id="f-513">8.00</ix:nonFraction> per share during the 6 months following the data release; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">aggregate trading volume during the same <ix:nonNumeric contextRef="c-147" name="vtl:ThresholdTradingDaysForAggregateTradingVolumeCalculation" format="ixt-sec:durwordsen" id="f-514">10-day</ix:nonNumeric> period is at least $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="vtl:SaleOfStockAggregateTradingVolumeOfLast10Days" format="ixt:num-dot-decimal" scale="6" id="f-515">100</ix:nonFraction>&#160;million.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The third tranche must occur no later than <ix:nonNumeric contextRef="c-149" name="vtl:SaleOfStockEquityOfferingsPeriod" format="ixt-sec:durwordsen" id="f-516">three years</ix:nonNumeric> after the second tranche and is conditioned on the same volume-weighted average share price and minimum trading volumes as the second tranche. The third tranche provides for the issuance of $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-517">80</ix:nonFraction>&#160;million of shares of common stock (or pre-funded warrants) at the same price per share as the second tranche, but permits investors to fund their purchase obligations on a &#8220;cashless&#8221; or net settlement basis, which would reduce the cash proceeds to be raised by the Company in the January 2024 Financing.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The volume-weighted average share price and minimum trading volume conditions of the second and third tranches have not</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">been satisfied as of June 30, 2025. Any of the conditions in the second or third tranches can be waived by holders of a majority of the outstanding securities (including the lead investor).  The fair value methodology used by the Company assumed the conditions will be waived if the trading price of the stock exceeds the purchase price.  Through June 30, 2025, the investors in</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the first tranche have not purchased any additional shares of common stock from the Company pursuant to the terms of the January 2024 Financing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The January 2024 Financing resulted in gross proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="6" id="f-518">80</ix:nonFraction>&#160;million in the first tranche, and an additional $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="6" id="f-519">80</ix:nonFraction>&#160;million if and when the second tranche occurs. If the second tranche is completed and conditions for the third tranche are satisfied or waived, the Company could receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="6" id="f-520">80</ix:nonFraction>&#160;million in the third tranche. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of the closing date of the transaction of January 8, 2024, the Company did not have enough authorized shares to be able to issue the potential shares for tranche 2 and tranche 3 (collectively referred to hereafter as "the tranche rights").  Therefore, the Company recorded the value associated to the tranche rights as a liability of $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="vtl:FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" format="ixt:num-dot-decimal" scale="6" id="f-521">23.6</ix:nonFraction>&#160;million and allocated the remainder of the $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="vtl:TrancheRightsLiabilityRemainderAmount" format="ixt:num-dot-decimal" scale="6" id="f-522">80</ix:nonFraction>&#160;million received (or $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="vtl:TrancheRightsLiabilityReceivedAmount" format="ixt:num-dot-decimal" scale="6" id="f-523">56.4</ix:nonFraction>&#160;million) with the common stock and pre-funded warrants to equity.  On March 4, 2024, the stockholders voted to increase the Company's authorized common stock from <ix:nonFraction unitRef="shares" contextRef="c-155" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-524">130</ix:nonFraction>&#160;million to <ix:nonFraction unitRef="shares" contextRef="c-156" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-525">500</ix:nonFraction>&#160;million shares.  As a result of the ability to issue shares in satisfaction of the tranche rights, the instrument was reclassified to stockholders' equity.  The Company allocated the transaction costs across the instruments on a relative fair value basis at the grant date. As a result $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-526">4.0</ix:nonFraction>&#160;million was netted against the equity proceeds and $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-527">1.7</ix:nonFraction>&#160;million was recorded in other expense in the Consolidated Statements of Operations for the six months ended June 30, 2024.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company registered for resale by the investors in the January 2024 Financing up to <ix:nonFraction unitRef="shares" contextRef="c-146" decimals="INF" name="vtl:CommonStockNumberOfSharesRegisteredForResale" format="ixt:num-dot-decimal" scale="0" id="f-528">55,944,850</ix:nonFraction> shares of common stock issued (or issuable upon exercise of pre-funded warrants) in the first tranche. The Company will not receive any proceeds from the sale of these shares of common stock. These shares are registered on a registration statement on Form S-3 (registration No. 333-277040).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-456-4" continuedAt="f-456-5"><div style="margin-top:12pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:12pt;padding-right:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2024, the stockholders of the Company voted to increase the authorized shares of the Company from <ix:nonFraction unitRef="shares" contextRef="c-159" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-529">130,000,000</ix:nonFraction> shares of common stock to <ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-530">500,000,000</ix:nonFraction> shares of common stock, par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-113" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-531">0.0001</ix:nonFraction> per share. The voting, dividend and liquidation rights of the holders of the Company&#8217;s common stock are subject to and qualified by the rights, powers and preferences of any holders of preferred stock.</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="c-3" decimals="INF" name="vtl:NumberOfVotesPerEachShareOfCommonStock" format="ixt-sec:numwordsen" scale="0" id="f-532">one</ix:nonFraction> vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Board of Directors, if any. Through June 30, 2025, <ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" format="ixt:fixed-zero" scale="0" id="f-533"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" format="ixt:fixed-zero" scale="0" id="f-534">no</ix:nonFraction></ix:nonFraction> cash dividends had been declared or paid.</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice of Non-Compliance with Nasdaq Listing Rule 5450(a)(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2025, Immunic, Inc. received a written notification (the &#8220;Notice Letter&#8221;) from The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that we were not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price for our common stock was below the $1.00 per share requirement for the last 30 consecutive business days. The Notice Letter stated that we have 180 calendar days, or until December 24, 2025 (the &#8220;Initial Compliance Period&#8221;), to regain compliance with the minimum bid price requirement. If we do not regain compliance by the end of the Initial Compliance Period, we may apply for an additional compliance period as provided for in the Notice Letter. Nasdaq&#8217;s determination of whether we qualify for an additional compliance period will depend on whether we will meet the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and a written notice of our intention to cure the deficiency during the additional compliance period by effecting a reverse stock split, if necessary.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Notice Letter has no immediate effect on the listing of our common stock on The Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we can regain compliance if the closing bid price of our common stock is at least $1.00 for a minimum of 10 consecutive business days. In the event that we do not regain compliance with Listing Rule 5450(a)(1) prior to the expiration of the Initial Compliance Period (or additional compliance period, if applicable), we will receive written notification that our securities are subject to delisting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to actively monitor the closing bid price of its common stock and is evaluating available options to regain compliance with the minimum bid price requirement. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or that the Company will otherwise remain in compliance with the other listing standards for the Nasdaq. If the Company&#8217;s common stock is delisted from Nasdaq, it could have a material adverse effect on the trading price and liquidity of the common stock.</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-funded Warrants</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued <ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-535">11,193,564</ix:nonFraction> pre-funded warrants in connection with the January 2024 Financing, <ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" format="ixt:num-dot-decimal" scale="0" id="f-536">2,613,057</ix:nonFraction> of which were exercised in the quarter ended June 30, 2025 and <ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-537">8,580,507</ix:nonFraction> of which remain outstanding as of June 30, 2025.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-538">20</ix:nonFraction> million shares of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-539">0.0001</ix:nonFraction> par value preferred stock, with such voting powers (if any), designations, powers, preferences, and relative, participating, optional or other rights, if any, and any qualifications, limitations or restrictions thereof, as shall be set by the Board of Directors. <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-540"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-541">No</ix:nonFraction></ix:nonFraction> preferred shares were issued or outstanding as of June 30, 2025.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-456-5"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Reserved for Future Issuance</span></div><ix:nonNumeric contextRef="c-1" name="vtl:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" id="f-542" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares reserved for future issuance at June 30, 2025 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock reserved for issuance for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2021 Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-543">708,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-funded stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-164" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-544">8,580,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Placement agent warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-165" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-545">283,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-546">25,853,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the second tranche of the January 2024 financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-167" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-547">46,620,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the second tranche of the January 2024 financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-167" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-548">46,620,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Pre-funded warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-168" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-549">86,666,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Series A warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-169" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-550">86,666,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the May 2025 Series B warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-170" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-551">86,666,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options available for future grant:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-552">46,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2019 Omnibus Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-172" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-553">596,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total common shares reserved for future issuance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-554">389,308,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_49"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-555" continuedAt="f-555-1" escape="true">Stock-Based Compensation Plans</ix:nonNumeric></span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-555-1" continuedAt="f-555-2"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On April 25, 2021, the Company adopted the 2021 Employee Stock Purchase Plan ("ESPP"), which was approved by stockholder vote at the 2021 Annual Meeting of Stockholders held on June 10, 2021. The ESPP provides eligible employees of the Company with an opportunity to purchase common stock of the Company through accumulated payroll deductions, which are included in other current liabilities until they are used to purchase Company shares. Eligible employees participating in the bi-annual offering period can choose to have up to the lesser of <ix:nonFraction unitRef="number" contextRef="c-173" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-556">15</ix:nonFraction>% of their annual base earnings or the IRS annual share purchase limit of $25,000 in aggregate market value to purchase shares of the Company&#8217;s common stock. The purchase price of the stock is the lesser of (i) <ix:nonFraction unitRef="number" contextRef="c-173" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="f-557">85</ix:nonFraction>% of the closing market price on the date of purchase and (ii) the closing market price at the beginning of the bi-annual offering period. The maximum number of shares initially reserved for delivery under the plan was <ix:nonFraction unitRef="shares" contextRef="c-174" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-558">200,000</ix:nonFraction> shares.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">An increase of <ix:nonFraction unitRef="shares" contextRef="c-175" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-559">1</ix:nonFraction>&#160;million shares to <ix:nonFraction unitRef="shares" contextRef="c-176" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-560">1.2</ix:nonFraction>&#160;million shares was approved by stockholders of the Company at the Company's Special Meeting of stockholders held on March 4, 2024. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The first enrollment period under the plan commenced on August 1, 2021 and the Company has issued <ix:nonFraction unitRef="shares" contextRef="c-177" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-561">491,839</ix:nonFraction>  shares life-to-date under the ESPP.  The Company recognized  $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-562">22,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-563">48,000</ix:nonFraction> of expense related to the plan during the three and six months ended June 30, 2025, respectively.  The Company recognized  <ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-564"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-565">no</ix:nonFraction></ix:nonFraction>  expense related to the plan during the three and six months ended June 30, 2024, respectively.   </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Programs</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Company&#8217;s stockholders approved the 2019 Omnibus Equity Incentive Plan, (as amended, the &#8220;2019 Plan&#8221;), which was adopted by the Board of Directors (the "Board") with an effective date of June 14, 2019. The 2019 Plan allows for the grant of equity awards to employees, consultants and non-employee directors. An initial maximum of <ix:nonFraction unitRef="shares" contextRef="c-182" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-566">1,500,000</ix:nonFraction> shares of the Company&#8217;s common stock were available for grant under the 2019 Plan. The 2019 Plan included an evergreen provision that allowed for the annual addition of up to <ix:nonFraction unitRef="number" contextRef="c-183" decimals="INF" name="vtl:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" scale="-2" id="f-567">4</ix:nonFraction>% of the Company&#8217;s fully-diluted outstanding stock, with a maximum allowable increase of <ix:nonFraction unitRef="shares" contextRef="c-183" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-568">4,900,000</ix:nonFraction> shares over the term of the 2019 Plan. In accordance with this provision, the shares available for grant were increased in 2020 through 2023 by a total of <ix:nonFraction unitRef="shares" contextRef="c-184" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-569">4,408,871</ix:nonFraction> shares. At the Company's Annual Stockholders meeting on June 28, 2023, stockholders voted to increase the allowable shares under the 2019 plan by <ix:nonFraction unitRef="shares" contextRef="c-185" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-570">4,440,000</ix:nonFraction> shares as well as to eliminate the evergreen provision.  On March 4, 2024, the stockholders voted at the Company's Special Meeting to increase the allowable shares under the 2019 plan by <ix:nonFraction unitRef="shares" contextRef="c-186" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-571">9,100,000</ix:nonFraction> shares.  On June 4, 2025, at the Company&#8217;s 2025 Annual Meeting of Stockholders,  the Company&#8217;s stockholders approved a proposal to amend the terms of the 2019 Plan to, among other things, increase the allowable shares under the 2019 plan by <ix:nonFraction unitRef="shares" contextRef="c-187" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-572">7,000,000</ix:nonFraction> shares. The 2019 Plan (as amended on June 28, 2023 and </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-555-2" continuedAt="f-555-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">March 4, 2024) is currently administered by the Board, or, at the discretion of the Board, by a committee of the Board, which determines the exercise prices, vesting schedules and other restrictions of awards under the 2019 Plan at its discretion. Options to purchase stock may not have an exercise price that is less than the fair market value of underlying shares on the date of grant, and may not have a term greater than <ix:nonNumeric contextRef="c-188" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durwordsen" id="f-573">ten years</ix:nonNumeric>. Incentive stock options granted to employees typically vest over <ix:nonNumeric contextRef="c-189" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-574">four years</ix:nonNumeric>. Non-statutory options granted to employees, officers, members of the Board, advisors, and consultants of the Company typically vest over <span style="-sec-ix-hidden:f-575">three</span> or <ix:nonNumeric contextRef="c-191" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-576">four years</ix:nonNumeric>. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares that are expired, terminated, surrendered or canceled under the 2019 Plan without having been fully exercised will be available for future awards. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Repricing</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2024, the Company's stockholders voted to approve the repricing of outstanding stock options having an exercise price above $<ix:nonFraction unitRef="usdPerShare" contextRef="c-115" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-577">3.00</ix:nonFraction> per share to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-114" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-578">1.72</ix:nonFraction> per share.  All other terms of the grant remained the same. There were <ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="vtl:ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-579">3,317,596</ix:nonFraction> stock options that were repriced to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-116" decimals="2" name="vtl:ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" scale="0" id="f-580">1.72</ix:nonFraction> per share.  The repricing resulted in $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-581">1.2</ix:nonFraction>&#160;million of stock compensation being recognized by the Company over the remaining term of the repriced grants.  $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="0" id="f-582">52,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-583">0.1</ix:nonFraction>&#160;million was recognized in the three months and six months ended June 30, 2025, respectively and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="0" id="f-584">17,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-585">1.0</ix:nonFraction>&#160;million of this amount was recognized in the three months and six months ended June 30, 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction Option Acceleration Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2025, the Company established a Corporate Transaction Option Acceleration Plan, pursuant to which in the case of a merger or consolidation of the Company with or into another corporation or a sale of substantially all of the stock of the Company each option award held by an eligible employee will become fully vested upon the occurrence of a Corporate Transaction.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Movements during the year </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-586" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the six months ended June 30, 2025 and 2024, respectively, for the 2019 Plan:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:52.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.421%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-192" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-587">16,136,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-192" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-588">1.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-193" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-589">9,937,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-193" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-590">0.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-193" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="f-591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-193" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-193" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-593">219,540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-193" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-594">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-194" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-595">25,853,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-194" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-596">1.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-193" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-597">8.77</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="0" id="f-598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable as of June 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-194" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-599">7,042,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-194" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-600">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-193" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-601">7.04</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:fixed-zero" scale="0" id="f-602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:52.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-195" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-603">6,196,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-604">7.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-605">4,810,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-606">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="f-607">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Repricing Modification</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="vtl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" format="ixt:fixed-zero" scale="0" id="f-609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="vtl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" scale="0" id="f-610">9.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-611">186,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-612">2.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-197" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-613">10,819,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-197" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-614">1.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-196" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-615">8.43</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="f-616">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable as of June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-197" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-617">3,606,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-197" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-618">2.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-196" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-619">6.97</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:fixed-zero" scale="0" id="f-620">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-555-3" continuedAt="f-555-4"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the BSM option pricing model to determine the fair value of the employee and non-employee stock option grants relating to the 2019 Plan were as follows:</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free rate assumption is based on U.S. Treasury instruments with maturities similar to the expected term of the stock options.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has not issued any dividends and does not expect to issue dividends over the life of the options. As a result, the Company has estimated the dividend yield to be <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="f-621">zero</ix:nonFraction>.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected volatility based on the historical volatility of its own stock. The historical volatility data was computed using the daily closing prices during the equivalent period of the calculated expected term of the stock-based awards.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The expected term of options is estimated considering the vesting period at the grant date, the life of the option and the average length of time similar grants have remained outstanding in the past.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of stock options granted under the 2019 Plan during the six months ended June 30, 2025 and 2024 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-198" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-622">0.67</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-199" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-623">0.98</ix:nonFraction>, respectively. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-624" continuedAt="f-624-1" escape="true">The following are the underlying assumptions used in the Black-Scholes option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:</ix:nonNumeric></span><ix:continuation id="f-624-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six  Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-625">4.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-626">4.10</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-627">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-628">0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-629">116.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-630">99.6</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-198" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-631">5.91</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-199" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-632">5.95</ix:nonNumeric></span></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-633" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense for all stock awards recognized in the accompanying unaudited condensed consolidated statements of operations is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br/>&#160;Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months<br/>&#160;Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-634">761,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-635">842,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-636">1,592,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-637">2,005,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-638">1,138,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-639">1,040,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-640">2,349,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-641">2,627,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-642">1,899,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-643">1,882,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-644">3,941,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-645">4,632,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, there was $<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-646">15.6</ix:nonFraction> million in total unrecognized compensation expense relating to the 2019 Plan, to be recognized over a weighted average period of <ix:nonNumeric contextRef="c-198" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-647">3.16</ix:nonNumeric> years. There was $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-648">28,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-649">24,000</ix:nonFraction> of stock-based compensation expense during the three months ended June 30, 2025 related to the repricing included in general and administrative and research and development expense respectively. There was $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-650">56,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-651">49,000</ix:nonFraction> of stock-based compensation expense during the six months ended June 30, 2025 related to the repricing included in general and administrative and research and development expense, respectively.  There was $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-652">9,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-653">8,000</ix:nonFraction> of stock-based compensation expense during the three months ended June 30, 2024 related to the repricing included in general and administrative and research and development expense respectively. There was </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-555-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-654">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-655">0.3</ix:nonFraction>&#160;million of stock-based compensation expense during the six months ended June 30, 2024 related to the repricing included in general and administrative and research and development expense, respectively.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Equity Incentive Plans Assumed from Vital Therapies</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Upon completion of the Transaction with Vital Therapies, inc. ("Vital") on April 12, 2019, Vital&#8217;s 2012 Stock Option Plan (the &#8220;2012 Plan&#8221;), Vital&#8217;s 2014 Equity Incentive Plan (the &#8220;2014 Plan&#8221;) and Vital&#8217;s 2017 Inducement Equity Incentive Plan (the &#8220;Inducement Plan&#8221;), were assumed by the Company. All awards granted under these plans have either been forfeited or expired.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are <ix:nonFraction unitRef="shares" contextRef="c-221" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt-sec:numwordsen" id="f-656">no</ix:nonFraction> longer any shares available for grant under the 2014 Plan as of June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 2017, Vital&#8217;s board of directors approved the Inducement Plan, which was amended and restated in November 2017. Under the Inducement Plan <ix:nonFraction unitRef="shares" contextRef="c-222" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-657">46,250</ix:nonFraction> shares of Vital&#8217;s common stock were reserved to be used exclusively for non-qualified grants to individuals who were not previously employees or directors as an inducement material to a grantee's entry into employment within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules.   </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-658"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-659"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-660"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-661">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> expense was recorded for the plans assumed from Vital during the three or six months ended June 30, 2025 and 2024, respectively.</span></div></ix:continuation><div style="margin-top:17.6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_55"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-662" continuedAt="f-662-1" escape="true">Related Party Transactions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-662-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Chairman Agreement with Duane Nash</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2020, the Compensation Committee of the Board of Directors of the Company independently reviewed and approved entering into an employment agreement with the Executive Chairman of the Board, Duane Nash, MD, JD, MBA (the &#8220;Executive Chairman Agreement&#8221;) and pursuant to such approval, on April 17, 2020, the Company and Dr. Nash entered into the Executive Chairman Agreement. The Executive Chairman Agreement establishes an &#8220;at will&#8221; employment relationship.  On October 17, 2023, Immunic, Inc. and Dr. Duane Nash entered into Addendum Number 5  to the Executive Chairman Agreement to extend the term of Dr. Nash&#8217;s employment as Executive Chairman of the Board of Directors of the Company to December 31, 2024.  In connection with  Addendum Number 5, the Company increased Dr. Nash&#8217;s monthly base salary to $<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="0" name="vtl:SalaryAndWageOfficerMonthlyBaseSalary" format="ixt:num-dot-decimal" scale="0" id="f-663">32,368</ix:nonFraction> from $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="0" name="vtl:SalaryAndWageOfficerMonthlyBaseSalary" format="ixt:num-dot-decimal" scale="0" id="f-664">30,250</ix:nonFraction> (which includes the cash retainer payable for serving on the Company&#8217;s Board or for acting as the Chairman of the Board). On August 29, 2024, Immunic, Inc.  and Dr. Duane Nash entered into Addendum Number 6  to the Executive Chairman Agreement to extend the term of Dr. Nash&#8217;s employment as Executive Chairman of the Board of Directors of the Company to December 31, 2025.  In connection with  Addendum Number 6, the Company increased Dr. Nash&#8217;s monthly base salary in 2025 to $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="0" name="vtl:SalaryAndWageOfficerMonthlyBaseSalary" format="ixt:num-dot-decimal" scale="0" id="f-665">33,986</ix:nonFraction> from $<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="0" name="vtl:SalaryAndWageOfficerMonthlyBaseSalary" format="ixt:num-dot-decimal" scale="0" id="f-666">32,368</ix:nonFraction> (which includes the cash retainer payable for serving on the Company&#8217;s Board or for acting as the Chairman of the Board) All other terms of the Executive Chairman Agreement remain the same.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_760"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-667" continuedAt="f-667-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-667-1" continuedAt="f-667-2"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, the Company has non-cancelable contractual obligations under certain agreements related to its development programs for vidofludimus calcium and IMU-856 totaling approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="6" id="f-668">2.1</ix:nonFraction>&#160;million, all of which is expected to be paid in 2025 and 2026.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments and Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Daiichi Sankyo Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#8217;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-667-2"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%">Ludwig-Maximilians-University Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently a party to any litigation, nor is it aware of any pending or threatened litigation, that it believes would materially affect its business, operating results, financial condition or cash flows. However, its industry is characterized by frequent claims and litigation including securities litigation, claims regarding patent and other intellectual property rights and claims for product liability. As a result, in the future, the Company may be involved in various legal proceedings from time to time.</span></div></ix:continuation><div id="i3f98a63a9d28482ab81ca8a270389f57_767"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-669" continuedAt="f-669-1" escape="true">Segment Disclosures</ix:nonNumeric></span></div><ix:continuation id="f-669-1" continuedAt="f-669-2"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision making group, in deciding how to allocate resources in assessing performance. The Company has <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" id="f-670">one</ix:nonFraction> reportable segment: life science. The life science segment consists of the development of clinical and preclinical product candidates for the development of the Company&#8217;s proprietary new therapies. The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is the Company's Chief Executive Officer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the life science segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the life science segment based on net loss. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM allocates resources and assesses performance on a consolidated basis, focused on the Company&#8217;s cash resources and an assessment of the probability of success of its ongoing research and development activities. Resource allocation decisions are informed by forecasted cash expenditures and actual expenses incurred to date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not generated any product revenue. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances product candidates through all stages of development and clinical trials and, ultimately, seeks regulatory approval. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-671" continuedAt="f-671-1" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the significant expense categories regularly reviewed by the CODM for the  three and six months ended June 30:</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-671-1"><ix:continuation id="f-669-2"><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.596%"><tr><td style="width:1.0%"/><td style="width:46.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical product candidates</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="vtl:ClinicalProductCandidates" format="ixt:num-dot-decimal" scale="3" id="f-672">17,710</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="vtl:ClinicalProductCandidates" format="ixt:num-dot-decimal" scale="3" id="f-673">14,931</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-clinical product candidates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="vtl:PreClinicalProductCandidates" scale="3" id="f-674">231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="vtl:PreClinicalProductCandidates" scale="3" id="f-675">219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs- research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-676">2,594</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-677">1,887</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs-general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-678">2,083</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-679">1,348</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-680">1,899</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-681">1,882</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:DepreciationNonproduction" scale="3" id="f-682">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:DepreciationNonproduction" scale="3" id="f-683">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other segment expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-684">2,523</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-685">2,513</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-686">27,083</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-687">22,814</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-688">27,083</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-689">22,814</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-690">241</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-691">998</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-692">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-693">436</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-694">26,820</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-695">21,380</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical product candidates</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="vtl:ClinicalProductCandidates" format="ixt:num-dot-decimal" scale="3" id="f-696">35,491</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="vtl:ClinicalProductCandidates" format="ixt:num-dot-decimal" scale="3" id="f-697">29,882</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-clinical product candidates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="vtl:PreClinicalProductCandidates" scale="3" id="f-698">345</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="vtl:PreClinicalProductCandidates" scale="3" id="f-699">400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs- research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-700">4,761</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-701">3,881</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs-general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-702">3,643</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-703">2,704</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-704">3,941</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-705">4,632</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DepreciationNonproduction" scale="3" id="f-706">86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:DepreciationNonproduction" scale="3" id="f-707">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other segment expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-708">5,641</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-709">5,139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-710">53,908</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-711">46,695</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-712">53,908</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-713">46,695</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-714">424</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-715">2,185</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of the tranche rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:fixed-zero" scale="3" id="f-716">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts" format="ixt:num-dot-decimal" scale="3" id="f-717">4,796</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-718">1,191</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-719">1,658</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-720">52,293</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-721">50,964</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-722" continuedAt="f-722-1" escape="true">Subsequent Events </ix:nonNumeric></span></div><ix:continuation id="f-722-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 7, 2025, the Board of Directors (the &#8220;Board&#8221;) of Immunic, Inc. (the &#8220;Company&#8221;) authorized grants, subject to the final approval of the Compensation Committee of the Board, of up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-242" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-723">35,000,000</ix:nonFraction> stock appreciation rights (&#8220;SARs&#8221;) to the Company&#8217;s employees and executive officers. This includes an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-243" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-724">22,015,000</ix:nonFraction> SARs to the Company&#8217;s executive officers. The SARs could be settled for cash, but it is the intention of the Company that these SARs will be settled for shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-242" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-725">0.0001</ix:nonFraction> per share (&#8220;Common Stock&#8221;) provided the Company obtains stockholder approval to amend the Company&#8217;s 2019 Omnibus Equity Incentive Plan, as amended (the &#8220;Plan&#8221;), to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock. The Company intends to seek stockholder approval to increase the number of shares available under the Plan. The exercise price of each SAR is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-242" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-726">0.77</ix:nonFraction>, the closing price of the Common Stock on July 7, 2025.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Of the <ix:nonFraction unitRef="shares" contextRef="c-242" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-727">35,000,000</ix:nonFraction> SARs, (i) <ix:nonFraction unitRef="shares" contextRef="c-244" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-728">5,000,000</ix:nonFraction> will be exercisable beginning August 1, 2026; (ii) up to <ix:nonFraction unitRef="shares" contextRef="c-245" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-729">10,000,000</ix:nonFraction> will be exercisable beginning August 1, 2026, subject to the exercise of the Company&#8217;s Series A  warrants by the holders thereof; (iii) up to <ix:nonFraction unitRef="shares" contextRef="c-246" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-730">10,000,000</ix:nonFraction> will be exercisable beginning August 1, 2026, subject to the exercise of the Company&#8217;s Series B warrants by the holders thereof; (iv) up to <ix:nonFraction unitRef="shares" contextRef="c-247" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-731">5,000,000</ix:nonFraction> will be exercisable beginning August 1, 2026, subject to the Company&#8217;s issuance of Common Stock or pre-funded warrants to subscribers in connection with the second tranche of the Company&#8217;s January 4, 2024 private placement (the &#8220;January 2024 Offering&#8221;); and (v) up to <ix:nonFraction unitRef="shares" contextRef="c-248" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-732">5,000,000</ix:nonFraction> will be exercisable beginning August 1, 2026, subject to the issuance of Common Stock or pre-funded warrants to subscribers in connection with the third tranche of the January 2024 Offering.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_61"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of financial condition and results of operations should be read in conjunction with our unaudited interim condensed consolidated financial statements and notes thereto included in Item&#160;1 &#8220;Financial Statements&#8221; in this Quarterly Report on Form 10-Q (this "Quarterly Report") and audited Consolidated Financial Statements for the years ended December 31, 2024 and 2023 of Immunic, Inc. filed with the Securities and Exchange Commission ("SEC"), in our Annual Report on Form 10-K on March 31, 2025. As used in this report, unless the context suggests otherwise, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;the Company&#8221; or &#8220;Immunic&#8221; refer to Immunic, Inc. and its subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to historical information, this Quarterly Report includes forward-looking statements within the meaning of federal securities laws. Forward-looking statements are subject to certain risks and uncertainties, many of which are beyond our control. Such statements include, but are not limited to, statements preceded by, followed by or that otherwise include the words, &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;expect,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; or similar expressions and the negatives of those terms.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements discuss matters that are not historical facts. Our forward-looking statements involve assumptions that, if they ever materialize or prove correct, could cause our results to differ materially from those expressed or implied by such forward-looking statements. In this Quarterly Report, for example, we make forward-looking statements, among others, regarding our development programs, potential strategic options; financial estimates and projections; and the sufficiency of our capital resources to fund our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The inclusion of any forward-looking statements in this Quarterly Report should not be regarded as a representation that any of our plans will be achieved. Our actual results may differ from those anticipated in our forward-looking statements as a result of various factors, including those noted below under the caption &#8220;Part II, Item 1A-Risk Factors,&#8221; and the risk factors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">described in our most recent Annual Report on Form 10-K filed with the SEC, and the differences may be material. These risk factors include, but are not limited to statements relating to our development programs and the targeted diseases; the potential for vidofludimus calcium and IMU-856 to safely and effectively target diseases; the nature, strategy and focus of the Company; expectations regarding our capitalization and financial resources; the development, timing and commercial potential of any product candidates of the Company; and our ability to attract and retain certain personnel important to our ongoing operations and to maintain effective internal control over financial reporting.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although our forward-looking statements reflect the current good faith judgment of our management, these statements are </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">based only on facts and factors currently known by us. As a result, investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and we undertake no obligation to revise or update such statements to reflect events or circumstances after the date hereof, except as required by law.</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Immunic, Inc. (&#8220;Immunic," &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or the "Company") is a biotechnology company developing a clinical pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. We are headquartered in New York City with our main operations in Gr&#228;felfing near Munich, Germany. We had approximately 90 employees as of July 31, 2025.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are pursuing clinical development of orally administered, small molecule programs, each of which has unique features intended to directly address the unmet needs of patients with serious chronic inflammatory and autoimmune diseases. These include the vidofludimus calcium (IMU-838) program, which is in Phase 3 clinical development for patients with relapsing multiple sclerosis (&#8220;RMS&#8221;), and which has shown therapeutic activity in Phase 2 clinical trials in patients suffering from relapsing-remitting MS ("RRMS"), progressive MS (&#8221;PMS&#8221;) and moderate-to-severe ulcerative colitis (&#8220;UC&#8221;); the IMU-856 program, which is targeted to regenerate bowel epithelium and restore intestinal barrier function, which could potentially be applicable in numerous gastrointestinal diseases, such as celiac disease, inflammatory bowel disease (&#8220;IBD&#8221;), Graft-versus-Host-Disease ("GvHD") and possibly weight management; and the IMU-381 program, which is a next generation molecule being developed to specifically address the needs of gastrointestinal diseases.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes the potential indications, clinical targets and clinical development status of our three product candidates:</span></div><div style="text-align:justify;text-indent:22.5pt"><img src="vtl-20250630_g1.jpg" alt="pipeline-20250721-2000px.jpg" style="height:301px;margin-bottom:5pt;vertical-align:text-bottom;width:654px" id="i-1"/></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our most advanced drug candidate, vidofludimus calcium (IMU-838), is being tested in ongoing MS trials as part of its overall clinical program in order to support potential approvals for patients with MS in major markets.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Phase 3 ENSURE program of vidofludimus calcium in RMS, comprising twin studies evaluating efficacy, safety, and tolerability of vidofludimus calcium versus placebo, is currently ongoing. On October 22, 2024, we announced a positive outcome of an interim analysis of the ENSURE program, with an unblinded Independent Data Monitoring Committee ("IDMC") confirming that the predetermined futility criteria have not been met and recommending that both ENSURE trials should continue without changes, including no need for a potential increase of the sample size. On June 5, 2025, we announced completion of enrollment for both ENSURE trials. Each of the trials enrolled adult patients with active RMS at more than 100 sites in 15 countries. In total, 1,121 patients in ENSURE-1 and 1,100 patients in ENSURE-2 have been randomized in a double-blinded fashion to either 30 mg daily doses of vidofludimus calcium or placebo. The top-line data for both ENSURE trials is expected by the end of 2026. Although we currently believe that this goal is achievable, it is dependent on numerous factors, most of which are not under our direct control and can be difficult to predict. We plan to periodically review this assessment and provide updates of material changes as appropriate.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our Phase 2 CALLIPER trial of vidofludimus calcium in PMS was designed to corroborate vidofludimus calcium&#8217;s neuroprotective potential and to evaluate the clinical efficacy, safety and tolerability of vidofludimus calcium in a broad set of PMS patients to determine the suitability of advancing to a confirmatory Phase 3 program. On October 9, 2023, we announced positive interim data from the CALLIPER trial, showing biomarker evidence that vidofludimus calcium&#8217;s activity extends beyond the previously observed anti-inflammatory effects, thereby further reinforcing its neuroprotective potential. In April and June 2025, we announced positive clinical data from the CALLIPER trial, showing substantial and medically relevant reductions in 24-week confirmed disability progression as well as in the annualized rate of thalamic brain volume loss and volume of new or enlarging T2 lesions. The top-line data also confirmed the favorable safety and tolerability profile of vidofludimus calcium already observed in previous clinical trials.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If approved, we believe that vidofludimus calcium, with combined neuroprotective, anti-inflammatory, and antiviral effects as well as a favorable safety and tolerability profile, has the potential to be a unique treatment option targeted to the complex pathophysiology of MS. Preclinical data showed that vidofludimus calcium activates the neuroprotective transcription factor nuclear receptor-related 1 (&#8220;Nurr1&#8221;), which is associated with direct neuroprotective effects and may enhance the potential benefit for patients. Additionally, vidofludimus calcium is a known inhibitor of the enzyme dihydroorotate dehydrogenase (&#8220;DHODH&#8221;), which is a key enzyme in the metabolism of overactive immune cells and virus-infected cells. This mechanism is associated with the anti-inflammatory and antiviral effects of vidofludimus calcium. We believe that the combined mechanisms of vidofludimus calcium are unique in the MS space and support the therapeutic performance observed in our Phase 2 EMPhASIS trial in RRMS patients and in our Phase 2 CALLIPER trial in PMS patients. Vidofludimus calcium has shown a consistent pharmacokinetic, safety and tolerability profile in clinical trials reported, to date, and has already been exposed to approximately 2,700 human subjects and patients in either of the drug&#8217;s formulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">IMU-856 is an orally available and systemically acting small molecule modulator that targets Sirtuin 6 (&#8220;SIRT6&#8221;), a protein which serves as a transcriptional regulator of intestinal barrier function and regeneration of bowel epithelium. Based on preclinical data, we believe this compound may represent a unique treatment approach, as the mechanism of action targets the restoration of the intestinal barrier function and bowel wall architecture in patients suffering from gastrointestinal diseases such as celiac disease, IBD, GvHD and other intestinal barrier function associated diseases. Based on preclinical investigations demonstrating no suppression of immune cells, IMU-856 may have the potential to maintain immune surveillance for patients during therapy, which would be an important advantage versus immunosuppressive medications and may allow the potential for combination with available treatments in gastroenterological diseases.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Data from a Phase 1b clinical trial in celiac disease patients during periods of gluten-free diet and gluten challenge demonstrated positive effects for IMU-856 over placebo in four key dimensions of celiac disease pathophysiology: protection of the gut architecture, improvement of patients&#8217; symptoms, biomarker response, and enhancement of nutrient absorption. IMU-856 was also observed to be safe and well-tolerated in this trial. In a post hoc analysis of this Phase 1b clinical trial, IMU-856 demonstrated a dose-dependent increase of endogenous glucagon-like peptide-1 (&#8220;GLP-1&#8221;) levels. IMU-856 also showed a dose-dependent reduction of body weight gain and food consumption in preclinical </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> testing. These two effects may indicate the potential for IMU-856 as an oral treatment option for weight management. Contingent on financing, licensing or partnering, we are currently preparing further clinical testing of IMU-856. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Immunic has selected IMU-381 as a development candidate to specifically address the needs of gastrointestinal diseases. IMU-381 is a next generation molecule with improved overall properties, supported by a series of chemical derivatives. IMU-381 is currently in preclinical testing.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additional research and development activities remain ongoing through preclinical research examining the potential to treat a broad set of neuroinflammatory, autoimmune and viral diseases with new molecules leveraging our chemical and pharmacological research platform as well as generated intellectual property in these areas. We are also exploring several options to possibly support further development of certain assets and technologies, including a potential spin-off into a new company and potential licensing transactions.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect to continue to lead most of our research and development activities from our Gr&#228;felfing, Germany location, where dedicated scientific, regulatory, clinical and medical teams conduct their activities. Due to these teams' key relationships with local and international service providers, we anticipate that this should result in more timely and cost-effective execution of our development programs. In addition, we are using our subsidiary in Melbourne, Australia to perform research and development activities in the Australasia region. We also conduct preclinical work in our laboratory in Martinsried, Germany and in Halle/Saale, Germany through a collaboration with the Fraunhofer Institute.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our business, operating results, financial condition and growth prospects are subject to significant risks and uncertainties, including delays in clinical trials, the failure of our clinical trials to meet their endpoints, failure to obtain regulatory approval and failure to obtain needed additional funding on acceptable terms, if at all, to complete the development and commercialization of our three development programs.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Strategy </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on the development of new molecules that maximize the therapeutic benefits for patients by uniquely addressing biologically relevant immunological targets. We take advantage of our established research and development infrastructure and operations in Germany and Australia to more efficiently develop our product candidates in indications of high unmet need and where the product candidates have the potential to elevate the standard of care for the benefit of patients. Given the mechanisms of action and the data generated for our product candidates, to date, we continue to execute on the clinical development of our programs for established indications as well as explore additional indications where patients could potentially benefit from the unique profiles of each product candidate.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are currently focused on maximizing the potential of our development programs through the following strategic initiatives:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Executing the ongoing Phase 3 ENSURE clinical trials of vidofludimus calcium in RMS.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Completing the analysis of the full data set of the Phase 2 CALLIPER clinical trial and discussing the results with healthcare authorities to determine appropriate next steps for vidofludimus calcium in PMS.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Executing the IMU-856 development program, including preparation of additional clinical testing.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Continuing preclinical research to complement the existing clinical activities, explore additional indications for potential future development and generating additional molecules for potential future development.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Facilitating readiness for potential commercial launch of our product candidates, if regulatory approvals are received, through targeted and stage-appropriate pre-commercial activities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Evaluating potential strategic collaborations for each product candidate in order to complement our existing research and development capabilities and to facilitate potential commercialization of these product candidates by taking advantage of the resources and capabilities of strategic collaborators in order to enhance the potential and value of each product candidate.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Financial Condition, Liquidity and Going Concern</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">We have no products approved for commercial sale and have not generated any revenue from product sales. We have never been profitable and have incurred operating losses in each year since inception in 2016.  We have an accumulated deficit of approximately $563.7 million as of June 30, 2025 and $511.4 million as of December 31, 2024.  Substantially all of our operating losses resulted from expenses incurred in connection with our research and development programs and from general and administrative costs associated with our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future as we initiate and continue the development of our product candidates and add personnel necessary to advance our pipeline of product candidates. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect that our operating losses will fluctuate significantly from quarter-to-quarter and year-to-year due to timing of development programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From inception through June 30, 2025, we have raised net cash of approximately $496.3 million from private and public offerings of common stock, pre-funded warrants, common stock purchase warrants and tranche rights. As of June 30, 2025, we had cash and cash equivalents of approximately $55.3 million. With these funds, the Company does not have adequate liquidity to fund its operations for at least twelve months from the issuance of these consolidated financial statements included in this Quarterly Report without raising additional capital and such actions are not solely within the control of the Company. If the Company is unable to obtain additional capital, it would have a material adverse effect on the operations of the Company, its clinical development program, and the Company may have to cease operations altogether. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Key Status Updates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On February 20, 2025, we announced that IMU-856 demonstrated a dose-dependent increase of endogenous GLP-1 levels in a post hoc analysis of patients from our Phase 1b clinical trial in celiac disease. IMU-856 also showed a dose-dependent </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">reduction of body weight gain and food consumption in preclinical </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> testing. These effects may indicate the potential for IMU-856 as an oral treatment option for weight management.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The post hoc analysis of our Phase 1b clinical trial of IMU-856 in celiac disease patients measured blood concentrations of GLP-1, between baseline and day 28, in a fasting state. A highly statistically significant (day 29: 80 mg p=0.014; 160 mg p=0.003) and dose-dependent increase of GLP-1 versus placebo control was detectable, even in the small patient population in this Phase 1b clinical trial (baseline: N placebo = 11, N 80 mg IMU-856 = 13, N 160 mg IMU-856 = 13). These clinical findings were corroborated by effects observed in a 6-month preclinical </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> study, where IMU-856 was found to reduce body weight gain accompanied by food consumption in a dose-dependent fashion up to -40 %, compared to the control group, which was found to be linked to reduced food intake.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On April 30, 2025, we announced positive data from our Phase 2 CALLIPER trial of vidofludimus calcium in patients with PMS. In the overall PMS patient population, vidofludimus calcium reduced the relative risk of 24-week confirmed disability worsening (&#8220;24wCDW&#8221;) events based on changes in the expanded disability status scale (&#8220;EDSS&#8221;) by 20% compared to placebo. Further analyses by disease subtype demonstrated that vidofludimus calcium was associated with a 30% reduction in the relative risk of 24wCDW events in the primary progressive multiple sclerosis ("PPMS") study population compared to placebo and a respective 15% reduction in the non-active secondary progressive multiple sclerosis (&#8220;naSPMS&#8221;) study population. A consistent reduction of disability worsening was observed in the different subpopulations with or without inflammatory gadolinium-enhanced lesion activity at baseline and during the study. Vidofludimus calcium reduced the relative risk of 24wCDW events in patients without gadolinium-enhancing lesions at baseline by 29% compared to placebo.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">While vidofludimus calcium had a modest benefit on the exploratory primary magnetic resonance imaging (&#8220;MRI&#8221;) endpoint (annualized rate of percent brain volume change: 5% improvement compared to placebo), vidofludimus calcium substantially reduced the annualized rate of thalamic brain volume loss by 20% in patients with PMS compared to placebo. The total volume of new or enlarging T2 lesions showed a substantial difference between vidofludimus calcium and placebo over time, with vidofludimus calcium decreasing and placebo increasing (mean percent change, 3.19% benefit for vidofludimus calcium (-0.22%) over placebo (+2.97%) at month 24).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The top-line CALLIPER data set supports the favorable safety and tolerability profile of vidofludimus calcium already observed in previous clinical trials. No new safety signals were identified.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Additional Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in PMS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">    </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 5, 2025, we announced additional data from our Phase 2 CALLIPER trial in PMS, further supporting the positive top-line results announced on April 30, 2025, and underlining vidofludimus calcium's neuroprotective potential. Building on the top-line data showing reductions in the relative risk of 24wCDW events based on the EDSS at the end of the main treatment period, newly available data for the secondary endpoint of time to 24wCDW based on the EDSS further reinforces the neuroprotective potential of vidofludimus calcium. In the overall PMS patient population (n=467), vidofludimus calcium demonstrated a clinically meaningful reduction of the hazard ratio (&#8220;HR&#8221;) for 24wCDW by 24% compared to placebo (HR 0.76). Further analyses by disease subtype showed that vidofludimus calcium was associated with a 33% reduction in 24wCDW in the PPMS study population (n=152) compared to placebo (HR 0.67), a 19% reduction in the naSPMS study population (n=268) compared to placebo (HR 0.81), and a 34% reduction in the active secondary progressive multiple sclerosis (&#8220;aSPMS&#8221;) study population (n=47) compared to placebo (HR 0.66).</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">)</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Similarly, consistent with the top-line data, further analyses of subpopulations &#8211; both with and without inflammatory gadolinium-enhanced lesion activity at baseline, who are largely shown to not benefit from current anti-inflammatory therapies &#8211; continued to demonstrate promising results. For the overall population, vidofludimus calcium reduced 24wCDW in patients without evidence of gadolinium-enhancing lesions at baseline by 34% compared to placebo (HR 0.66). Encouraging results were likewise observed for the PPMS (reduction in 24wCDW: 35%; HR 0.65) and naSPMS (reduction in 24wCDW: 30%; HR 0.70) study populations compared to placebo.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:21.3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Completion of Enrollment for Both Phase 3 ENSURE Trials of Vidofludimus Calcium in RMS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 5, 2025, we also announced completion of enrollment for both Phase 3 ENSURE trials. The ENSURE program comprises two identical multicenter, randomized, double-blind Phase 3 trials designed to evaluate the efficacy, safety and tolerability of vidofludimus calcium versus placebo in RMS patients. Each of the trials, titled ENSURE-1 and ENSURE-2, enrolled adult patients with active RMS at more than 100 sites in 15 countries, including the United States, India and countries </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">in the Middle East and North Africa (&#8220;MENA&#8221;) region, Latin America, and Central and Eastern Europe. In total, 1,121 patients in ENSURE-1 and 1,100 patients in ENSURE-2 have been randomized in a double-blinded fashion to either 30 mg daily doses of vidofludimus calcium or placebo. The primary endpoint for both trials is time to first relapse up to 72 weeks. Secondary endpoints include time to confirmed disability worsening based on the EDSS, volume of new T2-lesions, time to sustained clinically relevant changes in cognition, and MRI-based endpoints. The top-line data from both ENSURE trials is expected by the end of 2026, which should allow for a synchronized readout and a pooled assessment of the confirmed disability worsening secondary endpoint.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:21.3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in RRMS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 24, 2025, we announced new long-term open-label extension (&#8220;OLE&#8221;) data from our Phase 2 EMPhASIS trial in patients with RRMS. The data at week 144 showed that 92.3% of patients remained free of 12-week CDW, and 92.7% free of 24-week CDW. A total of 29 CDW events were confirmed at 12 weeks following the trigger event through week 144. Of these, 44.8% were associated with relapse-associated worsening (&#8220;RAW&#8221;), while only 13.8% were associated with progression independent of relapse activity (&#8220;PIRA&#8221;). Additionally, the cumulative data available from the EMPhASIS OLE period, thus far, further reinforces the favorable safety and tolerability profile of vidofludimus calcium, showing low discontinuation rates and low rates of treatment-emergent and serious adverse events. Importantly, no new safety signals have emerged during treatment durations up to 5.5 years.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Phase 2 EMPhASIS trial in RRMS includes an optional OLE period for up to 9.5 years to evaluate long-term safety and tolerability of vidofludimus calcium. Of the 268 patients that started the double-blind main treatment period, 254 patients continued in the OLE period. At the time of data cutoff on January 14, 2025, 182 patients (71.6% of patients starting OLE) were evaluated up to week 144, which translates into approximately 952 overall treatment years.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">April 2025 Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2025, Immunic entered into a securities purchase agreement with certain institutional and accredited investors relating to the issuance and sale of an aggregate of 5,666,667 shares of the Company&#8217;s common stock, par value $0.0001 per share. The purchase price per share was $0.90 for aggregate gross proceeds to the Company of approximately $5.1&#160;million. The offer and sale of the shares is referred to herein as the &#8220;April 2025 Offering.&#8221; The April 2025 Offering closed on April 10, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on April 9, 2025, the Company entered into a placement agency agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (the &#8220;Placement Agent&#8221;), relating to the April 2025 Offering. Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the April 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection therewith. Additionally, upon the closing of the April 2025 Offering, the Company agreed to issue to the Placement Agent, or its designees, warrants to purchase up to an aggregate of 283,334 shares of common stock, representing 5.0% of the shares sold in the April 2025 Offering (the &#8220;Placement Agent Warrants&#8221;). The Placement Agent Warrants will be exercisable, in whole or in part, commencing 180 days from the date of the Placement Agency Agreement and expiring on the five year anniversary of the Placement Agency Agreement, at an initial exercise price per share of common stock of $1.125, which is equal to 125% of the price per share to investors in the April 2025 Offering. The Placement Agent Warrants and the shares of common stock underlying the Placement Agent Warrants were offered pursuant to the exemptions from registration provided in Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds to the Company from the April 2025 Offering, after deducting commissions and the Company&#8217;s offering expenses, was approximately $4.7&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The April 2025 Shares were registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on the Company&#8217;s Registration Statement on Form S-3 (Registration No. 333-275717), previously filed with the SEC, and declared effective on May 31, 2024.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">May 2025 Equity Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2025, Immunic entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Leerink Partners LLC, issuance and sale of (i) pre-funded warrants to purchase an aggregate of 86,666,667 shares of common stock, par value $0.0001 (&#8220;Common Stock&#8221;) of the Company (the &#8220;Pre-Funded Warrants&#8221;), (ii) accompanying series A warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#8220;Series A Warrants&#8221;), and (iii) accompanying series B warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Company (or Pre-Funded Warrants) (the &#8220;Series B Warrants&#8221;) (the &#8220;May 2025 Offering&#8221;). The price per Pre-Funded Warrant and accompanying Series A Warrant and Series B Warrant was $0.7499. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.0001 per share and will expire when exercised in full. Each Series A Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.75 per share and will expire on December 31, 2025. Each Series B Warrant is exercisable on the earlier of (i) October 1, 2025, (ii) the first day following any five trading days during which the volume weighted average price for the Common Stock of the Company during such five trading day period is $1.25 or greater (the &#8220;VWAP Target&#8221;), or (iii) immediately prior to the consummation of a Fundamental Transaction (as defined in the Series B Warrants) for one share of Common Stock at an exercise price of $0.75 per share and will expire five years from the date of issuance. Each Series A Warrant and Series B Warrant will immediately expire in proportion to the extent that the corresponding Pre-Funded Warrant is exercised prior to September 30, 2025; provided that this term will not apply to the Series B Warrants immediately as of the date of achievement of the VWAP Target. The holder of the Pre-Funded Warrants and Series B Warrants may also satisfy its obligation to pay the exercise price through a &#8220;cashless exercise,&#8221; in which the holder receives the net value of such warrant in shares of Common Stock determined according to the formula set forth in the applicable warrant. Holders of Series A Warrants may, provided there is no effective registration statement or prospectus available which covers the warrants and shares of Common Stock issuable upon exercise of the Series A Warrants, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Series A Warrant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is prohibited from effecting an exercise of any Pre-Funded Warrants, Series A Warrants or Series B Warrants to the extent that such exercise would result in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding 4.99% (or 9.99% at election of the holder) of the total number of shares of Common Stock outstanding immediately after giving effect to the exercise (the &#8220;Beneficial Ownership Limitation&#8221;), which percentage may be increased or decreased at the holder&#8217;s election, not to exceed 19.99%. Any increase to the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. If a holder is not permitted to exercise a Series A Warrant or a Series B Warrant for Common Stock due to the Beneficial Ownership Limitation, then the holder may exercise such Series A Warrant or Series B Warrant for an equivalent number of Pre-Funded Warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The aggregate proceeds from the May 2025 Offering were approximately $65&#160;million before deducting underwriting discounts and commissions and offering expenses payable by the Company in connection with the May 2025 Offering. The Company may receive up to an aggregate of $130&#160;million of additional gross proceeds if the Series A Warrants and Series B Warrants are exercised in full for cash.  Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the May 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection therewith. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The May 2025 Offering was made pursuant to an effective registration statement on Form S-3 (Registration Statement No. 333-275717), as amended, previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on November 22, 2023, and declared effective by the SEC on May 31, 2024, as supplemented by the preliminary prospectus supplement, dated May 28, 2025, and a final prospectus supplement (the &#8220;Prospectus Supplement&#8221;) filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on May 30, 2025. The closing of the May 2025 Offering took place on  June 3, 2025.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice of Non-Compliance with Nasdaq Listing Rule 5450(a)(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2025, Immunic received a written notification (the &#8220;Notice Letter&#8221;) from The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that we were not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price for our common stock was below the $1.00 per share requirement for the last 30 consecutive business days. The Notice Letter stated that we have 180 calendar days, or until December 24, 2025 (the &#8220;Initial Compliance Period&#8221;), to regain compliance with the minimum bid price requirement. If we do not regain compliance by the end of the Initial Compliance Period, we may apply for an additional compliance period as provided for in the Notice Letter. Nasdaq&#8217;s determination of whether we qualify for an additional compliance period will depend on whether we will meet the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and a written notice of our intention to cure the deficiency during the additional compliance period by effecting a reverse stock split, if necessary.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Notice Letter has no immediate effect on the listing of our common stock on The Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we can regain compliance if the closing bid price of our common stock is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">at least $1.00 for a minimum of 10 consecutive business days. In the event that we do not regain compliance with Listing Rule 5450(a)(1) prior to the expiration of the Initial Compliance Period (or additional compliance period, if applicable), we will receive written notification that our securities are subject to delisting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to actively monitor the closing bid price of its common stock and is evaluating available options to regain compliance with the minimum bid price requirement. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or that the Company will otherwise remain in compliance with the other listing standards for the Nasdaq.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s common stock is delisted from Nasdaq, it could have a material adverse effect on the trading price and</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">liquidity of the Company&#8217;s common stock.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To date, we have not generated any revenue from product sales and do not expect to generate any revenue from the sale of products in the foreseeable future. If our development efforts for our product candidates are successful and result in regulatory approval, we may generate revenue in the future from product sales. We cannot predict if, when, or to what extent we will generate revenue from the commercialization and sale of our product candidates. We may never succeed in obtaining regulatory approval for any of our product candidates or achieving market acceptance and commercial success for any product that does receive regulatory approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist of costs associated with our research activities, including our product discovery efforts and the development of our product candidates. Our research and development expenses include: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">external research and development expenses and milestone payments incurred under arrangements with third parties, such as CROs, contract manufacturing organizations, collaborations with partners, consultants, and our scientific advisors; and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal personnel expenses.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development costs as incurred. Non-refundable advance payments for goods and services that will be used in future research and development activities are capitalized as prepaid expenses and expensed when the service has been performed or when the goods have been received.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in March 2016, we have spent a total of approximately $421.2 million in research and development expenses through June 30, 2025. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These costs primarily include external development expenses and internal personnel expenses for the three development programs, vidofludimus calcium, IMU-856 and IMU-381. We have spent the majority of our research and development resources on vidofludimus calcium, our lead development program, for clinical trials in MS and UC.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses are expected to increase in the foreseeable future as we continue to conduct ongoing research and development activities, initiate new preclinical and clinical trials and build our pipeline of product candidates.   Our research and development expenses may also increase in the foreseeable future due to the current inflationary environment as well as supply chain shortages and tariffs, which result in increased costs. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The process of conducting clinical trials and preclinical studies necessary to obtain regulatory approval is costly and time consuming. We may never succeed in achieving regulatory approval for any of our product candidates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Successful development of product candidates is highly uncertain and may not result in approved products. Completion dates and completion costs can vary significantly for each product candidate and are difficult to predict. We anticipate that we will make determinations as to which programs to pursue and how much funding to direct to each program on an ongoing basis in response to the development and regulatory success of each product candidate, and ongoing assessments as to each product candidate&#8217;s commercial potential.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of personnel expenses, professional fees for legal, accounting, tax and business consulting services, insurance premiums and stock-based compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest earned on our money market funds and bank accounts which are a portion of our cash and cash equivalents balance. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in the Fair Value of the Tranche Rights</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The change in fair value of the tranche rights is a non-cash charge related to the change in fair value of the tranche 2 and tranche 3 rights associated with the January 2024 Financing from January 8, 2024 until March 4, 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) primarily consists of (i) deal costs from the January 2024 Financing related to tranche rights that were established at the time of the deal closing (ii) a research and development tax incentive related to clinical trials performed in Australia and (iii) a German Government research and development grant.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended June 30, 2025 and 2024 </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our operating expenses for the three months ended June 30, 2025 and 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:43.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.954%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,083&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,814&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,269&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27,083)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,814)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other  income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(26,820)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(21,380)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,440)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses increased by $3.0 million during the three months ended June 30, 2025, as compared to the three months ended June 30, 2024. The increase reflects (i) a $2.6 million increase in external development costs related to the vidofludimus calcium programs and (ii) a $0.6 million increase in personnel expenses. The increase was offset by a $0.2 million decrease related costs across numerous categories. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">General and administrative expenses increased by $1.2 million during the three months ended June 30, 2025, as compared to the three months ended June 30, 2024. The increase was due to (i) a $0.8 million increase in personnel expenses and (ii) a $0.4 million increase in legal and consultancy expenses.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Interest income decreased by $0.8 million during the three months ended June 30, 2025, as compared to the three months ended June 30, 2024, due primarily to a lower average cash balance.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other income decreased by $0.4 million during the three months ended June 30, 2025, as compared to the three months ended June 30, 2024. The decrease was attributable to activity across numerous categories. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Comparison of the Six Months Ended June 30, 2025 and 2024 </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our operating expenses for the six months ended June 30, 2025 and 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:43.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.954%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">42,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">37,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53,908&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(53,908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(46,695)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,213)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of the tranche rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other  income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,269)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,884&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(52,293)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(50,964)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses increased by $5.8 million during the six months ended June 30, 2025, as compared to the six months ended June 30, 2024. The increase reflects a $7.3 million increase in external development costs related to the vidofludimus calcium programs. The increase was offset by (i) a $1.5 million decrease in external development costs related to IMU-856 due to the completion of the Phase 1b clinical trial in celiac disease patients in 2024. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">General and administrative expenses increased by $1.4 million during the six months ended June 30, 2025, as compared to the six months ended June 30, 2024. The increase was due to (i) a $0.7 million increase related to personnel expenses, (ii) a $0.5 million increase in legal and consultancy expenses and (iii) a $0.2 million increase related costs across numerous categories. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Interest income decreased by $1.8 million during the six months ended June 30, 2025, as compared to the six months ended June 30, 2024, due to a lower average cash balance.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the six months ended June 30, 2024, there was a non-cash charge related to the change in value of the tranche rights associated with the January 2024 Financing from January 8, 2024 until March 4, 2024. These tranches were initially classified as a liability, but were reclassified to equity on March 4, 2024, when stockholders approved the increase in our authorized shares from 130 million to 500 million shares of common stock and therefore the tranche 2 and tranche 3 rights needed to be revalued to fair value upon the reclassification to equity. There was no change in fair value of the tranche rights recognized in the six months ended June 30, 2025.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other income (expense) increased by $2.8 million during the six months ended June 30, 2025, as compared to the six months ended June 30, 2024. The increase was primarily attributable to (i) a $1.7 million expense related to the portion of deal costs from the January 2024 Financing related to the tranche rights that were established at the time of the</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">deal closing in 2024, (ii)  $1.0 million of grant income from the German Federal Ministry of Finance recognized in the first quarter 2025 and (iii)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">a $0.1 million increase across numerous categories. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financial Condition, Liquidity and Going Concern</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">We have no products approved for commercial sale and have not generated any revenue from product sales. We have never been profitable and have incurred operating losses in each year since inception in 2016.  We have an accumulated deficit of approximately $563.7 million as of June 30, 2025 and $511.4 million as of December 31, 2024.  Substantially all of our operating losses resulted from expenses incurred in connection with our research and development programs and from general and administrative costs associated with our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future as we initiate and continue the preclinical and clinical development of our product candidates and add personnel necessary to operate as a company with an advanced clinical pipeline of product candidates. To the extent additional funds are necessary to meet long-term liquidity needs as we continue to execute our business strategy, we anticipate that they will be obtained through the incurrence of indebtedness, additional equity financings, product licensing or a combination of these potential sources of funds, although we can provide no assurance that these sources of funding will be available on reasonable terms, if at all.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From inception through June 30, 2025, we have raised net cash of approximately $496.3 million from private and public offerings of common stock, prefunded warrants, common stock purchase warrants and tranche rights. As of June 30, 2025, we had cash and cash equivalents of approximately $55.3 million. With these funds, the Company does not have adequate liquidity to fund its operations for at least twelve months from the issuance of these consolidated financial statements without raising additional capital and such actions are not solely within the control of the Company. If the Company is unable to obtain additional capital, it would have a material adverse effect on the operations of the Company, its clinical development program, and the Company may have to cease operations altogether. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In December 2020, the Company filed a Prospectus Supplement to the shelf registration statement on Form S-3 filed on November 13, 2020 and declared effective on November 24, 2020 (the "2020 Shelf Registration Statement") for the offering, issuance and sale of up to a maximum aggregate offering price of $50.0&#160;million of common stock that may be issued and sold under an at-the-market sales agreement with SVB Leerink LLC (now Leerink Partners LLC) as agent ("December 2020 ATM"). The Company used the net proceeds from the December 2020 ATM to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The December 2020 ATM terminated in May 2024.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a Prospectus Supplement to the 2020 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $80.0&#160;million of common stock to be issued and sold under another at-the-market sales agreement ("May 2022 ATM") with Leerink Partners LLC (formerly SVB Leerink LLC) as agent. The 2020 Shelf Registration Statement expired in November 2023. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, we filed a shelf registration statement on Form S-3 (the "2023 Shelf Registration Statement").  The 2023 Shelf Registration Statement permits the offering, issuance and sale of up to $250.0 million of common stock, preferred stock, warrants, debt securities, and/or units in one or more offerings and in any combination of the foregoing. The 2023 Registration Statement was declared effective on May 31, 2024.  Unsold securities from the expired 2020 Shelf Registration Statement can continue to be sold under the 2023 Shelf Registration Statement, As a result of the April 2025 Offering and May 2025 Offering, the amount available under the 2023 Shelf Registration Statement was reduced by $70.1 million to $342.2 million as of June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2024, we filed a Prospectus Supplement to the 2023 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $80.0 million of common stock that may be issued and sold under an at-the-market sales agreement with Leerink Partners LLC as agent ("May 2024 ATM"), which rolls over the $80.0 million of unsold common stock from the May 2022 ATM. We intend to use the net proceeds from the May 2024 ATM to continue to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The May 2024 ATM will terminate upon the earlier of (i) the issuance and sale of all of the shares through Leerink Partners LLC on the terms and subject to the conditions set forth in the May 2024 ATM or (ii) termination of the May 2024 ATM as otherwise permitted thereby. The May 2024 ATM may be terminated at any time by either party upon ten days&#8217; prior notice, or by Leerink Partners LLC at any time in certain circumstances, including the occurrence of a material adverse effect on us.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, $80.0 million in capacity remains under the May 2024 ATM.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We agreed to pay Leerink Partners LLC a commission equal to 3.0% of the gross proceeds from the sales of common shares pursuant to the May 2024 ATM and have agreed to provide Leerink Partners LLC with customary indemnification and contribution rights.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We did not have any ATM activity during the six months ended June 30, 2025. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the six months ended June 30, 2024, we raised gross proceeds of $0.2 million pursuant to the December 2020 ATM through the sale of 150,000 shares of common stock at a weighted average price of $1.31 per share. The net proceeds from the December 2020 ATM were $0.2 million after deducting sales agent commissions of $6,000. We did not have any ATM activity for the three months ended June 30, 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">April 2025 Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2025, Immunic entered into a securities purchase agreement with certain institutional and accredited investors relating to the issuance and sale of an aggregate of 5,666,667 shares of the Company&#8217;s common stock, par value $0.0001 per share. The purchase price per share was $0.90 for aggregate gross proceeds to the Company of approximately $5.1&#160;million. The offer and sale of the shares is referred to herein as the &#8220;April 2025 Offering.&#8221; The April 2025 Offering closed on April 10, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on April 9, 2025, the Company entered into a placement agency agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (the &#8220;Placement Agent&#8221;), relating to the April 2025 Offering. Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the April 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection therewith. Additionally, upon the closing of the April 2025 Offering, the Company agreed to issue to the Placement Agent, or its designees, warrants to purchase up to an aggregate of 283,334 shares of common stock, representing 5.0% of the shares sold in the April 2025 Offering (the &#8220;Placement Agent Warrants&#8221;). The Placement Agent Warrants will be exercisable, in whole or in part, commencing 180 days from the date of the Placement Agency Agreement and expiring on the five year anniversary of the Placement Agency Agreement, at an initial exercise price per share of common stock of $1.125, which is equal to 125% of the price per share to investors in the April 2025 Offering. The Placement Agent Warrants and the shares of common stock underlying the Placement Agent Warrants were offered pursuant to the exemptions from registration provided in Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds to the Company from the April 2025 Offering, after deducting commissions and the Company&#8217;s offering expenses, was approximately $4.7&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The April 2025 Shares were registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on the Company&#8217;s Registration Statement on Form S-3 (Registration No. 333-275717), previously filed with the SEC, and declared effective on May 31, 2024.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">May 2025 Equity Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2025, Immunic entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Leerink Partners LLC, issuance and sale of (i) pre-funded warrants to purchase an aggregate of 86,666,667 shares of common stock, par value $0.0001 (&#8220;Common Stock&#8221;) of the Company (the &#8220;Pre-Funded Warrants&#8221;), (ii) accompanying series A warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#8220;Series A Warrants&#8221;), and (iii) accompanying series B warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#8220;Series B Warrants&#8221;) (the &#8220;May 2025 Offering&#8221;). The price per Pre-Funded Warrant and accompanying Series A Warrant and Series B Warrant was $0.7499. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.0001 per share and will expire when exercised in full. Each Series A Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.75 per share and will expire on December 31, 2025. Each Series B Warrant is exercisable on the earlier of (i) October 1, 2025, (ii) the first day following any five trading days during which the volume weighted average price for the Common Stock of the Company during such five trading day period is $1.25 or greater (the &#8220;VWAP Target&#8221;), or (iii) immediately prior to the consummation of a Fundamental Transaction (as defined in the Series B Warrants) for one share of Common Stock at an exercise price of $0.75 per share and will expire five years from the date of issuance. Each Series A Warrant and Series B Warrant will immediately expire in proportion to the extent that the corresponding Pre-Funded Warrant is exercised prior to September 30, 2025; provided that this term will not apply to the Series B Warrants immediately as of the date of achievement of the VWAP Target. The holder of the Pre-Funded Warrants and Series B Warrants may also satisfy its obligation to pay the exercise price through a &#8220;cashless exercise,&#8221; in which the holder receives the net value of such warrant in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">shares of Common Stock determined according to the formula set forth in the applicable warrant. Holders of Series A Warrants may, provided there is no effective registration statement or prospectus available which covers the warrants and shares of Common Stock issuable upon exercise of the Series A Warrants, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Series A Warrant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is prohibited from effecting an exercise of any Pre-Funded Warrants, Series A Warrants or Series B Warrants to the extent that such exercise would result in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding 4.99% (or 9.99% at election of the holder) of the total number of shares of Common Stock outstanding immediately after giving effect to the exercise (the &#8220;Beneficial Ownership Limitation&#8221;), which percentage may be increased or decreased at the holder&#8217;s election, not to exceed 19.99%. Any increase to the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. If a holder is not permitted to exercise a Series A Warrant or a Series B Warrant for Common Stock due to the Beneficial Ownership Limitation, then the holder may exercise such Series A Warrant or Series B Warrant for an equivalent number of Pre-Funded Warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The aggregate proceeds from the May 2025 Offering were approximately $65&#160;million before deducting underwriting discounts and commissions and offering expenses payable by the Company in connection with the May 2025 Offering. The Company may receive up to an aggregate of $130&#160;million of additional gross proceeds if the Series A Warrants and Series B Warrants are exercised in full for cash.  Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the May 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection therewith. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The May 2025 Offering was made pursuant to an effective registration statement on Form S-3 (Registration Statement No. 333-275717), as amended, previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on November 22, 2023, and declared effective by the SEC on May 31, 2024, as supplemented by the preliminary prospectus supplement, dated May 28, 2025, and a final prospectus supplement (the &#8220;Prospectus Supplement&#8221;) filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on May 30, 2025. The closing of the May 2025 Offering took place on  June 3, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement of up to $240 Million (the "January 2024 Financing")</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2024, Immunic entered into a Securities Purchase Agreement with select accredited investors, pursuant to which the Company agreed to issue and sell to the Investors in a three-tranche private placement shares of the Company&#8217;s common stock, $0.0001 par value per share or in lieu thereof, pre-funded warrants to purchase shares of Common Stock. The pre-funded warrants are exercisable immediately for $0.0001 per share and until exercised in full.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The first tranche, which closed on January 8, 2024, resulted in the purchase by the Investors of an aggregate of $80 million of Common Stock (or pre-funded warrants) from the Company at a price of $1.43 per share;  The second tranche is a conditional mandatory purchase by the Investors of an additional $80 million of Common Stock (or pre-funded warrants) from the Company at a price of $1.716 per share, equal to 120% of the price paid in the first tranche and is subject to the satisfaction of three conditions:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">release by the Company of topline data from its Phase 2b clinical trial of vidofludimus calcium (IMU-838) in progressive multiple sclerosis, which data was released on April 30, 2025;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the 10-day volume-weighted average price of the Common Stock is at least $8.00 per share during the 6 months following the data release; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">aggregate trading volume during the same 10-day period is at least $100 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The third tranche must occur no later than three years after the second tranche and is conditioned on the same volume-weighted average share price and minimum trading volumes as the second tranche. The third tranche provides for the issuance of $80 million of shares of common stock (or pre-funded warrants) at the same price per share as the second tranche, but permits investors to fund their purchase obligations on a &#8220;cashless&#8221; or net settlement basis, which would reduce the cash proceeds to be raised by the Company in the January 2024 Financing.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any of the conditions in the second or third tranches can be waived by holders of a majority of the outstanding securities (including the lead Investor). The fair value methodology used by the Company assumed the conditions will be waived if the trading price of the stock exceeds the purchase price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The January 2024 Financing resulted in gross proceeds to the Company of approximately $80 million in the first tranche, and an additional $80 million if and when the second tranche occurs. If the second tranche is completed and conditions for the third tranche are satisfied or waived, the Company could receive up to an additional $80 million in the third tranche. However, the amount of cash received in the third tranche would depend on the extent to which the Investors elect to fund the third tranche through a &#8220;cashless&#8221; or net settlement basis. Therefore, total gross proceeds from the offering to the Company could actually be between $80 million and $240 million. Gross proceeds to the Company will be reduced by fees paid to the placement agents, capital markets advisors and payments of transaction expenses. The Company intends to use the net proceeds from the January 2024 Financing to fund the ongoing clinical development of its three lead product candidates, vidofludimus calcium (IMU-838), IMU-856 and IMU-381, and for other general corporate purposes.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Future Capital Requirements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, we have not generated any revenue from product sales and we do not know when, or if, we will generate any revenue from product sales. We will not be able to generate any revenue from product sales unless and until we obtain regulatory approval for and commercialize any of our product candidates. We expect our expenses to continue to increase as we continue the ongoing research, development, manufacture and clinical trials of, and seek regulatory approval for, our product candidates. We also incur additional costs associated with operating as a public company. In addition, subject to obtaining regulatory approval of any of our product candidates, we anticipate that we will need substantial additional funding in connection with our continuing operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our future expenses and capital requirements are difficult to forecast and will depend on many factors, including, but not limited to:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and structure of any strategic options and transactions, if any;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personnel-related expenses, including salaries, benefits, stock-based compensation expense and other compensation expenses related to retention and termination of personnel;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, progress, duration, results and costs of research and development and ongoing clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of future regulatory submissions;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of developing and validating the manufacturing processes for any potential product candidates;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of any commercialization activities, including reimbursement, marketing, sales and distribution costs;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish new collaborations, licensing or other arrangements and the financial terms of such agreements;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number and characteristics of any future product candidates we pursue;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved with being a public company;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patents, including litigation costs and the outcome of such litigation;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost, timing and outcome of any future litigation; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, receipt and amount from the sales of, or royalties on, any future products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Until such time, if ever, as we can generate substantial product revenues, we will seek to finance our cash needs through a combination of stock offerings, debt financings, strategic alliances, collaborations and licensing arrangements. We do not expect to achieve revenue from product sales prior to the use of all the net proceeds from our public and private offerings to date. We do not have any committed external source of funds. Additional funds may not be available on acceptable terms, if at all. To the extent that we raise additional capital through the sale of equity securities, the ownership interest of our stockholders will be diluted and it may be on terms that are not favorable to us or our stockholders.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Sales of equity securities will also be more difficult for at least the foreseeable future because of general volatility in the equity markets for companies like us and the</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">relatively low trading price of our common stock.  Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt or other terms that are not favorable to us or our stockholders. Also, the cost of debt financing has increased due to the rise in interest rates over the past few years. If we raise additional funds through collaborations and licensing arrangements with third parties, we would expect to relinquish substantial rights to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">technologies or our future products, or grant licenses on terms that may not be favorable to us. If we were to complete a merger, or other business combination, we may relinquish all control over the organization and could experience detrimental tax effects.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to raise adequate funds, we may have to curtail our product development programs and liquidate some or all of our assets. Any of these factors could harm our operating results and could result in substantial declines in the trading price of our common stock.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, we had cash and cash equivalents of approximately $55.3 million. </span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of our cash flows for the six months ended June 30, 2025 and 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(46,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(41,008)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">65,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">74,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2025, operating activities used $46.4 million of cash. The use of cash primarily resulted from (i) our net loss of $52.3 million adjusted for non-cash charges of $4.1 million related to $3.9 million for stock-based compensation, $0.1 million related to non-cash lease expense and $0.1 million related to depreciation  (ii) a $1.8 million net decrease in our operating assets and liabilities. Changes in our operating assets and liabilities during the six months ended June 30, 2025 consisted primarily of a $2.3 million increase in our other current liabilities partially offset by a decrease in other current assets and prepaid expenses of $0.4 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2024, operating activities used $41.0 million of cash. The use of cash primarily resulted from (i) our net loss of $51.0 million adjusted for non-cash charges of $11.4 million related to a $4.8 million change in the fair value of the tranche rights, $4.6 million for stock-based compensation, $0.3 million related to non-cash lease expense  and $0.1 million for depreciation expense as well as $1.7 million in fees expensed as part of the January 2024 Financing, partially offset by a $0.1 million foreign currency gain and (ii) a $1.4 million net decrease in our operating assets and liabilities. Changes in our operating assets and liabilities during the six months ended June 30, 2024 consisted primarily of a $1.8 million decrease in our other current liabilities partially offset by an increase in other current assets and prepaid expenses of $0.4 million.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2025, net investing activities used $0.1 million due to the purchase of property and equipment.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2024, net investing activities used $0.2 million due to the purchase of property and equipment.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $65.5 million during the six months ended June 30, 2025 primarily consisting of net cash proceeds from the April 2025 Offering and the May 2025 Offering.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $74.4 million during the six months ended June 30, 2024 primarily consisting of net cash proceeds from the January 2024 Financing.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Through June 30, 2025, we have not entered into any transaction, agreement or other arrangements, and did not have any relationships with unconsolidated entities or financial collaborations, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purpose.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Other Commitments and Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2 - &#8220;Summary of Significant Accounting Policies - Collaboration Arrangements of the Notes to the condensed consolidated financial statements regarding the Company&#8217;s obligations under the option agreement with Daiichi Sankyo and Ludwig-Maximilians-University which includes the potential payment of future development, regulatory and sales milestone payments</span><span style="color:#008080;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the operating lease obligation are as follows as of June 30, 2025:</span></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:84.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">415,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">444,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">82,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,026,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(47,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Present value of obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">979,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, we had non-cancelable contractual obligations under certain agreements related to our development programs for vidofludimus calcium and IMU-856 totaling approximately $2.1&#160;million, all of which is expected to be paid in 2025 and 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements are prepared in conformity with U.S. GAAP. The preparation of our unaudited condensed consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. We have reviewed these critical accounting policies and related disclosures with the Audit Committee of our Board.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The new guidance is expected to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information by requiring 1) consistent categories and greater disaggregation of information in the rate reconciliation and 2) income taxes paid disaggregated by jurisdiction. The guidance is effective on a prospective basis, although retrospective application and early adoption is permitted. The standard was adopted for the annual period starting January 1, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_73"></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents of $55.3 million as of June 30, 2025, which were held for working capital purposes. We do not enter into investments for trading or speculative purposes. We do not believe that we have any material exposure to changes in the fair value of these investments as a result of changes in interest rates due to their short-term nature. Decreases or increases in interest rates, however, will reduce or increase future investment income, respectively, to the extent we have funds available for investment.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our primary research and development operations are conducted in our facilities in Germany. We have entered into and may continue to enter into international agreements, primarily related to our clinical studies. Accordingly, we have exposure to foreign currency exchange rates and fluctuations between the U.S. dollar and foreign currencies, primarily the Euro and the Australian dollar, which could adversely affect our financial results, including income and losses as well as assets and liabilities. To date, we have not entered into, and do not have any current plans to enter into, any foreign currency hedging transactions or derivative financial transactions. Our exposure to foreign currency risk will fluctuate in future periods as our research and clinical development activities in Europe and Australia change. We currently maintain a significant amount of our assets outside of the U.S.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The functional currencies of our foreign subsidiaries are the applicable local currencies. Accordingly, the effects of exchange rate fluctuations on the net assets of these operations are accounted for as translation gains or losses in accumulated other comprehensive income (loss) within stockholders&#8217; equity.  Foreign currency transaction gains and losses related to long-term intercompany loans that are payable in the foreseeable future are recorded in Other Income (Expense). Our German subsidiary is currently a significant portion of our business and, accordingly, a change of 10% in the currency exchange rates, primarily the Euro, could have a material impact on our financial position or results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although operating in local currencies may limit the impact of currency rate fluctuations on the results of operations of our German and Australian subsidiaries, rate fluctuations may impact the consolidated financial position as the assets and liabilities of our foreign operations are translated into U.S. dollars in preparing our condensed consolidated balance sheets. As of June 30, 2025, our German and Australian subsidiaries had net current liabilities (defined as current assets less current liabilities), subject to foreign currency translation risk, of $13.9 million. A change of approximately $1.4 million in net current assets would result as of June 30, 2025, from a hypothetical 10% adverse change in quoted foreign currency exchange rates, primarily due to the euro.  In addition, a 10% change in the foreign currency exchange rates for the six months ended June 30, 2025, would have impacted our net loss by approximately $4.1 million, primarily due to the euro.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Inflation and Tariffs</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced a general increase in costs as a result of global inflation, however, we do not believe that inflation and changing prices had a material impact on our results of operations for any periods presented herein. We do not believe that currently enacted or proposed tariffs will have a material impact on our operations going forward, but the actual</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">impact of potential or unannounced tariffs are not knowable at this time.</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-bottom:8.85pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was carried out, under the supervision of and with the participation of our management, including our Chief Executive Officer and our Principal Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15 (e)) under the Securities Exchange Act of 1934, as amended ("the Exchange Act"), as of the end of the period covered by this Quarterly Report. Based on such evaluation, our Chief Executive Officer and our Principal Financial Officer have concluded that as of June 30, 2025 our disclosure controls and procedures are effective to ensure that the information required to be disclosed by us in the reports we file or submit under the Exchange Act was recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:0.2pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting that occurred during the six months ended June 30, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_79"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Part II - OTHER INFORMATION</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any litigation, nor are we aware of any pending or threatened litigation against us, that we believe would materially affect our business, operating results, financial condition or cash flows. Our industry is characterized by frequent claims and litigation including securities litigation, claims regarding patent and other intellectual property rights and claims for product liability. As a result, in the future, we may be involved in various legal proceedings from time to time.</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;Risk Factors</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">You should carefully consider the risk factors included in Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 31, 2025 and the other information in this Report, including the section of this report titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and related notes. If any of the events described in our Annual Report, and the following risk factor and the risks described in our Form 10-K and elsewhere in this Report occur, our business, operating results and financial condition could be seriously harmed. This Report also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of factors that are described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and elsewhere in this Quarterly Report.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Failure to meet Nasdaq&#8217;s continued listing requirements could result in the delisting of our common stock, negatively</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">impact the price of our common stock and negatively impact our ability to raise additional capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2025, the Company received the Notice Letter from Nasdaq notifying the Company that we were not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price for our common stock was below the $1.00 per share requirement for the last 30 consecutive business days. The Notice Letter stated that we have 180 calendar days, or until December 24, 2025, to regain compliance with the minimum bid price requirement. If we do not regain compliance by the end of the Initial Compliance Period, we may apply for an additional compliance period as provided for in the Notice Letter. Nasdaq&#8217;s determination of whether we qualify for an additional compliance period will depend on whether we will meet the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and a written notice of our intention to cure the deficiency during the additional compliance period by effecting a reverse stock split, if necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Notice Letter has no immediate effect on the listing of our common stock on The Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we can regain compliance if the closing bid price of our common stock is at least $1.00 for a minimum of 10 consecutive business days. In the event that we do not regain compliance with Listing Rule 5450(a)(1) prior to the expiration of the Initial Compliance Period (or additional compliance period, if applicable), we will receive written notification that our securities are subject to delisting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to actively monitor the closing bid price of its common stock and is evaluating available options to regain compliance with the minimum bid price requirement. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or that the Company will otherwise remain in compliance with the other listing standards for the Nasdaq. Any delisting of the Company&#8217;s common stock from Nasdaq, including as a result of its inability to regain compliance with Nasdaq Listing Rule 5450(a)(1), could adversely affect the Company&#8217;s ability to attract new investors, reduce the liquidity of its outstanding shares of common stock, reduce its ability to raise additional capital, reduce the price at which its common stock trades, result in negative publicity and increase the transaction costs inherent in trading such shares with overall negative effects for the Company&#8217;s stockholders. The Company cannot assure its investors that its common stock, if delisted from Nasdaq, will be listed on another national securities exchange or quoted on an over-the-counter quotation system. In addition, delisting of the Company&#8217;s common stock could deter broker-dealers from making a market in or otherwise seeking or generating interest in the Company&#8217;s common stock and might deter certain institutions and persons from investing in the Company&#8217;s securities at all. For these reasons and others, delisting could adversely affect the Company&#8217;s business, financial condition and liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_91"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_94"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(c) During the six months ended June 30, 2025, no director or Section 16 officer <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-733"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-734">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-735"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-736">terminated</ix:nonNumeric></ix:nonNumeric> any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K promulgated by the SEC).</span></div><div id="i3f98a63a9d28482ab81ca8a270389f57_100"></div><div style="margin-top:12pt"><span><br/></span></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBITS</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/e664551_ex1-1.htm">Underwriting Agreement, dated as of May 28, 2025, by and between Immunic, Inc. and Leerink Partners LLC</a></span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 30, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380519000646/e618557_ex3-1.htm">Amended and Restated Certificate of Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">July 17, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380519000646/e618557_ex3-2.htm">Third Amended and Restated Bylaws.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">July 17, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001280776/000119380524000341/e619340_8k-immunic.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Immunic, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 8, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380519000837/e618652_ex4-2.htm">2019 Omnibus Equity Incentive Plan, as amended</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">August 21, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380521001075/e620824_s8-immunic.htm">Amended and Restated 2021 Employee Stock Purchase Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">July 28, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380524000022/e619173_ex4-1.htm">Form of Pre-Funded Warrant</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">January 4, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/e664373_ex4-1.htm">Form of Placement Agent Warrant</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 9, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/e664551_ex4-1.htm">Form of Pre-Funded Warrant</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 30, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/e664551_ex4-2.htm">Form of Series A Warrant</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 30, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/e664551_ex4-3.htm">Form of Series B Warrant</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 30, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1280776/000119380524001079/e663859_8k-immunic.htm">Addendum No. 6, dated August 29, 2024, to Employment Agreement, dated April 17, 2020, between Immunic, Inc. and Duane Nash.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 3, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/e619130_ex10-3.htm">Employment Agreement, dated December 18, 2023, between Immunic, Inc. and Dr. Andreas Muehler.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 18, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">F</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/e619130_ex10-1.htm">ifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Daniel Vitt.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 18, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/e619130_ex10-2.htm">Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Andreas Muehler.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 18, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/e619130_ex10-4.htm">Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Hella Kohlhof.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 18, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380524000022/e619173_ex10-1.htm">Securities Purchase Agreement, dated January 4, 2024, by and among the Company and the Investors.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">January 4, 2024</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380519000646/e618557_ex10-4.htm">Form of Indemnification Agreement.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">July 17, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000128077623000004/imux-ex105dienstvertragand.htm">Service Agreement, dated August 22, 2016, between Immunic AG and Dr. Andreas Muehler.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000128077623000004/imux-ex106dienstvertragdan.htm">Service Agreement, dated September 29, 2016, between Immunic AG and Daniel Vitt.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.10+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380519000646/e618557_ex10-5.htm">Employment Agreement between Dr. Daniel Vitt and Immunic AG.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">July 17, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.11+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380519000797/e618637_ex99-3.htm">Employment Agreement, dated September 4, 2019, between Immunic, Inc. and Dr. Andreas Muehler.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 5, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.12+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1280776/000119380520000499/e619564_ex10-2.htm">Employment Agreement dated April 17, 2020, between Immunic, Inc. and Duane Nash.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 20, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.13+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001280776/000119380521000860/e620704_ex10-3.htm">Employment Agreement, dated June 10, 2021 between Immunic, Inc. and Dr. Andreas Muehler</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.14+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001280776/000119380521000860/e620704_ex10-4.htm">Employment Agreement, dated June 10, 2021 between Immunic, Inc. and Glenn Whaley</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.15+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001280776/000119380521001455/e621010_ex10-1.htm">Employment Agreement, dated October 14, 2021, between Immunic, Inc. and Patrick Walsh</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">October 14, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.16+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="tardioagreementa01.htm">Employee Agreement, dated July 9, 2024, between Immunic, Inc. and Jason Tardio</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1280776/000119380524001496/e664091_8k-immunic.htm">Employment agreement dated December 13, 2024, between Immunic, Inc. and Dr. Daniel Vitt</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 18, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/e664373_ex10-1.htm">Form of Placement Agency Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 9, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/e664373_ex10-2.htm">Form of Securities Purchase Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 9, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1280776/000119380522000711/e621604_ex10-1.htm">Sales Agreement, dated as of May 2, 2022, between SVB Securities LLC and Immunic, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5/2/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="imux-63025xexhibit311.htm">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="imux-6x30x25xexhibit312.htm">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="imux-63025xexhibit321.htm">Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="imux-63025xexhibit322.htm">Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Database.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management&#8217;s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i3f98a63a9d28482ab81ca8a270389f57_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span><br/></span></div><div style="text-indent:288pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">IMMUNIC, INC.</span></div><div><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date: August 7, 2025&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By:   </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ Daniel Vitt                                 </span></div><div style="text-indent:288pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">         &#160;&#160;&#160;&#160;Daniel Vitt</span></div><div style="text-indent:288pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">         &#160;&#160;&#160;&#160;Chief Executive Officer and President</span></div><div style="text-indent:288pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span><br/></span></div><div style="margin-top:12pt;text-indent:49.5pt"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>2
<FILENAME>tardioagreementa01.htm
<DESCRIPTION>EX-16.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>tardioagreementa01</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:966;"><!-- tardioagreementa01001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01001.jpg" title="slide1" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  US_ACTIVE\127388755\V-1  EMPLOYMENT AGREEMENT  This Employment Agreement (the &#8220;Agreement&#8221;) is dated July 22, 2024 and effective  as of July 9, 2024 (the &#8220;Effective Date&#8221;), by and between IMMUNIC, INC., a Delaware  corporation (the &#8220;Company&#8221;), and Jason Tardio (the &#8220;Employee&#8221;).  WHEREAS, the Company has appointed the Employee to be an officer of the  Company effective as of July 9, 2024;  WHEREAS, the Employee will begin to serve pursuant to the terms of this  Agreement on July 12, 2024;  WHEREAS, the Company desires that the Employee joins the Company to serve in  the capacity of Chief Operating Officer and President of the Company, and the Employee  has agreed to serve in such position in accordance with the terms and conditions of this  Agreement;  NOW, THEREFORE, in consideration of the premises and mutual covenants  contained herein, and for other valuable consideration, the Company and the Employee  hereby agree as follows:  1. Certain Definitions.  The following terms, as used herein, have the following  meanings:  (a) &#8220;Cause&#8221; means one or more of the following: (i) the Employee&#8217;s willful  failure to perform his duties hereunder or the lawful directives of the Company&#8217;s Board of  Directors or nominees thereof (other than as a result of illness or injury), (ii) the conviction of,  or plea of nolo contendere by, the Employee to, a felony or a crime involving moral turpitude,  (iii) the Employee&#8217;s commission of any willful acts of personal dishonesty in connection with  his responsibilities as an employee of the Company that could reasonably be expected to  materially impair or damage the property, goodwill, reputation, business or finances of the  Company, (iv) the Employee&#8217;s willful and material violation of the Company&#8217;s policies  regarding ethics or conduct (including sexual harassment and other similar policies) that could  reasonably be expected to impair or damage the property, goodwill, reputation, business or  finances of the Company or its affiliates or (v) the Employee&#8217;s breach of his obligations under  the Confidentiality Agreement.  (b) &#8220;Change of Control&#8221; means the occurrence of any of the following  events: (i) a change in the ownership of the Company which occurs on the date that any one  person or entity, or more than one person or entity acting as a group (collectively, a &#8220;Person&#8221;  for purposes of this definition), acquires ownership of the stock of the Company that, together  with the stock held by such Person, constitutes more than fifty percent (50%) of the total voting  power of the stock of the Company; (ii) a change in the effective control of the Company which  occurs on the date that a majority of members of the Company&#8217;s Board of Directors is replaced  during any twelve (12) month period by Directors whose appointment or election is not  endorsed by a majority of the members of the Company&#8217;s Board of Directors prior to the date  of the appointment or election; or (iii)  change in the ownership of a substantial portion of the  Company&#8217;s assets which occurs on the date that any Person acquires (or has acquired during  the twelve (12) month period ending on the date of the most recent acquisition by such Person  or Persons) assets from the Company that have a total gross fair market value equal to or more  than fifty percent (50%) of the total gross fair market value of all of the assets of the Company  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01002.jpg" title="slide2" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  2  US_ACTIVE\127388755\V-1  immediately prior to such acquisition or acquisitions; provided, however, that for purposes of  this Section 1(b)(iii), the following will not constitute a change in the ownership of a substantial  portion of the Company&#8217;s assets: (A) a transfer to an entity that is controlled by the Company&#8217;s  stockholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1)  a stockholder of the Company (immediately before the asset transfer) in exchange for or with  respect to the Company&#8217;s stock, or (2) an entity, fifty percent (50%) or more of the total value  or voting power of which is owned, directly or indirectly, by the Company.  For purposes of  this Section 1(b)(iii), gross fair market value means the value of the assets of the Company, or  the value of the assets being disposed of, determined without regard to any liabilities associated  with such assets.  For purposes of this definition, Persons will be considered to be acting as a  group if they are owners of a corporation that enters into a merger, consolidation, purchase or  acquisition of stock, or similar business transaction with the Company.  Notwithstanding the  foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies  as a change in control event within the meaning of Code Section 409A, as it has been and may  be amended from time to time, and any proposed or final Treasury Regulations and Internal  Revenue Service guidance that has been promulgated or may be promulgated thereunder from  time to time.  Further and for the avoidance of doubt, a transaction will not constitute a Change  of Control if: (i) its sole purpose is to change the state of the Company&#8217;s incorporation, or (ii)  its sole purpose is to create a holding company that will be owned in substantially the same  proportions by the persons who held the Company&#8217;s securities immediately before such  transaction.  (c) &#8220;Change of Control Period&#8221; means the twelve (12) month period  following a Change of Control.  (d) &#8220;Date of Termination&#8221; means the date specified in a written notice of  termination delivered pursuant to Section 6, or the Employee&#8217;s last date as an active employee  of the Company before a termination of employment due to his death or Non-Renewal.  (e) &#8220;Disabled&#8221; or &#8220;Disability&#8221; means a mental or physical condition that  renders the Employee substantially incapable of performing his duties and obligations under  this Agreement, after taking into account provisions for reasonable accommodation, as  determined by a medical doctor (such doctor to be mutually determined in good faith by the  parties) for four (4) or more consecutive months or for a total of four (4) months during any  twelve (12) consecutive months.  (f) &#8220;Good Reason&#8221; means, unless the Employee has consented in writing  thereto, the occurrence of any of the following: (i) the assignment to the Employee of any duties  materially inconsistent with the Employee&#8217;s position, including any change in status, title,  authority, duties or responsibilities or any other action which results in a material diminution  in such status, title, authority, duties or responsibilities, (ii) a material reduction in the  Employee&#8217;s Base Salary by the Company or (iii) the relocation of the Employee&#8217;s office to a  location more than fifty (50) miles from his current residence in Massachusetts.  2. Term of Employment.  The terms and conditions set forth in this Agreement  will comence on the Effective Date and end on the earlier of: (a) December 31, 2024 (subject  to extension as provided in the following sentence) and (b) the Employee&#8217;s Date of Termination  (such period, including any extension as provided below, shall be referred to as the &#8220;Term of  Employment&#8221;).  This Agreement and the Term of Employment shall be automatically extended  for successive additional one (1)-year terms, unless either party provides written notice of non- renewal at least ninety (90) days before the end of then-current Term of Employment.  The  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01003.jpg" title="slide3" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  3  US_ACTIVE\127388755\V-1  Employee agrees to sign all documentation evidencing the foregoing as may be presented to  the Employee for signature by the Company.  3. Employee&#8217;s Duties and Obligations.  (a) Duties.  The Employee shall serve as the Chief Operating Officer and  President.  The Employee shall be responsible for all duties customarily associated with the  Chief Operating Officer and President of a publicly-traded company.  The Employee shall  report to the Chief Executive Officer of the Company and shall be subject to reasonable policies  established by such Chief Executive Officer.  (b) Location of Employment.  It is understood that Employee will be  working predominantly out of his home office in Massachsusetts unless the Employee and the  Company agree to an alternative arrangement.  In addition, the Employee acknowledges and  agrees that the performance by the Employee of the Employee&#8217;s duties shall require travel  including, without limitation, overseas travel from time to time.  (c) Confidential Information, Assignment of Rights, Non-Solicitation and  Non-Competition Agreement.  In consideration of the covenants contained herein, the  Employee has executed and agrees to be bound by the Confidential Information, Assignment  of Rights, Non-Solicitation and Non-Competition Agreement (the &#8220;Confidentiality  Agreement&#8221;) attached to this Agreement as Exhibit A.  The Employee shall comply at all times  with the covenants (including covenants not to compete or solicit employees, consultants and  independent contractors) and other terms and conditions of the Confidentiality Agreement and  all other reasonable policies of the Company governing its confidential and proprietary  information.  The Employee&#8217;s obligations under the Confidentiality Agreement shall survive  the Term of Employment.  4. Devotion of Time to the Company&#8217;s Business.  During the Term of  Employment, the Employee shall devote substantially all of his business time, attention and  effort to the affairs of the Company, excluding any periods of disability, vacation, or sick leave  to which the Employee is entitled, and shall use his reasonable best efforts to perform the duties  properly assigned to him hereunder and to promote the interests of the Company.  5. Compensation and Benefits.  (a) Signing Bonus.  The Company shall pay to the Employee a cash bonusof  sixty-thousand dollars ($60,000) within one month of the Effective Date.  In addition, and  provided that the Employee is an employee of the Company in good standing on January 12,  2025, the Company shall pay to the Employee an additional cash bonusof sixty-thousand  dollars ($60,000) after January 12, 2025.  (b) Base Salary.  The Company shall pay to the Employee in accordance  with its normal payroll practices (but not less frequently than monthly) an annual salary at a  rate of five hundred thousand dollars ($500,000) per annum (&#8220;Base Salary&#8221;).  The Employee&#8217;s  Base Salary shall be reviewed annually for the purpose of determining increases, if any, based  on the Employee&#8217;s performance, the performance of the Company, then prevailing salary scales  for comparable positions, inflation and other relevant factors.  Effective as of the date of any  increase in the Employee&#8217;s Base Salary, Base Salary as so increased shall be considered the  new Base Salary for all purposes of this Agreement and may not thereafter be reduced.  Any  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01004.jpg" title="slide4" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  4  US_ACTIVE\127388755\V-1  increase in Base Salary shall not limit or reduce any other obligation of the Company to the  Employee under this Agreement.  (c) Annual Bonus.  During the Term of Employment, the Employee shall  be eligible to receive an annual cash incentive award (&#8220;Annual Bonus&#8221;) pursuant to the bonus  plan then in effect for Employee employees of the Company (the &#8220;Bonus Plan&#8221;).  All Annual  Bonuses are subject to the terms and conditions of then-current Bonus Plan adopted by the  Company.  If the Employee achieves his target performance goals for a fiscal year, which goals  shall be determined by the Compensation Committee of the Company&#8217;s Board of Directors  (the&#8220;Compensation Committee&#8221;) on an annual or more frequent basis, the Annual Bonus shall  be not less than forty percent (40%) of the Employee&#8217;s Base Salary.  To be eligible to receive  an Annual Bonus, or any portion thereof, the Employee must be actively employed by the  Company at the time the Annual Bonus, if any, is paid, except as otherwise provided below.  (d) Equity Awards.  The Employee has been granted stock option equity  awards under the Immunic, Inc. 2019 Omnibus Equity Incentive Plan (the &#8220;Equity Plan&#8221;).   From time to time, the Employee may receive additional equity incentive awards under the  Equity Plan (or under any other equity incentive plan adopted by the Company to supplement  or succeed the Equity Plan).  All such awards are referred to herein as the &#8220;Equity Awards.&#8221;  (e) Benefits.  During the Term of Employment, the Employee shall be  entitled to participate in all employee benefit plans, programs and arrangements made available  generally to the Company&#8217;s senior employees or to other full-time employees on substantially  the same basis that such benefits are provided to such senior Employees of a similar level or to  other full-time employees.  (f) Vacations.  During the Term of Employment, the Employee shall be  entitled to twenty (20) days paid vacation per year, or such greater amount as may be earned  under the Company&#8217;s standard vacation policy.  (g) Reimbursement of Expenses.  During the Term of Employment, the  Employee shall be entitled to receive prompt reimbursement for all reasonable business-related  or employment-related expenses incurred by the Employee upon the receipt by the Company  of reasonable documentation in accordance with standard practices, policies and procedures  applicable to other senior Employees of the Company.  6. Termination of Employment.  The Term of Employment shall be automatically  terminated upon the first to occur of the following:  (a) Death.  The Employee&#8217;s employment shall terminate immediately upon  the Employee&#8217;s death.  (b) Disability.  If the Employee is Disabled, either party may terminate the  Employee&#8217;s employment due to such Disability upon delivery of written notice to the other  party.  The effective date of such termination of employment will be the Date of Termination  set forth in such written notice or immediately upon delivery of such written notice if no  effective date is specified in the written notice.  For avoidance of doubt, if the Employee&#8217;s  employment is terminated pursuant to this Section 6(b), his employment will not constitute a  termination of employment by the Company without Cause or by the Employee for Good  Reason.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01005.jpg" title="slide5" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  5  US_ACTIVE\127388755\V-1  (c) Termination by the Employee Without Good Reason.  The Employee  may terminate his employment for any reason other than Good Reason upon his delivery of  written notice to the Company at least thirty (30) days prior to his Date of Termination.  (d) Termination by the Employee for Good Reason.  The Employee may  terminate his employment for Good Reason if (i) not later than ninety (90) days after the  occurrence of any act or omission that constitutes Good Reason, the Employee provides the  Company with a written notice setting forth in reasonable detail the acts or omissions that  constitute Good Reason, (ii) the Company fails to correct or cure the acts or omissions within  thirty (30) days after it receives such written notice, and (iii) the Employee terminates his  employment with the Company after the expiration of such cure period but not later than thirty  (30) days after the expiration of such cure period.  (e) Termination by the Company Without Cause.  The Company may  terminate the Employee&#8217;s employment without Cause upon delivery of written notice to the  Employee at least thirty (30) days prior to his Date of Termination.   (f) Termination Upon Non-Renewal.  Unless otherwise agreed to by the  parties, the Employee&#8217;s employment shall terminate on the last day of then-current Term of  Employment if either the Company or the Employee provides the other party with a written  notice of non-renewal of this Agreement in accordance with Section 2 and the parties do not  enter into a new employment agreement prior to the expiration of this Agreement (&#8220;Non- Renewal&#8221;).  (g) Termination by the Company for Cause.  Upon the occurrence of any  act or omission that constitutes Cause, the Company may terminate the Employee&#8217;s  employment upon delivery of written notice to the Employee at least fifteen (15) days prior to  his Date of Termination, unless the Employee cures, if curable, such acts or omissions  constituting Cause to the satisfaction of the Company prior to the expiration of such period.  7. Compensation and Benefits Payable Upon of Termination of Employment  Unrelated to a Change of Control.  (a) Payment of Accrued But Unpaid Compensation and Benefits.  Upon the  Employee&#8217;s termination of employment for any reason outside of the Change of Control  Period, the Employee (or his Beneficiary following the Employee&#8217;s death) shall receive (i) a  lump sum payment on the Date of Termination in an amount equal to the sum of the  Employee&#8217;s earned but unpaid Base Salary through his Date of Termination plus his accrued  but unused vacation days at the Employee&#8217;s Base Salary in effect as of his Date of Termination;  plus (ii) any other benefits or rights the Employee has accrued or earned through his Date of  Termination in accordance with the terms of the applicable fringe or employee benefit plans  and programs of the Company.  Except as provided in Section 7(b) or Section 7(c) below or as  expressly provided pursuant to the terms of any employee benefit plan, the Employee will not  be entitled to earn or accrue any additional compensation or benefits for any period following  his Date of Termination.  (b) Termination of Employment Due to Death or Disability.  In addition to  the compensation and benefits payable under Section 7(a) above, if the Employee&#8217;s  employment is terminated due to his death or Disability outside of the Change of Control  Period, the Employee (or his Beneficiary following the Employee&#8217;s death) shall receive:  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01006.jpg" title="slide6" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  6  US_ACTIVE\127388755\V-1  (i) the Employee&#8217;s accrued but unpaid Annual Bonus, if any, for the  fiscal year ended prior to his Date of Termination payable at the same time annual bonuses for  such fiscal year are paid to other key Employees of the Company pursuant to the terms of the  Bonus Plan;  (ii) fifty percent (50%) of the Employee&#8217;s outstanding unvested  Equity Awards as of the Date of Termination will be fully vested and exercisable; and  (iii) reimbursement of the COBRA premiums, if any, paid by the  Employee&#8217;s spouse and dependents for continuation coverage for the Employee&#8217;s spouse and  dependents under the Company&#8217;s group health, dental and vision plans for a six (6) month  period from the Date of Termination.  (c) Termination of Employment by the Company Without Cause, by the  Employee for Good Reason or Upon Non-Renewal by the Company.  In addition to the  compensation and benefits payable under Section 7(a) above, if the Employee&#8217;s employment  is terminated by the Company without Cause, by the Employee for Good Reason or upon Non- Renewal where it is the Company that provided written notice of non-renewal of this  Agreement in accordance with Section 2, and such termination occurs outside of the Change  of Control Period, and the Employee returns an executed Release to the Company, which  becomes final, binding and irrevocable within sixty (60) days following the Employee&#8217;s Date  of Termination in accordance with Section 10, the Employee (or his Beneficiary following the  Employee&#8217;s death) shall receive:  (i) the Employee&#8217;s accrued but unpaid Annual Bonus, if any, for the  fiscal year ended prior to his Date of Termination payable at the same time annual bonuses for  such fiscal year are paid to other key Employees of the Company pursuant to the terms of the  Bonus Plan;  (ii) fifty percent (50%) of the Employee&#8217;s outstanding unvested  Equity Awards as of the Date of Termination will be fully vested and exercisable;  (iii) a severance payment payable in a single lump sum within five  (5) business days after the Employee&#8217;s Release becomes final, binding and irrevocable in  accordance with Section 10, in an amount equal to twelve (12) months of Base Salary; and  (iv) reimbursement of the COBRA premiums, if any, paid by the  Employee for continuation coverage for the Employee, his spouse and dependents under the  Company&#8217;s group health, dental and vision plans for a twelve (12) month period from the Date  of Termination.  Notwithstanding the foregoing, if the Employee materially breaches this Agreement or  the Employee&#8217;s Confidentiality Agreement, then the Company&#8217;s continuing obligations under  this Section 7(c) shall cease as of the date of the breach and the Employee shall be entitled to  no further payments hereunder.  8. Termination of Employment by the Company Without Cause, by the Employee  for Good Reason or Upon Non-Renewal by the Company in Connection with a Change of  Control.  In addition to the compensation and benefits payable under Section 7(a) above, if the  Employee&#8217;s employment is terminated by the Company without Cause, by the Employee for  Good Reason or upon Non-Renewal where it is the Company that provided written notice of  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01007.jpg" title="slide7" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  7  US_ACTIVE\127388755\V-1  non-renewal of this Agreement in accordance with Section 2, and such termination occurs  during the Change of Control Period, and the Employee returns an executed Release to the  Company, which becomes final, binding and irrevocable within sixty (60) days following the  Employee&#8217;s Date of Termination in accordance with Section 10, the Employee (or his  Beneficiary following the Employee&#8217;s death) shall receive:  (a) a single lump sum within five (5) business days after the Employee&#8217;s  Release becomes final, binding and irrevocable in accordance with Section 10, equal to the  Employee&#8217;s accrued but unpaid Annual Bonus, if any, for the fiscal year ended prior to his  Date of Termination;  (b) a single lump sum within five (5) business days after the Employee&#8217;s  Release becomes final, binding and irrevocable in accordance with Section 10, equal one  hundred percent (100%) of Employee&#8217;s target bonus as in effect for the fiscal year in which  Employee&#8217;s termination of employment occurs; provided that, for avoidance of doubt, the  amount paid to Employee pursuant to this Section 8(b) will not be prorated based on the actual  amount of time Employee is employed by the Company during the fiscal year (or the relevant  performance period if something different than a fiscal year) during which the termination  occurs;  (c) one hundred percent (100%) of the Employee&#8217;s outstanding unvested  Equity Awards as of the Date of Termination will be fully vested and exercisable;  (d) a severance payment payable in a single lump sum within five (5)  business days after the Employee&#8217;s Release becomes final, binding and irrevocable in  accordance with Section 10, in an amount equal to twelve (12) months of Base Salary; and  (e) reimbursement of the COBRA premiums, if any, paid by the Employee  for continuation coverage for the Employee, his spouse and dependents under the Company&#8217;s  group health, dental and vision plans for a twelve (12) month period from the Date of  Termination.  9. Terminations Within Sixty (60) Days Prior to a Change of Control.  If (a) the  Employee incurred a termination prior to a Change of Control that qualifies Employee for  severance payments under Section 7(c) and (b) a Change of Control occurs within sixty (60)  days following Employee&#8217;s termination of employment, then upon the Change of Control, the  Employee shall be entitled to a lump-sum payment of the amount calculated under this Section  8, less amounts already paid under Section 7(c), subject to compliance with Section 10.  10. Release.  As a condition of receiving the compensation and benefits described  in Section 7(c) or Section 8, the Employee must execute a release of any and all claims arising  out of the Employee&#8217;s employment with the Company or the Employee&#8217;s separation from such  employment (including, without limitation, claims relating to age, disability, sex or race  discrimination to the extent permitted by law), excepting (i) claims for benefits under any  employee benefit plan in accordance with the terms of such employee benefit plan, (ii) any  right to exercise Equity Awards that are vested on the Date of Termination pursuant to the  terms of such Equity Awards (as modified by the Employment Agreement), (iii) claims based  on breach of the Company&#8217;s obligations to pay the compensation and benefits described in  Section 5 and Section 7(a), Section 7(c) or Section 8 of this Employment Agreement, (iv)  claims arising under the Age Discrimination in Employment Act after the date the Employee  signs such release, and (v) any right to indemnification by the Company or to coverage under  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01008.jpg" title="slide8" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  8  US_ACTIVE\127388755\V-1  directors and officers liability insurance to which the Employee is otherwise entitled in  accordance with this Agreement and the Company&#8217;s articles of incorporation or by laws or  other agreement between the Employee and the Company (the &#8220;Release&#8221;).  Such Release shall  be in a form tendered to the Employee by the Company within five (5) business days following  the termination of the Employee&#8217;s employment by the Company without Cause or by the  Employee for Good Reason, which shall comply with any applicable legislation or judicial  requirements, including, but not limited to, the Older Workers Benefit Protection Act, and shall  be substantially in the form of release attached as Exhibit B.  The compensation and benefits  described in Section 7(c) or Section 8 will not be paid to the Employee if the Employee fails  to execute the Release within the time frame specified in such Release, if the Employee revokes  the Release within the applicable revocation period set forth in such Release or if the revocation  period expires more than sixty (60) days following the Employee&#8217;s Date of Termination.  11. Excess Parachute Excise Tax.  (a) Anything in this Agreement to the contrary notwithstanding, in the event  it shall be determined that any payment, award, benefit or distribution (including any  acceleration) by the Company or any entity which effectuates a transaction described in Section  280G(b)(2)(A)(i) of the Internal Revenue Code of 1986, as amended and the regulations  promulgated thereunder (the &#8220;Code&#8221;) to or for the benefit of the Employee (whether pursuant  to the terms of this Agreement or otherwise, but determined before application of any  reductions required pursuant to this Section 11) (a &#8220;Payment&#8221;) would be subject to the excise  tax imposed by Section 4999 of the Code or any interest or penalties are incurred with respect  to such excise tax by the Employee (such excise tax, together with any such interest and  penalties, are hereinafter collectively referred to as the &#8220;Excise Tax&#8221;), the Company will  automatically reduce such Payments to the extent, but only to the extent, necessary so that no  portion of the remaining Payments will be subject to the Excise Tax, unless the amount of such  Payments that the Employee would retain after payment of the Excise Tax and all applicable  Federal, state and local income taxes without such reduction would exceed the amount of such  Payments that the Employee would retain after payment of all applicable Federal, state and  local taxes after applying such reduction.  Unless otherwise elected by the Employee, to the  extent permitted under Code Section 409A, such reduction shall first be applied to any  severance payments payable to the Employee under this Agreement, then to the accelerated  vesting on any Equity Awards.  (b) All determinations required to be made under this Section 11, including  the assumptions to be utilized in arriving at such determination, shall be made by the  Company&#8217;s independent auditors or such other certified public accounting firm of national  standing reasonably acceptable to the Employee as may be designated by the Company (the  &#8220;Accounting Firm&#8221;) which shall provide detailed supporting calculations both to the Company  and the Employee within fifteen (15) business days of the receipt of notice from the Employee  that there has been a Payment, or such earlier time as is requested by either the Company or  the Employee.  All fees and expenses of the Accounting Firm shall be borne solely by the  Company.  If the Accounting Firm determines that no Excise Tax is payable by the Employee,  it shall furnish the Employee with a written opinion to such effect.  Any determination by the  Accounting Firm shall be binding upon the Company and the Employee.  12. Legal Fees.  Each party shall be responsible for its own legal fees and expenses  in connection with any claim or dispute relating to this Agreement.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01009.jpg" title="slide9" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  9  US_ACTIVE\127388755\V-1  13. Beneficiary.  If the Employee dies prior to receiving all of the amounts payable  to him in accordance with the terms of this Agreement, such amounts shall be paid to one or  more beneficiaries (each, a &#8220;Beneficiary&#8221;) designated by the Employee in writing to the  Company during his lifetime, or if no such Beneficiary is designated, to the Employee&#8217;s estate.   Such payments shall be made in accordance with the terms of this Agreement.  The Employee,  without the consent of any prior Beneficiary, may change his designation of Beneficiary or  Beneficiaries at any time or from time to time by a submitting to the Company a new  designation in writing.  14. Notices.  All notices, requests, demands and other communications hereunder  shall be in writing and shall be deemed to have been duly given if delivered by hand, email or  mailed within the continental United States by first class certified mail, return receipt requested,  postage prepaid, addressed as follows:  If to the Company:  Immunic, Inc.  c/o Immunic AG  Lochhamer Schlag 21  82166 Gr&auml;felfing, Germany  Attn:  Chief Executive Officer  Email:  daniel.vitt@imux.com  If to the Employee:  To the address on file with the records of the Company.  Addresses may be changed by written notice sent to the other party at the last recorded  address of that party.  15. Withholding.  The Company shall be entitled to withhold from payments due  hereunder any required federal, state or local withholding or other taxes.  16. Arbitration.  (a) If the parties are unable to resolve any dispute or claim relating directly  or indirectly to this agreement or any dispute or claim between the Employee and the Company  or its officers, directors, agents, or employees (a &#8220;Dispute&#8221;), then either party may require the  matter to be settled by final and binding arbitration by sending written notice of such election  to the other party clearly marked &#8220;Arbitration Demand.&#8221; Thereupon such Dispute shall be  arbitrated in accordance with the terms and conditions of this Section 16.  Notwithstanding the  foregoing, either party may apply to a court of competent jurisdiction for a temporary  restraining order, a preliminary injunction, or other equitable relief to preserve the status quo  or prevent irreparable harm or to enforce the terms of the Confidentiality Agreement.  (b) The Dispute shall be resolved by a single arbitrator in an arbitration  administered by the American Arbitration Association in accordance with its Employment  Arbitration Rules and judgment upon the award rendered by the arbitrator may be entered in  any court having jurisdiction thereof.  The decision of the arbitrator shall be final and binding  on the parties, and specific performance giving effect to the decision of the arbitrator may be  ordered by any court of competent jurisdiction.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01010.jpg" title="slide10" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  10  US_ACTIVE\127388755\V-1  (c) Nothing contained herein shall operate to prevent either party from  asserting counterclaim(s) in any arbitration commenced in accordance with this Agreement,  and any such party need not comply with the procedural provisions of this Section 16 in order  to assert such counterclaim(s).  (d) The arbitration shall be filed with the office of the American Arbitration  Association (&#8220;AAA&#8221;) located in New York or such other AAA office as the parties may agree  upon (without any obligation to so agree).  The arbitration shall be conducted pursuant to the  Employment Arbitration Rules of the AAA as in effect at the time of the arbitration hearing,  such arbitration to be completed in a sixty (60)-day period.  In addition, the following rules and  procedures shall apply to the arbitration:  (e) The arbitrator shall have the sole authority to decide whether or not any  Dispute between the parties is arbitrable and whether the party presenting the issues to be  arbitrated has satisfied the conditions precedent to such party&#8217;s right to commence arbitration  as required by this Section 16.  (f) The decision of the arbitrator, which shall be in writing and state the  findings, the facts and conclusions of law upon which the decision is based, shall be final and  binding upon the parties, who shall forthwith comply after receipt thereof.  Judgment upon the  award rendered by the arbitrator may be entered by any competent court.  Each party submits  itself to the jurisdiction of any such court, but only for the entry and enforcement to judgment  with respect to the decision of the arbitrator hereunder.  (g) The arbitrator shall have the power to grant all legal and equitable  remedies (including, without limitation, specific performance) and award compensatory and  punitive damages if authorized by applicable law.  (h) Except as otherwise provided in Section 12 or by law, the parties shall  bear their own costs in preparing for and participating in the resolution of any Dispute pursuant  to this Section 16, and the costs of the arbitrator(s) shall be equally divided between the parties.  (i) Except as provided in the last sentence of Section 16(a), the provisions  of this Section 16 shall be a complete defense to any suit, action or proceeding instituted in any  federal, state or local court or before any administrative tribunal with respect to any Dispute  arising in connection with this Agreement.  Any party commencing a lawsuit in violation of  this Section 16 shall pay the costs of the other party, including, without limitation, reasonable  attorney&#8217;s fees and defense costs.  17. Recoupment.  (a) Policy.  Any incentive-based compensation received by the Employee  including Annual Bonus and Equity Awards, whether pursuant to this Agreement or otherwise,  that is granted, earned or vested based in any part on attainment of a financial reporting  measure, shall be subject to the terms and conditions of the Company&#8217;s Claw Back  Compensation Policy (the &#8220;Recoupment Policy&#8221;), and any other policy of recoupment of  compensation as shall be adopted from time to time by the Company&#8217;s Board of Directors or  the Compensation Committee as it deems necessary or appropriate to comply with the  requirements of Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection  Act, Section 304 of the Sarbanes-Oxley Act of 2002, and any implementing rules and  regulations of the U.S. Securities and Exchange Commission and applicable listing standards  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01011.jpg" title="slide11" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  11  US_ACTIVE\127388755\V-1  of a national securities exchange adopted in accordance with any of the foregoing.  The terms  and conditions of the Recoupment Policy, including any changes to the Recoupment Policy  adopted from time to time by the Company, are hereby incorporated by reference into this  Agreement.  (b) Non-Indemnification and Advancement for Recoupment.  The  Company shall not be obligated to indemnify or advance funds to the Employee for any  payment or reimbursement by the Employee to the Company of any bonus or other incentive- based or equity-based compensation previously received by the Employee or payment of any  profits realized by the Employee from the sale of securities of the Company, as required in  each case under the Securities Exchange Act of 1934 or under the rules of the stock exchange  on which the common stock of the Company is listed (including any such payments or  reimbursements under Section 304 and 306 of the Sarbanes-Oxley Act of 2002, or pursuant to  Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act and any  implementing rules and regulations of the U.S. Securities and Exchange Commission and  applicable listing standards of a national securities exchange adopted in accordance with any  of the foregoing).  18. Miscellaneous  (a) Governing Law.  This Agreement shall be interpreted, construed,  governed and enforced according to the laws of the State of New York without regard to the  application of choice of law rules.  (b) Entire Agreement.  This Agreement contains the entire agreement  between the parties with respect to the subject matter hereof and supersedes any and all other  prior agreements, promises, understandings and representations regarding the Employee&#8217;s  employment, compensation, severance or other payments contingent upon the Employee&#8217;s  termination of employment, whether written or otherwise.  (c) Amendments.  No amendment or modification of the terms or conditions  of this Agreement shall be valid unless in writing and signed by the parties hereto.  (d) Severability.  If one or more provisions of this Agreement are held to be  invalid or unenforceable under applicable law, such provisions shall be construed, if possible,  so as to be enforceable under applicable law, or such provisions shall be excluded from this  Agreement and the balance of the Agreement shall be interpreted as if such provision were so  excluded and shall be enforceable in accordance with its terms.  (e) Binding Effect.  This Agreement shall be binding upon and inure to the  benefit of the beneficiaries, heirs and representatives of the Employee (including the  Beneficiary) and the successors and assigns of the Company.  The Company shall require any  successor (whether direct or indirect, by purchase, merger, reorganization, consolidation,  acquisition of property or stock, liquidation, or otherwise) to all or substantially all of its assets,  by agreement in form and substance satisfactory to the Employee, expressly to assume and  agree to perform this Agreement in the same manner and to the same extent that the Company  would be required to perform this Agreement if no such succession had taken place.  Regardless  whether such agreement is executed, this Agreement shall be binding upon any successor of  the Company in accordance with the operation of law and such successor shall be deemed the  Company for purposes of this Agreement.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01012.jpg" title="slide12" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  12  US_ACTIVE\127388755\V-1  (f) Successors and Assigns; Non-alienation of Benefits.  Except as provided  in Section 18(e) in the case of the Company, or to the Beneficiary in the case of the death of  the Employee, this Agreement is not assignable by any party.  Compensation and benefits  payable to the Employee under this Agreement shall not be subject in any manner to  anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, charge, garnishment,  execution or levy of any kind, either voluntary or involuntary, prior to actually being received  by the Employee or a Beneficiary, as applicable, and any such attempt to dispose of any right  to benefits payable hereunder shall be void and no payment to be made hereunder shall be  subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance or other  charge.  (g) Remedies Cumulative; No Waiver.  No remedy conferred upon either  party by this Agreement is intended to be exclusive of any other remedy, and each and every  such remedy shall be cumulative and shall be in addition to any other remedy given hereunder  or now or hereafter existing at law or in equity.  No delay or omission by either party in  exercising any right, remedy or power hereunder or existing at law or in equity shall be  construed as a waiver thereof, and any such right, remedy or power may be exercised by such  party from time to time and as often as may be deemed expedient or necessary by such party  in such party&#8217;s sole discretion.  (h) Survivorship.  Notwithstanding anything in this Agreement to the  contrary, all terms and provisions of this Agreement that by their nature extend beyond the  Date of Termination shall survive termination of this Agreement.  (i) Counterparts.  This Agreement may be executed in two or more  counterparts, each of which shall constitute an original, but all of which, when taken together,  shall constitute one document.  19. No Contract of Employment.  Nothing contained in this Agreement will be  construed as a right of the Employee to be continued in the employment of the Company, or as  a limitation of the right of the Company to discharge the Employee with or without Cause.  20. Section 409A of the Code.  (a) The intent of the parties is that payments and benefits under this  Agreement comply with, or be exempt from, Section 409A of the Code and, accordingly, to  the maximum extent permitted, this Agreement shall be construed and interpreted in  accordance with such intent.  The Employee&#8217;s termination of employment (or words to similar  effect) shall not be deemed to have occurred for purposes of this Agreement unless such  termination of employment constitutes a &#8220;separation from service&#8221; within the meaning of Code  Section 409A and the regulations and other guidance promulgated thereunder.  (b) Notwithstanding any provision in this Agreement to the contrary, if the  Employee is deemed on the date of the Employee&#8217;s separation from service to be a &#8220;specified  employee&#8221; within the meaning of that term under Code Section 409A(a)(2)(B) and using the  identification methodology selected by the Company from time to time, or if none, the default  methodology set forth in Code Section 409A, then with regard to any payment or the providing  of any benefit that constitutes &#8220;non-qualified deferred compensation&#8221; pursuant to Code Section  409A and the regulations issued thereunder that is payable due to the Employee&#8217;s separation  from service, to the extent required to be delayed in compliance with Code Section  409A(a)(2)(B), such payment or benefit shall not be made or provided to the Employee prior  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01013.jpg" title="slide13" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  13  US_ACTIVE\127388755\V-1  to the earlier of (i) the expiration of the six (6)-month period measured from the date of the  Employee&#8217;s separation from service, and (ii) the date of the Employee&#8217;s death.  On the first day  of the seventh (7th) month following the date of the Employee&#8217;s separation from service or, if  earlier, on the date of the Employee&#8217;s death, all payments delayed pursuant to this Section 20  shall be paid or reimbursed to the Employee in a lump sum, and any remaining payments and  benefits due to the Employee under this Agreement shall be paid or provided in accordance  with the normal payment dates specified for them herein.  (c) To the extent any reimbursement of costs and expenses (including  reimbursement of COBRA premiums pursuant to Section 7(c)(iv)) provided for under this  Agreement constitutes taxable income to the Employee for Federal income tax purposes, such  reimbursements shall be made as soon as practicable after the Employee provides proper  documentation supporting reimbursement but in no event later than December 31 of the  calendar year next following the calendar year in which the expenses to be reimbursed are  incurred.  With regard to any provision herein that provides for reimbursement of expenses or  in-kind benefits, except as permitted by Code Section 409A, (i) the right to reimbursement or  in-kind benefits is not subject to liquidation or exchange for another benefit, and (ii) the amount  of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year  shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in  any other taxable year.  (d) If under this Agreement, any amount is to be paid in two (2) or more  installments, each such installment shall be treated as a separate payment for purposes of  Section 409A.  21. Employee Acknowledgement.  The Employee hereby acknowledges that the  Employee has read and understands the provisions of this Agreement, that the Employee has  been given the opportunity for the Employee&#8217;s legal counsel to review this Agreement, that the  provisions of this Agreement are reasonable and that the Employee has received a copy of this  Agreement.  [SIGNATURE PAGE FOLLOWS]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01014.jpg" title="slide14" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  US_ACTIVE\127388755\V-1  IN WITNESS WHEREOF, the parties hereto have caused this Employment  Agreement to be executed as of the 22nd day of July 20244.  IMMUNIC, INC.  By:  /s/ Daniel Vitt    Name:  Daniel Vitt  Title:   Chief Executive Officer  EMPLOYEE  /s/ Jason Tardio    Jason Tardio    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01015.jpg" title="slide15" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  US_ACTIVE\127388755\V-1  EXHIBIT A  CONFIDENTIAL INFORMATION, ASSIGNMENT OF RIGHTS,  NON-SOLICITATION AND NON-COMPETITION AGREEMENT  [SEE ATTACHED]    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01016.jpg" title="slide16" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  US_ACTIVE\127388755\V-1  EXHIBIT B  WAIVER AND RELEASE  This is a Waiver and Release (&#8220;Release&#8221;) between Jason Tardio (&#8220;Employee&#8221;) and  Immunic, Inc. (the &#8220;Company&#8221;).  The Company and the Employee agree that they have entered  into this Release voluntarily, and that it is intended to be a legally binding commitment between  them.  In consideration for and contingent upon the Employee&#8217;s right to receive the benefits  described in the Employment Agreement between the Company and the Employee (the  &#8220;Employment Agreement&#8221;) and this Release, the Employee hereby agrees as follows:  (a) General Waiver and Release.  Except as provided in Paragraph (e) below, the  Employee and any person acting through or under the Employee hereby release, waive and  forever discharge the Company, its past and present subsidiaries and affiliates, and their  respective successors and assigns, and their respective past and present officers, trustees,  directors, shareholders, Employees and agents of each of them, from any and all claims,  demands, actions, liabilities and other claims for relief and remuneration whatsoever (including  without limitation attorneys&#8217; fees and expenses), whether known or unknown, absolute,  contingent or otherwise (each, a &#8220;Claim&#8221;), arising or which could have arisen up to and  including the date of his execution of this Release, including without limitation those arising  out of or relating to the Employee&#8217;s employment or cessation and termination of employment,  or any other written or oral agreement, any change in the Employee&#8217;s employment status, any  benefits or compensation, any tortious injury, breach of contract, wrongful discharge (including  any Claim for constructive discharge), infliction of emotional distress, slander, libel or  defamation of character, and any Claims arising under Title VII of the Civil Rights Act of 1964  (as amended by the Civil Rights Act of 1991), the Americans With Disabilities Act, the  Rehabilitation Act of 1973, the Equal Pay Act, the Older Workers Benefits Protection Act, the  Age Discrimination in Employment Act, the Employee Retirement Income Security Act of  1974, or any other federal, state or local statute, law, ordinance, regulation, rule or Employee  order, any tort or contract claims, and any of the claims, matters and issues which could have  been asserted by the Employee against the Company or its subsidiaries and affiliates in any  legal, administrative or other proceeding.  the Employee agrees that if any action is brought in  his name before any court or administrative body, the Employee will not accept any payment  of monies in connection therewith.  (b) Miscellaneous.  the Employee agrees that Section 7(c) of the Employment  Agreement (which is specifically incorporated herein by reference) specifies payments from  the Company to himself, the total of which meets or exceeds any and all funds due him by the  Company, and that he will not seek to obtain any additional funds from the Company with the  exception of non-reimbursed business expenses.  (This covenant does not preclude the  Employee from seeking workers&#8217; compensation, unemployment compensation, or benefit  payments from the Company&#8217;s insurance carriers that could be due him.)  (c) Non-Solicitation, Confidentiality and Non-Solicitation Covenants.  the  Employee warrants that the Employee has, and will comply fully with Section 3(c) of the  Employment Agreement and the provisions of the Confidential Information, Assignment of  Rights, Non-Solicitation and Non-Competition Agreement by and between the Company and  the Employee.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01017.jpg" title="slide17" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  US_ACTIVE\127388755\V-1  (d) THE COMPANY AND THE EMPLOYEE AGREE THAT THE BENEFITS  DESCRIBED IN SECTION 7(C) OF THE EMPLOYMENT AGREEMENT AS SUBJECT  TO EMPLOYEE&#8217;S COMPLIANCE WITH SECTION 9 THEREOF ARE CONTINGENT  UPON THE EMPLOYEE SIGNING THIS RELEASE.  THE EMPLOYEE FURTHER  UNDERSTANDS AND AGREES THAT IN SIGNING THIS RELEASE, EMPLOYEE IS  RELEASING POTENTIAL LEGAL CLAIMS AGAINST THE COMPANY.  THE  EMPLOYEE UNDERSTANDS AND AGREES THAT IF HE DECIDES NOT TO SIGN  THIS RELEASE, OR IF HE REVOKES THIS RELEASE, THAT HE WILL IMMEDIATELY  REFUND TO THE COMPANY ANY AND ALL SEVERANCE PAYMENTS AND OTHER  BENEFITS HE MAY HAVE ALREADY RECEIVED.  (e) The waiver contained in Paragraph (a) and (b) above does not apply to:  (i) Any claims for benefits under employee benefit plans in accordance  with the terms of the applicable employee benefit plan, including the  Employee&#8217;s right to elect continuation coverage under the Company&#8217;s  group health, dental and/or visions plans pursuant to the Consolidated  Omnibus Budget Reconciliation Act of 1985, as amended (COBRA),  (ii) Any right to exercise stock options or stock appreciation rights that were  vested and exercisable on the Date of Termination in accordance with  the terms thereof (as modified by the Employment Agreement);  (iii) Any Claim under or based on a breach of the Company&#8217;s obligations to  pay the compensation and benefits described in Sections 5 or 7(a) or (c)  of the Employment Agreement,  (iv) Rights or Claims that may arise under the Age Discrimination in  Employment Act after the date that the Employee signs this Release, and  (v) Any right to indemnification by the Company or to coverage under  directors and officers liability insurance to which the Employee is  otherwise entitled in accordance with the Employment Agreement or the  Company&#8217;s articles of incorporation or by-laws or other agreement  between the Employee and the Company.  (f) EMPLOYEE ACKNOWLEDGES THAT HE HAS READ AND IS  VOLUNTARILY SIGNING THIS RELEASE.  EMPLOYEE ALSO ACKNOWLEDGES  THAT HE IS HEREBY ADVISED TO CONSULT WITH AN ATTORNEY, HE HAS BEEN  GIVEN AT LEAST [21][45] DAYS TO CONSIDER THIS RELEASE BEFORE THE  DEADLINE FOR SIGNING IT; [HE HAS RECEIVED A RECEIVED A WRITTEN  DESCRIPTION OF THE JOB TITLES AND AGES ALL INDIVIDUALS SELECTED  FOR THIS JOB ELIMINATION PROGRAM AND THE AGES OF ANY INDIVIDUALS  IN THE SAME JOB CLASSIFICATIONS WHO ARE NOT SELECTED FOR THIS JOB  ELIMINATION PROGRAM AS PROVIDED BY THE ADEA (SUCH DESCRIPTION  ATTACHED AS EXHIBIT A HERETO)]; AND HE UNDERSTANDS THAT HE MAY  REVOKE THE RELEASE WITHIN SEVEN (7) DAYS AFTER SIGNING IT.  IF NOT  REVOKED WITHIN SUCH PERIOD, THIS RELEASE WILL BECOME EFFECTIVE ON  THE EIGHTH (8) DAY AFTER IT IS SIGNED BY EMPLOYEE.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- tardioagreementa01018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="tardioagreementa01018.jpg" title="slide18" width="966" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  US_ACTIVE\127388755\V-1  BY SIGNING BELOW, BOTH THE COMPANY AND EMPLOYEE AGREE THAT  THEY UNDERSTAND AND ACCEPT EACH PART OF THIS RELEASE.      Jason Tardio      (Date Signed)  ACCEPTED AND DATED AS OF ___________________  IMMUNIC, INC.  By:          Name:         Title:          </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>imux-63025xexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i961bd20ee18e40c3a2d17605e8c5ba17_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel Vitt, certify that&#58;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Immunic, Inc.&#59;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c)Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 7, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel Vitt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Vitt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>imux-6x30x25xexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if33ec03e30b14ee3bf018235740699da_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn Whaley, certify that&#58;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Quarterly Report on Form 10-Q of Immunic, Inc.&#59;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for the periods presented in this report&#59;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 7, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Glenn Whaley</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Glenn Whaley</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>imux-63025xexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i090950d7f5784c459c14d742ee5d234e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Immunic, Inc. (the &#8220;Company&#8221;) for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, Daniel Vitt, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to my knowledge&#58;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) the Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 7, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel Vitt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Vitt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>imux-63025xexhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i2f5dbb9c4a8344d8a9433e90bef78e0d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Immunic, Inc. (the &#8220;Company&#8221;) for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, Glenn Whaley as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to my knowledge&#58;&#58;</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) the Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 7, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Glenn Whaley</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Glenn Whaley</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>vtl-20250630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:21259784-9322-473c-b39e-2847017b16ee,g:8411c107-5431-4a14-ae41-df3b5f39857c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vtl="http://vitaltherapies.com/20250630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://vitaltherapies.com/20250630">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtl-20250630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtl-20250630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtl-20250630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtl-20250630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://vitaltherapies.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementofCashFlows" roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows">
        <link:definition>9952157 - Statement - Condensed Consolidated Statement of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofFinancialStatements" roleURI="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatements">
        <link:definition>9952158 - Disclosure - Description of Business and Basis of Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952159 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://vitaltherapies.com/role/BalanceSheetDetails">
        <link:definition>9952160 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://vitaltherapies.com/role/Leases">
        <link:definition>9952161 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://vitaltherapies.com/role/FairValue">
        <link:definition>9952162 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStock" roleURI="http://vitaltherapies.com/role/CommonStock">
        <link:definition>9952163 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationPlans" roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlans">
        <link:definition>9952164 - Disclosure - Stock-Based Compensation Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://vitaltherapies.com/role/RelatedPartyTransactions">
        <link:definition>9952165 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://vitaltherapies.com/role/CommitmentsandContingencies">
        <link:definition>9952166 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosures" roleURI="http://vitaltherapies.com/role/SegmentDisclosures">
        <link:definition>9952167 - Disclosure - Segment Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://vitaltherapies.com/role/SubsequentEvents">
        <link:definition>9952168 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsTables">
        <link:definition>9955513 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://vitaltherapies.com/role/LeasesTables">
        <link:definition>9955514 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://vitaltherapies.com/role/FairValueTables">
        <link:definition>9955515 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockTables" roleURI="http://vitaltherapies.com/role/CommonStockTables">
        <link:definition>9955516 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationPlansTables" roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansTables">
        <link:definition>9955517 - Disclosure - Stock-Based Compensation Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresTables" roleURI="http://vitaltherapies.com/role/SegmentDisclosuresTables">
        <link:definition>9955518 - Disclosure - Segment Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofFinancialStatementsDetails" roleURI="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails">
        <link:definition>9955519 - Disclosure - Description of Business and Basis of Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>9955520 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails" roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails">
        <link:definition>9955521 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails" roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails">
        <link:definition>9955522 - Disclosure - Balance Sheet Details - Schedule of Other Current Assets and Prepaid Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsScheduleofAccountsPayableDetails" roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails">
        <link:definition>9955523 - Disclosure - Balance Sheet Details - Schedule of Accounts Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsScheduleofAccruedExpensesDetails" roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails">
        <link:definition>9955524 - Disclosure - Balance Sheet Details - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails" roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails">
        <link:definition>9955525 - Disclosure - Balance Sheet Details - Schedule of Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://vitaltherapies.com/role/LeasesAdditionalInformationDetails">
        <link:definition>9955526 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails" roleURI="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails">
        <link:definition>9955527 - Disclosure - Leases - Schedule of Maturities of Operating Lease Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1" roleURI="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1">
        <link:definition>9955527 - Disclosure - Leases - Schedule of Maturities of Operating Lease Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>9955528 - Disclosure - Fair Value - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueAdditionalInformationDetails" roleURI="http://vitaltherapies.com/role/FairValueAdditionalInformationDetails">
        <link:definition>9955529 - Disclosure - Fair Value - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueScheduleofFairValueofTrancheRightsDetails" roleURI="http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails">
        <link:definition>9955530 - Disclosure - Fair Value - Schedule of Fair Value of Tranche Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockShelfRegistrationStatementDetails" roleURI="http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails">
        <link:definition>9955531 - Disclosure - Common Stock - Shelf Registration Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockApril2025OfferingDetails" roleURI="http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails">
        <link:definition>9955532 - Disclosure - Common Stock - April 2025 Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockMay2025EquityOfferingDetails" roleURI="http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails">
        <link:definition>9955533 - Disclosure - Common Stock - May 2025 Equity Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockJanuary2024FinancingDetails" roleURI="http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails">
        <link:definition>9955534 - Disclosure - Common Stock - January 2024 Financing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockCommonStockDetails" roleURI="http://vitaltherapies.com/role/CommonStockCommonStockDetails">
        <link:definition>9955535 - Disclosure - Common Stock - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockPrefundedWarrantsDetails" roleURI="http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails">
        <link:definition>9955536 - Disclosure - Common Stock - Pre-funded Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockPreferredStockDetails" roleURI="http://vitaltherapies.com/role/CommonStockPreferredStockDetails">
        <link:definition>9955537 - Disclosure - Common Stock - Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockScheduleofSharesReservedforFutureIssuanceDetails" roleURI="http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails">
        <link:definition>9955538 - Disclosure - Common Stock - Schedule of Shares Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationPlansAdditionalInformationDetails" roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails">
        <link:definition>9955539 - Disclosure - Stock-Based Compensation Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationPlansScheduleofStockOptionActivityDetails" roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails">
        <link:definition>9955540 - Disclosure - Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails" roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails">
        <link:definition>9955541 - Disclosure - Stock-Based Compensation Plans - Schedule of Valuation Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails" roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails">
        <link:definition>9955542 - Disclosure - Stock-Based Compensation Plans - Schedule of Stock-Based Compensation Expense for Stock Awards Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://vitaltherapies.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955543 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://vitaltherapies.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955544 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresAdditionalInformationDetails" roleURI="http://vitaltherapies.com/role/SegmentDisclosuresAdditionalInformationDetails">
        <link:definition>9955545 - Disclosure - Segment Disclosures - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresScheduleofSignificantExpenseDetails" roleURI="http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails">
        <link:definition>9955546 - Disclosure - Segment Disclosures - Schedule of Significant Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://vitaltherapies.com/role/SubsequentEventsDetails">
        <link:definition>9955547 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" abstract="false" name="FairValueChangeInFairValueOfTrancheRightsTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_May2025PIPETransactionMember" abstract="true" name="May2025PIPETransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_April2025PIPETransactionMember" abstract="true" name="April2025PIPETransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_January2024PIPETransactionMember" abstract="true" name="January2024PIPETransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_AtTheMarketSalesAgreementMember" abstract="true" name="AtTheMarketSalesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_GainLossFromChangeInFairValueOfTrancheRights" abstract="false" name="GainLossFromChangeInFairValueOfTrancheRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" abstract="false" name="ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" abstract="false" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vtl_NumberOfDevelopmentPrograms" abstract="false" name="NumberOfDevelopmentPrograms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtl_January2024PreFundedWarrantsMember" abstract="true" name="January2024PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_May2025PreFundedWarrantsMember" abstract="true" name="May2025PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_NumberOfFinancialInstitutionsUsedForCashDeposits" abstract="false" name="NumberOfFinancialInstitutionsUsedForCashDeposits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" abstract="false" name="GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" abstract="false" name="GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_LesseeOperatingLeasesNumberOfExistingLeases" abstract="false" name="LesseeOperatingLeasesNumberOfExistingLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtl_PlacementAgentWarrantsMember" abstract="true" name="PlacementAgentWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_PrepaidClinicalAndRelatedCostsCurrent" abstract="false" name="PrepaidClinicalAndRelatedCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_ClinicalCostsPayableCurrent" abstract="false" name="ClinicalCostsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_LegalAndAuditCostsPayableCurrent" abstract="false" name="LegalAndAuditCostsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_AccruedClinicalCostsCurrent" abstract="false" name="AccruedClinicalCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_AccruedLegalAndAuditCostsCurrent" abstract="false" name="AccruedLegalAndAuditCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_AccruedCompensationCurrent" abstract="false" name="AccruedCompensationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_NewYorkCityMember" abstract="true" name="NewYorkCityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_GrafelfingGermanyMember" abstract="true" name="GrafelfingGermanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_PlaneggGermanyMember" abstract="true" name="PlaneggGermanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_OperatingLeaseIncrementalBorrowingRate" abstract="false" name="OperatingLeaseIncrementalBorrowingRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_OperatingAndVariableLeasesCost" abstract="false" name="OperatingAndVariableLeasesCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_TrancheRightFairValueDisclosure" abstract="false" name="TrancheRightFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" abstract="false" name="FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" abstract="false" name="FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtl_December2020ATMMember" abstract="true" name="December2020ATMMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_May2022ATMMember" abstract="true" name="May2022ATMMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_April2025AndMay2025FinancingMember" abstract="true" name="April2025AndMay2025FinancingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_May2024ATMMember" abstract="true" name="May2024ATMMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" abstract="false" name="MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" abstract="false" name="UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" abstract="false" name="ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtl_SaleOfStockRemainingCapacity" abstract="false" name="SaleOfStockRemainingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_SalesOfStockCommissionsPercentOfGrossProceeds" abstract="false" name="SalesOfStockCommissionsPercentOfGrossProceeds" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_SecuritiesPurchaseAgreementMember" abstract="true" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_PlacementAgencyAgreementMember" abstract="true" name="PlacementAgencyAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_OfferingMember" abstract="true" name="OfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_PlacementAgentAgreementBrokerageFeePercent" abstract="false" name="PlacementAgentAgreementBrokerageFeePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" abstract="false" name="ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_PreFundedWarrantsMember" abstract="true" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_SeriesAWarrantsMember" abstract="true" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_SeriesBWarrantsMember" abstract="true" name="SeriesBWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_SeriesAWarrantAndSeriesBWarrantMember" abstract="true" name="SeriesAWarrantAndSeriesBWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_VolumeWeightageAveragePriceTargetMember" abstract="true" name="VolumeWeightageAveragePriceTargetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" abstract="false" name="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" abstract="false" name="ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtl_OwnershipLimitationPercentage" abstract="false" name="OwnershipLimitationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_OwnershipLimitationPercentageUponElectionOfTheHolder" abstract="false" name="OwnershipLimitationPercentageUponElectionOfTheHolder" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_AccreditedInvestorsMember" abstract="true" name="AccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_CommonStockAndPreFundedWarrantsMember" abstract="true" name="CommonStockAndPreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_SaleOfStockPrivatePlacementNumberOfTranche" abstract="false" name="SaleOfStockPrivatePlacementNumberOfTranche" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtl_SaleOfStockConsiderationReceivedPercentage" abstract="false" name="SaleOfStockConsiderationReceivedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_SaleOfStockNumberOfTrancheConditions" abstract="false" name="SaleOfStockNumberOfTrancheConditions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation" abstract="false" name="ThresholdTradingDaysForWeightedAveragePriceCalculation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtl_WeightedAveragePriceOfLast10Days" abstract="false" name="WeightedAveragePriceOfLast10Days" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation" abstract="false" name="ThresholdTradingDaysForAggregateTradingVolumeCalculation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtl_SaleOfStockAggregateTradingVolumeOfLast10Days" abstract="false" name="SaleOfStockAggregateTradingVolumeOfLast10Days" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_SaleOfStockEquityOfferingsPeriod" abstract="false" name="SaleOfStockEquityOfferingsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtl_TrancheRightsLiabilityRemainderAmount" abstract="false" name="TrancheRightsLiabilityRemainderAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_TrancheRightsLiabilityReceivedAmount" abstract="false" name="TrancheRightsLiabilityReceivedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_CommonStockNumberOfSharesRegisteredForResale" abstract="false" name="CommonStockNumberOfSharesRegisteredForResale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vtl_NumberOfVotesPerEachShareOfCommonStock" abstract="false" name="NumberOfVotesPerEachShareOfCommonStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtl_May2025SeriesAWarrantsMember" abstract="true" name="May2025SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_May2025SeriesBWarrantsMember" abstract="true" name="May2025SeriesBWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_EmployeeStockOptionsforFutureGrantMember" abstract="true" name="EmployeeStockOptionsforFutureGrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_A2021EmployeeStockPurchasePlanMember" abstract="true" name="A2021EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_A2017InducementEquityIncentivePlanMember" abstract="true" name="A2017InducementEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember" abstract="true" name="TwoThousandNineteenOmnibusEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_A2019OmnibusEquityIncentivePlanMember" abstract="true" name="A2019OmnibusEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" abstract="true" name="TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_TwoThousandFourteenEquityIncentivePlanMember" abstract="true" name="TwoThousandFourteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_IncentiveEmployeeStockOptionMember" abstract="true" name="IncentiveEmployeeStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_NonStatutoryEmployeeStockOptionMember" abstract="true" name="NonStatutoryEmployeeStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" abstract="false" name="ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" abstract="false" name="ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="vtl_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_DuaneNashMDJDMBAMember" abstract="true" name="DuaneNashMDJDMBAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_ExecutiveChairmanAgreementMember" abstract="true" name="ExecutiveChairmanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_SalaryAndWageOfficerMonthlyBaseSalary" abstract="false" name="SalaryAndWageOfficerMonthlyBaseSalary" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtl_ClinicalProductCandidates" abstract="false" name="ClinicalProductCandidates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtl_PreClinicalProductCandidates" abstract="false" name="PreClinicalProductCandidates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>vtl-20250630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:21259784-9322-473c-b39e-2847017b16ee,g:8411c107-5431-4a14-ae41-df3b5f39857c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_5ab3d402-a5bb-44ed-99c5-83fdc4e8773f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3ae634e0-5554-445c-9864-b8fe5b7fc545" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5ab3d402-a5bb-44ed-99c5-83fdc4e8773f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3ae634e0-5554-445c-9864-b8fe5b7fc545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b015337e-6e7a-4045-9533-41cda8a894b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b2085428-bb4a-4224-81c7-43563517818a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b015337e-6e7a-4045-9533-41cda8a894b3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b2085428-bb4a-4224-81c7-43563517818a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_109ab557-66db-41ce-a908-5198c7fddbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b015337e-6e7a-4045-9533-41cda8a894b3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_109ab557-66db-41ce-a908-5198c7fddbfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f7242a1e-b4d9-4a77-8e94-0d543bad7f89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_69ab0294-147e-4137-aef3-8f0a511d5fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f7242a1e-b4d9-4a77-8e94-0d543bad7f89" xlink:to="loc_us-gaap_PreferredStockValue_69ab0294-147e-4137-aef3-8f0a511d5fa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_921f4747-1618-43c6-b923-088b1b41cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f7242a1e-b4d9-4a77-8e94-0d543bad7f89" xlink:to="loc_us-gaap_CommonStockValue_921f4747-1618-43c6-b923-088b1b41cd29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7ec69ea8-a909-46e5-9951-4ddc7b5dd060" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f7242a1e-b4d9-4a77-8e94-0d543bad7f89" xlink:to="loc_us-gaap_AdditionalPaidInCapital_7ec69ea8-a909-46e5-9951-4ddc7b5dd060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48c968a1-2ba5-4a0e-929d-6e9fc2e47b23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f7242a1e-b4d9-4a77-8e94-0d543bad7f89" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48c968a1-2ba5-4a0e-929d-6e9fc2e47b23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b40db656-97cf-404d-b2e1-d54e0553c418" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f7242a1e-b4d9-4a77-8e94-0d543bad7f89" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b40db656-97cf-404d-b2e1-d54e0553c418" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2861d4ad-80bc-45b4-bc2d-f6b1d0f6b21f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3f7f0685-09b2-489d-852e-5ead044b0e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2861d4ad-80bc-45b4-bc2d-f6b1d0f6b21f" xlink:to="loc_us-gaap_AssetsCurrent_3f7f0685-09b2-489d-852e-5ead044b0e3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b7a443c8-34ae-417d-902c-d29fa50fae3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2861d4ad-80bc-45b4-bc2d-f6b1d0f6b21f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b7a443c8-34ae-417d-902c-d29fa50fae3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a7f079ee-6e62-4efd-bf0f-7783515bc153" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2861d4ad-80bc-45b4-bc2d-f6b1d0f6b21f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a7f079ee-6e62-4efd-bf0f-7783515bc153" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_830fd513-8d19-4d15-b460-d5c3ad340f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_21d11a01-91d7-4103-aaa9-657d5e361b44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_830fd513-8d19-4d15-b460-d5c3ad340f0d" xlink:to="loc_us-gaap_StockholdersEquity_21d11a01-91d7-4103-aaa9-657d5e361b44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c4b2362c-705c-4c44-ab07-096bddcbfadf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_830fd513-8d19-4d15-b460-d5c3ad340f0d" xlink:to="loc_us-gaap_Liabilities_c4b2362c-705c-4c44-ab07-096bddcbfadf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bc2a51f6-e046-44ca-b664-9992227a2414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_830fd513-8d19-4d15-b460-d5c3ad340f0d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bc2a51f6-e046-44ca-b664-9992227a2414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_aea29a71-61c0-459d-a523-1f8a7da6f6db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5d64a562-326a-482a-bb2f-660bcb0ff27f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_aea29a71-61c0-459d-a523-1f8a7da6f6db" xlink:to="loc_us-gaap_LiabilitiesCurrent_5d64a562-326a-482a-bb2f-660bcb0ff27f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_fe234948-bbd3-435e-87b4-690194ae3453" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_aea29a71-61c0-459d-a523-1f8a7da6f6db" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_fe234948-bbd3-435e-87b4-690194ae3453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d784304e-a6d8-4ec6-ab53-1b6883ea85ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6dc1766a-14e6-4a1b-9117-bc8448aa16fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d784304e-a6d8-4ec6-ab53-1b6883ea85ad" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6dc1766a-14e6-4a1b-9117-bc8448aa16fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2a3c123d-9b91-482a-a561-dace0648a62c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d784304e-a6d8-4ec6-ab53-1b6883ea85ad" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2a3c123d-9b91-482a-a561-dace0648a62c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_01ee593b-a498-4bc7-b12e-5994e83beeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d784304e-a6d8-4ec6-ab53-1b6883ea85ad" xlink:to="loc_us-gaap_AccountsPayableCurrent_01ee593b-a498-4bc7-b12e-5994e83beeeb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_70643505-7f14-4390-8764-a2159882b66d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_02b11bb8-3c86-480c-88e8-3e2ebe6ed914" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_70643505-7f14-4390-8764-a2159882b66d" xlink:to="loc_us-gaap_OperatingExpenses_02b11bb8-3c86-480c-88e8-3e2ebe6ed914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4c54f81b-64df-4846-acd2-2e9263c2e959" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4eb9abbc-cb98-43f9-b681-79c143b3f443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4c54f81b-64df-4846-acd2-2e9263c2e959" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4eb9abbc-cb98-43f9-b681-79c143b3f443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5dec5a74-2177-44a1-ba0d-431770bbb0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4c54f81b-64df-4846-acd2-2e9263c2e959" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5dec5a74-2177-44a1-ba0d-431770bbb0b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_2553fe10-307e-4e7a-8221-54221a0998bd" xlink:href="vtl-20250630.xsd#vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4c54f81b-64df-4846-acd2-2e9263c2e959" xlink:to="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_2553fe10-307e-4e7a-8221-54221a0998bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_08b0ddc0-0fe2-4524-917b-acebaeaa751c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1903a424-ddb2-4a1e-89a7-968fcc738e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_08b0ddc0-0fe2-4524-917b-acebaeaa751c" xlink:to="loc_us-gaap_OperatingIncomeLoss_1903a424-ddb2-4a1e-89a7-968fcc738e0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_486f6d41-5f88-4361-a0af-37527ca92d92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_08b0ddc0-0fe2-4524-917b-acebaeaa751c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_486f6d41-5f88-4361-a0af-37527ca92d92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0c66ff2d-d861-421a-8041-565e08581fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_64dc88ea-ef98-43ed-b0e0-7b33c95b867a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0c66ff2d-d861-421a-8041-565e08581fbd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_64dc88ea-ef98-43ed-b0e0-7b33c95b867a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8a262dbe-1ef1-4350-ae6d-1a9bfbd4a1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0c66ff2d-d861-421a-8041-565e08581fbd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8a262dbe-1ef1-4350-ae6d-1a9bfbd4a1c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_23689eb5-9e6c-4ae1-ac50-5944b8a19e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_50a0bcc3-1db7-4cc9-87ea-045a35e198b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_23689eb5-9e6c-4ae1-ac50-5944b8a19e3a" xlink:to="loc_us-gaap_NetIncomeLoss_50a0bcc3-1db7-4cc9-87ea-045a35e198b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_274b5e89-4dde-4c53-b60d-8a1e0c16e26c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_23689eb5-9e6c-4ae1-ac50-5944b8a19e3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_274b5e89-4dde-4c53-b60d-8a1e0c16e26c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementofCashFlows"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d2b16f-8b4d-4927-a764-42bf62ae9641" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e1dff7c5-b08d-4ee5-97f6-9476d9296a08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d2b16f-8b4d-4927-a764-42bf62ae9641" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e1dff7c5-b08d-4ee5-97f6-9476d9296a08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5241c8cc-817a-4097-8fbf-1cd17f193c82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d2b16f-8b4d-4927-a764-42bf62ae9641" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5241c8cc-817a-4097-8fbf-1cd17f193c82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a029082e-e58f-4a69-8271-0d8daa413401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d2b16f-8b4d-4927-a764-42bf62ae9641" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a029082e-e58f-4a69-8271-0d8daa413401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1efd443e-620f-4d2a-bec8-a4d4fcdd4f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d2b16f-8b4d-4927-a764-42bf62ae9641" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1efd443e-620f-4d2a-bec8-a4d4fcdd4f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c83e9ed2-c763-4024-ba4f-9c46e7d5edd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0791bebf-756f-4260-9a61-28d5eba966ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c83e9ed2-c763-4024-ba4f-9c46e7d5edd1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0791bebf-756f-4260-9a61-28d5eba966ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec98b285-5c6a-4e51-94b9-066f0aa57d70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1e5d20df-d828-4d4e-b038-6e6c46c13ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec98b285-5c6a-4e51-94b9-066f0aa57d70" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1e5d20df-d828-4d4e-b038-6e6c46c13ed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e85f493a-4fb4-4ede-922a-1ce6024f304a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec98b285-5c6a-4e51-94b9-066f0aa57d70" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e85f493a-4fb4-4ede-922a-1ce6024f304a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_4d628430-b06c-4b74-a7ca-73f2eca0d7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec98b285-5c6a-4e51-94b9-066f0aa57d70" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_4d628430-b06c-4b74-a7ca-73f2eca0d7a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5ebf9152-e4f7-433c-9054-015b2fdc6d31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_NetIncomeLoss_5ebf9152-e4f7-433c-9054-015b2fdc6d31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dbf8c5f2-87ae-4169-b63e-63ab13ddf11c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dbf8c5f2-87ae-4169-b63e-63ab13ddf11c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_197c43fb-4932-4590-9179-f3fce277796c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_197c43fb-4932-4590-9179-f3fce277796c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_37833b67-979e-4d7e-9b72-f70575dca4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_ShareBasedCompensation_37833b67-979e-4d7e-9b72-f70575dca4dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_5acd0275-82e4-47c9-9b88-e3a618b87b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_5acd0275-82e4-47c9-9b88-e3a618b87b4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights_48eeb24f-4c93-4bc7-8837-7db24f727c8f" xlink:href="vtl-20250630.xsd#vtl_GainLossFromChangeInFairValueOfTrancheRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights_48eeb24f-4c93-4bc7-8837-7db24f727c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_6b2b8759-0f20-4cf2-8568-f3e71c1b6b97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManagementFeeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_ManagementFeeExpense_6b2b8759-0f20-4cf2-8568-f3e71c1b6b97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a02d45ff-3d0c-45ce-9428-c694fda0f932" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a02d45ff-3d0c-45ce-9428-c694fda0f932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0d60fcec-d30c-401e-8f4a-fb7961529c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0d60fcec-d30c-401e-8f4a-fb7961529c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_34c7b0d8-149c-4038-b4d2-fb9ef4aa489b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_34c7b0d8-149c-4038-b4d2-fb9ef4aa489b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b1661e6c-515c-4f3c-8fc8-7565478482de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b1661e6c-515c-4f3c-8fc8-7565478482de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c1ff6614-0d14-43f5-b744-4c03b398a24b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a00c8398-67d9-4271-a153-39788015c610" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c1ff6614-0d14-43f5-b744-4c03b398a24b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8e73eea4-ca28-4559-a6d4-c0d0a3e91f96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PrepaidClinicalAndRelatedCostsCurrent_5479dab2-7d12-4d8d-aff0-e2a8919e5869" xlink:href="vtl-20250630.xsd#vtl_PrepaidClinicalAndRelatedCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8e73eea4-ca28-4559-a6d4-c0d0a3e91f96" xlink:to="loc_vtl_PrepaidClinicalAndRelatedCostsCurrent_5479dab2-7d12-4d8d-aff0-e2a8919e5869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_e6ae0eab-d29b-444c-a3b1-400b9cba15e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8e73eea4-ca28-4559-a6d4-c0d0a3e91f96" xlink:to="loc_us-gaap_OtherAssetsCurrent_e6ae0eab-d29b-444c-a3b1-400b9cba15e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_fcfa5ce3-7fba-4509-8375-532f5060833c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8e73eea4-ca28-4559-a6d4-c0d0a3e91f96" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_fcfa5ce3-7fba-4509-8375-532f5060833c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_30ea6152-edb5-4c65-a38a-389b59eab4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8e73eea4-ca28-4559-a6d4-c0d0a3e91f96" xlink:to="loc_us-gaap_PrepaidInsurance_30ea6152-edb5-4c65-a38a-389b59eab4c5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofAccountsPayableDetails"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4b0b73df-c1c5-4ddb-bc2b-97df0aac2a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClinicalCostsPayableCurrent_32bcfeb1-17c8-43c3-9584-08d2b3bfcec5" xlink:href="vtl-20250630.xsd#vtl_ClinicalCostsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableCurrent_4b0b73df-c1c5-4ddb-bc2b-97df0aac2a5a" xlink:to="loc_vtl_ClinicalCostsPayableCurrent_32bcfeb1-17c8-43c3-9584-08d2b3bfcec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_LegalAndAuditCostsPayableCurrent_d3a43730-e123-448e-9335-52382c5f056c" xlink:href="vtl-20250630.xsd#vtl_LegalAndAuditCostsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableCurrent_4b0b73df-c1c5-4ddb-bc2b-97df0aac2a5a" xlink:to="loc_vtl_LegalAndAuditCostsPayableCurrent_d3a43730-e123-448e-9335-52382c5f056c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_9ef585fc-1a34-4cdf-b876-45fd0087092f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableCurrent_4b0b73df-c1c5-4ddb-bc2b-97df0aac2a5a" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_9ef585fc-1a34-4cdf-b876-45fd0087092f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6929b8f2-df03-48d0-a770-cbb751691df9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c45c2498-8be3-4188-8383-905e2c67a973" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6929b8f2-df03-48d0-a770-cbb751691df9" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c45c2498-8be3-4188-8383-905e2c67a973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedClinicalCostsCurrent_9544655c-af21-4bfc-8c6a-4f95baf1949e" xlink:href="vtl-20250630.xsd#vtl_AccruedClinicalCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6929b8f2-df03-48d0-a770-cbb751691df9" xlink:to="loc_vtl_AccruedClinicalCostsCurrent_9544655c-af21-4bfc-8c6a-4f95baf1949e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedCompensationCurrent_fd0d0dcf-fbee-42c4-befe-353db1eeb760" xlink:href="vtl-20250630.xsd#vtl_AccruedCompensationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6929b8f2-df03-48d0-a770-cbb751691df9" xlink:to="loc_vtl_AccruedCompensationCurrent_fd0d0dcf-fbee-42c4-befe-353db1eeb760" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedLegalAndAuditCostsCurrent_46ad580f-3d8f-4e6e-b9ec-5b3e9f390362" xlink:href="vtl-20250630.xsd#vtl_AccruedLegalAndAuditCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6929b8f2-df03-48d0-a770-cbb751691df9" xlink:to="loc_vtl_AccruedLegalAndAuditCostsCurrent_46ad580f-3d8f-4e6e-b9ec-5b3e9f390362" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4747e11e-5ea1-48af-a70c-ad1ed3fa89cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_2dda2867-a69f-4c6b-9288-8517caf2f11c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4747e11e-5ea1-48af-a70c-ad1ed3fa89cd" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_2dda2867-a69f-4c6b-9288-8517caf2f11c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3039d188-61f4-453c-b4b5-5ed2df916d80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4747e11e-5ea1-48af-a70c-ad1ed3fa89cd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3039d188-61f4-453c-b4b5-5ed2df916d80" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbcd9a12-5342-497b-9ae6-317ee048276c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_92744832-9a51-4e67-a382-dac21208991f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbcd9a12-5342-497b-9ae6-317ee048276c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_92744832-9a51-4e67-a382-dac21208991f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6393cdb9-aa5a-4cc5-b32c-bf4a74231651" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbcd9a12-5342-497b-9ae6-317ee048276c" xlink:to="loc_us-gaap_OperatingLeaseLiability_6393cdb9-aa5a-4cc5-b32c-bf4a74231651" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1" xlink:type="simple" xlink:href="vtl-20250630.xsd#LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd6252bb-a0a9-4590-a20d-727ee0ce0414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_24018cec-efe2-4745-9483-b1636ff93f81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd6252bb-a0a9-4590-a20d-727ee0ce0414" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_24018cec-efe2-4745-9483-b1636ff93f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_131c9ad9-f175-496b-8aef-280674d1f977" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd6252bb-a0a9-4590-a20d-727ee0ce0414" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_131c9ad9-f175-496b-8aef-280674d1f977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_06e27fc3-cd22-42ad-b538-72e632d9c6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd6252bb-a0a9-4590-a20d-727ee0ce0414" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_06e27fc3-cd22-42ad-b538-72e632d9c6c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_488d78a4-ed8f-4edf-af4f-81e48b9d8721" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd6252bb-a0a9-4590-a20d-727ee0ce0414" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_488d78a4-ed8f-4edf-af4f-81e48b9d8721" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>vtl-20250630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:21259784-9322-473c-b39e-2847017b16ee,g:8411c107-5431-4a14-ae41-df3b5f39857c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dac4734f-fed5-424b-b99f-4b40c3c497bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dac4734f-fed5-424b-b99f-4b40c3c497bc" xlink:to="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b154993b-defa-4742-9617-f3002e6cbb93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b154993b-defa-4742-9617-f3002e6cbb93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b154993b-defa-4742-9617-f3002e6cbb93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b154993b-defa-4742-9617-f3002e6cbb93" xlink:to="loc_us-gaap_EquityComponentDomain_b154993b-defa-4742-9617-f3002e6cbb93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b154993b-defa-4742-9617-f3002e6cbb93" xlink:to="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_39444e91-e57d-4215-91ad-3fcaaf79b61c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_CommonStockMember_39444e91-e57d-4215-91ad-3fcaaf79b61c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_55f7abce-c9fe-4bcc-9e15-8c9b074c6aba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_55f7abce-c9fe-4bcc-9e15-8c9b074c6aba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_44cdd699-c08c-407e-bd92-0d4abe54363d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_44cdd699-c08c-407e-bd92-0d4abe54363d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_722ffc8b-1138-451f-853f-e7ecf174aaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_RetainedEarningsMember_722ffc8b-1138-451f-853f-e7ecf174aaa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PIPETransactionMember_88ae2c0e-4ab4-4e73-8bc7-fcec85138423" xlink:href="vtl-20250630.xsd#vtl_May2025PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_May2025PIPETransactionMember_88ae2c0e-4ab4-4e73-8bc7-fcec85138423" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025PIPETransactionMember_42efcc07-9a29-4fb0-9254-880ac8cd80e1" xlink:href="vtl-20250630.xsd#vtl_April2025PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_April2025PIPETransactionMember_42efcc07-9a29-4fb0-9254-880ac8cd80e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PIPETransactionMember_c762ac9f-e745-4855-be8a-c7345b5cb988" xlink:href="vtl-20250630.xsd#vtl_January2024PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_January2024PIPETransactionMember_c762ac9f-e745-4855-be8a-c7345b5cb988" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AtTheMarketSalesAgreementMember_cbd5cc38-fb09-4efe-abbc-81ba6c150e9f" xlink:href="vtl-20250630.xsd#vtl_AtTheMarketSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_AtTheMarketSalesAgreementMember_cbd5cc38-fb09-4efe-abbc-81ba6c150e9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dac4734f-fed5-424b-b99f-4b40c3c497bc" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_751ff6e3-3a91-4ffc-bfc7-2a7599b76f45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_751ff6e3-3a91-4ffc-bfc7-2a7599b76f45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_436fc173-9e0a-42df-a118-1af50cce1516" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockholdersEquity_436fc173-9e0a-42df-a118-1af50cce1516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf1b85dd-f022-41d0-90da-bf13d9270fea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_NetIncomeLoss_bf1b85dd-f022-41d0-90da-bf13d9270fea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_78a2d56f-5aef-4958-a9e4-9ae6f0f9c299" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_78a2d56f-5aef-4958-a9e4-9ae6f0f9c299" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_10f8f0ad-bf62-45de-8e78-e2e5b6feab5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_10f8f0ad-bf62-45de-8e78-e2e5b6feab5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1b4a6adf-9b2c-4cde-b3fb-01482e2b6cac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1b4a6adf-9b2c-4cde-b3fb-01482e2b6cac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3ffed846-c981-4213-9560-b04e1d570c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3ffed846-c981-4213-9560-b04e1d570c8a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity_6cebf43b-62b2-4adb-9b11-973ca5c8eaeb" xlink:href="vtl-20250630.xsd#vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity_6cebf43b-62b2-4adb-9b11-973ca5c8eaeb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_09040fdc-30bc-4df8-bb2b-6cae098e04ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_09040fdc-30bc-4df8-bb2b-6cae098e04ce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aec743ba-475c-4e74-ac0d-f7178a6c6efa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aec743ba-475c-4e74-ac0d-f7178a6c6efa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_aba5951c-c9d1-400a-8c70-26cf6a9ccd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_aba5951c-c9d1-400a-8c70-26cf6a9ccd0c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c592cfae-266f-44c3-8696-61cb793dea2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c592cfae-266f-44c3-8696-61cb793dea2b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_81c5c654-553a-4339-ad1b-c56b19dc29a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c7a1fa1b-0e18-4187-8cb2-68fd7f1c2da7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48ae1e90-315f-4557-a636-8ea5e5873ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_85abb791-5f79-4f31-bed2-746fb16365a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_48ae1e90-315f-4557-a636-8ea5e5873ce8" xlink:to="loc_us-gaap_StatementTable_85abb791-5f79-4f31-bed2-746fb16365a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4af993f0-398f-41d2-838a-18ebd9c4eb52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_85abb791-5f79-4f31-bed2-746fb16365a5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4af993f0-398f-41d2-838a-18ebd9c4eb52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4af993f0-398f-41d2-838a-18ebd9c4eb52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4af993f0-398f-41d2-838a-18ebd9c4eb52" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4af993f0-398f-41d2-838a-18ebd9c4eb52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4af993f0-398f-41d2-838a-18ebd9c4eb52" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PIPETransactionMember_a83176b6-45d1-4c3a-b524-d4a95fbc487f" xlink:href="vtl-20250630.xsd#vtl_May2025PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_May2025PIPETransactionMember_a83176b6-45d1-4c3a-b524-d4a95fbc487f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025PIPETransactionMember_c71262ee-f68a-42a6-a2b7-23e360758537" xlink:href="vtl-20250630.xsd#vtl_April2025PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_April2025PIPETransactionMember_c71262ee-f68a-42a6-a2b7-23e360758537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PIPETransactionMember_eee53a5e-9283-42f4-870b-208e4d1d86d5" xlink:href="vtl-20250630.xsd#vtl_January2024PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_January2024PIPETransactionMember_eee53a5e-9283-42f4-870b-208e4d1d86d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AtTheMarketSalesAgreementMember_c3a23166-15ed-4374-a3cd-e42c4d1d5629" xlink:href="vtl-20250630.xsd#vtl_AtTheMarketSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_AtTheMarketSalesAgreementMember_c3a23166-15ed-4374-a3cd-e42c4d1d5629" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5528c5b6-ddc1-4b1c-ad07-bfc5474ab413" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48ae1e90-315f-4557-a636-8ea5e5873ce8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5528c5b6-ddc1-4b1c-ad07-bfc5474ab413" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementofCashFlows"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_16829f09-739d-443b-b9a5-348ab8b35a32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_StatementTable_16829f09-739d-443b-b9a5-348ab8b35a32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e8cf2b52-30aa-481d-ad71-9a5a697a5b85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_16829f09-739d-443b-b9a5-348ab8b35a32" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e8cf2b52-30aa-481d-ad71-9a5a697a5b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e8cf2b52-30aa-481d-ad71-9a5a697a5b85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e8cf2b52-30aa-481d-ad71-9a5a697a5b85" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e8cf2b52-30aa-481d-ad71-9a5a697a5b85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e8cf2b52-30aa-481d-ad71-9a5a697a5b85" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PIPETransactionMember_ae20999c-ff0f-4fa3-8c1e-fa0c2fec08dc" xlink:href="vtl-20250630.xsd#vtl_January2024PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:to="loc_vtl_January2024PIPETransactionMember_ae20999c-ff0f-4fa3-8c1e-fa0c2fec08dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PIPETransactionMember_47e38900-35b4-4deb-9c40-c72df5682ebc" xlink:href="vtl-20250630.xsd#vtl_May2025PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:to="loc_vtl_May2025PIPETransactionMember_47e38900-35b4-4deb-9c40-c72df5682ebc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025PIPETransactionMember_0d5020e8-26f5-4ba3-91c5-ec69d459c067" xlink:href="vtl-20250630.xsd#vtl_April2025PIPETransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:to="loc_vtl_April2025PIPETransactionMember_0d5020e8-26f5-4ba3-91c5-ec69d459c067" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2bbc5436-57cc-4ab9-b476-f78f600f464a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:to="loc_us-gaap_NetIncomeLoss_2bbc5436-57cc-4ab9-b476-f78f600f464a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ed887a75-6389-4acd-8c17-236168200009" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ed887a75-6389-4acd-8c17-236168200009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0161016f-d27e-4c41-8ccc-e45e8f09275c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0161016f-d27e-4c41-8ccc-e45e8f09275c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3e2b74b8-5fbf-440d-aae9-685e422e40a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ShareBasedCompensation_3e2b74b8-5fbf-440d-aae9-685e422e40a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_124d8d35-213a-4706-aefe-82c0492d8960" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_124d8d35-213a-4706-aefe-82c0492d8960" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights_6bd91d92-22ae-4ebc-8a6b-2fb52767b923" xlink:href="vtl-20250630.xsd#vtl_GainLossFromChangeInFairValueOfTrancheRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights_6bd91d92-22ae-4ebc-8a6b-2fb52767b923" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_ee9a7fed-ca24-43a7-ab26-2b76919f7e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManagementFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ManagementFeeExpense_ee9a7fed-ca24-43a7-ab26-2b76919f7e8e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99cac229-09f6-4ad6-97b6-ce181149cef0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99cac229-09f6-4ad6-97b6-ce181149cef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b4aa6780-d02b-4970-a791-ce4eea168fef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b4aa6780-d02b-4970-a791-ce4eea168fef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_32159340-5828-4717-a8f8-68f6c2dfd811" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_32159340-5828-4717-a8f8-68f6c2dfd811" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2af78e8c-29b0-46a1-be54-d17e232d93e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2af78e8c-29b0-46a1-be54-d17e232d93e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4730e93a-2881-4568-b807-220a7ca9c8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4730e93a-2881-4568-b807-220a7ca9c8e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e70ab0a3-86ba-4516-a836-06726308d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e70ab0a3-86ba-4516-a836-06726308d58b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84c0b785-f098-4967-bb11-40f5fc9879d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84c0b785-f098-4967-bb11-40f5fc9879d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_345785a7-70eb-43eb-b5df-39c7a8a200b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_345785a7-70eb-43eb-b5df-39c7a8a200b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_900091f3-b256-4064-bbb0-57c8934056c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_900091f3-b256-4064-bbb0-57c8934056c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_ef6ce059-44bb-4c75-bd81-2c56f2f957ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_ef6ce059-44bb-4c75-bd81-2c56f2f957ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_394ef286-a38c-445a-9138-4dfb0cea7c65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_394ef286-a38c-445a-9138-4dfb0cea7c65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c3cec5d-a7d8-420a-b5dc-ac8781afe1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c3cec5d-a7d8-420a-b5dc-ac8781afe1b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_649eff86-9113-4a5f-ac01-3cd3576e22de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_649eff86-9113-4a5f-ac01-3cd3576e22de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_053a4c9d-926a-47b5-8922-3eddd4fcc707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_053a4c9d-926a-47b5-8922-3eddd4fcc707" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b83d484c-89fb-4b22-a7c0-52d1cce82a31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b83d484c-89fb-4b22-a7c0-52d1cce82a31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80d5f92d-a1c5-4952-8ce4-5e315ea0864c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_660672fa-2352-46e4-9073-de6fad121068" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_660672fa-2352-46e4-9073-de6fad121068" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares_35643bda-72d9-4231-8991-a76e0ac590d5" xlink:href="vtl-20250630.xsd#vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_660672fa-2352-46e4-9073-de6fad121068" xlink:to="loc_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares_35643bda-72d9-4231-8991-a76e0ac590d5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#DescriptionofBusinessandBasisofFinancialStatementsDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4ac9f817-3b0e-47ea-81af-306d6f714eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4ac9f817-3b0e-47ea-81af-306d6f714eaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8954e77f-bf55-441c-a6ad-d330f6e15728" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4ac9f817-3b0e-47ea-81af-306d6f714eaa" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8954e77f-bf55-441c-a6ad-d330f6e15728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8954e77f-bf55-441c-a6ad-d330f6e15728_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8954e77f-bf55-441c-a6ad-d330f6e15728" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8954e77f-bf55-441c-a6ad-d330f6e15728_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0655b8b1-6484-4039-83a7-d61a0de1a05c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8954e77f-bf55-441c-a6ad-d330f6e15728" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0655b8b1-6484-4039-83a7-d61a0de1a05c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_aabbcbb8-9bb0-4b50-bfb8-03f072947c31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0655b8b1-6484-4039-83a7-d61a0de1a05c" xlink:to="loc_us-gaap_SubsequentEventMember_aabbcbb8-9bb0-4b50-bfb8-03f072947c31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_ae6cd5ef-b46d-4b6c-804c-3fe4b84e7453" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_dei_EntityNumberOfEmployees_ae6cd5ef-b46d-4b6c-804c-3fe4b84e7453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfDevelopmentPrograms_81587b6f-0db0-4407-b324-c9b07e9a7b71" xlink:href="vtl-20250630.xsd#vtl_NumberOfDevelopmentPrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_vtl_NumberOfDevelopmentPrograms_81587b6f-0db0-4407-b324-c9b07e9a7b71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_da6f1f3a-d9de-49bf-af9c-6bb0b401ce62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_da6f1f3a-d9de-49bf-af9c-6bb0b401ce62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_eaf258f7-5852-499e-aaee-4633976e2b61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_eaf258f7-5852-499e-aaee-4633976e2b61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41f95409-3a86-497c-8434-d69f4fe90e50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41f95409-3a86-497c-8434-d69f4fe90e50" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6262d0a2-5c30-48c7-b5d0-80690329684c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_srt_StatementGeographicalAxis_6262d0a2-5c30-48c7-b5d0-80690329684c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6262d0a2-5c30-48c7-b5d0-80690329684c_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6262d0a2-5c30-48c7-b5d0-80690329684c" xlink:to="loc_srt_SegmentGeographicalDomain_6262d0a2-5c30-48c7-b5d0-80690329684c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6262d0a2-5c30-48c7-b5d0-80690329684c" xlink:to="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9e48c3ae-1098-4101-9262-2e2bf7783457" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:to="loc_country_US_9e48c3ae-1098-4101-9262-2e2bf7783457" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_dbba2861-f555-46ec-a9bf-ffd3ef62a2b5" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:to="loc_country_DE_dbba2861-f555-46ec-a9bf-ffd3ef62a2b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_8eebe77d-ae28-4d33-936c-eb2eb3f59113" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:to="loc_country_AU_8eebe77d-ae28-4d33-936c-eb2eb3f59113" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_34e00c91-970d-425e-807f-cfff71b6b164" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_34e00c91-970d-425e-807f-cfff71b6b164" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_34e00c91-970d-425e-807f-cfff71b6b164_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_34e00c91-970d-425e-807f-cfff71b6b164" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_34e00c91-970d-425e-807f-cfff71b6b164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e900eee-11f2-4b48-8c8e-7d71f7c34c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_34e00c91-970d-425e-807f-cfff71b6b164" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e900eee-11f2-4b48-8c8e-7d71f7c34c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_310e5f9f-2f25-4977-93d2-01d98a8d94cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e900eee-11f2-4b48-8c8e-7d71f7c34c0f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_310e5f9f-2f25-4977-93d2-01d98a8d94cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b22325f-bc13-4228-89e3-39e1e4c6d03f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_srt_RangeAxis_6b22325f-bc13-4228-89e3-39e1e4c6d03f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b22325f-bc13-4228-89e3-39e1e4c6d03f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6b22325f-bc13-4228-89e3-39e1e4c6d03f" xlink:to="loc_srt_RangeMember_6b22325f-bc13-4228-89e3-39e1e4c6d03f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6b22325f-bc13-4228-89e3-39e1e4c6d03f" xlink:to="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e37cf99d-9e0f-4473-ae9a-7bcacf81f908" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:to="loc_srt_MinimumMember_e37cf99d-9e0f-4473-ae9a-7bcacf81f908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_684500f8-be98-49b7-9da5-c5b1aa2eb189" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:to="loc_srt_MaximumMember_684500f8-be98-49b7-9da5-c5b1aa2eb189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_785078e6-9457-4a23-ab16-e913df33952d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_785078e6-9457-4a23-ab16-e913df33952d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_785078e6-9457-4a23-ab16-e913df33952d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_785078e6-9457-4a23-ab16-e913df33952d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_785078e6-9457-4a23-ab16-e913df33952d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_785078e6-9457-4a23-ab16-e913df33952d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PreFundedWarrantsMember_c99bdc39-fb71-4e46-94db-0ad6ff9d08c4" xlink:href="vtl-20250630.xsd#vtl_January2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:to="loc_vtl_January2024PreFundedWarrantsMember_c99bdc39-fb71-4e46-94db-0ad6ff9d08c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PreFundedWarrantsMember_f286fe31-aac9-4b4c-b2f8-685a6182d5bd" xlink:href="vtl-20250630.xsd#vtl_May2025PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:to="loc_vtl_May2025PreFundedWarrantsMember_f286fe31-aac9-4b4c-b2f8-685a6182d5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf5b5484-9f4d-4ef7-9205-ac642f287aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf5b5484-9f4d-4ef7-9205-ac642f287aa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits_fc943b4e-3e74-47ed-8d8d-9bc79715d54e" xlink:href="vtl-20250630.xsd#vtl_NumberOfFinancialInstitutionsUsedForCashDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits_fc943b4e-3e74-47ed-8d8d-9bc79715d54e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate_b6b869c4-cefd-44e1-9905-fd81285382d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_InvestmentInterestRate_b6b869c4-cefd-44e1-9905-fd81285382d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8bceea0f-0b25-4bec-b7e8-ca7a8a0ca599" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8bceea0f-0b25-4bec-b7e8-ca7a8a0ca599" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a61b4f25-ab97-467d-b0dd-606c38e2fe43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_DepreciationAndAmortization_a61b4f25-ab97-467d-b0dd-606c38e2fe43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_c3992146-76e0-44ca-9f48-8006a159f0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_c3992146-76e0-44ca-9f48-8006a159f0a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent_50e9b1b9-c9cb-42ae-8a2b-a95a9b5054f1" xlink:href="vtl-20250630.xsd#vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent_50e9b1b9-c9cb-42ae-8a2b-a95a9b5054f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount_a3936315-86af-4f9a-9467-d5bdbe5a90cb" xlink:href="vtl-20250630.xsd#vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount_a3936315-86af-4f9a-9467-d5bdbe5a90cb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_0fdb8bb3-5699-4404-8701-a82d1e636c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_0fdb8bb3-5699-4404-8701-a82d1e636c6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceExpense_5469a5df-bcb1-40f6-9bb1-fc86e0921669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceExpense_5469a5df-bcb1-40f6-9bb1-fc86e0921669" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmount_7347fbc1-8b0e-490d-b5d6-764811ed570f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceAmount_7347fbc1-8b0e-490d-b5d6-764811ed570f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_c5f9682e-2976-45ec-8d94-85469f0387f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_c5f9682e-2976-45ec-8d94-85469f0387f4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_490df6e6-7b2d-4ef7-a594-0c21dbf3ae3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_490df6e6-7b2d-4ef7-a594-0c21dbf3ae3a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_LesseeOperatingLeasesNumberOfExistingLeases_743a3b35-4c1a-48b7-a0d9-9dbaddd4231e" xlink:href="vtl-20250630.xsd#vtl_LesseeOperatingLeasesNumberOfExistingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_LesseeOperatingLeasesNumberOfExistingLeases_743a3b35-4c1a-48b7-a0d9-9dbaddd4231e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_aaad5f9e-2a70-465d-9a68-5c8e1f84b9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_aaad5f9e-2a70-465d-9a68-5c8e1f84b9e2" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0ef7211-0692-4a71-b1f7-09332ea70720" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_01387f20-4910-4139-a67f-b5ca50474d31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0ef7211-0692-4a71-b1f7-09332ea70720" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_01387f20-4910-4139-a67f-b5ca50474d31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_01387f20-4910-4139-a67f-b5ca50474d31" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_1b9e4dd8-d3ad-44e1-848f-ec0df7ce435b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:to="loc_us-gaap_StockOptionMember_1b9e4dd8-d3ad-44e1-848f-ec0df7ce435b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentWarrantsMember_fa85be82-9751-46c0-823e-4ae660e1f661" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:to="loc_vtl_PlacementAgentWarrantsMember_fa85be82-9751-46c0-823e-4ae660e1f661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_34f8dd81-63c4-4641-b617-847b35607d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0ef7211-0692-4a71-b1f7-09332ea70720" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_34f8dd81-63c4-4641-b617-847b35607d1e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_7b502b65-5f62-4381-904b-55a67eda3b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_7b502b65-5f62-4381-904b-55a67eda3b1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4344c8ff-225c-4797-80ea-b3136935ef09" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b502b65-5f62-4381-904b-55a67eda3b1a" xlink:to="loc_srt_StatementGeographicalAxis_4344c8ff-225c-4797-80ea-b3136935ef09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4344c8ff-225c-4797-80ea-b3136935ef09_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4344c8ff-225c-4797-80ea-b3136935ef09" xlink:to="loc_srt_SegmentGeographicalDomain_4344c8ff-225c-4797-80ea-b3136935ef09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4344c8ff-225c-4797-80ea-b3136935ef09" xlink:to="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NewYorkCityMember_cad7a044-7015-47ad-b021-464a29061be7" xlink:href="vtl-20250630.xsd#vtl_NewYorkCityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:to="loc_vtl_NewYorkCityMember_cad7a044-7015-47ad-b021-464a29061be7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GrafelfingGermanyMember_5bd4455d-806a-4891-a13c-2275cb347f90" xlink:href="vtl-20250630.xsd#vtl_GrafelfingGermanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:to="loc_vtl_GrafelfingGermanyMember_5bd4455d-806a-4891-a13c-2275cb347f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlaneggGermanyMember_ee836060-e46e-4908-985b-25e2f4cd8a37" xlink:href="vtl-20250630.xsd#vtl_PlaneggGermanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:to="loc_vtl_PlaneggGermanyMember_ee836060-e46e-4908-985b-25e2f4cd8a37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_cad683d8-bbbb-461c-93d6-e9142ad2f817" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_cad683d8-bbbb-461c-93d6-e9142ad2f817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b9e9b43c-bb8c-4244-8264-0c77f83022c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b9e9b43c-bb8c-4244-8264-0c77f83022c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_360254be-e5f2-4b55-b82a-f342570cf6cb" xlink:href="vtl-20250630.xsd#vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_360254be-e5f2-4b55-b82a-f342570cf6cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OperatingLeaseIncrementalBorrowingRate_2f3ff100-e322-436f-ace5-a9f73aa8fb49" xlink:href="vtl-20250630.xsd#vtl_OperatingLeaseIncrementalBorrowingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_vtl_OperatingLeaseIncrementalBorrowingRate_2f3ff100-e322-436f-ace5-a9f73aa8fb49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OperatingAndVariableLeasesCost_2a5e2a1c-1f31-44cc-acaa-28ad0be24eca" xlink:href="vtl-20250630.xsd#vtl_OperatingAndVariableLeasesCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_vtl_OperatingAndVariableLeasesCost_2a5e2a1c-1f31-44cc-acaa-28ad0be24eca" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19796317-3b57-42c7-994f-dffd4f32cdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19796317-3b57-42c7-994f-dffd4f32cdb4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de0afbd1-8b26-4d39-a95f-4a6380686b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de0afbd1-8b26-4d39-a95f-4a6380686b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_de0afbd1-8b26-4d39-a95f-4a6380686b0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de0afbd1-8b26-4d39-a95f-4a6380686b0b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_de0afbd1-8b26-4d39-a95f-4a6380686b0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_075267eb-b551-4dc2-b382-efacf4b56b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de0afbd1-8b26-4d39-a95f-4a6380686b0b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_075267eb-b551-4dc2-b382-efacf4b56b3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5860ae0c-0f6d-41ca-9464-2286766438ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_075267eb-b551-4dc2-b382-efacf4b56b3e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5860ae0c-0f6d-41ca-9464-2286766438ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f7292c7b-3021-480c-b5e0-a291b4955e92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:to="loc_us-gaap_InvestmentTypeAxis_f7292c7b-3021-480c-b5e0-a291b4955e92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f7292c7b-3021-480c-b5e0-a291b4955e92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_f7292c7b-3021-480c-b5e0-a291b4955e92" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f7292c7b-3021-480c-b5e0-a291b4955e92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_60453fa4-aee6-4cdb-8c7c-accf5637859f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_f7292c7b-3021-480c-b5e0-a291b4955e92" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_60453fa4-aee6-4cdb-8c7c-accf5637859f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f39f3f10-7351-4211-baf7-1a56839c394d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_60453fa4-aee6-4cdb-8c7c-accf5637859f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f39f3f10-7351-4211-baf7-1a56839c394d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8a48782-73d8-49c5-a17c-1096e709b600" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8a48782-73d8-49c5-a17c-1096e709b600" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b8a48782-73d8-49c5-a17c-1096e709b600_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8a48782-73d8-49c5-a17c-1096e709b600" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b8a48782-73d8-49c5-a17c-1096e709b600_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8a48782-73d8-49c5-a17c-1096e709b600" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_32760b33-7f17-4276-9b1e-780471c98d14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_32760b33-7f17-4276-9b1e-780471c98d14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9cd48a3e-e84a-4556-b5c9-c93ea5fbe111" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9cd48a3e-e84a-4556-b5c9-c93ea5fbe111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fd39e0bf-a0fa-43cc-8566-defef2350ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fd39e0bf-a0fa-43cc-8566-defef2350ccb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_eb4f6161-21a0-4e81-bf6e-9db74bf4489a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19796317-3b57-42c7-994f-dffd4f32cdb4" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_eb4f6161-21a0-4e81-bf6e-9db74bf4489a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d44d80f7-d85a-496b-9357-2bddc33809c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eb4f6161-21a0-4e81-bf6e-9db74bf4489a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d44d80f7-d85a-496b-9357-2bddc33809c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/FairValueAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#FairValueAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/FairValueAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64ad839c-3589-4e95-b93a-27b1b02d607c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:to="loc_srt_StatementGeographicalAxis_64ad839c-3589-4e95-b93a-27b1b02d607c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_64ad839c-3589-4e95-b93a-27b1b02d607c_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_64ad839c-3589-4e95-b93a-27b1b02d607c" xlink:to="loc_srt_SegmentGeographicalDomain_64ad839c-3589-4e95-b93a-27b1b02d607c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cbabfaad-1987-46d9-9e66-28f8ec1abeb0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_64ad839c-3589-4e95-b93a-27b1b02d607c" xlink:to="loc_srt_SegmentGeographicalDomain_cbabfaad-1987-46d9-9e66-28f8ec1abeb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a194e4ff-3f38-4721-a23d-1bbf777911ef" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cbabfaad-1987-46d9-9e66-28f8ec1abeb0" xlink:to="loc_country_US_a194e4ff-3f38-4721-a23d-1bbf777911ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_936891bd-22c2-478d-b265-fd69d9d020c9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:to="loc_srt_RangeAxis_936891bd-22c2-478d-b265-fd69d9d020c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_936891bd-22c2-478d-b265-fd69d9d020c9_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_936891bd-22c2-478d-b265-fd69d9d020c9" xlink:to="loc_srt_RangeMember_936891bd-22c2-478d-b265-fd69d9d020c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_936891bd-22c2-478d-b265-fd69d9d020c9" xlink:to="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_75f84e57-0697-4dea-bee4-0e30c2c7b57b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:to="loc_srt_MinimumMember_75f84e57-0697-4dea-bee4-0e30c2c7b57b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ab72edf7-b014-4efe-8083-7a67d34bb88c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:to="loc_srt_MaximumMember_ab72edf7-b014-4efe-8083-7a67d34bb88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate_b4efff56-6988-4dbf-8d61-23d39289bba4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_InvestmentInterestRate_b4efff56-6988-4dbf-8d61-23d39289bba4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightFairValueDisclosure_a12430a8-b5b4-4bc7-acda-e3eb8cd1489c" xlink:href="vtl-20250630.xsd#vtl_TrancheRightFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_vtl_TrancheRightFairValueDisclosure_a12430a8-b5b4-4bc7-acda-e3eb8cd1489c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2b83ab40-b500-41e2-b1c0-0d0add1a6ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2b83ab40-b500-41e2-b1c0-0d0add1a6ea4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388d8a0e-e4b2-40d5-bb89-cfc075290efa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388d8a0e-e4b2-40d5-bb89-cfc075290efa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6c739227-9e41-47f5-bd9a-69383d43913f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6c739227-9e41-47f5-bd9a-69383d43913f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bdfa0a89-986b-4abd-a833-e76440fb684c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bdfa0a89-986b-4abd-a833-e76440fb684c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_527f9768-0dc0-4931-b5f9-3dcbb22c36ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_527f9768-0dc0-4931-b5f9-3dcbb22c36ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_203e56e7-df4b-49ef-b710-e0c33b424fcb" xlink:href="vtl-20250630.xsd#vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_203e56e7-df4b-49ef-b710-e0c33b424fcb" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockShelfRegistrationStatementDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d4465640-f672-446c-b39c-8e57bf41c3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d4465640-f672-446c-b39c-8e57bf41c3f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d4465640-f672-446c-b39c-8e57bf41c3f9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_December2020ATMMember_c42eb115-b4db-4236-b585-c3ff9fbb923e" xlink:href="vtl-20250630.xsd#vtl_December2020ATMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_December2020ATMMember_c42eb115-b4db-4236-b585-c3ff9fbb923e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2022ATMMember_5042b461-9a0e-4878-a979-9ad8c4fd77f3" xlink:href="vtl-20250630.xsd#vtl_May2022ATMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_May2022ATMMember_5042b461-9a0e-4878-a979-9ad8c4fd77f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025AndMay2025FinancingMember_71f427f2-e98a-4f50-97f0-00a1f64ed39f" xlink:href="vtl-20250630.xsd#vtl_April2025AndMay2025FinancingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_April2025AndMay2025FinancingMember_71f427f2-e98a-4f50-97f0-00a1f64ed39f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2024ATMMember_fd1f173a-9a9a-4fbc-a4bb-b5a633850e18" xlink:href="vtl-20250630.xsd#vtl_May2024ATMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_May2024ATMMember_fd1f173a-9a9a-4fbc-a4bb-b5a633850e18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration_63ed44d9-6d2d-456f-98a5-64b1241a711c" xlink:href="vtl-20250630.xsd#vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration_63ed44d9-6d2d-456f-98a5-64b1241a711c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration_bc0f834b-803f-4965-9d00-fdabe8f8f11d" xlink:href="vtl-20250630.xsd#vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration_bc0f834b-803f-4965-9d00-fdabe8f8f11d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays_67cf2fce-4142-456c-9286-6f2477d9cc37" xlink:href="vtl-20250630.xsd#vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays_67cf2fce-4142-456c-9286-6f2477d9cc37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockRemainingCapacity_767828de-24f0-4b9a-bd6c-9935a03cd940" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockRemainingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_SaleOfStockRemainingCapacity_767828de-24f0-4b9a-bd6c-9935a03cd940" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SalesOfStockCommissionsPercentOfGrossProceeds_9b3f76db-8566-4917-8ef9-2283c137461b" xlink:href="vtl-20250630.xsd#vtl_SalesOfStockCommissionsPercentOfGrossProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_SalesOfStockCommissionsPercentOfGrossProceeds_9b3f76db-8566-4917-8ef9-2283c137461b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_525239d6-c2ac-4f73-953b-992701d14749" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_525239d6-c2ac-4f73-953b-992701d14749" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27306873-eb53-458b-a8f0-bd36a56b0dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27306873-eb53-458b-a8f0-bd36a56b0dfa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a9831482-65ac-4ef4-8606-f8ac0328b4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a9831482-65ac-4ef4-8606-f8ac0328b4c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_da719d09-f4f0-4c5e-9a03-33a54d265ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_da719d09-f4f0-4c5e-9a03-33a54d265ba1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions_27461a08-5310-4a33-beda-b048b4aca7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_PaymentsForCommissions_27461a08-5310-4a33-beda-b048b4aca7c1" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockApril2025OfferingDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_99cb8e09-0876-4fa2-87c5-3ae20c4b8675" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_99cb8e09-0876-4fa2-87c5-3ae20c4b8675" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_012bd8cb-401d-4699-be0a-4b7258bd153f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_99cb8e09-0876-4fa2-87c5-3ae20c4b8675" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_012bd8cb-401d-4699-be0a-4b7258bd153f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_012bd8cb-401d-4699-be0a-4b7258bd153f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_012bd8cb-401d-4699-be0a-4b7258bd153f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_012bd8cb-401d-4699-be0a-4b7258bd153f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_012bd8cb-401d-4699-be0a-4b7258bd153f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SecuritiesPurchaseAgreementMember_ddf3d99d-9fcd-43c6-865a-41f628d3b308" xlink:href="vtl-20250630.xsd#vtl_SecuritiesPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:to="loc_vtl_SecuritiesPurchaseAgreementMember_ddf3d99d-9fcd-43c6-865a-41f628d3b308" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgencyAgreementMember_0cffefa3-45d0-444b-a388-7dd723000bc1" xlink:href="vtl-20250630.xsd#vtl_PlacementAgencyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:to="loc_vtl_PlacementAgencyAgreementMember_0cffefa3-45d0-444b-a388-7dd723000bc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OfferingMember_bdf8bf2f-af3c-43a5-ba60-64ba21f5ca19" xlink:href="vtl-20250630.xsd#vtl_OfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:to="loc_vtl_OfferingMember_bdf8bf2f-af3c-43a5-ba60-64ba21f5ca19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a3351915-03de-4157-bda2-484222fb5468" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a3351915-03de-4157-bda2-484222fb5468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c1adfd13-9a43-418e-92db-2838244c3641" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c1adfd13-9a43-418e-92db-2838244c3641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_ca178945-b040-44a3-a87c-9980ac72c9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_ca178945-b040-44a3-a87c-9980ac72c9bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1eeae173-71b1-4c73-b00c-0d8e4ca967b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1eeae173-71b1-4c73-b00c-0d8e4ca967b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_fe176168-e577-4d49-bbf2-5cbdd3d710bd" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentAgreementBrokerageFeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_fe176168-e577-4d49-bbf2-5cbdd3d710bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_bc1df7bf-9778-48cc-a86e-dabe4918a584" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_bc1df7bf-9778-48cc-a86e-dabe4918a584" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_c4d3427d-baa9-4dba-8d65-ed1b0d5c7095" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_c4d3427d-baa9-4dba-8d65-ed1b0d5c7095" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_bf647bcd-b5a2-476d-bef3-1bb16177a642" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SharePrice_bf647bcd-b5a2-476d-bef3-1bb16177a642" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a402e209-31f6-4099-abf0-e5973c1746d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a402e209-31f6-4099-abf0-e5973c1746d2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses_df1ff91f-f4b7-457a-bc63-8c8039e525e4" xlink:href="vtl-20250630.xsd#vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses_df1ff91f-f4b7-457a-bc63-8c8039e525e4" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockMay2025EquityOfferingDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_63ba5e44-9b7b-4f9f-bffd-8dc945392428" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_63ba5e44-9b7b-4f9f-bffd-8dc945392428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_63ba5e44-9b7b-4f9f-bffd-8dc945392428_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_63ba5e44-9b7b-4f9f-bffd-8dc945392428" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_63ba5e44-9b7b-4f9f-bffd-8dc945392428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_63ba5e44-9b7b-4f9f-bffd-8dc945392428" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_7f0591fa-b8b1-4923-984d-3dd9962c51ae" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:to="loc_vtl_PreFundedWarrantsMember_7f0591fa-b8b1-4923-984d-3dd9962c51ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgencyAgreementMember_73e00deb-12ad-4b52-9c1a-2bc3daff9dc0" xlink:href="vtl-20250630.xsd#vtl_PlacementAgencyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:to="loc_vtl_PlacementAgencyAgreementMember_73e00deb-12ad-4b52-9c1a-2bc3daff9dc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0777c47a-b63a-449b-8e20-eff36e066dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0777c47a-b63a-449b-8e20-eff36e066dfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0777c47a-b63a-449b-8e20-eff36e066dfc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0777c47a-b63a-449b-8e20-eff36e066dfc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0777c47a-b63a-449b-8e20-eff36e066dfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0777c47a-b63a-449b-8e20-eff36e066dfc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantsMember_7938bc73-6bd9-483e-a6d7-2cebbd3ac0d0" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_SeriesAWarrantsMember_7938bc73-6bd9-483e-a6d7-2cebbd3ac0d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesBWarrantsMember_ab38b462-d945-491b-af7d-b6488d48faf0" xlink:href="vtl-20250630.xsd#vtl_SeriesBWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_SeriesBWarrantsMember_ab38b462-d945-491b-af7d-b6488d48faf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantAndSeriesBWarrantMember_54ada079-28ee-4e53-904e-88c9c3e8598a" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantAndSeriesBWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_SeriesAWarrantAndSeriesBWarrantMember_54ada079-28ee-4e53-904e-88c9c3e8598a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_VolumeWeightageAveragePriceTargetMember_cf77657c-c189-4418-9306-dc08bbced7b4" xlink:href="vtl-20250630.xsd#vtl_VolumeWeightageAveragePriceTargetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_VolumeWeightageAveragePriceTargetMember_cf77657c-c189-4418-9306-dc08bbced7b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_30f688f0-db7d-419f-8387-0f578309fd65" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:to="loc_srt_RangeAxis_30f688f0-db7d-419f-8387-0f578309fd65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_30f688f0-db7d-419f-8387-0f578309fd65_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_30f688f0-db7d-419f-8387-0f578309fd65" xlink:to="loc_srt_RangeMember_30f688f0-db7d-419f-8387-0f578309fd65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e842565b-4dbe-488e-a485-7e780520bacb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_30f688f0-db7d-419f-8387-0f578309fd65" xlink:to="loc_srt_RangeMember_e842565b-4dbe-488e-a485-7e780520bacb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_678ff0f8-3971-4405-a1ad-047d01100c5c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e842565b-4dbe-488e-a485-7e780520bacb" xlink:to="loc_srt_MaximumMember_678ff0f8-3971-4405-a1ad-047d01100c5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3b586b8d-37f2-4d9f-966c-d804d1a028e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3b586b8d-37f2-4d9f-966c-d804d1a028e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_65cfa1b7-89bf-43b6-aafa-2b1b89fb581b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_65cfa1b7-89bf-43b6-aafa-2b1b89fb581b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ae4ae92c-062a-4bad-bcdd-7f86343035a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ae4ae92c-062a-4bad-bcdd-7f86343035a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod_4d8e442c-4a9e-4765-a12a-df510dcd4f1f" xlink:href="vtl-20250630.xsd#vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod_4d8e442c-4a9e-4765-a12a-df510dcd4f1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance_9c64648f-6d61-4782-af0e-f0b14d3d8cb7" xlink:href="vtl-20250630.xsd#vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance_9c64648f-6d61-4782-af0e-f0b14d3d8cb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OwnershipLimitationPercentage_01936c44-baac-4f61-9450-6dd605126172" xlink:href="vtl-20250630.xsd#vtl_OwnershipLimitationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_OwnershipLimitationPercentage_01936c44-baac-4f61-9450-6dd605126172" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder_ca55a04a-aca9-456d-8bbb-463ffa12486c" xlink:href="vtl-20250630.xsd#vtl_OwnershipLimitationPercentageUponElectionOfTheHolder"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder_ca55a04a-aca9-456d-8bbb-463ffa12486c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae32b2e9-cad3-4b71-be11-570b02a435d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae32b2e9-cad3-4b71-be11-570b02a435d3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_cf1851e7-2f05-4aaf-9b18-7f8d67de0052" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_cf1851e7-2f05-4aaf-9b18-7f8d67de0052" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_f4bc504c-7941-4e0b-a0bf-778387866844" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentAgreementBrokerageFeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_f4bc504c-7941-4e0b-a0bf-778387866844" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockJanuary2024FinancingDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_8ae6f5ba-7142-4cad-9a71-10c70f7d9212" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_srt_TitleOfIndividualAxis_8ae6f5ba-7142-4cad-9a71-10c70f7d9212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ae6f5ba-7142-4cad-9a71-10c70f7d9212_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_8ae6f5ba-7142-4cad-9a71-10c70f7d9212" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ae6f5ba-7142-4cad-9a71-10c70f7d9212_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eab22d97-8cc1-411c-a395-88c9fe3438a4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_8ae6f5ba-7142-4cad-9a71-10c70f7d9212" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eab22d97-8cc1-411c-a395-88c9fe3438a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccreditedInvestorsMember_708e465c-baa3-4670-8f7c-75fb6ceedc43" xlink:href="vtl-20250630.xsd#vtl_AccreditedInvestorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eab22d97-8cc1-411c-a395-88c9fe3438a4" xlink:to="loc_vtl_AccreditedInvestorsMember_708e465c-baa3-4670-8f7c-75fb6ceedc43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2f1da554-4e5a-4b3f-ac17-11d788fe595b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2f1da554-4e5a-4b3f-ac17-11d788fe595b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2f1da554-4e5a-4b3f-ac17-11d788fe595b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2f1da554-4e5a-4b3f-ac17-11d788fe595b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2f1da554-4e5a-4b3f-ac17-11d788fe595b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2f1da554-4e5a-4b3f-ac17-11d788fe595b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_79a2e16a-d90d-4e20-9b6e-fc9e0f73407b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:to="loc_us-gaap_PrivatePlacementMember_79a2e16a-d90d-4e20-9b6e-fc9e0f73407b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7e7a49ee-466b-4663-afea-b9f4a8220cca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:to="loc_us-gaap_CommonStockMember_7e7a49ee-466b-4663-afea-b9f4a8220cca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockAndPreFundedWarrantsMember_e63b1d1c-e756-4f2f-8114-62734594ded3" xlink:href="vtl-20250630.xsd#vtl_CommonStockAndPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:to="loc_vtl_CommonStockAndPreFundedWarrantsMember_e63b1d1c-e756-4f2f-8114-62734594ded3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fadfb4db-149d-418f-bf28-b87db802bbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fadfb4db-149d-418f-bf28-b87db802bbe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fadfb4db-149d-418f-bf28-b87db802bbe1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fadfb4db-149d-418f-bf28-b87db802bbe1" xlink:to="loc_us-gaap_ClassOfStockDomain_fadfb4db-149d-418f-bf28-b87db802bbe1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fadfb4db-149d-418f-bf28-b87db802bbe1" xlink:to="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_677fcbad-6186-47f7-add6-7643ae55ae34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:to="loc_us-gaap_CommonStockMember_677fcbad-6186-47f7-add6-7643ae55ae34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_0bb0e241-0033-4601-8ddb-a3997364e7c7" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:to="loc_vtl_PreFundedWarrantsMember_0bb0e241-0033-4601-8ddb-a3997364e7c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockAndPreFundedWarrantsMember_37c80d53-ea92-42a6-857e-1ce0693c394d" xlink:href="vtl-20250630.xsd#vtl_CommonStockAndPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:to="loc_vtl_CommonStockAndPreFundedWarrantsMember_37c80d53-ea92-42a6-857e-1ce0693c394d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_2e9b3667-0ef4-40f0-a08d-5e32fed342c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_VestingAxis_2e9b3667-0ef4-40f0-a08d-5e32fed342c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_2e9b3667-0ef4-40f0-a08d-5e32fed342c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_2e9b3667-0ef4-40f0-a08d-5e32fed342c6" xlink:to="loc_us-gaap_VestingDomain_2e9b3667-0ef4-40f0-a08d-5e32fed342c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_2e9b3667-0ef4-40f0-a08d-5e32fed342c6" xlink:to="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_356bd748-82f1-4707-804a-f7bdf2306ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_356bd748-82f1-4707-804a-f7bdf2306ff2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_86960ecf-8c51-4f78-be25-70e6b674d322" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_86960ecf-8c51-4f78-be25-70e6b674d322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_f69d29bf-cb57-4762-9c6f-eb9970250071" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_f69d29bf-cb57-4762-9c6f-eb9970250071" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_d4d58171-8ebd-4907-b8e8-6d624d07de8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_d4d58171-8ebd-4907-b8e8-6d624d07de8c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_d4d58171-8ebd-4907-b8e8-6d624d07de8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_d4d58171-8ebd-4907-b8e8-6d624d07de8c" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_d4d58171-8ebd-4907-b8e8-6d624d07de8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_d4d58171-8ebd-4907-b8e8-6d624d07de8c" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMember_c587a202-23f2-4906-91cf-e8aaa9d7bb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:to="loc_us-gaap_EquityMember_c587a202-23f2-4906-91cf-e8aaa9d7bb3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5aa1db22-ca63-49a7-a518-20655aa8f8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5aa1db22-ca63-49a7-a518-20655aa8f8a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_45b7dd07-742f-4d4e-83de-b240a1320bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_45b7dd07-742f-4d4e-83de-b240a1320bc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockPrivatePlacementNumberOfTranche_c433fbeb-13ea-4218-a94d-e930f6688c1a" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockPrivatePlacementNumberOfTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockPrivatePlacementNumberOfTranche_c433fbeb-13ea-4218-a94d-e930f6688c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_7da928f5-124f-4737-a21b-32ac038373b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_7da928f5-124f-4737-a21b-32ac038373b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ff959d7b-4d65-46de-9258-4170f8fa60f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ff959d7b-4d65-46de-9258-4170f8fa60f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockConsiderationReceivedPercentage_275f18bd-7c5c-4a77-92bf-b70488267e7e" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockConsiderationReceivedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockConsiderationReceivedPercentage_275f18bd-7c5c-4a77-92bf-b70488267e7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockNumberOfTrancheConditions_9ca9779c-2305-40e8-b5d1-143c32fe5a26" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockNumberOfTrancheConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockNumberOfTrancheConditions_9ca9779c-2305-40e8-b5d1-143c32fe5a26" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation_626cb05d-cb5c-47b3-bcc2-32883205ba4f" xlink:href="vtl-20250630.xsd#vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation_626cb05d-cb5c-47b3-bcc2-32883205ba4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_WeightedAveragePriceOfLast10Days_880d77f8-4f93-4640-901a-8890e67f4a04" xlink:href="vtl-20250630.xsd#vtl_WeightedAveragePriceOfLast10Days"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_WeightedAveragePriceOfLast10Days_880d77f8-4f93-4640-901a-8890e67f4a04" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation_50a50cef-d48d-4642-8626-43849e244d43" xlink:href="vtl-20250630.xsd#vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation_50a50cef-d48d-4642-8626-43849e244d43" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days_7509dac1-9715-41f0-9fbf-b6d16c54000f" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockAggregateTradingVolumeOfLast10Days"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days_7509dac1-9715-41f0-9fbf-b6d16c54000f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockEquityOfferingsPeriod_689f4d79-b266-4fb2-97ad-98bc3a3dfe1f" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockEquityOfferingsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockEquityOfferingsPeriod_689f4d79-b266-4fb2-97ad-98bc3a3dfe1f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_2b7d1c70-4e21-4a40-8472-75b0a631de24" xlink:href="vtl-20250630.xsd#vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_2b7d1c70-4e21-4a40-8472-75b0a631de24" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightsLiabilityRemainderAmount_a7f9901b-634f-4402-8cf0-208f0563e007" xlink:href="vtl-20250630.xsd#vtl_TrancheRightsLiabilityRemainderAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_TrancheRightsLiabilityRemainderAmount_a7f9901b-634f-4402-8cf0-208f0563e007" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightsLiabilityReceivedAmount_fde84fba-1f0f-4bb8-b6eb-e3f9c60055bd" xlink:href="vtl-20250630.xsd#vtl_TrancheRightsLiabilityReceivedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_TrancheRightsLiabilityReceivedAmount_fde84fba-1f0f-4bb8-b6eb-e3f9c60055bd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8c2d0590-2318-4135-81d4-8686a843b275" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8c2d0590-2318-4135-81d4-8686a843b275" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_9b93cda2-9b87-45f9-a6de-02f18df71443" xlink:href="vtl-20250630.xsd#vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_9b93cda2-9b87-45f9-a6de-02f18df71443" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockNumberOfSharesRegisteredForResale_d988b5a3-b747-49bd-bde8-e1dbe9841e07" xlink:href="vtl-20250630.xsd#vtl_CommonStockNumberOfSharesRegisteredForResale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_CommonStockNumberOfSharesRegisteredForResale_d988b5a3-b747-49bd-bde8-e1dbe9841e07" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockCommonStockDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockCommonStockDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CommonStockCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e3198a0d-6554-4580-91e5-35dac82dfea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e3198a0d-6554-4580-91e5-35dac82dfea8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e3198a0d-6554-4580-91e5-35dac82dfea8" xlink:to="loc_srt_RangeAxis_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f" xlink:to="loc_srt_RangeMember_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f" xlink:to="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f57e079e-ba88-4880-9e19-6b033cb35a1c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:to="loc_srt_MinimumMember_f57e079e-ba88-4880-9e19-6b033cb35a1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2f6e345-bfdd-4ec9-9a33-e1392afb59e4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:to="loc_srt_MaximumMember_a2f6e345-bfdd-4ec9-9a33-e1392afb59e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7e7d0de2-8ab8-4cef-a3f9-31b53cb7038c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7e7d0de2-8ab8-4cef-a3f9-31b53cb7038c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_49e7fcf8-bed9-4efa-b1d6-2988cece5a84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_49e7fcf8-bed9-4efa-b1d6-2988cece5a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfVotesPerEachShareOfCommonStock_8a0fd6af-f750-4134-ab5a-10eaab88e9ff" xlink:href="vtl-20250630.xsd#vtl_NumberOfVotesPerEachShareOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_vtl_NumberOfVotesPerEachShareOfCommonStock_8a0fd6af-f750-4134-ab5a-10eaab88e9ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_7820f4a2-2c4c-4091-8a24-0112e3bea1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_7820f4a2-2c4c-4091-8a24-0112e3bea1f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2fcb910-c397-42ce-bd19-143dc48bac18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2fcb910-c397-42ce-bd19-143dc48bac18" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockPrefundedWarrantsDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_63e1b1f3-1a99-487f-803a-8f47283c75fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_63e1b1f3-1a99-487f-803a-8f47283c75fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e17aff69-e59a-4e52-9243-1f98b2d0e8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_63e1b1f3-1a99-487f-803a-8f47283c75fe" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e17aff69-e59a-4e52-9243-1f98b2d0e8aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e17aff69-e59a-4e52-9243-1f98b2d0e8aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e17aff69-e59a-4e52-9243-1f98b2d0e8aa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e17aff69-e59a-4e52-9243-1f98b2d0e8aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_851c2d9f-d53c-4395-81b6-42e2a3790f44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e17aff69-e59a-4e52-9243-1f98b2d0e8aa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_851c2d9f-d53c-4395-81b6-42e2a3790f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_e1f2c4b6-ede6-4148-ba33-55270d923f5d" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_851c2d9f-d53c-4395-81b6-42e2a3790f44" xlink:to="loc_vtl_PreFundedWarrantsMember_e1f2c4b6-ede6-4148-ba33-55270d923f5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6f8c4bca-8937-4f9b-a1e6-3bcc45b3bfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6f8c4bca-8937-4f9b-a1e6-3bcc45b3bfa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_6f4b273d-9505-45e7-8d2c-0ab0336593f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_6f4b273d-9505-45e7-8d2c-0ab0336593f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_81e4c138-2730-48a4-abcf-f9b6453113a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_81e4c138-2730-48a4-abcf-f9b6453113a7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockScheduleofSharesReservedforFutureIssuanceDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_565e84a3-a5a3-4eeb-9dfe-017aecebae9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_565e84a3-a5a3-4eeb-9dfe-017aecebae9e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cd936f70-a410-49ce-ab6d-c58a00a5e265" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:to="loc_us-gaap_AwardTypeAxis_cd936f70-a410-49ce-ab6d-c58a00a5e265" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd936f70-a410-49ce-ab6d-c58a00a5e265_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cd936f70-a410-49ce-ab6d-c58a00a5e265" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd936f70-a410-49ce-ab6d-c58a00a5e265_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cd936f70-a410-49ce-ab6d-c58a00a5e265" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bc39f827-5687-4cc7-9925-1071e508a375" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bc39f827-5687-4cc7-9925-1071e508a375" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_97c06adb-08d0-4bf2-96b7-22ef480369f9" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_PreFundedWarrantsMember_97c06adb-08d0-4bf2-96b7-22ef480369f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentWarrantsMember_c2351965-f6d9-4825-8fab-df2c581e2646" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_PlacementAgentWarrantsMember_c2351965-f6d9-4825-8fab-df2c581e2646" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PreFundedWarrantsMember_9db4788c-5668-4a99-b0d0-2f4c2f5dc113" xlink:href="vtl-20250630.xsd#vtl_May2025PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_May2025PreFundedWarrantsMember_9db4788c-5668-4a99-b0d0-2f4c2f5dc113" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025SeriesAWarrantsMember_912e096a-19a9-4ad7-83a1-5c8af2895703" xlink:href="vtl-20250630.xsd#vtl_May2025SeriesAWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_May2025SeriesAWarrantsMember_912e096a-19a9-4ad7-83a1-5c8af2895703" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025SeriesBWarrantsMember_348ee840-06c9-4a79-b725-6d5f3ef12e5f" xlink:href="vtl-20250630.xsd#vtl_May2025SeriesBWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_May2025SeriesBWarrantsMember_348ee840-06c9-4a79-b725-6d5f3ef12e5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_EmployeeStockOptionsforFutureGrantMember_c40799af-fce2-4279-bbd1-2749979ed48a" xlink:href="vtl-20250630.xsd#vtl_EmployeeStockOptionsforFutureGrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_EmployeeStockOptionsforFutureGrantMember_c40799af-fce2-4279-bbd1-2749979ed48a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:to="loc_us-gaap_PlanNameAxis_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6" xlink:to="loc_us-gaap_PlanNameDomain_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6" xlink:to="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2021EmployeeStockPurchasePlanMember_d68e1f47-b716-4093-8a2f-dc9a37d7d591" xlink:href="vtl-20250630.xsd#vtl_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:to="loc_vtl_A2021EmployeeStockPurchasePlanMember_d68e1f47-b716-4093-8a2f-dc9a37d7d591" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2017InducementEquityIncentivePlanMember_b0f00558-1937-471a-a296-70325f18524e" xlink:href="vtl-20250630.xsd#vtl_A2017InducementEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:to="loc_vtl_A2017InducementEquityIncentivePlanMember_b0f00558-1937-471a-a296-70325f18524e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_4cfca840-be88-4d12-9eda-3f4a1c2b1bb6" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:to="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_4cfca840-be88-4d12-9eda-3f4a1c2b1bb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f87dfa2c-8449-423c-a16c-372ce53b874d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:to="loc_us-gaap_VestingAxis_f87dfa2c-8449-423c-a16c-372ce53b874d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_f87dfa2c-8449-423c-a16c-372ce53b874d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_f87dfa2c-8449-423c-a16c-372ce53b874d" xlink:to="loc_us-gaap_VestingDomain_f87dfa2c-8449-423c-a16c-372ce53b874d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a6aedb09-d570-422a-89ea-48bd0f994572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_f87dfa2c-8449-423c-a16c-372ce53b874d" xlink:to="loc_us-gaap_VestingDomain_a6aedb09-d570-422a-89ea-48bd0f994572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0c537ba1-57f8-4009-9568-bf7c8138c380" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a6aedb09-d570-422a-89ea-48bd0f994572" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0c537ba1-57f8-4009-9568-bf7c8138c380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7268b0d1-b285-4347-9971-1a8f4e5ee114" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_565e84a3-a5a3-4eeb-9dfe-017aecebae9e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7268b0d1-b285-4347-9971-1a8f4e5ee114" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8c85b47b-af72-4914-b8c1-81530e2ce662" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_us-gaap_PlanNameAxis_8c85b47b-af72-4914-b8c1-81530e2ce662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8c85b47b-af72-4914-b8c1-81530e2ce662_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8c85b47b-af72-4914-b8c1-81530e2ce662" xlink:to="loc_us-gaap_PlanNameDomain_8c85b47b-af72-4914-b8c1-81530e2ce662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8c85b47b-af72-4914-b8c1-81530e2ce662" xlink:to="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2021EmployeeStockPurchasePlanMember_381b0d2a-3fbb-4484-8f13-a900e51d4cfd" xlink:href="vtl-20250630.xsd#vtl_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_A2021EmployeeStockPurchasePlanMember_381b0d2a-3fbb-4484-8f13-a900e51d4cfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2019OmnibusEquityIncentivePlanMember_3341d6b9-6b11-450c-8cf8-7497b7399194" xlink:href="vtl-20250630.xsd#vtl_A2019OmnibusEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_A2019OmnibusEquityIncentivePlanMember_3341d6b9-6b11-450c-8cf8-7497b7399194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember_d9770181-1fc5-44ea-a363-9a97fa7e16c5" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember_d9770181-1fc5-44ea-a363-9a97fa7e16c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandFourteenEquityIncentivePlanMember_5c887a9d-53d7-4315-8ef6-68c8d6194d6f" xlink:href="vtl-20250630.xsd#vtl_TwoThousandFourteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_TwoThousandFourteenEquityIncentivePlanMember_5c887a9d-53d7-4315-8ef6-68c8d6194d6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2017InducementEquityIncentivePlanMember_860b7c7c-de0e-49f7-bd61-ca9e110c9e53" xlink:href="vtl-20250630.xsd#vtl_A2017InducementEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_A2017InducementEquityIncentivePlanMember_860b7c7c-de0e-49f7-bd61-ca9e110c9e53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2850e340-5292-41df-83ee-38e4a18297e0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_srt_RangeAxis_2850e340-5292-41df-83ee-38e4a18297e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2850e340-5292-41df-83ee-38e4a18297e0_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2850e340-5292-41df-83ee-38e4a18297e0" xlink:to="loc_srt_RangeMember_2850e340-5292-41df-83ee-38e4a18297e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2850e340-5292-41df-83ee-38e4a18297e0" xlink:to="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_03f9f4de-e197-4ae9-9d1c-5917f0b59ec5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:to="loc_srt_MaximumMember_03f9f4de-e197-4ae9-9d1c-5917f0b59ec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2215d454-0406-463f-bdca-e9eaee58af14" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:to="loc_srt_MinimumMember_2215d454-0406-463f-bdca-e9eaee58af14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bda4c471-8e96-4d25-954f-c1ec4dc1f994" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_us-gaap_AwardTypeAxis_bda4c471-8e96-4d25-954f-c1ec4dc1f994" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bda4c471-8e96-4d25-954f-c1ec4dc1f994_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bda4c471-8e96-4d25-954f-c1ec4dc1f994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bda4c471-8e96-4d25-954f-c1ec4dc1f994_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bda4c471-8e96-4d25-954f-c1ec4dc1f994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_IncentiveEmployeeStockOptionMember_4f37de90-6a10-4141-a251-7233fd5d1157" xlink:href="vtl-20250630.xsd#vtl_IncentiveEmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:to="loc_vtl_IncentiveEmployeeStockOptionMember_4f37de90-6a10-4141-a251-7233fd5d1157" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NonStatutoryEmployeeStockOptionMember_370fc548-87ad-4b8d-a7d1-6841d708ebea" xlink:href="vtl-20250630.xsd#vtl_NonStatutoryEmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:to="loc_vtl_NonStatutoryEmployeeStockOptionMember_370fc548-87ad-4b8d-a7d1-6841d708ebea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b6ff9100-c33c-42a0-a200-196ebcd6450d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b6ff9100-c33c-42a0-a200-196ebcd6450d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b6ff9100-c33c-42a0-a200-196ebcd6450d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b6ff9100-c33c-42a0-a200-196ebcd6450d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b6ff9100-c33c-42a0-a200-196ebcd6450d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b6ff9100-c33c-42a0-a200-196ebcd6450d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4e1453fa-5fee-4f1a-a1a4-ced08a3ada51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4e1453fa-5fee-4f1a-a1a4-ced08a3ada51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11ff3b8f-58f0-4df2-ad34-33754a467272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11ff3b8f-58f0-4df2-ad34-33754a467272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_79be4f8f-a607-4252-b38d-2bcec0ac3ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_79be4f8f-a607-4252-b38d-2bcec0ac3ba1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_aae2ee0a-0427-4813-8ebd-8a78cfdc030b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_aae2ee0a-0427-4813-8ebd-8a78cfdc030b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_40c47fac-0b18-40f6-ad50-325262035540" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_40c47fac-0b18-40f6-ad50-325262035540" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d5edab63-e49f-47ef-a559-5f7674b09116" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d5edab63-e49f-47ef-a559-5f7674b09116" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c02af09e-973d-40f4-b365-154a1016c90d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c02af09e-973d-40f4-b365-154a1016c90d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_613d04d3-e71b-436a-b9a5-98e87d5b987a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_613d04d3-e71b-436a-b9a5-98e87d5b987a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent_d712ec43-5c5e-47d8-aea8-c45b33428977" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent_d712ec43-5c5e-47d8-aea8-c45b33428977" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_d3464433-c0ae-4255-be1f-a7f6b9600a29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_d3464433-c0ae-4255-be1f-a7f6b9600a29" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7bcdd9c8-388d-452a-a0a0-3a136713a9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7bcdd9c8-388d-452a-a0a0-3a136713a9e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2a17b0fe-ea3b-489b-b521-d8cf599db557" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2a17b0fe-ea3b-489b-b521-d8cf599db557" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e146943c-e445-489e-b4bd-6e0dec00242d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e146943c-e445-489e-b4bd-6e0dec00242d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares_8ac339ac-1406-4418-ad49-c2fead3804ec" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares_8ac339ac-1406-4418-ad49-c2fead3804ec" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice_6b453bcb-ee88-4aca-b409-1717bad4a976" xlink:href="vtl-20250630.xsd#vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice_6b453bcb-ee88-4aca-b409-1717bad4a976" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_c7d27374-b8bd-4945-9609-4679ec894b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_c7d27374-b8bd-4945-9609-4679ec894b9e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a7311e47-c456-47a0-8475-6e518d80d498" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a7311e47-c456-47a0-8475-6e518d80d498" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b0fd719d-da37-4839-ac8d-7c3f55952004" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b0fd719d-da37-4839-ac8d-7c3f55952004" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_53be04db-ce1a-4c34-9499-2753f7102435" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_53be04db-ce1a-4c34-9499-2753f7102435" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_818d4998-e738-419a-b4ef-96362a82fb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_818d4998-e738-419a-b4ef-96362a82fb2d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_debb4694-2a24-40ab-95f6-888a28d65682" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_debb4694-2a24-40ab-95f6-888a28d65682" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansScheduleofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:to="loc_us-gaap_AwardTypeAxis_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_574e635f-fa83-41b7-a459-5b5ae4732e31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_574e635f-fa83-41b7-a459-5b5ae4732e31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e1ae39f6-1dac-46e0-8a72-d32f1e553033" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_574e635f-fa83-41b7-a459-5b5ae4732e31" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e1ae39f6-1dac-46e0-8a72-d32f1e553033" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e4c61f88-8858-4615-ab71-23eabd7982df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:to="loc_us-gaap_PlanNameAxis_e4c61f88-8858-4615-ab71-23eabd7982df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e4c61f88-8858-4615-ab71-23eabd7982df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_e4c61f88-8858-4615-ab71-23eabd7982df" xlink:to="loc_us-gaap_PlanNameDomain_e4c61f88-8858-4615-ab71-23eabd7982df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c763e8a7-1b66-49fb-a7cf-a87fe6d90cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_e4c61f88-8858-4615-ab71-23eabd7982df" xlink:to="loc_us-gaap_PlanNameDomain_c763e8a7-1b66-49fb-a7cf-a87fe6d90cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_f2eded7e-bb42-45e2-a7f6-811c2b50db5b" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c763e8a7-1b66-49fb-a7cf-a87fe6d90cf5" xlink:to="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_f2eded7e-bb42-45e2-a7f6-811c2b50db5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4710f824-ca4c-4a0f-9409-d5a05ffd4690" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4710f824-ca4c-4a0f-9409-d5a05ffd4690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_be6c31b3-1ba5-4926-9c53-48443bd08137" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_be6c31b3-1ba5-4926-9c53-48443bd08137" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c72acbc6-93e5-4105-9788-881b8daae4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c72acbc6-93e5-4105-9788-881b8daae4aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod_f992a185-a39f-4b79-aa70-777268ed7d38" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod_f992a185-a39f-4b79-aa70-777268ed7d38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2d162a28-49bc-42fe-acfc-6f32db4f7927" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2d162a28-49bc-42fe-acfc-6f32db4f7927" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d40988b8-f659-48ff-95a8-95494688d818" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9b27a2c0-c5cc-49d2-9c2d-7466eae8402c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9b27a2c0-c5cc-49d2-9c2d-7466eae8402c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_705d5da3-4b6e-4ea0-a493-4a3343f87b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_705d5da3-4b6e-4ea0-a493-4a3343f87b4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_385aa6bc-3930-4d27-97e1-1d1bc750c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_385aa6bc-3930-4d27-97e1-1d1bc750c7a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd0328c3-d7f2-4525-b694-ace230ed1311" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd0328c3-d7f2-4525-b694-ace230ed1311" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice_b27892f7-28ba-413d-861e-e735f529cf07" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice_b27892f7-28ba-413d-861e-e735f529cf07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_7168109a-b6fb-4c0b-b850-7eac089326e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_7168109a-b6fb-4c0b-b850-7eac089326e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3373bda0-6a69-47ab-9cf3-c3964972a804" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f3bd6cda-433c-4b89-873f-b2aa7a67dd00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f3bd6cda-433c-4b89-873f-b2aa7a67dd00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0b327352-6390-4d06-b04a-825f7a772ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0b327352-6390-4d06-b04a-825f7a772ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ea0ad9f3-0e65-4d00-bceb-3e84d4bfbf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ea0ad9f3-0e65-4d00-bceb-3e84d4bfbf1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_beede89e-9a00-4402-8d37-d611ac37383c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_beede89e-9a00-4402-8d37-d611ac37383c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_699d364f-94f4-493d-aa07-abec18e9c7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_699d364f-94f4-493d-aa07-abec18e9c7ef" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3efdb6d7-7a2e-4a23-a7d4-9e05cab2dd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3efdb6d7-7a2e-4a23-a7d4-9e05cab2dd5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6c2e0995-90c2-41b1-a6da-4a4efae06bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3efdb6d7-7a2e-4a23-a7d4-9e05cab2dd5a" xlink:to="loc_us-gaap_PlanNameAxis_6c2e0995-90c2-41b1-a6da-4a4efae06bb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6c2e0995-90c2-41b1-a6da-4a4efae06bb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6c2e0995-90c2-41b1-a6da-4a4efae06bb6" xlink:to="loc_us-gaap_PlanNameDomain_6c2e0995-90c2-41b1-a6da-4a4efae06bb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ec9a94d1-7e9e-4bf2-8a65-4599485d380f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6c2e0995-90c2-41b1-a6da-4a4efae06bb6" xlink:to="loc_us-gaap_PlanNameDomain_ec9a94d1-7e9e-4bf2-8a65-4599485d380f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2019OmnibusEquityIncentivePlanMember_9106bb97-62cb-4100-93d9-0d0e5ea0059f" xlink:href="vtl-20250630.xsd#vtl_A2019OmnibusEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ec9a94d1-7e9e-4bf2-8a65-4599485d380f" xlink:to="loc_vtl_A2019OmnibusEquityIncentivePlanMember_9106bb97-62cb-4100-93d9-0d0e5ea0059f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6a1a26d3-f008-4ebc-ada5-78c6cbe4a145" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6a1a26d3-f008-4ebc-ada5-78c6cbe4a145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26af62f8-21f0-4779-9a75-075d320d736d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26af62f8-21f0-4779-9a75-075d320d736d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f96c086b-ff9d-4c06-8225-8c1b10a292d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f96c086b-ff9d-4c06-8225-8c1b10a292d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f3a3b6f1-9dcf-4647-ae9c-0651b9356117" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f3a3b6f1-9dcf-4647-ae9c-0651b9356117" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f6460f8f-5c19-4241-bf16-f0efc42ed1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f6460f8f-5c19-4241-bf16-f0efc42ed1ac" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_87bf74fc-87b4-4368-8a9f-9a28dc65f742" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:to="loc_srt_TitleOfIndividualAxis_87bf74fc-87b4-4368-8a9f-9a28dc65f742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_87bf74fc-87b4-4368-8a9f-9a28dc65f742_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_87bf74fc-87b4-4368-8a9f-9a28dc65f742" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_87bf74fc-87b4-4368-8a9f-9a28dc65f742_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e00a2318-f899-4909-b874-47c8cbcaadd2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_87bf74fc-87b4-4368-8a9f-9a28dc65f742" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e00a2318-f899-4909-b874-47c8cbcaadd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_EmployeeMember_1cad9ab9-970c-4ded-9e30-1d4506f59819" xlink:href="vtl-20250630.xsd#vtl_EmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e00a2318-f899-4909-b874-47c8cbcaadd2" xlink:to="loc_vtl_EmployeeMember_1cad9ab9-970c-4ded-9e30-1d4506f59819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fdd03815-537c-4f48-8df6-fb800fbdc92f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fdd03815-537c-4f48-8df6-fb800fbdc92f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fdd03815-537c-4f48-8df6-fb800fbdc92f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fdd03815-537c-4f48-8df6-fb800fbdc92f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fdd03815-537c-4f48-8df6-fb800fbdc92f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fdd03815-537c-4f48-8df6-fb800fbdc92f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2913584d-32d1-4062-b12e-cb446b183a84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2913584d-32d1-4062-b12e-cb446b183a84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_dc1f9608-dd75-4766-8c15-2fcae7d2b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_dc1f9608-dd75-4766-8c15-2fcae7d2b7f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a5103cda-48e3-4bfa-b9c7-7b22152f3879" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f6460f8f-5c19-4241-bf16-f0efc42ed1ac" xlink:to="loc_us-gaap_ShareBasedCompensation_a5103cda-48e3-4bfa-b9c7-7b22152f3879" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_40a86369-18dd-4c3a-8fbd-1228014680f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_40a86369-18dd-4c3a-8fbd-1228014680f4" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e39f7319-9a78-41d5-aef7-86ec8ed36e9f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:to="loc_srt_CounterpartyNameAxis_e39f7319-9a78-41d5-aef7-86ec8ed36e9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e39f7319-9a78-41d5-aef7-86ec8ed36e9f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e39f7319-9a78-41d5-aef7-86ec8ed36e9f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e39f7319-9a78-41d5-aef7-86ec8ed36e9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_782787a4-c302-4609-8291-3d328aed6915" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e39f7319-9a78-41d5-aef7-86ec8ed36e9f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_782787a4-c302-4609-8291-3d328aed6915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_DuaneNashMDJDMBAMember_41f0a88d-56c0-4f98-9479-c292e23a74fa" xlink:href="vtl-20250630.xsd#vtl_DuaneNashMDJDMBAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_782787a4-c302-4609-8291-3d328aed6915" xlink:to="loc_vtl_DuaneNashMDJDMBAMember_41f0a88d-56c0-4f98-9479-c292e23a74fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5a9a4ab5-97cf-4b29-aa0b-674706985f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5a9a4ab5-97cf-4b29-aa0b-674706985f9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5a9a4ab5-97cf-4b29-aa0b-674706985f9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5a9a4ab5-97cf-4b29-aa0b-674706985f9e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5a9a4ab5-97cf-4b29-aa0b-674706985f9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_9ea14036-18e7-440e-bbfa-eb0b64af760a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5a9a4ab5-97cf-4b29-aa0b-674706985f9e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_9ea14036-18e7-440e-bbfa-eb0b64af760a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ExecutiveChairmanAgreementMember_04d70268-cbcf-4c87-8212-39a19858f320" xlink:href="vtl-20250630.xsd#vtl_ExecutiveChairmanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9ea14036-18e7-440e-bbfa-eb0b64af760a" xlink:to="loc_vtl_ExecutiveChairmanAgreementMember_04d70268-cbcf-4c87-8212-39a19858f320" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4277a7d-f6c4-4e1b-b518-211b28306ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4277a7d-f6c4-4e1b-b518-211b28306ed3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e4277a7d-f6c4-4e1b-b518-211b28306ed3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4277a7d-f6c4-4e1b-b518-211b28306ed3" xlink:to="loc_us-gaap_RelatedPartyDomain_e4277a7d-f6c4-4e1b-b518-211b28306ed3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_17fb15f6-2258-48e5-97b3-588ee3115d50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4277a7d-f6c4-4e1b-b518-211b28306ed3" xlink:to="loc_us-gaap_RelatedPartyDomain_17fb15f6-2258-48e5-97b3-588ee3115d50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_095b51cc-7753-4f52-a391-62816b7c6ce7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_17fb15f6-2258-48e5-97b3-588ee3115d50" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_095b51cc-7753-4f52-a391-62816b7c6ce7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SalaryAndWageOfficerMonthlyBaseSalary_f27a91ba-c961-42d1-a56c-5432ecc5b1b0" xlink:href="vtl-20250630.xsd#vtl_SalaryAndWageOfficerMonthlyBaseSalary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_40a86369-18dd-4c3a-8fbd-1228014680f4" xlink:to="loc_vtl_SalaryAndWageOfficerMonthlyBaseSalary_f27a91ba-c961-42d1-a56c-5432ecc5b1b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SegmentDisclosuresScheduleofSignificantExpenseDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_6e61956e-0d9a-481f-8255-67dfa9797f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_6e61956e-0d9a-481f-8255-67dfa9797f9a" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c" xlink:to="loc_us-gaap_SegmentDomain_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b6d85fa-71ee-471d-a4bf-fcf30e782ada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c" xlink:to="loc_us-gaap_SegmentDomain_8b6d85fa-71ee-471d-a4bf-fcf30e782ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ReportableSegmentMember_3779f061-4782-4a4d-8606-2935ffc4a1b2" xlink:href="vtl-20250630.xsd#vtl_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8b6d85fa-71ee-471d-a4bf-fcf30e782ada" xlink:to="loc_vtl_ReportableSegmentMember_3779f061-4782-4a4d-8606-2935ffc4a1b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ae047cf5-21af-42ae-86b7-cbf87b582c96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ae047cf5-21af-42ae-86b7-cbf87b582c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ae047cf5-21af-42ae-86b7-cbf87b582c96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ae047cf5-21af-42ae-86b7-cbf87b582c96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ae047cf5-21af-42ae-86b7-cbf87b582c96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ae047cf5-21af-42ae-86b7-cbf87b582c96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_55d57322-7802-458f-88a6-a97806b31cee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_55d57322-7802-458f-88a6-a97806b31cee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_24988aef-192d-4168-8daa-13e5bf3b9515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_24988aef-192d-4168-8daa-13e5bf3b9515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_6e61956e-0d9a-481f-8255-67dfa9797f9a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClinicalProductCandidates_2dbad13e-6ed5-4f8c-9258-4aad2cb84f1b" xlink:href="vtl-20250630.xsd#vtl_ClinicalProductCandidates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_vtl_ClinicalProductCandidates_2dbad13e-6ed5-4f8c-9258-4aad2cb84f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreClinicalProductCandidates_8ff4fd41-ed33-4150-bf88-10083bbf8817" xlink:href="vtl-20250630.xsd#vtl_PreClinicalProductCandidates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_vtl_PreClinicalProductCandidates_8ff4fd41-ed33-4150-bf88-10083bbf8817" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_cf46a2f2-cf2a-4d7c-b497-24770c13b707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_LaborAndRelatedExpense_cf46a2f2-cf2a-4d7c-b497-24770c13b707" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c1c21803-0990-43ff-9634-06f233b6fe33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_ShareBasedCompensation_c1c21803-0990-43ff-9634-06f233b6fe33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction_0e317186-244e-4c00-81ce-ad4e07792012" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationNonproduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_DepreciationNonproduction_0e317186-244e-4c00-81ce-ad4e07792012" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_217b7d89-d685-4169-a215-d721edbaebca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_ProfessionalFees_217b7d89-d685-4169-a215-d721edbaebca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9a0eb80d-47d7-488e-bf60-076759ba8ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_OperatingExpenses_9a0eb80d-47d7-488e-bf60-076759ba8ab7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5821a5f4-3950-4f8f-ae97-6d5a25f08ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_OperatingIncomeLoss_5821a5f4-3950-4f8f-ae97-6d5a25f08ecd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_12caab36-629f-4ea0-b0bc-83e92527bc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_12caab36-629f-4ea0-b0bc-83e92527bc8f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_7196ec27-f98c-4d7c-a6ef-eb3eadc700dd" xlink:href="vtl-20250630.xsd#vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_7196ec27-f98c-4d7c-a6ef-eb3eadc700dd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e75f48a7-150a-4b0f-9f67-84ad72729eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e75f48a7-150a-4b0f-9f67-84ad72729eaf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b33cdfd8-6053-4015-a68a-5c005d0fa327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_NetIncomeLoss_b33cdfd8-6053-4015-a68a-5c005d0fa327" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://vitaltherapies.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c8c6a928-11be-4cfb-af5a-a168abd374c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_AwardTypeAxis_c8c6a928-11be-4cfb-af5a-a168abd374c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8c6a928-11be-4cfb-af5a-a168abd374c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c8c6a928-11be-4cfb-af5a-a168abd374c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8c6a928-11be-4cfb-af5a-a168abd374c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adb75517-d5f0-43df-9743-5f6049595370" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c8c6a928-11be-4cfb-af5a-a168abd374c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adb75517-d5f0-43df-9743-5f6049595370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_78034bcc-04c1-410b-bee4-f560397d32fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adb75517-d5f0-43df-9743-5f6049595370" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_78034bcc-04c1-410b-bee4-f560397d32fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4b5c7e10-da4f-4033-9a1e-296bad4f2883" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4b5c7e10-da4f-4033-9a1e-296bad4f2883" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4b5c7e10-da4f-4033-9a1e-296bad4f2883_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4b5c7e10-da4f-4033-9a1e-296bad4f2883" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4b5c7e10-da4f-4033-9a1e-296bad4f2883_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e6388d4e-ed83-436a-933d-f94ae84541e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4b5c7e10-da4f-4033-9a1e-296bad4f2883" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e6388d4e-ed83-436a-933d-f94ae84541e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8a59bc8e-35e2-4b39-aa48-2ee1c30f9e49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e6388d4e-ed83-436a-933d-f94ae84541e7" xlink:to="loc_us-gaap_SubsequentEventMember_8a59bc8e-35e2-4b39-aa48-2ee1c30f9e49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_srt_TitleOfIndividualAxis_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9625cdeb-a7a0-42d7-9931-5a4f677b9a30" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9625cdeb-a7a0-42d7-9931-5a4f677b9a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_20719b0d-5488-471e-8030-7af7ff45b49e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9625cdeb-a7a0-42d7-9931-5a4f677b9a30" xlink:to="loc_srt_ExecutiveOfficerMember_20719b0d-5488-471e-8030-7af7ff45b49e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_545cab82-bdd3-4b2c-99e8-3e7e6a720785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_545cab82-bdd3-4b2c-99e8-3e7e6a720785" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_545cab82-bdd3-4b2c-99e8-3e7e6a720785_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_545cab82-bdd3-4b2c-99e8-3e7e6a720785" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_545cab82-bdd3-4b2c-99e8-3e7e6a720785_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_545cab82-bdd3-4b2c-99e8-3e7e6a720785" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantsMember_082f3e1e-d54e-4fc4-a0b0-422c48f3e719" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:to="loc_vtl_SeriesAWarrantsMember_082f3e1e-d54e-4fc4-a0b0-422c48f3e719" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesBWarrantsMember_51ccbd5f-4bbf-498f-945c-5a61c39ba5dd" xlink:href="vtl-20250630.xsd#vtl_SeriesBWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:to="loc_vtl_SeriesBWarrantsMember_51ccbd5f-4bbf-498f-945c-5a61c39ba5dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PreFundedWarrantsMember_4b6d436a-626e-4759-8e3d-e0543e121e69" xlink:href="vtl-20250630.xsd#vtl_January2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:to="loc_vtl_January2024PreFundedWarrantsMember_4b6d436a-626e-4759-8e3d-e0543e121e69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_519a62db-6e2e-4c4a-a67c-f07532e3a475" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_VestingAxis_519a62db-6e2e-4c4a-a67c-f07532e3a475" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_519a62db-6e2e-4c4a-a67c-f07532e3a475_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_519a62db-6e2e-4c4a-a67c-f07532e3a475" xlink:to="loc_us-gaap_VestingDomain_519a62db-6e2e-4c4a-a67c-f07532e3a475_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_519a62db-6e2e-4c4a-a67c-f07532e3a475" xlink:to="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b0107027-ed6d-4907-9cd0-be7505c2af99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b0107027-ed6d-4907-9cd0-be7505c2af99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_929bea09-d980-4541-b97c-b09a01de908b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_929bea09-d980-4541-b97c-b09a01de908b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_89a14112-d965-44ce-bf8e-555fb434abe5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_89a14112-d965-44ce-bf8e-555fb434abe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_dc451862-850a-4d37-a5ef-4e5e829285f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_dc451862-850a-4d37-a5ef-4e5e829285f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ec337bf0-0e20-4efc-aff3-002cf6f1ce89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ec337bf0-0e20-4efc-aff3-002cf6f1ce89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0583321e-e9c4-4c95-8d9e-97141a0979d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0583321e-e9c4-4c95-8d9e-97141a0979d0" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>vtl-20250630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:21259784-9322-473c-b39e-2847017b16ee,g:8411c107-5431-4a14-ae41-df3b5f39857c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_cce26479-2425-4877-8fa2-054dca8cc92f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, cash dividends declared (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_87fffada-b652-4666-9569-770030453e30_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_May2025SeriesAWarrantsMember_454a9f38-c52f-4008-b371-22d41861c1ec_terseLabel_en-US" xlink:label="lab_vtl_May2025SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares reserved for the May 2025 Series A warrants</link:label>
    <link:label id="lab_vtl_May2025SeriesAWarrantsMember_label_en-US" xlink:label="lab_vtl_May2025SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2025 Series A Warrants [Member]</link:label>
    <link:label id="lab_vtl_May2025SeriesAWarrantsMember_documentation_en-US" xlink:label="lab_vtl_May2025SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2025 Series A Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025SeriesAWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_May2025SeriesAWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_May2025SeriesAWarrantsMember" xlink:to="lab_vtl_May2025SeriesAWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c63ba79b-74d8-44b0-8aba-5bb869a38760_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3999b4d5-e3cb-4ee4-a9c7-7935765f0cff_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_c6c0ae8e-4820-4327-a856-0cb1fa052e23_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2ebdeb04-0d56-424c-9f12-71156106b514_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c505e465-dd9e-4072-a59a-7608469d4756_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_8f996cb8-2c39-4ea5-8e67-7a0a769af1e2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_ea8201cc-8d57-47f9-bb3f-ed1cabf75559_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c0b6b6e4-7382-4abd-b84d-240c99fc3ed2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued and/or Adopted Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_bd6827f5-c63e-48ab-981a-ad07a72333dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_0ce63d26-18d6-499b-98dd-f4ad69150d84_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued from exercise of pre-funded warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c528fca7-8c3c-4e18-bbf7-5047571ba14e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d33e1336-b945-4b9f-98a7-2597313516bc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_bf413dba-1a93-47d1-a55e-3c890f5c0b98_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total common shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod_6572bb6d-ea6b-447e-bc8a-9a418f6acc3c_terseLabel_en-US" xlink:label="lab_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod_label_en-US" xlink:label="lab_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights, Consecutive Trading Day Period</link:label>
    <link:label id="lab_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod_documentation_en-US" xlink:label="lab_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights, Consecutive Trading Day Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" xlink:href="vtl-20250630.xsd#vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" xlink:to="lab_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_263359c0-4c7c-4a78-bd16-81abcf4f230e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value through March 4, 2024</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_ebaf45e6-e28f-4fd0-ae63-c9fa7eab9002_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5232d38c-e40e-44d9-b85b-56eda224a6bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Significant Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e891d3ba-5c61-44e7-a47a-593972513f1c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in connection with the Company's employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_c9a3b258-ed6e-42c6-bda1-bfaf53047967_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_54b391b0-9e19-4033-965a-d7e7cabbe1d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_c63b5a48-17df-4e15-9e2b-f879ca791f65_netLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Non-cash stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_1cbbbb1e-6ec6-4412-9209-c4632a004984_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_AccreditedInvestorsMember_d1b59b9c-a4c4-4ec9-962e-c5782c1780f0_terseLabel_en-US" xlink:label="lab_vtl_AccreditedInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accredited Investors</link:label>
    <link:label id="lab_vtl_AccreditedInvestorsMember_label_en-US" xlink:label="lab_vtl_AccreditedInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accredited Investors [Member]</link:label>
    <link:label id="lab_vtl_AccreditedInvestorsMember_documentation_en-US" xlink:label="lab_vtl_AccreditedInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accredited Investors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccreditedInvestorsMember" xlink:href="vtl-20250630.xsd#vtl_AccreditedInvestorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_AccreditedInvestorsMember" xlink:to="lab_vtl_AccreditedInvestorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a0de15b0-2898-475a-b497-988384aecfcc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_5ef7c325-aca8-4679-8697-5164c3bfcd2a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_62eaf4fe-41da-4e79-9f41-60c2761d289b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SecuritiesPurchaseAgreementMember_c4aaade5-e207-45fb-9b24-b2d43bf48180_terseLabel_en-US" xlink:label="lab_vtl_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement</link:label>
    <link:label id="lab_vtl_SecuritiesPurchaseAgreementMember_label_en-US" xlink:label="lab_vtl_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
    <link:label id="lab_vtl_SecuritiesPurchaseAgreementMember_documentation_en-US" xlink:label="lab_vtl_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SecuritiesPurchaseAgreementMember" xlink:href="vtl-20250630.xsd#vtl_SecuritiesPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SecuritiesPurchaseAgreementMember" xlink:to="lab_vtl_SecuritiesPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a7c432e-5be7-46dc-b792-fa013ddf71d5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fd3bd592-46b1-4fc1-9dfc-ae234714a017_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_06a9fc53-250d-49ab-9bd9-1d4805e3cbe0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6e2aac35-7ea6-40cf-81c9-2104291999b8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_d27c50c8-363a-4d4c-991a-b756773ab190_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_c0687656-115d-48cf-a692-1ad9f1e0dbca_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2b4b1038-5bee-4792-a0a6-b365cba0d5d9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4bda2d40-ca43-4544-95d4-c68b276be53d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of pre-funded warrants and common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_eff071e1-b31c-44ea-a5ce-d3185b9fb886_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_e89e2588-743f-4589-bc04-94e74c8fe6e9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1cdadabb-66c3-4881-833d-7c00fa0e8d7c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_99a8c9c1-f6a5-4ec2-8e5d-a9c3e0c563f4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation and Presentation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_9f14c64c-ab67-4d85-982d-f3e8b196ae43_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a1d5e60b-3298-4474-8f05-9f1b646b96cd_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7b72fd99-c540-467f-a92e-50b1bd5b42f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_EmployeeMember_cd999aa1-0ba8-462b-a477-71227d63dd53_terseLabel_en-US" xlink:label="lab_vtl_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employees</link:label>
    <link:label id="lab_vtl_EmployeeMember_label_en-US" xlink:label="lab_vtl_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee [Member]</link:label>
    <link:label id="lab_vtl_EmployeeMember_documentation_en-US" xlink:label="lab_vtl_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_EmployeeMember" xlink:href="vtl-20250630.xsd#vtl_EmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_EmployeeMember" xlink:to="lab_vtl_EmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c7d565c3-ce52-421c-a664-0026191602a2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ce942eed-3107-4909-8bd1-00df7aacae23_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_91808a17-3f37-4663-8b6d-4d6eaccd8b54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable, ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_bd9f5189-6422-4678-b1a2-1e40b6afe02e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_64752517-4b11-44c5-89bb-61e973b2081b_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_b045c091-8b30-4b02-9b4c-667431073952_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee costs-general and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_May2025SeriesBWarrantsMember_fef3281b-0938-4658-bd1b-ffbdaf7c4910_terseLabel_en-US" xlink:label="lab_vtl_May2025SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum shares reserved for the May 2025 Series B warrants</link:label>
    <link:label id="lab_vtl_May2025SeriesBWarrantsMember_label_en-US" xlink:label="lab_vtl_May2025SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2025 Series B Warrants [Member]</link:label>
    <link:label id="lab_vtl_May2025SeriesBWarrantsMember_documentation_en-US" xlink:label="lab_vtl_May2025SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2025 Series B Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025SeriesBWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_May2025SeriesBWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_May2025SeriesBWarrantsMember" xlink:to="lab_vtl_May2025SeriesBWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_120bda1c-2638-44aa-a196-bd0737ceb296_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_656f6afa-c053-4a1d-b554-763b063bec9e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Operating Lease Obligation</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d186f8e6-197d-47ad-8294-2f861ddd8a33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice_6d15642d-e888-45a9-ae18-a418d246f41e_terseLabel_en-US" xlink:label="lab_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation, exercise price (in usd per share)</link:label>
    <link:label id="lab_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice_label_en-US" xlink:label="lab_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Option, Exercise Price</link:label>
    <link:label id="lab_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice_documentation_en-US" xlink:label="lab_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Option, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" xlink:href="vtl-20250630.xsd#vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" xlink:to="lab_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_ffdac65a-edda-4f54-9dad-158cd937bc50_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_fa7cf25d-bc40-4d9d-80fd-ea6d19f343ae_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Present value of obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ae5528f3-35c5-450c-b97f-2b4e161ee94f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_42b91f59-7dd7-4b7a-947f-f2e454f1de45_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_e9d0c585-1d68-4b62-b805-a3677efa441d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_09d91c2b-e108-418b-aeda-5d9938370be8_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_TrancheRightFairValueDisclosure_567fdc34-f4b3-4a9c-9293-f24608736c72_terseLabel_en-US" xlink:label="lab_vtl_TrancheRightFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche right, fair value</link:label>
    <link:label id="lab_vtl_TrancheRightFairValueDisclosure_label_en-US" xlink:label="lab_vtl_TrancheRightFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Right, Fair Value Disclosure</link:label>
    <link:label id="lab_vtl_TrancheRightFairValueDisclosure_documentation_en-US" xlink:label="lab_vtl_TrancheRightFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Right, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightFairValueDisclosure" xlink:href="vtl-20250630.xsd#vtl_TrancheRightFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_TrancheRightFairValueDisclosure" xlink:to="lab_vtl_TrancheRightFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_PlaneggGermanyMember_8e05d976-1359-4057-a791-c92c51cc4bbf_terseLabel_en-US" xlink:label="lab_vtl_PlaneggGermanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Planegg, Germany</link:label>
    <link:label id="lab_vtl_PlaneggGermanyMember_label_en-US" xlink:label="lab_vtl_PlaneggGermanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Planegg, Germany [Member]</link:label>
    <link:label id="lab_vtl_PlaneggGermanyMember_documentation_en-US" xlink:label="lab_vtl_PlaneggGermanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Planegg, Germany</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlaneggGermanyMember" xlink:href="vtl-20250630.xsd#vtl_PlaneggGermanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_PlaneggGermanyMember" xlink:to="lab_vtl_PlaneggGermanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_OfferingMember_f735d46c-3818-4dd8-8fec-717ab45e76f5_terseLabel_en-US" xlink:label="lab_vtl_OfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offering</link:label>
    <link:label id="lab_vtl_OfferingMember_label_en-US" xlink:label="lab_vtl_OfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offering [Member]</link:label>
    <link:label id="lab_vtl_OfferingMember_documentation_en-US" xlink:label="lab_vtl_OfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OfferingMember" xlink:href="vtl-20250630.xsd#vtl_OfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_OfferingMember" xlink:to="lab_vtl_OfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_GrafelfingGermanyMember_297b88f6-5ad2-45e9-88a2-e540d221f3ba_terseLabel_en-US" xlink:label="lab_vtl_GrafelfingGermanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grafelfing, Germany</link:label>
    <link:label id="lab_vtl_GrafelfingGermanyMember_label_en-US" xlink:label="lab_vtl_GrafelfingGermanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grafelfing, Germany [Member]</link:label>
    <link:label id="lab_vtl_GrafelfingGermanyMember_documentation_en-US" xlink:label="lab_vtl_GrafelfingGermanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grafelfing, Germany</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GrafelfingGermanyMember" xlink:href="vtl-20250630.xsd#vtl_GrafelfingGermanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_GrafelfingGermanyMember" xlink:to="lab_vtl_GrafelfingGermanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_34b04b20-221c-4557-9a51-adc0ec5b1509_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation_79ab28c7-694e-418d-be1f-ae25518534fc_terseLabel_en-US" xlink:label="lab_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Threshold trading days for aggregate trading volume calculation (in days)</link:label>
    <link:label id="lab_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation_label_en-US" xlink:label="lab_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Threshold Trading Days for Aggregate Trading Volume Calculation</link:label>
    <link:label id="lab_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation_documentation_en-US" xlink:label="lab_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Threshold Trading Days for Aggregate Trading Volume Calculation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation" xlink:href="vtl-20250630.xsd#vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation" xlink:to="lab_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d6a0f3c-1b43-4792-b7c9-02469b0e8d75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3175ef61-1b72-443d-89c0-07638042d339_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_06cc1a8e-b2a0-4c16-86e3-dbbebe3693dd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_98fa1c95-6f2b-4a10-8ac5-e98aa5a0e893_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_7f98dac1-51c1-4aae-9e2c-0cc3bc499b5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Current Assets and Prepaid Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ff5d126c-b8c1-49f4-9d82-59644c1bed9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense for Stock Awards Recognized</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2dde6278-1596-48b8-9fcd-2264dafe0b0e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_76174017-52a8-4ad6-8e66-5410a479c86b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Tranche Rights</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementFeeExpense_fb96af65-477d-4995-9a31-443ace04f7ee_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fees expensed as part of January 2024 Financing</link:label>
    <link:label id="lab_us-gaap_ManagementFeeExpense_label_en-US" xlink:label="lab_us-gaap_ManagementFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManagementFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementFeeExpense" xlink:to="lab_us-gaap_ManagementFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_a2190a7a-5a0f-4e54-84b5-05476de545bd_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9b09a75f-11b5-4a92-9ca9-9e9ba4b37f0f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_WeightedAveragePriceOfLast10Days_3404648a-c19e-478e-914f-98c085d289b8_terseLabel_en-US" xlink:label="lab_vtl_WeightedAveragePriceOfLast10Days" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average price (in usd per share)</link:label>
    <link:label id="lab_vtl_WeightedAveragePriceOfLast10Days_label_en-US" xlink:label="lab_vtl_WeightedAveragePriceOfLast10Days" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Price of Last 10 Days</link:label>
    <link:label id="lab_vtl_WeightedAveragePriceOfLast10Days_documentation_en-US" xlink:label="lab_vtl_WeightedAveragePriceOfLast10Days" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Price of Last 10 Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_WeightedAveragePriceOfLast10Days" xlink:href="vtl-20250630.xsd#vtl_WeightedAveragePriceOfLast10Days"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_WeightedAveragePriceOfLast10Days" xlink:to="lab_vtl_WeightedAveragePriceOfLast10Days" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_33bcda88-ab91-435d-9362-b335f4dbc64b_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration Arrangements, Daiichi Sankyo Agreement and Ludwig-Maximilians-University Agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e4813489-18a4-4943-a3f8-e7acc1544502_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f2ad5271-bd7a-4ed2-ba1a-80feb7dffd56_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3f075f58-efa2-4c15-9396-32ba46e85c8e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c7681adf-0f50-4fe0-affd-342f1deb9a9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1f777e5c-0f1b-423d-91da-0aced4123540_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0fab097c-acd2-412b-b481-7c35ac9bdef9_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_7b056546-26e4-4be1-bce3-7311f8804ba7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_bcd88701-6c46-42fa-8d83-110746f7075e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_AccruedLegalAndAuditCostsCurrent_e8051c40-c610-46b6-ac3d-b6a8b60304bb_terseLabel_en-US" xlink:label="lab_vtl_AccruedLegalAndAuditCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued legal and audit costs</link:label>
    <link:label id="lab_vtl_AccruedLegalAndAuditCostsCurrent_label_en-US" xlink:label="lab_vtl_AccruedLegalAndAuditCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Legal And Audit Costs, Current</link:label>
    <link:label id="lab_vtl_AccruedLegalAndAuditCostsCurrent_documentation_en-US" xlink:label="lab_vtl_AccruedLegalAndAuditCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Legal And Audit Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedLegalAndAuditCostsCurrent" xlink:href="vtl-20250630.xsd#vtl_AccruedLegalAndAuditCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_AccruedLegalAndAuditCostsCurrent" xlink:to="lab_vtl_AccruedLegalAndAuditCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5e21ba0f-746a-4f01-b52f-6828ea0df6da_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3d0fc1c6-49f2-400e-bf98-f00ef9e500bb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_13862e6a-4bc3-4c20-8abd-a1fa717118a5_terseLabel_en-US" xlink:label="lab_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Shares Reserved for Future Issuance</link:label>
    <link:label id="lab_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_label_en-US" xlink:label="lab_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]</link:label>
    <link:label id="lab_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_documentation_en-US" xlink:label="lab_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:href="vtl-20250630.xsd#vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="lab_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent_554b4f3a-0841-4e0f-a1c2-a870412aa3fd_terseLabel_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional shares authorized (as a percent)</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent_label_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-Based Payment Award, Additional Shares Authorized, Percent</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent_documentation_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-Based Payment Award, Additional Shares Authorized, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" xlink:to="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_baf07848-f216-4b71-ba48-2c3c3bd98129_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_ac945bf3-ad4e-4774-b214-a80b708ecf71_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_eb29b54f-f52e-483a-9688-6a858a31d9d1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_5a715e38-41ac-4b55-97ff-073278beb526_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, cash dividends paid (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_9e6a75a7-b188-4596-8e97-f2387a236664_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ClinicalProductCandidates_dbe84042-d814-4886-87bb-eba5821afe14_terseLabel_en-US" xlink:label="lab_vtl_ClinicalProductCandidates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical product candidates</link:label>
    <link:label id="lab_vtl_ClinicalProductCandidates_label_en-US" xlink:label="lab_vtl_ClinicalProductCandidates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Product Candidates</link:label>
    <link:label id="lab_vtl_ClinicalProductCandidates_documentation_en-US" xlink:label="lab_vtl_ClinicalProductCandidates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Product Candidates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClinicalProductCandidates" xlink:href="vtl-20250630.xsd#vtl_ClinicalProductCandidates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ClinicalProductCandidates" xlink:to="lab_vtl_ClinicalProductCandidates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_44c39e1c-fd89-4388-9d6a-fea288f1cfe8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_efd2e437-bc39-4aac-8e2e-e556b8b58cd4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b8a2265b-536b-430d-9f8d-dab475d312a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_AccruedCompensationCurrent_c4ca2fd4-8ca3-4a75-946e-31df563c9a86_terseLabel_en-US" xlink:label="lab_vtl_AccruedCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_vtl_AccruedCompensationCurrent_label_en-US" xlink:label="lab_vtl_AccruedCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Compensation, Current</link:label>
    <link:label id="lab_vtl_AccruedCompensationCurrent_documentation_en-US" xlink:label="lab_vtl_AccruedCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Compensation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedCompensationCurrent" xlink:href="vtl-20250630.xsd#vtl_AccruedCompensationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_AccruedCompensationCurrent" xlink:to="lab_vtl_AccruedCompensationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_January2024PreFundedWarrantsMember_954cf4ee-8261-479d-a784-ec4bf020e076_terseLabel_en-US" xlink:label="lab_vtl_January2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 2024 Pre-Funded Warrants</link:label>
    <link:label id="lab_vtl_January2024PreFundedWarrantsMember_label_en-US" xlink:label="lab_vtl_January2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January 2024 Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_vtl_January2024PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_vtl_January2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PreFundedWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_January2024PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_January2024PreFundedWarrantsMember" xlink:to="lab_vtl_January2024PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_NewYorkCityMember_9c0a24c8-00c8-4916-8128-c97583eed1dd_terseLabel_en-US" xlink:label="lab_vtl_NewYorkCityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New York City</link:label>
    <link:label id="lab_vtl_NewYorkCityMember_label_en-US" xlink:label="lab_vtl_NewYorkCityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New York City [Member]</link:label>
    <link:label id="lab_vtl_NewYorkCityMember_documentation_en-US" xlink:label="lab_vtl_NewYorkCityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New York City</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NewYorkCityMember" xlink:href="vtl-20250630.xsd#vtl_NewYorkCityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_NewYorkCityMember" xlink:to="lab_vtl_NewYorkCityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4262d9bd-cc1c-444a-8c7b-d93b8ed4f4a3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_800f3dad-4594-424f-b239-80eb9b40582e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_26f197df-9a4a-4316-bb2b-31f70c4dfc03_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_PlacementAgentWarrantsMember_7e353529-3cea-4f36-8ce4-9dd1ba8e8126_terseLabel_en-US" xlink:label="lab_vtl_PlacementAgentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Placement agent warrants</link:label>
    <link:label id="lab_vtl_PlacementAgentWarrantsMember_c4124657-4d1c-423a-8fb7-a129c05e2180_verboseLabel_en-US" xlink:label="lab_vtl_PlacementAgentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Placement agent warrants</link:label>
    <link:label id="lab_vtl_PlacementAgentWarrantsMember_label_en-US" xlink:label="lab_vtl_PlacementAgentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Placement Agent Warrants [Member]</link:label>
    <link:label id="lab_vtl_PlacementAgentWarrantsMember_documentation_en-US" xlink:label="lab_vtl_PlacementAgentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Placement Agent Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_PlacementAgentWarrantsMember" xlink:to="lab_vtl_PlacementAgentWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_3649db84-2559-4890-9943-8b8294667a0c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d6445a63-5487-432b-b7cc-1753e6a5323f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_54c023bc-b98a-4b44-b05b-794c4975b2e5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_5af3f81d-f397-4680-8ccb-a562ad070596_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_65212705-f20e-450d-ad14-46d723eba50c_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_645c1400-caba-48fe-93bd-df708e4192f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized foreign currency gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityNumberOfEmployees_7bbe7ef9-38bd-4ec2-9474-f1ab64fc1b42_terseLabel_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_dei_EntityNumberOfEmployees_label_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityNumberOfEmployees" xlink:to="lab_dei_EntityNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_88656546-98e3-443a-8554-7f1e51073a78_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8a58a3aa-c798-42e1-8cf7-088444b258d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1fb7f39d-d9c2-4f0d-abd8-01b57f6467e0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cc46b969-06a8-465e-aa5b-0e987c8c02f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_TrancheRightsLiabilityReceivedAmount_a2f082d0-645c-4445-a5b0-a6076610a61d_terseLabel_en-US" xlink:label="lab_vtl_TrancheRightsLiabilityReceivedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche rights as a liability, received amount</link:label>
    <link:label id="lab_vtl_TrancheRightsLiabilityReceivedAmount_label_en-US" xlink:label="lab_vtl_TrancheRightsLiabilityReceivedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Rights Liability, Received Amount</link:label>
    <link:label id="lab_vtl_TrancheRightsLiabilityReceivedAmount_documentation_en-US" xlink:label="lab_vtl_TrancheRightsLiabilityReceivedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Rights Liability, Received Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightsLiabilityReceivedAmount" xlink:href="vtl-20250630.xsd#vtl_TrancheRightsLiabilityReceivedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_TrancheRightsLiabilityReceivedAmount" xlink:to="lab_vtl_TrancheRightsLiabilityReceivedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5013ae36-f3fb-4580-994e-ee22d6bb3133_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f23bb8f1-ffdf-49d7-972d-0b97141af4e4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3ad392e9-8268-4a26-9c7d-a0bdca173e5a_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4558cd7e-cee6-4b8a-9c2a-c89da0cf459e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3267c703-1f47-42e4-83ba-0a453a0642bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f3d64417-bb37-4b76-bd15-5968b65c5f8a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a5de919-1fc5-45ab-9762-2eba2e147bfe_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76810a8b-7f9e-433f-8e91-e4e60eba472d_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_50dedcea-083b-4a22-9298-7b8e3feff472_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_abb19def-4433-443a-84de-8cc7a1df7574_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_5d69e0d0-1535-4ed4-9c86-c4072a32226f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Capitalization [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Capitalization [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis" xlink:to="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_ccd9c05c-3fe1-4a0a-826e-9920242dc6b4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance_2a2dee79-1f30-46c2-88c7-7234933e72e0_terseLabel_en-US" xlink:label="lab_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration period from the date of issuance</link:label>
    <link:label id="lab_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance_label_en-US" xlink:label="lab_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Expiration Period From The Date Of Issuance</link:label>
    <link:label id="lab_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance_documentation_en-US" xlink:label="lab_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Expiration Period From The Date Of Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" xlink:href="vtl-20250630.xsd#vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" xlink:to="lab_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_b772ca3e-5a0c-4cdd-ad78-2cd44e80f7aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7df903fe-4ac8-48f9-83b6-468555d5c7aa_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_dfe34d5b-3ff9-4e32-989b-663753ee5fe4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and Tranche Rights</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6e62ab4b-da09-4941-a06d-4dc0075eabef_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a24d434e-976a-4e5e-afc5-83325d894be2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_6ebfe3ed-482e-4119-9246-02397094a391_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_4aa21229-3805-44f8-833e-ffb95b4c9327_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeDisclosureAbstract" xlink:to="lab_us-gaap_LesseeDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_EmployeeStockOptionsforFutureGrantMember_e1231060-c2b2-4173-815d-cee7bdcd3b81_terseLabel_en-US" xlink:label="lab_vtl_EmployeeStockOptionsforFutureGrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock options available for future grant:</link:label>
    <link:label id="lab_vtl_EmployeeStockOptionsforFutureGrantMember_label_en-US" xlink:label="lab_vtl_EmployeeStockOptionsforFutureGrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Options for Future Grant [Member]</link:label>
    <link:label id="lab_vtl_EmployeeStockOptionsforFutureGrantMember_documentation_en-US" xlink:label="lab_vtl_EmployeeStockOptionsforFutureGrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Options for Future Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_EmployeeStockOptionsforFutureGrantMember" xlink:href="vtl-20250630.xsd#vtl_EmployeeStockOptionsforFutureGrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_EmployeeStockOptionsforFutureGrantMember" xlink:to="lab_vtl_EmployeeStockOptionsforFutureGrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9c215da8-d002-4a63-a091-5d1bdd62eebd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_425b19df-cf1d-4cde-9972-9b7fc6423550_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7ab8a199-7e1b-4cea-b6ae-e539aec35076_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_d5b290b9-bb98-4304-8bf9-a1917ef8c9b3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2604193c-694a-475c-970b-b84bdb9fda1a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_19e7052d-618b-4e0f-a924-1e74b786e682_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_31e7c604-75b5-4e84-9c00-604cbe9aabf5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fcaa5744-9616-45f0-b500-afa6320566e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Valuation Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_ab9b58da-7305-47bd-afd9-e657a2aebb0f_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_3289a460-00cb-4ab0-b107-591baa8b8c88_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_PlacementAgentAgreementBrokerageFeePercent_5d3cf11b-4163-4738-a31e-ca648406e12d_terseLabel_en-US" xlink:label="lab_vtl_PlacementAgentAgreementBrokerageFeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Placement agent agreement, cash fee, percent of gross proceeds from offering (as a percent)</link:label>
    <link:label id="lab_vtl_PlacementAgentAgreementBrokerageFeePercent_label_en-US" xlink:label="lab_vtl_PlacementAgentAgreementBrokerageFeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Placement Agent Agreement, Brokerage Fee, Percent</link:label>
    <link:label id="lab_vtl_PlacementAgentAgreementBrokerageFeePercent_documentation_en-US" xlink:label="lab_vtl_PlacementAgentAgreementBrokerageFeePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Placement Agent Agreement, Brokerage Fee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentAgreementBrokerageFeePercent" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentAgreementBrokerageFeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_PlacementAgentAgreementBrokerageFeePercent" xlink:to="lab_vtl_PlacementAgentAgreementBrokerageFeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceExpense_80881b84-bafc-4f7e-b1bd-c8a4bda423a1_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government assistance, expense</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceExpense_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Expense, Decrease (Increase)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceExpense" xlink:to="lab_us-gaap_GovernmentAssistanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_1bd47a5f-726e-4b6f-8a71-193a47886a52_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SeriesAWarrantsMember_0a19aef6-89e5-46e1-8392-43b2145f1783_terseLabel_en-US" xlink:label="lab_vtl_SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A Warrants</link:label>
    <link:label id="lab_vtl_SeriesAWarrantsMember_label_en-US" xlink:label="lab_vtl_SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Warrants [Member]</link:label>
    <link:label id="lab_vtl_SeriesAWarrantsMember_documentation_en-US" xlink:label="lab_vtl_SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SeriesAWarrantsMember" xlink:to="lab_vtl_SeriesAWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_13e272a0-bdaf-46a5-b17d-47a4c618fd88_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_02ac4370-5ac9-4a8a-bfdd-f0b7d53fbdce_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity_e44792d3-74cf-4f18-aaea-5511d2ef0c51_terseLabel_en-US" xlink:label="lab_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification to equity in March 2024</link:label>
    <link:label id="lab_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity_label_en-US" xlink:label="lab_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Reclassification To Equity</link:label>
    <link:label id="lab_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity_documentation_en-US" xlink:label="lab_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Reclassification To Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" xlink:href="vtl-20250630.xsd#vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" xlink:to="lab_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount_b67101bd-4c15-4922-af65-cea9d7a8c02e_terseLabel_en-US" xlink:label="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Australian research and development tax incentive</link:label>
    <link:label id="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount_label_en-US" xlink:label="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Qualified Research and Development Expenditures, Maximum Amount</link:label>
    <link:label id="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount_documentation_en-US" xlink:label="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Assistance, Qualified Research and Development Expenditures, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" xlink:href="vtl-20250630.xsd#vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" xlink:to="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_3a241528-4f0f-44c4-a198-499ef87873c1_terseLabel_en-US" xlink:label="lab_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:label id="lab_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:label id="lab_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:href="vtl-20250630.xsd#vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SalaryAndWageOfficerMonthlyBaseSalary_269be2d6-d85b-4366-ad33-1af864769231_terseLabel_en-US" xlink:label="lab_vtl_SalaryAndWageOfficerMonthlyBaseSalary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monthly base salary</link:label>
    <link:label id="lab_vtl_SalaryAndWageOfficerMonthlyBaseSalary_label_en-US" xlink:label="lab_vtl_SalaryAndWageOfficerMonthlyBaseSalary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Salary and Wage, Officer, Monthly Base Salary</link:label>
    <link:label id="lab_vtl_SalaryAndWageOfficerMonthlyBaseSalary_documentation_en-US" xlink:label="lab_vtl_SalaryAndWageOfficerMonthlyBaseSalary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Salary and Wage, Officer, Monthly Base Salary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SalaryAndWageOfficerMonthlyBaseSalary" xlink:href="vtl-20250630.xsd#vtl_SalaryAndWageOfficerMonthlyBaseSalary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SalaryAndWageOfficerMonthlyBaseSalary" xlink:to="lab_vtl_SalaryAndWageOfficerMonthlyBaseSalary" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_34dc0dbd-9445-4bb2-8129-ba630ebc4987_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_19e49c67-44ac-44b7-866f-266adee0c051_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_676b022d-3dfa-44fb-8ea7-8880a9cd96fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_a015b8dc-c684-4601-9a90-f8899c8fc07c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_NonStatutoryEmployeeStockOptionMember_69559234-1ed9-444c-914e-94b527631efa_terseLabel_en-US" xlink:label="lab_vtl_NonStatutoryEmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-statutory options</link:label>
    <link:label id="lab_vtl_NonStatutoryEmployeeStockOptionMember_label_en-US" xlink:label="lab_vtl_NonStatutoryEmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Statutory Employee Stock Option [Member]</link:label>
    <link:label id="lab_vtl_NonStatutoryEmployeeStockOptionMember_documentation_en-US" xlink:label="lab_vtl_NonStatutoryEmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Statutory Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NonStatutoryEmployeeStockOptionMember" xlink:href="vtl-20250630.xsd#vtl_NonStatutoryEmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_NonStatutoryEmployeeStockOptionMember" xlink:to="lab_vtl_NonStatutoryEmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_753e08bc-c80a-434f-a54c-d945151985d4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SeriesBWarrantsMember_5def9ddd-f3e0-4d75-8757-bd25ceb0fd69_terseLabel_en-US" xlink:label="lab_vtl_SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B Warrants</link:label>
    <link:label id="lab_vtl_SeriesBWarrantsMember_label_en-US" xlink:label="lab_vtl_SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Warrants [Member]</link:label>
    <link:label id="lab_vtl_SeriesBWarrantsMember_documentation_en-US" xlink:label="lab_vtl_SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series B Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesBWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_SeriesBWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SeriesBWarrantsMember" xlink:to="lab_vtl_SeriesBWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_19d5dffb-081b-4309-b7ae-543429f7a4cb_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_b1eea742-e24e-440e-84d9-b26f629447db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_53b4864d-4cd8-4d44-a812-c21d9bd758c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b4f7173e-7d44-46b7-bca6-fa3ec74090d7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_5919c561-ef24-4dec-ab23-3a4d65ec4cfd_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee costs- research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation_6af570ef-46d9-4796-aa6f-c715a5f3f4a7_terseLabel_en-US" xlink:label="lab_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Threshold trading days for weighted average price calculation (in days)</link:label>
    <link:label id="lab_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation_label_en-US" xlink:label="lab_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Threshold Trading Days for Weighted Average Price Calculation</link:label>
    <link:label id="lab_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation_documentation_en-US" xlink:label="lab_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Threshold Trading Days for Weighted Average Price Calculation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation" xlink:href="vtl-20250630.xsd#vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation" xlink:to="lab_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_91e6666a-a9d5-4055-88d1-c2f815b157d0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_TrancheRightsLiabilityRemainderAmount_4c79ef5f-5ad2-4e13-8739-dc15703f1701_terseLabel_en-US" xlink:label="lab_vtl_TrancheRightsLiabilityRemainderAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche rights as a liability, remainder amount</link:label>
    <link:label id="lab_vtl_TrancheRightsLiabilityRemainderAmount_label_en-US" xlink:label="lab_vtl_TrancheRightsLiabilityRemainderAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Rights Liability, Remainder Amount</link:label>
    <link:label id="lab_vtl_TrancheRightsLiabilityRemainderAmount_documentation_en-US" xlink:label="lab_vtl_TrancheRightsLiabilityRemainderAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Rights Liability, Remainder Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightsLiabilityRemainderAmount" xlink:href="vtl-20250630.xsd#vtl_TrancheRightsLiabilityRemainderAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_TrancheRightsLiabilityRemainderAmount" xlink:to="lab_vtl_TrancheRightsLiabilityRemainderAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SaleOfStockPrivatePlacementNumberOfTranche_27d3b735-0207-4275-9993-870576a2bc8b_terseLabel_en-US" xlink:label="lab_vtl_SaleOfStockPrivatePlacementNumberOfTranche" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private placement, number of tranche</link:label>
    <link:label id="lab_vtl_SaleOfStockPrivatePlacementNumberOfTranche_label_en-US" xlink:label="lab_vtl_SaleOfStockPrivatePlacementNumberOfTranche" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Private Placement, Number of Tranche</link:label>
    <link:label id="lab_vtl_SaleOfStockPrivatePlacementNumberOfTranche_documentation_en-US" xlink:label="lab_vtl_SaleOfStockPrivatePlacementNumberOfTranche" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Private Placement, Number of Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockPrivatePlacementNumberOfTranche" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockPrivatePlacementNumberOfTranche"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SaleOfStockPrivatePlacementNumberOfTranche" xlink:to="lab_vtl_SaleOfStockPrivatePlacementNumberOfTranche" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a4a5e97b-072a-4c5b-a4a2-ada481d4088f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_A2021EmployeeStockPurchasePlanMember_7f85fd43-6eb5-4784-896b-c073c9052b8a_terseLabel_en-US" xlink:label="lab_vtl_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 Employee stock purchase plan</link:label>
    <link:label id="lab_vtl_A2021EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_vtl_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_vtl_A2021EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_vtl_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2021EmployeeStockPurchasePlanMember" xlink:href="vtl-20250630.xsd#vtl_A2021EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_A2021EmployeeStockPurchasePlanMember" xlink:to="lab_vtl_A2021EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c57ea9af-24e0-4905-b21d-13df7cedecc1_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2b0c3f6a-7d7d-4fe7-9379-ef328084f8d0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ea8d739d-75ba-4158-8372-959b7251bba6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_73109b65-6fb2-495a-a170-80cd47e897de_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_352feb87-44f8-474d-8ff0-a2e335dcd0b7_negatedTerseLabel_en-US" xlink:label="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of the tranche rights</link:label>
    <link:label id="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_03132853-2ecd-4238-8a2d-35e5e25a5241_terseLabel_en-US" xlink:label="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of the tranche rights</link:label>
    <link:label id="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_98dc0d5f-d00c-42d1-9a09-992aac712527_verboseLabel_en-US" xlink:label="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of the tranche rights</link:label>
    <link:label id="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_label_en-US" xlink:label="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Change in Fair Value of Tranche Rights, Transaction Costs</link:label>
    <link:label id="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_documentation_en-US" xlink:label="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Change in Fair Value of Tranche Rights, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:href="vtl-20250630.xsd#vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:to="lab_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_DuaneNashMDJDMBAMember_79fdd1c7-99cf-4828-976f-99e382018103_terseLabel_en-US" xlink:label="lab_vtl_DuaneNashMDJDMBAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Duane Nash, MD, JD, MBA</link:label>
    <link:label id="lab_vtl_DuaneNashMDJDMBAMember_label_en-US" xlink:label="lab_vtl_DuaneNashMDJDMBAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Duane Nash, MD, JD, MBA [Member]</link:label>
    <link:label id="lab_vtl_DuaneNashMDJDMBAMember_documentation_en-US" xlink:label="lab_vtl_DuaneNashMDJDMBAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Duane Nash, MD, JD, MBA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_DuaneNashMDJDMBAMember" xlink:href="vtl-20250630.xsd#vtl_DuaneNashMDJDMBAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_DuaneNashMDJDMBAMember" xlink:to="lab_vtl_DuaneNashMDJDMBAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_9af5860d-8baa-4e59-a361-271a227ba4f3_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceAmount_9de54c91-be16-4393-839e-961fff51ec8c_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government assistance, income</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceAmount_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Income, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceAmount" xlink:to="lab_us-gaap_GovernmentAssistanceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bb55974c-cee8-454b-86ae-62f661e7115a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period over which compensation cost will be recognized (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_334fac8c-23a9-4059-832d-989de4bce13e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_3fddcc76-ba62-499c-ba0d-4a1dcbcc6fef_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b2664f29-85d2-41c2-a73d-417eddb7a29b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable, Aggregate Intrinsic Value, Ending balance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d72ec3cf-4dfb-4e0e-9915-f5cd49f6b713_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Disclosures</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_PreFundedWarrantsMember_38ae184f-1132-4f19-ac37-c962e7365559_terseLabel_en-US" xlink:label="lab_vtl_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-funded stock warrants</link:label>
    <link:label id="lab_vtl_PreFundedWarrantsMember_label_en-US" xlink:label="lab_vtl_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_vtl_PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_vtl_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_PreFundedWarrantsMember" xlink:to="lab_vtl_PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_75314815-1cc8-46ee-8684-5e4aab209362_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5d167f21-427a-4c0f-aaf2-610b5b5b076a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a96117ac-5be0-416c-8f64-2f181978ded6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_31ceab7e-6681-4ed3-bbe5-1ade6d34befa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_GainLossFromChangeInFairValueOfTrancheRights_74b80297-e70f-45ac-98d4-060fff71b1f2_terseLabel_en-US" xlink:label="lab_vtl_GainLossFromChangeInFairValueOfTrancheRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of tranche rights</link:label>
    <link:label id="lab_vtl_GainLossFromChangeInFairValueOfTrancheRights_label_en-US" xlink:label="lab_vtl_GainLossFromChangeInFairValueOfTrancheRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) From Change In Fair Value Of Tranche Rights</link:label>
    <link:label id="lab_vtl_GainLossFromChangeInFairValueOfTrancheRights_documentation_en-US" xlink:label="lab_vtl_GainLossFromChangeInFairValueOfTrancheRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) From Change In Fair Value Of Tranche Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights" xlink:href="vtl-20250630.xsd#vtl_GainLossFromChangeInFairValueOfTrancheRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights" xlink:to="lab_vtl_GainLossFromChangeInFairValueOfTrancheRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4c91ce94-29e7-42f1-b3f3-7b2210ee292c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_31baba38-6f70-4a5d-b213-c4e26da4d52a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4e18b0d3-a3c8-4cbe-aa83-d7b2ae62a1a2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMember_67c790de-94cd-4da4-97e8-204fb602e75d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_EquityMember_label_en-US" xlink:label="lab_us-gaap_EquityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMember" xlink:to="lab_us-gaap_EquityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70419cc4-4cae-4e58-8499-59b7f8666c4e_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">December 31, 2023</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c6612d48-7617-49ec-967c-6f05ae9d0893_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">December 31, 2024</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0b7f4fb9-d329-449e-86ca-564b88b52fcb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 1</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1699bf65-9589-495e-9e24-2dffb65cf4f1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial exercise price per share (as a percent)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6af06286-da84-469b-b705-faa317b4ac10_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8bc26735-9f34-4159-b21e-9c66c31506d9_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_905ae565-f7f0-4ee7-82a0-a5261e02dc57_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_aff0c053-4d61-4e49-bea2-0bad051dc091_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_0f3645cc-4ad9-4e11-9ea4-b1e45929d96e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f80a650f-cdc6-458d-93b5-396c707575dc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_8d496075-307a-402c-9783-94d55c6c59d7_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial exercise price per share of common stock (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_fbfef708-f623-4f94-9366-470952d4b4f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price of the stock, at discount from market price at purchase date (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_fdcd45b4-4c37-4ba6-ba5e-d5442ef8c797_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1e3494b2-7d24-4300-8eed-0f3db151e0a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration_8f52716e-9aad-444c-81be-769e3cbe52a9_terseLabel_en-US" xlink:label="lab_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsold securities to be sold under shelf registration</link:label>
    <link:label id="lab_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration_label_en-US" xlink:label="lab_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsold Securities Rolled Over To Be Sold Under New Shelf Registration</link:label>
    <link:label id="lab_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration_documentation_en-US" xlink:label="lab_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unsold Securities Rolled Over To Be Sold Under New Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" xlink:href="vtl-20250630.xsd#vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" xlink:to="lab_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_LegalAndAuditCostsPayableCurrent_c1ae2aaa-2420-4ee7-834e-e04696828821_terseLabel_en-US" xlink:label="lab_vtl_LegalAndAuditCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal and audit costs</link:label>
    <link:label id="lab_vtl_LegalAndAuditCostsPayableCurrent_label_en-US" xlink:label="lab_vtl_LegalAndAuditCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal And Audit Costs Payable, Current</link:label>
    <link:label id="lab_vtl_LegalAndAuditCostsPayableCurrent_documentation_en-US" xlink:label="lab_vtl_LegalAndAuditCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legal And Audit Costs Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_LegalAndAuditCostsPayableCurrent" xlink:href="vtl-20250630.xsd#vtl_LegalAndAuditCostsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_LegalAndAuditCostsPayableCurrent" xlink:to="lab_vtl_LegalAndAuditCostsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8d8d8be1-54dd-4921-bb9f-694136bc2c46_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_974591d5-f8af-4959-aa61-ec4f94129775_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_6354c64b-3d98-497f-8ac1-93c32f57c664_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_8e0d5607-12ce-4659-a2ce-a7eb2384b1c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a8b2f7e0-b8c8-4b89-9835-2bdac6c83e2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExecutiveOfficerMember_a66feca1-dd8d-4b13-9cfb-324764b288fd_terseLabel_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Officer</link:label>
    <link:label id="lab_srt_ExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExecutiveOfficerMember" xlink:to="lab_srt_ExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ab9c9c3e-19b5-4df2-a37a-bd49a1efbc03_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_370f6775-7698-4876-af46-75984159da82_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_6a1efe4c-5cea-47cf-919a-7cd016a11106_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_423b34ea-c0a5-483a-9204-14c5acf3f23e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_0804f9e3-98d6-44bf-b3ba-a875e62767d4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e0adffa8-b916-4268-a526-71073b72370e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3de09356-d0b9-4046-91cb-2a1ef38a3da2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of pre-funded warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_OperatingLeaseIncrementalBorrowingRate_3f4c18d4-4633-42bc-8925-fe44d847cbae_terseLabel_en-US" xlink:label="lab_vtl_OperatingLeaseIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incremental borrowing rate on operating leases (as a percent)</link:label>
    <link:label id="lab_vtl_OperatingLeaseIncrementalBorrowingRate_label_en-US" xlink:label="lab_vtl_OperatingLeaseIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Incremental Borrowing Rate</link:label>
    <link:label id="lab_vtl_OperatingLeaseIncrementalBorrowingRate_documentation_en-US" xlink:label="lab_vtl_OperatingLeaseIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Incremental Borrowing Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OperatingLeaseIncrementalBorrowingRate" xlink:href="vtl-20250630.xsd#vtl_OperatingLeaseIncrementalBorrowingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_OperatingLeaseIncrementalBorrowingRate" xlink:to="lab_vtl_OperatingLeaseIncrementalBorrowingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3d3dd5a3-b50c-4939-a598-ecb87873191d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_1d14da79-faf9-4c70-a5a2-7d37af911986_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_d86dec4b-9860-47e0-9181-e358d37a4774_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee costs</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationNonproduction_b2cb91e1-1f8c-4ed4-aba0-8bd7443fb834_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_DepreciationNonproduction_label_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationNonproduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationNonproduction" xlink:to="lab_us-gaap_DepreciationNonproduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2a3d21e3-6056-4506-a000-5c28e955f5bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued under the ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_2e9a9d09-f216-4bd5-8609-f1b4b060a6db_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f1ffe9a8-f76a-4b19-b274-f572006e45ae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_28fb509a-88e0-4cce-873d-8077c905dd58_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_1d9a3204-a5d9-450b-918c-41c17d27cf90_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_0d60708d-1694-4725-aee8-6bc4632b5f6d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_99ae476f-d21e-41e0-9061-c0d7c6a7cb5f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_cd8e6248-dfcb-496d-a09b-949f9ec50efc_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Loan, Lease, and Other Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:to="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_44a3ea19-6464-4ff3-9447-4843523a37fb_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_db6d8b79-cbc5-42ed-a15f-d99d975fe22b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0cf42d5e-ebcc-49a2-aec5-2c331751d624_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted-Average Remaining Contractual Term, Ending balance (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod_904fdcb9-c03c-41c5-8a25-83e83eb0178f_terseLabel_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repricing modification (in shares)</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod_label_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Repricing Modification in Period</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod_documentation_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Repricing Modification in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" xlink:to="lab_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_d557f347-0794-4aae-8ac6-4461c6a8f796_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_53ea64c6-4808-435c-a09c-5db1fa95dd83_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_71cc5b95-7b3c-4927-9c76-10a648566119_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1b98490-c7e1-4fb4-acf9-ba19f2a2243b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fdebf5e1-ed97-4d8c-8d15-cbde284b6612_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Aggregate Intrinsic Value, Ending balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_23ae0028-f16e-43fd-af68-bfe3121ce2e7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in connection with the Company's employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_4334ce5b-fcf9-442c-b11d-8985eb96a4fa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3035a2c-f48a-46fe-b991-21d9487b1148_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ClinicalCostsPayableCurrent_01a8118c-5ee3-4ba7-9f21-1b43d3766fcf_terseLabel_en-US" xlink:label="lab_vtl_ClinicalCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical costs</link:label>
    <link:label id="lab_vtl_ClinicalCostsPayableCurrent_label_en-US" xlink:label="lab_vtl_ClinicalCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Costs Payable, Current</link:label>
    <link:label id="lab_vtl_ClinicalCostsPayableCurrent_documentation_en-US" xlink:label="lab_vtl_ClinicalCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Costs Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClinicalCostsPayableCurrent" xlink:href="vtl-20250630.xsd#vtl_ClinicalCostsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ClinicalCostsPayableCurrent" xlink:to="lab_vtl_ClinicalCostsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_251118ea-c407-4347-bd63-c3ad9135a150_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares_d02674e6-3b9c-44b3-ba73-e490df5a21ce_terseLabel_en-US" xlink:label="lab_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of tranche rights liability to equity upon increase in authorized shares</link:label>
    <link:label id="lab_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares_label_en-US" xlink:label="lab_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Tranche Rights Liability to Equity Upon Increase in Authorized Shares</link:label>
    <link:label id="lab_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares_documentation_en-US" xlink:label="lab_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion of Tranche Rights Liability to Equity Upon Increase in Authorized Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" xlink:href="vtl-20250630.xsd#vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" xlink:to="lab_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_88460e14-2531-474b-b33d-088a585a3a96_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ee773fb4-5031-496e-b10b-817c785f9428_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b85f3cf6-bff4-4560-844e-6a78feba66b8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_PlacementAgencyAgreementMember_680cfb11-9a8a-4778-9fd9-58c42c82fae8_terseLabel_en-US" xlink:label="lab_vtl_PlacementAgencyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Placement Agency Agreement</link:label>
    <link:label id="lab_vtl_PlacementAgencyAgreementMember_label_en-US" xlink:label="lab_vtl_PlacementAgencyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Placement Agency Agreement [Member]</link:label>
    <link:label id="lab_vtl_PlacementAgencyAgreementMember_documentation_en-US" xlink:label="lab_vtl_PlacementAgencyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Placement Agency Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgencyAgreementMember" xlink:href="vtl-20250630.xsd#vtl_PlacementAgencyAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_PlacementAgencyAgreementMember" xlink:to="lab_vtl_PlacementAgencyAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_A2019OmnibusEquityIncentivePlanMember_18a68513-df17-446d-87d0-655c832701b7_terseLabel_en-US" xlink:label="lab_vtl_A2019OmnibusEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019 Omnibus Equity Incentive Plan</link:label>
    <link:label id="lab_vtl_A2019OmnibusEquityIncentivePlanMember_label_en-US" xlink:label="lab_vtl_A2019OmnibusEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2019 Omnibus Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_vtl_A2019OmnibusEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_vtl_A2019OmnibusEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2019 Omnibus Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2019OmnibusEquityIncentivePlanMember" xlink:href="vtl-20250630.xsd#vtl_A2019OmnibusEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_A2019OmnibusEquityIncentivePlanMember" xlink:to="lab_vtl_A2019OmnibusEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AU_eeaca69e-e4d1-48a9-ba14-2c6951117758_terseLabel_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Australia</link:label>
    <link:label id="lab_country_AU_label_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AUSTRALIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AU" xlink:to="lab_country_AU" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_May2022ATMMember_837cfdcc-f1dc-481c-8cbc-992636be1afc_terseLabel_en-US" xlink:label="lab_vtl_May2022ATMMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">May 2022 ATM</link:label>
    <link:label id="lab_vtl_May2022ATMMember_label_en-US" xlink:label="lab_vtl_May2022ATMMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2022 ATM [Member]</link:label>
    <link:label id="lab_vtl_May2022ATMMember_documentation_en-US" xlink:label="lab_vtl_May2022ATMMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2022 ATM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2022ATMMember" xlink:href="vtl-20250630.xsd#vtl_May2022ATMMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_May2022ATMMember" xlink:to="lab_vtl_May2022ATMMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_deab494f-196d-433b-b2d7-ecdcf1054bef_terseLabel_en-US" xlink:label="lab_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in operating lease, right-of-use asset</link:label>
    <link:label id="lab_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:href="vtl-20250630.xsd#vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:to="lab_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_6c40e3f5-fc7b-483a-81c6-01ca42cbe02e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of pre-funded warrants</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c6e60d4a-a3d5-44ac-9b52-199c7ac0854f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f03702c-be21-497b-8ee6-94335f691ea0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_22df3ea1-50b4-4c30-84fd-6f9cf8fb5737_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ExecutiveChairmanAgreementMember_0bd6f1e8-e8c6-40e2-8967-1f5d9b9a3285_terseLabel_en-US" xlink:label="lab_vtl_ExecutiveChairmanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Chairman Agreement</link:label>
    <link:label id="lab_vtl_ExecutiveChairmanAgreementMember_label_en-US" xlink:label="lab_vtl_ExecutiveChairmanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Chairman Agreement [Member]</link:label>
    <link:label id="lab_vtl_ExecutiveChairmanAgreementMember_documentation_en-US" xlink:label="lab_vtl_ExecutiveChairmanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Executive Chairman Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ExecutiveChairmanAgreementMember" xlink:href="vtl-20250630.xsd#vtl_ExecutiveChairmanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ExecutiveChairmanAgreementMember" xlink:to="lab_vtl_ExecutiveChairmanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d2bea125-d2c6-4326-99b1-2066ebb2650e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_75cfba7e-f5c4-4405-b983-c612a4e7e2d0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares sold in the offering (as a percent)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Percentage of Ownership before Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_392c5cfe-e5e5-4c18-b15c-4610c63a79be_terseLabel_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VAT receivable</link:label>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value Added Tax Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForCommissions_af1a1345-8594-47e9-a3e0-ee4e7e5d6128_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwriter commissions</link:label>
    <link:label id="lab_us-gaap_PaymentsForCommissions_label_en-US" xlink:label="lab_us-gaap_PaymentsForCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForCommissions" xlink:to="lab_us-gaap_PaymentsForCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cb784ca-a1de-4a5b-8b9d-14b0f9839d14_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_f20392e9-8585-448a-b1eb-426d4e45ffc4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Capitalization [Domain]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Capitalization [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain" xlink:to="lab_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_81570db3-aa91-44bf-bccc-fb2c779c0969_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_eb00f1e6-55ff-4e68-b131-1b8712432ff5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_LesseeOperatingLeasesNumberOfExistingLeases_14c11335-ea93-4f65-899f-26729cd682ba_terseLabel_en-US" xlink:label="lab_vtl_LesseeOperatingLeasesNumberOfExistingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of existing leases</link:label>
    <link:label id="lab_vtl_LesseeOperatingLeasesNumberOfExistingLeases_label_en-US" xlink:label="lab_vtl_LesseeOperatingLeasesNumberOfExistingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Number Of Existing Leases</link:label>
    <link:label id="lab_vtl_LesseeOperatingLeasesNumberOfExistingLeases_documentation_en-US" xlink:label="lab_vtl_LesseeOperatingLeasesNumberOfExistingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Number Of Existing Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_LesseeOperatingLeasesNumberOfExistingLeases" xlink:href="vtl-20250630.xsd#vtl_LesseeOperatingLeasesNumberOfExistingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_LesseeOperatingLeasesNumberOfExistingLeases" xlink:to="lab_vtl_LesseeOperatingLeasesNumberOfExistingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_e2478d24-d3e4-40cf-a440-2bb782cc9977_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_bdfc120e-e729-4446-a17b-809c26f239a4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.0001 par value; 20,000,000 shares authorized and no shares issued or outstanding as of June 30, 2025 and December 31, 2024</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0f3d482d-2572-47df-993d-d2fc8de0ca93_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_bade8d4e-030e-46e9-b7c7-04d7921bdf2a_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_165e1327-fee6-4a65-95d3-af2b9f061152_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SaleOfStockNumberOfTrancheConditions_980986a7-1e16-45bf-9baf-b3d8b681869c_terseLabel_en-US" xlink:label="lab_vtl_SaleOfStockNumberOfTrancheConditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of tranche subjected to condition</link:label>
    <link:label id="lab_vtl_SaleOfStockNumberOfTrancheConditions_label_en-US" xlink:label="lab_vtl_SaleOfStockNumberOfTrancheConditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Tranche Conditions</link:label>
    <link:label id="lab_vtl_SaleOfStockNumberOfTrancheConditions_documentation_en-US" xlink:label="lab_vtl_SaleOfStockNumberOfTrancheConditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Tranche Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockNumberOfTrancheConditions" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockNumberOfTrancheConditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SaleOfStockNumberOfTrancheConditions" xlink:to="lab_vtl_SaleOfStockNumberOfTrancheConditions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_A2017InducementEquityIncentivePlanMember_09901666-8224-452f-9657-659c2dc273ee_terseLabel_en-US" xlink:label="lab_vtl_A2017InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017 Inducement Equity Incentive Plan</link:label>
    <link:label id="lab_vtl_A2017InducementEquityIncentivePlanMember_label_en-US" xlink:label="lab_vtl_A2017InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2017 Inducement Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_vtl_A2017InducementEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_vtl_A2017InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2017 Inducement Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2017InducementEquityIncentivePlanMember" xlink:href="vtl-20250630.xsd#vtl_A2017InducementEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_A2017InducementEquityIncentivePlanMember" xlink:to="lab_vtl_A2017InducementEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_36b90744-7f24-407e-9a13-eb9ecbe29cdc_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2025 and December 31, 2024, and 98,650,590 and 90,150,869 shares issued and outstanding as of June 30, 2025 and December&#160;31, 2024, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_AtTheMarketSalesAgreementMember_a8928ac7-2ace-4c55-a98e-4b25032338c2_terseLabel_en-US" xlink:label="lab_vtl_AtTheMarketSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At The Market Sales Agreement</link:label>
    <link:label id="lab_vtl_AtTheMarketSalesAgreementMember_label_en-US" xlink:label="lab_vtl_AtTheMarketSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At The Market Sales Agreement [Member]</link:label>
    <link:label id="lab_vtl_AtTheMarketSalesAgreementMember_documentation_en-US" xlink:label="lab_vtl_AtTheMarketSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At The Market Sales Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AtTheMarketSalesAgreementMember" xlink:href="vtl-20250630.xsd#vtl_AtTheMarketSalesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_AtTheMarketSalesAgreementMember" xlink:to="lab_vtl_AtTheMarketSalesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_394a88e4-4fde-4f4d-8215-2e2649d23fea_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_93432d22-c6c0-4c40-8218-46773b3afc3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 2</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_7fe9b413-20a7-49b3-9e91-854858e05eb9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Second tranche</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_61d6878e-ad08-4fa9-8397-49f5dcf0a282_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98f4c3bc-640a-463a-b158-41a1984ede48_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days_3c5f020c-6fb9-43b4-80e8-32e950ab73a8_terseLabel_en-US" xlink:label="lab_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate trading volume of last 10 days</link:label>
    <link:label id="lab_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days_label_en-US" xlink:label="lab_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Trading Volume of Last 10 Days</link:label>
    <link:label id="lab_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days_documentation_en-US" xlink:label="lab_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Trading Volume of Last 10 Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockAggregateTradingVolumeOfLast10Days"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days" xlink:to="lab_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_82c52afe-52ae-47cb-a1d2-d15c22934d0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 9)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SalesOfStockCommissionsPercentOfGrossProceeds_330d5cfb-33b4-4a8c-bc73-3e2b8181138e_terseLabel_en-US" xlink:label="lab_vtl_SalesOfStockCommissionsPercentOfGrossProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commission, percent of gross proceeds from sale of common stock (as a percent)</link:label>
    <link:label id="lab_vtl_SalesOfStockCommissionsPercentOfGrossProceeds_label_en-US" xlink:label="lab_vtl_SalesOfStockCommissionsPercentOfGrossProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales of Stock, Commissions, Percent Of Gross Proceeds</link:label>
    <link:label id="lab_vtl_SalesOfStockCommissionsPercentOfGrossProceeds_documentation_en-US" xlink:label="lab_vtl_SalesOfStockCommissionsPercentOfGrossProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales of Stock, Commissions, Percent Of Gross Proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SalesOfStockCommissionsPercentOfGrossProceeds" xlink:href="vtl-20250630.xsd#vtl_SalesOfStockCommissionsPercentOfGrossProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SalesOfStockCommissionsPercentOfGrossProceeds" xlink:to="lab_vtl_SalesOfStockCommissionsPercentOfGrossProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_29091408-aee9-40b3-bde2-c88c6837206b_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_April2025AndMay2025FinancingMember_a0e29f0e-a0c9-4a2f-9f04-f1190d5618cf_terseLabel_en-US" xlink:label="lab_vtl_April2025AndMay2025FinancingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">April 2025 And May 2025 Financing</link:label>
    <link:label id="lab_vtl_April2025AndMay2025FinancingMember_label_en-US" xlink:label="lab_vtl_April2025AndMay2025FinancingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">April 2025 And May 2025 Financing [Member]</link:label>
    <link:label id="lab_vtl_April2025AndMay2025FinancingMember_documentation_en-US" xlink:label="lab_vtl_April2025AndMay2025FinancingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">April 2025 And May 2025 Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025AndMay2025FinancingMember" xlink:href="vtl-20250630.xsd#vtl_April2025AndMay2025FinancingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_April2025AndMay2025FinancingMember" xlink:to="lab_vtl_April2025AndMay2025FinancingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_PreClinicalProductCandidates_737cc148-26ef-4c58-854c-bc20d513a53a_terseLabel_en-US" xlink:label="lab_vtl_PreClinicalProductCandidates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-clinical product candidates</link:label>
    <link:label id="lab_vtl_PreClinicalProductCandidates_label_en-US" xlink:label="lab_vtl_PreClinicalProductCandidates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre Clinical Product Candidates</link:label>
    <link:label id="lab_vtl_PreClinicalProductCandidates_documentation_en-US" xlink:label="lab_vtl_PreClinicalProductCandidates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre Clinical Product Candidates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreClinicalProductCandidates" xlink:href="vtl-20250630.xsd#vtl_PreClinicalProductCandidates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_PreClinicalProductCandidates" xlink:to="lab_vtl_PreClinicalProductCandidates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_29c380a6-3ecc-4115-a340-ad19ad2ad1a3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SeriesAWarrantAndSeriesBWarrantMember_c9f521e0-b37f-4553-881e-e6d38ae51f0b_terseLabel_en-US" xlink:label="lab_vtl_SeriesAWarrantAndSeriesBWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A Warrant and Series B Warrant</link:label>
    <link:label id="lab_vtl_SeriesAWarrantAndSeriesBWarrantMember_label_en-US" xlink:label="lab_vtl_SeriesAWarrantAndSeriesBWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Warrant and Series B Warrant [Member]</link:label>
    <link:label id="lab_vtl_SeriesAWarrantAndSeriesBWarrantMember_documentation_en-US" xlink:label="lab_vtl_SeriesAWarrantAndSeriesBWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A Warrant and Series B Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantAndSeriesBWarrantMember" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantAndSeriesBWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SeriesAWarrantAndSeriesBWarrantMember" xlink:to="lab_vtl_SeriesAWarrantAndSeriesBWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2a10db00-066c-4577-8b3c-ee043a580c1a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ffa12559-d3ec-4c27-b0eb-0f4f6e1c29df_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b51aaefe-42dd-4da3-ba09-67e4fc2e731c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_011302b6-e9b9-43fc-9383-cf3f2f324bff_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_a45833e3-a628-4ca5-ac2e-deb73eb8e565_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_34364976-732c-4062-a22f-65577ab41780_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_d6376fda-d452-4f44-a39b-fd92880d6442_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual obligation</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4108f29e-c95b-454a-8e8d-c6e499e7f31b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable, Weighted-Average Remaining Contractual Term, Ending balance (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c303943b-93d1-4afb-bad3-608f9aff566f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2ee8af7e-306c-49db-a628-707192e2006f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_061417ba-dc6b-4ead-a896-e41564d55895_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_0ea9c1f8-d006-4d95-944a-6f10d0aa21ae_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5d41de00-436c-4d8b-919c-2fd96ad87e38_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from public offering of common stock through At The Market Sales Agreement, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_3b0c6c11-9915-46ae-bb47-814c70f524d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_TwoThousandFourteenEquityIncentivePlanMember_86d6400f-6360-4d0f-9822-4c6e3b4c2cc6_terseLabel_en-US" xlink:label="lab_vtl_TwoThousandFourteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2014 Equity Incentive Plan</link:label>
    <link:label id="lab_vtl_TwoThousandFourteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_vtl_TwoThousandFourteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Fourteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_vtl_TwoThousandFourteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_vtl_TwoThousandFourteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Fourteen Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandFourteenEquityIncentivePlanMember" xlink:href="vtl-20250630.xsd#vtl_TwoThousandFourteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_TwoThousandFourteenEquityIncentivePlanMember" xlink:to="lab_vtl_TwoThousandFourteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_December2020ATMMember_9fc4abb1-7580-4e93-adb2-cfe9329bb5cc_terseLabel_en-US" xlink:label="lab_vtl_December2020ATMMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">December 2020 ATM</link:label>
    <link:label id="lab_vtl_December2020ATMMember_label_en-US" xlink:label="lab_vtl_December2020ATMMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">December 2020 ATM [Member]</link:label>
    <link:label id="lab_vtl_December2020ATMMember_documentation_en-US" xlink:label="lab_vtl_December2020ATMMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">December 2020 ATM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_December2020ATMMember" xlink:href="vtl-20250630.xsd#vtl_December2020ATMMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_December2020ATMMember" xlink:to="lab_vtl_December2020ATMMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_PrepaidClinicalAndRelatedCostsCurrent_32341486-75b2-4755-adab-78ad29da1f97_terseLabel_en-US" xlink:label="lab_vtl_PrepaidClinicalAndRelatedCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid clinical and related costs</link:label>
    <link:label id="lab_vtl_PrepaidClinicalAndRelatedCostsCurrent_label_en-US" xlink:label="lab_vtl_PrepaidClinicalAndRelatedCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Clinical And Related Costs, Current</link:label>
    <link:label id="lab_vtl_PrepaidClinicalAndRelatedCostsCurrent_documentation_en-US" xlink:label="lab_vtl_PrepaidClinicalAndRelatedCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Clinical And Related Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PrepaidClinicalAndRelatedCostsCurrent" xlink:href="vtl-20250630.xsd#vtl_PrepaidClinicalAndRelatedCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_PrepaidClinicalAndRelatedCostsCurrent" xlink:to="lab_vtl_PrepaidClinicalAndRelatedCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f2a8b8df-c8df-4916-a697-53936d7b5442_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_45ca7f89-f9ce-449f-a6c9-2cca7db10359_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_abe23e04-331e-4a9a-93b1-b5c998f5c694_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f69dff41-234c-4bf8-9aaa-7494f902aa51_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_76e0fdcf-194a-4b8c-892a-bef2684d212d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited or expired (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_c2814480-c6be-4fdd-9f74-e0bd3566b047_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment arrangement</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Accelerated Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_6ac074d8-3ba1-4623-9464-b9db70cfb499_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_April2025PIPETransactionMember_2c00d054-ee00-4dcf-8eeb-d788a3eaa19f_terseLabel_en-US" xlink:label="lab_vtl_April2025PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">April 2025 PIPE Transaction</link:label>
    <link:label id="lab_vtl_April2025PIPETransactionMember_label_en-US" xlink:label="lab_vtl_April2025PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">April 2025 P I P E Transaction [Member]</link:label>
    <link:label id="lab_vtl_April2025PIPETransactionMember_documentation_en-US" xlink:label="lab_vtl_April2025PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">April 2025 P I P E Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025PIPETransactionMember" xlink:href="vtl-20250630.xsd#vtl_April2025PIPETransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_April2025PIPETransactionMember" xlink:to="lab_vtl_April2025PIPETransactionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f1306325-1245-44a6-b8de-734d608c3546_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c3afce3e-5eb1-4aa0-b80b-ead87ccf92b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Remaining Contractual Term and Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_765c63a1-0dad-4ecf-87dd-7e6bf510d36e_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Income, Increase (Decrease), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_8e41df68-ac1c-45b8-952f-0c6da2a7ff16_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_867d7197-827c-4774-9221-141e536b2a0d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays_baf1aa51-d092-4699-afb4-bc882a2be5b9_terseLabel_en-US" xlink:label="lab_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shelf registration, termination, prior written notice (in days)</link:label>
    <link:label id="lab_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays_label_en-US" xlink:label="lab_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shelf Registration, Termination, Prior Written Notice, Number of Days</link:label>
    <link:label id="lab_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays_documentation_en-US" xlink:label="lab_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shelf Registration, Termination, Prior Written Notice, Number of Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" xlink:href="vtl-20250630.xsd#vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" xlink:to="lab_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_January2024PIPETransactionMember_33123d0f-7481-455a-ab8b-47233e7f86ec_terseLabel_en-US" xlink:label="lab_vtl_January2024PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 2024 PIPE Transaction</link:label>
    <link:label id="lab_vtl_January2024PIPETransactionMember_label_en-US" xlink:label="lab_vtl_January2024PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January 2024 P I P E Transaction [Member]</link:label>
    <link:label id="lab_vtl_January2024PIPETransactionMember_documentation_en-US" xlink:label="lab_vtl_January2024PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January 2024 P I P E Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PIPETransactionMember" xlink:href="vtl-20250630.xsd#vtl_January2024PIPETransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_January2024PIPETransactionMember" xlink:to="lab_vtl_January2024PIPETransactionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_bdd5de21-07fb-4677-8f6f-3e0eca736654_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_b121cca6-9ed2-4b56-bd24-31160f976a24_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_3e89eb16-70fe-4624-8e17-4c235f63975b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3b0f5e00-cb16-4432-86cd-45b659812ff1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits_c39c8805-3364-4ae6-ad0e-c5f05c0f01a3_terseLabel_en-US" xlink:label="lab_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of financial institutions used for cash deposits</link:label>
    <link:label id="lab_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits_label_en-US" xlink:label="lab_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Financial Institutions Used For Cash Deposits</link:label>
    <link:label id="lab_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits_documentation_en-US" xlink:label="lab_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Financial Institutions Used For Cash Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits" xlink:href="vtl-20250630.xsd#vtl_NumberOfFinancialInstitutionsUsedForCashDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits" xlink:to="lab_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0c16610d-99e5-4c93-b265-2e484ad24340_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4b4a2f76-959f-4f39-8a91-22ec3db3a1a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_21cde0a3-90a1-4d1b-a38a-dfaf512ecdba_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4d6ce98e-b28b-4f01-8a96-9159a4b0852a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_61571a6f-946c-4c30-8abf-a21b2714b076_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent_396b717b-ff96-4ba7-b373-4a83d04fdef2_terseLabel_en-US" xlink:label="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government R&amp;D assistance rate (as a percent)</link:label>
    <link:label id="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent_label_en-US" xlink:label="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Qualified Research and Development Expenditures, Percent</link:label>
    <link:label id="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent_documentation_en-US" xlink:label="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Assistance, Qualified Research and Development Expenditures, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" xlink:href="vtl-20250630.xsd#vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" xlink:to="lab_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice_39a622b8-50ae-4359-b314-7157487b7da6_terseLabel_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repricing modifications (in usd per share)</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice_label_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Repricing Modifications Price</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice_documentation_en-US" xlink:label="lab_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Repricing Modifications Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" xlink:to="lab_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_b6622c33-1d61-49cf-9289-df9ee34e3d09_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_ba980f3e-737b-4c9a-8585-813c292f61f4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8d7459d4-57d0-4b2e-8925-d10e9aaf3b80_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_0acb28ee-915f-48c8-ba0e-ad780979e64a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_941ea721-af2c-40e0-bba5-c0ad2f17fa07_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of Business and Basis of Financial Statements</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_8b2b8813-8aa2-4fdc-99f9-a22daae32af3_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_abfd4ea6-281b-486d-8e94-6a5d36bad0bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_May2025PreFundedWarrantsMember_51ecddf4-ecef-4b18-8a63-28a50ba0ac15_terseLabel_en-US" xlink:label="lab_vtl_May2025PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">May 2025 Pre-Funded Warrants</link:label>
    <link:label id="lab_vtl_May2025PreFundedWarrantsMember_67f85084-8d22-490b-bfa1-1d3b4b5266ef_verboseLabel_en-US" xlink:label="lab_vtl_May2025PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares reserved for the May 2025 Pre-funded warrants</link:label>
    <link:label id="lab_vtl_May2025PreFundedWarrantsMember_label_en-US" xlink:label="lab_vtl_May2025PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2025 Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_vtl_May2025PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_vtl_May2025PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2025 Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PreFundedWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_May2025PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_May2025PreFundedWarrantsMember" xlink:to="lab_vtl_May2025PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_OperatingAndVariableLeasesCost_7cdd7086-d342-4179-8be0-0f2a8826844d_terseLabel_en-US" xlink:label="lab_vtl_OperatingAndVariableLeasesCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating and variable lease costs</link:label>
    <link:label id="lab_vtl_OperatingAndVariableLeasesCost_label_en-US" xlink:label="lab_vtl_OperatingAndVariableLeasesCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating And Variable Leases, Cost</link:label>
    <link:label id="lab_vtl_OperatingAndVariableLeasesCost_documentation_en-US" xlink:label="lab_vtl_OperatingAndVariableLeasesCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating And Variable Leases, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OperatingAndVariableLeasesCost" xlink:href="vtl-20250630.xsd#vtl_OperatingAndVariableLeasesCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_OperatingAndVariableLeasesCost" xlink:to="lab_vtl_OperatingAndVariableLeasesCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1d0cda9e-39aa-4838-ac44-96189b24e6be_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrent_5600f5a9-cd1c-4007-b260-a6430d2b6cfd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableOtherCurrent" xlink:to="lab_us-gaap_AccountsPayableOtherCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2d17f21f-e11a-43ec-990a-b9b149f21e0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e7f71b0-7294-440e-bab5-3491fbcfd414_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_63442d88-675f-4311-b7a0-bf562c3f55eb_terseLabel_en-US" xlink:label="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019 Omnibus Equity Incentive Plan</link:label>
    <link:label id="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_label_en-US" xlink:label="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Nineteen Omnibus Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Nineteen Omnibus Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember" xlink:to="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_AccruedClinicalCostsCurrent_0d73cff1-6eca-4223-b95d-d79f20d67f57_terseLabel_en-US" xlink:label="lab_vtl_AccruedClinicalCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued clinical and related costs</link:label>
    <link:label id="lab_vtl_AccruedClinicalCostsCurrent_label_en-US" xlink:label="lab_vtl_AccruedClinicalCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Clinical Costs, Current</link:label>
    <link:label id="lab_vtl_AccruedClinicalCostsCurrent_documentation_en-US" xlink:label="lab_vtl_AccruedClinicalCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Clinical Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedClinicalCostsCurrent" xlink:href="vtl-20250630.xsd#vtl_AccruedClinicalCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_AccruedClinicalCostsCurrent" xlink:to="lab_vtl_AccruedClinicalCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_500f5515-7342-4007-91fe-fba59c8ac642_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_b1562d1c-6093-462e-9ed1-45060b355d7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2d7fe1f5-1aea-4fa3-8a8e-c345ad808a1b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_c82e565a-74e9-4c80-9015-7b1022bbdaf3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Renewal option period (in months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c3d27064-1d01-49f0-bbf8-9f7d3cbd72c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares exercised from pre-funded warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_caa11040-7066-49c9-8bdb-ccdbabb6619c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_6b63aa00-7dfe-41ff-b295-7d4c246ae8f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_CommonStockNumberOfSharesRegisteredForResale_9c95994b-c523-4ade-aae0-cd122790e0ed_terseLabel_en-US" xlink:label="lab_vtl_CommonStockNumberOfSharesRegisteredForResale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares registered for resale (in shares)</link:label>
    <link:label id="lab_vtl_CommonStockNumberOfSharesRegisteredForResale_label_en-US" xlink:label="lab_vtl_CommonStockNumberOfSharesRegisteredForResale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number Of Shares Registered For Resale</link:label>
    <link:label id="lab_vtl_CommonStockNumberOfSharesRegisteredForResale_documentation_en-US" xlink:label="lab_vtl_CommonStockNumberOfSharesRegisteredForResale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Number Of Shares Registered For Resale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockNumberOfSharesRegisteredForResale" xlink:href="vtl-20250630.xsd#vtl_CommonStockNumberOfSharesRegisteredForResale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_CommonStockNumberOfSharesRegisteredForResale" xlink:to="lab_vtl_CommonStockNumberOfSharesRegisteredForResale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_83068d60-fa19-4d79-88ef-21b3f832e3a5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_d5958aa3-61c7-4d6e-a61a-3ef1eee3b2b2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_25e36bdf-4491-4354-bc84-96687f2b9453_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_c8e434f4-0642-4afe-93bb-25a5cbda950c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder_372fd84d-a1e8-4b05-ab75-49ac307746eb_terseLabel_en-US" xlink:label="lab_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership limitation upon election of the holder (as a percent)</link:label>
    <link:label id="lab_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder_label_en-US" xlink:label="lab_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership Limitation Percentage Upon Election Of The Holder</link:label>
    <link:label id="lab_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder_documentation_en-US" xlink:label="lab_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ownership Limitation Percentage Upon Election Of The Holder</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder" xlink:href="vtl-20250630.xsd#vtl_OwnershipLimitationPercentageUponElectionOfTheHolder"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder" xlink:to="lab_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_1b063cbb-6c92-4913-837a-4892d82b87bf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity_1e56d0cc-85cf-478c-8de9-f8df69018b30_terseLabel_en-US" xlink:label="lab_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of tranche rights liability to equity</link:label>
    <link:label id="lab_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity_label_en-US" xlink:label="lab_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Conversion of Tranche Rights Liability to Equity</link:label>
    <link:label id="lab_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity_documentation_en-US" xlink:label="lab_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Conversion of Tranche Rights Liability to Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" xlink:href="vtl-20250630.xsd#vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" xlink:to="lab_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_7a3a8482-4e7a-4906-b1a4-dffa63e1868b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_29fb5df0-ed41-4e87-b7a0-ea899dada9a3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_CommonStockAndPreFundedWarrantsMember_ed7ade1b-a210-4ad9-868b-64ce7dc116ee_terseLabel_en-US" xlink:label="lab_vtl_CommonStockAndPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Pre-funded Warrants</link:label>
    <link:label id="lab_vtl_CommonStockAndPreFundedWarrantsMember_label_en-US" xlink:label="lab_vtl_CommonStockAndPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock and Pre-funded Warrants [Member]</link:label>
    <link:label id="lab_vtl_CommonStockAndPreFundedWarrantsMember_documentation_en-US" xlink:label="lab_vtl_CommonStockAndPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock and Pre-funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockAndPreFundedWarrantsMember" xlink:href="vtl-20250630.xsd#vtl_CommonStockAndPreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_CommonStockAndPreFundedWarrantsMember" xlink:to="lab_vtl_CommonStockAndPreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4428e457-e226-4bed-904f-2dac2709077d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2890b39d-e463-4d5e-840a-e6675274ae9b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c6302f7c-33a3-46cb-95e2-71de6f424e8e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_c315f78a-37e7-441c-8d02-eefbe41f2aba_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of stock (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_OwnershipLimitationPercentage_9da9cb04-ecba-437a-b109-44b3d4c77c03_terseLabel_en-US" xlink:label="lab_vtl_OwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership limitation (as a percent)</link:label>
    <link:label id="lab_vtl_OwnershipLimitationPercentage_label_en-US" xlink:label="lab_vtl_OwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership Limitation Percentage</link:label>
    <link:label id="lab_vtl_OwnershipLimitationPercentage_documentation_en-US" xlink:label="lab_vtl_OwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ownership Limitation Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OwnershipLimitationPercentage" xlink:href="vtl-20250630.xsd#vtl_OwnershipLimitationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_OwnershipLimitationPercentage" xlink:to="lab_vtl_OwnershipLimitationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_cd7271d0-f9d3-45e2-85cc-896e9ebbdab7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from shares issued in connection with the Company's employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_6cc24c01-e7a7-4411-9831-95380b19f675_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in other share (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Other Share Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_NumberOfDevelopmentPrograms_cae858f2-45a5-494b-9129-232e64bff557_terseLabel_en-US" xlink:label="lab_vtl_NumberOfDevelopmentPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of development programs</link:label>
    <link:label id="lab_vtl_NumberOfDevelopmentPrograms_label_en-US" xlink:label="lab_vtl_NumberOfDevelopmentPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Development Programs</link:label>
    <link:label id="lab_vtl_NumberOfDevelopmentPrograms_documentation_en-US" xlink:label="lab_vtl_NumberOfDevelopmentPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Development Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfDevelopmentPrograms" xlink:href="vtl-20250630.xsd#vtl_NumberOfDevelopmentPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_NumberOfDevelopmentPrograms" xlink:to="lab_vtl_NumberOfDevelopmentPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5cdb359b-d9bc-4ed8-8227-21e6c5be25eb_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_26864ba1-ffc3-492b-a861-0e4fdc1bc1fb_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease term (in months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1f5d2c18-6ff9-42d3-97e6-6b31c9c1df1d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentInterestRate_fff8b099-215b-412b-a3f3-1a126951a412_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_InvestmentInterestRate_label_en-US" xlink:label="lab_us-gaap_InvestmentInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentInterestRate" xlink:to="lab_us-gaap_InvestmentInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_ef4191d4-af0f-4dca-a6cc-d380b85daed3_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5f4ec5b2-a737-436a-9fc0-2d86dbcf9f05_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b36ebb4f-6d8d-4827-b749-c3ec3452bd1c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ae35839d-e55b-435a-83fe-6893dc01f77d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses_0b800f97-1833-4d38-a49a-e293c98a5a25_terseLabel_en-US" xlink:label="lab_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance, net of offering expenses</link:label>
    <link:label id="lab_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses_label_en-US" xlink:label="lab_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Net Of Offering Expenses</link:label>
    <link:label id="lab_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses_documentation_en-US" xlink:label="lab_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Net Of Offering Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" xlink:href="vtl-20250630.xsd#vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" xlink:to="lab_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ReportableSegmentMember_d7d24604-dd7f-487f-9536-0462a27b2eba_terseLabel_en-US" xlink:label="lab_vtl_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_vtl_ReportableSegmentMember_label_en-US" xlink:label="lab_vtl_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_vtl_ReportableSegmentMember_documentation_en-US" xlink:label="lab_vtl_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ReportableSegmentMember" xlink:href="vtl-20250630.xsd#vtl_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ReportableSegmentMember" xlink:to="lab_vtl_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_cb2f8183-bb03-4bbf-b018-9e38a180a4a6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_bbe97524-b967-4eeb-a836-c6ed007b9b42_terseLabel_en-US" xlink:label="lab_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of future tranche right liability upon settlement</link:label>
    <link:label id="lab_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_label_en-US" xlink:label="lab_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Reclassification of Future Tranche Right Liability Upon Settlement</link:label>
    <link:label id="lab_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_documentation_en-US" xlink:label="lab_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Reclassification of Future Tranche Right Liability Upon Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" xlink:href="vtl-20250630.xsd#vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" xlink:to="lab_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_528120b7-2bf1-4ed8-8b32-96c06eefe3ed_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_50192288-0926-4d3b-bdcd-0a52d4d13d0e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_33afa9b0-a7fa-44e0-9486-f3e780678fcc_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government Assistance, Expense, Decrease (Increase), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Expense, Decrease (Increase), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_963fb280-d2a4-4401-b0f8-22328a911b73_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repricing cost during the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_88b0fbad-6ec7-4fae-b7a2-a87571a024a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f8bbff6a-309c-4097-a326-aea9c746111f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_ff5a71aa-6e7f-4b01-ae54-afbe49a9250b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum annual contributions per employee (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a03d7c71-2d47-42f2-95c5-dc333fccdcb9_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected term of options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dd4c266a-324c-44e1-8d5a-cc3c7169c151_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term of options (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_3a5ce01d-e5ea-44b9-821a-e43c3a95de18_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SaleOfStockConsiderationReceivedPercentage_bb18c4bd-87c7-4128-b096-6f45e14eb144_terseLabel_en-US" xlink:label="lab_vtl_SaleOfStockConsiderationReceivedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, consideration received (as a percent)</link:label>
    <link:label id="lab_vtl_SaleOfStockConsiderationReceivedPercentage_label_en-US" xlink:label="lab_vtl_SaleOfStockConsiderationReceivedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received, Percentage</link:label>
    <link:label id="lab_vtl_SaleOfStockConsiderationReceivedPercentage_documentation_en-US" xlink:label="lab_vtl_SaleOfStockConsiderationReceivedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockConsiderationReceivedPercentage" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockConsiderationReceivedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SaleOfStockConsiderationReceivedPercentage" xlink:to="lab_vtl_SaleOfStockConsiderationReceivedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_29cb6942-3c31-4367-aa29-8013c00b370f_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional fees and other segment expenses</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8778d2d5-88bb-4ff5-9049-90e2cdc12ece_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_fccd949a-f253-4685-a7cb-d25f92b45596_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_21d77fac-d4e8-45f6-82ab-ff2d5069e98f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_aeda6bc7-86a3-49d6-9e83-0333299b7b64_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_BoardOfDirectorsChairmanMember_fbeb32b1-645c-403a-9e14-e290409b17e4_terseLabel_en-US" xlink:label="lab_srt_BoardOfDirectorsChairmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Board of Directors Chairman</link:label>
    <link:label id="lab_srt_BoardOfDirectorsChairmanMember_label_en-US" xlink:label="lab_srt_BoardOfDirectorsChairmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_BoardOfDirectorsChairmanMember" xlink:to="lab_srt_BoardOfDirectorsChairmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce59e4c5-f68d-45ca-8ca6-4a0a2bffa213_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted in period, weighted-average grant date fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_IncentiveEmployeeStockOptionMember_92700655-77f5-4d41-b884-5de1fe1fb6b4_terseLabel_en-US" xlink:label="lab_vtl_IncentiveEmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incentive stock options</link:label>
    <link:label id="lab_vtl_IncentiveEmployeeStockOptionMember_label_en-US" xlink:label="lab_vtl_IncentiveEmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incentive Employee Stock Option [Member]</link:label>
    <link:label id="lab_vtl_IncentiveEmployeeStockOptionMember_documentation_en-US" xlink:label="lab_vtl_IncentiveEmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Incentive Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_IncentiveEmployeeStockOptionMember" xlink:href="vtl-20250630.xsd#vtl_IncentiveEmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_IncentiveEmployeeStockOptionMember" xlink:to="lab_vtl_IncentiveEmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ba5e8893-7c2e-4e05-85bc-885b5a196ee5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_8941f332-a7d5-4270-99e6-d4e6144eda0d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from offering, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_74eb2694-3fe8-4688-abd3-8f366da06723_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e763f866-a4e7-4775-926c-5504a8e14364_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4ff9e95a-861b-41bf-951b-d2efdbc0b0e5_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_02ed9298-876f-47ec-947d-07adb34a3018_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_05532cb8-00b5-4763-8178-31cf77855c20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_VolumeWeightageAveragePriceTargetMember_c23bfb92-c9de-42f4-a890-551e5b270ff5_terseLabel_en-US" xlink:label="lab_vtl_VolumeWeightageAveragePriceTargetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VWAP Target</link:label>
    <link:label id="lab_vtl_VolumeWeightageAveragePriceTargetMember_label_en-US" xlink:label="lab_vtl_VolumeWeightageAveragePriceTargetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Volume Weightage Average Price Target [Member]</link:label>
    <link:label id="lab_vtl_VolumeWeightageAveragePriceTargetMember_documentation_en-US" xlink:label="lab_vtl_VolumeWeightageAveragePriceTargetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Volume Weightage Average Price Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_VolumeWeightageAveragePriceTargetMember" xlink:href="vtl-20250630.xsd#vtl_VolumeWeightageAveragePriceTargetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_VolumeWeightageAveragePriceTargetMember" xlink:to="lab_vtl_VolumeWeightageAveragePriceTargetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_50492322-156e-4d33-90a1-85a2376dc3ab_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f44cafbf-3538-42f1-9af7-2d6db52370e0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_May2024ATMMember_b9706695-a568-4008-b83b-4b34f69d0fd8_terseLabel_en-US" xlink:label="lab_vtl_May2024ATMMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">May 2024 ATM</link:label>
    <link:label id="lab_vtl_May2024ATMMember_label_en-US" xlink:label="lab_vtl_May2024ATMMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2024 ATM [Member]</link:label>
    <link:label id="lab_vtl_May2024ATMMember_documentation_en-US" xlink:label="lab_vtl_May2024ATMMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2024 ATM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2024ATMMember" xlink:href="vtl-20250630.xsd#vtl_May2024ATMMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_May2024ATMMember" xlink:to="lab_vtl_May2024ATMMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_May2025PIPETransactionMember_65972f82-5f8d-4e1b-8fb3-839ac10dff7e_terseLabel_en-US" xlink:label="lab_vtl_May2025PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">May 2025 PIPE Transaction</link:label>
    <link:label id="lab_vtl_May2025PIPETransactionMember_label_en-US" xlink:label="lab_vtl_May2025PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2025 P I P E Transaction [Member]</link:label>
    <link:label id="lab_vtl_May2025PIPETransactionMember_documentation_en-US" xlink:label="lab_vtl_May2025PIPETransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2025 P I P E Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PIPETransactionMember" xlink:href="vtl-20250630.xsd#vtl_May2025PIPETransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_May2025PIPETransactionMember" xlink:to="lab_vtl_May2025PIPETransactionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_823f21c9-3713-45b2-85df-60789e3e8b50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche 3</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SaleOfStockRemainingCapacity_9643b4f5-4be6-4edf-a7d3-0dedae36ed09_terseLabel_en-US" xlink:label="lab_vtl_SaleOfStockRemainingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, remaining capacity</link:label>
    <link:label id="lab_vtl_SaleOfStockRemainingCapacity_label_en-US" xlink:label="lab_vtl_SaleOfStockRemainingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Remaining Capacity</link:label>
    <link:label id="lab_vtl_SaleOfStockRemainingCapacity_documentation_en-US" xlink:label="lab_vtl_SaleOfStockRemainingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Remaining Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockRemainingCapacity" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockRemainingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SaleOfStockRemainingCapacity" xlink:to="lab_vtl_SaleOfStockRemainingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_513b1be0-574a-4834-a18a-0a6c0d9a6c40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_42e19a5c-a669-49b1-ab40-55ebf162f620_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_591779c9-3ea1-482b-aa7f-50083b0b16ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_1e489cd4-bc16-4e49-b99d-59d48edfc1de_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8a744cc9-2da3-4541-85e0-ab4b607efb60_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_647620ce-e2fd-48a1-aeee-586b3a8d2b76_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_13b8d51f-e705-4849-9d10-170884bcf64b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_0f0cb753-57ef-4b56-9b33-4b436df57f66_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d9f98573-4072-4582-afbf-64bd29c02038_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3fd16322-e37a-4821-b236-fd114311af00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_21a611e9-c117-48ea-b7ed-d72aaf0a5b3e_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a948ac15-8244-4142-8f5b-8cf9bb3ae891_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_SaleOfStockEquityOfferingsPeriod_3a5efafa-e05a-480b-8d25-669726dae6ad_terseLabel_en-US" xlink:label="lab_vtl_SaleOfStockEquityOfferingsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Third tranche close period after second tranche (in years)</link:label>
    <link:label id="lab_vtl_SaleOfStockEquityOfferingsPeriod_label_en-US" xlink:label="lab_vtl_SaleOfStockEquityOfferingsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Equity Offerings, Period</link:label>
    <link:label id="lab_vtl_SaleOfStockEquityOfferingsPeriod_documentation_en-US" xlink:label="lab_vtl_SaleOfStockEquityOfferingsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Equity Offerings, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockEquityOfferingsPeriod" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockEquityOfferingsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_SaleOfStockEquityOfferingsPeriod" xlink:to="lab_vtl_SaleOfStockEquityOfferingsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c8ca563e-9ab6-471d-9574-3020f51dff26_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_00c2b4ba-8e56-4edd-bf02-3eecb0cf7bd4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_239f28ed-5951-4354-9b4c-56229e40a9db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1652b7d5-57b4-45d8-b5cb-ea8462040b94_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e559f5cb-3825-49f5-9253-203c488a14fb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistancePolicyTextBlock_6d64c998-65f2-4481-82b7-25ad0c740003_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government assistance</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistancePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistancePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:to="lab_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a3996537-388f-4fae-af6d-6ec6ca23a20b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember_cbd24396-043f-4124-bb49-774d29e7b2a7_terseLabel_en-US" xlink:label="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019 Omnibus Equity Incentive Plan, Evergreen Provision</link:label>
    <link:label id="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember_label_en-US" xlink:label="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Nineteen Omnibus Equity Incentive Plan, Evergreen Provision [Member]</link:label>
    <link:label id="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember_documentation_en-US" xlink:label="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Nineteen Omnibus Equity Incentive Plan, Evergreen Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" xlink:to="lab_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_0a089e59-d025-41fa-a285-01a4719c6ea8_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_45a9216c-7e86-4c01-8770-86eb7ce0f938_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value as of January 8, 2024</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_ac5e24c7-cbc3-40b7-8994-6173e7737316_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_81eb41bc-6396-405e-bcd1-17af80817218_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_f63776ca-df97-4eb7-aebb-e5e4c29f3bf5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_2ca37435-958c-4c73-b997-1a460e326c1f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_26265899-1dcc-4289-99d2-ac8c7d502316_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_31c711bc-96f0-46ac-9c0e-a90203cceba1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_020d8b51-2065-4929-977e-2ec1a53134ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_83ce14bb-c840-419c-8d8b-2fb68f7246b0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c35122b2-97fa-417e-81f5-fa49bfaf1dd8_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_57a921c7-a349-4fc0-a648-0ee84201d564_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_b535b0d8-6406-403f-89e1-e27e69a01ca8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_36c80340-9201-470e-be40-7e6c87890337_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_NumberOfVotesPerEachShareOfCommonStock_7c24c241-d094-45b2-acae-d0798bdb0cac_terseLabel_en-US" xlink:label="lab_vtl_NumberOfVotesPerEachShareOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of votes per each share of common stock</link:label>
    <link:label id="lab_vtl_NumberOfVotesPerEachShareOfCommonStock_label_en-US" xlink:label="lab_vtl_NumberOfVotesPerEachShareOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Votes Per Each Share of Common Stock</link:label>
    <link:label id="lab_vtl_NumberOfVotesPerEachShareOfCommonStock_documentation_en-US" xlink:label="lab_vtl_NumberOfVotesPerEachShareOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Votes Per Each Share of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfVotesPerEachShareOfCommonStock" xlink:href="vtl-20250630.xsd#vtl_NumberOfVotesPerEachShareOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_NumberOfVotesPerEachShareOfCommonStock" xlink:to="lab_vtl_NumberOfVotesPerEachShareOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_2bac2581-7d08-4429-bbab-91d6b021fa43_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of pre-funded warrants and common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_16d56d5f-86eb-460e-b817-685e3cd74b82_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4aa1f005-941b-4fec-9359-56d97a175720_netLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Aggregate proceeds from the offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_46418f04-8644-46bc-ac76-7f0822f2d0da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_18f8f5df-901e-4566-b615-00c4f92a42de_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_e970c782-f68f-433a-bc27-620d65cc418e_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_e477ecec-49b9-4e5b-9f86-d95a781c7a45_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d118b837-a5d0-49ef-9249-f1a5608e87ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9501eee8-6349-4609-92aa-65dcdaf28f31_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares_1c2c7918-5cd4-4fb6-b681-0825fd16d000_terseLabel_en-US" xlink:label="lab_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options repriced (in shares)</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares_label_en-US" xlink:label="lab_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation By Share-Based Payment Award, Options, Repriced, Number Of Shares</link:label>
    <link:label id="lab_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares_documentation_en-US" xlink:label="lab_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation By Share-Based Payment Award, Options, Repriced, Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" xlink:to="lab_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration_5f636d39-7282-4359-878e-b3f9d2978a97_terseLabel_en-US" xlink:label="lab_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum aggregate offering price of common stock, preferred stock, warrants, debt securities, and/or units</link:label>
    <link:label id="lab_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration_label_en-US" xlink:label="lab_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Aggregate Offering Price Of Securities Under Shelf Registration</link:label>
    <link:label id="lab_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration_documentation_en-US" xlink:label="lab_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Aggregate Offering Price Of Securities Under Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" xlink:href="vtl-20250630.xsd#vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" xlink:to="lab_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7c5e162d-abbc-4368-b8b9-6943159d9e94_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dd6367e1-85db-44d0-95f8-bbdb96a83276_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>vtl-20250630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:21259784-9322-473c-b39e-2847017b16ee,g:8411c107-5431-4a14-ae41-df3b5f39857c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://vitaltherapies.com/role/CoverPage" xlink:type="simple" xlink:href="vtl-20250630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c4433711-bc7b-41cc-8d8e-c8d4e40c0561" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_DocumentType_c4433711-bc7b-41cc-8d8e-c8d4e40c0561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_826b28f3-c1ff-441a-8369-643c88fb6492" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_DocumentQuarterlyReport_826b28f3-c1ff-441a-8369-643c88fb6492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c4d5c58f-ef5b-4645-9928-4fab0bebfbf5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_DocumentPeriodEndDate_c4d5c58f-ef5b-4645-9928-4fab0bebfbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_77d90812-efe4-4ae1-bd07-cb5255809804" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_DocumentTransitionReport_77d90812-efe4-4ae1-bd07-cb5255809804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b732e650-8cf1-4f91-a303-1325fa9c94b7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityFileNumber_b732e650-8cf1-4f91-a303-1325fa9c94b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0be287f2-c2a7-4a53-b79f-ea054ab8d520" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityRegistrantName_0be287f2-c2a7-4a53-b79f-ea054ab8d520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_66d990af-89d4-4f07-8df7-3b7ed9bf14e6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_66d990af-89d4-4f07-8df7-3b7ed9bf14e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7f53eac7-3432-44ba-8987-f2a16cc7bc3a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityTaxIdentificationNumber_7f53eac7-3432-44ba-8987-f2a16cc7bc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_055e28e7-18f3-4ff3-a52c-50e408e4c11e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityAddressAddressLine1_055e28e7-18f3-4ff3-a52c-50e408e4c11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_aba84fa5-84e7-458e-b3f8-857ac868fed0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityAddressAddressLine2_aba84fa5-84e7-458e-b3f8-857ac868fed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a5c017da-2f93-44d5-b199-5caa8e9fa069" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityAddressCityOrTown_a5c017da-2f93-44d5-b199-5caa8e9fa069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_cde4beea-a04d-4c1c-83d2-6e53f45b07d6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityAddressStateOrProvince_cde4beea-a04d-4c1c-83d2-6e53f45b07d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7050bdbe-3787-4004-b6bb-b9c92d6b8798" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityAddressPostalZipCode_7050bdbe-3787-4004-b6bb-b9c92d6b8798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3c76663b-bbf3-4c42-8c82-bedcf3b131a7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_CityAreaCode_3c76663b-bbf3-4c42-8c82-bedcf3b131a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_506ecbd9-9a4b-41cd-99a4-76743e3ca678" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_LocalPhoneNumber_506ecbd9-9a4b-41cd-99a4-76743e3ca678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8fce1d4a-6356-48c4-abf0-14c75cced64f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_Security12bTitle_8fce1d4a-6356-48c4-abf0-14c75cced64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9cceef37-bc97-4cd7-9e9a-3e276eb19539" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_TradingSymbol_9cceef37-bc97-4cd7-9e9a-3e276eb19539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fff1bdb3-bd55-4cf0-a1a3-4fe8f6551085" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_SecurityExchangeName_fff1bdb3-bd55-4cf0-a1a3-4fe8f6551085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c6c88509-945d-4f6c-843e-dd02476f7e8f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityCurrentReportingStatus_c6c88509-945d-4f6c-843e-dd02476f7e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ddc1db9c-534c-4e89-8a98-2f1afccaf246" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityInteractiveDataCurrent_ddc1db9c-534c-4e89-8a98-2f1afccaf246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_455d0af7-d546-46de-9064-c75d5ff0e287" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityFilerCategory_455d0af7-d546-46de-9064-c75d5ff0e287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c0a87195-8f21-40f0-826a-35feb7f5cf85" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntitySmallBusiness_c0a87195-8f21-40f0-826a-35feb7f5cf85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a70c44a3-b01a-4dc0-a429-71635605900d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityEmergingGrowthCompany_a70c44a3-b01a-4dc0-a429-71635605900d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c5e7b7ad-3697-4c26-9cbf-0ba5dd62b4be" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityShellCompany_c5e7b7ad-3697-4c26-9cbf-0ba5dd62b4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cd9675c1-0b4d-4c9c-a35e-c3fc6f52520b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cd9675c1-0b4d-4c9c-a35e-c3fc6f52520b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_18793a22-af67-4f71-97ba-8ddbfc01ea52" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_DocumentFiscalYearFocus_18793a22-af67-4f71-97ba-8ddbfc01ea52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e3a5d9f3-9fe1-487c-8e1d-88f02072c66a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e3a5d9f3-9fe1-487c-8e1d-88f02072c66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_183e2c79-17d4-4774-afdc-5c55a48dd66a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_AmendmentFlag_183e2c79-17d4-4774-afdc-5c55a48dd66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3fbe64c5-3b2d-479f-979f-8ac5c691e5ae" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_CurrentFiscalYearEndDate_3fbe64c5-3b2d-479f-979f-8ac5c691e5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e3f0d861-4ac0-4442-bfdf-c7e85805a206" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_262512ce-36c1-4600-9fce-018dcc87cbcd" xlink:to="loc_dei_EntityCentralIndexKey_e3f0d861-4ac0-4442-bfdf-c7e85805a206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_78e5a44c-9a63-494a-b20e-2553482cdd73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_24d4be7a-d241-4079-acf2-92c9830843b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78e5a44c-9a63-494a-b20e-2553482cdd73" xlink:to="loc_us-gaap_AssetsAbstract_24d4be7a-d241-4079-acf2-92c9830843b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_27722a03-acb5-467b-8cb4-b5341934352e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_24d4be7a-d241-4079-acf2-92c9830843b9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_27722a03-acb5-467b-8cb4-b5341934352e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f4cb029a-ff6d-4a22-98c0-e3c96c5018ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27722a03-acb5-467b-8cb4-b5341934352e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f4cb029a-ff6d-4a22-98c0-e3c96c5018ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d9148a66-524d-4ca6-be20-c1793515f8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27722a03-acb5-467b-8cb4-b5341934352e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d9148a66-524d-4ca6-be20-c1793515f8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_558182be-5cd0-4a3b-8f67-7ab5b140e2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27722a03-acb5-467b-8cb4-b5341934352e" xlink:to="loc_us-gaap_AssetsCurrent_558182be-5cd0-4a3b-8f67-7ab5b140e2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aa4b03e2-f4e3-4f08-93cf-57813acb91b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_24d4be7a-d241-4079-acf2-92c9830843b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_aa4b03e2-f4e3-4f08-93cf-57813acb91b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e6005907-f4c6-48f5-9062-b9fd617958d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_24d4be7a-d241-4079-acf2-92c9830843b9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e6005907-f4c6-48f5-9062-b9fd617958d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2b8b3cca-007e-4439-8bed-434e2b107140" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_24d4be7a-d241-4079-acf2-92c9830843b9" xlink:to="loc_us-gaap_Assets_2b8b3cca-007e-4439-8bed-434e2b107140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78e5a44c-9a63-494a-b20e-2553482cdd73" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a132f2bd-f8d4-4ae3-bfb8-d650fd3d8442" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a132f2bd-f8d4-4ae3-bfb8-d650fd3d8442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fc263c42-1526-4804-8c2b-86c85fe36441" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a132f2bd-f8d4-4ae3-bfb8-d650fd3d8442" xlink:to="loc_us-gaap_AccountsPayableCurrent_fc263c42-1526-4804-8c2b-86c85fe36441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_17d7d339-1a8b-48d0-a3a8-fef480082773" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a132f2bd-f8d4-4ae3-bfb8-d650fd3d8442" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_17d7d339-1a8b-48d0-a3a8-fef480082773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_973e1b4d-4691-4513-923f-70105b4478c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a132f2bd-f8d4-4ae3-bfb8-d650fd3d8442" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_973e1b4d-4691-4513-923f-70105b4478c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0195f0b2-37a6-4115-8152-a5fb757b77f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a132f2bd-f8d4-4ae3-bfb8-d650fd3d8442" xlink:to="loc_us-gaap_LiabilitiesCurrent_0195f0b2-37a6-4115-8152-a5fb757b77f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_62f3608d-8d1a-4107-aa31-157b5f8ab346" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_62f3608d-8d1a-4107-aa31-157b5f8ab346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_39f44b4a-f3b1-4340-9788-910acadd1fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_62f3608d-8d1a-4107-aa31-157b5f8ab346" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_39f44b4a-f3b1-4340-9788-910acadd1fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_d1eec3d7-80ea-4596-b7ba-46f8d63bf78b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_62f3608d-8d1a-4107-aa31-157b5f8ab346" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_d1eec3d7-80ea-4596-b7ba-46f8d63bf78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_edbdbb5f-1ae8-43f1-88b7-7767771f755f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:to="loc_us-gaap_Liabilities_edbdbb5f-1ae8-43f1-88b7-7767771f755f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_95d7d505-59f4-41fe-8432-0294c67ba4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:to="loc_us-gaap_CommitmentsAndContingencies_95d7d505-59f4-41fe-8432-0294c67ba4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:to="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ebc390c2-31a1-42ea-89a5-b05b163fc511" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:to="loc_us-gaap_PreferredStockValue_ebc390c2-31a1-42ea-89a5-b05b163fc511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c259fa2a-2906-40de-a58e-3cb52929d2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:to="loc_us-gaap_CommonStockValue_c259fa2a-2906-40de-a58e-3cb52929d2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0516bc7e-ce6e-4f45-95fb-68bf6d079531" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0516bc7e-ce6e-4f45-95fb-68bf6d079531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_78ea577b-c900-4866-80c4-e1ce19e13fca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_78ea577b-c900-4866-80c4-e1ce19e13fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8345b867-d3ee-43c1-af91-a04ece7a0892" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8345b867-d3ee-43c1-af91-a04ece7a0892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_04502f44-cec8-44b8-9c7b-5e804ef7696a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7cac57a0-4e5b-4866-add0-5435d1fc5e07" xlink:to="loc_us-gaap_StockholdersEquity_04502f44-cec8-44b8-9c7b-5e804ef7696a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1baa8365-b276-4f9b-b0b9-2484e210a657" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_00cb2bb3-3fc0-4fac-9db6-219d5ed75c54" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_1baa8365-b276-4f9b-b0b9-2484e210a657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_887f5114-fd19-42d3-a880-7d60bba213c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_887f5114-fd19-42d3-a880-7d60bba213c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7e144063-1072-45e4-9cfb-26cbbf3e4ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7e144063-1072-45e4-9cfb-26cbbf3e4ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_c51d05bd-c87d-4036-823e-09aa8028d6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_PreferredStockSharesIssued_c51d05bd-c87d-4036-823e-09aa8028d6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_98c70bde-1da9-446d-9eb2-199f01c6838e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_98c70bde-1da9-446d-9eb2-199f01c6838e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3b090802-5392-4316-b6cb-3f5b9fb3b268" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3b090802-5392-4316-b6cb-3f5b9fb3b268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_29f4e806-75c6-46c4-8383-7cf5ca403f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_29f4e806-75c6-46c4-8383-7cf5ca403f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_98679dcf-118d-4952-b564-b11deaad1b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_CommonStockSharesIssued_98679dcf-118d-4952-b564-b11deaad1b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2bbac818-bff1-4f10-94d1-2488919edeba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e4c28db2-9ce8-428c-936e-8cab7d6cac76" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2bbac818-bff1-4f10-94d1-2488919edeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0aa20629-324a-41e6-bbd2-25351fd4e145" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0aa20629-324a-41e6-bbd2-25351fd4e145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a57dcea3-6af1-46a3-9953-be05bdbe92ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0aa20629-324a-41e6-bbd2-25351fd4e145" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a57dcea3-6af1-46a3-9953-be05bdbe92ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ee54877d-4262-4d64-8763-3f25441368ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0aa20629-324a-41e6-bbd2-25351fd4e145" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ee54877d-4262-4d64-8763-3f25441368ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3f3777f2-b35c-426a-aea8-28e7ce32f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0aa20629-324a-41e6-bbd2-25351fd4e145" xlink:to="loc_us-gaap_OperatingExpenses_3f3777f2-b35c-426a-aea8-28e7ce32f46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4c49d0c3-b2b5-4380-a55e-99d4dd3a4c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_OperatingIncomeLoss_4c49d0c3-b2b5-4380-a55e-99d4dd3a4c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_de6f3a89-db5b-4cc5-9bd4-2070823ff45f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_de6f3a89-db5b-4cc5-9bd4-2070823ff45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e6e4e6d2-ff67-4bc8-acd2-87b75abb7db9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_de6f3a89-db5b-4cc5-9bd4-2070823ff45f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e6e4e6d2-ff67-4bc8-acd2-87b75abb7db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_136ca604-b06a-4684-bfc5-110a792310b6" xlink:href="vtl-20250630.xsd#vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_de6f3a89-db5b-4cc5-9bd4-2070823ff45f" xlink:to="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_136ca604-b06a-4684-bfc5-110a792310b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_38880308-3f66-41cc-a0a0-4e2182184e53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_de6f3a89-db5b-4cc5-9bd4-2070823ff45f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_38880308-3f66-41cc-a0a0-4e2182184e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e1a7d2e1-7196-4aa8-9b84-f6af12fc4320" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_de6f3a89-db5b-4cc5-9bd4-2070823ff45f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e1a7d2e1-7196-4aa8-9b84-f6af12fc4320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1f57c6f2-e852-4387-96fe-2e6533fa4568" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_NetIncomeLoss_1f57c6f2-e852-4387-96fe-2e6533fa4568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a0e1dc9d-90aa-4807-8434-5d3d7f7cae63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_EarningsPerShareBasic_a0e1dc9d-90aa-4807-8434-5d3d7f7cae63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d390740d-e3a9-4fcb-8142-b8fce086957a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d390740d-e3a9-4fcb-8142-b8fce086957a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c5812a3-9014-4e29-a0e6-a77981e820d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c5812a3-9014-4e29-a0e6-a77981e820d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0cad5a55-37bc-47be-8b6e-a8f984baa25a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_03eef420-b904-4b33-9870-eee9ae5b5283" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0cad5a55-37bc-47be-8b6e-a8f984baa25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99043d8b-8bb9-41ab-a462-9e024f5673f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2ff79cc-8d93-49c9-93dd-367c8449ccbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99043d8b-8bb9-41ab-a462-9e024f5673f3" xlink:to="loc_us-gaap_NetIncomeLoss_c2ff79cc-8d93-49c9-93dd-367c8449ccbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7b619434-5500-4092-8f3b-3e0a677d2873" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99043d8b-8bb9-41ab-a462-9e024f5673f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7b619434-5500-4092-8f3b-3e0a677d2873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8b902981-f2af-45a4-81b0-11393811b1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7b619434-5500-4092-8f3b-3e0a677d2873" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8b902981-f2af-45a4-81b0-11393811b1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5ce262b6-7011-49af-bbe9-bb68e77681a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99043d8b-8bb9-41ab-a462-9e024f5673f3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5ce262b6-7011-49af-bbe9-bb68e77681a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c62b88b2-c31a-4904-a3c9-49a5ff82e323" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c62b88b2-c31a-4904-a3c9-49a5ff82e323" xlink:to="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b154993b-defa-4742-9617-f3002e6cbb93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b154993b-defa-4742-9617-f3002e6cbb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b154993b-defa-4742-9617-f3002e6cbb93" xlink:to="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_39444e91-e57d-4215-91ad-3fcaaf79b61c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_CommonStockMember_39444e91-e57d-4215-91ad-3fcaaf79b61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_55f7abce-c9fe-4bcc-9e15-8c9b074c6aba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_55f7abce-c9fe-4bcc-9e15-8c9b074c6aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_44cdd699-c08c-407e-bd92-0d4abe54363d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_44cdd699-c08c-407e-bd92-0d4abe54363d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_722ffc8b-1138-451f-853f-e7ecf174aaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ae728166-86d0-42e5-a74a-aa57cd4a88f2" xlink:to="loc_us-gaap_RetainedEarningsMember_722ffc8b-1138-451f-853f-e7ecf174aaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd4bd5bf-24de-4135-b3de-c2cb4e9a7dbe" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PIPETransactionMember_88ae2c0e-4ab4-4e73-8bc7-fcec85138423" xlink:href="vtl-20250630.xsd#vtl_May2025PIPETransactionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_May2025PIPETransactionMember_88ae2c0e-4ab4-4e73-8bc7-fcec85138423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025PIPETransactionMember_42efcc07-9a29-4fb0-9254-880ac8cd80e1" xlink:href="vtl-20250630.xsd#vtl_April2025PIPETransactionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_April2025PIPETransactionMember_42efcc07-9a29-4fb0-9254-880ac8cd80e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PIPETransactionMember_c762ac9f-e745-4855-be8a-c7345b5cb988" xlink:href="vtl-20250630.xsd#vtl_January2024PIPETransactionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_January2024PIPETransactionMember_c762ac9f-e745-4855-be8a-c7345b5cb988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AtTheMarketSalesAgreementMember_cbd5cc38-fb09-4efe-abbc-81ba6c150e9f" xlink:href="vtl-20250630.xsd#vtl_AtTheMarketSalesAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50b22b15-3195-402c-8ca3-db802c0f23e2" xlink:to="loc_vtl_AtTheMarketSalesAgreementMember_cbd5cc38-fb09-4efe-abbc-81ba6c150e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dac4734f-fed5-424b-b99f-4b40c3c497bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_44faf914-78f4-49ec-bcb9-1ba04923b572" xlink:to="loc_us-gaap_StatementLineItems_dac4734f-fed5-424b-b99f-4b40c3c497bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dac4734f-fed5-424b-b99f-4b40c3c497bc" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_751ff6e3-3a91-4ffc-bfc7-2a7599b76f45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_751ff6e3-3a91-4ffc-bfc7-2a7599b76f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_436fc173-9e0a-42df-a118-1af50cce1516" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockholdersEquity_436fc173-9e0a-42df-a118-1af50cce1516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf1b85dd-f022-41d0-90da-bf13d9270fea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_NetIncomeLoss_bf1b85dd-f022-41d0-90da-bf13d9270fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_78a2d56f-5aef-4958-a9e4-9ae6f0f9c299" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_78a2d56f-5aef-4958-a9e4-9ae6f0f9c299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_10f8f0ad-bf62-45de-8e78-e2e5b6feab5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_10f8f0ad-bf62-45de-8e78-e2e5b6feab5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1b4a6adf-9b2c-4cde-b3fb-01482e2b6cac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1b4a6adf-9b2c-4cde-b3fb-01482e2b6cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3ffed846-c981-4213-9560-b04e1d570c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3ffed846-c981-4213-9560-b04e1d570c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity_6cebf43b-62b2-4adb-9b11-973ca5c8eaeb" xlink:href="vtl-20250630.xsd#vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity_6cebf43b-62b2-4adb-9b11-973ca5c8eaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_09040fdc-30bc-4df8-bb2b-6cae098e04ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_09040fdc-30bc-4df8-bb2b-6cae098e04ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aec743ba-475c-4e74-ac0d-f7178a6c6efa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aec743ba-475c-4e74-ac0d-f7178a6c6efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_aba5951c-c9d1-400a-8c70-26cf6a9ccd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_aba5951c-c9d1-400a-8c70-26cf6a9ccd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c592cfae-266f-44c3-8696-61cb793dea2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c592cfae-266f-44c3-8696-61cb793dea2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_81c5c654-553a-4339-ad1b-c56b19dc29a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_81c5c654-553a-4339-ad1b-c56b19dc29a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c7a1fa1b-0e18-4187-8cb2-68fd7f1c2da7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_875547a7-7e32-4be0-bcea-26cea7a50524" xlink:to="loc_us-gaap_StockholdersEquity_c7a1fa1b-0e18-4187-8cb2-68fd7f1c2da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3dee3a20-ed4c-4efc-8a4b-55fe28bda280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_85abb791-5f79-4f31-bed2-746fb16365a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3dee3a20-ed4c-4efc-8a4b-55fe28bda280" xlink:to="loc_us-gaap_StatementTable_85abb791-5f79-4f31-bed2-746fb16365a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4af993f0-398f-41d2-838a-18ebd9c4eb52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_85abb791-5f79-4f31-bed2-746fb16365a5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4af993f0-398f-41d2-838a-18ebd9c4eb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4af993f0-398f-41d2-838a-18ebd9c4eb52" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PIPETransactionMember_a83176b6-45d1-4c3a-b524-d4a95fbc487f" xlink:href="vtl-20250630.xsd#vtl_May2025PIPETransactionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_May2025PIPETransactionMember_a83176b6-45d1-4c3a-b524-d4a95fbc487f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025PIPETransactionMember_c71262ee-f68a-42a6-a2b7-23e360758537" xlink:href="vtl-20250630.xsd#vtl_April2025PIPETransactionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_April2025PIPETransactionMember_c71262ee-f68a-42a6-a2b7-23e360758537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PIPETransactionMember_eee53a5e-9283-42f4-870b-208e4d1d86d5" xlink:href="vtl-20250630.xsd#vtl_January2024PIPETransactionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_January2024PIPETransactionMember_eee53a5e-9283-42f4-870b-208e4d1d86d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AtTheMarketSalesAgreementMember_c3a23166-15ed-4374-a3cd-e42c4d1d5629" xlink:href="vtl-20250630.xsd#vtl_AtTheMarketSalesAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_998e3648-a170-4b71-b4e2-9c3a7fb63dd4" xlink:to="loc_vtl_AtTheMarketSalesAgreementMember_c3a23166-15ed-4374-a3cd-e42c4d1d5629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48ae1e90-315f-4557-a636-8ea5e5873ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_85abb791-5f79-4f31-bed2-746fb16365a5" xlink:to="loc_us-gaap_StatementLineItems_48ae1e90-315f-4557-a636-8ea5e5873ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5528c5b6-ddc1-4b1c-ad07-bfc5474ab413" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48ae1e90-315f-4557-a636-8ea5e5873ce8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5528c5b6-ddc1-4b1c-ad07-bfc5474ab413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows" xlink:type="simple" xlink:href="vtl-20250630.xsd#CondensedConsolidatedStatementofCashFlows"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b83975fa-1845-4cde-8b1b-f638bd5a6e53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_16829f09-739d-443b-b9a5-348ab8b35a32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b83975fa-1845-4cde-8b1b-f638bd5a6e53" xlink:to="loc_us-gaap_StatementTable_16829f09-739d-443b-b9a5-348ab8b35a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e8cf2b52-30aa-481d-ad71-9a5a697a5b85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_16829f09-739d-443b-b9a5-348ab8b35a32" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e8cf2b52-30aa-481d-ad71-9a5a697a5b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e8cf2b52-30aa-481d-ad71-9a5a697a5b85" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PIPETransactionMember_ae20999c-ff0f-4fa3-8c1e-fa0c2fec08dc" xlink:href="vtl-20250630.xsd#vtl_January2024PIPETransactionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:to="loc_vtl_January2024PIPETransactionMember_ae20999c-ff0f-4fa3-8c1e-fa0c2fec08dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PIPETransactionMember_47e38900-35b4-4deb-9c40-c72df5682ebc" xlink:href="vtl-20250630.xsd#vtl_May2025PIPETransactionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:to="loc_vtl_May2025PIPETransactionMember_47e38900-35b4-4deb-9c40-c72df5682ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025PIPETransactionMember_0d5020e8-26f5-4ba3-91c5-ec69d459c067" xlink:href="vtl-20250630.xsd#vtl_April2025PIPETransactionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0586dbf4-168b-4d7a-a118-ce4307fe6ca3" xlink:to="loc_vtl_April2025PIPETransactionMember_0d5020e8-26f5-4ba3-91c5-ec69d459c067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_16829f09-739d-443b-b9a5-348ab8b35a32" xlink:to="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2bbc5436-57cc-4ab9-b476-f78f600f464a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:to="loc_us-gaap_NetIncomeLoss_2bbc5436-57cc-4ab9-b476-f78f600f464a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ed887a75-6389-4acd-8c17-236168200009" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ed887a75-6389-4acd-8c17-236168200009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0161016f-d27e-4c41-8ccc-e45e8f09275c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0161016f-d27e-4c41-8ccc-e45e8f09275c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3e2b74b8-5fbf-440d-aae9-685e422e40a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ShareBasedCompensation_3e2b74b8-5fbf-440d-aae9-685e422e40a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_124d8d35-213a-4706-aefe-82c0492d8960" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_124d8d35-213a-4706-aefe-82c0492d8960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights_6bd91d92-22ae-4ebc-8a6b-2fb52767b923" xlink:href="vtl-20250630.xsd#vtl_GainLossFromChangeInFairValueOfTrancheRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_vtl_GainLossFromChangeInFairValueOfTrancheRights_6bd91d92-22ae-4ebc-8a6b-2fb52767b923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_ee9a7fed-ca24-43a7-ab26-2b76919f7e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManagementFeeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_ManagementFeeExpense_ee9a7fed-ca24-43a7-ab26-2b76919f7e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ed5a483-6057-463a-bc85-a2cdf6fb4fb9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99cac229-09f6-4ad6-97b6-ce181149cef0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99cac229-09f6-4ad6-97b6-ce181149cef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b4aa6780-d02b-4970-a791-ce4eea168fef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b4aa6780-d02b-4970-a791-ce4eea168fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_32159340-5828-4717-a8f8-68f6c2dfd811" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_32159340-5828-4717-a8f8-68f6c2dfd811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2af78e8c-29b0-46a1-be54-d17e232d93e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2af78e8c-29b0-46a1-be54-d17e232d93e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4730e93a-2881-4568-b807-220a7ca9c8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c33886a-1247-4fe2-8d27-48f9444aa0a4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4730e93a-2881-4568-b807-220a7ca9c8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e70ab0a3-86ba-4516-a836-06726308d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_029d6a9a-0021-4f3b-8709-24e0bfc9596d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e70ab0a3-86ba-4516-a836-06726308d58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84c0b785-f098-4967-bb11-40f5fc9879d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84c0b785-f098-4967-bb11-40f5fc9879d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_345785a7-70eb-43eb-b5df-39c7a8a200b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_3600b7a0-5f51-414c-80cb-b29a3d1bc458" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_345785a7-70eb-43eb-b5df-39c7a8a200b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_900091f3-b256-4064-bbb0-57c8934056c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_900091f3-b256-4064-bbb0-57c8934056c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_ef6ce059-44bb-4c75-bd81-2c56f2f957ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_ef6ce059-44bb-4c75-bd81-2c56f2f957ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_394ef286-a38c-445a-9138-4dfb0cea7c65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_394ef286-a38c-445a-9138-4dfb0cea7c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c3cec5d-a7d8-420a-b5dc-ac8781afe1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_5adde626-6d43-45cb-b9e7-cec0eb22d2d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c3cec5d-a7d8-420a-b5dc-ac8781afe1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_649eff86-9113-4a5f-ac01-3cd3576e22de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_649eff86-9113-4a5f-ac01-3cd3576e22de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_053a4c9d-926a-47b5-8922-3eddd4fcc707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_053a4c9d-926a-47b5-8922-3eddd4fcc707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b83d484c-89fb-4b22-a7c0-52d1cce82a31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b83d484c-89fb-4b22-a7c0-52d1cce82a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80d5f92d-a1c5-4952-8ce4-5e315ea0864c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80d5f92d-a1c5-4952-8ce4-5e315ea0864c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_660672fa-2352-46e4-9073-de6fad121068" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0933a8af-63dc-4a42-b765-741f8a3d67a9" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_660672fa-2352-46e4-9073-de6fad121068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares_35643bda-72d9-4231-8991-a76e0ac590d5" xlink:href="vtl-20250630.xsd#vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_660672fa-2352-46e4-9073-de6fad121068" xlink:to="loc_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares_35643bda-72d9-4231-8991-a76e0ac590d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatements" xlink:type="simple" xlink:href="vtl-20250630.xsd#DescriptionofBusinessandBasisofFinancialStatements"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_089e6299-877b-44d5-8f0d-c82bfd83dc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_96a31ed3-c94b-4a8f-9582-1bfa9f2a7d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_089e6299-877b-44d5-8f0d-c82bfd83dc2a" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_96a31ed3-c94b-4a8f-9582-1bfa9f2a7d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="vtl-20250630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ef68a0df-84fb-4324-b83e-bd77f817d006" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_bfb1b2f0-c76d-4718-9d0e-71b665f9df7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef68a0df-84fb-4324-b83e-bd77f817d006" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_bfb1b2f0-c76d-4718-9d0e-71b665f9df7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_92dee1df-4594-4702-a41c-e230d56e264f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_12518f38-10b1-486c-9859-77d95bed9b83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_92dee1df-4594-4702-a41c-e230d56e264f" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_12518f38-10b1-486c-9859-77d95bed9b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/Leases" xlink:type="simple" xlink:href="vtl-20250630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_50a6e0dd-12d8-4cf9-9c86-4084fec329c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_9cc6cfcb-1ae1-4197-9e2a-f3be6936cd79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_50a6e0dd-12d8-4cf9-9c86-4084fec329c1" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_9cc6cfcb-1ae1-4197-9e2a-f3be6936cd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/FairValue" xlink:type="simple" xlink:href="vtl-20250630.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04214f8a-ff66-46ea-9a52-6328b60428fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_cb475f97-7f21-4fe0-9410-676186c19087" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04214f8a-ff66-46ea-9a52-6328b60428fc" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_cb475f97-7f21-4fe0-9410-676186c19087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStock" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b60a0a8f-c3a6-4adf-ad77-ef61545d0ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0ac0b672-de45-499c-8b3a-4d13c792fac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b60a0a8f-c3a6-4adf-ad77-ef61545d0ee4" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0ac0b672-de45-499c-8b3a-4d13c792fac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlans" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlans"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c6b7d23-b62e-4b31-a239-940e5b9af856" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8cccf428-a359-490c-a7aa-c12f17c6ea81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c6b7d23-b62e-4b31-a239-940e5b9af856" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8cccf428-a359-490c-a7aa-c12f17c6ea81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="vtl-20250630.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0ddaeaa0-e361-49d0-b546-14ee14c85bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_629c295f-712b-40f2-9fea-af0c2dd32581" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0ddaeaa0-e361-49d0-b546-14ee14c85bcc" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_629c295f-712b-40f2-9fea-af0c2dd32581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5d1873d2-2515-4079-a976-80d3f9ad2d98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5385b647-1564-4f8d-b5d9-8e2def33274f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5d1873d2-2515-4079-a976-80d3f9ad2d98" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5385b647-1564-4f8d-b5d9-8e2def33274f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SegmentDisclosures" xlink:type="simple" xlink:href="vtl-20250630.xsd#SegmentDisclosures"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SegmentDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5d1d756c-a8f5-418a-936c-dbb75b23c200" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b432af6f-6c00-433c-93c4-d99a07fd2d36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5d1d756c-a8f5-418a-936c-dbb75b23c200" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b432af6f-6c00-433c-93c4-d99a07fd2d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SubsequentEvents" xlink:type="simple" xlink:href="vtl-20250630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_87730dcb-9461-4c0f-b925-36c13da54f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_ce8e63e8-66a9-481b-a686-14837e4dd3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_87730dcb-9461-4c0f-b925-36c13da54f5e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_ce8e63e8-66a9-481b-a686-14837e4dd3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="vtl-20250630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b0ad57cd-5d03-48d3-ac05-5ba742ca4a80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b0ad57cd-5d03-48d3-ac05-5ba742ca4a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1aea8a9b-00d8-4f60-bd6c-0467fcac059c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_UseOfEstimates_1aea8a9b-00d8-4f60-bd6c-0467fcac059c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b44803d4-1ad9-4be3-8ff2-5bfbe35be4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b44803d4-1ad9-4be3-8ff2-5bfbe35be4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_39406f3c-ba13-4619-9aaa-f15fabd1e8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_39406f3c-ba13-4619-9aaa-f15fabd1e8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c5337a6f-2ed3-4c33-bbea-3d64dc292526" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c5337a6f-2ed3-4c33-bbea-3d64dc292526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_33e141d5-843f-4b80-963d-194c214c0a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_33e141d5-843f-4b80-963d-194c214c0a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_737c118f-7bdc-4fac-8a0f-8869f40de658" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_737c118f-7bdc-4fac-8a0f-8869f40de658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_46ee711b-f5ed-4746-a34d-28708e2e4191" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_46ee711b-f5ed-4746-a34d-28708e2e4191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_f527a8f7-84f0-48fb-8b0c-b3ecc410f648" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_f527a8f7-84f0-48fb-8b0c-b3ecc410f648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistancePolicyTextBlock_17b93d3f-2c91-4031-9818-51312cee5cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistancePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_GovernmentAssistancePolicyTextBlock_17b93d3f-2c91-4031-9818-51312cee5cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_cec7ee0f-fae1-4168-b85a-7a6163c085d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_cec7ee0f-fae1-4168-b85a-7a6163c085d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f3e8f7a9-4ad3-4568-8fcb-83cbd1c3575c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f3e8f7a9-4ad3-4568-8fcb-83cbd1c3575c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_39eeef60-8a14-40c2-8ba4-e23829aebdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_39eeef60-8a14-40c2-8ba4-e23829aebdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_560fa6d9-2572-4298-87ad-9ae9fb28f6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_560fa6d9-2572-4298-87ad-9ae9fb28f6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ea8c0d90-9f6c-4107-8da9-f01ed049138f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ea8c0d90-9f6c-4107-8da9-f01ed049138f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_5d7cc5d9-2316-4682-88ba-ab2c7a332df2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_5d7cc5d9-2316-4682-88ba-ab2c7a332df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9c8ac6dd-804e-4554-b4be-4a8bf9cc822a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9c8ac6dd-804e-4554-b4be-4a8bf9cc822a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b72d2992-05c8-4371-8b71-0f46e511897a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b5649bd-2ecc-4e0f-88b0-8945e21c141e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b72d2992-05c8-4371-8b71-0f46e511897a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="vtl-20250630.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_443272e4-8b1f-4489-a5c6-c0abf969e002" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_cb067c0d-1a42-4ac3-b19e-f0f37ce2c821" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_443272e4-8b1f-4489-a5c6-c0abf969e002" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_cb067c0d-1a42-4ac3-b19e-f0f37ce2c821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c42fc16d-18c5-46f7-8906-1c052daf2ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_93140908-b759-4cdf-a9ab-bd409bdf6ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c42fc16d-18c5-46f7-8906-1c052daf2ffe" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_93140908-b759-4cdf-a9ab-bd409bdf6ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_297b31d3-cccb-45d2-9459-0952d2fb52fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c42fc16d-18c5-46f7-8906-1c052daf2ffe" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_297b31d3-cccb-45d2-9459-0952d2fb52fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_40575f79-390b-4cfc-bcb8-ba7c00f3ecb6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c42fc16d-18c5-46f7-8906-1c052daf2ffe" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_40575f79-390b-4cfc-bcb8-ba7c00f3ecb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/LeasesTables" xlink:type="simple" xlink:href="vtl-20250630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_9f6d3593-f7b5-4f6b-a377-f6631b01ed20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f7d3d961-b372-4a52-8b8b-575cb665021a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_9f6d3593-f7b5-4f6b-a377-f6631b01ed20" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f7d3d961-b372-4a52-8b8b-575cb665021a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/FairValueTables" xlink:type="simple" xlink:href="vtl-20250630.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_452690e2-0220-4d30-b5dd-239951d1d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4e10a5e5-7242-42fa-b34b-1e21af090d21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_452690e2-0220-4d30-b5dd-239951d1d8da" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4e10a5e5-7242-42fa-b34b-1e21af090d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1529d9e1-6521-4bc7-af5b-8ca77ad4259e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_452690e2-0220-4d30-b5dd-239951d1d8da" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1529d9e1-6521-4bc7-af5b-8ca77ad4259e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockTables" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockTables"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8793fa76-ce89-4704-9819-defd0c876737" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_8b7ca177-4c29-4e0f-af28-dfdd92146aa2" xlink:href="vtl-20250630.xsd#vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8793fa76-ce89-4704-9819-defd0c876737" xlink:to="loc_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_8b7ca177-4c29-4e0f-af28-dfdd92146aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansTables" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansTables"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12853f2a-dca6-4d58-a33f-778a729fd1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca2cdab1-9749-413d-8909-286548de6284" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12853f2a-dca6-4d58-a33f-778a729fd1fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca2cdab1-9749-413d-8909-286548de6284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_955e6df3-67b2-457d-aeba-622845d23807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12853f2a-dca6-4d58-a33f-778a729fd1fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_955e6df3-67b2-457d-aeba-622845d23807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_dc4ffcda-cb2e-4841-9b9b-f28b2c3adb74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12853f2a-dca6-4d58-a33f-778a729fd1fd" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_dc4ffcda-cb2e-4841-9b9b-f28b2c3adb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SegmentDisclosuresTables" xlink:type="simple" xlink:href="vtl-20250630.xsd#SegmentDisclosuresTables"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SegmentDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c598a97c-cd49-4bea-b2f5-26513150518a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9255c65d-0ff8-4646-b73b-0d670ae9f60e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c598a97c-cd49-4bea-b2f5-26513150518a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9255c65d-0ff8-4646-b73b-0d670ae9f60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#DescriptionofBusinessandBasisofFinancialStatementsDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9ba7811a-fc6f-4e4a-9025-da47b63237ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4ac9f817-3b0e-47ea-81af-306d6f714eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ba7811a-fc6f-4e4a-9025-da47b63237ad" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4ac9f817-3b0e-47ea-81af-306d6f714eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8954e77f-bf55-441c-a6ad-d330f6e15728" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4ac9f817-3b0e-47ea-81af-306d6f714eaa" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8954e77f-bf55-441c-a6ad-d330f6e15728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0655b8b1-6484-4039-83a7-d61a0de1a05c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8954e77f-bf55-441c-a6ad-d330f6e15728" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0655b8b1-6484-4039-83a7-d61a0de1a05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_aabbcbb8-9bb0-4b50-bfb8-03f072947c31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0655b8b1-6484-4039-83a7-d61a0de1a05c" xlink:to="loc_us-gaap_SubsequentEventMember_aabbcbb8-9bb0-4b50-bfb8-03f072947c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4ac9f817-3b0e-47ea-81af-306d6f714eaa" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_ae6cd5ef-b46d-4b6c-804c-3fe4b84e7453" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_dei_EntityNumberOfEmployees_ae6cd5ef-b46d-4b6c-804c-3fe4b84e7453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfDevelopmentPrograms_81587b6f-0db0-4407-b324-c9b07e9a7b71" xlink:href="vtl-20250630.xsd#vtl_NumberOfDevelopmentPrograms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_vtl_NumberOfDevelopmentPrograms_81587b6f-0db0-4407-b324-c9b07e9a7b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_da6f1f3a-d9de-49bf-af9c-6bb0b401ce62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_da6f1f3a-d9de-49bf-af9c-6bb0b401ce62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_eaf258f7-5852-499e-aaee-4633976e2b61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_eaf258f7-5852-499e-aaee-4633976e2b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41f95409-3a86-497c-8434-d69f4fe90e50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_097438bb-071c-456e-801c-6821fd2b7e5f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41f95409-3a86-497c-8434-d69f4fe90e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e5d3c1f7-4600-40f8-bbb4-f3873fbc8ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e5d3c1f7-4600-40f8-bbb4-f3873fbc8ec1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6262d0a2-5c30-48c7-b5d0-80690329684c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_srt_StatementGeographicalAxis_6262d0a2-5c30-48c7-b5d0-80690329684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6262d0a2-5c30-48c7-b5d0-80690329684c" xlink:to="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9e48c3ae-1098-4101-9262-2e2bf7783457" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:to="loc_country_US_9e48c3ae-1098-4101-9262-2e2bf7783457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_dbba2861-f555-46ec-a9bf-ffd3ef62a2b5" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:to="loc_country_DE_dbba2861-f555-46ec-a9bf-ffd3ef62a2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_8eebe77d-ae28-4d33-936c-eb2eb3f59113" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0d4ddb91-025e-4c19-81f8-b987281a86d2" xlink:to="loc_country_AU_8eebe77d-ae28-4d33-936c-eb2eb3f59113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_34e00c91-970d-425e-807f-cfff71b6b164" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_34e00c91-970d-425e-807f-cfff71b6b164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e900eee-11f2-4b48-8c8e-7d71f7c34c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_34e00c91-970d-425e-807f-cfff71b6b164" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e900eee-11f2-4b48-8c8e-7d71f7c34c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_310e5f9f-2f25-4977-93d2-01d98a8d94cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e900eee-11f2-4b48-8c8e-7d71f7c34c0f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_310e5f9f-2f25-4977-93d2-01d98a8d94cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b22325f-bc13-4228-89e3-39e1e4c6d03f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_srt_RangeAxis_6b22325f-bc13-4228-89e3-39e1e4c6d03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6b22325f-bc13-4228-89e3-39e1e4c6d03f" xlink:to="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e37cf99d-9e0f-4473-ae9a-7bcacf81f908" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:to="loc_srt_MinimumMember_e37cf99d-9e0f-4473-ae9a-7bcacf81f908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_684500f8-be98-49b7-9da5-c5b1aa2eb189" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad27805b-d02a-42c4-9038-528509658dce" xlink:to="loc_srt_MaximumMember_684500f8-be98-49b7-9da5-c5b1aa2eb189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_785078e6-9457-4a23-ab16-e913df33952d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_785078e6-9457-4a23-ab16-e913df33952d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_785078e6-9457-4a23-ab16-e913df33952d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PreFundedWarrantsMember_c99bdc39-fb71-4e46-94db-0ad6ff9d08c4" xlink:href="vtl-20250630.xsd#vtl_January2024PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:to="loc_vtl_January2024PreFundedWarrantsMember_c99bdc39-fb71-4e46-94db-0ad6ff9d08c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PreFundedWarrantsMember_f286fe31-aac9-4b4c-b2f8-685a6182d5bd" xlink:href="vtl-20250630.xsd#vtl_May2025PreFundedWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2131d191-375e-4221-bf15-48bd8005e4f1" xlink:to="loc_vtl_May2025PreFundedWarrantsMember_f286fe31-aac9-4b4c-b2f8-685a6182d5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cc6a49d8-8616-481d-a55e-3ded2e81b0f3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf5b5484-9f4d-4ef7-9205-ac642f287aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf5b5484-9f4d-4ef7-9205-ac642f287aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits_fc943b4e-3e74-47ed-8d8d-9bc79715d54e" xlink:href="vtl-20250630.xsd#vtl_NumberOfFinancialInstitutionsUsedForCashDeposits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits_fc943b4e-3e74-47ed-8d8d-9bc79715d54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate_b6b869c4-cefd-44e1-9905-fd81285382d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_InvestmentInterestRate_b6b869c4-cefd-44e1-9905-fd81285382d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8bceea0f-0b25-4bec-b7e8-ca7a8a0ca599" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8bceea0f-0b25-4bec-b7e8-ca7a8a0ca599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a61b4f25-ab97-467d-b0dd-606c38e2fe43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_DepreciationAndAmortization_a61b4f25-ab97-467d-b0dd-606c38e2fe43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_c3992146-76e0-44ca-9f48-8006a159f0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_c3992146-76e0-44ca-9f48-8006a159f0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent_50e9b1b9-c9cb-42ae-8a2b-a95a9b5054f1" xlink:href="vtl-20250630.xsd#vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent_50e9b1b9-c9cb-42ae-8a2b-a95a9b5054f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount_a3936315-86af-4f9a-9467-d5bdbe5a90cb" xlink:href="vtl-20250630.xsd#vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount_a3936315-86af-4f9a-9467-d5bdbe5a90cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_0fdb8bb3-5699-4404-8701-a82d1e636c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_0fdb8bb3-5699-4404-8701-a82d1e636c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceExpense_5469a5df-bcb1-40f6-9bb1-fc86e0921669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceExpense_5469a5df-bcb1-40f6-9bb1-fc86e0921669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmount_7347fbc1-8b0e-490d-b5d6-764811ed570f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceAmount_7347fbc1-8b0e-490d-b5d6-764811ed570f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_c5f9682e-2976-45ec-8d94-85469f0387f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_c5f9682e-2976-45ec-8d94-85469f0387f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_490df6e6-7b2d-4ef7-a594-0c21dbf3ae3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_490df6e6-7b2d-4ef7-a594-0c21dbf3ae3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_LesseeOperatingLeasesNumberOfExistingLeases_743a3b35-4c1a-48b7-a0d9-9dbaddd4231e" xlink:href="vtl-20250630.xsd#vtl_LesseeOperatingLeasesNumberOfExistingLeases"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_vtl_LesseeOperatingLeasesNumberOfExistingLeases_743a3b35-4c1a-48b7-a0d9-9dbaddd4231e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_aaad5f9e-2a70-465d-9a68-5c8e1f84b9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2cd95344-37c6-40e4-822d-d6623f91f005" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_aaad5f9e-2a70-465d-9a68-5c8e1f84b9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8dfb48f2-c009-4305-bcf8-1d4464ed2d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_01387f20-4910-4139-a67f-b5ca50474d31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8dfb48f2-c009-4305-bcf8-1d4464ed2d8a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_01387f20-4910-4139-a67f-b5ca50474d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_01387f20-4910-4139-a67f-b5ca50474d31" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_33cfcc17-8ff9-4eba-8a00-86a8f2037d9b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_1b9e4dd8-d3ad-44e1-848f-ec0df7ce435b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:to="loc_us-gaap_StockOptionMember_1b9e4dd8-d3ad-44e1-848f-ec0df7ce435b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentWarrantsMember_fa85be82-9751-46c0-823e-4ae660e1f661" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11cf5eda-c70a-4c35-bd68-6ff06e8aad77" xlink:to="loc_vtl_PlacementAgentWarrantsMember_fa85be82-9751-46c0-823e-4ae660e1f661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0ef7211-0692-4a71-b1f7-09332ea70720" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_01387f20-4910-4139-a67f-b5ca50474d31" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0ef7211-0692-4a71-b1f7-09332ea70720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_34f8dd81-63c4-4641-b617-847b35607d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0ef7211-0692-4a71-b1f7-09332ea70720" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_34f8dd81-63c4-4641-b617-847b35607d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ce9614bd-f9d4-4149-b113-15ec597712bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PrepaidClinicalAndRelatedCostsCurrent_30f95a79-0230-49cb-a0cd-cebbee22550b" xlink:href="vtl-20250630.xsd#vtl_PrepaidClinicalAndRelatedCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ce9614bd-f9d4-4149-b113-15ec597712bf" xlink:to="loc_vtl_PrepaidClinicalAndRelatedCostsCurrent_30f95a79-0230-49cb-a0cd-cebbee22550b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_6d1914bc-d92e-4641-ac16-c3b86f60de78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ce9614bd-f9d4-4149-b113-15ec597712bf" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_6d1914bc-d92e-4641-ac16-c3b86f60de78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_96b42876-49c7-4939-b6e8-92901ceb3d04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ce9614bd-f9d4-4149-b113-15ec597712bf" xlink:to="loc_us-gaap_PrepaidInsurance_96b42876-49c7-4939-b6e8-92901ceb3d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_59387fe1-2d98-4e99-b9eb-786fd474fc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ce9614bd-f9d4-4149-b113-15ec597712bf" xlink:to="loc_us-gaap_OtherAssetsCurrent_59387fe1-2d98-4e99-b9eb-786fd474fc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4bb0c65e-32d9-4a67-b9be-2375aebf876e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ce9614bd-f9d4-4149-b113-15ec597712bf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4bb0c65e-32d9-4a67-b9be-2375aebf876e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofAccountsPayableDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c7a72f3-ee06-4257-9e7f-2148ecd85e09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClinicalCostsPayableCurrent_1dd4ef15-7956-4b85-ad8e-36b6abdda8b9" xlink:href="vtl-20250630.xsd#vtl_ClinicalCostsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c7a72f3-ee06-4257-9e7f-2148ecd85e09" xlink:to="loc_vtl_ClinicalCostsPayableCurrent_1dd4ef15-7956-4b85-ad8e-36b6abdda8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_LegalAndAuditCostsPayableCurrent_19c95ca5-cd63-4eb3-94ee-9f1c3f12fee6" xlink:href="vtl-20250630.xsd#vtl_LegalAndAuditCostsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c7a72f3-ee06-4257-9e7f-2148ecd85e09" xlink:to="loc_vtl_LegalAndAuditCostsPayableCurrent_19c95ca5-cd63-4eb3-94ee-9f1c3f12fee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_6c4be84f-ed12-4a81-8fc2-45fd08f21a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c7a72f3-ee06-4257-9e7f-2148ecd85e09" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_6c4be84f-ed12-4a81-8fc2-45fd08f21a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_65479255-fc94-4544-b20f-39af7b8244d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c7a72f3-ee06-4257-9e7f-2148ecd85e09" xlink:to="loc_us-gaap_AccountsPayableCurrent_65479255-fc94-4544-b20f-39af7b8244d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e22e8bed-4810-4835-b412-69404b87112d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedClinicalCostsCurrent_399b7b03-862b-44ea-b6b4-d4909efdbb13" xlink:href="vtl-20250630.xsd#vtl_AccruedClinicalCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e22e8bed-4810-4835-b412-69404b87112d" xlink:to="loc_vtl_AccruedClinicalCostsCurrent_399b7b03-862b-44ea-b6b4-d4909efdbb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedLegalAndAuditCostsCurrent_2ccce378-cbdd-4a95-a80e-a586a198f040" xlink:href="vtl-20250630.xsd#vtl_AccruedLegalAndAuditCostsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e22e8bed-4810-4835-b412-69404b87112d" xlink:to="loc_vtl_AccruedLegalAndAuditCostsCurrent_2ccce378-cbdd-4a95-a80e-a586a198f040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccruedCompensationCurrent_c283b87e-a311-47c7-bd62-8812dadd6772" xlink:href="vtl-20250630.xsd#vtl_AccruedCompensationCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e22e8bed-4810-4835-b412-69404b87112d" xlink:to="loc_vtl_AccruedCompensationCurrent_c283b87e-a311-47c7-bd62-8812dadd6772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_645478a3-7534-462f-a248-9ad32fa5a020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e22e8bed-4810-4835-b412-69404b87112d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_645478a3-7534-462f-a248-9ad32fa5a020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5faa5931-6bbb-4f63-9b7f-720fbdb49aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e22e8bed-4810-4835-b412-69404b87112d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5faa5931-6bbb-4f63-9b7f-720fbdb49aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75f7bc4d-d116-482e-b025-6f07a12c6aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a8504cfb-155f-4f4c-8454-41b900ae0b09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75f7bc4d-d116-482e-b025-6f07a12c6aa6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a8504cfb-155f-4f4c-8454-41b900ae0b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c749d2cd-2f50-4773-9602-4970aebe7cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75f7bc4d-d116-482e-b025-6f07a12c6aa6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c749d2cd-2f50-4773-9602-4970aebe7cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_3763ba35-ae1a-4ae7-9a89-35c6f1b35da1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75f7bc4d-d116-482e-b025-6f07a12c6aa6" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_3763ba35-ae1a-4ae7-9a89-35c6f1b35da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7d908639-f216-4ff1-8d98-aa0bd659f613" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75f7bc4d-d116-482e-b025-6f07a12c6aa6" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_7d908639-f216-4ff1-8d98-aa0bd659f613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_1f5e846d-57f5-4a3c-a5f0-cb3d21a5deba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_7b502b65-5f62-4381-904b-55a67eda3b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_1f5e846d-57f5-4a3c-a5f0-cb3d21a5deba" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_7b502b65-5f62-4381-904b-55a67eda3b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4344c8ff-225c-4797-80ea-b3136935ef09" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b502b65-5f62-4381-904b-55a67eda3b1a" xlink:to="loc_srt_StatementGeographicalAxis_4344c8ff-225c-4797-80ea-b3136935ef09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4344c8ff-225c-4797-80ea-b3136935ef09" xlink:to="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NewYorkCityMember_cad7a044-7015-47ad-b021-464a29061be7" xlink:href="vtl-20250630.xsd#vtl_NewYorkCityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:to="loc_vtl_NewYorkCityMember_cad7a044-7015-47ad-b021-464a29061be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_GrafelfingGermanyMember_5bd4455d-806a-4891-a13c-2275cb347f90" xlink:href="vtl-20250630.xsd#vtl_GrafelfingGermanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:to="loc_vtl_GrafelfingGermanyMember_5bd4455d-806a-4891-a13c-2275cb347f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlaneggGermanyMember_ee836060-e46e-4908-985b-25e2f4cd8a37" xlink:href="vtl-20250630.xsd#vtl_PlaneggGermanyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_346cbdd3-a296-4833-ab5a-e41cb8a1d1d6" xlink:to="loc_vtl_PlaneggGermanyMember_ee836060-e46e-4908-985b-25e2f4cd8a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b502b65-5f62-4381-904b-55a67eda3b1a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_cad683d8-bbbb-461c-93d6-e9142ad2f817" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_cad683d8-bbbb-461c-93d6-e9142ad2f817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b9e9b43c-bb8c-4244-8264-0c77f83022c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b9e9b43c-bb8c-4244-8264-0c77f83022c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_360254be-e5f2-4b55-b82a-f342570cf6cb" xlink:href="vtl-20250630.xsd#vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_360254be-e5f2-4b55-b82a-f342570cf6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OperatingLeaseIncrementalBorrowingRate_2f3ff100-e322-436f-ace5-a9f73aa8fb49" xlink:href="vtl-20250630.xsd#vtl_OperatingLeaseIncrementalBorrowingRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_vtl_OperatingLeaseIncrementalBorrowingRate_2f3ff100-e322-436f-ace5-a9f73aa8fb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OperatingAndVariableLeasesCost_2a5e2a1c-1f31-44cc-acaa-28ad0be24eca" xlink:href="vtl-20250630.xsd#vtl_OperatingAndVariableLeasesCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8ea96353-d975-4648-a563-54a4df270ddb" xlink:to="loc_vtl_OperatingAndVariableLeasesCost_2a5e2a1c-1f31-44cc-acaa-28ad0be24eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1a9c9907-6438-4048-9bb3-ee119ba2f709" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1a9c9907-6438-4048-9bb3-ee119ba2f709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b6c30dd9-95ed-4d03-9ecf-2e466286ba50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b6c30dd9-95ed-4d03-9ecf-2e466286ba50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6c76d86e-06fe-4716-91b0-32d64108e952" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6c76d86e-06fe-4716-91b0-32d64108e952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a1a92f37-2774-4399-822a-6805ba59ef43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a1a92f37-2774-4399-822a-6805ba59ef43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9361e0fd-d0a8-4ce2-bcb6-b603bade20db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9361e0fd-d0a8-4ce2-bcb6-b603bade20db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fe95e3ec-5e7d-4faa-81f6-4f7746a3e8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fe95e3ec-5e7d-4faa-81f6-4f7746a3e8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_073f5681-90c3-4dd2-91d8-67ab8703a3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_14e193b5-06fa-4007-bb75-d8efad9e12bf" xlink:to="loc_us-gaap_OperatingLeaseLiability_073f5681-90c3-4dd2-91d8-67ab8703a3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a1d671db-af55-4cbf-acd2-cde8169a39e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a1d671db-af55-4cbf-acd2-cde8169a39e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de0afbd1-8b26-4d39-a95f-4a6380686b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de0afbd1-8b26-4d39-a95f-4a6380686b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_075267eb-b551-4dc2-b382-efacf4b56b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de0afbd1-8b26-4d39-a95f-4a6380686b0b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_075267eb-b551-4dc2-b382-efacf4b56b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5860ae0c-0f6d-41ca-9464-2286766438ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_075267eb-b551-4dc2-b382-efacf4b56b3e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5860ae0c-0f6d-41ca-9464-2286766438ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f7292c7b-3021-480c-b5e0-a291b4955e92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:to="loc_us-gaap_InvestmentTypeAxis_f7292c7b-3021-480c-b5e0-a291b4955e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_60453fa4-aee6-4cdb-8c7c-accf5637859f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_f7292c7b-3021-480c-b5e0-a291b4955e92" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_60453fa4-aee6-4cdb-8c7c-accf5637859f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f39f3f10-7351-4211-baf7-1a56839c394d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_60453fa4-aee6-4cdb-8c7c-accf5637859f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f39f3f10-7351-4211-baf7-1a56839c394d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8a48782-73d8-49c5-a17c-1096e709b600" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8a48782-73d8-49c5-a17c-1096e709b600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b8a48782-73d8-49c5-a17c-1096e709b600" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_32760b33-7f17-4276-9b1e-780471c98d14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_32760b33-7f17-4276-9b1e-780471c98d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9cd48a3e-e84a-4556-b5c9-c93ea5fbe111" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9cd48a3e-e84a-4556-b5c9-c93ea5fbe111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fd39e0bf-a0fa-43cc-8566-defef2350ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac3f574f-7159-46b9-8f42-5da9eab8ffc7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fd39e0bf-a0fa-43cc-8566-defef2350ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19796317-3b57-42c7-994f-dffd4f32cdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_177c609a-6140-40da-ab5c-f4dc80f61d89" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19796317-3b57-42c7-994f-dffd4f32cdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_eb4f6161-21a0-4e81-bf6e-9db74bf4489a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19796317-3b57-42c7-994f-dffd4f32cdb4" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_eb4f6161-21a0-4e81-bf6e-9db74bf4489a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d44d80f7-d85a-496b-9357-2bddc33809c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eb4f6161-21a0-4e81-bf6e-9db74bf4489a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d44d80f7-d85a-496b-9357-2bddc33809c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/FairValueAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#FairValueAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/FairValueAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e0b9ac18-7ef8-4f25-a250-31734ed21737" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e0b9ac18-7ef8-4f25-a250-31734ed21737" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64ad839c-3589-4e95-b93a-27b1b02d607c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:to="loc_srt_StatementGeographicalAxis_64ad839c-3589-4e95-b93a-27b1b02d607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cbabfaad-1987-46d9-9e66-28f8ec1abeb0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_64ad839c-3589-4e95-b93a-27b1b02d607c" xlink:to="loc_srt_SegmentGeographicalDomain_cbabfaad-1987-46d9-9e66-28f8ec1abeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a194e4ff-3f38-4721-a23d-1bbf777911ef" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cbabfaad-1987-46d9-9e66-28f8ec1abeb0" xlink:to="loc_country_US_a194e4ff-3f38-4721-a23d-1bbf777911ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_936891bd-22c2-478d-b265-fd69d9d020c9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:to="loc_srt_RangeAxis_936891bd-22c2-478d-b265-fd69d9d020c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_936891bd-22c2-478d-b265-fd69d9d020c9" xlink:to="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_75f84e57-0697-4dea-bee4-0e30c2c7b57b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:to="loc_srt_MinimumMember_75f84e57-0697-4dea-bee4-0e30c2c7b57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ab72edf7-b014-4efe-8083-7a67d34bb88c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_42b3376d-13a4-4bab-bcab-6abfa5a331c3" xlink:to="loc_srt_MaximumMember_ab72edf7-b014-4efe-8083-7a67d34bb88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2a08dbfc-35bd-4018-b97f-f7a84d7880e5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate_b4efff56-6988-4dbf-8d61-23d39289bba4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_InvestmentInterestRate_b4efff56-6988-4dbf-8d61-23d39289bba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightFairValueDisclosure_a12430a8-b5b4-4bc7-acda-e3eb8cd1489c" xlink:href="vtl-20250630.xsd#vtl_TrancheRightFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_vtl_TrancheRightFairValueDisclosure_a12430a8-b5b4-4bc7-acda-e3eb8cd1489c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2b83ab40-b500-41e2-b1c0-0d0add1a6ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2b83ab40-b500-41e2-b1c0-0d0add1a6ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388d8a0e-e4b2-40d5-bb89-cfc075290efa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388d8a0e-e4b2-40d5-bb89-cfc075290efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6c739227-9e41-47f5-bd9a-69383d43913f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6c739227-9e41-47f5-bd9a-69383d43913f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bdfa0a89-986b-4abd-a833-e76440fb684c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bdfa0a89-986b-4abd-a833-e76440fb684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_527f9768-0dc0-4931-b5f9-3dcbb22c36ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_527f9768-0dc0-4931-b5f9-3dcbb22c36ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_203e56e7-df4b-49ef-b710-e0c33b424fcb" xlink:href="vtl-20250630.xsd#vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c4920629-335d-42ee-b223-6798baaf81d3" xlink:to="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_203e56e7-df4b-49ef-b710-e0c33b424fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#FairValueScheduleofFairValueofTrancheRightsDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f6cde538-4681-4cfe-91c1-7c99f3970a38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6cde538-4681-4cfe-91c1-7c99f3970a38" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c99ff331-274b-47d2-bef8-02d3887b94e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c99ff331-274b-47d2-bef8-02d3887b94e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_17a4bfa2-f7eb-497d-b32f-aa67c94b41b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_17a4bfa2-f7eb-497d-b32f-aa67c94b41b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_b43e97a4-8515-477c-bb44-fb235027b56d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_b43e97a4-8515-477c-bb44-fb235027b56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity_e5bddee2-141b-4a1c-a9b1-373cc38d903a" xlink:href="vtl-20250630.xsd#vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:to="loc_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity_e5bddee2-141b-4a1c-a9b1-373cc38d903a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_22a7bea6-d14a-479b-bebf-aa9f55f6d50a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_22a7bea6-d14a-479b-bebf-aa9f55f6d50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_24487606-07e2-42b3-ac8c-d42587dbf95e" xlink:href="vtl-20250630.xsd#vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_85f99243-dfd1-4bba-9f59-b619b9605d87" xlink:to="loc_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag_24487606-07e2-42b3-ac8c-d42587dbf95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockShelfRegistrationStatementDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_16f938e7-728e-40f3-9244-8f488ed64637" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d4465640-f672-446c-b39c-8e57bf41c3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_16f938e7-728e-40f3-9244-8f488ed64637" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d4465640-f672-446c-b39c-8e57bf41c3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d4465640-f672-446c-b39c-8e57bf41c3f9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_cf2d53cc-3a19-4467-a5d1-7f8881aa63f2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_December2020ATMMember_c42eb115-b4db-4236-b585-c3ff9fbb923e" xlink:href="vtl-20250630.xsd#vtl_December2020ATMMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_December2020ATMMember_c42eb115-b4db-4236-b585-c3ff9fbb923e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2022ATMMember_5042b461-9a0e-4878-a979-9ad8c4fd77f3" xlink:href="vtl-20250630.xsd#vtl_May2022ATMMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_May2022ATMMember_5042b461-9a0e-4878-a979-9ad8c4fd77f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_April2025AndMay2025FinancingMember_71f427f2-e98a-4f50-97f0-00a1f64ed39f" xlink:href="vtl-20250630.xsd#vtl_April2025AndMay2025FinancingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_April2025AndMay2025FinancingMember_71f427f2-e98a-4f50-97f0-00a1f64ed39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2024ATMMember_fd1f173a-9a9a-4fbc-a4bb-b5a633850e18" xlink:href="vtl-20250630.xsd#vtl_May2024ATMMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b48ad7e4-b688-4750-bffe-d703a2280b7b" xlink:to="loc_vtl_May2024ATMMember_fd1f173a-9a9a-4fbc-a4bb-b5a633850e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d4465640-f672-446c-b39c-8e57bf41c3f9" xlink:to="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration_63ed44d9-6d2d-456f-98a5-64b1241a711c" xlink:href="vtl-20250630.xsd#vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration_63ed44d9-6d2d-456f-98a5-64b1241a711c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration_bc0f834b-803f-4965-9d00-fdabe8f8f11d" xlink:href="vtl-20250630.xsd#vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration_bc0f834b-803f-4965-9d00-fdabe8f8f11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays_67cf2fce-4142-456c-9286-6f2477d9cc37" xlink:href="vtl-20250630.xsd#vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays_67cf2fce-4142-456c-9286-6f2477d9cc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockRemainingCapacity_767828de-24f0-4b9a-bd6c-9935a03cd940" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockRemainingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_SaleOfStockRemainingCapacity_767828de-24f0-4b9a-bd6c-9935a03cd940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SalesOfStockCommissionsPercentOfGrossProceeds_9b3f76db-8566-4917-8ef9-2283c137461b" xlink:href="vtl-20250630.xsd#vtl_SalesOfStockCommissionsPercentOfGrossProceeds"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_vtl_SalesOfStockCommissionsPercentOfGrossProceeds_9b3f76db-8566-4917-8ef9-2283c137461b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_525239d6-c2ac-4f73-953b-992701d14749" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_525239d6-c2ac-4f73-953b-992701d14749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27306873-eb53-458b-a8f0-bd36a56b0dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27306873-eb53-458b-a8f0-bd36a56b0dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a9831482-65ac-4ef4-8606-f8ac0328b4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a9831482-65ac-4ef4-8606-f8ac0328b4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_da719d09-f4f0-4c5e-9a03-33a54d265ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_da719d09-f4f0-4c5e-9a03-33a54d265ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions_27461a08-5310-4a33-beda-b048b4aca7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForCommissions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5cffd179-1665-4869-9bc5-29db869733b3" xlink:to="loc_us-gaap_PaymentsForCommissions_27461a08-5310-4a33-beda-b048b4aca7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockApril2025OfferingDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_61afb331-2d3c-4264-a307-230db7fc3e91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_99cb8e09-0876-4fa2-87c5-3ae20c4b8675" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_61afb331-2d3c-4264-a307-230db7fc3e91" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_99cb8e09-0876-4fa2-87c5-3ae20c4b8675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_012bd8cb-401d-4699-be0a-4b7258bd153f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_99cb8e09-0876-4fa2-87c5-3ae20c4b8675" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_012bd8cb-401d-4699-be0a-4b7258bd153f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_012bd8cb-401d-4699-be0a-4b7258bd153f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SecuritiesPurchaseAgreementMember_ddf3d99d-9fcd-43c6-865a-41f628d3b308" xlink:href="vtl-20250630.xsd#vtl_SecuritiesPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:to="loc_vtl_SecuritiesPurchaseAgreementMember_ddf3d99d-9fcd-43c6-865a-41f628d3b308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgencyAgreementMember_0cffefa3-45d0-444b-a388-7dd723000bc1" xlink:href="vtl-20250630.xsd#vtl_PlacementAgencyAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:to="loc_vtl_PlacementAgencyAgreementMember_0cffefa3-45d0-444b-a388-7dd723000bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OfferingMember_bdf8bf2f-af3c-43a5-ba60-64ba21f5ca19" xlink:href="vtl-20250630.xsd#vtl_OfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_740755f8-ed4b-4e54-8bbf-e18dd112eef9" xlink:to="loc_vtl_OfferingMember_bdf8bf2f-af3c-43a5-ba60-64ba21f5ca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_99cb8e09-0876-4fa2-87c5-3ae20c4b8675" xlink:to="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a3351915-03de-4157-bda2-484222fb5468" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a3351915-03de-4157-bda2-484222fb5468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c1adfd13-9a43-418e-92db-2838244c3641" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c1adfd13-9a43-418e-92db-2838244c3641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_ca178945-b040-44a3-a87c-9980ac72c9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_ca178945-b040-44a3-a87c-9980ac72c9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1eeae173-71b1-4c73-b00c-0d8e4ca967b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1eeae173-71b1-4c73-b00c-0d8e4ca967b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_fe176168-e577-4d49-bbf2-5cbdd3d710bd" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentAgreementBrokerageFeePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_fe176168-e577-4d49-bbf2-5cbdd3d710bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_bc1df7bf-9778-48cc-a86e-dabe4918a584" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_bc1df7bf-9778-48cc-a86e-dabe4918a584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_c4d3427d-baa9-4dba-8d65-ed1b0d5c7095" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_c4d3427d-baa9-4dba-8d65-ed1b0d5c7095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_bf647bcd-b5a2-476d-bef3-1bb16177a642" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SharePrice_bf647bcd-b5a2-476d-bef3-1bb16177a642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a402e209-31f6-4099-abf0-e5973c1746d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a402e209-31f6-4099-abf0-e5973c1746d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses_df1ff91f-f4b7-457a-bc63-8c8039e525e4" xlink:href="vtl-20250630.xsd#vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8607d54a-c586-4823-838d-17aafbaf49fc" xlink:to="loc_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses_df1ff91f-f4b7-457a-bc63-8c8039e525e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockMay2025EquityOfferingDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_36f73c80-be52-4a55-9130-c5773b520e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_36f73c80-be52-4a55-9130-c5773b520e1e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_63ba5e44-9b7b-4f9f-bffd-8dc945392428" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_63ba5e44-9b7b-4f9f-bffd-8dc945392428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_63ba5e44-9b7b-4f9f-bffd-8dc945392428" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_7f0591fa-b8b1-4923-984d-3dd9962c51ae" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:to="loc_vtl_PreFundedWarrantsMember_7f0591fa-b8b1-4923-984d-3dd9962c51ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgencyAgreementMember_73e00deb-12ad-4b52-9c1a-2bc3daff9dc0" xlink:href="vtl-20250630.xsd#vtl_PlacementAgencyAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de281cb3-e56b-4277-9981-61790bf858d9" xlink:to="loc_vtl_PlacementAgencyAgreementMember_73e00deb-12ad-4b52-9c1a-2bc3daff9dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0777c47a-b63a-449b-8e20-eff36e066dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0777c47a-b63a-449b-8e20-eff36e066dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0777c47a-b63a-449b-8e20-eff36e066dfc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantsMember_7938bc73-6bd9-483e-a6d7-2cebbd3ac0d0" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_SeriesAWarrantsMember_7938bc73-6bd9-483e-a6d7-2cebbd3ac0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesBWarrantsMember_ab38b462-d945-491b-af7d-b6488d48faf0" xlink:href="vtl-20250630.xsd#vtl_SeriesBWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_SeriesBWarrantsMember_ab38b462-d945-491b-af7d-b6488d48faf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantAndSeriesBWarrantMember_54ada079-28ee-4e53-904e-88c9c3e8598a" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantAndSeriesBWarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_SeriesAWarrantAndSeriesBWarrantMember_54ada079-28ee-4e53-904e-88c9c3e8598a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_VolumeWeightageAveragePriceTargetMember_cf77657c-c189-4418-9306-dc08bbced7b4" xlink:href="vtl-20250630.xsd#vtl_VolumeWeightageAveragePriceTargetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e7ba4a4d-8477-4fd7-a214-c683d1791125" xlink:to="loc_vtl_VolumeWeightageAveragePriceTargetMember_cf77657c-c189-4418-9306-dc08bbced7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_30f688f0-db7d-419f-8387-0f578309fd65" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:to="loc_srt_RangeAxis_30f688f0-db7d-419f-8387-0f578309fd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e842565b-4dbe-488e-a485-7e780520bacb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_30f688f0-db7d-419f-8387-0f578309fd65" xlink:to="loc_srt_RangeMember_e842565b-4dbe-488e-a485-7e780520bacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_678ff0f8-3971-4405-a1ad-047d01100c5c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e842565b-4dbe-488e-a485-7e780520bacb" xlink:to="loc_srt_MaximumMember_678ff0f8-3971-4405-a1ad-047d01100c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a7e05d6b-e488-4936-a978-52d945287f6b" xlink:to="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3b586b8d-37f2-4d9f-966c-d804d1a028e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3b586b8d-37f2-4d9f-966c-d804d1a028e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_65cfa1b7-89bf-43b6-aafa-2b1b89fb581b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_65cfa1b7-89bf-43b6-aafa-2b1b89fb581b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ae4ae92c-062a-4bad-bcdd-7f86343035a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ae4ae92c-062a-4bad-bcdd-7f86343035a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod_4d8e442c-4a9e-4765-a12a-df510dcd4f1f" xlink:href="vtl-20250630.xsd#vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod_4d8e442c-4a9e-4765-a12a-df510dcd4f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance_9c64648f-6d61-4782-af0e-f0b14d3d8cb7" xlink:href="vtl-20250630.xsd#vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance_9c64648f-6d61-4782-af0e-f0b14d3d8cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OwnershipLimitationPercentage_01936c44-baac-4f61-9450-6dd605126172" xlink:href="vtl-20250630.xsd#vtl_OwnershipLimitationPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_OwnershipLimitationPercentage_01936c44-baac-4f61-9450-6dd605126172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder_ca55a04a-aca9-456d-8bbb-463ffa12486c" xlink:href="vtl-20250630.xsd#vtl_OwnershipLimitationPercentageUponElectionOfTheHolder"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder_ca55a04a-aca9-456d-8bbb-463ffa12486c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae32b2e9-cad3-4b71-be11-570b02a435d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae32b2e9-cad3-4b71-be11-570b02a435d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_cf1851e7-2f05-4aaf-9b18-7f8d67de0052" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_cf1851e7-2f05-4aaf-9b18-7f8d67de0052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_f4bc504c-7941-4e0b-a0bf-778387866844" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentAgreementBrokerageFeePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f49433b0-1e85-4c96-b776-e2fce0a229ad" xlink:to="loc_vtl_PlacementAgentAgreementBrokerageFeePercent_f4bc504c-7941-4e0b-a0bf-778387866844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockJanuary2024FinancingDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c7218bd2-0ddc-4f10-8838-5e61e0724c48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7218bd2-0ddc-4f10-8838-5e61e0724c48" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_8ae6f5ba-7142-4cad-9a71-10c70f7d9212" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_srt_TitleOfIndividualAxis_8ae6f5ba-7142-4cad-9a71-10c70f7d9212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eab22d97-8cc1-411c-a395-88c9fe3438a4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_8ae6f5ba-7142-4cad-9a71-10c70f7d9212" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eab22d97-8cc1-411c-a395-88c9fe3438a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_AccreditedInvestorsMember_708e465c-baa3-4670-8f7c-75fb6ceedc43" xlink:href="vtl-20250630.xsd#vtl_AccreditedInvestorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_eab22d97-8cc1-411c-a395-88c9fe3438a4" xlink:to="loc_vtl_AccreditedInvestorsMember_708e465c-baa3-4670-8f7c-75fb6ceedc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2f1da554-4e5a-4b3f-ac17-11d788fe595b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2f1da554-4e5a-4b3f-ac17-11d788fe595b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2f1da554-4e5a-4b3f-ac17-11d788fe595b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_79a2e16a-d90d-4e20-9b6e-fc9e0f73407b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:to="loc_us-gaap_PrivatePlacementMember_79a2e16a-d90d-4e20-9b6e-fc9e0f73407b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7e7a49ee-466b-4663-afea-b9f4a8220cca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:to="loc_us-gaap_CommonStockMember_7e7a49ee-466b-4663-afea-b9f4a8220cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockAndPreFundedWarrantsMember_e63b1d1c-e756-4f2f-8114-62734594ded3" xlink:href="vtl-20250630.xsd#vtl_CommonStockAndPreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc4e44c0-cacf-4c97-bed6-6659b235210d" xlink:to="loc_vtl_CommonStockAndPreFundedWarrantsMember_e63b1d1c-e756-4f2f-8114-62734594ded3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fadfb4db-149d-418f-bf28-b87db802bbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fadfb4db-149d-418f-bf28-b87db802bbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fadfb4db-149d-418f-bf28-b87db802bbe1" xlink:to="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_677fcbad-6186-47f7-add6-7643ae55ae34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:to="loc_us-gaap_CommonStockMember_677fcbad-6186-47f7-add6-7643ae55ae34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_0bb0e241-0033-4601-8ddb-a3997364e7c7" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:to="loc_vtl_PreFundedWarrantsMember_0bb0e241-0033-4601-8ddb-a3997364e7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockAndPreFundedWarrantsMember_37c80d53-ea92-42a6-857e-1ce0693c394d" xlink:href="vtl-20250630.xsd#vtl_CommonStockAndPreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a0f317c4-3e02-49eb-a283-d97aad4ca145" xlink:to="loc_vtl_CommonStockAndPreFundedWarrantsMember_37c80d53-ea92-42a6-857e-1ce0693c394d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_2e9b3667-0ef4-40f0-a08d-5e32fed342c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_VestingAxis_2e9b3667-0ef4-40f0-a08d-5e32fed342c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_2e9b3667-0ef4-40f0-a08d-5e32fed342c6" xlink:to="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_356bd748-82f1-4707-804a-f7bdf2306ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_356bd748-82f1-4707-804a-f7bdf2306ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_86960ecf-8c51-4f78-be25-70e6b674d322" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_86960ecf-8c51-4f78-be25-70e6b674d322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_f69d29bf-cb57-4762-9c6f-eb9970250071" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a11b9761-0716-4ffe-a5aa-c399b71a233c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_f69d29bf-cb57-4762-9c6f-eb9970250071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_d4d58171-8ebd-4907-b8e8-6d624d07de8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_d4d58171-8ebd-4907-b8e8-6d624d07de8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis_d4d58171-8ebd-4907-b8e8-6d624d07de8c" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMember_c587a202-23f2-4906-91cf-e8aaa9d7bb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:to="loc_us-gaap_EquityMember_c587a202-23f2-4906-91cf-e8aaa9d7bb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5aa1db22-ca63-49a7-a518-20655aa8f8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain_35935193-a34c-4e01-8925-6342de4a70ec" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5aa1db22-ca63-49a7-a518-20655aa8f8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_650bc146-69b5-4131-8ab1-30d0c4a48372" xlink:to="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_45b7dd07-742f-4d4e-83de-b240a1320bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_45b7dd07-742f-4d4e-83de-b240a1320bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockPrivatePlacementNumberOfTranche_c433fbeb-13ea-4218-a94d-e930f6688c1a" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockPrivatePlacementNumberOfTranche"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockPrivatePlacementNumberOfTranche_c433fbeb-13ea-4218-a94d-e930f6688c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_7da928f5-124f-4737-a21b-32ac038373b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_7da928f5-124f-4737-a21b-32ac038373b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ff959d7b-4d65-46de-9258-4170f8fa60f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ff959d7b-4d65-46de-9258-4170f8fa60f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockConsiderationReceivedPercentage_275f18bd-7c5c-4a77-92bf-b70488267e7e" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockConsiderationReceivedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockConsiderationReceivedPercentage_275f18bd-7c5c-4a77-92bf-b70488267e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockNumberOfTrancheConditions_9ca9779c-2305-40e8-b5d1-143c32fe5a26" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockNumberOfTrancheConditions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockNumberOfTrancheConditions_9ca9779c-2305-40e8-b5d1-143c32fe5a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation_626cb05d-cb5c-47b3-bcc2-32883205ba4f" xlink:href="vtl-20250630.xsd#vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation_626cb05d-cb5c-47b3-bcc2-32883205ba4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_WeightedAveragePriceOfLast10Days_880d77f8-4f93-4640-901a-8890e67f4a04" xlink:href="vtl-20250630.xsd#vtl_WeightedAveragePriceOfLast10Days"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_WeightedAveragePriceOfLast10Days_880d77f8-4f93-4640-901a-8890e67f4a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation_50a50cef-d48d-4642-8626-43849e244d43" xlink:href="vtl-20250630.xsd#vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation_50a50cef-d48d-4642-8626-43849e244d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days_7509dac1-9715-41f0-9fbf-b6d16c54000f" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockAggregateTradingVolumeOfLast10Days"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days_7509dac1-9715-41f0-9fbf-b6d16c54000f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SaleOfStockEquityOfferingsPeriod_689f4d79-b266-4fb2-97ad-98bc3a3dfe1f" xlink:href="vtl-20250630.xsd#vtl_SaleOfStockEquityOfferingsPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_SaleOfStockEquityOfferingsPeriod_689f4d79-b266-4fb2-97ad-98bc3a3dfe1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_2b7d1c70-4e21-4a40-8472-75b0a631de24" xlink:href="vtl-20250630.xsd#vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement_2b7d1c70-4e21-4a40-8472-75b0a631de24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightsLiabilityRemainderAmount_a7f9901b-634f-4402-8cf0-208f0563e007" xlink:href="vtl-20250630.xsd#vtl_TrancheRightsLiabilityRemainderAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_TrancheRightsLiabilityRemainderAmount_a7f9901b-634f-4402-8cf0-208f0563e007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TrancheRightsLiabilityReceivedAmount_fde84fba-1f0f-4bb8-b6eb-e3f9c60055bd" xlink:href="vtl-20250630.xsd#vtl_TrancheRightsLiabilityReceivedAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_TrancheRightsLiabilityReceivedAmount_fde84fba-1f0f-4bb8-b6eb-e3f9c60055bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8c2d0590-2318-4135-81d4-8686a843b275" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8c2d0590-2318-4135-81d4-8686a843b275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_9b93cda2-9b87-45f9-a6de-02f18df71443" xlink:href="vtl-20250630.xsd#vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_9b93cda2-9b87-45f9-a6de-02f18df71443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_CommonStockNumberOfSharesRegisteredForResale_d988b5a3-b747-49bd-bde8-e1dbe9841e07" xlink:href="vtl-20250630.xsd#vtl_CommonStockNumberOfSharesRegisteredForResale"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4af1ed61-a3b9-4508-9251-27cc0e7697a9" xlink:to="loc_vtl_CommonStockNumberOfSharesRegisteredForResale_d988b5a3-b747-49bd-bde8-e1dbe9841e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockCommonStockDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockCommonStockDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ab4c169a-9a52-47eb-bf70-0d783c641191" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e3198a0d-6554-4580-91e5-35dac82dfea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ab4c169a-9a52-47eb-bf70-0d783c641191" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e3198a0d-6554-4580-91e5-35dac82dfea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e3198a0d-6554-4580-91e5-35dac82dfea8" xlink:to="loc_srt_RangeAxis_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2b1a36d7-b937-4d8d-9f97-90afdc5c1d8f" xlink:to="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f57e079e-ba88-4880-9e19-6b033cb35a1c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:to="loc_srt_MinimumMember_f57e079e-ba88-4880-9e19-6b033cb35a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2f6e345-bfdd-4ec9-9a33-e1392afb59e4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_794b7fa1-21ff-4f1e-85ec-65d187304314" xlink:to="loc_srt_MaximumMember_a2f6e345-bfdd-4ec9-9a33-e1392afb59e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e3198a0d-6554-4580-91e5-35dac82dfea8" xlink:to="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7e7d0de2-8ab8-4cef-a3f9-31b53cb7038c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7e7d0de2-8ab8-4cef-a3f9-31b53cb7038c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_49e7fcf8-bed9-4efa-b1d6-2988cece5a84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_49e7fcf8-bed9-4efa-b1d6-2988cece5a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NumberOfVotesPerEachShareOfCommonStock_8a0fd6af-f750-4134-ab5a-10eaab88e9ff" xlink:href="vtl-20250630.xsd#vtl_NumberOfVotesPerEachShareOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_vtl_NumberOfVotesPerEachShareOfCommonStock_8a0fd6af-f750-4134-ab5a-10eaab88e9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_7820f4a2-2c4c-4091-8a24-0112e3bea1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_7820f4a2-2c4c-4091-8a24-0112e3bea1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2fcb910-c397-42ce-bd19-143dc48bac18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f120ac7c-f67c-4265-93b1-47e5de68e6b1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2fcb910-c397-42ce-bd19-143dc48bac18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockPrefundedWarrantsDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7e6afc91-d1ab-4478-aa04-59055202d426" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_63e1b1f3-1a99-487f-803a-8f47283c75fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e6afc91-d1ab-4478-aa04-59055202d426" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_63e1b1f3-1a99-487f-803a-8f47283c75fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e17aff69-e59a-4e52-9243-1f98b2d0e8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_63e1b1f3-1a99-487f-803a-8f47283c75fe" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e17aff69-e59a-4e52-9243-1f98b2d0e8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_851c2d9f-d53c-4395-81b6-42e2a3790f44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e17aff69-e59a-4e52-9243-1f98b2d0e8aa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_851c2d9f-d53c-4395-81b6-42e2a3790f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_e1f2c4b6-ede6-4148-ba33-55270d923f5d" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_851c2d9f-d53c-4395-81b6-42e2a3790f44" xlink:to="loc_vtl_PreFundedWarrantsMember_e1f2c4b6-ede6-4148-ba33-55270d923f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_63e1b1f3-1a99-487f-803a-8f47283c75fe" xlink:to="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6f8c4bca-8937-4f9b-a1e6-3bcc45b3bfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6f8c4bca-8937-4f9b-a1e6-3bcc45b3bfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_6f4b273d-9505-45e7-8d2c-0ab0336593f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_6f4b273d-9505-45e7-8d2c-0ab0336593f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_81e4c138-2730-48a4-abcf-f9b6453113a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6abea9c6-956d-4729-8182-0432ea7f9918" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_81e4c138-2730-48a4-abcf-f9b6453113a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockPreferredStockDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockPreferredStockDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_28fd7c73-a813-4f34-9cfb-e2c1676f0ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_56b3e5d5-6a6f-4677-91ca-3ccdc8b337b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28fd7c73-a813-4f34-9cfb-e2c1676f0ad6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_56b3e5d5-6a6f-4677-91ca-3ccdc8b337b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_eb27e611-bd4e-4c3c-aec6-9c87cde6dafc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28fd7c73-a813-4f34-9cfb-e2c1676f0ad6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_eb27e611-bd4e-4c3c-aec6-9c87cde6dafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_5994fda6-aa25-407a-b908-47731236858f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28fd7c73-a813-4f34-9cfb-e2c1676f0ad6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_5994fda6-aa25-407a-b908-47731236858f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0511ce69-38fa-4651-9dd8-bfd8832c2c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28fd7c73-a813-4f34-9cfb-e2c1676f0ad6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0511ce69-38fa-4651-9dd8-bfd8832c2c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommonStockScheduleofSharesReservedforFutureIssuanceDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2dfb434c-66a4-4eb5-b7b9-de6d4ab3355a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2dfb434c-66a4-4eb5-b7b9-de6d4ab3355a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cd936f70-a410-49ce-ab6d-c58a00a5e265" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:to="loc_us-gaap_AwardTypeAxis_cd936f70-a410-49ce-ab6d-c58a00a5e265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cd936f70-a410-49ce-ab6d-c58a00a5e265" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bc39f827-5687-4cc7-9925-1071e508a375" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bc39f827-5687-4cc7-9925-1071e508a375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreFundedWarrantsMember_97c06adb-08d0-4bf2-96b7-22ef480369f9" xlink:href="vtl-20250630.xsd#vtl_PreFundedWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_PreFundedWarrantsMember_97c06adb-08d0-4bf2-96b7-22ef480369f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PlacementAgentWarrantsMember_c2351965-f6d9-4825-8fab-df2c581e2646" xlink:href="vtl-20250630.xsd#vtl_PlacementAgentWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_PlacementAgentWarrantsMember_c2351965-f6d9-4825-8fab-df2c581e2646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025PreFundedWarrantsMember_9db4788c-5668-4a99-b0d0-2f4c2f5dc113" xlink:href="vtl-20250630.xsd#vtl_May2025PreFundedWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_May2025PreFundedWarrantsMember_9db4788c-5668-4a99-b0d0-2f4c2f5dc113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025SeriesAWarrantsMember_912e096a-19a9-4ad7-83a1-5c8af2895703" xlink:href="vtl-20250630.xsd#vtl_May2025SeriesAWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_May2025SeriesAWarrantsMember_912e096a-19a9-4ad7-83a1-5c8af2895703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_May2025SeriesBWarrantsMember_348ee840-06c9-4a79-b725-6d5f3ef12e5f" xlink:href="vtl-20250630.xsd#vtl_May2025SeriesBWarrantsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_May2025SeriesBWarrantsMember_348ee840-06c9-4a79-b725-6d5f3ef12e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_EmployeeStockOptionsforFutureGrantMember_c40799af-fce2-4279-bbd1-2749979ed48a" xlink:href="vtl-20250630.xsd#vtl_EmployeeStockOptionsforFutureGrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1bc4a38-9062-484b-9d21-74e2c69de795" xlink:to="loc_vtl_EmployeeStockOptionsforFutureGrantMember_c40799af-fce2-4279-bbd1-2749979ed48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:to="loc_us-gaap_PlanNameAxis_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6a2b16ac-b835-4c4a-b9ee-fc28d7d8eea6" xlink:to="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2021EmployeeStockPurchasePlanMember_d68e1f47-b716-4093-8a2f-dc9a37d7d591" xlink:href="vtl-20250630.xsd#vtl_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:to="loc_vtl_A2021EmployeeStockPurchasePlanMember_d68e1f47-b716-4093-8a2f-dc9a37d7d591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2017InducementEquityIncentivePlanMember_b0f00558-1937-471a-a296-70325f18524e" xlink:href="vtl-20250630.xsd#vtl_A2017InducementEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:to="loc_vtl_A2017InducementEquityIncentivePlanMember_b0f00558-1937-471a-a296-70325f18524e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_4cfca840-be88-4d12-9eda-3f4a1c2b1bb6" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4e94756c-e2cc-411d-b909-147775320b1d" xlink:to="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_4cfca840-be88-4d12-9eda-3f4a1c2b1bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f87dfa2c-8449-423c-a16c-372ce53b874d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:to="loc_us-gaap_VestingAxis_f87dfa2c-8449-423c-a16c-372ce53b874d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a6aedb09-d570-422a-89ea-48bd0f994572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_f87dfa2c-8449-423c-a16c-372ce53b874d" xlink:to="loc_us-gaap_VestingDomain_a6aedb09-d570-422a-89ea-48bd0f994572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0c537ba1-57f8-4009-9568-bf7c8138c380" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a6aedb09-d570-422a-89ea-48bd0f994572" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0c537ba1-57f8-4009-9568-bf7c8138c380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_565e84a3-a5a3-4eeb-9dfe-017aecebae9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43601813-11dc-4e96-a89e-642d744c5b4b" xlink:to="loc_us-gaap_ClassOfStockLineItems_565e84a3-a5a3-4eeb-9dfe-017aecebae9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7268b0d1-b285-4347-9971-1a8f4e5ee114" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_565e84a3-a5a3-4eeb-9dfe-017aecebae9e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7268b0d1-b285-4347-9971-1a8f4e5ee114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2c238345-771c-49e6-8a64-3fba42373061" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2c238345-771c-49e6-8a64-3fba42373061" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8c85b47b-af72-4914-b8c1-81530e2ce662" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_us-gaap_PlanNameAxis_8c85b47b-af72-4914-b8c1-81530e2ce662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8c85b47b-af72-4914-b8c1-81530e2ce662" xlink:to="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2021EmployeeStockPurchasePlanMember_381b0d2a-3fbb-4484-8f13-a900e51d4cfd" xlink:href="vtl-20250630.xsd#vtl_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_A2021EmployeeStockPurchasePlanMember_381b0d2a-3fbb-4484-8f13-a900e51d4cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2019OmnibusEquityIncentivePlanMember_3341d6b9-6b11-450c-8cf8-7497b7399194" xlink:href="vtl-20250630.xsd#vtl_A2019OmnibusEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_A2019OmnibusEquityIncentivePlanMember_3341d6b9-6b11-450c-8cf8-7497b7399194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember_d9770181-1fc5-44ea-a363-9a97fa7e16c5" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember_d9770181-1fc5-44ea-a363-9a97fa7e16c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandFourteenEquityIncentivePlanMember_5c887a9d-53d7-4315-8ef6-68c8d6194d6f" xlink:href="vtl-20250630.xsd#vtl_TwoThousandFourteenEquityIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_TwoThousandFourteenEquityIncentivePlanMember_5c887a9d-53d7-4315-8ef6-68c8d6194d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2017InducementEquityIncentivePlanMember_860b7c7c-de0e-49f7-bd61-ca9e110c9e53" xlink:href="vtl-20250630.xsd#vtl_A2017InducementEquityIncentivePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cc511b53-c2fe-4877-86f2-7ef80810595f" xlink:to="loc_vtl_A2017InducementEquityIncentivePlanMember_860b7c7c-de0e-49f7-bd61-ca9e110c9e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2850e340-5292-41df-83ee-38e4a18297e0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_srt_RangeAxis_2850e340-5292-41df-83ee-38e4a18297e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2850e340-5292-41df-83ee-38e4a18297e0" xlink:to="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_03f9f4de-e197-4ae9-9d1c-5917f0b59ec5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:to="loc_srt_MaximumMember_03f9f4de-e197-4ae9-9d1c-5917f0b59ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2215d454-0406-463f-bdca-e9eaee58af14" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5148f504-b559-4d18-a849-eba393ea102d" xlink:to="loc_srt_MinimumMember_2215d454-0406-463f-bdca-e9eaee58af14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bda4c471-8e96-4d25-954f-c1ec4dc1f994" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_us-gaap_AwardTypeAxis_bda4c471-8e96-4d25-954f-c1ec4dc1f994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bda4c471-8e96-4d25-954f-c1ec4dc1f994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_IncentiveEmployeeStockOptionMember_4f37de90-6a10-4141-a251-7233fd5d1157" xlink:href="vtl-20250630.xsd#vtl_IncentiveEmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:to="loc_vtl_IncentiveEmployeeStockOptionMember_4f37de90-6a10-4141-a251-7233fd5d1157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_NonStatutoryEmployeeStockOptionMember_370fc548-87ad-4b8d-a7d1-6841d708ebea" xlink:href="vtl-20250630.xsd#vtl_NonStatutoryEmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb185557-7b01-4f43-bee6-9e5f30781fcd" xlink:to="loc_vtl_NonStatutoryEmployeeStockOptionMember_370fc548-87ad-4b8d-a7d1-6841d708ebea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b6ff9100-c33c-42a0-a200-196ebcd6450d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b6ff9100-c33c-42a0-a200-196ebcd6450d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b6ff9100-c33c-42a0-a200-196ebcd6450d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4e1453fa-5fee-4f1a-a1a4-ced08a3ada51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4e1453fa-5fee-4f1a-a1a4-ced08a3ada51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11ff3b8f-58f0-4df2-ad34-33754a467272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eca45098-e12d-43fe-b4d2-a97a2c49d6d4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11ff3b8f-58f0-4df2-ad34-33754a467272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_737f62cb-bcce-4cc5-9223-e8aa28d97ada" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_79be4f8f-a607-4252-b38d-2bcec0ac3ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_79be4f8f-a607-4252-b38d-2bcec0ac3ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_aae2ee0a-0427-4813-8ebd-8a78cfdc030b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_aae2ee0a-0427-4813-8ebd-8a78cfdc030b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_40c47fac-0b18-40f6-ad50-325262035540" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_40c47fac-0b18-40f6-ad50-325262035540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d5edab63-e49f-47ef-a559-5f7674b09116" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d5edab63-e49f-47ef-a559-5f7674b09116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c02af09e-973d-40f4-b365-154a1016c90d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c02af09e-973d-40f4-b365-154a1016c90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_613d04d3-e71b-436a-b9a5-98e87d5b987a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_613d04d3-e71b-436a-b9a5-98e87d5b987a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent_d712ec43-5c5e-47d8-aea8-c45b33428977" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent_d712ec43-5c5e-47d8-aea8-c45b33428977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_d3464433-c0ae-4255-be1f-a7f6b9600a29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_d3464433-c0ae-4255-be1f-a7f6b9600a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7bcdd9c8-388d-452a-a0a0-3a136713a9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7bcdd9c8-388d-452a-a0a0-3a136713a9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2a17b0fe-ea3b-489b-b521-d8cf599db557" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2a17b0fe-ea3b-489b-b521-d8cf599db557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e146943c-e445-489e-b4bd-6e0dec00242d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e146943c-e445-489e-b4bd-6e0dec00242d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares_8ac339ac-1406-4418-ad49-c2fead3804ec" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares_8ac339ac-1406-4418-ad49-c2fead3804ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice_6b453bcb-ee88-4aca-b409-1717bad4a976" xlink:href="vtl-20250630.xsd#vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice_6b453bcb-ee88-4aca-b409-1717bad4a976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_c7d27374-b8bd-4945-9609-4679ec894b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_c7d27374-b8bd-4945-9609-4679ec894b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a7311e47-c456-47a0-8475-6e518d80d498" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a7311e47-c456-47a0-8475-6e518d80d498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b0fd719d-da37-4839-ac8d-7c3f55952004" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b0fd719d-da37-4839-ac8d-7c3f55952004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_53be04db-ce1a-4c34-9499-2753f7102435" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_53be04db-ce1a-4c34-9499-2753f7102435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_818d4998-e738-419a-b4ef-96362a82fb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_818d4998-e738-419a-b4ef-96362a82fb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_debb4694-2a24-40ab-95f6-888a28d65682" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8dce055-41f9-4161-808b-be626c177731" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_debb4694-2a24-40ab-95f6-888a28d65682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9dd9f024-f6c4-43fb-8061-ee9ded1ec409" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9dd9f024-f6c4-43fb-8061-ee9ded1ec409" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:to="loc_us-gaap_AwardTypeAxis_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_574e635f-fa83-41b7-a459-5b5ae4732e31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8f8f3390-bd64-4629-8cd8-b17ee7cfe5eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_574e635f-fa83-41b7-a459-5b5ae4732e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e1ae39f6-1dac-46e0-8a72-d32f1e553033" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_574e635f-fa83-41b7-a459-5b5ae4732e31" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e1ae39f6-1dac-46e0-8a72-d32f1e553033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e4c61f88-8858-4615-ab71-23eabd7982df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:to="loc_us-gaap_PlanNameAxis_e4c61f88-8858-4615-ab71-23eabd7982df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c763e8a7-1b66-49fb-a7cf-a87fe6d90cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e4c61f88-8858-4615-ab71-23eabd7982df" xlink:to="loc_us-gaap_PlanNameDomain_c763e8a7-1b66-49fb-a7cf-a87fe6d90cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_f2eded7e-bb42-45e2-a7f6-811c2b50db5b" xlink:href="vtl-20250630.xsd#vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c763e8a7-1b66-49fb-a7cf-a87fe6d90cf5" xlink:to="loc_vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember_f2eded7e-bb42-45e2-a7f6-811c2b50db5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46677c96-32dc-425c-9865-80f99e2fc20f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4710f824-ca4c-4a0f-9409-d5a05ffd4690" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4710f824-ca4c-4a0f-9409-d5a05ffd4690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_be6c31b3-1ba5-4926-9c53-48443bd08137" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_be6c31b3-1ba5-4926-9c53-48443bd08137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c72acbc6-93e5-4105-9788-881b8daae4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c72acbc6-93e5-4105-9788-881b8daae4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod_f992a185-a39f-4b79-aa70-777268ed7d38" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod_f992a185-a39f-4b79-aa70-777268ed7d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2d162a28-49bc-42fe-acfc-6f32db4f7927" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2d162a28-49bc-42fe-acfc-6f32db4f7927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d40988b8-f659-48ff-95a8-95494688d818" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6f63571-e9f2-4e87-a662-52180498ef44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d40988b8-f659-48ff-95a8-95494688d818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9b27a2c0-c5cc-49d2-9c2d-7466eae8402c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9b27a2c0-c5cc-49d2-9c2d-7466eae8402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_705d5da3-4b6e-4ea0-a493-4a3343f87b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_705d5da3-4b6e-4ea0-a493-4a3343f87b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_385aa6bc-3930-4d27-97e1-1d1bc750c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_385aa6bc-3930-4d27-97e1-1d1bc750c7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd0328c3-d7f2-4525-b694-ace230ed1311" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd0328c3-d7f2-4525-b694-ace230ed1311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice_b27892f7-28ba-413d-861e-e735f529cf07" xlink:href="vtl-20250630.xsd#vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice_b27892f7-28ba-413d-861e-e735f529cf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_7168109a-b6fb-4c0b-b850-7eac089326e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_7168109a-b6fb-4c0b-b850-7eac089326e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3373bda0-6a69-47ab-9cf3-c3964972a804" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_94781750-5bcb-4004-807a-9f6ea4b27f22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3373bda0-6a69-47ab-9cf3-c3964972a804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f3bd6cda-433c-4b89-873f-b2aa7a67dd00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f3bd6cda-433c-4b89-873f-b2aa7a67dd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97f20bf5-3621-44c7-85f9-511db8b13010" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0b327352-6390-4d06-b04a-825f7a772ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0b327352-6390-4d06-b04a-825f7a772ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ea0ad9f3-0e65-4d00-bceb-3e84d4bfbf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ea0ad9f3-0e65-4d00-bceb-3e84d4bfbf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_beede89e-9a00-4402-8d37-d611ac37383c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_beede89e-9a00-4402-8d37-d611ac37383c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_699d364f-94f4-493d-aa07-abec18e9c7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b1b6e0eb-66f7-47b3-9b9a-3c84f747344d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_699d364f-94f4-493d-aa07-abec18e9c7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ac59117-498b-47c7-9294-2747993c4c44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3efdb6d7-7a2e-4a23-a7d4-9e05cab2dd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ac59117-498b-47c7-9294-2747993c4c44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3efdb6d7-7a2e-4a23-a7d4-9e05cab2dd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6c2e0995-90c2-41b1-a6da-4a4efae06bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3efdb6d7-7a2e-4a23-a7d4-9e05cab2dd5a" xlink:to="loc_us-gaap_PlanNameAxis_6c2e0995-90c2-41b1-a6da-4a4efae06bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ec9a94d1-7e9e-4bf2-8a65-4599485d380f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6c2e0995-90c2-41b1-a6da-4a4efae06bb6" xlink:to="loc_us-gaap_PlanNameDomain_ec9a94d1-7e9e-4bf2-8a65-4599485d380f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_A2019OmnibusEquityIncentivePlanMember_9106bb97-62cb-4100-93d9-0d0e5ea0059f" xlink:href="vtl-20250630.xsd#vtl_A2019OmnibusEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ec9a94d1-7e9e-4bf2-8a65-4599485d380f" xlink:to="loc_vtl_A2019OmnibusEquityIncentivePlanMember_9106bb97-62cb-4100-93d9-0d0e5ea0059f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3efdb6d7-7a2e-4a23-a7d4-9e05cab2dd5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6a1a26d3-f008-4ebc-ada5-78c6cbe4a145" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6a1a26d3-f008-4ebc-ada5-78c6cbe4a145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26af62f8-21f0-4779-9a75-075d320d736d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26af62f8-21f0-4779-9a75-075d320d736d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f96c086b-ff9d-4c06-8225-8c1b10a292d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f96c086b-ff9d-4c06-8225-8c1b10a292d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f3a3b6f1-9dcf-4647-ae9c-0651b9356117" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e03fc8a1-fbf5-4d10-80b3-117edae42f74" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f3a3b6f1-9dcf-4647-ae9c-0651b9356117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0bff300a-893e-4469-bee2-c9c5d170c001" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0bff300a-893e-4469-bee2-c9c5d170c001" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_87bf74fc-87b4-4368-8a9f-9a28dc65f742" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:to="loc_srt_TitleOfIndividualAxis_87bf74fc-87b4-4368-8a9f-9a28dc65f742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e00a2318-f899-4909-b874-47c8cbcaadd2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_87bf74fc-87b4-4368-8a9f-9a28dc65f742" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e00a2318-f899-4909-b874-47c8cbcaadd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_EmployeeMember_1cad9ab9-970c-4ded-9e30-1d4506f59819" xlink:href="vtl-20250630.xsd#vtl_EmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e00a2318-f899-4909-b874-47c8cbcaadd2" xlink:to="loc_vtl_EmployeeMember_1cad9ab9-970c-4ded-9e30-1d4506f59819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fdd03815-537c-4f48-8df6-fb800fbdc92f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fdd03815-537c-4f48-8df6-fb800fbdc92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fdd03815-537c-4f48-8df6-fb800fbdc92f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2913584d-32d1-4062-b12e-cb446b183a84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2913584d-32d1-4062-b12e-cb446b183a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_dc1f9608-dd75-4766-8c15-2fcae7d2b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5fc5f1fc-eff1-4c78-813b-a4a96d35c9c1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_dc1f9608-dd75-4766-8c15-2fcae7d2b7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f6460f8f-5c19-4241-bf16-f0efc42ed1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9be31b7c-930b-4292-996b-ed97a17a2f32" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f6460f8f-5c19-4241-bf16-f0efc42ed1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a5103cda-48e3-4bfa-b9c7-7b22152f3879" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f6460f8f-5c19-4241-bf16-f0efc42ed1ac" xlink:to="loc_us-gaap_ShareBasedCompensation_a5103cda-48e3-4bfa-b9c7-7b22152f3879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a5c58a6e-af8c-4a8b-8c2e-596cc6fc59f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a5c58a6e-af8c-4a8b-8c2e-596cc6fc59f8" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e39f7319-9a78-41d5-aef7-86ec8ed36e9f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:to="loc_srt_CounterpartyNameAxis_e39f7319-9a78-41d5-aef7-86ec8ed36e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_782787a4-c302-4609-8291-3d328aed6915" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e39f7319-9a78-41d5-aef7-86ec8ed36e9f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_782787a4-c302-4609-8291-3d328aed6915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_DuaneNashMDJDMBAMember_41f0a88d-56c0-4f98-9479-c292e23a74fa" xlink:href="vtl-20250630.xsd#vtl_DuaneNashMDJDMBAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_782787a4-c302-4609-8291-3d328aed6915" xlink:to="loc_vtl_DuaneNashMDJDMBAMember_41f0a88d-56c0-4f98-9479-c292e23a74fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5a9a4ab5-97cf-4b29-aa0b-674706985f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5a9a4ab5-97cf-4b29-aa0b-674706985f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_9ea14036-18e7-440e-bbfa-eb0b64af760a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5a9a4ab5-97cf-4b29-aa0b-674706985f9e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_9ea14036-18e7-440e-bbfa-eb0b64af760a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ExecutiveChairmanAgreementMember_04d70268-cbcf-4c87-8212-39a19858f320" xlink:href="vtl-20250630.xsd#vtl_ExecutiveChairmanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9ea14036-18e7-440e-bbfa-eb0b64af760a" xlink:to="loc_vtl_ExecutiveChairmanAgreementMember_04d70268-cbcf-4c87-8212-39a19858f320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4277a7d-f6c4-4e1b-b518-211b28306ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4277a7d-f6c4-4e1b-b518-211b28306ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_17fb15f6-2258-48e5-97b3-588ee3115d50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4277a7d-f6c4-4e1b-b518-211b28306ed3" xlink:to="loc_us-gaap_RelatedPartyDomain_17fb15f6-2258-48e5-97b3-588ee3115d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_095b51cc-7753-4f52-a391-62816b7c6ce7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_17fb15f6-2258-48e5-97b3-588ee3115d50" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_095b51cc-7753-4f52-a391-62816b7c6ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_40a86369-18dd-4c3a-8fbd-1228014680f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ff5012ee-54ae-4990-8322-47a9351ef856" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_40a86369-18dd-4c3a-8fbd-1228014680f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SalaryAndWageOfficerMonthlyBaseSalary_f27a91ba-c961-42d1-a56c-5432ecc5b1b0" xlink:href="vtl-20250630.xsd#vtl_SalaryAndWageOfficerMonthlyBaseSalary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_40a86369-18dd-4c3a-8fbd-1228014680f4" xlink:to="loc_vtl_SalaryAndWageOfficerMonthlyBaseSalary_f27a91ba-c961-42d1-a56c-5432ecc5b1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bcd50067-3edd-4f45-ad18-31fbb527b815" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_0fe05b01-3f3a-4d3b-a3d3-09c518d7418a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bcd50067-3edd-4f45-ad18-31fbb527b815" xlink:to="loc_us-gaap_ContractualObligation_0fe05b01-3f3a-4d3b-a3d3-09c518d7418a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SegmentDisclosuresAdditionalInformationDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SegmentDisclosuresAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SegmentDisclosuresAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dc1c65b2-1d05-4e8b-b4c4-3286c7b9d79f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_891c34f4-2b54-40d4-af55-871956d21d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dc1c65b2-1d05-4e8b-b4c4-3286c7b9d79f" xlink:to="loc_us-gaap_NumberOfReportableSegments_891c34f4-2b54-40d4-af55-871956d21d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SegmentDisclosuresScheduleofSignificantExpenseDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b756851a-7f1e-4747-abf2-84f9a4f32f88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b756851a-7f1e-4747-abf2-84f9a4f32f88" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b6d85fa-71ee-471d-a4bf-fcf30e782ada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6ce02af-d2f0-4e13-a1e8-d754b4842d7c" xlink:to="loc_us-gaap_SegmentDomain_8b6d85fa-71ee-471d-a4bf-fcf30e782ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ReportableSegmentMember_3779f061-4782-4a4d-8606-2935ffc4a1b2" xlink:href="vtl-20250630.xsd#vtl_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8b6d85fa-71ee-471d-a4bf-fcf30e782ada" xlink:to="loc_vtl_ReportableSegmentMember_3779f061-4782-4a4d-8606-2935ffc4a1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ae047cf5-21af-42ae-86b7-cbf87b582c96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ae047cf5-21af-42ae-86b7-cbf87b582c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ae047cf5-21af-42ae-86b7-cbf87b582c96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_55d57322-7802-458f-88a6-a97806b31cee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_55d57322-7802-458f-88a6-a97806b31cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_24988aef-192d-4168-8daa-13e5bf3b9515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3bdbf027-a650-4d94-84da-f7cbc0732993" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_24988aef-192d-4168-8daa-13e5bf3b9515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_6e61956e-0d9a-481f-8255-67dfa9797f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_c24fd691-41be-4707-8c85-602993b6054c" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_6e61956e-0d9a-481f-8255-67dfa9797f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_6e61956e-0d9a-481f-8255-67dfa9797f9a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_ClinicalProductCandidates_2dbad13e-6ed5-4f8c-9258-4aad2cb84f1b" xlink:href="vtl-20250630.xsd#vtl_ClinicalProductCandidates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_vtl_ClinicalProductCandidates_2dbad13e-6ed5-4f8c-9258-4aad2cb84f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_PreClinicalProductCandidates_8ff4fd41-ed33-4150-bf88-10083bbf8817" xlink:href="vtl-20250630.xsd#vtl_PreClinicalProductCandidates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_vtl_PreClinicalProductCandidates_8ff4fd41-ed33-4150-bf88-10083bbf8817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_cf46a2f2-cf2a-4d7c-b497-24770c13b707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_LaborAndRelatedExpense_cf46a2f2-cf2a-4d7c-b497-24770c13b707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c1c21803-0990-43ff-9634-06f233b6fe33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_ShareBasedCompensation_c1c21803-0990-43ff-9634-06f233b6fe33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction_0e317186-244e-4c00-81ce-ad4e07792012" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationNonproduction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_DepreciationNonproduction_0e317186-244e-4c00-81ce-ad4e07792012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_217b7d89-d685-4169-a215-d721edbaebca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_ProfessionalFees_217b7d89-d685-4169-a215-d721edbaebca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9a0eb80d-47d7-488e-bf60-076759ba8ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_OperatingExpenses_9a0eb80d-47d7-488e-bf60-076759ba8ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5821a5f4-3950-4f8f-ae97-6d5a25f08ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_OperatingIncomeLoss_5821a5f4-3950-4f8f-ae97-6d5a25f08ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_12caab36-629f-4ea0-b0bc-83e92527bc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_12caab36-629f-4ea0-b0bc-83e92527bc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_7196ec27-f98c-4d7c-a6ef-eb3eadc700dd" xlink:href="vtl-20250630.xsd#vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts_7196ec27-f98c-4d7c-a6ef-eb3eadc700dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e75f48a7-150a-4b0f-9f67-84ad72729eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e75f48a7-150a-4b0f-9f67-84ad72729eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b33cdfd8-6053-4015-a68a-5c005d0fa327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4f235822-0e54-49d3-b010-567d4d54691d" xlink:to="loc_us-gaap_NetIncomeLoss_b33cdfd8-6053-4015-a68a-5c005d0fa327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vitaltherapies.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="vtl-20250630.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://vitaltherapies.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d0b81b58-a74b-4842-acc2-643b4d818ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d0b81b58-a74b-4842-acc2-643b4d818ffd" xlink:to="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c8c6a928-11be-4cfb-af5a-a168abd374c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_AwardTypeAxis_c8c6a928-11be-4cfb-af5a-a168abd374c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adb75517-d5f0-43df-9743-5f6049595370" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c8c6a928-11be-4cfb-af5a-a168abd374c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adb75517-d5f0-43df-9743-5f6049595370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_78034bcc-04c1-410b-bee4-f560397d32fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adb75517-d5f0-43df-9743-5f6049595370" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_78034bcc-04c1-410b-bee4-f560397d32fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4b5c7e10-da4f-4033-9a1e-296bad4f2883" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4b5c7e10-da4f-4033-9a1e-296bad4f2883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e6388d4e-ed83-436a-933d-f94ae84541e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4b5c7e10-da4f-4033-9a1e-296bad4f2883" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e6388d4e-ed83-436a-933d-f94ae84541e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8a59bc8e-35e2-4b39-aa48-2ee1c30f9e49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e6388d4e-ed83-436a-933d-f94ae84541e7" xlink:to="loc_us-gaap_SubsequentEventMember_8a59bc8e-35e2-4b39-aa48-2ee1c30f9e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_srt_TitleOfIndividualAxis_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9625cdeb-a7a0-42d7-9931-5a4f677b9a30" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_c79aa5dd-ca80-4d7f-b6c1-ba4288dca1f1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9625cdeb-a7a0-42d7-9931-5a4f677b9a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_20719b0d-5488-471e-8030-7af7ff45b49e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9625cdeb-a7a0-42d7-9931-5a4f677b9a30" xlink:to="loc_srt_ExecutiveOfficerMember_20719b0d-5488-471e-8030-7af7ff45b49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_545cab82-bdd3-4b2c-99e8-3e7e6a720785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_545cab82-bdd3-4b2c-99e8-3e7e6a720785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_545cab82-bdd3-4b2c-99e8-3e7e6a720785" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesAWarrantsMember_082f3e1e-d54e-4fc4-a0b0-422c48f3e719" xlink:href="vtl-20250630.xsd#vtl_SeriesAWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:to="loc_vtl_SeriesAWarrantsMember_082f3e1e-d54e-4fc4-a0b0-422c48f3e719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_SeriesBWarrantsMember_51ccbd5f-4bbf-498f-945c-5a61c39ba5dd" xlink:href="vtl-20250630.xsd#vtl_SeriesBWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:to="loc_vtl_SeriesBWarrantsMember_51ccbd5f-4bbf-498f-945c-5a61c39ba5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtl_January2024PreFundedWarrantsMember_4b6d436a-626e-4759-8e3d-e0543e121e69" xlink:href="vtl-20250630.xsd#vtl_January2024PreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cbd38bb3-a548-4602-b7db-2408d3949070" xlink:to="loc_vtl_January2024PreFundedWarrantsMember_4b6d436a-626e-4759-8e3d-e0543e121e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_519a62db-6e2e-4c4a-a67c-f07532e3a475" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_VestingAxis_519a62db-6e2e-4c4a-a67c-f07532e3a475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_519a62db-6e2e-4c4a-a67c-f07532e3a475" xlink:to="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b0107027-ed6d-4907-9cd0-be7505c2af99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b0107027-ed6d-4907-9cd0-be7505c2af99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_929bea09-d980-4541-b97c-b09a01de908b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_64ab667e-6168-440d-9799-4a47f01d8401" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_929bea09-d980-4541-b97c-b09a01de908b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1c79e8e-30f4-47be-993d-82200be2305a" xlink:to="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_89a14112-d965-44ce-bf8e-555fb434abe5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_89a14112-d965-44ce-bf8e-555fb434abe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_dc451862-850a-4d37-a5ef-4e5e829285f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_dc451862-850a-4d37-a5ef-4e5e829285f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ec337bf0-0e20-4efc-aff3-002cf6f1ce89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ec337bf0-0e20-4efc-aff3-002cf6f1ce89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0583321e-e9c4-4c95-8d9e-97141a0979d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1f2af89-a7b8-4dc1-938d-6ac226491dfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0583321e-e9c4-4c95-8d9e-97141a0979d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tardioagreementa01001.jpg
<TEXT>
begin 644 tardioagreementa01001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% 'C'CW3CJ'QL\.7=QH]W>Z/;VOE7;BPDFB!)DX.%(/5?7K72G4(+3P[?\
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MZ* /(? EK>0?&CQ??3Z??0V=Z,6\\MI(D<F&'1BN*]*\0ZJ^C:)<7<-O/<7
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M/F[9H ]9CD2:,21NKH>C*<@_C7+^,/%$FAQ6:V$]B]R]];V\\$IW.(Y)%4D
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M*^'+_P 4S:UHNN2:G<S6*Q3^2T1A5 P*;PBC$G) SS@'TKM: "BBB@ HHHH
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MT^%25UW",$C+8[D#) [G%<AIEUKF@^-I](U+6)-6TQ]-:_$\\*)+;LKA2"4
M!5@21QG@^E '8&PLP%VV=OE/N9C QW]..:P/"OA=]&;4);^*RFN+C4)[R*:-
M<M&)6W%,D9X]1U]!7.KXMU2'P/8>.;BY;[/<72--8[5\M+627RU .-V\ JV<
M\G(Z8QI>,XO$UEI6J>(+'Q#]B_L^)YX;$6\;Q2(@R1(2-Q9L'H1C('N0#LS:
MVYG\\P1&;_GIL&[\^M-6RM4NFNDMH5N'&&F$8#L/<]:S;C5KE-'LF2W"ZI?(
MHBMWSA'*Y8M_LIR3],=2*H_#S5+W6O .D:CJ$QGN[B(M+(5 W'<1T'':@"U:
M:5JTFNR7NK7]M/:P2NUA!! 4,888W.Q8[F"DJ, ?>;U&-=[2VDF$KV\32#H[
M("1^-8^J:NY\1Z?X>M'*7%S%)=7$@ZQ0(0./=F95![#<>N*H2>*TU#4O$.B6
M@O;:XTVW7%S]G;[Y1VSEE*@85<%OO9.,\&@#I/[.L0A3[';[202/*7!/Y>YI
M9;"SF$0EM()!"<Q!HP=A]5]/PKD?!'C.QOM!\.V5]J#RZO>V2/N>-]LL@3<X
M#XV%AR2H.1Z5O7?BG1[&Y6"YNFCW3BW\TPN8A*>B&0#8&SQ@GKQUH TGL[:2
M7S7MX6DZ;V0$_G318VBQ-$+6 1N0601C!QZBB^>YCT^YDLXEENEB8PQL<!W
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MFZUJ1N?#^JRW%O:EX8U,4B3-&HW*H).54?23VH ]:CL[:*XDN([>%)Y.'E5
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MP&05((QW KUJB@#Q;XE^']3#^"+:TLK_ %&6PO#<7\]O:.X+,R,[DJN.6W'
MKT#4H;76M>FTVZM+M[2[TN2"1S:R"/YV'&\K@-CGKQ74T4 >*:9X,UGP]\'?
M$6FWT=S=W\JSV=E!#"TA$0=MNT*"0&8LV?0KZ5<M?#6JZO\ LY'PY'97$.JK
M!_Q[7$31,66?S-OS =0..W->OT4 >:^'K^2_^&%GX973-3AU4Z>NG2Q7%E+&
ML1V>6SL[*%V@9;KD] ,\5UMW< >,]/C^SW3(+*X1I5MG:)69X2H+@;1D*W?M
M6[10!Y3:?#RY\+?%VPU710Z^'[]Y7N;9/N6\PADVG'93N.#V)([BH+&ROU_:
M+O\ 6&TS4%TV6R$"71M)!&7V(,;MN.H//3BO7:* /(?"&D7WPS\;^((;VQO)
M]"U:03VM[:P/.(R"Q".J LO#XSC' ]:[Z^\2W$>CZAJ.GZ'?WJVL.^*,QM"]
MR_\ =1&&[CU*_3-=!3)8Q-$\;,ZAA@E&*G\".1^% &7X8US_ (23PY9ZL;.6
MS:=6WV\OWHV5BK*>!W4]A7G.M65_)^T5H>LIIFH/IEM9-!-=+:2&-7*3#&0O
M/+KR..:]8MK:&SMH[:VB6*&)0J(HP% [5+0!S$%O9ZW=^)-+O["X>TN9%#">
MVD2.5/*13M8@ X(/0YXR*X[P/\/K_P /7GBWPW>SS3:)=VJQV$YYQ')YH=?9
MAGD>^>]>L44 >3_#$7_@#3+SPQXBT^]3RKIY;6\MK22>&=&QT,:G!R"<'!YK
ML-=\5ZAI?AV35K+PSJ&H-YZQQ6J K*Z'K(5P649SP1GID#MU%% &/;^(89_$
M;:&]E?0W"VPN1++#B%QE0RJ^<%EW+D>]9_CFYN[73=/DM=/DNE_M"'SY(;7[
M1+:Q\YEC3!RP. #@XSG!Q71"UA%VUULS.5V;B2<+Z#TS@9QUP,]*FH X;P+#
M<6WB/Q6);'488;B[CGAFO(V'F+Y*#.YNIR#QVZ$#I1\2XYYH/#@M[.\N3;ZY
M:74OV:VDEV1(Q+,=H/3TZUW-% ' ^-X[WQOHX\,Z597D=O>2Q_;;ZYMW@2")
M6#':' +N<   $>I%9]U"-$\7:W::KH6L:AI>J>4]I+8+)(A A6)H9%4@#[G!
M;@@G)KTZB@#@OL<MIX]\+^1I4\%K:Z3/ RQ1.T,#-Y>V/S ,?PD9SVKG+-M1
MNI_!][-H6JP3VFI2_:[2*Q:*"TW1R *B@ %<D?O.1SRPSBO8** /.]5\*WE[
MXIUG1UC== \06ZW-W,O'E2H-C*/=_P!T?<*U.TR/Q"GP]U2^U+2DO=<%DUFM
MG,N]9UA#(-R_Q;V+MCN& KT*B@#S+1'G3X@:?JK6&MO:R:$\#SW%DZ;9!*C%
M?+P-@ !P !G'&[J:NGZ1J[_ S3[*UTZZ74K&2*=[&5'@>3R[@2%!G!R0.".]
M>KT4 <?X6ET[5=4;5K70-3LIUMO(DN=321)<;@WE*')) .22. <8SDX["BB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ JEJVJVVBZ9+?W9;RH]H"H,L[,0JJH[DL0![FKM<
M]XVT*Z\1>%Y[*PG2"^22.XMI)/NB6-PZ[O8E<?C0 C>+([*?48]8L;C3TL;0
M7KSM\\31<@@./XP1RO7IC-(/%BPZEIUGJ.G7%E_::G[&[LK!G"[O+?!^1R.0
M.0<'G-9M_I?B'QIX4U/2];LK?1_M-J852.X\\M+D$.2 ,*".G).3G&!2OI.L
M>('\.?VO8BT;2+A;NX=95<3RHC*HCP<[26W'=M/ &#G( "#X@FY@O+J'PWJK
MVEC+<Q74H,(\IH0=PP7YS@],CISZ+9_$.&>[T1;K1M0L[+6E06=[-L\MY&7<
M$(#;EST!(&<<<<U4L=+U#2?!'C"/4+7R6N9K^\BQ(K924,P!P>"._P#,U!HN
ME7OB/PGX&AGLS;6NG+:7TDS2*WF&.+Y @!SR2"=P& ".: -N[\<6UKIUSJZV
M4\VC6L[03WD94XVML=U3JR*V03UX) (YI+[QL8-<GTBQT/4-0N8K6.[!@:+;
M)$[%=RDM['@X)[#'-8EMX5UJR\':QX,2W26TNGG2TOS(NV.&9BQ\Q2=V]=S8
MP"#QR*UM,T*]T[Q\UXEJ?[+72(=/CE,BEMT;LV2,YP0P&>N1TH GE\:PP7,'
MF:=<I9SZG_923MA29LE0=AYV%@1N_'&.:AT[Q-J-[XG\3:?/I4C6NF>4B+%(
MA9MT>_/)'+!AQG Q]:YV\\,>*KSR9+G3[.ZO[378[U;V2[P9K=9=RH@VGRP%
MP"/;."2:Z+3]+UC3O&'B6_-G#-9ZFL$L;I. P9(1&4VD>HSDD#'OQ0 WP_XC
MTB#PIX=31["6)-20KI]B7^8*H+,68DX  R3D]0!DD4Z\\?VMAI>N7%SIUV+O
M1-IO+-2A8*PRKJQ(#(1WZ\'BL+2O!^N:7HO@N[2W1M2\/"6&>T\U<3Q2+M8H
MW3<, C..A!Q4_B#PEJ>KV/BV]BM0E]K5I%9V]L\J_NT0'YG8'&26/ )X ]3@
M Z.Q\5BZ\1QZ-<:7=V;W%JUU:RS%"LR*0&X!)4C<#@X.#VZ4SQ?J\UD-)TNU
MD:.ZU>^2U$BG#1QX+2,/?:I /8L#VJM)I>IS>.-!U7["R6MI836\Q:5,J\A0
MC !Y V'/UIOCBR<7GAS75&8])U$/<?[,,BF-G^B[E)] ">U #[O6[S3_ !SI
M7ANSTT?8);*6=F6103M9%XST W$GN2?;GF/#GB1?"NF^(9I-,NY].A\17,<]
MRC+M@5I%1>&;<V,CH#@5U>KZ5JA\=Z/K=C;PW%O#:3VLX>;88][(P8<'=]PC
M'TKFKOPKKUQX&\4Z2M@!=ZIJLMW;@SIM$;RJXW'/! 4Y'/)'X '4:[XTL]&E
MOHEC%S)81":Y03I&P!&[:H8C<VWG'N.<FM:UOTUSP_'?Z7/M2\MO,MI67[NY
M<J2/;(XKE9K#Q/H_B[4-4TG2K74K#6%B>:"XNA"]K,B!,YPP92H&<9.1Q[]I
M:)-':1+<NCSA1YC(N%+=\#L/2@#E++3?%\4?ATW!T<FV:1=1B5Y2K*2-LB$\
MM)@-G=QER:YJTUF^^(WQ)U72([J:V\,Z$=EQ';R&-KR;)7#,,'9E7X!Y"\]>
M/5J\S\/^%]>\"^+_ !!<Z=IT>JZ3K,PN%V7"Q2V[Y8E2&P"/G/(/84 =#=Z5
MH7A&\?Q/).-.L+6T>.:%681$EEVN$'&_@KP,G=3[#QQ9WOB"WT62RN[6[N[
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M;CZD]36E110 4444 1RV\4S1M+&KF-MR;N<-Z_6I*** "BBB@ HHHH ****
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M+^\$8PZ ]& 888>^"*R?!'B*2X^'>E:KK=[YES<;E:0K\TK^8P 55')XX %
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M5R7BWQ0-,N=#L;>651J=VJ//!"TF(=CL2A"D%CM XR<$GT-8J:I?_P#"3_\
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MKD<UJT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:,\JW'W21@E3R 1ZUD^))_$4VJI;6OAK^T-)C"NQ-]'%Y\G4 @Y.P>G<^PY
M,&WU76KFT^'V@ZO+*EUJT<D^H,"4=TABWA&QR"Q*;OH1W-:6EO<W'B7Q1X22
M]N(+6W^S7%O(CGS(HI5_>1JW4#*G!ZKOXZ#%J_TO6-4N/#OB.;3XX-4TNXE9
M[!)U?,,JE&4.<*7QM;L,C'O3(=-UG3;OQ'XEMM,%QJVIM%';63S(OE1QKM4N
MV<9)+,0">PSWH @T'29=!^(MW8:9>7DFBG35GN(+FX><0W!DPFUG)(W*')&>
MV?2H-2U*]O\ Q]X0N8KB2/2IKJYCAA4X%P%MW/FMZ@G[OL-W\7%[1X=;O8KC
M2]5\.&QM+R.0WMZVHI)+,S+MXV $'I@]%"@#MC-U+X:J?$/AV>SO=9>TM9I6
MN6DU:8M$IB(79ELC+8!V]N#Q0!W%MJ#W&K7UBUA=1):B,K<R*!%/N!)"'.3M
MQ@\"KU8UIJ]]-XIO])N-+\FUAB26WNUG5_.!X.4'*<Y SUVGTK9H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV<H8QS)(&5@IPQ&.P/4]N]3RZWI<-O!</?P>3.GF1.KA@Z#!+#'51D9/09%
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MTR>WL;]["YD7$=TD:R&,YZ[6X/IS3-(TS^R[(Q/<275Q(YEGN90 TTAZL0
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M4;&1^1(_6N)T_2-5\'^)M8N-/TY]2T;5[C[8T<$B+-;3D8?AV4,K<'@Y'H:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5>]OK33;5[J^NH;:W3[TLT@15^I/%6*Y'XHJK?#'Q#N
M4'%FY&1T- '6JP90RD$$9!'>EKDM/\0ZG#XHM-$U"QMDAN[![JU>"4LX\LJ"
MCY &2&!R..W/6J^G^,[Y_$.BZ9?VMK%+JB3%[:.3,MDZ+O"2')#$KG^[@^M
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M.6YNF"N'W\$!<AOEP!TZDGH*CT;Q]_PD5KH<5C:K!J.IQS22QSDLMJ(6V29
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MG+2S2!%7ZD\5.K!E#*05(R".]>1ZMJ&KZK\.?B$VJR6TJ6]S=6\812-GEA
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M8RJYE,)9.,;0PZ'DCTK6'BZ2Y\3WFC6KV275I=11-97!*S2PML+3(<X( 9N
M#]WDC.* .MHHKB7\9WUKJVE6][:6T/\ :&H/9&S\S-Q OS^7(Q!((8)G&!@,
M.3@T =#J'AO2-5U6SU.^LDGO++/D.[-A.0?NYP>0",@X(XK1F2%X_P!^J,BG
M=\X! QSGGTK@;WQQK\-EXGNX-)T_R] N&68/<N3+&L:N=N%^]ACUP!P.>HWC
MXAFU+6O[(TE(/-2R2\N);D%E19,B--H(R3AB3G@ =<T ;EG?6FHVPN;*YAN8
M"2HDA<.I(.",CC@@BK%<3\*-_P#P@4/F1K&_VR\W(IR%/VB3(![BMS4=9ECU
MZTT*Q6(WMQ!)=-),"4BB0JN2 06)9@ ,CN<\8(!M45R:^*-3C&DZ=?:9'::W
MJ5Q-"D32[X@D0+--D<E2H!"\'+ 9'6L_4O'=_I-GXF@GL+:35-#@6Z $K)%<
M0L"0Z\$@C!!4]QUYH [RJUWJ%G8",WEW!;B5Q''YL@7>Y. HSU)/:N:MO%6H
MP^)K+3]6L[2"TO[&2[@EAF9FC\O:6$F0!T<'CIC'/6N;\5:M?>(/"V@:PMO;
M)IUUK%D\*-GSDC,Z[')Z988RN.,]3B@#TM+VTDO9;)+F%KJ%%>2$."Z*V<$C
MJ <'\J+J]M+%8VN[F&!99%BC,KA0SL<*HSU)/05RLVO7@\1>)[*WL+&&ZL-/
MBGANB2QE#>9@/@ X&T\9/7KS639>(M3M_ 7@^^U&TL]0?4;FQB>25CN0RE<2
M8(.7!)/48XH ]'HKF'\0:AJ%[K-OH=O;2G26$3BX+#SYB@<QJ1]W *C<<\GI
MQDY<'C^ZU:7PP='TZ"2#7;>>1&N)RIB>)1N5@%/ )QD9SCH.M '=T5P:>/YK
M?P[=7FJ6]O:SV>KG2[J92SP1$$?O3T.S!'7')ZCK75Z+>W%_9O/.UK(AD(AG
MM'W1S1X!#@Y/7)XR<8ZGK0 EYH.G7^K66J7$4K7EEN^SNL\BA-PPWRA@#D<'
M(K2K$U?76L]9TS1;1(VO]1\QD:3.R*., LQ Y/)4 9&<]1BL"]\3ZA=:/XNT
MPQPVVL:-;LSNK,8Y(WB9DD3N#@'CG!'4T =;;:QIE[>RV=KJ%K/=1+NDACF5
MG49QD@'.,\57UCPWI'B"2T?5;)+HVCF2$.S  D8.0#A@?0Y%9?@>P4^%=!O;
MJVM#=QZ;#%!-&GSK$8T.TD\]1R!Q4'B'4M9@\?>&=.LI;=;.Z2YD='#99HT'
M4CMA^!ZC/I0!T]IJ%E?B;['=P7 AD,4ODR!]C@ [3CH<$<>].:^M$OH[%[F%
M;N1#(D!<!V48!(7J0,CFO+K36]3\,VWCK5-/L;2:ULM:DFN%EE*,R^5%N"
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MOG[6PP$YFV[>W)QG/2KVM>$+OQ!,@OS9'R;V.YM+U PN;5596,:G'.<$9R,
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MFM)H@6S*)0H8@XXQL''OUK$3P%X@C\-V7AU=8L&L-.O(9[2>2W<R^7'('5'
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M9. 1R>:KVGANY\1Z)J6DW^M:Y<:-=QH$DO;>."XR"2P4&,$+POWE!]*WM?\
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MXWMWWLA5,+@KP"-V2/6M.Y\#6U]H+Z7>:OJEPTLL<LUW)(AFD,;!D&2FT*"
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ML\;(09W'))SM //' !K4\:6]A8>.O "S6IFMX!>IL$)F8JL P-H!+8P#T]Z
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MVL-U'-+>%5E1PY[(2#\O Y'7)Z HGC^WN+;P\ZBVLVUJS-S$U[*5C##9^Z#
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M3-'*[F/(4+@H&&.H)'85=?Q,ECKGB]GT6$2Z18PW+36[;I;M2LC*I^4$8VD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@#B].\(78\3:9KU\EA!J%K \5W<63,#?EEVCS%V@  _-U8Y KM*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "L#QEKDOA_PZ]Y 46:2>&V1W&5C,DBIO/LNXG\*WZH:UHU
MCX@T>YTK4H?.M+E-LB9P>N00>Q! (/J* .:\0ZAK'@S3-;UI]1&HV,%CYD%O
M<(HE6<'&<H%!0Y7([=L4S4M1U;P]JGAIVU.2_M=5N!8W*21H-LC(662/:HP
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MT4T$,D<+LLMP<1H0I(+G^Z.I]JRK?1[R'Q<^I_VC?O:FS\B2":93$S@J5=$
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MTN\L-3,NH)>1^7</<$;G7L!M "XZC:!SSUYH Q+^^U70?&&@Z>=1GO;+6!-
M_G)'OAE1-ZR*54<$ @@Y XQ7,)KWB=? EIXC.O.US%JQM7A:VB\J:,W9A^<!
M<YP1C:5Z>O-=]9>&8;6XM;B>_O;Z>TB:&UENBA:$, "1M498@ ;FR?S.<_\
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MR.V!&,(,#L2 3D@$@=3734 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;]/GM//D@$R&,R1;=P!&#C<"/TJAH7A^/P_X=@T6TO;IX+>/RX99=A=%[=%
M./<4 >;>$+_6-%\%> [J+40UE>W:6$MEY"[=CF3YMWWMP(SP0/;N>@EUOQ/K
M=MJ-WX>643V>H26T,#^0+:18I-C"0L?,!(#'(QC*\=2=.'X?V4&AZ+I$>IZB
M+?1[I;JV;,6XNI)4,=G(^8^G6E?P#9C7+S4+75-3L[>^D\V]L()@L%P_=B,9
M4MWVD9H ZQ260$C!(Z9SBO*K#4[CPI:_$+77O+F\-C?L1#(L865_)B"EBJ C
MD@<$# Z5ZL  ,#@5SEKX,L8$UN*XN;F]M]:=I+N&XV;264*=NU01P .O;UH
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MS<PW[VMMIXO+&.!(T82"*,[RY8$_,2P&",#'4UVWAK_D5M(_Z\H?_0!6+=^
M+2>;6OLNJ:A8VNM(XO;2 QF-W9=K.-RDJQ'7!&:Z/3+!-+TNUL(Y998[:)8D
M>4@L548&< #I[4 >;7;ZK;:W\2K_ $O4_L,ED(+D8@60R,EHK!3NR IQ@X&>
M>H[[:^)=1UJ_M=.M!=02/H\&H2/9"$ONE) '[XXVC:>@).1R,<ZDG@RVD?Q"
MQU*^_P")\@2Z \OY0$\OY/DX^7CG/YU5N_A_:3C2IK75M3L=0TVV%I%?6SHL
MDD(_@<;=K#C/3KS0!D2ZGXS2[\(Z9?7MK8WVH&ZAO?*A649CC9E<9X!P <=,
M^HXJ=M2\1WD^K:-97MU+J&D0PQ?:H(;=5GG:(/OD60\*<@87'1N>F-R3P?;/
M?:-=KJ%\DFDM(\7SHWFO("':0LI))!/0CKQBHM5\$6^H>(#K=GJNI:5>RQK%
M<M8RJHN$7IO#*1D= 1R!0!2&L:_'XL\+Z?>R00?;["X>\MXD#*LT:IT;J1ES
MQQTKGI/$GBB'PI?Z^^LHQTW6FM#;BU0+/$+E8L,>HX/&W!]<]NXE\*6KZUI6
MIQW=U"^EP/!;PJ5*;7 #;MREB3M7G/:L^3X?64GAV^T1M4U'[->WAO96S%O\
MPR"0X.S &X ]* .NKB_BGN_X0:380&^W6>,],_:8ZU[32[^#Q=<Z@VHWLEC)
M;+&UO.ZF(2#;AHU ^7@-NSU+#'2IO$GA^'Q-I8T^YNKBWA\V.8FWVAB48,OW
ME/&0#0!ST>JZWIWBS6]'GU2WN@NCKJ-M+=1K#' Y9T*L5'^KRH.3D@9Y-0Z)
MKNJW'BVTTF74;BXMKS1FNOM#VZ)B9712T7R E#O.-RG. 1D5L:CX)LM6U*^O
M;V]O)#>Z:=-FC!15\K).1A<ALL3G/X8IMAX)ALM7T[5)-8U2ZNK&V:U5IG3$
MD1*D*P5!T*CD8)[DT 96A:YK%[ILNCWFH,/$-OJK6<\JQ1C]V#YF\+MP%,/0
MD?>(IMQK7B76X]8D\/><MQ87[VD$;"#[/(8R PE+'S/F^;[N, K[YZJ'P]80
M>)[KQ#&A%]<VR6TASP54DYQZG@9]%%9$_@*T?7KK4[35=4L$OF#7MI:S!8KA
M@,9(P2I(X)4@F@#J(V>2W1G&QV4$A2#M..Q[UXU?I=-\)O'DMSJ5U=E=1NX<
M3[/X)E4-D*#G  QT] *]H551 B*%51@ #  KD;KX>V%UI>M:8=2U*.RU:X>X
MEB1X\1L[!GV90GD@=<X[8R<@%6;7-5T'QC/:W]_]NL7T:;41$(%C\IXF4%4(
MY*D-_$2<CK1I&H>*K^70=4B$DEA>1K)?1S^0L2HZ@JT)0E^"1PQ.1[UN2>%X
M)_$-OK,][=2S0VCV9B<1^7)&Q!;<-F<DJ.A%4= \"6OA^=%M]6U2;3X&+VVG
MSSAH8#VQQN('8$D#KU - '37,3S6SQQSR0.1Q+&%++]-P(_,5Y5X0U:[T7X;
M>#K>&\E:;6;F.T1I40K;*2[,5PHR2%P-V>2.PP?5IXVE@>-)7B9A@2( 2ON,
M@C\Q7+P^ --B\)V?AXW=Z\%C(LUG<,R":WD5BRLK!0,@D]0>.* (8M6U&R\:
M7WAJ\N&O;:72SJ%M<.BK)'AMCQMM !&2"#@'J#FN3L_^29?#/_L*6/\ [/7H
MD/AU$N+J\GO;B?4+BW%L;IE0-'&"3M0!=HY))R#D^P &:O@*S30M$TA-2U 6
M^CW$=Q;-F+<63.T,=F"!D]A0!6AU75O$<GB8Z9J#6+:3=-9VT8B1A)(B*Q:3
M<"2I9L84C@=<],^P\7ZEJ!\':U).UMI.MQM;W$ 1,0W)4E"&()VDJPY/7;[U
MT<GA& :IJ%]9:A>6+:DH6]C@V;96 VAQN4[7QP2.OIGFIM1\)Z3J7AF'P_)
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M83.03\G,F-NS@J>.*LVVJWEAXNMK37QJ$7VC49?L.HV]RTEI=*V_9 Z XC8
M@ 8Y*9SR<@'HU%4=.TW^SY+UOMMY<_:KAI\7,F\0Y &Q./E08X'N:O4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ2WM()+AXQZNL:L5_'%6M)UG3]=LS=Z;<"XMPYC+A2/F'4<@=.GUH OT444
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M;Y3&S*N3@9V@XY('- %^BLF/Q)IKW$$!-W$\[A(C-931*S$9 W,@&>/6M:@
MHHHH **SH-<L+G7+K1XI7-]:Q+++&T3* K$@$$C!S@],]*T: "BBB@ HHK-U
MGQ!I7A^*VEU6\2UCN9UMXF<$AI&S@<#CH>3Q0!I4444 %%%4]0U.VTR.![GS
M=LTZ6Z>7$S_.YP,[0<#W/ H N45F)K^G2:Q=Z4LDIO;2$3S1B%^$)(!''S9P
M?NYZ4VR\2:3J'AX:]!=C^S"KOY[J4&U6*DX(SU![4 :M%9FF:]8:M>7EG;M,
MMU9E?/AFA>-E# E3A@,@X/(]*=K.N6&@6B76HRO%"\J1*RQ,_P S$*H.T'&2
M0,GB@#1HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ4#%4<R."P!XRO/M0!J?\(-X;_LZYT]=-"6ES<?:98HY9$#2;MP/## !Y '
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M8)Z#N: ,^;PIHT^A0:)+:R-IT&SRH/M$F%V$%1G=G (&!GC J;_A'M-_M?\
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MLS*^IQ"*\WRNRS( 0 5)P, G&!QGBK<6M:5.L[0ZG92+ BO,4G4B-6&5+8/
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M6MYIWF)IZ[;5Q/(LD2XQ@.&#8QVS6A;^(=%NYT@M]8T^:9V*I''<HS,0<$
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M\817#=3LSP><9]*]29$?&Y5;:<C(S@TZ@#E_B%!GX:>((8(N!ITH5$7H IX
M'M7-7NHZ/JGC#X>LMS:7$!@NRN6!4GRDVD9Z_,,#W'J*]-H  & ,"@#QFVU?
M2;#2M8\Q;62!?&9\J1I"(;,G:RS.%(^0,#QD D]1UJCK5[8R>&OB?#)>1W#O
M+#-$SH%WEH8P&48QR>A'4#.3UKW,@,,$ CT-+@ DXY- 'G@ETNW^*_A];&2T
MC$NBW"8A91O&^,J..O\ $1^-:/C35+'3==\,B[\FWEDGF\C4+EB(K4^40<C(
M!9@Q5=QQU/.,'LJ0@'&0#@YYH \<T5[:Y\-RVT6O-IFH6_BBZ:SN98AM64F4
MJLB' PR;^..2/:N]\"ZA=ZAHMR]]9VUO=17LT4KVC$P7# \RQY[$D_B#72E$
M92K*I!Z@CK2@!5"J  . !VH \5\3ZSITNGZ['#)%8/:^(H))[4Y:5V6:(-<.
M6SL0@#;@ <#DYQ7I7C.6VD\ :Y+,8_)?3IBIDX&3&=O7OG%=!M7).T<]>.M+
M0!Y->FRTKP!X/UNSB6.QB>S?5+FRB5G$8B8!WX.X)(P8Y!P>>M6;B'PSJ&GZ
MMJ>F^(;J(W]U9L^K_*84N8V_='&%4X(4-]1DYZ>H$9&#TIHC14"*BA!P% XH
M \AUG4-0N/!6N?VK!9M/I^L64ESJ%CDPW*AX29,<X*H &'08K>L-;TN[^+]W
M<V]]!);MX?BVSJX\M]L\I)5NA '<''!]#7H C18_+"*$QC:!QCZ4JHJ_=4#@
M#@=A0!XKI5Y:P_##X=7<EQ$MO:ZU%Y\I8;8O]</F/\/)'7U%>A^/TU"]^'.L
MKHPD:[EM"8@@(=E.-P ZY*Y&.M=00#U&:* /.[VYL=?UOP/>^')8FDAE9Y/)
M(S#:&(AT<#[HW;%P?XOI5KP/>VD_BOQJD-S#(YU-& 1P21Y$8)^F01^%=PJ(
MA8JBJ6.20,9-.H X7Q?-:0_$+P,TLD*3?:KD98@-M,#@?AN('U-9"7]G]I^*
MA^U0<*#_ *P?\^BK_P"A<?7BO4:* /([632KF_\ A0)GM)3_ &?(I#%3R+90
M ?\ @0X]QZU1>^2TTGQ%/9R,UC9>+Q<WBV@5V2VVQDN%P00'PW3^$^E>U44
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M#<!><"O8::40N'*C<!@-CD4 <O\ $9+Y_A]JPT^*2:<1HS11_>DC#J9%'KE
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M1[63]Y&?X\@$*!D9W8(R,XS7)ZI9%]4^(4U[IUU)87NF0I$<&(3E(Y RJ[#
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M+C4F@FM+86[$B624MMZ@$8W9/H%)Z5V.FZG:ZO:?:K-G:+S'CR\;(=RL5/#
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MJ-JJ36>/O3[&B,G_ 'Z;;^O84_2?#%[I?@&717NH[O4I;9HI+F4E5=BFQ22
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M5XD1<2(I+1LD3X((&0V!CG.:ZCQ%H%GXFT2?2KXR+%+M99(FVO&ZD%74]B"
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M(UR<9<L>IY))P!B+PAH]M:RZOK4-I+;'6+HW BE4JRH!@94\J6;>^#R-_/-
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M=CUW3[V;3=56+R'FB572>/.0LB'AL'H1@CUJT=#6\M+B#6+@Z@+B%H)%*"-
MC##!5'3/J23Z$4 <]=Z_K&BCPS?W=S%=VNKW,-I<PK$%$,DRY1HR.=H/!#9)
M!SD5CWGBCQ5'X:\5ZNFH62OH6HS1)&+3Y9HXPAVG+97ACR,G)Z]JZJP\'BWA
MTJUO-2FOK/27$EE'*BA@RJ50NP^^5!..!ZG)JK)X$670M?TE]4E\G6[F2XN'
M$2[D+@!@G;&%&,Y[T ,35M=M?&NG:;<WEM-;:K8SSQ(+?;]FDCV8YW9<$/SG
M'3MTKF5\7^+X? =EXTFN["6UBG*W=BEJ5,D7GF,LK[N&'&!CMR37;S^'?^)Y
MI>MW&I$-I=O)"%,85'5PNXL<\'Y1TZ5RG@#06UGX?6%E?W;FQ2ZDFELC%M?*
MSLZHQZ["0K8QD^N.* +?BKQ5J^B+JUY%=0L;*ZMUBM(8O,0PN8PQG;'R.=S8
M&1P!P:NW6H^([SQQJVA66HVEI!#I\-U#*;3>REF=<'+8/W>OIV[T:C\.HK^'
M6[4:U?06>K7(NY+=%C(28%3N#%<D91?ESBM2#PS+;^(KK6EU.5[BXLTM&$D2
MD;4)(;C'S98D]N>@H YF+QCK$GA3PGXIFEBBTZZ>./5D6('RPY*B12?NKOP#
MUX/'2NPTFZNK[4=4F,P:PBG^SVZ[ ,E !(<]QOROU4US%W8V/ASP=#X%,-[J
MC7=I+;VH^S,5;/ $CJ-J8+9W'& ,_7L-'TR+1M&L]-@+-';1+'O;JY Y8^I)
MR3[F@#GOBC-=V_PVUN:SNGMI4@Y= ,E20"O/3(/7K69K5OJ'_"P_"<$-\GVH
MV%^/M,D(.!^ZY" @$]OUYZ'K_$.B6_B/P_?:/=/(D-W$8V>,C<OH1GWK.'A:
M8ZWI6K3:O//<Z=!+"IDB3$@DQN+;<8^Z,8QC'>@#$TWQ+K-SX;=KB\LTN;76
MI--NKLIM+QHY7=''SF1OE 7GDG@]*Q-?\1:OJ'PZ\7 WLD,NFZ@+19O)$<DL
M+>5PXQP<2$' '3H*Z4_#U1 !'K-U%<IJSZM%.D:925\AUVD$%2&. >1ZT^3X
M>6TVF^(+";5K^2+6I1-(6V9CD 3YQA1DY13CIV % '6V\<L5NB33&:0=9"H7
M=^ XK!O-5N;OQA_PCEI<?9#'8"]EG5%9SN<HBJ&!&,JQ)(/8#'6MRS@EMK2.
M*:YDN95'S32!07/KA0 /H!6#K_A'^UM9M-:L-5NM)U6VB,'VFW5'$D1.2CJX
M((SR/0T 48]:UU-1T'PWJ,MK#J]W!//>7%J-R*D9 'EAA]YMRDY! PW!X-8V
MJ^,];TS3/%%LTL3:CH-U:A9_*&RXAG9=NY>S %@<8&0#CM747?@^"9]*NH+Z
MXBU/3'=XKU\.TGF?ZP2#@,&]!C'&,8IE[X)LM1T;6;*ZN)FN-799+F[4!6WI
MM\O:.@"[%P.>^222: '#5[U?B5_8AD5K%])-X%*#<L@E"<'TP>GK7(^$-<FT
MWP1X9TRT*I=ZMJ5W DKKD1(LTSNV.YPN /4CKC%=99^$I[?Q%'KUQKEW=7Z6
M1LV+Q1JCJ6W9*@<<@="#[U17X<VR>&['2DU2Z2?3KMKRROD51+#(S,QR,892
M68$$<B@"'PS#<P?%+Q8ES=&Y(M+'9(R!6V_O>&Q@$]>0!VKJ/$5U=6'AO4KR
MR>)+FWMI)HS*A=<JI/(!'IZU0TCPO)IOB&]UN?5[F[NKR"*&96CC1#LS@@ 9
M'WCW^N:UM6L/[4TB\T_SC"+F%H6D"Y*AA@X![X)H XFW\0^(K;0]$O[R[@NI
M->%K%;P06RH8':)I)&RS@,2%X!P 3Z<&VVI>+;&QULW:6T$$+PFQO]0>)#L8
M@2>8L;$;EYV]-W Q5^\\$VM_X.L?#]Q>W -@(C:7L6$FA>(81QVW <>^34%S
MX'EU'1'L]2\07]W?F6*9+\I&K1-$VY-J!=N,\G()/<\# !GVWBG6B_B^TM(I
MM0FTN&":R$MOY<TGF(Q(*87)!4D# )Z>]0_\+ BB\-ZGJ]AJ:ZD(F@MX8+F'
MRIK>>1RA$R@+P"5/09 (![ULQ^"9(]1U/4%U_4!=:C% LL@6,8>(DJX 7WQC
MIZYIUYX$T_5EU=M7?[1/JD$5O-)"GE;5C)9&49/SACG<2>@XP,4 176K:MHG
MC#2-'N+M+RVUB*98I7A"M!/&F_D+C<A&>.H(ZUSNG^+/$[^&O#^OW-[9O'=:
MJMC<6R6VW>C7#1;@V[((P,#VYS79VWAV47UI?ZAJ+7UY8PO%:R/"$"%P SL!
M]YR !G@8S@#)K*C\ )%X9T_0UU6;R+&^%]'(8EWLXD,H![8W$]NE %#Q1XIU
M?11J=W'=0L;.]MXX[2&+S$,#M&I,SX^1R7; R. .#G-,DMM8NOB;XGCT;4;>
MPF_L^R)FEM_.Y_>X &0 /4\U?O\ X=1WUMK-I_;=]#::I=+>O B1D)."C%@2
MI)&47Y<XK3;PO-%KD^K66KW$%S=6T=M<EXDDWA,[7' VO\S>J\_=H X^37KG
MQ)H_@+4;V%(;S_A(/)N$C^[YD:3HQ7V)7/XUNCQ)?Z3X@\0Z;K%QO$-J+W3/
M+B56EB.5*^[A\+[[EXYJ_<>"K0VFA6EG<R6L&CW(NH5VAS))A@2Y/7.]B>A)
M.:HW$>G>,/%VGNEE=AM N96EGF@>)2PX6-2P&\%@KY&0/+'J* .KTU+R/3;9
M-0F2:\$8\]T7:I?'.!V&>E<7XAAOY_BIH\6G745I<-H]T//DB\W8/,BY"Y&3
M]3CZ]*[ZL/5/#QO==LM;M;Y[6^M(9(!F,21O&Y!(93@YRH(((_&@#D]/\:ZR
M(O[%OHXYM:36'TLW%LBJLB+$9O,578*&*C&"< G//2NH\-S>(6NM3@UNV*VT
M4B&QN9#&))D(^8.L;$ J>,\9!''6J=_X!TZ_T0V7VJZAO/MO]HKJ,; 3"Y_Y
MZ=,=/EQC&.*U]$TBXTN&1KW5+C4[R7 DN9U1/E&<*%0  #)]R2<F@"'Q3K<F
MA:3'-!&)+BXNH;2$'& \CA<\D XR3C(SC&1UK-LSXOEO]2LY T-FUN)+&^N4
MA+I-G!1TC8AEZ'. >HST-;/B+0+/Q-HD^E7QD6*7!$D3;7C=2"K*>Q! -9MG
MX7U&#3KB&Y\3ZA=WLD7D1WDD<:M AZ[0H W' RQR>!Z4 9O@CQ#J_B7SA=SP
MP7&F!K2_@"JV^Z!.7&#D1XP1Z^ORDGGW\6>,8O \WB[[9I\D6GW<R7%DMJ5^
MT1).R$A]WR$ <#GIR3G [1?"MO8^(X-=M+O[$(;-;6>"-%$4T:\C?GNO8]O<
M5RW@C0SKG@V?3[V\;^SY-2N))K,Q!79?M#.J[NH1L GC)R<'!H T[WQ!K^KO
MK:^'(9?-TV400+MA*32^6DA$F]PP4[PORXQ@G)Z"S#K&M:[J.IZ9:R1Z7>Z=
M96[R(0LO^DRH6"D\C8N "1R<G!&.9;WP2[^([C6=*UV_TE[T*M]#;A&2?:,!
M@'4[&QQN%%]X'5M;BU;1M8O='N?LZ6L_V=4D6>)?N@B0$;AT#=: ,N9]=D^(
MGAB"]OT@D?2YY;BWMU#1"53$&VEADYR0">@Z=3E;?Q#XHUFRM=9T2QDF@DO&
M0VS^0L36ZR%"=Y?>),#/3&>,=SO7/A*&35M(U"WOKJVETZ*2#Y2KF:-]I8.6
M!.25!W#GDU0L? 8TW4K@V>N:A#H]Q.UQ)I(V&(NQRP#$;E0GDJ",Y/8T 8OB
M+5K[Q)X(\;W-K=K;6E@MW9)#Y0;S1'&1(SD\C)W!<8Q@$YSBNY\/_P#(MZ7_
M -><7_H KG;OX?K(=>AL=9N[*PUL2-=VB1HZ^:Z[6=2PRN>X[^U=1IEB-,TN
MUL1/).+>)8A)+MW, ,#.T ?I0!RFK-J#_%C1+>/49(K5M.N9?)"*5RKQ@GW)
M!QGMVZG-&3Q;J]WX$O/&NGS1""WDFDCL'C&V2WBD9&W-]X.0K,"#@<#!ZUU.
MI^'$U#Q#INM1WUQ:W%E')"1$%(EC<J2IW XY4<C!ZUFKX$MXK/4-*AOIDT2_
MF:::QV#Y=QRZ(_548YR,$\G!% '3V=TE[8V]W&"(YXUD4-UPPR,_G4U(JJB*
MB*%51@ #@"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HKC_ (I/+%\-=:G@N)X)HH0Z202M&P.X
M#JI&1R>.E9EYI,<7Q+TZQ6\U#[+J6F7$EY']LDQ,R/'M/7Y?O'[N...G% 'H
M=07EW;V%G-=W4JQ00J7D=N@ KS#2KS&@1Z5/?WK^7XFN+*TMQ*2US'&[E87=
MCGRP!DDDG"XYS@Y6L"2Y^''C:UO&++8:XJ6\0G9UA7= =JDX)4%VP".,]!0!
M[717 7P^W>.9?"YN8X;6/3$GMH)VD;S6:202,"'4EEPF,DD9.,5ERZ7=+J_@
MC1[WQ%?:BLBW]O=7,,\D/V@(AQD!C\PY4L#DX/- 'H_VB]_M@VWV$?8?L_F?
M;/.'^LW8\O9UZ<[NG:KG:O/HU30OB)-:#4+Q-/MO# D)GN'E$>V4J9,,3\VU
M1GCG%9VASSV_BGP4T$MP+74M/N6DEGG+2WH"1LLLJ<J&R<CDD!L<=* -Z7QZ
M\7A3Q#K9TARVC7<UL]O]H&7\O&6W8XZ].:[&&3S8(Y,8WJ&QZ9%>27G_ "3+
MXF?]A2__ /9*Z#Q'(?#>KZ#XJDGF73 !9:BAE;RHUD $<VW.!M;"DXZ-[4 =
M]5.^N+V"2T%I8BZ66<).WG!/)CP<O@_>P0!@<\U1\,02+I9O9_-6:_D:Z,<C
M$^6KG*)@],+M! XSD]ZR/'#RPZKX1DAN)X_,UJ.&14E95=#'(<,H.#RHZB@#
ML:*\JO;#[;<_$A)KW42MB$EM0+V4>2_V4/E<-V;D \#TJ:T$T&K?#[4A>WKW
M6KP,M\SW+E9@;4R?=SM&& (P!0!Z?17BTVGS3> O%.MC6=534=(U.^:RF^W2
M$1B*0[4*DX;(&WYLGG%:'BN]GNM)\47<4]PVHV&FP22[IC"FG2^67Q%CDN<@
MGH,8&3TH ]-FN+U-4M8(K$26<B.9KKS@/*88VKLZMNR>1TQ[U<KA+F::3XA>
M$B;FXV7>F7331B9@C,%BP=N< _,>0,U#\/=*6Z%WJES>ZC/<V>JWUO#YMY(R
MB/S"H4J3AL =3D^_ P >@T5RGQ&U>ZT3P9<W=K(\),T,4DZ'!AC>15=P>Q"D
M\]B<U0OK=](^(7A^STV2=;#5;>ZCO8!,Y4"-%991SE6RVTL.3N'>@#NJ*\_^
M%NF+-X9T[7;F]O[B^9+B%FGNW=2OGMC*DX)^7KUY-:?Q U:;3-,TJ*.9[>&_
MU6VLKF=&*M'$Y.XAA]W.-N>V[UH T8_$+/XUE\.-9%-E@+U;@R A@7V8VXXY
M![UN5YG>P6.@_$?69DN9+"V7PN97E0E_(Q*V713GD8S@=3[DT:$9X/'&CV@-
MQ#9WNA2.ZO=,TDY5HPLLF#A9#N/()//6@#TRBO%;6*X'PW\/ZT-3U+^TEUE8
M!<&[=CY;7C1LI!.&RI[@G\JW[F2'PWXH\56BZI>V>F_V"EX\K3/.T,I:5#(F
M\D[L <=R!0!Z717G/A]KJS^(=K9()+>VN/#YF\F2X,AD=9459)!T$A#'."<^
MIK/TFPU?6=+\,-NU!=22]=M7O(YY(XYX!OW$2*0'4MLV!2<#T&: /5J*\O\
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M3QM 7+;2<+MVY&T#K5":]N8_A7>S_;KD7-OX@:&*0W#;U7[:$VYSDC9D8]*
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MI3K6VBL[=8(0PC7. SECR<]22:XE;"V/QNN9F5@_]APRY\QAEO/=?7T XZ4
M=%X4U_\ X2?P_#JOV4VIDEEC,)?>5V2,G7 Z[<_C6U7BFF6YLO 6@ZU;W-W'
M>)XA\I=MPX3RWO71TV [2""<Y&??@5T$D-WXOO/%5J=9CTZ\T^]\J%\/YEG&
MJ*R2+B10 WS$DCGD$X   /2Z*@LF9["W9YA.YB4M*$VAS@?-CMGKBIZ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH IZII5EK5A)8:C +BUDQOB8D*V.QP>1[5 = TUM0M[]H'-W;QF
M**8S.61#U .>AP,^M)XCU^S\,>'[S6;\M]GMDW%5^\Y)PJCW)('XU2@;Q7-I
MHO'.EQ7+Q^8M@T3G:<9"-+OZ]BP3'M0 ]_!?AV6T:UDTR-X6N?M95G8D3=Y
M<Y#')R1U[T]?!_AU+>_MUT>T6'4 !=($P),  <=N@Z=QGK5B'5X;?1;*\UB>
MWL))H4:19Y!&%<J"R_,>W-7'OK2-(7>Z@5)R%B9I !(3T"^I/M0!D:EX*\-Z
MO:6EK?Z1;S16G^HSD&//7# YY[\\]ZLOX;TA[BPG^Q(LFG+LL_+9D$ Q@A0"
M ,C@^HXJ3_A(-%^R/=_VO8?9HY/*>;[2FQ7_ +I;. ?:K$VH65N$,]Y;Q!U+
MKOE5=R@9)&3R .<T 5Y-!TR75GU22U#WCPFW>1F8[HCU0C.-N><8QGFJ-IX(
M\-6,EG);:-;(]FQ>W;!)C)]"3T]!T':M2/5-/FT_^T(KZV>RQG[0LRF/'KNS
MBD35M-ELI+V/4+1[2,D/.LRF-2.N6S@4 4?^$3T/[#>V)L0;6^D,MU$97(F<
M]6;GDGC/K@9JCJFG:E?SIH"Z;;#P\T<9FNY;DNY"MEHA&02<@ 9+< D]0!6X
MFK:;)-<0IJ%HTMLN^=%F4F)?5AGY1[FA=6TUK,WBZA:&U!VF<3+L!]-V<4 7
M*H:CHNGZM+:R7L'FO:R"6 [V7RW'1A@CGKS[U>!# $$$'D$4M &2?#.D%M0;
M[(<ZB,7A\U_WXQCYN>>./IQTII\,Z0HL&%F2=-'^A@2O^YXQA?FXXX^G'2H;
M'6I-9T^_U"SG@@LD,L-K/*,J[(2IE;D?)N! '<#.>1BW9:I;):V$%YJEA+>S
MPHP,4BJ)R1]Z-<DE2<XZT <UX0\)?9XM4;6=->.2?5I[U$:?=&ZM(70LBL5+
M+QU'! P>*W;[PAX?U*]N;R]TJWFN+J+R9W8?ZQ<8&1T) X!ZCUJQJ.HNEM<M
MIKP7-U9C?+:AP688)V\'Y6/8GO5G3-1M=7TNUU&RD\RVNHEEB?U4C(_&@"FG
MAC1HKBSN(K)8Y;*,Q6S([+Y2GJ!@]^_KWJ?2]%T_18YH].M_(2:0RR*'8AG/
M5N2>3W/>H?$'B'3O#6F&_P!2N$BCW"- S %W)P%'^>!D]JQF\5-%X[%C+?6
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MB?=M<8.UBIQ]1R*KS:KIUO>):37]K%<N0$A>95=B>F%)R<UBKK.H#XDOH3M
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M*KH'>)E$JC9M\L2%<D+C<..17K3HDB%)%5T88*L,@T>6GE^7L79C&W'&/3%
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M;$$L3VS(&@E2,1E) [+A2 #GM4'BK1+S4;K[7#:7]CK]O8(+/4=,;*22?,3
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MR#);:#T.,YZTM?T&_P!6;Q=K%M8W :_T4:9:6[*%DF?#DN03\HRR@9P>#[9
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MM9O(QC9MNX8'(!SDCCCUXK0U_P 06'AK3#J.I-*EL'5"R1EL%F"C.. ,D<G
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MO)?0M/9M/'M6X1<%BO.1@$'# '!Z4_Q%IL_B+P;J6FH#:W%]9R1*)"#L9E(
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M&4-'("JE6&X?7FL\?$&>73-$U6WTA9;'6;O[+:DW6V0,2VPN-N #L/0G''X
M'<T5Q>K^/UL$OYK.RCO8;"X\B>))R)W((#^7&%.[:3W(SM/L3V4<BRQ)(N=K
MJ&&1C@T $DB11M)(ZHBC+,QP /4FE5E=%=&#*PR"#D$5Y;JFIZGKO@[XC1:K
M;6;6]B;J&';(7\LI A4 %!GDEMV0<GI6_H7B:[M[W0=%O],6W@OM/,EI<"Y#
MLQB1"P=-N%X;(PS?X ':45Q,7Q"2>;2IH+%+C3M2N%A22"8O-$&SLD>/;@(>
M,G=QD9]!V<K.D+M''YC@$JF<;CZ9[4 /HKSNW^)MX^BZ3K]SX<:#0[Z589;G
M[6&> LY0,4V\IG )R#STZ9U8/%^IW7B'4M,@T%##IEU%%=W#WJJ$B= _F ;>
M2 ?NY_&@#KZ*XR7QX8-#LO$<NG!= NI43[0)_P![%&[;4E:/;C:21D!L@$>X
M#+SQKK(O]>L]-\,?;)=&9/-W7JQ^8K)O^7Y3\V#P/KR. 0#MJ*X^+Q_9:A::
M?)I@@:6]LA>A;R?R5C0G: 2%8[MP8<#'RGGIFK'\0KJYM] :W\/3>=J\LT'D
MS3^6898U8X.5Y4[?O>AS@GB@#NJ*X:P\0^)[KQR-,NM,LK94TA;IK7[:6VNT
MA4Y81D$@I@8'0DYYQ5O3O&<^H>&IM0_LN.+4(K\Z>^GM=$E9?,"8+[/<-T(V
M\T ==12#.T;@ <<@'-97B378O#FC/J$L32GS(X8XP<;W=PB@GL,D9/8>M &M
M17*'QE)9Z_J6F:I81V\>GV(OYKJ.XWKY.&Y *@Y!5ACZ&D;QE/:?V)<ZCIBV
M^GZQ(D,,R7&]X9)!F-9%V@#=TR"<'CWH ZRBN0N_&LJ:3J>M66F+=Z5ILTD<
M\@GVRNL9Q*Z)M((4ANK#.T].,VSXD35[U].T:UM[_%G'=3-/*8XPDH/EK]UB
M2P!.,<#ZXH Z&&:*XC$D,B2(20&1@1D'!Y'N"*?7EG@7Q!+H'P_\*(=.0VE_
M?S6;R&?;]F=KB7;\H4Y!(V]1R1ZUTT'C222Y\36LEA"MUHFS]TMT6-QO7<F/
MD^7=]WOSQ0!U/GQ"<0&5/.*[Q'N&XKG&<=<9/6F&\M1 \YN81#&2KR&0;5(Z
M@GM7.IJ4<OQ!ATN[T6V2];2'G^VB0.0GF(K1#Y02NYL]NG2O/KRUMQ\%/$J"
M"/9!K-QY2[1B/%X -OIQQQ0![51169XBU5]"\.ZAJR6WVG[' \YB\S9N"@D\
MX/8>E &G17'Q^-+R.TMKC4-(BLUOVB73R]X")=T;2,7PO[L*%/KG([U2N?B/
M-9Z1JMW+HK22:;=00/Y,^8I4E8*CQN5&[EL$8X(ZT =[67KV@VGB/3#I]\\P
MMF='98GVEBK!EYQGA@#^%847C+48O$,VB:GH2V5R]H]W8M]K#I<*A^96(7Y'
M&0<#</?U6#QRT^D^%=1&F@0Z_,D.WS_F@9D9A_#\PPI]* .N12J*I8N0,%FQ
MD^YQ3JX72?%&N,_BZXNM-6[33+QH8+:SD9Y&VQ1D(JE!G.XDMGJ3QQ5Q/%]V
M^HZSI(L[/^T;"Q6\3R[LR1-DL"KG8"K KTQR".E '52SQ0*IFE2,,P12[ 98
M\ #/<U)7G-OXCN9? ?A34=<TBUU!M0NK)0QFSL>0KMEP4X8$DX&<>M='/XDN
MI[W5K71M.COGTO:L_F7!BWR%=_EIA6R=I')P,D#UP ='17%)\0/M\GAS^R-+
M:[AUV&:2!WG$?EM&N65A@]#P2,]#@'C.QX6\02^(+.]:YLQ9W=C>265Q$LOF
M*'3!RK8&00P/04 ;M5;>*S^V7-Q"R27)(CE?=N9<<A/]D#.<>^>]6J\JTG5=
M1\-S^-I])\/)?6EMK$DTZI<+"500Q%MB[3N;J<<>Q)H ]5HKF--\8IJNO6NG
MVEHK07FD#5;:X,N"REE4*R[?E/S=<GITJC;_ !!AFT32[Z>V@LY-0O9K)1<7
M.(HVC9QS)M[^7P,<DT =C+/%!L\V5(][!$WL!N8] /4^U25Q^MZVT-MX??5O
M#\$LESK$=LJO,'%M)O94F4E>>!N!P#\PJ*^\;:I#>^)+6S\/QSMH:)+(TEZ(
MQ*C1F3C"$[L#@=.N2.,@':T5RLOC6WD33ULEMS/>V"WZK=SF%4C;&T$A6.2<
M]!_">>@-2T^(,5Y;:+FS6QN]3\X+%J$QA5'B*@H'VG<6W KQR,GVH [6BN7G
M\6RV][I>FS6EM:ZG?6SSB"[NO+7<I4&-7V'<V6]!P,UT-C-+<V%M// ;>:2)
M7DA)R8V(!*Y[X/% $]%<]/XBNI]3U.PT:PBO)M,5/M'FW!B!=EW"-<*V3MP2
M3@#</?&0/B(;V/PY)H^DM>)KBS"+S)Q$8I(T8LC#!Z%2">V#C/ (!W%%5M/F
MNKC3K>:]M1:73QAI8!()!&V.5W#KCUJS0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/>.-$O/$?@_
M4-'L&@2>[0('G<JJC(.> 2>G2JGB;0=;U"71M8T>>SM]:TQGQ%<,S02I(H$B
M%@ W\*D'';I75LRHI9F"J!DDG  KFQXZT<W]G9JM\SWP1K5ULY&29&( <,!@
M*"1DG& 0>AH H:MH?BG5M/T^2:XTQ[J&]6XN+ NZVLD04CRRVTLV"=V2N"0.
M.!4.G^&/$%@-<5QHUW#J6I?:VMY-X22-D57C;*MC&WC@Y[XZ5W5% 'G ^&UQ
M!ICKITT%C+;ZM'JFFVGF-)!;E5 :,D@':^7)P.-PQG'.Q=^&]1U/4KW6;J.T
MBOFTM].M8$G9T7>=S.S[ >NT !>@/KQU]% '"P>$]9ALO!,!-@3X?VB<^>_[
MS$)B^7Y/?//T]ZS_ /A"?$YMK2*2XTF6>TUM=2-W(TADND#.0'^7Y2JMM &1
M@ 97'/I5% '&Q^'M=L;_ ,2"S>P>#6I?-6>21U>W8Q+&?W84A\;<CYAGIQUH
M3PA<6&M^$WTXV_\ 9NA6DULPEE82N'5%R %(R-F>HSGM7944 <*FGZ=K?Q(B
MU;2M1BN+5+57U!+=U>.65&(MRQ'\0S(?;8M=U5&&UTO0-/F:WM[33[.,--+Y
M4:Q(O&68XP.W)JOIOB*QU34)K"%;F.XCB6?;/ R;XV^ZZDC!'ZCN!0!@1^&M
M;M&\36MJ]B;;6[EYUN7D8/;[XUC8>7M(; 7(^89[XJ!O".M^'=7M;WPA-8-;
M_8(;"YM-19U5EBR(Y%9 3N )!&,5U6NZ]8>'=(N-4U&21;6W_P!8T<;2%?3(
M4''4<GCFM('(!H KV,5S#91I>3K-<X)D=5VJ6)R0H[ 9P,Y. .37*7VA>)=/
M\7WFM>')]-DM]2CC6\MM0+KL>,;5D0H#_#@$''3KZ=G4=Q<0VEO)<7$J0P1*
M7>21@JJHZDD]!0!S>K>&KGQ!;C2]8>*YTS[,=Y21D>6X/1BH7"JO)7DX.#S@
M5S'B*#Q#9>&O"%MK$ME=:I!KUHBS1RMMGQOP7)4%21U(!YY]J[&3QEHL-BU]
M-+<Q607=]IDLYEB([$,5Q@]CWR,9K2OM)T[5#$;^PMKHPL'B\^)7V-ZC(X/O
M0!RNK^")O$TVLW>I2QVEQ>:>EA;"W<R>2JN9 Y)"Y)?;QCHO7FI8-%\4:WHM
MYI7BNYTU8)K62V+:=O+3%E*[VW !< YVC//< 8/8@ # Z44 <IX7T_Q;90VM
MEKEUIKVMDGEI-:;S)= #:I<, $XY.,Y([#KAP^!-?@\(VNF0W]A#?Z3J#7NF
M7 #LLA+R-B48& 5D*D+GUR>E>CT4 <1J_AKQ'XH\,S0:K>6%GJ:2Q3V8L][P
MQ21MN#,6 +;CP>.!TS4MIHWB2Y\::=K^I1Z7 L%A+:316\\DA)9U;<I*+_=Z
M'IZFNRHH S]>TUM8\.ZGIB2"-KRTEMPY&0I="N?UKE(_"NNPR>&]65]/_M72
M(&LY8%D<0SP,JJ1OVY# J&'RXYQ[UW=% &#H6A2V&K:SK-V8A?:K)&9$B8LD
M:1IL102 2>I)P/O8[5%XRT2_U[3K*WL#;!X+^"Z<SR,H(C</@84\G&*Z.B@#
MEK?1-6@\8:WK.RR:&^LX8(D\]PP:/?RWR8P=_;/2L:W\%ZW;^$O"6D;M/:;1
M+Z&YE?SW"R+'N&%^3.3N[],=Z[9]2A35XM-*3^=+"TRN(F,852 07Q@'GI5L
M,&S@@X..* /-M#@U6^N_'UC8I:!+G5)(O.FE8&(M!&"VT*=P ((&1DC''6K<
MO@C5;6Z^S:=/8RZ6NC+IMO\ ;"_F6C*I4NB@8;>",G*G@=0,5V=EI.FZ=+-+
M8V%M;23MNE:&)4,A]6(')^M7* .#M/">NPQ>"%E;3F;0$V3[)7&\>281M^3G
M@[N<>GO6QX6T74='O=?EO?LICU'4&O8O)E9BH*(NULJ/[F<CUK5U+5[;3#$D
MHDDGFW>5!"A>23:,M@#T'\P.I%9#^/-"&F#48Y;B:V$*SS&*V=F@C9BH:1<9
M7E6XQGY2<8% %SQ;X>C\5>%K_19)F@^TH-DJC.QU8,K8[X916=_8FKZMJ6BW
MVMI8I)I.^55MIF<3SLFP,<H-B@%CCDY(].;DGC#28=$M=6F^UQ6MU.+>+S+6
M16WE]@R"/E!/0G K3_M*'^V/[+V3^?\ 9_M&_P IO+V[MN-^,;L_PYSCF@#(
M\%:)?^']$EL=0-L7-U/.K6\C,,22,^#E1R-V*/&GAVY\1Z1;I87,=OJ%C>17
MUI)*"8_-C.0' YVD$CCUKHZ0,#G!!P<'':@#A)_#GBG4?$%UJ\LVG:=-/HCZ
M<IMII)6AE+%ED!*+G!QZ?C3-)\)^(;/6= U"5=&B&GV4UI/% \AWEMAWABHR
M6*<Y'&<Y:N_HH \Z3P3KJ> +3P_NTXW,.I"\,GGOL*_:3/C_ %><\[?U]JT-
M7\,:[J'B35=3M+JVLOM>B?V=#*DKF2*0,[A_NCC+XX.1C/M7:T4 <!I_A[6-
M'UK3==OO['M+/3]*EM;J*V,C;1N5RZDJ-V=ASG&,_P 58&AIJVG:1I^K_P!G
M^'K^Q21KNW6'495<-(2?W4)4QK)AR H/4D \DUZ]UK$T_1_#=OK$\NG:1I\5
M]%Q-/!:HK*Q&=I<#[Q!SCK@C/49 ,.V\/^*]$US4UT:\TQM'U*Z:[)NP_G6D
MC_?V #:X)Y )'/Z]JB[$5=Q; QENI^M*[;49L%L#.!U-0VEY;WULMQ;2"2-B
M1D<$$'!!!Y!!!!!Y!&* .*N?"&MFQ\9Z?;RZ>UMKKRRP/([JZ-)$L9# *0 -
MN>,Y]JMMX:U676O"MW(MEY.DVLUO<J)W)?S$5,K\G;9GG'6NP9E7J>3T'<UG
M:-KECKT%S-8/(R6]P]K)YD31D2)PPPP!X)]* .9\+Z!XM\/Q0:')?:;+H5H^
M+>Y ?[480<K&RXV_[.[/3MGD=Q14<Z126\B31B2(J=R%=V1Z8[_2@#RWP7HM
M_P")?A-H6DW"6L>F-(LLLJRL9'CCG+A FW )*@$[CQS[#KM(\/7UOX@\3W5^
MMJUEK#QLBQ2L74+$(R&!4#D#/!X_6DT;Q#X7@LI8-#MIDM;>9XI([+29PD<B
MGYEPL> 0>HKHK.[@U"Q@O+5]]O/&LL;[2-RL,@X/(X/>@#AK?P3JK>#8?!E]
M+:2Z3#*B_;%D;SI+=) ZH8]N WRA2=V,<X[4W2FU7_A/O'B:;#:.7DM 'GE9
M-C?9EP<!3N'MQT]^/0JIVND:;97<]W:V%M!<S_ZZ:.)5>3_>(&3^- '$IX&U
MCPU)HUUX3NK.26RT\:=<P:AN6.XC#%PX* E6#%CT/WOST[_0->O=5\-:A+-8
MRRZ=<2W%SEW0'?&R;(QM/"ANI/..V:W=7UVQT/[']N>1?MES':P[(F8&1V 4
M$@87D]3BM*@#F;C1K^'Q^/$4,UF+%].6SN1,S!T"R-)N7 P<AB.2,=>>E9FE
M:98:C\1;W6]+OX[C3O(BEE2!P\37FUD#AAQN$1P1_M*:[AT61&1U#*PP5(R"
M/2H+&PL],M5M;"T@M;=,[8H(PB#/H!Q0!EZ=?:O+XGU6TNH[)M-B6-K66W+>
M8I(^99<\;NX"]!C/45G_ !%DC/A1K%I+))=0N8;6$7N1$S%PQ!8<K\JL0PY!
M QSBNLJKJ,%E<Z?-'J-O#/:;2TL<T8D4@<\J0<T <)::;?7<]_HFM:?I@&LV
M;P37EAJ,MQ,J!2 6$J@A1N.#G&X].2:OP>%M8O=*T'2=:>R:WTBXAF-Q!(Q>
MY\D?N\H5 3)VEN3T('7(V/"4GANZT1+[PO;6D-A<$\VUL(=Q!(.5P#D'/45O
M4 <)!X0U?3]'U[P]9RV;Z5J<D[0SR2,);59L[UV!2'P22OS#.>:DMO">J>&_
M$YU#P[]CFL+FR@L[FVO)6C9/)7;&Z,JMGY3@J0/KZ=+IFNV.K7FH6MH\AET^
M40W DB9-K%0P W 9X(YZ5I4 <'8>![\?"Z?PM?SVWVO]Z\$\!;:DAE:6-N1D
M88C\JLIX&=/$.C:I]L!:"!DU(8Q]LDWB5&QVQ*6;\0.E=G10!S<NBZBWQ#AU
M]/LILX],>R*&5A(6:17W8VXQ\N.O?/M7/3>"=<F^'^LZ!OTX75_?R722><^Q
M5>;S<'Y,Y&,=/>O1:S;K7;&TURQT:9Y!>WRR- OE-M8(,M\V-O QQG/(H IB
M_P!;'BZ&S:&P;2WM"\GEN[3Q2@]2<!=AX Z$G)Z U8\4:=<ZQX6U33+0Q">\
MM9+=6F8JJ[U*Y. 3QG/2M:B@#C-6\+ZQ>>'-!^PW5I:Z[HK1R0LQ9X)"$,;(
MQP&VLI/09%9/CQ->_P"%:ZC-K+V*WCW%D(X+0LT,>+F/G<P!))// X 'N?0+
M_4+;3;;[1=2;$+K&N 26=B%50!R220 />L9]1T#Q%I5\]_8&>#3Y62YM[NR+
MM&Z@-]P@[N"""N>M #&T&[U3Q+;ZQJBV\ L[26VMX8)3)\TNW>Y8JO90 ,=R
M?:N:LO!GBB'1_"^F2RZ2(] ODE619)"9XU1U!(VC:V&'R\COD8P>\T;4+/5M
M&L]0T_/V.XB62'*[?D(XX[<4ZTU*&\O+VUC2=7LW5)#)$RJQ*AAM)&&&#VH
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ML!)AN(EEC)&"58 CCZ&IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP&&UMXE>-8SLW"X9ER&.YL!6!QM..M=EH^B6^CF]DC9I)[ZX-S<2L -[E0O
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MJVC/JFH&WU2\:\G8>5O#LP<A3LP!D#M0!!J6L:WJFKZ_IFB&YAGTM8XXFA6
MJ\KQB0&3S#G9\RCY0#PW/3'5:5)>S:3:2:E#'#?-$IN(XFW*LF/F /IG-8.H
M^!XKS7?[9M-9U/3;Z2)8;M[-T472KTW@J1N'0$ 8KI(+6.ULDM;?,<<:!$.=
MQ  P#DYR?K0!YGX-FU^+1?&!T6TLI9!KNH&)IIV5M^[CY0A![=QGVKHM?O\
M5;3QCX;TC3;R*ULK]+I95%NK%3&@((S]>GMSGI5C2?!C:''>1V'B#5(UO+J2
M[ERENW[QSEB,Q<?2I5\'VZZAHM[_ &C?--I(E\LL4/G-+_K&D^7DGKQ@#M0!
MQT^N^*H?"OBJ]&N(9_#MY-'&YLX\W2HJ.!)Q@<-CY I[YK9N=2\0ZGXW_L:Q
MU:+3[6;1DOE<6JR/&YDV\;C@]._&,\9P1HOX$M9-*U[3GU._,.MS/-=']UN!
M90K;?DX&% YS6,-/N4^*T*6]Y>Q)!H*VWVHP!DD<3$[6.W;NQ@\8_F* ,>ZU
MO4=:\)Z2NK^6VHZ?XMMK"XEB7:LK1W &\#MD8_'-=7!J>I^(]5\1VFG:BVG_
M -E2K:P;8D?S)=@<M)N!^7+  +@X!.>1BS<^!["?2++3DNKN!+6^74#*A0O-
M.'W[W+*0<L23@#TZ<5/)X4C36KS5;#4;NPGOXU2\$(0K*5&%?#*=K@<9'XB@
M#E;7QGJMWI'A+Q3++]FTF^E^RZG;K&I$4A+(CAB,A/,&#ST8>]:=_P"([^TA
M^T12R2Q:EJZZ?8*$CS&@!#L,X!):.3;N..5//0NU^UL8=!7P)8Z->217=EY$
M#I S6\*YV[GD[%?O^IQZD5KZMX1TO5_#,.@S"6*VMQ']GDA?;) T>-CJW9AC
MK0!SUYKOB;P];:E+?Q-+:RW%M#ILUSY(F5I76-PXC(0A2V0>,]">];.C-XD3
MQ%<Q7PFDT9[</#+=F 3QS!L%<1<%"#G)&01BF_\ "#VEUH-[I>LZA?ZM]L14
MDN+J0"10IRNS: %P><XR3USQ5O0/#;:)E[C6-1U68)Y<<M](K&-..!M ZX&2
M<DX'- %3Q'/=^&M!@ETNVO)XA=AKY[6-9;@1MN9Y%4@ACNVY&#P3@<#%SPGJ
ML.M:+]MM]675('E?RYP@1@N>%=0!AAT/ ]>]7=4TU]1%JT5[<6DMM/YR/#M.
MX[67:P8$%2&/'7IR*9HNB6VB172P,SR7=R]U<2, -\C8!.  !P /P[G)H X*
M"TUZX\3>/'T/5X]/FANX74-;+*)6%M&0K%NB]N!GGKQ@NM/$_B+Q+=^&4L=0
MBTQ-8T>:YDQ:B0Q2IL&Y=QY&6. >WK752^$8CJ6JW=OJ=[;)JNW[9#'LPQ"!
M,JQ4LI*@ X/TP>:D'A*SCUS2]2MIY[8:9;-:6]K$$\H1';D'*D_PKW[4 <[)
MJ_B?58=8BT669KW2[@6<3". 0SR(B%S*'.\!BQX7&!CK3?%/B'7=/L=8NHKY
M(+BRTV.ZAL[2-9MCA6:0SLRX"DC"X8$@,1DUL7G@6WF\0W.KV6KZIIK7FW[;
M!9S!8[@J, G()5L<94@_0\TR_P#A]87MQJ[)J%_:VVK6RV]W:P.@C;:GEJPR
MI92%QP#@XY!'% "1:U?:]KTFD6MXVGF#3(;QY(D1G:27=@#>&&U=O/&26'(Q
MSCZM%K3^*_ 4-]=VJ:MY5\L]Q;(6C#>4H)56QS]> >Q'%;%UX!MY;G3KVTUG
M5++4K.V%H;V!TWSPYSM<%2IYY' Q^57W\)6K:KHU^E[>(^DK*(4W*PD,@P[.
M64LQ/7.1S0!7\$:IJ&HVFK6^IW(NI]-U2:R%QY:H947:5+!< '#8X Z5%%J>
MH>(/$?B'3+'4'T]=)\J%&CB1S)*Z;RS;P?E&5&!@\-STQJZ#X>BT!]2:&[N9
M_P"T+M[R43;/ED8 ';M4<?*.#FH9_"\?]OW.LV%_<V%W=Q+%=>2$99@OW6(9
M3AE!(!].H- '!ZEK%YXK\'^#-5GFELKB77K>">* (4\Q)70NNY2>JY SCGD&
MO3;Q&CT6X1Y7E9;=@9' W,=IY. !GZ 5CW?@G3Y]*TC3;>YNK.UTJXCNH%@*
M$M(A)!8LISR23ZDUO7-L;JPEM3-(ADC*&50-PR,$C(QG\* /+O"FH:QH_A[X
M>N-062PU%8[*2S\A0%!A9E</][<"G/.#GH*VUU[Q$6\:PVP%]<Z9<1)9Q11*
MK;&C1V"@_>8!FQG.2!6G%X%M(=.T"Q34K_RM#E66U)\O+%5*@/\ )R,,1QBI
MAX.B2?69X]5U".;59XKB1U,8,3Q[=I3Y/1 ,'.: (_!VOP:^+Z6VU::\CB9$
M:WNH%AN+5\'<LBA5]L''KZ4TZK>:SXRU70;2]DL(],M89'EB1&>227<1]]6&
MU0H[9);KQ6KIFA0Z?J=]J;S//?7JQI-*RJN5C!"@  ?WCSUY]  (+SPS%/X@
M77+.\GL=0,'V:9X0K+-'G(#*P(R#T(P>W(XH \_N-;U/Q'#X3,[0P:K:^(I[
M&698R8S)'%*I<+GN.<9ZU?O=2UF'3_'7AO6;U-0-KH[W5M>"%8F:.2.0%75>
M,@KP1U%=1-X*T]M.TZVMKBYMI=/NC>0W*%6<S-NWL^X$-NWMGCOQCBII?"=M
M<:?J\$UU<M<:O%Y-W=_()"FTJ%4;=J@ G QW)Y)S0!@6^JZC8'X>6=O<(MG?
MP"*XB\L$MMM2X^8].0.E4M:\6:W'8>)IK6[%MJFFZ@EM9::8D;[1&=FUB"-S
M%]S$%2!P/0YZ<^#X"_A]CJ-[G0QBV_U?S_)Y?S_)S\IQQBN-1+B76M2E.J>+
M-(U&>\D<6D6F_:(B =JLLAB9<%54_? &<< 9H V_$^K:UIJ:DL6K*);/2OM,
M45I K2-* Y9Y@RE4C^4 88$_-C) JHUU?:MXU\%7)U&YMTO=)FNG@B">6K[8
MB<!E/7>1SD@=,<YU!X(;4#/>ZAJ=[!=ZGI\=IJD-LR+'.RH5W<J2I&YOND#\
M.MJ/P1;1-H,B:GJ*S:/"UO'*'3=+$P4%'^7&,(O*X(QUSS0!@7/C35-(L/&$
M]S+%<2:?J45G9YBVHGF+'C=CD@&3)YYQVK6O-2U;0_&.BZ7)?M?6FL1SQ*\T
M2![>:--X8; N5(SD'D$=:M-X%TR>#7K>\FN;N#6Y!+<QRE0%8  %"J@C&U<=
M>1FK5IX;$5W:W=YJ-U?W5G"\-K+.$!B# !F^50"Y  R?R&3D X>Q\3>)SX6T
M'Q!<:M')Y^KBRGMA:HJRQM<M%DGJ& QC&!QSGK6Q=^*+JU\8/I.I7MQI+R7L
M2V!D@4VMY#\NY1)M)$A^<8R.=N*O)\/[./PY9Z&NJ:A]FM+P7L;_ +K?Y@D,
M@!.S&-Q)Z5=NO"45\)(+S4+J>QDNUO#;.$PKJP<!6"Y"[ADC/KS@XH C^(.J
M7VA^!M4U73KCR;NTC$B-L5@>0,$$'CFF7>J:C'\1+32(KH+:7.ES7&QHU.R1
M'100>#C#'C-;.N:/:^(-#O-(O=_V:[B,3E#A@#W!]1UK'M?!IAUFTUB?7=3N
M;^VMGM1+)Y0#(Q!Y4)C@J.@!/<F@#D],\3>)G\->%M?NM5CE%]JB6-Q:BU15
M='F>/=GJ&& 1C XY!ZF]K&J7WB7POXXFM[]K2VTW[58QPI&C"4QQ9D+E@3R2
M0-I&  >36Q%\/[.'P]IFBIJFH?9].O%O(7/E;RZN7 8[,$;B>U%UX!MI;K6'
MM-5U"RM]81A?6L/EF.1V7:7&Y258CK@C- &5I6L7UQ!I.@6!NXC#H-K=O+:"
M R$N"J_ZTXVC82< DY'(QRR75?&:W?A'3+V[M;"^U$W4-[Y4*RC,<;,KCD@'
M !QTSZCBM:Z^'MK(-*EL]8U2QO\ 3;86D5[ Z"22$=$<%=K =1QUYJ[)X/MG
MO]%O%U"^6726D>++(WFO("':0LI))!/3'7C% &UI\-U;Z?;PWMT+NZ2,++<"
M,1^8P'+;1P,^E6:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH CGGBM;>6XGD6.&)"[NQP%4#))_"
MLJX\0QV_BNRT!K2?S+NWDN$GROEX3;D=<Y^8=A6'\6H5E^&.M%FD&R)6&R1D
MR=P'.",CGH>*IZUIB/\ $?PQ8QW-Y%%_9U]EUN&,I&Z(D>8Q+#ZYR.Q% 'H-
M%>4Z?XAU*WTBQTN6]EF$GB2ZTK[5<W#([1)YA1#* 6#$JJ[NN/0\CL_#6GZI
MINH:K#?:@D]K(T<UI;-<//);*00P,C@,REE)&>G(H NZIX@M=,O;;3Q'-=:C
M= M#:6X!=E'5CDA54>K$>@R>*;#K^[5[?3+K3;RTN)XWDC:0(T;!<9^96(SR
M.#@URFF%HOCOKJWAP\VDP&QW=X@WSA?^!\UV.NWJ:;I%U?>4DMQ;02S01GJ[
M*C' ^H!'% &E17F%QJ.HV?@KPOXKM-1NKB^NI;,W<33,T5R)RJN@CSM4@MQM
M (V_6JNI'4I;'XAW']O:JCZ1*TMF([DH(V6W60#C&5R3\O3GIGF@#T?5=8BT
MR:RMA&9KR^D:*VA! WLJ%R23T 53D_3UJOH&N7FL-<"ZT&_TL0X -WL_>-E@
MP7:3D#:.>A!!%<EK=NFJ^+/A]=7$ER)+I)VD\JYDC&?LQ;Y=K#;R>HP3T-,U
M+Q#J/A_5OB%=1W$]TNG:?:3VL$S;DB=EES@>F0">YQUH [+5/$$>EZYH^ER6
MD[MJDKQQS*5V(51G(/.<X7TQ[UL5YKJ%@L/B?X>W8O[NZ>:>4R/+<,ZRDVSG
M>%)PO?[H P>G PW3)]<\3Z);Z_::G'97$5](\SO>R&-8TD96A>#;L'R@#/7H
M<\T >F5&T\2W"6[2*)I%9T3/)"X!/X;A^8KRK4CJ4MC\1+C^WM51]'D::R$=
MR4$;+;K(!QC*YS\O3GIFM.WA74?BGH=Y/)<>;-X=:X8)<2(N[S8?X0V,<\CH
M>X- '=6-W/=M=B>QFM1#.T49D93YR@#$BX)P#D]>>*75+X:9I5U?M!+.MO$T
MK1Q;=S!1DXW$#I[UY]::G=+H/BJ.ZUV\B:/Q&;.WFQYDI0^3B&,9&"V2H(QC
M<3[U+97=\9_'^FW+7"VUK9Q26\$]P9VA\R!RPWDD\E0<9(!S@T ==9Z])J&D
MZ'J-KIMQ+#JB1R-M9?\ 1D>/>&?)Y X''K6JD\4DTD*2*TD6-Z@\KGD9KS6U
MN;NU\.?"W[/>3Q1W M8)HD?"R*;4MAAWY45-H&AK>ZYX]@AOK^VF:^5(IX[R
M7,9:",AL;L$@GC/;CIQ0!Z117GWA75KG7X-'TR>>YCU#2&D&L!9WR9(\QA6.
M<D.Q\P9XPA%=MJE_'I>EW-]*I98(R^Q>KGLH]R< >YH JV?B+3K[Q#J.AP3;
MK[3TC>=?0."1CUP ,_45JUY'?K>^$]9\.^*+O3+FU(=K/6KEWB*2+</NW?*Y
M(593D9'3 KK_ !%=W<7B[1;:9[E-&F@N/-^RLX<S#;LW;/F"X+<CC)&>U '6
MT5Y-=?\ "26/@?3[B[U?5+>[FUR&*,ROB3[.UQM3>",Y*8)!Z]^XK:E2YL_%
MEOX4CO[RZ@DLI;X-=ZC)%+(QD VB1%W$(,X7_:YS@4 =_17FZ76MZ=?:!X7U
M'4XKV:X-V7F%T\+2>7L,<32*N[<%<DXP3M&>X,&K0^(-%TO3;:;Q!,SMXEMH
M4,$Q=TMY77$4CL,N0#U/4$9S0!Z?17G=KIMS/XV\0Z VN:P-/6SM[I +QO,C
MD<R*=LGW@/E!V@XSVQQ6?H'B75-:T[P9874^^34=,FN)7:Z>W:XDC**!O0%L
MX+,0,9QU[$ ]4I'=8T9W8*JC)8G  KS'4X?$&D6.AV=QXBG:5_$<=MOMYBSK
M;NI98Y&89=@,<D<C&1536EGCTGXF:-)?W]Q:65C'<6_GW3L\;/"[,-^<E<J#
MM)QR1C% 'J\4J31)+&P:-U#*P[@]#3ZS/#MLEKX=T^.-I64V\;9EE:0Y*CNQ
M)Q[5IT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 5-4TRSUG3+C3=0A$]I<H8Y8R2-P/N.1]16?%X3TB&^LKY8[DW-E$T
M4$K7<K$*WWLY;YB<#).3P*VZ* .=D\#>'9M'O-*FL&EL[R<W,R23R.3*3DN&
M+95L\Y!%7]$T'3_#]HUM81R!6.YWEE:61STY9B2>.G/%:=% &7K'A[3-=-N]
M] QGMF+6]Q%(T4L)/7:ZD,,]QG![U+9:1;6+%U:>:4KM,MS,TK;?0%B<#IP,
M9P*OT4 8=CX1T;3FA%M;R+#!*9H+9IG:&%SGYD0G:O4XP.,\8I'\'Z*\6JQM
M!.4U8DWH^U2_ON-O][CCCC''%;M% &(_A/2))],F:*X\S2U*V;"[E!B!7:?X
MN>..<\5*OAK2EU+4;\VS//J,8BN_,E=TE0 @*4)*X )'3N:UJ* .8M/ 'AZR
M>Q:*"[(L)#):*]],RP$C&$!?@8)&.E2)X$\.Q:_)K,=B4NY91-(JS.(GD'(<
MQYV%L\YQUYZ\UT=% &$_@_17BU:-H)RFK9^VC[5+^^R-I_BXXXXQQQ3SX4T<
MW.FW)MY?.TZ(PV[_ &B3(CX^5OF^=?E'#9Z5M44 <[)X&\/S6-]9R6DK0WUR
M+N?-U*6,X((D5MV5;@<KCI3HO!>A0S7TR6TPEOX!!=.;J4M*H!&22V=V"1NZ
M\GFN@HH PO\ A#]%^S:5;^1/Y6DLK62_:I?W1 VC^+G XYSQQ3;W2;?1[C4O
M$&EZ3+>:M.JE[=+DH)V "@X8[ VWC=C.!CO6_10!A^'=-DMVO]4N[..UO]3F
M$T\2,&,85 B*6'#$!<GW8XR*NZIH]GK,,4-ZLS)%*DRB.=X_G4AE)VD9P0#S
MW%7Z* ,[6M"T_P 0Z3)I>J0O/9RX\R,2NF[!R,E2">0*X[Q+X;9]7TY6T'4M
M2TNTLS#!+8:D8[F)V8;@Y>1"RX5,?,>^1TQZ%10!QNF>#+:ZTQK;5$U+[']H
M2YMK2ZU&222!EQ@EU<]QD+N8#&<\G&OKWA+1O$L=J-3MGDDM&W6\\<SQRQD\
M'#J0W/?GFMNB@# U#P5X?U/1;;2;FP!M;9_,@*R,LD;]=P<'=N))).<G/.:&
M\&:&^G6E@UM-Y%I<+=18N90YF4Y#LV[<S ]V)K?HH R5\-Z:FJW6J*EPMY=1
M"&:47,@W(,X&-V!C)QCU-9\_P_\ #5QH-GHSV+_8[)]]KBXD$D!_V'W;A],X
MKIJ* ,%_!VB/96%H;:416,XN8,7,@82C/SLP;+-R>6)ZU*?"NCO<ZK</;/(^
MK1"&]#SR,LR!2H&TM@8!(XQUK9HH Q;;PKI-HVEM%%/NTS>;8O<R.1N7:=Q+
M'=\N -V<8&,5M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQFTY 9B2OIQC';% 'IU%>3IKM]HNDZO8"_G:WB\3IIR7%U<,S0V[K&Q!E.6
MRQ7<>0&Z\"NRT'2]2TO7[XW&IK)97,2R0V+3R3-"R\,RN_.TY''3/2@#4UK7
M++0+-+B\9R995A@AC7=)-(WW41>Y/_US@53G\17%B+9K_1+V".XN(K=75XY
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MHE+21C"N<#) ]#4] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-/T+3]+O;V[LXI$GO7$EPS3._F,!@'#$@'  X["DU30-,UJ:TEU"V\V2T<O
MP=E*$C!Y4C((X(/![BIH=5TZYO'M(+^UEN4R6A296=<'!RH.>M(-9TMKE;8:
ME9F=I#$L0G7<7 !*@9SD @D=<&@#/;P=H;V^IV[6LIBU-B]XINI<3$C!S\WH
M ..PQ46J>!O#NL+9?;K!I'L4\NWE6XD21%_N[U8,1[$FM:#5M.N;V2R@U"UE
MNHP2\$<RLZ@'!RH.1S5;Q!XBTWPU8+=ZE<)$DDBQ1JS %W8@ #/UR?0 F@#0
MMK:&SM8K:VB2*")0D<:# 51P !67=>%=&N[ZYO);5Q+=H$NA'/)&EPH& )%5
M@K\<<@\<=*R3XK,'CJ6RN=0T]=#&D"_2X)"@,9=G,A;!'IC'6NEDU.PALX[R
M6^MDM9,;)VE4(V>F&S@YH ;?:78ZE9I:7=M'+;I)'(L9' 9&#+^14?RIR:;9
MQZI+J:P(+R:%('F[LBEBH_-C_D"D&JZ<;6&Z%_:FWG8)#+YR[)&)P IS@DGC
MBEL]2L-1\W[#>VUUY+[)/(E5]C>AP>#[4 9K>#]$>#4X6M93'JC%KU?M4N)B
M1@Y^;T '';BH=3\#>'=82Q6]L&D:Q3R[>5;B1)$7^[O5@Q'L2:W+J[MK*$S7
M=Q%!$" 7E<*N?J:A_M73OL O_M]K]C/2X\Y?+/;[V<4 5&\,:.;W3KL6A2;3
M4,=GY<SHL*D $!00,$  Y'.*)_#&DW-U<W$T$KFZD26>,W$GE2LH4*6CW;3P
MJ]N<#.:NVVI6%[<3V]K>VT\UN=LT<4JLT1]& .0?K38-6TZYO)+.WU"UENHP
M2\$<RLZC..5!R.: *3>%=':;5)3;S;]44)>G[5+^] &T _-QQQQCCBFKX4T:
M)]+E2UFWZ2A2QQ<R_NE(VD#YN>..<\<=*UKBZM[15:YGBA5W"*9'"@L3@ 9[
MD]JALM4T_4O-^P7UM=>2VR7R)5?8WH<'@T <=X5\)D_V_P#VYIES"MYK$]VD
M4ET&BFC9@4+(CE3TY##TZUWE4K?5],NYIH;;4;2:6$9E2.=69!ZL >/QIL>N
M:1*6$>JV+E8C,P6X0XC!P7//W<\9Z9H J+X2T5+F:=;1E$TXN981,XA>4$'>
M8L["V0#G'4 ]:GD\/Z;+KJ:V\4O]HI%Y*RBXD&$SDKM#;<9 .,59M]3L+N&2
M:VO;::*+_6/'*K*G&>2#QQ26NJZ=?1RR6E_:W"1?ZQHIE<)QGD@\<4 2W=K!
M?6<]I=1++;SQM'+&W1E88(/U!K(@\':%;OIKQ6LJMIN?LC?:I28\C:?XN?E^
M7G/''2K\.MZ3<7,-M#J=E+/,ADBB2=6:11_$H!R1P>15XD 9)P!0!A_\(?H+
M6FIVLEAYL&IOYEY'-*\@E?CYOF8X/ Y&.@]*FT'PSI/AJW>#2K4PJ^-S/*\C
M$#H-SDG R<#.!DU:M-5TZ_:1;._M;EHP"XAF5ROUP>*2WUC3+JX2"WU&TFF=
M6=(XYU9F53M8@ Y(!!!]#0 NIZ58ZS826.I6L5S:R?>CD&1QT/L1V(Y%5K'P
M]8:>\;1F[E,?^K^U7DLX3ME1(Q ..,]:NWE]9Z=!Y][=06T.<>9-($7/U-,_
MM33Q';R&^M?+N?\ 4-YRXEXS\IS\W'/% %"X\)Z+<WEU=26C![S'VI$F=([C
M' \Q P5^..0<C@Y%3OH&FR:TNL&&07ZP&W$JSR+B,G)4*&QC(!Z=1FJ^H^+M
M#T[P[=:Z^I6LUA;A@9(9E<,X_@!!Y8],4]M26\O=)DL-7T\6L[2;XB0[W("G
M C(;JI&3P> >E %<^"= .D/I)LY38O/]H:'[7-@R;MV[._/WOF^O-8MCX:GG
M\>^([V_L+V*PNX+:&WG2]V>8$5@X8))NYR,;AZ]*VK#QKX>U![\1:M9JME<&
M!W>=5#$*I)&3TRVW/J#6N=0LA]GS>6X^TG$&95_>_P"[S\WX4 9UUX2T*\N+
M&>73T5[&,PV_E.T86/CY"%(#)P/E.1[57@\#>';6"S@@L&BBLIS<VZI<2J(Y
M#GYAAO<_0$BMVXN8+.!I[F>."%?O22N%4=N2:9;ZA97EJ;JVNX)K<9S+'(&0
M8Z\@XXH Q[S3AH']H:QH6C2:AJEX\9GA-Z4\[&%SF0E1M7ITX&*L^'M+;3;*
M>2>&**\OKA[NY6+E0[=LX&<*%7/?&>]%SXHT.UTF[U1]5M'L[1<S21S*X4XR
M!P>I[#J:@76DU.#1KO3M6L(8;F4&2.0J[3*4),:$,,."1Z]* -ZLM/#>CQZ?
M;6"6$2VMM<"ZAB X24.7##WW$G\:DGUW1[4L+C5;&(K((6$EPBXD/(4Y/WO;
MK5B[O[.P17O+N"V5LX::0(#@9/7VH K7NA:?J&J66I7,4C7=EN^SR+,Z^7N&
M&X! .1P<CI5&3P7H,MCJ-E)9RM;:C+YUW&;J7$S\<GYO8?D/2MJ"YM[J/S+>
M>*9/[T;AA^8J"XU;3;2Z2VN=0M(;A\!8I)E5FSP, G)S0!FZMX,T'7'M)=0L
MGEFM%V0S+<2)(%_NEU8,P]B35A_#6DO?:?>?92DVG1F.T\N5T6%2 " JD+@@
M =.PJW=ZKIUA(L=Y?VMN[#(6:94)'3.":MT 9VE:'I^BFZ-A"\?VN9KB?=,[
M[Y#U;YB<$^U)J6@Z=JMU;75U"_VJVW>3/#*\4B ]0&0@X/<=*FM-6TV_F>&S
MU"UN94&YTAF5RHZ9(!XJS--%;PO-/*D42#+.[!54>I)Z4 9-YX4T/4-".BW6
MGQRV!;?Y9+9WY)+[L[MV23NSDDGGFFIX0T%= GT-M/233[CF:.9VD,AXY9V)
M8G@8.<C QTJ]%J^F3([Q:C:2)'DNRSJ0N.N>>,40ZQI=P)3!J5G*(8UEE*3J
MVQ&&59L'@$<@GJ* *-AX1T/3M(NM+@L0;2Z0QSK-(\K2*1C!9B6(P3@9XSQ4
M-IX(\/V-S:7,-G+]HM(VB@F>ZE=T5L9&YF)(X&,].V*U(M8TN>UENHM2LY+>
M$XDE2=2B'W.<#\:>-2L#);QB]MB]RNZ!1*N95QG*C/S#'/% &?;^$]%M-#DT
M:"UD73Y'\PQ?:)#AMV_(8ME3NYX(YJY8Z39Z=--/ CF><*))I96D=@N=H+,2
M<#)P/<^IIKZ]H\4L<4FJV*222F%%:X0%I!C*@9Y;D<=>16A0!GZIHFGZS]G-
M[ 6DMI/,@ECD:.2)L8RKJ01D<'GGO56Z\*:+>:3+I=Q:,]I-*)I5\^0-*X((
M9V#;F.0.I/0>@IVA:Q_;EM+J<11=-9W2V/>158J9">P)!P/3D]<"[9ZII^HF
M06-];71C(#^1*K[<],X/% %=- TY-;36!%*=02#[,)FN)#^[SG:06P1GGIUY
MJ75M(L-=TZ33]2@$]M(58IN*G*D$$%2""" <@TZVU73KVX>WM+^UGFC&7CBF
M5F49QR <CFN+;Q5KB^%_&]]YED;O1+J>.W/D-L*1Q(X!7?G)R><_AVH ZF+P
MQI,&IC48H)4NQ;_9?-%S+GRLYVXW8ZDG/7//6J<O@/PU/X?CT*730^G12F:*
M-II"8G))W(Y;<IR3T(ZGUK0AUBUM]#L[_4[RVM1-"CM)-(L:[BN3R3]:M2ZA
M90V:WDMY;QVK %9FE4(0>F&SCF@"/2M(L=$L%LM/@\F!26P6+,Q/4LS$EC[D
MFJFJ>%](UC4;;4+NWD%[;*4CN()Y(9 IZJ61@2OL>*CU3Q?H>E6UA//J-L8[
M^=(;9EF4K)DX+ YQM R2>GYBI1J 7699'U?3_P"SULUD^SY D0[C^]+;ON$$
M#I^- %)? /AI+2VM8].,<=M.UQ 8[B1&CD;.XA@P8 Y.1G'M4@\#^&QIU]8+
MI:+:WTPGGC61QF0$,&4@Y7! /RXK4&K::;-;P:A:&U9MBS"9=A;T#9QFB;5M
M.MKR.SGU"UBNI2!'"\RJ[D],*3DT 9.J>!?#FLR6DM[IV^:T3RX94FDCD"_W
M2RL"PZGDGJ?4UO0016MO';P1K%#$H1$08"J!@ #TKFH/$%U%X[UC3+^XM8]-
MM+""ZC<KY93>SJ=[%B#]WVK>_M73OLD=W]OM?LTC!4F\Y=C,>P;.": ,^X\(
M:'=7&HSRV1\S4DV7>V:11*-NWH& !*\$C!(X-.7PKHZSZ9,+>7S-+4I9DW,I
M\I2,$?>YR..<\<5LU4O=5T[3=OV^_M;7<"5\^94SCKC)]Q0!B1?#[PO D"1Z
M6 EO<?:85,\A$3G.=H+853N.5'RGN*U+30-,L-5O-3M;7R[N\.Z=P[$,V ,[
M2=H) &2 "<<UHJP90RD%2,@CO7$_\+ C&DK?26MU&!JAL+@?8I2;?@D94<MG
M"KN'&6[XP0#H]6\.Z5K=Q9W%_;&2>S9F@E25XV3<,,,J02"!R#P:H+X$\-QV
MZP1Z<8XEN_MJI'/(@6;.0PPPQ@DD#H,G K(^('C#5?#>I^'=.T>.RFNM7N_L
MXCN8V;:,@%\JPX&X<?K1X7\;7VI>/M=\):C!;/-IB+*MY:*RHX.WY2K%L-\X
M[GH: -R]TN/2)-0U[2-*EOM9FC5&B-ZR>>%/"Y<E1@$D<>OK4GA[3I;87NHW
MEK%;ZAJ4PGN(XV#;,*$12P^\0JC)]2<<5>75M->2>-=0M&>W&9E$RDQCI\PS
MQ^-":MILB%TU"T95B\XE9E($?3?U^[P>>E $UW:6]]:36EW"DUO,A22.1<JZ
MG@@BL^P\-Z9II1K>*8M'$8(FEN9)6BC.,JA9B5' Z8Z#T%7K74+*^#&SN[>X
M"8W&&0/C/3.#38-2L+II1;WMM,8?]:(Y5;9]<'CIWH R1X)T!=)BTL6<HLHI
M_M*1?:YL+)NW;L[\YW<_7FFZCX%\-ZMJZZK>Z:LEZ%"-()77S5'02 $!Q_O
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MD?.V#G^ \'TPRU[-!:6=C9?9K>W@M[10?W4:!$ .2>!QSDD_6IRH/4 _6EH
M\+8:0/@Y<R+]C$BZ]E7!4,/].XP?]PG\#71:V GCW6+3P^]O%?3>$G6V2W*J
M6E$C;, =\'CV]J]1V+_='Y4;5!S@9^E 'E;36FL^&/ 2:(Z#5+2]M?W2'$MN
MB+MN%<=5  8-GJ<>HIWAVQL;V+Q^=+@LI-5BU.Y:R=%4O$_V= C*?X?F+#(]
MZ]16.-79U10S?>8#D_6E"@= !0!Y=X2O/#GB!O#3)J-[-K.EIL6PV)&]HVS;
M*) J*0G&.3@G'<UO?%%EB\'+/(0L4.H6<DCGHBB="2?0"NR6-%=G5%#-]X@<
MGZTI 8$$ @]0: //3<Z1J'QC21Y;2>(>'MR%RI'^O)R,_P"R2<^AST-<UX8U
MK3++POX(2:2VAD^U7Z07\\A\FTPT@VD @%F1@%#''?GH?9]JYSM&?I2%$( *
MKP<CCO0!X6+C39/!:6UQ-%(T'C+!$ZA653=9.00-N5R2,# ["N[T-[&'XN>(
M+>T:W0/IEHQCB( +*T@Z#N 5_ BNZV+_ '1Z]* H!R ,_2@#B?$UVVG_ !$\
M,7=^P32#%<0B5SB.*Y8+L+'H"5#*"?4CO7%>*K>"/P_\0;I6A_L>XO[-K(Y&
MQI\Q^>R'W/4CNK>AKVIT61"CJ&4]0PR#2A%"A0HVCH,<"@#S'5A%%\0[RVT%
M[:&\F\)SK;+ RKF7S 8\8[\Y'M3?"5YX;\02>&Y(M1O9M9TN,HMCL2-K,[-L
M@D"HI"\8Y."<8Y->H;5!S@9^E(L:*[,J*&;[Q Y/UH X?XK):'PYITMXL?E1
MZO9EG<?=7S5W<]ACK7/^(=)=_$FOW'@^*-2WAJ2&X^Q !7F+9B4;>/,V!L=P
M,>HKN_%N@7/B*QL[:VNHK?R+V&[+21E]WEN&"X!'4CK6Y%&L48541/4(,#/>
M@#SG0+[PEXDU+2M3M]3N+N[L[62-K>18XUM(F7#+,JHHP"  #WY'&361X6T_
M09O@K87+W,&GSG9$=3B1#) _VD%-Q/\ "'$>03C KUY8XT+%44%CEL#J?>EV
MKC&T8/;% 'CVJZCK<FB:FFH6UK<_V=JMC+J=[IRDQWMJ"&8E><,JA=P';VKH
M;\V>H_$2TU/3[BVFL%T>==3F1U:)D)4PACTSG>1GL#7?I&D:!(T5%'15&!2)
M%'&FQ(U5>N%&!0!XII#:9:^ _AG<1M:Q7']JP"20%0_*2!LGK_=!_"O0OB7'
M?R_#W5ETV.26;8A>./[SQ!U,BCZIN&*ZO8O]T?E2T >?:A-8ZWXT\):CHEQ;
MS0QP7!O)(F!46C1\+)CH-^W /<'T-'PFL])D\*I=V\%F]W'>7B^<BJ70&=\#
M/4 J%X],5WR11Q[MB*NXY.!C)IP '0 ?2@#@/%VK)H?CS2;O5;^?3](EL98(
M[Q$1DCN"ZDARRL%W*.#QT^M8-]8>&[/_ (0R&Q82V$NN221O=E?WB-'(6*@@
M?NRYX&,'/'!%>N/&DJ%)$5U/4,,BEVJ>H''M0!XUKIMVTWXM6ED8BJB&010X
M./\ 1TWL /<'/N*Z'6-2TJ\\;?#^\MKJUD622Z"3*P^9?L[ 8/<;N/K7HFU>
M>!S[4;5X^4<=..E 'G?ABUTW5W\=>'+\HSW.K7!EMS]\1/'& ^.P]#ZCCI5C
MP.=3U":.VUB)O.\-A[ RL.+B;H)1_P!L=AS_ --6KKM8MM0N=-FBTF^CL+UB
MNRXD@$H7!&<KD9R,CKWI=)T[^S+$0M,UQ,SM+-.R@&61CEFP.@[ =@ .U '/
M^/\ 4;+3;31I+Z*+:VJ0B*YN'98;60!B)9,$9 P0 2 21DBO/I=0,6F^+6@E
MDOH;?Q%;7M]'''\TMIB$NVT#[IQ^(!ZC)KVYE5AA@"/0BC !) &3U]Z /.]<
MO/#OB#PQXMU3P_LO;J?198I[NW+%6Q&VQ#VW<G@#(XSU%4M2U+2KJ+X;W4%U
M:OB^B02AAT%NX(!]-Q /OQUKU!(TC0)&BJH[*,"EV+@#:,#IQTH \;O8]&?2
M_BNQ6R+J7\L_+D'[,N,?\#';N/6M*ZU^PT;Q%X9UBZU2SV3Z"T!2[F\N/EHV
MWJ^""Q(P1Z#/8 ^I;%_NC\JYO4]!UB377U/2]5M$26!('M;^S,\:A23N3:Z%
M2=W/7.!Z"@"#X<6&G:;X+M+;3K^ROT#R-)<63!HR[.6*@CKMW!1GG '2N#\>
MZK83:;X\M(7CLKN-X3- V7GNRJQD2@$D+&!@?*.JY)&:]7T?2ETN*<LT;W%S
M)YL[Q1")&;:%^503@84=23[FKY1"22JDD8.1U% 'E_BJ_,-]K&L:+J5E?1&U
MB&H:+>?\O46TE&@8?,"0Q X()_#/?:Y=1P^%M1NKBTFFB6RDDDMD)#N-A)0$
M=">G%:+11LRLT:EE.5)'(^E/H \D\/ZM83>./!\UO?VKPRZ--;Q16V3'%CRB
ML(8Y+,HZY.>,D+75?$MXH/#%M=RW:6ZVNI6LX\W(BD*RJ0LA .U>Y.#C X/2
MNO"(N-JJ,=,#I6/XBT>]U:*S;3]2%E<6DXG7S(?.BE^4C:Z9!(YR,$8(!["@
M#@Q-X>U9?&^O)JFC7,MYIP7[/!.DK1+'&R[V) Y8D#CCY5Y)Z0306EE\-?!F
MK65K;_9(Y=.DU>:",%F@1<DR$<L%D(8@],'WKT#3-#N8[Y=0U6:QFO$C:./[
M':>0BJQ!.<LS$_*.X'MWK<P ,8&/2@#SK48/[3\=:G>:,Z7%K+X=DAO&@8,D
MDI8^2"1P7V[O?!'J*P=.UO2KG3_A;%%>P2/:LD-P%;/E/]D9"C_W6SQ@\U[%
M'&D2!(T5%'0*,"D$2(,I&@.21QW/>@#Q?^S_  _=>#?B#:S6]H^H?VK>I;1A
M5\[S,_N0@Z_?Z =\^]>IK;:A_P (:+61RVI?V?Y;-GDS>7@G/^]57POX<GT)
MM3:ZGM[AKS4)KU&2(J8_,()7DG.,=>*Z*@#RA6N/^&>=,>R@DF$-K;&Y@C'S
M/$DB^<N/]T."/3-7M=OM)\4:!KNI^#&%YK,FD-!]JM2WRQYW"+'0.<M@8W#'
M;BNYT[2X]+DN%M7VVDTC3"#'$;L<MM/8$DG'J3ZXJ\D:1KMC15&<X48H \XN
M[BRUV?P%<^')(C<P7*LRPD;H+3RF$JN!]T9"+@_Q8'6LN2]M&\&?%4"YA)-W
M=XPXYS;HH_,@CZUZVL<:,S(BJ6.6(&,GWI=J_P!T?E0!Y9<:Y:Z5XBT&ZU/5
M9+#1[K0HX;:]14:(3!LNC,RL%W+L],[:BBN=(\'ZKX4N!)<IX4$5W'!=76=D
M4SLI5SP-JL-X4XZ,>QKU=XHY$V.BLO\ =(R*'1)$*.JLIZJPR#0!YCXA?0K3
M1_#U_I:);Z1_PD\5R]PS$1-N#[I06/"%CC/ ]."*T[*>QE^,]X(7@)GT"$E1
M@%SYSGD=<[2.O;%=X5!&"!CTHVC.<#/K0!YWX4L;FRU>Y\'2P/\ V=H]V;Z"
M0CY7@<EX(_<K(7/_ &R%8@NM'OCXA\,^*=2OH+]]4EE6Q1$#W2F3= T3;"Q.
M @&&XV]A7K^!G.!D\9I#&AD$A12ZC 8CD?C0!PUC):S_ !>URTDDBD+Z-;1O
M$S!BWSR[@1WX(S]:J>%;*\M]7/@^YA<V&@7!NX)VY$L+9-LGN5)D_&%?6N]O
MH;B:PN([*=+:[>-EBG:,.(V(X8KWP>U5-#TNXTVWD>^O?MNH7#![BY$0C#$
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MP >M '47^KVNGSPVTGF274X9HH(4+NRKC<<#H!D<G R0.I%9K^-M"33;:_\
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MH!.'&<@C^#'%9-I#KTNM>!+K6+.9[JUBO/MLT5N0B%U"QEMHP"V 2!T).<4
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M/1[>6*[N8H6=$)MQ&IR!W;\N]=/XUL;G4_ ^NV-G&9;FXL9HXHQU9BAP/QH
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MO%T]MXBO=+UG3X[*.'3VU**9+CS<PJVU@XVC:PX. 6'/6@#J:CBGAG#F&5)
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M4 #)[B,XSD9W=$FT>6U?3+:[CO9-K/.7&3<$L0[^C MD'&0.G;% $NA^'X-
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M&I^'+ZUM&DM[9)G,$_G1NKEE*,"HPP*]#U!'2J?PIR/A;H& ,_9C@?\  FH
MT&\'6J:E<WEGJ>K60NI3-/!;W6(I'/5L$$J3CG:16];6T-G;);P)LC0<#))]
M223R23R2>2:Y>Q\8W-S9:^9]+B@U#2;G[,+071;SF(4QD-L& ^X!>#5MO$-[
M<ZG?Z9IEA;W%YIT,;W0DN2B"1U++&K;"2<#.2 !E?4X .BJ-;B%YY($EC::,
M O&&!90>F1VS@UP$OCB_U>;P?<:'!"MKJES,D\5S*8W#QQR;HVPK8 9>O.2!
MT'-:(\0K;:YXN,>A6ZWFEVL$\DR2@->*5D90S;<C:%(&<]: .RHKB],\;7UW
M>>&A=Z,EM9Z_;[[>5;K>Z2"+S<,NT#:1G!!)XY SBF7_ (_DMM(O]8MM,2?3
M[+43I\FZX*2%@XC+@;2,;V QG..?:@#MZ*9$TC0HTJ".0J"R!MP4]QGO]:?0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% #)H8[B"2"9 \4BE'4]&!&"*\\3X:3KX<TVR.J$ZA8W8*7
M@X86@!B\H'&1^Y)_X%D^]>C44 <UXFT&]U2[\/O8"U2+3+];MUE=ERJHR;5
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MKI^JS:3'>7ELUM'':M)Y*;NKLS*6)]!@8]3FNTHH YW4-*U"]TFPLI[+3+R
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M=XW#'HRLJL&7'; ^M;%9MAJ^F7.IWVDV<@^U6&QKB(1,H3S-Q7D@ YVL>,T
M8M]X,$^B010SH-2M]2&K).RX1KC>68$#)"$,R]R 1U(YN:;H4X\47GB/4?)6
M\EMDLX8H7+K%"K%C\Q R68Y/ Q@"N@J&ZNH+&TENKJ5(H(E+R2.<!0.] %*U
MT^5]0NK^](\Y@8+=5.1##GL?[S$!C]%'\.3S'A?PC?Z)>Z1)>S0+;Z-ILMBC
MHYS/O=6WL"!M 5!QSR3V&3U&F:]I^KW5Y:VLLGVFS*B>&:%XG3<,J<. <$ X
M/M1JNL:7ISV=MJ,@!OYUMH$,9<22'HO ('0]?2@#%\&:=(EWK^NRJ5_MB^\V
M$$8)@11'&W_ @I;Z,*CMO#FL:+JNO/I+V4MEK$INMMQ(R-;3LH5R %(=3@'&
M5Z8]Z["B@#AY/!5W8VOA"QTEK9K709A*[7$C(\O[MD. %(!.\M^E;GB_0Y?$
MOA#4]'AE2&:[@,:.^2JMU&<<XR*T=0U.RTJW$]]<QP1E@BECR['HJCJQ/8#F
MJT'B+2[B\ALQ<-%=SY\J"XA>&1P 22%< D  \]* ,9]$UVZ\5:#K-R-.'V"V
MGBG2*5^3+L^[E.0-@ZXSGM6,W@77/[,N7@O+*VU:+7)=8L9 S21Y?.8Y!M!P
M58@D5Z-10!DZ''KGE23:])9"X?"K!8[C%&!GG<V"2<^@ P/<G$NO"-W=^(_$
M4DLMNVDZ]91VUP,L)HRB.GR\8P0^<D\8Z=Z[&B@#B+?PIJ]WH^AZ+K,ED]KI
M,\,IN(78O<B'_5@H5 3)"EOF;H0.O$%YX/\ $!M/%MG8:C:6\>L7/VNWFRXD
M5BL89&QT4A",@DX;H*[ZB@#C-+\.ZY9>+'UITTB*&32X[/[);EP(V1W8!3M^
M[\W7 ]-O>M+P/HEYX;\'Z?HU\T#S6B&,O Q*L,D@\@$=>E=#10!S-QX4,OCN
M'7X[@);-;A+NVQ_KI8S^Y8_[H9_Q"U&N@:GI/C#5-;TG[)/!JT47VFWN96B*
M2QKM5U8*V05X(P.F<]JZJB@#@U\"WNFV7AH:7<VLEUI5Y-=3FX#*DQF5Q(1M
MR1@OD#T&,U9E\,ZPVL>++Q38E-9LHK:$&5P49$=<L-AX._/!.,=\UT>E:WI^
MMI=-I\YE%K<-;391EVR* 2OS =-PJ1]3M4U>/2V=_M<D+3JOEM@HI )W8QU(
MXSF@#DX?"FL11^"4)L3_ ,(^@6<^<_[W]P8?E^3WW<_3WKFK3[;>?VCK5BGA
MF]TN;49+P+<W\UORC84O$ T8?Y <D9)P3ST]=)P"3T%<[I$'A36[RXU?3M-L
M);N"Y>"6Z-D$E65<;AN90V1GK0!MV5P]W86]Q)"\#RQ+(T3_ 'HR0#M/N.E3
MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!S/C_6=0\/^"[_ %73'@6YM]A'G1EP07"GH1@\]>?I
M6/>>)-=\+^++>WURXM;W3-0M+FXC-O;F-K9X$\QEY8[E*]"<'/I5KXL?-\-=
M6A4DRRK&J*HRS'S%/ [G )_"M6'0(K^_@U34KM-1,=L\%OB,+&$DQO8@$[F8
M  G@8Z 9- '.W'BK6+#PKH?BV:6*6SOGMS=62QC$44Y 4QMU++N7.<AN<!:-
M1\1:]93>*].^U1?VC9117.E VX(N(Y,JJ$=V,@V9&.2IK5L? \5IIUGI$NH3
M7.CV4ZSVUK(@W#:VY$9_XD4X(& >!DD<5J7OANROO$NG:[+O%U8Q21(%/RN&
MP1N]=I&1[G- &':>+FN]'MM;AN#)8V^CMJ-ZFP;F;!VJ#V.4ES_NCUI-.U+Q
M==7VD7269DTZ]A+79E$(6W)3*-'MDW,N>"#DD<\5L:/X3TS1=-U'3X8R]M?S
MS32QOTQ(3E!Z* <8]SZUG^'_  7<:#Y5O_PD6H7FG6N?L5G<*A6'C"[F #.%
M[ G X]!@ K^!]1\2:_:Q:IJ&H67V59KJ"2WBM2I<I*R*P;<=OW<8Y^O/%TZO
M>ZQXLU?0["[%DNE6\#R2^4'9Y90Q48;C: HSW);J,<WO#'A\>&M*;3TNWN8S
M-),K.@4@NY=AQVRQQ45UX9/_  DCZ]IMZUE>S0"WN08Q)'.@.5)7(PRY.#GH
M<$&@#A==UV_\3?#VQNIG2TNX-;@L[R.)-R-*ETB[ESSC(!Q[X[5W^O\ VRT\
M(:G)!>&.]BLY'%RL:YW*I.<=.U9][X'MI_#MIHMM>36\,%TMX\NQ7DEE$GF;
MF)XY?)/'L,"NANK-;[39[*Y;*SPM%(4&W(88..N.M 'F#I?'0/AB1=++<R3P
MM')*G"9LWZ@'+8Y/49]16LGC#5=+@U^ROGAOKZQU.VL;:98A&'^T"/:67=CY
M=Y[C.!R.M:<'@=X;3P_;MK5Q,-$E62W:2%/FVQF-5.,<!2??)SFENO -GJ*^
M(4OKN:6/6Y(Y9 BA&@>,*$:,]B-JGG/(_"@"SHL_B4>(;JVU&TD;2#;K)!=3
M^2LJRYPT96-CD8Y!P.X.:RO%'BRXTC7I=/N;TZ1%+;H=.O)H UM/,=VY)'Q\
MN,+@9'4G)X%;N@:#>Z43)J6NW>KW 3RHY+A$01IP2,(!DG RQR>!TJ/6O#$F
MM1ZE:S:@?[/U&(13VSPJ^P8P6C)^ZQ'<@@$ @9H P3?W=G\2O$-S<ZA(]A8Z
M1#<^0(U("9E) ]_ESGJ?H!3;CQ7K%AX4T3Q;-+%+9WSVYNK)8QB**8@*8VZE
MEW+G.0W/"UO_ /"(VR^(6U2*ZF2*6R2RGL\*T<R(6VY)&1]X@X//\ZMCX'BM
M-.L](EU":YT:RG6>WM9$&X;6W(C/_$BG! P#P,DCB@"!-6U_7[;5[K09[6*6
MPU![."VN%_=S>4P60R-@L,_-C;C&!G.:Q+O6QI7Q3UZTBD6*_P!2MK&VM))1
M^Z23$QRQZ=N%ZL>!ZCH/^$&,&N7]YI^N7UC8ZE+YU]81!"DLA&&96(+)NQSM
MY/J.,)J?@&UU:[UJ:ZNB4U2WB@,8B \CRL^6Z'.0REB<^M '1M,VF:5)<7L[
M3_9XFDED"!<A1DX ^G2N(N/%NL6?@S2O&<DD4EG<O ]U8B,8C@E8*NQNI==R
MYSD'G@5VUA8RV^EQV5[=M?LJ>6TTJ -(,8^8#@GUZ5S]EX%AM=,M]%>_EGT.
MVN%GALY$!8;7WK&S_P 2*V"!C/ !)'% %"V@O&^,VH9OLQKH\#;#$/N&:7Y/
M_KU-XP:_'B_P;;VFH-;037<X:-8P02L$A!.>N.1CISGTK:B\//%XPN/$/VYC
M)/;):- 8QM$:L6&#G.<L>??I2Z]X=76[K2[M+Z>SNM.N#-#+"JM]Y"C A@1R
M&/TH X:>XUBQUGXD:AI5[;VSV)AN3YL'F>:4M%;;U&T''7D\]L<[Y\3ZCK%[
M;V&FQ312-I4.H2R0+$[*9=P5<2,!M&TYZDY'([VW\&;_ /A)<ZE)C7T"3YB&
M8P(_+^7G^[ZYYY]JKW7@)V?2KO3M=N].U33[1;'[7#&C>? .BNC J<=<^I/M
M@ U=)O==;P>+O6=/CMM:2"0R6\;!U+KG:1@GAL XSQG%87P@"R?#73KTOYMS
M?/-<W4QY:25I&W%CZ\ ?A78:?9#3[&.V$TLY7)>68@O(Q.2QQ@9))Z  =  *
MP;'PC+H=S<G0=5>RLKF5IGL9(%EBC=OO&/D%,]<9(ST% !KFH)H.H:=I^G(D
M-WKVH$-(RY5,1Y=\=VP@ ]SDYY!R-2\3ZUH][XET=IH)KFQTAM6L;J2'[T8W
M I(JD#(9>",<'IQSO:MX2MM5LK9'N[A+ZUNEO(+X;3(LPXR1C:01\I7&,4RY
M\)+?0:L]W>E[_4[/[#+<K$%$<.&&U%R<??8\D\GT % & FN^)UU'PFAO[)X]
M?MG#(;4XMW6'S=X(;+=",<#Z55OO%_B+3O"WB63[3:3W^C:G':+.]OM$T;F+
M&5#85AYG7D<=*Z8>$2+CPW-_:+[M!1DA'E#][F/RSOY_N^F.>?:N6\>^'_[)
M\%^)I5OI)IM7O;>X,:Q@,KB2('8!G("IGG/3- &O_;/B71O&UOI&I3V5];ZI
M:3S6;1PF#R98@"48Y;*88?,>:ATCQ/JLGB/1-.FO(;I=3L)I99$@Q#'/'L)\
MEQCS(_G(ZGH/FK;E\,0ZQ))=ZG?&\:2QDLH7A41K'%*!O9>3\[ +\V<<# '.
M:5CX$EL[S0[M_$%[/-H\+V\.Z*,*T;!1M("_["Y.<GU% '/V_BWQ0/#%EX@G
MO+)HUU?[%/;):D>;&;DPY#;OE(&,#GIR3GCH'\17FC^,=3T_6KI!I[6!OM/=
M(@I*IGSE)_B9?E(QV--'@!1X870?[5E\A;[[=YODKOW^;YN/3&_VZ<4S58]/
M\8>(]/TXVMTTVB7OVBXN'MWBC4!#\JL1AP[%> 2" <]L@&U8P^(9(-&FN;VW
MC8*SZC"8,ERR_*J$'Y=IZGG.*R?B#=NL?A_25.(M5U>"VN/]J$9=E_X%L /L
M36MK-GJEQK.CS:?J$\$4$K&Y@5%,4T9QG>3SD8( '=L] :C\7:)+K&G6DMJH
M:^TV]BO[92<!VC/*9[;E++]2* (=<UC4+#QEX7T^"2$6.HRSQSH8\O\ )"SC
M#9P!D#M^-)X<U>_U+7_$^GZ@\$D6GW4<,/EQ;1L:)7YR3D_-5B]T9==U70];
M2ZE@.FO))'"T.-S.I1@X/(P"1CC!]:2QT=?#^H:WJ[7,MRVI2K,\"1#(=5"*
MJ8]0!U^N10!G?#>\DFT34M.D8LND:K=:=$QZ^4C90?@K!?PK/OO%6KV&J6.^
MY@E\_7%T^6V@BWPQPNQ5<R8XE^ZQ7/&<;171^$-#DT+1&CN=IO;NYEO;LJ<C
MS96+$ ]P,A<]\5B_\*X5;2*SCU^_2UMM3&I6L82(^2^\N1DKEN6;&?7O0!N>
M*-;DT:UL$MPGVG4+Z*QA>095&<G+$=\*K8'<X%<UXXBUN#P)XRBU&X@N;#[#
MNLY@-LWW3O5P %X.,$=CS74>)?#=KXGT4Z==2S1%72:&XA;$D,J'*NI]0?YF
MLVX\&W&H^'+_ $O5->N[V>^B\B6[>*-2D?\ =1% 49[GDG\!@ JV&JZU8^,-
M+TF\N;:XM-0TV2>.-(=A@>/9QNR=P(?J1U&>.E4]-\5:N?$'AVSN;J"X_M07
M*70ABS!#)&A<"&3 W@8*GEOJ*W;CPG]KU?3]0GOW+6=G+9A%C"ATD #$G.0?
ME&,=*S;#X>M8_P!@_P#%07TG]AEUM 8X@/*9"FPX7GC W=>.,'F@##G\6^*8
M/#.KZZU[8E=)UB2T:W6U(%Q&LRQGDL=O!R.O/?TZ#5O$%^/$.LZ9%<QZ>NGZ
M6M[!)(@;SV)?).?X%V@'&#\W4<4DW@!9_#>K:(^JR^3J=ZU[+((5WJ[2"0A>
MV-P'4'C/X8/B%FF\977VO6K_ $F6&*&&#=I*W4-Q@%C)'N1@IRVT@'/R\]L
M&G8>*M<O[7P_:30E-1U.P?4)OLL"HT*#8 JK*^,YDZDG@?=YR.C\+3Z]/I<H
M\0VBV]Y%</'&RE/W\0/R2$*S!20>1GJ#6$_A;4/$6G:;?WFKW5GK>GRR&TU*
M&W6*1HF.,20MD?, ,J<=!P.175:3ISZ;9^5->37MP[;YKF; :1L 9PH  P
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M8U$C!G ^9@, GZ4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO_B+=^'+LR_8+32XYK: S/\ O2\C!Y"<Y8KA5&3QSZURIN=4N-'TNUN-2O\
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MV3D"L0^%6:[TW2K+18=+TC2M42_BFCF#B<+&PQM^\K;F YXP.O05U']O:/\
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M).!GL,"M#4]*L-9L7LM2M(KJV<@F.5<C(Z$>A'J.:6VU.PO9I(;6^MIY8O\
M6)%*K,G;D \4U-6TV2=8$U"U:9MP6,3*6.W[V!GMW]* (;#0M/TUU>WCE9U&
M$:>XDF*#T4NQVCZ8J)O#&C->S79L5$D\BRS*'81RN,8=XP=K,,#D@G@5=M-2
ML=0+BRO;:Y*8W>3*K[<],X/'2IYIHK>%IIY4BB099W8*JCW)H HG0M..JRZI
MY#"^EB\EYEE<,4[+P>@))'H>:J#PAH2Z;;:<MABSMIO/@A$KA8Y,Y##YN"#R
M/0DFK_\ ;&F?N?\ B8VG[_\ U7[]?WG./EYYYXXK"\:>))]&T.2ZTJYLWN(+
MJWAGB<;RJR2JG0,-I^;/.>G2@"AI/A5I_%7BB[U;39DM=1FB,)-S\LL:Q*A6
M14?YAD$X8$8)]2*Z.]\,:)J.H07UWIL$MS!%Y*.R_P#+/.=A'0KGG!R!5ZVO
M[.]DFCM;N"=X&V2K%(&,;>C '@^QIL&IV%S=26L%];2W$?WXHY59UYQR <CF
M@#-MO!^@60L!:Z<D/]GEC:^6[#RBPPQ'/4C@^HXZ5%=Z?-X?@GNO#>C1WE[=
MW"O<QRWC1!\\&0LP;)&!VSCZ8K7&IV!O?L0OK8W><>1YJ[\XS]W.>G-!U/3Q
M?BP-];"\(R+?S5\PC&?NYSTH KZ%I?\ 9.EK _E_:)9'N+AHAA6ED8NY'MDD
M#/8"K&H:;::K:_9KV+S8MZN!N*D,IRI!!!!! ((JU52?5-/M;F.VN+ZUAN),
M;(I)E5FSP, G)H +'3;33A+]FB*M,V^5W=G>1L  LS$D\ #D]!5&?PKHUQJD
MFIR6K_;I$\MIUGD5RN<[<ANGMTJ]=:II]CYGVN_M;?RU#OYLRIM4G )R>!GB
MGM?V:1PR-=P*DPS$QD $G&?E/?CGCM0!7T_0]+TNWG@LK""&.X):8*@S*3U+
MD\L?KFHM.\-Z3I+QO96GE^2I6%3(SK"IZB-6)" ^BXJ[:7]GJ%M]ILKN"Y@R
M1YL,@=<CKR#BFV>I6&H>9]BO;:Y\L@/Y,JOM^N#Q0!CCP)X64 #1+7 N/M*@
M@D+)SR!G@<G@<'TK2L-$T[3+FZN;.W,<UV^^X;S&;S&]3DGGMFHM-OC'8-+J
M6J:?,3<O&DT!")@N0B<L?F' /O4KZ[I,=G=W;:G:?9[//VF03*1"1U#8/!]J
M ,M? /A9&&W1H-HG%RL>6\M)!SN5,[5_ "MR\L;74+&6RO+>.>UE79)%(H*L
MOH15+2O$>EZOI5EJ%O>0"*\53&K2KNW,H;81G[P!Y'6I/[?T;[']L_M:P^R^
M9Y7G?:4V;_[N[.,^U !8Z'I^F[S;0N':,1&229Y'"#HH=B6 &> #@4NE:)IV
MB121:=;F".5S(ZB1F!<\EL$GD]SWJQ=W]GI]O]HO;N"VASCS)I B_F3BAM0L
ME6%FN[<+.,PDR#$@QGY>>>.>.U %"[\,:1?:H-3N+5FOE3RUG$\BLJ9SM!##
M SV%6=.T;3M)\W[!90P-,VZ5T7YI#ZLW5C]35/5/%FBZ5X>GUR74+:2QB!Q)
M%*K"1QT12#@L3QBM6WN(+N!9[::.:)ONR1L&4]N"* ,A_!^@R6-Y9/8;K:]F
M\^YB:5RLTG]YOFY/ _(>@JQJWAS2-=TM=-U6Q2\M4(*K,2Q4CH0V=P/OG-7[
MBYM[.!I[F>*")>LDKA5'XFHAJ=@;#[>+ZV-GC/VCS5\O'KNSB@"@_A+0)?#_
M /8+Z5;MI?7[.5XSG.[/7=GG.<^]$?A30HM!ET--,@&FR_ZR Y(<\')).2>!
MR3G@>E:=O>6UV91;7$,QA<QR>6X;8XZJ<=#[4^66.")Y9I$CC099W. H]230
M!F3>&=(G%IFSV/9J5MY89'BDC!Z@.I#8/<9Y[T7'AK1[JUL[:6R7R+*02V\:
M,R"-QT<8(^;D\]>3ZU0\3^(FM/ ^JZYH5W97+V<#R*^?.C)49(^5AS^-:HU6
MUM=*MKS4;RWM5DC4EYI!&NXC/4F@!E[X?TW4+IKJX@<S/"+=V29TWQ@D[&VD
M;AEFX.>IJ]]GB^R_9E39"$V!8SLVKC&!C&/PIDU_9VUH+J>[@BMB 1,\@5"#
MTY/'-9NI^*]%TF+3Y+C4+?;?S+%;$2KB3/5@<XV@<D]/S% !#X3T2WM+2UM[
M-H(K,L;813R(8=WWMI#9 /ITK2M+&VL+-;2UB$4*YPJYZDDDYZDDDDGJ2<U5
M@N)Y==E47]E)9_9D9+9!F96).7)S]TC&.*L1:G87%V]I#?6TES'G?"DJEUQU
MRH.10!!IVA:;I,-Q#96HCBN7:29"S,'9OO,0Q/)[^O>L_3?"&@^&A=76B:+%
M#<2HP(AZG/.U=QPH)QP,#BM276-+@;;+J5G&WF^1AYU!\S .SK][!''7FKM
M'%> /"2Z-X4T>WU2P:/4+%3E'G,D:R<Y=%#%02">0 >3ZUO2^%]%FEU&2:Q2
M1M20)>;V9A.H& &!..!P/3MBI[^:YCU'34AO;."-Y6$T4PR\Z[#A8^1R#R>#
MP*F_M.P%[]B^W6WVK./(\U=^<9^[G/3F@#/LO".@:=>07EKI<$=S!$88Y>68
M(>Q)//U//:FZ1X/\/:!>RWFE:5;VL\N=S(#P"<D*"<*#Z#'2MRJ5QK&EVI<7
M&I6<.QQ&WF3JNUCT4Y/!/I0!GV7@OPYIVMR:S::1;0ZA(Q9I5!^\>K!<X!.3
MD@9Y-177@7PS>SWDMQI$+F]8/<+N8)*P.=Q4';NXZXS6U=WUGI\(FO;J"VB)
MQOFD"+GZFL_6/$^DZ':6=S>7L*QWD\<$!\P?O"[ 9![@ Y)[ 4 :L44<$211
M(J1H JJHP /2GTV.2.:))8G5XW4,KJ<A@>A![BG4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!QOQ0
MEN(/!,LL22/;)<P-?+&"2;82*91@=MO7VS66FK:+?_%_2;G3[VRG6;1)XA)#
M(K!CYD95<COC)Q7HW48-1Q6\,  BACC &!L4# ZT >):=JVFQ_#WP'9/>0"Z
MLM<MUN8BPW6Y$D@.\?P?CBNK\*Z?H5[XZ\9E[6PG>"_@EBW(C>6?(3++Z'=G
M)'>O0A;PJQ80QABV\D*,ENF?K[TX11J20B@GJ0.M 'A\C:6WPQG4M:[(_%1$
M?*_(IO!T]!M].U=2\>GP_$?Q#96<\-C'-X;C+&U !1@\HWA5ZLJD'UQBO1?(
MBQCRDQ_NBJ>KZ7_:6D7EE!</92W$+1+<PJ-\>1C(H \O\+W&A^(+CP.DNJZ'
MYVBVK1B!;E'EN',810$/(QC<1U#  9ZU[!7*6OAG4IV@CUF?1YH()$D4V>G&
M*1RA#*2S.P7D#( ^A%=70!XKXQU?3I=)\6Q030V4T&L6[3V[L6GF=)( 9CD_
M)'M Q@8^7J,XKH((]"O?B?XCDE6QEB?1[:3+A2#DR[FY[[2.?0^]>CF&)BQ,
M:$N &)4<CWH,49))C0D]3M% 'DNEVLMQ\'?"WB+3@)]4T"%;F(*<EXU!66'/
MO'D8]0*]!\+@W5C+K,D;)+JLGVD*XPRQ8 B4^AV!21V9FI-:T;4M3GAM[;4X
MK327C:.]MUMP9)@>ROGY,C(Z'KZ]-P *H50  , #M0!A>.(S+X"\0HJ%V.FW
M 50,DGRVKD=2FMCX&\,^+=+>.X?0?)ED:#YMT#($G08[A6R?=/45Z931&@C\
ML(H3&-N.,?2@#S#2[34;;Q3>Z%<VK+9>(V76&4)A8 #^_B;U) A4_P"^346H
MWVD'Q-XMT+Q9JTVGI?LA@5EC"7-L8E4+&S(3D,'X!SDY SFO5=HW!L#(& ::
M\,4CH\D2.R'*%E!*GV]* . MVM[7XG^&[02R*8_#TL:I<N/.^_%@/_M8!S]#
M46DV$VG>*-2\&"W;^RY;E=7A<+\BP,2SQ>G^N4#'=6->BF-"^\HN[UQS2[1N
MW8&[&,T >3WEYH\VM^+?#_BW5I[%KRY#Q0E4Q=6YC0)Y9*%BP((PIR#T&<UZ
MCI\?E:;:Q_OODA1?WYS)P!]X]V]?>I7ABDD21XD9TY1F4$K]#VI] '$R+(GQ
MO@DER(9?#KI"3T+K<*7 ]\%*3QY<P0Z[X+66:-#_ &R&PS <>3*,_3) _&NG
MU+2H[^:TN5?RKRS<O;S 9VY&&4CNK#@CZ'@@$76C1\%T5CCN,T <YXI\9:5X
M=:&QN-4L[._NE)B-S( L:]Y&'<#L/XCQP,D/\-7F@2^&)$T2[2ZTZU#I)< Y
M#OC<[%NC$EB21QDFN@:*-SEHU8^I&:J:GIJZEI\E@7\JVF!2<(,,Z'JH/\.>
MA/7&<8/( .<^%,4\/PN\/K<A@YMMPW==A8E/_'2M5/B4EBUQX1^UBW).O0+^
M]QDH4DW#GMTSVZ5W4<:0Q)%$BI&BA551@*!T %#1H^-Z*V/49H \QAM=$/C7
MX@1R0V.Q+&V.Q@N%)BD#G'8\+G\*H^%-2,%U\/KG4)U.EOH36\$SM\B7F$X8
M] Q12HS[@=Z];\F+)/EID]?E'-(\$,D1B>*-HSU0J"#^% 'BWB&UMX?#GBZ7
M,(TB77[1]/)(V[C)%Y[1GTW;NGHWO7321V$'Q0U.SL$MHQ-X94^3 % =A*^/
ME'4X(_"O1#%&4"&-=J]!C@4"*,-N$:AAW H \9AO=*O/AY\-[8W%K*J:G9QW
M"%@0&$3AE;W&0"#ZC/6NO\)-:0_$?QM:VIA1 ;)_*BP #Y1#' ^@S7;^3%@#
MRDP,\;12B-%8LJ*&/4@4 9_B&*.?PWJ<<L:R(;63*N,@_*>U>5V&F:9=>$/A
MQ/HT=M_;27-F[2P8\W8J?O\ >1SM"@@YXZ#TKUO5+:6\TF[M8&199XFC5GSA
M=PQDX^M4?"^B'0/#UAITOD23VMM';M/$FWS BA03W[=,T >;65QHVJ6=_P"'
MO$FK7L&M0ZM+*;",1K+-)YQ>)XCLW'*[0"&X [+6YX;T_0[WXC^-!+:V$\D%
MS:2QAD1O+80J2RCL=W4CN*]#,,1F$QB0R@8#[1N ],THCC4DA%!/4@4 >*Q7
M"P>$+J6UV/I5KXSDDU!(<%5M!.3D@?P [#Z8'I6[XF%]<>*]5U'PI*)9CX;G
M6=[9MP>7.8.1P9/OD=\>QKTU8T4$*B@'K@=:2*&*!-D,:1IUVHH _2@#R.76
M_#MW9?#:2QN[,&WO8XV3>H>#,#AE8=5.X#.>I%>OU$MO CEUAC5BVXD* 2>F
M?K4M 'F0MO#LOCCQXOB&*R9&2U*BY"EC']G 8IGGJ,9'<#O55-+U/0?AYX4\
M2W$,AU;P_"'N8V&9&LVXDC/NJ$-[%*]3>"*21)'B1G3[C,H)7Z'M6-J^CZGJ
MNIQ(=3CBT0Q@7-D+?+S,&SCS,\*1@$8Z9]<@ F\.6TD>FM>7,92[U"0W<ZL.
M5+ ;4/NJ!$_X#4'C::.'P)K[2R(BG3K@ L<#)C; K>I&17&&4,/0C- '!>'_
M !?H^D?#+0W^V0W5VFEP)'96[B2:601*-BHN3G/'3CO7*VV@GPIX.^'EEJOD
M1:BNO1RR!B,Q[_-8J#Z#*@]LU[,L:)]Q%7Z#%#1H^-Z*V/49H \XT'3])O?B
M%XY$=M8374%Q:2VVY%;RI! IWJ.QW]2.XK+\)7.A:WIOANRO]5OCX@TJX1FT
M[$:31W"\2,V$#%#EF8DD$'DDUZVL:*Q944$]P*00Q+,TRQ()6&&<*,D>YH \
MM\+ZGH-]HRZ#XB ?Q'::M)-)9LS+/)<B9F21<$%EVE?F^Z%'/ JMJ4MR(_B?
MI^E/C69)%D@@C_UK1_9X]S*!STW 'UP.N*];\F+SO.\M/-QMW[1NQZ9IP50Q
M8*-Q&"<<F@#SF_FL-:U'P+>>'7A9XY27$1'[NR\H^8K@=!D(N#_%CO69X;TW
MPW=>#?%T]RMM&D6HZE&UY"JF2VB9F7*'^$;3T'!'UKU:."&)G:.)$+G+E5 W
M'W]:411J"%C4 ]<#K0!Q/@^]U,>);W3=5:PU&9+&&2/6+$;1/%N<(LBY(5\E
MB,'!!-=M+$DT3Q2HKQNI5E89# \$&DB@B@4K#$D8)R0B@9/KQ4E 'BTMMJMC
MH4EG;P.TW@6]:YBD9>;B#AD0'W@=P0.ZIZUM^-C%_P *TN+^[VPRZIJ%I<LL
MAVMM,\6Q3[K&J@^X)KTPHI# J,-][CK]:&1' #(K =,C- 'ENMH8/&_B*T\.
M>1#>S>%,P1VVU2THDD"X _BP1C\*=++::OH7P^?07C%_;WEMA(B/,AA5"+A7
M'4  $-GO@=2*]/$4:MN"*&]0*1((8Y'D2)%=_OLJ@%OJ>] 'F>G75QIGB+3U
MM;FTUK1+O5[@1(?EN].N&\TR=#AT!,F<\@-Z5G>'KC1M8TNQT?7=6O4\16&I
M&5]-41I-]J$C'>OR;BISN+9Q@G)Q7KJV\*2F588UD(P7"@$CTS2^3%YWG>4G
MFD;=^T;L>F: 'UXOX_U6PFTWQ[:P216=W&T/G0NQ>XNF58RLBJ3\D8&.0.H)
MR._M%,:&)F8M&A++M8E1R/0^U 'G#1^'K_XNW<EXFGS6]QH,,R&8*4E_>R N
M,\-\O?T]JYBQTRSL[#P4FH11?V<VO7:VAN!_RZ,LOE*2?X6X(!X((KTT>&YG
M\<W&O3M:RVLMDEF+=HR678[.'R>,Y8C&/QIWB+P_=:SJ^AW<4MND6FW#3M'*
MI;S=R,A7V&&/K0!YQK^G363>.;CP_;_\29GL3<PVJ_(Y5LW 0#C[F-V/4BNL
MO6M=4^(WAG4-&G@GM_L-T-0DA8,C6Q5?*#XXQO.0#Z-Z&N[CC2*,1QHJ(O 5
M1@#\*;%!#"K+%%'&K'+!5 !- 'B).EO\,8E9K4I'XJ(3E?E4WG./0;?TKI+F
M.RB\=>++*P2W02^&XSY$  W.#*!\H[@%?P(KTKR(L8\I,?[HIPBC5MP10WJ!
MS0!XZ+G1;[PS\+_WME,4N;:"4DJ<8MF#(?\ @6T$>N :N_9=%.O?$Q'BL2D=
MM$0I"X0FV.X@=LD#/N!7JGDQ8 \I,#H-HXH\F+G]VG/7Y1S0!Y!IVNP:=)X.
MN=7U:2QTNX\.100WH"-&MQ\ID1F=6"DJ%]/NXJ6;3/#EG?> [6R;S]/;4KDP
MO=[29(VBD/R\#]V7/ Q@Y&."*]9>WADB\J2&-H^NQE!'Y4XQQL06121TR.E
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MK@_7D#.>G:JIT6_A\5IJ>AV^H:;=2ZH?[1M7^:SNK?>09^<J'*@$8PV3R.]
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MRQLR)O< D+G&3Z9KSR/XG7?]A:?XAN/#<D.AW$_D7%S]K5G@)D,8;9M^9<@
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MR\Y_O#I7I-! (((R#0!Y?H-AJFLZ+XVTBV6U2WOM:OK=KEY&W1*Y"N=FW#$
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MKSPUJ&I:'>W6KB"YB62 6RK>6L>1YJF/: 7 W$9'YXY(?&HFTBVETW5&U/\
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M,6XQS76ZCI]KJNG7.GWL0EM;F-HI8S_$I&#6-8>$H[7^S5NM1NK^/2\_8EN
MG[L[2@9B%&Y@I(!/J3R>: .+G\3>*(/"^LZZVK0DZ3K,EK]G6T4+/$LZQX8\
MD<'C'.>I/;U1U+1LJN4)! 9<9'N,\5R4OP^M)O#VJ:*^JZA]GU*\:]F<>5O#
MLX<A3LP!N [5UJ*5C56<NP&"Q R??B@#QB47DGP1U"XN-0GNY9-6 _?A>"-1
M SE5!Y[]O3%=7=>)=5\->(-=M]1NUU&VMM$.K1*(5B*,K,IC&.JG QG)'J:N
MR?#NSDT&[T4:MJ26%Q=_:EC4Q_NCYOF[5)3IOYYR>V>M:,WA.UNO$$VK7=U<
M3M/IYTZ6W<)Y3PDDG("YR23WH S],N?%,FKZ5<$23:5<PL;W[0(%$3%04:'R
MR6()X(8GC'-:'B_79=!TJV:V"?:[Z]@L(&D&51Y7"[B.X R<=\8JMX=\%)X>
MDB4:UJE[9VV19VEU*K);C!'!"@M@$@;B<"M3Q'X>LO$^C2:9?&58V9726%ML
MD3J<JZGL0: .2\F]L?BX[-J'VMQX;E:)[I40*1.G#%% VYP>F1S2Z/XAU:7Q
M+HFG3:B]W#J>FS2RS"!%C69-A+0':"R?.<%@01@@GFM,^ X[J^>]U/6]1OII
M=.DTV7>(D#PN<L,*@P>AR.?Y4MAX$BLK[1;Q];U2XFTF)X(3(T8#1,%&Q@J#
M@;!SU/<F@#F/#.M:AI7@>RF:]NKRZU/6IK)#((R48W$N6&0H+$*<;CC)'&.*
M[+P^WB)-6U&'55=].PCV4UP8A/G'SHPB^4@'&#@=>:HM\.M,DT&\T:6]OWM)
MKEKJW D56LY"YDW1,%!R&).6SZ5L:%H3Z.CM<ZK>ZI=. IN+QEW!1T4!0 !W
M)QD]R<# !@>+UO)/'?@R&#4[JVBFGNMR1!"-RV[D-\RG)P2.<CGIGFN?N9M7
ML;WXDZGI6I+9O82I<X,"R>:4M4;:=W12!CCGGKQSWVN>'(=;N],O#>75I=:=
M,TL,MN5S\RE&4[E(P5)[9]*H/X(MI(O$4;:G?;=>&VZ_U?R#9Y?R?)Q\HQSG
MUH SM6U[5)(8IK:_6V631_MD5O:QK+.9B,Y<,I58@,#)*Y)(STK+.HZEKNL?
M#B]?49[4ZC937,T4"IL$GV<'< RG^^PYS@=,'FN@_P"$"MEO$N(]6U*,G3UT
MZX5&C N(ESMW?)\I&X\KBB#P%:V]GH$,6JZBLNB!DMYPT>]HV0(4/R8QM &0
M >,YSS0!T.K3SVVCWL]J]M'<1P.\3W3;8E8*2"Y[+GK[5Q^B:]JMQXO31S?R
M7%O<:,;Q+B>V5 )ED5"4 "$QG?D;AVX.#76ZUI%MKVB7NDWF\6]W"T4A0X8
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M'8W( GC\UR9 .BLQ;<1[9QS5L>'-+%[8WOD.;BQ0QVTAGD)C4]0,MT.!G/7
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M>&,YR.X[4 4+_P &^'M3O;N\O=+BFGO(A#<,2P$J@8&X X) X#8R.QJ._P#
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M<:E86EJES<WMO%!)C9(\@"MD9&#WXH H75M+H.DW,N@Z4M]>NZN89+K8TYR
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M#M;G/W:Q->E\,ZIX0\6ZWI%[/J$EUI9AFNY#B-G /EH 5 +C)Z#(X!ZBO7*
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MW,%_<Y19&6"2(2.BQ%#E3@!<D -D=:V?^$F^T^-KKPR+.Z18K-)6N%7&2[$
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M0 4444 %%%% !1110!72R@CO9+N-=DTJA9"IP'QT)'<@<9ZXXJQ110 4444
M%5TLX4O)+O;NN'4(78Y(4?PCT&>?>K%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tardioagreementa01002.jpg
<TEXT>
begin 644 tardioagreementa01002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRA4DC&65B5PIZ]<9P: .AHHKA-2\7MJFE>,K:R%[8SZ1#*L4XA9276'?G)!
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M?$B80)X5E,;R!/$-L2L:EF(VR= .3]!S79"VA%TUSLS,5V;R22%]!Z#IG'7
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M"0"%SG^+ YZ]:J^'/#^J^"=7\/7%[!/=V:Z&--N&MHVF-M,)/,SM4%BIR5R
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MRI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2'.-F"6( /(  '6JWA_Q98CPGH;Z?H\5G+JEU-;VFG1N%165Y"[%@O PC,2
M>3CG-5[;4;.P\<ZIK%OK6D26.H6T",LEPPE5X@X & 1@[ASG(QT-8%C86UGX
M;\/HNOZ,NL:'>RW,)%RQAF21G+HQV@KE7QG!P1[T ===^.9=.37[>[TL#4M'
MM/MQ@CN,I<08)WHY4$8VD$%>#Z]:DT_QA>3ZYH]C>Z.+6#5[5Y[29;D2-N15
M9E==H"\-D$$].<=N=U7[!K \0:A)J^D1:EJ6E?V5;Q_:B8X8SO)9FVY)+/G
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MSST(/-;=_90:IIMS8W2;K>YB:*5#W5A@C\C7"Q_#FZ;2= 2YU(2:E92[;VY
M_P"/BV:/RGB_%%C&?4$]30!I2Z\)]8\(#4- A%QJ32O!,TH=K,B%GXRH.2HP
M>F,GKBL%+.VQ\5+?[/%Y.0WE[!MS]D5LX]<\_6NKU[1-0U'Q/X<U*U^R_9]+
MFEDE$LC*S;XS'A0%(XW9Y(K/7PQK D\:-_H/_$\'^C?OW^0^2(OG^3VSQGT]
MZ -7PDSI\/\ 0FBC\R0:7;E4W8W'REXSVK"TWXAW=[8^'M3FT(0:;K-RMJLG
MVL-)'(Q8+\FWE?EQG(//3UZ;0+&\TKPIIVG3+ ]W:6D<!V2'8S(@7.2N0#CT
MX]ZY"T\%:Y;>#_"VCEM.:?1]1BNY7\]PLBHS'"_N\Y.[OTQ0!M77B^?[)K%]
MINF+>V6D2O#<,;C9)(T8!D\M=I!VYQR1D@CT)J1>*;_4O'6CVVFK;2Z/>Z0]
M^C-*RLX+Q#<1M/(#'"]\G)%);^%]9TI?$5AISV4FGZQ/+<QR3R,KVLDHQ(-H
M4AUS\PY7T/K4EOX/N]'U_P /W6D26S6>GZ8VF2K<,P?9N0AUP,,?DY!(Z]:
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M *D%D6:- ,Y.Y@"2<^F!@=>36-:^'M8T/5]>DTDV<UEJ\IN@MQ*R-;SE0K'
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M%\_R>V>,^GO58>%O%&DW>D:KHLVF->PZ9%IM_:W4C^3*L>2KHX7(8$MU'0T
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MW8)7.['.>V*D\2^"[KQ!-(GV:PA:"6)M,U..5DN;-%";A@+\W(<@;L'=SC%
M$UCXBUEO%WBNWN+..:RTJ*$QQ6\C-*P,;R#:NWYG;@8R,8 &>ILZ=XON+KQ
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M-\B+L^T";GY3@G&,<X]30!Z112+N**7 #8Y .0#]:6@ HHHH **** "BBB@
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M=ZQ=W']LV2VEVA2-0<*R[A@<8#G _/-;>A:9+HVC6VGRWLEX8(UC$LB*IVJ
M ,+[#^=:59^MZQ;:!HUSJ=WN,, &53JQ)"JH]R2!^- &-8^$KG3H;X6VLNDU
MWJ3:D9! ,*[?>3&>4(&,=>O/IHZ)H$.C7&I789'NM1G$]P8X_+3<%"C:N3C@
M9.2222<U+IE_J-S>7MMJ&E&S\@KY4R3B6*=6!^Z<*01C!! [8S6G0!R+^")(
M=?OK_3->O=/M-2<2WUE"B%97Q@LK$$QD@<D<^XXQ;;PJ;77[K6-'OOL,M["D
M5W$81)')L&$<#(VN!QGD8QD5T=% '*IX(M[6?P\UC=-!#H9D:*-D#F5I%*NS
MG(Y.XGC')S[5!<> DN]+\16,^I2%-:N!=.R1!3#(-F-N2<C]VO!]^:[&H8;J
M"XDGCAE5WMY/*E _@;:&P??#*?QH PX_#-P/$UCKDVJO-/:VCVK*T"@2*[!F
M)QC!RHQCH!WZU$WA%K?4=6N-,U)[.#5_FO(?*#XDV[3)&21L8C&<AAD XKIZ
MQ#XAQXU3PX;-P6L6O5N2XVD*ZIM"]?XNIQTH JOX/@CU+P]<65Q]FM]"C>*W
MMQ'N#*R!#N.<_= Q[\G-5I/ 5K=V?B&SO[R2:#6YQ<R;$\MH9 %"E#D]-BGG
MN/PKKJ* .3@\%R7.D7FG>(M<N]:2XMVM@TL:1>7&<9QM'+Y"G<<G@=.<Q6W@
MB]6\T*XO/$EW=-HS.;<_9XU9U9"F'.#D[203W]CS75S74$$UO%+*J27#F.)3
MU=@I8@?\!5C^%96A>(?[:O\ 6;0V;VS:9="V;>X8OE%?=QTX8=S0 [Q%H"Z_
M;V2_:I+6>RNTO+>5%# 2("!N4]5PQXX^M598;3PRNH>)M6GEN;EXXXYIH;=C
MLC5L*B1KN(7<Y)Y)Y))P!CHZ* .6\'Z/:VLVL:U;VTMN-7NC.D<JE66,# .T
M\KN;>^#@_/SS5_Q)X>'B"&P"WDMI/8WB7D$L:JV'4$8(/!!#&F-XD%SK%UI6
MDV;7UQ9[1=2>8(X86(R$+')+8YP <=\59TS66U"_O;*:PN+2XM%C+B7:0X?=
M@H03E?E//'T&* ,V/PG+%JFM7ZZF6DU6VCMY \(.P(K*I&",G#'/;/8=*SG^
M'ABL-#&GZY<V.IZ-!]E@OHHE)DAP!LD1LJPX!^O-=O10!3TNP;3K(0R74UW.
M27EN)L;I&/4D  #L  ,  "L2/PG+IFL7NH:#J9L%OY/.NK22 30/+WD RI5C
MWP<'TKIZ* .?U;PG;ZYHTME?W=P]P\B3I=IA7BE0Y1D&,*%/;W.<DDTL?AV9
M[YM2O;Y+C4EM6M(91!L2)&(+$)N.6) R<]A@#G._10!QT7@0PZ!X?TA-4;RM
M$N8[F!S "TA3(4-ST^8YQCMTK-\:Z"=/T'QMK!O?,DU;3O(^S^7C!1&6,*<Y
M).XY]?:O0Z* .4T;0QJ-MH>H7U^+Q;*W_P!%6./8 S)L+L03N8+D<;0,GC.,
M4;'X<M96^B0+XAO6CT:X:2T'DQ#"%64J3MY.&QN/Y=Z[-;J![N6T653<1(LC
MQCJJL6"D_7:WY5-0!QD_@(W&@>(-(DU5O*UNZ>ZG<0#=&7V[@O/3Y1C.>_6H
M?$T=AXIF@\(SQW,]];7$%Q-.MN\<<2#YF8/C;\RY3 ).7]CCN:I:CJ<.FI"'
M!>:XE$,$*_>E<@G ^@!)/8 F@"X %    '  KG];\-3:TFHVTFH :?J$ AFM
MI(!)LX(+1G/RM@]2" 0#BI];\1QZ%+I4=Q9SR'4+R.S5XL%(W?IN)(..#T';
MMFK=]JD>G7-JERI2"YD$*3Y^59#]U6]-W0'UXXR,@%JVMX[2UAMX@1'$@C0$
MYX P*EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@##\6Q:C-X>ECTF:*.],D1C660QK, ZEHMPY7
M> 5R/6O-_$%W:ZKX!UN*6RU'3[^SU2R-Q87-PS?9F:2%1L8-AD(R1CC)) '%
M>LZCIMIJMI]EO8C)%O5P [*0RD%2"I!!! .1527PSH]QIUY87%D)[>](:Y$S
ML[2D8P6<DL2-HQSQ@8H YV-UU#XAWOARZ>X%C9:9%-;0_:'!E+NP>0MG<V,*
MHR>.>]<[I/B#46N-'T'5;V=K%M=OM/-XTA5[F.$'RE9QSDMP>[;,'.3GT.?P
MQI$YM&-H8Y;12D$L,KQ2(IZC>I#$'J03R>31?>%]#U+1%T:\TV"73T(*0X("
MD<[@1R&Y/(.>3ZT <5XTT\:1X0O;:#4)[T'6;.:.">3=]F#3QD1!CD[>,@'H
M&],5?T:^CUKPUK^IW$ERFK".:&]L9)6VV;JA'EJF=N,8._'S9SQT'0GP?H)T
MB+2O[/ L8Y!*(ED<9<'(9B#EFR <DD\"GOX5T:2^N[UK5Q<WD0AN9%GD4RH!
MM ;#<\4 >?:!"^EVOPRO+>\O-]_;I;W*-<.8WC^RE@OEYVC!48( /KDT_P"W
M76K_  SUWQ.U]<VVMV4UW*C),P%NT+MMBV9V[=JJ"".=Q)YKO5\*:*D>G1K:
M.$TTYLU\^3$/&/E^;TX^G'2G/X6T62]GNC9 /<2++.BR.(YG&,,\8.QCP.2"
M>!0!RGV^X_X6+9:A+;$77_")2SO .N_S8F*_GQ6#=A-7^'_A#Q#-=33W]WJU
MC-/+YS;2S3#<FW.T*IX QQM^N?46T33WUM-9:!O[02+R5F\UQB/.=N,XQGG&
M.O-91^'_ (6)?_B41['G%P8O,?RQ(#G<J;MJG/H!F@#F734/%T_B>&/6%TZ\
MT^_:&&3S)%>T154HX4,%*MR22.<D'@ "2'37UOXA:C97>K:D;9=+L[H+;W<D
M2^:7?+* ?E!V_=Z<\C(&.HU#P1X:U35X]5O=(MY;U%"^9R-P'0, <,!@?>!Z
M5>BT/3H=:EUB.!A?RH(WF\USN0=%QG&!V&.* .'TZ_O--\5V%OKL-R1=7TQL
M=6M;EGM[L.)"L,J9^0A3P,$93CO6W\3Y)H/AOK=Q;W$]O/#;ETD@E:-@01W4
MCCVK8M?#6DV<\<L-LP,4C2Q*\SND;MG<RHS%5)W-R!_$?4U:U72K+6].ET_4
M8?/M)>)(BS*&'H<$9'M0!Q]_;-??%"QL9;V^6SGT.626"*ZD1682Q@'Y2-IP
M>JX)_//*-]KM_AO=:N-4U-K[2-8:VM)'O)"%B6\$>UAG#Y4D$L"<<= *]3'A
MW3!J4.HB&3[9##]GCF-Q(66/^[][IP#]1FJQ\&Z"VES:8UDQLIIO/DA,\FUY
M-V[<?FZ[N?KSUH YQM._M;XB^)=-NK[4?L8TZUE6&.\D0([&4$KM8$=!P./4
M'BN?TN>]_P"$4^'_ (A?4[^34KN_MK6X>2Z<I)$X=2I3.T] <XSD9SFO2T\.
MZ9'?W%\D,HNKB(0RS?:)-SH.@)W=LG\S5=?!^A+I]E8+9,MK8RB:UB$\@$+C
MHR_-P1SCTR?6@#C574?%EKK\\6N)IE]IVJ31+/ODW6B1/\N4#!2K(,G(P=QZ
MXXM).?$USXVAU">97TT?9K>&.5H_*3R0WF  CEF+<GL /7/37?@GPW?:ZNM7
M.DP2:B-I,Q)&\KT+*#AB,#D@]!4E_P"$="U/4VU&[L%:[>+R9)%D=/-3^ZX4
M@./][- '"Z/+-#IGPH\JYN(TFA$<L22L$D M6(W+G!P1W%-U2_G$MMJFG7UW
M.I\416S7DDY0%#*(V@2,9#1@97)QDC(!ZUWD7A'0H4TY(; 1IIIS9A)'41'&
M"1@]<<9/;BH)? GAB=[AI-(A8W$XN9/F;'FYSO S\I) SC&>^: .-E9M$\0?
M$S5K 2F\L[:&>$&5V7>;9FR5SAN><$<=L5MZ+IMPVJ:'KEKKZ&RN(&22$/)(
M+[<FY6^9R RX)R!TR.E=,OA[2$U9]46PA%Y)$(7D ^\H! !'3@$C.,X..E5-
M&\%>'/#]U-<Z3I45K-*"&9&;Y0>2%R?D!]%QT% '"Z9I=_J/PPOY-*N+F+4;
M/5;VYMU@G>/SBERY,;;2,A@"N#ZBNM\,:I!XKOCXALY9_P"SUMHX(8_-8*9&
M&^0E<X)7<J9QD$.*L36-SX8L(X/"NAQW0FN"TT<M\T:Q[LDR98-GYNH')SGF
MM/0]*CT71K:P383&I,C(NT-(Q+.P';+$G'O0!C>)I$FU_1-/$\\DTHGD&GH_
MEQS@*!OE<<A4ST .2PX..."OVFU+X#W$M_<3S3VUZT*N;AR=JWH0 G(WX4
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M5=F+*/8$557P=H*:9:Z:MDRV=I,)[>$3R 1R Y##YN"#R/0DT <5J"S:3?\
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M:7* -/:1)+HDY,BHP81CZE1DGMD=\@ T;"66?3K668;97A1G'HQ )_6K%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 -DD2&-I)75(T&69C@ >I-16E]:7\1EL[J"XC!VEX9 X!]
M,BN=^(5[8V/A*234;?SK9KFW0AI#&B,95VM(PY" X)]0,=ZQ?!=_;S?$?Q<@
MU&VNI)X;*56@ 5),(X9D&3D#Y1G)[#- '>75[:6**]W=0VZ,=JM+($!/IS6=
M=>*-'M-6L--DOX/M-ZC21+YBXV 9W9ST.0!Z]NAK#\7QWAU^PN-&U6SM]8@M
M)MEG?KF"[A+)O7.<J057D?CQ7/6NIV$GB#X>:C/:1Z9;3:7=1QP2D80XA"HI
M/WN!\O<C% 'IDFHV,-XEI+>6Z7,GW(6E4.WT7.31=ZA9:>JM>WEO;*YPIFE"
M!CZ#)KRE98;OX9>+]/U4@:_'=W3/&3^^:X+%K=D'4Y_=A"/0 5=M=6M--\5:
MKIWCJY@@:]TBUCAENGVQRH(R)T5NF3(22!R<CT% '776N7T'Q T[1@;<Z?=6
M$UR3L/F!D9!][.,?-Z5#XG\33:?!I$^D7-E<17.JVUE<?\M,)(X!VE6P#]0>
MM<5XE6YM_$7AVU\+CR9H=#G%O;3N5E>$/#^[#$[D=D4@$\@^AY%OQ!K'A_6O
M _A:72S!'I[ZW8H;<D*8L2?,C#L1SG\_>@#TVVO;2]#FTNH9Q&Q1S%(&VL.H
M..A]J;;ZC8WDLD5K>6\\D7^L2*56*?4 \5Y1K\<UMJGQ%L_#BI%=/I%HZ0VH
M"DD>8'*@?Q;/3GI[5MWTMCJNL> [[PT\)=9#GR"/DLO*.]6 Z $(,'HV.] '
M0^$M;OM7&NC43;[M/U6:S1H4**8T5""02>?F.>:@M_%$EW\0XM&M;JQN=-?3
M)+K? =SK(LB+@L&(QAB<8'6N"O;YHO"WB^6%O-LT\6[M06+YC]ES#YG YP0,
M'VS[UK:GJ5C>?$GS] O;.6\G\,7,5M);RJ=\N]#&H([]P/2@#TF+4;&>[DM(
M;RWDN8AF2%)5+I]5!R*(]1L9IU@BO;=Y6#%8UE4L=IPV!GL>#Z5YGX5G\+^(
M(?#,@U:YEU;3HR@T_$2R0'9MF650@;9UR6.#QU)%:7PKTW1WT.6^@M+-KN'4
M;U$G5%+QJ9FPH/505QP.* .^N+F"S@:>YGC@B7K)*X51^)JAJFOV&E^'KK6F
MN(I;6&!YE9)!B3:I.%/0DXP*YWQ)=M9?$?PM+?,$TEH[B-)'X1+H@;-QZ E0
MX7ZG'6N?NH4M]&^*4L31C19(7-IR/+\\VQ\XIVY<@<?Q CK0!V7AK4-8U4P:
MA+=Z9<:9<VB2;;<,)()S@E,Y(9<'J<'(Z<TV_P#%UG)!KUOI-[:2:CI4#.RR
M'>N\*6*X# G  S@\9]B*O>%3"WA/2&@*%&LX3E,8)V#TKAS<V-KKGQ-MYI8(
MKAXDDC1B Q3[&N6 ],\9Z9H [7PSKL>KZ%I,L]S;?VC=:?#=30(X##>BL2%S
MD#)K2.HV*WPL6O+<7;#(@,J^81Z[<YKRS2X].LV^$]Q;K;132VY621,!GS9G
M()ZGYL=>^*BT6?1=8TR+2->UB\A\066J/*^GIY:3M<B5F5T^3<P((.[. .I
M% 'JVJZG:Z-I5UJ5])Y=K:Q-+*W7"@9X]3[5BZ5?>(]8TJ'5573[*.YC$L-E
M-$[OL(RN^0. I(QG"G;GO3?B'HEUXB\ :SI5D,W4T&8ESC<RL&"_CMQ^-'AC
MQ9H^H>&K29KZWMI885CN;>:0));R  ,C*>00: -*PU5AH-M?:WY&G3LN)TDD
M"I&^<%0QZ\CKWJ\;VU%LER;F$0/C9*9!M;/3!Z'-<7>ZB8_BEHL^H!H=+N-+
MFCLFG&T"Z,@)SG[K&,<9P<9'J*XW6+2"#PUKK'RAI)\3V[::6QM4&6+S3&>R
M[M_3CAJ /83J^F".XD.HV@CMFVSMYZXB/HQS\I^M2F\M1'%(;F$)-_JF\P8?
MC/RGOQSQ7!1Z?HH^,5S;_9;$1?V#'(8MB[-PF<;BO3(4XSZ'TKD-*CTNX\)_
M#HW8MI(%UBYMV:0@C9F<!"?[I^48Z'B@#VJWU"RN[5KJVO+>:W7.Z6.5608Z
MY(..*2WU*QNX'GMKVVFAC^_)'*K*OU(/%>3ZM!I>AWGC>XCL5?P](+&.6"%S
M% +HO\QROW5 ,9?'K@TL]]87.L?$!+C4+&\%SH44@:-0(I"J3 E1DY"_*,Y.
M#@9[4 >KQZG833>3%?6SR^6)MBRJ6V'HV,_=]^E$>IV$MO)<1WUL\,?WY%E4
MJOU.<"O,-.BTVSU#X536RVT4L]M()'3 :3-ISN/4_,!U[U>.G3Z5XIU'P?!;
M-_9.OR?;XW5?DA3@749]FPH'IYM 'I*2))&LD;JR,-RLIR"/4&L&TUFXUK0;
MW5-/FM;>W9)%L9K@$JVW($K\CY"1D#^[SGG OZ[%/)X<U*&T!%PUI*L(7^\4
M(7'XXK@P+2;]G ;UB,:^'3C>!@2"$COWW#\Z /08[Z&&V@^UWEJ)7BWE@X57
MP,LR@G[O?V%(-7TPQ6\HU&T\NY;; WGKB4^BG/S'Z5YXT6F77C+X?>:EK*9=
M(N-VX*=^(X=N?7!W8_&N>O[725^&OQ#ECBM!);ZO<K P"YBPR,H3^Z-Q) '?
M- 'M%QJ%E:%Q<WEO#L3S'\R55VKG&XY/ SQFD&IV!EMXA?6WF7"[H$\U<RKZ
MJ,\CZ5PJ0:3>?&.4RQV<P?P]'(VX*P9O.;YCZG;W]*Y&RBTR#X3>';V-;5+F
M/7H@LXV[U"WC  -U "=O2@#VFXU&QM)XH+F\MX9ICB..2559S[ GFF:C?P64
M'[R]M;660%86N6 4M],C/T!KS&ZN]$N]5\6^'_%FL36,EU=AXX2(Q]IMRB>4
M8BR%F(((PIR#T&2:T=*U*RLO'GB"P\0S+#YEA:)8?VBZ@RVWEGS%!/!/F$[@
M.I^E &SX;U_5->\(>'=7DN=/M9[V4-<I(A D3+ I'\W#<+C.>]=-)J5C#>)9
MR7MLET^-L+2J';/HN<FO&]&FL&\ _#&426YFBUB./=N&Y>)<KGJ.=O'TJ3Q9
MJ^FR:7XE6WG@LI+?7H'G@E<M<22))"IFY/[N/ XP,<=1G% 'JD/B32I_$-QH
M<=Y$U];QH\D8<9&[=A?]["DD=@1ZU<CU&RGNI;2"]MI+J(9>%959T^J@Y%>?
M2W2+\0/%2V,T2ZA>:);OIHR TKXFP4]><9(JOX2N?#6O+X7FCU>[DUG34VK8
M*(TEMVV;91(H0-LZY)."<=210!U/ACQ/)?6FJR:U<V4#6FJW%C&Z_NE98R #
M\S'D\GK72&[MA-%";B(2RC=&F\;G'J!WKS?0=&M/%GA7QII+2QDS:[>F.12"
M8I P*./H0#6WX*OKWQ(5UK5+1K>ZLH3IQC=<8G#?Z0R_[)94 _W#0!?\4:W?
M:-J/AY+8V_V>_P!16TN!(A+!2CME3D ?<[@]:W;2^M+^$S6=U!<1 E2\,@=<
MCJ,BN-^)"6KOX4^W"(V?]N1";SL;-IBE'S9XP20.>N<5RVOZ>]A=>-+OPS;%
M=+-G:?:H[)1LDE67,P0#Y2?)^]Q_%S0!ZM#JVFW,4TL&H6LL<'^M9)E81_[Q
M!X_&N9\/>)=1\2K;:O97>F#2S-.EU:R9\Z*)6=4<,"1DE 2" ,'@\9-;P]+X
M7UGQ&NN:7K<NIW)L/)F*F,1QP[@5$JJBX;/0'GKV!KC["Y6+X/>'[J#9)80Z
MT'U7R\'_ $874A.['50=A/M[4 >Q6NH65["TUI>6\\2'#/%*KJI]R#21:E87
M!80WMM(5C$K!)5.$/1C@]/>N$U:&VNO']S=V;P2Z?)H,HU-@0T3_ ##R=W8M
MC?C/8'M7/6UO9:=\&_#NM6EJ@""S_M2YMHE>8VZN"X)P=P4X)4Y&!TQ0!Z]9
MW]GJ$1ELKN"YC5MI>&0. ?3([U1U#Q)I6EZO8Z7=WD4=W>;C'&S@$*JDECGH
M,@ >I/UK$\+#P_>^(K_6=%UB;5)[J"-+J5&C,(V_<!V*H\S!/N!UQQ5;Q;-:
M6?Q&\&7-X\44.R^0R2X +&--JY/<\X'Y4 7_  YXGDNKK6X-9NK&%K/56L;8
MK^Z$@$:,!AF.6^8]*Z*\U"RT]%>]O+>V1CM5II50$^@R:\>U6'3+GPE\4;F1
M+:2XCU";RY&VEE(BBV[3V^8=NX]JV+S6=/A\87<'B/6#86.HZ3;BSGD\KR9D
MPWFIO=6 .6!QD9&/04 >H@@@$'(/0BJPU*Q:]-D+VV-V/^6 E7S.F?NYS5+P
MM9VNG^&-/M+%[I[.&+; UT<R-'D[2>!QC&.!QBO*I];TJ:#P_<VUS;6<$7BH
MO):/)NGA)>4.\S,<KN/1<  $#)H ]C;4;%+L6C7MNMR<?N3*H?GI\N<T#4;$
MWGV,7MN;K_GAYJ[^F?NYSTYKSA[FXTSQ LUK/::SHMYKNR2V<;;NPNB^TLI'
MWE!!." 0OM2V%Q<Z7XBT\03VFM:)=ZQ<"#C;=Z?<OYOF9QPZ#,@.>0#Z4 >C
M'4;$7PL3>6XO",BW\U?,QUSMSFJ6E^)-*UB_O[*QO(IIK*7R90K@_-M!./4#
M< 3ZY%>:>'[C1=9TJRTO7-8O(_$5AJ9E?3D\M)_M0D)W+\FXJ0<ELXP>2 *Z
M?P3-:0^+/&5D7B6\.JF58>-_EF&+YL==N>_2@#I-3\2:5I&IZ?IUY>117-\S
M")'<# 52Q8YZ#C'U(JZ=1L5G$#7MN)B_EB,RKN+XSMQG.<<XKCO&4UI9^//!
M5U>O%%;B6\1I9<!<F [02>Y/0>M9GARRT)M?\<W4EA;7+V6HB>-8XU:2/$"D
MF/\ NL3NY&#GZ4 >AP:E8W5Q);V][;33Q_?CCE5F7G'(!R.:3^U=.\V.+[?:
M^9*YCC7SER[#JH&>2/2O)=%U72IM?^'LMO=V26;6EU"EK$^_R%:)-L4CDY9\
M]0<<CIW-&6#28?A;K5[#':)<0>(SY,RA0T8%\N-I[#:3P.Q- 'M4VHV-M<);
MSWMO%.^-L<DJJS9] 3DUS6J^)IIO$\GAO2+_ $^WODLOM EN?G5I"^Q(L!@>
MQ)[X(P*YWQ)=7&EZUK.I:?<6>K:>;NU&I:1/Q-')MB\MX&'4D>60I&,@XYK4
M5[8_&F]CC:#[0- B*J2,[_/?]>1^= '6V6I1.8;*[N[(:L(E:>V@F!*M@;MH
M/S;<]"1TITFH6KL;:"_M5NW9HXU9PQWJ,D;<@G ()'7!KRWPK/H6N:3X?LM3
MU>\'B'3+Q7DTX>6DZW2DB0D;-Q0Y9F.<$'DYK;^'>F:+-J'B6Y2SLI+FU\07
M/DR!%+0C:H^7^Z.6Z>] '8:'K*:Q:SDH(KJUG>VNH=V?+E7K@]P00P/<,.G2
MI+F6Z76K&..[LX[9DD\Z"0'SI#@;2AST'.>#VKF/"*R'X@>/)4S]E:[M40]O
M,6W7?^/*YIFOBT3XM^$BWDB:2TOE?.-S#;'M!]?XL?C0!UYU73A)'&;^U$DD
MAB1?.7+..J@9Y(]*MUX7<6^DP_##Q->0QVBSP>(G\F90NZ,"\7:%/88)P!V)
MKV37#=OX=U(Z:2;QK27[,5/_ "TV'9C\<4 3)J>GRW$UO'?6SSP@F6-95+1@
M=V&<C\::NK::\8D74+1D+[ PF4@MZ9SU]J\Y\*77AC7?^$9N8=8NI-6TV,JM
MBOEI);G9ME$JA P08.2QP3CJ2*@MIM-T#QE!JO[L>$M6O7^R-Y@\J&_V[3,!
MV5\. <X!R> PH ]0N=1LK.6*.ZO+>"24XC6655+GV!/-<^?$D]KX]OM)OY[.
M'3(-,CO5E8>65+2,F&8MC'R^@ZUS*:IH)UOQGH7C":*.2]N%:%9V*FXM#&@C
M6(CEB&#<+SN)[YJW';Z9=_%J:&\@A=(_#D&(;G#F/][)D$'/(!Y/O[T =Y/?
MV=M:K=3W<$5NV-LLD@5#GI@DXI?MUIY$4_VJ#RIB%BD\P;7)Z!3WSVQ7D'A7
M6=.MO#/@!)YK>&Y\N[%O?74I\FW"DJ5(R SE2 H)&!D^QH6SZ9<>"- MYI()
M6M_%_E$. "BM<R$C'\.5Y(XXH ]NM;VTO5=K2ZAN%C8HYBD#A6'4''0^U,@U
M*QNI&CM[VVF=3AECE5B/J :\WFAL8?$/Q'L;:YBTZ%M'MV9[=?\ 5'RY@SA5
MYR!MZ<]*;X=ET7Q'X@\+7?V_0A<Z5IS0"UANXYI)9"$QM4<A4V$@]03T[T >
ME_VC8_;OL/VRW^V8S]G\U?,QZ[<YIU[>V^GV4MW=2K%#$I9F8@#]:\E\,W&B
MZUI.D:=K.KWB>(].U#S)-.7RTG%TKG<P^3<5.22<XP3D\5ZCKK1+H&HM.4$8
MMI"Q?&!\I]: ,#PUX@U+6[2QUU[S2AH]Q:^=<0Y*RVC'!0;LD'@X;(7D9'I7
M31:A93VANX;NWDMAG,R2 H,=?F!Q7E-C=I:>#OAG=N8_[&C>$:@XQM63R2L1
M<]@)".3P"![5)XIMH6O/B#<6_DOI4F@AI^AC-Z%DVD=MX0)G'/*^U 'JEO>V
MMVTBVUS#,T>-XCD#%<C(SCID<TV[U"RL-GVR\M[;><)YTJIN/MD\UD^#].TR
MT\/6-UI]K;1O<VD!EFA0!IB$X+,.6/)Y/J:P;&ZMT^(GBZSU]H4CGMK<VGVD
M@)):!") N>,!RVX>] ';SWEM;;//N(8M^=OF.%W8!)QGK@ GZ"A;NV>T%VMQ
M$UL4WB8."A7UW=,>]>-:581!/AI;ZVD;L;B]2,70&\V_ER>2K9Y(QLP#Z@5[
M);65K9V4=G:VT4-K&NQ(8T"HJ^@ XQ0!$=7TT)&YU&TVR$A&\Y<-CTYYJ+4[
MTBPOH[&_LH;Z&(D-<-E(CC@N 00*\INM,U.WTG4?#VGVQ\[PG?'5K&1DR'A_
MUD40/<D-*I_W!ZUO>)C;ZG\)?$FNW$"J=3M'N(EF4;D0)B$<]#@!L=BYH Z^
M7Q+IMIJUEHUS?VW]HW,!E"AP!@8&<$\ D\#OSZ5G>%O%$FH1ZC'K%U8Q7$.K
M7%A $/EB41D 85F)).?4]:Q)KJQM_B#X1N;F6!(IM&GCBD<C$CYAPJGNWH!S
M7*:FFFM\.O'E_BV:ZC\03-'/\I=")T*[6ZCOT]Z /<:*165U#*0RD9!!R"*6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^G2WT5GY5VEQ<6S75JCPD&YC7&2GOR.&P>>E)X-\2'Q7X=@U4VDML)BQ577
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ML]2NS8)O%Q:W$QE#94[7#/EL@]LXYSCB@#92-(EVQHJ+Z*,"FM!$Y8O$C%@
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MB@MG?S$R!\I PQ^;MTP<XH VYH(;F(Q3Q)+&>J.H8'\#0T$+HJ-%&57A5*C
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M0P,7AER/E8#('WE^;.WD<T =%Y:&02;%W@8#8YQZ9IB6T$<LDJ0QK))]]U4
MM]3WK*T[Q1IVIZS/I,2W,5W%")PMQ;M'YL1.W>FX<KGBKU_J4&G^2L@>2:=B
MD,,2[GD(!)P/8 DDX ]: *VKV.I/9JF@W5II]SYJEY)K;S59.<C:"O/3G/;W
MJUIE@FF:=#:([2; 2\C_ 'I')+,Y]RQ)/UK#;Q_H$=@EW)-<1J;X:?(C6[[H
M9\@;'P,+U!R3@CIFE;QQIWV+6IHK:^-QI$7G3VLENT4K(02K -C@[3SVP<T
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M]>'Q.!;R/&!/+;B.78SJ/X\9]R,<9XKUFLG6?#]MK<^GRW$]Q&UA<"Y@$3*
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M5+4<$\-S$);>6.6,]'C8,#^(J2@ HHHH **** "BBB@ HHHH **** "BBB@
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MR"*Y=1);3?\ /*9"&C;/LP'X9H @U#Q4NFK>R36H:.*ZBLK;9+EKF>3;A "
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M/6-<IMR#G.!\PY_(&J-A\0HKK37-SILEKJZ:D-+;3VE#?Z0>1AP,%-N6W8Z
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MH3%*3YD4V60AXG*J21D@\<'BNIL/$MS/XMDT"^TLV<C69O;>03B3S(PX0A@
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MD<'WK@+?Q;K4G@#0M9:Z3[7<:PMG/B)=LD9NFBZ8X.T#D=ZO7NN>(]7;7/\
MA'8YA/IMV;6W3; 897159A*78. 2Q VXP,'F@#O**RM5UEM&\*7>M7=OA[6S
M:YD@5L_,J;BH/UXS7,76OZSH]GX8U>XNUN[?5;BWMKNV$2JL1F'RM$0-V%;
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M6[&YEF0P;VCDC"Y()/(RQQ^&<]*I7'B3Q5;^#_$6J?VM TWAZ_F@_P"/1?\
M3%0J?GYPN5;'RXY&<T >D6.D:=IDD\EC906SSMOF:) ID;U;'4^YJ[7#7NH>
M(]0\=7>@Z?JMO8VW]E17L<OV02/&S2.N,$X/W>OIVSR*>C>*M:U31=-^W75O
M9W,=_<V.H/;IOFF>+<!Y$95@<D MQP >G8 ]%HKS!?&'B&7PCIMY'<0)>'Q
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M9D=V38P*E=F"O& HQCZYZJJ>G7-W=02/>6#63K,Z+&TBON0,0KY7IN'..HH
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M8V2S+7,G[L$8*\MT( !SG@"J>A6NHW^IMKVMZ3#IMZ+<6L-NLZSLB;MSDN
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M8 ESL6+9G;C:!G(Y)SUQ7H]AX(\-Z9K4FKV6E10WKN9"RLVT,>"P3.U2>>0
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MN/";)9RP'(DD\R3&QAP3[@]?H: /28]6L+R>6SLM2LY+Q%),:RJ[)CC)4'.
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MG2(/M-YIU_!?K:[MOGB-LE 3WP<CW%=*US MRENT\8G=2RQ%QN8#J0.I%2T
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M&R/3OTK;\$VVKV4.I6VH7=U>V,=P!I]S>Q[+B2/8,^9D G#9 ) )QZ8KJJ*
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M=N-.U"3PU\1;9=-O#-J=Q,UFGD-F8-"B CCCYE/7%>GJRN@=&#*PR"#D$4M
M'F$MO>:1XBAU.[\,7>LZ;?Z;;0,L,"O-:31;AM*,1\IW=?45H'3IK?Q=X.DM
M]#-E9V<%Z)8K6']U:^;LV*=O&>#G;D Y[<UW]0/>6L=PMN]S"L[?=C9P&/T'
M6@#SC7Y)K3QAXB6TTW6)8-1LH;:\EL+5;D%MK#(^<&-PC 8((.0<=,QSPI:W
M'A[6M+\/7NJZ%;6#Z5-8M!FYM2C*%;RWP204*G\Z["3PA92:G<:C::AJ=DUV
MXDN([2[*QRO@#<5.0#@ 97'2MRUM8;*V2WMTVQKG +%B23DDD\DDDDD\DG-
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M##Y@P(SG'.>W?7U?P[K5^NA7BWMI)J6G7QNI/,5EA8,C(54#)  88SUQSUH
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M> ]8U>T ^TV\'[HD9VNQ"AL>Q;/X4OAWPUIMOX6M;:>UANWG@5[J:= [W$C
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MS$OS(D:, XZ'[QY&* /1:P=9;PW<:SINE:Q96MU>W>_[(EQ:>:#L4LV&*D#
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M8<.I&",5AZ7X8OM'M$T^U\0WATZ(;(HY8D>6)!T42$<@=!D$X[UTE(2%!).
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M8S@C@C'7O4%K\/K33;C2Y]+U*\LI+&&: F-8R)4ED\QP0RD+\_(P!CI7844
M<.OPTM(M"L-/M]7U"&YTRYDN+"]4IYEN7)++C;AE.XY!SGUQQ6C>^#5U'0/[
M/N]6O9;PW,5V=08)YGFQL&4A=NP*-H&T#'7N2:U/$6K/H/AW4-62U-S]C@>=
MH@X3<J@D\X/85;T^Z^W:;:W>S9Y\*2[<YV[@#C/XT 9 \, ^)K?6Y;^::6*R
M:Q,<B*5D1F#,6P!R2HZ8';%4K3P);6FF1Z*;Z>70X;@3Q6+JIVX?>L9?J8PV
M"!UX )(XKK** .:;P@&N_$5P-1F#:[&L4X\M<1!4\L;/?:3USS^5:%GH-O;^
M%HO#]PS75FEH+-O, !>(+LP<=]OI6K10!Y9K'A^7PT_@^S?6[[4+:UUF(PQW
M"I_H\ CD&6*J"0,J-S'CVKH-1^'T5^->@76+VWL-:)DN+6-4P)2H4L&(W8(4
M'&<9'IQ79T4 <C<> XYKV\G76M1C2^L5L;Q (_WRJ&56SL^4X8_=QFI+?P4M
MN_AM_P"U;F1M!1D@+HG[P-'Y9W8 XV\#&/4Y-=/*SI"[1Q^8X!*IG&X^F>U9
M/A37AXG\,6.M"V-L+I2PA+[]N&(ZX&>E %:V\*_99=?E349=^LOOE)C7]T=@
M3Y/^ @=<\U5D\#QR>$M-\.G4[@6^GR0O%*(UWGRB"@/&.H&>.:ZRB@#D[_P2
MT_B*76M-UV_TJYND2.^6U"%+@*, X=3M8#C<.U6-0\)B]M;RP74)4TV\M5M9
M;5XQ(%4+MW(3R'([G=T!QFNDHH CMX([6VBMX5VQ1($09S@ 8%2444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!SWC:Y@MO#4@GN[JV$\\,*&T($DC-(H$8)( W?=)R, DYKD;1=3
M;4_'>CVMW#IL@BL_LD8G9H8)958$ X!7<0N=H&"<BO0]4TJPUK3Y+#4K6.YM
M9,;HY!D'!R#[$$=:SQX-\.*9RNCVH-Q$L,I"<NBG(!/U[]3WH Q_!6H>;J^J
M6%YI,^D:K#%"T]GYOF0,N7"RPL.,-SD8'(]<UG>,I([N_P#$4=O--<7%CHWF
M.CS&**R)$C+(A')E;;^ 4?,,XKN;+2[/3WEDMXF$LH422R2-([!<[068DX&3
M@9P,GUJI?>%]#U/43J%[I=M/=&+R6D=<ED]".AZ\9Z4 -\.WEQ<^#-*O)"9[
MF33X96)/+N8P3GW)KE/":VOB#PQX>\2S:O<1:EYX>YECDYFD8E6MW4Y^3<0
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MM1+::QFL\7LH\EQ:K("/F_O=CD#L!S7I]_HVGZI-;37MN)9+63S8&+,/+?\
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M[>X6U_U&5P8QZ*1@@<#CIQ4MWX=T:^@LH+G3;:2*R(-LA0!8L#&% Z#'&.E
M'GFL:OJ6AR?$VZT^>XDFM(K1[</(TGD[HLLRAB< 9+8Z<5K:G%_9&O>$+C0Y
MYFBU&8VMT@F9A<PF)G\ULGEEVYW]>>M=A#H6F6][>WD=HHGO@!=.Q+>< , ,
M"<' X'H.*CT_PYI.E,ILK01>6ACB^=F$2GJL8).P' X7 X'I0!Y3)#+!X"U/
M6UO]0:_T_P 0O';2O>2-L07BIM(+88%20=V2?RKUC7[C4K70[J72+-KN_"@0
MQ*R@Y) +?,0IP"6P2,XQWJL?".@G3I=/.GH;.:7SY("[;7DSG<1GDYYSZ\UM
M(H1%49PHP,DD_F>M 'E.DWE_;?%72[?_ (1B_M0-&EB837,#OM:XC9IV*N<_
M-U_B);.*H6\;VW[.VKV$ZDWL4EU:2QXRQG:Y8 ?4EE_,5ZZ=/M#J:ZD;=#>K
M"8%FQ\PC)#%?ID _A5=]"TQ[_P"VM9H9S()2<G:9 ,!RN=I<  !L9&!S0!Q\
M^GZAX)N-4\2QW=H]M=V<'VR&XW;UGB01J8]OWRW V\9.,&F:%I^J>&_A3I6A
MXVZW>AHD3=M,;RL\C\\X*(7/?E:[F73+.>]CNYH?-FB.Z,R,6$;8QN52<*?<
M#--N=)LKO4+:^GA+W5KGR9-[ IGKC!QST/J* . MEN/"'Q,LI);&"QTK7[=+
M$I#.9%6XA7]T3E5QE,H!WQ7I0EC:1HU=2Z %E!Y&>F16?JV@:7KH@&IV:7(@
M<21!R<(XZ,,'J/7K5>U\-VEKXINM=CB2.YGMUMW92Q:4#;\SD]2-H _'DYX
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M=ID'8*VQB#T^4UVVG1BX^+-[J.F2I)ISZ1''>/"P*/<>83'DC@L(\_0%?44
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M<,!'+;*A$BJ3P<.Q)'^UFN2TNRBM8OAQ:ZNL6[[;>>2EUC>+8I+Y(;=SC!3
M/J!0!Z_!JVFW-@;^#4+26S7.;B.96C&.OS XJ2TOK2_C:2SNH+F-6V,T,@<!
MNN"1WY'YUY7#_9DQ\9V2ZQ'I:C7X);>YBVLL,VR(JS*>"ID7!SWKK_ ]_J%V
M=9M]3M[/[9;W:K+>V)/DW9,28<9Z,%"AAV(H Z.]U*QTU%>^O;:U1L[6GE5
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M9S(%QD+C@GD=.G4X%4%^(V@-H2ZN6NTA^UBREC:V8203;@NR1?X2,CKZ\9H
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MJ*VJS_9[F1K4@6<F_81+Z$-UQG&0>XH Z^BBB@ HHHH **** "BBB@ HHHH
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M65E((((R"#0!QV@7K/XLMKO6-'UZ#49;;[!!<WD$2P[1F0C]V[?,VW.3Q\H
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M60 MM.<D$ ],?2GWNF:KI^L^'/$=EX>5+:U^T17.EV?EB2%)MN' !"LP*C<
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MFZ^TZ5>P2WB#;^Z5(W5CG.#RPZ9KU"JYO[,6\MP;N 0PL5DD,@VH1P03T!%
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M>XMHCL!>-YE<-G=@< ]3FO5Z* &QOYD:OM9=PSM88(^M.HHH **** "BBB@
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M;*O\H(#*Q!QG'6M.]\,ZCJ=]J6KW"6<6H3Z4VF6T*3,T:*Q+,S/L!))V\!>
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M!R:@L_%>N0://-=7'VK[1KG]E:?.L*+OBW$>:#D*Q(# =%W#/3B@#TFD+*I
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M=074$!MF2)E"31E@^UL@G[P!X(/;I4=OXB>X\5ZEH0L&5[.UCN5E,HQ*'+
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M9>&Y/$>B7^FZSJ&J7VER^4]I/>0+;744BDDLN%4@ [,%E!SNZBNZHH QM"T
MZ,CM/JE_JERP"?:+V0,RJ.B@* ![G&3W)P,&J^'(-4UG3=5-W=VUU8"1$-NR
M@2))C<C9!X.T<C!'8ULT4 <E-X LI]#UK29-3U$V^L7+75R<Q;@[8W!3LX!V
MCUZ4_4O T%]K,6KVVL:IIVH>2L%Q/9R(OVE!TWJ5*Y'." ,5U5% $-K:Q65I
M%;0@B.)0J[F+'ZDGDGU)ZUB67A*"VN-+FN+^[O3I086?VC9E-R["254%OE)
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MMB*TU%1#")FE6$-"C%59@#MR2<8 &373:OHNG:]9K::G:)<PK(LJAB05=>C
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M2;X6T7A?2])MT\/SVWDS7+W1S A.&C6,@DY3@'( )]N>I1%CC5$4*B@!5 P
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M-J-833[S3[WRH7RXDM(U16210'48;YB21SR"<  =>/!^@C3(M-%CBRBF\^.
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MDLZJ5CR!N()X&2!GW%>6>([L16/BO1KC-MJ::#$DKK&TDNI,L+<C(("*2P)
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MQLSS'!.%3&[(P<\<8.<8-8^I_$'3+32H+RS6>Z,FI1Z;(BP/N@D,BJX=<9!
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M60O'/S<?KTYKH?#-]+9Z/X;TF;3-061].02S& B.!HT4%9"<$$G...<5TU%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-Y<LPL[=;>Z>%F@''.P@[2%C_6@#M/AQXZF\9Z1J-Q?6\%O+8736\DL+'R9
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M0BARX4;B,%L<D4ZB@ JA>Z7'<WUKJ$;^5>VP94E SN1L;D8=U. ?8J#];]%
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M<@0$KS@@XQCO7H5% '&>-H-0\5^!=7LM'MI0[Q(T)G1HC.RNKE K '!"D9.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8^&?#]VTIT;0]$%_% 4(-W,BE4R#_="[N>A!)Z4 >NW&L:9:64]Y<:A;1VT
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MSCJ: /43J5B+X6)O;<7A&1;F5?,(ZYVYS2RZC8V]W':37EO'<R_ZN%Y5#O\
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MAP\:L&!R#QUH C&I6#7WV$7ML;L?\L!*OF=,_=SGI4\LT4$32S2)'&HRSNP
M ]R:\6GUO2IH/#]S;7-M901>*B\EH[[IX27E#O,S'*[CR%P  P&37M,D<=Q
M\4J!XI%*LK#A@1R"* *W]JZ=^Z_XF%K^^_U?[Y?GYQQSSSQQ3WU&QC,H>\MU
M,1"R RJ-A/0'GC->/2V^J6.A/9V]N[3^!+UKF.1EYN(.&1%/O [@X[JGK6SX
MYAM9?AK/JE['''-J&H6MT#* KHIFC"CU!$0 ./\ :H [RZOVGFL3IVIZ<(OM
M1BN!(V\R  YC0AN'SCU[\557QIX?,VJHVIVR+I?%R[2C"G&2!ZXR <=SCK7-
M>+=/T;2M;\&-96EC:&36P^88TCW;H7!/'7)"_I5#?:BZ^)]@3%]MD5I(X,#>
MR_8U^8#KC/?IF@#T"QU_3;[0X-76[@CLY8UD+R2J FX X8YP#R.*MKJ%DT$,
MZW<!AG8+%()!MD)X 4YP2?:O*EUZQL[3P%>RZG]FT06#6\MY $:."Z,46W>6
M5@#@2+G&1D\CFH]8T[PW!I.AMI]S]LLKGQ7#*)YRA1R_^L\H@ >7GJ!QG- '
MK5K?6E\CO:74%PJ,49H9 X5AU!QT/M3Y;B"W*"::.,R,$3>P&YCV&>IKB?"Z
MV=M\3O&%I:"")/(L7\F+ &[9("<#O]W/X4WXDPV,MYX0%VD#%M=B0^9C)0QR
M9'/\).,CITH [6UOK2^B:6SNH+B-6*EX9 X!'49'>H[?5-/NQ,;:^M9A#_K3
M',K;/][!X_&O)->$EN?B9:Z)&N4^P2/;6N 3'L'G84=R@;-=1?-:ZIX[\'W^
M@2PRIY%Q]I>W(*FT,8VA\=M^W:#WSZ&@#:7Q/;:[X:O+_P /ZKI\;QLZ)<71
MW1)MD*[F (.T[3@Y&>#6W=W]GI\2R7UY;VR,<!II @)]LFO&+B;37^ 6MVKO
M;&ZM;FX\R,XWQ.;M]N1_"<'COBNLO-=TO3?B/J<7B6Y@@L+_ $N%-/GN7"PL
M@+^<@8\9)921U( ]J .\NK^SLK87-W=P6\!QB660(O/N3BIHY$FC62-U>-P&
M5E.00>X->77-]I?A[Q+H44UW<Z/X=?2&M]/GE"E%<29*LTJMMW1A",X.!@^E
M=GX+L--TWPU#;:--<3:<'=H))R#N4L3E< ?)DG''3IQB@#7N]1L;#9]LO+>V
M\PX3SI53<?;)YK'\5^)H?#UO8KYMNMQ?7D5K'YK#"!VP9",C(49/;G'(K!L+
MJV3QYXQLO$+0HL\,#6_VD@))9B,A@N>JAR^[W:N:19;+X>_#Z+6) LXURW"?
M:#A_)WR>6#GG[FR@#U'1#JIMYCJ=Q97*F4FUGM%*B2$@%2P)(#=>A((P:TZ1
M=H4;<;<<8Z8I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **Q/%WB*/PIX8O=8D@EG\A/DCC0MECP
M,XZ+GJ3_ #P*GF\06,$,3L+IGE1I%@2TE,NU3@DQ[=P&<<D=QCJ* -2BN<D\
M=^&X[?3I_P"T=\>HJ[6C1PR/YNT$L!A?O#!&WKGC&:9'X^\/3';#<7,LWV9;
MH0QV4S2&-N 0@3)Z'H.,'.* .FHKFX/'GARZ;3O(OFDCU!E2WG6WD\IG;[J%
M]NU7/]TD'VI8]:TJWU[79'U:\=[*"%KNU>-C%;+\^&0!<DM@YP3T% '1T5S^
MG^-M!U.\L+6UNY&?4(O-M6:WD6.8;=Q"N5"E@.2N<CN*E7Q=HKWD5L+ILS7+
M6<<ODOY3SKG,8?&W=P1UZ@CJ* -NBN6M/&5GJ&I:_8M%>6T>ED1O,;:3/W-S
M,#M('!& >3UP15G2M:TRV\,Z1,FIW-_%=1JMK-*C//=?*3G:%!)P"3QP!DT
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MQFN<_P"$]T#%XOG7GG69'GVWV"?SE4C(;R]F[;@9W8Q[U-<>-O#UM'ITDFH
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M7.LZE)+%9ZU<VZS3\D(K*J* HZ\@  <D\#F@#L)H(;F/RYXDE3.=KJ&'Y&I
M !@<"L>/Q1I4DMY"9)TN+2(3S6\EM(LHC/\ &J;=S#C&5!YXZT0^*-(N-%M=
M8AN))+&[=(X)%MY"7+-M7"[=W)XSC% &G-;07!0S0QR%#N0NH.T^HSTISPQ2
MD&2-'(Z;E!K(OO%>CZ;+LNKETC$RV[S^2YACD. %:0#:IR0.3P3@XI=4\4Z3
MH_G&]GD6.W*BXE2!W2#=C&]E!"]0>>@()X- &P      .@%+2*RNH96#*PR"
M#D$4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4'B;0[^ZTCQUJ5K8WCKK,EFEI;+;OYDGE;0TA3&5SSU X7/<5Z#_ ,(KH_\
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MJFEC3+6W:4?NUP^6D89&2S]!GA1Z\ %[_A.)5U/3[)] O0=3MVFL6$D9\XJ
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M8K F]W &<*.Y-<?8:9XN\/ZOJECIUO87>DW]Y+>0W<TY1[-I3N<,FT[P&)(
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M/>/;7A,L8*!0I9@-WS?>S@=AU[5J6WBPR>)(-(N-*N;87EO)<64SNA$ZIMW
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MANKB-QN&PXD9$_B53G)R#\IP#WK2^"/LWQ#L_$FF3>3;2.[ZA:9PLDOE.B3
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MV73+:348(K>]:,&:*)]ZHW< ]Z +5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 51U71[#6[46VHVXG@#!_++,!N!R#P
M1G!&15ZB@!$4(BJ,X48&22?S/6EHHH *SK'0=)TR_O+ZRT^W@N[U]]S-&@#2
MGKDGZ\UHT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% #9(UEC:-MVUA@[6*G\QR*J:5I-CHEBECIMN+>U0D
MI$K$JN3DX!/'/-7:* "BBB@#.TC0=*T&&6+2M/M[-)7,D@A0+O8]SZUHT44
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MV*X^RRN(G*QR<##D+A1D@;C@9XSP:D/BNU_X30^&Q!=><EJ+AY?L\A7YFVJ
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M+O#]M!832ZK;B+4/^/5U)99>">"/8'K5C1]>TW7X9I=-N#*()3#*K1M&\;@
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MB@ HHHH **** "BD+*I ) +' R>II: "BBB@ HHI-R[@NX;B,@9YQ0 M%%%
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M<$L)/,\SC*C*]L\>N!0 6OCVQN]!TG4%C2"?4VD2*"ZG6-4:,D2;GYP 5QD
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MM=4C=/D^7DG?GG'2J'C+2-1LM'^(VJ7,4*VFI6,7D%)=SCRHRIW#'&<Y&":
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M7>L<[E$FX $'"XZY.>>E ':T453U;4H=(TFZU&XR8K>)I"HZM@<*/<G 'N:
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M10 4444 %%%% !1110 4444 %%%% '+^/M:N-#\,B:VD\F2XNH+4W''[A9)
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M)X7CF>)XW (RKH0PX)[T 87P_O+VXA\06U[+))]BUF:WA$DS2F./9&P7>W+
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MIBPB7_B/QQ]CN-7U:PM[C0+:^:"UN#&8I6E8''''W0#Z]ZZY_".BO=74YM7
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MNI4>)GSOVL&! ;)R,X/I3CX#\-G3;W3AI[+9WMQ]IGB2XE4-)NW9X;@;N<#
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M?A.5N[5Y(H1'(0ZDIFS9=K'M\W&#W%);V^D_\(1\2K9H;,7,=UJ;"/:N]4"
MJ<=0 <$>^* /5K:<FW@%S-;FY:-2XB;Y2Q'.W/.,]*F$L9WXD3Y/O<_=^OI7
MFVM6\>G>&O"/C.*%7ET:& W#*N6:UDC"2?7:"&'I@^M.\42?V5X?TW5KL-:V
MVH:Q%<:M(L0)CB96$?F @@A2(0<CJOO0!Z-#/#<1"2"5)8ST9&# _B*<TB(5
M#.JECA03C/&>/P%<GX1LM%AU?6;W1M7;4!>&*2X\EHS;HX4@%?+  <C!;O\
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MXT?>DBR,2A=%5F'RG)QN [<@BNCLKM+J",^9&9C&CR(IY7<,].HKR*9=.M_
M_P 3H(UMH[M;R^PBA0XCV1XXZ[<D>U;J65AI?Q!\+/90Q6S7>CW7VAX@ TP
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MV%M91'R;*UM7DP95MT !/U &?Q%4?%?B*#PKX;O-8N(I95@3*I&A;<QZ X'
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M<^:K(T+8SAD(# XYZ<TMAXIT34]3_LZSOTENO*\X(%8;DX!*DC#8) ."<=Z
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MMH[8K*5FC*?:&B W9#%B>-V#DCKCT6B@#ROQ)IUQ?'QSK-E;W+6M[HJ64*)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,=9U6]=@2[]4AS[$!-HX' ]:^AIIH[>"2:9PD4:EW9CPH R2: .!NOB#J?\
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MWB'3^'DA"J[&9>N_ 5MV2"?<F@#U571B0K D'!P>E5=3U2ST>Q:\O9A%$&5
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M,8D9VFR"<*H&XG )(QQ@YQ@TVV\3:1=Z<;Z"[WPK,;<J(V\P2@X,?EXW;_\
M9QF@#6HK/TK6]/UI)S8SEVMY#%-&\;1O$X[,C $?B.:@O_%&CZ8\ZW5TRK;E
M1<2+"[QP$X(\QU!5."#R1@$'H: ''PQH#7!N#H>FF8OYAD-HF[=_>SCK[U:O
M=+T_46C:^L+6Z:+/EF>%7V9&#C(XR*YKQ5XE^QZYX?TB)KI8=1ED,\UM!([&
M-8F8!&53DE@N=N2!GIG-:MO,GAG1(AJ^KS7>9O+BGFC_ 'LF]OW<>U1EFY X
M&3C.* -.ZL+.]M#:7=I!/;' ,,L89..GRGCBA+"SCLWLTM(%M7#*T(C 1@>H
M*].<G-94OC+0;?2;W4Y[_P JULI3#<F2%U:)^#M9"N[/([<YI]MXLT6[O[FQ
MM[MI+FWA\]XQ!)EH\XWI\O[P9XRN: +<&AZ1:S6TUOI=E%+;1F*!X[=%:)#U
M52!\HY/ JU<VMO>0-!=013PM]Z.5 RGZ@\5F0>*-'NM"CUN"Z:33I'"),L$A
MW,6V !=N3EN.G6K][?VNG6IN;N411 A<D')8G 4 <DDD  <DG% $,>AZ1%9R
MV<>EV*6LI!D@6W0(^.1E<8-,N/#NB7EI#:7.C:?/;0',4,EJC)&?55(P/PIM
MKXATV\:[CAEE,]F 9[<V\BS(#R#Y97<0>Q .:YCP9J%[XLMK+7_[3OK=Q-/]
MHM&@802Q;W5$7<H&5"J2RDG.0>O !U\^E:==1V\=Q86LR6S!X%DA5A$PZ%01
M\I'M48T'1Q%/$-)L/+GD\Z9/LR8D?^\PQRWN>:Y74_&)U+1O&$.FF]LKK1X9
M1'<&V89=(M^<NI4<D#!Y(Y'4&M+PQXMTW4+72M.>^:35)K".8AXW E(1=Y5R
M-K$$\@$D=Z -S^RM.%C+9?8+7[)+GS(/)7RWSURN,'-/ATZQM[5[6"SMXK=P
M0\21*J-D8.0!@Y%4'\4Z/%?06DEV5>XF-O%(T+B)Y1G*"3&PMD$8SG((ZBJ/
MCWQ%+X9\)7E_;!_M.%CB986D",SJNXX! QNR,\$C'/2@#:.DZ:8;>$Z?:>5;
M-O@3R5VQ-ZJ,?*?<5<KF;&Z@TBZEEFU?4KJ&^'F6UC/:R/-%LXD8+M\S:25Z
MC .,?>%9WC/Q"9? JZUX?U5E7[7;IYD('S!ITC=&##*GD@C@@B@#MZHG1=*+
MW#G3+,O<C$[&!<RC_:X^;\:P?MU\OQ973C>2M8/HK7 MB%VK()D7<,#/3U)Z
MFM-?%6C-<V\ O"/M$IA@E:)Q%+(,_*LA&QCP> ><''2@"U_8>D;8%_LJQQ;G
M,(^SI^[_ -WCC\*<VC:6VJ#5&TVS.H 8%T8%\T#IC?C/ZU1D\7:)%#J<KW<B
MII;;;TFWE_<G&>1MZ8YR.,<]*MC7-/)LQYLG^F1M+#^Y?YD !)/'RC!'7'44
M $NA://+<2S:58R27( G9[="9<$$;B1\V"!U]*<=&TLS33'3;,RS+ME<P+EQ
MZ,<<CZUAZ;XHT+3_  ]:WD_B&2[M;J\>"&[N4(+N92NSA1@ _+DC&!UQ6GIO
MB?1]6:^6TN_FL<?:5FC>(Q@@D,0X'RD D-T..M $K>'M$>..-M'T\QQ B-3;
M)A,]<#'&:;<:#97.K:?J#P0"2P!\AEA =<J5QNZA<,?E'?![57B\7Z'+=VEJ
M+QEFO%#VJO!(GG*>Z$KAAR.1ZCU%7M.U>QU5[Q+*?S6L[AK6<;&79(H!*\@9
MZCD<4 76574JRAE88((R"*S[;P_HMFL2VND6$ A+&,16R+LW8W8P.,X&?7 J
MC;:NVJ^*=0L()"EII(C%PPZRS.-VW/957:3ZE@.@(-?3[DZCH^ISZ'K<U]<1
M7LQC:=<*D@_Y88VCY!T]1GKD4 :W_"/Z+]G-O_9%AY!;?Y?V9-N[UQC&?>IH
M]+T^&\^V16-JET5V^<L*A\>F[&<55T/7[77?#5IKENLGD7$'F[ I9U/\2X')
M(((P.XKBM7\;RZMX&M->TR>[TX?VI#$X>'8'B-SY>"S+CE1D[3P>": .\M=%
MTJQNI[JTTRSM[BX_UTL,"H\G^\0,G\:2VT32;(.+72[*#>I1_*MU7<IZ@X'(
M]JKZ=XFT?59KV&UN\R60#7"RQO$44@D-\X&5.#\PXXZTMGXETJ^U)-/AN'%U
M)%YT4<L+Q^:G=D+ !QR.F>M %NSTK3M.+&QL+6U+##&"%4R/0X%37-K;WML]
MM=013P2##Q2H&5AZ$'@U2U'7M.TJ=8+J9_/:)IA%#"\K^6N-SE4!(49 S[TW
M_A(=+:VL[B*Y,\=[$9K?[/$\K2( "6"J"<#<N3CJ0.IH G&C:6)Q.--LQ,(_
M*$@@7<$QC;G'3'&*;_8>D?V?)I_]EV7V*0Y>W^SIY;'W7&#4)\2:7]GMITFE
ME2YA-Q$(K>1V,8Q\Q55) Y'4"JDFKZ;=:_H0BUF:.2Z@DFM[-%^2[0H#N;*Y
M&T<CD=: -JTL[:PM8[6SMX;:WC&$BA0(BCV X%07NC:7J,BR7VFV=TZC"M/
MKD?0D51O/%VAV!D-S>[(XI_LTDHB=HUE_N%P-H;G&,]>.O%17/C?P]:3S027
MY,\,*SO%'!)(X1NA"JI)Z'..F.<4 :$&@Z/;>;]GTFQB\U-DGEVR+O7T.!R/
M:C^P=',,4)TFP\J%MT2?9DPA]5&.#]*J2^,- ACTV1]2BV:FF^S(5B)1M+<8
M'' [_3K5-OB#X96RFNVU"01V\ACG7[+-OA(QDR)MW(!D<L />@!WBKPPFJ^'
M-8M-+LK"'4-1MW@:XD7RR=PQEF523]*T=%T>VTRRA"Z?96UUY2I,UL@PV/\
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M6]G&SLD$2Q*SG+$*  2>YXJ>BB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME"VQ9=K+&SDAMQQ]WMR<<"N\HH XKQ%/=#QG!;'3;S[)+ISJEY96Q:264O\
MZAI0,QI@!NJ@G^(8YY;2-+>?P9X3@G77=#U:QLY4AOX;5SY+@H&CD3:<JW!
M;&=G';/KU% 'E\]KJ>H:=H]Y?/J.A^)8+%C'>V%H[PMES^ZEC"D<[4;8<').
M.F*N)_:MQXC^'UUJ&ES0W$-G<_;1!;N8K=WB0!20"%Y!&,\5Z)10!XW++8K%
MK.AWL6LPZ/)K;W3-'I,T^=LP=@LR97:70GH2!D=>G5V,PD^)>IZHEO=/I\^C
M6ZQ7*VLC1R$/(Q"L%P>&4\=<UHV'@S^S5^S6OB#64TW)(LC+&54$Y*B0IY@'
M/9\^]=+%%'!"D42*D:*%15& H'  H \D\/6=];Z-\-89],U%)+">;[6K6<O[
M@&*106^7@99:TI8+DK\30-/OO].3%K_H<G[_ /T41_)\OS?-D<?7I7IE% 'D
M\9NM$U'1-2O])UJXTRXT.VLG^Q1S"6UGC+$AXT(;!W8SCJ*T3IZ6GB+P-]@T
M*ZLK&WEO9&B2!W%NLD;!2Y (4L3D@G@FO1Z* /(M2T_4+GPGX\BATR_:6;6X
M[N"/[*ZM-$K0$L@(&[_5OT]*]$UGS-7\':DMK!,)+JQF2**5"CDLC!05/()X
MX.#SSBMFB@#RZS%_ / 6M-IVH?8M-LWL;Z%K5Q+"S1(OF>7C<5#*5)QTY&1S
M72>&=.F_X3'Q/KHCEBLM1-LD"R(4,ABC(:3:<$ D@#(&=N>F#76T4 >?A;FQ
M\8>-_-T^^:._M8'MY8K9W1PL#*P# 8SNP-O7GIC)&796MW%H/PSB;3K]9;"6
M/[6OV.3, $#H=WR\?,0*]4HH \HTFU$277A;7O#>K7MVM[+)!+^]:SN%>5I$
MD+;MBXW9.1G(XR>*Z?XHP3W?PYUFSM+6XN;FXA"116\+2,QW#LH-=A10!QMM
M-HUM_9TUAX?NAJ2[8HV32I8-N\!6+N4 "C.3D]NYQ6!-;W3Z+\3(AIU^9+YY
M?LJ_8Y,SYMU0;/EY^8$<?6O4:* //&CN&\0_#R5;&^\NUM9UN&^R2 0EH%4!
MSM^7+#'-<]90#7?A3K/AZVM)IKZ\U*ZCB'D-LW&Y)$A?&T!<9)S_  XZX%>Q
ML"R,%8J2,!AVK(\-^'HO#6G26,%W<7,;SR3YGVY#.Q9ON@<9)H Y/4M+OKWQ
MQK=M;I=1_:?#(L8;UH'$?G;I/X\8R-RGK5/[+=Z]X+\+:$-/O+35-/NK/[0)
M+=D6V\C&]PY&T@A3MP3G</?'J%% 'G_B'1[V'QO&NG@?8O$D'V;4UW8*>5@F
M0>[1%H\]B4J+7#+H?CVXO;[2M6O-(U&RAACETP2L8)(R_P CI&0=I#Y!]?QK
MK-*\.QZ9J-S?2:A?WT\S/L-Y-O$",VXI& !A<@>I^4<\5LT >6W=H?#6LZ/J
M*^'=2307L'M#:Z:9&ELG,ID4LL;9(8'!QD CZ9[30K""/PY+#IVGR:3'<>8\
M44F1(I;^-@2<,3\V,Y]><UO44 >2IIE_J/PGM/!DFGW=OK<$D-LQ,#B./RYE
M8S"3&TKM4MD'DG'7BNGC$H^,$]R;2[^S'18[<7'V9_*,@F9BN_&.A!ZUV=%
M'(>)[JYA\4Z+&=/NFLGBF#WUG:F:9'.W$6X F)6[MQ]T<C!-<7IEI?P^#_"%
ME+I&J)-8^)&FG1K21BD?FSG>2 <C#I\W0YX)P:]CHH XG1[+[5X[\:)=V-Q]
MAOHK6-6FMW6.95B97 8C!ZXZU%X#T[4H)Y[34V\V'02^FV,Q;)F0D-O/N$\I
M/8A_6NMUC36U;2Y;)+^\L&DVXN+.0)*F"#P2".<8/'0FGZ;I\.EV$=I 79$R
M2\C;G=B269CW)))/UH Y/Q*UWI/Q T/7I+2ZNM)2TGLYC;0M,UL[LK!RB@L0
M=NW(!Q7+7MEJ%]X4\<K!I6H;YM;BOH(WMG1IHE: DH",DXC;CK^->P44 >?V
M]Q-JOQ,?4(-.U!+*?0#!'//:/$I?SBV#N *\9^\!T]""<&.&^;X1>'--.DZF
MMY97EDLT1LI-R^7*I<XQDJ ,[NA[$UZ]10!YE>YTSQAKT&LZ)K.H:=K#1S6L
MMBLKQL/*6-X9%4@+]W^+@@G-1Z_I,UJSW&A1:AI.L6FG111VT5NUQ9WJ*IVV
M[#:5)4DKG((#9Z=/4:* (K9IGM86N$6.=D4R(IR%;'(!^M2T44 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:EHV:XB8L 4*L1G*D8)]*Y,^$?$,?AO4M,73+53+X@&HPB"X7;Y7G+(1R!C
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M=6\#:1?BZMK2YE\01V<PA@.UU6[V <MD#Y02,Y/3(H ]4K,?P]I$FOIKKZ?
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M2(SO,Q&Y_FW8*A63MU)YXH UJ*Y[5=<G3Q1IWAVQ:..YNK>6ZEFD0L(XD(7
M7(RQ9AWX /6N,\3^*=:E\*^*-.:>&VU/1[NV@FFAB.V>"9DVD M\A*L<C)Z'
M!YX /1O[8T_^VO['%W&=1\DW'V<<L(P0-Q].6'YU<D021LC%@&&#M8J?P(Y%
M<!J,>JGXJZ;';W-HM\=!N UP\#&-?W\?(CW9/88W#USV+M,\<7]YHFCI+!%_
M:U]>7-H[0Q%D'D%][JF[)R$&!GC=GG&" =AI&C6&A6*V6FP&"V5BRQ^8S!23
MDXW$XR23]35^O.]3\5>+=)\.W]W<:?;)+;:A!!;S31%%NH975,[0Y*,"V#G(
M[XKM=)35H[>4:Q/9S3^<QC:UB9%$?\((8GGKW]* +]%<%XC\7ZOH;WMPWV,)
M;7T$*6:HTK202,BF1W4_NV)=MH8#[O?-:4^M:SJE[KUKH!M$ETDK$BW*%A<3
ME!)M)##:N&49Y.<GMR =752PU2RU07)LIUF%M.]M-@$;)$^\O/I7()=Z[-\5
M+2UENH(81H?VA[7RBZHQE0. P89.5X8C ';K4,'CF_BT>^>ZBM&O_P#A(3HE
MIY:,L98N%5V&2>!N8\\XQQUH ] IKQI*C)(BNC#!5AD&N1FU_5M,\5#0+I[6
M8WEC)=6-T(64!X\;T==W(P0001Z>]8^E>,?$4VG>#]7O?[.-GKDZ6TMO#"X=
M&='8.'+8QE/N[>_4]: /2**HZPVHIH]V^D^0=06)F@6="R,X&0I (//3.>,U
MQ=MX]NY[CP9-YMG]AUR,I=?Z.^^&;;PN=^%!<,G(/([\X .TU#6-/TJ2TCOK
MN.![N98+=6ZR2,<!0*M3SQVUO+<3.$BB0N['LH&2:\[\6WE_?:9H%VYMG#^)
M[;[&%1D!C#L$+'+9W8SD <$<5I6OB'78KCQ9IUW)837FD6\=S;SI;ND;K(C-
MM9-Y/!0C(;O0!U]C>V^I6%O?6DHEMKB-98I " RL,@\^U07VL:?IEQ:6]Y=Q
MPS7DHAMT;K(Y[ 5S.E>*K[5X?#-C$;>&_P!3TD:E<2F,E(U 0$(N>I:3C)X
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M>.\MIMNDK?6]ZEJRJ&+,I !;$B\ A@<>YH [JBO-O#/B34[?P9X3AEF6ZO\
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M:)R6 +_-P"%)&,\8H 5?#MS-J']J7]_#/J,=HUI;R1VQ2.)7(+ML+DEB0O\
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MEL'(4=^#R*NW_A&ZOX-)$FL,]Q8WZZA)-+;AC-(H*@8# *N#C ]!SG)/544
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M,+.Y\-^;)!O.TNOE ,/0X8]*P+R>[U7PKI+7E_=R/%XP6U#"8@F-;HJH..N
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MVR+#Y>W[\00APW)^8G@\8Q4>NZ]?:7JTLNM/>0:5-]G^RZKITI>WMFVKO69
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M3W'B?Q%INH-:0VVFO;+!(K%=XE0M\Q)QGH.*R_B"MDFM^#KB^6W6$:J4DDF
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MJ5N)A</NN))4,6&C&1Y: =#SGYNE 'M%%,BFCGA2:&19(W&Y70Y##U![BGT
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M9#\S,0#L'J<$<"MM;^U?4)+!9E-W'&)7B[A"2 WT)!'X'TH L*JHH50%4#
MZ 5!=V%GJ$8CO;2"YC4[@LT8< ^N#69J6KN-?L=!LV"W=S$]S+)@'R8$(!8
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M%#*WU!JEIWB#2-7NKFUT_4;>YGML><D3@E<]#].#R.*Y_P"(NM:YX?TFTO\
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MIA Y;(*RG&$VGG<=R_+C/(I]MK>F7=E/>0WL)M[=F2=V;;Y++]X/G&TCT.*
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MRP#*<$<9]>E5-3<OI/Q-@"W\SW<<#V[SVS*T^8$7CY0,DYP ,X'3BO::* .
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M*?LFN^#]=MXM^B6LTHNVA3(C\R'RXY"!_"O()[!JP/$UHUS;_$+5K,%]/O\
M38;>$H"1=7"HP+)_>P"JY'4Y]*];HH \\NFM7\=> Y(Q&8X;&Z5G"_+&62((
M"?X22& 'L:O_  \92WBD#@/KUS*@(QN1@N&'JI(/(X/-=I10!P,<ENOQ/\2S
M3;!&=(@B$C#@D&0NH/<\KD?2N<TQ]G@_X8QR!EEMKZ,SJRG,($4BDL/X0"5'
M/J*]AHH \Q9KK3_$_FZ'>M=6UUK&V^T.[CRT;>9AKB%NJJ,;^Z]><\5T'Q&C
MOO\ A&8;JRMI;L65_;7D]K$,M-%'(&90._0''M7744 >?:S=:;XM\)>)KO0-
M.EFN+G2I(6NFM7B>5@K;8AN4%B,GIP"0.>U&#6+74?%O@6ZMDN7MH;&[CEF-
MM(%1C'$,$D<8(Y/0>M>GT4 >5Z&L ^$7B9?*"W#-J>%,>'8R-)LP,9.X;<>O
M%2ZJK6O@3P=J=M9W$]II[VSW\-F&681B!D)PN&RC/DCV->GT4 >1^)TT*_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!Q&H>+]>TB[LKS4=!@CT*\NH[99$N2;F'>=
MJ/)&5  )(R 21GUXKMZXK4?$/AS6=2B2ZUK3DT_3+@3,K7*;IYT^Z N<[5//
MNP&.!SUL=_:2WLME'=0M=PJKR0!P716Z$KU .#0!8HHHH **** "N5\3>(=;
MT'3]8U.+2[.6PTZ+S%,MRR2380,V $( R<=>H-=57*_$L@?#/Q'DX_T&3^5
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MPH7'D,2!CCJ3^)-80$.J?#3Q;=ZDH7Q!9W=VSR])H9T8F (>HX\L+CJ#@=:
M/7&D1 2[JN!DY../6AY(T3>[JJ_WB<"O-+/1[;5/B6L6N6-O//+X9MY+N&1
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M\DCO4461Q=+*#&T/&1O5@"N1R,CFG:?KFG:I<W%M:7.ZXM\&6%T:.1 >A*L
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ML;:.Y8;6F6)0Y'H6QFJNH^(M)TERM]>I#M*B1RK%(MWW=[ 83/;<14-[XO\
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M0.=K%$D;&U&?&U6.1@$@\CUJ"]\8^'=.NY;2[UBUBN(61)(RV2A<X4''3)%
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M^X,%U9VSSQML5@2HS@@@\5DW$WBFU\(0Z[8:G'?W*6BW4MG=6ZJLHVAF5&0
MJ<9QG=S0!U5YI&FZA/#/>Z?:7,T!S%)-"KM&?521Q^%2RV5K-=0W,MM#)<0Y
M\J5HP7CSUVGJ,^U9&E^+M+U/PWIVM*[I%?1>9'$$,DF1]Y0J@D[2#G [5<C\
M0:3-ID&I0WT4MI<';"\67,C<_*H');@\ 9X/I0!?EBCGB:*6-9(V&&1QD$>X
MJO#I6G6]I):PV%K';2 AX4A4(P]P!@U!!X@TJYTYK^&]C>W60PL1G<) <;"N
M-P?/&W&<]JK-XO\ #Z:?-?2:I!%;P2^1*9<HT<G]QE(#!N1QC- %Z'1],MK-
M[.#3K2*UD^_"D"A&^J@8-/73-/2P:Q6QMA9L"&MQ$OED'KE<8K,_X3/P[YUU
M#_:UOYMLH:1!G."< J,?.,\?+FL7Q-XJ5+/PQJ^D:Q&NEWFJQ03R*%,<D)#E
MLLPRN"G/3'.: .J&CZ6)EF&FV8E1/+5_(7<%QC:#CICC%2VEA9Z?&8[*T@MH
MR=Q6&,("?7 JCI7BC0];MKJXT[4[>>*U)%PP;;Y6!GY@<$# /)XXI(O%&BRR
M7,?]H1Q/;1">59P8BL9Z/A@,K_M#B@"]/IUC<W,=S/96\MQ%_JY9(E9D^A(R
M*@_L'1_)DA_LFQ\J1M[I]G3:S>I&.34&E>*-$URY-OIFI0W4RPK<%8R<^6WW
M6JIXKCUH:=<W6G:W#I4=M TN]K=9=[ $X;=P%X'3GGKQR =!'&D,:QQ(J1J,
M*JC  ] *JRZ3IL\D\DVGVDCS@+,SPJ3(!T#$CD#WJA:WFKW'@N"]N(XK/5WL
MEEE1XRZQR[,D%<@]>V>*;X+U.ZUKP5HVIWKA[JZM$EE8*%!8C)X'2@"^-&TM
M7@==-LP]N,0L(%S&/]GCC\*;_86D""2'^RK'RI6WR)]G3:[>I&.36A7 >(;S
MQ?H'V77#J5M/;/>0PRZ.+50 DL@0!),[BXW#GH>> .* .YMK2VLH?)M;>*"(
M$G9$@5<GJ<"F3:=8W%W'=S6=O)<Q?ZN9XE+I]"1D5SAU:_UOQ;K.BZ=>&RCT
MB"'?*L:N9)Y064'<#\BJ!D#!);J,5!I6K:UXV\*:9?Z7>Q:.TR/]JE$(F9)4
M;8416.,;@QR<\ >N0 =1>:7I^HE#?6%K=%/N^?"K[?ID<5R5]X3U&?6[RXET
MWPWJ]I<.IA.HP$2VR!0HC7"L&48)'W>6-7?!NNZA=:+JA\02P>?I5[/:2W:+
MLCF2, ^9C^'@D$=BIJ+PMX@U35_%_B.TO4$-I;16DEI;E,.BR"0DN>NXA5)'
M\/3U) -72?"VEZ996T)L+)Y;=G>-UME41EG+D1CG8H+' !X%7[S2--U&:&:^
MT^TN98#F)YX5=HSZJ2./PJGXCUO^Q;.V$2J][>W,=G:(WW3(YZG_ &5 9C[+
M4MQJUEH\:Q7UX[R+&9'?RRQ"#J[!!A5]S@4 3W^DZ;JJQKJ.GVMX(VW(+B%9
M-I]1D'!ITFFV$UU'=2V5L]Q$,1RM$I=!['&14,>N:=->M91W(:Z6W%UY(5MQ
MB/ <#'(SQQWKE_$?BM(F\+ZIIFL1KI-YJ1@N7 7RWC"2%LLPR,-'C@CO0!U'
M]A:/Y,D/]E6/E2MND3[.FUSZD8Y-+=:)I-['!'=Z793QV_,*RVZ,(_\ =!''
MX5G#Q5H>K^']1O+#7K>*&W1XY;L$ VS8X8JPZCJ 1S5J#5K.ST73YI]0:[$T
M"-',L1:2Y&T$N$09Y')P.,T 7)-,L)KM;J6QMGN5&U9FB4N!Z XS48T325M9
M;4:99"VF.Z2$6Z;'/J1C!_&HX_$&DS:9!J4-]%+:7!VPO%ES(W/RJ!R6X/ &
M>#Z5E:GX[T:PTVTO8IC<I=7T=BHB1B4D+A6#C&5*@DX.#QCO0!TRJJ*%4 *!
M@ #@"EID4JS0I*A)1U#*2"#@^QY%/H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/UW2(->T&^TFY_
MU-W T3'^[D<$>X.#^%>9I'XL-OH7BHV<G]KVQ_L>:V;I)&V8S,W?'G!6_P!T
M ]Z]<HH X/Q79I82>";.!)9([/58F=@A8J@BD4NY XY89)[FDL9/*\<>.Y72
M58I+6U$;F-MLA2-PP4X^8@D X]:[VB@#EOANKQ?#K0898Y(YH;1(Y(Y$*LC
M<@@\BN<L+^+2]2\3>'/$.C7=Z^H:C)=6BBS::*]B<+M7=@J"NT [B ,#GBO3
M** ."TV=]!\<>)AK43I;ZDL$]G,(V>.15CV-$"!]X$<+U.[(%8&AZ1>:+)\-
M[._@F#VLE])*I0L+9)$?RU<C(7&Y5Y[CVKURB@#RBXCW:#\446VE,EY)-]G
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M(+=^2!GI5'Q+#I-_X"\17VAZ7J!.HO:!IITG:6[9)%Z))EL*HZXP>?2O6:*
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M@'4JP!]0>0?8T^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .<\>:[>>&_!>I:K80++<0Q_+N8 (
M2<;CGKC/3O4\OB!UOK?3([%GU66!KEK<RJ!%&K;=S/SU)P  <\^A-1^.-%NO
M$/@K5=*LB@N;B';%YAPI8$'!/;.*RWTK6X/&%EXJ2Q21IM/-A?6$<ZEHP'WH
MZ,VU6()((R.O&: -[P_X@M?$5E-/!'+#+;SO;7-O, 'AE0_,IP2#V((.""*P
MM0^)&DZ>RS/M>P^U_8WG2=-Z/OV%O+SN*!AC/7N 1S6GX6T*72/[6N[G:MUJ
ME\]Y)&C9$0("JN>Y 4$GU)[5A:#IOB[P])/H,-G8SZ2;F22UU-KC#P1.Y<JT
M6TEV!8XY Z9H TKGQQ'::Y>Z--IERM_"D<EM%O3-ZKMMS%SS@]<XQWXYHO?$
M6IP^/M+T./3P;:>QEN9&\U<DAD7\EW'W.?;FCXET#6M8G.LV<?V?6-+G!TA3
M*NQH^/,\S!Z.,@CL%7'.<V[O3=9G\9:'K\5C"%2RFM;J&2X ,)=D;<" =X^0
M^G;IV (KKXD:3:RV\C;7L9KO[']H2="RON*AC'G=LW#&[KWQCFFWGQ#%M#K<
MR:!J,L6BS&.]8-$-B!0Q<?-\W!S@<X'..*K^&M-\7>'E/AT6=C-I44SFVU4W
M&'2%F+;3%M^9QD@'('3KCF&X\-ZU-I7CRV6R ?7'<VA,RXPT*Q_-SQRN>_%
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MT;1Z#/K0!L>+=>T\>&=:;5M%N+W3+2>."58Y% E.4.1\P.%8J#WR#P<5=O\
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M>TO($50LBN<D^RGH*L^+-'OO$7A9K>R=;/4HY(KJV,V"JRQN'4-C/!*XX]:
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MP /3:*;&S/&K,A1B,E202/;CBG4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'#/%.',,BN$8HQ4Y
M 8=1^%<U\1-7N=&\&7<ME(8KNX>*TAD'5&E<)N'N 21[@4GB'7;?P;;Z/:!H
M;#3Y6-N;R>)GAM]J_(K8(QNZ9)QP: .JHKD?^$DU.#6?#%E.+"6/5VN%DD@R
M1B-&=71MQ!# #KZU5C\;W446JQW$%N]U!K::1:;,HLC.$*LV2<8WDG'9>.M
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M=5(R05Q@$>N>,&G%\12WAOPWJE[]GTR/51(L]W-&TD$$B<!3@KC<<X). %H
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M'M]0-Y;3^5&6B0J5,7(PPPS<GG)S0!T.H:[H^DRI%J6JV-G(XW*MS<)&6'J
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M>:F "@   #@ =J .3\.^&_$&D1PVM]XE6_LK--MHGV78YP,+YK!OG"CL ,D
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M)..!DYX' Z"IZ** .)\:>!;SQAJ^C7+:M#;V>EW*W*VK6AD\Y@5/S-O''!'
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MSYDA;!*#@9Z#V%<T-9U"*^\.7EMJ=U>Q7NM26D]V6VV]Q&PE(2.(DX"[ -X
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ML54  NQ8_B3R?J:?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>QM_A9XEMW:WCD@\1RK%&2 8\7:G"CM\OIV]J /;2RKC<P&3@9/4T,RJ,LP
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M7&6 STR>M!900"P!/3)ZUY3KEE<V]F+RT:W\26%MHL45]9ZA\EP8!O(GB<C
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M6UCO<'SEMG+1@Y/0L >F.M<QX5N+7QG;Q^(9[%$7[&+-$>/!1L9G ]MV$_X
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MD!DD"9)ZAD"'WZUZ+XQM;=?A_KEN(42"/39]B*-JIMC.W '3&!CZ4 = &4G
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M,K&H P.!UR<#'KG9H \?O[.\E^&WCRTCTS4#<WFKW,MO$+*7?*KNI5E&W)!
M/-:E_,=,\::I-JND:U>Z5K$$#6TMC',P4JFQHI$0@C/49'<^]>F44 >?6EE]
M@^(&@&'2+BTLK?19H=J0.\<#-)&RQEP"N<*>_;Z5@Q6E]'X0M)#IFH?Z)XM^
MVR1"SD\P0?:&;>J;=S## \ UZ_10!G6VKI=:H]@+*]B=+=+@RRP%8R&)&T-_
M>&.1VK1HHH CFF6"%Y7#E5&2$0N?P !)_"N+^$T4^G_#/3+2]M+JUN;82^;#
M/ Z.N978<$9/!!XKN** /'H;6\3X8:7:G3-1%U%KZW#P_8I=ZH+PR;R-N<;"
M#FM!@MAK_B#2M=T'6=0MM4NC<VDEHLKP7".BCRW 8*I7;CYL#'7@5ZC10!!9
MPBWL;>$1+$(XU01H<A,#& >X%3T44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1145RTR6LK6Z+).$)C1C@,V. 3V&: ):*X4W7BK0?%^B6U_JT.K6
M.K/)#)$MHL+6S+&7#(022O!!W$GWKNJ "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ&YN[>SC6
M2YF2)&D6-6=L NS!57ZDD ?6D>\MHKI+62>-9WC:58V8!BBD!FQZ LN3[B@"
M>BLK3?$NAZQ<O;Z;JMG=3(NXI#*&.W.-P]1[CBM6@ HJM:ZA9WSW"6MU%.UM
M*89A&X8QN,$JV.AY'%4HO$^A3ZI_9D6KV3WNXIY*S*6+#JH]2.XZT :U%<\?
M'7A07'V<^(=.\[=MV?:%SG.,8^M:L.K:?<70M8KV![@F0"-7!8F,@.,?[)8
M^F10!<HK-U#Q#H^E>;]OU.UMO**"3S90NTOG:#]=K8^AJ/3_ !1H6JN$T_5K
M2Y8N(\12AOF*LP''<A&/_ 30!K45"]W;QW45J\\:W$RLT<18;G"XW$#N!D?G
M5./Q#HTM_-8QZK9M=PAC)")E++M^]D9[=_3O0!I45C6/B[PWJ=Q]GL->TRZF
MVE_+AND=MHY)P#T%3VGB'1K^TN+NTU6RFM[<9FE2=2L8QG+'/ QSDT :5%9D
M7B+19M,EU*/5;-K&$[9+@3+L0\<$YX/(X]QZU'-XK\/6]A#?3ZYIT5I.Q6*:
M2Y14=AU )/4=Q0!KT5C/XM\.1Z?%J#Z]IBV4KF..X-T@C=AU ;."1Z4Z[\5^
M'K&WM;B[US3H(;I-]O)+=(JRKQRI)Y'(Z>M &O15)=8TUHU<7T!1IEMU;>,&
M1@"JCW(((]<BIWN[>.ZAM7F1;B96:.,M\SA<;B!Z#(S]10!-14-Q=V]HJ-<S
MQQ+)(L2%V W.QPJCU))P!4U !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %0W5S'9VDMS+O\N)"[;$+M@>@&23["IJ* ."T
MCQ98:KKT-W-IVL?;Y?\ 1[6&339D2VC8C<6=E"[C@%CGHH SC+=[110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 <SX]#+X;2XVLT=K?V=S+M4DK''<1L[8'HH)^@K#U/4]*\1>
M));C3Y#J^GVN@WL5W_9SB0DRM%B-6!QO*H^!G/%>A4BJJC"@ >PH \W\/ZK#
M)XBT.SM-:T_Q';JDB1LD 2ZT]!&?FD*': <!""JG)'7%=QK^JIH>@WVINA?[
M/$76,=9'Z*H]RQ _&KD\ F@DC61X3(,&2+ 8>X..M4+71GMKE)FU;49PO_+.
M:12K<=P%% 'GVDV.O>&;V&VNK:"U?6;%[1KB*Z,GF7X#RK(WR+M+;I/7HH[5
MIZ-KOA@>%-!T5HDN-0A-M%_92 &YAG0KN9D)!7:P+%C@8!.3GGT*DVC=NP,^
MN* .9(_XN@O_ &!3_P"CA7-Q1FUTN]U^,'S-(\17=P^!R;=I"DP_!&+?5!7I
M=&* /*=69HO#NF>(9[R+3Y]4UZ*]-S<KE8(BCK$&!(Z1JF1D<DUM2:HFI>';
M^Z@\2:=KESICQ7R_8$53&(VW%2 [?>577MU-=Y@'J*3:/04 <A=V%E'\2=$U
M*WC!GN[2Z\R;<6W*!#M R>%ZG P,DGJ361I&M>'_ !!XGL+73[_3K6QTNZF>
MTM5F7S[N<JZLP7.50;Y#ZL3G@ 9]'P!VZ4FT#L* .-L_LVHOXE\0:E;-=VR&
M?3X8%CWG[/%E90J]R\@?/J%4=JY76KR"_E\1S6-Y;ZK9W&GVR"ZME^2P03_*
MK;<AMBNTA!YPA! !KUVD"A1@ #OQ0!Y#=7'F-JDBZM;WL3ZGI\K:_&B^3;E0
M>H4[#LV+DYQ^]&<8K6T_5+C3_"GB.:PNH[RZGU7R+348U'EW,L_E(KJ!QA&?
M:<<'RR>I->D!5"[0H ],4      #H* .#UG3=)T.YT"V?Q!/H<5G;7"PW!6+
M;(YV;BTDH9=YP3C&6RQSUK(DU5Y(;36-5\1S:+JYT?\ =*;:-4N?WC$$"13D
MMM0F-<,,KZUZF5##! (]Z"H.,@''(S0!P,EA>:Q;7MC<QBTU#5],M]2B7IY-
M[$%#'_@+"W_(U-X>U"\\137OBJTL5>9;>.RL[:XD,0!&'GRVUL?.=AX/,-=Q
M@9SCGUI: .)\66/VNRT+4]1LHXM2AU2R552=I4AS<IG:2 ,D?Q;0<<=*[:BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
;"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tardioagreementa01003.jpg
<TEXT>
begin 644 tardioagreementa01003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-Z@@CL0:ETW1TTYC+)=W=[<E=GGW<@9@O7   51P,X S@9S@4 <C]GNF\1>
M)A8WGEV=G/'<N;9P(6:)%4-QQDJ1_P#6KH?&LFH1>$KY]+L!?70V;8#$)"5W
MKN(0\,P7+ 'N!6_10!YSH\5U!XVUJ^.F:S]CO-)A$=Q=1EF9E,FX$9R#\P^0
M 'G[H%9UOI^H1?#WP%9OIM\+FPU*UDNHA;.6B6/=N8C'09'U[9KU>D)"@DD
M#DD]J *NIV\M[I-Y;02>5-- \<<G38Q4@'\":\M1M5D\&>$]%D\.ZJFH:-J5
MB+I!;$ILA;!D5_NL"!G@]^<5Z[10!YWI\%]HH\8:5?:;>77]I7<]Y9210-(D
MZS(!Y98 A"I&WYB!C!Z50TO3]8\ :KI$USIU]JUDVB0:=.]A'YSP31LS?=Z[
M#O(S[#->ITA(! ) )X'O0!P6LQWEMK/@_6AHEREK:2W2SVUG#YCP++&0F43/
MMNQD GKWKGK^PU:?P=XTMO[$U%;B^UU+FWC\G<9$W0$D;<]!&W/3CJ:]?HH
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MP)O?RT?+$*.3CT%;.F:(FGR>=+?7M_<[2@FNY S*IP2 % 49P,X&3@9Z5J4
M<1:?:!\1]6U*73[Z.UETB")7:V8@NK2,RY () 8=,^V:Y'2].U71=!\&:C=:
M!J%]!8V4]C?V443>?"7965U3@L,H <=C7LM% &)X8@MXM.FFM=&.E17,[3"!
MT"2.2 "\@!.&)'KG&,\Y R=>CG;XD>%KF.TNI+:UAO%GFC@=DC,BH$R0.^T_
M3O78T4 >:VEGJ&EZ)XO\/7FFWES/?W-W-92QP,\=RDX.T,X&U""<'<1CKTJ?
M0]'O-&\;Z#!-#<S167AL:?)=B%C&9@\9QNQCD*3^G6O0Z* /+HK.2PU?7-%U
MCPC>ZLE]?2W5G<QQ[[>5)&W!)6)PFT\<CH..V4UMWTWQ7KT-K8:J8K_3X+:Z
M>QT\W:;@KJ"NU@8V",!@@YR#CU]2KG9?"$']JW6H6>K:K8-=N)+B*VG'ER/@
M+NVLK8.% ^7'04 <O9Q+9:WX7US2;6_N-"M=.ETB2(V[F>U(9<,T>-V<Q[6P
M..O2J?B#0-0G\+^/KRVL;IFUR6/[':+"WF,$1%+E<97<0QYQP!GK7I]I:0V-
MLEO I$:Y/S,6)).223R22223U)J>@#BR)F^*=KJ0L[S[$-#> S&V?:)#*CA3
MQUVJ?Y=:Y..UN;'P+HPETW4EU&T\02W,$<=L6D4&29]WED@R*8V((4@C.>,&
MO8*Q]<\.VVN/:3/<WEI=6C,T%S:3;'3<,,.0000!P0: ,/P9=V4^MZQ.T&IP
M:MJ++<3+?6#VH9$58U\L-D$ 8SR3EO<59\73W\.K:"(=/N9[!I91=7%G#YD\
M/R80*>J*Q)#,.0!U&<UM:;H\>G$R/=W=[<E=IN+N0,^WT  "J/7 &<#.<"M&
M@#R;3=%,OAF;3-7TC7+7&OW,T-U;AC/;%C(R3*5W,W!"D\@[^_-=MX*764T2
M6/6I6GECN9$@N)(?*DGA!^1W3LQY[#H#WKHZ* ..:.=/BT]\;2Z^QC1/L_GB
M!RGF"8OM! Y.WG].O%<I'IVHK\*M/T\Z7?B\BUH3M!]E?<(Q>&7=C'38<_IU
MKURB@#R3QC#K.KZ=XLLO[$U(S&>)[);2#;%/$/+/F,PP9)."-IR0 N!P371>
M,[;44GT;Q+HD0BU5'%DT,^!OBG(7# ==C['Q_LM7<UCKX<MAXBDUJ2[OYI3@
MQVTMP6MX&"[=R1] Q!.3[GUH OZ=8Q:9IUM8P9\J"-8U+<DX&,GU)ZFN3C,^
MC?$77K^YL+V2UOK.U6WDM[9I@[1^9N4[0=I^8?>P/>NUHH \AMO#FI^$+?PW
M>W.C7.IVD,%U!>6=B/,DM3-,)E**#\P7&TX],UZ)X9M[>'39);71SI45Q,TP
M@= LC$@9>0 G#$C/7.,9YR*VJ* .#EOH['XS7C2PW#JV@0C,$#RD'SY>"$!/
M/TQQ]*P[70+_ $JV\+A].NO^1@GU*6&*%G%K#()=H;:" 1N3(]2?2O0(_#L$
M?BJ7Q"+NZ-U+;+:M$2GE^6&+ 8VYX+$YSWK8H \[UN.XT?Q[>7]YH%_J^E:G
M:PQI)8QF5[>2/<"K("/E8-G/3-1:MH,>RR.GV6I^'M0M+(M93Z9 TL:;G8_9
MY40%6_A)'3).#Z^DT4 >6NNL:5KUEJVN^'+O4(=0TFV@N%TV,R-:7,>XE=BG
M[AWGD9 (K0_LYK7Q1X*:TT.6QLK1+TR0P0$I;"4#8&*Y4,3G."0#GG'->A44
M >2WFEZG-X1\6QQ:7>M-)XC6_AB\AE::$2PL60$#/"-QUXK1U)KFP\:7&K7O
MAO5-2TK5K2%$^S0EY;:2,N-KH#PK!LY['@]Z])HH \W2TN_#/C'2=6CT">/1
MI=*:P-K80F4V+F;S061,G!! )7(R/3%:_P /H;R"'Q!]KT^ZL_/UJZN(A<)M
MWH[9!'/M78T4 <?K,%Y!\2M"U-+"YN+3[#<VKR0)N$;LT97=_=!"GD^E<U;Z
M5J</PUU?P1<Z==2ZDSW$-O-Y+&&=99&=93)C:N-^2"01MZ9QGU6B@""RMS:6
M%M;-(9##$L9<]6P ,U/110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8J;-UC9&;8%(9FROS9!&,=*M:;X>UV#5O"-U<VML$TG39+.X$=QN.YEC *Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6@V[&^7C#8![#CM79?\ ",V7_/UJW_@UN?\ XY1_PC-E_P _6K?^#6Y_^.4
M8_Q'T&]UG1;"ZTR+S[[2-1AU&*#.#-Y9.4!/<@G'N*7Q%XA@U3PK?66D1S76
MIWUL]O#:>4RR1NZE<R@C]V%SDEL=/I6O_P (S9?\_6K?^#6Y_P#CE'_",V7_
M #]:M_X-;G_XY0!Q=GHZ>#_$G@^*\W&SL=&FLVO/+)C$Q:,\MCY<X?&<>E9N
ML:5/:^!O$\\=I-'#JFNQ7=I;+"V\QB6'<^P#(SL9L8Z8->C?\(S9?\_6K?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?$'Q)T\W-DLMK-X6CF6VNE#8!F! 93P2,]^] 'HSSPQP^<\J+%C.]F 7'UK
M\9^(+KP_X7?5]/CMIRDL*GS22I5Y%3(QU^]GK7G_ (;O["+PMX'M;ED^T&[O
MA:/<RXMXA&TJY<?Q$*0%7(^HQ50W4#?!WQ#;QW4$@M]>*A8B JH;Y"N%R=JG
MD@4 >F-KMXOQ#C\/M#!]CDTQ[Q9 3YFY9$3![ ?,?6NA)"@DD #DDUQL[#_A
M=-D,C/\ PC\W'_;>.M7QE;)>>%;NV?4%T\RM$B7+*&57,J[0P/!4MA2/0F@#
M:BGAG3?#*DB_WD8$?I21W$$T9DBFC>,9!96! QUYKR35-7O[/2-:AU73(+"Y
MM-0L6UBXTX;X;BV9N9 I&?NJ RG/'7@U/KNG>')O#OC'4M,U9-2:XT5VGC@\
MHVZ,BDQN0@P).N#UP/:@#U/[5;DD>?%D=?G''&?Y5)O3?LW+NQG;GFO.M2\#
MZ=>?#U+G1].MDU@06]_!.(P6EGB4,NX_Q;N5)/7=3-2U*;6OA_K/C'3;:5)[
MFP2.VVKB5(%YDQW#9:3IU"J: /1HIX9BXBECD*':P5@=I]#Z4]F5%+,P50,D
MDX %<'X<A\,WWB2QUG1=<6ZN&LC%]GM!$J>3P095101M. ,X()QZUI^/[NPM
M=$LUU!"\<^HVT4:F7RX_,WAE\UL']WE<G@YZ4 =-'/#-#YL4J/%_?5@1^=$4
M\,Z;X94D7U1@1^E>2VIMKRZ\?:9_;EE:M->63Q30(/*#LL0SY>XY4OM5N><G
M-=;X*N[MM3URQU32K6SU:V>%KF:R8F"YW*=KJ#R#A<$'GI0!T5_K-CIMY86E
MU.J3WTC1P(2,L0I8GZ +U]QZUDZ)XCN+W7_$.GWZVL$>FW,,,+HQ^<21AQDG
MOR!P*R/'46GCQAX+GU".V$'VR=)))U7;C[.Y )/&,_K7/:IIFFZC+\5)KJU@
MN&@@1X6D4-Y3"S!#+G[IR!R.>* /69IX;>/S)I4B3.-SL%'YFI <C(Z5Y0NJ
MVKZ_HUOXAU&.VL[OP] UI+=+&T4DISYPS("-Q!C^HKN?!MC9:9X4LK+3KVXO
M;&$,L%Q.P9G3<<8( !7LI_NX[4 1WGB.:;Q,WAW1X8IKV&$3W<\S$16R,<*"
M!RSMU"\<<YIMUJNO6-Q-;S65G*JV,US'=H[*C.A3Y&3DKPQ/WCG':N>T9U\.
M_&#Q-'J;B%=>CMI[":0X67RT*/&">-P)Z=<<UV&KWMN;#4+59 TJVDCN%Y\L
M;3C=Z9[>N#Z&@"+PMK;:[X9TG4+@PI=WEG'<O%&>FX G )SC)J[9O?M>7RW;
M69@60?9A 6WA-HSYF>-V<XQVQ7E6C6-C9:7\+-0MH(HKV=TBEN% \R16MGRK
M-U(X'!Z8&*=?R/IFG?$B33T9$BU2V>9;=1D0E83,0/\ <WY_&@#UN.Y@E5VC
MGC=4.&*N"%/H?2N9T#Q!JWB+[#JEBE@VC7$LR2QMN$\2HS*C[LD-N*\K@8W=
M3BL_0+'PQ?\ B1M3TS6(]1:YT\13V]N(O(,08%6D55&&Y(&><9&.#AWPCM[6
M/X=:=-!#"KRF;>Z* 7Q-(!DCKB@#;U[Q(-*U#3=)M8!=:KJ3LMO"7VJJJ,O(
M[8.% ]B2< >U;4/$5[X;O+ :XEL]A?3K;+>6P9/)E;[H=6)^4XQN!X.,CG-8
MOB:%M*^*WAOQ#<_+ICVTNGR3'[L$C<H6/8,?ESZT[XJV[:WHUAX:LSOU'4+V
M$HB\F.-&W/*?15 Z^I [T =W)<0PY\R:-,$#YF Y/3\Z6::*WC,DTJ1H.K.P
M _,UY?%X>\.:KXP^(4&KVEJ\$?V>0^8!B$-;Y:11_"V<G<.>O-9>AW\ULWA2
MT\6W_P!CAGT+%O+>(A1IM_S*QD! ?RO+Z\]1WY /9&EC4*6D4!ONDGKQGC\*
M8UW;*L3-<1 2_P"K)<?/]/6O*)M T*"Z\!V-M,=1T[^T+J**:XVMYD1BD.P$
M !H]W '0CCD4GBN/0K*'Q?I-A#:6;66B+&RW)R-NR1T2W3(QR<ELGYMO!ZT
M>GSZS86^L6VDR3H+VXC>5(LC.Q< D^@R0!Z_A2V<MZ);\ZA)9"&.8^086.5B
MV@_O,]&SGIQC%>=VTVF7'C7P9?73VD@FT*7]_(5/F2J8?XCU8'/OUK'UBULU
M\"?%&(0PB.+5'=%"C"-Y</(]#G- 'LZS1/(\:2(SIC<H8$KGID=J19X6F:%9
M8S*HRR!AN ]Q7!Q6%CI?Q7T<:?!%;F[T:X,YC !F(DB(9C_$>2<G)ZUS&BV>
MG>(-'\-:5/>:3<SV.JR7%Q=R7$3F\CW29&PG>6D)7(8#&,\X% 'LQ(52S$
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M7V^:(2;;K[7N8/O ^8K@DD'C:/04 >G&>%9U@,L8E896,L-Q'J!0T\*N$:5
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M;2X+-K.'3;..U9MS0) H0GU*XQFL&\U"_B^)VF:<M[)]@N=-N)FM]J[0Z/&
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M5G:,-G&0H)_A.<=,<XIT'B_0+F_M+*#5(9)[Q=UOMR5D^7=@/C;G;SC.<=J
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METL>)+>0$90HZY#=L$9P:TM2\1Z5I$DD=[=%'BA\^4)&\GEQYQO?:#M7@\G
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M7\MF2+=]WS& *IG_ &B* -4    8 [44@((!!R#T(I: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
M[QWN?P%K\,<4LLT^GSPQ1Q1L[.[1L%  !/)-5?!FAZ9%X>T2_.FK'J,-A%$9
M)H2)8FV .HW#*\YSC%=710!YMHVG7>H>&/']A;03V]Y?ZA?&V::%HMXD0*C
ML!D$]Q1X=N=,UIM.>;PYK*ZOIL3B5;[SPEJ3&5<*SDJV[H N<@YP,5Z1D9QG
MGTH) ZD#MS0!YOX0CO=)UJPMM/N;N\\/-92-Y-_;,L^EXVD1;R 2#TV'GY.,
M@5AZ9%J.G>$/!^H/IU\]MI6KW,M_:BV?S41WF"2>61DA0X;@'K7LM(2%!+$
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M[8S[@F-Q&T@\ UU%K-O^*UYJ#6MVELVAQ1K+):N!N$KL5SC[VT@XZ_C7<T4
M<?\ "Z*:W^'&D6]Q!-!/"CH\4T31LIWL<$, >A%1W#26/Q=^URVMTUM<:(D"
M31P.Z;UG9F!8#"X4@\X_/BNS) &2<"EH \<@M[A/A?I5O_9]Z+J/Q L[Q?9)
M-ZH+QGWE=N<;"#FM!S;V>O\ B+1_$6CZU>PZI=&XM'M!.\-U&Z*/+8(0JLNW
M!W8&,9.*]3I-RX)R,#OF@"&RA%O86\ B$0CB5!&K%@F!C )ZX]:GHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%#7:&Y2.3[H<K&I^^P4@XX'( ).0,G7M7EU?Q7X0@M[)+S2-0M[BZ6*5P%G
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M8!F'V9&;;GJ>IQWJWX1TCQ9X=M(?#;PV+Z5:2'R-3\\^8T&[<$,6W[^#MSG
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ME=QV9MX9%E$\DN/*\MQ@,&SU.,8.<8JAIS3M\:KDW-BEK,=!4GRY?,63]_\
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M"%0YW8R#]WGK@79-?UK59-;3P_#:"72V6$17:$FXF*+(4R&4( &5<G/.>PY
M.MHKB(KW7)OBI%9RW,$-JNBK<M:F(ML+2A7&X,,ME>&QC';J3)XJN]7C\<>$
MK.QOH8+>YEN2Z20%]S) Q!;#KD8/ XYYYX% '9T5Q<OBG5K[3->U71DLVM](
MN)H!!.C%[DPC,F'# )DY"\-T!/7 U9O$+7/@-_$>F1H2^GF]A2?.,;-^&Q^5
M &_17!VWBS7HM'TK4-1CT_&M"V2RCMHI7>-WC:20N,_, JD@+CG@G^*K">(/
M$Z6NM"32X7:U:(VEY*AM898W(WLRR-D>6,D_-\V.,4 =I17"0^-M0V>*T6WC
MOY-'BAFMWMH'3SUD4G[A))QM)R#\PZ4O_">I%X;OM<@O=/U:T!ABM#:JT1,T
MC;-DBEF*X)0] <$\4 =U17*3Z]JND^*]-T74/L=PFK0S?9+B&)H_+FC7<5=2
MS94KR"".F,=ZP+#QQXCFT'0==N8-+%I?:D+">"-)-_S3-$'5BV!@@<$'/)R,
MX !W<.BZ?!J\VJQ0%;Z90DDWF,2ZCH#SC SP.U/M]6T^[U&ZT^VO(9;NT"FX
MB1LM%NSC=Z$X/%<AXE\8ZMH!OKAXK)8K6[@CCM"#)+/ [(IE+*V(N78#<O\
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MHVD^O/MQ765@V_BNUN[^U@M[*^EM;F66&*^CB#0%XR0P)!W*,JP!( ..#TH
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M/LY&Y&;<3NW\<]L=/SJGX:\(ZIH"06$OB*2[T:S/^B6QM@D@4?=5Y,_,J]L
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MQ!"D#HHSM'3G-J+PM=PZQXDU!=3A_P")U'&@0VI_<;$* YW_ #<'GIS73T4
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M&><@@CD$$ @^U9%EX(T^STV>R-[JER955!<7-X\DL:JP951C]T @'CT&>@H
MX?7M;CUGX?>,$AO=7L[JULU\[3;W*36[?-GYNK(_'<YQZ'%=3>FYBOM-TR/5
M;V4-8R2?9+<@7#-E0LK2<!47)&#C)(^]C%:TWA+3;R#4H[]I[Q]1MQ:W$TK
M.8ANPHV@ 8+,>!G)Y[5!_P (1IGVVSO?M.HBZMK<VQF%XX>:(G.V0YR1GGC%
M '#P7^H^);'X8WES>M%?W4EQYES&B[@?L\@+ $;<D#TQGMVJ;5+K5+;P]\1O
M#NH:A+J4&GZ;YUK=3JOF[)8G)1RH )!7@XZ&NOMO .CV>EZ;8VLE[#_9DK36
M<XN"TD+,""!NR,8)&T@CVJY/X4T^YTC4=.E:=EU//VV?>/-GR-IRV.!M&
M .F* ,*2_O[7Q)X$M(;V1+.]MIA/;@+M<I &4YQNZGUQTJMI>OW<?BVVTS79
M;^POY+N<PEL-9ZA#A_+6-APK*"AQP?EYR373-X6LWO='NVN;LS:0C):G>N &
M7:VX;?FRN!_]?FDA\*6<3VN^YNYXK29KBVAF=66&0AAN'RY. [8!) SP.!@
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MN?J34EO<P7<"SVTT<T3<K)&P93]"*XWXO@'X4:_D?\L4_P#1BUV=N +:( 8
M08'X4 245Q4_B_4I]"UC7]*M[66PTN:9#!(&\RY6$XD97!PG1MH*MG Z9XLP
M>*;GQ!//!X<%OF"P@O#)=(6#F96:., ,,<+DMGC(X/. #K**Y.[U_78;>R,]
ME::6\MDTTS7+B<"X&,0*J,"Q/S'<,\#I6%)XIUG7&\ 7MC+;V46KM))-"\;2
M?,(';!(897VXYP<\8H ] BU"SGO[FQBN8GN[8(T\*L"T8;)7([9P<59KBI?&
M/]E:KXP;4;.WCM]%M;><209,DX=7(#$XY^4 #MGK4]SXEU31[W0O[5@M'M-8
ME6V!@#*UM.RED4DD[U.",@+TSCF@#KJ*\VG\>>(8="U;6FL--%KI.J/9W$8D
M<O*BR*A*'@ _-G)Z],#OZ30 45A:QKLEIKFEZ'9B/[=J ED#R@LD4<8!9BH(
M+$DJ ,CJ3GC!P+[Q)J5WH_C'29!!;ZMH]NS--&K&.6)XF9'4;LJV 1C)P1WH
M ZRTUS2KZ^DLK74+::Z1/,:)) 6VYQN [C/&1QFK=S=6]G T]U/%!"O+22N%
M4?4GBN>\$66/">A75U':/<IIT,<,T<.UDB,:';DDGJ!G& <#BM'Q.,^$M9!Z
M?89__1;4 ">)_#[LJIKNF,S$!0+N,DD] .:U:\[\(WL\WP[\,:?+H%S+:7%I
M;02W$C1>6$*CYL!R_IC@8)!XK3G\0^(;CQ/KFBZ=;::C6-K#<0RW#.P;?OX8
M#']SMT]^E '8T5Y]8^.=8N=/\+:S+8V4>FZU/%:M$KLTT;NK88'[NW<IXQG&
M.>P;/XO\630>(YM.TO2F&AW;QNDDTA:=%C5R%P!AL,>3QT&#UH [A]3L$U*/
M36O(!?2(72W\P>85'4[>N/>K=>?'5(=:\=^!M6@4K%>:3>3J&Z@,L)P?IFI9
M_'-\/!Y\96]M;RZ*LI+6VUO/-N)"AD#YVYXW;=O3C=F@#O**Y:#Q+<Q^,KC2
M=0-I%8O8_;K&X56!E0'#AB3@%<@G'4'/%47\4Z_'>>&+;[%8E];$S$N70Q!8
MRZ@KSSC&>>N1QUH [>BO.I?&7B>/1/$=S]CTDW'AZ:1;DYDV7"*BR?(.J':W
M4D\]O37N_%D]S>-9:4@2=+&*\9I;26X7,N[8F(^GW"2Q/I@'G !UU%<(GC#Q
M#/=^&;3^Q(+*XUB"X:6*\=PT$D0&<@#[O.1W(],YK+UCQ9KUUX(OI5>TM-0L
MM:32[IXD9DD'G(N4RV5R'&<Y[CCJ #T^BHX!,($%PR/+CYFC4JI/L"3C\ZDH
M *IW6KZ;8SQP7FHVEO-)]R.:949OH">:N5PGCD ^,_ >0#_Q,I?_ $2U '=Y
MR,BBN-T*^UBZ^(OB>UN;N![*S6U6.(1,"JLCL,'=C.3R<<X'3%=E0!6M]0L[
MNZNK6WN8I9[1E2>-&!:(D9 8=L@YJS7#OXON[,^,I9-,@+Z-+$!]G#.TJM&K
M;WXR=JMD@#HIK<\-ZRVMPS745]I]_8D(8+JRR Q.=RLI9BI'''O0!N44V0.8
MV$3*KX^4LN0#[C(S^=<):^.=0N/"7AG6S:VJOJFI1V4\7S84/*T>Y3GJ-N<'
M/6@#O:0D*I)( '))[5P5_P"+O$:3^+8[.RTL#0 LF97D;S4,/F[>,?,1QGH/
M?MJ0>*9M7U+3]-TM889[C34U.:2X4R+%&^ BA05W,3GN,!>^: .@L-2L=5@:
M?3[N&ZA5S&9(7#KN'49''%6J\N\(:[+HVASP21H=0O\ Q'?0*(XWD1&#.[MM
M4;F "G '7(Y')%_4O&WB'2O#VMWLVCQM)IT\*PSR12P174<C*NY4?Y@RDX()
MQ[\T >A45Q.I^*M4T"YLX/$$FE:?'>SRK#>@2201JH0HDA)7#L6?G(&$]^(-
M1U3Q"_BGP;;"ZLH%O4N9)XTC:1&=(^NX,,KAL@>O)SP  =[17%S^+=2N=&UK
M6])@M9;+2IYHS!*&\RY$/^L*N#A.C!05;.!TSQ8L_%DGB+45L]!:! -/AOWG
MNHV< 3 F--JLO. 23GCC@YX .LJI:ZG87MU<VMK>03SVI N(XY QB)S@-CH>
M#Q7(Z?X^DU2WTZSBM(X-;N[^?3Y878M' \ )E?(P64 # XR6 R.32>$!=K\1
M/&PO3 TP-C\\*E58>4V#@DD''N: .ZJIJ&J6&DVXGU"\@M8BP0--(%!8] ,]
M3[59?<4;80'P=I89 /O7CNH7VK:E\&=5O-4N8;F0ZH%79&4(*WZKCEB,<  =
MAW- 'LE%<E;>(M9B\4ZAHE]96DTJ:=_:%HMH[ L-Q3RF+<9R!AN!STJOI?BW
M4;KQ'::-<?8&FN].DN=T"L1;3(5#1,=Q#XW\D$'CH,T =K3)98X8VDE=8XU&
M69C@ >YKD_AK?ZKJGA"*^U2ZBN))I[@@I&5((GD!SECQP, 8P!CFNOH R/\
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MD%QM"ME>>0.><C5\/:SJM]JFHV6HV#+#;[&MKY;:2!)U8<KLDR0RGW(.<\4
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MGT %%%% !1110 445DZ9X@M]3UK5M*CM[B*?3&B68R@!6\Q2RE<$Y&!WQUH
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MH\:9"KN9L  ].<#!W+OP;I-[I$FFS"X,,UP+J=EE(>:4$,'9ASD%5Z8 P!T
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M2'52<*0>!C[PSG%00WWB.UO-"\+ZI?6MU>SQW4DT\-TT)F$938F]4R&VR9;
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M>><B7?OSNZ_>).,XS1?^ ]$U#6WU>3[9#=3*J7/V:Z>%;I5& )54@-QQ].*
M.@LWDDLK=YFB>5HU+M"<H21R5/<>E34BJJ*%4 *!@ #@"EH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@"CK&KV6@Z/=:KJ,HBM+:,R2/C/'H!W). !ZFLR#5?$-QIHU%=$MU5X_,2S
M>Z(G*XR ?DVA_P#9SC/\58_Q>TZ[U+X=7RV<33O!)%</"@R9$1PS#'?@9_"N
MKLM8T_4-(BU6VNXGL9(_-6;<-H7&>3VQW]* )--O#?Z59WK1^4;B!)2A_A+*
M#C]:M5P@E@UGXGW6FZO;I-9_V1%-I]O<QY1@SD2MM8?>^X#W ^IKD1;RR:'H
M4%U)-);6WC(V=A*96W-:AG"C=G) ((!_V10![1D8SFEKRVW\,Z)+XK\;Z4^G
MPG3H[2UG2TQB))7CDW.$Z!OE'.,UG:;;0ZTWPN74F><7>F7*3!Y6_?!84P&Y
MY[Y]><]30!['G(SVH!!&0>*\=B@L=".OZ(?M!T/^W[.#3K=9ML1F=5D>%F8'
M$6[[PP>XQDU5U/R5\.?%&P\VUV0%)HH;4[8T8P(6*KG^]U]3V'2@#VS-%><I
MI-AIWQ)T)+:W1%U+2+E;T'YOM.TQ8,F?O'YCR>QQ5/1[!;._NOAS+:AK:.]&
MH12,F0]B6\S!)ZD2 1'/.#[4 >I49![]*IZI/!9:->W$[R16\%N[NT/WE55)
M)7W '%>8: ]I9^,/!+V;6UO!>:5< JL@::5,1&-IW& [DDGIPV[!- 'K>1G'
M>C(KQZTTLZ]IUK8E[:?4H=?DEGU07$?[Z%9FW#AMYRO[O9C' [ &MG3?#FDZ
ME\3O%<=W:^<ELNG3PHTC820+(0PYZ@C]3ZF@#TC(SC/-&1G&>:\A\.I8>(M)
MTO4[W6K>TUZTO]UP(H0MY]H#E6A8EMQ5LXVXQMQT H@2P\26>J_VKK5OI^M6
M.JREI!"/MD!28F(1L6R5*;5  P<D<DT >O$@ DG %5=-U&UU:QCO;*42VTA8
M)(.C ,5R/;(XJ::"*Y@>">))8I%*NCJ&5@>H(/45XMX?GMK+X>^ X5C@CL;V
M_2/560 ;P3((UEQU4N #GKC'M0![:#D9%!.!DUQ&DVK:7\5-3L=-01:3+I45
MS<01C$<=R9&4$ <*6123CK@&K7C&6Q?5?#MA<J9;BXNI&MX)9 MNY6)LF7(.
MX '*J.2V.G) !UN>,T5X>?(G\ 7EO]HC=;3Q:(H?L[E5CC-TH&P G:N"<<\=
MJ[70[&UT?XKZQ8Z="MO;3:5;W,D4?"M+YLBER/[Q &3W[T =WTK \9Z]<^&?
M"5_K-I;17,EJ@?RY9"H(R!G@'/7IQ]:I>-9K(SZ#972M+-<Z@/L\#2!()&5&
M.)B0<J!R%QDL%K@)YHQ\)OB#:K<6[I!J=PL20<1HF8CA%R<+DGCWH ]?_M.U
M&J0Z895^V2V[7(B'7RU95)/IRX'OSZ5<R,XSS7G]U9Z=_P +GLIKFVM-[:$S
MJ\J+DR">,*<G^(#@'K6#X;2P\1:1H^J7NM6]IKUK?!K@10A;PW&\JT+DMN*M
MG&W&-N.@% 'KV11D>M>9^$_#.CZCJOBJXN[7SI+/79_LY:1OW688P<<]P2#Z
MX'H*Y_0M/M;3P=\-=9ACVZE+J4$#W6XEVC=90R9/\)QTZ4 >V9&<9YJI#J5I
M<:G=:?%*KW-JD;S(/X ^[:#[_*3CTQZUY+KES82!]4L)(T>/Q5%&US<R!KEI
M!*J.B8P4B R #G*YX%='H%CI,GQ0\8,UO9[Y([)HF"J&;?%)O*GK\PSDCK0!
MVVEOJ$FG1-JL5O%>G/FI;.7C')Q@D GC';K5RO'M-T9M1^!VCZA:0+/J6DN]
M];!AN,ACG=FC/J&4$8]<>E:^N:F+KP1K/C338V0W4,,<,JQXD6T5U\QN.0<-
M*<@] I[4 >E @]#1TKA_#FG:.OB>/5=)UBSD-U9;6M-.B5(9$!!$K@$_,,[0
M>#SBKOC::R\S0K*Z5Y);G4%%O T@2&5U1CB8D'*#KC&2P6@#J\C&<\49%>'7
MGD/\-?&%M]HA86OB," 6S;$C4RV^=BY.%R[<=.372^(_"FB6/BSPE:6UF(H+
MS4;I[A!(V)2ULV[.3WP,^O/J: /2\CCD<]*6O(/%5EHEI9>+-.TZ&*,Z3HT:
M?Z9)N6V^1WC6W4_,&)();=U"X!Q6@EG9:WXY\,&\"W<=SX>E,ZLY992&BX89
MP>2<@T >GT Y&1TKQVU9[;X>P01SHMG9>)W@^R22A1/;K<L! "QQTP<$@87!
MXJWJ%G<:5I?CCQ)I4:P1S0Q_9(;>16>% H$[@(Q"EN6X.?ESP30!ZOD'H:,C
MUKSK3]+T&ZU%-4TW6+.1;K3I(WM-.B$:3QXR'D 8G*G W'!YQWKF-/TFQ7P5
M\-M26(I?7%[;VTMRCLLKQ/')NCW YVG'2@#VS.:,@]#7C^I,?#+_ !%@T2+[
M+;6\>GS^3;+@1!\B9U48P=@))&.F:UETK0Y9+W4M-UBSE6[TB57M--C6.*5
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M1G,HDE*@#O\ -BLQXX#X*\$Z[HFW^V);JS1KA/\ 67)?B=)&ZM_&6ST*Y[4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#1NEI&K(1T(('!I__"/Z+LN4_LBPVW)S./LR8E/^UQ\WXU2LAJUKXAUBXO\
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M+-@\7[TK"4(^_P <GOCB@#4NM:T:\UOPJV^]>6_$D^GR0EEA8&$L3)R ?DZ
M@D'%5-.\>![?Q)?:II]Q966DWCP;SL<_*L?RD*Q)8LQ(P,8(YS678Z-K4(^'
M ?2)Q_8T!COCYD7[H_9C%_?^;YN>,\4-I_BO2[#QE!I6FM]JN]1:]L[CS8]L
ML;B(,J@G(<*K_>  ..M '22>+X4&KQ?V;>K?Z9;+=26;^6&DC8'!5@Y7'RL#
MSD8Z=*R%\2VNI>&/"M_K=IJ%M-J%U:&#[.VU6F< J24;_5DD\-R<?=JE9:%J
MK^)M:N(]$GM+34M%2W22YN4=Q*#)Q(0S$L=R\Y(QW[5$VE:]+X(\&6#:%<I=
M:5?6+7,9FA)"0 !W!WX(/89R?04 =A?^*;6RDOTCM+R\&GJ&O&M45A!D;L'+
M L=OS84$X(XY%5[CQQI,5UIEO EW>-JEN]Q9M:PEEE50"<$XY^8?3/.*S--L
MM6\.:[XE TR;4+/59_MMK)$Z<2,@5HI-S#;]T8/(Q[\5FZ-X3U/P_J/@:U6U
MDNK?2+*ZBN[E'3:LDH0\ L&(R&[=,4 =IH&OVOB+3WN[6.>$Q3/;S0W"!9(I
M$.&5@"1D>Q-:%S<0V=K+<W$BQ00H9))&. J@9)/L!7 Z;=:SX0T3Q%J$WAVZ
MG\W6I[P1+/$#]G?!\S[QY 4_+UY%=7XJT=_$/A35-(CE\F2\MGB1ST5B.,^V
M>OM0!7A\763WFGV\]K>6BZD";*:X10DYQN"C#$JQ7D!PI/UXHL_%]E>Z?K%V
MMK=QC297AN8I%0/N10Q &[G@@@]#GC-83Z9JWB.S\+6E_IDMA-I5[#=WDKNA
M3="C ",JQ+;F(],+G//%6[OPS>_\+ ^W6NT:1J,,<FI*3R9H&!B(_P![(!]H
M^>M &KJ'BB#3XKAOL%[</:P"XNHX%0M;H03\V6 )P"<*2>/<9H7'Q"TB.:VB
MM;?4=0>[L3?VXL[8OYT8QPN2,M\W3VQUXK(U/2]3TOQSJ.HKX7B\0:=JJ0D%
M3$)+65%V$'S"/D8 '(/'-78M+U.'Q_HU\=*"6<&E2VTLELR"**1W1@J@D,5&
MTC.WTXH V8_%-M/(1#97LD27,=I+*J+B*5MORL"VX8WJ#QQ4.J>---TB*:ZN
M(;IM/M[@6]Q?1JIBA?<%.[YMQ 8@$A2 >.QQSVH^'M0D\3'5]'L;W2]6^WH)
MYHY5^RWUL& +2IN/.S(Z!L@=N17L-&U;2-4U/2IO"-IJD%U>S7-GJCF(HBRN
M7(F#?/\ *6/0'/:@#J-1\;:9IDE^98;J2WT^6*&\N8D4I TFW;G+!CPZD[0<
M9^N+5]XEMK.YO8$M;JZ-BB/=&W"'R@P)&06!/ SP#Q7#>+M&\3ZW8^)["31I
MKMWDC;3)5N(T@$*[#@*6SYN0W)'?&0, W/$^A:CJM_<ZGINF7^E^(8TC%C?V
MTZ!)A@'RYQNP0K%@<@\=">A .YUG4&TG1KS4%MI+DVT+2^3&RAFP,]6('^>]
M<W9>/8HM \/7>JZ??1W6KQQB)8H@X=VBW\;6. >< \^H%='J]I-?:!?6:;3/
M/:R1+V&YD(_+)K@X=,UY](\!0R:#=1R://%]K4S0DJJ0-&6^_P @L<@#G [=
M* .A?QW9);2RG3-5$EO9_;KJW:!4EMXLL,NK,.?D8X7)P/<9NGQ98?VMI&GK
M%<N=6A,UG.%7RW4*&/).00I!QC/ZUSWBJP\0:GJFLV1TN6]TVXTSR[ QSI'$
MDQ5PYF!8%CDKMX8#'8Y-)>Z#J]W\.-"-O9?9_$&BI;SVT,DBY,D2A60L"1AU
MW#KW&: .H?Q%:Q_: T%P&BNA:1KA2;B4C.V/YN>.I. ,'.,''+>+O$D&K>!O
M%UO;->V&IZ5;,9H2_ERQ$IN1MT;$%6'H2#WJ?Q3X:U(^'=&?3K:#4K[2[P7D
MUK,0JWA97$H^;@$F1F&> :KZII^HZOX"\00V?A1-,N;ZT,$%HIA65V((W.5.
MT+R,#.>#ZXH [>P8_P!EVK'+-Y"'W/RBO.(=6&J?\)+J^M0:S;QZ+J;-%+:R
MJ#!'#'&QCVJYSG+%N""&Z\#'HVF^8NE6HEA>*185#1L02I Z<$C]:X.#2=:'
MAKQ]9MHURL^K7-W+9*9(OWBR0I&O._CE2><<4 =#;>-]/N;;[1]BU*&.1H$M
M3-;[?M;2@E5B.<,>#GH!USCFI3XQT^,:JES!>6UUID/VBXM7C#2>402'7:2&
M7@\@\8YQ6'JFAZO<>'/"5Y:V;_VAHDT$TMB\B!I%$9CD4'.W=@DCG'YT:IHE
M_JVKZUK\>GSQM)H+Z7;6SL@DF=F9BQ^;"@':!D_WO;(!HQ_$#3))=,4V.J(F
MJ0>;92M;968[-^P8).['J,'!P2*U=!\16VOK>"&WN;6XLIS!<6]T@62-L!AG
M!(((((()KDX](UA8?AZITFXSI"@7O[R+]UBW,7]_YOF/;/%:_A>PU"U\4^*K
MJ[L98+>^NXI;:1W0AU6)4/"L2.5/4#B@":;Q/=)\0(_#JZ9.T'V W3SJR<YD
M500"V=H^;/&22,#C)H6OB[0='T#6-8CCU0VL.J217(E5G=9BRJVT,?E3<0 .
M /2K%W8:E!\3K75X;![BQETMK)Y4D0>2_G!\L"02,9Z \_G7+WGA_7Y_ WBK
M3DT6X^UW^MO=VT9EA^>(S(X;._ X4\'GI0!UY\;6@U:?2O[+U;[<D/VB&#[.
M ;F/.W<GS8 !Z[]N,BI['Q=IVHZ-9ZC:I<.;R5H(;4H%F,JEMZ$$X!78V<G'
M'6J$EIJ+?$ZVU<:9<?8%T=[9I=\?$C2(X7&[/12,XQFN2B\,>(;;0M.O!H*W
M-UINKW=R^FW,D1%S!.S_ '3DKN 8$9[@_B >BZ'XAL]=-[' DT%S8S>1=6TZ
M@/$^,C."000<@@D&LZ#Q1<2^.[[06TV9+:TM8YFN"\>#O+?,?FR%^7'3.<Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MH:QHNGZ]8_8]2M_.A#B1<.R,CCHRLI!4CU!J#3?#MAIC%XVN[B0J4\R\NY;A
ME4]0ID8[<]\8S6M10 R**.&)8HD6.-!A548 'H!3Z** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH CE@BG"B6-9 K!U##.&'0_45)110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ+=,/^/1H'256]'##Y/<GCWK1O\ 38=1\OSI;M-F<?9[J2'.<==C#/3O5/\
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MBV:)F0@2!8%5BI/!PP(.*C^+JO/\,M8M8(Y)KB=$6**)"[.?,4\ <].:W_\
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MS[F0HK,<X8@-QGU%8?ERKX1FE6VN3';>,?MCJL#EE@^U;MX4#)7!SD"O2_\
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M-@  .22:0^$M.-RMPUQJK2JI5&.J7&4!QD#Y^^!^52_\(U9?\_6K?^#6Y_\
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MC(L9V*2\952<8!PIP/:NA_X1JR_Y^M6_\&MS_P#'*/\ A&K+_GZU;_P:W/\
M\<H J>/+A[;P7J$J:8NI%0F;=XC("-ZY8H.6"CYL#KMKBQ/GQ'XKG_XF5S%>
MZ!&(;F>S=!*1YH( V #J !@$YXSUKO\ _A&K+_GZU;_P:W/_ ,<H_P"$:LO^
M?K5O_!K<_P#QR@#A+,"*W^%@$,BM:QXN (F'DDVI0[^/E^<XY[UBW=S/#\)=
M=\+W]E>MK\-S(TB"UD?[1ON?,$JL 0001SGJ,>E>J_\ "-67_/UJW_@UN?\
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MH62W$7F*-J?.AW;3ADY&<X_*@#H+CX@:3:Z'=ZG+;WH^Q70M+NV$0,L$A8*
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M5?)#;M@8_-N";N-VW'?H<TR]\<VMIJ&KV,6DZK=7&E1I+.L$*8*,&.Y2S '
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ME-?)<13)'9K&7FPI5VD.%C7!R7)(XP/O#U%9LGCJPMKG4K6[LKVWN["S^WM
M51VD@!(+H4<@X(P02#6?JOAK6-6^'CV[_9U\0321:A(K\Q-<(ZN(SZJ @3Z
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MT=Q!'/"X>*10Z,.C C(-/J."-HK>*-BI94"DHNU<@=AV'M4E !1110 4444
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M[O#;2RQQB,*6(13N;EU Y'4GCI0!I_\ "-Z%_P! 73O_  %3_"C_ (1O0O\
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M2M<9DC6-"N(R?DR"2<E<$^A..U<C%>:O=>(_'=K=7D$EG9V\<<<0@(PK0,X
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MR=J@#U/.3WK*G\/ZA#XKNM=TV^MD:\M8[:6*X@9PNPL592&']\Y!Z^HKI**
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M =512*"% +%B!U/4TM '%>+-1OX;^^BL]3F4P:6T\5K9HIECDRW[V1F&T)@
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M\@!&!D<%B2*P_#^M00>&? UMJ5U$VC/J%[!=L[?N@RO*+=7R3A.. >/E7TH
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MN8+224[C);+(RIDGJ,# ]@*X"6VTZW^#GB=8(;:&X_M69'\M55PBWH !QS@
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M8#@[3ZU*E]KP:U>32[$P2R*LAAO'9T5OX@IC .._(XS6'\73CX4Z_G_G@O\
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MXVD]CGC!YSQ0!H7:W+VSI:.D<S#"R.,A/]K'?'IQGUJ'2=+M=%TJVTZS4K!
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MQ)(-&T;4M U.-H+C5K:VD>-5<.CRA'7D?*>H/<>U '81QI%&L<:*B* JJHP
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M!^MV-_.-9@\*OIUQ"T4\5AIOE-+GLQ(P5ZY!KO8HHX8DBB18XT4*B*,!0.@
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MNUTVS@N7)+2QP*K,3U)(&>>]9VG:?K4^L-?ZZ^GE;8R)8Q68?A6(^=RW\>T
M<<#+=<\.T'Q7IWB&]U.VLV8M8W+0$LI&_:J$L,CIE\>^,]#6G?:C::=&KW4P
M3>2$4 LS8&3A1DGCG@4 1ZEHNE:RL2ZGIMG>B)MT8N8%DV'U&X'%+J&CZ9JU
MJMMJ6G6EY;H05BN(5D52.A (P*JGQ5H M[.X.L67E7N1;OYRXDQG./I@Y],<
MU6/CCPPME)>'6[001R&)VW\JPY((Z]"#GTH W8X8H8%ABC1(D4*J*H"J!Q@#
MTJE;:#H]FKK;:58PJZ&-A';HH*GJO Z'TJ&]\4:#IS*MWJ]E"SP^>H:89,?'
MS?3D8/?/%8'B_P 5;OAU=>(/#&K0L$>,)/$%D!S(J,N"#@X8^XH Z/\ X1W0
MQ;Q6XT;3_)A?S(H_LJ;4;^\!C /N*)?#VB327,DNCZ?))=8^T,]LA,N""-QQ
M\V" >?2I+_6-/TPA;NY6-BI?8 6;:.K8 )VC(R>@J*3Q'H\1L0VHV_\ I_\
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MCYF7:1LZG/ YK$T'3+K1[[X:6.JJQN;.TO!-O&[R"ZKY:L>@./E'NO%>MT4
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MDX%26GCBQETC4+V[M+FSFL+O[%-:/M:0S';L1=I(;=O7'..:YO1/#7B"RM?
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M6V:*<K&0_G$ 8&_=P2 >,\@@8(IZCQ-JWA_4HK_P_;:=,]E+ D,-TDK32LN
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M6 .#@J1WZ<5+;:-XCM[3PK9RZ='=:=9Z:+6\LGN511.JHJR-U$B85N.>N<9
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MTMKYMJFBBR::-D7?,)-Y(0MPIZ?7VYH B@^(UI<:=INIC2-133KRX6UDN7"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\]Y;8C)@19LAX N<A-N!D'@C..U6=5\$SZOI_B$S7D$>HZU;I:O*L19((E!
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MJKG)P!U)Y))XZ5<N/#E]<^)/#^K->6X&E0S1/$(6_>^8JJ2#N^7&T8ZUTU%
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M:5:RV[1B%OWOF!02#N^7&P<<]36_I]]#J>FVM_;$F"ZA2:,L,':P!&?P-6:
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MN81@@%=P((/(P>Y%=M10!RFH^%M2O3H=VNKQG4]-NGN'FFMRT<F]&1@$##:
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MNCLD\EH]P;I=TIWQS%M^]&'*MNYJS_PC-FT-ZL\US//>P"VGN9''FF(9^0$
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M=*Q;3P1IEI?V>H"XU&6]M(7@BN)KMW;:V.#G@@8& 1COC/- '#:=JNNKX/\
M#/B";7KV:YEUE;.:)]@CEB>Y>(A@%Y.,8/; P!6K?7MQXHT/QW*][<6Z:8]S
M8V\,+[0OEP@L[#^/<6/!R, 8P<FNB3P+I$>B6FCH]X+*TN1=PIYW*RARX.[&
M3AB3@\<TMYX%TB\U"_O-][;OJ,7E7J6URT:7'R[0S*.-V.XQGOF@#F=%U"^O
MX] \.VS^7&GANVO"%NFMW<L-F0RHQPNWIP/FYS23GQ3;WO@[2=1\0XNKF>ZM
MKR6QVE9 L3LK99 0X&.V,\XKHKSX?:'>6FEPK]NMI=+C\JTNK:[D2>-,8V[\
MY(XZ'IVQ5Q_".F--I4J&YC;2F9[4K,3AF!#LQ.2Y8$Y+9SD^M &I86<EEID%
MI+>3W4D<80W,Q'F.?[QP ,_A7CUS;-%\'?&3FYN96_M2YC_?2E_NW0 //?U-
M>UUS$_@+1+BQU.Q;[6MKJ4YGN(5N6V[BVYMHS\H+ $XQ^7% &-=ZIJ/AOQI?
MPMJ%UJ%L=!GU(P3[<++$X'R8 V@AL8J714\27C^']<CU*V^Q7,2O?+)>,ZW
MD4%3&GE@(P8C !'H<]:Z,^'+-]=BUF62>2\CMC:9=QM:(D$J5Q@Y(!S5'0_
MFB^'KSS[ WHB1F:"UDNW>"W+9R8XR<*>3S[G% &3\93=#X5ZS]EW](Q+LZ^7
MYB[_ ,,9S[9KM;,VYL;<VFTVQC7RMG39CC'MC%230Q7$$D$\:212*4='&592
M,$$=Q6#8>#[+3(1:V=[J46GC[MD+IC&@_NJ3\P7V#8H SA?#4/'+>&()Y+73
MK/2DN46UD\LR,SE!AASM4+T!ZMSG%<P_B#Q#+I=K;-JLT=Q9^+%T=[E8T_TJ
M'<,,PQUP0#C )!SFO0;[PU87E_::A'YMG?6D9AAN+5@C",]8R,%2O ."#@],
M5!<>#]*N+*SM,3QQ6EV+Z,I*=S3ABWF,3RQW$GGKF@#&T1K[_A)_%6@7&JWM
MS;6\-K/!+*X\V,R*^X!@!QE!QCC)KEM-FOM'^ FDZCI^I7<$^+7HRD;6G5&4
M9!P,,>F#7I">&[2+5=0U..>Z6[U")(IW$@Y5<A<#&!C)Y'K5/_A!])/A:+PW
MON_[+B92D7G<C:V]1NZX# 'KV]* *L-]/X@\:^(-(-Y<6MOI$-NL:V[[&:25
M2YD)[@#  /'7(/&.1\%ZI>+X5\$Z!;.JB^MKN:1C.8#)Y<G"*ZJQ'WRQQ@_+
MUZY[^\\(Z=>:U'K'FWEO?B(02S6UPT1GC'19-O7ZC!'K5!_AQX>;P]9:,([M
M(;&0RVLZ73B:!SU*/G*YST''M0!@:H_BO1M,TNWN]=432>(H;9'MV$K&UD;*
MI*60$L/48R,9S4.J2ZA%:?$71I=6OKB"RTM+NWDDD E1GBE++N4#Y<QCCW(K
ML9/!FERV%E9O)>,MI=+>+*UPS2/.OW9'=LEB/?CH,8 Q,WA339+[5;N;SY7U
M6W%M>*\GRR1@%0,#I@,W3UH Y66>^TG2O "VFI72Q7=W;PW$;,K"1&@9L$XS
M@%1P#BJWB+6]2LEOM0LM3N+E[;6H(-\7R6\,;/&C6[*3^\;YF)8 X)ZC&*ZP
M>"],%II5MYUZ4TN99[8O<,S*ZKM!).<X7C'3':JUU\/-!NQJ".+U8KZY%W)%
M'=NJ+-N#&15!P&) )/\ *@"M&I?XQZ@JNR$^'X0'7&5_?R<C((_.N1>YOM9\
M ^#;J_U*[EN9/$<<4DHDVF0"YD4$@8' 48[#%>E1>&[.'7'UB*6Y6\>U%H6,
MNX"($E1@YY!).3SGKFJ2^!=&3P]#HB_:A:6]R+J B=A)%*'+[E<<_>)/XT 9
M>H:I-X1\:12:GJ-S)H5]9.(?-?(@N(AN8>^] 2,]U('6NFT""\M]%MQJ$LDE
MW(OF2^8VXHS<[ ?1<[??&:Q-0M)->U2WT.?0KA=-TVYAN?MURRLDNP;E"?,6
M+;L DCH&R>1774 <OXHD-_J%CHPT^:_M\_:[V&(I_JU/[M6WLHPSC/7_ )9D
M5D?"^ZFLK34_"5Y'+%<:)<%8$F*ES:R9:(DJ2"0,C@G&!77VFCP6>JWFHI-<
M//>!1*)'W+A<[0!V R>GJ<\U2E\,VB>(Y?$D)N#JIM_( \[;&Z#D(1C&,]\9
MH XF#4_$.I:=I1AO[V#7Y-9>WU&WA"E8;<2.&PK*R*JH%(?')XR2<5J64>K:
MEX[\26DGB'44M-+ELYH88A&-P9"[(WR\J>1C@^YP*Q=*\/Z@;-8((/&&E:M@
MLRB_'V**8DDD9=E,>XDXP21V)KT.P\/VNGZU?ZM%).UW?A/M)9\J^P87"]L#
MCC\<T <=H=SXF\0:5H'B6SU"UA2XF26\26\9HGA8D-$(_+PKJ< $'.1R3FDM
M;OQ-XETDZYI5_;6DT5_*")[QA$L,<K*T4D0C(Y1<[LYR<Y X'0Z?X!T/2]6>
M_LQ=QHTQG^Q"Z?[*LI.=XBSMSGD=@>F,"A? .AQZ[/JL0NXFN)?/N+6*Z=;>
M:3^^\8.UCGGG@]Q0!S5Y+K%U>>/HO^$@U"%-*5);/RMBE";?S,'Y>5W=NXZD
MU+9ZEJ\>J>!=0EU:YF&NQ$7ELP40\VQE!10/E(8=<\UU1\)Z>9=9D\VZW:RH
M6\_>_? 78,<?+\OR\=O?FFKX0TY1HH$MUC1ABR_>_<&W9SQ\WR_+SGB@#EM.
MN_$WB71[3Q#IM_;6K"\=Y1->,(O(21E:)HO+(!VC[V<YYSCBJ6HW6N/8>/[E
M?$6H1MHDK268C\L8VP+(%;Y>5R<8XZG.>W70> =#MM<FU2 7<7G3?:);1+IU
MMI)<YWM$#M)SSZ9[5,_@W39(-9A:2Z,>LDF]'F_ZS*[3CCY?E '&.* .<A$F
MH?%31;J2ZN4,OAUK@QI*0@;S8<@#T/?UP/2NN\3-J:^'+PZ,%;4-H\E6<)N.
MX94,> Q&0">Y%0?\(GIIO=,O";G[1IT!MXG6=E+19!V/C&X953@^G.:TM3TZ
M'5;![.=I5C9E;=$Y1U*L&4AAR""!0!Y9XBUNWU?X:^,8XY-2AN+>")9]-U('
MS;1BWJ2=RMU!R>A]@.F2YO\ 2/B']@EUB>>SNM'FNW%UMV0R1R( R@ ;5PQR
M,]NO>M:]\&:9J=EJ%M?/<W!U%8TNIFD"O(B9V)E0  "2> .ISUJ>X\+:?=ZH
MFHW3W$TZVCV9WO\ *T+XW*0!SG YZT <CHVKZE'XF\)Q?;[RZMM4M+EKB>?B
M.Z9$1UDCC/,:\G'"Y!''>LN[_P"2:_$W_L*7W_H*5VEEX T6QETJ6-[]WTO<
M+0R7LC>6A &SK]W ''MSFICX)TIM)U73&>Z:UU69Y[M3+R[MC<0<9&<#@8'%
M &Y8_P#'A;?]<E_D*X.+7+NU\71Z=KSZA8RSZA(ME=(^^SO(CN$</'".!C@@
M$E>ISBN^MH!;6T4"N[K&H4,YR2!ZUDIX6L5GC=Y;J:&*[:]CMY9-T:3%BVX<
M9X+$@9P/2@#A;S7=7A^'/BF^34K@7>G:W-;VTVX;EC6=4"GCD;21S6Q>1:MJ
MGQ(U+1T\0ZA9V2:;;W2+;B,%',K@@$J?E(7G.3[XXK2O?AYH5^NIQS?;?LVH
MS>?/;)=.L7FY!+A0>&)49/Y8K4MO#EE:Z^^M1R7)O'MUMF+S%E,:DE5(/H23
MGKSUH Y2+4]1TW6O$?ARYO[B:\G\N;2))'Y$4OR8&.HC<$D]2.M:+S7L'Q,L
MM(_M&ZDL)=%FD,3,/]8LD:[\@ [L$]3WXQ717&BV%UK5EJ\T :]LHY(X)/[H
M?&[^7ZGUJ*30;27Q'#KK//\ ;8H&MTP_R",D$KM]R <]>* .0T74=18:CX6O
M-1N9-9M]4$:W)?#M:M^]63@8'[L,O3&X#/6EEG\0^)I?$,6C7J6ESIUZ;2U9
MKMD$11$.YXQ&P<,2?O'ITP02>S&BV"Z^VN" ?V@UL+4R]_+#;L?F:R-0\!Z+
MJ.NR:PWVRWN9U5+H6MT\*72C@"55(W#''TH Z"S>62QMWF:)I6C4NT)RA;')
M4]QZ5-2*JHH55"JHP !@ 4M !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 07M[;Z=8SWMW*L5O!&9))
M&Z*H&2:R;GQ!);>,]/T$V8,=[;37"W/F\CR]N5VX_P!H<YK'^+<$4_PPUKS4
M#>7&KKGL0XYJEK.E64WQ'\,:>%9;3^SKX-'%(RY&Z(D$@YQD\C/Z4 >A45X]
M9ZM-IV@V6FR7ODZ8/%%UIKS7)9U2%3(8XV.X':6"CEN@P>.*[OPOHYT74]7A
M75DN89FBG2QBB*1V>00=N7;AB,[>,8]Z &>(O%E[X?L]6OSHC3:?IH!>8W(0
MR?*K':NT]-V.2.0:OZ7J^HWMW%%=Z1]FAFMS/'.EP)%/*_*> 0<-G\#65\4_
M^27^(?\ KT/\Q1XJU.YT?X837]H[1RQ6L.9$!)C0E%=ACG(4L?PH Z^BO/CH
MD4$]SJ-GKT(MKS2Y0+2P5XUFP-PG#"1B&&0-PZ[@">:YF[TB*W^"=IKT=WJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW)(,1]5QT/N*T** (KBVBNK9[>9=T3C:RY(R/3BL9?!7AM+/[&FCVRVN"/(
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MH634/^/M6&X3]LMGJ?>GP>'](MKBSN(-/MXYK*)H;=U3!C1OO ?7_'UK2HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN21[=S@4 7**SM(UA-7CN2+.\M);:8P2Q74>U@P .002K @@@@D5HT %%%%
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M#<Z@C&)6 #8(C!)(4#+9/'N: .TKA/B_N_X5]-LQN^V6N,],^>E=%_:&N_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%P">,  X'I3?!TEQI_B9-&UC2(;/55T\M'>63[K>^B5D!<CJK@D9SR=QYZ4
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M5Q801:C:6B0.ZG< P4!RA[!B,G&,]ZU8-#TJU>[>#3[9&O,_:2(Q^^SP=_\
M>_&N*U/QRVI^&M%UO1;M[6&?5[>WF5XQ\T+S;.2PXRHSQTSUKL=-\0Z1JXNC
MI^H03BT.)]K?ZOC()SV(Y!Z&@ M-$L-(AD.DV%M#-Y6R/C P/NKGDA<]AP/2
MJF@6.J-<2ZMKT5G%J4L2P"*T8ND4:DG[S $DEB3VX4<XR;EEK^E:C>M9VMXC
MW*QB7RB"K-&3@.H(&Y?]H9%9/B3Q%<VFN:1X<TH1_P!IZF7;S95W);PH,NY7
M(R>RC.,]>G(!I7WAC0M3U.'4K[2+*XOH,>7/+"K.N.G/MV]*75?#&A:Y<07&
MJZ19WLT'^K>>$.5[XR>WMTJM/9Z[9S6;VNJO>PFX074=U#'N\LG!*%%4#'!.
M0>,XP:M7'B+2+6Z^SSWT2/YHA+'.Q9#T0O\ =#'(PI.>10!J  # & *SH] T
MF*\-VEA LS2F<L%ZR'J^.F[_ &NM07OBK0=.N+BWNM5MHY[=!)+%ORR ],@<
M^O'7BF1^+_#TUS96\6L6CR7H!MPKY$F1D 'IDCH#R: )3X7T(V]U;G2;,PW;
M^9<1F(;9F]7'\1]S23>%M N+E+B;1[&29(?LZR/ K$1XQMR1TP3^=5KWQQX7
MTYI5N]=LHS%+Y4@\T':_H<>F1GTR,U>O=?TNP6,W%XG[R(SJ(P9"8QC+X4$[
M1D?-TY'- #8_#>B1-9-'I5HC6"E;0K$!Y /79_=SWQUJ>RTC3M.GN)[.R@@E
MN6WS/&@!D;U8]S[FJT_B?0K8V8FU:S3[;&9;;,H_>H%+%A[8!.>E0CQAX>.D
M?VK_ &K;_81+Y!G)(59,XVGC@^Q]10!H:GI.GZU9-9ZG9P7=LQ#&.9 PR.AY
MZ'WJO9^&]#L&G:TTFRA:X3RYF6%<R)C&UCCD>U6GU&TCO+>T>7;<7*L\494Y
M8#&3T[9&?J*M4 9FC^'-%\/K,NCZ7:6(F.Z3R(@NX]LXJ[%:P0SSSQ0HDLY#
M2NJX+D  9/?  %4I?$6D07\=E+?1I/++Y*;LA6D_N!L;=_\ LYS[5'_PE.B9
MOA_:,6; JMT,',)8X4,,<9[4 2MX?TA]0>_;3K8W+LKO)L'SLOW6(Z%AV)Y%
M32Z1IT^J0ZG+8V[W\"%(KEHP9$4]@W4#D_F:9?:UI^FHC7=QY>]#(JA&9]@Z
MMM )P,C)Q@9YKG]8UVX'B7P>=,U%'TS4YY5E6,*ZS(('=2&QGJ!T- &S:>&-
M"L-6FU6TTBR@U";/F7$<*J[9Z\^_?UK0NK6WOK66UNH8Y[>52DD4BAE=3U!!
MZBL]O$VBII]U?MJ$2VMG*8;F0Y A<8RK\?*1D=?6IM0U>QLD5)KORY)49XPB
M&1]HZOM )P,C)Q@9&: '6VC:;:1S1PV<069!'("N[>@R ISU49/'3DU4L_"7
MA[3VMFM-%L86M69H&6%<QLV,D'L?E S[5R_AKQ)-J?@;0[W4O$L=K>7>HO&L
MWEQYNPMPZ")5QCYE"C*C(ZUTM[XQ\.:?)=QW6L6D<EF5%PF_)C)S@$#V!/MC
MF@"S!X=T:VO3>0:9:QSF0REEC ^<]7QTW?[76G-H&DO>O>-I\!GDD661]OWW
M7&UF'0D8&">1@8J2;5[""&VE:Y1ENO\ CW$>7,W&[Y N2W'/';FFZ9K>EZTC
MOIFH6UV(\"00R!BA.>& Y4\'@^AH ;-H&CW%Y<7DVEV<ES<Q>1/*\*EI(\8V
ML<<C'&*KV_A/P]:&$V^BV,30QM'$R0*"BM]X X[U+=>(]'LKIK:YOHXY$=(W
M)!VQN^-JLV,*3D8!(SD>M17WBWP_IL]S!=ZM:QS6RAIH]^60'.,@<YX)QUP,
MT .'A;05M+:T&D68M[63S8(A$-L3_P!Y1T!]Q4SZ!I$EY=7CZ;:FYNHQ%<3&
M(;Y4'&UCU(P!^0IA\2:/YVGQ#4(6?45WV84Y\]<9RF.O'/L*MQ7]K/?3V4<H
M:X@"F6/!RH;IGZ\_E0!0D\*>'Y;>SMY-&L7ALR6MHV@4K"3UVC''TI3X5T!K
M9K8Z-8^0TYN6C\A=IE)SO(Q][WJ'4/&GAK2I+F.]UJSADM2JSH9,F,MG ('?
MY2<>U7I=:TZ*R@O#=H\%P T#19D,HQG*!<EN.>.U $5QI%K%//JECI]HVL"W
M,<,T@P6P/E1G )VYQ4&@6.HK)/JFM1VJ:I<I'$T=JQ9(HTR54,0"?F9V)Q_%
MCG&2YO%OAY;2TNVUFS$%V2L#F4?O",YQ],'/ICFJMKX@TS6=8TJ33/$D+Q30
MS.ME&%;[2 0-^2-R[2".V<^U '1,JNI5@"I&""."*QK7PCX<LFMVM=#T^%K>
M0RPE+=08W/5AQP:FD\1:1#>+:R7T2R-+Y )SL\W_ )Y[_N[_ /9SGVIFN:U9
MZ=:W$3WXM[D0-*"J;S$O]]A@A5SW;B@!P\,:&+6ZM?[)M/L]V_F7$7E#;,WJ
MP_B/N:T8((K6!(((UCBC&U$48"CT%<OX2\2BX\#Z%?ZO=&2]O+03.5B)9\8W
M-M0< 9&3C R/6NFM;J"^LX;NVE66WGC62*1>CJPR"/8@T 4[SP_I%_>?:[O3
MK>:X*>6TC(,NG]UO[P]CD4^]T73-1N+>>]L+>>:W.87D0$Q'U4]C]*B3Q%I$
ME[':+?1>=*[1Q9R%D=?O*K?=9A@Y )(P?2N<U+Q!-JGC&[\,V&K2::\-BLB7
M$4 <F=G90"&4@J GMG<>: .V*@H5(^4C&*R/^$5T#[$UE_8]E]E:3S6A\D;"
M^<[L=,YYS5N2]CTO3X'U.ZC\S"1LZH1YLA'14&3DG.%&37&:9XGDO)?&HN?$
M*VUE92I%:WDD2)]EW0@G((&2KD\-SQB@#KVT#2&NY;MM.MFN)H?(DE,8+/'C
M&PGNOM3['1M.TQMUE9Q0ML$8*C[J#HH]%]AQ4']M6%C8VINK_P TO;B7S1&2
M70 9D(4?*O()/ &:+OQ)I%E'')/>H%>#[2-JLQ$7_/0@ X7G[QP* +M[8VFI
M6DEI?6T-S;2##Q3(&5OJ#3+'2['34=+.UCA#XWE1RV!@9/4X''-<KKOB<Z5X
MQ\/,^K11Z'>VES-+D)L;8(RC!L9.=_0'GBK^I>)=(O\ PA-J=CXGMK&U<A$U
M%-KB-LCC:W!;M@C/- %NW\'>&K79Y&A:?&$F\]0+=<*_/S#CJ,G'IGBK5OH&
MDVER+BWT^".4.TH*KPKMG<P'0,<G)')R:QKW4[^W^)6E::+L_P!GW.GW$SP%
M%QO1HP&W8ST8]\5!<>,-/T/PYJFL2ZS_ &Q"E\\<1BC&(V) 6'*#!"DCYCZT
M ;3>%M!>VN;9M(LV@NI/-N(S$"LK_P!YA_$?<U871-+34(K];" 7D4?E1S[!
MO5/[H/7'M4=OXATFZU)-.AO$:]>+SE@VL&,?3=@CIGC/KQ5JTO[6^:=;:42&
M"0Q2X!&UQU!SWH I6/AC0M,U.;4K'2+*VO9\^9/%"JNV>3R/7OZT^T\.Z/88
M^RZ=;PA49%54X16^\%'10>^,9J?5-5L-%L6O=2N4MK5" TLG"KGID]J5M2M$
MFMH6EVR72EH5*D%@!D]N,#UH BL-#TO2W5K&QA@*)Y:;%QL3KM7^ZN0.!@<"
MK5W9VU_:2VEY!'/;S*4DBE4,K@]B#UJC9>(](U"[CM;6^CDEE0R1#! E0'!9
M"1AP,CE<TK>(M(6_CLFOHA/)*84SG:T@ZH&^Z7X/RYS[4 "^'=&26SE32[17
MLE*VK+$ 80>H3^[GOCK49\+:";.XM#I%F;:YD\V>$Q#;*_\ >8="?<T]O$>D
M+?+9F^C$S3_9AP=IEQGR]^-N_P#V<Y]JHVOC'2[S6]7TM9_);30HEFD!50Q4
ML>2,8  Y[YH TAH>EB^@O186_P!J@3RXIM@WHO\ =!Z@>U0V?AC0M/U:;5;/
M2+*"_FSYEQ'"JNV>O/OW]:ATG5;2#PS8W=QK:ZC'( J7VP*;EB3C:JCDGL .
M<5*WBC0TTN?4I-3MX[2W<QS22-L\IQU5@>0WL1F@ T'P_::!'>+:0PPB[N3<
M/'"FQ%8@#@?\!!)[DGIP!/?Z'I6J75M<W^G6MU/;$F&2:(,T>>N"?PJ.Q\1Z
M-J6I2Z=9:C!/>1)YCQ(V2%SC(]0#P<=#P:U* ,@^%O#YTY=..BV!LEF^T" V
MZ[!)_?QCK[U:&CZ:-4_M06%L+_R_*^T^4/,V?W=W7%07GB+2+"=H;J^BB9'5
M)&;.R-FQM#M]U2<C )&<CUJ'4_%WA_1KB6#4=7M+>:&(321O)\RH2 "0/<B@
M!^G^%= TFYN;C3M'LK6:Y!69X80A<'J,CM[4#PKH LH;(:/9"UAD\V*$0C8C
MYSN Z YYS5^YOK:TM?M,\RK"=H#==Q8X4 #DDD@ #KFL76=>TZ70+F:'Q FE
M;)EA-T\8W1R J2FQQ]X@XQC/S4 :3Z%I,E]-?-IUJ;N:+R9)S$-[I_=+=2*9
M_P (YHO]E+I8TNU%@C!TMQ$ B,#D%1V(/.13]1UO3=)S]MNEB(0RL I8J@ZN
M0 2%'=CQ6%/K-V?B'HMI;7ZRZ3?:;/<>6BJRL5,>U@P&2,.>^* -Q] TB739
M-.DTZVDLY6W20N@99&]6S]X\#D^E*NA:4MY;W@T^W%S;IY<,VP;HU_NJ>P]J
MET_4[/5;87-C,)H"<"100I^A(YKG]#U6]D\:>++&]O?,L[#[*T 9541*\;,V
M2 ,\]SZ4 ='?6-IJ=E+97UM%<VLPVR12J&5A[@UGIX3\/1Y\O1;!,P?9CM@4
M9BR24Z="2<COFI;3Q#I-]=26L%]&9XXO.:-@4)C_ +XW 97_ &AD>]-M/$FD
M7\QBMKU9)/)^T*H5@9(O[Z9'SKTY7(Y% "CPWHJ_8\:7:C[#_P >N(Q^X_W/
M[OX5!=>#_#=[=W%U<Z'833W./.=X%/F8[MZGWJ>#Q'I%UI+:K!?1RV"ML-P@
M)7.<'G'KQ]:+_P 1:1I;[;Z^C@QMWLX.V/=]W><83/;=B@#1BBC@B2**-8XT
M&U408"CT [4^CJ,BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** .4^(D%]-X4,MA;373VMW;W4EM Q
M$DT<<JNRKCG.!D8YXXJEH-WX<O[R[\0:9::@'%EY$][>_: 0,Y$0$I^8@Y.5
MSCIGFNXHH \???\ \,WI8^5*;T620FV$;>;OWCY=F,YP,].G-=-J%TUC\2-*
MUV=B^AW&E262W"@E+>8R*^7/\(8*!D]UQ7=44 >.:SILD6@Z]<^1*;+4O$EO
M=6T'E,2T:O%YDFW&=K%6/3D#/>NL\4N+;QKX.U(03/9H]VKR00M( TD0"9V@
M_>(ZUV]% '(?$Z&:;P'=^3#+*T<]M*RQ(7;:L\;,<#DX )_"J,5^=/\ B3<Z
MK?B5-*U/3(H[.ZEB95C:-V+1MD?(6W;AG&?KQ7>T4 <E\/=,N-,T6_\ -C>&
M"ZU2ZNK2!U*F*!Y"4&T_=R/FQVW5R=VSP>&?B9IDEM="[N+FZFA7R'Q(LD**
MFUL8))!P <\'TKUFB@#SB7#^+/ _V7*!-+NHFD5#MB9HXP@;CY>5. >XK-\(
M_P!EWEAHF@ZOH^KGQ!I$T1:"9[CRHY(SCSP^?+VXR1ZYP <UZS10!R?CJ^^P
MQZ*[69DB.HIONQ;F8V7RMB0* ?FYV@D$#=D@]*Y"U=H_!_Q*M7BO_-N)[IX?
MM%LZO-YELBI@;1EF(/ &1Z"O6Z* /-O$4Z/X%\(A [M'?Z<[HB$LBHRERP R
M-H'.>E0>+[PW5]XKL([.XA>?10+>6TM&D;4<QR<&0*0%0G&.#\QYQQ7J%% '
MF<$ZRZU\-9?+F58;.=93)"R^63 JC=D?+E@0,]>U2>'([)_#WCH7EG++%+J5
M_*\:1D230LF,IQD[AN (KTBB@#@_!C:E:^()=..I#6](2R#V^H2Q;9X#N $$
MC# 8X^;D!ACD<BI;J:71OBH^HZB&72[W2UMX+H@F.&5)"S(Q_AW @@GKC':N
MWHH \?U33KBQ^%WB=3!,$U'6FNK&U$3;Q"9XR,)C(!VL^,< UZ[%+'/$LD3J
MZ,,AE.0:?10!XM:,1\+/"VFS6ERMQ9:Q;+<PR6SC:%N"7SD<@#DGH,BM3Q%:
M7FI^(/'%OI:,\]UHULD. 0L[H9"R!NA.T@=?XJ]5HH X/PS>:!XAUFRU*STS
M5AJ=K$Z2O?FX'V0,/FC)D.UB3C@9Z9XQ1XNL;K3/'6@^,(;::ZL[6*6SOHX$
M+R1QORL@4<L >N.<5WE% &5:>(;'4GC73'-X6(W,BD+&.Y8D8!]NI/;J1YQ%
M#/\ \*R\0>$=1MI9->::Z2.(QDFZ>61GCF4]"N6!+?P[3G&*]<HH \_TM#9?
M%"0W<F]H?#MO;R7+*=K2+(Y<;CQG!!(ZXKF+%!#\*O"<'D2)/!KL,LD7E,'C
M5;IF+%<9 "D'/H17L]% 'F5G=Z5'XI^(D%\BR?:&@41>7N:X4VJC8O'S'G[H
MYYJEI<-YH46B:%J-I<072^'Q&;RWMC-),^[FV#@$*%X)_#!&.>^T?P^^E:YK
M.IM>"8ZI(DLD?E;0A1 @P<GC:!G/>MR@#Q[P\P:W^%BS6\Z&S6=9Q- R^4?L
M[*"<C@;\ 'H2..E;VA:3:Z\OCW2;M&%M?ZDY4E2-RF&,"1,]<,IP1W%>AUFZ
MWIUWJ=DL%GJUSIDJRJYGMT1F('5<.",'Z=J .:\%3ZG<V$VK>((V%UIT3Z=E
M1O\ ,\IB)95QR=[*O'_3.NFT/6K/Q#I$.IV)D\B7< )8RCJ02""IY!R#4]E8
M1:?IT5E;EUCC3:&)RQ/=B3U8G))/4FI+6UALK<00+M0$MR2222222>I)))/O
M0!Y3H*Z=+9KX7\1:5J\^N6MZ[K"6N?(F;S2Z3JZG8J\Y)..<\$\&[XG'E^)!
MXRTZT:>WTV>.TO[94;?>J#]]5_B,18%21SAO[JD^GT4 >=W>NQ:'\09M4U&"
MZFT75M-ABM;J*VDF6-T9R8F55+ MOST[8[<+JB6]OK?@);73C86L%U._V=8M
MH@C:%U4L ,)DD<'H3CM7H=% 'CFM2O:^'/B1HKVMVVH7=Y+<P1);NPDB>.,!
M@P&W&5(Z]1CKQ6]9ZH=&^(=S>:I!=K8ZGIEM'83FVD(1H]V^(@+E6);=@@9K
MT6B@#QBQW)\-?"\#6MS')!XD25HWMW4K&+MW+X(^Z%()/09KH5:$>,/'TSI\
MDVGVR1N4.),1R!E4X^;!*@@=R*]&HH \@@OHM$T?X<ZG.;A)[/3Y+>5&MI70
M#RHU=7V*S(X8+CY<<-GM78?#V72GTJ^&FZB+R66^FN[H>4\7E22L6VA' 8+V
M!/7!-:.K^';F^U>'5;#6;K3KN.$VY"HDL;H6W<HP.#D#D$'CO5_3M--CYDLU
MU+=W<H427$H4%@N<* H  &6P,=SUH \K\974EYIGC"S2PN[6XCOH76VMK)B+
MI%:(_:'DVG.0IP 1C;SDUTUI<6[_ !3U:^=&2!]%@19)8BHR'D9EY'7!4E>O
MJ*[VB@#RC2=)NKKX)Z+<6J&+6=$07ENLH*LLD98F-@>0&0E<'^\*[SPLLLVE
M'5+J%H;K4W^UR1MUC4@"-#[J@0'WSZTNM:#+K5U;[]6N[>Q562YLH@FRZ4XX
M8D$@<8.",@GI6U0!Y[;7NFV7Q3\7?VB8U$EA9*"Z9#+B3<@XY)X^7J<=#BN9
MTNQN_!EEX5NM;M-2&E)9W5O+]E,N^Q:682Q[Q&=V-H"GK@CZ5Z98>'WLO%6J
M:X;P2'4(XHWA\K 01[MN#GK\QSZ^U;E 'E>J6NDP6WA=]+TVYM[*3Q(E\PG6
M5G92CAIF5\L@+$=<=CQFM_6=J_%+PL40A([2]5V5#M0OY>T$] 3AL>M=K10!
MX]%;7,_PAO?!MW;RGQ(DLD(A9#NEE,Y=9U..4Y#%^@P:V;*]DT'Q=XIL];2Y
M=M1CA>RN%MWD6X18=A0;0<$-D[?]HGO7I%% 'CVC6Q?P?X2>'4[SP_K5IIK+
M#<SVY$+#*[HI5< $$A2/7&1G%>@:*^J:EX!MO.MDTW4YK$H(D!587VD+@'E1
MT.#R.E=#10!Y(L$NK_"_0_#,-M-;^(;*>TB:%HR'MGAD7?,3V7:K$-T.X $D
MXKI;.9/^%P:H_P P1M)MX5D*D*TBR2$J&Z$@,.*[:B@#A_&<\^E^+O"NM3PS
M2:/:O<1W3Q1E_(>1 L<C* 3C[PSVW>]<[<SK=6OQ2:&WNMEY;K]F8VLBB8FT
M"@+E>26[=3G->M44 >8:C&6MM(O=,UB;2-9MM'C\N26+?;72\Y@=2/O!EZ#Y
MOF. <5%=ZA=7,HMKS1I]+N[CPY&!]DM&D>9R&S;AMI"*A/3@_-U '/JE% 'D
MVDR+;GX::A=P3PVEGI<UM/--;NJPRF*)0&)'RY*L 3@''!J#Q%I<J>#/'U[;
MVLJ6VKWD3V5NL1W2E1&'D"8S\S!CTY STKV"B@#B=0GCD^*V@3H2T TRY4RA
M24!=HRH)Z D*<#VKD[N&:X^'/CB."WGDD/B"2Y6-8F+/%]HB;>HQDKM5CD=<
M&O8J* .&\9-*EKI7C32+>6:YTV7#0E#&]S;2D(Z8;!SG:RY[CWK4_M&T\&Z'
MIR:LTIENI]DTL,3.OGR$N[' ^5=Q;D]!BK=WH$M[KT=]/JMVUC&$8:: @B,B
M'*N3C<<'!QG&0/3%:=U9Q7J)'."T:N'*9P&(.1GU&<'% $6JZ;;ZSI%YIEVN
MZWNH6AD'LPQQ[UQ_A(:P^@3W&LV+S7NE6TNFQ1-_R]&,G<X]I-L8^JGUKO**
M /(-'NS<Z]X#NT@O41+>Y@D@2P>.&R=HD B4;<X!!!))Z9R!6CX*U"W&B:9X
M6UG1;F77M,N<M%-:,4#JY(N1*5VXP2V<Y).!G(SZ=10!XUJ5Z]U%;O\ V?>V
MCV?BJ*:>QM[%]D:"?)F9@I+LP^;@X^;@<9KJ]'N!8_$'QC]JAN(DNQ:SQ.T#
M;&18 K'=C'!&,9SFNZHH \<\/)>:=X=^'&IS03_8--\^'4(_+;=;O(A5'9<9
M &2">P;/2I_%%C+=6GQ!U:S1WL=0T^"W@"(3]JG56!9!_%@%5R.N#Z5ZY10!
MP$DD/_"Q/"DL*GR4TJXC9T0[5)\K:I('!.UL#VKJ] U^Q\2:;]OL/.$6\QLL
MT31NK#L5/(X(/T(K4/2H+2TBLXC'$#\S%W9CEG8]23Z__J' H \SM]]KX5\9
M^'-6MY7U.YN;Q[>/RRQO5F!,31G&#U _V=O.,5;T6RDLOB'HUKJ(\^:W\+I9
MS3,A93,'7*[L8R0"<=2*](HH YSQK;6=WHD4%Y/=VJM=1F.[M,[[:0$E9.AX
M!&#GC!YKAM;GUBY^&GB&UU(QW\Z7\"6]_:6Y7^T%#PMY@09R0 02O'R''2O7
M** /.Y]7AT#Q_K,FLVMS-I>M6EN+.XAM7N$;8K*T)" G)+%@,8.XUD^*M-N[
MWQ#H-GHL8TJ2+29TCA*8B3YHF2"0CA0ZJ5(!SUP3W]:HH Q/"FNP:_H-O<Q6
MDEC(J!);.2,H8&'&T# RO'!'!%<+J]G>ZEJ/Q*M=.C=KFYMK06ZX*B?9&0Z*
M>A_NG'0FO5:* /-;74-"UR";5].\/ZO>ZK9Z?.LD%\;@>7E#F#]X2K,QP,#/
M<^F:6A7?G^,O"%XL=Z\+:7/;D"Q>*&W<^5B)1MX5<$9)/3K7J]% ' :7I%]8
M>,]2T(6[?V%+<KK,4O\ "K$G=#[?OE$@'IGUK)FDT^UU[Q)H?BG3M7G74[LS
MVGV;[0T5Y$Z(HC_=G:&7;M.['&.<5ZK10!!90BWL+>%8O*$<2H(]Y?9@ 8W'
MKCU[U/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '/>-]?N/#'@_4-7M;5KF:"/Y5!4!2> S9(R
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M<L0 !QR2.H'4BN+T[PYJ%MXILM5TW3[K1I)KAVU> 3HUI<H5;YU0,<.6VD8
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MEE&WYLA@,Y# #@\D\4 =[<>)K>*]N[:&SN[K['-%!<O"$(B=PI&06#$ .I)
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MJ?;+87HLC<1?:C'YH@WC>4SC=MZXSQFIJYE]6<?$0Z0-+M#-_9+W45Z9/WC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<\=ZOT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !67<^'-'O+A[BXT^&25SEG8<FM2B@#&_X1/0?^@7!^1H_P"$
M3T'_ *!<'Y&MFB@#&_X1/0?^@7!^1I&\):"5(&FP D=0.E;5% '*Z1\//#^C
MQW");O<B>9IB;C:2K,<G&T#C/:M'_A$]!_Z!<'Y&MFB@#&_X1/0?^@7!^1H_
MX1/0?^@7!^1K9HH QO\ A$]!_P"@7!^1H_X1/0?^@7!^1K9HH QO^$3T'_H%
MP?D:/^$3T'_H%P?D:V:* ,;_ (1/0?\ H%P?D:/^$3T'_H%P?D:V:* ,;_A$
M]!_Z!<'Y&C_A$]!_Z!<'Y&MFB@#&_P"$3T'_ *!<'Y&C_A$]!_Z!<'Y&MFB@
M#&_X1/0?^@7!^1H_X1/0?^@7!^1K9HH QO\ A$]!_P"@7!^1H_X1/0?^@7!^
M1K9HH QO^$3T'_H%P?D:/^$3T'_H%P?D:V:* ,;_ (1/0?\ H%P?D:/^$3T'
M_H%P?D:V:* &0Q1P0I#$H2.-0JJ.@ X I]%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY@GG@U&TDBM^)G692(N_S<_+QZU%;^(M$N[R*TMM7L9KF6(31PQW",[QD9#
M Y(QSGTH TZ*SCK^C+927K:O8"TBD,4DYN4V(XZJ6S@'VZU)>:QIFG/LO=0M
M;9MH;$LJKP3@'D]">* +M%4K[6-,TL@7^H6MJ2-P\Z54X]>3T]ZQO%WBNV\/
MVNGJMW;1S:A>0VZ/)(O[N-V^:7!/("YYZ9QF@#IJ*R]"34%M9FOM2@U")Y2]
MI<1(%+0D KNQ\I/7E< C%:E !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M (B@#D1+I\7C_P $_9'MT5M+N8SY1 !!$14<>I#8'L:YC3=1\/S:?I/AV_\
M$&G01Z9KCW0>Z9DN) LTC!71E 4L6P3N/';)P/5&\/RLI7^WM7&1C(E3(_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT1BE:)TF3:RL.O\ /J.#VK+\1ZQ):W^CZ+:/LO-6G:-9 .8XD4O(X]\  >[
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M,TGDP/+L=]BEMJ#+''8#N:X_Q7:/J'C3P;9P#_CUN9KZ4C^"-(]HS]6=1_\
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M7<:C?R^5:P+ND?!..<  #DDD@8]ZS1XMTY?[32YCNK:;3(5GN8'A+.L; E6
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MMI+;7Y?*@5KED:$E2R[R$;.54YP!@\9/6NKUO5[70-$O=6O2PM[2)I7VC)(
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M8/RG*Y4\]<?PGI5^P\2ZPGB>PT37-+M+-[VS>>*6&Y:0/(A&Z,94<@$-UZ4
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M_P#".R7#S1[XG^U6ZNQ9HT(.W&2<,>1GI7;U#<W,5I;RSREMD2[WV(78#_=
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MU7P"?$%OKD]_<);ZCJ:P")[?+K:^2=T>"0"WS9)X&0<=LUVRJ%4*H 4#  '
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M4GOEEWN5C#2B0J1MY(VXSWSGC&#Z%5/2]2M]7TZ*^M1,(9=VT31-&W!(.58
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M)4 MG@D\UT'A_6;\^+-;\.:C(+EK%(;BWNM@5I(I ?E<* -RE2,@#(["HHO
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M;\PSV@V!(FD7:[1X7()ZG)(SS6=K4$=GX='@MX=3U>>_LV@BGDM\QC@("[H
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M=?W9NIXYO/,/V=GCN9(]T>2=K;6&1DGKZU?@@BMK>.W@C2.&)0B1H,*J@8
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MX(MWEQJ%7<Y8X^I))_&LS3?"^C:1?3WMC9"*XFDDD9M[, TA!<J"2%W%5SM
MS@5KT4 <Y)X"\,2M.7TF,^=<"Z8>8X ESNWJ,X4D]=N,]\U:_P"$4T8/J+BU
M<'4D"7>V>0"50-H!&[@ <<8XXZ5LT4 84_@[0KFVTZWELF*::"MH1/(K1*0
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M>HH K:?I]KI6G6^GV47E6MM&(HHP2=J@8 R>3^-6:** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***AN
M;N"T5&GDV[W"( "2['L .2>">.P)[4 345GZ7K>GZRUX+"<RFSG-M/E&79(
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M77],N[Y;&.X*WC(9!;31/%*5&,ML< XY'.,5I4 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAH6@N[A?(BV2H'^<9(^7YN_.!5W_ (0&W2&Q2"\:%K;5&U9MD(VR3MNR-O\
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MSO[J3PEK)9(="UM!#-&8P6@N67*#=_=8@KTZX]:M7'B;4(DMC$3-_:VIO;6
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M%N#;&(Y&1P<'C-2TR*)((4BC7;&BA54=@.!3Z "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **PO&.D
MW6M>%-0M+&XGM[[RB]M)#*T;"51E1E2.">#[&N!B\8(-=T7Q:HN1HMU9_8;J
M/SG*QWA3S  F<;ACR\]RV.HH ]/O;B\@ELUM+'[4DLP2=O.">1'@G?@_>Y &
M!SS5?5=;AT_3M4N(4^U3:= 9I8$<*0-I8#)X!P,__KKD=:M+K1SX(C-W="XE
MU=$N@+ERDA>.1V4@G!4,!C/0 5GV]A;077Q0D0.'7<!F5B/FM%8Y!."<D]:
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M?UO68=%M8)9%+R7-S%:P1YQOED8*H)[#N3Z \'I2Z1>ZA>)<C4=,-A-#,8U
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M_$=)K_4MEC#%-:HE[*HA?[,7R,-_>YQT]J /5**\YTJ^N[KQ5X+EFNIC]O\
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M@*H&236#XTN88-$ACEO+JW-Q>001K:X$D[,X_= DC:&P03D8&:\_U@3/X?\
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MM>+LG0%CO7^Z23G')XZ<U4L/$\E_\0I]'M[NQNM,73!=H]O\S"0R["K,&(/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6 8D@GIGC/:NZ\.>&YM)U#6+J\:UG-_?->QE(SNA+*J[<GKP@YX^E=#+#%.
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M5^+[OPG\0_#.NVE]?6UG?:)<3I#,TH5XG3@.,\E6Q@^N/4"N8N_$VMW/PO\
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M*"0?44 ):S&XM(9S$\1DC5S&X^9,C.#[BI:** "BBB@ HHHH **** "BBB@
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M+!+AEC4OM<_>(SD^OJ:T+?QGI5S<V<<?G^1?7$EK:W13]U-*F[<H.<C[C8)
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MUG:SI%_J>AP:KHGA9=,FM-2M;\6#I%#/>"(G<'VDJ.&^4$Y^4^HK3T\ZC?\
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M$9!89*CL03R,XJU#XIM]%\)R:CI&C*WAK39'@W1W!\SRHW*.Z(5(*@ANK D
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MG"H%^0?*H  .>0/NU<BU34]4\7>*M&O;6SDTNTM8%"&4DX=9&W%2F&+8 (R
M !C- ':12QSQ++%(LD;#*LAR#]#3Z\P\">);O2O"?@FRN-+ T_4(DM([L7 W
MB78S#,>W[IVD9W9]JV=1^(45G%+=VUG'>64%V;6417!-P=K^6[I$%.X!L_Q
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M(ZXR2!ZX;)XX$]R;73+*.:\_LZ._CM;J<P33*X8A47:<L-N#Z$@4 =?1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% &!XQ\.MXG\/26$-P+:Z26.XMIB,A)8V#*2.XR,'ZU6_L74
M]2\0:9K>J06<,^EV\R6\$$[.KRRA0S%B@PH"X P3\Q/;%=.S*BEF(50,DDX
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MR;I&$4*($5%!"Y8A4ZX&2Q]*[.?2-.N;^&_GL+:6\@_U4[Q O'_NMU'X5<H
MY-]"U6R\92>(]/6TD^W6B6]]:2SL@#H24='"'/!((('K[53FT/1=&\&:II7B
M"_MHSJ\EU=7)+A=TDA+-Y0/)V_+COP#WKIM8UVPT*.VDOWD1;FX2VC*1,X,C
ML%4$@87D]3BI-1LM-F\J]O[&&X>R)EA=[?S7B/<H,$@\#ISQ0!RT?@^\U'X9
MC1KZ^D36+I([F:\9<LMR"KJ2.^TJJ_1:E.A^)?$?A^_TOQ3/IL"7%J]N/[-+
MMN9A_K#O QC'"CUY-=)H^KV>O:1;:II\C26ERN^)V4J2,XS@\CI5Z@#F/#EO
MXPC,,7B*XTMHK9=HELBY>Z., N& "^I SD^@&#KZW!>W.E20V$=I+,S(&BN\
M^5)'N&]6^5NJ[AT/)K0HH Y?PAX6_P"$:GU5H8X[2RO)DD@T^&4O';D+ABN0
M,;CS@# P*P-&CU6YUSQ]::?%:$3WPC$LTK+Y;&WC&2H4[@ 0<9'3''4>CUDR
MV^D>'+6_U6+3HX?E,MPUK;9DEQW(498T <L/!NM^&M0TZ[\)3V,J1:=%IUU:
MZ@SHLJQDE) R D-EFR,8P:T;O0-<N?$?AG4Y);*;^S?M#71+LA8RKMQ&NT\+
MVR<D#GUKJTE21$<$@.,J&&#Z]#S5:RU*"_FO(H5F5K28P2>9$R M@'*DCYAR
M.1Q0!BW.BZI)\0K/78ULS8P6$EHRM,PD)=U;<!LQQLQC/>L:W\&:O9>&=6\)
MP2VC:1>R3""Y:1A+!#,270IMPQ&YL'<,YYQCGOZ* .5T_P .7NG^.6U2);5=
M+&E1:=&@F8RKY;,P.-N/XL=>V:RIO!^MR^'/&6FYT\2:[=2S0-Y[XC5T5,-^
M[ZC;GCUKOZ* .0N?#VL7'B+PWJ(-E%'IEI/!-B9F;=(J+E!LP<;,\XSGM6+I
MO@SQ/;/X:EN)-(:?2;J62XF$DC/=[XV0RL2H^?YA\ISG^\.E=[=:E!9WME:R
M+,9+QV2,I$S*"JECN(&%&!WJY0!YU=^"==N?!WBG1@VG+/K&HRW<3^>Y6-79
M3AOW><C;VZY[5?FT+Q/IWBV\UK0WTMXM5BB%];7DD@$4L:[0\;*OS#;P00,X
M_+J=0U2VTWR5F+O-.Q6&&)2SR$ L0 /0 FL_PYXOT?Q4;L:3/+(;0JLXDA>,
MHS9^4A@#G@YH QM1\/>)K'Q'!KN@WEA<W$MFEIJ$%^6C2;82RR*4!VD%FXQC
M!K1FNO$-AJ.AVN[3[N.X9Q?_ 'UE7/(,0' 1>02W8 =372U2U#4[?38(YYEE
M=))D@7R8FD.YFVC(4' SU/:@#(\6:)J&JS:)=Z:UM]HTR_%T8[EV59%V.A&5
M!(/S9Z=JSQX:UK^TO%]T?[/8:U;10P8F<;62(QY8;#@'=G@G'3GK7:44 >>1
M>$O$^CKX?U#1Y],;4;'2X]+O+:XD?R9XTQM97"Y5@<GIWQ]>XTV.]CLD_M&:
M*6[8EI/)!$:D_P *YYP!QD\GKQG%6Z;)&DL;1R*'1AAE89!% 'E7@[1;[Q-\
M)]*T>=+:/399R\TPE8R-&EP7VA-N 25QG/ YZ\5T$.@^*]$U_4SHESI<FD:G
M<FZ;[9O\VUE8 .5"C#@XR 2.?S/6Z?IMCI5J+;3K."TMP21%!&$4$]>!Q5J@
M#F-/T+4K3QWJ&L2M;/97-E#:J?-8S9C+'<1L YW^O:J2>$;V\U#Q@NI?95L/
M$")&I@F9I(@L/EY(* 9[]?SKHDUVP?Q$^A*\GV]+;[4R&)@OE[@N0Q&#R>Q/
M0UI4 <3!X7UB_P!+T#2M::R,&D7$,[7$$C,UR801'\A4;,G:6Y/0@=<B[X;T
M35M';Q$UPEDQU'4)+V 1SN<;D5=K908^YG(SUZ5U-9EYKVGV&IZ=IT\CBXU%
MF6VVQ,5<JI8_,!M' />@#CK;P7KEOX/\*:/G3FGT:^AN9G\]PLBQEN%_=YR=
MW?ICO4^K>$_$-YJ'BRYL;NTLVU>TMX+:59GWQF+=G=A1@,&(R#D>]=[10!P=
MMX7U^/Q!-J8AT:WAFT8:?]D@DD"Q,&9A@[!E?FZX&.F#UIEOX/UN#1/!EB3I
MY?09TDG;SWQ(%C:/Y?W?4[L\^E=_10!PVB^'/%'A^ZN]+LKO3FT">ZDN(IW+
M_:;=9&+/&JXVGDG#$\9R0>E.AT'Q7HFOZG_8EUI<FD:G<F[;[9O\VUE8#>5"
MC#@XR 2.?U[>LVVUVPN]<O-'A>0WMG&DDR-$R@*^=I!(PWW3TS0!1\6^&W\2
M>&6TV*[,-U&\<UO<.-VV6-@RE@.H)'/UJ!-%U'4_$6EZWJT-I!+I<$RP0V\S
M2!Y90JLQ8JN% 7 &"?F]JZ>B@#FO!VBZEH<.J1Z@+0_:]1N+U#;RL^!(V[:<
MJO(]:@_L'5[7Q?KFJ6AL9+35+6%"LLCK(CQJZ@<*1M.X'.<C'0UUE% 'GMKX
M-URW\.>#M-)T\R:%=QSS-Y[XD5$=<+^[ZG?GGTJSIGA[Q7H5_?:?IUYIK:#=
M74ES'+-O^TVOF,6=54#:W))4D\9YSTKN"0" 2 2<#WI: ,+Q=X9A\6:!)ILL
MS6\H=9K>X09:&5#E7 [_ $]":;9/XK>W6WOK;2HY0-KWD%P[ _[0B*#!]BV!
MZFI5\5:4^IVUBLDS-<RR00S"%C$\D>=Z!\8R-K?]\D=16U0!R<>@:IH_C#4M
M:TK[-=0:K#$MU#<S-&R2Q+M5U8*P(*\$8'3/M6;!X&O].7PPEG):2C3;Z:^N
MWD=D,KRAPVP!3P#(<9/0 >]=]2 AE#*001D$=Z .*?POK+2>-6Q88UY MO\
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M1/%.E:L;98=:N[F97MI6<HDPQ@[E7D8KK+2SMK"UCM;.WBM[>,82*) JJ/0
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M.$_V3*SX/<*M=9>V-IJ5I):7]K#=6TF-\,\8=&P<C(/!Y J:**.&)(HD6.-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[&/8-HVX;<F[<2V"0,5I:CX'LM4T?5;&YO;OS=69&O+I-@D<* %494A5
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M1M/EDCO=6L;:2,*76:X1"H)P,@GC)Z4^;6M+M[Z.QFU&TCNY&"I \RAV8C(
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MO<&25]D05X&!W;MNSL02I]*]"\117T_AG58=,8K?R6<JVQ!P1(4(7GMSBM+
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M@C?Q>Y#>OW.<^GM6M=ZAHZ:_XHT'Q9>WENFISB6V1$+)>V[1(JK&0I)8%2,
MYR>.<UZS1@$@XZ=* /-K"RTF3XK&RGMX'"^'+>(0W.V1MPE?*MG.7"[<]^]8
M]K<:/>PZIX5\37.HKJXU.:9;% 5:Z)F,D4D3!<XQM&=W 7G KV&C SG'/K0!
MXMXRU:RFTKQA;1$6,\&J6[S6H1GEGVO#_I#DYVQX QMP/EY)SBNNNM1LY/B_
MHK+<QX;1IP-QP<M)&5&#T) ) ]J[NB@#QZ>XG7PUXXLK1)I;Z#Q ]Y-:Q+F1
M[;S8F; QCYD#8SU /7FM">\\*Z[IVNZ]IM_<:A.=$FMIKB;Y8T4C*QL-JC?N
M)P.HY]1GU&D  Z#% '-> ;:P3P5HD]I#;K(^G6Z2R1J-S$(,AB.202W7N36/
MJ[:=;?%VUN=7-M%:MH;QQ2W>T1F3S@2H9N-VW/'7&:[ZD(!ZC- 'B\<<OA>Q
MT_5)EN[3PRNOWDZ&"/FVMY%*PR;"#A-V\]. X]:]!\&Q:*_]IZCH<UQ<P7TX
MEENI"=DTN,$H, =,9(&"?<&NHZT 8&!TH X#4XM,N?C/8PW<=K+NT29"DH5L
ML94P"#W*[N/3-8#W.BF^\2^%O%=S?02W=^\L%I''Q>0-M\KRR%)) 55P#QM'
MX>O48&0<<B@#S*SU6UTGQ=XKT_Q#(+>:\@@^P?:3D7$ AVF-#_$0Y;*CDECP
M:Q="U"TL-(^%FIWDZ6]C;PW$$UQ+\J1NT&%#$\#)!%>S$ ]11@8Q@8H \6DU
M!ETOQ%?6\4\]I:^,([Z]A6)MS6H6++;<9(!4''^S6]XDO=+UWPQKFL^%('OI
MY%MFO+FU5O\ 2(XY%)C7(PS"/?D8[@'KBO3.E   P!@4 >3:C/IGB;1];UGP
MA?7^I:TVCR6WGC*[$)#>60%'[P_-@=1@^V7R>(- U36_AW-I<\+);S2QM&@^
M:VS;,OEL!RIS@8/I7JP '08I, = * *6FZO8:N+HV$_G"TN7M9_E9=DJ8W+R
M!G&1R.*O48Q10!QEN3XJUO4[VQU&T-K;*=-5&A$P8'#2M]X8#'"^_E@]ZYCP
MUJ=O8^!O%7@^_O(9I=$CN((7=AB:W*DQD9ZD9VD#., 5ZU10!Y)I\FGVZ?"=
MHGMXW6$B0J0""UH0V?J^ <]_>M2XTV[T[QE?>'+>W8Z/XD;[<S*/E@*D"Z4^
MT@V#ZR&O1ZP]#T2_L;B6[U?5VU6]*F*.4VZPK%'NSM"KW/&3WVKZ4 ;G2BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHILF\1/Y04R;3M#' )[9/I0 ZBN/M
M)/$EAXYM;"YU6+5+"YM)9KA/LRQ&S92H0@KR58D@!B3\IY.#784 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !14-S=V]G&LES,D2-(L:L[8!=F"JOU)( ^M(]Y;1726LD\:SO&T
MJQLP#%%(#-CT!9<GW% $]%96F^)=#UBY>WTW5;.ZF1=Q2&4,=N<;AZCW'%:M
M !15:UU"SOGN$M;J*=K:4PS"-PQC<8)5L=#R.*I1>)]"GU3^S(M7LGO=Q3R5
MF4L6'51ZD=QUH UJ*YX^.O"@N/LY\0Z=YV[;L^T+G.<8Q]:U8=6T^XNA:Q7L
M#W!,@$:N"Q,9 <8_V2P!],B@"Y16;J'B'1]*\W[?J=K;>44$GFRA=I?.T'Z[
M6Q]#4>G^*-"U5PFGZM:7+%Q'B*4-\Q5F X[D(Q_X": -:BH7N[>.ZBM7GC6X
MF5FCB+#<X7&X@=P,C\ZIQ^(=&EOYK&/5;-KN$,9(1,I9=OWLC/;OZ=Z -*BL
M:Q\7>&]3N/L]AKVF74VTOY<-TCMM'). >@J>T\0Z-?VEQ=VFJV4UO;C,TJ3J
M5C&,Y8YX&.<F@#2HK,B\1:+-IDNI1ZK9M8PG;)<"9=B'C@G/!Y''N/6HYO%?
MAZWL(;Z?7-.BM)V*Q327**CL.H!)ZCN* ->BL9_%OAR/3XM0?7M,6RE<QQW!
MND$;L.H#9P2/2G7?BOP]8V]K<7>N:=!#=)OMY);I%65>.5)/(Y'3UH UZ*I+
MK&FM&KB^@*-,MNK;Q@R, 54>Y!!'KD5.]W;QW4-J\R+<3*S1QEOF<+C<0/09
M&?J* )J*AN+NWM%1KF>.)9)%B0NP&YV.%4>I). *FH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*YN$M+6:YD#E(D9V$
M:%V( R<*.2?8<FI:* . _L_3-<\:Z'XC\/0217"-(=0N1;O")(3&P".& W-O
MV8!Y&">PKOZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#F?'H9?#:7&UFCM;^SN9=JDE8X[B-
MG; ]%!/T%8>IZGI7B+Q)+<:?(=7T^UT&]BN_[.<2$F5HL1JP.-Y5'P,YXKT*
MD55484 #V% 'F_A_589/$6AV=IK6G^([=4D2-D@"76GH(S\TA0[0#@(054Y(
MZXKN-?U5-#T&^U-T+_9XBZQCK(_15'N6('XU<G@$T$D:R/"9!@R18##W!QUJ
MA:Z,]M<I,VK:C.%_Y9S2*5;CN HH \^TFQU[PS>PVUU;06KZS8O:-<171D\R
M_ >59&^1=I;=)Z]%':M/1M=\,#PIH.BM$EQJ$)MHO[*0 W,,Z%=S,A(*[6!8
ML<# )R<\^A4FT;MV!GUQ0!S)'_%T%_[ I_\ 1PKFXHS:Z7>Z_&#YFD>(KNX?
M Y-NTA28?@C%OJ@KTNC% 'E.K,T7AW3/$,]Y%I\^J:]%>FYN5RL$11UB# D=
M(U3(R.2:VI-434O#M_=0>)-.URYTQXKY?L"*IC$;;BI =OO*KKVZFN\P#U%)
MM'H* .0N["RC^).B:E;Q@SW=I=>9-N+;E AV@9/"]3@8&23U)K(TC6O#_B#Q
M/86NGW^G6MCI=U,]I:K,OGW<Y5U9@N<J@WR'U8G/  SZ/@#MTI-H'84 <;9_
M9M1?Q+X@U*V:[MD,^GPP+'O/V>+*RA5[EY ^?4*H[5RNM7D%_+XCFL;RWU6S
MN-/MD%U;+\E@@G^56VY#;%=I"#SA"" #7KM(%"C  '?B@#R&ZN/,;5)%U:WO
M8GU/3Y6U^-%\FW*@]0IV'9L7)SC]Z,XQ6MI^J7&G^%/$<UA=1WEU/JOD6FHQ
MJ/+N99_*174#C",^TXX/ED]2:]("J%VA0!Z8H      '04 <'K.FZ3H=SH%L
M_B"?0XK.VN%AN"L6V1SLW%I)0R[S@G&,MECGK61)JKR0VFL:KXCFT75SH_[I
M3;1JES^\8@@2*<EMJ$QKAAE?6O4RH88(!'O05!QD XY&: .!DL+S6+:]L;F,
M6FH:OIEOJ42]/)O8@H8_\!86_P"1J;P]J%YXBFO?%5I8J\RV\=E9VUQ(8@",
M//EMK8^<[#P>8:[C SG'/K2T <3XLL?M=EH6IZC91Q:E#JEDJJD[2I#FY3.T
MD 9(_BV@XXZ5VU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tardioagreementa01004.jpg
<TEXT>
begin 644 tardioagreementa01004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2;G3VO(IW*+<FS,9B82"<'!CV$9W9_3GIS4J>(=/:UDN"TR".?[,8W@<2&7
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M"<?(""-S-QD@@<\&M&72-1MKNQEL-6NV@2<&ZM[AA()4((X8C*D$@\''!XH
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M$CC#,-C$#L0#BH)K&_S\0EBTC6#'JNDQI9O/&SM*_DR)CJ2"68<=NX6O6:*
M.7;0X_$7PXAT:Y26W:6QCC^="CPRJHVM@\@JP!_"F^!/[1O=$76M95!J5\B!
M]ARHC0;5P?1COD'_ %TK5US08M=CMXYK[4+5(9-Y%E<M#YHQ@JY')7GV^M:4
M44<$*0Q(J1QJ%1%& H'  H YKQKIUKJEO8074.I+BX+Q7NFAS-9R!3AQM!.#
MDJ>".>?4<N\'B"6R\*#5(+F\FL]>:9KA+-E9[8+(JRR(H^5CN!(Z\YQUKU"B
M@#R_45UBUU#QW=V&C7%RUS-9-;B2T+"1$1$D9%889EP2 >I /-6-)ANX/%WB
M.\_LO6/LE[I<'E3W,;,SLOFY!&20<L/D !&>@%>D44 >50V%_'X$^'UHVFWW
MVC3]0M7NXQ;.6A6-6#$C'0$CZ]J]3=Q'&SD,0HR0JDG\ .33J* /([+3M1A^
M'/@^R?2[];JSUJ&>XA^RONCC6=G9CQTVD&MBP@OM%7QAI5[IMY=?VE=SWEE+
M# TB3K,@ C+ 80J1M.\@8P>E>B44 >;:7H>I>&M<\&)-:7-Y'::-)8336Z[U
MCE)B(R>R_*0"?2N]U?/]C7NU'=C X"HI9B2IP !R:N44 >6QV-^G@OX=VK:;
M?>?I]]:O=QBV<F%4C=6+<= 6'U[5>-M=C4OB*YL+S9?0QBU/V9\3D6_ED+QS
M\W'Z].:]$HH \UBM+U;?X:J=/O=VG*HO!]F?]Q_HQC.[CCYCC]>G-5;[2-2O
MO#/Q(M(-/NO/O[IY;17A9//7RHURN1SRC<?XUZI10!4TNZ-YIL$YMI[?<@_=
MW";''U7M^-<3IT5[H-WXOT^^TZ\NX]2NY;VSEA@:1)EDC5?*+ $(5*X^; P<
MYQ7H-% 'F>AZ#?Z%KW@BSN(+B<:=I,]M<W"1,T<<C^60N[&,?*PS[#.*]+=@
MB,YR0HR=H)/Y#DTM% 'EVGZ'JUW\%KC2(+*:#54GEF2WN8S%YA%T9E7)QPRX
M'X\U+/8_\)=X?U1--\*WFCZG)ILUM]HU&+RW#,/]4A)R5)SENF,>O'IE% 'F
M+WFH:M+X(9?#VK02Z==C[;'):E%A/D.G#' 9<G@CC'H>*S=9LM63PIXYT&/1
M-2GO+S4Y;NW:. F.2)W1@0_0G@@J.1Z8R1[!10!YZ;O4O#_CC5[RXT'4[_3=
M;@MVA:T@$K0O&FQHY!GY0>N3QR??$&JPWNC^+K?5KSPW=WVF7>FQ6KPZ:GFO
M92QN[!=JD93#XR.,BO2:* ,OP]:0V6B6\-OIB:9%\S)9H /*#,2 0. QSDX[
MD\GK7G/C6WUG5K'QAI_]B:BTK-&UD+.';%<1@)EW<$>8_!&TYP N!U->M44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$C()DLV3=*C8Y'1,'L6'K0!>/C2(6U@&@@@O;VV-VD%U=K$JQ9&"SD<$Y&
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M2SN3%<9RS)&H*Y49'[OG..O>LU_!7B V,US MK'J5MXCDUJTC>8F.9')S&Q
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M\[94(5@!ACE<?GVLW.C:U/XO\-ZI,L$R6$%RETZ/M^:;;@(N.57;CD@D8[T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&UB-IZ'L?2LWPS?7T_C#Q?975Y+<06=S;K;K(%'EJ\*N0, =V/O0!UE%<?\
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MMZTD8EDB;:\F]\(7"[ VT<+D'&.*ZC4?%.CZ2[B]NFC2-UCEE$+M%"S8P'<
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M2+>"+SQ#/!)$SQYQN4.HW#/&1G%7+V^MM.M_/N9"B%U1<*69F8X  &223V%
M%FBN&\9^(V708+[2]1N+3R-7MK:Z#1>5PTB;E8.N0-K Y&.O6M^S\6:)??VA
MY5[L_LY0]UY\;Q>6A!(?YP,J0"=PXXH VJ*R;'Q#IFK7+V-I<RI=&W%PJ20/
M$YB;@2*'49&>_//6O/QKNMGX16VJG5KG[>NJ>2\^$W2H;TQ;3\O V_W<=* /
M5J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7QG9VE_HL=M>0W[1/<QXFT\,9K9ADK*NT$_*0.W>N@+JK*K, S'"@GD_2G4
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M,3('5V?.-N,?-CKVH O:KK%S8WT%G:Z>9VDADG>>:0Q01*F!AI-K88EA@8Z
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MUAC9&,:MM/5E8XZ#=U/?I+'1M2B^(&HZW+';BRN;&&V0+*3(&1G;)&W&#O\
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MEO)DWK+^^?Y\[5.>W(_A],4^^\(ZQ<^!?#=E!):1:UH+VT\(9V:&5X4V%2<
M@,">W%7=,TK7I/'S^(;^TL;:WETM+-HHKII'5UD=\_< (^;V_&@"77]1:Y\7
MZ'X94D0W237EX!_%%& %3Z,[#/J%(Z$U'>Z!XBEN/$(MM1L4@O8X_L1>)O,B
M90H*.0?]6<'@<_.QZ]4UZQ:T\?>'_$/_ "[".;3[ENT?F8:-C[;UV_5A77T
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M\3IX;;7YFTO[/:ZN;&>W2!]TR?:!#N5B_P A&0<8;/KVH ].HK-\0:Q%X?\
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M0%YK"RD4[>"Z9#;,_P"\HQZ9/K0!M21I+&T<B*Z,"&5AD$'L12JJHH50 H&
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MN6(<$$_PC%.L?%/B+58='U;3=--QI]].OG0&':8K=LXD$A?EEX)&WG) Z9H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDDC)P>@.<]<GTQW%% '+W/A*YN;G1+E]7:2?3+AKIY)H QN)&4H<X("C#$
M<8%6]%\/RZ3K.M:@]ZL_]J3),T8AV>650( #N.1A1^-;M% &%?>'YKOQ;I^N
MI>I']B@E@6 P;MPDV[B6W#^Z,<>M8K^ )W\*76@G6$V7%^;XS?9>0WG";;C?
MTW#\OSKMZ* *>HZ;!J^CW.F7ZB2"ZA:&8+\N0PP<>E8?AWPQJVCB*.^\37&I
MV]JI6TCEMU0IQM!D93F0@'';KG&<$=110!RVF^$KK3M$UG31JD<AU.>XN#*;
M7'EM,26P-_(&3C^M5;CP%)-X;T33X=9DMM1T0*+#488 &0*FS#(20P*]1D9K
MLZS=?U==!T"^U9[:6Y2SA:9XXBH8JHR>I Z"@##U'P3-K&AI;ZCKMS+JT5PE
MW!J4<2H894SMVQC@* 3D'.=QY]'WG@^YU?PMJ6DZSK<UY<W\0C:Z6!8A&%.5
MVQCCKR<DD^N,8Z.QNA?:?;7:J4$\2RA2<XW ''ZU'87=S=&Z%S826@AN&BB+
MNK><@QB08/ .3P>>* )+*&X@LXX[JZ^TS@?/-Y83<?91T'^<FN;@\$(UMXBM
M-2O%N[3796FGC6#RS&Q55^4[CT"C''49KK** .9M/"UR6TG^U=36_723OM/]
M'\LM)L**\AW'<P4GH%&3GTQ9\,>'Y?#T%_$]ZMT+N]EO,B'R]C2-N8?>.1GI
M_6MBWN(;NVCN+>19(95#HZG(93T(H>XACGB@>11++GRT)Y;')Q]* ,+Q5X9G
M\2-I1CU!+0:=?1WR9M_,W2)G:#\P^7GD=?>K*Z;K$E]!/=ZO \< 9EAAM#&K
M.5(!<F0D@9)P,<X]!6S10!Q$?@":/PC8: NKJ4LKU;Q9C:\L1*90I&_IN/Y?
MG1XFT-[3_A(O$<^HQ8GT5[(PF': %#LI#%NI9CV]*Z/5];@TK2M2O5C>Z;3X
M3--#"5W@!=W<@=.:LZ7?+J>DV=^J&-;J!)@A.2H90<?K0!R'A+16U?PKX2N+
M[4(KFUT^W@N(88H=I\U8MJ[VW')3)X 7D9/3%69? $-Y8^(K+4+XRPZU<BZ)
MBB\MX) %"E3N/38IZ=?KBNQHH YU-%EAO;76M<U!+V;2[>00M%;&,+N WN5#
M,68JN.,#DX'-9GAVWTO7_%]WXQTU9C;2VD=NDCQO&LT@+;I K '(4JF[']X=
MJ[""XANHS)!(LB!V0LIR-RL58?@01^%2T <>_@J]MM?OK_1_$=SIUEJ,GG7M
MDL"2!I, ,\;-_JR0.3@_RPMWX*NX_$4VKZ#X@GT@W<<<=[ +=)TFV#:K#?\
M=8+QGGH.*Z^B@"O'9PI8+9,&DA$?E'S#N++C')[D]ZY?P]X+O] ,5F/$MU<Z
M+;-NM;&2!0T8!RJM*/F95/0<= .G%=A10!Q$W@":?PKK&A-JZA-4O7O'F%KR
MA>02,H&_ID#'MZUIW>AR1^)8O$MSJ4""VL'M'C,.U2K,K,VXOQRH_#UZUTE%
M 'F/P]T1]=^&WAR"]OXI=/MV2=K9(<.71RRH[;B,!L'&T$X&3USTDO@F&]O_
M !)+J%T)[37HHXIK=8MIC"*54JVX\\YZ=0.E=56-I'B%-6UC6=.%I-;R:7+'
M$YD93OWH'!&">,$?_6H I6GA:XW:3_:VIC4$TD[[4"W\MF?84#R'<=S!2>@4
M9.<=,9NEKH_B[QK;^*=,$[PV5JT#3/$\2RREB%&U@"2@,G./^6@]*[BB@#DK
M_P '7I\37&MZ)XAGTE[U46^A%NDR3%!A64-]Q@.,\]!Q3=1\$W)UFWU?0M>N
M-*O%MEM+@M"MPMS&O*[E8CYQD_-[UU]% '.W/AN[EA:W34TEM9;7[/<0WUMY
MXE8EB9#AE 8ECQC'MP,:>D:1;Z/H-GI$):2VM;=;=3*<EE5<<U!XFUU?#7AV
M]UB2UENH[2,R/'$5!P._)''Z^U3K?7+ZA:PII\C6LT!E:ZWKMC;C"$9R2<GD
M#'% '.6O@(6^B+X=?4?.\/I.)4M7A_>A _F"(R;N4W ?PYQQFM,>'K@>-G\1
M_;TPUD++[-Y'\ <OG=N^]DGMC':M"\U)X]+NKO3K9M1FA+(+>&15+NIP5RW
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M[B+5_$6H+J,>[68XXRAM^(=B%%(._G@G/OZ=*Z!;B%[F2V613-&JNZ \J&R
M3]=I_*I: ,OPWH[>'_#MAI!N!<+9PK"DOE["RJ,#(R>:32-*N=/NM1N+J\CN
MI+V<2Y6#RR@"A0GWCD *,>Y)[U'XA\0IX?\ [-,EI-.M]?0V09&4"-I&V@MD
MYQ] ?PK88E49@I8@9"C&3[<T <G:>#KJQU;Q#>6^K1K#K7S26WV7Y8GV;=Z_
M/U(Y/J?2HX?!$\.G>&+-=50KH#J\3&UYEVH4 ;Y^/E8]._Y5L^&=?3Q+H_\
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M2 SJ[\A2& (Z9P:F\8C5O[)@.CHLUPMRC/:?:/(:ZC ):-''W6XS]%(/%6=
M\+:/X9A>+2K5H0^ S/*\K$#HNYR3@9.!T&:MZCI5IJL<*7:R'R)1-$T<KQLC
M@$9#*0>C$?C0!YQ)KHNM+T6YTZZUBUE'B>"TNK6\FD$D.[&^%\L=R]",Y&"*
ME\0W-P9?B?9M<SR6T6B1R1PR2LRQL\,V[:"?ES@<#TKM;GPGHMYI4VFSVA>"
M:<7,C><XD,H((D\S.[<,#!SP !TIEOX.T&VEO)4L SWL M[HRRO)YT8!&&W$
M[C@G)/)R>: ./CM;[0-0\%7UEJVHSC4W2TN[.><O$R&!GWJG1-FS^$#W[YK+
MX@U#2]#U[??S.O\ PE7V#[1<3']Q QB!&[G:,$C(Z;L]:[5]%MO#UHMWI.E7
M.HW5L@BMX'O"S)&2 PC,K87CMD9V@>E5M%\*Q-I&N6NLVB2PZQJ$UW):RX;:
MK[0JD@D9P@/!X/0\9H Y[Q#+K?@S2]=U1=546TL$7DVK327#6S&5(WF5I.<!
M7SMZ9 ]ZVM4T.*"#49HM:O7L[K2I$^Q/=.X=E^;SE<MN'! ., Y&:U-+\&Z!
MH^FW.GVFGJ;:Z3RYDGD>8NF" I+DG:,G Z#)I=$\'Z%X>AEATVRV)*GEMYLK
MR_)_<!<G"^PXH I_#FV2W^'?A\HTI\S3X';S)6?!,:]-Q.T>PP/:LS6;&&?X
MO^'W=[@%M-NF.RXD0?*\6. P&.3D=^^:ZO1M$T_P_8+8Z9 8;9?NH9&? ],L
M2<#L.@INH:!IFJW]E?7EMYES9EO(D$C*5#8W X(W*<#(.1Q0!YY_:E_JOPQU
MCQ:NHW=MK%I+=3(JSL(X?)D8+$8\[2"B@'(R2V>N*],T^XDNM-M;B:+RI984
M=X_[C$ D?A6:WA+16NKFX^R,/M4HFN(5F<0S2#'S-&#L)X&<CG SFMN@#RF&
MQAAL_BG(CW!9#.H#7$C+@VBDY!;!.3U/(' XJQHZW&E:Q\/S#J%\Z:GI\D=U
M#+.S1,$MU=-J?=4@C&0 3WS79W'A'0[JZU&XELV\S4D\N[*SR*)1MV] P .W
M@D8)'%.7PIHZ3:7*+>;?I2E+(FZE/E C:1][GCCG/'% '%Z')K/B;0])\2P:
MNEG.+OS+DM=2LC+O*M;M#]P=E'<$ \DY/I4L:S1/$Q8*ZE258J<'T(Y!]Q6!
M;^!O#=KKLFM0::L=[))YS%9'\LR?W_+SLW>^,YYZUT5 'COAR\?1/AOX:6VG
MDB&J:N]G/)+=2!57S9R #D[-Q55)4 G/KS5_Q9::WH'A#Q7,-=FC7RHKBS@A
MNI'EM3G:W[QOF*L<D#M@XKL_^$(\.'2;S2FTN-K&\<R30.[LNXL6^7)^3YB3
M\N,$DTV/P+X=CT*?1?L+M8W!!F1KF4M+CH&?=N('IG% '.^(],N=&O\ PZ+7
M7=8/]HZVB7&^[+#:T+DJ!T"Y0''0'. *I#3YWO\ QSI7]LZR+338XKBS OY=
M\3O 6)\S.\@,N0I)7D\&N\O?#NF:C]@^UQ32&PD$ML3<R@HX& V0V2<$C)SU
M-,_X1?2/M.IW'D3"74T"7C"ZE'F@# 'WN,#CC'% '$2ZOKDOA[P[K4MM>:K8
MOH\4FH0Z?<F&YBD=5/GA5(W]&&,\<X[UWWA^ZM[WP[IMS:W3W<$EM&R7$F=T
M@VCYFSSD]_>JD7A#1[>.WCMXKF!;>W%K'Y5Y,N(AT3(;D#MGIVK6M;6"QM(;
M2UA2&WA01QQH,*B@8  ^E 'F/CC4[R"P\5ZCIFIWLL^G/#M=)FABLF 0F, '
M$K'=N;*XPV,\8K8O+6?4OBG=Z5+JFI1V#Z)'<&""Z:(!S,RY!4@KPHZ$=/3(
MK:O_  +X;U.XU":[T[S&U  72^=(J2$# 8J&VA@!]X#/O5J'POI-OJ7]HPP3
M)=_9A:^8+F7/E YVXW8ZDG/7))ZT <!X=\1:AJ6G> ])OKZX(U(7AN;@2%9)
M_LY(1-XYR>"2#D[?<UO>"K5++QKXXMTDED5;NV(,TA=L&W4XW$DD#.!GL!6N
MW@7PZVBVVD_8'%I:R^?;A;B4/ ^2=R/NW*<D]#WJYI7AK2M%O+N\L;=TN;S;
M]HE>9Y&D*@ $EB><#KU- &7XNU62TU7PWIAG>VM=3OFAN)D<HV!&S*@8<J68
M*,CG&1WK'\1377A6U2T@UFZEAU/6K6!O,<L]A!*<,%<DG!V, 3]W=QTKL=;T
M+3/$>FMI^K6B7-LS!MK$@JPZ,I!!!'J#5:+PGH<6A3:+]@62PG.94E=I&D/'
MS,[$L6&!@YR,#'04 <W?->Z5XX;2+2\O&TZ_TB>X=&N'D:WEC8 .C,25!# 8
MSC(S6%HT^H6^D?#K66U?4I[K49H[:[6:Y9HY4>%VY3.W(*@[L9]2:]&@\.Z;
M DZA)W>>(0232W,CRF,9PH=F+ <GH1US59?!NA)::;:K:RB#3)!)9H+J7$+
M$ CYNP)'/8F@#S[6[E_%'PM\8:O=75TMQ%-=0I"D[*D"1-M6,H#M.0,G().[
MV&.G:6X'Q'T6T%Y<BTN-$G9[=9F";E:(!@!T.&//6M2]\!>'+^XOYI[%Q_:
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MD3CY$,C':#@=QG ST%<UX!\)?8O"UC!K6G7$-Y;W$D_D2W/F1AS*S(X57*9
M(/3@\]>: ,>21M"\0?$S6+/SWNK&VAGA5IY&7=]G9OF4MA@#S@C@=,5IQ1ZG
M8FQ\26VJK)8_8I7EMC=RW OSY1="H;A&&TGY1R,CM76?\([I)UJ?5S9J;VXC
M$4SEV*R* 0-R9VDX)&<9P2.E4]#\$>'O#EU)<:5IX@=P0 97=4!.2$5B0@/^
MR!0!P=ZIU/P=X%U^>^N9[R\UC3YYV\]C&6=P64)G: IX& ,8]SGURN77X=^&
M$41II\BP+<"ZC@%U*(HY0<[D3=M0Y_N@5TX   '04 >*0V=Y9?#'4/$FGZQJ
M-M?Z??W<L$4<Y$#8NGRC1CA]W/7)R1VXKK-2U6;PCXR-]J$]Y)IFKV3>3 ]P
M[K!=Q@L8T!.!YB]/]I<#K72P>$M%MYF>*U<(T_VDP&>0P^;G=O$1;8#GGIUY
MZ\U4NK?4==U^*UO]%C@TK3KI;J&Z>=9#<LJG9M0#*88Y)/\ =QSDX -70K&?
M3]%M;>ZGEGN@@,TDDK2$N>6P6).,YP/3%<JMC"WQMGD+W ;^PXI<"XD W>>P
MZ!L8P!\O3OC-=W69=^'M+O=8AU:>V)OH8C"DRRNAV9S@@$ X/(SG!Y&#0!Y3
MI2W&G> ]%UFUU"]BG3Q T/E).RQ-&]ZZ.C1CY6R"3D@D=B*Z.0ZMXMNO$UM:
M:E]AN]/O?L]O(MW)&;95165S&ORN&)8_-G(R.@KIAX(\/KI,>EBTF%E%/]I2
M+[7-A9-V[=G?G.[GZ\TW4? OAO5M775;S31)>A0CR"5U\U1T$@! <?[P- &W
M9.\EA;/)*DLC1*6DC&%<X&2/8U/0  ,#@44 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G:]K=EX;T
M.[U?4'*6MJF]]HR3V"@>I) 'N:SX+KQ1-IHU#[)I\<K1^8NFN7W],A6FS@-Z
M_(0#W[UE?%C2+W6?A]>Q:?"T]Q!)%<B!>3*$<,5 [G&3COBN@T_Q-HVIZ/'J
MMMJ$#6CJ&W%QE2?X2.H;MCKF@">TU-#HUG?7[1VC3PQNZRL$"LR@E>?>KC2Q
MHJLTB*&("DG&2>@%<1%=+/\ %>>WU6(""?1XVTU+A1@C<?. !XW\ID=< =JX
MU;!!H6@17*(]BGC,PZ8S\G[&6<*JGKL.#CL1CMB@#V,ZA9"!YS>6_E(VQI/,
M&U6]"<\&IGFBC ,DJ*""1N8#.!D_I7F=MH6B/XU\<V;Z=9FVCL;618#&OEHS
M1R!F"] < <XS6/I-KI^I-\*O[1B@G$^FW$3^< ?-VPIM1L_>&<\'- 'L2W5N
M]M]I2>)H,;O-#@KCUSTI([RVEMC<QW,+P $F57!7 Z\]*\A,6FZ _B"V\@#0
M9/$5G'81^;Y5O%<;5:0L1P(E<<CID8X[4]6FLKC0OBG;/=65T1Y5S&(E 0MY
M"9=%R<?-@9R>>] 'M0N[9GD07$1:(!I%#C* ]"?2@7=L8C*+B+RP<%]XP#Z9
MK@$L-.L/B7X;6SM[>+[9H]TMQL4#SP#$1O\ [W5CDY[U6TC3GL-8N?A\;3_B
M6)=C4X'V?)]C+%S']1, F#U4GTH ].!! (.0>]1W'G?9W\AD67'RF125S[@$
M5#;ZC97-]=6-O=0R75IL%Q"C M%N&5W#MD<BK$C!8V9B  "23VH XG2/'LDW
MPP?QGJ<$$8\B69+6%B,E&90NX]22OIQGO6[H]SK,MQ+-?S:9-IK0I)%-;!D9
M'_B5@68$#KNR/I7F&GBWE_9;=I!&^RRN"I;!VMYK@8]#S^M>O6%O;+I4,44,
M(@>(?(BC:P(].G- ',:UXW5?#$&M:!):W4+7\=JYDRV5,_DEEVGUR03U%=?%
M<0SM(L4T<AC;:X1@=I]#Z&O$X&T__A2UK;H\"W"ZQ$MPJ,%=?]/. V.1QG'M
M6UK=L^D^*O%]MX<@2VN)/#"3)%:*$+2AY0& '\6,8/7I0!ZA%=VT\LD4-Q%)
M)$<2(C@E#[@=*YWQ?XAU#0)]$2SBMI5U+4([ ^<&_=EPQW\'D?+T_6L'PR?"
MNL:SH.KZ1KDEQ>PVKQI:0>2I2)EY6=$0, I QG^(CUJ;XI>2S^#XYY3&C>(;
M?+"0QD#:^2&!!'7J* .KM9-:74TAO%L9+5HF9I(-RNCY&T$$G((W<^U7A>6K
M21QK<PEY,[%$@RV.N!WQ6#:V^C6.MR1+J$EY+J<*P_99[EKC"QAV+?.Q(7Y\
M'MG'K7F-AINF#X5>#KP6\"W!UR",7"X#[3=.I4-U VY&,T >W17-O,)#%/'(
M(V*N4<':1U!]#21W=M++Y4=Q$\FT/L5P3M/0X]/>O+M8T_3K37_'EA;6EM#;
M/X;29K>.-50N!, VT<9 V\_2HH-%T^.U^&VIZ'!"FK2RP>=-!]^:W\@F8N>K
M 84<]"0.] '=>%=<O=9N->AOH[=#IVI/:1^2" R!$8$Y/7YCZ5MQ7MI/&\D-
MU#(D9P[)("%/N1TKR+4KFX@\-^/9;;<\2>(U-X(N6^S;8/-Z=MH(/MFNHOK6
MWF^)7AR?2%@>VN=/N5U$0@&.2VVKY.X#@C>?E]MV.] ';?:[;RO-^T1>7G&_
M>,9],T27=M%-'#)<1)++_JT9P&?Z#O7F^AZ>]GJLWP^DM2=.L[L:E"Y3Y&LR
MQD2//=A-\O/55-4)I-#U>Y\5:+XHUN33[W^TF98?W22O$"I@:$LA8G   4DY
M[<\@'J\UW;6S1K/<11-(=J!W"ECZ#/6IJ\GNY]'N_$'BG0_%FLMIYGCB$'VH
MPJ9;8PJ/D9U/S!_,)VGACD"NPUJ:STOX8W;W?]H7%E#I963<VVYD3R\?,1C#
MD=3V.: .BM[RVN]_V:XAFV'#>6X;:?0XZ4@NX))9;>&XA:YC&3'O!*^F0.0*
M\GBOS'XRF_LJ]T]KN7PG(EG'8L"OFJX,: Y^=AGK@<=A6UX/O/"6LZ?X5N+:
M:.36;. JL,4N)HW*8F\U0<XR"26ZG!Y)&0#H/!WB277-%6XU)K6&\:[N+=8X
MCM#".1D^4,23PN36NCWW]MS1O+9FQ\A3'&N?/#Y.XMSC;C&/?->.BTL$^&RZ
MLL,'VZ+Q+F.ZP"Z?Z=C ;J!@G@<<D]ZZ75$G@\>^,3HZ*NI/X:22(1 !FFS+
MM/'4YV_I0!Z(M[:O)+&MS"SP\RJ) 2GU';\:47EL8C*+B$Q@X+[Q@'TS7F_A
M?_A%=<N?#>HV.MR3:C;0-&ME%Y*NJLF)%F54#;01_%_%C&21E^AZ>;#7-1\!
MFU_XEZ7@U2$[/D^R.V_R_3B9=N#U4GTH ]%DO+:&2*.6XA1Y>(U9P"_T'>B6
M\M8)5BFN88Y'&51W +#V!KRNZET/5-3\7:'XJUIM.N'O,I&_E*SV^U?*:)G0
ML2,'A3PV>,FI?$1NM*EU75+<PZSIT<=LFJZ;>X6[B*HI1XV'&[#!MI'WLXYH
M [7QOK5[X=\':EK%A'!)<6D7F!9P2I'X$']:V8+J&<E%FC:5%!D16!*Y'<=J
MY;XI,/\ A5WB DX!M#UX[BLU+'3]/^*FC)9V\$*W>BW G"*!YV'C(+?WCRW)
MR>M '8Z?<W,=A+-JUS8;DFD!DMV*QJ@8[0Q8\,!C/O5Z*:*>,20R)(AZ,C C
M\Q7DV@VGG^!K6WTW4K;3[R/Q'=&Q\U T$DBR3%8G4?PE<XQR" 1SBNT\"WTE
M[I-\MQID6G7=O?S0W44#[HGE&"SQG^Z2<^QR* -;3=>TW5I[^*RNHY6LIS!,
M58$!@JL<>PW 'W!%7+>\MKJ-I+>XAF13@M&X8 _45Y']JT+3/#WQ!COX(VQK
M$BO;PR"*0Q-Y"C)'*Q[B,G&,9Z]*F^T65QXI\8V\]WIMRMSH$3E+< 1.RB;H
M,G<5 '/\J /5H[NVEW>7<1/M4.VUP<*>03['UI8+F"ZC\RWFCF3.-T;!AGZB
MO)Y-)TNS^"NF:G;?8K.YFL]/-Q.^%%R%:,^5(_\ =8DKD\#OP*M30PZG?^+/
M$V@S:<^I/H_E6<5K-%-<+*J/F3*$[2<JHP><#/:@#TQ+VUD>5$N86>'_ %JB
M0$I_O>GXU6T;6[#7[ 7NG7"30%W0,I!SM=ES]"5)'J*X3PTOA/7K_P /:EI^
MM/<7D-L\2V47D@K&R?.DZ*@;:"!][^+'7/.A\)'LO^$$M88#!]ICDF%PJ8WJ
M?/DP&QR..F: .UDO+6$XEN84.X)AG ^8]!]?:EN+JWM(_,N9XH4SC=(X49],
MFO)DT'PW?2?$A-3M+,BWN6=2ZC-N#;H=Z?W26!Y')([XINFWQL]3T>Q\::B;
M#S_#MNL,EV(_+:3+>>C-(I <@QYZ9Q0!ZY)<0Q!3)-&@8$@LP&0!D_IS7.ZM
MXE8:]9Z%I=S9)=W-I+="XG'F1J%*!1M#*26+@]>@/7-<5_8&@QZY\/=.B+:A
M8%+^*.2]VNT\03*@D !D_N\8QBMJ33-*L_BYHUE!9VL44>AS".(1KQMEB"X'
ML <?2@#L=/O9OLMI!JTEG#JKQ@RP02Y&[OLS@D?A5N6ZMX#B:>*,@ X=P."<
M#K[\5Y&ICU#X3^)1J( \1VUY<M*>DRW8D)@V]\X\M5QVX%:=KH>GZI\4+BVU
MNPM+F=_#UK+<Q.BE6F\UPSXZ$C@9Z@?6@#T=[RUC.'N85.\1X:0#YSSM^O(X
MIZW$#SO DT;31@%XPP++GID=J\9O=*TEO!/Q-D-G:E[;4KHPML&8F$41&W^Z
M=WIZ>U=%)!8Z7X_\'7-I#%%)=:;>&X>)1OG 2)P6(Y<YR<G)SF@#T)+RUEN'
MMX[F%YT^_&K@LOU'44C7EJCA&N80S/Y8!<9+_P!WZ^U>.Z3JFE/J?P^NK.ZL
MX+-I[H)"9=\T:O%)Q-(3RS-CC YXRV,U6U'3=+C^'/CV\CM;9;BTUVX^SRA1
MN@(EC(V'^'GTQ0![9/=V]J%-Q<10ASM4R.%R?09I;BZM[2/S+F>*%"<;I'"C
M/IDUYY<ZGHO_  GGBG2_%=Q;06]U90+9-=R!$>V*$2!&/ .\MG')X].*MQ>:
M38^+K73M5OY-.TB71(8],>]"%& 9A(K-*K8<KY60<$@#- 'J0((!!R#WJ%;J
MW:Y:W6>(SJ,M$'&X#W'6LGP=8V6F^$["STVZNKJQA5EMY[E@SNFXX.0 "N/N
MG'W<5YEI,&E:_H_A_1+G4M'N);#69+F:XFN8F:[3S),CRR=^Z3< 0P'KD\4
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M<3*K'@,25SW( ]*@FT_29?&G@?3XH#+IR:9>+#%=$ON0>5L+!NHP,C/MTQP
M>D12QSQ++#(DD;#*NAR"/8BF275O%.D$D\232?<C9P&;Z#O7(?#,1Q:3K=K
M%6WMM=OHH8T^[&@E)"@=ASTKE-=-C>3>./#USJFEM<:C=1>5/=W<<9MSY<>%
M96(;"8RI4$$DC@YH ];N+FWM(_,N9XH8\XW2.%&?J:66XA@@,\LT<<0&3([
M*!]:X.R6VM/B:FF7,=N-/.B(-*4(HB;YSYVP#Y=Q&PD#^$#M7/:7<VVFV>FV
M=V5%J?$=Y_8DUS*5MH8$5]I;GYE&7"+D9.,$"@#O/&GB&YT+P7>:YI7V6X>
M*R^82R,"P7C:1GKZUOSWEM;,BW%S#$SYVB1PI;'7&>M>*W%W;M\)?'D"7<$O
ME:Q,0(B H5IHR"%R<*3DBNF\;+<V]_K6IV+V&IVL>G(FK:1=_*Y@&]@\3]CA
MFX(P2/7% 'I5%16TPN;6&<(Z"5%?8XPRY&<$>M2T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5372
M=-2^-ZNGVBW9Y,XA42?]]8S3[^_M]-M3<W3E8]RH, DLS,%50!R220 />N-\
M>:^__"%7]YIUW>6%Q87MM#-E3$PW2Q!@21R-DG4''/6@#L[NQL[^-8[RU@N4
M4[@LT8< ^N#1-8VER$$]K!*(QA \8;;],]*S+/Q;H]Y=WULL\L,MC$+B87,#
MP_NN?W@W@;D^4\CCBET_Q1IFK7D=E;RSQSW%K]K@\R%D\V$D#>NX8/4<'GD<
M4 :!TVP+R.;*V+29WMY2Y;/7/'-<]J_A1K_Q-H=[#;:>-.TX7 EMW7'F^:JC
MA0N.-N>>OM7'W.K:NGPCUV^75[T7EKJLT27'F?.4%T$"YQP-O'&*];H KM8V
M;68LVM8#:@8\DQC9CTV]*1].LI X>SMVW[=VZ)3NV\#/'..U<#8^,[?P_KWB
MV/6[^_GM[:^C$9$#S"WB,*,2VQ2$3+'DX_&NSN/$&GPPPR1O)=^=#]HC6TC,
MK-%Q\X"]N1CU[9H GDTVV"%[:TM([E$(AD:$'8<<=,' /8$52T#3-2MO-O=<
MN[:ZU.9$C=K:(QQ(BYPJ@DGJS$GOGT J]I>J66MZ9;ZEIUPMQ:7"[HY%S@CI
MT/(.<@@],57U+6;2TG-BSW#W30F4QVL1DD2/IO( ..>F>I!P#@T :"00QS23
M)%&LLN/,=5 9\# R>^*66*.>)HIHTDC;JKKD'\#7%> /$)D^'FD7NHW=Q>75
MU).L;$&268B63& .>%7Z #M5C4_B%IMMI5M>64=Q=&74X].DC$#AH)#(JN'7
M&0P!.!U)QC(YH Z4:7IXB,0L+7RR=Q3R5P3ZXQ5B&&*WB$4,:1QCHJ* !^ K
M)O\ Q/IVFPO+.+IA%"+B=8[9W:&,Y^9P!E>AX//!XX-4[WQYX>L9(XWNII7E
MM/ML0M[:27S8>/F0JIW?>SQT ). * -M]-L)%97LK9@SF1@T2G+'JQXZ^].2
MPLXI_/CM($F QYBQ@-CIUKGYOB!X?A6_/FWCFP"M=+'8S%HE9=VYAMR%V\YZ
M5:MO&.BWFJ6>GP7$K/>H7M93 XAGPNXA)"-K$#G /KZ4 :UO86=I)+);6D$+
MS'=(T<84N?4D=?QHN+"SNW#W-I!,P& 9(PQ _&N:@\3Z'IEKXAU675-0FMK2
M[VW8GAD86S[%^1%VY"]#Z9)YK3L/%6DZEK#:7;RS"Z$/VA!+ \:RQY +(S !
MP"1R,]: -"/3-/AW>58VR;U*MMB494]0>.E-_LG3C&(SI]KL!R%\E< ^N,50
M3Q;I#W]G:>=*OVXE;29X6$5PP&2$<C!XY'J.F:YGXB>*5B\)7SZ5>WL,\%U%
M!]IMHV$?F>:JNA?'H6!(.,\9SQ0!U&NZ''?Z+J5M96UI'=W=M);B9TV[=ZE<
MD@$\9Z4>&]$CT71K.W>VM$O(K>."::!/];M4#). 3G&>:V:\VT/QQ9Z$WB%-
M?U&^F2#6YH5G>%Y5MXMJ!=[*NU%R3C.._O0!Z%#8VENSM!:P1%_OE(PN[ZXZ
MU"FG0V5G<1Z5;VMI+(I*E80$WXX+!<9YJO#XCTR?7_[$CFD:^^SBZ"^2^QHB
M<;P^-I&3C@U:T_4K;4XYI+4R%(IG@8O&R?.A*L!D#."",CC@T 4=!TS4;42W
MFM75O<ZI<*B2/;1&.-43.U5!)/5F))ZECT&!6C+86<UU'=2VD$EQ%Q'*T8+I
M]#U%8NH^*H['QAI_A_[+<LUU!),TR0LP4*5  P.>6Y/0?C7-^&_&5MI,6MIK
MFH7LXBUZXM5G>)Y%@3<JH'91M09.!G'6@#OKBPL[N6*6YM()I(3NB>2,,4/J
M">GX5.RJZ%'4,K#!!&0165JOB/3]'$_V@SO]GB\ZX\B!I?)CY^9MH.!P?? )
MQQ6C:W4%[:0W=K*LMO,@DCD0Y#*1D$?A0 R&QL[<QF&U@B\I2D>R,+L4\D#'
M04D>GV4,LTL5I;I)/_KG6, R?[QQS^-<I;ZM=^*/&NKZ3;W4MII6C"..=H"%
MDN9W!;&[JJJ!VP23UQQ6Q#:7FE:K)<S:K+)HR6KEDN64^0X(.[?C)&W=]XG&
M.O/ !H?V3IOE^7_9]ILSG;Y*XSZXQ4B6-G%/Y\=K DV,>8L8#8^M9MMXITNY
MOK:S\R:*6[C,MKY\#QBX4#)V$CD@<XZXYQBJ$GQ$\.1V\ERUS<_9X;DVL\WV
M.79!("%/F';\@W$#YL4 =#!86=M/+/;VD$4TQS+)'&%9S_M$=?QJ;RT\PR;%
MWD;2V.<>F?QK%M?%NDW>IW&GQO<BYA@-P%>UD7S8@<%X\K\XS@97/48JA:_$
MCPQ>3:>D-[*8]0?R[:=K:187<GA-Y7:&./NDY_.@#HYK"SN+F*YFM())X?\
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M5EC&FVVS.X8.YSR1C^' '?GC'3UQ.B:G=^--:UMUO)[71M,O&L(H[=MCSRH
M9'9Q\P )  4CN3GL ==!86=K-+-;VD$,LQS*\<84N?5B.OXU)%;PP;_)BCCW
ML7?8H&YCU)QU/O6+"MQH-QJ=YJFK/+HZ01/"UQMS"07W@D %NJ8)R3TYJ>W\
M2Z=/?O8$W$-XL/VA8)[=T>2/^\H(^;W Y'<"@#,T/PL]GKVM:CJ5O83_ &Z[
M%U P&]X2$5,991_<!R*Z.[L;2_C6.\M8+A%;<%FC#@'UP>]<Y'\1?#4MO972
MW<XM+R4PQW+6LBQ!]Q4*SE<*25. <'IZU;M_&.C7']I#S+J)].C$MQ'-:2HX
MC.<.$*[F4X/(':@#7DL;2:5)9;6!Y$P%=HP2N.F#VH>PLY+@7#VD#3@@^88P
M6R.G.,U@1?$#P]*]@!<7"I?Q>;:RM:RB.;Y=VQ6VX+X_A'.>.O%$_BK1=2\.
M:S/]LOK.*R5XKQUMY([BU^7.X*5W [2&!QCOVH WFT^R>]6]>SMVNE&%G,2E
MP/0-C-.%E:"Y^TBUA%Q_SU$8W>G7K7-2>+K:PU3P[I$45]=)J-LTRW30LY9%
M08)P.6)92>..<XS4FB^-+357UQIH9[2WTN[> R30LH*HB$DDC .YCA>N,<4
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M^\MM<T+PUI<@AOM7DD+7)4-]GAC7<[ '@L>@R",]C0!T9TS3VCCC-C;%(O\
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M9.G;&3^S[78Q!*^2N"1T/3W-4]#T_P"RO=745_J4UK=%6CMKXN3 1D-MW_.
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M;W3",2?+LF^X=Y !&TCC.0>]16O@[Q%;^"M%T9XK%I].UA+UF6=@KQ+.TO\
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M?=R02/EQC!QSUK5N/$7BC5+:^OO#E@TYM+^2VBMF\D13K')L?<[.&5CAB"
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MEY\PFD\A,/Y87"[1@<5YY(^H3>&?BDUYJ#7"1&[A5&C P!:IC&.@ .,?CUH
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M59,\+GVS@D9 KI:* .:E\)F\N;4W]^;JWM-0;4+=6A DC?<S*N_/W 6Z8S@
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MVE+I[7CVL8FCF+(@9B48.HYXQD#-17?AIY/$$&OV=\+75%M_LL[>3OBGCSN
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M47=]:KI^GQ7=HK7;320,T,C'#MDC)0' ) YP:]"UG1=/\0::^GZE!YUN[*V
M[(593D,&4@@@CJ#69_P@OAXM?,;.4M?VXM[IC=S;ID (^8[LDX)&[J02,\T
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MUV$KNK?.S;1A<'[G. U=%?>!/#VI7&H375G(_P#:('VJ(7,BQR' &XH&V[L
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MF\F_>R$Y+$[\\D#IQQ2:MX&\/ZW>V][>VDK7=O'Y2SQW,D<C)_=9E8%A]<T
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M"TK2,VY]R$$A<* ,XR3[8YC[=K\_@JXU0WM[/<^&]7FBE\N5D.H6L,F'W!2
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MYWA2<+W^Z ,'V&/2ZYBT^'_AVS:R,5O=$6$ADM$>]F98"01A 7P!@GCI73T
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MI?/AV;_-CVYQNW#&:\BTBPL++3?A7?V\$,5Y.4CEG4#?(K6K95FZD9 &#TP
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M@\]\D4MAJNGZI]H^P7L%S]GE:&;RG#>7(.JG'0UR%TEO#\9UEPL;R>&YC(Z
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M&5OJ#P:;%96L%I]DBMH8[;!7R4C 3!ZC;TJ>B@"F-)TT/$XT^U#0@+&1"N4
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M32VO[>">!%GE@,<X&X-&Y0YP2.H/>@#6HHHH ***9+-'"%,KJ@9@B[CC+$X
M^M #Z*IQWLKZM-9&QN$BCB60738\MR205'.<C'/'>KE !1110 4444 %%%5M
M0NI+'3KBZBM)KN2*,NMO!C?(1V7) S0!9HJ%;E#Y*R?NI9EW+$Y&[@9(_#O4
MU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8,&;F$C!#$$=#WS6M8>&EDMHH]0LTMG@OQJ"M:W\DAFFYRTA*)GK]WD8QT
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M27*CH)%4@..W/4<'BGZGX1T>YU;^W&ANH[Q(?*D^R3R1^>@Z(ZH0' ]#].E
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M)'0<C% '>"[MFMUN!<1&!L;9 XVG/ P>E-:_LUMGN6NX! A*M*9!M4@X()Z
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M^UT4A6-NQ+8[$GOUH ].%U;FY^S">+[1MW^5O&[;ZXZXICWUI&X5[J!6,GE
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M  R?+<@*_'/RD\<]* +[Z?92AA):6[[F+G=&#ECU/3K[TZ>RM;JW%O<6T,L
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M6<4OD2,R,&CDSC8R8W*V2."!U%26/BG1=1O;NSMKU3/:QB:571HQY9S\ZE@
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M2737+6NQ8G.)57<5)Q@<=R<'!QT- &T;: W'V@P1F?9L\PH-VWKC/7'M4?\
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MYC@;I*VTX4_4\?C5JB@#R72OMMSX@\$WW]F:M&8[2YM[C=8-##9R-'&!&J8
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M/;W&PR%]R2-\XR,XV\#MGO0!VU%>=V?B/7-&\%^$=2O);.XLKM+2*]N&B</
MLB*%=COP?F.">/O XKL+&_N;S6M2A'D_8;0I$K!3O:4J&89S@@!E[=21VY )
M+S7=(TZ80WVJV-K*1D)/<(C8^A-.N-:TNUTPZG/J-I'8 9^TM,OE_P#?6<5Q
MOB^40?%/P-+Y$DV(]0^2-06/[I.U<[?Z%J&F^"?B3J%Q9FPL-2#36=@S*3&
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M;I=V:%'Q=1,&(_BSG<I3COCUH [>BN8TGQ'<ZS;Z1<V/V>>*ZT\WEP%0@C.
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M/3/$TTL,5RVC3Q()[:)PDD4@1O,V9+84,2<$Y"\'F@#O*:[K&C.[!4499F.
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MM,]PPPJ9]LD%O0?04 =/J>CZ;K5NEOJEA;WD,<@E6.XC#J''0X/?D_G5P
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MD%BW()/KZU7\2^&[KQ#'?6<TUE+IMW;"(07-N7,$@W?O4.>N&'''*@YKIJ*
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M,LTC]7<G+,?<DDUGZ5I=_:/?W=[=V]U?W+_)*L)18XQ]R/&X\#D]>22:V:*
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDW*3@,.N.O>EH ****
M"BBB@ HHHH ***,C.,\T %%%% !1110 449&<9YHH **** "BBB@ HHHH **
M** "BBD) QD@9XYH 6BBB@ HHHH ***"0!DG H **** "BBB@ HHHH ****
M"BBB@ HH!!Z&B@ HHHH **** "BBB@ HH!!Z&B@ HHHH **** "BBC(SC/-
M!1102!U- !11D9QGFB@ HH!!Z'-% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"]N-'.N_\(K+9RQ2Q1R6.BOJ*2"*09\Q@5+;$.Y> >H[9%>C1ES&ID4*Y W
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M;5DQN0B;:P.#@\J?RI=*\->)=/T_PM93V=I>65A9-;W5G)<[8_.RNR;[IW@
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MCV$>DQ0Z;+:DRSB1BT4BEF  (^;'3H./?( .KU#4+32K":^OITM[6!=\DKG
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M1-+@9CZ 1C-9MCXNUO43HE_9Z:;G3]2=/-A6TE1[:)QE9#*QV.!QN '?C.*
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MRI(HYT:(R<J23V(R#@\&ICXE\2QZUH5F\6E-'K=K(\.%D!MW1%<ECGYP03P
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M@"'W')^<GIV%=4JJ@PJA1[#%5-3O);"S\^&QGO7WHODP;=V&8 GD@8 .3]*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML_>YQG&: ,&YFUGQ1J?B>PT^[^R7.G3);VKK>O"828E=9&C5") 69N&."%P
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M"..-1@*H& ![ 4 >93ZQJD'PWT;QK;ZA<3:A(]M+<P>:3#.LLBHT0CSM7&_
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M"YBFN'D*-''O65&)RIZ@X('(XS6XGA+1D754>V::/5F+7L<TK.LIP!G!/'
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MMKVIWFDZO'>?;(XWGAM=GV>-AD*P"<!F&?J!GTH ZYI$0$NZJ ,DDXXI2R@
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M89[5DWNE:=#\//%^HQVT2W=AXBG-I/CYK?;<IC8?X/PQF@#V8MJ']M!,6O\
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M$R29DVO&3W0)ORO0!3[T >HZ+KUWJ/BGQ#I-Q;PQQZ8T B>-BQ<2(6RV<>W
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M '8X[T >Q45!8FX.GVQNP!<F)?- Z!\#=^N:GH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DT,5Q"
M\,\:2Q2*5='4,K ]00>HJHNBZ4DD,BZ99!X5V1,(%S&OHIQP/85:N+B&TMY+
MBYE2&")2SR2,%50.I)/050@\0Z7<O<1QW)\ZWC\Z2%XG60)V8(0&(.." <T
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M'M;*2RM])L8;24[I(([=%1SZE0,&G#1=*5X'73+,-;C$+"!<Q?[O''X5>HH
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M+9A"PR!BXQ\N&(Y/K3M<M-0O-1^((TVUGFF=].GBC4,GVE8=ID5&[G"E>.Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2% 0!SR ?R_45YWIDEA;: ='F$K0)XMN+.PM!*$A(5V98I"0?W0Y.,$D@ 5
M94C^'_Q-LEGMRD-Q<>5%;\1H##&2$7)P-Q/XDT >@7'B2Z@\3>'=+^R0F#5H
M)I6F\P[D,:!L!<8Q\PYSZ\5T<A<1L8U5G .U6;:"?<X./R-<+J!'_"=?#[_K
MUO?_ $3'7>4 87@[7IO$WA:TU:XMTMY9VE#1(Q8+LD9.IQG[M;M>%V^AVO\
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M;^6(&N"V&QL5MI.<>N..O(/0UH6'BC1=3U-]-L[^.6[6+SO+"L-R9P64D88
MG!P3@]: )X-"TBUO6O+?3+.*Y9BYE2%58L>"<@=3W-)>:!H^HW\%_>Z597-Y
M!CRIYH%9TQR,,1D<U$OB;1WU&&Q%X!/.S) 6C8)*R_>5'(VL1@\ D\&N:^(W
MBQ=,\)ZD^E:G+;ZA;2)'YD,.] Y908V<J5#;3TR#TH [NBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .5^(5IJ%UX5+Z;;RW4UK=6]VUM"Q5YTCE5V52.<X&1CG(XYKF[U]*UGP
MUXCU/2M%U<7<VC3V9GO8IS*[,IVPJKY+<DY(X![G)QZ=10!YPBO_ &]\.76T
MN@EM9SI.WV9P(2T"J YQ\N6!'..E9,D5TOPK\8Z.=.O_ +=]JO=L8M)#YGF2
MLR;#CY\@YRN<=\<5Z[10!P<SR0?$+PYJ)M+Q[672)K421VSL%E+Q,%? ^3@'
MEL#@US\]GJ<^B>+7LK"]EFC\2)J*6_EO$UU"AA)\ML#.=C8QW'':O7** /*=
M:LH/%GA77;KPUH^J)J4VG_9VGU#SDDD4.KF!1(?FR X.. 2!DY-7YM9CUWQI
MX)O[33M22*$7:W DL)4^SLT04*Q*X'/&1Q[UZ/10!ROQ*LKG4/AQKMK9P23W
M#VQV11KN9L$'  ZGCI67)>2P?$+3_$<EO>?V+>:2UDLC6S@V\HEWY="-R!A@
M9('*CVKOJ* .2\#Z9/92>(;UXY(;;4M5ENK:)U*D(55=Y4\C<5)P>V/6H;L3
M6GQ=M+M[6Z>VN-&:U2:*!G02>>&PS 87Y><G XKLZ* /+M1\):I>W?B7PS;J
M\&F32?VO9W(. L[@XC'IB9/,XZ# [U:U"SUW6_AC=ZD;&1=;O?L]V]D&*MMB
M=&\H'J,JC''JYKT>B@#S=+C2=:T[5-5L-$UE+Q=*FMGGOXY_,7<.(55R2YW<
M_+D#'7FJUI'+'!\+A]BNU-G'MN1]ED_<'[*4._Y?E^<XYKU&B@#@_"FGI=0>
M+]!U2QN5CNM5O)'\V!E22&4C:5<C!R">A.,<XXJ3P#;:JZN=9^>71P^E6\V<
M^>%;YI?^!*(AZY1O6NHUG39M5TYK6#4KO3I"RL+BT*AQ@YQ\P(P>G2IM.L(=
M,L(K2#>4CS\SMN9V))9F/<DDDGU)H Y3XF02-HND7H!,.GZU9W5Q[1K)@GZ#
M<#^%:/BOQ*=$2"VBM=0EGN<CSK6QDN! O=CM4C/H#WZ\5T%Q;PW5O+;W$22P
MRJ4DC<95E(P01W%,L[86=JENLLDB1C:IE;<P'8$]\=,GGU)/- 'GNJVJ>(/!
M,2Z#I6HQ#1K^"\BBO+=H9+EHWWO@/AF)!8Y/WF/UK62U;7OB18:U!'*-/TS3
MY(Q+)&R;YI6'R@, 3M5>?0D#KG'9TV16>-E5S&Q& Z@$K[C/% '&>%()'^(/
MCC45!^RRSVENC=F>*$;_ ,MX'X5'KL]QHOQ-TW6KNVN9M'ETV2Q\V"%I?L\Q
MD5\LJ@D!@H&<=0*[&QL;?3K5;:V3;&"6.3DLQ)+,3W))))[DU8H \AMKNYL]
M-U.7^QKPQS>+7G,TFG.[V\+8Q<1H5Y8$8Z':3DCL=GPMID>HWOC;2]0LM0^Q
MZA<*P>[A9/-C:!%R"0!G.>!RN.0.E>BUGZUILVK:>;6#4[S3GWJPGM"H<8.<
M?,",'Z4 <AX0AU.72KV778?M,NE02Z5#M;/VE4)WR#'=PL:^N4/K47@Z"_TW
M7[2QL;N[U#P^UD[(-0MREQII!3;$7(!(/]T\C9Z#GN]/L8=-L8K2WW>7&#\S
MMN9B3DLQ[DDDD]R35F@#B/B9)'%9>'))49XT\06;,JH7)&6Z*.3]!6/XAMKB
M?7/$?B32](&I6ZZ$MF8)("4O)O,+'"]7"IC..N=H.1QVOB'P\/$ TX->26XL
M;R.]38@.Z1#E0<]N>1^M;0S@9.30!YOHD[?\+*&H^7JTUI/H2H+NYLGC4LLI
M8C;M 0 =!@9[9SDX.D1:CIGA/P-J4NG7S6FDW]RU_:BV?S8Q(9%23R\;B%WY
MX!X->S44 <-X6N/M/Q%\57D=K>):W<%D8)I;62-9-B.&P64<C<.M:7CW2;G4
M_#+SZ>N=4TV5;^RQU,L?.W_@0W+_ ,"KIZ* .$UJ6]MO YU*32#<75]=P7-S
M"T'GM:H77#>6/O-$BKP/XESZURVH:=J>I/X\@TVTU.::^MK&>UDNX&C^TB/)
M=<D  G&W;@=>F*]DHH X63Q!!K^CZAJ6G^%;FXOHM-E1TO[)HF)(S]FRPR^3
MU"Y''J163H,LLOCSP_?BVU1X9-&EMVDEL7ACBDWQ'RPNT!% !P3UQC+&O4**
M /&S%=CX%S:,VFZB-0M[D1O!]CDW%OM>_P"7Y?F&T9R,CWKJ[>>71?B1K%]?
MQSMIVK6=L;.Y6%W5#$&#1' )4G?N /7)[UW-% 'D5GHUYI5GX1BGL[D(/$$]
M\(5@9OLL#B78&P#M^\O!Q@GVKJ_"H=?'/C.1H)XXI[BW>%Y(619 L"JQ4D8.
M&!'%=E10!POBVY@M/B5X)FN ?+5+_P"8(6VGRX^3@<#W[5S>IZ-J4;:WXBT[
M3[N6Q?7;:^%G!NCFGACCV2N@&#DLQ8="=F>XKT/4/#W]H>)=*UHWDD;Z:LJQ
M0J@*L)  VX]>BC&,8]ZVZ /*M?33M7\#^)[_ $31=5^T7MB+<S7,4YFN''W4
M5'RQ"^N,<\$\X]+TYT?3;9HU*H8EPK(4(XZ$$ CZ5:HH X?QM:ZCINM:7XCT
M.-7OGSI<\;' DCE/[MCZ[),-]"U4O$MHWAG6/#E[]CU*[T2TLY;"<V+2&6$L
M8RLI$9#,#Y>#]<]<5UB>'A_PD4FK7&I7URN0\%G(Z^3;MLV%E &<D$]2?O&M
MF@#S6=[735T>?3- O;/3[S4YIY;TVDD]S"S18\T(P9D:1LKD@\<D9;C E@N1
MX,UNQ;2]4,A\4BX5)+21V>(W"/NZ'=\H))YKVFB@#(OO$-GIVJ:98S171;42
M1%,D#&-",8#M_"3D 9[UF_$73-0U?P'J=GI:&2[(218@<>:$=69/Q"D?C713
M6D,\\,TJEFA):,$G ;&,X]<$_3-3T <+>./$OBSPKJUA%<QQZ:+B>[DE@>,Q
M*\>WRB"!EBV,J,XVD^F9_AA&T'@_R9;:>WF6]NF9)H&C;#3NRG# 9RI7FNSH
MH X[QK917E]I3+?W^E7\*S/:ZG;1F2.(_("DJX*E6X.&QG9UK -SJD-QX$UW
M7-.EB,!O(KPVEH[;&D7$;F-067?M!QC@M@XKU"B@#QUXM6&G:Q?VVD:@YL_%
MHU1[4P,KW%N%4'9GAB",X!SE:V_%-];>(? ?B6[TG1;L27=EY(F:Q>.:Y?D*
M@4KO8+GJ1CGCO7H]% '!N6?XA^%9XK:Y\B/2[B*23[.X1&;RMJL<84_*>#Z5
MH_$B%)_ UZ&6X+)) \7V>/S&$@E0H=HY8!L9 Y(SCG%=765KVAQZ]910-=W5
MI)!.MQ#/:N Z2+G!P001R>""* .-TG6=)U#Q)J6J37-R-4N-.%K':MIT\ ,<
M>YCMWK\[$L3@<@#H>36?;V&I?\*4T!;33KM[K37MI[FP5'AFD$<@9T4<'=W&
M.I'%>@:=HL]M,D^H:M=ZG/'GRFG2-%C)&"0L:J,XR,G)P3C&36O0!YC?7.GW
MOA_6=<T3PO?WUR;189#J<,S-*-ZG8(Y#F0(-S''&0 "<G"62SW7C76)88=5N
M(K_0$CANKJU>,2.&ER.54)U  P/7!SFO3Z* /((9;RT\+>!=2?2]8DL])MS:
M:E!#%+%/&QB5=X4;68*RD$CC#'K5O7K:PF\-Q76D:)J$<-WK=I<R>;!,\LX2
M12\K(P+ 8'5L9QTZ9]4HH 12&4,O0C(XQ7CWB":[O;34XSI.HV\UKXAAF-K:
M6#^6\2SI_I!95_>LP&>"?]WC->Q44 >?V;D>-O&EU):7:17%A:K$[6SXD*I)
MN53CYB-R@@9K$M(9XO!?PV@-C>+-9W]NURGV63="%BD5BXV_*,L.3ZUZW10!
MY=;17-GX4\8>&M2LKF;4;JXO&M@L#,+Q9\F-E8#'4X.3\N.<"K-G!<^%_&FB
M-J,5W<+_ ,(Y'IWVB"W>8/<(X)4E0<9'.3@=>:](HH \;TR*Y7P=X(MYM-OT
MFM?$3SSHUI)F./?<$.?EQM^=.>G-7]9LKN]E^*$-M973O>6<(MOW#@3E8"K!
M"1AB#QQ7JM% &=H5VM[HEG,D4\:F)0!/$T;< ?PL 1^(_2O+_$<UW>V6LP_V
M3J$$UMKT,HM;2P?RY(EFC_TAF5?WK,!G )QQ\O&:]AHH \QUJ.]@U^]U3P[)
M?17TEU +K2+NV9[>_&V,>8A(^1E7 + X!CYQ7HFI.$TRZ8AB!$W"J6)X[ <F
MK5% 'D=M!-'X%^'%N]A>":SU&V>YC^R2;H0L<@9F&WY0"PY/K5C5Y;JVU;XA
M7,&B2Z@)8;$0PS6;O'-M!60@8P^S.< \XKU2B@#SOP\6E^)5_<-#JEQ:WND0
M*MU>6CQK(5>3=D%5"]0-N!GK@YS4GA#2;ZRUVXT*==VDZ!.\EA(6SN$RYC4^
M\:M(O/9U]*[;4K1[_3;BTCNY[1Y4*K<0$!XR>ZY!&:AT?2H]'LO(6XGN97;S
M)KFX8-),^ -S$ #H .    * ,[QW9W.H> M>L[2%YKB:QE2.)!EG8J< #UKG
MY;7_ (2/5?"$NFQ31G2P\MQ</ T7DJ82GE_,!\Q8C*]@O/;/H-% 'E'A**VE
ML-)\.ZUX?UA];TJ:/(F:<VRM&>+A7)\O&.1W). .:[3Q[87^I>"-3M=,C,EX
M45XX@VTR;75B@/\ M!2/QKHZ* /-8[W3M7T^_P!7TSPKJMUJ=OILT;QZJL_=
M?^/?$A._<>H7(P.N2,U]$N'/CK0]3-OJKV[:)+ \LE@\4<3[XFV!-HV* #CU
MQC+&O4J* /)K*VG7]GR^L!87:WIMKJ(6QM7$I=I'*C;MR<@@YQ6M>QRW'C+P
MFUM#<QHNE74+3"V<+"[K&$#'&%.5/!]*]#HH \K\(+:7%CHFA:MX>UC^V](>
M(%;@SFWB:+Y?/5R?+QC) '7. ,<UD7,E[;_";6?"EYINHR:[#<R%@EG)(+D-
M<^8)5<*5((/KG(KVNB@!D4BS1)(H8*P! =2I_$'D?C3Z** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH S/$&NVWAO1IM5O8YGM8,>885#%02!G!(SR1TIDWB&U@\0'17AN?M7V1KQ2
MJ;E>-6"G&#G.6'&*H^/](O-=\"ZMIM@@DNYH1Y2%@N]E8-C)X&<8K)@&LWOQ
M!L=>?P_>6]DNDRVS"62+S%=I$8 J'QSM.,$^^* +EC\1-(U!-)GBM=12TU2;
M[/!=26^V/S26 0G.<G:<8!'8D'(J#QQXAC;PIXE@L8[^22QM9%ENK-]@MY?+
MW*"P8,2,J3M!P#S6!9>']>@\ ^#]-?1KC[9IVKPW-U$)8ODC25F+9WX/##@'
M-2R:7X@TS2?&^@KHMS?)J[WEU8W<,D>P^>A^1PS @J>.AS0!U6FZZMKH.EPK
M;75_>_V;%<20V^TN$V@;B791R0<#.3@X!P:KGXBZ&\&D2VJ7UX-6CDDM!;VQ
M8N8P2R]OF!&,=CUP.:YMM'UG2M4TO59?"HUBWETF"QN[,M"TUK+%NPR[CM*G
M<0<'WK6GTK4QXF\'W<6AK!;61NVN4M6C$=N)4PJXR-Q]2HQG)H ZE]7V^'3J
MZ6-V?]'^T"U=!',.,[2&("MZY-<#J7B.ZU/0O FO31WEF]UJ=OYL44A*S(\3
MN0$1CN&0,9&>.E>CZA ]UIMU;QXWRPNBYZ9((KSBWTG7SX5\"V,F@W,<VC7U
MNUTIFA.$CB9&<8?D$L,=^O [@'86/C'3;NWU22:.ZLI-,D6.Z@NHL2*6 *8"
MD[MV1C')Z5-8^);6\UV71);:YLM12 7*PW 7]Y$3MWJ59@0#P1G(]*XS6?"^
MMZO>>-Q!9>2;Y[&>PDN&0QSM;A258!B0"5QR!UKHO"WVBZN/M,_@^'0&CB*2
M,WE%W<D<(8_X!@\G&>,#K0!!XIUJ\E\7:%X3L+A[5M0$EQ=W,?WT@C'W4/8L
M>,]0.G-:D_AUHI+.73=0OX3#<(\L<EY)*LT8/S*V\MVYR,9(P>*S/%F@Z@WB
M31?%6C0+=7NF^9#-9EPAN('&"%8\!E/(S@'UK;M=4O+]HQ%I-U:+D&1[P(NT
M=P K$ENWIWR<8(!2O/&FFV4%Q>/%=/IMM.;>XOXT4Q1.#M;/.X@-P6"D YYX
M.%N_&-E;:S/I$5GJ%W?16RW0CMH,^8A) *DD ]#SG''7/%<K;:!K5EX'USP6
MVG23M</<QV=[N7RFBG9F#N<Y5E+G(QDX&,UK:;H]]I?C[[2MC<2:=!H4-@ES
MN3YY(W9L8W9Y!'.,9H LV_Q#T>Z@TJZBM]0^Q:E*D$=VUOB-)6.!&Y)SG<-N
M0" >,TE_\1-+L)]4A%AJUS)I;*+L6]F6\I2N[><D?+@Y]^V<&N8M_#^O1?#;
M0-*;1KC[=::O'<S1"6+Y8UN3*3G?@_*1QG.:T-+O+B'QMX_BATRXNVDDM=BI
MMVEC:H-K$D8^O3K0!TC^,=-;[*+%+C47N;(ZA&EJJY\@8&_YV4=2!CK[<5%)
MX[T=8]$>-;R=-:0O9F&W9MV$+X/H<#&/Z<US5AX=UW0X=%T![*74=)@TGR6:
MWF6-!=EB6,N2&,>#P,'OE2<8@T+0]>M;/X>QW.B7$9T<RK>?O8CL!A:,'[_.
M2>V>/RH Z9_B!ID6@7VL2V>HQQ:?<FVO(6A7S;=^.6&[&WYE.02,'ZUNOJL:
M:G9V'D3-+=1/,I7:515VYW'/JZCC/6N<\/Z)<27OC"#5M-DCLM5O2\?F,A$L
M1B2,_=8D?=/7%)\/--OK73)9=2N5NI(&;3K68?Q6T+LJ,?\ :8YR>^%H MZ9
M&_A#2+V74]0OKR&6^'V87<PEF'F%$6/=P.7)QS@!AD\&MK3M2&H-<H;2YMI+
M:41.DX7))56!!4D$88<Y]?2J?BJS34/#\UG-I/\ :L$SQI-:A@K,F\;F4DCE
M1\PY!R..:SO!6EZGI U*VN+F]FTL3+_9POW#SHFT;@3UVAN%SS@?2@#1O?$M
MM9W-Y"EK=71LE1KIK<*?)W#(R"P)XYX!XJA;>+9)/%^N:5/830V>EV\,KW)*
M$#<)&+G#9VX48P">#D"L3Q;X?OK_ %>\U'1[*^L->A$:V.HVLJB*Y7 .R=2V
M"H);.X=,8STJW)8>(+'QAXFO+#3Q*VHZ;"+2Y9T$23Q)(-K@G=RS+T!&.XH
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MJ=?%%M?0QP0Z=JCW4MK]HELQ&(IX(R2 7W,NTD@X .3@D=,UQ>AZ%X@M-(\
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M9&[!RP+';\V%!."..17GFA:?=>)_@^GAN&QF7[7=S(UTVWRTC%VSL^<YR,$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *R]/T"STS5=0U*W:<W.H,K7)>4L'*@*IQT&
M .*U** "BBB@#.UK0['Q!8K9Z@LQA6191Y4[Q-N7I\R$&KEM;PV=M%;6\2Q0
M1($C11@*H& !4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !377?&R[F7(QN7J/I3J* ,W0M"LO#NFKI^G^:MLK,ZI)(7VEF+-R>>22
M?QK2HHH **** *NI:?;ZMIMQ878<V]PA1PCE&P?1@013=+TNST;3X[&QB\N"
M/. 6+$D\DEB222>I)S5RB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHK#O-7>7Q/;^'[1]DWV<WEU+@$QQ;MJJ,\;F
M;/T"MWQ0!N45EWWB/1]-DE2\OXH1"5$SOG9"6^Z';[J9XQN(SD52O_$$>GWF
ME7:W,5SI&ISK:K(A!$<K ^6RL.JL1M/7DKCC- '0T444 %%%% !17*?$?6-0
M\/>!=2UC3+@175HJNFY%=6RZJ001Z$],52O-=U?0/&WA[1YKN/4K76!*K*T(
M2: HH;>"O!3G!R./6@#N**S=2\0:5HY/V^\2 *H9R02(U)P&<@84$YY; X-5
MI=1M3XGM8%UZ)"+225M. 0^8N5Q*6ZJ /P.: -NBL%?&OAEVMPFMV;?:93#$
MRR95GR5QGIR00/7'%(_B33M4L]4@T?5H7O;2 NQCPQ3@X8 C##CKR* -^BN+
M\%^-]-U31=#M+[6;:37;JRCEDB+!6=RH8\#C/? [=JWF\3:,MA=WS:A$MK9R
MF&YD.0(7 !*OQ\I&1U]: -:BL34?&'AW299(K_6+2"2.(3.C2?,J$@ D#UR*
ML_V_I?VI+;[6ID>01*0K%6D(SL#8V[L<XSF@#2HK,N/$6D6MZEG/?1QS/*(5
MW9V^8>0F[&T,?[N<^U5;OQGX;LOM/VC6;1?LKB.?#[O+8\X./U].] &[165!
MXFT2YU9=+@U.VDO70ND2/G< ,G!Z' Y('-.E\1:1!?QV4M]&D\DODINR%:3^
MYNQMW_[.<^U &G16!<^-O#-IYWGZW9KY,ODR'S,A'XX..F,C)Z#/-+<>+-.M
M_%MMX=9F-S-;-<%@A*J-R*HSC!)W'Z8YZB@#>HHK+F\1:1!=BUEOHDD,H@R<
M[!*>D9?[H?\ V<Y]J -2BN-UWQ)GQA9^&8;^6Q\VTEFEN(8PSJX**BC<I&/G
M)/'8=.:Z?3(;RWTRWAU"[6[NT0++<+%Y8D;UV@G% %NBN'T>^UK5?&?BC27U
MB6*WTJ2W6 I!%N(DBWG<2O.#TZ5M0ZW;Z/I5K)K>KP2?:92MO<[-JS!F)C'
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MUNVO[R[EN;>)+=V$D3Q1@,& VXRI'7J,=>*])_X1FR_Y^M6_\&MS_P#%T?\
M",V7_/UJW_@UN?\ XN@#F+1X;GXJ6,SP2>6WAWR=TL#* YE!V'<.&VY.#SBJ
M(%UI_B@2Z'=R7%M=:P5O]$O(LF(^80]S"V,JO&_NISUSQ7:_\(S9?\_6K?\
M@UN?_BZ/^$9LO^?K5O\ P:W/_P 70!YYIBZ<\-YX5\2:3J]QJJW\TL40:Y\B
M[#3-(DJLIV*.023C&#WXJ^QC_M+XG,8SBX@C6(F,_OL6NPA>/F^;Y>,\G%=I
M_P (S9?\_6K?^#6Y_P#BZ/\ A&;+_GZU;_P:W/\ \70!PT!6.+X6@1LIMDQ/
MB,CR<VI0[^/E^<XYQS570ETZ6T_X1;Q%I.KSZW;7KNL):Y\B<^:72=74[%7G
M))QSG@G@^A_\(S9?\_6K?^#6Y_\ BZ/^$9LO^?K5O_!K<_\ Q= ' 7BH^E_%
M-1$QDNRX@'EG,W^C*HV<?-\^1QGFM*RF-MXX\,7LD-PT$_A]K19$A=QYWF1'
M:V!\IP#UQC!KK?\ A&;+_GZU;_P:W/\ \71_PC-E_P _6K?^#6Y_^+H V:\@
MBM[B7X3:IX.O;>5O$0EFB6$H<SR/,7293CE?F#%N@P<XQ7HW_",V7_/UJW_@
MUN?_ (NC_A&;+_GZU;_P:W/_ ,70!SLC&W^*NBK/(TABT66"6<J=OFEXR 6Z
M G:3BN[K&_X1FR_Y^M6_\&MS_P#%T?\ ",V7_/UJW_@UN?\ XN@#AM,30YOB
M)XUN=9L89[>>2T%M+<6AD5PL.U]C%2#R,'%;%_\ V3J_@Q/#=O92_9+@C3K$
MS1LN BC$O(!4(0<$XW%1C[PKH?\ A&;+_GZU;_P:W/\ \71_PC-E_P _6K?^
M#6Y_^+H X">^F3X4^+M U&-AJ>F6MS'+<%6VW@()$P8]2<_,,\-GVK1DM8-=
MU7P1+HX ETU'DGF1,?9XC!M\MO0EBORGG@G'%;VN>![36-&NM.74=3A%S&8W
M=[^>4!2,'Y6DP?QR/:K-EX2MK:RA@EOM4D>- A==2N$!QQT\SB@#A?"8TRZT
M_1_#VM:1J[^(=)N(R897N?*62,\7 ?/E[<9;WS@ Y&:FHQB7X=_$:*.!VN+K
M5IW@01'?,#Y>UE&,L,AL$>AKTS_A&;+_ )^M6_\ !K<__%T?\(S9?\_6K?\
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M+2*Y*G9!,K[F5S_!N&.3C)7':H]-\(3:MX5\46QWVJ:CJLU]I;,I5H6!4QR
M'E<NI;'H?>O1ZRM<TFZU:.W2VUF\TU8Y-TIM0F95(P5)8''U'2@#D;:XO=7^
M'6N:_JEJ8+[4-->!8!\Q54C90H Z[I&D88ZAU%44$6[X79B.+:,^=^[/[D_9
M2OS<?+\^!SCD5Z9;6\-G:PVUO&(X84$<:#HJ@8 _*I: /']2BO96\8SV%K<W
M(AURSOC;P;E>YAC6+?Y9&,G*GD'JM7]1DT#6/"_B;5M%L=2>YGT::T>ZNA<;
MG8J=D*K)]XY)Y4<<#/->HT4 >;JT8\2_#IHD(2&QN(Y"J$"(M"@56X^7+*0
M<<BG>%->MO"WA353JEO?QFTU2Y\Y5M)&($D[%2./F!# Y&>/PKT:H+NUCO;9
M[>;=Y4@PZJ<;E[@GT- $L4B31)+&P9'4,K#N#TKB[B7[#\7_ +3/%.+>XT-(
M8YEA9DWK.S,"P&!A2"<XXKM0 JA5   P .U+0!XQ;KL^%NE1>1(MRGB)9WC\
MI@X47A?>1C.-F#GTK2EETZVUWQ'HOBC3]6N$U2[,]F;;[0\-Y$Z(H0>6=NY=
MN#NQQCG%>JT4 064(M["VA6+RA'$J"/>7V8 &-QZX]>]3T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!@^-BZ>!]<FBFFAF@L)Y8I(96C9'6-B""I!ZBN7\/W.C7^@^&XVUS4#K%
MY# V5U*=R91&)'W*7P0=K9!&.<5UGB^VNK[P?K%C96SW-U=6<T$4:LJ_,Z%1
MDL0 ,FL?2I-:L/".D:=_PC%TVH6=I#"K2S6_E1R*@0N2)2=HY/ R1VH M7?C
MBUMKW6+.+2M5NKC251[A((5Y1@S;E+, >%Z=3G@'G!;>.]-N[K242TOUM-6
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MT965ESNSDC&!CKS1XKL-2N_$?A>YLM.EN8+"\>>X=)(UVJ8G0<,P).6!X[4
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M6&Y247YTTVKA1)]H!P4SNV]LYW8Q^53OXGMH+7S+FTNX)S=BSCM75?,EE(!
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M63W\=U($,;1+M)/RL2#AP<$ XSZ8K$\.)KS0QQ7W@^QTZ[M8F$ET'B=;APA
M\L+R QP3NQ@9'.>*&D^&M2TB]EN-%TJXL=/GL)S=Z+=SI);-<D#8L0#$*"=P
M8\+C'T !VFFZXNI3QQBPNX%EMQ<122["CH2.A5CSR./>F^(_$5IX7TO^T;Z*
MX>#S$C/D)N*EF"@GD<9(KE?#_A&>SU.ZM[2+4],\.75D5ET^6['[FX+#!@9'
M)0;=V<$#D8]G^*/"$T'@^XTW0H=1U">>[MIBMS?F4J(Y4<X:9^.%/ [T ;T/
MBN.8"/\ LK4H[QY)%CM)HTCDD1-NZ0;F"[/F49)')QBN8\2>(;7Q!H6A:CIL
MUU 8_$=I:SPES&R.)@KQR*IP?U'I5_Q;I>J_\)!I/B+3]%CU=(;>2UN].E>-
M7V.58.A8[=RE>>>1TJ+7=*U?4-!TD6V@)!*FLVU[)9V\D0\F*-U)W-D*SD#M
MGKC)QD@&QJOC?3M(?4C+;7DL&F-$M[<1(NR$R $9!8,V RD[0< TT^)KO_A8
M1\/#39OLZ6 NFG#QX.Y]H;!;(4;6'J2>F ">5\8Z)XHU^T\4V#Z.]V)U0Z5*
M;J-88T 4E=A;/F[@WS$=\;@.N[-IFK2^/DU1M,<65[HPL9G6=,VSB5F.[G)^
M5OX0>1Z<T 7_ /A-]-6ZTQ9(;I+35)1!9WK!/*E<@E1PVX;@#M)4 _E7-_$K
MQ$EYX!UE].BU!HK>40?;K:0)&)%D"L.'#,H.5/!&?H2)/!VEZYI<%CH6H>%;
M%6T\K&-9#Q%)8D/RL%^_O( '/0\Y[''G\/>*+7X<:MX*CT26[D69S9WR7$0B
MFC:?S/FW,&5AD@C&..M 'KM%,B9GB1WC,;D E"02I]..*?0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !16/XFUY/#NC&],7FRO+';P1%MH>61@J@GL,G)/H#6:_B#4]-\5V>@ZA':
M3-J5O++8W$*M$IDC +QNI+=B"&!]1B@#JJ#R*Y#P1K_B#Q/IMGJ][:Z=;Z=<
MP.=D3N9A*)"HZ\;< ]\Y ]<"]K7B"2TUFWT:TPMU+;O<M*UK)<"-%8*/DCP3
MDMUR ,'VH O:3H-AHC7C6*2H;R=KB??,\FZ1L9;YB<$X'3TK3K@6\9^(8K+0
MC<:)#;75]J9T^9+AG0'Y799$!&0K!<\\C.,&C_A)_%1D\26*V^D?;=$"S&8^
M9Y<T;1[U4)G(;@@G=CIP: .^KGWT[PUX7OKWQ!<-!93W;8FN;B<X)..%W'"Y
MP.%QG ]*Q#XSUB^N_#4&EZ?9 :[IK7J-<RM^Z(5&P0!R!O[=<=NM8/B7Q%>Z
MY\,O%-EJ]I#;ZII=W#;7"P$F)_WL;*Z9Y (/0\T >LT5SLNN7E_XDO\ 0](:
MVCFT^WCFN)KF-G7=)NV(%5E[*23GN.#VP/\ A/[^30=.UD6EM;VRZC_9VKK)
MN<VCA]A<$$ KNQUZ!@?6@#T&BN/\2>*-4TG3O$FH6,%G/;Z3 I42[E+2[=[@
MD'D!2G89+$9&WF*7Q'XCA\2:;I;VNF%=6M)9K5@SY@:/86\S^\,., 8YXSWH
M [6BN%LO'-T=(87UM"-4769-'_T='>-I%!8R!1EL; 3MZY&,C.1!JOC7Q#I&
M@^(KR728I#I@CDMKJ2"6WBN4;K\C98,IX(S@]<B@#T&BN3AU[6QXP.@WD5A'
M]JT][RTEB#OY3*ZJ5D!(W??!R-O0CWJAX&\3&/P%I^K>)]:L(?M;R%99V$.6
M,CDC+-@]. ,8 H [NBN-UCQ7J)US1+#P\NEWD&K07+PW3S,R!H@#G*=5RW;/
M3MUJ"Z\6:V8-1CL;2";4=+5(YX([6>9+FX\M9'2-UP$'S  MDY/( &2 =<=4
ML!J@TS[9!]O,9E^S!QYFP8&[;UQR.:MUP@N&O/BEX>NI+>2VDFT&>1H91AXR
M9(3M;W&<4ZU\9:F-?T33[^"SC?4Y9XI;6(EI+)D1G4.X8JQ(7D84\T =S17G
M.C>*-4T_3?$VI:K<0WGD:T]C!%'"R$N6BB0#YFPO(R ">IY/%7YO&=_HLFJS
M:Q8O+I=G8F[COHK.6W#.#@PE9"?F.000<<]J .LGU2PMM0MK":\@CO+K/D6[
M. \F 22%ZD  \U;KSO56U:3Q]X!EU+[&!)+=-L@1@8F-L^5+$G>/?"].G/'7
M^(M:30-&DOWC,C>9'#'&,_-)(X11P"<989P"<9X- &K17)V>L^(KG5[S3A9Q
MM']D$]KJ#V4T$/F;L&)U<YST(8'IVXQ4/A+Q3JWB1BDMK;VLUCOAU.%T8&.X
M#$+&AW'(V_,6P>"N.IV@'945YG-X[\4IX=U'Q!'I.F/9:5>SP7<(E?S9(XI-
MK-&<8& ,\]>>!CG8O_&-Y<MJ2:! LTEA'&P22SFE^T.\8D"!DX3Y67DYY;I@
M<@':45Q*^*?$%[XDM-(M=,M+1[K1_P"T/],9R\#[U4JZC&<%B, \]<CI56+X
MAR#PMH^J:@MMI_VN[EM+JZ=&DM[=XV=<G!!PS( "2,9Y/% 'H%%<G+XHNHET
MJR8VS7^H+/*L]M#)<0B&-@ X5"2VX-'QD8R>>,'.E\=:AIVCQ7&MV(TS.I-9
M27TUO)Y CVEDGV$A@K$*N">">3QR =[58:A9MJ3::+F(WJQ"=H-PWB,D@-CT
MR"*@T6ZN+W2H[BYDM9'=GVR6C9BD3<0C+R>J[3U/6L<ZW>_\)WJ&C)96>8M*
M2[AF+'>^9&4*QQP,J3@ ]: .HHKSK2_'.NW6F^%=7N[+3TL-:N5M7CB9S*CN
M'*L">,97!')[Y[#7_P"$AUS4[6\O] LK6Z@M+YK06LAVR7 1PDC!RP5,'=@$
M'(7WP #?UK1K+Q!I4VF:C&\EI,,21K(R;AZ$J0<5;@A6"!(D+E4&T%V+''N3
MR:Y7_A)M1^W^+K,1VN[188IH'V-B0/&SX8;O]G&0??VJ@?&.O71\*0Z?8Z?Y
MNO:<]UNGD?;%(L2/@@<[<O[D^W6@#O:*X>V\0>+KOQ'>Z)'9:,D]C!:332-+
M*4(DW>8%XSGY3MXXQSG/#4\::I>PV.I:7IKWEA<77E-;I9S>8L.XKYPE^X<8
MW;<=#C/% '8WVH6>EV<EW?W4-K;1C+RS.$5?Q-%S';:CILD<CDVL\7S,CE,H
M1_>&".*\_P#%VMWVO^ ?&$VGBU73[..YLR)49GF*+B1@00%P<@#!SM[9X[S1
M_P#D!V'_ %[1_P#H(H J^&ET:'1(;70;A)].MLP1F.<S*NWC:&).<=.M:]>1
M:1K>O^'/"^NZOI]C87.F6.LWTMU%)(PF>,3MN*8&T8'/.<X/3OV=MXGN?^$Q
M73+S[-'IUW8?;;"<*RM*!C>K$G *@@^X.>,4 =545S<V]G;27-U/'!!&-SRR
MN%51ZDG@52T"\N]1T6WO;U8U>X!D18T*XC)RF023DK@GT)QVKD([W5[OQ#X[
MM;N\@DL[.WCCCB$)!"M SC!W8SEN20<^W H [NTNK>^LX;NUE2:WF0212(<J
MZD9!!]"*FKS/PAKVK:7HW@.SN+>S.F:G9QVR%"QF1U@WJQ/W2#M(QCCU-:3^
M--4N;>+4M)TU[VS-X8&MDLYC(T2R%&E67[G8MMQTXSF@#MY98X(FEFD2.-1E
MG=@ ![DUE_\ "5^'-N[^W]*V^OVR/'\ZUZ\I^'&HW5O\*M/@CT&XNX6FFB:3
M=%Y6QKAPQ(+[B "<C;VH ]55@RAE(*D9!'0TM<E=ZSJUMXQA\,:9;6*P-I;7
M,4T[NQ4HZ)@@=1\W3.3ZBL1?'?B!?"T>OS6.FK!:W_V*^B5W+.1/Y):(]%&2
M#ALYYZ=P#TBJESJEA9W=M:7-Y!%<W3%8(7<!Y"!D[1U/2N4N/$7BF[\2:_HV
MCV.E>9IL4$L4ES*Y$@D#G!  Y.T>PYZUCS>(%\51_#O6A;FW>XU1P\1.?+=8
MIE9<^FY30!Z=17&3>*]3NM+US5](@M)+32)Y83!,&WW/DC]YM<'"<[@N5;.,
M\9X=;>,+BX\0Z H2!=$URS,]I.R-YGFA0_E-S@$J20?]DC'>@#L:*X]O%ETD
M=FI6(R:G=S1V31V\D@$$88^8RJ26R , 8X8'(YJ"/QGJ=M:R1:GICQ7;ZBMC
M9S"VE6.Y5E+B01G+C"JV5YY YYR #MZ*Y[P]K&K7VHZE9ZE8,D5L4:VO5MI(
M$N%8<C8^2&4C!Y(.<TNH:Y=V7C71M&5(6MM1@N)"Y4[XVB"GUP0=_IVH Z"B
MO/;CQWJ]OH=Y>+8V<TUKKW]DD;F0,OF*@8#GD[O7 ]ZFD\<:EX?UK4K#Q3:6
M:10Z<^I6T]BS$.B'#1D-_'R,'@'/:@#O**XZ?Q3JFE/X?N=3@M&L=9GCML0!
M@]K+(N8P221(I/RDX7'7':L>[\=^(K?0M?UC[!I@M]$U&2VFCWN6FC0IG:>
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M.3QTH ]*@GBNK>*X@=9(94#HZ]&4C((_"I*X#P[KVK6$WA#2KRWL_L&J:=B
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MC27L8679)<2W&R-=L<6]BVQ%R<*.@_/OBJ[^';W_ (32Z\01WL 6;3EL5@:
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M4K#PU:W/_$RT^Z1I8[?(:W@*'S QQPKQG9]67TKO::$4.S!0&;J0.30 H
M P!T KE9?"E\NN^(+ZUU.%(-9@1'ADMBS(ZQF,$,&'RXYQC.1U'?JZ* .+@\
M%7T-EX2MO[3MR/#Q4[OLS?OP(S&/X_EX.>_-)IG@[6=&O;FTL/$"Q^'I[A[C
M[(UMF:'>VYHXY-W"DD\X)&>.>:ZF34!'JT&G_9KIC-$\HG6(F)-I VLW9CG@
M=\&JNO>(K#P[I4FHWGFO!'(L3>0F\AF8* >PY(ZXZT :<HE,3"%D63'REP2
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M-6RE1+(A$8;P&7YR=N'/!))/<#BNUHH XZ+P;?1)X17^TK<CP\NW_CV;]_\
MNC%_?^7Y3GOS56SCT7Q;X]M?$&D71N(;&V:*ZDBSY4LF[]TIR.63,C>V5]17
M=TU$6,810HSG &* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!SGC;7IO#_AX7%MM6XGN8;2.
M1AE8C(X7>1[ D_7%4+B^U+1O'>DZ,U_/=V&LVUQAI53S+:6)0VX$*!@ANA!
M(&..*Z/6='L=?TFXTS48?-M9UPZY(/!R"".A! (/J*K67AZ*UO([V>]N[Z\A
M@,$,]T4+1(<%L;5 R=JY)!)P.: .=^&EM+%!K\CWMQ,/[<ODV2!,$B7[_"@Y
M/UQ[5=\=W^J6"Z!_9FH-:-=:O!:2_NU<,CYSU&>PZ$5K:#X>M_#T=VEM<W4J
MW5S)=2"=E/[QSEB,*,9/;I2Z[X?M]?\ L/VBXN8?L5TEW%Y!4?O$^Z3E3G&3
MQTH YG[1K*Z\_A8:K=W4MM8"[>[!AAFD\R5U7^ KA H' &2>?2EBNO$20Z'8
M:SJ<0U!HIQ=0:8 9KEE(".I(VHH!RQ.T;B!GG%;.O^#;#7[^TU%KN_L-1M4,
M:7EA/Y4A0\E&.""N><8ILO@K36O=.O(;F_MKBRB>$2PW!#3(Y#.)&.2V6&[.
M0<\YH Y:Q\5:_/X"\/ZS<0WMY$TDRZF^GQH;@*C.BN$Z$94%MO/IQD5=LO%#
M:I>^&M)L-9>ZM]2BNKE]05%621(VPL8!7"M\V&^4$;#C&>-K3/!%GHUK:6^F
MZCJ=NMJ\K1$3*_$C;F4AE(*YY''OG-.;P1I7V6P2!KBWN;">2YM[R%E$RR2$
MF0\@J0V3E2,>PP* ..U[Q-X@TS1_&EA'J4GVK0Y+:2UO3$A:2*;'R.-N"5^8
M9 !/!^N^E]JVE^/Y]+GU@W-K<:/)?#[5&B);RI(J\;0"$PW0DGCK6G?>"].U
M'1M0TZYGNV_M&19;RX#*)9BN-N3MP  J@  =/<YDO/"5EJ&K'4;NYNII6L7T
M]T+($>%\%@0%!R2 <@CVH YK1==U4>*/#5K+?W%Y;:G83R7$LD2K%-*@0^9"
M,!POS$#( (((SUKFM/GUW0_A<WB73-9=$T^\NI#IS0H8IX_M;AE8D;MQR<$$
M8X&.]=_8^ =.L;G1[@7^JS2Z2C1VQENLXC8 ;"  "!M'N<<DU+;>"=.M8#9B
MXO)-,^T&Y&GR.IA#E]_7;O(W_-M+$9[4 8&H:H=(\?\ B?5A$7-IX9BN?+/\
M6UYFQ^E7]*;Q1-J.C:B+M)=,N8<WR3RH0VY04:$*H(Y[$G(/KS6V?#-F_B"[
MUB66>66[M1:30N5,31 DA<;<]6;OWJEX?\#:=X<G1K6^U2:WAS]EM+FZ,D-M
MG(^1?H2!DG )]: +/C77W\+^#M3UF.-9);:(>6K_ '=[,%4GV!8$^U<UJEE<
MV/Q(\%/<:G<7N8[W?YJI]X0C++M QGTZ<#'?/<:GIEGK.F7.FW\(FM+F,QRQ
MGN#_ "^M8%GX$L[6]TFZEU75[N32MXM/M%P#M5E"E3M4;A@8YY]2: .9E\4Z
MS+\,1X]MKYA*K&Y-B53R6A$I4Q'C=G;_ !9SN'IQ6U%?ZKXIN_$=OINJ/IDV
MFRI;VBA%(WF-7WR @D@EMN/13WK1A\#Z9!#-9QS70TN6X^TMINY?(W[MYQ\N
MX*6&=N[;[8)%)J'@;3K[7Y=9BO-2L;FX14NULKDQ+=*O \P 9R!QD$''>@"K
M9ZCJ;_$*71YM1,EJVAQ7>(D0*LQE9"R'&<8' )-<W8^(_$-YX6\$WAU=UN-2
MU1[2Z?R(R)$S-@XVC!'EKTP/7-=M>^$K&ZUFUU2*XO+*>"W^R$6DHC66'.0C
M<9P#T*D$9ZU1M?A_I=GIVDV,%WJ"PZ7=&[M@958B0[N3E>GSMP,#F@#!$OB!
M[OQCI8\37H32$CN+:X\F'S27A+[6.S:5!'0*#SUJQ8>)M4U]M"L(V>*:[T*/
M4[AK=TC9F?:ORE@0 #DD =UYQD'H_P#A%+47NM78O;P2ZQ&L=S@I@!5VKM^7
MC"DC\?7FJ%U\.]*N+#2+>.\U*UN-)C\FSO;:<1SI'@#86"X9< =1_6@#%GO/
M%]E)X4L-1U>**\NK^:UNF@CC<2((W=&.5&'P!P.,\X(XK(\2WVJMX%\?:9<Z
MO=3G2KA(XKDA$DDB=(V*/M4 CYR. ,CCIQ7?2>#[%WTEQ=7H?3)6GB<RAF>1
M@0SN6!+$AC^?TJ.?P/IEU!KT-S/=RQZV0;M6=1@A0H*X48("C\J *6M3ZA;:
MA'81:S=28T^658;=(_M+2;N)')4(L:C(&<9/]ZN;CO\ 4?$,OPRU"XU*XAGO
M4F>80! I<6SG?M*D9Y(YX )P!78/X)L7U*#4&O\ 5/M26OV2:071!N8MQ;$A
MQZDD%=N,XZ5'!X TJVTS1[&&ZU%!I$A>UF%Q^\4%2I7.,;2IQ@ ?GS0!B:CX
MMU+0+WQ]<2SM>0Z1;6LMG"Z* C2(Y()4 D;L=><"KNHZAJOA_4?#$W]IRW]K
MJMRMC=1R(G#NA998]JC;@J<CD8/KS6TOA+3O[0UB[G:>X&KQ+#=P3%3&R*I5
M0  ", D=>_-)I_A.TL#8![R]O$TX$6273JPM\KMR"%!8A25!8L0"?6@#A+C7
M/$D'A+6]=.OSM+I.MR6T</D1!)HEN%CVR?+G[I/W=OXUZU7*R> M.ET+4='>
M]OS:ZA=M>3_.FXR%PYP=G + ''M74(I2-5+LY P6;&3[G'% 'FNHZ]KEOHOQ
M"DCU:43:1+FSD\J/,:^2K[<;<$98\D9]ZT[.^U>P\;Z%:7.K2WEMJVGS2R0R
M1(JQ21^604V@$ [R,$GZUIS^!["XM]=@DO+XQZVVZ\ =.?E"_+\O'R@#\*M?
M\(O;'5M+U)KR\:XTV%X(,E-I5@ VX!><[5_*@"QXCNIK+PWJ%S;7MM93QP,8
M[FZ&8XCCAF'?_/6N+?Q9J.B:OKRR->7-G9Z -4ACO4579PSJ2-H!56VCA@".
M>!7<:YHMGXAT6ZTF_5S;7*;7V-M88(((/8@@'\*RH/!&G1ZJ=1N+K4+VX>R-
MC-]JN-RSQ$DX=0 #]X\# YSC/- %>W;5[6WT_76UK[59-8O->VSQKB5C&'0P
MX VXP>"3D>IYJ+0)-:UC2_#WB%-:01W<:SWMJ\:F(I(N0D>!D,K$ $GGG.:N
MZ!X(T_P\R+!>ZE<V\(*VUM=W)DBME(P0BX]"1SD@$@=33-$\!Z9H%T'L[K43
M9I(9(-/EN2UM QR<HF/<X!) /(YH YEO$VL7OPTN/'-G?O'-$\MPEBR*83#'
M*R^4W&[)5<ELYW'CCBKR7.NZWXXO].MM>N;"R73[2]B1;>)F0NSY3)7H0O.>
M>G/4';7P/IB)=VR372Z9=SFXFTX,OD,Y(8_P[@I(R5#!3SQ@D&]!X>M[?Q-<
MZ\MS<FYN(5@DC)7R]BDE0!MSP2><]Z /-O%.HWGBGX/:_KYOYH8WDE2*T15V
M+%'-Y85LC)8[=Q.>"1CC@]!XSUC5+%?$4UCJDOF:?IPN;>WLXT/D,%=B\Y<8
M(;  4'. 2!WJ_=?#;2+FWU2S6]U*WT[4Y#+<6,,ZB'S"02R@J2N2.0#CVJ>\
M\ :7>W.I2O=ZDBZG;+;7D27)"S!4**S<9W ''7![@T 9DNH:SJ7C+1]/BU>:
MSM+_ $5[N5(8HR4D#1C*%E.#\QZ[AUX[BCHWBO5;C3M"TNZOB;N\U:[L)+_8
MH<QP&0@@8VAVVJO3N3C-=5:>#[2SU*POXKZ_,]C:&SB,DBMF,D$YRO)RH/MC
M P.*IR_#O1YM#;2Y)[XI]L:_AN%E"S03EBQ=&51@Y)]1S0!5U6_UKPU;K;2Z
MFMXVH:K%:V4C*JRP12 G#'&TG*,%)'<9STK4\/P^(;;5]0CU2=9=-<(]D))%
M:>,]'4E5 *YP0>HSBDG\$:5>^'I]'U"6\O5G97DNKB<M/O7[K!QC:5QQ@ =>
M.3F[H7AZ+0HG O\ 4+^=P%:XOY_-DVCHH.  .3T'.><T 9GCN_U'1M*M=9LK
MR6&ULKN)[^)$1O,MBP5_O*2"H.>". :PT\47\'BCQ%IKZA/-'+;J^BLR1A6D
MW>4ZJ0O.V5E&3GC/ID]]?6<&HV%Q8W2;[>XB:*13W5A@C\C67'X1T>)M#9;<
M[M$4K9DGE04V'/KG@_49H RI;K5+3X@:/H[:K/-:SZ7.\H:.,%I4,8#Y"]?F
M/'3VKAIHKC_A2>MRRW]Q<,VJLH\\JV"+\#=D $D]\GZ8KU2X\/V]SXEM-=:X
MN1=6L+P1HI79L8@L"-N>2H[]JR9?A]I<NDW^EB[U!+*]N3<O"LPPC&3S"$RI
MP-X!]??'% $>FW>J67Q(N-$N=4FOK2?2Q?*)HT7R9!+L(7:H^4@C@Y/'6M?Q
M5<:I:^'IYM'@>>[1XSY4942-'O'F!-W&_9NQGO2IX>@7Q,NOM=W3WBVGV/#%
M-ACW;N0%Z[N<_P!.*MZIIJZI9BW:XN+<K(DJRV[!75E8,,9!'4<@C!'% 'F/
MB'6DUSX=:M<6.M:B3#J5JCV\\8BGM@TD2&&0;<GDL>^<XR0*Z'Q->ZG937UO
M;:S<R/:Z4T\<5O'&9EE!<^;*2H0)@ !>,X;@XXU[SP5IFH:?JEK=R7,LFIO&
M]S<[E64M'M\LC:H V[1CCZYJ.?P+IUQ?S7CWNIB2YM!:786Y(%R@S@OQG(W'
MH0.<8QQ0!@C6=<U/4? Z1ZL]I'K6ERW%VL4,9PZQ1MN3<IP<N>N1TXJM:>+-
M6MM)&FS7S37DGB9]$BOI(TWK$#NWD !2^T%1QC.#@]*ZBR\$6%A/HDL5[J#-
MHT+06OF2JWR, K!LKSPJCC&,<8J*7X?Z1<:9?V,\U[(EY?'4?-\Q5DAN,Y\R
M-E4;3Q]/UH P72YTKXD>(9%U1?,3PXDD-Q?XV0$228WD 94$9/?!/M5K1-7U
M27QE;Z2]_>R6EUHC77G7$4:DS+(B^9&-N5!#GY6 Z#BM.3X?Z9=3WD^H7NI7
MTMY8?V?.T\X&^/)/154 _-V&.,XSDF6T\#V=GJ5GJ*ZGJLM[:VK6J32W(8M&
M2" PQ@X*@],'OF@#C=.\1^(+/X<6WBV\UM[JXN8_LJ6SV\:Q+*]QY:RG !^4
M9R,X/3BMJ>RGL_BWX=\W4+B[5M,O,>>$RK Q9(VJ.O''08XQ6W;^"-(A\'/X
M5E\^ZTME*A)W!906W<, .0W(/:FV7@JUM=5T[4YM5U:]NK")X87N;@'Y&QD-
MM49^Z.3R>^>* )_'%[>:;X(UF_T^Y:VN[6TDFCD"*V"JD]&!':N9:]\1:1K_
M (8FGUJ2^LM<S;W%LT$:B"0Q%U>,@9P-IR&)_P .B\?137'@'7;:W@FGN)[*
M6***&-G9F92   ">M-T/0(FM-)OKJXOI[BTM=ENMTH4VY90K$+L!W8&,MDXS
MZG(!S&B7OB*[\+:CKMQXJ6%K22^@474$8@^21E1W*KG*X[<'CCKF0>*]1T;6
MM865[VZLK7P\=4C2\1$=Y$9@2, %58 ?*P!!'05T<7@?2T\,:AX?EENY["^>
M2202.NY6=MS%2%&/FY[T6_@C3HM574I[O4+VY^QFRE-U<;UFB)SAUP >IX&!
MW(SS0!%IEOK5TFC:F/$&^UNK4M>1-&F&9T!1H<#Y=ISP<Y'7)YKB+&^U;2/@
M;?:Q9ZS=K>1W$[*\BQO@_:W5NJY);))))YZ8KO/#_@C3_#DB?9;W4I[>#/V6
MUNKHR16P.1A%QZ$@9R0"<=34+_#_ $IO#U]H0NM073[R4R-$)@?+!<R%4R.!
MN)/K[T -FO[W6_%FLZ%;:A)IXTZSA=&B52SR2[R&.X'Y5VKP.I)SVJFVIZW-
MK-IX;ENQ)>1:6+JZN+)DB,LF\QY7<#@ J20!U(Z#@ZFK>";+5=5M]5^WZE9:
ME%#Y#W5E.(GGCSG:^!@C// %)J_@72M5.GRQSWVGW>GH8[>[L;@I,$/52QSN
M!ZG.3G/J: ,"[U?Q5H>D:5)KR3W,47GIJ=QI"J\J8*^5(4V_=V[BP4=<'IP>
MQ\.7D>H>';"[BU%=126($7:J%\[_ &L #!]1@8/%0+X9AA-DUIJ%_;26L<D?
MF+(KM+YA5F,F]6W$E0<_6J*^$UL;W05TJYOK6UTWS-\:W&(95;);>G\;%CG/
M &2?04 ;.NRSP:!J$UM.8)XK>22.0*&*L%)'!!!Z5YY!J_B>PTKP5XBFUM[V
M+59+.VO;%X(U3$RC#J0-P8'D\X.>@'%>@^(-W_".:DJ1R2.UK(JI%&79B5(
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M(R6#$KAE+ 8XR,D9Z59?P!H\V@WNCW$EW-;W=VUZ7:0"2*=FW%T90-IW<_\
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MIVAG W12*XC*,5 RA+*<GD<C-;<YU;18CK3:U]NT^+3Y99[>5%!EE5=ZM$5
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M]ZL7?A.TNDNH5N[R"SNK9;6:TB9/+:,*5P,J2ORDC*D'\A@ W4=9(UD1@R,
M593D$'N*=3(88[>"."% D4:A$4=  , 4^@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN<\<7-M;^
M&9%NKBZA6>>&!?LK!7D9I% CR> &Z$GL37!WK3VUO\3K,.MFEMI\-Q#;V4[*
MD$A@D)VD;>NQ2> #CI0!Z_17EK:1_9.M^"=1TRYO#=:F?L]^K7+L+B(P%RQ!
M.!M(!&W&,CVK!?2]WPLU#Q!#?7XUK3;^Y-E/]KD8J5N654VDX;=T.02<CVH
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M:]JNFZU%LN+6%VL[*!EC@7S55YU =MI*,W3&=N>HJ\^BI!)>W^G>*+2SCO\
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M\U&VU"YL;>6\M@1#.\8+QY]#5VB@#,3P[H\=^]ZFGP+.\OG,0O!D_O[>F_\
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MPAX=>*>(Z+9".XD669!$ '=?ND@=<=O2GWFD0V[SZKINGVTNM+;F*&29RNX
M<(S\G;G_ !K7HH QM!L+V(W.I:K';QZG>E/-2W8LD2(,*@8@%L98YQU8]L5>
ML],L=/DNI+.UB@>[F,\[(N#)(0 6/OP*MT4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M50N=8LK6^2Q+M)>.N\00H7<+G&Y@/NKGC)P*OT %%%% !1110 445A:GXOT;
M1WO%O9;I5LE#7,D=E-)'$"-WS.J%1P0>O>@#=HK(TWQ+INJW:6ML;H2R0&XC
M$]G-"'C!4%E+J ?O+T/>M>@ HHHH **IZEJ,>EVGVF6&XE7S$CVV\1D;+,%!
MP.<#/)["KE !112,RH,LP R!DGN>!0 M%4QJ,;:P^F^3<>:L G,IB/E$%BN
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M&F)J<+WSV+IY@N%TZX*;?[V=G3WKH: "BBB@ HK,NM>L;/7;#1IC*+R^61H
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M"!48JSIUR",J?Z&@""UUF3Q%KWPTU>:(12W=I>2NB] QA7./;/2G/XGUF_\
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M*&"[CLY #,/QJ"7X<:?)#/;KJFJQVSZ@-1BA25-L$V_>2F4R06[,6 SQ@\T
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M#CFLK2["UC^(?CR8*PD6"U8'S&ZM#)G(S@_CT[4 =CX;UD>(?#6G:P(/(%Y
MLPBW;MF1TS@9_*M2O'?#]N=,T#X9ZE;7-TMQ=2QVLP-PY1XF@D.S9G;@%01Q
MU&>O-7[6.\\5:3J.I?V_%INHV&IS"2;8[26@CF(6,KY@!4Q@#&,')/)YH ]2
M) !). .IKD8/%NLZC;6-]H_AK[?IU\-T,XO5C9%W ;G5EXRN6&"W3!QFNEU*
MWCNM-N(9@2C1G(5BIXYZCFO)(+<6/P%T2\M)KF"=FL2S1W#KNW3HI! .,$,>
M.E 'LM%>>W6D1ZS\4]4T^ZO=1%G_ &5;7 ABO9$"R><XW##<?=' X]LU6M+J
MZTWQ590ZY;2RPW>HS?8=9LYR4FWB3;!,F<KM!P.HR@QC!- 'HEO>6]V9A;RK
M)Y,ABDV_PN,9'X9H-Y;K?)9&5?M+QM*L?<HI )_-A7%_#"QMK73M:,*E6&LW
ML8&]B JS$ 8)_6H[BRMQ\:);@1,\PT 3 "1AN<3X'?Z#'2@#OZ*\@>_O+CX/
MVWC*UNISXB219S()&^>0S[&@*YP4Y*A.W'>N]\=ZK?:+X#UG4M.4_;+>U9HR
M!G8>A;_@()/X4 =%17G^HH='U?P;>Z'<32+J%R+6Y0S,XNH6B9_-;).67;NW
M=>?2H/"WD>)O"^F>(KO5;FUU2._+W+QRD'>)&7[,RGC8057;CT/4Y(!Z/17G
M&E>1XITG6;Z_U6YL=1L-6F5YH92'M$BD^5 O3:4 R,?-N/6DEE=-1^)D#7$R
MPV]M#)"IF8"(FV+$KS\OS#/&.: /2**\ICMWU>^^'MM=7^H>3J&A2FZ6.[D3
MS2(82"<'@Y8\C!/<XKL?%MW=>&?AWJ=QI7F/<6-B1 TA,C#:N-Q)^\0.23UQ
MS0!TM<W?>)KL7^H6FCZ3_:4FFO$MV@N!$^9!NP@(PQ"D$Y*]<9K U!6TF\\%
MZCHEQ/)_:%U':W*F9G%U"\3.9'R3EEV[MW7KVJ;P=IMK!X]\9O&KAH;RW"9E
M8X!MD)SD\]>] ';37EO;SVT,TJI)<N8X5/5V"LY _P" JQ_"LK0_$+:QJFMV
M+V1MFTNY6 DR!O,W('#<#CAAQS7/^,;"VNOB)X(,Z,=TMXA(D9>!;L>QXYKG
M=5L([B/XH7OGW4<UDWVBW:"X>/9(EHC*WRD9.0.N?U- 'KU%><+>W'B+Q+%H
MU[=PH'T2WNH8I0_[YG+^:Z[77YAA,=<<D8YKK_"MM<67ANTM+K5CJT\ :)KT
MIM,NUB.>3R,8)R<XS0!3OO$UV+_4+31])_M*337A6[07 B?,@W80$88A2"<E
M>N,YKI*\H0'0KSXEZIIL3M>V&Q[?,C-@_95.2"?FQUY]*OWA?3;7P1K&C7,\
MDU_>6UM=$RLXNX98R79P3RPQN![8/:@#<_X323[!XIN3I3;M =E:+SQF8+$)
M"<XPO!Z<UT.E7O\ :>D65_Y?E_:8(YMF<[=R@XSWZUYX?^07\5_]Z;_TC2IM
M+O&N]>\)Z!>%AIK^'1=)'N(6XG'EKM/][:F3CISGL* /2**\GGM=7NM \7V-
MI<W<IT'41-IDAG?<RJB2M;ELY=<$I@Y^\/2E7Q0L7BN/7K199M'UZR-M8J\K
M%&O%4, !T7?N*<?Q1F@#TNYN+V+4+*&"Q$UM*7%Q/YP7R %RIVD9;)XXZ=:N
M5P-]9/H_C'P%8Q7EVZ8NHIMUPY$Q6W)W,I."<DG/O7*:E#+'X)\<ZJNH:C]L
MTK69S9.;V4^3M,9'\7S=<?-GB@#VFBN&UDS3>-[BVODN;K37TC-O%:[F:*;>
MP+%5Y5F& KG@;6P1S5KP]X=N5\)Z#!XAO;W^U+>6.ZE8WTC%YP#\K$L=R^JC
MY21TH Z^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** *]]8VNIV,UE>P)/:SH4DB<95E/8UDZAX*\-ZII]K8
M7ND6\UO:',"D$&//7# YY[\\]ZWJ* ,E_#6CN^GM]A1#IPQ9B-F00<8^4 @#
MCCW%2G0M..JR:IY#"^EB\EYUE<,8_P"[P>F3GV//6M&B@#$'A#05TV#3EL +
M.WE\^& 2.%CDSG<!G@YY^I)J9O#>DO=7ERUJ3/>QB*Y?S7S*@X"MSR.OYGUK
M5HH QU\+:,J:>BV>%TXYLP)7Q!QCY>>../IQTJL? WA=C(6T2T.^X^TD%./,
MSG<!VYZ@<'O70T4 9JZ!I*:G<ZD-/@^V7,8CFEV9,B@8P1TZ<?3BJVB^$/#W
MAR:>72-)M[22<8=HQU&<X&>@SV&!6W10!SD?@+PM$4V:+;!8Y_M$:$$HDG/*
MJ3A>O0#'3T%;EW9V]_9S6=W"DUM,ACDB<95E(P014]% &%:^$]!TF2"[LM'B
M-S:QLL##YG .,@%CUX R3T&.E8W@#PB-'\+:9;ZK8&/4+-F8JT_F1ARS$.JA
MBH.&ZX!ZUVU% &5=^&M'OKV6\N+)6GF01SLK,HG4=%D (#CV8&I9=#TZ;5(=
M2>W_ -,AC,44JNRE$/51@X /I6A10!1TS1[#1HI8]/M_(260RR*'8AG/);DG
MD]SWJ&X\.Z1<ZE+J,MC&;V6+R7G&59DY&,@^A(SUP2.E:E% &,OA/1$M[&W6
MQ AL'\RT02OB%NQ7GCJ?S-,F\&^')]?77)='M6U,$-]H*\EAT8CH2.Q(R,5N
M44 17%O'=6\D$P)CD&U@&*Y'U'-91\):&='CT@V _LZ-@R6WF/L4@Y&!GC!Y
M^O-;5% &=%H6G0:NVJQP$7[1B)IS(Y9D'13D\COCUYIEMX<TFTN%FAM,,DK3
M(ID9D21L[G5"=H8[FY SR?6M2B@"A8Z)IFF7=W=V5E%!/=R&2=T&"['J3]>I
M]:+G1-,O-5MM3N+**2^ME*PS,/F4$YQ[\\\]#S5^B@#)B\,Z-#>/=1V**[S?
M:&0,WEF7_GIY>=N__:QGWK4=$EC:.15=&!5E89!!Z@BG44 9>G>'-)TEXWLK
M,1F)2D0+LPA4]5C#$A <#A<#@5!#X/\ #UOKSZW%I%LFI.Q=IPO)8]6QTW=>
M<9Y-;=% &)+X/\/3Z\-<ETBV;4@0?/*\DCHQ'0D=B1D8IU]X4T+4M1?4+S38
M9;J2+R7D.1O3G (!P<9.">1VK9HH QX?"NB6T]A-!I\<4E@A2U,;,HA4]0H!
MQSW]>^:UW19$9'4,K#!4C((]*6B@#*T[PYI.E21O96:Q>4&6%=[,L(/41J20
M@/HN*DLM"T[3KZYO;2W,=S=,&GD\QB92!@%LGD@<#TK1HH H:GHFF:R+?^TK
M**Y^SR>;%Y@SL;&,C\#@CH:K'PMHS)J"&SRNH_\ 'X/-?$_&/FYYXX^G'2MB
MB@#!U+P7X<UBTL[74-*AN(K,;;?>6W1CT#9SC@<9QP*VK>WAM+:*WMHDA@B4
M)'&BX55'   Z"I** ,VST'3+"\NKNVMMD]V<W#^8Q\TXP"P)P>..:9I_AK1]
M+ECDLK)8O*W>2NYBD.[[WEJ3A,]]H%:M% &1_P (QH^S4$^Q_+J.?M@\U_W^
M1@[N>>./IQTITOAK2)[.SM7LQY=B<VI61E>#C'R.#N7CC@].*U:* *]G8VVG
MVPM[6%8HLEB!W8G))/4DGDD\FH(]%TR&TLK6.RA6"Q</:QA>(F (!'OAC^=7
MZ* *%WHNGWVH6E_<V^^ZLR3;R;V!BR,'&#QD<'U'%4V\(Z$]E>636 :VO93-
M=1&5RLSGJS#/).!GUP/2MNB@#SO7_",E]XDEN+SPO:ZU9>1%#:2B],,T"KG<
MKYY;+$G.3QVK?TGPC8V^EVMM>VB.MK>"]M8#,\JVC@?*$=N3CD\\98X&,5TM
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/HUU=7%O;7&WS3!MW$*P8#+ XY I^NZ OB#PU<Z)=WDZQW,?ERS1A0[+WZC
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M;G8*!G\ !DYS_#UK::SXGNO&$6G7-H9K2.TB^U1&*23!+,Y0].JJ">?E/;%
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M-M<7EK+"WDR1HD*XQMZ88?CGWH [6BO,39S1^(/!*IJNJ :O9S)?#[;)B4+
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M<F@#IM8\56^EPZ5-#;M>0:CJ$=BLL;@*C.^W<<\D9!Z#G'6N@KQ6PM$7X3^
M?+EG1Y]7L"S>:S%3YA&5#9"_0#'M7:^%A)8>._%.D)=74MC#%:7$27-P\QC:
M19-^&<DX.T'&: .UHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@JH'(..Q!I-<T*/5CHVAVT'E:=87,-S/@814B&8XAZDL%X[*ISU&0#J:***
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M,6+.>^68DXQUXQ45QX(D'B&ZU72]?O\ 2UORIO[:W5&29@,;EW ^6Q P2.:
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MAL]3TZ=:IRZ[XTB/A:RO8['3[_4;B>VNE:(2CY8W99%VN0 0H.WUXR!6A/\
M#_$&BR:=KEWI^IZ3:BRBO88T8RP  ;)$8%6Z _7FKT_A S76BW/]J7#3:7,]
MQYDJ*S7$CJ58OT&,,0 H&.,< "@#9LH=1BTB**\NX9]06/#W"PE49_79NZ>V
M?RKS2+QCXNB\#Z7XTN+G3Y;+SE2\L8[8JS1M-Y>]7W<,"1@8QCJ37JTDB0QM
M)*ZHBC+,QP *\T^'N@MK'PZTBSU"\9[&&8S261BVOO68NJ.?[N0K8P">.<<4
M 7/$WBK5]%.H72W,#&TO[>*.TAB\Q# [1J3,^/DD)=B!D< <'.:M3:CXGO\
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M"CU/XUI0:[X@MK_Q9I<UU875UIUK#=6D\R?9XQYBO\LG)PJE,YST/)[U/%X
M6'0--TA=5E,6GZB-1CD,*[FD$AD ;MMW,>F#C'-2:KX#AUFXUZ2ZU&8+K%M%
M;2K$@7RQ&24*GGG).<YS[4 4K+Q#J5SX@U+1DOWEB_L=;Z"\>U".KEF0[00
MR< @D?B16?X8U[4K7P9X/M!-+=WNL1%A(%3>BK&7<C<0&8G')/<G!Q@]):>#
MY(O$*ZU=ZU>7=R;'[%,K1QHLJ[BPX5>.2>GY]JH?\*XA'AK3M)76K])]+D$F
MG7RA%DML @+@###!P<]: -CPQ/X@D%_#KUIY8BGQ:3DQAIXB,@LJ,P# Y!Z
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M[9<:/=RS9&,L8X"3CMGK0!Z717D1U"\U#X17/C!;NXA\0P22S[UE;]VZ3$"
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M^]R,]CD 9QC)JUX8U:]\3ZYIVGZ_Y@'_  CMO>B#<4$TLAP\A QDC"@#L2:
M/3:*\=:ZU272;"TGU*_Q9^,1ID-RMPP>:V#G <YPY!XR<_=^M=;X3C;3_'7B
MO289[E[*%+.>*.>=Y=CR*^_!<D\[0>M ':UB6GB$W/B_4- :S:(VEM%<"<R
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M)I)=3T^ S":^MHS  90\JCRP>A;)X_&@#,T;P;X>\/2SRZ1I<-G)."KM$6R
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M3TR ,YXKO/!]C8:9X5L;/2WN7L(E86[7)R[)N)!Z#@@\>V*V'MX98Q')#&Z
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M(Q[U[@D$,3N\<2(SG+E5 +'W]:/(BQCRDQ_NB@!Z.LB*Z,&5AD,#D$4M(
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ML!"-@P.?8?+6GI[Z1HOCV]M1X?L["\ETQM2N=0B?=N&]5=?N@XR,]LXSC)H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"#@D_,&[].U7]9\)^)-4N]=)ETN2'4],^R0O,\A:R;RV5PB[<%6)R6R#Z@X
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M5C*"KL^XC;C'SXZ]JP+?P5X@@\#Z%HYETQKS1+Z"X@_>2".=(F)^9MN5)!Z
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MO;),S(J;R[%GVCDM@<+P%[YXTM(UVPUS[;]A>1OL=RUK-YD31E9% )&& /\
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MX-N"+$)HD4B7(\]\N6B\OY/DY]><>GO79TC*'4JP!4C!![B@#RSPWI.H^(?
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ME>)9["_O9](MY?*&FW;0*UK.Q'S+(Y4E&SD=0,8/U[>Z1Y;65(YGA=D(66,
MLAQU&01GZ@U@ZIX2CU>/4+:[U&YDL-1*&YM65"ORJJ_*=N5SL&?S&#S718&,
M8XZ4 >6^$M<U"S\"^$81=75U=ZW(ZER(B\8"R2.5W8!8E?XR>I/.,&WKNL>,
M]"\+:U=S2)&;>[MQ8W%PD32RQ22*C*ZH=H(+'D#D8XK4_P"%;:=_PC%OH?\
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MP9#=ZS?:A!J=[9KJ%LMO>00%-DP4,%.2I92 Q'RD9H RK+7=6U'1_#$TFI+
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MMR8Y]FV3/[W 4A%(.>I(],UK'P_)9:?#I3:/K]QI$$_VB*REDLMN[?Y@#,)
M64/\P!/89R.* +_B&ZDTWXD^$I83@:@MU97 '\:A!(F?]UE/_?1]:[.N*=;_
M %GQMI>J3^'M2AM-,26.(R- /WTF%9R/-SM5 0",YW'T&=GPMIVH:9IT\-_?
MW=[NN&>![QE:58R!PQ7C[VXCT! [4 <YJ%O>W7Q?FAL;[[#(WAY,SB(2,O\
MI#= W'7U!_J*EOXOURY\&>#]5^T0I/?ZK#97N(1^]4RLC$=ESLSP._&*Z]O#
MB'Q7)XA6_NEN7L_L7E )Y:IN+ @%<YW'/6LN'X?6D&@Z5I":KJ'D:9>B^@<^
M5O,@<N WR8(RQ["@"C?>*;JT\8/I6HWL^DF2\A73VD@4VMY#\F]?,VDB0_O!
MC(Q\N/?J/$VLCP]X8U/6/*\TV=L\PCSC<0.!^>*I7OA*+41/!>:A<S6$]TET
MUJZIA65E8!6QD*2H)'7DX(S6U?65OJ5A<6-W$);:XC:*6,]&5A@C\C0!S%H_
MBS^V[3#O)IEQ;N+B2Z6 >3+C*-$(VRRDY!5B2..>M<Q9>)O%4GA#POX@?5H&
MDO\ 4([.>V-HOELLDK1[B1\V1P>"!@8.>M==H'@S^PE2/^WM5O8;="EG%=2(
MPM@1C(PHW$ D#=G XJ"+X?VD/AS2]#35-0%MIMVMW"_[K>75RZACLP0&)["@
M#*NM=\0:5<>,;!]3CNI=.TM=1M)Y;904)63*%5P",QC!///.:9'KGB?3+CPE
MJ5]J4%[I^MO%:SVBVRH89)(]RNK#D\@YSQZ =M'Q3X=2VL/%.MI=7DUW?Z1)
M:?9PBLK81]@4*N[.6/?O4_A?05N=$\.75_=7%R=/MHVMX)HPGE2^7L)88!+*
M"RC/3)ZGF@#G+37Y/#NG^,+F!4-S/XH^RPF0957D6%=S>PR3COC%=#=:CJND
M^,]-T*749;FUUFVG\B=XHQ+;31 ,3\JA2I!Z$9R.M3GP%ILNFZW87=S=W,&K
MW1NY@Y13%+\N&C*J",;%QG/3ZU<CT9=/G76=0NKO5+NQM7CA8Q+N53@OM5 ,
MNVU1[X &,G(!SVB^(-7OM(32;F^*>)(=4-E=.L2 !5.\N%QC:81D$C[S 56O
M-8\32GQN(-:CM_[#(DMBEHAW#R!+M;=GCG![^A'0[?ARSM=5\27OB]-.N;-K
MJUBM8Q=1&*1PI+,Y0\C.549Y^3T(JP?!D#'Q"?[2O?\ B>C;<\1_)\GE_)\G
M'RC'.: ,:TU[7%USPA/<WT4MIK\+F6T6!56!A!YJE&^\>F#DD'/ %,L==\3Z
M[I^G:YH\4K0371,EM+Y @-L'*G#9\P2 #.>F<\8K<7P; LGAY_[2O<Z$I6VX
MC^<%/+^?Y.?EXXQ5:P\ VNF:E-)::MJ<>F2SFX;2A(OV?S"<G'&X*3R5!P>_
M'% '.ZAK_BD:9XUO8=8AB.@W+F!%LU(D58DDV-G/')&1SSU[5I)+>7WQ8TU_
M[1N8H'T!KD6ZA"BDS1;EY7.#@9/7C@BM27P-;2V/B&T;4[[R]==GNO\ 5Y7*
MA"$^3CY0!SFK(\)0KK&F:HFHWJ7-C:?8R5* 7$6Y6VO\OJHY7;0!+XP?5X?"
MM_<Z'/Y6HV\1FB&Q7$FT9*8(/49 ]\5S4?C7_BKM'<ZD[:!J6F^<K-&@6.?9
MY@5G SS&K-CL0.QQ7H-<HOP]T)?#\.BB)_LL5\+Y<GG>'W;?]W;^[Q_=XH H
MW^K:]IL/A)Y+SG4]36&YCE@7>(W1W"9  !4* >,DYY[4FF_\C_X]_P"O2Q_]
M%2UT.N>'8M=N-,FEO+F Z==+=Q+#LPT@!4;MRGC#'@8ZU%%X7CAUG6=3CU"[
M$VK11Q3+B/;&$4JI3Y<Y 8]2: *7PS_Y)GX<_P"O&/\ E63=ZGXDNM?\86-M
MK,=I#I=M!/;%+168%DD;:=V<C*C/Z8KKO#VB1>'-!M-(M[B:>"T01QO-MW;1
MT!V@#]*H_P#")Q?VGKE^NHWBR:Q"D,Z@1[8U12J[/EX.&/7/6@#%TGQ9>^(;
MSP[IB3?8IK[0UU:ZFB12W)10B;@0/F9B<@\ >N:Y_P 0ZYJ][X;UG3+F^EBO
M-)UJUM7N+=%7[3#))&5+ @@':W(& 2/0D5V,/@6TM(-$^R7]W#>:-#]FMKO"
M%FAP 8Y!MVLN .P((R#4MYX)L+W0KW39+BY62]N5O)KQ2HE,RLK*W3;QL4 8
MQ@4 =#"C0P(DDSS,HP9' #-[G: /R%<=H>HZ]XET;2?$6GZA!%!=7.^:RF1?
M+%KN92 P7=YH !R6VYSP!786T+06\<3323,HP99,;G/<G  _( >@%<OI7@*U
MT>^<VFJ:BNEF<W*Z5YB^0DA.[CY=VW=SMSC/K0!F-XBUG5?"^O>(],O1 =-G
MN%M[1HE:.5("<B0D;LMM;[K#&5]#DMM?UOQ!XILK2QU%;"PO] 34D'V97DB9
MG4=6X)P>XQUXZ$;#>";53JL-O?7=OI^K2-)>6<>W8S,,.5)&Y-XZX/TP:MKX
M7MXO$J:W!=W$,L=C]@CMT">4D6[<,#;G(('>@#DK7QGK!\$:)K%\MRT#3SPZ
MG=Z?;J[QB-G19-A!PI*@M@'':FW]Y<ZMJ/@2:U\227%O=WESBXM5C"R@12E6
M(*?> ^4@\ YXSS72:5X-&B6-E;:?K-^@M'F93((V#B5M[*X"C(W<C&"/6FGP
M'IZ6>F0VMW=VDNGW<EY%<0[-S22;O,R"I7!WMP ,<8Q0!F7>KZQ+J7CG3CJ+
M11Z?I\,UG)!$JO$721CR0<GY1S^6*IZ-J.IZ5HGP[BCU&6:'4TBBGCFCC.$^
MS%P 0H/!4<DD^N:ZJ/PG:IJ^LZ@]W=2_VM EO<0N5V!%5E7:0N[.&;DD]:HG
MP'"-!TG34UG45FTF9);*\/EF2+:A0+C9M*[21R,GJ30!R_B[6-6G\+_$6T.I
M3(NF,B0/&J*^QXD9D)"]#O(R,''>NDNM3U!-<@\-VUS?22II_P!LDN85M_..
MYRBC#@)@8.<*3]WISF1OA_82VWB&WN-0U"=-=51=>8Z9#! FY2%X/&?[O8
M8HU+P*E^^G7B:YJEMJ]BC1+J43())$;JCKMV%?;;Q^= &KX8DUN30H?^$ABB
MCU-"RR>405< _*V 2 2,$CUS7)>+?$VLZ-'K-[;7Z.UA<VXBM;>)7C6)B@83
ML5RKG<V K XVG'4UW6FV":;9);)+-,1DO-,VYY&/)9CZGVP!T  &*YC4?AU9
MZA'K5N=6U*&SU:87,UM$R;5F&WYU)4M_ O!./;I@ [*BF0QF&!(S(\A50"[D
M;F/J<8&?I3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWR,5"R%3;M'N"XQ@ 8]#R3D@'J%<[J7B:XAO;^TTK2GU.?3EB>ZB281OB3)
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M:G_X2;X+ZQX@O)YSJ#W,F]!,P6 )<[%BVYQ@(%R".2<]>: /:**** "BBB@
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M_,^M7I[^SM;=;BXNX(87QMDDD"J<\C!/%$E_9PV@NY;N!+8_\MFD 3_OK.*
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MYJR2S79"6A;G=L8,7!)8E1CGZYK>TS3[?2=+M-.M$V6]K$L,:^BJ,#^56J*
M"LY= TI+&"R6QA%M;SBYBB X20.7##WW$FM&B@#/U#1-/U2YM+F\@:26S?S+
M=A(R^6W3(P1SC(_&JUQX4T.YN;^YEL$,VH)Y=TRNR^:N-N#@]QP<=1P:V:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>/CKPH+C[.?$.G>=NV[/M"YSG&,?6M6'5M/N+H6L5[ ]P3(!&K@L3&0'&/\
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M5=HH \PG\.^)K3Q_X4!UF*:WM[>Y421:4(XX8P(LQG#D#<!@'MMX!KT^BB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tardioagreementa01005.jpg
<TEXT>
begin 644 tardioagreementa01005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBN?N]6>[\7P^'K:0QB*U^VWDBGYMI;:D8/;<0Q)ZX7WR #H**Q-0\6
MZ-I;2_:KEUBAF6"><1,T4,C8VJ[@8!^9?ID9QFH;C5I-)\7V.F3R%[35TE-N
M6Y,4T8#,F?[K*21Z%2.A  !T-%%% !1110 45G:I87=^]LMOJ5Q8Q1L6E-N%
MWR<8"Y92 ,G/KP*XOPF-<UV/Q"7\1WZS:=K<]I;Y6+:8XRI"N-F3G)!(P>:
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M,2*5(+*<=3FG>"-<U+4=>\3:9<7G]I:=IMQ''::B44&3<N7C)0!6*' R!]:
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MD:9(1=3R)"LRV\EP(7,,<A( 5G VCD@=< G!Q3M4\4Z5HPG:\EE$5L5%S+'
M[I!NQC>R@A>"#[ @G .: -FBD1UD171@RL,A@<@CUI: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HIBS1/+)$LJ-)'@N@8$KGID=LT^@ HHHH
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M5FM2R3; PDVAAABH;(!ZD=Z[3_A%-%_Y\S_W^?\ ^*H_X131?^?,_P#?Y_\
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M*H_X131?^?,_]_G_ /BJ ,+XK6MUJ'@2XL;*SN+NYFG@*Q01,Y(65&;.!@<
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M_A%-%_Y\S_W^?_XJ@#EYX+SQ3!X0A&G7EC=:;?0W=Z9X&C6$1QL&16(P^YB
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MM[R$36T\4\1Z/$X93^(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[T :U]XNU9?$.J:)I?AW[;=65O%<*SWBQ+(K[N^TX/R\=<]\5@:KK=GXKL_
M6O06QA>774C*R*/,B(28.A/^\OXX!J_:2ZFGQ7UXVMK:RR'2K/S$DN&0*VZ7
M&"$.1U[#^E./@>_M-)\-65E+:2MINJ'4KN25VC\UV\PL% 5N\AQGL!0!J77B
MVX:#6;K2],2]M=(E:&X)N/+>1T4-(L:[2"5!QR1D@CWI(/&B76MZ';0VB'3=
M:MFGM+XS$98*&,93;PV#GKV/IBJMOX9UG1Y_$5MIC64MAK,\ETC3R,KVTTBX
MD^4*0ZY&X#*^GO5+Q'HVFV7@W3/#&GZE%%K&GFV.F?.IF$RL%5]F<X/S;N,8
MW>E &EJ7C2YT^WBN1HXGMYM773(FCN1ELOL+X*C^(,,9[=<<TV/Q;KDNKZIH
MR>'8#J5G%'<(/[0_<R1/NP2_EY#94C&TCWQS4OB#PO=76B:'INDFWV:;>VUR
MQN9&4LL+ XR%.6;'4_6I(-%U6'QOJNN;+)K>ZL8K:-//8,&0N<GY, '?[XQ0
M!!;>/K2^TC1;JWCBCN-6MVN(XKJ?RUC5,!]S '.&8 8'/M@U3'Q$F.FV%R-!
ME,T^K?V5+&)P LG.'C8@>8A R#QUK/L? _B71=%\-S:9=::-9T:*6UDCE=S;
MW4,A!(+!0RD%01QU%;.KZ#XBU>TT5[B73FN[358M0G19'6-%0$>7&=I)ZYR<
M<YX[  K:AXUU:+1?%RC3+:UU?0K<3[3<F6)T:,NK!M@)("GY2!R.O.:ZG0)[
MNYT&QFO5C6=X$8E)"^[*CDDJ.3Z8_&N:O?".IW]]XT:22TC@UZQ2U@99&9HR
ML;IEAM P=^>#VKI=!M[^TT.TM]2%L+F&)8V%LS,GR@#@L 3G&>@ZX[9(!RNJ
MR7]W\5['3I+2TN+$:1.XBFG.U@TD2LQ781NQD =P3R,XIT/BNWT;PB=4TK1U
M;PQI\C0!HYSYHBC<QM(B%2"H(/!8$@9]JU)]%U-_B);:\@M#8Q:>]D5:9A(2
MTBONQLQQMQC/>L6W\%:M:>%=2\(12VC:/=22K!=-(PF@@E8LZ%-N&8;FP=PZ
MC(&,$ T+GQCJ+^([C1])T%;YXK6&\24WBQK)%(Q7/*G!X) [^U=3>W)L["XN
MA#+.88FD$4*[GDP,[5'<G& *YW3O#M[8>.;C5$6U73&TV&QC02L9%\MF(.-N
M,?-CKVK:URSN]0T'4+.PNS:7D]N\<-P/^6;E2 W'H?2@##T[Q?<77B!-$N=.
MBAO)=.-\D<=UO*8*@QR J"K?,/7OZ5FZ?\1+R\T[0M5ET$0:=JEZ+$R?:PTD
M4C.R*0H7YERH!.0>>A R32?"WB"RU_1]4>+1H4L]-DLI;>"20@EF1MX8J,[B
MG.1QG/S57MO!.NP>"_#^C%M.:XTS5([Z1_/?8ZI,9,#]WG)SC\* .@M/%;OK
M&O:=J%G%9/I,2W =K@L)H6!(D'R#"C:0>N"#^.UI=S<WFEVMS=VHM)YHU=[?
M?O\ +)&=I.!DCOQUKC_$&GZ?XB\9:,;'4(C=P&6'4HH'5]UJ,,T<F.G[P1C!
M_O-[UW= '(P^+M3NO$>I:5;Z K1Z9=0Q75P]XJA8I$#^8!MY(!!V_K4%O\0$
MN+G1WBLDFT_5)5BCD@G+S0[AE'DCV_*IXR=QVY&:NZ1H%_;>)?$][>K:FSU=
MHBBQ2L74)$(R&!4#D#/!X_6J/A;0_%VA06VB7-[ILNBV1"P72!_M3PJ?EC9<
M;1P I.3QVSR ":7QM-;:AID5YI7V:'4=0>QA66?;<#!8+(8BOW&*=0W0J>^*
MM67BM]3U2ZM+&UMYEM+TVERGVG$\0!P9#'M^[GISR.?4#FE\%>*/LVGQRSZ3
M+<66M#46NW>0R7:Y?&_Y?E95<  $C  !4#G3OO!][JGB"RU2>"PM[ZSU#SDU
M.UE99I+8,2(G7: <KA#EB,<^Q +-WXWDCT;4-=L],%UH]A-)'-*L^)76-MLC
MHFW!"D-U89"GVRLOC"]G\1-H^D:1'>,^FIJ-O<278CCD1F*C/RDCH>Q[=.HH
M0>#M7L=!UOPS:RV;:3J,DYAN))&$MM'-G>NS:0Q&YMIW#.><5H67AJ]TWQFN
MI6J6G]G0Z-'ID,;3,)/D<L"?DQCG'7MGVH UO"^O)XF\-V6L1P- +E"3$S9*
M,"589[X(/-0W&OSRZW>:1I-I#=7=E DUP9IS$B%\[$!"L2Q"D], 8]:B\#Z)
M>^'/"5II-^;=I[=I/F@=F5@SLPZJ#_%C\*KOH.IZ;XUO=?TD6T\6I6\<5W;7
M$K1$/'D(ZL%;C!((P/7/:@#&N_'-]J=OX7N=%MHHX]0U)K2ZAN92DD<B*Y:,
MX4@#*<MSQCCGBG#?WNA>,_'MWIFCP7+116=S/']H$*\0LS8.TDL><< 'N1WT
M7\"W]GIFB_V?-:27]EJ[ZI<>>62.5I/,W@$ D8\SCC^'FK0\-:T-3\773?8&
M&M6T4,&)G&UDC9,L-AP#NSP3C&.>M %J3QM;2Q:<+);?S[ZP6_1;R?R52-L;
M<D*QR2>@'\)YZ9SX_B'<7%KH+V_A^8S:K/+;>3+.(S#*BL<9*_,IVYW>ASC/
M%5HO"7B?1U\/ZAHT^F-J5AIB:7>6]R[^1<1)@JRL%W*P.3T[_GIZAH.OWVH^
M&[Z66PEFTZZDN;D;W1?FC9-D8VG@!NI/..V> #IM-GO+G38)K^S%G=NF9;<2
MB01MZ;@ #]:\SU?5-3U[P'\0UU:ULS#92W4$.R0OY9CBC*@ H/4MNR#DGBO5
MJX"Z\':XVD^,M+@DTYK?7)IIX)))'5T:5%0A@%( 7:3QG.>U &AHWB6[BU;2
M-#OM+%O%>V!FLYUN [/Y83<KIM^4X8$89J2T\;3R:SHMA>Z5]D;5Q-Y,3S_O
MX=BEAYL94;=RJ>A.#QSUHF\.ZQ-K_AO4 UE$FF64]M*5F9FW2*@W*-F#C9GG
M&<UC:;X,\3VTGAJ6XDT@SZ1<RR7$PDE9[OS(V0RL2H^?YL[3G_>'2@"U/\1;
MZ#2M3U5O#P%EI6HO97C&]&X!752Z#;\Q^;.#MXZ$]N_KSJZ\$Z[<^#O%&C;M
M.6?5]1ENXG\]RL:NZMAOW><C;VZYKT.,N8U,JJLF/F"MN /L<#/Y4 >?^ &B
M\8?VIXFU6)+F9[Z6VM(YE#+:P(0 J@\!CR6/4\>E6K;7/"WA_4_%%Q;":V:P
M@BEU&W6V9$B(#LI7("Y<-T'7&>YJQI7AK4O"FKZE)HGV:YTG49S=/9SR-$UO
M,WWC&P5@5.!\I QV-4G\!W&KOXQDU::&#_A(HH(EBMV,GD>4A56+$+N.<'&.
MV,F@#6;Q5<V.J:1:ZOIJ6L.K$QV\T=QYFR7;N$<@VC!(!P02,@CWJI<^/##X
M?D\2Q::)M BF9'G6?]\8U?RVE6/;@J&!.-V2O/M3T\/ZQJS: NO?8E&CS"Y+
MVTK.;F94**<%1L'S%B,GG ]ZS;;P1JMKX0OO!B2VC:--)(L-V9&\Z*"1]S(4
MVX+#+ '<!R#CC! -J]UTZI<:II6F6%OJ*VENK77GS;$8R*66-?E;<2O)S@#*
M^IQ7^%O_ "3#P]_UZ+_,U#!X9UG0O%.IWNB?8)M-U6.(30W,KHUO)&FP,F%;
M>"H&0<<CJ*U? ^BWOAWP;IFCZ@\#W%I%Y9: DJ?S /Z4 <;XH_L.Q^+T%YK-
ME#+9IH$TLQ:S,X&V4?,RJIZ#/..*T/ #2Z)X:US6+PO;>'WN);[3H'<.8;3;
MNR,$[01R%SQ^-:USX?U.?XD6_B#99-I\>G/8O&TK>8P9PQ;&S';&,_C5.Q\%
MWMA8ZUX;6:"3PO?QR+;(9&$]F)%(=%&TAD!)*\@CWH LV7C9[C7-.L)-/0PZ
MA$[QS6LYF,+*N[;*-H"DCH02,@CWHL?&LTVMZ+IU[I8LWU>.62*)I\SP;%W
M2QE1MRH/0G!&/>DT#3?&D%G'I^L7^F""VB,<=W:!S-/A2J%U8 +C@G!.2.PK
M(TKP;XEM;GPM/</I DTB2;[3(DDCO=>9&4,I)49<]2#_ -]=J .@T3Q:VNR)
M+:6UN]EY\L,[K<YEMBF['F1[?ESM]>,CK5.;Q[Y&@6_B5].'_"/33!#<B?\
M>I&S[%E,>W&TG!QNR 0<=0*\7@NZN?$6G:S>6UA:7T/F)?75E*V;^-D*A73:
MHZE6).<;>.O$-OX'U7_A"_\ A"KJ6TDTA90BW@D;SFMQ('"&/;C?@;<[L8YQ
MVH O7OC34X]2\0V-EH"7#Z-%',SR7HC65&1GX^4D-A>!C'7)'&>FT?4HM9T6
MQU2!66*\MX[A%;J ZA@#[\US?_".:NNM^+;U18F+6+:*&W4SN"A2-DR_R<9W
M9XSTK:\+:;<Z-X5TK2[PPF>SM8[=FA8LK;%"Y&0#SCTH S_^$KF^V^)[0:<G
MFZ'%'*/](.V=70OUV?*<+Z&J/_"=W<S^'8K+0C/-KFGF]A#7014(1&*L=O0;
MQ\V/H#TI-0\-:ZOB'Q%<Z<VGM::Y9QQ.UQ(X>!T1DX4*0P(8=QCWZ'%6PU31
M/$WP\TUDM)[RRTN[MW"RLJ,$2%<AMI.>,]/\: -JQ^(:3Z?,MYICVFLPZDNE
MMIYF# SORI$F/N%<MNQT!X/&;DGB^>SU34-)OM-5-0M[$W\"17&Z.YB!PV&*
MC:P/!!'<'FLJ^\ WE[#<ZDMS;PZZ^KQ:M$<LT*-$H1(B< E2F03C.6)QQBM&
MY\.ZCJ>J76LW4=I%>_V8^GVL"3LZ+O.6=GV ]E  7H#Z\ $&F>.KN\E\-276
MB"VL=>C'D3"Z#NDGE&3#)M'RD X.<^H%=)K\,5QX=U**:-)(VMI,HZY!^4]J
MY2#PEK4.G>";8FP+: RF<^>^) L1B^7Y/?//T]Z['5()KK2;NWMQ&9I87C3S
M&*KDC') )[^E '!>"O$MWIV@>"--NM+"6.HV4=O!="X!<2+#O^:/;PI"G!W$
M^H%:$7BRQTN+Q9?OH\5F^G7L<5RZN/W[,J!9'8+P '7)YP 3STJ*W\(ZU#IG
M@JU)L"V@.IG;SWQ(%B:/Y?D_VL\^F/>K5KX>UVSN/$UQ&NF.VJ7L5Q%'+*S(
M8P$1T?Y.-R*W(!^]0!T&D:C<Z@)FFM[=81M:">VN/.CG4CJ#M'0\8YJ/5M<^
MP:EI^EVT*W&H7Y<Q1M)L540 N['!( R , Y)'N1F^$?"O_"-WNK30Q16=G>O
M&\6GV\I>*!@"'9<@8W$C@#'RCZ!/$N@:I<^(='\1:));&]T\2PR6]T[)'/#)
MC(W*"58$ @X/O0!S?AG5XO#UUXSNKRTAMG;6HH5MXI!L,CQQJN&P, D[B<<#
M)Q6G>^(UUS3O$NBWNGP_N=->=)H9#/;S*5/&XJN'4XXQZ&JD_@;7;Z'Q!)+>
M65G>7FH0:E8R0,T@AFB5  V5&1\F,^^<=JW([+Q7J.A:C#K!TJ.ZFM7MX8;1
MY/*+,,%W9ES] !QSR<\ &-I>I6]EX:^'%O<Z3%=_:H;:*&X=AFVD^SYW*""<
MX!';K6Y:^+9'U#Q%97MC':RZ-&LO_'P7$T;*65Q\@P.".^""*S1X4UD:7X*M
M1]@WZ"\37!\]\2!(3%\OR=\YYQZ>]:6M>%&U+Q;I>LPW A2&-H+Z/'_'Q$&$
MD:_A(H/T+#O0 R\\72VTHL?LMFFJ):)=3V]Q>[$CWE@J!]AW,2K=@!CW%4%^
M(-U=#P^MAX>GDFUJ"=XHKB<0M&\0^9&RIP,_Q>G.#5G6="\16WBW_A(/#4VG
MN;FV2UO;2_9U1PC,4=64$AAN(QC&*?=:!K=QXF\-:I)-93#35N?M3%V0N9@!
MA%VGA<<9.2/SH FTKQ1?7/B231-5TF+3KE;%+U#]K\T."<,!A0/D;@\]P>AK
M7T/49M6T>WOYK9;?SUWHBR%\H?NG) ZC!QCC-<MXSL;#Q%JVD6=GJ4::M!=-
M%*L$@:1;9XSYZN <J"F,$]&V>HKN%544*JA548  P * .?G\174^IZG8:-81
M7LVF(AN/-N/*!=EW"-<*V3MP23@#</?'+^(_$\OB#PWX4U+1XD:QU'5[5'2>
M4QL6#G,3 *>-R8)R>G0UNPZ#JNC>+-7U721:7-KJRQO-!<3-$89D7;N4A6RK
M#&1P01Q6=+X&OK/PYX:TC3)+67^R]2CO[B6=VC\U@S.X4!6QEG.,G@>M '7:
M7I=IIJ3O;V<-K+=R?:+E822K2D ,<X&>@YP,]<5?I%W%1N #8Y .0#2T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 45A^+]0U72?"U]J6CQV\MU:1F;RIT9@Z+RP&U@<XR1],=ZQX
M_&4A\:Z;IS7-DVDZCIIO()A"P<OC=M+;]H!0,PXSA3]: .TK+U Z)J=\FAZC
M':7=P8_M:VEQ&)/E5MN_!&."<5S%WXD\317/ABWB33/,UMIAF2&1?* C:1"1
MO/( &1GDY QUJW::QKR^,;?0-0_LSS7T9KMIX(G($PD5. 6^YR3CK[T =>
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M6=*U&*)-1TFY$,K0@B.5&4/&X!)*Y4\C)P1UK/M[K5Y/BU?637T)L8=,AF2
MP'@/(X.#O^]E!\Q!XP,=Z .HTW4[+6+"._TZY2YM9=VR6,Y5L$J<?B#5NO(_
M!^MZQH7@CPM/&+%M+NM3-C)$48S?O;B10X?( P<?+M.1W[#H]0\6:W<)JDWA
M^R6Z;3[MK9;5K9V-R4($G[T,%0Y) X/W<GK@ '<UF7'B'1[6YDMY]3M4FB_U
MJF0?N_\ ?_N_CBJ?BW5;K2_ FKZK:HT=U!8R31JPR4;:2,_3K^%0_#^R@LO
M.B+#\QGLX[B60G)EDD4.[D]R23S0!IV-EHTUT^L6-M9/<395KR%%+28)!!<<
MG!!'6M*N5ENX]"U;2O"FBQPPR78N;K=(A9((PVYL*",Y:3 &0  >N,'"U;QY
MK.F:-XH0V]DVKZ!+"'8HXAGBFP4<+NRIP3D9/(Z\T >CU5.F6!U(:D;*V-^$
M\L7)B7S0G]W=C./:N5EUGQ/'XS_X1_?I.+NQ>\MYO)D/V?8ZJ58;_P![]X8(
M*=_I68/'6NGP]I5RMKI[WTVN'1[D'>L;$2,F].25!V]\XSWH ]'HK@X?%'B:
MSUG6M"O[+3[O4[?3_P"T-/>V)ABF3<5VOO8[2&[YZ>E2V'BS4;C7M0TE9;&[
M\K2UO[>ZC@>.,L692O+'>N0"&4^HYH [>BO.]*\9>()K3PAJE]'IOV+79%MY
M(88W$D;M&SJX8MC'R?=QQZFK\'BO5+:;Q/8ZH+,:AINV2R2&%E%Q'(,1'!<Y
M)?Y" 1@]^: .UHJO$;N/3U,XBEO%CRXB!1&?'09)P,^IKC-,\7:K+XAT;2[P
MV+OJ5K.\HMXV*VDT84E/,W%9,;B#C!R.V<4 =W5(:OIYU@Z0+N(ZB(3.;<-E
MQ&"!N([#+#\ZYKX<76JWVBWMSJ=[%<L=0ND!6$HP*RLO7<1C &!@8'<U'>S)
M;_&&WGD.$C\.7#L?0">(F@#MJ*X?3_%.OZBVA:A:Z;]HTW4BAGB6V='M8G7*
MR>86VOC(W #G/'2HY?&&K6>K:5#=I9?Z;JK6$MI$K.UNI#F-C*&*[B$#%2 <
M-T&": .\HKB[+Q?/?>*+C1OM-G:WEO>-&VGW,+)+);C.)8W+ /D?-P.!D=LE
M? 5UJUY=>)7U&^AN$AUB>!0L!0C8L8&#N("X'3&<\Y- '46VG:?I\MS<6MG;
M6TEP_F7$D42H9&_O,0.3[FDTW5K#6+=[C3KN*YA21HFDB.5WKU&>^*YB^NM7
M/Q9TZQAOH4L3I4T_DM 6R1+$&Y#C+8Z'H.>#FN6TW6]8\.>'M>U>T%BUC;>)
M+E;B&5&:257N0AVL" A&[/(;/MW /4?[3LCJQTK[0GVX0?:#!_%Y>[;N^F>*
MMUS!UK43\0;C05CM! -*%Y#(5;?O,FS#'/3@GCUKC+[Q/XPU7X3WOB3S]+LH
M)-.E8+!%(9E<.5^4EL %<^I!P?H >M45Q]YK>M:'J_AV&]EL)-+U!S;33I;.
MC1S%28QS(0 V-N>>?KQMZ-?7>H/?SRF$V:W3PVA1"K,J?*Q8EB#\X8# ' ![
MT :$UQ#;F,2R!3(X1 >K,>P'?N?H":H?\))HAUK^QO[6LO[3_P"?3SE\SIG&
MW.<XYQ6'HMZ^K?$GQ)YIS'I$5O:6R]E,B^9(WU/R#Z)6?X\:UTZZ\.O<Z-+_
M &3:ZI%<2W\!3]Q(20N1G=AG8;F_#DF@#M+[5M/TS9]NO8+?>"5\QPN0.I^@
MR,GH*F^U0>?'!YJ>9(I>-<_? ZD>O;IZBN-T!VO_ (I>-?M0WK:0V5K"K#(6
M-HV=A]"S'\JYK2[JZ/P$>_CD/VK1VFELICR5$$S;/PV*4/J"1WH ]=JE>ZOI
M^G3VL%Y=Q0S7<HBMXV;YI'/8#O43:U;Q>&3KLP9+5;/[8X')";-Y_2N#UZ[U
M;4X? FIWC6B6]YK-M.+>.-M\6Z-V4;RV&P"0>!STH ].HK@]7\8:MI-^@F2R
M"'5XK+[(JM))Y$C!5E:16PC'.X*P'''O5]/$U[8>+=7TO6I+.&TALOM]C-'$
MP,D0R)-Q+$$H<9  R"#Q0!UM%<)?^,-0T<Z1;ZY/9:5)?6ID:[FMG-NL^1B$
MG?\ (0"<DGG'&*[&TDNI=+@DE\D7;PJS[#F/>5YQZC/Z4 6J*\M7Q[XJB\&6
M?C"XM-*;2TG,=[;Q+)YOE^>8MZ,6P,<?*0<\G(S@;T&M^)]0\8:SI-F-)CMM
M,GM2SRI(6>*12S 8/WL=#TXZ<\ '4V.IV6IBX-E<),+>=[>;;_!(OWE/N*MU
MP-MXXO8M'O9+JWM/MQ\0-HMJL:LL;.7"J[9)/3<Q]<8XJ_-XAU;3O%!T&\^Q
MS/=6,EU8W*1-&NZ,C?&Z[CZ@@@CT]Z .OHKDO ^L>(/$.DV.LZD--CLKRS61
M(K='$BR9YR22-I';J/>JT]]JB?%EK5M0A73H=&^T^4T!. 9@&Y##YOD'., <
M8ZD@';57OKZUTVREO+VXCM[:)=TDLC;54>YKA[CQQJ<'@NV\:^5:MI#NKRVG
MEMYR6[/L#A]V"XR&(VXZC/&3TWB_!\$:]W!TVX_]%M0!JVUS#>6D-U;N)()D
M62-QT92,@_D:ALM3LM1:Z6SN$F-K.UO.%_@D !*GWY%<1X<UO6-.D\%Z;="Q
M?3]5T[9$L:,)86C@5P2Q.&! /&T8]3U,L?C/4H- \1W]Q:0,^F:P;(M;0NX2
M$>5NE90=S%0[,0,=/QH [VLN[\2Z%87OV.\UBPM[K&[R9;A5?'K@G.*A\,ZL
M=:L)KQ-0L;^U:;%M<68(#)M4_,"QPP8L"..@X%<_=_\ )<M-_P"P#-_Z.6@#
ML+'4K#5(3-I][;7<8."]O*L@!],@U:KSCQ/&NB?%GPE?Z<HBN-6:>TOHTX%Q
M&JAE9AW*DYSUJVGC#5H-;T:UO4LLW]]+:3VL*L[6N [)F4,5+80$K@'YN@Q0
M!WE%>;:5XDU32K7QEJFI74-Y'::N;6*%8&0[RL"1@'<<)EAD8)ZG/:NBTK5=
M?D\2-97EF)M,>V\Q+U;5[?RY0<&-E9FR".01]#0!T]!( ))P!U-8&JZY-'XE
MT[P]8F)+N[AEN7FE0NL<28'"@C)+, .>,$\]*Y?6/$6IZAX2\<Z5.UO!JFC6
M\JS2QQ,4FB>%G1E&[*,1[M@CO0!VECXATG4[Y[*SO8Y;E(A-Y?(+1DX#KD?,
MI_O#(]ZRKG6_ TFIQ7MUJ6A-?P,8XYY)HC)&W0J&)R#QTJYX5MI$\/:7-=?9
MI;@6<:)+%!L*QE5.WEF)Y'J ?2N<\?VT-H_@>WMXQ'%'XBM@JCM\LE '9Z=J
MVG:O%)+IM];7D<;[':WE#A6QG!P>#@C\ZN5SVO:I'HE[90VD"_;M7N/+W^4T
MF D;,6*J06(50.HZCL*YW5/%WBG2/#FKWL^FV_F65W!';SRPO&EU%*ZID(6)
M5E+8.3CB@#T.BN(OM:\6:7K>BZ=<_P!C2'5+R>)7CCE&R-8BZYRW)!!SZ^V<
MBA)XI\6)IGBDAM'-SX==VDD\B39<H(A*%";\H<'&=S<]N] '=SZG96VHVFGS
M7")=W8<P1'K($ +8^@(JW7(OXFO9/$?A6WB@MA9ZS9S7!W@F2,K&K@ YQCYQ
MV[5@S>-O$T'A_5=;:/2OL^DZL]G-"(Y"T\:RK&2IW80\YY#9]!W /3**XCQ?
MXJU?P^FKW$2V,<5C;)<6T4BM+)=]3(2$8&-1@+N(QDYSVI&U#5KKXIZ?;PWL
M,=@^BO="W> MUEC#<AAEO0XP.>#DF@#K;'4[+4C<BSN$F-K.UM/M_@D7&Y3[
MC(JW7 P^.;R#2-6FN[>U-Y%KW]CVBQ!E1V8HJL^23_$2?88K1DU_5M.\60:!
M>FSF.H6DL]C<QQ-&!)'C>CKN;(P0001Z>] '6T5YOI7C;Q#<Z3X3UJ\BTT66
MM726DMO%&_F(SA]KABV, K]W!^OIZ10 4444 58=,L+:^GOH+*VBN[C'G3I$
MJO)CIN8#)_&K5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C*KJ58 J1@@]"*XA?A
MGIJ^&K31OM,Q6VOA=),?O; 2OE=?N^4?+^G-=Q10!@ZSX>GU37]#U2*^C@&E
M222")H"_F%T*$9W#'!/;K^5#^'YG\<1>(Q>H$CL6LOLWD')4N'+;]W7*CMTK
M>HH X=?A],G@^7P\-:/E)=BZLI?LHS 1-YP##=\_S''5>,<"I[[P=JIUY=;T
MCQ&;"_F@2"_W6:RQ7(4G:VS<-K#) .3QQSSGL:* .:/A:X'B/2=675-W]GVT
ML!2:#<TQD*EG+!@ <J#@# Y_"QX8\/S>'H-0BEO4NOM=]->Y6'R]C2-N*_>;
M(STK=HH YC_A%KI=;\0:BFI1#^V+>.#RS:D^2$5E!SO^;ASGIVJE9^!)M-C\
M/SV6J(FI:-:_8A.UL3'<08 V.F_.<@$$-P>W:NTHH Y"_P# J7^A:K:-?[-0
MU*[CO9KP0Y DC9"@"9^Z!&HQN]><FKC^&KN;Q1IFMSZG'(UG:RVSQ?9<>;YA
M4L<[OE^Z,#!XZD]:Z.B@#C?#_@J_\/,MC#XAEDT"&8RV]@;<"2,;MP0RYR4!
M[8![9QP4L?!.H:7J-U'I_B.:#0;J=KA].^S*SHSG+JDN<JI)/&,C)P0>:[.B
M@#/UW2H]=T#4-)ED:..]MY(&=1DJ&4C(^F:P3X.O%FT744U=/[8TR)K?[0;7
M]U/"P *-&&SV!!W<'/;BNNHH R=%T--*FU"[DE$]]J$XGN9@FP$A0BJJY.%"
MJ .3W.>:JS>'+C_A,6\06FI" RV2VDT#P;P^QF92&W#'+$$8Y'0CK7044 <-
M#\/[F#PKI&AKK,1&FZ@M\LQLSERLAD"D>9QRQY]*G_X0O4[/7KZ\T?Q)+86&
MI2^?>6?V59#YA #/$Y/R%L>AYKLJ* (9+6":S>TEC$EN\9B:-^0RD8(.>O%<
MWHOAG5_#EJNFZ9K<#:5&2+>*\LVEE@7.=@<2+N4=LC(]37544 <UJ?A1KJ^T
MG5+/4'AU736DV7$R>:LR2??1U!7@]1@C;@8XXJEJW@0ZKHVMVSZBD=]K4D3W
M5T+?("Q[0B(F[@ +W)Y+'OQV5% '/2>'KN7Q?:>(#J$(:"R>T,(MCA@[*Q;.
M_CE1QZ?G7$>)M&?PQI.B6<FL6S37'BJ*\25X=@0N[LV5+G<H)]1QW[UZQ1C-
M ''ZOX'_ +?M]8>_U'%[J-FEDD]O%M6")6+@!2QW98DMD\C XI8_"&J?V\VL
MSZ_')=2:;_9\BK8A8R-Q8,!OR!DGC)R>X'%=?10!Q</@6Y@T7PQIJZO$5T&X
M2='-H<S;59 "/,XX8_CBH571?&7CBPU33I))O['6:*[E5&1&<,NR)L@;BKJ7
M&.A4'N*[JB@"O?V@O]/N;-I'C6>)HB\9PR[@1D'UYKD--\":A977AN>;Q LI
MT.)[>-([%8Q)$RJN#\QPV%&3R#V ZUV]% &!X9\.S>'$O8/[0^T6DUU+<PQ&
M$(8O,<NP+9.[DG!X^E)<>&Y+CQG'KS7D9B6P>P:U: G<CL&)W;NN5';IFN@H
MH X[P[X,U/0&BL1XEFN-"MGW6UDUNHD0 Y5&FSEE![8'0#..#1A^'5]#8:;8
MCQ&3!IFIG4+4FR4OR7)5V+?,W[QL-Q[@]N_HH Y6[\(3:G>6<FI7\-Q'9:B;
MZV<6NV>/YRRQ^9O/RC(!X&0,>]6]!\.S:'J>KSKJ'FVFH7;W@MS" 8Y'"[LO
MGYA\O P,9.<\8WZ* ,#4?#LUUXKL->M=0^S2VUO):RQF$2"6-F5N#D;3E1SS
M6+-\/[J;PKJVAMK,0&HZ@U\TPLSE"THE*@>9R,J!GTKN:* .=_X1V\_X3%O$
M(U&#>=.%CY/V4XX??NSO_O'IZ=^]4;3P+Y7PVF\&W&I>;&\$D"W*0;"H8D@E
M=QS@GU&:["B@#@_%+VEQH7_"%ZA?M>:_>0*]MY-NT9#!\)*,9"A&7<<MG"FN
MTL+*'3=/M[* $16\:QIDY. ,<^IJQ10!RUKIS:)X\U/42#]CUN*#<_:.XB!0
M ^@=2N#ZJ1U(S,V@:IJ$)M-<U:WO;'[0LWEQ67DNX5PZ*[;V! (&<*,X^M='
M10!@W?AZ8:Y<ZQI5ZEG=7=LMO<[X/-5PI.QP-RX9=S#)R"#TXK*UKPY%;^ T
M\%Z.&'VF(6H8\E(B?WLKGZ;C[L0.]=G10!3GTNTN-%DTB2/-E);FV9,_\LRN
MTC\JX^+P%JPT_1-.F\2K+:Z+>1W%H38@2E(U951VWX; ;&0!TY![=Y10!P4_
MP[O9;6[M(_$)2WDU4:K &LPSI)Y@D*NV[YUR./ND>I Q3M731O&/B;2].@GE
MN+W1+PO>R*C($38=T;G 4AVV?*.H!]*[NB@#$UG1;O5)9E6[M38SVWD36=W:
M&9&.2=X^=<'G&.^!5K1]-M_#WA^RTU)F-O8VZ0B69N2JC&2>G:M&B@#RSP#H
M[>)?AK96%QJ-O)I1NY9)H(XOWC!;EG"%]V "0"?ES@X]Z[32_#UQIWBC6M9:
M^CE75/*S +<KY?EKM7YMQSP>>/RK?QBB@#B3\/1-HNIV%UJ>Z6ZU1M6M[F&#
M8UK.6# @%B& (]N":U%\.74^I?VKJ%];S:C':/:6[1VQ2.(.07;:7)).U?XA
M@#'J:Z*B@#&\*Z')X:\,V.C/=K="SC\I)1%Y>5'3(R>:@N_#<D_C&'7X;_RA
M]C^Q7%NT(<2Q[]XPQ/RG.0>#D'L>:Z"B@#B[7P"8- _X1I]2$OAY9Q(ELT'[
MX1A_,$1DW8*[AC.W.WC/>NEUO3GU?0K_ $V.=8#=P/ 96CW[0RE2<9&>#ZU?
MHH Y./P?=)<^%ICJD1_L")HP/LI_?AH_+)/S_+\OUY_*ET_PIJ6F1ZH;76XT
MGOM3.H[_ +(<(3M#1D>9\RD*!U!Y-=710!A^'_#<.A76J7:M%YVI3K-*D$7E
M1*0H7Y5R>3C).>2:IWWA?4)_&L/B2UU6VADALVLU@ELVD78S!B21(O.0*ZBB
M@#G;+PJJ^(?^$@U2]>_U-(C#;G8(XK9#]X1IDX)[L23VSBL*S^'5_:66BVG_
M  D9:+1[UKFV/V)=S*P<$.2QW-\Y^;@>JFN_HH XZ;P#'=1>)+*XU&1M-UN8
MW)@2(*\,Q"#<'R<X,:D# P>N:T?#^B:UI[*VM>(FU9HDV0XM5@ ']Y\$[FXQ
MG@=>.:Z"B@# UOPVVHZSIFM65V+34]/WHCO%YB2Q.,,CKD$C@$$$8(JK<^#F
MN='\06YOD%_KJE;N[\C("^7Y854W< *.,D\DGO74T4 4])LY=.TFULIITG>W
MB6+S%CV!@H SC)]/6LCQ1X9N/$5QH\D>H1VJZ9?1WRJUN9#(Z9 !.\8&&-='
M10!S_BGPRWB.RL_)U"33]2L9Q<6E[$@;RY "#E2?F4@D%<UGZGX/U36O#%QI
MFH>(!->7$D+R77V,!%$;AU5(PXQR.222<GVQV%% &!JWAZYU36="U+[?%$VE
M2O*4^SEA*S(4/\?RC#''6J#^#+IX?%49U6+'B $.?LA_<9B$7'S_ #?*/;G\
MJZZB@#E(_"-TFH^&KPZI$?[#MI+<+]E(\X.BH23O^7A1Z\YJC/X N9_"VM:(
MVLQ :I?O>M,+,YC+2"0J!YG/('/I7<T4 <1JO@*\U.?Q#C7O)M]=MDBN(Q:!
MF1UCV HQ;A#U*X)ZX89S5^/PG=Q:]I.KIK'[^TL38W&;88GC+*WR\_(<K_M<
M>_-=110!Q+?#U;C1]9L+S4][:AJ1U.&>&#RVM9LJ01EFR 5'ZUJQ^'KN;5(=
M6U&^M[C4+:U>WM6CM3'''OQO<J7)).U1U&!QWS70T4 <1;^ ;FV\-^'-'36(
MBNB7B722FS.9=F["D>9Q]XY/TKJ;&UOX+R^DN]1%S!-*&MH?("?9TV@%<CEL
MG)R?6KU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 444A(4$D@ <DF@!:*1F"J68@ #))[4*ZN,JP8
M>H.: %HHHH **** "BBB@ HHHH **** "BFI(DB!XW5U/0J<@TZ@ HHIKR)&
M 7=5!(49.,D]!0 ZBBB@ HHIK.JE0S %CA03U/7B@!U%%% !1136=5959@"Q
MPH)ZGKQ0 ZBBB@ HHHH **** "BBF[UWE-PW@9VYYQZT .HHHH **** "BBF
MR2)#&TDCJB*,EF. /QH =12*RNH96#*1D$'((I: "BBD)"C)( ]Z %HHHH *
M**.E !12(ZR(KHP96&0P.012T %%%% !1110 4444 %%%% !1110 44T.I<H
M&!< $KGD ]/Y&G4 %%%% !1110 4444 %%-5U?.U@V#@X.<'TIU !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:BNBI\_R]1MSQGK6I+J5C-XJ\,:F=;T!8-,M9X;@?VFI8M(J#Y1CD#9W(ZT
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MU.WA:#RY2SCRT"'<"H SUX)KK#H]_J^O:)JE_!!;II,<KHB2[S+,Z;,YP,(
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M-3AA8,DCQ/\ Z.6(_B#%S_VSH [:)I&A1I4"2%0616W!3W&<#-/HHH ****
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M#EB"#@\8&,]3C)6;QCJUQX-OO&&G+:O86LLS+9O&=TL$3E')?=\KD*S#@@<
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M]OV[N.NS'M5BY\*;=<L=:TN]^R7UM:?87,L7FI/!G(5E#*<@\@@CJ>HKI**
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M))/( 'KG1@\/74FIVFIZGJ$-Y?6,$D-JZ6WEHA? 9V7><L0H'! QG YKH**
M.(@\ 30>&-&T1=74II=\EZDIM>9"LA<*1OZ98YQVQTKMQG'/6HEN(6NI+99%
M,\:+(Z \JK%@I/U*M^1JI9:F\FEPW>I6C:;+)((S!-(K%6+[%&5)!W<8QZT
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MD2(2#[R*6.6([X& >,YH SXO!<\4/A:(:HA'A\ 1G[-_K@(S'\WS\?*>W?\
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MTU/1 \=K?I;@[HW^\DD9.&!P.XZ5WM87B3Q/#X:_L_S[&[N1?W<=G";?R_\
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M*VDMEDDEC\J0@LI21D.<<=5K8H 9%&L,*1("$10J@G/ I]%% !1110 4444
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M==W]O+Y+B2&)I\9\E7E5&?GN Q(]\5?_ .$9TC^U+74A:8O+6$01R"1_N Y
M89PV#R-V>>>M7[VRMM1LIK.\@2>VG0I)%(,JRGJ#0!QGB4W'A#2]:US3-4NI
ML:6S0V$\K3J)$/\ KP7)/ 89 X/%0:C)=:+<>#[_ $S4+RY74KN*SNTEN&E6
M=)(V;S<,2%9=N[*XX)'3BNFT7PAH>@6TUOI]CMBF3RW$TKS93^YER<+R?EZ4
M_3O"VD:4T!M+>0"V#+;K)<22+ #P1&&8A...,<<=* /,KR748?!7B?6EUO53
M>:3KLR6A-V^U46=%VLN<."IQALCTQSG?\6ZG>Z/K-]=ZDE^^@L(E2_TZY8-I
MS #/FQ*1E22&+<\''I73/X)T"32[W37LY6L[V<W%S$;N;$DA.2Q._/) )^E3
MS^%=(N9;AYH9W%SL^T1M=2E)MH"C>N[#<* <CG'.: .:T'3H)/BEXRD$MT#Y
M%DP*W4F/G27/&[!]@1A>V*Y>/S=6\ > [G4+N\N+A_$"1O,US('8&:4<D$<X
M48/4=L5ZD_AW2WUJ36/LS+?R1"%Y4E==RC(&0#C(#'#8R,\&JB^"] 70H=%6
MR<6$$PN(8_M$N8I VX,K[MRG))X/<^M &':O.OC'Q?IQO;TVD&G6LD*-=2'R
MV*R[BI+9!.T9(/:N<T^-M8E^%EW?W-Y+<7%K/YLOVJ168_9R<Y5ASGJ>IZ'B
MO0KOP?H=[J$=[-9GST@%L=DSHKQ#HKJI"N!DXW TP>"O#ZZ?IUB+#%OIS;[0
M":0&,D8(W;LD$'!!)!'6@#D@^L>*K77+BSU9=.O-/U.:%)S=R*+98GX#1#Y&
M5D&3NSG<?08?K>JWVD^()KC65O3H\MW;FWU/3[EMEH1Y8,4T0(PK,&RQ!R),
M'MCI[KP+X;O-=.M3:8IOFVF1ED=5EV]-Z [7Q[@U;F\,:5/<W$\L,K?:)5GF
MB-Q)Y4CKC:QCW;3]U>W.!F@"]J*W#Z9=I:';<M"XB/H^TX_7%<9\'I8I/ACI
MMO'^[N+8RP7*,/FCF$C%@P]><_C7>5CR>&-*;4)[^**:UNKC'GR6EQ)#YI]7
M"$!C[D9]Z . N?&>M+H7B&::>WB-MXA72!<6\.PQQ%XU:5B2?FVMC/8XK6UR
M^OO"7BZS73GNKNSO=-O)I;2>=Y@LD"!U=2Q)&[<%(!P<CO750^%]%ATF[TM=
M/C>SO7:2Z24F0S.V,L[,268X').>!4NGZ#I^F2B:!)7F$0A$MQ.\SK'G.T,Y
M) Z<#K@9Z4 <!/J%_;> _#/BRRU&[GU*XEM#<HT[-'<^<RJ\?EYVC!;C !&W
MZTS4KE_$_@SX@7MW=722V$M[9PPQ3LBQ)#'P"H.#NY)R#D-CH!7<V7A+1=/D
MC:UM&2.*4SQ0&9S#%(<Y9(R=JGD]!QDXQ4-]X'\/ZC>WUW/92"2_C\J[$5S+
M&DXQCYT5@K'!ZD9H O\ AW_D6-)_Z\X?_0!7GFI2:_#\1?&4_AL6SZA'I=HR
M13QEO,^_PI# !L9QD$$XKTVRLK?3K&&SM(_+MX4"1IN)VJ.@R>:I6WAO2[37
M+C6H895U"X4)+*;F1MZCH"I;;@=N.* .&LM0T[PW\&)-4\-W$K([+)+<7!'F
MI+)*JRL^!@,NX\8P-O>M&YM;_1)-0U23Q&EAIDNF2?(T\EYY<BC(N$W\\ C*
MC@\=S721>%-$AEU%X[$!=2+&\B\QS%,6&&)CSLR1U.,U5TWP'X:TJPN[&UTT
M?9KJ(PRI+*\N8SU0%F)5?88H YK2+K4;7QI%9"YNH+6?P\]S_IURTI,J2(HF
M922$.&.0">.O2J5KXDU'0K>^CU2SU&W\066C7$R1R7+W%IJ!0*?-C). 01RN
M 0'Q79V_@7PY;3031V#&6"!K9))+B5V\ML94EF)(&!C.<8XQ5VR\.:982121
M0R.T4)@B,\[S>7&<95=Y. =JY]<#T% '%W=U>Z;HW@W7M/U&\N;B_NK2"[62
M=G2Z2<?,=A.U2"=P*@8P1TXK'U$Z@/"WCS4AKFK"XTC4YC9%;MP(]L<3 $#[
MR\D;3D>V237H^G^%-&TMX#:6KJENS/;Q-.[QP,<@F-&)5."1P!@$@8S4;>#-
M">RU&S:TE-OJ4AEO(S=2XF<XR3\W? ''H* -J"0RV\3G&YD#''N*XWXN0I-\
M,-:+%QLC5QM=EYWKUP>1ST/%:T7A:T@\56^M0HT<D%G]DWF>1VD3.0K!CC Y
M.>221R,<ZVI:;9ZQIMQIVH0+/:7"%)8V) 8'Z<B@#B=:TN*3XD^&[!;B\CA_
MLV]W,MR_FD;HB1YA)<=>H.1V(K'T_7]1MM'T_2I+Z5XY/$EUI9NKFX8.8HS(
M8T,HRV255<]<<>]=]%X4T>&]L[U()A<V<3102&ZE)56Y8'+<Y.,DY)Q4+^"/
M#LNCWFDRZ=YME>3&XFCEFD?,I.2X)8E6SSD$4 ,\,Z;J6EZAJL-YJ2W%O(\<
MUM:F5YGM000P+O\ ,5)4D ],$5B_%)9&MO"BQ.(Y#XDLPKE=P4_/@X[UU>BZ
M#IOAZS-KIL!BC9MS%Y&D=STRS,23QQR:9K/AS2_$'V;^TX99?LTJS0[+B2/9
M(O1QL8?,,G!H BM[74;?4YFU'5DFM[B)88$2/RBLGSEB.3DD8^FVO-+:74A\
M.M#UW^W-5.HKK M_,:Z8JT;7C1E60_*WRGJP)&!C@8KT^+PWIL5Y'=_Z9)/&
MK+&T]]/+LW#!*AG(!QQD<U5'@G0%T>+21:3"QAG^T1PB[FPLF[=NSOS][GZ\
MT <M=_:])\2>*-+MM4U$VYT!;]#+=/(T4VZ12R,Q)4':.!Q]*SX5U73=+\ ^
M(8-;U.YN=1DLK6]MY[@O%-'+%DG9T#+C.[J>22:[37/#=JUOJNI65G//J]QI
M[V:D7+9=2IVKAW"8R<\^I-0^#O#,6G^'="^W6<\>H6-HD?ESW!E$,FP*Y0;F
M49Y ([$C@'% '(7VM7.@:?\ $&_M',4HUF"+S@,^2KI C/SZ!B1[XKHM12XT
M;QUX?L;*ZO9+#5XKF"[AENI)-NR/>LJ,6)1NQ((SD=\5T$7A;1HAJ:BSWIJ9
M)O$FE>19B1C)5B1T ''H*6TT"QT=?/LK>6:XA@,4'GW+R%5Z[%9R=H)"]/09
MZ"@#B](NKU&NO ]WJ%])JL.HAA=M<OYLED3YHDW9R/E!B.. Q'K3V_M;Q7)X
MDAL]3^P7>G7YMX)1>2(;9452K&,?*X;YB2V<Y([#'2Z!:7U[J4OB'6-)CTV_
MDMTM8[<3+,\<88L=SKP<L>@Z!1W)%.U'P-X<U76O[7O--5[TJ%=UD=!*!T$B
MJ0KC_>!]* .:,VJ>*M7\0:3'J"PW%E% EO+#=RP;"\*OYP5/O NQ^\2,*!W.
M>YT<W']BV7VNZCN[@0H);B(865L<L!Z'K^-9FL^"?#VOZE#J.H:?OO(D\L2Q
MRO$S)_=;81N7V.:WHXTBB6.-%2- %55&  .@ H \K-AJ&K6GCB0^(]8MY=+O
MY39-'=LJQ%84<9 ^\N?X3QU[G-.L7U+Q3XAT*&^U74[--1\,"[N(K2X,.)=\
M0W+C[IYS^G0D'8T#PJ\^K>*9-:TV[AM]0OS+&K70\N>'8BX9$<@\ALAAR#@^
ME=2WA_36UR+6?(<7\4/D)(L[@+'G.W:&VXR <8[4 <992W/B+3/%\LNI7UK>
M:7>SVEHT=RZ>0L**4<J" VXY8E@<@XZ"JXUO4(;7P5XRU"YN(;.]B2WU2#SW
M6%&E0>7-LSM W\'V<>E=K=>%='O+ZYO);9UENT"70BG>-;A0, 2*K /QQR#Q
MQTJ[J&E6&J:9)IM[:QS64BA6A(^4@$$#CT('Y4 <-XHDOK7P,-6BO[^WN+K4
MK:95%PXV123HHCP3P-A&5'&2:OV]RWB/QIXGTNZNKJ&'2H[>*WBMYWB.9(R[
M2G:1DYP!G(&WW-=-K&B:?KUDMGJ4+36X=9 BRO'\RG*GY2.A /X54O?"6C7^
MJQZG-;2B]2+R3-%<21M)'_=?:PWCV;- 'G7@_4;D^'O N@I(L<%YIUQ,0;AX
M?.D1E 0.GS<!F; ZX'ISM3V?BC2=)BMX[O\ MQK74)));*.\:.X:V*96/S20
MSLA=3R1N&VNAE^'_ (8GT"UT1],!L;1_,MU$SAXF]5?=N!^AJVGA31XK2SMX
M+>6%+-F>!HKB1'5FX8E@V6)[[B<T 0^#-2M-4\-17%G->R()IE9;[=Y\3"1L
MQON).5SMY)X K$6QA;XVW$A>X#?V'%+@7$@&[SW'0-C& /EZ=\9KLK#3[73+
M7[-9Q>7'O9SR6+,Q+,Q)Y)))))Y-5;OP]I=[K$.K3VQ-]#$84F65T.S.<$ @
M'!Y&<X/(P: /*=*6XT[P'HFLVNH7L<Z>(##Y23LL31O>NCHT8^5L@DY()'8B
MNBD.K>+;KQ-;6FI?8;O3[W[/;R+=R1FV545E<QK\KAB6/S9R,CH*Z<>"/#ZZ
M3%I8M)A913_:4B^US863=NW9WYSNY^O--U'P+X;U;6%U6\TT27H4(\@E=?-4
M=!( 0''^\#0!MV3O)86[R2I+(T2EI(QA7.!DCV-3T 8&!THH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#.U[6[+PWH=WJ^H.4M;5-[[1DGL% ]22 /<UGP77BB;31J'V33XY6C\Q=
M-<OOZ9"M-G ;U^0@'OWK*^+&D7NL_#Z]BT^%I[B"2*Y$"\F4(X8J!W.,G'?%
M=!I_B;1M3T>/5;;4(&M'4-N+C*D_PD=0W;'7- $]IJ:'1K.^OVCM&GAC=UE8
M(%9E!*\^]7&EC159I$4,0%).,D] *XB*Z6?XKSV^JQ 03Z/&VFI<*,$;CYP
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MDKWC;O-1A(52&,D<YZMSSM&#79>"[I+SP1H<R3K-FP@#.K;LL(USD^N<Y]Z
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MC=L>1_"I'..F* /<5974,K!E(R"#D$4M16SP/;1-;%# 5!C,>-I7MC';%2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5372=-2^-ZNGVBW9Y,XA42?\ ?6,U)>WUMIMG+=WDRQ01
M#+.?R P.22<  <DG%9UOXITF:XOK>2=K6:PB$]Q'=1F(I$02'^;^'@\]L<XH
M T;NQL[^-8[RU@N44[@LT8< ^N#1-8VER$$]K!*(QA \8;;],]*SK?Q1IEQ?
MQ6):>&XGB,UND]N\9G0=2F1R1D$KU&>E9\?Q"\.2K"Z7-P89;K[)YQM)1''+
MNV!78KA"6X^;'Y4 ;YTVP+R.;*V+29WMY2Y;/7/'-<]J_A1K_P 3:'>PVVGC
M3M.%P);=UQYOFJHX4+CC;GGK[5JW/B+3[6YE@<SN898X)GBA9UBD?;M5B!P3
MO4^@# G&:SK+QA!>^(=<TMK6\B33!&K2_9G)8LI8G@'C&W'<\XSQ0!OM8V;6
M8LVM8#:@8\DQC9CTV]*1].LI X>SMVW[=VZ)3NV\#/'..U<?'XQL-(T#PR+*
M74M6M]4G6"&\GC>21E^8EFP 2Q"G QGOCBN@7Q3I3'55$DX?2D5[Q#;2!HU9
M2P.,9;@$\9H N2:;;!"]M:6D=RB$0R-"#L...F#@'L"*I:!IFI6WFWNN7=M=
M:G,B1NUM$8XD1<X5023U9B3WSZ 5GW'CBS75_#]G:P7,\&L0-=1W"6[D>4$#
M#  SD[E)XX'7%7K[Q;I&G2@7,TB0B<6SW(A8PI*3@*S@8'/&>@/!(- &Y32B
M&02%5W@%0V.0#C(S^ _*J&OZS;^'M O]7N@6ALX6E91U; X ]R<#\:Q-#MK[
M4O#]MK.MZM<P75U"MQLMY1%#:JPR% Z-@$9+[LG/;B@#J#;PF%H3%&8FR60J
M,')R<CW))J(:?9"#R!9VXAW;_+\I=N[UQC&:R-.U2/2]"C.JZM'?3_:&A$T0
M#-,6D;RU"H/O%<< <8/85:M?$NE72W^;CR'TX9O([E3&T"XW!F!_A(Y##@XZ
MT 7#IE@S2,UC;%I/ODQ+EN<\\<\U-#!#;1"*")(HQT5%"@?@*R[7Q-IMUJ,%
MANFAN;F(S6R7$#Q>>@ZE-P&2,@D=0.<5RWQ \4JGAF5])O;V*6.^AMQ<V\;"
M-G\Y5="^/3<,@XR,9SQ0!W<EG;2SK/);PO,JE%D9 6"GJ ?2GQ11P1+%%&L<
M:#"H@P%'H!1+'YL3(69=PQE#@CZ&O&X?$FNVOPI7Q*/$=S)K(NY(X+:5(W6Z
M*SF,1[ N22H_A(/>@#V5T20 .JL 0PR,X(Z&@1H'9PBAV #-CD@=,_F:HRZM
M':6EH]Y&Z75PHVVT:EW+[<L !Z<Y/2J,7C+1)["*[BN7;S;HV2P^4PE^T#.8
MBA&0PP2<]!STYH U8M/LH%D6*SMXUD&'"1* P]#QS0-.L1;M;BSMQ QW&,1+
MM)]<8QV%9\'BG2KG3WO(II"J71LVB,3"03@X\O;C.[/X8YSCFG_\)'IHLY;F
M5Y85BN!;,DD++(93C"*N,L3N&,9SVXH TC;PFX%P88S,J[!)M&X+Z9ZXJ*/3
M[*&>:>.SMTEGXED6)0TG^\<<_C6:/%ND"+47EEFA?34$EW#) _F1(1D-M )*
MX!Y&1P?0U#I_C71-3O[&SMII_,OX3-:O);2)', H8A7(VD@') /'/H: -7^R
M=-\OR_[/M-F<[?)7&?7&*MJJHH50 H&  . *6N?GU9[WQBOA^WD9([:U%Y>2
M(<$[FVQQ@]LX9B>N !W- &K_ &7IV''V"UP_+_N5^;Z\<T3:9I]S;);SV-M+
M!&<I$\*LJGV!&!6#'JVD^=XID&K:F?LP47B%'_T/]WUB79GI\V1D9YJO?:RN
MB^#-,\26=[=7FG000-.UR=SSVS;09#P,2 -OSQG!!ZC !UDMM!/!Y$L$<D7'
M[MT!7CIQ3196JW/VD6T(N#_RU$8W>G7K3IIUBM7N-KR(J%\1*69ACL!UKS;4
M_&<NL^$?#NOVLUWIL<VLVJ2K@QJ\+38*EB/F&T<X..M 'HT-C:6T\L\%K!%-
M,<RR)&%9S_M$=?QH2PLX[Q[Q+2!;IQM>81@.P]"W4UFV'BO2-1.HA)I8&TT!
MKI;N!X&C0@D.0X!VD G/M3[/Q+IUYJW]EAIX;UH?/CBN('B,D><;EW 9P>HZ
MCN* ->JUMIUC92/):V=O [_>:*)5+?4@<USOC3Q%=Z5)H^DZ8434]9NQ;0RN
MNX0H!F23'<@=!TR15J]T+48K)6TS6K_[6CHSF>19%G4,"RD$87(R,KMQGTH
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MX;>/.=D2!!GUP*P6\=:"FD3:JT]P+.&Z-G*YM)<I*&"[67;D?,0,XQDU?O\
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MKHVDTOV.79!)N"XD.WY/F('S8H ZD  8' HHHH **** "BBB@ HHHH ****
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MI=Z-;7^GB']TPE\J>WFSPR-C@8QD@]AP: .DLKA[NPM[F2!X'EB61H7^]&2
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M87%Y-N\JWB:5]HR=J@DX'X5Q6E>$;R'Q5IVN_8H-+O%60:JUI-F*_P J0OR
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MHGNQ'&555W.S[>,EP, $Y/H"1'8_$*SU"SLFC@6&[NKV6Q$5S.$C66,$M^\
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M[N01VP,?AD@'4S3)!$\LAPB*6. 2<?0<FJNDZM9:YI<&I:=-YUI."T4FTKN
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MCOTU!D0L9TX!*8"[<?+M  Q73T4 <=)X#,I\0O+K=W))KMJEK=%HTP%"%,J
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MGA0JR;%4NK8W9^52!G -=510!RVE^$[^RLY(+WQ+>ZF1"T%LUS$@\E2,$G:
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M HASN OS)C_GGY2]?;=M_'%=0FB:<NF7&GM;B6VNMWVA927,Q888N3R21Q]
M!T J&QT*STRX^VAKBXN(X/(CEG<R.D0YV+^(&3U.!DG H P-$GD@^*WBFP0G
M[/-:VEX5[+)M*$_4A5_[YJS=:E+J7Q"/ALW$UO:VVFB]<0N4>9VD*#YAR%4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT <;)X%EET+Q'I;:J-FNW,EQ*XMN8BZJK!?FZ848S[]:NW/A6:[UG2-1EU$
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MA/>0++)8S_:+=F_@?:5S^3'\<'M5'Q#X2TGQ,]K+?QS)<VC$V]S;3-#+'GJ
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ME9:/IFG.7L=.M+5B-I,$*H<9SC@=,TZ^TK3M355O["UNPARHN(5DQ],BK=%
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MHH **IV]\UQJ-[:&SNHA;;,3R(!'-N&?D.><=#P.:N4 %%%% !1110 4444
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M%V1ID=2!DGW8XR.: -RBBB@ HHHH 3:"P; R.AKA?AJH8>,58 @^)KT$'O\
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MU*^NO!7Q(L;QYS'81SQVZ7#!Y(T:V#[2P)W8+'G)//4UZ'H7_(OZ;_UZQ?\
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MV=&_=+']K15CV^V 2WWB0><<5W6B^ M&T"]\^Q:^$*.TD-D]V[6\#'.2D9.
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M9BNI&LY(39VZ1 /"R\B=%&<*<8ST8X[UREOH&C']GF;5_L%NU^=+E3[4RY?
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M@VY91NX7GKWXKS35(=&T#QS9:/.UII&BS:?(]H'BC^SFX:4F4?.-H8J4Q[9
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M2)6N4:2%6#!G5>I (S]/7MFH/^$]\+BSCNSK$ @>0Q[BK?(P.W#C&4YX^;%
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MI'E/%_9=EY;L&=/LZ88CH2,<FH(O$NCS7D-JEZOF3NR0,48),R]51R-K$8/
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M^>(S)"(V)9!U88&".WUXJ"#Q/H]SI;ZE!=F2S27R3*L3D;]VW;C&2=QQ]>*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/<T <S\1;34+C0+.XL()+DV&I6U[/;1#+S11N&95'<]#C_9JC=*NK>.K37[
M2_8;/29XKF?R77S2[*4C (RQ&&8CMQW-=Y10!R7PQA:W^'&B6\MO)!/#;B.6
M*6(QLK9.000#[U%XU$D&O^$=0^SW,MM:ZA)YS00-*4#0.JDJH)QD@9QWKLJ*
M /,)U>2Z^)[_ &2Y_P!,MHUM\V[_ +XBTV$+Q\V&XXSS56*YDT34-!U+5++5
MWTJXT&VLVELUG#VUQ&22LB1X8 [L<CJM>LT$@=3B@#'\+V5G8:!!!I^G2:=:
M9=XK:0MN4,Q.2&.03G.#R,\\UQ^NQ64_Q?L[C4=.DNM/BT>2)G>Q>:)93*"!
MD*1G ->D44 >;>*/L+_#[Q1I6@:3<I ;<LJ1V;QJ\TG\,:;03TR2!@;A[XNW
M963XA>$+B.WF,,.GW2/((&VQEA'M#'&%)VMP:[RB@#Q:_(A\,:FUQ;3K&WC5
M)PCV[@R1-.A!52/F!P<8SFNP^SI>?$:?Q%:(_P!AM]%:UGG6,XFD:0,JCCYM
MH4YQG&X"M_Q)X?'B.TM;=KM[9;>ZBN@40,6>-@RCGMD<ULKD*-Q!..2!B@#R
M#08-0TW0_ASJDUG=_8]+2>WU"'R'\R!I$VK(4QG .03C@-FNGTS0X]8\4>+;
MZ6%CHVK6T%KM92HN"J,'< ]L,%#=\''2NYJAK.G3ZIIKVMOJ5UITK,K"XM=N
M]<'./F!&#TZ4 <=X/L=9NK"\M]2?%SI$,ND6=SN_UI!YF_%1"/4%7]:S?"!L
M+VST/1]2T#6%UW2#$K)<F?R('C&WSE<GR\$ X ZYQC'->CZ;80Z98QV<#.RQ
MY+/(VYW8DLS,>[$DD^YJW0!Y+X;CM6LK?PQK^AZQ/K5E=EE#F<VTA$A9;@.#
ML"X.?7.0 3Q7J5]_R#[G_KDW\C5BH;N%[FSF@23RVD0KOVYVYXSB@#R/1[:+
MQ!\,/!.EZ?"YOH+FTN"PB*_9UC;<\A.. 1G!_B+#&:Z'P_:SW5SX^@@26VN;
MR\<VL\D+(&!@5%=6(Y 8'I76>&]%7P[X?L]'CN&GBM(Q%'(Z@,5'3..,UJT
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MEK4%]-JE[]CB5<Z>K*()'5MRNW&XD''&<' _':H Y#QS:7L+Z/XATNU>ZO\
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M_AKQ5;>(Y-1MXX_*NM/F$4Z+()$.1E61QPRD?0\'(JQ?:X(-8CT>SM_M6HO
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MJ$R/.<$1L">6).2  !TJ?Q!IGB"U\5VGB70+:VO6-I]BO+"XF\HLF[>K*^"
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M8DG60;EVDJP P>W'&>E='8:3K/A_Q)KEY:6D5[::NR7(03A3;W 0*P8D<H<
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MQ72>'KC6[NW>YU86"Q3)');):[]R@KE@^[@G/0B@"_?ZE9:9%%)?7,<"2RI
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M4_NO+# '._YOOGCCM73T4 <5;>!;NSL_"R0:RBW&@(\*RFTR)HW38?EW\-@
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M@#8HH XF'X<64>CZ!927DTLNDW F:X;[]PNS8T;?[)4(N/1 *[:BB@#E=?\
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MY_/-N3PM<MXBT35?[4W_ -F0SQLLL&YYS+MWL6# +RHP N!TZ8KIJ* .'G\
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MY=N #V/(QM3UCQOI,'@G0+C4W?Q!J5T[WJ1+&?W"L#M9MIP0IQN'HW6NZN_
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M07<MOY@1S;0F4Q@Y)=@.B@ Y-:B1I&NV-%09)PHQR: '4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!B>+;I[/P[-)%J0T^1I(HUG\LR-\SJ"J*.2[ E1[D5Q%SXLU30(O'#9N%
MCTV.SDM([UQ*T!F!5BS G(! ;!8]Z] UW0K'Q%IC6%^LAB+K(K12%'1U(*LK
M#D$$5G1>!]$CN=0GDBN+AM1MUM[L7%R\BS*H(!8$\G!(SV[8H @O-(O+8W4R
M>(+IK&?3W0P.^9&F'S"5'S\ORYRJ@#N,4WX9PF+X<Z"QEED,EE$Y\QL[?E'
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M]1N-7\&:+J-VP:YN;*&65@,;F* DX^M!\,67]HZI?K-=+<:G$L-R1)P44$*
M,<8#$9'K5S1]*M]#TFVTRS,GV:V01Q"1MQ51T&>^* +DB>9&R;F7<"-RG!'N
M*\6CMW3X&QR_:IY))=749F<N 1J)&>>YZGGFO:ZY<^ -$.ES::IO%LY;G[5Y
M(N6VHX?S!MS]T;_FP.IZYH R#?:AHOB[7]-DUZ5K8:(NHQW%_M9;67?(A;
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MT-Z]]%,ERRR1S/G>0PYPV3D=.: .;M9_$FK^#?$R6-_=Q:GI6JSQV8+AG>-
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MY> MYG8VWV"IN&.,2CTJYXXO'AU?PK:7'&D7FHF*\S]USY;>4C?[)?'!ZX%
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MMLDEC N;>%0IB>)RPVC'/ ZDYZT >LT9K&UJ[@L?!M_=7UQ=)#%8NTT\(VS
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MML ?CY?FXYQ6+JD%S-X"^(%M'87SS7>LO);Q"TDW3(3%AE&WD?*W(]*]CHH
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M^R>4^YV)8 9P"!C[V[CC)J;5M.U+4[OXD0:?:W'GW0M'M=\;QK<>7&N]5<@
MY*E>#WKU2B@#@M"U'1]3O%UN'0=;CO+*UD\^2_2?? ,9,2!R=[$CHN1QU!P#
MUNB:Q;:]I$&I6B3)%-N&R>,I(A5BK*RGH0015]UWHRY(R,9!P14=M;0V=NL$
M";(US@9SR3DDD\DDDDD\DF@#"\:6MI>Z)';WGVY(VN8RMQ8AC+;.#E91M!.
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M%( [1H"5W,V3QQNYP<U5NHKVT\1R7V@27JR7&IQB_P!$O+<O#,-Z@SQ,1\F
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MF",<9/4=\XZ3Q;9:AJ&J>%9[/3YIH[/4A=7!#(/*3RW7G+#)RPX&>] %V_\
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M>QW4EC]O@BD5 9XL@94AB <E1AB#R*YU?&%IK7PX76=<LM2M+2>=0#:-AO\
M7X0!D;(&0H).,Y/K4>AZ9JZ>.-)UB70KV&%M)DM;J:ZN8WD$I>-B7PQX^4X
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M,@BN=LO ^B:>0ENM\+5?NV;7\S6Z^WE%]N/;&/:NCHH **** "BBB@ HHHH
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MAZ(7^Z&.1\I.>16%X@\2A/%UAX;BOI;+S[>:::XBC#.K#8$5=RL.=Y)..PH
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M[;M/)N'V1MO_ (L[<-_=YXYQS6AJ6N:;I"DWUTL05/,;Y2VQ.[-@':O^T>*
M-"BLBY\5:#:2I%/J]HLCP?:$42@EH^,,,=0<C'KGC-4-2\=:+8Z/IVIPW(NK
M;4+J.V@>$%@2SA6)P.-O)(/<8ZT =-13(I4GA26,Y1U#*<8R#3Z "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .>O$;4?&VGP%3]GTR!KQSC@S29CC_)?.
M/XBM.'5;>?6;K2T6<7%M&DKLT3!"&SC#8P3QT%7J* "BBB@ HHHH *\^U"";
MPO\ %&7Q+/!-+H^J6*VMQ/#&9#:RH?E+A02$(XSC@]<5Z#67<Z#:W5P\[W&I
M*SG)$6HSQJ/HJN /P% $$VJ+K=A<V^BRF1Y8)%6[4$1Q,5(7YL<G..!TZG'&
M?/UAEUCX9:!X;AMIK?Q!97%I$T+1D/;/#(N^4GLNU6(;H=P R37H7_",V7_/
MUJW_ (-;G_XNC_A&;+_GZU;_ ,&MS_\ %T <4YC-[\3V,9_TF%%B/EG]]BU"
M$+Q\WS?+QGFFP%$_X5=MC9?LT9$^(S^YS:E#OX^7Y^.<<UV__",V7_/UJW_@
MUN?_ (ND;PS9[3MN]6!QP3JER?\ VI0!YK"MEJ/@+QOHB0"?4KO6;^."V"?/
M)(93L8>H4X);HN#DC%7Y6M]"\3ZKI_BJ#59[34K:W6VN;07#QS;81')$PB_B
M+ D9'.XUTV@^ ;?1H;N.35-2G%Q<R7.4O)X<,YRWW9.>>YY]2:UO^$9LO^?K
M5O\ P:W/_P 70!R=A;6NG_$C14CLVL[2U\// B2$N+<^8A6,N<_,$!XSTSU%
M8NCVL$_A+3X)+^]T6^@U6^EM+Z./BW8R2%?,5ACRV1N^ >!GFO1O^$9LO^?K
M5O\ P:W/_P 71_PC-E_S]:M_X-;G_P"+H X>'6-25?#;:QIRP2M=7L9U:SLF
MD(P2%>--K;#-DG)!! .!R,9-JD\/@>TWV=^!I_BU;FXWVS[EB^U,Q;&/FP""
M<9ZUZ=_PC-E_S]:M_P"#6Y_^+H_X1FR_Y^M6_P#!K<__ != '+WIEOOB;*UF
M9(7G\-20PS/&RA)6E#*"2.&Q\VT\X[5BK#+J_P ,-"\-0VTUOX@LI[2)H6C(
M>V>&1=\Q/9=JL0W0[@!DFO0O^$9LO^?K5O\ P:W/_P 71_PC-E_S]:M_X-;G
M_P"+H X:Y$;2?%,^42UU %A/EG]]BU"87CYOGXXSS7=^%6W>$='Z[A90JP(P
M0P0 @CL0013?^$9LO^?K5O\ P:W/_P 71_PC-E_S]:M_X-;G_P"+H RO&M]]
MAO?#Y>T;RFO&#:@EL9VLSY; %5 /S-G:"00,G@UP,ZL?!7B*RDM;UI7\4+.%
MGMG#21F>-MV-O/R@DXZ=\9KU/_A&;+_GZU;_ ,&MS_\ %T?\(S9?\_6K?^#6
MY_\ BZ .)\307>H^,/$<.D%OM%UX7\BWD085Y?,D.P-TW;6'?C.:@?6K75!X
M ^RV5ZDEC>JES!]BEW6Q%NZ%6^7C!Q^ STKO?^$9LO\ GZU;_P &MS_\71_P
MC-E_S]:M_P"#6Y_^+H V:\V\0KITWQ?TV74;99[*'298W=[<R1I(9 0"<$!L
M UV'_",V7_/UJW_@UN?_ (NC_A&;+_GZU;_P:W/_ ,70!Y[9Z+?2:YXMM?"E
MO<V?A^\TB1$$L;11M?L" T0< @8ZD<9_"M'PM=Z%K$VCO)I.K1:UI2'S5O&N
M%2P.S:YW.=A!Q@ 9R#T&#CL?^$9LO^?K5O\ P:W/_P 71_PC-E_S]:M_X-;G
M_P"+H \QME$?PKT2'R)%N(_$*SO'Y3!U47C/O*XR!L(.?3%:,DNG6^N>(]$\
M4:?J]PFIW9N+0VWVAX;V)T4!!Y9VAEVX.['&.<5WO_",V7_/UJW_ (-;G_XN
MC_A&;+_GZU;_ ,&MS_\ %T <Y+Y=K\3_  ]'Y3110:/- W)=(F+1;4+GOA3C
M/)Q[UAWUO->Z-\4H+:"626Y=F@18SF4"W124_O<J1QWKO_\ A&;+_GZU;_P:
MW/\ \71_PC-E_P _6K?^#6Y_^+H X_5I8M1.EZEI>L76B:I#I_\ H]S<6[?9
M[A,C=%(C@=U&.AY)&<5VGAF>ZN?#&ES7UBMC=/:QF2U48$1VCY0#TQZ=NE1_
M\(S9?\_6K?\ @UN?_BZ/^$9LO^?K5O\ P:W/_P 70!SGQ='F^!GMDCDEEDN[
M<K%$A9BJRJS$ <X !YK=?2=+L+'4=6T_3$O;N6T<$EC))<*%)$>]LG!/&.E3
M?\(S9?\ /UJW_@UN?_BZ/^$9LO\ GZU;_P &MS_\70!Y[HMW]H\3^!+Q(;WR
MELKF"2)+!XX;1RD0$2C;D!<$9)/3K6Q#I-Y8^.+OP_%%G0M0F762P/$3*W[R
M+Z-*(FQTP7%=2WABS9"!>:NI(P&&JW&1[\O6;I'@6'3XW>]UO6]1O7 5[J6_
MEC8H"2JX1@,#)/U)H XGQU<2WNG^.+".PN[:Y!B9(;:S9OMJA4_?/)M((&,
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M3M @B.Z8'R]I48RPR&P1Z&O8+>5)K>.6-@R.H(([UE?\(S9?\_6K?^#6Y_\
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M@XN]6SV_XFMS_P#'*R-#\ 6^C_;O,U34IQ=W3W1V7D\6UFZCY9/FZ=3D^I-
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MA>2*L+%E@^U%MX4#)7!SD"O2_P#A&;+_ )^M6_\ !K<__%T?\(S9?\_6K?\
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MRO+$GWX%=)IWBO3KS53I.+J&Y6V^THUQ"T:31@@,R$]0"1^>>E9?C>+4]>\
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M.-X[M\;)BV<JHSG(QSD=Z +]%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!5OM-L=3B6*_L[>ZC5MRI/&' /3.#WYJA_PB/AO_H :
M9_X")_A6S10!C?\ "(^&_P#H :9_X")_A1_PB/AO_H :9_X")_A6S10!C?\
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MB@#&_P"$1\-_] #3/_ 1/\*/^$1\-_\ 0 TS_P !$_PK9HH QO\ A$?#?_0
MTS_P$3_"C_A$?#?_ $ -,_\  1/\*V:* ,;_ (1'PW_T -,_\!$_PH_X1'PW
M_P! #3/_  $3_"MFB@#&_P"$1\-_] #3/_ 1/\*/^$1\-_\ 0 TS_P !$_PK
M9HH QO\ A$?#?_0 TS_P$3_"C_A$?#?_ $ -,_\  1/\*V:* ,;_ (1'PW_T
M -,_\!$_PK6BBC@A2&&-8XHU"HB# 4#@ #L*?10 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M78_$B*]?PU;7%I#+/'::C;75W!$I9I8(Y S@*.O0''M6O_PCL?\ T%-6_P#
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M?E-X?,:LA&TGSE95R.,[<D#TYJ7Q-J4-IXUT:&:)[4R6LX34D@:5P24_<Q@
M@,V <D'A< 9-;?\ PCL?_04U;_P->C_A'8_^@IJW_@:] 'E>D20'P9X M;A&
M5[77W,R3Q%=@!GY.1T!9.>@)%6O$:75S-\1H],B:X=IM/E:"$9:>)%3S@O\
M>X!!Q].]>E?\(['_ -!35O\ P->C_A'8_P#H*:M_X&O0!R3:[IFM_$SPM?:8
M[SP-87:-(D#X4GRL*QQP1SD'IWQFIOBVT+Z!I4$N&W:O:NZ#D^6'RQP.< =3
M73_\(['_ -!35O\ P->C_A'8_P#H*:M_X&O0!PFLVMG_ ,)MX;O?!2-)J)NA
M'?R0!G@%E_'O8Y53TQC!_2JXETAKOQ#X7\5V^J275WJ,T]O;1><4OHG<-%L*
M<9&%4Y(QMY/!QZ'_ ,(['_T%-6_\#7H_X1V/_H*:M_X&O0!Q\)M$\:>.FF\H
M9TNVB#.<[L1R!U#'K@E0?PS6%IFHIHMEX+U+5FOH]'_L,6,EQ;>9_HMQE"1(
M$Y (4#ZJ*]-_X1V/_H*:M_X&O1_PCL?_ $%-6_\  UZ .$\00Z1I_@*R72;>
M>WLY];M[F)9RY>0>>C/)M?YE7@GMQSWK=U&X@?XM>'I$D1E_LVZ4NIR,LT94
M9]\''KBM[_A'8_\ H*:M_P"!KT?\(['_ -!35O\ P->@#S[2Q92^#;S2K^[O
M=,N8->G<74<9!M9#.[QN21M*GC/;!YP.:Z'PYXCN-.TO4I_$4D$PBU!+=-3L
M8&*7Q9457VKGD9"DCC*X[5T'_".Q_P#04U;_ ,#7J[8:<NG^9MNKN??C_CXF
M,F,9Z9Z=: +E<+XO#:;X]\*^()T<:9;+=6UU.%)$!D5=C-CHI*D$]!QFNZHH
M YF34K/7]>T<:5<1WD-E-)<SSP'?$@,+QA=XX+$R9P#G"FN&A.DSZ!\1]-N(
MX9;ZZU2[2*WV RS,8T\L(.K$/TQT//%>OGIQ6%X<\/S:#)JK27J7(U"^>]($
M/E[&<*"!\QR,** .2\/&Y\*^+S'XDG"1W&BV4%O>2M^[$D*D2Q[SP&+-NQWK
M$AT\Z=I7A:&[C\NV?Q3+=VT$JX\FU;S=A(/W1RIYZ;A7LM% '%>%I(S\1/&P
M1EVR2VC)CHV(0K$>N#P?>FW%PEA\8A-<B1(KC0DBBD\MBK.L[,PR!@8!!.>@
MYKMZ* /%+=H(_A9I8&Q;A?$:S,,8< 7I;>1U^Y@Y]/:M.>ZTF+7/$NA>*X]2
M(U.Z,]H(!,T=["T:*JKY?5AMV]NU>L44 5[&(6^GVT*QM$(XE0(S[RN !@MW
MQZU8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#"\:/)%X)URX@FF@G@L9YHI(9&1E=8V(.0?4=.
ME<QH%YHVHZ%X=0>)+HZU>0P.0FJ22,THC$CAHRY&#M8$8[XXKJ?&$%S>>#=9
ML[.VDN+FZLIH(HT(!+.A4<D@ 9-8VDSZG8^$-&L3X9O9-1LK2&)!(T(C258P
MA8L),[1DYQSCM0!=N_'.G6MYJUHEEJ=S<:4J/<I!;$D*P)R,D9 "GZ]LTZV\
M<Z3=WFEQ11WGD:H/]#O&@*PRMLW[ 3SG /;'!&<UF06&IP^*?&EVVFW!@O[6
MWCM7!3]\R1NK #=D<L.N*RX-&UF/PW\/K1M)N?/TFYA>]7='^Z5(70G.[GEA
MTSQ0!LW/Q,T2UAO)VM=5>WL;IK:[F2R8K;D8RS]PO/UXZ4DMRS_%?2?(NYGM
M+G1IY?+$S&)B)(MK!<XS@]0*P-*^U7NC_$#2+73IKB:]U:\@B?Y?*R\:+\QS
M\H7.3QR.F3Q6M#X=O;'Q;H,26\\FGV.A/IKWBE0 Y\L XSGHAYQZ4 ;3^-=+
MCC@NG2X739[C[-'J.P>07W;1SG<%+# 8KM/KR*MV/B*VO]<U+2([>YCN].5&
MF$JJH(?.TJ<\@X//;'.#7"Q>&M9N?AB/ 5WI\B7,;I;&]!7R#"LH82@YSG:/
MNXSN]N:V?&>BW<WB'1KW2IUAN;W?I5YS@O:NK.6'^TFTD'U:@#=A\46US9VD
MUK9WD\MW";B&V14$C1#'S\L% .1C)YSQ3++Q?IFIZ;:7FGB>Y:[9TBMD0++N
M3AP0Q 7;W)('3GD9P/%&DWMAXJT_6[/P_'K>G+9&PGLD$?F0@-N1T#X![J1D
M<8JKK6C:G%/H6O6GA6TGBM3<)<Z+&(MRQR[,,/X#(#&"<>N 3C- &Y=WD?CC
MPI?1:/>:C9744YMW\B403P3HPRC'G Z9QG*GC-:EQK2:=*FGM'<W][':B>9;
M=5W;!\N_!8=2#@#)XZ4>'8F6PDF.C0Z0)I-ZVJ*@<# &9-GR[C@]"<#'-<_X
MTT,ZOJ0ECLM2@OK>US8ZMIL@61)26S$PW#*G"'D;>3R* .SMKA+NUAN8P0DJ
M+(NX8.",C-<_K'B>?3O%^C:)%IL\RWR32M,A3&$ R "PZ%E))[=,\XV-'6_3
M1+!=4:-M0%O&+EH_NF7:-V/;.:Y_Q%8ZC_PF_AG5K/3Y+NWM8[N"?RW13&91
M'M8[B/E^0YQD^QH N7_C+3=-'G7$=S]@%S]D>_5 88Y=VW!.=V WRE@" >,U
M"WCG3O[9N=*ALM5N+FUN(X+CR;)V$1<95F[A<8YQ],\US&CZ/J6DW-YH-WX/
MMM05KN66TU9UB:(QR2%P9=WS[EW'@ YP,8ZUT'A^TO[7QKXMO;C3YXK6]DMW
MMI25(D$<(1L -D<CC(% #4^)&BM86VH?9]16PGN3:FZ:U(2*3>8P'YR,L.P.
M,C.*TK'Q797^I7NG&UO[:[M81<&*>W*M+$20'0#)(R",<'/:N'&@ZY_PJ]=(
M_L:Y^W_VO]I\G?'_ *O[7YV<[L?=[9SFNF%M?K\4)=7_ +-N38'15MA*-G,H
ME9]N-V>AZXQF@"/2O%^@:5X5T*:!M4ELM0F-O:/,CS2LQ9OO$Y.?E; ZX' J
M_%XYTDV&KW5TEW9?V2RB[AN8=LB[@"A !.0V1BN.T[0=<MO!7@BPDT>Y%UIF
MK+<7<8>,^7&#+EL[L'[Z\#)ZU>U&R\3V^J>.+[2--E$]ZMG]B=C'^]$8VR[<
MDX;!.W<,9Q0!TTGB^WC35XSI]ZM]IELMS+9N$#O&P)!5@Q4CY6[\8K(7Q-::
MGX:\+7^LP:C:3:A=6AA%L2JO,P!7<5;'EDD\-UQTJA9Z)JDGB;6YX]%N[6TU
M+14MXY;JX1W$@\SB0[V.X[E[GCN.E1MIFN3>"/!=BVAW27.EWUBUS&9(B52$
M ._#XQZ#.3Z4 =A?^*+2QDOE2VN[L:>H:\:V0,( 1NYR02=OS84$XQQR,P7'
MC;2(;K3;>'[5=OJ5NUQ:&V@+K*J@'@^OS#Z9YP*RM-L]4\.:[XF1M,GO[/5;
MC[;:R0E3\[(%:)\D;<;1@],'KVK-T7PKJ7A_4O MK]FEN8-)L;J*[N4*[%DE
M"$ 9()&0PX'3% ';:#KUIXBT]KRT6:/RYG@EAG39)%(APRL/459U+4K72-/E
MOKV7RX(\9."222   .222  .I-<]X&L;ZP77Q?64MM]IUBXNH?,*G?&Y&T_*
M3CIT/-2^/=%O];\-JFE[6OK2ZAO88G;:LK1.&V$]LX_/% %VW\2VTVJR:5+:
MW5KJ*P&YCMI@FZ:,'!*%6*GG@C((R,UR_A5IO%EW>:C>G5;6XL=8G$4D<X2/
MRXWV"!E#$$8'S#')R0:TVL;K7/&6BZ\]A<V4&E6MP"LX4/))*%&P $\*%8YZ
M9(QGG#O -G?V%CJL6H6$UH\VJW5U&)"IW1R2%E/RD\X/2@#IKR[M]/LYKRZE
M$5O"A>1ST51R:QAXOL4U-].N[6^M+L6QNXHI8@3-&."4V%LD<94X/M3_ !GH
MUQX@\'ZGI=I(B7,\7[HO]W>"& /L2,'ZUB:&UY=Q--/X'CT>Z@@=97VPEI'(
MQLA*G.">=S8';G.0 6H?B-HTT.EW'V?44M-3^6VN6M3L9R"1'QDEB <8!!/&
M<U-_PGFE1V&L75S;W]LVD;3=V\MN?,567<K *2-I /.>QSBN6MM#UJ'P3X$T
M]M(N?M6E:A;S7D8:/]VB*X8YW8/WATS3?%5E?00?$N_GL9HK.]TJ);>=BN',
M<4@;@'(Y8=10!UMCXYTJ_P!<MM(,-];37D1DM);FW,<=R ,MY;=R!SVXY&1B
MLGPAK$>F:/XBN-2O+B2*#7[FVB,LC2R'YU2.-<DDG)  IZV%SXAO?"-S]AGM
M8=)!N9I)@ 2QBV+&N"=V2V21QA>N36&WAC7KC0M1>'3Y(KZV\4-K5K;RR(!=
M1B3<%R"0"1GKCD#ZT =PGBJU-[=V$EG>PZC;6_VK[&Z*9)8LXW1[6*MSQ@'.
M>W(I+7Q98WOA^PUFVAN9;:_D2.!55=Y+' R-W'/7TYST-4(M.N-9\=:?X@>S
MGL[>QL98 LX"O))(R\8!/"A3SW)XS5'PYH,]CXTU2U61&T2RG-Y:1#K%<3K\
MZ>P4;R!Z3T 7KGXB:3;6^IW'V34Y(=,N#!>.EJ?W. I+G)'R@,/?J<8YJ_:^
M+M/NM=@TH0WD4EU$TUK-+"5BN57&[8>IP"#R!D<C-<E-HVL2>'OB%:KI-SYV
MK3S-9+N3]Z'A6,'[W'*GKCBM"?3=2G\1^"K@:;<K!8VEQ%=R90>2TD2(/XLG
ME3TS0!M2>,M-BN+!98[E+2_G^S6M\4'DRR\X4$'<,X."5 /8\BJ$WQ(T:&VO
M+HVVI&VL;LVEW,+4A8&&T%FSCY<L/?OC'-8?A#2=3TNWLO#^H>#K5I]/=476
M"L1ADB4_+(/X_,V\8QUY)%5[[0=;N/ WCK3DTBY^U:IJ4TUG&6C_ 'B/L ;.
M[ ^Z>N#0!U__  D\Y\?MX=739S#'9"Y:<%,-N?:#][(488=,Y[8&3TM<<MIJ
M47Q+AU==,G>RNM(2T:3>@\B196<AP6ST;C&>?SKL: /-TNV\2^(_$UOJ;:KI
MUMIDD/D7,-PL7V15B$C,Q#$98DYX8;< UU,/BZPDN]/AF@N[5-2!-C-/& EP
M<;@!@DJQ'(#!2?KQ7,MX=U+5Y?']E+:3646MA5M+B0J5;$ CR0I) W+W'0U,
M^FZKXBT[PK8WNF3V,^E7L%W>22%2@,*D8C()W;FQC'09S@\$ VM.\;:?JVIM
M8V=EJ<C)=R6DLOV1A'#(B[CO/\(/09[^F1GI&(52S'  R37)^![*_L9/$7VZ
MQFM1=:Q/=P&0J=\;A0#\I./NG@UU%SYPM9?LX0S[#Y8?[N['&?;- &#I_C73
M-1NM.BCBNDCU..22QG>,;+A4&6VX)8<<@,!D53/Q'T86[W/V;4OLL5X;*XN#
M:D)!('"?.2>!N('<CN!D5S>FZ=XBEUGP?JM]H-]]KLFG34999XC\[Q%<HH?
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MSSC5MO$MM=W4$4%M=/!/<2VT=TJJ8C)&'W#[VX#,;#)&"1QU%<G9Z5K=G=^
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MM?CB7[+IS:E%<VP(6:)3AUVDDJX..,G.1TH Z>?4+*VNH+6>[@BN+@E88GD
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M$MUN@!(R17$+ D.."00005/<=>:Z30KK6+R*6?5+2TMXG"/;""5G8J5R0^0
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MB31-9L;R&"33Q/&Z31%PZ2A0<8(PPVC';FL6X\#ZE<^'/%6E&\M%.NW<EP)
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M'89/ [# JQ6?J6KV^F-#$ZRS7,X8PV\"[I) HRQ ] ,?F!U(% &'X?L&\/\
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ML>[<-P50,@^F,]\U43X>V">&8/#ZZGJ?V*WG2:',D99 C[T093&T-[9/<D4
M+%J5_P"(?$OB'2K/49-.321#$C11HS/(Z;RS;U/RC*@ 8Z-SR,<[I_B_Q!KJ
M^"WCNH[%]3FN[6]18 ZEX4D!92>1RF0/IG(R#V4WA:$ZY-K%G?W=C>W,*PW3
MP>61.%^ZS!E(W#) (QP<5%_PA>G1S:$]K-=6R:+O-K%$RE274JQ?<I+$@G)S
MU.>M $'@K4M1NI->T_4KPWLFF:DUM'<-&J,\>Q'&X* N1N(R *ZB0,T;*C[&
M((#8S@^N*R=&\/0:+>ZG=0W=U,^HW'VB99BF ^T+\NU1CA0._2M9U+(RABA(
MP&&,CWYXH \OM_%'B.X\#>%-174XQ>WVM"RN9&MU(=#/(G08Q@*!Q@^_>NE\
M,W^J#Q;XBT/4-0:_BLEMIH)I(D1P)5?*G8 " 4XXSSWHA^']C!HFF:2FI:E]
MGTV]%] Q:+=Y@<N-Q\OD;F8X]ZU;'P]#8^(M1UM+NZDN+](XYHW*>6!'G;@!
M01C<>_>@#8KSBU\2:S'K?AM9-2%[%J-Y<6UT88E^R\*[*(6*ASMV@9Y!YYS7
MHS*&4J1D$8(KC;3X;Z?9P:5 FK:NT6E7!FLD:9,1*0P,?"#*X8C)RP[,* .;
MOO$'BB'PSXMUA-< ?0]4ECAB%K'MEC01G8^03C#'I@Y/4\ >K(VY%;U&:Y67
MP#8SZ-K>E2:CJ)M]9N&N;H[HMVYL;@IV< [1^5=/!&88(XC(\A10-[XRWN<
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M1<(6/ 1NC$_PDUP%]J=[H,?Q%6R>*W-LEC(L%BQVV^]2)2@XPP0$D@#D9P*
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M&XWC+-C)VCN!D<^OTH Q_#'A+[->ZY<:QIMJSWFJ27L+;A)\AV[0PQU4J3W
M)X-=1)I.G2ZE'J4EC;M?1KL2Y,8,BKZ!NH'M2_VKI_VR:S^W6WVJ&/S98?-7
M>B?WBN<@>]5_^$CT0P6TXUBP,-T2MNXN$*RD9!VG/.,'..F#0 Z/0-(BOVOH
M]-MEN6D\UI!& 2^,;_\ >Q_%UK/6QUG4?$ DU2.P32[*<S68A=FDE;:54N"
M%QN8X&><=,<VXO%&@3Z;+J4>M:>UC$_ER7 N$\M&]"V< U<_M.P^WI8?;;?[
M8\?FK;^:/,9/[P7.2.1S0!#J^AZ5KULMMJVG6U["K;E2>,.%/J,]*2[T#1[_
M $E-*NM+M)M/0 );/"IC3'3"XP,>U/MM:TR\NOLMM?V\LY4N(TD!)4$ L!W
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M>Z1:SWT&=48F&3S!L"!&?>6Z;3@ >I/%3^(_$NG^&-+%]?RJJO(L4:YQO9B
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MT!YZG!QZX- %F'0=)MKLW4.GV\<QD:;<J ?O&SN?'3<<G+=3DU'_ ,(UH?\
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M2UT?2[W_ (1O3;"&\DS(L97RHY)/5RHS^-3V^N:5=WQL;?4;66Z"EO*24%B
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M@)3:X?("XX"@<YXP.#CTJB@#F/%LV@W#VNB>)+6*73KZ*5S+.I\N-D* 9;^
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MT-G=7;6)C%T8-G[HN 1D%@3P020.GT..(?PWX@/@.YTP:/-]K?73>K'Y\/\
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M%P2%&1G )&2<<5J4BDLH)4J2,[3U'Y4M !1110 4444 %%%% !1110 4444
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MU%<I<^)=5NH]6GT'38KY-+N?LS0O)MDN77:9 AZ+MW8!.<D$8'!-?Q1XPO\
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M$IPP.0Q1@>W.<@\4 =?17.>$M9UG7M/MM2OM/M+6RN[.&X@,4Y>3<RY8,"
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MU_8K;49_LEP]K/LM'.R5,;E^HR.E;5A>PZC807D&_P J9 ZAT*L!Z$'D'V-
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MB;;)#*O1U/8]?4'/-,M]!AMVO)_M5S)?7:+'+>/L\W:N=JC"A0!EN O4D]:
M,#X30/%\-=$=KF:426RD(^W$?)X7 !_,FLZR@G_X3#X@L^H74B100!8G*E<-
M;LV/NY !)P 1[YKL_#^A6_AO1K?2K.6=[6W7;$)F#%5SG&0!GKWJI-X3L9=7
MU'4DN+R"?485BN%BEPC;5*!MI!&X*2/3OC(S0!P_AFZU32-)^',B:I-)::E#
M':3631H(E7[.74KQNW J,DL<\\ <5HVVI>*/$6E+K>CW44+I?2#RIYE$'DQR
MLC(Z["P)5<YSG)[#BN@C\%6$5KH=LEW>B+16#68WI\N%*C=\O/RDC\:BC\ :
M3!K=QJ-O<:C!%=3>?<6$5T5M9I.[-'WR>HS@]P: ,WXRRW47PKU@VI<9$:RE
M.HC,BA_TR#[$UVUHMNEE MJ$^S"-1%L^[LQQCVQBEN;>&\MI;:YB26"5"DD;
MC*LI&"".XK"T[PC%I5NMG9ZQJR:<HVI9&961%_NJY7S /3#\4 41?-=^-&\*
MV=P]C86&EI./LV SEG** 2#A5"]NI// P>:;Q/XADTJUA.HF.\L_%2:-/.(4
MQ=Q;Q\S+C@D$9VD<YKNKWPO97.I6>I6\D]A?6D)MXY[0J"83_P LV5E*E<@$
M C@],5!<^#--N+"SM!+<Q):WHU /&XWR7 8MYCD@Y.XD^GM@ 4 8%NFN3^*_
M$/A\^)K\6]O:P7<,_E0^<C/O!7.S;MR@.-N?<<YSK#Q#X@UJV^'[+J[VK:S;
MSB\,<$9W,D).\97AL\_W<XX.,5W">&H(];O]72]O%NKV!8)2"FT*N=N!MX(W
M'\ZY#4/#']DZ[X'TS3#JOV'37N<W,<1D,"M$0@+;"N"W'(/!YH CMM:UVP/B
M30KW7@7TV\M%M]2FA!EDAGP3&%5<-+@%1A>21Q3+KQ#KD&E>/XXKV[MWT>&.
MXLFG6)Y8]T.\JQP01D<9R0#UKK+SP1I=_I\UO/+=F>:[2]>]60+/YR8V."!@
M8    P!VJ"3P!I<HUC?=ZD3J\*P7A:YW>8%7;GD'!(X]NV* ,RVO-8M/%WAZ
MUGUFXN8-:TZ=Y8VCC589(UC(:/"Y'WS]XM4.F:SK'V?4/#-YJD[^(8=36WCN
M=D89K=_WBRA0NWB)7[?>4CO72OX8MDO]+U(W-[+/I,#Q6Z@I\RL &!&T9)"J
M.W3M5+0K==<\1-XKN-%N=-F6S%E EZ@2<C<6<LH)P,[0._WNQ% '5J-J@$DX
M&,GJ:6J-OIBVVK7NH"ZNY&NUC4PR3%HH]@(^1?X<YY]:NL"RD!BI(QD=10!Y
MAX.776MO'']C26*R?\)!?>6+A&)\S"XY! QT[5N^-KO5M&TFTUO2[R3;8S(;
MS3HU0_:T)^=%)4D/SD8/.#5[3O!L.D&]^P:QJD'VVY>[GPT1W2OC<W,9QG X
M'%7;3PY;6<M@ZW-W(+(2;%E<.'=R2TC9&2YR><]SZG(!SMQX@NK/PEHMY'JP
MNI=<OX($NPJE+=9F)P@VC.U05!89S@GTJ37KW5_".G:K>MJJW5M*]M'9)<*/
M,MF>18W9FQ\R@N&&1QTZ5;7X?:+_ ,(_>Z'*UU+I]U,;@1/(!Y$A;=NB*@;/
MFY ' ].3FS#X+TS^Q;S2[^:]U6*\C$4\NH7!ED9!T /&,$Y&,<\]: ,341XL
MTJ'6[L:B([!=*EF@\V1)9XKE 3E?W8!0CJ#G!Z8K.34?$FF+X,UF;7);VWUF
M2WM+NS>&-40RQ;ED0@9!!!)R3G/8<#8N_"4.A>#]:CMKK5]4N)-/FMK<74S7
M+H&0@(@ X!.WMV&3Q5CPGX>3^P?#T]_)?2S6%K'Y5M=J%%O+Y>QCMV@D@%E!
M8G )QZT 5/AO#.J>(9)K^ZN-NMW<6)F4_=< '. <X '7'H!4?C'5=2M7UYK+
M5)@]CI?VF"WLT7,#@.QDF+C:5.U0%SD@-A3UKIM)\.6>BWVH7-I)<_Z=.]Q)
M"\I,:R/@L57MD@'O[8JEJ/@C3-3U+4;V2>^B.I6PMKR&"X*1SJ%*J6 YR 2.
MN/4&@#GM:\4:E96NEZC??;X-'N=,266^TZ)9/LMPPR7D0@G9C&.".N0>,=I%
M*USX=CF@O@[26H=+N( ALKD.,@@YZ]*SHO!]M;V\<%OJ>IQ1K9K9./-5_,C7
M=C=O4\_,1D8XXK4^S6^E:$+2UA9+:VMQ%%%&K.0JKA0 ,D\ 4 >86VM>*;?P
M9X8\82:]+=&XFMXKRP:",1R1RN$)7"[@^2#G./8#BMFRO=;EU;Q1=7&O79L]
M"OBZ6R0Q?OHQ KF-CMSCG@C!ZYSQB7X?^&#_ ,(3X?BU8Z@'L LGV&Z0(L4R
MYP<%0QP3D9) .,=!CI]+\.VVE7^IW<4]Q*^I2^;<),5*EMH7( 48^4 8]J .
M-N/$&LV?@70_&2Z@\[W#VTEY9[5\IXYF52B#&5*EQ@YR<<YJ_)K>HZ'XNUO3
M=0OI[F*XLUNM(1@B_-G8T0(49;>R8SGAA6O8^"M-L(8+2.:Z?3;:?[1;V$CJ
M88G!W#'R[B QR%+$ XXX%:6H:%I^J:EIE_=0[[C396EMV]"RE3GU'0_50>U
M'/7-SJ^E^,O"&ER:M-<PW5O="[#QQ@3/'&I#\*".6/ XZ5R7B34+OQ3\'=3\
M1/?S1)/.?+M$"^6D27(C",,9)(7<3G.3Z<5Z5?>'[>_U[3=8DGN%N-.$@@5&
M4)AP ^01DY  Z\=L5B7/PUT>XM=1L5N]2@T[4)?.FL8;@+")-P8LHQE<D<@'
M'MTH KZA?ZWKFM^(M+TBY:UFTP11P,DJ+B1XA('<,C;ERP&.GRGOT=IVJZKK
M/B7^P;V[6UFL=,AGO&L6&)IY"0=K,/N+M)QZMSTP;^I>!--U#5X]5CO=4L;T
M1+#--97;1-<(.@D/\7UX/OTJ:\\&:;<:G9:E:S7>G7EI +59;.0*7A'2-PP(
M91UZ9'K0!F?"I'C\$[))#*ZW]X&D( +'[0^3@<#-4[G5]8CU#X@P)JDH&F6<
M,]B?+C/DDPNY'W<$9 ZY..]=7X>\.V7AG3WLK%[AXGF>8^?*7.YV+'&?<FJD
MOA"RFNM<N#=W@?6HEANP&3&Q5*@+\O&%)'X^O- '-:7J>MV^K^!Y;C6)[N+7
M+1Q=6\D<8166W$JLF%W Y!SDG.>W KIO&.@Q^(]'BL/[0?3[P7"365S'RT<Z
M993COP&X],TB>#[-)="D%W>YT1"EIEDX!38=WR\_+Q_]?FI/$VG2ZG!:1QVL
MTQAG$ZO#=^0T;J"%.<'/WCQ[<Y'% ',:/XGUO3/$,>B^,M-A.I"TGDL=2LS^
MZNT4!I%V_P +8521[=!QF31;OQ3K%IX=U^VNX1;W?ERWT,LR^48I!RL8"9#J
M2 .><8)-7[;3=5CU6/4[S3;C4+R&-HH)+J]BQ"K8W;52-1DX&203QC.*SM'\
M(RZ'?>=9:5?BT64S1:<VK@VL3DYRL>WUY )(!Y R!0!8T*\UCQ1H-AXCM-9%
MH7O7>6W=%,(MTD9#$1C.[:H.[.=V>@XJEH4=[%J'C^>/5KP2P7;",MY;A2+>
M-@<%>W0#ICM4UGX2EL-7FO;72;V*":?[2^GKJP%J9<YW^7MZYP<9QD#CBK?]
MAWJW^K7D6E74+ZH/](1-279NV!"X4J1N*@#G- %#1_$NHZG#X(TN:[D2;5=+
M:]N[I0H>0JB_*O&!DL22!G XQFL[7O$OB#3-'\:6$>IRBYT26UDM;TQH6>*?
M!V.-N"5Y&0 >A^NR/#-RFF:1:1:1<1R:/Q87::A'YT(QM*YV8(*\$$$'O3K[
MPW<ZCHU_IMSI%PPU&59;RX%_&)9V7&W)V8 &U0 H X^N0"U8W6J6'Q+.CW&J
MS7MI=:4U[LFC1?*D654PFU1A2&Z')XZFNN?RTS,^U=BG+GL.IY].*Y(:;JG_
M  DD.NMIMP]Y%:FT&;Z+88R0Q! 3J6 .?;TXJ[J3:OJFEW6GRZ*T<5S$T+M%
M?(&"L,'!V\'!H X[Q!<3I\+;S406CE\1W\;2-T*P32(B@_\ ; (OXFMOQW!(
M^M^#(+6;[*YU-U214#&,?9Y.0#QG'3.1['I5CQ%I^IZ_X8NM%.AI DD86)UN
MU_=,I!1@,=F"G'M3+^UU;Q!;V3WNARVM]83>;%-!?(ICE"E2RY4JRD$]0>#R
M >@ OA:[U:U\6:[X;U+4)-3@M(H+FVNID59 DFX%'V@ X*G!QTI/AA<R2>&+
MJR<DQZ;J5U90D_\ /-)#M'T ( ]A4]JNJZ.MS<0Z!)=7MVZF::2]0O*P&%R0
MH"J!V  '/&3S;\%:3=:)X>CL;RV6*X#M+-() _G2NQ=VXZ#<3@>F* ,!=8U;
M7=!\3ZO9:E+9SZ7=W,%I"JJ8QY Z2 @EMY!SSP",8(R:L&KZYXHU_2(+76;C
M2K;5/#O]H&.*&-C#*6C&5++G^+OGC.,9R.IE\&Z>]SJ4D-Q>6T&J'-]:P2*(
MIR1@L<J2I(X)4KGZU9'AFS3Q%;ZU%+/%/;VOV..)"HB$60=NW;Z@'KVH /$>
MCVNM^%[G2-1N72*Y183.I"L'+#:P[9W;>*X^PUGQ'X;U_2=$\900ZC;3W'E:
M=K=N-I,I1@%E3LQ4L,CCGOR1V7B2Q?4]'>Q%I)<I,R[UCN/(90I# ANHY Z<
MUA+I.JR7UG=7UC=Z@;)_,MH[F^AV1/@KOPL:EF ) +$XSZ\T 9T.I>*/$6EO
MK.BW44$D5_*BQ3S*(/)CE9&1UV%@2JYSG.3Q@<5=@N]8\51^()-,U<Z==:?J
M+V5JFQ6C7R]NXR C+;LMWX!&.<DU5\(2Q:W<ZE!I5]!'=2^?<V$6K!;:>3NS
M)MYSW&<'N#3KGPG-<:[<ZK'I5]:M>8^V6UMJPCANB!C,BA>>.#@C/?J: )-,
M@N)_BQKQ&J710:;:.JJ4*88R\ %3@#J,=^N:S-*\6ZM)X9\/07%\[WNJZS<6
M,EZ40,D:2R]!C:&(0*..^>U;SZ7?GQ&VN1Z//#=O;K;NL6HJ(W522I9=O)&X
MX[>H-4(_"<J>'UT9M&N'@BNC>02MJ*"6";>7WHP08.XD]^I'3B@"/5=8UG1]
M8\1:)'J,SQQZ$^K65TZ(TENRDJ8SE<,"0",C/49]&Z7J>MV^K^!Y;C6)[N+7
M+1Q=6\D<8166W\U63"[@<@YR3G/;I6C)HVH3V^H+<Z9<3W.H6_V6>[>^B$IB
MY^1<1A5'S-T7J2>M1IH%^DNA2#3;K.B(4L_]/BX!38=W[OGY>/\ Z_- '<%%
M9E8J"5Y4D=/I7GNJZE<6WA7QMXKMB1,T<EO9N.JQP!HPP_[:&5A[$5U+W^N,
MC*-$"DC&X7J9'O\ =K,73[Q?"_\ PCQ\/[K VIM&#7REF0KM))V]3USZT 5K
MK4&\.^$_"6FV4@@^W36NGK/@$QJ8RQ89X+$)@9SRV>:WM*L=0L[_ %&.\U,7
MME*4:TBE4>;"-N'#,/O MR...17+G1M3U;PA!X;US0#,;2.)!<QWHC8L@^25
M& ^5N/P.>Q&;VFP:QX?LY!#I-YJ-W*54SWFI"61L9V@MM "C)/ '4]2>0!OP
MNN99?!YM9"673[VYLHF/>..0A!^ P/PKFK:TUEK3QWJ&DZ[-ITMEK%S/'$D,
M;)*RPQL1)N!)! QQC')Y[=OX*TFXT/PW!IUU;B*:,L\CB0/YTCDL[\=,L3QZ
M8H?P;8--J6VYO8[34Y#+>V:2#RIF( 8DD;AD  A6 (H YVQ\1:QXND-M9L]E
M(NDVEV1#*J,)9U9L_,K95< 8^N<\82X.J'Q+\.1K;VSZFLMXMR]L<QLXMW!(
MX'IR,<'-=!K/@C3-8U*UU)+B^TV^MXO(6?3I_)9HLY\MN""N?RJQ-X4L9;W1
M[I)KF)M)WFV5'!&74JQ8L"6)!.23W)Z\T <H=>U?5O ^N>*K+49+:XL9KE[>
MUVJ8A' Q&QP1DE@I).<@MQC%3R>(KR'7M.NKW4;BUT;6M':>%-J$VMPBB1@#
MMR?D)(!SRIXK=?P5II?44CFNXK+4I#+>V,;J(9G/WB<KN7=CY@K 'O6EJN@Z
M=K*6*7L =+*Y2Z@ X"NF<?AR>* ./\(:WJ^LZ=IVFWU]<1ZU:7DR:H2D8;;%
MVP%P V^'IV+8/%;OC+7+C2(=(M[5_*EU34X;#S]H/E!\EF /&["D#.1DC@]*
MU+30["QUK4=6@AVWFH",7#_WM@(7]#^@HUS0['Q#IK6-^C&/>LB.C%7B=3E7
M5AT8'O0!R=_JFKZ1XIO]#349Y;:?1I=0M9W5&DMI(VVD9*X93D'Y@<'(K1\!
M+JMYX?TW6M2UJ>\:^TZ!VMVB14C<KDL"!G)SSD]<]. -$>&;<B[DGO+NXN[J
MW^RO=RE/,6+GY5 4*.22?ER>_08N:+I,.A:/:Z7;2S26]K&(HO-(+! , 9 &
M<"@#A_&^NZKIL'B6[L-4E:73H(I8(;6-=EMQN;SRPPQ;^Z"2%P<#.:E\6^(K
M_2KUY+V6_L-(FLT%OJ5G&LL=K<'=N,ZX)V\I@XQU[\C8U+P!I.J7&KR33W\<
M>KQA;N"&X*QNP7:'QC[V /8XY!JS+X0MIH+BW.HZC]GN;86MS$9E83( 1R64
MD$@D$J0?R& #?C=)8UDC8.C ,K*<@@]Q3J9##';P1P0H$BC4(BCHH P!3Z "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **Y3XAZG-I'A7[3',8(3=V\=S/@GRH&E4.QP0<8)!P0<'@
MCK5&R\/:;%J6HO+J]F^G7]ANEL;2/RH$"G_CX!WML.#C(QG&>U '<T5YG\/U
M\K5I=(UEIFO[*UQIDDR^6T]BS'$O!SYG.&S@CCH2V>:?25;X5ZAK\-Y?#6M.
MU"Y-E<?:I&9&6Y950 G!W=#D$G/TH ]QHKSBRT2VUGXE^(HM2-RZPV^GW*Q"
MZD"I+^\.1ANQ'3IR>*SM"C_X2;1;+6Y]=MK'5K74"URZ6Y-RL@D*FW8^9RI&
M%";<8Q@4 >L45YF9;C2?%<$FJ64=]I]YK#K9ZQ:/^]AD9V003*>2H.4!!P-H
MXS2:;+<:3XJTU=7LH[N"\OYCI^N6C_-(SK(1#<*>>%) QD#8.F* .P\,>()M
M?CU0SVB6SV&HRV)5)?,#; OS9P.N?2MVO,--T#_A)/#7C?3XY3#=-KUVUM,K
M$&.4!"IR.V>#Z@FMGPAJ:>+[BUUEK7[/_9UM]EDA*[=ET2/-3'^P%4#_ 'S0
M!VU%<-X_@$^L>$8S<7,23ZKY,@AG:/<AAD)'!ZY YZCL17(Z[IS:':?$/2M.
MGNDTF#38;R*,7#XMYV#Y53G."%#$9QR* /9Z*\UU*RMM$U3PM:Q^>MAK=Z/[
M2DDG=Q-(L!\I&R< ,V,@8!VXZ<5-'HOVGQ=XH\,0L\>BSZ=#.JQD@6=PY=?W
M?]W(4/@<9'O0!Z)5/3Y;^9;@W]K%;E9W6$1R^9OB!^5SP,$^G./6N+\%7+>(
M+73+6]@"77A]7M[T 8_TI28Q@]QM5G/NR'M7.C5)]*\,:A%]IG2TG\9/8W5P
MTK%HK8R@-\Y.0, +G/ :@#T5-?F/CI_#KV:+&-/^W)<"7);]X$VE<<=^Y[5N
MUY;K$*>'_'VMW&AV\<5RGA*6>*&)?E\Q93M(7IV'UJ?2;6"2/1/$VF:W:O*;
M60?9[6!@^HL8R=LI,C%F4C.2,@YH Z[Q3K\WAVUL9X[-+A+F^@M'W2[#&)'"
M[@,'.,].*W:\9F%EJOPW\)Z_(ZSZG<:M927%T3\[2&<;T)_N@Y 7H-HP.*]&
M\=@_\(!XA=9)(WCTZXD1XY&1@RQL0<@@]10!T%%>5?V.NEWW@/5=,FN6O=1:
M.VOE>=I%N8&@+,64DC"[1C  &1[5GW,_E?"G56,Y2:W\1/%"Q?#1@7JC:IZC
MY,C'I[4 >RT5YVNAV>L?%+Q!;7S74D$=G97"1"ZD55DWR'<,-Q]T<=.O%5=+
M>;3?$NFP:U817EO?7<YL-;M7SYY=9#Y5PAYX4D#J/E'3!H ].HKQK[1Y?PJM
MG:<K<1>(O*C8R?.H^W$%0>OW.,>E3^/+F&33O&.H6$KO<Z?+ INYY,-:2J$(
M2W &0#G))(R6(YH ]>JO=7UM9-;K<2JC7$HAB4]7<@G _ $_A7#76EVFK_%F
M[L[QIIK.30HY'@^T/L9O/93P#Z <=,C/6N8TZ&+4_#7PTFU!1=2?VG+;F2;Y
MF*!9P%)/^XOY"@#V:21(8GEE=4C0%F9C@*!U)-1V=U#?64%Y;MO@GC66-L8R
MK#(/Y&L;QC;V]SX"UN-XTDA_LZ9E4C(XC)4_H#7&:?)!%+\/=&:.--*OK!I9
MXQ]R>X6!"JOV/!9L'J0/2@#U*JTE_;IJ":>)$-Y)"\Z1$\E%*@D^@RZBN5\(
MK/9>+_%FDQ,QTBUEMWM4)RL+R1[I(U]%'RMMZ#=[U6N;&Q;XVV\TMO"9/[":
M3>P&=ZW"!3GU% &_X4U^7Q'I4UY-:+:R17<]L8UD\P9C<IG.!UQZ5NUXDUG%
M;^ K[7(FE74+3Q*Y@E$K#RP;X*P !Q@ACGCG//05T%W&OBGQ!XMTB_U.TL[F
MT=%MC-$3+;0F%&6:)O,7:=Y8D@>@)Q@4 >FU7L;ZVU*U%U:2K+ S.JNO0E6*
MG'J,@\U!I\*W&@6L-Q/]N22V19)I$V^>"HRQ7MNZX]Z\DT*[@T?X:^#E22WL
M[6_U PW\SIE"N9M@D 9?E+JH/('&#QD4 >U45Y'XMT8:-X+\5_9]:WJ[VMQ'
M:6:M#%9EG"G: [</R2IX[XYK5\1^';#2M?\ "T5D]Y$E[K#M<#[9*?,)@?)Y
M;@G:.10!Z/17DDFA6);XBZ=B;['IRK/9P"=PL$C6H<LHSUW<^W;J:LWDFKW.
MC:)K"VD&O0KH<+W^G22;)UWKDSQ$\;SM8=C\O!H ]2HK(TN]CN/"%G?:8LDT
M;V*2VRRC#N-@*AO<\9KS9YI9_A)I7BRPE9O$@F@<W /[R:9IQ&\+>JG<R[#P
M,# &* /0=5U^ZAU=]&TFSBNM22R-Z4GF,:%=VU5! /+$-[#%;-G+-/9037%N
M;:=XU:2!F#&-B,E<C@X/&17$1Z;8M\:[ES;1%QHD4X.WGS//?YOKP*UO&L]J
MMOI-K</,7NM1BCAMXW"I<N S>7*2#^[XR>"3@#!SB@#IZ*\4U-Y4\ >/[;[1
MY0L]5'D1VLS*D((A+*O/W<LW'3)/ KK(]+M;+XJMI\0E-KJ&ARR74<DK.)76
M9%#G)^]AF&?>@#OZ*\P\/QOYQ\ 7:O)+IM\;F29\DS68/F1.6[L6*QGU >NH
M^(.I7&D>"+^]M9&B:,Q"21 28XFD59&&"#PA8\$$4 =/17G4VBVT!U+4+/7+
M<0WFCR_Z%IJ-%')M&1/D2'##(&1C.><UBVNFPIIOPSO4ENDN;^.*WNI5N'#2
MQ-:EBA.>F5&,=.W- 'K](VX*=H!;' )QDUXQX@A&F^'?B9IME+/!:6,MM+;1
MQSN/*+PQLX'/0DDXZ<UTLND+H/Q-\.3:3-<[=4ANAJ2/.\@E5$#+(02<$.5&
M1_> H Z?PGK\OB32);V:T6UDCNI[8QK)O&8W*9S@9SCTK<KQVSU":R\*:?#O
M:.RO?%T]M>R*<8B:>0[21T#,%!]B1WKHVTF-?B)?:!;H4T2_T7S[FVB.U(9O
M,V*Z ?<8C/3&2F>HH [^BO-?"3RZ@;'PK?QYNO#<[_;G*X$H48@;_MH'W^YC
M;/6J.E1_\)/HXU:XUVVT_5K+4Y#/*MN3<PNLS 0$^9RI7"A-N"".": /6*H:
MU?RZ7HE]J$,"W#VL#S>4TFP.%!)&[!QP/2O.#$/%2>)!>:Y:Z;J&G:G*HN&A
M)N;..-@8V1O,&%*@=!@Y;J:[[Q(2?!FKECN/]GS9)7&?W9[=J +.AZB=7T#3
M=3:,1->6L5P8P<A=ZAL9[XS5^O([71TTK3/AWK.DRW*:I=O9V]P//=Q/;M#F
M0%2<855R,#C%2:7'_P )/I!U6XUVVT_5K+4Y#/*MN3<PNLS 0D^9RI7"A-N"
M".": /6**\@U/2K>YM?B=+-)=.]AF>T)N9/W,@M5D##GJ&Z>G08YK2%ZVN^)
M;31]5N;,1S:%;W%O%>PF19G8MYK+AU^<83U(&2,<Y .XUW6DT6"T)C\R>]NX
M[.W0MM!D<GJ<'  !/3M4&CW_ (BN=1N(-6T6VL[6(,$N8KSS/.8-P0NT$*5/
M?D$$8[UPVLZ-;0Z%X&MKF_&LO%KL5J;Z5,-*@\[Y3R<@8 SGG&:VUM(1\6Y[
M$JS6DGAU0UN[EH\>>5X4G & !Q0!V5C?6VI6BW5I*LL#,RJZ]&VL5./49!YJ
MQ7#?"*WMH/AOI+0QQI+)&QD*CEL2.!G\C6>OAZP\0_$'QE8:E+=R6JP63K&+
MN10C,LGS#GC'8=!Z4 =9K?B";2-;T*Q6T26+5+EK<RF7!B(1G^[CG[OJ*W:\
MAT>ZO[S0_AC-J4SS7)U&5?-?[TB".8(Q/?*!3GOFC6[F%P=6TZ5V9/%$,!OI
MY/WY;S51X8P!Q$!D8)YYX[T >O45Y;=:3::IXE^(4=T]Q-#%9VTL2&Y?:C&&
M1MPY['D=AVKL?!VI"Y\'>'&N[M7O;K389,2.-\I\M2S8ZGKD_6@#9OKZVTVS
MDN[N58H(\99O4G 'U)( ^M9(\03?\)W_ ,(XUF@B.G-?+<B7).)%3:5QQU)S
MD]JQOBQ;07'@=FGB1_+O;0J6&=N;B-21^!(_$U4O-(T^^^+%OI\D0-D/#T@,
M,;E5(%PHVG!Y&>WJ* /0J*\<TC5YHO#7@[3[R]C33[B_OK626\!DC8QO(L,;
M_,,@@8 )Y*CK7?>$=)713J=I'JJWD1N?-6".,K':;ADQIEFP.^W/&>G- "7W
MB>]M_&4/ANVTR":::S:\2:2[*+L5@I! C)!R16MIUW?SSW$-_IZ6K1;2CQ3&
M5) <]"57D8Y&/3UKC=7MY;GXV:9'%>3VC?V%,?,A"%O]<O'SJPQ^%'C6W;3_
M (=^*+275KFZO!!)>+*7V2*I "[M@4 94@#&"%Z<&@#T*BO-;K1;2+Q_X;@0
MW BU/3KD7R_:'Q<;!$5W<\X+'\..G%8$Z-%X0N[.*ZNH8+'QBMI;[)V'EP^>
MGR]>0-QQG.* /9+AY([:1X8UDD5251FVACZ$X./RK+\)ZXWB7PMIVM-;BW-Y
M%YGE!]VSD\9P,]/2N6T_2E\/?%&>RTIYQIMYI#7-U;R3/(J3"0*LF6)(+ L/
M?!/:L#PS>NOAWX8Z5<<:5?I.+D'A))%0F*-O4$DG'<J* /8:*\V306U+7/&7
MA:*62'23;P36I1B!97#JV1'C[HX5MHXY]#4GAK4Y_$5M;3O9!+WP_:R0W$&W
M ^VC*;1[ (6Q_P!-$/44 >BT5Y;X7MXM;TSPQXD3Q!;17H>/[2T,!\ZZD88D
M@E/F'=SG^'Y<9  %0Z''_P )-HMGK4^NVUCJUKJ!:YD2W)N5D$I4V['S.5(P
MH3;C&,"@#UBBL?Q3HO\ PD/AF_TQ7:*::%A#*K%3')CY6!'(P<?AFO-(?$X6
M^\/>,GM#'90Q#2]415/R7+*>B] 4=53/I)CM0!ZO?RW\1M?L-K%<;[A4G\R7
M9Y<1SN<<'<1Q\O&<]:RK;Q%=7/B?7-%%A$&TZWAFB<SG$WF;\ _+\N-GO7->
M(=.;2M/\'9+Q74OB"W>Y6.0A"\F]G7 ." < 9Z!1BM+2O^2J^*O^P?8_^UJ
M-OPGKK>)O"NGZTUN+<W<?F>4'W;.2,9P,]/2MFN.^%7_ "2_0/\ KV_]F-<I
MJ>E6]W)\3C/)<R?846:US<R?N9/L@<,.>H;D>G;'- 'KE5[V^MM/BCENI5C2
M26.%"?XG=@J@?4D5P&EWSZYXNTG3-: N+1_#D5Y%%,,I/,S 2.0>&8#;CTW$
M]ZYV[MWN-'M[._!NK33_ !K%9V,DYWL+?S%!3<>2 2R9]L=J /::*CA2*.".
M. *(D4*@7H . !4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM$L9)+Q@UPSP@^:00V6]>5!/K@9I9/%_AV*_%B^LV8NC.MMY0E!/FMT3CO\
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MI^I2SPVMR'FM]IEB92CH&&5)5@" <'!Z&@"_62OAC04T^ZL%T>Q%I=L7N(1
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M/*:9<E0^<;<^N>/KQ56'6;"'5M:FF\16\EO:1Q&:V;8JV/#9+/URV.AZ8]Z
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MM<>3?1O)YD9!0[%QP#G &WD\'%;QM<R7>E^-+!+&ZM;E)866WMK1W-XJB/\
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MMX7^R32LNY?/WQY7=TR0&]R/K75>.9C;>"=5E72UU/;#_P >C(6$@R <J.2
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M>2>2,^_>@#IHI8YX4FA=9(I%#(ZG(8'D$'TI]1V\$5K;16\"!(8D"(@Z*H&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^/6HKJ**U< DR. 4R<*&]">./?%:5AJ=CJ<;R6-U%.L;E)-C9*,/X6'4'V-
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MOX?74(EC@C6YA:TAM7$5DS0X$.2NXL",$DGIG !KTO\ X1U?^@MJW_@6:/\
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MVK.FCU*]\>^'M7.CW<%K!8W,<Q<H3$TA3:" QY^0],XR* -BQ\7:;J&C1:C
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M,G.6'&*Q[+XB:+?II<T4-^MKJ4_V>"YDMBL8ER0$)[$E3CKZ'!XJA"VK7WQ
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MZZA-U-]D.A).8GF8QJ_GLI8*3A>%'3TKE=*MKK7?AYXB\/6UC,TU[JE["DS
M>4H:X;+EL\;>3CJ2.!6_>>'KV[\:7T2V]Q'I\_AS^RUO?EP)-['IG/1@<XZT
M ;D?C+3&;3W=+F*SU&0165[(@$,[G[H!SD;L?*6 ![9R*FL?$]G?S:O"D-S'
M+I3;;E)E52#MW#'/((Y!Z>]<@FB:OJ_@C0O"U[ILUK=6$]JES<$J8A' P.]&
M!Y+!0 ,9!;G&*O\ B;0KB;QKI\EA(B0ZQ UGJL1_C@C(</CUP6CS_P!-10!O
MGQ/ UM#)!8WUQ-);"[-K%&OFI$>C,"P S@X&<G!P.#A+;Q;INH:?8WFE^=J'
MVZ%I[>*W4;V12 Q.XJ%P2 <D<\5SGB'3K[3O'+:TOAL:_IM[9QVTL4:QM+;2
M1LY5E$A *D.<X/;\ZNJZ-J.G:MI&MQ>$[6_LA:26MUI5LL6ZV#2>8CH&PK,.
M0V,9))H W;Z<>.?"<=QX>U._LI?/^22!Q"\<B$J4E!'*@_>7O@=C6IJ7B2UT
MZ:[B^SW5T]E;BYN1;JK&)#NP2"P))V-PN3Q[BI= A,.F G2H-+\QS(+2)5!C
M!_O;?E+'J<<<XR<9/)^,M"N-1U2YO=.M-2L];M[91I^I6+@+.>3Y,H)P5#==
MPQAN#UH ] HJ*U$XM(1<E#<;%\TI]W=CG'MFI: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **R_$&
MM1Z#I?VMXVE=YH[>&-<Y>21PBC@$XR<G )P#@'I7-S^,=9LHM=,NBM,NGV#7
MT%T89K>&8*#NC.]20XQD8SD'M0!W%%<,OB_7AJ'A^%]*L3'KMLSVVVY8-'(L
M8D._Y<;2,],GCO5>Y\?:I8^&=:O9]+M9+[2-12QGCBG8(X<QA73*Y_Y:#@XZ
M'F@#T!F5$+NP55&22< "H;.]M=0MEN;*YAN;=R0LL+AU."0<$<<$$?A7,6?B
M;5HO&4?A[7M,M8%OK=Y[&:VG,@8(1OC?<H^8 @Y'%8/@?7!H_@#P[8P1))>Z
ME?W5M;(QPJXFF9F..RJIX'4X'&<@ ],HKCW\4:O'J&LZ(+"VFUJQM%O;559E
MCO(22..I1MP*XY&<<^EC3?%$VL:=X=N=/2WE?5(S-*I+ 1(J_.?JKE4^K>V*
M .HK*N] M+S7K+699)Q=V2ND&U\*JOC>,8YS@=?3C%<=)\0-;C\-W.OMH]D+
M2QU%[.ZB%RQD8"819C^4#J0><9YX'?87Q9>Z?XCOM-URTM888=,?5(Y;:5GV
MQHVUU;(&6&0<CB@#KJ*XRS\6ZO<:EI:?V-++9ZC&Q+I;SI]D;;N7S'9-K*>F
MX8P>Q%9UOX_UJ30['6YM)LH[!]2^P7"K<,T@S.80R?* 0#CKC// [@'HE(S*
MB%F8*JC)). !7(:)J>LW?Q%\2V-Q+;FQLDM1'&N[*JZR-D=BQ/4^P]*ZB_EE
MAT^XEAB2:1(V98Y'VJV!T)P<?D: '6EW;7]I%=6D\5Q;RKNCEB<,KCU!'!J:
MN!L_',$'AKPK<21V.D1:O"2LDJD6UN0H(CXP 3GC) ^4_2NSTR:ZN-.AEO(H
MXKAAETB?<@Y['N.^: +=%<?K>IZS#\1/#^F6LMNME<6]S,Z-NRS)L')'L_ ]
M>O;%:?QS?/"FH:9I,]]8_;#;M##:S-*T:R&-I58+LX()V^G<'@ '<T5QMMXE
M\1:AXEU72[+2=.\O3+N&*:26[<;HWC#Y7"?>P1P1CZ]LN+X@:VWAFP\0OH]F
M+.6_-G/$MRQD&9VA!3*@<$#KC//2@#T8G R>E06=[:ZA:1W=E<Q7-M(,I+"X
M=6'3@C@USNG^(-7?Q/J&@7]C9+=1627ML8)V*.C,R;7)7((*]0.AZ5BV'C:[
M7PGX2OK'1+.--9N1:_9TF,:P$[R, +C'R')_0T >AT5QMIXKUED\1VDND0W&
MK:0\02&TF.R=95#*<L 1@$Y^G%0'QE?3?\)-96SZ?-=Z78K=P7<.3$^X/D%<
MGE2AZ-S[4 =S17"Z1XHOK?PSX7M[HK/J6IV*S+*L4DN(UB0L[JH+,V748&!S
MUXJ6V\;7S6<-O=Z1);:M<:DVGVT<J/'%, "WGKN4-LV G&,Y&.^: .MBO[.>
M\FM(;J"2Y@ ,T*2 O&#G&X#D9P>OI5BN#\,K=+\5/%8O%M_-^QV7SP A7'[W
MYL'.#VQD].M=1XBUR#PYH-SJEPC2+" %C4X,CLP55'IEB!GWH N-?V:7T=B]
MU MW(I=(#(-[*.I"]<>]6*\]OEU3_A:WADWBV2R-I]Z4>$-@-B/*MGD@<8/&
M<G@58@\=WDW@_1M=-C &O=26QEAWG"@W!AW*<?[.<$=Z .ZHKB]6\9W\?]J/
MHVFO??V9-Y+P+;S.URP"EU1D4JI&[ SG)!X P3U]M-]HM8I_+DC\Q ^R1=K+
MD9P1V/M0!+17#6_B'4K;QQXL_M">W&D:59V\Q50VY(RLSDCL6..?8 =JFD\8
M7UC9Z%JNH64"Z9J\L4.(V)DM3*,QEB>&!X!QC!/>@#?UO0;37H[5+QY@EK<)
M<QB)]N)$.58^N#VZ5;LKZSOXG:SNX;I8G,3O%(' <8R"1WY'%6:\ETW7M1\+
M:1XLU2UL+6;3[3Q%<M<AY2KE2Z*?+ &,C.>30!Z9>O87IFT6>Y037%NQ:!)M
MDIB/REA@[@,G&X=Z;HVBV6@Z>ME8(ZQ@[F:21I'=L 99F)). !SV '05DR:R
M\?Q#_LEM-@(&DO=I=H=TS 2*ICQ@8&3G&3GCI47A+Q7)XH$%S!)8R6LENSSQ
MQ,1-9S97$4BGJ<%^<#[O3F@#JZKSW]G;7,%M/=013W!*PQ/( TA R0H/)X!Z
M5'JVIVVBZ/>:I>,5MK2%II"!DX49X]ZX/6I]3O/%'@*\OK>TB2>\>0)&27A)
MMW(0D\-P>HQR.AZT >D45PTOCF^EBBU#3=)GOK!KPV[10VLS2F,.4,JL%V$
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M9>JY&,CW'6N3B\)^)IG\.?;]6TU_[$GWB5+=]TZ^6T8+#< &P>W&>?:N\HH
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M-'M#8LTT3/!=0'!PP!#*<J",'K7H6?UK/TW6]/U:>]@LIS))92^3< QLNQ\
MXY SP1R* 'Z7;WMO9 :C=+<W;DO*\:%(P?[J*22%&.Y)ZGO65XH\+_V\^GWU
MI=_8M6TR8S6=ULWA21AD9<C*,.",@UMB\@-ZUGY@%P$\S80067ID>H!(!QTR
M,]:GH R+6+79S&-1DLH$0@M]C+L9<=LL!M'J.<CC(KFKCP3J=QH'BS3#=6BG
M7KEYUD^;]P'55((Q\V @].M=9K6M6'A[2Y=2U.8PVD6-\@C9\?@H)K0!R,T
M<-?>#=:N[[4Y4U*S6+4M*6PD$D+2-;D*P/E'(PK;LD'N!UQ4NG^$]6M-4\-7
MDUW9R_V/8/9NJ(R>9N"#(ZXQL'UR>E=ITK!;QEH2Z/J&K->,++3YF@N9/(DS
M&ZXW#;MSQD=J .+US2YO#_ANYTV_U'3(6UK76N8Y;F-C;KO<RF.0DC:/DP&!
M!)(QCK5K3K"YUR'5?#VH2Z%=VNI6K_:+S2))&EC?"JAD+LV3C[N6_@Z$9QZ&
MR07EMMDC26&50=KKD,#Z@T6]M;VD0BMH(H8QT2- H'X"@#GO#FF>*;0Q1Z_K
M-G>0VR[8C;0-').<8#2DL1T[ =><\5LZQI=OKFBWNEW8;[/=PM#)M." PQD>
M]7:* ./MO"NI7-GH=AK5W;3V^C3QSQRPJP>Y>-2L9<'A,9!."<D#H*NZ/H=_
MI_BS7=7GEMG@U1H2(TW;HO+38.2,-GKVQ[UT=4[#4[74FNUM7=C:SM;R[HV3
M#J 2!D#(Y'(R* )+ZRM]2L+BQNXQ+;7$;12H>C*PP1^1KG-!T7Q%X=T^+1X+
MVQO=/MQY=M/<JZS11C[JL%X?:.,Y7(%=710!R^I>%[N36=)UVPO5.IV"R12?
M: =ES%)RRG'*X."I .,8P:SM7\"W6IZ/KB+<VR:EK5U!/<2E6*1K"4V(HZG
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M]G5RX#=L9)Z <8I[^!6BUV\O]-U_4-/M=0?S;ZR@"%)GQ@LI8$QE@.2O/N*
M*$T=]+\8[%OM;0YT.23RC&K;!YT6Y,]\GO[5'%XRU*ST[7S<FUDN+;74TJSV
MQ%(U#B(*6&22!O)//.,<5TC>&_\ BKH-?CO"C0V9LEMA$-GE%@Q]\Y4<]/:L
MZ7P!9W>FZ]87MY--#K%U]L<J C0RX7#(1TQL7&<]/>@"W/\ \))IPU:1KVTN
M+-+/S;2::+]XDP!W*RKM!3@$'(//>LNR\0:I?>'?"EY+>0VXU*S$UU)%'OG>
M0QJRK%'ALC))/!P!VZUJV/AF]ATZYAU#7[O4;J:!K=+B>)%\J,]<*H )/&2<
MDX'TJE;^ _L@T!K36KN";1K9K..5(T)EA8*-K!@0#\B\@?A0!AQ>,O$-WX0\
M+ZC#)9QW6H:O_9USO@)! DD3<!NX_P!7DCWX(K6DU#Q#X>\0Z#;ZUJEO=Z=J
M#R6TD\5J(MMQRT0/)P&4$?[PZ\TL'P[2VTO3]/BUF[,-AJ1U*#?&C$/O9@IX
M&5R[9[G/45)XS>SU]'\'M;7DE[<B*598X'"0J'!,@EQM!7:2!G).!WH V_#]
MW=:A:3WT\P>">=S: (!B$'"G(Z[L;@?0BN8:.Z'QGF8WY$2:&DA7R@?D^T-E
M?TZ]:[F""*VMXK>% D42!$1>BJ!@ ?A6./#K#QB_B+[<WF-9BR-N8QL\L.7Z
M]=V2>>GM0!R<OC'5E^'L?CJW>(V@;S6TWRQM^S>9LP&ZB0+\V<XSQBM2S8/\
M8K]UZ-H-N1_W^EJ:W\!6UOI<NAK>RGP^\_G"P9!\HW[S&'Z^66YQC/.,XK27
MP\T?BVY\0)>MYTUFMGY)C!155BRGKG.6/X4 <1X.UR73O!/A/2K4JEUJU]=P
MK*ZY$2)+,[L!W;  &>,G/.,'9GUKQ#%K.N^&H)XIM2@T]=1TVY>$?O%)*^7(
MHP,[EQD8X/3CFQ!\/;6#PYI^E+J%QYVF71N[*]"*)(I"S,<CHRG<P(QR#^-;
MFG:(MIJ=UJMS/]IU&YC2%Y=FQ5C3)5%7G RS$Y)))^@ !R%KXXN)]2\'S+=@
MZ;K$&VZ!A&89RIV*6[;G21<>J5;U;Q!K5CH>EZG!=0-'?ZQ!"H>#)^RR2A4P
M01@E<')!^]VQ5R7X=Z-+H.I:3F98;Z]-X75L-"WF;P$/\(!S@#^\?6M+Q#X<
M37;*RM!<M:1VEU%=)Y: Y:(AD'/;(H Y^ZU;Q+=>)?%.F6>HV=M%IMK!<6[_
M &3>PWK(=IRV#RHR?3H.<TZU\7WVI6W@H$+:#7K=I;BX100CK$'$:;L@%B3C
M.>%/?D;"^%W76=9U-=082ZK;QV\B>4-L80,%*\YS\S=<UQ^O:4FAP>'=!DU7
M4K.PT^V<1Z@M@MS$[?*JQR)L90P7<0Q ZG'4T =5X)U;5M8M-2EU.6WDCM[^
M:TMY(8"GFI&Q7S"=Q#9]@ "#U[4;5M0D^+VI0MJ+FUBTN"1("B[5#22 @?\
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M)^\0!VSZU5FN]9TR?XC:II-Y;VYL+H7)66#S/.V6T;%#R-H('4<\]L<]/;>
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M.T!BBV;(B?E4\G)'KWJ]5'3+&XL8[E;G49[TRW#S(TRJ#$C'B,8 X';/-7J
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD9@JEB< #)- "
MT5YWX6\37/BKQ++);^*H8H879I-#?3O+G2,9"Y=R&.?E)(! SCT->B4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGC6XF5FCB+#<X7&X@=P,C\ZIQ^(=&EOYK&/5;-KN$,9(1,I9=OWLC/;OZ=Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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G 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tardioagreementa01006.jpg
<TEXT>
begin 644 tardioagreementa01006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@>-&&5;;C)4@=1QZXID/CO0)YXH5N+A3+<16T3O:2A)))!E K;<$$ \YQ[T
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M0R0.)(T(R&VXRR\'D9'!]*KV'C?0M2O+"VMKB8OJ$)FM':VD5)@%W$*Y7:6
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MU5KF=;6:Y^R FUEW)-NV['4+E#NX^8"@#HZ*J'4[9=4CTTF3[5)"9POE-MV
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M?336MYY>^TGCDE,BM(Q.%*EN1C/'&37HFC:/;Z)8_9H);B=F;?+/<RF265L
M;G8]3@ ?0 5H4 >8?99-,\0Z]IFK^$[[6+?4KMKFTN;>/S(75U4&.4D@)M(Q
MEN,?KZ5:Q>1:0P[(X_+C5=D?W5P,8'M3HYHIBXBE1S&VQ]K [6]#Z'GI3Z /
M-M,TV_L?$]G=:$FIVUM<WLIU+2KR!C;Q ARTT3L,*2<'"DYW]!@UO>+I[^'5
M]"$.GW,]@TLHNKBSA\R>'Y,(%/5%8DAF'( ZC.:ZNF3316\+S32)'$@RSNP
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MVZR:6\OG1%5 QE<#)!X.*S;#PSXFT_P?IEQ+;7$G]G>(/[2ATLR"26.RY41
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M&*WA2&&-8XD 5448 'I0!Y7)H6K:MX(\::;:VES!>W6L37MJEQ$T8GC$D;J
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M_BY->@>(+.YU'P[J-C9B+S[FVDA0S.54%E*Y) )XSZ5S-YX7UJX\+>%M,46
MN-(NK2:9C.^UU@ 'RG9G+8[CCWH TE\5O<Z[>Z986MO/+8W44%Q$]SLG"/L)
ME6/:<H ^<Y&=I_%EUXKO##J%UI.C/J5MI]U]EF$<N)I&! D\M-I#;<]R,[6]
MB:&O^#[W7]16YFM["&[M[R.6RU6&5EN(8@RED("#=QN !;&&]N2Q\.^*-#UG
M58=)N]..C:G=O>>9<;_/M'DYDVJ!M<9Y&2,=\]P"SXE\;3^'(=3NY=*_T'3S
M$&EGG\IKC< 6\D;2'V@^HR01QC-07442_&?2YDC19)-$N-[A<%L2Q8R>]9_B
M+P3XAU<>*+:.XTV2'58D2UN;EW,MNH4 Q8"X"E@3D'J22#6X-$UB3QOIFN3?
M8?)M].DM)E25]VYV5LJ"O(&S')&<YXZ4 6_%7B*;PU;6=Y]A2XLY;J.WN)FG
M\L6P=@HD(VG*@D9Z=1^":IXHCTFXU-KBW!LM/MHY9)UE^8R.2%B"D8SP.2W\
M2^M3^)Y-$?0[JQUV[MX+2\ADB832!2PV\[<]2!SQ7/V/@ZYU#X7MHNHWLHU.
M^A26>[=?G68;2A8>JA(U/^[0!;M_&LAU>XL)M,\XI9/=PRZ=*;A9"O6(_*N)
M/0=#3].\7W%UX@CT6ZTV*&\FTXWR1QW6\H05!CD!4%&^8>O?TYABT_QOJ.AW
MMIJNH:9979M9(8)]/+DM*5P)&W ;<=<+GDYR,8JEI/A;Q#9:]HVIO%HT*V>G
M2V4T$$DA!+,C;PQ49+%.<CC.?FH T_"/BK4O%-O;7QT(6FFSQRGSVNU=A(DA
M3;LP"00"=WJ",=";&L^*EL-2GTVT2UEO(+=;B1;FY\E<,6"*"%;).QNV!QZT
M>!M$O_#GA2VTG4#;-- \AWV[LRL&D9^Z@C[V/PJCK&A>(K7Q<?$'AJ;3W^U6
MR6U[:7[.B-L+%'5E!((W$8QC% $4/CZXO)?#T=GH,Q?6H)Y(UN)A$T3Q ;E<
M%2<9/7TY /2I;3QV)=%DN+K3_)U)-4.D"S2;<KW.[  ? ^7!W$XX /!QS+<:
M!K4_B?PWJLLUG,--CN1<L79"[3!1\B[3\J[>,G./SK#G\!ZW-87KQW%C#J*>
M(#K=@WF.\9.,>7)\H(!&1D9ZT )'?C1_BEKVIZK:V]G';^'HYYFMW\P2*LLA
M+_=4YXVX(_A%;5MXXSK=I8W=G"EO=023+<VUP9E@*+N*S?* GRYP<D$@CWJA
M=>$-9\0:YJ5WK L+6UU'1/[,DCMIGE>-M[MN!**#]X>GIVR;NDZ1XLN=.;2?
M$UUIKV:P/;M-9%_-N@4* N& "<')QG) Z#J 8'BK5)]>LO!NK#2X4L;C7;*2
MUG:7,RHSY5BNW"AAS@,<<9]NV\6Z^WA?PQ?:TMF;L6B;VB$@3(SCK@_RKCT\
M(^+?^$>T+0Y9-(DBT2_MIH;KSI TT,)^5639\K8 'WC6U\4\_P#"KO$&<9^R
MG^8H 6+QC?Q>*;71M2T%K,:C%))ITPN5?SF1=S(X ^1L<]2/>J-GXTU'7/"U
MSJTOA5&TDVETTHDO5.\QNR&/;MY#*IY]01CH3JG1M1U37-'U74(K2+^RHI6@
MBBF9_-FD39DDJ-JA<]B<M[<U-$\,:OIOPVNO#LQLFO7CN8XW29_+/FL[ DE,
MC&_T.<4 6-.\2Q-9>'M/TO3X4NM0TY;N*T\S9%;0!$ZD*> 650 O/MBJ-[\1
M#9:'J=V^D,;[2KV.SO;03CY2[*$=6V_,I#@C@'KTI+;PCJVG2^&-4M7LVU'2
MM/&FW4#2L([B':O*OMR"&4,,KSG'O4.L>!]2U#1]=,+60U36;ZWN9=\K"*)(
M3'L0$(2QQ'UP.6/I0!V&DW6I75O.^I::EA*LS+$BW E#Q\8?( QG)X[8KD-(
M\:7]OI?B/5-<@@\JSU26SACMYBS%P4C2-05'4G[Q/4G@"N]0N8U,BJKX^8*<
M@'V.!G\J\_N/ .I7FD^)-*EN[6*&^U)]3L;F/<TD<I=74.I   *XX)R#VQR
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M";TV [@549!QR.HJW#H.JQ>/;?6GEMIK6/2OL$CM(PE=]X<OM"[>HQC/?\*
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M,#'4YXFU+P/J.KWGBTRW-O;1:P+5K26)V9X9(,%692H&-P!X- &MI'BR2_\
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M+M)[&<W"_(,M&WRKM;'(Z@UF/\-UO)-:(BMM&@U2P^SS6]A*SQM<;@PGVE5
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MO>@#M-/FNKC3[>:]M1:73QAI8!()!&V.5W#@X]:LT44 %%%% !1110 4444
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MZ2.>:8Y9(R#GRU_B<D !>>O0UQEUXVUV+P3XAU&!K<W>DZK]B1Y[9E,L9:(
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MM;:4LMF T0<S2B(,^[/1?F"C&#D$Y[4 =E87UOJ>G6U_:2>9;7,2S0O@C<C
M$'!Y'!'6K%<_X$_Y)YX:_P"P5;?^BEKC=-\1ZEH.A^+=6O+P7TL6N26<$<D>
MT&0F*-"2#PH!''H.N: /4J*Y.;6=3T3QEHVD7T\=[::PDRQRB((\,T:[R.."
MA7..X(ZFKOBC7I-'_LJUM@GVO5+Y+.)Y!E8\@LS$<9PJG SU(H WZS[W6].T
MZ^L;*ZN!'<7TACMDVL=[ $XR!@< ]:Y'5=?UG3]2USP])=J9ET=]3L+]8@'4
M*2K(Z_=+ X(( &#R#BL5UOSX?^&+?:HY;F2XA:.26,X0&T?J <MCD]1GVZT
M>L45Y\GC'5=,@U^SOV@O;ZPU*VLK::.+RUD^T"/867=CY=Y[C..HZU/>:OXO
MTVWUZ9[9?L5MIKWEI=W<<>1,@):)DCDY! R&XQSG- '=50AUK3[C6KC1XKC=
M?V\2S2Q;&^5"< YQ@\@]#6;X3FUR]TZ'4=6O+26*\M8)H88("AB)3+ L2=V<
MCL.]<IK6N)HOQ9NU#*MW?:3:VEHTG$8E::;;O;H!Q]3T&2: /3**Y74M7U*Q
MU'2]"21KF_NX);B:XAA12JQ[ =B.P R7'4M@ ]>HQK_7O&.D^%SJNI6\-L+#
M4-EW^Z5VGL=P'GJ%<A' .2I)Z'VH ]#K-U/7M,T:2"/4+H0-<-LAW(Q\QO[H
MP.3QTZU#8W]Q?Z_?"&>-]-MHXT&U02TS#><-Z!&C/U8^E<S\3#*MUX-:!$DE
M'B"#8KOM!.R3@G!Q^1H ZVTUW3;Z]^QV]SFY,9E$;1LA*@@$C<!D L/SK1K%
MM)-8N=3O!>V%I:&&W3[).DAG4LQ??GY4/&V/C]:XBS\7^*9?"OAGQ ]QI[?V
MC?QV4UK]G8 ^9*T88/NR,$#C'3N: /4:*\_N/$?B'2Y_%UC/=65S<:7IJZC:
MS?92BX*R$HRA^>8^#GOSFHXO$GB?3[KPK?ZE-8W.EZZT5L\$,!1[>62/<C!M
MQW X.>!CM0!VNEZUI^M"Z.GW'G"TG-M-\C+MD !*\@9X8=.*OUYAI^OMX<L?
M&%U$B/<3>)S:P!\[?,D6%06QV&<GUQBN@N-7U;2_&%AH-Q=1SPZO;3-:7/D@
M/#-$ S!@#AD(.1T/&,GK0!U]%<)HWB;5]0T..SGF@C\1IJAL+E%B^1"I+,P7
M.=IA&X'/)(%-N_$7B;4H=3N?#ED9WL+Y[6.W98A'/Y;!9-[LX923NQ@8''7-
M '>T5PU]XA\0ZE+K4?A^T<7&F.L,<;)$RRS>6LA60LZD#YPOR^A.3T$&L>,K
M_3]0CL]2D70)KBRB>SDN(A);R7+ [XI)1P-IP!R/7)X% 'H%4WTC39-274GL
M+9KY%VK<F)3(!Z!L9Q2ZIJ$6E:1>:E."8;2!YW"]2JJ6./P%<9<>*=8TW0?#
M_B2YD@FL]2EMUNK1(\>0D^-K1MG)*EE!SG=SC;0!U.K^(]*T)';4+EHQ''YL
MFR%Y/+3.-[; =JYSR<#@^AJS=66FZU9Q+>6MK?6Q*S1B:-9$S_"PSD9YX/O7
M':1!>O\ %KQ*)+U'B6RL]R&$?,A,V%Z\8YY[U:^(LM]#8Z$MC>FU676K.&0*
M@.\&48!]@0#COTZ4 ='!K6G7&LW&CPW :^MHUEEA",-J,2 <XQV/0]JT*\[E
M@U:3XHZI%I]]!;W7]A6VZYD@\SD2R]$R!R??CT[B32?&VH:WI/AJ.* K?ZI8
MR7<[6ZJ2@C*J=@=@.6<'G. #P>H /0*I:AJ]AI?E"\N5C>8E8H@"TDA'4*BY
M9OP%4?"USKMQILP\0V:V]U%</'&ZE?W\0^Y(55F"D@\C/45S/A25M1^*_C6X
MO/FGL1:VEJK?\LH64L<>S-R: .QL]<TV_NVM+>Z4W:H9&MW4I*BY RR, P'(
MZCFM"L/Q+>67A_3;WQ1-;^9-864H&W@NI(;;GW95^F36->:_K&AS^&[F^G@N
MK36+B.SGC2+;Y$LBDHR'/*9!!#9/0Y[4 =K17E]YXM\4P^%_$NM+=Z>#H>IS
M0>2+5L7$<908)W_+P3SR<UOIJVNVOC>VTBZNK.6#4;":XA"6Y7[,\;(,$[LN
MI#^QR.W2@#L:*\HB\9^+8O!&F>,[B;39+'SE2\LH[=@S1M,8]ZN6X()&%Q]2
M:U_$WBO5]$_M&[6>W/V2^MXH[.*,RJT#M&I:5Q_JW)=MHR.@X.<T >@45Q%U
MJOB2[\8:YHEE?6-M%:6,-S!*UJ78%RXP1OP?N]?3MSD4X_&6KOX?\(>))6MX
M=+U Q1:HHBR8F<85U8GY4WX!SG 84 >AT5DZ1=W5]?:G*TJM8QW!@M@$P24
M$A)[_/N7_@)K"U35/$4WCUO#NFWEC:P/I1O%FEM6D>-O-"=-X#?IC/?% '9T
M5YI8>-M=ELM)%VMLEZOB(Z'J"I&2DFT,2Z<Y&0%]>IJYJOBK6K+_ (3M8);4
MG0[:*XM3) 3D-$SLK889Z8!_0T =_17 WVO^(-$T:TU;5;E)-.NY(FFEL;(L
M]A$8F+,1D[QOV#=MX!/'0"1O%%\L7A:>VU*RU"VU74GM7FAC^5XL2,A&#\K
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M4Y'S*3[@9Y%:T7@."POM)N=(U*YL/[/LVLBJJDGFQ,P8YW X8L,[L?A76T4
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M\(I(=1\.WC:CEM$C>.-1!Q*&0(2W/!V@=._Y46GA-EO]'O-0O_MLND*XM93
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M8+<O@#.-N,'K572-0\0+JOCF9+BVO9;*X"6T$J>4N1 K*N_=A5&XYR.>3D4
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M4: /$FC_ &);IK2:.>*Y@G5 _ER1N&4E3U&1TK9ILCF.)G5&D*@D(N,M[#)
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MLNQV80AFFDVX#EB>A&W"].3716G@O2;*XTF> W8DTJ(PVA:Y=MJ, &!R><@
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M[I-$U*RFA*B4A8+B,;PPQT+(& 'JO'6NDTW0;/2K_4+VV,WGW\@EN"\A8,P
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M3P[K\6J6XM;B-'OEDO'D2Y611C9&4"QL&(P%(]#FNJLM!M+.Y^U.\]W=>5Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4EO&L=B$$D3(JX/S'#849/3V'4I+\.VN=&U:QN-6Q->:H=6MKF&WV-:SY!!
M+$,!M]NI_#N:* .5L/#.K)XLM_$.I:S;W$\=@UD\4%F8E=2X?=R[$'('_P!:
MNEN8%NK2:W<D+*C(2.H!&*EHH Y#3?!<\&F:-I6H:C%=:?I#QR6Z1VYC:0QC
M]WYA+D';P> ,D ].#4"Z+XR\<Z?J>FS/-_8ZS17DB*RHS!EV1-D#<5=2XQT*
M@]Q7=48 Z4 %<_=>';E_&4?B&TU%8#]B%G- \&\.H<NI!W#;R2#P<CI@\UT%
M% '"I\/[M/"5IH(UJ$BWU$7XF^Q'YB)C-MQYG]XXSGI^=6'\':K:>(;W4-%\
M1MI]KJ3B6]M3:+*/,P%+Q$GY"0!U##/KTKLJQ_%'B"+POH%QJ\]K/<PP;=Z0
M[<C) !^8CC)'3)]J -6*-884B7.U%"C<23@>I/6GT44 %%%% !1110 4444
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M9:I.9C#=).9;/4%VL08^2J,!A@N!@#OQ7H5K;065I#:VT2Q6\*+''&@P$4#
M ]@!63:>&=,TO[++%'<RK8!C:QR3/+Y.00=@8GG!('H"0,"@#S*.ZU^'X76'
MC*/Q%J<VHVMSS;R2 PW"&Y,91EQR2#P>HX QQCJ[2YN_%,OB[=J%W93Z;>/9
MV8@F:,0A(U82%0</N8D_,", #UI/ 'A3[/X2L+?6;2[BN+:XDG-I/*3&)/-9
MD<*"5. 5..@/.,\UTEUX5TJ[U&YOBD\4]W&(KKR)WC%PH& '"D9(!QGKCC.*
M ..\-^(M3UK6O!MU<S31#5-&N)KJ!7(C=T,8#A>@^\3QZTRSO_$$WAJ^>R:X
MU%[3Q%=0O;&[,<TULC.!''(3G<,*>N2%(SS7::EX5TG4WT]Y898'T\%;5[2=
MX&C0@ H"A!VD #'M4%OX)T2SA\JTBN+8?;6OU,5S(NV9@P+#G &'(VXP1U!H
M Y.W\5"]AT2QTVYO/+U#4KB"=-0F>">!D0O]G9\,RG)&".2!C/.:ZSPO8ZMI
MLFHVVIW\=S$9A+:1&=II((V'W&=@"PR#@GGJ,\4M]X*T'4M'DTR\LS+#)<&Z
M9S(PD\[_ )Z;P<AO<'IQTXK0T;1;+0K(VMDLFUFWO)-*TLDC8QEG8DDX '7H
M* .1\87=PUWKB6>HWCS6>D^<MO:RM MF^'82R.&^8MM&$P?NGC!S507FIZKK
MG@B.35[V&+5-'EFNT@<(&<1Q'(P.#ESSV[8KJ]0\':)JFISZA=6\IGN+?[-<
M!+B1$FCYP'56 ;&3C(I+3P9HME/ID\$5PLFF0M!:L;J4[$( (Y;G( '.>@]!
M0!Q%GXBU*UTJWT>34+A_.\4S:.+V5\RK K,P&\_QD#:&Z\YZ@5MZ+9+8_%[6
MHTFN)$;2+9U$\S2%?WD@P&8DXXSR>];#^!?#\NEWNG26DDEM>7)O)0]Q(S"<
MG/F*Q;*MGN"*L:;X4TO2]6;58?M<E\T"V[SSW<LK,@)(!W,0>3W_  H S_$N
MJ3+XK\->'UFD@@U-KB2:2-RCL(D#",,.1DL"2.<+CO7'2ZA-X5U'QY+;7$A/
M]HZ=#Y]Q*6,22I&I8N03\JL<$YQ@9S7H^N>'=-\1001ZA$Y:WE$T$T4C1R0N
M/XE=2"#5.+P3H,:ZHKVLEP-414O!<7$DHF"J%&=S'D =>OO0!SNLV?B#1['Q
M#>QZN;:S.CS306PO7N98YXP3YB/(N0I! (]<$8S5-6UC1[GP3JZ:YJ%Z-7DA
MM+VTN) T3!X2^]%Q\I7:3GJ>Y/.=J_\ !ECHG@K7++1+2ZGN;NPEMHEDN'F?
MYD(5%+L=JY(X&!ZU?\+^'K>UTG1I[J&Y^V6=JL:1W,I?[.VP*^T$D9X(SSQP
M#@T <UHUQK_B;1-,\26FHQ6<GVHR7!DOI#&8@[*T#0[=@(& #G=D9SS6=J,V
MK'0O'U\/$&J+-HU[(]GLF"A=L,;@$ <KR1MZ<GC/-=Q;^ _#UIKDFKP6DD<\
MDOGO$L[B%I?^>ABSMW9YSCKSUYJ1_!>B26FJVK0W!AU9S)>K]JE_>L0 ?XN,
M@ <8X% &39ZG-XB\:76D7%Q/;V]EIMO<".WF:(RR2Y)?<I!PH  &<98YSQCE
MO"FI75GX:\+:)#+E=0U#45DD>X,#2>7+(0N]5)4L3GC!.W'>O0+GP;H]U=V5
MX4NHKNSA^SQW$%W)'(8O[C,K LOUJN_P^\-2>'QHCV+FR6<W,8-Q)NCE))WH
MV<J<D],=30!RVNQ^(]"T"2.77I%8ZS:_9Q#.99(H)954QR.RAG'WL$\D<'-3
MW:W5KKGBW0WU/4+FS;0UO4\ZX8O'(3*K;&&"H.T<#BNH;P3H;Z1'ICPW#VZ3
MK<DM=2F1Y5(*NS[MS$8&,GL/2K0\-:9_:]QJC12O=W%N+65GG=E>(9^4J3CN
M>W<T </8_P!IZ9\/_!]QIUK>ZC9BPBFOK.VO'6X93"@#1?,"0I/W 0.17:>$
M=0M=4\,6=W9WEQ=P/OVRW((EX<@J^>=R_=/TJ*T\&Z3I]O90V7VR 609;=UO
M)"R*P4%<LQRN%4!3D#' K6T[3K72K%+.RB\N!"Q R226)9B2>22222>I- '"
MQV\=I\5/$=ZK7<C6^DV]P(Q<O\YW3';C."..%Z#L*SY]8U.+X9Z3XVMM0N9=
M2=[>:XA\UC#.LLBHT(CSM7&[ ( /R]>N>_A\.Z?!K\^MQK.+^XC6.5S<.59!
MDA=I.W R>W>JUIX/T:R91!!(MND_VF.T,S&".7.=RIG YY Z \@ T <_IEK?
MZKX_\2V\^O:HEMIEW9RP0Q3!5.Z(.R,,<H2<8X_/&-CQMK$VDV.F)%,;=;_4
M[>REG'!B1R=Q![$@;<]MV:T['P_I^G:O?ZI;),+N_*FY9IW8.5&%^4G P..
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M3F;)$9=95W9VD;3G'RD'I6]9^%-'L8-2@CMY)(=2=Y+N*>9Y5E9P Q(8D<@
M<4NG^&--TUH&A%Q(;:(PVQGN'D,"' (3<3C@ 9ZX&,XH YOX?6U]J-L=6OM<
MU.XDM[V]MU@>8>4Z"5E7<N.2,<'C'3I3_'%FESXO\%!Y;A U],A$5P\8QY$A
MS\I'/OUQD=ZZC1=!L/#]K+;:<DJ122M,RR3/)\['+$;B<9)S2:QH&GZZ+7[=
M'(S6DPG@>*9XG1\$9#(0>02"/>@#SR_M)Y-8^)=S;ZE?6<EG%!/$;678=ZV@
M92QZD<=.AR<YXQI6^M:CX@U73=*9\&708-18)>O:-))(2&8-&I)VX'' ^?G/
M&.G_ .$/T?=JS>5.#JR!+S%S(!(H7:!][Y?EXXQQ5:_\!>']1L]-MYK>=3IJ
M>7:3Q74B31)C&T2!MQ&..30!=\+0:G:^'[>VUB_AO[^$M')<1='PQQG@?,!@
M'CJ*Y2UCOY/C+XC%A<V\##3;3<9[=I0>7Z8=<?K7>6-E;:;916=I$(H(AA%!
M)_$D\DD\DGDDYK);P?I+:S<ZN/ML=]<JJ2RQWTR;E7H,!@,"@#GO%T^L:9X+
M@#:PZ:I'J%NLTMMA-Z27(49')"E3P,]L<XI%L;L_$6^T Z[JYT^?2H[UE^TG
M>LOFLAV/C**0 <+@9'IQ703^#-%NK"2RGCNI8I;E;J0O>2EWD7;M)<MN.-JX
M&<#'2K0\.:>-;;60+C[>UM]E,OVA_P#5YSMQG'4DYQG- 'G-AJVMZCX<\",V
MMWL4MYJ,]G<RH5W2HGG $Y'+8C7D\9YP:GNFU'3;;XA^'I]1N]1L+?1FNK:6
M[?S)(O,BE#(7[C*Y&>@K1UWPA%8OX6T[1K"^.GV6IM=3&*=F,*LCY(9FW??;
M.!GOQ76/X9TR33]0LY8Y9$U$$7DC3-YDP*[<%@<@;>,#  Z4 <KI6HRWFM>&
M_#4DTT%E_P (\M\WDRM&TTF40+N4@@*"QP",Y'I5!G\17^A^*=/L]0O)+W0-
M0S93+*RM<Q;5D\AR/O':2N>O(/KGMI?">DRP:;&(YHY-,&VSG2=Q+$N,%0^<
MD$<$'(.!3+L3>&M/B30]"FU%YKDF9$N%5LMDF5WD/S<X![\^@H YN[\5F]T'
M5?%NC2RR6FGZ3N@C,C%'G9/,.]<X)12F?=F'88E"ZUITEMK]OJ,<FG?897FM
MY+^2Y^V-Y9>-HPR@(?E)(7 (/08KI="T&WTKP['I<D$!5P[7*(G[MWD):0 ?
MW<L0!Z8%5=!\$:%X;F:73;>9>"L:2W$DJ0@]0BL2%S[4 8.A)KNHP^'/$,6J
MPI;SQH]Z'OI)4NA(HX6,J%C8,>-N/0YKJ=:M;F+0]5;1WB@U.>)O*FE;CS<8
M7)/3G '8>E4M'\">']!U%KW3K22)MS/'";AVAB9OO%(R=JDY/('<@8K;U"PM
M]4L)[&[5F@F78X5RA(]B""/J#0!RO@S64OM5U&SN(=4T_4H88C-IFH3-,(^7
M_>12$G>K9 R/[HXIWC.\U2PO;.ZALKW4-)BBD^VV^G7!CN8R2NR4 $%P '&T
M'OGG''0V.C6EC=R7B>;+=21K"T\\A=_+4DA<GMDD^Y/.:2]T6VOKZ*]:2YBN
M8XVB62"=D^1B"00#@\@=1D=L4 <''=3ZUX@\+6ECXEU)]+OM%ED>6)PCRE/+
M&_.,JYR<GJ.<8JC9^(=9TX_\(Y=:C<7$8\2KI2ZC(W[TP-&)0A?^_P!%W=>>
M,'%;U[X:,?CKPZMC875OI6G6$]N)K9]HB9BFT=<MPK9R".>:Z2;PKHUQHSZ5
M+:;[9Y?/8F1O,,N[=YF_.[?GG=G- '(:S=ZAI&OZ_HUO>WCV+^'Y=3@=YW:2
MUF1BN%<G=M/!P2>0>W%30:G?M>?#:0WMP3J-LWVL>8=L^+0N"PZ$[N<UU]MH
M-A;?:69'N);J,13RW$AD>1!G"DG^'D\#CDGJ3679^ = L9-.DBBNV?36)M&D
MO97,((V[5RW"XXV]/:@#G]+UJ\L_$UI8Z^NHV][+/.]K=1SM+9:BA5RJ*,[4
M8*5(7 ^[WS3= FU_Q#H_A_Q-;:G#;F69);S??2/%+&Q*O"(=NQ6!(4$'((Y)
M))KL+3POIEG+:LBSR+:2-+;1S3O(L+L""RAB><,P'IDXQ52Q\!^'M-UF34[2
MTDBE>4S&$3OY D/5Q%G8&]\<=J +/BZZ-GX6OIAJ9TQMJJMTL7F,A9@ %7NQ
MSM'N17()?ZI#JOC"P6XO[2&'2(KRV2:Y\Z6!R)02&8MC.P<9(].M=WK.C6.O
MZ5/IFI0^=:3 ;TW%3D$$$$<@@@'(]*RU\#:$L]Q<>3=-/<VOV2>5[R9GECY^
M\2V2V&(W=0#@'% ')Z1<ZG:W/P[O7UB_N6UBV\N\BGEW1O\ Z+Y@(7H&##[W
M4\Y)K*U^[E\4?!G5O$5S>72W$MP^($F81Q(EQL6,IG:?E4$DC.3G/2O1T\'Z
M.BZ0JQ7 &D#%B/M4G[H;=O\ >Y^7CG/%4KKX=^'+O^T$DMKA;?4)/-N;:*[E
M2&1\@E]@8 $X&2!^M '544R*-88DB3<50 #<Q8_B3R?QI] !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<X?$5P?'UOH*1VSV<UA+=><KEGWHZ+M/8#YO?\*H_$Z^GT_P7)-&SI;&Y
M@2]>/.4MS(HD/'^SD'V)K!U)K"T^)=O-H(LENI?#=SY M]N)'#H8P .#[>P]
MJ /3!+&TC1K(I=>64'D?44>;&'53(NYB0!GDXZUY9X5B\.ZY;>&-2BUM3JD"
M[7MH5C$\CLF)DF&-S#J6)],YK _X1_3)OA-J6I6T"KK=GJ=PMA<1G]]%*+HB
M.-#VSD?*.N[/7F@#W)Y8XRH>15+'"ACC)]!2O(D>=[JN!N.3CCUKRJ\;3-8U
MWQ7HOBK5;:PN#Y?E>>L:D6YA3#0N_3#[SQT-6K31-+O?B;!;7D OHF\,0M)]
ML0%IB)B \JG@M@#J.#]* /2RZA-Y8! ,[B>,>M<_H/B"ZU7Q'XATV>*W6+39
M(%A>%BWF+)&'R2?J.@_.O./#^HK%HGP[M-1D']BRW5[%*93F,R1LXMT8GC'7
M /=1Z4NI7=OI-S\13I;1QP)>:?)<):X)$!$?GD*/8OGZF@#V5)8Y03'(K@'!
M*G.#Z4++&[;5D5F*[L Y./7Z5YC>:;X<N++Q!J6FZO!?&XT&59;>T$8@VJ"4
MD<(.'&< GG /IQ!IFG6-CJ?PPNK6WBBN+RSDCN95'S3K]CW8<]6 (& >F!B@
M#TK3]7L=46Z>SG66.VF:"1P1MWKC=@^Q./J#5Q)$E4-&ZNI[J<BO)-'T^PF\
M->)+&UN['3=0;Q%.D3M$I'RW*F.-U')C)VKCI\U==X&NYGGUNROM(M].U2WN
MD-Y]D;=!,S1KM=. 1E0N0>1WZT =<6 (!(R>U&]<$[A@=3GI7$_$ 00ZGX.N
MY1&GEZY&AF; V@Q2\9[ G'XXKC]=;3;FW^+*0M;2+Y$$J!""-PM^6&.^[OZT
M >RK(C,55U+  D \C/2N>\7>(KCP_:6<MI';3/+?6]O*LKG*I)($W #KU[X_
M&N6:QM]'\=>&IM)M8HKJ[T:\\W8,&Y95B9-YZL<D\GFN=DN=(OOA=X:U*:2W
M?51J]J]W-*0)A<>>/-W9Y!Z\'L!V H ]K:6-&57D56<X4$X+?2E:2-/ONJ_4
MX]J\GNFT;7M2\6Z5XCUF"PN%N@8C*(UD%OL0Q/"[<\')^7H23U-7;?P]I&J_
M$Z^M=1M!=H=#M)66Y7#/()'&]A_?X'/;)]: /320!DG KD=<\9BW\-VVM:*+
M>[MY;^.T9Y&.,&?R2RXZ\YQSTYKK)(TFC:.5%>-P596&0P/4$5XC:Q:>OP6L
MHH1;I<-J\*W B(63_C_8+N(Y'&<?I0![<LB.6"NK%3AL'.#Z&D66-V94D5F0
MX8 Y*_6O*]9MWT'Q+XQ@\-6ZVLS^&DN5BM5VYF#RKO '\>._7I6GX;A\-:CK
M>AZUH^MQR7 MGC6UM%C4O$5R1.JC=A2!R<88^] '>WU[;Z=87%]=RK%;6\;2
MRR-T55&2?RK"TK6-<US3(M6M+"TM[2=!+;074C>;)&>59BH(C)'.,-C/X4WX
MA:3=ZY\/];TZP!:ZFMCY:#JY!#;1]<8_&I?!^N:?JG@[3[NWGC5(K9$G1F ,
M#JH#(X_A((/6@#0TG49;W18;Z^MQ92L#YL+OGRF#$$$]\$=:O[U";RPVXSNS
MQ7#:C?I>?$S0;>]0/I%QIT[V8E7Y)+H.O.#U/E@E<]F..M<?K=D(?#/BJV51
M_9-KXAM1IW.!$6EA\U8SV4,S# Z'<* /:/.B <^8F(_OG</E^OI3MZ[0VX8/
M0YZUYT/#NBCXMSV']F6OV2?0UGFMO+'ERR"<J'=.C-@GD@FN6L;6TN?"'@".
MY :-?$$]H"7(/E;KA1'G.<8"C'T% 'MJ2)(NY'5E]5.121RQS+NBD1USC*L"
M*\@U2RTKPQ?>-K>*"6'PX]K9^=;6DGE(ES(^W:#T0%=A?C[K=.E3;K0^(O&]
MG+-IK)/H<4A@M<"/>JS=!GYF  YXZ#@4 >LK+&S!5D0DKN ##IZ_2E#J02&&
M!UYKR72=.L;&3X67MM;Q175W;>7<3 ?/,ILR=K'JP! P#TP,8JV=-71/$6K>
M"X+-5T_Q&XN[9DC^6-#@72$]L*,KZ%P* .VO-5U*V\5Z9I\5C!+IMW&_F7 F
M_>1.JLV=F.4X49SU<?CL>;&9#'YB>8.JYY'X410Q01I'%&D:(H1550 JCH![
M5YG8F?2/$VFR7-O9ZMI5YJL_V'4H1MNK:>3S=T<H_C4?.N0> HR. * /3Z8L
ML;2-&LBEU^\H/(^HI)P3!(%D\LE3A_[O'6O(/#MA9>(+'P= TNFR3Z?,\MU<
MFYBD-XI#=%SO)=BKG> 01ZB@#V$R1A@I=0Q.,9YSC./RI!+&9#&'4R 9*@\@
M?2O,=%T*QFU?QO=VVGP3:E8:DTNGY&?*E^SH05';+'GUP,]!5'9%<_#'PIJ^
MDX_X2!;JU"S#_727#.%N%<]3G]X6![#)Z4 >N[UQG<,?6AI$099U48)R3C@=
MZ\CU)M/M=.^*]I,;:)CEXX6V@DM:*5(7U+9Y]:L6FFZ/K'CKPY'>06]U!<>&
M#N1B&28J\6 PZ-C!X.>F>U 'JJL&4,I!4C(([US^L:]=Z=XM\/:5'! UKJ;3
MK)*S'>ACB+C Z=AS^E9/PRM&T_2]:LXF8Z9!K%S'IP))"P@CY5/=0^\#Z&F^
M,K:WO?'7@FVNHUDADGO T;=''V<\$=QZCH>AH [='21 Z.K*>C*<@TD<L<J;
MXY%=?53D5XW+<)H>A^(X(,6VC6WBM$N4BCRD%LRQ%_EZ;-Q&5Z8)'>M+5HO"
M^G:3XCU.+5Y+ZUOK>!+N#3I(XX02X1&+(,(6SACW4'B@#TR>Y)L9YK,PS2(K
M%07^4L!T)&:P/#_C"#4/"_A_4M2:*WNM8"K%#&>KD$D#)S@ $DUSOA^X@A^(
MOB6W%SIX\[3+9_*LR%CWCS0<#/S$*!D\<8X%8%C!82>"_A9->Q6S1?:EC=YE
M4C:89?E)/;(''J* /1M(\0W-YXH\0Z7>1VT,.F-;B*1')+B5"WS$X&>@P/UK
MHZ\IO=*TO5=<^)!NK6WN8XK&V:'> RH?LS$,HZ ^A'([5V/A+6;1O#'AFUNK
M^'^T;S2X)4BDE'F2XB4LP'4^] '2USGB3Q%<:/J.AV]M';2I?ZBEG/O<[XPR
MLP( _P!P]?RJ_P")+B]M?"^K7&G*6OHK.5[=0,DR!"5P._..*\RFFT"30OAM
MJ-I+:&<ZE;^9.67S"3$_F[SU)WXW9[T >O&6-9%C,BAVY52>3]!0\L<>=\B+
MC&<G&,]*\BB_LCQ!;:U::[K8L-9M=6E9E58UND*RY@,)8;B"FQ5QG/3O5B[T
M/2;[7OB8MU8V\PBM8)%6100CFV8EP.@;/.[KUYYH ]+N-6LK75+3399E%W=A
MVBBSR5499OIT'U-6O-C\WRO,3S,9V;AG'KBO*;46,^M?#2]U-;9VFT.5I)K@
M*=[B* @DGJ1DD?4UGWNH:9(=(U&RGMX$/BT;FN) UTQ\UED+-D;$QP%(/R[<
MD=* /2-)UZ[OO&.OZ-<00)#IT=L\+QL2SB4.3NSQ_".!^9KH2<#)Z5Q?A]U?
MXI>,"K @VNGD8/\ LRU<^(%U86OA.4:BLCV\UQ!%M27RPS-*N [8.U,_>.#\
MN: .ECECE3?'(CI_>5LBA98W;:KJ6P&P#S@]#7CURUHY^*5I)/82 Z5%,D5L
M L8D$$N2JY/S#:N3Z@=*TK+3[/3/$_P\N;&WBAN;W3[A;B1.&N +=& =NK8(
M&,YQ0!U_C3Q%<>&]#:^LX[::99H4>.9R"%>18\@#K][VKHZ\-N;K3=2^#":C
M?M;G7%U.)KQY<"9+C[4H<'/(PF0!V4#L*]Q5E=%=&#*PR"#D$4 ('4YPPXZ\
MU4D>_P#[6MEB^R?V<T3F4LS>=OR-NT="N-V<\]*X"XL1X?\ &NJZ%:6JI:^*
MHA+;LD8Q%*N$N.W]PB09XR".]:-Q96=C\6_#T=K!%"HT>ZC"HH'RJT6T?AS0
M!W"RQL[(LB%E."H/(JKICW[6KG4_L@G$L@'V5F*[-QVYW<[MN,^^:\\\+B;3
M=<T.QOK:RU.RO89_[,UJV&V5T*[V6=3U)'\0/) SR36-9W'V#P3I4> FCMXK
MFAO\?<6'SY-H;MLW;,YX[=#0![/')'*@>-U=3_$IR*198W8*LBEBNX 'J/7Z
M5YKKFGQP>+O$=O9PQKI<_AMYKZ%5'EBX#$1N1T#%0WX*/2J&D:?96#?"N^M8
M(XKNZMQ'/.H^>539D[6;JP! P#TP,8H ]<I@EC+A!(NX@D+GDXZTD\4<]O)%
M*BO&ZE65AD$>AKP[3M#L3\)_"NMZ;$H\1)>6Z6MRC$RNQGVM'G^[LWDKT&"?
M6@#U31]>N[_Q=XAT>X@@CBTU;9H7C8EG$JN3NS_NC@?F:WHY8Y=WER(^TX.U
M@<'TKS/4;RSL=<^)MQ?&Y^RII]F)?LK;9<&*0?*>QYZ]JCT<V ^)!LVDTL6]
MSX<"M;6K QG$HVJ3GYV"D\X'!Z4 >H"6,L%$B%B"0 >2!UH\V/S/+\Q-X&=N
M><?2O%=#T^RM/!7PTU6""--0DU."%[H#]XR,LH9"W7;_ +/2MXF?2?$T%S-;
MV>L:/>:XRPWD8VW=C<L[(4;^^@.5XY"^P% 'I]<K:^(-6UB^N'T>&RDL[+4S
M87,<Y99&5<;Y%8' P2<*0<@=1G%=2Z+(C(ZAE88*D9!'I7C#1C3/A]XZO=(M
M8X[B+6[F%Y+:,+(EOYR>8%(Y ";NG3K0![*DL<F[RW5MIPVTYP?0THDC9MH=
M2W/ //!P?UK@M0LK2/QUX2FT&*!;>\M[A+Q+=0(YK01@J6 X(#%<'_:QWJ+X
M4Z%I2^&K754LXOM\=Q>PK/U94^T/\H]!P./<GN: /0R0H))  Y)/:DCD25 \
M;JZ'HRG(-<OX^NK"WT:Q2_1G2XU*VBB3S?+C:3?N42M@_N_EYX.>E9/@&XA7
MQ;XRLTNK23%Y#*J6N%CR8$WE5R>_!.>M '?.ZQH7=@J@9))P!5/49;[[(CZ6
M;-I?-CW&Y9@GEEANP5_BVYQVSBL?QM:7%[8Z=%8WUK;7XOE>U2[0M#<.J.?+
M<#G! 8Y'(*@CFN&U2>"]\#Q--H\6F7EEXEMXIX$8-&LWGQEVC8?PMNS^8[4
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M6:")K^T\0SO;W)&7@83Q\H?X??&,]Z /;Z*** "BBB@ HHHH **** "BBB@
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M!3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS+P*P/#EW-8Z1X(L[K3[NVVZ;)$]['8O)/%("H\@?*?+W 9)(YVC&.M>N44
M>-:9'<VW@+P>9=/U!/[,\0L]TIM9"\:EY_FV@$L/G7D9'-;NIVUYJGC;Q)%8
MI-#->>&EMK>9XV51,6E.W=C&X;E)YXKTBB@#RXQR>(/"7@_2;6UN+?5=/O+-
MKB)X60VGDC$C$D8 P"!_>W#%5;V)I/"OQ-B6UG::\NY3;J(&W3@PHJE./F&X
M-TKUNB@#&TS6+=YK#2_+N?/>P6YWF!A&%!"D%B,!L_P]:V:** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP9P.&P2N"?[^.]9VGZ>FG:I?_#MK4&UN+M;^W<ID&R9M[J3ZJZ^7D\XD7TH
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MD!NG;S@DB@C&R(#("G.5QG%:5PUC%>_%")S;K UK!*BD@*2UJ<,!TY;OZ^]
M'J><4F0!DGBO*6AOI_#_ (>U#3X-/UI;;0(/M>D7;89HV4?O(G.0'^4@Y]![
M40:EIFM:Y::??2VUOI=SH-M-ID.J0APZG>),98#S,>6#CG XXSD ]7IDID$3
MF%5:0 [5=MH)]S@X_(U@>%I-/TK0M*T@:X+Z0HZ6LMQ(HEN41CRHS\P QR,\
M 'O714 87@[7I?$WA2PUB>!();I78Q(Q(7#LO4]>E;M>%V&A6B_"70=>TZ-E
M\21W4:64Z2-O9C<E3'U^[M+97IP3ZUU6K(W@[QI=M8VB-%XG@\F#$>5COEX
M;T1E;<?]QC0!Z55-]3MQJ9TR.1'O_LYN!"6QA 0H+'G )/IV/I1I6FV^CZ5:
MZ=:(%@MHUC3CK@=3[GJ3ZFN-:STU?C=++-;6HE.AQ2*[HN3)]H90P)_BQM&>
MO04 =!X.UZ?Q+X;AU.YMX[>9YIXS%&Y8#RY63@G&?N^E;V0._6O$+/3[2'X?
MZ'K4<0&I0^(]L=SD[T5KYU90>RD$Y X.:V+M=/\ $>J>+-,UW5;.PN[:[_=/
M/&!/! $0QR0N6&T9R>!U)SUH ]7HJO8[AI]L&DDE;RES)(NUF.!R1V)]*L4
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ML\\]O=:1#-<?ZZ2/20K2_P"\1)S^-75\4:,UM?7#7RQ)8#-VLR-&\((R"R,
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MKOPI?WM_I]Y-?Z9YM@VZW<:7\Z<8P&\S(7IP,=!VXK3^Q^(/^@S9_P#@O/\
M\=JH?'GAC(_XF\1!N/LQ8(Q59,[<,<87DXR< GO71T <O;>%KFSO&N[:;1H;
MEB6,L>D!6)/4Y$G4]_6JL.C>,;S5_M&JZKHZV]G,TE@+>S=F;*E=T@+C#!6(
MP"1R?:M.?Q7:P^,X?#9AN3.]HURT@MW*CYT51D#&/F.6Z# R>:L2>)]&BN4@
MDO0I>?[,LAC;RC+G&SS,;-V>,9SGCK0 GV/Q!_T&;/\ \%Y_^.U4N/#^H7=W
M%=W-WI,US$I2.:32@SHIZ@$R9 />NCKGI?%-L?&#>&5CNEN!:>>TRV[D+N8*
MN#M(Q][+'Y01CU  *G_"'/\ 95M<:#]G5_,$7]BKL#?WL;\9]Z?=>$Y[Z]M[
MV[DT6>ZM\>3-+HX9X\=-I,F1BLKP1XUM9-!T^#7-7\W5+J\N+=7DCQO83R*B
MDJNU20HP#C/:NHU+Q+I&D,XOKOREC*B601.R0[NGF, 53.1]XCK0!I0+*D"+
M/(LDH #NJ;0Q]0,G'YU)2 A@"""#R"*6@ HHHH **** "BBB@ HHHH ****
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M61M+9+9V>01&(22; ,@$AN2.0N>XKT?_ (1FP_Y[ZK_X-KK_ ..4?\(S8?\
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MIC4;?0M5BN$MF@GGU19E:-6(S"/,)W<Y)QD#'7D5O?\ ",V'_/?5?_!M=?\
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M<H_X1FP_Y[ZK_P"#:Z_^.4 >8^*UD3P_\3))+6Y2*>[M9(FDMW195 A4E20
MWS CBNHUB!M8\8Z1J^E6,DZZ787AF#Q-&)2Z!8X/F R<[B1_#CG&16GK_@'3
M]>TB73FO]6@CE(WL-0FDX!!QAW*]0.H-:$?A>R6-5>ZU5V P6_M6Z&3ZX\R@
M#S_2)KB;Q!X&U!M.U1$AMKF&XC&GR0PV;M&@$2IM&U001N.<X^\<<02VUT?A
M;J5JNFZA]J?7S.D(LI=[)]M63>%VYQL&<UZ5_P (S8?\]]5_\&UU_P#'*/\
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M),8VX.XMGJ".O%>O44 -C4I$BLQ8JH!8]_>N-N#+8_%P7DEI=M:W&BK;I-%
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MLLD9&Y]K$D8Z^H[6AH^K)KOC2Y_L]VAU2UABM&$L?SLD3(<C=\O+ CVSTZ4
M;"^++2Y:P33X);R6]L1J$4:LJ,83C!^8C).X<?F13+KQ:D(18=,O)YO[/_M&
M2,!4\N+^Z2Q W]?E]CDCC/,/X2N+WPOH6EZKH$[SZ=ID4,-Y9W4<=Q:W"+M)
M5MX^4X!_#D>DLVB>+9FM;35(8-7MSHZP,[7 2..\YWR.I&7R,8.#@CH,DT :
M5WXUFEU;PG'I=A+<6.MQ27/F;D5B@B+!0&(P?F4DY[8&<U-::]H=CJ_BV[DM
M[BRET_R7U&>=MRR#R\H4 8C[N.@!)/3-8>G^'?$5E9^ YCIL+7&B0R6US!]J
M48#0B,/NQC&1D@9.#WI^J>#=2UZ7QW:RQ&TAUI;;['.SJ1NB0#Y@"2 64=NG
MOQ0!TR^*HX]6LM.O]/NK*;4(V>S,I0B5E&3&2&.U\<X/![&LI/B1:-9+?G1M
M32P6^-C<7#K&%@D\SRQN&_)&['*Y SZ\4^73=6\17_AVYU336L6TF4W4^94?
MS91&4"Q[6/RY8G+;> !CDXPI?#&O2?#W4M'&F-]MN-8-XBF>/;Y9NA-R=W7:
M,8]?;F@#TUW$:,[?=49/&>*YK3_&EO?7NE0-I]Y NK023V+R!?WBH 2&&<J2
M"",_H>*Z"Y^T26$WV8B*Z:(^5YG(1\<9QGH:\XTS0/$HUGPIJMYHT8N[!9X]
M1N)+U7EF9XPOF9Q]W(.%SQG&% H V1\2+0V1OVT;4TL(KXV-S<.L8%N_F>7E
MAOR1N(Y7./TK2UK7(Y1JNEVMG<WLMK;;[O[.X3R]RDJH)8$N0,X';&2,C/)S
M^&->E^'VLZ0NF,+R[UAKR)3-'M\LW*S<G=P=HQCU_.M2'3-?T;Q3K]Q:Z9]N
MT_7 DRM]H1'M91&$*N">5. <KG'H: -'X:NTGPU\/.[%F:RC)).23BN:L=?D
M\-^)?&\D>DZIJ4$-Y#))]F(?R4^SHS'YV&>23M7)^E=;X#TV_P!&\#Z1INI0
M)#=VMNL3HD@<<>XX_G69#IVMZ5X@\4S0:8+J/5WCEM9A,@2,B%8R)02& RN?
ME#<>_% &D_C+3I8+233_ /37N[47D2"1(_W1Z$ER "3D =<@],&J-O\ $?3+
MV+0Y;*QU"Y76?-6W\M$RKQABR,"W#97&?N]\XYK$B\(ZUX/O-'N=%T^#7+>'
M2X]-N[:6587RC,ZRH6XZNV1Z8K7O-*UJY\0^$]0?3X@MC+<2W2V\B;81)&R*
MJYP6(R,G SR1Z4 7[/QO8W&DWEY<VUQ9S6=[]@FM)BGF"<E=J@AMISN4YSC'
M)( -11>-H;M]8LH+.7^T].@$YMQ)&PD1APZL&VD#'()!&.G2N=N_"6OW5MK\
MMO;1P7C:Y'JU@MPZM',$5%V/M)QD*WYBNDLFUR]TB^EO/#T.F2M;M%'9Q7$<
MKR.1U+C"A?3GUSV% '%6":1)X/\ #?B77](U&6\G^S))<0W 3[1)(ZE9)-L@
M+ /@C(R/3%=E'XJNO^$XU;29[%X[#3[.*<SAD/WMY+D9SC"8 &3US6)-X=UM
MOA?H&AC36-_8RV?G)YT>W$+JS$'=SD+Q_2M:33-:M?'.JZK:6,4UM?Z9%$KR
M3*/+EC,AVLO?.\=..O- &QI'B#^UVMF2PGCM[JV^U07!9&1ERO!VDX;Y@<=.
MO)P:;XB\2V_AI+![FTNYUO;I+1#;H&VNV<9&<]CT!K \+^%[C1_$HO=/L9]&
MTR:V?[9IS7"R0FX)4JT2JQVX^?)^7/R\=</^)+R1V_AEXHC+(OB"T*QA@"WW
MN 3QGZT 6;?X@6)_MF+4--U#3KS28!<S6L\:M(\1Z,FQB&SC'7@U<A\5;]0O
M--DTJ\34+:S6]6V4HQFC8D#:=V-V5(()'U-8FLZ%XAU#4-;\0:5']@U-]+33
M[".61-YQ(9'8E254G.U>3C&3BET+1-4M/'@UAM%AL;";25MI<W8DD619&8ER
M!\['(YR>!DG/% &U8^+[74?#VEZQ:V=U)'J4JQ0PC9Y@))SD;L?+M8GG( /I
M44OC:UBN8@]C=BTDU/\ LI;DA0//SM'RDYV;OEW8Z]L<UG>&] >R\:ZT8YU?
M2+:<SVL '^IN9U!E'X#D8Z><U8NH>'?%5_Y<EWI4-W?6>O17J7;W:CS+9)=R
MI&I'R +@$<<C/S$T 26>NR>'/%?CB2+2=3U.&&Z@DD%L0YB3[.K,?G89Y).U
M<GV%7]0U"UU;QOX U6PG>2UO$NW0AB%9?(R,KTR,GMFK5OI^N:5XC\3W46EK
M=+JYADMI$G01QLL*QD2;B& R,Y56X[9XJI:^$+W1;[P+;6D+75IH<4Z7,^]5
MR9(MN0I.?O9/L/6@#3O_ (@Z5IY2:1)&T\W?V-KM'0A'W;,E-V[9N!&['O@C
MFNDU"\&GZ=<WAB>98(VD*1XW, ,G&2!^M<+H&D^)M!EFT'^QK&ZT\7,DEKJ[
M3J#'$[E\/&1N9UW$#'!XY'6NZU"V-[IEU:JP4SPO&&/;<",_K0!BQ>,K*6/P
MY*MI=>5KZ@VSD)\A,9D <;LCY0>F>:S)_B1:P66HWS:+JGV33+QK2^EVQX@Q
MM!;[_P PRW\.3@9..,X^GZ'XH^Q^"+:;1HH?[!E"7#->(?,586CWKC/!R#CK
M[#K2WOAC7;GP7XUTM=-87.L:A-/:@S1X*/L +'=P1L.1[CK0!V=_K<9OY])M
M;.>^N8[<37"0.J>6C9"@L2/F;:V /3)(XKD_A]K\&G?#?P\DQ>6ZNS<>3&\@
M5FVRN6+,Q  '&23U(ZYJ]!I^O:-XXU#6+72S>V.LV]N)H_M")):2Q*5&<G!0
M@\E23GMZ\_IWA3Q3I'A_PQ>0Z9:7&HZ.UU'/ITEPN)X9GW':Y&T,"%//'7Z4
M =(/B5IATU+L6-\S?VF-+GBC",T,Y8 9PWS*<Y!7.:Z;2;^;4K$7$^G76GR;
MV0P7.W>,$C/RDC!ZCFN1US3=>U?2-*?^QHH)XM7MKU[2&:,^5%$P)#.<!G.#
MTXZ#/&3W8.5!(()['M0!Y9<ZUI^G^,=6T[QN;NR>[N"=)U(S/' (=H"HCJ0(
MW!R2>,D\GI791ZI%X=TK1]*FG-]?M: *QE4>:(U4-(78@8R5YZDL..M8]]J8
MO;#4M+UK2K35;:6:46^R]M]K1ECLWAW4H1GJNX@ 'KQ7.PZ/?>&=/\+W6GW>
MEZU=Z99R65Y:2WB)YD;LK#RW;@%"H SU [4 =IIWCO3-5L()K2*=[N:[DLEL
MOE\P31@EP3G;A0-Q;.,8QDD"L[7/'5U:Z%+<V>D72746J1:=,DX5=A9U&Y23
MAP0PVD<<\XQ6;K#:C,VB>(K'^R%U+3KF60Z4+V,*T,B!&3S. 7X#9QCG'..;
M'B2XOO$/A,EFTZ&^2]MKF*P%_&Q"1R*Q!D^[N.#[#CGJ: -S^T=/D\>V5M<:
M9=PZL=-EECF>0>6L6]-R85R"VXKSCMP:;)XZL(K&VU1[6Y&BW$X@34?EV EM
MJN1G<$+<!L=P< '-95RWV_QW8:G.UK'9C2IK2=DO8B4>1D;CY@3@*03CJ>_6
ML6'2II_AVO@.]FL_+C=(/[26[B\IK=90X8+NWA]HVXQC/.<4 =7>^.DM;W6[
M2'0]3N9M'1)+@1B( HREMRDN ?E'3[QSTX-=)IU]!JFF6FH6K%K>ZA2>(D8)
M5@&'Z&N#^9=<\;7(-L8=4M88K0B\A^=DB9#D;^.6!&>V?I6_X1N[73?!VC:?
M>WEI%<VEE#;RK]IC8;D0*2""1CB@#$\9^%+=-.U'53J>L/J=RXBM5CU"6*-9
M9&$<2A$8# )7/K@DUI?:#)XKT_PBDLCVMCIHN[MW8EIOF$<:,>I!PS-ZX&>"
M<V=4N;34->T?-]9_8+1Y+J5C<)S*%V1KC.3]]V^J"LG[38V/Q9_M(W]J;74M
M*^SA_.4A9HI-VT\\91B1_NF@#5OO&UK8/</)8W9LK:^CL)[K"@+*Y4 A2<E0
M74$@?3.*35=1;0/%^CJ&/V+69'M94)X2<+O1QZ;@&4^ORGL<\3XAM-5U>WUF
M&9=.O+C^TXKBPNGU&, 6RRHPC13]QL*=QXSZG@5T'B6YM=:\3^$+1;RT!MKM
MM1N"DZLL81"H&>,Y=P!ZX)QQ0!V&LZK!H>D7.I7*2R10+DI"FYV)(  'J217
M,Z[KL>IZ'XJT>:VN;.^L=-:=AY@Y5D<HRLA]5((XZ=Q6SXNAUFX\,7D6@.%U
M)@OE_/L++N&]0W\)*[@#V)[=:Y*'PMK$FL>()(](MK"UU;1EM4)N0Q24"0?/
M@$EB7!)Y^I/% %KPQXSBM=/\+Z5?Z9J%K'>V<,-K?3*ODS2B(';PQ92<'&X#
M..*UKOQQ96EA/JOV2ZET>WG,$U]'M*J5;8SA<[BBMD$@=B0".:S+70=3U33/
M"FFW]@UC'HDL%Q/(\J/YKPQE5$>TDX+')+;>!C'/%&V\+:W9^!]5\$BT$L$[
MSQ6FH^:GEK#*Y8EU)W[UW-P 02!R.P!UT'B6"?Q5)X?^RW"3BT%Y'.Q3RI8B
MVW*D-D\^W\Q4)\6VOV:T?[-*L]XTGV>&22-2Z(<&3=NP$Y7!SD[AQS6?XE\*
M7EPF@S:'/Y%YIK?9C*QY^RR+Y<GU8#:X]UJ/Q1H>J6VJ:)K/A[3[:^_LZ&2T
METZ601B2!]F-C-P&4HO7J* -SPUXDL_$^GS75HLD;6]P]K<0R8W12H?F4E20
M>H(()!!%:\CF.)G6-I"H)"+C+>PR0/S-<M<ZMKND:1;7C:!;EY[Q$FM(;E0;
M:)L+G=C$CYQP/[V 3C-=2[%(V949R!D*N,GV&>* /,M3U^&V^#*W_ABRO;6T
MF;RH]TH\R%6N-C9+.3DY;&"<9'3%=OH>BV6FR75Y:64M@]Z5:6U+C8C+D9"J
M2JDCKCKQGFN(_P"$7UX?!R+PV--)U-9PQ3SX]@ N?-SNW?W>/K[<UZ;&[/&K
M-&T9(Y1L9'Y$C]: /,=;\0WWB#P+X]6ZL9[1=/:XAA=9E&WRXD(!*MDDDENA
M'.,G%=-HGBF-[_3M$N=/O+5Y['S[6>8)LG5 H? #%E(W X8 XK!NO#FOC0_'
M6DQ:<DJZO<3SVDRW"C=YL:* 0>F-IR3[8S6C<:)J=YXD\,7+V$B6MGI]Q;73
M>;'E&D1%& &YQL/3U% %L?$#2_M>EJ8Y!9ZI.+>TNPZ%7=L[,J&W*&QP2/3.
M*VO$""3P[J()88MI&!5BI!"G!!'(-<EX0T[Q1H]M9:!?:+8?9[ K&FL+,I\V
M%#\N(L;@Y4 <D =<GH>PUN.:;0[Z&V@:::6!XT1649)4@<D@=Z /.O"D^BWW
M@30DO+O43JE[#%%YZS3[O-;^+=G;QU]#C'-=?=^+_)UR_P!&MM%U&[OK2W2X
MV1^6%D1B0"K,X'\)ZX/H#67X<BUW0_ NFZ._AN2>_L[9(QON(?),B]#G?NQD
M _=S5NSTW5+;Q_J6K2V;RVLNF06R2H\8,DD;.Q^7=P#NXH ;:_$.RO(=%O(]
M,U!=-U:5((;QU0*LSYVHR[MW4$;@-N>YJ.]^(D-J=7\K0-8N1I$NR],21_NU
MVABXR_S#!S@9/J!6):>&->M_ ?A+26TUC=Z7JD%S<J)H\>7'(6)4[N20>!]>
ME3:3+?MKOQ M;/37N7GO%1'\Q%17-L@^?)SCD'*AN_'J 7;Z]M]1^(7@?4K&
M=Y+:]L[R12'.UU\N,J=O0'YCVSS6I=>.;&UT^75C:7,FC0W!@EOTVE%(?8S[
M<[B@;(+ =B<$<UE6OA2^TC6/!,5M UQ9:)9S6]Q<;U7+.B*"%)SC*DGT!'6J
M5KX4UNU\!ZCX&-H)()7EBMM2\U/+$$CELNI._>H9N I!('/4@ Z^V\2P7/BJ
MX\/_ &2XBN(;9;I97*>7-$3MW)AB3SP>!C\15=?&%J]K:2+;2K/>>8UO#+)&
MA>-" 9-V[ 0Y7'.3N'%9/C+096_X1Y]'N_LNI03"PCDZLUO(A64>Y55\P9[I
M3_$NA:I9ZMHNL>'=.MKY=/MY+*7399!'O@;81L9N 5*#KU% %RQ\?:5J&F1W
M,*R"X>[DL3:NR*ZS1@EU+;MN !G=G&",9) IB:I8^/=!UC3(DN(;BWE^S7$*
MW'E,KC#*1(A/RGCD9R,C':L[6]'\1W<.D:Y::98C4M/N9)3I+2KL>&1 C)YF
M,;^ V<8'3G'/4:"=0EMGN-1TZ#37D(VVD<BR% .[,H )/H,@ #GK0!674_[%
M_LO029M1U/[&7R756E6,*K.2Q&6)8<?7)'6M>PNOMVG6UYY,D/GQ)+Y4HPZ;
M@#M8>HS@US7C#0(]?GMX+O19KRWCC9X;NTG2*YM9LC!1F9>"/?J!D'ML^&[;
M4K+PWI]MK%R+G48H%6XF!SN;'KW^O?K0!C:K\0=*TE);F:.1]/@N?LL]TCIB
M-]VPG9NW%0WRD@=C@$<TMWXY2"[UNU@T/4KJ;1U1[@1^4 492^Y27 (VCI]X
MYZ=:R=*TGQ-H5]?Z1%HUC>Z=/=RW%KJCSJ#;K*Y<J\9&YRI8XQP>!D=K::1J
ML>N^-;K^SW,.J6\,=H1+'ERD10Y&[CDY&>WY4 7;7QS:75[HZ#3KZ.RUA<V5
M[(J!)&V;]NW=N&5!P2 #CCCFJ%S\3+6WM+Z]_L'6'L].NWM;Z98XR+<H0"Q^
M?YAD_P .< 9..,U(?#^M1Z1X!MCIS^9HCQ&\_?1X 6!HCM^;GDY^GOQ5'1X=
M0U/0O'>C6=@7-]K%];K<M(@BCW@*2P)W< YP <\4 ;1EBE^+^GW$,S/!/H$T
M@/F$H1YT6& Z#@]JOOXZL8[*TU.2UN5T:ZG$$>H?+LRS;5=AG<$8\!L=QD '
M-4%\,74'B_3?+MY'TFVT)]+:X\Q V2R8.,YZ)UQU-9L7A36KKX>P^!;^T CB
MDCA;45E3RGMTE#A@N=X<JH7!&,\YQ0!UUCXFAO==U;2&L[FVN--1))#.4"R(
MX)5D(8Y'!Y.,=#5 >.8C<Z1;+HNIF?5K:2YM4Q'EE4 D'Y\*<,IYP.>O:J?C
M+0GU#Q+HD]C<+#<77F:??*.LMD5+N/8@J #V,GO5W5M+OY_'WAS4;>S+6-A!
M=1S2!T&TRA N%)R0-AS]1UH I/\ $FVCT:YU1]$U18+"X:WU'(C_ -$96"G/
MS_/U!^3=QZ5KZQXMM=*ENH8X'NYK2 7$Z1R1H50Y( WL-S$*2 /QQD9Y*[\,
MZ[<>"?&FEKIK"ZU?4)Y[4&:/!23;@L=W!&TY'N.M7KG3O$6E>++C5]/T*#5;
M/5((5GMIKA(I+66-=N<G(*D8SC)R/S -)/']C=76FP:=I]_?-J5DU[:M$J!9
M%&T%268;2-W.[ ]ZHZAX_E?P]I>HZ9IL_F76KQ:=/%,4#P-YP1T(S@L<$#!Q
MSDD5:.E:N/'&BZI)9(\%KI\\$[P.@59)&1@%!()4;2,X]*PO^$6UX>&GC73A
M]KA\3?VND#3H/-B\_P S:&!(#8/>@#TN)VDA1WC:-F4$HQ!*GT."1^1I],A:
M1H$:9%CE*@LBMN"GTSQFGT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSPYK6K6@L6L+?Q)<I<0RHS22J]T$.U@0$(W9Y#9]J /4/[)TW_H'VG_?E?\
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MWQ^68P&^<_-M/WNGMWK;T'P[-H6I:O,NH>=::A=O>+;F$*8Y'V[LOGYA\O'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME_I^UPS QPW7E^:%)Z[O+!!'3)'>M>9M0@;0K*ZU*[>XN8YII["%O](E8A2
M),@(D>[!)(R=O4G!UU\&:$FCQ:4MBHLXKP7J)Z2B3S,_3/&/3BIM5\,V&KZI
M9:E,]U#=VBNB2VT[1%D;&Y&*GD' H \^EU2]UCX8>&;S49C-='7[>)Y& !;9
M>% 3CC.%&:]:KED\ :-%I$.EQ/>QVD-Y]MC07!.V0.7&,YP Q)QT]<UU &%
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M_8(F$:R?(#YX! 'H<#/K6G?_  _T74I=4>X:]*ZI&JWD:7+)'*P4*'*C W8
M]N.E71X4TT:K8ZF&NQ=6<'V97^TO^\CW!L2<_-\PSS0!N5P=ZFKZM\1-4T1/
M$-_96*Z9#<H+98PZ.TCK\K%3Q\H)SD^X%=Y7"MIEU=?%:^O5.HVENVE16R74
M,>$=Q([,N64KT93G\C0!SUCKWB34=/\ "L-QK$T-S)J]SIEY-#&@%PL8E'F
M%3AOD'MGG!Z5T.ER7EYXHU'PO<:O?M%I-C PGWA)KB24N?,9E SM 4 ="2<Y
MXK:D\':6T>DQQ>?;QZ5(9;58I,;7((+-D$L3N;.<YR?6K%]X<L[W6(M7CEN+
M348XC ;BV<!GB)SL8$$,,\C(R.Q% '!-X@U]_!(UN:\G,N@ZL]MJ7DJ%%[;1
M2['?&.#M^;C'W6_#H]7O;N;0/%&MZ=J<\,4%G(+)HRK)NB0LT@# CEOD_P"
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M,DT_48?-MY"#PQ5E8'*LK#D$$ @BHK/0H+2XDNS<7-Q?/"(/M4[*TBQ@Y"C
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M^S:)9H9I9<PH=TK9/W1Q]*J7'A/3;G0KW2',X@OV9[QQ)^\G+<,6;'< #C&
M !@<5JV5J+*SBMEEDD2)0BM(06P.!D@#- '-_$Q7;X;>("DTL3)92-F)MI.!
MT)]#W]:PM4L93XJ\ VL=]<HS6][^_P JTB@PIT)&!Z=#7?:GIUKJ^EW6FWL?
MF6MU$T4JY(RK#!Y'2LF+P?817FE70N;YYM+5UMWDG+G#@!MV0=V0 /;'&* .
M(O=;UNT^&OBV2/6+K[7HVJ2VL%TP0R-&&3 8E<$X<C( / K7\::U?:/J=Q)>
MG4;?17M%2'4M/^<6,^6W-,@Y*X*<D$#'3)S6S+X$TJ?2=5TR6:\:UU2Y-U=K
MYH!>0X)((' .U>!CI]:MWGABVOFNO.O+[9>0"WNHQ( LZ $8(QP2"02N#SUZ
M4 ;,4B31)+&X>-U#*RG((/0BGTR**."%(8D"1QJ%55&  . !3Z "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *YJ/QA;/X_D\+&)E86OFI.?NO(,%XQZD(Z-^)K8U;4X-'TFZU&X/[J
MWC+D9Y8]E'N3@#W->:^*M%U[1O#-CXA<V4E]H5T=3E,(8/*'),Z9)QM*L?P4
M"@#U621(HS)(ZHB]68X _&CS8_*\W>OEXSNSQCUS7!^*M7LI+_P9K*7UM)IS
MSR2BWEF6,3JT)VN"Y"Y3.<$C[W'.*Y77-"T^T^%OBN_ L'-WJ0N83;NCFWC,
MT>U-ZY (RQP#@;R!0![(9X0CN94"(2'8L,*??TIPEC,7FAU,>-V_/&/7->;^
M)+;2/#'B708,0:5HM[)<O/-Y:F(W>V,1M)N!7)4/@GOD^]9EZ-*\.6NEK:ZS
M)+X;FUR5KNY*QO;PN\9**H V>4)#]%;W% 'K*SQ/")EE0Q$9#A@5_.C[1"!(
M?.CQ']_YA\GU]*\B\3Z3H=MX)\03Z9J0OXIM1LYV,93R8)3-&&\HH %8KRV/
M4>M;A\/Z*/BZUE_9MI]EGT+SIK?RQY<LBS@!W3HS $\D$T >AF2,1>:77R\;
MM^>,>N:19HFB$JR(8ST<,,'\:\7TO48].\+>$H[VZ%MH:ZK?6\LSJ&CB*R2B
M /NR-HYQG@8!["K7B'1]#MO"UTVFZA]O@EUZSFWH4\J"5Y4#B(H %R.3CUH
M];DN[:*&::2XB6* $RN7 $>!D[CVP*BTS4;;5],M=1M&+6]S$LL9/!VL 1D=
MN#7GEUI>GV/C7Q5IUE96\-K/X<CGDMXXP$>0/* Q4<%L <UTGPW-C_PK[0Q9
M?9\_88//\G'^L\M<[L?Q>N>: -W??_VWL)M/[.-MD#+>?YN[GCILVX]\U9$\
M)=4$J%FSM 89..N*XDVMJWQHND:&(B?PZIF4J,2?Z01\P[\8'-<3HFGV%MX
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MCCI^E 'MR2QR%@CJQ0X8 YP?0UB^*/$*^';&TD"1M->WD=E!YK[(P[YP7;G
M !/OP.]8&E6-GI/Q?O[33[>&UAGT.&>6*%0JNXG==Y ZG'&:W/%R:%=Z7!IG
MB**)['4;@6W[UMH5RK,IW=CE< CN10!+9WVLIKJ:=J-I:F![9YDN[=V +*R#
M84/W?O9SN.?:M<31-,T*RH95&60,,@>XKS33;?7_  =XH/AFRU6;6--N=.GN
M;1+K#SV3I@(&;NC$@#/IQT.:GA-= UNS\+:@NNL-:M&7=;1"-;AIBN)DE&-Y
M7.XL3Z9S0!ZMYT7G>3YB>:1G9N&['KBL^#6+?4O[3@TN>&6ZL7,#;S\@EV!L
M$CG W#/IR*\^\(W/A[6O#VF'69T7Q+::FTD\0DVW1NQ(PP1]XJ0>G3:.P7@T
MRTT@0?$>VDM[(3_:[C;&44.(_L\9X'7;GGTS0!Z39S3+I5O-J,ELL_E*T[PL
M?*W8Y*D\[<],]JL>;'Y7F[U\O&=V>,>N:\LT6YQ<?#6UOPITJ;1 (@XS&UV(
MH]H/;=LW[<^IQ65XEL5@\.^/;=$7^Q[?5+)K$?PPRLT1G$9_A&YN@Z$L/6@#
MVE98W9U1U9D.& .2I]ZHZO=7]M:*-,LTNKR5PD:RR%(TX)+.P!(4 =@220.^
M:Y.PL++2?C');Z?;Q6L=QH/FS)$H42.+C =L=6P3R>>:ZS6=:L- TYK[4;B.
M&$$*N]PN]CT49(&3^7<X )H Q_"_B34=2U75=%UK3X;34]-\MW-O*9(9HY 2
MK*2 1]T@@BNHKDM U30DFU/46UK3;B_N$^U7KV]PLB6\2#"J6!X51W.,DL?8
M=/:7=M?VD5W:3QSV\RAXY8V#*ZGH01UH <T\*3+"TJ"5N50L,GZ"B2>*(,9)
M40*,G<P&!ZUXWXQO].ETWQ1<6DMO!/;ZU;+(]R^ZY:5'A!,?(,<8&<=<_-T%
M;ZZ1HNK_ !,\1BXM+2[MY=(M9<,H='),OSXZ$XQANOIUH ]'>1(XS)(ZH@&2
MS'  ^M<_X7U^[UN\UV"ZBMT&GW_V:(P,6#IY:."2>I^;MBO/?#.J P?#>WU>
M53IDVG2^6TQS&]TH4(&)XR%W;<]SQR*Z?X=FPBUKQG;6+0",:P76.%A@ Q1Y
M( [;LT =U)-%#M\V1$W':-S 9/I2B1#T=3QG@]JXCQE;:A)KB7FDG3[ZXMK!
MQ<:1?C"SP,W+1M_"V5P<@CIGM61I5_I9\;^&M2\M+"SO/"[B,7)"G >(A2QZ
MD+^G- 'IWF)L+[UVCDMGBN=\8>(KG0?#7]K:<EM<@3PQGS&)7:\BID;>I^;U
MKS;2-6L[#0?#_P!IEB701XBO4ONGEIEY?(\P=DW;3SQP*VO&-OH,7@;7WT28
M/#<ZE9RW#0S;H1*9XLA"#@' !./44 >HI+'(S*CJQ0X8 YVGT-4]4U>RT:"&
M:]F6-9IX[>,$\O([!5 '?DY^@)[5R6FV-GI/QAN[73[>&UAGT*.:6.%0H=Q.
MRAR!U;!QGK3OBA#:OI&C2W44+1QZU9;GE4$*AE&[)/0$=: .UDGAB"F25$#G
M"EF W'T%+)-'$,R2(@P3\S <#J:\NOI]$O\ Q;K^C:UJ=I8V4ME -/\ -6(1
MO;&/#>4SC P^[IZ#TX2/P]HU[X[T#3[J,ZC:OX<E0O> ;[A5DC",_3<<<C(R
M.#P10!ZB\\,8)>6-0,9W,!C/3\Z7S8_-\KS%\S&[9GG'KBO*'T#1I=3^)=O)
MIUJ\-O!"T4;("L1^R9W*.BG/.1S2V-G:6TGPNU.&*-+^\0"YN1_K)PUF20[=
M6&0.O3 Q0!Z79RWPGOS?M9B!)?\ 1S"S;A'M!_>9X#9STXQBK:RQN[(LBLZX
MW*#DC/3->-ZQ:6@\%_%.(0PB.._9T4*,*WDQ'(]#G-;\MKIVA?$;1Y[2!+=9
M]$NWNF@'SS;3&P+'JS<DY.30!Z(D\,DCQI*C2)]Y0P)7ZCM66NLKJNF:C)H,
M]K+<VS201O.Q\GS5'\17G:"<$CT->9:+>:8-?^'T]I/90VD\%TJQ>:'FV-%D
M"=\_,S,,D8X;(R>M(EKI(^&?Q"A$%F+F*\U,[ BAT57.SCJ .,?A0![ LPBM
M$ENI(4.T;V#83/L3VS4A= H8LH4XP2>#GI7GMI.)?B#HECJ2(]A)X?#6*R@%
M'GW#S, \%]FW\,^IKE[NQ5=":WD4'3;?QI#%IASCRX3*@98VZA0V\#'3!]*
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M^=*LL;NR+(C.H!*A@2 >E>+:D]G+I/Q4M'N+&?;#%<1I;J%CW_9QEU7)P=V
M3GK72V^GV.E_$3PB]A!%!)>Z5="Y>,8:?:(6!<]6.23DY- 'H@FB,QA$J&4#
M)3<-P'KBAYHHW1'E16<X168 L?;UKQS3;.RU[2=(TB>\TNXNK379+F>^DN8F
M-U&)7+#83O+."%VD8XSG %7+K^Q=7U3Q;HWB76(M-N%NAY2RB-7%L$0Q-"S#
M/!!.%Z,2>IH ]:HJO8J5T^V4O,Y$2@M,,.W Y;W]?>K% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M075E:WT0BN[:&XC!W!)HPXSZX-$ME:SVHM9K:&2W  $3Q@I@=.#Q3KFY@L[:
M2YN9DA@B4L\DC;54#J235&UU_3+RXGMX;AOM$$8E>"2)XY AZ,$8!B/< B@#
M%U[PO=3W-B^E6VC/96ZR*^F7UOB%F8C]X"H.' !'*GACZU/HWA"QM/M,UYI>
MD))<B,/;6EJ%A&S=@X(^9OG/S8'&!CCG*T#5[[Q;J%U<VNK7-E]AU66+[-]E
MS%-;QL%*MN4$,W)SG*YZ<5O^+_$D/A+PO>:S-$9C" L4(.#)(Q"JOXDC\,T
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M!EQD>_/% %6;2=-N;2.TGT^TEMHR"D+PJR*1TPI&!2S:7I]Q!%!-8VTD,/\
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MRHY&UF&#D D\'TKE_#/C2WMEU2W\0:R&G36[BR@>5 "$5PJ!MBA5STR<9.:
M.^HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNB8;:<8Z'D#VKT;PK:6-IH__ !+M.FL+6:5YDBGW"1MQR78-RI8Y.#STS@Y
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M %%%% !1110 4444 %%%% !1110 4444 <3\6HHW^&NJNZY,?E,I[@^:@X_
MG\ZNV_C15\1?V/JVE76E/+ ]Q:37#HR3HG+\J3M8#D@]JL^-]$NO$?@[4=*L
MFB6YG5?+,I(7*NK8) .,[<=*H7_AZZ\5:M:7FJ6QL(+2TN8$B$JO(TDZ!&;*
M\!0N<=R3R!CD 2V^(6GSZII5L8E$&JDK:S).CL&QN D0<IN'3KZ'!JU%XO\
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M)YM\P0L&0J O7GG/.* )-.ET:WO=2OM)TZ[CDLK8+- (&@\W=\PPDFWD!>O
M^8C/%5(/B();70KUM!OEL=9VQV\P>,GS64LJ;<YYVD;C@9]N:UYGUN[EG!TN
M&W@-LZD^>K23/T1>F HRQSGKCWSS,'A?6X?"W@G3C9QF?1+N&:ZQ,N"L:.IV
M'N3NSSCI0!J2^/UM--\03WNC7<5UH85[FV62-R4==RN&R 1C.>XQWJ:U\;"7
MQ%9:/?Z->V":E&SV%Q,R%9]J[F4A22AQR V#]#Q7->,-*U"TTOXCZG<6ZI::
MCI\8@82 M^ZC93N';.<C]<5T$>E7VN:AX:OKRT%K!I*-.1YBN9I6CV +C^$
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M\JDID2ND*+(_F.J@,^,;CZX'2GT %%%% !1110 4444 %%%% !1110 4444
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M3]*BC?4+R&V6618H_,?:7=C@*/4\]JL0PQ6\2Q0QK'&O15& *\LUGQ%=^(?
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M :HT:>7%Y=J(!VRS@$[FX]@,GCFN@HH Y?7],>'Q5HOB6)2R6:RVMV%&2(9
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MF))R<DMWJ/PYX3UK0T@L9_$SWFDV8Q:0-:A9 H^XLD@;YE7C@ 9P,\<5U]%
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M.FW$LL=O<QM%+Y1 9D8$$9(.,@]N:R8_!UM'I4.E_P!J:HUA#&D2VYF4 QJ
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M-V-WS;<[<]JJWL+>*/$5K:W6A74-KHUZ+H7=TJA)G52$\K#$GELDD ?+CJ>
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MCD@!5!ZG)' JU7CK:AJFJ?#+PEJ=_+%=75QKEG,N%*$L9SP3D]_0# [5U?\
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MNP,YY'.!B@#M:*BMIC<6L,QB>(R(KF.089,C.".Q%2T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M4R66."%Y97"1HI9F8X  Y)-<W%XT6>ZL(X- UF6"_2.6WNHX%:(QN0-[$-\@
M ()# '!Z=: .GHHHH ***R7\06Z>*H?#S07 N9;5[I9=H\LHK*I&<YSEAVH
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MM2\,7L_CK3_$MC?06QM[9[6XA>$L;B-CNP6##&#R.#S7444 <-<>!;^X\/\
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M' %4M#U'4O\ A,M/TW[9J!M+W1'G:2Y(+22J\8\Y%;)CR'/RD =/E&*VM.\
M:)I^G75@3>W=M<0-:^7>7<DHBA;JD>3\@Z=.>!SP*?:>!M*LKRRO8Y]1:[LX
M&MXII+QW;8<<')P0-HP,8[X- &7\-EU34] L->U+7;Z[DD2>)K=]@B.)F ;
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M9LGEJ01;+( V%P5SVXSDYSQB_:W^JP>)/!ES)JMS.FNV\OVNW<*(E(@$BE%
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MRT^WM9;J:[>*,(T\V-\A ^\V !DU9HHH **** "BBB@ HHHH **** "BBB@
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M?BEI4=I#Y0U'2KG[858YN"K1D,YSEF&X\GGF@#T&BO";/1+<?"/0_$5@9/\
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MTMNK/'CI@D9&*TJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXBT^\66Z>.&X1DC0DN0L0PQ#,.%XY)%7;'7=)U07)L-3L[H6K;9S#,K^4?\
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MW4!<UZ=10!Y+ID^G7VM_#7S?*D"Z--&XE7^,Q1* 0?4A@/7!Q5J+4K31M?\
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M...0,\]:ZR2#3-5\=>%M2\/FU>&P@N#>7%KMV+"T>U(V(XSN((4\C:37H%%
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MOHCO!XI\&^0\L=KJ6F7)DDDN"9KQ0D;++,!P'))(P21D\]J /5**\52!X/
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M[MF>V<#/Y5IW'_'M+_N'^5>2>'W>#PM\+)(Y'C,EP(9"K$!U,,IVGU&0#@T
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MXCY6E&1Q3I+=8/BS8V:/-]D?09\P-,S1\2QC(4G .#C(H [BBO,]$1X+[4O
M=P\TDT>H"ZCF>1B[6+'S VXG)P5,.<\9%-DMY?%E[XJLI=9@TZ[T^[\N%V1O
M-LXE1"DB$2* #R2<<\@DC  !Z=14%B6;3[9GF\]C$I,NS9YAP/FV]L]<=JGH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!_G^'_ &NE &A15*RU?3]1FDAM+N.66-5=T!^8*V=K8]#@X/0XJX2%!)(
M'))H 6BN*O?%GG>//#6G:7J<$ME>BX-Q$B EPL19&#?W<]QP<=:Z.+7])GOE
MLHM1MWN79T1 X^=D^\JGH2O.0.1CF@#2HK.M=>TF^@NIK74;:>*T8K</'(&$
M1'4-CH1Z&F3^(]&MX$GEU*W6%HA,)-_R^6>C$] IP<$\&@#4HHK.OM?TG3)3
M%?:A;P.JJSAWQL5C@%O[H)R 3@&@#1HKD_%'BJ'3-<T;11?QVC7\DGG7&5W0
MQI&S @,",E@HR01C-'A3Q+'>75]HEWJL-_J&G/LEN5C$7FYRWW>G"[<D<9SB
M@#:UW1H==TI[.5S&X=)H9E&3%*C!D<?1@.._([TU](MM2>RO-4LXFOK0EHF5
MV(C;H60\8S^>.#1!XCT6YEEBBU2T9X8_.<>:!B/^_P ]5_VAQ1I_B31-6NOL
MNGZK9W4_D^?Y<,H8^7G&[ [9QS[CUH !X<T@/?N+-0VH#%V=S?OQC'S<\\<?
M3CI52_\ #5O>:;::'%"D.C1/&\L0).]48,L0'9<JN?88 YR+/B7Q#9>%O#]W
MK%\Q\FW0L$'61NRCW)_+K6#J7BLVGC+1%&J6RZ%=V=U+*Q"A0T>P [S[N1@8
MH [2BJ%OK>EW>E+JEOJ%M)8-TN%D!0\XQGUSQCUXI^GZK8:M%))87<5PL;F.
M38V2C#JK#J#[&@"Y39(TFB>*5%>-U*LK#(8'J"*Q_%U_=Z5X1U;4K&58[FSM
M);A-Z;E8HI;!'H<5G:;-KMYH>CZB=7MO-O$@E:![4!7# .Z*=V0=N[!]J +U
MIX,\-V$EI);:+9QO9LSV["/F,GK@_@/ICBM6^L;74K.2SO8$GMY0 \;C(;G/
M\Q6==^+?#MC]I%UK5A$;9@DX:=?W;'. >>#P>/:IH_$>BS:HFF1:K9O>NGF+
M LREF7&<@=^#GZ<T /BT/38H+F'[(DJ72A)_/)E,J@8"L6)) !. >!DU#H?A
MC1/#44L>C:;;V2S$&3REY;'3)ZX&3@=LU#)XT\,0R1I)K^FJTLIA3_25^9QC
M*]>V1^=4Y-5U%/B?;Z0;A3ITNDRW7DB,9$BRQJ#NZ]&/''6@#H8+*VMI[F>"
M!(Y;EQ),ZC!D8*%!/X*!^%9:>$/#L>OMKJ:/:+J;'<;D1_-N_O>F[WZU:&O:
M2;Y;(:A;_:7<QJF\?,XZJ#T+#N.HI]KK.F7MS=6UK?V\T]H<7$<<@9HCZ,!T
M_&@!EIH.EV,EX]O9HC7I+7.26$Q/!+ GDXXR:I6W@KPU9M:M;:+:1M:,S0,J
M?-&3U(/4>WIVJX_B#2$L(KXZC;FVE!,<BON#@=2N.N.^*D.M:8-/AOQ?0-:3
MX\F5'#+)D9^7'WN >GI0!3_X1'0?[/;3_P"S8_L;2^<8-S;#)G.[&>N><^O-
M)J'A#P]JVH6]_J&D6MS=P*%2:5-S8'0'^]^.:@UO4KS4/"DE_P"$]0M9)R08
M9!'YZ28."F%/4GC/;G..HTKK6++38D_M*[@MY#'YC@MPH'WF/HH/<\4 5M:\
M)Z!XCE@EUC2;6\D@_P!6\J9*CTSW'MTK71$BC6.-%1% 5548  Z "B-UEC61
M&#(P#*1W!KD-?U;6+;Q[H.BV5[%#:ZG#</(7@#LAB52-IR.N[O0!#I7A4S>*
MO$]]JVFD6VI31-%F88DC6)4*R*K?,,@G!!&#71WOAO1=1OX+Z\TRVGN8$\N.
M1XP2$SG;[C/.#TK%\(^)-0U37O$6AZDMO)-HT\:"[MD*),LBE@"I)PRXP>:W
M8M>TF;45T^/4+=KMMVR(.,OM^]M]<=\=.] &+?:+>6=G%X=\/:5I]MHMQ"\5
MQ/YI5H W!*Q[3O)4G&3UQG@<[=[H>F:CI:Z9=V<<MBH4"W;.S"_=&.X&!^0K
M$\):W=W<7B1]8O(F33M6FMDE*K&J1(B$9_[Z/)-;5OK^D7<5W)#J-L4LQFY)
MD"^2,9R^?NC'.30 '0=-.HIJ)MR;U(O)6<R-O$?]W.>G?Z\]:K-X2T!](GTI
M]*MWL)W,DENX+*SDY+8/0YYR.:MVFMZ9?F<6U]"[6ZAIEW8,:D9#,#R 0"0>
MAQ2VFLZ;?221VUY%(\:"1U!P50YPV#_"<'!Z'% %)/!_A^+1DT>/2K=-/1Q(
M+=00I<'(8^IR!R?05;30]-35/[3%L#>F+R#.SLS&/^X23R.^/7GK19:YI>I7
M4EM9W\$TZ()&C1_FV'HP'=3ZCBI=4>>/2KN2VD6.=(69'9=P! ST[T ,TK1M
M-T.T^R:790VEON+>7$N!DUS=YX>N+_XF)JT]E(=/32S:+.D^QUD\S?D;6#!=
MN1_3'-.\&>--/U?1=%M[[6+.37;JRCGEMQ(JR,Q4,?E'3UQZ5OW.O:39WJ6=
MQJ%O%<.XC".X'SGD+GH&/8=30!%=^&-#OK*TL[G2[:2WM&WV\93 B/J,=/?U
M[U2N=,F\/PL_A+0=-:>[N0UT'E\A<$'Y\A3G!QQCN:T[[7=*TR7R[[4+>W;Y
M21(X&T,<*6_N@G@$XS3K_6M-TO'VZ]A@.TOAVY"CJQ]%'KTH AT_0[6T\/+I
M%Q'%<0NC"X#1C9,SDF0E>F&9F./>H;+PCX>TZXM;BSTBTBFM4*0R*GS(#C//
M7L*M7&O:1:-;+<:I9Q&Y4O 'F4>8H4L67GD8!.>E4CXU\,+8B];7M/%L93#Y
MAG4#>,9'U&1GZB@">Q\,Z-ILRRV>GQ0E&+QHN=D3'J43.U"<GE0.IJ:'1--@
MO[N^CM$%S> +<R$DF4 8 ;)P0!P/04^^U;3]-A66\NXH48%E+-]X#DD =0.Y
M[4U];TN.V@N3?0-#<+OA='W"1>I88Z@9&3T&: *NB^$] \.SSS:/I-K9RS_Z
MQHDP2,YQ[#V'%7]1TVSU:QDLK^!9[648DB?.UQZ'U'M4MM<PWEK%<VTJ2P3(
M)(Y$.5=2,@@]P17-^+_%,6AW&DV NXK>;4+M87D8C,,6UF+@'(_@VC((YH U
ME\/:6M[!>"UQ<P1>3%+YC;DC_N@YX'M4VF:18:/#)#I]LMO'(YD=5)P7/5N>
MY[GO6!H=[<6FI7Z:IXQL=1C@A$@@$4<301EB5DE93U(('11QG%:MKXJT"]O;
M>SM=8LIKFY3S(8DF4M(N,Y [\<_3F@!]]X<T;4]1BU"^TVVN+N)#&DLB G;G
M.T^HSS@]#5G3-+L=&L(['3;6*UM8_NQ1+@"H7U_28[X63ZA;K<-+Y(0N/]9C
M.S/3=CG;U]JR--U749?B)K>DSW"O96]G;3P1B,*4+F0')ZG[HH U9O#NE3WD
MUW+9JTL[H\WS-ME90 I=<[6(VC&0<8%#^'M*DO+J[:T!N+N/RKB3>P,B?W3S
MT]JTZY+Q-K]SHGB[PW%)?PVVE79NOM@E50,1PEP2YZ#./3I0!K+X6T58K&);
M!!'8-NM%#-B ^J<\?A7#CP+)=:A=/JW@_2;V\GN))3J<=\T*N&8E245=P(&!
MQG.,YYS77WGB+2M0\*W6HZ;XDL;2W*LB:EN21(7]P3@D?W35J?Q%HVGE8+W6
M+-)U@$S!Y55BG W[<\ DC\Z $L?#EC:R6-U*IN-1M+9;87CLWF,H !R<]"1D
MCN:CM/"'AVQUN36;71[2'49"2UPD>&R>I'8$\Y(Y.35R+6]+GTA=6BU"V?3W
M&5N1(-AYQU^O&/7BN7TSQ3)>^*_%-K)K%LFFV-K;R0RLBH+9G\S=O)YR-J\-
MC\,T =I-"EQ"\,@)1P58 D9!]Q63)X3T&71HM(?3(3I\+B2*#G$3#H5YRO?I
MCJ?6H[+7],L]+TQ-0\0V5Q/<6X=+EF2+[2 FYI%4' 7 )XX%7+/7M)U#3)-2
MM-2M9K&(L)+A91L3;][<>V/>@"J?!WATQ7<?]CVH2\"K<!4QYJJ %5L=0 !Q
MTXJQ_P (_I9O+6\-KFYM$,<$ID8M&IZ@'/ /?UI;?Q!I%U>BRBU*V-X>ELT@
M64C&<A#\Q&.<XZ5I$X&3TH X;Q;X.CGT:*RT72D<3:I!>W:>8 L@1PSD[CRS
M 8]^YKK+#3+2P,DMO 4EF"^8\CEY&QT!8DD@9.!G R<5%:^(='OIS#;:E;22
M>69@%D'S1@X+K_>4'N.*KQ^+_#DTUK#%KE@\ETYC@59U/F,"5PO//((]R* +
M^H:99ZI%%'>0B412"6,[BI1P" RD$$'D\CUJK<>&]'N]*DTRXL(I;.5_-D1\
MDL^<[RQ.2V1][.:A\1Z[:Z5IMX/[1@M;Q;=I8_,&[9P<,P[#(QD\9I?!^H7.
MK>#-$U&\D$EU=64,TKA0NYF0$G X')H 1?"'AY%N%32;9?M,0@F*K@O&/X2>
MN#DY'?)SFIO^$;T@/8/]C7=IXVVAWM^X&,87GCCCZ<=*;J5XD>LZ3;#6X+.2
M21B;-E5GO%V'Y5R<K@_-D>F*8WC#PVLXA;7M.$AE:$#[2OWU 9EZ]0",_6@"
MY8Z-I^F7%S/9VPBENGWSL&),C?WFR>3[U8N[2WO[.:SNX4FMYT,<D;C(92,$
M&LZT\5:!?2O':ZS8S.D!N6"3J=L0.-YY^[[TY?$VAM!=S?VI:B.TP;@M(%\D
M'H6ST![$\&@"\;*V:\BO#!&;B&-HHY,<JC%2P'L2J_E4"Z-IZZPVK"V47[1^
M49]QW%.NWKTSSCIGFE&KZ<T%I,+V Q7A"VSAQB8D9 4]\CGBHY->TF*^6SDU
M"W6X:3R@A<<R==F>F[_9Z^U %1?!OAU+9+:/2;>.%)_M*H@*A9<Y#C'<'IZ9
MXQ5AO#NE-=7=R;0&>[C\JXDWMNE0=%8YY'M[U)J&N:7I1Q?W\%N=N\^8^-JY
MQN/HN>,GBDOM>TG3"!>ZA;P_N_-.Y^B=-Y]%_P!H\4 0IX6T6-;!4L$4:?G[
M( S?N,\?)SQQQQVXJS8Z-I^FW-S<6=L(IKIM\[AB3(WJV3R?>N;UGQ.^C^.-
M-BN]4MH-#GTZ>XD,@55#(T84[SZ[^ /UH\8>)WB\!2:]X;U.WD42PA)XPLJL
MK2JC =@?F/Y4 ='J>BZ=K*PKJ-JMPL,@EC5R<*XZ,,'J.Q[4G]B:<=4BU,V^
M;Z*/RDG9V+A/[N<].^.YYI=1UK3-(7=J%]#;#;N/F-C"]V/H/<\5=CD26-9(
MW5XW 964Y# ]"#0!$+*V%^;X0)]J,0A,V/FV DA<^F2367J7A#P[K&JPZGJ&
MCVES>PXV321Y/'3/KCWS4E[>(GB+3;8:W;VS%96?3V53)<C;PP).Y0N"<@<U
M&?&'AL/$G]NZ>6EF,$>+A3ND&!M'/7) ^O% &W1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$_
M%:*1_ <\J F.WN;:XF [QI,I;\ .?PKHM8U_2M%^S+JEP(([MC'&[1L4)QG#
M, 0OXXS6C-#%<P203QK)%(I1T<9#*1@@CTQ4&GV?]GV:6BRO)%$-L1D.65!T
M4GOCID\XQG)Y(!S_ (-T>+3+G7)[&$V^E7MX)[2#84 _=J'=5/W59@<#VR."
M*I_#"*1?#VI7!SY%WK%[/;_]<S*0"/8D$_C77WENUU:O LSPAQM9X_O =\'L
M??M2VMK!8VD-I:Q+%;PH(XXT& J@8 % '(?$1$!\+W,\>ZTMM<AEN7*;DB3R
MY1N;T4$KR>!D5SVOZ2^J2^.]4T:'S+*\T-;<-",K=W"AR63'W\*57(ZDXZ@U
MZM10!YE!K5EJGC7P1<61FF@73[N-I%@?:&*Q<$XXQCGT[TSP?//IVKZ196&H
M)JOA^2VD>(7" 76DJ%!".PZJ>%^8 \#L*]0HH \41K=_AKIT$@1L>* [1LO2
M/[8S$D?W=ASGI@UJ^(X;C4/$GC:UT@A[JYT&!(EC/^N=3)N0'N=I _X$*]6H
MH \SL;[PIXD_XF<%KJ]Q>V=C.EPDQF5K6-D(>,[L*6)& !GU'2JEBTD,&H:1
M>ZA_PD'AS^Q)RE[%'B[M8OE!A<KP6*\C@-E#D<5ZO10!PG@RXU./Q!<Z=<:C
M;ZY81V:/;ZLB!95&X@0RD?*S8R<\'J3UK4^(EKJ-[\/=;MM)5WO)+8A$C^\Z
MY&Y1[E=P_&NGHH \RG\0:5K?C/P)>:8LCQ1?:U=4MWS!N@ "-Q\I!P,=OI6'
M;:K#<CP?<I;W%FEMK4@ETV&T?;9%EF^5CM+%R3D\X.> *]IHH \[U?3+W3_&
ML^GV,3'3/%4?^DE#@6\L>!*_MOAXS_> JOXRWV.K:G>Z+J4<-_'9)'<:1=Q;
MX-2B ;:B#J'^9E^7U (YKL=)T*ZLM0GOM1U>?4YSO2W,L21BWB9@Q0!0,GA<
MD_W1TK;H CMY'EMHI)8C%(Z!FC)R4)'(_"O*?'-ZD[^.=-2WEM+DZ<A7R;9G
M?4!Y1(8M@@(F2O&#D')[5ZU10!YS?:A;2^*/AY/YI6-8[EG9U*[ ;?:I;/W0
M3P,]>U4-3AO9[[XEZ5913?VC?1Q26J"-OWJ?9E4X;&.2&7KUXKU6B@#SSP_J
M?A;7]3LM7MX]1.H6$$BS&\,R"Q5EPZ/OPI.0!CGU'2KGPF@@C^&VB;842XC@
M:.7Y,.K;B2#W'8_E7;T4 <G\3K>:Z^&FOPV\3RRM:DA$7).""<#Z"LJ^U"PU
M+XD>#[R)U> 65X5>1"NTMY>T_,.,X;'K@XKT&B@#Q99Y+71[C4(HKF;3[#Q?
M=7-W':9\P6[[PLBA>2H+!N/3/:N^\(#0;N\U/6="2[E6]\KS[V<RXG9 0 HD
M_NC ) QSCD@XZNB@#F_B!(B?#[Q K, TNGSQQKW=VC8!0.Y)[5S>AR^$['P]
MX>OE2$ZM:6\1CA@'[YYFB\LH0.<DN0<]#R>E>D44 >:J]I_PD_Q(>0Q?O+2!
M S8^?$#*P![X. 0.^!6?:/;PZ#\*PI1'@DB\X 8,?^C,K[O3YR <]S7K5!S@
MXZ]J /'(QI5WX3^(FER10S:C=:M?)!;A0999#CRMHZG#]QTY/'-;<4-S:_$#
M1[.2Y7[=%X7DMFF)R//WQ8R?4[2<>@KJ_#7A^70/[3$EZER+^^EO3B'R]C/C
M*_>.1QQ6[0!XZJ/J?PBL?#$:M#XHMIX(A;,/WT,Z3@M-Z[=NY]_0@]>:Z/Q1
M:ZEH_B^WU'18V/\ ;\?]F76S_EE, 6BN,=]J^8#[ 5W]8EIH5TFNS:C?ZO/?
M1AV:SMGB1$M=PP<%1ECC(!/0$^IH Y+Q!-:>%/&6F3:@+VV\/'2A8P7%KYA6
MWE5\[7V<@,NWGU7VXSKM=-\+W'AS4H+/4[7PJ%NXV=#-O@>5D9967[ZJVUOI
MNZ#.*]9HH Y[P?;:3#IMU/HMO<1V=Y=O<^9.7S.[ ;I 'Y )'MG&1P<GGO&V
M^WUZ6^TO64T_5X=.7=;7D8>VOX=\A$1'7<"&^Z<_...:]"HH I:/++/HEA-/
M:FTFDMHV>V/6%BH)3\#Q^%<+XRCM+_XH>%+:>:1(EMKU)GAF:,Q%T7;EU(*D
MX..>:]'HH \X\*F?P[:ZGX)N52WU&-7?3[\1[%OE<'8[,!@R@\-GDXSS5#PA
M/H6K6OA_3;NSU7_A(=',8:SF,RBUD1=K.3]S9C..><@=:]6HH \=D:X?P_XK
MGLHIKH6_BH7TUO;D^9-;JT18ICK]TD$?W:O:C>^&K[0==\1:/I=[K3M8+!<M
M<^?L==XPA5L%MN68[>0!C(S7JE% 'DIN[*[\6Z])>3WU_87GAD!YH[5H_,4-
M*7$>%X&#QG)R<9)J.X3Q#<Z-K^BV=]#XAB_LD/::C$H68C?S;2%>&8KNQT/7
M(YKUZB@#@_#-]X:\2:Y9ZMIL6IS:E;0/'(UT9E^R*W6-MWRELXX&>A/:NSU%
M&DTR[1%+,T+@ =2<&K-% 'C^G6=MJW@+P3I-A&G]LV%U:2RHJ;9+,QG,S2#J
MG (YQN)'6G6[Z3,-8\*>*+;59-2DU&>:*U0S!+U6E,D3HR?* ,J,DC;MYZ5Z
M]10!YC;ZII^FZWXJ\/>*;*>9]3OC<6J?9GE6]A:-%5%(!R5V8P<8_.K^G7:Z
M%\0/$ UT):6VH6MJUC)*?W12-"KPANF0Q)V]3NSBN_HH \<TO3Y-*M?A[:Z@
MAC\O4[J9(IAS!"RRF(,#]W[R=>AP.U7I3:%OBH1Y69XL1\#]Y_HH7Y?[WSY'
M'?WKU6B@#R*#5;?1=1T#4-:DOHM(NM MK:.[MS(5AN$)+H^SD%LCKW7':KEQ
MIFGZ=:Z,/#NI3>&KFW@N'L&O@6AFB>169)1)R-Q"L!D,!VXP/4:* ,;PG=7-
M[X3TNXN[!;"=[==]LH(6/M@ \@8Y /(!K!\=7$46O>#@\BCR]6$C_P"PGE2+
MN/H,D#)]:[>B@#@6N;9/BIK4KRQB(Z#$A<GY2PDD)&?4 @X]#7,::;>W\"?#
M1 $CE@U.%IEQAH_DD#EO3DC)/J*]EHH \7UG4HKF"39;SV36GBF&6>QAM7.T
M"X&9Y&VDDM]X;2!@X .,UU=GJ-M:_$[Q+>S.5@32;9R=AS\AE9P!C)(!&1UY
MKO::ZED90Q0D8#+C(]QGB@"GH^KV6O:3;ZGI\ADM9P2C,I4\$@@@\@@@C\*Y
M;QGY,'C'P;?WBA;"VN+GSIY%_=Q%H2$+-T7YL8)[UV-I:0V5LL$"E44D\G))
M))))[DDDD^IJ:@#R/7+!5T'XDZG:1A=.U2&-+157 GE6,AW0=]S$#(^\5)YZ
MULB>TE^)?AJ<O$R)HDP$AP0K%H\#/8D!OUKT.B@#Q2TN7L=)TO4#'))I%AXI
MNYKU(D+>7&SR>5*5'.P%@V?H:WK?4K&Z\8>-;N!B]K<:1;[)Q$WER%5E!PV,
M'JH]^U>FT4 >1::UNUE\*$FV$VZ'S5<?ZHBV*C=_=._ Y[TS45MKC0?B3$9Y
M(HVU*.XC:&,R9(6$AMH^\N]<,1VW5[!65X@T9M<TY+:._GLI8YHYXIH0IPZ'
M<NY6!##('!]* .2\-:UHNO>/I-575K0ZB^G+9QV40D&Y5<NSYD523S@ #@ ^
MO';:M)Y.C7THM6N]EO(WV=>LV%/R#W/3\:HV&CWRW$-QJ^J_VA);L6A"6RPH
MC%2I; )).UF'7')XK:H \AT74K>;Q-X%O$>7[.MA<P&*.T=(;0[(L1 E<_+@
M@EF/W<\"J2FV3X4NJ!%G_P"$B\[:%P^/MNX-CK]SG/I[5[710!Y@FJPZ9K?C
M>QUG>L^HCSK"0QEENH/("JB$ YVD'(_VB?6NI^'C;OAUX>4I(C1V$,;*Z%2&
M" '@CUKIJ* .)\8R1IXS\$EF \N^F9C_ '5,#J"?0%B!]:K^"VT_^U_&<\OD
M9&KM,LC@?<$2 .">V=XS]:[ZB@#Q[2[.7_A1&F2:?9/-=6;Q2W-O NV9XTN!
M)(@[Y(&<=^*ZGP[_ ,(MXEU2YU33(KV\>:Q-G=7%UYP7RRV?)(? )Y8\9QW/
M(SW%% '!>!;/48F.D:C')Y7AN22TMIGZ3A@#&X]UA8+_ ,#/I7,QI+<_""]\
M)7:-_P )1'-)%]F/$LDYG+K,O<J<AMXX'//%>QT4 >91:I::'XJ\2Z3XLAFE
MCU80M;2_9GE2[C\D1M$ H/(8-\O^T3WJ#Q%=PK=:WI2:?)I<S>'T2%8;<RR7
M8V28B! *A4S@X&3NSD 5ZI10!Y5IMS:Q:OX!U.]'DV4>AR0?:;F,HB3;8@ 6
M8 *3AL9ZX.*H:SIYLO 7B^XAA,-EJ6M13V, 0@LHDAW.J]<,5=NG09Z5[)10
M!YCJVI:=IOCG5U\1/?)I>KVL L;FW\UHI5"LKQ'R\\Y8D#ON/KSWGA^SM]/\
M/V-I9VLMK;11!88)F+/&G8-G)SC'!Z=*TJ* .)\22Q+\3O!A9E'EI>[R?X=T
M:A<GMD@@>N*XN_-NWPT\="-4,TVO321A5^>0&=&1@.I& 2"/0U[510 V.1)8
MUDC=71AE64Y!'J*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% %/5-4L]&T^2^OY?*MXRH+8))+$
M*H ')))  ]ZIVWB?3)_[2$DK6KZ8 UXERNPPJ5W!B>A! )R">AJMXUDU.+PW
M(^E6;7<XFBWHD:R2+'O&]D5N"X'(SW&>U<'>^'=8U23QM;V.F:A!_:=I926<
MUZX/F-%N)5F+$@L<#'8'G% 'H=MXITRXU)]/=Y;:Z6V^UA+J(Q;H<X+C/8'J
M#@CN*2U\5Z5=ZE:6"O-'+>Q--9F6%D6Y1<%BA/7 (.#@X.>E8-Q<:EXW\,ZE
M8C0;S2+F?3YK=YK]%3$CK@(A!)9<\EN!@#J3P_0K_5=<TB#2[SP]>Z7>0VK0
M7-U<HH2-MA7,+ Y;)P>., Y.<9 -@>,-',EKF:5;>[F^SV]VT3"&63) 4/TY
M(.">#V)J(^-]%_MF724:\DO(;B.VE1+.4^6\@RI8[>%/'S'CGK7'IHVIZG\,
M]/\ !=QIUS;:G;2V\$DQC/DI'%*K&99/NG*+P =V3C YKH-$L[L^,_&DC6]S
M;Q7S6_V:X>(JK[8 C$'V;\^U %#QQXH5]*L9-)N[Z,'5K>W%S;JRQ2GSE5TW
MCJ,;AGH<$9/2NDO_ !CH^G3723RR^79RQPW4R1%HX'DQM#$>NY>F<9&<5YXM
MOK:?#C3/#,OAW43J6EWUJ)#%$#%*D<ZMYB/D @J/J#G.!S4_B^UU[6-.\563
MZ%J+3&:)[%;956&2(>62S$,/,DX((.[&%P!R: .ZOO&6DV&J7.F/]LEOK>$3
MO!!9R2,4)(!4!?F'!Y' ]:L1^)]*N-,T^_MIVN(]17-HD2$O-QDX7J, <YQC
MOBL.T^T_\+-O=5ET^]BM)-&AA#M 3^\61W*?+GG##IQVKD]#L->\.Z-X,U8Z
M+?7(TR"ZL[^QCC_?QK*P8.BG&[&T9P>A^N #T6T\5Z3?:>+RWF=Q]I:T\D1M
MYOGKG='LQG<,$GM@$YQS5C1]>L=<6Y%H[B6TE,-Q!*A22)^N&!]CD'H>QKC_
M !-#JE];:/X@@\.23165\\TNE,JB>6%XRA<KDCS 26"YSC&<'(KH_"\=N\=U
M?6WAXZ,ER5RLT*Q3S%0?F<*3@<X&3G@^U $[>)].74M1T_\ TDW6GPBXGC%N
MY/EG."O'S9P?NYZ&EM?$VFWNGZ9?6S326^IN$M6$+9?*ELD8R!A2<GTK%\4Z
M-JDGB?2-5T8$2S1R:;?.#@I;N-XD^J,IQ[MCO47@OPY?:'J=_8SQ[=)TV>0:
M1SG,<V)&'/\ <.4!]VH CN_&%AH?A;Q#K5A+J6I&WOY(GCN5?]S.0HV , 5C
M4D<>YQG-)J>O267Q%TEVGU$65QIERYL1$Y+2*\8&(@,EL$]NG/ K$O-%U6\\
M#>.[.'3;K[3>:M)=VT3QE3-'F(@KGUV-QU_.NAE:ZO/B-HFJ_P!FWT-HFFW$
M4C20']VSNA4-C."0I/MT.#Q0!TVBZU9>(-+CU'3Y&>!RR_.A1E925964\@@@
MC%<9?>(X%^(5_HFOZK=Z3&8XCI#))Y,4X*_.V_HSASC:W' XR36K\/;6ZL](
MU**[M9[=WU6[G19HRI:-Y2RD9]0:36_L>L2:KI'B;P]<W>FK(OV25+1IA(IC
M0G;L!9&#%QGCV/6@#4LKF?1=&MH=8NY+R^>5XD=4!DN#N8KA5&,[!DXP  >@
M%);>+M'N;&>Z6=T^SW'V26%XF$J39 $>S&2QR,8SG/%>?0^'=?T7PQX:NY]-
MN-6CTJZN/,TUV5YQ:29$??#.@V\9[X[5HZMIUW/I=EKV@>%7LWL]4BOGL&C2
M*XNT5'1R0#C=A_E!.?E]P* -S7?B#8:9X>UR^MX+B6]TH*DUH\1#1NXRA?\
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M['D'VKG=9O;^U^(OABTBOI18WL=WYUMM7:3'&I4YQN_B/?'2E^&EG=:=\/\
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M,5O#'##&L<4:A$1!@*!P !V%/HH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** &31":"2)F=0ZE2R,589&,@CH?>L[0M!M?#]F;>W
MFNKAW(,EQ>3M-+)@8&6;L!P!T%:E% $26T,=Q).J#S9  SGDD#H/8<GCIR?4
MU+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !169K^M1:%I37;IYLKR)
M!;P@X,LKL%1,]LDCGL,GM4-Q/<07^D6TNMV<,\DCF:W:-=UV-I.V,%LJ%//<
MX'- &S15&WUK2KN.XDMM3LIDMB1.T<ZL(B.NX@_+^-4+K7DL=3TPO-%-IFJN
M(+>>,@A)BI91D<,KA3@]B .=PP ;M%%% !1139)$AC:25U1%&69C@ >I- #J
M*S;;Q%HMY*T=KJ]C,ZPF<K'<(Q$8.-_!^[GOTI$UO3+VTO'LM6LB;=<2RB56
M$)(X+<\#OSC- &G16-8:Q9V^EZ:-0UVPN+BXA#+<*Z1K<X7+.BYZ8!/&1B@^
M+O#8L4OCK^F"T>0Q+-]K387'50<XSSTH V:*Y'4O$TNE>/H+*^O[2WT5M*EN
MV>4!-KK)&H)<G&/F/IU[UO)KND/!:3KJED8;Q@ELXN%VSL3@!#GYCGL* -"B
MJ+:SI:-=*^I6:M9@&Y!G4>0#TW\_+G!Z^E11>(]$F68Q:O8R"$(9-EPIV;QE
M,\\;NWK0!IT5235]-DL6ODU"U:T5MIG$JE V<8W9QG/&/6HE\0:,UBMZ-6LC
M:M)Y0F\]=I?.-N<_>SQCK0!I45DGQ3X?$=W(=;T[99D+<M]J3$)/ #<\<\<U
M;_M73_[.34/MUM]BD 9+CS5\M@>F&S@YH MT5G+K^C/9Q7:ZK9&VFD\J.43K
MM=\XV@YY;/&.M1?\)1H1L;Z]35[*6WL,_:GBF5Q$?1L$X/MWH UJ*S=!UNS\
M1:+:ZG92H\4\2.55PQC+*&VMCHPR,BK=U>6UC#YUW<1019 WR.%&3T'/>@">
MBLB^\2:7:>'KG6DO;::T@C=@Z3+M=E!^0'.-V1C'K69X3U#4];AL]7_M>SN[
M"YLT>>VC12UO<$*VU67^$!B"&R>G/- '545BZWXITKP_>:=:W]U%%-?2^7&'
M<*  "2Q)Z 8Q]2!6+8^,$M?$_B6UUW5K"WL;*6V2TDD985/F1[\9)^8_CVZ"
M@#M**J7NJ6&G0+/>WMO;Q-]UY9 H/&>,]>.:GM[B&ZMX[BWFCFAD4,DD;!E8
M'H01P10!)17.>)?$DNEZCI6BZ=%'-JVJR,L ESY<2(-SR/CD@#H,C)XR*EN%
M\1V36CQ75M?1/<1I<J;8HZ(6 9DPQ''H0>,G/'(!O45R>E:]?>*]0U0:5-%:
M:9I]RUG]H:+S)+B9<;RH) 5!D#N3[=W:5XBO;G7-5\,7S01:Q91+/#.D9\NX
MA;H^PG((/RD9Z]#SP =517F^D^+?$U]\+E\9--I)=+>6YDM&MG166-F!4/YA
MP2%X)!Y/2KVN^+M372/".I:3]G@CUZ[MK=H[N!I&B69"V>&7D8QB@#NJ*Y#3
M/$NI)\0+GPGJ:VMPPL!?P7=K&T>%W["CJ6;!SR"#T[58\=^)[CPMX?-[96AN
M[O=N$(_YY)\\K'V"!N?4B@#IZ*@L[N"_L;>\MI!);W$:RQN.C*PR#^1IUQ<P
M6=N]Q<SQP0H,O)*X55'J2>!0!+16;;>(=%O;XV-KJUC/=B,2F".X5GV$9#;0
M<XP0<^XH@\0Z+=7<5I;ZO8RW,I<1Q1W",SE/O  'G'?TH TJ*S[?7M(NYI8;
M?5+.66%/,D1)U)5/[QYZ>_2HH_$V@S7%M;Q:UI[S70)@C6Y0M* 2"5&>>0>G
MH: -6BLRWU[2=1L[N;3]7L9DM\K+-',KK"V/XL'C\:BTK5;86&F07>N6-[>W
M,0,<L;(GVH@9+1H"<C@GC- &Q16<^OZ-%;7%R^K6*P6S[)Y#<)MB;^ZQSP?8
MTP^)="$MW$=9T\262[KE3<IF$9QE^?EYXYH U**HQZSI<NFQZE'J-J]C)PEP
MLJE'.<8#9P3GBI[2]M=0MQ<6=S#<0DE1)$X9<@X(R/0\4 3T45C0:C%'JFKO
M<:[8R6MN(LVX*JUGP0?,;=_$1D9 QCO0!LT5Q7A'7M0\61V.M6FJV9LY#+]K
MT[:K-$F6$1##Y@WRC.[(.3@"NONKRVL8#/=W$4$0(&^5PHR3@#)[DT 345G?
MV_HXT\WYU6R%F',9G,ZA PX*YSC.>W6B+Q!HTSWB1:M8NUE_Q]!;A#Y'^_S\
MO0]?2@#1HJB-;TEM/34!J=D;)V"K<"X7RV8G  ;."<\5>H **KWM_9Z;;-<W
MUU!;0+P9)I BC\34-GK>E:C>7%I9:E:7-S;'$\,,RN\9Z?, <B@"]15"UUO2
MKZY-M::E:3SA2_EQS*S;0<$X!Z \9]:KZ3?*]OJ%Q-K5G?01W4F)8=JK;H #
MY;$$@E1U)QUZ"@#7HKC[+Q0]_P#$HZ1::A:7.F?V2UUMA ++*)47YFR>S9'3
MKWZUTFK2W$&D7DUJZ)/'"[QM(FY00,\C(S^= %RBN6\'^+;/6=$T:.[U2R;6
M[JQBN);995$A+(&)V9R!WZ=*V[;6])O(;B:UU.RGBMB1.\5PK+$1UW$'Y?QH
M O45'!<0W5O'/;S1S0R*&22-@RL#W!'!%8\OBK2QXF/AQ+V!=1^S^;AV&%)(
M"KC(RQR3@'.![T ;E%<;X+\81:EH=B-:U2Q75[J>XCCAWK&TH29T&U,YZ+[]
M*Z2\UK2].F2&]U&TMI7("I-,JDY.!U/<\#UH O4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$_$
M:.3/A2XY^SP>(;5IO10=RJ3[;F7\Z;XQEMXO'/@@R/&KK>SDEB 0I@<#\"Q
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MUVSGDN+@G9</YB>8R @?+M') P<'TK4O&MY/'OBNWLS&S3^'(U6.(CYW!EX
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M(*L>"P((8=1Q4FE1)?\ Q(U;QF76+1[?34TZ"XD.U)SOWNZD]5!PH;H>V:]
M(!&",T4 >#^'K3PM=?!"VMM1O"-22"5DMH[EVE\X.Y0" $[CG;P5P:VO$-U>
MS>$_AW'XD<6^J-J]I)=H&\IT4+("QVX*<%<D8P3VKUZB@#SCP^\'@CQ??:7J
MCJ\&K,;G3]8G;<\P[P2RGDE<_*2>0?7BM6W8^*M>U*]L-2M?LUHITY4,0F#
MX:1OO# 8X7W\O-=E10!YY\+]02PAU+P;/=I-<:+<M%;/N_UUN?F0CU*Y*D#.
M, 5TWC55?P)X@#*&']FW!P1G_EFU;M9VO:;)K.@7^F17"V[7EN\!E:/?M#J5
M)QD9.#ZT ><06FF:G:_#MM$%L=0M)(IKAX,;HK?R3YWF8Z9;:.>I/UIFD6$>
MI>!_'(T>*"353J.I?9GC ,@WE@NP]1N7(!'7->FZ+82:7HMEI\LR3O;0)#YJ
MQ[ X4  XR<=/6KU 'G'AS4_"GB/4]+U.VN+R;4-/@D62*8%%L49,.LHVA<9
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M(((R#V-:3+N4KDC(QD'!%<8NL+X?T"ZUR#P=<6<$DJF2UAAB2XV '=+(%.,
M=!DGCWX[,L I;!P!G@<T ><>#_&-OINC>3JUQJ%PSZO<6@NY$>5(R9V2-7D/
M [ >F1G (KI1JNE1^+]21[V]2ZM=/66XAE+K;QQ!F/F*",%NN6&>!CM7$OI&
MK-\-KS31I5Y]MDUPW2P^7R8OM8EW9Z?<'K[5OW5M>-X]UG4%TF>YM)=!6VC#
MIA)I5>1C&<],A@.>.M '3Z?KD&H7*0+;74+20?:(VFC 62/(&003ZC@X(SR!
M4^HZG!IJP>:'>6XE$,$48&Z5\%L#) ^ZK'D@8!KC_!^CWNCZ^8M.?4D\-M9D
M_8]2!+6D^Y<)$S<E=N[(!*C P3FMCQGIMKJNG6=I>6%W<P&Z#&:S)$UH0C%9
MEV\Y!P.,_>Z&@!UWXUTBPM[66]%W;_:;IK2-7MG)\U<Y4X!&?E./7MFDTWQO
MHFHP:G(TLUFVEC=>17L+0R0J1D,5;G! XKB-276=.TGPL-7DN;YH?%*"VDDC
M N);<1R[&=>/GQGW(QQGBK?BCPAJ7BN;Q-J%A&UJUSI]O:VBSJ8S</%+YQ+
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MA)7+@EB1AAD@@\_6@#T2\\0VNF0$/%<W,L%NMQ.EO'O:.,Y^9N>^UL 9)P<
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M;TZ^CM+FWCFW1*LF")]^ ?+VDL>,\5!/\09X=!\47D5G:7<V@N QAN2(IT9
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M(SC:,Y)'..:SM2\?W6E:=XD%QIT)U/05CEEA$Q$=Q"XRKHVW(/4$$<$=3UH
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M=)=_9V6&.5I@F\H9AA-I&1G&>G.<\  Z'6?#]MKDMA)<SW$9L+A;J 1,H E
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M6%%E+SN I=8RJ$#&[ SU(/ X) .THJ*VG%S:PSJCH)4#A9%VLN1G!'8^U2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!E>)- L_%'A^\T:_#?9[E-I9?O(0<JP]P0#^%4M-@\66UI
M'97DVEW!C4(-0#.'<#C<T.W&[U^?&?RKHJ* .5E\-W]AXM'B#29H9GGLUM+R
MWNY"GF[#E) ZJ<,,D$;<$'M6=-X&NX[+3DM9[9KB/7/[;O))"RB20EB44 '
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTR2^7=LA2,3LA('EGY4 '?) )X/% 'I-1R7$,4D4<DL:22DK&K, 7(&2 ._
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M0Z;<*" 2,,>G..UAOB"'-E=6M@+K3KJZ%ONAD9IT4L5$IC"8V9&?O9 (/J
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M64@NMY8IMW)( OR??!R"U'P]UC5==\,B_P!52W#O<7 5XI"V=L\B[=I48"@
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MF@":\MVUCP_<6S*UNUY:M&0XR8RZ8Y'J,UR,/A3Q -/\(6\[:86T*5&DV2R
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M$;I"BE5#\],,<XQ4EWX%L]1NO$+W]S)-!KD<4<\(4+Y?EC"%#U!'7G/('TH
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M[[SMH..?G[G/''%:5SX2BO\ Q!=:I?7/G)=::=,GMO+PC1$ECSG(.6/?I^=
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MK/[#,\<2$3PY#8PP(5LC.1Z]*I1?#V.#PW8:)'J]R8;._%_&[QJQWB0R!?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *]_86NIV$]C?0)/:SH4EB<9#*>U4(?"^C6]S:7,-GY<UI&8X'6
M1P8U/W@.>_?U[UJNZ1HSNRJBC)9C@ 4B3122/&DJ,\>-ZA@2N>F1VH QF\'Z
M"^GSV#6&;2>?[3+$97*O+G.\_-R<X/U -33^&M)NIYIIK9G:=56<&9]LP48
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M\]:[*.6.:,21.KH>C*<@_C3?M-OYB1^?%O?(5=XRV.N!WQ0!E"/Q*J@"?2<
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MD0MDG./0<5OPW,%P&,,\<@0[6*.#M/H<4 0V6FVFG"7[-$5:9M\LCNSO(<
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M5TS64U)YM#ECF@A\GR/+ W(TBHHPX/"YYX/H<>CV]A9V@86UI!"& 5O+C"Y
M& #CT'%1PZ1IMO;RV\&G6D4$IW21I"JJY]2 ,&@#D_!,'A_P_P" ]%UJ46=E
M)<Z99I<7CD*9"44*&8]>6P/P':NXJM_9UC]D^R?8[?[-D-Y/E+LR#D'&,9R,
MU9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX@0A!C SGKNS3;^VN+W5?B'')JVJI'800S6B17LB"%S;E\C:0<;N=OW?4=,
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MRE@/+SM&TJ,$ 'U)J;^T;W5_AMKWBC^T+NUUFRFNY8]D[!;<PNVV(QYVD%5
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MO@@SZ NARZ-H[Z<LIF2)KNX)C<DDLK$;E.23P1U/K6II.E:OH=@MEIUCI$,
M);'GS,6)ZEF*DL?<DUT5O<07<*S6TT<T3?=>-@RGZ$5D>)_$D?AVUM0L!NKZ
M^N%M;.U#;?-D;U/.U0.2<<"@#-U3P]J&KW<-Y=6&EB\@!6*Y@NYX954]5WH
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M+IC#=W"'S0,!@5 (X],5+<^%KJ]TJZTR[TG1KBUNW\V<37$SM(^  Q<C=D
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MBA?,('9<<_6NC@\/WEM"L,'B&_BB085([>U51] (JD.C:B1@^)M2Q_UQMO\
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MQRPO',B/$RD.K@$$=P0>U<[IOAG4[*W;S?%%^]U,_FW$D=O;JKR$ $@&,D#
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M=-=M&T\\!4D,D7G^6>PW%AQWW>]=CI]K9:;\9+BVL(8+:.70(Y'BA4(&83L
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8XW!>64)D \<#). ._  .LM?&.C74>J,99[<Z8H>Z2YMWB=$8$JVU@"00#C
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MT#KADA0>5'QZ$ O_ ,#KF=';5K;X(6]OIU@+C5;.+[+):LBNRM'+LDPK<%@
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MOV2;3/$>N66I^#[C6[35+HW5G=10HZ$.J@Q2[R-@!'4]C0!Z8CI)&LD;!D8
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M+&XCGFPT3*[!D!"D$$QL-WH>G/'?*S^2&= )-N616SSZ G&?TH 5'20$HRL
M2"0<\CJ*=7"Z5XMTJP\//>0:7%IJS:S+9&*24(GG[V#.[@$*"5/KS@5UNFW=
MS=PRF[LQ:R1RE-HDWJXP"&5L#(.?2@"[17)RZ[JP^)B:&EO;?V>NF&Z+&8AC
MF55+$;>HP0!GG).>PKI\1+.2XTN2."*:PU*X6WAE@N0\R%L['>(#Y4..NXXR
M,@=@#M*R(_#T$?BB7Q +FY-U+;BV9"5\ORPQ8#&W/!).<YYK$L?&NH:E<7JV
MOABZ>"QO)K2YE-U$"AC0," 3SDG'!XR.O(%>W^(DTUAH&HMX?N%L-9=8876X
M1G$K*S*NWC@[2-Q(QZ8YH [DD*"20 .230K*ZAE(92,@@Y!%<B/%9N[+Q-9Z
MEH;+<:3"&N+19UD6>)T+##' Y 8$'T[U#;>+H[*T\)66G:#)Y6L66^UBBE15
M@"PAPG/H,#/''KTH [6BN3L?&<UYI-W/_8MP-0M=1&FRV<;^8%E)4!MX'^KP
MX8MC@9XK/UCQU>1^&?%DUE9VZZGH0VR#[1OBY0,'5@H)(!^Z0.1C/>@#O**Y
M>3Q2]E'8V=REDFISVQN"DU[Y<008&2Y3.23P IZ'TJ'3O'EOJMAIC6EE)_:.
MH32PI9RN%V&+F1F< _(!C# '.Y>.> #K0ZEF4,"R]0#R*"ZJRJ6 +<*">OTK
M@_ 2NOBSQN)+..T?[?#NAC;<H/D+D@X&0>O0'GFD\8%K7XC^#[NTL/M5X8[Y
M%1"J,_[M< L>@&2?SP">* .^HKA'^(LL.@ZM?3:#-%>Z-.L6HV33@F%6 (D5
M@"&3!SGC@&NH&K.^LVMA#!'*DML;F29)<B-<@+QCG<2<'(^ZWIR :=-WKOV;
MAOQG;GG'K7,^.M;U+0])LYM,BA>2>_M[9VDD*[5>15..#G.<>V<\]*P9I;RR
M^+=U-9:1'/?S>'HGDACF"(6\]P2TA'H ,[<].,= #T:BN2M?'MC>Z'HU]$D<
M,^JH[0PW<XB5-G$FY\'@' X!))''7&CX7\2Q^);*ZE%NUO-:7+VTR;]Z%EQ\
MR.,;T(((.!0!N4 @]#7 WEPWB3XJR>';HEM(TO3UNI;8GY;F9V 7>/XE5?X3
MQGKVKH7\.:78ZE:ZK:Q16 M!(95A41QNA0@EE&!D<$-U R.] &[17(MXY6'3
MM-UFXT]H]#U"5(XKKS<O&)#B-Y(\?*K''(8D;AD=<17GCF\BF\0Q6OA^6=M#
MVM/ON40.AC\S*]>=O0?F1W .SHKDK;QLT^IZ)$^D316&M1LUE<M,I9F$?F89
M!]T%0<')]P*S)_B7<PZ9?:J/#%X^G:=>2VM]*+B/=$$;:S*O\>.IQP!W/. #
MT"LC7/#]OKYL?M%S<Q?8KI+N(0E1^\3.TG*G.,GCI65K?C4Z5:ZC>Q::T]AI
M]M'<R7$DOE"97!.(<J0Y '(R.2!3[OQ?,OB*#1K'1YKJ6YT\WT,AF6-& 91@
M]2!\W)Q] : .I' ZY]ZKW]HNH:?<6;RS1+/&T9D@D*.H(QE6'(/O7(_\+!)\
M.:;K?]DLD%S>_8;H23@?8Y/,,66(4Y3<,9'J..>.EBU*2;7KG3DMU,5O DCS
M^9T9RV$VXZX7/7H1ZT .T?1[;1+ 6EL\\F3NDFN)3++*V -SN>2< #Z #H*O
MUAZYX@?1-1T>![,26VHW0M/M'F[1%(02H(P<YP0/? XS5"W\9-*_B2%[!$N=
M$94:$7&XS%EW)M^7C=G [YXH ZG>GF>7N7?C=MSSCUQ0[JB[G8*.F2<5RXU*
M)O'PLFT2-=8&C-.MVTHP4\Q1Y0(&=N\YR1VZ5Q.IZO?>(OAAI6M:K9P&?^V8
M'A,3[V'^F%=H!4;< !1R<CKB@#V"BN5A\:I!>ZU;:U8MIK:7:K>LQF$H>!MW
MS<#A@4(*\\]":>?%LMK>:1'J6F?9+?5V\NTF$^_;*5W+'*-HVL1G&"PR",T
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M444 %%%% !1110 4444 %%%% &1XIL;O5/"NJ:;8K$UQ>6LMNAE<HJET*Y)
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M5FM'9EMY(9=N8U?&[*[%(8CDY. .*[>B@"AI U0V9EU?[.EU(V[R;=BR0C
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M\S?N4!3NR,C&1ZUG>%='\7Z!;VWA^:33I=(LF"P7X=O/: '*QF/;C=CY2V<
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MMR9+9X-QG5KA58%L_+PW&!V]^/2-.\.66EZYJVKVP87&ILC2@_=4JNW(';.
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MWF"0D$KEAN' / SWK:M?#2V?BBZUN'4+H&[ABCN+<A"DC1@JK$XR.&/ (&:
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MPTWPSB.C7VA6VN7UOHMS.)TLTCC;R&\P2$(Q4G;N&0.Q]>0>YC4I&JL[2$
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MDCJ,]<UFZMX&BOO[-N;'5K[3]4T\.(K^,J[N'.7$@8;7#'G&,9Z>E;VEZ?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4:YGCB6218D+L!N=CA5'J23@"IJ "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tardioagreementa01007.jpg
<TEXT>
begin 644 tardioagreementa01007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **SM;URP\.Z5-J>IRO%:18WNL;/C/ X4$
M]>]0:?XHTK4M7FTNWFE^UQQ>>%E@>,21YQO0L '7/&1D4 ;%%8<?BW1I)[2,
M7#K'>2&*UN&A<0SOS\JN1M).#CGYL<9JI=_$#P]9-?B6XN2=/<)=A+.9O(XS
MN;"\+@YW=/>@#IZ*;'(DL:21L'1P&5E.00>A%8#^-]"35Y-*\^X:\BN([:2-
M;24['D^[N.W 4\?-TY'- '0T5B'Q;HZWMK;-/(OVN0PVTS0N(II!GY5?&TG@
MXYYQQFJ+_$/PVB2R&[N/*ANOLD\GV27;!)D#$AV_(,D#+8YSZ4 =3165JGB+
M3]'\[[2T[>1%YTX@@>4Q1\_,VT' X/Y'T-1P^*M'N=1BL+>Y>:XFM/ML0CA=
MEDAX^=6 VGJ. <\T ;-%8EKXLT>^T:/5K::>2SDG%NCBUEW&0OLQMV[OO<9Q
MBFR>+]&BN_L[7#X^V"Q,PB8Q+<'&(R^,9Y ],\9SQ0!NT5R6FW=X?BAK=C)>
M3RVB:?;310N1MC9GD!P /]D>]=3//%:V\EQ/(D4,2EWD<X55 R23V&* )**Q
M[7Q/I=WJ%O8K)-%<749EMEG@>+ST')*%@,X!!(ZXYQBN7L]1G\7>(M<M([_5
M=.;3[N%+-X8I(U51&KOY@9=I+%B,/VQCU(!Z!167XCUN+PYX>OM7F@EG2TA:
M4QQ*26P,_@/4GI7):EXEF7Q)X+O#=WD%E>1W/VFU$+J)&6'<N$V[V.X\#G/&
M* /0:*Y+5/%6A:AX*U#4FU2_L+*)FM[BXMX9$N+:12,@J5)5N@Y'?WK7U#Q#
MI^E&9)VG=K> 7$_DPM(8HSG#-M!Z[6_(^E &M12 AE!'0C-8WBF]O+30Y8M,
MV_VI=G[-9;CP)6!^8^R@,Y]E- &U17/>"/$#>)?"-CJ,HV7>TQ7<9&"DZ':X
M([<@GZ$4L_C70[98Y)+F7[/+<-:Q3I;R/'),"044J#DY!'H2"!TH Z"BN=D\
M<:%'JDNFF>X:[BFBADC6TE)1I/N$_+PIX^;IR.>:G?Q9I$=[;6SSR*+J<V\$
M[0N(9)1GY!)C:3P<<\X(&30!MT5B7GBS1["94N9Y$B-P+8W'DN85E)QL,F-H
M.>.N >#@U6N_'>@V4FHQR373/II NUBLY7,((W;B OW<<[NGO0!TE%85MXPT
M2\U6TT^"YD:6\0O:R>0XBGP-Q"2$;6(') /KZ4ZY\6:1:7,44\\B)+<?95N/
M)?R?.SC9YF-N<@CKC(QUXH VZ*YB[^('AVS^W>;<W)^P2".[V6<S>1P#N?"\
M+@CYCQ[U)/XNMXO&5EH"6]Q(+BS>Z\](79,;D5<$ Y'S$EN@XYYH Z.BD8A5
M+'. ,\#-<E8^*M TS0IM1DUB]N+)]0DA,]U$Y,<I?'E_=&U5)VC.,>M '745
MD:5XETS6+^[L;62875J%>2*>W>%BC9VNH<#<IP>1Q5Z_O[72]/GO[Z=8+6W0
MR2R/T51U- %FBLFR\1Z=?7EQ9K))#<V\*SR17$31$1-G#_,!D<'Z8YQ4=IXJ
MTF\U&UL8YY%FO(FFM?-A=%N$7&XH2,-@$'Z'/3F@#:HK$C\6Z-+?6=JMRX-Z
MS):RM$PBG9>H1\8/0XYY[9I+CQ=HUJY,URZP"X^S-=>4Q@67.W:9,;1\W&<X
M!XSGB@#<HKGK[QOH6G:G/IT\]P;N#RS)%':2N5#G"MPO*Y[C@<<\BL#XD>*4
MM?!FL-I5]>0W5JZQ&YM8FV))N *%\$ \X.#P>,@\4 >@45B:GXLTC2);J.ZF
MD)LXEFNS%"\@MT;.UG*@XS@GUP">E)>^+]&L-233I9YGO)+<W,<4-M)(9(P0
M,IM4[CR.!D]3VH W**QK;Q3H]YHMMJT%T7M;E_*A C;S'DR04"8W;@5.1CC!
M/046WBG2+NUNITN67[)/]FGB>)A(DI( 39C))R,8!SGC- &S169I>OV&KW-Y
M:VSR+=6;*MQ;S1M')'N&5)##H1T(X-.UK7=/\/V2WFI2R16[2+%O6%Y &8X7
M.T'&20,GC)H T:*S(O$&G3:[-HJ23?;X81.\1@< 1DX#!B,$9!'!ZBLR?7=)
MO]3\/,FIZA ]W+(UI"D+QQW6$;(?<O0 %AR.Q&: .FHKS[5_&,FK>%O&G]G_
M &ZPN-(6=(9Q"R$F.%7R21@'<W3AL 'BMOP]XKTZ_P#[/TLW$[:A)9+,K2PN
MJS@*N\HY&U\$C.">M '344CE@C%5W,!P,XR:\Q\-:Y=>*M%E^S^(KJU\60LW
MVS3I=B^6P;F,1L.%QP''/0DYR* /3Z*RM4\1:?I'G?:6G8P1>=.(('E,4?/S
M-M!P.#]<'T-)-XDTN.&WEBF:Z^T0?:8EM8VE9HN/GPH/R\CD]>@YH UJ*Y.?
MQ]IIU#P]#8K->6VL"21+F&!W4(B$\8&2V[ (QP,YQ5O3]5TO^V/$,@U:Z<VA
MC-Y%=92*S 0GY-RC (&XG)'>@#H:*Q[;Q1I=S?Q67F317$\1F@2>W>,SH.I3
M<!N(R"1U]JSX_B%X<E$3I=SF*2Y^R>=]DE$<<N[;M=BN$);@;L?E0!U%%%<)
MXVM?$-CI&I^(K/Q)/:36*--;V*1(UNZ+_"X*[F9L=<C!( '&2 =W14-I)+-9
M02SQ>5,\:M)'_<8CD?@:D=UC1G=@J*"68G  ]: '45AV/B[1]1N;:"":7==P
M-<6I>!U%Q&N,LA(^;J#CK@@]*IQ?$+PY,('CNYS%-<_9!-]DE$:2[MH5V*X0
MEN &Q^5 '445S_B+7K6SLM1M4N+E;J&U,LC6L)D:W!!VLV 0.AZ\X!/;-'@6
M[N+_ ,!:#=W<SS7$UC$\DKG+.Q4$DGUH Z"BLW4-=L=-F>*8S/)'#]HD6&%I
M#''DC<0H/&0<=S@XZ&FQ>(=-GU-M-CED-XMJ+SRO)?F(G 8'&#SQ@'- &I16
M-;^*=(N](M=3MKEI;>[D:*W"POOE=2P*JA&[(VMGC@ GIS7,>+O%,5SX>MM0
MTC5)[86VM6]I>*!Y14^:JR)(&&1P?;(/<4 >@45DZ3XDTW6KR\M+1YA<V>WS
MHI[=X7 ;.U@' )4X.#[4OB36X_#GAV^U>6"6=+2%I#'$I); _0>I/2@#5HK%
M@\1VKZ;97$B7'GW,6];=+:3S&P 6(0C.T9'/3D<\BJK>//#JV5A=_;G,-]*T
M,!6WD),@SE"-N5;@_*<'C@4 =)17,P^/M N)(X8I+QKB6V:Z2#[#-YC(&V'"
M[<D[NP]">@I(OB#X<FM[*XCNYFM[N00K,+67RXY"VT)(VW$;;N,-@_A0!T]%
M<]_:FG1^+;Z,ZC?&ZM[!7FL?+<PI'N.)%&WYF)R.">!TXJ.Q\>>'M2FTY+:Z
MF9=1R+68VTBQ2-@G9O*[0V 3MSGB@#I:*PI/%^C17?V=KA\?;!8F81,8EN#C
M$9?&,\@>F>,YXJ"S\7P7?BG6=&^RW:#34B+2?9I#N9@['H#QA5Q_>.<9XH Z
M2BN:T/7-)@\)Z==PZK=ZA:W#F.VN+D,\]PQ9N,!02>#VZ+D\ FIW\8Z)%I^H
MWLUQ+$FFG%[&\#^9!QD%DQNP1R#C!'>@#>HK#T_Q=H^IZJFFVTTWVB6 W$/F
M6[HDR#&2CL KXR,X)ZUN$X&30 45AQ>+=&EN+.,7#JEZYCM9WA=8IWY^5'(V
MDG!QS\W;-+J/BW1M*:8W=RZQ6\J0W$ZQ,T4#MC:KN!A3\R_3(SC- &W16-JO
MBG2='^TF[FDVVJJ]RT4+R+ IZ%RH./7UQSTYJ6+Q%ID^I3:=#.\EU%;+=E%A
M<[HF) 93C# D'IF@#4HKG&\=^'EL--O?MLAM]29DM&%M*?,89RN-N0?E. >3
MV!IR^--&>P-ZC7;PI!]IEVVDA:&/+ %UVY'*-QCL3TYH Z&BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** .3^)=K<W_P\U>SL[::YN9XU2.*&,NS'<#T'T/-9NM6-UJOCN![>&[B
M@FT"YL_M1MW"Q2R,A7)QP< GVQ7?4PS1"983(@E92P0L-Q ZG'IR* /,5TW4
M=8^'NA>%9=-N[35+&:TBG=X6$<2P.NZ59,;6RJ\;23EOKB6YL[U[?XF(NGWI
M;48RMF/LS_OS]E$?R\<_,,?KTKTRB@#D++P[=ZAI6D3C7M;TLQ64,;VD'EHN
MY5YW*\9;/8\]JCT&VN/^$Y\9R/;74$5Z;;[/</"RJ^R$(Q4D=F_/M781313J
M6AE210Q4E&! (."..X-/H \M\(6CQ66E^']7\'71U/2I(U^VRQ;K3$9P)DD)
M^]M'  SD]ADBKJ&G:C/\//'5E'IE^;J^U:>:UB^RN&E1G0JPXZ?*?IBO7**
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MBM#[/=/XG\!3K8WGE6EE<1W+FV<"%GBC50W'&2I_*N_I&944LQ"J!DDG  H
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M@LXXI(IEVL"J@'BNDHH X'QKIDEUK+7FGMJ^GZS;6(-K?V4#S13_ #.?(E4
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M0"5P ,'!Y'/6L[7/!6HZSIWB>;-G'J>MV\=JJF5C'!$@.,MMRQ)+$\#L.V2
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M5?KR;Q/JVH>)OA>FOK<1Q65U?6[1VGE XA%TBH2W7>2 3VP2,=ZVO&7BK5]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#C*2(3AN@Y!&#S7;44 8/ASPT?#\NJ2G4I[QM1NVNY!(B*%<@ XVCT44Z_\
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M''S>G'TXZ4 >;ZO<WD7@/XC.FHWZR66J2"WE%W)OC4)%\H;.=OS'CIS70O\
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M/(!7& @D*9&,5W?A*PT>WUG6+S1]7^WB\\J2X2 QFWC< @%=@P'8<G\">HH
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MH Z?6?&?E:'INK:*+>ZM;O4HK-GD8_<:;RRR@=>A(.?2NHEE>2WE^Q/"\R<
M.<KN'\)QR/Z>AZ5XM8)IY^#WAV&+R%F.L6BW(B(5_P#C[8#<1R#@''TKMO#]
MG::5\5/$%EI]O#:VTFFVDS0PH$4ONE&[ XSC'- '5:-J\&M:<MW"K(0[Q2Q/
M]Z*1&*NC>X((]^O>KCSPQR+&\J*[#(5F )'TKC/ (D&L^--N?LW]MOY?IO\
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MX7\*^/Y9]/M4V>*+;[,I6($)>I]UF_V2C,3_ -<R: /0I)X8HO-DE1(_[[,
M/SIQD1=N74;SA<GJ?:O-M5&F:+XTTS0K^Y@T_1AI'EV)N(XS"TH<B127&W<4
MV<]^?7G7T+2O"]AH6A6DE^M[!;WC?V3/>2KN:3+8$1&-P W!?8#':@#M****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:Z!;6%I?2(3&SPXC+]BX3!(INAZ==64$T^HS0S:C=.)+AX$*Q@A0H5 22%
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M 5]#@XXJ>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^X-<-&TJ1 C<RJ0"1GW91^-9OAG7X_$VC#4H[:2V4S2P^5*06!C=D.<<=5H
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MHH **** "BBB@ HHHH **** "BBB@ HHHH *XG3Y9+CXR:TLV<6NDV\< /\
M==V9R/J0!^ KMJQ+S2'3Q+;:_9J&G6 VES%G'FPEMRD'^\K9(SU#-[4 <-K>
MIW<1?4M/U.]N?+\10V[7)F:.)%,JQM;K$"0ZC)!8@9/(R16]XPEDMO''@B>
MGS'O)[=@/XHWB)8'VRJG\!6C/X \,W+79ETTD75P+J51<2!?.W!O,4!L(Q(&
M2N">]63HOVOQ)::G/&L<&F1/%91#'WG #2''3Y0%4>A;/48 -RBBB@ HHHH
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M8HCE21\O!'4#TKJAH.G#7FUOR7_M!H?LYE\Y\&/.=NW.W&>>G6@#@9[^_M?
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MMXYX7#Q2*'1AW!&0:DI$18T5$4*BC"J!@ >E+0 4444 %%%% !1110 4444
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M<?OXZ]JO_*Z]F4CZ@BO$=1MK$?"_Q@@CA6.#Q1((MN!Y7^E1#Y<?=^4GIVH
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M@L&DY+66)MBY/)0X&!T(V]L5VG@V"VL?'7C:QLHXH+:.>T=8(@%1&: ;B%'
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M :QOAHM\OP]TE=0>1Y0C^6TN=QBWMY6<_P"QMK.D^P6_QM8W MXY)=#C\HN
M"\GVAQ\N>K8Q[T ;'@SQ)+K_ (=MKS46M8;V>>XC$41P&$<KI\H))/"C-;\M
MW;02QQ37$4<DIQ&CN 7/L#UKQ6UM+"/X;:-JJ0P"^3Q(NVZP-ZC[<PP&Z@;2
M>.G)]:UKR70]3U;Q=HGBO6CIT\ET&C23RE:2WV)Y31,Z$D@@\*>&R<9)H ]:
MHJO8KLT^V0M,Q6)1NG_UAX'+?[7K[U8H **** "BBB@ HHHH **** "BBB@
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M?FR1C'RG/<=\4 6_[-L-Z/\ 8K;=& J'RERH'0#CBI+>SMK0,+:WAA#?>\M
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MDB5K9%5VN!D&.60$%%  (&0#DYSTJMI]GJ2^'OAQ#+I.H12:;.GVI6@),2K
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MJS7L4##!1&"J"1V+;=Q';//.:AU^"XD^(GA.ZCM;F2WM4NQ/,D+,D?F(H3)
M[D'Z=\5U]% 'D>HZ;J4_@+QU91Z7?-<WVL236L7V9P98V:,AAQT^5NOI[BM;
MQ=IT]YJ5UJ>C)J]AKD5H@MIX+=W@OAR1#,A&W@DC+8QNSG@X]&HH BMC,;6$
MW*JLY1?,"'*AL<X]LU+110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '/>.U_XH+7Y 662'3YY8W1B
MK(ZQL0P(Y!!K#T_PR=0^'NF7.GZA?V6KOIT,T=W'=R',IC#9=2Q5P3U!!Z]J
MZ/Q?:76H^$-7T^Q@,US>6<MO&NY5 9T*@DDC@9K$MX/%">"K+0K+38[*]CLH
M[1[RYN%,<6$"EU5,ECP2 =O;)H B\(^/9=>\*^'[IK"2?4]2BF+)$ L8,)VN
MQ8\*"<8'/WO8FB_\?2S:+X<U+2-.FDBU;44M'$C(KQD,P9,$X))C89SCOGI4
M2^$]0\/Q>'-'TJU74=!LH)([JWDG$6^9B")7'.Y<E\KS@MG!P*S;+PGXBL_!
MN@V1T^W-UI&N&]\E+D8EB,DI^4XP.)!@'T[=* .HUGQS9:/'?.UM)-_9Z*]Z
MB31AXLJ'*@%AO8*02!QR,$GBM^WU&TNM+BU**939RPBX64\#RRNX-ST&.:XM
M=.\4:'XHU.XL=%LM4L-7D2Y;?=B(VD_EJCY)4ED.T'@9]JZZ]TTZCX=N-*NI
M1NN;1K>66-=OWD*D@=NN<4 8X\;6JQZ7=W%E<P:9JLBQ6EX^W:6?F/>N<J'[
M$^HSBL.X4^*/B#K6AZMI<TVGP6,"Q R(/(+-(3,I#9#':N"/F&T=*6+PWK6I
M>$M%\+ZI9K"-.GM_/O4E5HY8H""I0 [MS!5!R!C)Y.!G8T[3M2@^(NLZI+8L
MMC=VMO!%+YB$YC+DDKG(!W\?3M0!JWOA^TU"2R^TR7+Q6D;(L8N'7>3M^9B"
M"Q 4]<_>-<3\.M&AU7P\U[<7%X;NWU>8QRFZD)VQS<(1NP5P-N#V->E2,4C9
ME1G(&0JXR?89(%<G\.](U+0]!N;+5+3R)FO9[A<2*X*R.6'(/49YH 2Y^(>D
MVTUJ[*S6-S=_8UNEE0X<L5!*;MP0L,;L>^,'-26WC9KW5+NQM/#VJSM9WAM+
MAU$0$9V!@V2^"#GMT[XR,Y/AC2_%.@(OAU]*L9M/@F;[/K!G7(A+%@&BQDN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &O&DA4NB
ML4;<NX9P?4>].HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M- %,B30/$0&SM/S 9S@]/2EU'5K+2E@-W*5:XD$4,:(SO(^"<*J@D\ GV H
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M.T;FW<0%95 W2+A8PP^4-R",'% '545S=UX]\.68O3+?2$6,GEW7EVLK^2<
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M:6QCDD48B6-XI%!&W[N?FXY.:] L-/BTZ!E62661VWRS3-N>1L 9)Z= !@
M8X%6\\XH IZ5;+9Z1:6R6J6B10JHMT.5B 'W0>^.E<6UC>77BWQTB6=RJWVF
MP06TKP,L<CK'*& <C'!=>_>O0** /*=-EO+@_#E5T75D_LH&&],MFZ>4XM3'
MW R-W\73WJ"^L;Z;X<^/;./2]0-S>ZK<R6T7V.3=*KLNUE&WD'!Y[5Z[10!Q
M5T)9OB;X?O([.\-JFFW$;S&UD"(SM&5#$K@'Y3UZ5QVB6A\1_!C2- L[6X-[
M+=(5E-NP2$+<EVEWXVX"ANAR2<=:]DD5GC95D:-B,!U )'OSD5E^&O#\'AC0
MH-(M;FXGMX-WEM<%2P!)8C*@#J3VH UCTKS7PE8W^FZYI::3_:2Z%<12/<Z;
MJ5NX_LUMN0(I&4'!8[=N3QDCBO2J* /&K&+48?!?A716T353>:3KD+W8%H^U
M569VW*V,.,'.5R/7'&=XPW)O/B0_]GWVV]A06Q^R2?OR+81D+\OS?-QQ]>G-
M>CYS10!YI%;W2K\,\Z??@V*8NO\ 1)/W'^BF/Y_EX^8X_7I7I9 (((R#VHHH
M \CG\+:];Z%J%G;0R!?#%ZUWH8&3]I^82A<=]J%HAZ[CZ5N>,]-O6^%5];+9
MSW&IWC)-)#;Q-*WF-*KLOR@\*. ?117H%% '%S_:+?XJ6^I_8+V2RN=%^SK-
M';LRHXFWD/Q\ORG/.,XP,GBN46ROQ\,8K/\ LO4?M:Z]]H,/V*7>(_MGF;L;
M>FSG].M>OT4 <&RSCXA>(+S[%>FVET6&*.46DA5W5I"5!V\G#+Q6)96=[%X2
M^'%NVFZ@)["]A:[3[')F%5BD5BWR\#+"O5^M% ",0JECG &>!DUYC8P79^'/
MC>T.G:@MS=W.I/;PM9R!Y1*6\LJ"O.<CZ=Z]/HH X'6M-OI? >@ZKIUI,VL:
M(L%U#;F,I(X50LL6",_,A88[D"D\5:3J=MX;T:\@LIK^YL=16_O[6V8B28.K
MB01X()*F3Y1GHH%=_G/2B@#F?"HL;J>\U2RT.\T_[0L:O-?1M'/.5SU5B6PH
M( )]3C@51\8V\D?C'P3JI!^S6U_-;RGLK30LB$_\" 'U85VE07EG;W]I):W4
M0DAD&&4\>X((Y!!P01R",T 9NHZ];V>I#3;C3=2F$L.]98;)YH7R2"A900#Q
M_%@8/6L.+35\*_"C4;6=1&D-K=RB'.?*5S(ZQ#UVA@O'IQ791(8HD0R/(5&-
M[XR?KBH;RPAO_*6X!>*-Q)Y1^ZS @J6'?!&0.F>>PH S/!FGSZ3X)T/3[H%;
MBWL8HY%/\+!1D?@>*P;9Y-'\;^+IKS3;V:'4%MFM?*M7E6X"0[&7<H*@YXPQ
M'KTYKNJ* /*M/T2_\'OX!:\M+JYCL+2[MKIK.%IS#)+L900H)VY!7.,<"DLM
M-^UZ-JUMJVEZW:>?XFN+F&XMHG$UMG<4F4J#D C:2,CYO2O5NE% 'E6IP^(;
MCP%+:ZA#=:C<QZU ;>XCL666XMXY8V\UT4<$ ,,D#(4>O.];^;'\2M=OGLKW
M[+)I5O&DWV20J[*TA90=O)PR\5V]% 'C.DVFIZ'H7@S4KO1-5N;6SL)K"^M;
M>*1;BW9V1@X089A\F#CM707NCZ;>:;:&'2=8T037DMW;WEG&_P!H@E* &250
M&(W_ # ANHQG!)QZ-10!Y@]AJ.IZ/HXUQ]3LM7@>[-KK&G6KJR@. K2Q*I $
MJ_,58#[O8FNT\(R:K+X6LGUN)(]1*MYH2/R]WS'#%?X2PPQ'8DUMT4 <);S7
MGA_XDZ_-?:??3V6KQVS6=S;6[S*IC0JT3[0=G)+ G Y/-<[X9.J:=X;\%V5U
MH>I0PI%<1W,\5D6N(6)RJ#@M&C@\L,=!R.M>NYHH \T\.>&[C5OAC?Z#=VEW
MI]VEW<R027*E6CE\]Y(G4DDG!VG<.#S@GFKEA'+K/P^NM5\0:;+<3ZO%$;BU
MM,LZQ#:J^7MY./FE&.[&NHUS04UY;99-1U&UBB8EX[.X\H3J1@J^!DCZ8/O6
MK'&D4:QQJ$1 %55&  .@% ''^"H-7L]1U*TN;V[U'2HXXOL5[?0&.XR=VZ)B
M0"X7@[B/XB/7$_C*YN[:[T,PV$\UH;MOM-U:VOGSVH\M@I0 $KN)VE@. 3ZY
MKJZ* /(Q9:@GPY\>:;_8^JK<75]=M;1R0/(\HDQLP1DM[MDCWKH-8%R-;\#Z
MK'IU_-;VIG2=8[9R\9>#:NY2,@;N,G@=R*[RB@#RJWMC:WNM>'M<\+ZGJ1N[
M^:XM)45WM;B.1RZB1L[4*DX.?08S71>'X9H?B1XIEDL[F.">"S2&9K=UCD,:
MN'"L1@X+#OS79YYQ10!2UB"2ZT/4+>%=TLMM(B+ZDJ0!7F\"WDOAOX=0'2=4
M233;NW%TKV4F8PENR,Q&.!N(&>_4<<UZK10!Y1K.E:O?7GCIM/T^Z:5[O3[N
MV22-XENA (RZJY &<H1P?2NH\+2V&JZH=5MO#FI6$Z6QADN=3B>.498'REW$
MEAD$DCC.,9R<=?10!R?Q+AGN_AYK-G:VUQ<W-Q;F.**"%I&9B1V4&H+2?2K>
MVTN2TT"\.IQA(XR-+EAV,R[&+N4 "C))Y[=SBNSHH \SEM[IK3XF*-/OR;\,
M+4?9)/W^;98_E^7GY@1^O2IQ#<G5?AQ(+"^V6<$JW+?9),0$VVP!_E^7YN.?
MKTYKT6D8$J0&*DC@CM0!X]91?VU\-/$GA^VLIYKV\U2\BB'V=O+W&X.'+XV@
M+U))_A]<9Z"]TJ]N/'6H6T*7:++X8_L^.^:!Q&)M[G[^,9P0>OZUU7AWP]#X
M;LI[6"[N;A)KB2X)GV9#NQ9L;5'&2:V* /+A8WVM^ O#GAMM.O+35;"XLTG,
MD#*D @8;I%DQM8%5.W:3G</?&EXET>]B\:0-IN!:^(H?L.IKNP5$8W>:/?R_
M,CSV)2N_K&TSP[#INIW6H-?W][<3,Y3[9/Y@MU8ABD8P-JY ]3\HYXH Y77A
M/H?CQ]1N='U._P!(OK"&W5]-5W:VDC9SM9$(.TA^OK5&\LG\.ZKHNIQ>&;\:
M$;*6U>RTX,TMFS2^8K%$.3D?> S@_09]1HH QO#-M;6VDDVFE-ID$TK3+;R#
M$G/5G&3AB><=>F><BN3\9V%P^KWVH:,^J66MPVBK&8K9Y[745^8B&1=I7()(
MR2" V>G3T6B@"*U:9[2%KE%2<HID13D*V.0#Z9J6BB@ HHHH **** "BBB@
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MG@,NU2 < ^HK(UGP/J6LC7=7A>.RU:[GM)[*.1MRQFV.4$A7C+$MG&0!CDT
M=!+XL>R.JKJ.CWT3:?;"ZS"GG+.AS\J, ,OD8*_KCFJM[KR:DNM>'[ZQ:VNX
M]+-WM$H=6C8,!R,$,&7D8^A-1WH\;:SX7U%5M[71M2:W\NVCCNO-+/D;F+A1
MLX!"XR1NR>@K/LO#&L?\)1<7XTJQT^SN]%^PNB7.]HY-[MEL+\Y.X9/MU)H
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M7WA>\N?&,/B.WU2.&:&T:T2%K7>NQF#$GYP2<@>E-U;PK?:YI6JV5_K(;[?
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MD5A6?AATU^TUK4+R*ZOK6U>U26*W\II%8J29#N.X_+QC &6XYXZ*B@#'\4:
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M:GXDN=6CMUV6R20)'L&,9<KR[8XR?4\9YKI*1B50L%+$#.!U- &9XCTAM?\
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MY$N_?NSG/WB3C.,T:AX#T'4M:;5IH;A+N152X,%S)$MRJ\ 2JI <=N>HX/%
M&]9O))8V[RO$\C1J7>(Y1B1R5]O2IZ0 *H50  , #M2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:UU.V1X96S.[QM" R#(\N-5'& <X;I0!ZRNOZ:^OR:(EU&U]%"LLD8894,<
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M1!:*$.?W@<J!_%L]/:MWPV?"VK>(M.UG1==EO;M;)HO(@\E52$X.)D1%*X.
M >_0=: .YN;NVLXO-NKB*"/.-\KA1GZFG-<0I;_:&FC6$+N\PL N/7/3%<?X
MHU'3[?QIHEO</!;WGV6YDBNKQ\0(GR!@%R [GC'(P,GGI7">'=;M=/\ #?@2
M2^N4_L6"^O8;QV/[N"7=((/,'\('.,]/E/84 >M:EXCTK2M-BO[F]A^SS2I#
M$RN")'9@H"\\\G\ ">U7DO;20,4NH6"#<Q$@.T>I]J\R\5P^'$\+27ND>3)9
M/X@M;FXN0^^'>TT?F%6)("\#..,Y'7.--+_2K+XLS3R7%I!:7/A^(0N654EQ
M.^0O9N".G8B@#NI+VTBMOM,EU"EO_P ]6D 7\^E8/C'Q!=:)X;35=,-K,#<0
M1DR9962214RNTCGYLUYYX3U?2H/"_@."26VCN@]Z8;BYEQ!;E2P;>N1N?:X"
MJ2.I.>QA2[MC\'K^W2ZB?[/X@"[5(&Q?MX(X_A&,G'I0![=1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #)88KB)HIHTDC889'4$$>X-1&PLV!#6D!!4(08QRHZ#Z#M2:AJ%II5
MC)>WTZPV\>-SMD\D@  #DDD@ #DDUG?\)7HHM=1N)+PQ)IV#>+-"\;P@C<"5
M8!L$<@XYH T?[.L<H?L5OF/[G[I?EYSQQQS3HK*T@+F*VAC+C#;(P-P]_6L1
M/'/AQ[F* :CAYH?/AW0R!95P,[&*X=N1\JDG/&,U;LO%&C7^DW&J07RBTMI&
MBG:5&C:)QC*LK ,&Y'!&3D>M &A:V5K8QF.TMH;="<E8HP@)]<"FII]E&Q:.
MSMU8R>:2L2@[\8W=.N">>O-4H/$FEW$US DTJW%M&)I8)+>1)0AZ,$90S#MD
M \\4U/%.C26VEW"7FZ#5'"6<@B?;*Q!(&<<$@'KCI0!>_LRPPP^PVV&^]^Z7
MGZ\5(MI;*8BMO$/)SY>$'R9ZX]*P+CQ]X8M1<F75!BUF\BX*PR,(FX^\0IPO
M(^8\>]23>++6+QG!X<$%RTDEHUR9EMW9!\Z*H! ((^8Y;H,#)H 9XNT&[U]=
M)2V-L$LM0BO9!.3B0)GY, 'KGK^AK=ALK6WM3;0VL$4!!S$B (<]> ,4E[>V
MVG6CW5W,L4*8!9O4G  '4DD@ #DDXJG:^(=-O)+N*&64SVBAYK=K>19E4]#Y
M97<0<<$ YH N+8V:*%6U@50GE@", !/[OT]J/[/LOLSVWV2W^SO]^+RQM;ZC
M&#7&>$-1O?%L=OK8U._M7CN[@2VIMV$$L(D=$0;E W *I+*2<Y!]!M2>++6/
MQH/#A@N?-%I]I>7[/(4&7"K@@8Q][+=!@#.<X -N"TMK7/V>WBBR #Y:!<@#
M Z>@I[PQ22QR/$C21YV,5!*YZX/:N8LO$^AZ=H][J5QX@ENK/^T)(C-.A_=.
M6 \I0%!VJ2 .#]:L_P#";^'OM%S;_;G-Q;J':$6TI=U.<-&NW,@X/*9'% &S
M]AM/MGVS[+!]JQCSO+&_'INZU++#'/&8YHTD0]5=00?P-9L'B/2;K2+;5;>[
M$UG='; T:,S2-S\JH!N+##9&,C!ST-3:5K.GZW!+-83^:(96AE5D9'C<=596
M 93[$4 /_LG3?^@?:?\ ?E?\*D:QLWE:5K2!I&!#.8P21C')^E<?J^H:FOQ-
MT_1H]:N+33[G3I;AT2.'(=7 &&9"<8/2M6/4[?0[;5-0U+Q"UWIMOM5I)D3,
M#@$N/W:#(P4[$@YH V/[+T_8$^PVVP'(7R5QGUZ5@:5X6>W\5:WJM_;V$T5_
M+#+ H&YH#'&(^Z]]H.1C'3GK5H>-_#INS:_V@1-Y7G(I@D'FKP/W9VXD.2!A
M<G/:E'C7PZ=)CU0ZFB6CW'V8/)&ZLLN[;L92-RG/J!B@#9EL[:>599;>&21?
MNNZ D?0TU[&TDNUNWM8&N4&%F,8+J/9NM9>F>*-&\1SWEAI6IDW=NO[P",HZ
M ]'4.N&'H<$5D^!_$32_#G1-4UJ]:6ZNE*ERI9Y9"S8"JHR3@= .@]J -6XT
MK5K[7_,N[ZU.B1/'-#:I 1*TBC(WN6P5#888&<A?0YV9[>&ZA:&XACFB;ADD
M4,I^H-8\GB_0HM,O-0DO62WLG\NZW02!X#_MIMW+U!R1C%7FUBR5K!3))F_.
M+8>2_P _R[N>/EXYYQ0!9^RV_P!E^R^1%]GV[/*V#9M],=,4L%O#:PK#;PQP
MQ+PJ1J%4?0"LM?%&CMJ%O9?:R);EVC@9HG$<S+U5)"-C'@\ ]C1/XHT>VO(K
M::[*-+/]F20Q/Y1EZ>7YF-F[((QG.1CK0!G6OA>3_A--8UB_@L;BUOH[=(HV
M&]HC$' ;E<9._MTQWKH[BUM[N,1W-O%,@8,%E0, 1T.#WJ#6+F"TT:\GN;QK
M.%(6WW*#YHAC[PX/(Z]#5&TUO3[;2=,S?7%[Y]HLT4H@>26>,*N9&5%R,[E)
MX'+8H TWL+.165[2!E9BY#1@@L>_U]Z2?3K&YB2*XLK>6.,81)(E8+] 1Q3[
M.[@O[*"\MG\RWN(UEB?!&Y6&0<'GH:S9/%&CPWT%I)=E'GG-O%(8G$3RC(V"
M3&PMD$8SG((ZB@#2FL[6YB2*>VAEC0AD5T#!2.A /3%(]E:20R0O:PM%(Q=T
M,8*LV<Y([G-85QX^\,VL=U)+J?R6DWD7#)!(XB; /S$*<+\P^8\>]6[?Q7HE
MUJK:;#? W(B:908W"2(OWBCD;7QGG:3B@#1>PLY-^^T@;>06W1@[L# SZX%"
MZ?9)(LBVD"NGW6$8!7Z'%<^GQ$\)O):HNL1D74IAB?RWV;PQ7:6VX4Y!QDC/
M:H[._O1\4=4TZ6]EDL4TN"XCA8*%C9I'4XP >BCKF@#J8H8H=WE1)'O8NVQ0
M-S'J3[T>3%Y_G^4GG%=GF;1NV]<9]*RH/%.C7-W;6T=X=]WG[,[Q.L<^.3Y;
MD!7XYX)R.13K+Q+I6H1:A+:W#NNGNT=UF"13$RC)4@J"2!S@4 7H;&TMYY)X
M+6"*:7F21(PK/]2.M2RQ1S1-%*BR1L,,K#((]Q67<>)]*MK..Z>:8QO!]H C
MMI7<1?WV55+*ON0.AI[^(=+%K9SI=^<EZN^V^SHTK2KC)954$D $9.,#(S0!
M;.GV32>8;.W+XV[C&,XQC&<>G%-_LO3]@3[#;;0<A?)7&?7I7-?#S5KG6--U
MB>XO9KQ8M7N88995"MY2D!00 ,<=L"J,GBZ+0/'OB&'6M5F_L^&TM98(C$7\
MO=YF_"QKN(X&2<X[F@#M3IUB;I;HV=O]H7[LOE+O'T.,TW4+26]MQ%%>2VK!
MPV^-$8G';#JPZX/3/%45\6:(\^EPQWPD;55+61CC=UF &3A@,<#DY/'>K\&H
MVMQ?W-E$[FXMMOFJ8V 7<,CYB,'CT- &-;^%9+2:2:VUFXAED^^\=I:JS?4B
M+FGMX:N&NUNVUR[-RHVK,;6UW@>@;RLXI+CQ5;IXR3PR(;L3/9M<-,MN[*I+
MJJX.TC'+98_*, $]16!X.\:VL>EK;Z[JTDM]+JEQ:1RR1$@D3,L:LRKL0D 8
M!QGM0!T$GANXEN8[F37;MYXQB.5K6U+)]#Y613G\/7<DGF/X@O6DVE-S6UL3
MM/49\KI[58U3Q+I.C>;]NN7180K3.D+R+"#T+LH(0?[V..>E:$MW!#9/>/*O
MV=(S*9 <C:!G/TQ0!BIX9N(X7ACURZ6*3AT6UM0K?4>5S38_"\L5K]ECUJY2
MVZ^2MI:A/R\K%9_A2\U3QAHR>()]0N=/M[MF:SM+98_W<08A6<LK%F.,_P!W
MD<5K6=W<Z-8S'7[Y9G-V8[>58\-*K8V*$49+=00!R03C% $ \*R H1K-P"GW
M#]CM?EYSQ^ZXYJP^AZA+&T<GB._=&&&5H+8@CT(\JE/BW0UT^^OI+X1PV!Q=
MB6-T>$XS\R$;AQR..1R*@7QQX=:Z6V_M'$KP^=&##(!*O'^K.W#GD#:N3GC%
M "P^&[BWMS;PZ[=QP'.8TM;55.>O BQ5?3_"=[I^G+IB>([UK")!%!$T%NVV
M,#&PYC.0.WMQCC)LKXV\.G2/[5.I*EF)_LS-)&Z,LN0-C(1N4Y(X('44_3?&
M/A_5[F\MK/4HVFLT\R=75H]J?WQN RO^T,CWH A3PY?V=H8-/U^YMP/N*MK;
M!%/KM$0_IGUJSX?T Z!#+$-2N;M99'E?STC&9'8LS950222>I-+9>*=&U"X$
M%O=-YC6WVM!)#)'YD/\ ?4LHW+R.1GJ/6JEMX\\,WCV2V^IAQ>RF&!Q#)L:0
M$C86VX5B0< D$]LY% '0LBL5+*"5.5)'0XQD?@3^= C0%R$4%SEL#[QQCGUX
M 'X5G66OZ;J-]?V5K,[W-@0+F,PNIC)&0.5&<CD8SD5:T^_MM4L(;ZS=I+:9
M=\;E&3<O8X8 XH 0:98"-HQ96P1B"5\I<$CH<8]S3A868='%I 'CP$;RQE<=
M,<<5Q7Q#\5I9>&+QM)U*X@O(+F*'S8("T98R*'C,A4J#@G@$$$8]JZH:_IIN
M[^T$[FXT]%DN8Q"^Y%;."!CY@=IZ9Z4 79[2VNMOVBWBFV_=\Q V/IFDCLK6
M*8S1VT*2GJZQ@,?QK&E\;>'((-/FDU-!'J,;2VA$;DRJ%+$@ 9Z#IU/0<FH;
M+Q#I&I^((9[379GWZ8;D6/ED1F(NO[XY7(;D#&>AZ4 ;UO8VEH\CVUK!"TAS
M(8XPI<^IQUJ5(8HGD>.)$:0[G*J 6/J?6N?M?'GAJ]DL5MM3$@OI#%;N(9 C
M/DC86VX5CM. 2">V<BKFH>)]'TM[E;N[V?955KEEB=U@#?=+LH(7/7G''/2@
M"_<6-I>-&US:P3M&<H98PQ4^HSTI]Q;07<#07,$<T3?>CD0,I^H-,M;VWO;)
M+RVD\V!P65E4\CV'6O//$7CB;5/AYKNJ:-+?:=/8W/E([6Y0L%E6,Y+K@$_-
MP,,.,XH ])CC2*-8XT5$4855& !Z 5S&@>%Y+#6-9OM1@L9FO;XWD#*-[PG8
MJ[<LH_N Y%:>G^)M(U34KC3[.[WW4""5T:-TRA. ZE@ ZYXW+D4EOXHT>YU&
MWL([L^?<JSVV^%T2X"\DQN0%? Y^4GCGI0!H&SM6N!<-;0F<?\M"@W?GUI)K
M&TN+B.>:U@DFB_U<CQ@LGT)Y%8WC?Q _ACP?J6JPQL]Q# QA B9U#X."V!PN
M>YP/?FL>VDCA\0Z3++XLU9%O6_<Z;<6Y7SY%1MY)9 RJ1SC@97B@#LFL[5YQ
M.]M"TPQB0H"PQ[]:1[&TD>5Y+6!FE4+(S1@EP.@/J*ICQ#IIO$M1-(9'G-NK
M""0QF09RF_;MR-ISSU!'45'/XIT:UNTMIKS8SW M1)Y3^5YQ_P"69DQL#=L9
MZ\=: -0P0F99C$AE4%5?:-P![ ^E,CLK6&YDN8K:%)Y>))5C 9_J>IK-F\5Z
M+;W9MI+PAEN5M&<1.8UF;&(S(!M#<C@GN/6LRTOK[_A:6I:;)>2R62Z5#<1P
M,%"QNTCJ<8 )X4=<T =$^FV,D[SO96S328WR&)2S8((R<<X(!_"K59NHZ]IV
MDW=E:WL[137LGE6X$+L)'_NY (!^M/EUK3X+JZMIKCRY+6%9YRZ,%1&R 2Q&
MWG:W&<\'TH GMK&TLS(;6U@@,AR_E1A=Q]3CK0MC9J25M8 3)YI(C'W_ .]]
M??K6?#XIT:66\B:\,$EE#]HN$NHG@9(N?GPX!*\'D<46OBC2+N6:*.Y=)8K<
M7+)-!)$WE'@. R@LN1C(SS0!?CT^RBNFNH[.W2X;(,JQ@.<]><9IWV*U^V?;
M/LT/VK;M\[RQOQZ;NN*RM&\7Z%X@N5M]+OQ<R-!]H7;$X!CW;<Y( ZXXZ\TW
M4=6>7Q19^';1RDLEN]Y=2#K'"K!0!Z%F.,]@K=\$ &K-IUE<3&:>SMY92ACW
MO$K-M/5<D=/:K  4    < "LG4/$VD:6\ZW=TRBW"FX=(7=( >1YC*"$XY^8
MCCGI4.J>,O#^CSB&^U%$E:W-RJHC2%HQC+#:#GJ.G..: -6.QM(;J2ZCM8$N
M)/ORK& [?4]33?[-L/F_T*V^?[W[I?F^O%07^M6EAH$VM-YLMI'!]H_<Q,[,
MF,\*!GI^7?%<9J'BZ:<^"=6CN[BRL[^?%Y;O$41@;=I.K*&8 XP0<'WH ]!B
MBCAC$<4:QHO14& /PJ%M.L77:UG;LNXO@Q*1N/4].IJC8>)]'U+3KF_MKP?9
M[60Q3F6-XVB<8^5E8!@>1QCG(Q4NGZ_INJ7ES9VTSB[M@K2P30O%(JMT;:X!
M(/J.* +<=E:Q3&:.VA24]76,!OSHM[*UM#(;:VAA,C;G\J,+N/J<=36=J_BG
M1="NHK;4KX0SRH\D<>QF+*HRV-H/Y=3D5'/XPT.WL$OGNW-JT"7!ECMY'$<3
MC*L^U3L!'/S8Z'T- &O+;03O&\T,<C1MNC+J"4/J,]#36LK5[9[9K:$P.27B
M,8VMDY.1T/-<Q<:G='XEZ/;0:@\FFW>F3S^2NTQEE:/:X(&3PQ[D>E:Q\4Z.
MM_!9M=E9+B5H87:%Q%+(,Y19,;"W!X!SP?2@#2^R6WV7[+]GB^S[=OE;!LQZ
M8Z8HDM+:66&22WB>2$YB9D!,?^Z>WX5G6GB?2+ZTU"ZM[EVATYVCNR8)%,3*
M,L""H.0.2!4=YXMT73U<W-U(OE0+<38MY&,,;9PT@"G8.#]['0^AH TS8VAB
MBB-K!Y<1#1IY8PA'0@=C0]A9R(4>T@92Y<@Q@@L>IZ=?>LV]\6:'I]['9W%^
MOVF6 W$<4<;2,Z#'*A0=QY& .3Z5G:CX]TFUT73-4LS->V^HWL5I$T,$AP6D
M"-N&,J1\WRD9)& * .J551 B*%51@ #  I:9%(LT*2J&"NH8!T*G!]0<$'V/
M-/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#F_'4]U;^&))+33OM[">'>@M_/:-/,7=(L?.YE'S >
MH![5Q,D-UY_Q"\O3M:E34](B%K+/:R%IV\F53QC@[F4;< C/0 5ZU10!YQY4
MYU3X;O\ 8+[;9P2"X/V23$!-ML ?Y?E^;CFLB_TS5KF+Q+/9:?>NT'B2WU-+
M=K=T^UPQK'N";@ W*DX[[?<5Z]10!Q$MJ_B'QYIFLV,5Q%:V>G7$4TLT#P^8
MTA79'A@"<89CZ<=ZY/3C>CPGX#TTZ/JPN=(U6$7P-E(!%M24$YQ\PYSE<CU(
MR,^P"6,RF(2(9 -Q3<,@>N*?0!Y5>6UU)X?^)D*Z;?F6^FD-JOV.3,^8$0%?
MEY^8'I]:UK47-MX]T&_>POFMIM!-GYBVSXCE\Q&VOQ\G )RV.E=_10!R/Q!L
MM0N--TF\T^"2Y_LS5;>^GMHAEY8D)W!1W(R& _V:AA@.I?$6+Q';17$=A:Z2
M]M)(\#H9G:0,%"L QV@$GCJ0.N<=I10!QWPQ2:#P9%;7-K=6T\=S<LT=Q \3
M8:=V4X8#.00:2Y6XM/BW#>M97<EK<:,+5)HH&=%D$Y8AF PORG/.,]LGBNRH
MH \>O+2]D^'GBFU72]1:>Y\1O<0Q?8I=TD1NDD#@;<D;5)S76MO/Q<COOLEY
M]E_L)H?/^RR;-YF5PN[;C.T$X_#K7:44 >,V5KJ>G>'=!U)M'U6:#3M4OFO+
M.&*6*?RIG?9(B_*S8!!P.S'WKT3PI'8O'>7]AI-S81W<@=GNU=9KA@,;V5SN
M Z 9Y.#QC!/144 >=^((8I?BQI=U>:5=W6GP:9-%)(-/DGC61G4J.$(S@&E\
M1?9Y_!/BG3-"T2^CCELW(5;"6+S9Y%VA8T*@G[N6(&,D>IQZ'35=7+!6#;3@
MX.<'TH X.X663QEX%N$LKTPVUG=)-)]DD"Q%XXPH8[?E)*GKZ5RVK"2W\*>(
MWN;*[C23Q;%<QK+;.IEC,L."H8#=G:>E>SUB^)M!@\1:=%9W-[-:Q)<13!H=
MF6='#(/F!_B ^M &*+;[?\2(?$-O!.EG9:5);S3- ZF5F<,J*I&6VA6)P.I
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M5+*U\,:YX;U:XU6PN?EFD$K6;[7)6</G8, YQUSP!FO5Z3>N_9N&[&=N><4
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MFK*_DR1EP8W2,YP=^0?K[U##!)X6\8Z/J0T2[M]!DTE[%(;6%IS92&;S!O5
MQ&X;0<9 (QG'->E%U";RPVXSNSQCUJ,W, @$YFC$)Z2%QM/XT <C\.UG2'Q#
MY]G=6WFZW=3QBX@:/?&[ JPR.>AJ-9&TCXE:W>WEI>&UO+"V2WEAM7E61D,F
MY<H#@_,.#C-=O10!YDOA*]T[X3P( EKJVES2:M:*6&('$CR"(GIC8Q0]N37:
M>&(9QI O;R(Q7NH.;N>,G)C+ ;4/^Z@1/^ T:OX=CUF^MIKC4+^.WB4K)90R
MA8;@$@XD&,D<>HR,@\$ULT <9>B>S^+-I?O97<EI/H[6JS0P-(JR><K88@87
MY<GG&<<9/%<BUI>GX875H-,U'[4VOFX6'[%+O*?;!)OQMSC9SFO8:* /,)\:
M=XG\06.MZ%K.H6.KS+<6LMFDKQ2JT2(T4BJ0%(V8^;C'7 KOAID4WAL:4\*V
MT+VGV8Q1MD1J4V[0>^!Q6@SJI4,P!8X&3U-+0!P'@>_G\+>'[?PSKUE>Q7>G
M[H8YX;226&YCW$JZ,BD9P1E3@^U3^*1J4FJ^&/$,=A</9:=>R&XMD0O*(I(S
M&)2@YRI).T9(!Z9R!W%% 'E_B'3+G4)/&VLV5I=FWO=#%A!&MN^^YFVO\P3&
M[ #*H./7L*O21S/XE^'TRV-[Y=K:SK._V23$):%54.=ORY((YKT*B@#QC7%E
M@\(^,GN+*[C2;Q+;W$0EMG3S8S+;C*[@-V2K#BNEURVN-3\5/KVE:8]TMAHE
MU"R3P,BW<CX*088 L.&SV&X#J:ZKQ+X>B\3:4-/GNY[>+S8Y2T&W<2C!U^\#
MQE16F9HH=L<LZ>8$W'<P!('4XH \QT5[EO&/AG4VT[63"-*G@F>6Q>)(9,Q'
M8(\ (H"D#CG  +&J5M:7L?PQT"T;2]1%U!KR3R0_8I=Z(+MI"Q&W.-A!S7L
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M\P*Y.1D#'..,^MVMK#96R6\"E8T'&223W))/)).22>234K.J*6=@JCJ2< 4
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ME7X@V^J&RUN6TET%H3<W%BZ?O!*&*[-HV8 X&!GMG.3Z92*ZMG:P.#@X/0T
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M6?$WA^'4TL-2O9_EN/WG[HE=F<+\@08Z\@?=KUQB0I*C)QP,XS7!6GA?7(_
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MT<MW))CF380VT>QZ?7/&" =G17':;XOFU/Q%<:7%-8Q75K>O!/I\RLMQY*Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH!!Z
M&@ HHHH ***,C.,\T %%%% !11D#'/6B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBD) !). .YH 6BB@D 9)P!0 4444 %%%% !1110 44
M4$@=30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)N'/(XZT +111
M0 4444 %%%% !1110 4444 %%%!( R3@"@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-=LCX#%Q:08T.WEBNC'<!OO1>6NW(&3W/Z$T ;5IXYM9=%N[VZLI[:ZM;_\
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MI L@8&.4_=..AQU[>] ''&]N--^&6B>-6D+:O)<V]U=3YYGCFD"M$?\ 8"N
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M<05(.2H_.IO$.OKX?ALII;9YHKF\BM"48 HTC!5.#U&3S65X0DN;>]U"SO\
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M]0#U:BF1&0Q(945)"!N5&W 'V.!G\A3Z "BBB@ HHHH **** "BBB@ HHHH
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MR@+RP!S@X';)ZBWINO:WJ4>BZE!I<,FE:F-[*KXEM8V7<DC$G#9&,J!QGJU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7+SZBVJ>/?[ !/V2QLA>70'_+21VVQH?]D!68CN=OI7
M45QT-F^F?%BYO'&+?6--1(W/3SH6.4^I1MP]=K>E %'Q[KJW_@GQ3#8V=S<1
M64$L,US%($"3!,G'(+!"1N[=1R015C4-1;PYIOAK6$8B"=[:RO4S\K)(H57_
M -Y6V\^A(],9$_ASQ+8Z%XO\.6VFQWMKJKW4]E>"Y5-IF!)C=3SD$G!&0<\D
M5H^*--N]1\,^&_#TD2K>3W=MYR1OO$<<.'D;.!P H&?5@.] '>T444 %%%%
M&=K&KII$-LQMYKB6YN$MH8XAU=LXR>BJ "23Z>O%0Z%K\6N"_18);>XL+IK2
MXBD(.' #9!!Y!# @_I5/QA;:U<VE@-(C\^-+Q&O;99_):>#!RH?MSM)&1D C
MO@TO!6BZEHNH>(!=:?:VEK>7WVJW%O*& !C1=H 48QM/I].] '2:MJ=MHND7
M>IW986]K$TLFT9. .U9S>)8[6VO;G4;22U@M88YO-WJZ2B0L%"$'DY4#!Q]X
M=CFKVM1SRZ-=QVUI#>2O&5%O.0$E!ZJV>,$9%>?M\/[YM+US3]',^DZ;<PP2
MV5C=S"58;J.3S,KM9ML9VH",^O' H Z2+QS;2:I=:7]@G;4(K0WL4$,L<GGQ
M@X(5@V-X/\)(]B:MZ?XKM]4T31]4M+2>2/57"PQ[DW)D,Q+?-C@*V<$GBF>'
M)_$-VX?6=#M-)$:;6$5PLQF?CD8'RKUX)).1Z<U/"_A:ZT/7-4,DB'2UGDDT
MR(=8A-M>4$>@<87T!;UH +[XAZ58M'-(C-8/=_8S=)(AVON*;BF[=LW#&['O
MC'-2P>-?M6MW>F6^A:G(UE=I;74H$>V$,H8.?FY7!'3)]0.,Y'A[2_%.@/+H
M TJQN-.6XD>VU9IP#'$[E\-'C+.,D#L>.:TM#TO5[37O%MTUL+<:C,DUG*[J
MPRL*Q_, 21RN?I0!-8>-8+V]TF!M/NX$U>*66Q>3;EQ&-Q#+G*DKR,_C@\51
M/Q(MEL9;]M%U-;&VOS8W<[","!Q((\D;\L-Q'W<\?E6-IGA[Q,-6\*:G>:1!
M]MT\SKJ-P]ZKR3L\97S,X^[GD+GC., "BY\+Z]-X"\0Z0NFD7E_J[WD*F>/;
MY;7"R\G=P<*1CUQ0!V&I^*$LI-12UL+G4&TV(2WBV^W* KN"J"1N?;SM'8CG
MD5%?>,K.W4"VA>XG^R)>-"SI"RQMG:#O(^8[6^7VYQQG)6R\3Z%XPU6_TO2H
M=1T_6O*F9);M87M)E0(=W!W*0!]W)X_-M]I?B;1_%;:SIVGVNMPW]I#!>P-,
ML#1RQ[L2(6!&TACD=: .LT+6K/Q%H=IJ^GNS6MU'OC+#!'8@CU!!!^E4O$'B
M>#P[<:=#-8WERVH3_9X3;JK?/M+ '+ \A3[>I%:FGI<I8Q"\$0N""76'[BDG
M.T=,@=,X&<9P*Y'X@22Q:KX-DAA,[KK2D1A@I;]S+G!/&<>N/J* +%M\0;-[
M763>:7J%G?:1L^T6#HKRL'^X4VL58'IG.!WXYJV/%N)]8M'TJ[-_I<"7$EM$
MR.98W!(*'(!/RL,''([YK#U?P_XANIO$.NZ6GV34[R"VM;6!IE5S%&^Z3+J2
M%9@S $$XP#D$\6/#FB:EIWC;4-4DTBVL=.O+&!,+<!F1T+Y#8'+'<,G./<F@
M#9M?%5O?:1HFHVMI/*FKLHAC5DW("C/EOFQP%.<$X/%9$WQ(MX-,OM2;1-3^
MQ:?>O9WLI$?[@JP4MC?EAD_PYXIO@_0&TWQ#K6R=9=+L[F1-.B _U)E"R3+Z
M$!L >GS#UK)N_"^NW'@3Q=I*Z<1=ZKJ4]S; S1[=DCA@6.[@@#D>XZT =;:^
M+(I?$+Z/=Z?=V#FU:[@EN"FV:)2 QX8E2,@X;!P>W2J47Q!TV34-+@,,@@U4
ME;.<21MO;&Y0RAMR;ATS]#@U#JNAW^K^,K*\:RDCL#I-Q932&1-R-*5[!N<;
M347A*V\6:?:V>BZGH]BD5@JQ_P!J13JWVB-!A=L>,AB  22 .3[4 /'Q(MC8
MG4&T74TL([\V-S<.(P('\SR\D;\L-Q'W<XS^%7K'Q'?W?Q U70VT]EL[.W@=
M90Z'ES)ECSG!V@ #)XR<9KF)_"^O2_#_ %?1QII%Y=ZPUY&IGCV^6;E9N3NZ
M[1C'K^==)9Z9JEK\1-0U46B-I^HV5O&TC3 -"T9?*E1G).\=#CKS0!U3'"D@
M$D#H.]<+-\3[2'3Y=3?0M7&FVUT]K>76R/%LROL)(#Y89ZE<@#WXKNZ\HT2R
MU#7?!'B;0;:R(6^U>^@^ULZ>7&C3,&8C.[<!G  ()QR.< '8:QXUMM)74YA8
M75Q:Z7%'-=SQ[0 KC(V9(WD#DX]>YXJV/$T/_"60: UG<(]Q:M=07+%?*E52
M 0O.[<-PXQTYKCO$OA7Q#J4'B+2TL(+VSFLDATF6:Y"K;@1X9=A'WRV3N]#U
M &*U/%NG7USX<T:[MVALO$5C<P?9/F\P!W(C9#TRI4G/^[Z#- &P?%:-Y"Q:
M;=/+<WLME;K\NUVCW;W+ D*GR-R>3C@5RGB[7K?7/"^GZA%#=0R67B*WMIH<
MY99$G"NN%)#]..O6MW7-'U6V@\/V>CV_VS2K1RE]:&<1-.FS"$L?O -\S#^+
MWKG8O!_B"/P[?V8T^SBD3Q$-5MXH[@;9(A,)-B_* O P,X_"@#J+'Q1#K6I:
MAX>O]+OM,OTMC.(;EES-"3MWJT;$<'@C/&:QO VOP:7\-/"R3MYEU>6^(D:1
M5W$9+,68@ #N?<=2:V$TN]O?%+^)+BRDMS!IS6=M:,Z&5RS!F9BK%1]U0!N/
M<G%<O9^%?$ND^&?"-Q:6%O/JFA1RP3V$TRA+F*0 -M?D C:I&??\0#M_#7B>
MS\36UU);(\4UG<-:W$+E24D7T*DA@0000>:=XLNK.S\)ZK<:C:3W=BEK(;F&
M @.T>T[L$LO;/0YJ;1&U&6T:?4K*&QED;*VL4@D\M<?Q.  6)R>.!P.>I@\7
MV-UJ?@[6-.LH?-N;NSEMXUW!1N="H))/3F@#.;Q;;Z?<:-I-KI%_,]]9&>T6
M(H0515^4LS#! 9>6P/>M3PYK\/B/37NX[>:VDAGDMI[>;&^*6-MK*2"0>>X-
M<_%H^K#Q)X2O6T]Q!ING36UR?-CRKNL8&!NY \L_F*O^"M,O]+AUI;^U,!NM
M6N;R+YU;,<C97."<$=Q_.@#9UG58=$TF?49XII4A _=P)N=R2%  ]R1[55TK
MQ FHZQJ.DRVLEM?6"Q/(C,&5DD!*E6'^Z0<XZ4SQ?;ZS=>&;F+07"WY*%1YG
MEET#@NH?^$E=P![9[=:Q/#.AZGIWC75-1?2+:RT^^L[=0L=P&9'C+Y# #ECN
M!)SCW- ':2RI#"\LAPB*68^@'6L72O$IU:.VG@TVX-M=6C7=O,KHRNH*X0_-
M\KG>.#QP>>#6Q<>;]EE\@ R[#L#="V.,_C7#>'?#%UH_B--2T_39](LY;:0Z
MAIRW"/!-.=NTPJ&(7HV2=O&..M #M)\7Z-I/@_0;K3M(U"/3M1O&M+>(8=XG
M:1Q\V7)Y(8\9].*U;7QM9M%KK:E9W.FR:*BRW<<^QB(V4LK HS Y / /48KE
M[+POKUOX,\*Z8^FDW6F:RMY< 3QX\L22/\IW<G#CCCH?;-O5["ZL[SQSJ5]8
M0FPU*Q@@MQ<RC9*ZHZ!6"G<-S.H&.?H: -^/Q>K:UIVE3:3>QSZC ;BW8-&5
M$8QNW'<"&7<N0,]>,UA>#]4M="TCQ)-<NYC7Q'<P1*7RS,7544%C^I. .20!
M4>A+JFF:MI4NM^&[X-#"-/M[V34(+CR0V.-JA2<E5!;!.!Z9J!O"6OS:%JP@
M@BM]23Q"^LV*SR*T<HW9"/M)QD9!^HYH ZW0_%MIK6KW^DB,PWUDJ2.GF+(K
MHW1E9201V(X(-;LL:S1/&^=K@@X)''U%8WA^;6;L/<:KH]OI.%"K;QSK,S'N
MQ90 !V ^N>U;4C%(V949R!D*N,M[#/% 'G/@/Q#'HWP^\)1W,-Q-_:5R]FDJ
MD';(TDA&[)SC"GD9KH+SQM:V(\1^9I]ZS:#&DMR$V'>C(7#)EAT YS@_6N8M
M?"NOVG@#PQ:#3U?4M$U1;R2V\]!YR!I,A7SC.),\XZ&IKSP_XCO/^$[=],A0
MZ[8Q0VJK=*2&$+)AN@P"W)]CC/6@#<_X3E1J5C9/H>I*VHV[36+8C(N"H!9<
M;OD.&!R^T=:C?XAV<'A^YU6XTR_C-G?C3[JW 1GAE+*HSAL,OSKRN>O2HGTC
M57U[P7=_V>XBTNWFCNR98\J7B5!CYN>1D^WOQ7,>)=-U/2_"'BB6ZLC&;WQ#
M;7EL&E4[E,T"@'!.#E/UH [C2O&$5_XDFT&[TN^TR^$'VF!;H)B>+."RE6(R
M#U4\C\ZZ6N8CTJZU/QM::_=6CV<-A9R6\,<CHSR/(REB=A("@+@<Y)8\#'/3
MT <_IGB@:O%:W%EI\\MG=J[07"NA4[>S#.5)P< ^AS@\54A\>64^@Z+K*6-X
M+;5;Q;.,'9NB=I"@+#=TR#TS65H/A:^L_$]AJ]KITFBF1)#K%O'.K6UTY7"L
MB*QPV[G.%XR.<UE6_ACQ3!X7T70AI4!_LC68[K[0UVH6>)9FDRH R.#SGG/0
M'L =/>>.UMY]<@AT+4KB31=K700Q#Y"F_<I+X/R\XZ^U36OC>VNM3TBW_LZ]
MBM-80M8WL@0)*0GF8V[MRY7."0,X_&LT:+JXU'QS.=/;;J\,:6F)4^8K!Y9S
MSQSS]/?BH8M UE+7P#&=/;=H@47G[V/C$!B^7YN>3GZ>_% 'H%<Q+XTBA?Q#
M$=+O3-H:++/&#'NEC92P:/YN1A3UQTQUKIZY+7/"]SJ'C"PU*V=%LYK9K354
M;_EK$K"1 !WRP93_ ++F@#2M?$<=['I,EM9SRKJ5LUU'M9/DC 4Y;YN^]1QG
MDUR9\60Z7X+M[[PYH]Q%%<ZS]E>.>12T;M<;9#RQR2=V!G SV K:\%^&;OPU
M#?0W+B6&&5X=.13DI:[BZKS_ !9<KVX1?2N?3PKKP\!_8!8J+^#6_P"TDA:=
M,2I]I\W:&!(!VG'/>@"S->W-C\6+J:WTR\NKB7P_%(;..1<AO/<')9MB\ #@
M\XXS5^\\4:)K&C>%M4FTZ\GMM0U& 6A!"?9[C)"E\,#P0W W#CZ5-!8:L/B)
M+KLVFE;5]'2T_=S(Q\T2-(0,D<88#/'/MS7/V7A?7K;P5X3TM].)NM+U=+NY
M GCQY:R.WRG=R2'''L?;(!T%[X\6UNM<MH="U*YET94>YV>4!L9"^Y27P?E'
M3[Q]*Z>PO8=2TZUO[9BT%S$DT9(P2K $?H:XUM%U?^U?'$XT]C'J]O%'9GS8
M_F*PF,[OF^7DY^GOQ71^%;2YT[PEI%A>1>5<VMG%!*NX,-R(%."#R.* ,;XD
MZI>Z;X806<4K&XN[>"22-U7:K3(I7D@_,"5X]>U5+*RT'1_'EI'#H5W::I?6
MTUQ%B8>1&%""1517*AC\F<#'?-:7CW3-0UC08+33;7[1,+VWG;,BH L<JN>2
M>I"X%)?Z=J-U\0-"U:.R<65K:7$,SM(F5:39CC=SC8<X]>] $MCXR@O]%U'4
M4TZ[C>PNFLY+5RGFF56"[1AL9)88YYR/6H]:\<66CI?,;=Y_[.0/>*DL:M'E
M0Y"AF&]@I#$#L1SGBHAX6NHOB!/J<4B#2+N..XN8>[7<640X]"K G_:C6J+Z
M=XET+Q;JT^FZ/9ZMIFK2I< RW(A:UE"*C;L@[D(4'@9'I0!VME>0:C86][:R
M"2WN(EEB<?Q*PR#^1KG]=U-YO%6C>&H6*K=I+=W;*<'R8\ *#VW.R@^P([UT
M5LDD=K"DSJ\JH [*NT$XY('8>U<GK-F]G\2O#^N$?Z-+;3:;*W9&8AX\_4J5
M^I4=Z ,GXA27,-[;M?:/J\OAFTAW2W.E7GE/$Y/+,BD,R*H'L,MUXK3U^\M]
M!\$VOB/1I7F@T^&&56\PO]IM21N#$\L=I+ GD,/<YV+N^UPZC=64.A126K(!
M!>/=+Y;$CD2)C<,'/0-GVK!\5:)_9WPI'A;3R9IYH(M,MMW5V.%+'Z*&8^@!
M]* .XCD2:))(V#(ZAE([@TZH;6W6TLX+9"2L4:Q@GT Q4U !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 5=0U.PTFU-UJ-Y!:0 @>9-($&3T&3W]JM5QGQ7_P"29ZQQGB(X_P"VJ4Y?
M$>OV?BZVT35[/3XDU.&5]/N+9WD"/& S)(#C/RG.1CZ>@!V-%<':>.;^Y\+>
M%-:-K;*=8OHK2:+YOD#LPW*<]MO0CO5RU\72W_B6[TF":QBNK2\$,EA<*RSO
M#QF9"6 88.< =.^>* .GM]0L[NYN;:WN8I9[5@D\:,"T1(R P[9!S5FN#N?%
M^H65KXWN8],L1/H95@ [ 3#R1)ECC)."!C Z8S5JT\4ZM'XBTBRU2ULH[35K
M*6YA:!V+Q-&J,P?/!!#]NG3GK0!V5%<-9^,]5OSHU_9Z7)<Z;J4JJ\:6<RR6
MT3CY93(1L8=-P &,\$XS5G0_%TNN:RUI#-8I)!=30WFGR*R7-NB[PC\M\P8A
M#PN 'ZG% '845Q_AGQ=+XCNU$,UC\CR)>6)5DN;,KD+N!;YLD8)P!SQGMV%
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M15DYY"X<$CVQWK5T[7M5E\;7WA^Z@M'BM;:.Y^U1%D+*^X!=AW $%3_%R.:
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M)+?O,YQD*,'GI658^,M1/B'0]-U"WLXY-4,Z2VL1+26+HA=5=PQ5B5'(PI%
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MN"LV=RNJCH%;! SP !GO5R\U^RL=>TW1IA-]JU'S/((C.SY%+-ENG0=.M:E
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MPQ&2%Y'88!93_=&<@]\8I3X;G OX(]&OX].U"8S76GI>P>3(S?>ZC<H;'(#
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M=2_VS;"UNXF90AC"LH"X4$8#MSGO6CH^EIHVEP6$=S<W"0J$62Y?<Y   '
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M4:\;=+'&JL3'\GWL,3SCL!DT >AT5PTGC/6-0UJ#3] TNRG6ZTA-4MI;JY9
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MJI&[ SG)!X P2 =I145M-]IM89_+DC\Q ^R1=K+D9P1V/M4M !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%-DD2*-Y)&"(@+,S'  '4FL;3/$]MJM]#;Q65]''<6PN[:YDA'E3QG'
M(8$X/(.U@IP>E &W1110 4444 %%%-D=(HVDD941069F.  .I)H =15.YO\
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ME:-C'(&:1BI&01_K3W[#UKK=8T>'7O#UWH]^Q:*[@,,KH,'D8W =CGD5I44
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MP8-G&.V,?CGM5.V\*^(M)UC44TC6K6+1-1N7NI(IK=FGMG<YD\I@P')R1N!
M)Z'OVU% '+1>'=0@\0^(]326V9-5MX8(T9FS'Y:LH)..<[R?P[]:SHO!>IQ:
M!X2TT7-H3H%S%.TGS?OPB,@ &/ER')SSTKNJ* .-D\&W5V_C)+JYA6'Q%&$4
MQ@EH,0B(9S][@ ]O3WJ*U\+>(6UGPYJ5]J&G%](MYH&BAA?$@=47().03LR3
MT''!KHKG7[2U\1V.AR1S_:KV*26)A'^[PF-V6]>1TSUK5H X!_ NJ/X'NO#W
MVNS$D^H&\\_#84&<3;=OU&,Y]ZU;SP]JUQXLGURWNK:W9](?3XP-S-&Y;>),
MX&0&XQ^.>U:L&OVEQXEN=!6.<7=O;K<NS1X0HS%1@]^0>W:M6@#BXO"]U9:Q
MJ'B.$Z;IVI2Z<]NQ@5C#-+D,)I!@=",8Y."?F-=%H$NHS:%:2:LJ"^*?O=B%
M 3DX.T\KD8.#TSBM*B@#DK/PUJ5J?%+>=:,VM2F6/EL0DQB/!X^;A0>WI[UK
M>%]+N-$\,Z=I-R\4CV5NEN)(\X<*H .#T/'3FM>B@#SW5_ >M:A;>)+.+5K/
MR-6NH[N.2:!FE0J4(C+;L;!LXX[FMJVT'5+?Q;?:X\UG*;FPBM-@#)AD+-N[
M\$N>.WJ:T]$U^TU\7_V1)T^PW;6<HF38=ZA2<#T^8=<5JT >;W.FZ9H'PSB\
M$ZUJ%M+?/9O%:1Q-MEN'!RAC4\[@Y7'7D9^G07-CJNA>!5MM+O8?[5B16:XN
M(C()I2VZ0[1@EG); ]372/;PR31S/#&TL>=CE067/7![9IR2)(I9'5@"5RIS
MR#@C\""* (H6F:QC>Y58YC&#(JG(5L<@'TS7FG@71+OQ%\+/#EA=O;#2U9+B
M0H29)5CE+K&1C"_,HRV3D#H,Y'I\L4<\312QK)&PPRN,@CW%,MK2VLHO*M;>
M*"/.=D2!1GUP* ."U'P'K=W:ZS:1ZM9>5>ZFFHQ22V[-*"LB.(W.[[JA,#';
M'2M:Z\)7&H^)-1OK^>![._T@:7+'&"KXRQ+CJ!G>1CMQR:ZVB@#SU/!?B5M+
M\/Z9<:OIKPZ)?0SPS_9W+RQQJRJ&&X '! X//7/KU7BG0_\ A)?"VHZ-]H^S
MF\A,8EV;MA]<9&?SIZ:_:/XHD\/B.<7B6OVLLT>$*;MO![G/MVK5H YH:/=3
MZGI^LZ]-:1C28I#$EN6V;V7:TK,V, +D!>V2<GC&7H=EI6M>/;WQ-I%ZMS8&
MWB#&%@T,EUAEW@_WEB(4_P"_ZBNX(!!!&0>H-11I;6<<5O$L4"$[8XU 49P3
M@#Z G\Z (-9T\:OH>H::9/+%Y;26^_&=N]2N<=\9KEHO"FLY\*/<7EC(^AL2
MVQ'42CRC$ .N."6SZ\8%=#HNOVFO-J"VL<Z&PNVM)A-'L.\*K' ZXPPZXK5H
M X.[\!7E_#X@$FH1VT^H:A%J-G/ "S6LT84+D'AA\@].IKH=!M?$,8,WB&_L
MIY@NQ([&)HXP.[-N))8X'H!SCK6W61/XBM$U*73;6*XOKV$!IXK5 WD@\C>Q
M(521R 3G'.* ,WQ1X=U'6M8T*]LY[6)=*N3<[9@Q,I*E=O'08)YYJ\;;7Y[G
M?/<6*0)"X6&$/\\AX!9C_"!NX ZD'M5K3-;L]7DNHK;SEEM'$<\<T31LC$!L
M88<\$<CCT)K1H X.#P1J<'A?PMHXNK1FT.\BN6E.X"81A@% Q\N=W7G&.^>*
MGC'0[NQTCQ_K4TL!@U+2A&L:D[H_*C<#)(P<[S]/>O1ZBN+6WO(3%<P13Q$Y
M*2H&'Y&@#EM.T2\U9?#E]J3VWDZ9$)H4@+'SI6CV!VR/E 4M\HW<D<\<Y[>
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MUBVGB!P?)C*,)BR!/O,>V_I7GU]K'B*+P;XKUI?$-U]HT75IX[=?*BVR(C(
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MEQ"ZR*6#/N+@Y4A@2['!!Y/L*U=*TFVT>VEAM@Q,TSW$TCD;I)'.68X &3[
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MB9UYR#M!;@CD9K5FM=,TD7VO1>(H8+*?2)?,ATB#8'0#(N!\[#>N0 W?(!H
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M3G+ ;2>_>O1J* /&[HV+^"?BB!Y!DFU"X,8&,N/*CV8]?F#8]\UO33V*>.O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS70M;W1#<3H]S(VZ43!=X).0VUB,C% '7Z9/>W.GQRZC9+971+!H%F$H4!B
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M($4M[ DC%9;=T <E<X)3<''I@UUGAE5O%O-;4DIJ4WF0<G'D* J$#_: W_\
M _:@#0U+5(M.-M%M\VZNY/*MX0<%VP2>>R@ DGL!W. :VHZ]%8WUKID4+76J
M7*ETMHC]U!PTCL?NH"<9ZD\ $\5@7KR2?&G289<^1%HEQ+#GIYAE16Q[[0*S
M+#1WU?XB>./M-_>V=TJ6L=J]O,8S'$8B588ZC?NXZ$@Y% '8:CKK:?<Z=I_V
M=)=5U N(K=9<( @R[L^W(4#'.W.2!BH(/%44^E7EZ+63=IT[P:A &R\)3EBH
MQ\XP0PZ$J>!GY:X3PI?ZGJGBKP5K6L\S7FBW4 D"X#RK(#N] 6C ;\ZZ/P9
MTWBOQS=E<VD^HQPIGHS1PJK_ *G'X4 =K#-'<01SPR+)%(H='4Y#*1D$'TKF
M[CQ5=Q^,I/#5OI FN%LQ?"4W(5#$7*=USNR.GZU1^$DLLOPPT8S,6V++&A/>
M-975/_'0*B3_ )+S+_V+*?\ I2U &UI7BRWO]<N-"N[2XT[5H8Q-]FN-I$L>
M<;XV4D,N>.Q'<5T%>;^()([[XS^'6M''_$ELKJ?4I4Y$4<B;45CZYR<=<<UG
M:1.4U[P-<6LTS6FI+=B2YGFS-?)Y+.'F4<#D @9) ].E 'K-%>8*)='UG6O!
M)>=FUB5;C39VD9F6!^)@&)X,6UF7GNM.\5O/HFHW]]=61U#P]&D,3S6DQ%SI
M15020I^\IRK'!R03G(H ],;<$8H 6QP"< GZUPJ?$=UTG4]7GT&Y&GZ9>26E
MW)#.CNA1@K.%.,J,_7':NZ!! (Z&O*/"WA^?Q-H'BS2WU)K73[GQ#>I<+#$#
M*Z[QE0Y. #T^Z: /4[6YAO;2&ZMY!)!/&LD;CHRL,@_D:@MI[V34+V*XLEAM
M8B@MIQ,&,X*Y8E<?+@\=\]:X.Y\.V5W\2?[!>:^CTM/#T96VAO)$52LVU2,-
MQ@*.G!QSFL[6=5U'05^)USIT]R\UHMH8-\C2&$/$-S+N)QC<S8Z<4 >LT5P&
MIP+I/B7PE-H4LGDZC*]M=1K*S"YA,1<2MSRR[<[^O/7FF?#K2(;B&?5KBYOI
M[NUU.^@B:6[D91'YK+M*DX;@=3D^_ P =W=WMO8I&]S*L:R2I"F?XG=@J@?4
MFIZX7XDV5O=/X4,\>XC7[9,Y(X8-D?C@4S38X/$7BSQ5I6I;_*T\6\-G$LA7
MRHFBW>8A!X8MGYNOR@9XH [VBN6^'.H:AJG@'2KO5)#+=LCJTK=955V57/\
MO*%.>^<UQOC6\SIWBK5-.N)I)["]MX_M<LVPVDBF+,4  SCYLL3@$L?O4 >M
MUST'B675=0O;70[)+R.QE,%Q=33^5$)1U12%8LPR,\ #US70=0<'\:\]^#9-
MMX,FTFY.W4]/OKB*]C;[PD+E@3[$$8/?% &GJGC:XTS3;JYDT29)+6_ALI8Y
M9E7/F>6!(I .Y<R>QX.<'BNPKA_B?)#-X/GCBD'F)J%DLC)U4FXC(&?7!SCW
M'K6;=-;^&_&'B:W74+RSTYO#ZWLT@F>9HI=\B&5=Q/S8 ^I H ]*HKS/0ED@
M\?:?9!7MK2\\/O(\0N27E(DC"RR%< 2$,W()ZGYC6%H\4D'@GP1K8O+U]1DU
MJ*W>:2Z=MT3SNC(03@@CKQF@#VFBO,M;MM3U*[\9V2K<W&HGRAI$]LY MF,8
M(7>#^Z8-\S9(RK#J,"K$T<D_C"#PI>WD7EIH\<T,=V99A<2EW$K!C("6&%QD
MD@$XQ0!Z+16+X3M)M/\ #=K93ZNVKR6Y>(WK)M,FUR,'DY(^[G)SBN9L%3Q3
MJGC.VU662.XL;K[/;;9"AM8O*5DD3!^4DEFW=3@#H,4 =9K>M)HZV2>6);B^
MNEM;>,MM!<@MR<' "JQZ'I4FCW>H7EK(VIZ:+"XCF:/8LPE611T=6 !P?0@'
MVKS%FF\0>'_AIJ6M1EKZZO8UF8DJ77R92#@>HPWXUZK<P.=-FM[5O+D,+)$<
M_=.,"@#&LO$TVMS7/]A6$=U:6TK0/=SW'DQR.O#"/"L6 /!. ,]":T-&U9]5
M2[\RQGLY;:X-N\4Q4G(56R,$C!W#'/(].E<K\'9(U^&]A8$>7=V$DUO=PGAH
MI1(Q(8>O(/XU8\8ZMY6H^'[".4I8WNK"UOI(R5R1&66,L/[S!0?4#'J* .TH
MKR[7DN-+U;QAI5C-<1:7_P (XVHJD4S*+6X!D4!"#\H8)NVCC(/')IVGVOV#
MQ!X GAN+HR:I831WI>X=A,!;JZY!.!@CC % 'I%K>V][YQMY5D$,K0N5Z!UZ
MC\.E3UXC)906/PB\53V;RVL\6K7*(T$S(0HNMH'!Y&#C!KK=3LX-&\9>'=$1
M[K^S=7GNKB[\ZX>033)$NQ"6/ /+;>A(Z=J .M\1ZN^@^'-0U=+7[3]B@>=H
MO,V;E4$GG![#TJYI]U]MTVUNRFSSX4DVYSC< <9_&O,M4-S9:?\ $W1HWD?2
M;;3/.ME=BP@>2!R\:D_P\!@O0;O>O0M"D1=!TJ,NH=K2,JI/)P@S@4 :=<_X
MK\2MX8M;.X^P_:DNKN.T 6785>0X4\CIGK_*N@KA?BG_ ,@;0_\ L/67_HR@
M#H=4UR2QO=.TV&WBEU*_$ABC>4K&!&H+$L%)QRH^[WJYI-W>7NEP7&H6#:?=
M,#YMLTJR>602/O#@@XR#Z'M7'^)--M+GXJ>%#+%N,MM?%_G89VK%CH:WO'$]
MQ;> _$$UJ2)TT^=D*]0=AY'TZT :&E:HFKV[7=LF;-F(@FS_ *X D%@/[N1P
M>_7IC,][/-;6CS0V[7#(-QB5L,P[[>Q/H#C/J*XNZEL[7X;^&;8W%Q%'.+"W
M@BMB%-P2%(B)/16 .X^F>O0R>!Y)XO$WB_3I"D<-M=P&*VBD+QP[X$9@F0,#
M/., 9SQ0!V%A?6VIV$%]9RK+;3H)(W7N#227T*7GV)75KPPM,L.<$J"!D^@R
M0/S]*Y+X8/)_8>KP'/V>WUN]BMO3RQ*2,>V2U0BPM#\;IYFC'F?V'%+NW$9?
MSV4'KZ "@#H?">OMXF\/1:HUK]E9Y9HS#YF_;Y<C)UP,YVYZ=ZVZ\3T^U%GX
M!T36H)[E+V+Q"8T99V"A'OG1DV@[<$$YR.?RK?EAF\77_BNSFUF'3KRPO-D+
MLC^;9Q!$9)4(D4 $[B3CGD$D8  /3:*KV)9M/MF>?SW,2EI=FSS#@?-M[9ZX
M[58H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HK'\57MUIOA35=1LI5CN+.TEN(RR!E)1"P!'H<5E
M:5<:]?\ AS1]4.KVPGO88)C UJ K;E#L@.[(.-V#0!UM%8]WXL\/6!N1=:U8
MQ&U95G#3KF-FS@-SP?E/'M4D?B31)M3BTV+5K.2]E3S(X%F4LZXW9 [\<_3G
MI0!J45A3>-/#$#(LNOZ:I>8P+FY7F08RO7J-PSZ9JI<:KJ$7Q,L=)%PO]G3Z
M9-<&$1C.]'C4'=UZ,>.* .HHK._M[21?+9'4+<7#R&)4WCYG'5 >A;_9ZT^V
MUG3;R\NK2VOK>:YM/^/B*.0,T7^\!T_&@!]MIMG:W,ES%"/M$HVO,Y+NP'0;
MCDX'ITI(M+L8-4N-3BM8UO;A%CFG ^9U7.T'Z9J%M?TE;&.]_M"W:VE)$<BO
MN#XZ[<=<8.<>E2?VUIATZ'4%O[=[.;'E3(X99,]EQ]X\'@>E %ZBJUAJ%GJE
MFEW8745S;OD+)$P89!P1QW![52UJ\2"?3(1K<&G22W: 1R*K-=KSF)03D$Y'
M(Y&* -:BL6[\7^'+$SBZUS3XC XCEW7"_(Q_A//!_E5Z\U6PL(HY;JZBC609
MCR<EP!DX Y/'/% %RL#6]&U'68IK2:;3)-/D/^HGM)&W#T8B4!ORJ_%KNDSR
MV<4.I6LCWJ%[4+*#YZ@9)3^]@#/%12>)M#BM9[J35[)(()?(E=IE 23CY#S]
M[D<=>: *4&DZW;6"V,5WHXM53RQ$UC*R[<8VX,W3'&*R],\#/HL=TFF0Z!:"
MZ&V;R=/E4LO]W/G9 ]AQ6V/&7AHLRC7M.W+(\1'VE<AD&YAU[#DU(_BC0DT^
M&_.JVOV29#)'*) 59!P6_P!T=ST'>@#&;PA=MH8T5CHATP$$6IL9O+X.0,>=
MTSSCIGFICX:U,ZC%J!N-)-Y%%Y*3FUGWJG=0?/Z5NW6K6%K;PS2WD*I./W#
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MN+:4;HY8G#*P]B*Y[QCXHBT Z7:BZB@GU"]CMR[$9BC.XLX!XZ+@9XR1UZ4
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MB\<J=V4[E.\<#!R1BM[3O(M_B;JIOY87>/0K:&2=\89U:3S!D^Q!(]Q7H=%
M'C6@S?8_#?PPO+A91#9S317#"-F,3-#(JJP )!)(&/<5TGAZ.&\\8^._($(N
MI9H&MY'4'E;=5##UVOGIT->@T4 >/*C:I\)-.\,Q(T/B>UN+>(6S#$T$R3 M
M,>X7:&;?T(/7FNLT>6,_%KQ(-X^>QLU7_:*F3<!ZD;AGTS7:T4 8'CF"6Y\
M^(8((VDEDTVX5$09+$QM@ =S7(27UEJ&O_#>5&#Q1I/N,D94*?L^%)W#CYN
M?48'(KTZB@#Q\:E;V%EXDD:TCN(F\6)*LCHSI;*1%BYVKRRJRGIP3^-17?F7
M=C\4+>#[;=RW-K%+"\ELRM,HMU&1A0.HXP.0._6O9:* ,_0[V#4-%M+FV9FB
M:)=K,A7/ [$ UR5WK$>@?%.YFU@3):7VG0PZ?.L+.@=7<R1_*#ACN4^^![5W
MM(VXJ=I ;'!(R ?I0!XQ:2+!X!\/:@Z.EI9^+)+BX;83Y,?GSKN8#H 6&:MZ
MCJMNU]\1+Q=*EU*VFMK$I#)!($F4*06X&2%W!L<$@<>M>@^%?#\GAK27L'O%
MNE-Q+.'$/ED&1RY&-Q[L<5N4 >:Z'J,)^)M]=O>SW,%QHD++=26QCC;;)(6V
MG: %&1@DGKC)-85E)&GPF\"QR';)#J]H9$(^:,+,2Q(ZC .3GH#7L]% '#FZ
M@_X70I\U-IT+RMV>-YG!"YZ;L<XZXKE':X;P[XIN+&&:Y6W\5_;IH+;/F36Z
MM$24QU^Z2".NTU['10!YE)_PB&O:=JVK6;ZJ\5Q;16UUJ(,P:,>8NP*''+(3
MN. < 8/7%;7@F[U634M5M-1N[758K=(1!K%M&$^T*=YV.!\N]>^WLPKLZ* .
M.^*C+_PK37(LYEFMRD:#EG8D< =S56QF\)6::3>62P/J:*D44=L/G=I%"%6
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M(8UCB1411A548 'H!3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,$!T^\>]>W-PUL@C+K&"!N/SXY)X )/M7&ZQX=UG4H?B-##ITJG5HXOL+.Z
M3%(50C[W'(XSBKFO:3)X@6SGN=&U;3KV"TW6=_92H+BWER08WVO@@X4X.5ZY
M(- '=6ETE[8P7<081SQK*H88.&&1D>O-8,OCC3(=#U75Y(+L6^E7+VUVNQ=\
M;KC<<;N1\PZ$UJZ$NI)H&GKK#(VI"W0731XVF3:-V,<=?3BO-]8T77_^$>\<
MZ#;:'<7$FJ7LEW:W*R1B)TD$?&2V=P*D8QCWQ0!V][XQL;/6I='6TU"YOTM1
M="&WMBV]"VWY2<#KGGIQC.<"GV_B_2[S1M-U*U,TRZDVRT@5,2R/SN7!( *[
M6R20!@\UE6]MJ7_"R?[7DTJYCLSHBVQ<M&<2B4N5P&/8]>F>]<OI.@^(M&TO
MP?J?]CW$LVC3WJ7E@KQ^8T<[DAT^;:2HQQGN10!M^&=;6#Q)XWN+Z2]AM;:Y
MME2&[=I&B+1#*J,M]YSP%)!R,5N2>-=.MI]1MKVWO;2[L;3[;);R1!G>#D;T
MV%@0",'GCOBN/U'P]K^M2^,I8=)>V>\N+&\L1>/&4F:!8R8W 8XR5QSQSR>*
MU5BO-4\/:NT7@D:1<R:=-;!"(?-ED=<!4*G[@/4MC/''% '2Z#XFM?$09[2T
MOXH?)BF2:XMRD<JN,C8W1L8Y_J#FN:\;:^FB>*M,&N2WUMX9FMW4W-K))&JW
M188\UHR&"[<XYQDG.<<=1X5AN+7PEI%K=V[V]Q;V<4,L3D$JRH%/()!Y'K4&
MJ75XFJRVMQHTFH:+-:J'9%1]LFYMRLC'+ KMZ XQTYH BTF>#1](O;Z76)-0
MTZ:Y62RF:7SVV,L:+&K#ELOD#J3N&<GFGQ^,=+6ZU&UOQ-IUQI\ N9XKH*#Y
M)SAU*E@PR".#G/&*X5/ FI0^'M>71K$6UN^IP:AIFD73@K^Z*EU;DA1(0<+G
M@8SCMI7^C7WBOPGJL%IX7A\.W<ENJQF=8A)+*KJX7,><1Y3&3USG QR =*_C
M"VCNKBR?3[^.^CLC?1VTB(&GB!P2IW8!!QD,01GI6-'XJM-7\'^']3UFWU&S
M-_=6IB^RL0&D9@4RRM_J\G!W8SZ5J:9J6N:_8RQ7V@2Z0WV=DE^TRHV^4C&(
M]I/R]3N..V ><<JNDZZ_PX\+:4VAW27FFWMD9XS)$3MA<%W!#XQ@<<Y/I0!W
M%_XEM;*>\ACMKN\>QC62[%JBMY*D9&<D9. 3M7)QCCD9JS^.-&CETF.$W-W_
M &M$\MFUM SK(%7<1GUZ<=N^!S6;IUKJ?ASQ9XBG.G7%]8ZL\=W;R0%2RR!
MC1."1C[HP>F.I%9&C>$]3\/W/@*U^R/<1:5'=F\FB9=D33*2 ,D$@,2.!T%
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MV]L&W"&)8\^N!BIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@4 =W'(DL:21NKQN RLIR&!Z$&J2ZYI#W$D":I8M-&"7C%PA9<=<C.1BN/\
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M]*[2B@!D4?E0I&&9MBA=SG)..Y/<T^BB@ HHHH **** "BBB@ HHHH ****
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MBD&0!6"@+\Q(XJWIVI:_JM]XMT:UU"XAGLH[>33Y[J"(2*9$8X=0N"N5[@,
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M>_:%M%M)D,BE+A%8L-_RYSEB>" <X/'% &!I&I>*M4C\/ZS;EFL[T))?0SF
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M,W7/6DL_"BZ=::9;V6KZA"NGVIM(\^4V^/Y<!P4P2-HP1@]>N30!H:#=?;=
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MDD(E;8S*8L$+G:#R><5Q][)'K_P?LO$EU*\NISZA;R32>8WRL;M5,6,X"J,
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M$$+M&YW##=CR%^[[=*S='O[_ %/3_A==ZG(TMV]U.&E;K(!#*%8^N5 .>^:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+^80I88( ) QWIBZYJ^N6/B:_P!+O1:-I%W-:6T!B5TE:%06\S(W89B0-I7
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M1L19;-J;-F[=G&W.[=SUQ[4 <K8>,M5N?!_A:\N7CBDU&_-G>WJH L05I%#
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MW,Y)R68]R222?4T <E::GKWB2PO-3T6^M[=[?49+:*UG0>4\44FQ_,;:7#,
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M5Q+*J!B9-P)VDL% 4J< G//#U\!PC0M'TEM9U!XM)N8;BW=A%N_=<1J?DQM
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M7@SYCW%W$P'>,PY;/ME5/X"I_'&H2VU]X9L6=H]/U#4U@NW4D;AL8I&3Z,P
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M 4 >BU7NKVVLS MQ*J-/*(8@>KN<G _ $_@:XRP:,_$VZMS.\MG+X>@F82G
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M.DTY_>2I8S)(Z@  .Z3@L  !@\>U%UX6O;W11H]S_P (_)IJ@*ML=*?8H'3
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M5K6UK!96L5K:PQPV\2A(XXU"JBCH !T%4H_$6B37%O;Q:Q8//<@M!&MRA:4
MD$J,\C(/3T-36&KZ;JJRMIVH6MXL+;)#;S+($;T.#P: *(\):"MS/<C381/<
M$--*"=TA'0L<Y/XT\^%]#-M;6W]FP"&VF,\" $".4DG>/]K)//7FK%OKFDWC
MS);:G93- N^41SJQC7U;!X'O38-?T:ZNX;6WU:QEN)T\R&*.X1GD3^\H!R1P
M>1Z4 )_PC^E?:KNZ^QH)[Q0ES("=TJCH&.>0.WI7,ZIX15O$_A<V.EJNCZ4M
MR'$<H3RS(JA?+&01@KSC'7C-;VD>*M(US4M0L;"\AEFLI?*=5D!+$*I)4=2
M6QGID&KSZMIL=W+:/J%HMS$GF20F90Z+UW%<Y ]Z ()?#VD3Z4^ES6$,EC(Q
M>2%AE9&)R2W]XD\DG.3S2W6@:7>FV:XM%:2U!$$H9EDC!X(#@[@#W&>:D36]
M)DLTNTU.R:V=Q&DRW"%&<_PALX)]JR[CQ#:Z-#KFI:GK=E+8VC B*( /;C8,
MHV"=S,<D# /- $NJ1ZQ8VUG9>&M/T]8#NCD::0QK;+CY65 IW<YXX^O.1H6.
MDV=CHL&DQPHUG% (/+=00R@8Y'0Y[_6N8O/%[_\ "0^%S:WUE_8^I1W+W+9#
M%#'%OYDW8 !//';K75V.H66J6B7>GW<%W;/G;-!('0XX.".* *.B^%M"\.K.
MND:5:V8G/[WRDQO]C[<GCI3=(\)^'] NY[K2=(M+.>?B1X8PI(SG'L,]AQ56
M3Q;I]UJ>K:+I]_:_VG8PJV)"&&\ASM"Y!8J$R<'C(J'P9XKM]:\/Z,;[4;/^
MV;RS6X>V615D.1DD)G.* -N_T?3]3EMY;VU2:2V?S(&;.8V_O+Z'WJ(^'=),
MU]+]BC\R_7;=MDYG X ;GD8X^G'2IIM8TRWOH[&;4;2.[D(5('F4.Q/( 4G)
M-5_$FOVGA?P]>ZS?;C!:IN*K]YR3A5'N20/QH CN/">@W5E9V<^E6\EO9'-M
M&R\1<8POH,<8Z4H\*:"L;I'I5M&'N?M;&-=C>=S\^X8(;YC@]L\56MAXJGTU
M;R2?3H+QX]XL3 S(A(R$:3=DGL6 Q_LU<@UB*UT6QNM;N+>PGF@1I5FD$85]
MH+ 9/8YH 6;PYH]SIK:=<:=!-:-)YS1R+NW29SO)/);/<\UHK#$D"P)&BQ*N
MP(% 4+C&,>F*KOJFGQ16\LE];+'<LJP,TJ@2D] IS\V?:JG_  E/A[[%+>?V
M[IGV6*3RI)OM:;$?^Z6S@'VH ATWP=X<T9[I]-T:TM&NU*3-#'M+*>J\=![#
M JQ-X<T>X@L89=/A>.P(-HIS^X(X!7T('3TJQ/J^FVPC,^H6D0E0R1EYE7>@
M&XL,GD <Y]*;#K.EW.FG4H-2LY; =;E)U,8[?>!Q0!4N_"7AZ^UN+6;K1[.;
M48B"MP\8+9'0GU([$]*74O">@:QJ4&HZCI%I<WD&!'-+&"P Y /J![U976])
M>QEO5U.S-I"Q66<3KL0CJ&;. ?K1%KFDSW%Q;PZI923VR>9/&LZEHE_O,,Y
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MF))Y]3UH ZJRMS:6%O;-,\QAB6,RR'+/@8W'W/6IZ** "BBB@ HHHH ****
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MWEF&(!_H2",TOC);G1?$>B^)["U:YE.[2[F%.LB2\Q9/8"4*,_[9KMZ,9ZT
M>;^#=,O]-UB?PG=JTECH]Q_:$-QM"I(LH)C0#VD,Q]MBUEWA@GL_BW;V9CD=
MH\K'%@D_Z*H. /\ :!'UKUS'.>]% 'E]SJ.DZGXF^'#+<VT\/EW!&X@J3Y
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M#^Y\Z:1UP &4X" ]V(SUP,<@&NOCW36N[&W:QU-#J$!FLG-M\MQA0Q1<'.X
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MK,7F1?ZK[7YV<[\?=[9SF@#L-+\3W&H>-=9T0Z;/'!IZ0 3$H02X=BQ^;."
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MI-8C5[VZDMYG9&!CEB5 WRL2#E2<'% &Y%XML)=3L-/FM[RV.IHSV,TR!4N
MHW$##%E.TYPP4_C7/^$M=CTC0-4EOY[JX/\ PD-S8VZLYED=C-LC0%C]!DG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM"O-;MM,:PE@2YT_48KY!/G8^S<"I(Y'#'GVJE#X>U>+Q'KVJ,UC(-1LH;9
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M2Y$L4>Z3;"SKRJC&#CH!TJM\/H[K[=XKDN-2N[G9K<\6V;80<)%ALA0<@8&
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MF4&X6<<"3<1C..,8VXXQB@#FM8\0ZYHUUXJT@:@TLEGHQU:PO'A0N@&X&-P
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MZ3JU]H&A^*=0.H7-U-_PD3V,?VCRRJEI(HQ(3M'(!Z9"\ 8%>J*H50J@  8
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M"B,\DDH9L_.K#:H4<8Y).:W=&T>UT+3$L+,-Y2L[DMC+,[%F8XP.68G@ >@
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M&LG_ (06T-Y>WDFJZK)<WUD+*XD:9/G4;OFQLP&PQ' V]\9YH P-+UG7TN?
MMS=ZPUS%KUMMN;<P1JJM]F\T.I W;LCG)(.> .E36^NZS9OXBT"]U*276XYX
MQIDS11KNAFPL3A0H#;6W;^#]T]*W8_!=I&OA]5U"_P :$-MIS'R-GE_/\G/R
M\=OSYJIIL4/B?Q7:^(I-%O; Z;!+;Q-?P^5)([L 2%R?E4*<'OYAQT- '6Q(
MT<*(\K2LJ@&1@ 6/J< #\A3Z** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IZA/>P+;FRLENB\Z)
M*#,(_+C)^9^0=V/[O>N:^*C21_#76IH9YX)8H@R/#*T9!W =5(R,$\'BLSQ5
MH\.AQZ%+976H![KQ%9M/OO)&$FY@&!!;&#M!QC'IB@#T2L.^\0O8^+M(T,V6
MY-1BGD6X\W&TQ!21MQSG<.]<IKD5_>ZWXOM'2ZN9C90_V.UJQS;2%&XR#^Z<
MOAMQQE<<X&*9?:.Z>*? &F:A/<22BQOA<N+F1FD?RXB_SD[L%L]^G'3B@#T.
M\O+>PMFN+J58HE(!9O4D #ZDD#\:GKQ6_@27P+J%G.\LT.F^+5MK7S968QQ?
M:(P%R3DX#$#/:O9H(HX($BB&(T&U1G.,>YH 9'>6\MY/:1RJT\"JTJ#J@;.W
M/UP?\FIZ\GG9M"U3XG:KID/^GVB12P?,3AC;!BV,\\Y;GTK1O0=,3P1JVB7$
MSRW]Y!;7.96<7<,D;,[OD_,PV[@W4<]J /1Z*I:Q<SV>B7]U:IYEQ#;221)C
M.Y@I('YBN$\.Z>VIVWAKQ)#XDA E0+<+'"Y:^+I\T<F92"P.3]WY<'@ 4 >D
M45Y99QIIGCW^R+J\NI/#]W>M-8S22,1]L5<-;&0MDH.2!T+ KSM(-JXAG\7:
MUXLTR75XK"ZL9ECMBR.9;6+RD99D(D4#+%B3CG&"<8% 'I-%>9?V2FM^/UTZ
M_P!5O[JVD\.03NT-S) LLOFD>8%#?)G .T''KFI=)^S>*-(UB^U'5+BRU*PU
M:97GBEQ):+%)\D8!R-I0#(Q\VX]30!WD4]ZVJW$$EDJ621HT5UYP)D<D[EV8
MR,8'.><U<KSZ3[3_ ,)QXSMX=3EM<Z- \4TLK,EL[><-X!/R@8!P,=*Q)]>U
M#0=*U^&XTJ72O$%II0ES;R&:VFC#A6N(_1ANR01GIG.* /7*IZM>OINDW5\D
M(F^S1-*T>_:6"@D@'!YXKF-&T<6_B&PUBT\06[6=W:LGV2WB<I=\;A*2TK?,
M/[V,G.">:W_$O_(JZO\ ]>4W_H!H R]/\4ZCJ7A^UUNWT%GM+B%9U5;I3)L8
M9^[CD@=LUU%>?>"].O/^%>^&+PZ[/%:P6MO/+!(L0B\M5!(+! P Z]>W-/M[
MJW\2:[XNAU&1R--$:6L)D:/R8VA#^: ",,6)^;J H'% '?54U.>\MM-GFT^S
M6\NT7,5NTHB$A]-Q! KS+PW=7+O\+II+J=GN[.Y%PS2L?.(@W#?S\QSD\U7U
M.>4_#SXCF*]N5^QZK.+=H[AP8P$B^4$'[N2?EZ<]* /6#>P+>0V<DBK=31-*
ML6<DJI4,?H"RC\:L5Y_<:?:3_&+3Y)H\LV@R.27(R5FC [^YXZ50MQ-IFJ:O
MX%DEN'DU"Y6XL+AY69_LLG,F')R#'L< YZE/6@#T^L7Q5XFLO"6A2ZM?AFA1
MT3:G+,2<<?09;Z UL1HL4:QH,*H"@>@%<CK-O/XAUVXM$L;>]TZRMWMYDFN#
M&#-,GS8PC9*Q-C_MJ: .NCD26-9(V#(X#*P.00>AIU>?_#]I=1\'W_A'5W==
M0T=VTZ=HY"&\O&8I%88(^7&#_LURJ:Q=VNEZ'>3F5[CPK=&VUT^:V&CW^4&8
M9^<D'S<GI@^M 'M5%<#J#6YTRQN9I[I9=;U9)8;6)\"X7!,<39^XA10[8[[N
M#G!Y;4Y[R/X?^/(?M4UNUAJP6W6WN7Q I$)**>,KEVX(QSTH ]GK#T7Q ^K:
MSKFG26?V=M+GCA+>;O\ ,WH'!Z<<$<<US6IVMOH_C'P_H*S70T_5Y[FZNO/N
M7?SY4C7;'ECPI)+%1P2.F.*R[;3;B*_\?6&BW$5O/_:-D81<2-L?,<3&(D<A
M6Y3CH#@4 >JU!<WEO9B(W$JQ^=*L,8/5G;H!_GL:Y?P-J,=T^KVLFEW.E:A;
MSH;NQDD$D<19!M,3#@H0N>,<YXJI\0[*WNM5\&M,FXG6TCSN(^4Q2DC@^H'Y
M4 ;VE^(7U'Q/KFBO9>2=+$#"7S=WFB4,0<8XQM]3UK<KRZZTFUU'Q5X_25YQ
M'#I]FT8AG>/#"&4JV5()(QQGBIM,NQKUKX5@NII;Z_F\/K=36LTNR##",&=V
MP27SD# /4GCK0!Z)<7EO:- L\JHT\@BB!ZNY!.!^ )_"IZ\9TX#6M ^%]WJ4
MDES<273Q/*\C%F7RI>ISG/RCGJ<5[*NT(H7[N..>U "T5Y(EZ?M'A75=.N9Y
M8+S7I(3?S38ENXV\[*E!QY8V@*"<C:.!5W2]/,NI^,=0,^H7%QI&HO+8Q->2
ME0PMU8*1N^8$G&#D>F.<@'IU%>;^&[)]3M/#'B:#Q+"K.J_:/+A<M>LZ_-')
MF4@L&R?N_+@X  KT*[M8KVTEMIMWERJ5;:Q4X/H1R#[T 345YOX0DFO8;?PI
M?22O?:%>2?;I6=MTJ+S"Q.<_O Z'GJ$<53LHKKQ5I%[JC>(8=-U*PU.;S91
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M"PZ%<LP"_P .T8QB@#UJBO)M2TY;NZ^)8FO+\BPC2:T O)0(7^R"3<,-V;D
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M$Z-:B*[*FX14VK)M VY Z@8''3(!ZU>N]:TRQG\FZOH(9/ERKOC&XX4'T)/
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MXDT,0VLQU>Q$5V";=OM"XE !)*\\@8.?3% $(\(^'A:7UHNCV:V]^P:YC6,
M2$8QGZ8&,=#S4Z>'M)CO;6\CLD2XM(S';NI(\M3U YZ'OZ]ZH7_C?0+/PQ>^
M((M1@N[*TW*QMY ^Z0#[@QW/'YYZ4:CXCCL(K#5EGBFTBYF2VF92#Y+.VU7#
M#J-Y"L#Z@\8((!=3PUHZ7SW:6$:RR3"=P"0C2C_EH4SM+_[6,^]./A_2S>7E
MW]EQ<7J".YD$C RJ.@//09.!VS6G6/K>LFPNM-TVVVG4-2F:. ,,A%52TDA'
M<*HZ=R5'?- %[3].M-*L8K*QA$%M$,1Q*3A!Z#/0>U<M-X=N+WXF3ZO<V4HL
M#IB6<<\=QY;!Q(SG[K!MI# ?4<CO6TMXB^)OLQUZW80V):73BJ>8"&'[]F!R
M!@XQ@#G-9KZHH\*3W \9V"L]TRQ:IY49C4>9_J@N[:Q"Y3.<GKUH U[WPYHV
MH:5#IESIT#V4#*T,(7:(ROW2N,;2/;UJN?!WATQ7<?\ 9%J$O JW 5<>:J@!
M5;'4  <=.*74-7?2->T^WNF#66IR&WA<C!BG"E@I]58*V.X(QSD8V9)$AB>6
M5U2- 69F. H'4DT 4)]"TZYCM$D@;_1,_9W65U>+(P=K Y'''7I45WX8T2^T
MR'3KG3H7M8)/.B3D%),D[P0<[B2<G.3DYZTCZW9W]C?KI.HVSW<$)?C#E,@E
M6*Y&0<<'H:SO"_B1;CP/H6J:S>1+=7ULCDD!3(Y7)"J.O )P!T% %Q_!GAM[
M:\MVT6S\J\*F=?+'S[<;?IC QCIB@>#O#J_:-ND6RFYA%O,57!DC'\+$=0<G
M/KWS2:IK%G/HUK=V7B*RL8[B:,0W9V2+*-XS&H)P2W*\<C/M4]YXGT'3WN([
MO6+*%[8 SJ\Z@QYSC<,\9P?RH <OAS25GL)A:#S-/4I:,9&S"I&"%YX!''TX
MZ5+8:+IFEW-U<6-E#;S7<AEG>-<&1CR2?J>?K4*>)M"EO;6RCUBQ>YND$D$2
MSJ6E4C(*\\Y'(]:FDUK3(KT6;WT"W!D$00OR7(R$_P!['..N.: ':II&GZU:
MK;:E:17,*R+*JR#.UUZ,/0U7NO#>CWERMQ-8IYRQ>1OC)C+1?W&VD;D_V3D>
MU9OQ"U74=#\#ZEJ>ESI!=6R*RL\8?@L >#QW]ZU;#Q#HVJ7MQ96&J6=S=6W^
MNAAF5F3MR ?7B@#0CC2*-(XT5(T 5548"@= !5&ZT/2[W4X=2N+**2]@0QQS
MD8=5)S@$>_(]#R*2TU[2;Z[%K:ZC;33LI=420$NH."5_O '@D9Q3HM:TR>]6
MSBOH'N&+!8P_+%?O8]<=\=.] %,>$=!&GIIXTY!9I+YZ0!VV+)G.X#/7/.?7
MFDU'P=X=U;4X=2U#1[6YO80 DTBY8@= W]['OFKB:[I,FHKIZZC;&[8L%A\P
M;F*_> ]2.X'([US7Q#\6C0O#&H2:9JEM#JEN4 5E#G)8?+@\!MIS@\XYQ0!V
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <C\4();CX::['!$\LGV?(1%R2 P)X'L#6#K6OV5E
MXTLM9U">^BT"^TP06][ L@2.99&8A@!D!P5P<<[17IE% 'E;V6C:?K'@&WL+
M5[?38[R[ECCNMQ95>-]KD/RH9R" <=1T/%;$ L;?XPW9VV\446@Q1J<!50B6
M0E1V&%()'I7>44 >*6!MH/A/X40"..6+7H9'4##(%NF)8CJ,)CGTQVK;O)Y]
M/\1S7.B:A'?07.K1K>Z%=(#()-ZCSX&'( PK\Y7 )R,8KU"B@#D_B5::A>^
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MID$J6-QXGCO,W.XF0%'WRX?E4W'N ._<5H0M9#QM\0))#" ]C;*';'S8B<.
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MLT22IG:X!&5(./H>13Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+=TPQ!QU )!//MGJM&TJ>7QMJWB26"2VAN+6&TABD #N$+,SL.W+  'G@^U
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M#!)M.D)7:/D/)89W8!&1WZU1@M/%^B:AH/B&]L)=8N!ISZ?J,%NR+,N9-Z2
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M)X;FXNI@UR^TPK$]PTGF!@><*>%QG=V YJP^EWVB^*M8CF\()K]AJDZW%M=
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M[O1#E5/G-D \9 J?QYI^M2KI&JZ):Q:A+I5T;A].E;:+A2A7@GC>N<KGO^1
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M>T'5)?MVM:=:7@MXB%-W&)$B7JQ ;(&>Y]AZ4 :=M>6M[&9+6YAG0':6B<,
M?3(I\4L<Z;XI%D3)&Y3D9!P?UKR] NB>!]%L[&V2P;Q1JZ!T@01^3#,Q<J /
MND0J$^O-=M=ZJ\.N6_AW2XH$N?LAN6:0'RX8E8(H"C&23P!D !3[ @&T98Q,
M(3(HE*E@F>2!U./3D4^N)\07FJS_  WNM:N[#^S-:TV-[R./S X1XB3D,.JN
MH(Q_=<@UUFFWJ:GI5G?Q@B.Y@290>P901_.@"U17-2:_?ZAJ>L6.B06TCZ5L
M60W#$":5EW^6N/NX!7YCGD].*QH_B#>:HGAA]%TR"1==CN-OVF<H89(E)96
M4\!@1D<G'2@#JM<T&T\06\$%ZTPCAF2X01/M^=#E23[$9JQ<ZII^G/##>ZA;
M02R<1K/,J,_T!QG\*DL&NWT^W:_BBBO#&IF2%RR*^.0I(!(S7GFMWNH^"_%>
MLZOJ6BOJWAS5%C\VYMT$DMF%0*4=#UCZMQP,GN: /1)HH-0LIH&??#,C1,8W
M(.#D'##D'KR.1571=#L?#^GBSL$D$>=S-+(TCNV ,LS$DG  ]@ .@KF['7](
MTO0="LO#KK<VVH>:;)TB>18XERS$J@+';D+CCGJ1@TMIXTOV@2VO=(DM]3FU
M+[!;>8DD45P-I?SEWJ&"A58D<G(QGG- ':5!+>VL-W!:2W,*7-P&,,+. \FT
M9;:.IP",XZ5POC'7?%&F^#?$,IM8+2:T>.."]1CMGBD*@LBY)1@6QR?<9K8O
M-7NK7QCX=TR\T^RD>]CN6%VC$M$44$A01P""N3GG!XH ZFBN'N/'%V/"]QXL
MM+.&?1;>9P8]Q$TD*2%'E4]!R"0I'('4$XJ:3Q5K-YXCOM(TBPL)!%817L%Q
M/<.%=7+ 9 7(/R]/QSVH [*H;J\M;&+S;NYAMXR<;Y7"#/IDUG>%M<'B7POI
MNLB'R?MD"R&/.=A[C/?G-<YXYNK[1-?T37K&W_M)H$G@DTQ.9I(V"LTD0_O+
MLYSU#8SD\@';Q2QSQ)+#(LD;C*NAR&'J"*?7+?#^2UN?"XO[.\CN8[ZYFNR(
MLA(6=RQC ."-IX.0,G)P,XJ_K>NG3M0TK2[=$>_U25TA$APB*B%W=L<G  X'
M4D<CK0!LL,J0"1D=1VKG_#L.@Z1<WFE:9J<<US),]U-;M<K)('9CO;'49;KV
M!]*H#Q-J$TGB'19(H(=8TV!9XY%+>5-$X)#J.JD8((YP0.33/AS9";P3X<OK
MVVM7N8M/C%O.JYD570;LD]">^* .SJO;W]G=S3PVUW!-+;L%F2.0,8R>@8#H
M?K7+^+=3UBT\3>%K/3I;=(+R[E642;LN5A=@"1_#QGZ@?CSPU'5-$\1_$._T
MNRLYA:-;W,RSR% RK:JQ50H/S$ \G Z=>P!Z5+>VL%W;VDMS#'<7&[R8F<!I
M-HRVT=3@<G'2IZY*3Q)Y_B/PE&NFV[0ZO;S3Q7,C9E@Q$'*@8XR" 3GMTHT'
MQ=)K^I&*V:R(BN9H+NS+%;FU";PK,">0Q5>P W=3UH ZMW6-&=V"HHR68X %
M4?[>T?\ Z"UC_P"!"?XUH5Y/X*U!M.\+>(I$\/7%^L6K7S!HUA*'#G@AG#8'
M? /MF@#U9'22-9(V5T8 JRG((/<&G5R>H:O>:%KVA>&=+TVU:WNK680/).R^
M7Y*K@$!3QAATSG';K6++X]U^#PWJ^K/I-@?[#NY+:_47#?O=A&3%\O'RL#\W
M?B@#T:J]U?V=DT*W5U! T\@BB$L@4R.3@*N>I]A7+W_B;77\5W.@:1IEA)(N
MGI>Q3W-RRJ0SLN& 7(.5/ SUSD=*YW5/$(\4^'?"NH36?V2\B\3VUO<0$[O*
ME21E8 ]QQ^M 'J5%<O)XCU"_FUM=#MK:8:1)Y+K.S W$P0.R*1]W 8#<<\D\
M8&32MO';WL_A>[@MXET77@46XD)WPS!21$1TR2& .>H/M0!VM%<9K7C#4M+T
MVZU&"PMKFUCU..QB/FLK."ZQLV,$$ARRXR/NDY[4J^(O$C>)[WP]_9VF"\6T
M2]MYOM#F(1EF0A_ER6!7L "#VQ@@'945Q.G^/3J6A:%.EIY5_JHF_=A'F6+R
M25D;"#<PW8 ''WNHQ5:;QUK5KI44\_A\QW']L1::WG>9"LJ.X"RQ!U!(.>AQ
M@]S0!W]%<-<^*]<B3Q5836MA!J6EV*WMO)&[21,C*YP00#D%#['CI6]X/GO;
MKPAI%Q?R))/+9PN74DE@8U.6S_%US0!MTU)$E7=&ZNH)7*G(R#@C\""*S/$>
MKKHFA7-[OB64 1P^:P53*Y"IDGH-Q&3V&37%_#>]@TG7];\(+JB:A%$PU&RN
M!*)#)')_K 2.XDR?^!4 >DT5QNJ^,KNW_P"$GDL;2!T\.QK)/',Q5KC,?F,%
M(^X O0D')SP.IAN/%VOOJ&C6%GH^GFXU6PENXC)>.40KM(#'RP<8<=!G/''6
M@#N**X>]\9ZJMMJ#Z?I0NKG366*>VBAFD\^4(K2)&ZKA<;L MU(Z 8)FOO&5
MW(UY%I.GR/<V=M'-)#/:S,S2.F\0_(IV-MQDGN>G6@#LJ*XM/%^L7FM:7IMM
MHL=M)J&F/>@7LK(\+J4!1UVY&-W;.>.E9Q\?ZW'X9EUR72;%8=/OFLM007#%
MF99A$S1?+T&0?FZ\CMD@'HM%<AK/BV\ANM6MM'LC=3Z6J^9&;>:3SY"@?RU*
M*0IVE>3GENG&:B7Q;K5[X@M-)LM&A@>ZTD:@OVV5T>)MRJ4D4+D$%B,#.?:@
M#M**\UN_&.M:IX=\+7]FEO9R7VLK97<99F^9'<$*PQ\I,1SWP<>M>D)O\M?,
MV[\#=MZ9[XH =56XU*PM$+W%[;Q(LJPEI) H#MC:O/<Y&![UC>/==F\-^!]5
MU6VQ]IBB"0D\@2.P13^!8'\*J>(;A?"?AG2X8K"WOH1>6ULYN6Y#/(H\W&#N
M?<=V21SSF@#KJ9YT?G>3YB^;MW[,_-MZ9QZ5SR^(KJ'QO/H-]%;PVYLC>6MQ
MN.95#;7!SP"O!/L0>*RO%.HWR?#L^)C%'#J-@%OX F1A PRK9Y^:,D$=L^P-
M '<T5%;3I=6L5Q']R5 ZY]",BI: "BBB@ HHHH **** "BBB@ HHHH ****
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MK.G\$:G<>%_%.D&ZLU;7+R6Y60!B(1(%!7&/FQMZ\9S7>*P90RD%2,@CO2T
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ML*IC=\V,=QP#GF@#GW\,>(=-\2:A>^']8LX+#5)!-=6]W;M(89=H5I(L,.2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%6A07:));2:7$DJ2?=*E!D'VQ7">#-9UC3_AMX2:VNRMM-KR6*F2,,9;5I6
M )Z="/I7?0>!8(] @T&36=6FTJ*(0?9B\2;XP,;&=(U?&.#\PSWJYJGA.PU*
MQTJRCEFL;;3+B*YMX[0(JAH_N AE/ ]!0!S]_P")[NR\7OIFIWMSI*RWL(T^
M1X$:TNXODWH9-I(D/[P8)'\./>Q;ZAKWB6TU>[T;4XK.>RU*2S@@EC5H6$3
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M[HX^4 <?2N*\0>)=9TR2YNH=1$WD:Q!;>1;Q*T$<#NB;)'9=WF_,20K''R\
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MOO 5BA;;GL214M]\.=/OXM8MVU35([3591<3V\<J!1,-O[Q?DSD[!P25]NF
M"E)-<6GQ4UJYDU&\:VM-%BN1;C9MQODRH^7('R@YSG/?& )-(U'Q5J8\/ZO
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MY3 8CMD\X[4 9^F^)KKQ LUSH6GP7&G1R-$EW<W)B$[*<,8PJ-E001N.,D'
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M60NDZCJ?@C7XH3)<3:#K,[Z.TC%B\43*WDD]64X>/!]!Z4 >MT5YOJNMF_\
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MK.U[49='\/ZAJ<-NEP]I;O/Y3R; X52Q&[!QP/2O)-(LX[?P+X*UI))SJ/\
M;D<'VAIF9O+>Y=&3D_=(ZCOUK6N7MO$6A_$:35E22_L);J"%7/S6\*0YB*?W
M0QW-D=23UQ0!Z3H]\VIZ)8:@R"-KJVCF* Y"EE#8_6KM>56%S'?ZEH.A:A/9
M)9R^&[::UBO83)'-(<B3 WJ-X4)CJ0"<8R:9)HD*ZKX#TJ;6+K5;?S;^W>X,
MKIYR+$_RG#<X^[GJ0.M 'K%%5M/L+?2].M["T1DM[>,1QJSEB% P!DDD_C5F
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;;?Y)2!08]P ;!QQD #\*</"V@"RCLAH]B+6.3S4@\E=BOG.X+C .><UKT4
M<[#8:Q?Z\LFJPV$6FV$[2V*P.SR2DJ55GR %PK-P,\D>G/1444 9K>'](?4&
MOVTZV-T[*[R>6,LR_=8^K#L3R*E71]-356U1;&W%^R[&N0@\PKZ%NN/:KM%
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M$UI;?ZB%H%VQ?[HQQ^%3R:#I$LMG+)IMHSV0VVK>4,P#IA/[OX5HT4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 445'<&86TIMU1IPA\L.<*6
MQQD^F: )**X%X/&6F:WH=O<^+(+T7EUB:!-+2+]TBEW.[<2!P%Z=7%=]0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQI_A3Q'-874=Y=3ZKY%IJ,:CR[F6?RD5U XPC/M..#Y9/4FO2 JA=H4 >F*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tardioagreementa01008.jpg
<TEXT>
begin 644 tardioagreementa01008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **@O;VVTZRFO+R98;>%2TDC'@"N,37YKC
MXJVUHEQJ"69T>:=[2:%HUW"2,*X4J"3@MZD<CCI0!W5%<CIWBO0-,\-V]])K
M-[=65S>R0175W&[-YAE*[#\HVJ#D#<!P*TH/%FEW5JDT O)&=I%6 6D@F/EG
M#G85#  D<D8Y ZG% &Y16-!XJT>[TRSO[6Z-Q%>,4MUBC9I)&&=RA,;@1@YR
M!C'.*R=1^(.F6^GV%U9)/=BZU--.8+ ^89-X$BNN,A@,X7&2<8!% '7T5D7?
MB33K,NKFXDDCA%Q+'#;2.\49SAG4#*]#P>>#QP:KW?C30+-=.9[TR+J2-)9M
M#"\@F 4L=I4')P/N]22!B@#?HK 7QCH\EG]KC>Y>$1)-(RVLA\I7^[O&,J3U
MP>@Y.!S6_0 45F:CKUCIEU':3-+)=21/,L$$32/Y:X#-A1P 2![DX&:I2^-=
M B@TN<WQ:+51NLW2%V$OREL#"\' ^Z><\8S0!T%%8EEXLT:^TN]U%+EH8+&1
MH[H7$3Q/"P .&1@&!P1CCG-8,&N3W?Q9M;&*XOX[1M'EF>TN(FB4-YD85P"!
MG@GUQR..E '<T45B7WBS2-.-P;B>00VKB.YG2%WB@8XX=@,#J,^F1G% &W17
M&>*?$0@\2>']&4W@M;\S/</:Q2EG1(B5".@S]X@G:<C'/!K&MY[JZ\0W_A*?
M6M=*65DK0WJ12+-YKR289V50&"JJJ"WRMSUSP >F45R_AW6-+MO#)N_[;O=1
M@%T\)N;Q#YKRE]IC5 H/WN H%7[;Q3I%RE^?M#12:>ZQW44L;))$S %!M(R=
MV1MQG.<#F@#9HKGW\9Z)"FHFXGGMWTZ(3744MM()$C.</MVY*\'D9 QSBDM/
M&NB7V1;2W$C%HUC7[-(#*75G79D8?Y58DC@;3F@#H:*JZ?J-OJEJ;BV\S8'>
M,B2-HV#*Q5@0P!Z@UF>-9KBV\#Z[=6ES+;7%O83S1RQ$;E94+#J#W% &[17)
M6VI6K2^$(;S5+Z+4+FW\R*% WEW9\C+>8=I!P 6Z@YQ6A_PE^C?;([?[0^)+
MLV*S>4WE&X'_ "SWXQG@CTR,9SQ0!NT5YS9^,[;P_P"(_%L6N:C>S6UK>1"+
M$#S"WC,*,2?+7"+ECR<?C72W.K:7<>(M 1-6NEENHY9;2"#/D7:%,DL=N#M&
M".1U'K0!T-%>?Z;JK16?CK^V-7OUM+.^DB6Z3+26T1@0Y0*IQMW$]..M:LGB
MZVL-4\/:/''>W2ZA;-,MTT#N614&"=HY8EE)XP.^,B@#JZ*QK/Q5I%_9ZE=V
M\\IATQWCNR]O(AC91EAAE!.!SQFM2VN$NK:*XBW^7(H==Z%#@^H(!'T- $M%
M8?B&]L;:ZT:&[U&\LY)KY%@%N&VW#X.(G.TC:>202/N^U5;SQ]X?L9-0CEGN
M6?3B!=K'9S.801NW, O"XYW=/>@#IJ*RKGQ%IUMM_>23;K?[5_H\32D1=G(4
M'@]NYP<9P:(/$>F7&I_V='+(;LV@O1'Y+_-"2!N!Q@\G& <T :M%<XWCKP\N
MFV&H&]D^RW\[6]N_V:3YI S*5(VY!RK<'&<<9H7QQHCVRSI)=-F![EHA:2>9
M'$C%&=D*Y4;@1R,G!QF@#HZ*P;GQEH5K)IR/=NQU*$SV?EP2.)D"[OEPIR<$
M?+UY''-26?BO1[[1Y-4BN66WBF-O(LD3I(DH8+Y90C=OR0 N,G(QUH VJ*QK
M?Q3I%Q_:"FX:&73MOVN*>-D>+<,K\I&3N'3&<].M2:?XAT_4=2N--B>6.^@C
M65[>>%HG\LG <!@,KGC(Z'@XH U:*1F"(S'. ,G )/Y#K7+Z%XWL=6T:]U2X
MCFLK>WN9(<S0NO"R%!VP6)'W1DY('6@#J:*S+'7[#4-1FTZ-Y8KZ&,2M;SQ-
M&_EDX#@,!E<\9&<'@X-:= !17.OXYT"+2;W4WN9UL[*X-K<N;2;,4H(!4KMS
MU(YQCD5)X@U6-=,OK2WN+FWOCI\MU$\<+ H%'7<5*@YQP>: -ZBN,\&^,+&\
MT?PYI]U=7$FIWFG1.)989-D\@C#2 2$;68<D@'/6M#2M:TE!KUXNKW4L-M=D
M77VL,JVKA%S&@*@[>AQSDMQ0!T=%<EKGB6VN]#\06EA=W-GJMGITET$:(Q2J
MNUBK@..1D8]O8T>%/%UA>V.AZ;/<SOJ5SI\<JO+"X6=EC4R;9"-KL,Y."?YT
M =;117++XH34?$>M^'HHKRWDLK>,BY6!OON)"2"05  48)ZDG&: .IHK@? 7
MC2TN?#/ANUU*\N9=2OX !/+"Y267!8KYN-I? /&<\5T=_P"+-'TR0BZGD2%9
MEMY+@0N88Y"0 K.!M') ZX!.#B@#;HHKAO&FHWEAXL\*VT.K36-GJ%Q-%=;2
M@!58RR\L#CF@#N:*YRSNK>TNKR[7Q!/?V=K!FXC.V7RFSD$>6N<[0V1SVJ.+
MX@>')C8$7<RQ7Z;[:9K641RG;NVARN"^/X<YSQC/% '3T5S@\<Z"-+U'4);B
MXAATUPEVDUI*DD)(R-R%=P!!!!QBGV'C/0]4UDZ/;7<@O6B,L0D@>,3(.K1L
MR[7 ]1F@#H**XGP=KC0>']7NM9U&65;;6;JV268[F*B78B  <D\  #DG@5N)
MXJTIC?([SQSV,0FGMWMW$JQGHX3&67@\KGICK0!M45D1>)M*GTBQU2&:62SO
MG1+9U@D)<M]WY=N0#ZD5'>>+-'L)U2YGD2,W MC<>2YA64G&PR8V@YXZX!X/
M- &W16+J?BO2-'\YKR:188'6.XG6%WC@9L8#L!A>H^F03@&MD$, 000>010
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MX&GW=U:V5S/)=-%:O*J*T15<X!SR>@S7<RS10)OFE2-,A=SL ,DX Y]3Q3Z
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MV<KYBCR=VS<%W'.?;.*XB_U74/$'POT?6=5M;>2Y.M0/"T3[F_X^R"H# ;<
M!1R<CJ17>MHFH'XC)KX^R_85TPV)7S&\W<9 ^[&W&.,=:YN/P1XAB\$V?A[S
M-,?[%J,=S%+YLB[XUG,OS?(<,<A<#(&,Y.<  Z;1O$=U?>(]1T/4=-2SNK6&
M.XC,=QYRR1.6 .=JX8%2".?8FH?B'K&HZ#X(U#4-,$7VB,*N^1B-@9@NY< Y
M89XSCU[8+[31=1B\?WNNRBU%I<6$5J%25C(&1F;.-H&#OQU[5/XTT*?Q+X0U
M'2+66.*XN$7RWESM#*P89QSCY<4 <SJAO8/BIHUS#IEL^I2Z1=*R)/A#B2/&
MZ0IG '^R3STJ6^\8P:AX&CU6_P##\5P%U%;.YLY959895G$>X$K\V&P1P/PK
M3.C:Y/XSTO7;A-."VUC-;2QQSOG=(RM\N4Y V 9.,YS@=*Q9/!.NOX-O-'#:
M<+B?6#J ?SWVA#<";;_J\YXQT]_:@#H+KQ6XUV_TBPM;>XO+)(W>"2Y\N656
M&2T:[3N 'OUR.._35PWBOPA?>*&N%FMM/257C?3M229EN+(@+NQA/F 8,0-P
MSGG%=QR%]3COWH X?XB0WVMV+Z'I-X;:\B@.H%U8 EHSF%/^!2+G/_3,UKZ-
MXML]2\!1>*GRMN+-KF=4&2A13YB@>H*L/PHTW0&FNM1O-?T_39[FXGW1,O[[
M9$ %5/G08QC/'4L37.VNEWW@?2?%LUVVF1:#.\MW:Q[FD^SLZX*,A4 H6QQD
M 9([YH U(_&=Z=1\/VLFCIMUR%I[=DN\F,*H=@P*CG:P/!P<$>Y@LO'MY<1:
MA?7&A?9]*TRXNH+ZZ-VK&/R0>53:"^2,=L9'6LCP_;:QH$NBM=Z;H=U$BI9V
M\UMJLTLD:.5!,:.NT#@$A2,*OH,5LZ;X.NW\->)M%U9[=(]8N[J='MI&<QK,
M2>=RKROZT 36_CD?VU;65Y9Q);W-O).MS;7!F6$HNYEE^4!#MR002"014=KX
M]^TW^DHNGI)::IQ%)!<>9)"2NY?-3;A01QD,<'CWJ31]*\67%@=+\37.F/9I
M T#2V1?S;H%2F7# !.#DXSDXZ#K'X7TGQCI-O:Z1J-YI<VFV*A(;J'>+B>->
M$5E(VKT&2"<@>^: *4GQ&OH]!GUMO#P%A:7[65W_ *8/,7$HBW(NW#<GD$K^
M/6M>+Q=-;^(+S2]9TY+!8=/;4HYDN/-!A5MK;QM&UAD' +#GK6'-X)UV7P'J
M^A;M.%S?:D]XC^>^Q5:<2X/[O.1C'3WK5U/PM?:OXMDO[D6JZ=<:++I<R),Q
MD'F,&+#Y,8&,=??VH ;:^.GN-4TRV_LY'@U)&,4EO<>8T+!=RK,NT!,CC()
M/'O5.W^(E[+I-EJ\N@"+3I=0^P3N;P%XV\XQ!E4+\PR!GD'G@'K5[PQIOC+3
MH+;3=6N]+FLK) D=Q!O$URJC"!P1A.V2-V<>^:R1X)UT>!H]#SIWVE-5^W;_
M #WV;?M'G8_U><_P_K[4 ;.C:UK%[\0/$.F3PVPL+%+81[9FW*'61MV-O)/
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M\QO.^S^9OV%-N-^,KG=C'..,4 :I\6ZI/XHU'1+#P^+@V#6S23->*@,4N[+
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MZU9HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOV0YMBCJI &_Y\AQUQSS[4 =M4-W=06-I+=7+^7#$I=VP3@#OQ7G(\9^(O\
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M:QI^A:>]_JEU':VD9 :63.!G@5P\FO6O@)= \#65PDES':;YKJY!*PPKG+;
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M"U/I'BV>_P#%/]DW=ZMCJ$5U,LVF7,&PR6X#^6\+_P ><(Q.3_%P,4 =S17
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MD7PG$!C D$BHP0\!XSN!!YZ=37(#_DA:?]AG_P!R5 'LM%%% !1110 4444
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M!\^&-PI4A0Q!)]F![]: ,"/X<2Q:59:0OB.\_LW3[R.ZLXC#&7BV-N5"Y!W
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MYK[4YY-'U!I;*W^V2;,BW5MA&?F4D]#P.V,G,OA^VO=2LO#7B>'Q BB1%:Z
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MFC7;@J-A;;@8'&,<5/\ \(UI7VG4+G[.XFU%0EVXGD!E & #\W8<#'0'% '
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M60NV2YD+;,3*<_.RX88)S\W'-=_?^%]%U/5$U*\L$ENUB\GS-[#<F<[6 .&
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MVIR7B1?:YD>,P[E!"CY% WXZ]\8SC(H U](U:9O#=I?Z\;6QN'7][A]L6<D
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M4R!MI:-PP!]..]-DO;6&X2WEN84GD^Y&T@#-]!U-5]%T[^RM(M[0L'E4%II
M,>9*Q+._XL6/XUSOQ#@:UTZQ\301[KG0;I;L[1EF@/R3J/\ @#$_\!% '3)J
MNG212RI?VK1Q8\QUF4A,^ISQ58WKIJ[R/J.GC3!9B7RR<2AMW,A;./+VX[=>
M]<!I]M?P>*;W19K5EL?%(&IE0F%@4'$\;CU9/*4_[3FMF);1?C;=1H(1))X?
M3>H RQ\]NH[G&/PQ0 _4_'(GT?1M4T"XM9K:\U6"SE$BEF\MY=FX88;20,C(
M/!KL+:]M+T2&UNH9Q&Q1S%(&VL.H..A]J\5LKK3I?A%X/M&FMR\>LV<=S'N
M*GSSE6]#C/![5I:]'-;:O\0K/PXJ17;Z-:ND-J I)'F!BH'\6STYZ>U 'JL&
MIV%S)+';WUM*\/\ K5CE5BG^\ >/QH_M.P\E)OMUMY3ML5_-7:S>@.>37!WL
MEEJNI^ KWPT\1D67GR"/DLO*/F*P'0 A!@]&QWKE=1U+3[;X9^)M-FNH$O(O
M$+NUN6&]%^W(VXKU"X(YZ<CUH ]:B\2:5-XBGT*.\A:^@C622/>,C<3A?]["
MDX[#'K6I)(D,3R2,$1 69F.  .I-<+IUU8Q?&#6%>6 27>F6;VPR,S?-+DIZ
M^Y%==K=B^J:#J.GQOL>ZM98%?^Z64KG]: ,/0=<U?Q78?VOIIL[+3)786GVF
M!Y9)T!(\P@.H0$@X')Q@Y[5I:=JMPNG33Z\MKI\L5P\3'S?W94'Y&#-CJ,'\
M<5S7PVUNRM?!MEHNH3PV.J:5']FN[2X<(\94D!L'JI&"&'!S4OBC7M,35O#,
MDABA:6ZF-I?W;E;>(K$07(R ^X,0N2,\D'ID ZX:E8&."07ML8[@XA;S5Q(?
M]DYY_"I$N[:266*.XB:2+_6(K@E/J.U>*Q7=JO@>Y/VE'BT_QDLLSG"B&/[6
M#N8?PC!)[=:V[Z_T34O&/C%)-4CCLKG0(4:Y@<'Y=TH=U/1MN><9Z8H ],M=
M1LK[?]CO+>XV8W>3*K[<^N#QTHM-1L;\R"SO+>X,1Q((95?8?0X/%>5:I?>(
M(]'\2Z?<PVNH:A%IMO,-3TQ<?:K42G*.G(5]GFD 9!!.*Z/PW-X9UOQ-!K>C
MZW/J5Z+$PN(_+"1PY! E5$7!ST!YZ\8!H [NJT&HV-S<R6UO>6\L\7^LBCE5
MF3MR <BLWQB-1;P9K(TC?_:!LY?(V?>W;3C;[^GOBN+N)++5=-^'MQX?:+[7
M%=P@+$1NCMA&1<*P'0   Y_BP.M 'HPU&Q:X6W6]MS,SLBQB5=Q91E@!G.0"
M"1VS4>L7%Q::+>W-H8A<0P/(GFJ67*@GD @]O6N(^'>F:+-?^)+F.SLI+FU\
M077DR!%+0@JH^4_PCENGJ:[76U+:!J*J"6-K* !U/RF@"AX5\0Q:UX?TB>YN
MK4:E=6$-U+;QN PW("2%SD#)K4BU.PGBEEBO;:2.(9D=)5(3ZG/%>2Z?I>EW
M/A/X=S:+%:_VXD]F[RVP7S1&J#[1YA'.T#(.>^!UP*V[ZQN=%\7:AH-E XT[
MQ7^^5XQ@6\HPMSSVW1?,#_>% 'HT4L<\2RQ2+)&PRKH<@CV-94OB331X@.@)
M>P#4O(,VQF!V9("@C())SG'7 ^E:T<:0Q)%&@2- %55&  .@%<-+<6=G\:C]
MJDAB:?0HUAWD R.+A\A?4@8_"@#2\%^*&UOP_9W&JW%G%J-Q-<1K#&VS>(Y7
M3Y5))/"CUKH+C4;&TGB@N;RWAFF.(XY)55G/L">:\7M4TV/X9:-J*BV%VOB5
M6%Q\N\?Z:W\77&T_D:U[J[T2[U;Q;X?\6:Q-8275T'CA(C'VFW*((C$60LQ!
M!&%.0>@R30!ZU14%BGEZ?;)^^^6)1^^.9.@^\1W]?>IZ "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M1E#*58 J1@@]ZC^S094^1'E0 #L' K(\922V_@O6KJWGE@N+:QFGBDB<J5=4
M8@\=>1T/%<SH%]IVI:%X?QXKG.LWD,#F-+_S"T@02.K1YZ':P(QQ[4 =Z+>!
M49%AC".,,H488>].BAB@B6*&-(XU^ZB* !^ KG;SQQI-I=:I:^7?SW&F*C7,
M<-G(Q56!.1QR,*3GITQFG6WC?1;N]TZWA>Y:/4ES:7)MW$,K;=^T.1C=@'CV
M(ZC% '1,JNA1U#*PP01D$5'+;6\\:QS012(I!570$ CI@&N4N?B7X=M8[F5S
M?F&TN3;74JV,I6W88R9#M^49..>O.*2:[F/Q6TN.&]F>RN-'GF\D2DQ,1)&%
M8+TS@GGWH ZUH(7<.\2,PZ,5!(I#;0%BQAC+-U)49-8K^,=)C\F5WF6RGN/L
MT=\8_P!PTN2NW=V&X$!B-I/0U9L?$-GJ&LZCI4*7 N]."F=7CV@!LE2"?O @
M'D<<4 :'V2VP!]GBP.0-@I3:VY+$P19;K\@YK*B\3V5Q96MQ;0W4[W<3300)
M%^\>,8R^"0 O(Y)&<C&<TVT\6:5J&F6E]8R270NV9(88XSYK,N=ZE3C:5P<Y
MP!QZC(!K_9;<%3Y$65Z?(.*!;0 DB&,$OO/RCEO7Z^]4M%UVQU^SDN;%W(AF
M>WFCD0H\4JG#(RGH16'X\UVXTB'2+:W2Y_T_4H+>62!3GRRQ+*I'(8A<<<\G
M&#0!U301,7+1(2X 8E1\V.F:1K6W> P/!$T)ZQE 5/X5S=C>VGA\7=I%-K&H
MOC[:]O(3/)9Q..%R?FQE6PI+-UP"!4UQXZT&"'2IEN)KB/50QLVM[=Y!+A2V
M!@?>XQMZYXQ0!OFW@,2Q&&/RU^ZFT8'T%"V\"N'6&,,.C!1D5#IM_'JFFV]]
M#'-''.@=4GC,;K[,IY!KE+#4[GQ=XNUJS2ZGMM'T:1;4I;R&-[F<C+EG'S*J
M\ !2,G))[4 =K426T$4SS1P1I+)]]U0!F^I[UA68ALO$IAB\0":#R&4Z?/="
M22.0$'<"27.1G.XG&..IIZ>,=)>2R):9+6_D\FSO'C(AG?G"JW;.#@D -V)H
M VUMX5D\Q88P_P#>"C/YU)6'J'BS3=.^V/(+B6"P(6]GAB+I;G /S8Y. 03M
M!P#DXJ>ZUVRC>WMX#)=W%U"9XH[3#,8AC]YG( 7D8)/)/&: - VMNPP8(B,D
MX*#J>II5@A1RZQ(KGJP4 UR/PSOI]1\*S7$]S<W!_M&Z5'N68R;!*P4'=R,#
M QVJ'XB75S93^&#;:A<V:W>L0V=P8IB@:)E<D'L.@YZT =I#;P6^_P F&./>
MVYMB@;CZG'4T]E5U*LH93U!&0:X3P]JU^WQ)U+1K34)=4T&&Q69IY"'^RW);
M'E"0#YLK\V"216]>^+]*T^13<&=;0W/V0W@C)A2;.W:6_P![Y<XV@\$YS0!K
M_8[7_GVA_P"^!3S;PL^\PQEO4J,UAW7C+2;2>=)&F,%O=I97%RD>8H9GV[48
M]?XUY (&1DBK-UXCL[6YN(?*N)A;21Q7$D,>Y87?!4-SGHRG@$ $$XH T?LE
MMMV_9XL=<;!7/6GAB2/QEJFL7*V<MK>0P11PE,M%Y6[#<C'.\^F/>KNH>*-/
MTY[P,EQ.MBH>\>WB+BW!&[YL<DXYPN2!@D8(J&Z\9Z-:WEC:B6>XEO[=KBU%
MO;O()D !^4@88\C@>N3@4 ;DD$4I!DB1R.A90<4CVT$LR3201O+']QV0%E^A
M[52T/7++Q#IWVVQ,FP2/#(DJ%'CD0X964\@@BM*@#"U#2-4U+6H_-U*%=#41
MN]FMO^\>1&W#,F?NDA<C'.,=S6VZ)*C)(JNC#!5AD$5S<OCK2(-*U34I%NUM
MM+N#;WF8#NB<8S\O4CYEY''/I5K6-31[.:Q3[5#<3V,MPDD?'EA1U+ \')'U
M[=#@ V4ABBA$,<2)$!@(J@*!Z8I(8(;:(101)%&.B(H4#\!7$>"/&-K+H'A?
M3[Z6]>^OK%-EU-$YCFE$>YE\P\%L G\#SGBM73=;T:*?Q'=C4+W9:7 ^V"\W
MA(&"+\L:L,@$8. .2>,YH Z&>W@N4V3PQRI_=D4,/UJ155%"JH50,  8 %<K
MJWB2VO;#6M+B>\L-4ATU[Q$=3')Y>"%D4C_:&/4=P*J^#O%]G/I'AG3+J2\:
M_O=.B9+B:)]EQ(L2LX$A^\PY)_'F@#LI88KB)HIHTDC;JCJ"#^!IK6T#(J-#
M&5084%1A1[4^21(HGDD8*B LS$\ #J:P9-=M]5L98($O;<W%B]U;S[=@>,8^
M96!X/S+P<'GI0!M_9;<DGR(LGJ=@YKGM8\-2ZCXFT/48A:+::;Y_F0.I_?>:
M@4]L#&,]\^U8_@7QE;2>'/"]CJ$M[)?7]JH6ZFB<QS2A-S+YAX+8!/X$=>*W
MCXRTD7:0[IC$]]_9PN1'F+[3T\O/7.>,XQGC- &Y]GA\E8?)C\I?NIM&T?04
MV6TMIX1#+;Q21 Y".@*@_2N1TU[F;XA^+;%[Z[-LME9O$GG'$)<2[BG]W.!T
M]*M?#6[N;_X<Z'=WEQ+<7$MONDEE<LSG)Y)/6@#3URRUF\6VCTC5(=/C#$7#
M/;^8S(1@;.0%8=B<C\L&_;V-M:V$%E%$OV>&-8T1AD!5&!U^E5[_ %BWL;F*
MUV2W%Y*C2);P+N<HN,MR0 !D#)(Y( YJE;>+M(OM,T^^LIGN5U LMK%&A\R1
MESN&TXQMP<DX QUZ4 ;'V6WRI\B+*]/D'%*D$,>[9%&N[@X4#-<_<>.M#M=$
MOM5GEN$BL)?(NXO(8R0R<?*R@<9R,'[IR.:5O&VE+JDNFF+4/MBQ>=%%]CDS
M<)G!,8Q\P!_QZ<T ;J6EM'"(4MXEB!SL5 %S]*46T 96$$8*]"$'%<\?'V@+
MH]EJDDUPEO>77V1-UN^Y)MQ4HXQ\I!!Z^G&:C3Q7IWB&QUJQLY+VSO[*!FDA
MGA>WF0%25<!@#@XZT =0L:(6V(J[CN; QD^II6574JP#*1@@C((KB?"GBF&V
M\*^#[?4I+N:^U:SB$<S*7$DFS<VYST. 3SU[9KJ[?4H;G4KNQC27S;4+YC%?
ME^89 ![G';M^(H 2ZM)DTF>VTAH+*X*$0.80R(W8E1C-0:)IEQI]M*]]=+=Z
MA<N)+F=(_+4L%"@*N3A0 .,GN>]&L:]9Z')8I>";_3;A;6%DC+#S&^ZI/;/J
M>*B@\36-Q?ZK9*EPL^E('NE>/:%# LN"3@Y )X]* -FHVMX7+%H8V+$%LJ#G
M'3-<Z=9TRZ\3:0#/JD5Y-92SP6I1TBDC^4DNN,%AQ@=1GIS7)^(O&%UK?PTU
MW4[5;_2Y;.[,4<BL8SA9UC(+ ]<;LCMF@#TT6T"L&$$89>A"#(I5MX$G>=88
MUF<8:0* S#W/>LK3O$^GZGK-QI,2W,5W#$)PMQ T?FQ$[=Z;ARN>*O:IJ=GH
MVF7.I7\PAM+9#)+(03M ]AR?I0!;J&XL[6["BYMH9@IRHE0-@^V:R8_%>GF:
M_@GCN[:XL8%N9H)("7\ILX=0F=P^4].1CD"JNG^.]%U*YTR&#[6%U./?:326
MS+%(=NXH'(QNQGCV(ZC% '2[5V[=HVXQC'&*BBM+:&$PQ6\4<1Y**@"_E619
M>+--OK#5;V(7"Q:5(\=V)(MC(R+N88/7 P<]#GC-;-O,+BVCF".@D4,%D7:P
MSZCL: &_9+8@#[/%@=!L'%8_BO0&U[PSJ6E6GD037T+0F9U^Z&ZGCK]*;>>,
MM)L9[E96F,-K<QVMS<I'F."5]NU6/7^-<D @;ADBH=1\=:/IM_?6#I?SWEE&
MLDT-O922,%;/S# Y4;3ENG3G)Q0!M:;9+96<:&&".8J!*T*X#L!C/3)_&IUM
MH%^[#&,,7X4?>/4_7WKGG\?>'A#I4T=S-.FJH[V9AMI'\W:"2!@?>XQMZYXQ
M6)XF\66NN_#3Q)>Z-=WMG=Z?$ZR*0UO/;R*,X8<$4 =W]DML$?9XL'G&P5CO
MHVI7.O\ G76H0-HT+I+;6,=OM82*N!O?/(#?,  .0OIS!)?V \1^'K2>\U!-
M0DMI7AA0N()AL7<9.-K$<8YR"?>II_&.DV\\"R/-]GGN_L*78CS"9\D;-W7J
M",XVY&,YH WZ1E5U*L RD8((R"*P)?&6DQ71B9IC"M\-.:Y6/,2W!P!&3UZD
M#.,9.,US,/BI/#WC/QBNH2ZI=VMNUJ\<444EP+=#%N=L $(N3GM^E 'HNU2P
M; W $ XY _R!3?)B\WS?*3S/[^T9_.N+U?5A>>*_ MWIFHROI^H2SDK%(1',
MGV=V4LO?!YYZ5LW_ (OTK36WW)G%HMP+62\$9,,<I.W:S?[WRDXP#P2#0!LF
MUMV&#!$1DM@H.IZFE6"%'WK$BO\ W@H!J2N(\*ZH;.;QA)J5_/);V>L-'&TS
MM(44Q1811U^\V HZD^IH [**V@@=WA@CC:0Y<H@!8^IQUI#:VY=W,$1=R"[%
M!EL=,^N.U9,'BO3)+R^L[AI;*YLK?[5-%=)L(AY_> Y(*\')!X[XJ.+QEI<E
M_863I>Q3:C'YMF&M783)QEOE!V@9!.[;@$9Q0!O>6AD$A1=X& V.0/3-.KEM
M(U_1XK75[R"\U"=%U4V\B70?<MPVQ1%&K $+EE ' !)/3FLSQ_K4LWPZU^YL
M9+_3[RP9(V()B=6RAP"IY!5QR#B@#M9K*TN)4EGMH99$^X[QABOT)Z5))%'*
M )(U<*0P##.".AK'U7Q3I^DW%Q;RK/-+:VWVRY6"/<88<D;VY']UN!D\'BJ-
MYXRBB\1Z'IEK:3W,&IP27*W$:94HJ@C;W_C4D]A]> #I3!"T<D;11E),[U*C
M#9ZY'>A;>% 0L,:@J%("@<#H/H*YW3M;T:&?Q'>?VC>>79SC[;]L+A+=A&O$
M:L,A<8/ Y)XSFKL'B>QDU)=.FCNK6[DA-Q#%/"09HQU*8SDC(ROWAGI0!J06
MT%LI6WACB4G<1&H4$^O%+#;P6X800QQ!CN;8H7)]3CO7,6WQ$T&[CL9HC>?9
M[RY-K'<-:.L:R[R@5F(^4DC@'U&<9KJZ "HH[:WADDDB@B220Y=E0 M]3WK%
MO/&.DV*SSS--]BMY_L]Q>K&3##)D ACUP"0"0" >"1@U%J7CC2-+U2;39$OI
MKR&%9VBM[.20F-FVAA@<C/4C@?7B@#H(X(HB3'$B9Z[5 S4E(3A23G &>!FN
M1TWQ1HFGZ-/?)=ZG<6;ZI);/+=*[-%,T@79AL,J!CM QQ0!U4=M!#)))%!'&
M\AR[*@!8^Y[UCZ3I&J1:C)?ZUJ4-[,@>.U6&W\I8HV8$YY.YCM49]%]SFTNO
MV/\ ;=SI#N\5U;6PNI/,7"^420&W=,94_E7(:[XC-[XB\&O82:C#:WE^<-AD
MANHO*<YQGGG:0& R.0"* /0J8T4;L&>-68 @$C. >HKG--UO1HKCQ'=C4+W9
M:7 ^V"\WA(&"+\L:L,@$8. .2>,YJRGBG3IKR[TZ9+RVO(;7[6T+PMYC0DD;
MU"Y)YXQU!ZB@#7^R6V,?9XL=<;!2O;0221R/!&SQ_P"K8H"4^A[5S>C^(M)M
MO#NA+9W-_?C4$*V(G.^XN H+$L6QT R22.WTK*\8^($U+P NL:->W4&V_MXB
M49HG!^T+'(CCK_>!% '?4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!A^,HIKGP7K5K;02SW%S9
M3011QKDL[(P ]N3U-8NDW5Q9>#]$M'\/7\VIV-I#'&CPA5281A"2V<!1DY([
M9ZUVU% '"P6M[%XJ\;73V-UY-[:6\=M((CB9DC=6"_BPZ]?I65;Z9J4?AGX=
MVK:;=^?I=S"UZGE']RJPNC$^O+#IFO3Z#TH \KTUY;O1?B#H\&GW%Q<WNK7L
M,.(\QLSQHOS/T4#.3G''3)XK5@T&\L/%_A^W6*X>TLM!?3I+U$.T2'RPO/T0
MG/:NIT70+;0GOVMI[B3[=<M=3"9E.96QN(P!C.!QTXK326.0N(Y%<HVU@ISM
M/H?0\T >6QZ!JUW\+%\!7.GSQZA&Z6QN0G[@Q+*&$P?I]T9V_>W<8[UM^,M'
MO3XCTB_TB58KB_#Z3><X+6[*S[Q_M1[6(^IKNJR++PW8V6MW6K*]U+=7!)Q/
M</(D6<9$:DX3.!G'IZ4 <OXFTZXTKQ7IVL0>'FUG2%L3836EO&CR6^&W(Z(Q
M (ZJ>?2J>KZ3=VD^A:]9^$(I+&W-PESHT$4?FI'-L(D"YV&0&,$@'^+&>":]
M+HH Q?#4,:V,L\6AIHR7$ID%MY:)(> -T@0D;CCU/&,\\#+\=VUW=-X=%I9W
M%S]FUFWNIO*3.R)-VYC^8X'/M7744 <3:0WV@>/->U":RNKK3M9BMY898(B[
M121IL,;*.1G@@D8ZY(K"T[PSJ6ACP5"]E/(;2_NKN[$*[UMEF63:N1UP7 .,
M]">E>IT4 %<)I^E7_@[QIK5[%9S7FAZU(MRS6Z[Y+6?&&W)U96ZY4$C&,=Z[
MB26.(*9)%3<P5=QQDGH![T^@#SZ71+S7OB!JVJ0VUQ:Z?<>'CIB74T9C;SFD
M9LA&PV ".2!TJDFCZIJ_@'1/"=UIMQ:W]C-:QW$Q7]TD<#J3(C]&W*G '.6Y
M  )KTZFO)'&%,CJFY@HW'&2>@^M 'GUC8ZGHD/B[1Y]-N;P:G=W%W8S1)N24
M3+_JV;HA4\$M@8Z55T?1-6\$>(=+E>RN=4L&T2#39);0!V@FB)/W20=AW'GM
MWKTVB@#D?AW:7]EH=[#J&GSV<C:E=3(LQ7+(\K,"-I/8_P"&:K?$.QNM2N/#
M$=OI\]Y':ZS#=W.R/<J0J'#$^OWAP,GVKLC<VZH[M/&$1MC,7&%;I@^AY'YU
M+0!PVE:??>#?$LUK8V,]SX8U(M<(L*Y.GSGEEV]?+;.0!T.>*Q]&TNZTY[KP
MYJ?@I-1D^URR6NJ/#$]O)&\A</*S'<&7=T )../6O4:* /)_$]EXAU6RU^VE
MT._EN(]4AEL_LY58&MUEC(8#<-\A"MG<"1Z@5?\ $&DZA<:W=ZMH5KJ>F:_Y
MD"K@;[6_CVID3#E!MRRYR#\O&>*](9@JEF(  R2>U(CK(BNC!D895E.01ZB@
M#A=-MM0\.ZOXJMKC3;J]MM4N6O;.6!-XD+H%:)O[A!48+87!ZU0T3PWJ'A_5
MO UI)!-/'I>FW,%W<1H61))/+( /4C*L/P&<5Z710!YWH^I7GA+0]?O[K0]1
MF237+FYV1Q@,+=VW>;R>@ .1UZ<5Z)44]O%<JJS('56#A6Z9'3([X//U /:I
M: .$U7PI=7GC*]B6/_B0ZY:*=3(;!$D7R@#_ 'U90?9#3O#.E:Q8>#;T:RC2
MZBENUA$(QN:2&+<D9QZL26SZ,,]*[FB@#S&TTS4HM"^'-N^FW8ETN6,WJ^4?
MW($#1DGU^9ATS4>H^'M:U.U\<QV=I+%<W6H6U[8^>NU+CR1$<9[9,9'..H/2
MO3C<0A96,T8$7^L)8?)QGGTXYIZL&4,I!4C((Z&@#CWU;4M?\/:FS>&[_3V-
MA+$4ND7S9)67 2,*3E<Y^8X'(]\8]MIVHI#\-U;3KL-I<>V]_=']R?LQBY]?
MF/;/'/2O2:898Q*(C(HD*E@F>2!U./3D4 1WV[[!<[(1.WE-B(]'.#\OX]*\
M\T/1[[1KR1-(354T&33Y3+IM\A8VD_R[$A8\D'+9 )48SGD5Z510!Y=9Z5J<
M/ACX>6KZ9=B?2[N)[U/*/[E5B="3Z\L.F:KZG:>(M06"2ZT'49+RR\117)$+
M(L'V=9L@Q+N 8E<$L1G.<D# KU<R1K(L9=0[ E5)Y('7 IU '&:=#=V_Q!\2
MZA-872VMQ96J0R",D.T8DWJ,?[X^O:K/PWLKO3?A]H]A?6TMM=VT/ERQ2#!5
M@3^?7J*ZJB@#B->&K:'X^MO$5MI5UJFG3Z?]@N(K,*TL+"0NKA21D')!YXQ4
M>I6FKIXD\.>)_P"S)/(MUN(+JQAP\L$<N"KX!PS J-P7/7C.,UW=-62-W=%=
M69#A@#DK]?2@#RWQ+X<U*^TCQSJ-K87#2ZY]EBM+79B1A" "[ _=S\W7!PHS
MR<5T=U%<R_$W2M32RNC91Z7/"\WDG"N[QLJD=>BFNQHH \<NX;S3- L3=V%S
M'(WC5;J.)DPTD;S,RE?<@]*ZN?39[[Q9JWB..TN$@&B_V="KQ%9+AR[.2$/(
M ^4 D#))[#-=#KNAV>N?85O+F:+[+=)=0B)U7,J'*GD'./3IZUJLZQ1%Y'"H
MHRSL0 !ZF@#SS^P;B;X,:?:3JUAJFDV<5Q$\PVF"X@7<#GTX()]":ZSPQ;W,
M6BI<W\8CU"^8W=T@_@=P,)_P%0J?\!I=4\.6&MWUG>7<ETPM@<0QW+K#*"0?
MG0'#C('!X]<UK))'*"8W5PI*G:<X(ZCZT 8OC#1'\0>%+_3X6V73)YEL_=)D
M(:,_]] 5R/\ PC6NW.LZ7K$L0276H#;Z[#NRL47#HH'J%5HB?5R:]*HH Y'5
M;6ZD^)GA^]CM)WM+:TNHIIU3Y$:3R]H)_P" GZ5R=[I&M?\ "NO$NA#1;QKN
M75)98"H4K,KW(D!4YZ;<DYQZ=:]:HH X_P BYE^*MMJ2V=R+'^QGMC.T1"B0
MRJX4YY^Z#[=NM:OC!M57PGJ)T6V2YU#R_P!U$RJV[D;L!N"0N2 >,@5MT4 >
M9V]EJ">+-3U!-%U86EYH(@66Y8/(90TAPPW$@G<N .GH!3;73-2BT+X<V[Z;
M=B72Y8S>KY1_<A8&C)/K\S#IFO3/,C\WRMZ^85W;,\X]<>E.H X+5]"N1\0X
MDLV0:=K< ?5(B><V[+M8#OO#+&WM7>UD:+X;L=#DN9;=[J::X8EI+JX>9E&2
M=JEB=J@D\#UK7H \G\5V7B'5K#Q):2Z)?S3K?PR67V=E6![=7C.[&X;Y"%;.
MX$CC&!6O8ZD;7XI^());*\/F:79$I%%YC(V9<*=N<$Y//3CKTKT&LFV\/VUK
MXBO-;2>X-U=QI%*K,NPJF=H QQC<>_?G- 'G%GI<_A._^'MM=6[F876HS200
M#>8O,C=]H Z[0V#C/0XS5_6_#VH7FD>/]1MK&?S==BB@M+;9B1_+CV;V'\.2
M3UP< 9QG%=QJ'A^VU+6=-U66>X2XTXNUN(V4*"Z[6R"#G*\?RQ6M0!Q%Y;7<
M_C/P;>1V-T;>TMKE+F0Q$")I$15!_%3TZ=ZI^#FUW0["/PG>>'[F66TN'$6I
M'8;5X3(6$A.[=N /W0,Y Z<D>AT4 >3:Y9^(=2ANA<:%J$EU:Z]%<1"%D6 V
MRS*59%W#>Y49)(SG.2!@5T-F+_2/&?B>]GT>\FCU..V>T$2!U=DBVLC$'"'/
M=L#WKL);ZTAD:.6Z@CD5=[*T@!"^I'I[U8H \SL?#&H: /A[8_9Y;D:4\[WD
ML*%DB,D3CKW&Y\?09XJ+2]+NM.GO_#VI^"DU-I+V::TU)X8I+>2.20R S%CD
M%2W(P2<<=J]1HH *\LNO#^LWVE>+TM=/?[3+K<6I6<5RNV.Z2/RCM)/')C88
M/M7J=% 'GP^QZEH&LWD_@DZ5'_9DT$XN4B@FFR,^4CJ3A.#\QQR5('!JCX?N
M]NJ>'I-=TKQ!%/IUO]AM9[FQ5(4:0(A+LCMECM50< <],FO0]5TNSUK3)].O
MXO-M9UVR)N*D\Y&".000#D>E4-.\,6UA*DCWVIWQC.8Q>W;2JA['!X)]SDB@
M#C[72'FTCQ3::KH5[<6M_KS7"QJI60PMY8$J$$$%2F['7CIS575-&\0R?#KQ
M-HX;4-5BDEC32FNH\7,B?(6#YP< A@&;!./I7JM,:6-'1'D57D)"*3@L<9X]
M>* //_$R:SJ>I:O:#2+Z:QN=)VV+6^V-6E(?<)R6#<9&%.1R>":AL;'5[>[\
M 7S:+>%;'39K.YC&S?"[1Q!2WS<*2C<]N,C/%>DT4 >6:IX;UC6;/QY;6MK+
M#/>WMO=6)F7:DXB6+C/;)C(YQU!Z5O7,%QXD\3>&M6^P7EE'I(GGN/M$15@[
MQ[!$O][J22N1\O7FNUH) ZT >31:1JR?#73M..E7@O8=;%T\/E<K&+LR[L]/
MN$=_:O6 =R@C/(SR,4M% 'F%MHVK6?@/7O!<VG3SW<[W4=G<A<PS),S,)&?H
MI4N<@\_+QFM?2-+NM.^(JL;>Y>RBT*"P6[9/E>2-V)&?H0<].V:[BB@ KR1-
M.O=1\ >(DL+9[F>+Q//<B%,;I%CNPS!<]3A37IVJ::FJV8MWN;NVPZR"2UF,
M;@J<CD=1Z@Y!I^GZ?;:79BUM4V1[F<Y.2SLQ9F)[DL23]: /.]7TK6/$WB+7
M7@TN\LK?4O#7V*&>XVKMD\R4@. V1G<.!D@'G&:&DUK4X_!2OX:U*"XTN]3[
M:K*@1-L+H2K%L,N3D$=O?BO3))(XE#2.J D*"QQDDX _.G4 >6ZEX>UK4[;Q
MS'9VDL5Q=7]M>6!G7:EQY(B.,]LF,CG'4'I76Z9K=_K%M-<3^';[35CMV607
M2+YKR?W8PI)*CGDXSQCOCHY)(XEW2.J+D#+' R>!3J /+M&MM?TOPOX+T^32
M+\V\$4D.HI;!5N(W"_( Q((0DG+*1T'(&<T_[%UE/AOJ&D?V)>I=?VYY\<?R
MMOC^UB7(()X"CJ>IZ9KUVHOM,'E&7SH_+!VE]PP#G&,_7B@"16#HK $ C/(P
M?RI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH Q/%WB!O"WAF\UH6378M5#-$L@3(SC.3GU]#5";
MQ=<V<J6^I:9#87%S,ZV8N;Y DL2J&,CL =F,A=N"<D=N:L>.=%O?$?@W4='T
M\VZW%V@0-<.511D'/"D]O2JGB?0]<OIM%UK1I+.'6-,,G[BX=C!-'(H$B%@,
MC[JD''4=* &6'CV*\LCNL&743J!TZ*W67='-)@L'23 S'M!;=C( /&< K-XR
MO+2ZU^TN=(B6XT>Q6^;R[LLDR$.< E 0<(>HZ_G5?6?#_B?5K+3=3\_3XM=T
MZ]%U#;AG-OLV%&B+XW$D,3NQUXQWK-M+*_UCQKXML-1^SV]U>:%;PL+=C(D6
M_P Y?O$ MC.<X']: .D3Q;NOO#$'V'$>O0-*C^;S"5B\W!&.>.,Y_"L0^,;;
M1O#WBO6K;PX(GT[4GCNHHY54SN%CS*Q ZG<!W/%)8>&O%!O/!\UY'I42Z$CP
MRK%<.YE4P^5O!*#![[<=OO<\17W@K7KOPQXPTM?[.676[]KF!C</MC5@@PW[
MOK\G;U]J -R;Q;<V4J6^I:9#87%S,ZV8N;Y DL2J&,CL =F,A=N"<D=N:SS\
M1RNE"Z.C2/*FJQZ9*D<X*9=@JR1N0-ZG=QP/0XJ[XGT/7+^?1M:T:2SAUC3"
M^8)W8P31R* Z%@,C[JD''4=*@UO0_$NNZ+9)<G35O8]2M[QXEF<11)$X;8K;
M"68X/) Z^W(!*GBW69-:U#1%\.(=2MH4N8E-\/*DB<L 2^S*ME2,;3SWQS1:
M^/K*]T71;V%(H9]6B>6**[N!$D83 ?<^#T8@# ).1P!G$\.C:M%X]OM>\NS-
MM/IT=HB?:&W[D=VR?DP =^.IZ5S5AX(\3:+H7AN73I]-_MG11/"\3R.8+J&5
MMS*6VAE(PI''44 :8^(S'3+6Y&B3/+)JZZ3+&DZE0Y/#QN0/,0CD'C/?%.O/
M&NIQZ9XL3^R8+;5=#M1<A'N?,BDC9&=6W!0<_(V5QU'7G-2ZQH?B36K#2&N&
MT[[7;:M!?S1B5UCC2/\ Y9HVPEB>N2!R?2F7?A/5+[5?&$KM9QV^N::EE"PE
M9GC94D7++M P?,['M0!+:>*[FVL_#UE>QV8U+4[0RQM-=E(Y-JID;MGWV+YV
M@= >>.>HT^XFN].M[BYMFM9Y(U:2!FW&-B.5SWQ7(S>&]3U'P_INDZYI.CZA
M:16ODSP>>P*.H4(\;E,YP'S]TC<,9QS+I4?B#PV/#.AM+::A;^4\5Y-)(YG4
M@$J5XP47A26Z\="<4 7?&&HVNGKHHO-)34([C5;>",NP MY6;"R<@Y(Y(Q^8
MJE>^--1BU+Q!8V7A\W$FC11S.SW:QK(CJS<?*2#A>!WYR1WO>,=%U#6X=(33
MQ;9L]3M[V3SY63*QMNVC"MR:I#P[K"ZYXMO0EB8M8MH8;<?:'!4I&R9?Y. =
MV>,]* +MOXL34QI<6E6HGNM0L!J*QSR^6L4)VX+, QR2P  !Z'TKG/$UXVL6
M7@O4KO2I=/O/^$A@1H;A?WD>/,! /=3M!![C!I;;PAXFT1?#FHZ4^FR:CIVE
MKI5Y;33.(9XEP0RN%RK!AGE>_P">OKN@Z]JUKH),EC)=6>J1:A<[I'C0*NX;
M(_E)/#=3C.,]\  F?Q?(G_"4I_9RF70%5W'VCB93%YO!V\';QC!Y[]ZDA\5?
MV@^EVEA9)->W^GKJ#0S3;$AA(&-S!222S8  YP>F*R-2\,:^=5\6'3QI[VFO
MVJKYDTKJ\$BPF+&T*0P/'.1CG@]#':>%?$.C:GH>L6/]GW%U;Z3'I5]:R3NB
M.B'*R(^PD$'.05Z&@#!T>_M=(^'OB">_T"&ZM5\1SI+8EUV1$W"JHZ8(5BN,
M#M7:WOBK4(_%-UX?L-#^U7,5DMXDDETL:.I8K@G!(Y4]CVX YKGYO!7B*?P;
MKND$Z8+G4=8;4(V\]PBH9UEP?D)S\N/Q]JZ&/1M63Q_<:^8[(VTFEI9K']H;
M?O5V?)^3&/FQU[9QVH BL_'=OJ&C^';NVLV^TZZYC@MY)-HC959I-S '@;#T
M')QQZ7?#OB2;7+W5;273C:R:;<&VE83!U9\!OEX!P58') KAVT34]'\/^$_"
M[-I$FLV]S-<QJ]U)&'1-QRDH4,IS(HP <C/;-;%E>ZYI&EZU:P:3H]GJD>V[
M\U[Z2>&5W;#&5MH</A>!SG@# % '1^-88KCP-KT<T:2)_9\YVNN1D1L0?P-<
MSX?\77FEZ?X5L-1T.2WT_4+6"UM+[[0K9F\H%5= ,J&P<')]P.W6WEM<:[X2
MN+69!:7-_8M&ZM\WDN\>"#ZX)_2L*S\,ZI>67ANQU:.TAM]#>*;-O,TAN)(D
M*(1E5VKSN/4Y 'O0 DWCUH/"FJ:XVE@_V;J#V,T(N.I641EE;;SR<X('%6+?
M6]8F^)=[HQ@MO[/M["*=2)FW?.[ L1MY/R8QG '.3G Y_4O!7B2;0?$FA6IT
MS[-J.I-?P7,LS[OGE60HR!>,$'YLG/ QSD=)'HNK0^/GUQ/L9M+K3XK:X4R-
MOC9'=OE&W# [\<D8ZX/2@";7/$UQI/B#2-(@TI[N34Q-Y<@F5 K1INP<]NG/
MIGJ>#1M/':/H]Q<7FGM;ZA!JG]D_8TF#A[@E0H5\#Y2&!R0,#/'%7-:T74;[
MQCX<U6V%K]ETTW!F$DK*[>8FP;0%(XZ\D5SLW@36+JSU4M-907K:\NMZ>ZR.
MZ!U"@)(-HX(4@D9^][<@&[+XJN[?5;O1;G3X(=46R:]M!]I+0W"*<,-^P%2#
MC(VG@@BIO NJ:CK7@W3-2U)8A/<P)+NC<MNW#.2"HV_3GZU$- O-5\1)K>IQ
MP6TD%A)9P0PRF7!D(+N6*K_=  QZGV$_@G2M3T+PI8Z3J?V7S+*)8$:V=F#J
MO 8E@,$^F./4]@#D],EM=(TOXD3-ID=W9P:A-)+9C:JR)]GC+CGCD9K>/BN2
MTNO#NEV.A[AJEBTUN%G5$BV(IV=.@W 9QTZ ]*IGPIK9TGQM:$6 ?7I)7MC]
MH?"!XEC^?Y.VW/&?3WJQ%X<UE=;\)7C+8B+1[*6WN )W)9G1%RGR<@;,\XZT
M 4Y/B+?1:!J.K/X<(32;I[;4E^V+^[*$ F([?WG#!N0O7UK7GU.V/Q MK!=(
MB>]?2Y9X+]W .P.@,?0D E@<^W0UAW'@W7;CPEXOTG_B7+/K=]-<0-]H<K&L
M@48;]WG(V]O6MH:'JS>.=,UMTLUMK?37LY56=B^YF1LJ-@! V8Y(ZT 9?ASQ
MK>'P@FK:W':I+<W\MK;A;@A6?SY%"DLH"JH7KDDA2<9XJW'\0K6*/6/M]J$?
M3O**M:3>?%=>8<((WPOS;B%((&">N.:RT\#:_'X4&F0W=A!>:;JCZCIEP"[K
M(QE=\2C V@B0J0,^N>U7]7\.^)/%GA6ZM-7GL+"_W1R6B6C-)'')&X<,[, 3
MD@# ' ]30!5?[6WQCT62]TZVM97TFY_>03>9Y@W1\$E5.5_$<UK>)-;U>Q\8
M>&=,L(+9[>^DG,IDF9"Y2)CMX4X'(.>22 ..M5X-)\37OC'1M<U*VTNW6TM)
MK:>."Y>0L7*'<N4']WH>GJ:O^)-$U*^U_P /:MIAM6DTR:8R1W+LH9)(RA(*
M@\CKCC/J* (KOQA*MGJ^H:?I@O;'297BN7$^R1S& 9/+7:0VW..67)! [$]%
M87UOJ>G6U_:2>9;7,2S1/_>5AD'\C7'V_A?6=*A\1:98&SFT_5YYKB&::1E>
MU>88D!4*=Z@\CD>AQUJ_I\>H:!JNB^';**TET2&P$3.7;[2C(" Y'W=APH]=
MS>U #/$NMZQ8>+O#.FZ?!;/;WTDYE\V9D+E(6;;PIP.ASR20!QUKE[/6+CPK
MJ7C^^L-&2ZM;2^6XN%6980J"W1F*C!W-U..![YKK_$FB:E?:]X>U;3#:M)ID
MTQDCN79 R21E"05!Y&<XXSZBL>?PGK<UCXW@QIX;7]PMS]H?$>81%\_[OVSQ
MGT]Z -;4/&-O#.+:Q^QR7/V1+PK=W8MUV/G8 =K98[6XQ@8Y/(JS8>)XM1\$
MGQ)%:SQ)]EDG-O,NUU* Y4_BI&:Y]O#GBG2-5LM7T1M,EF?3X;'4+.YE=8V,
M>=DB.%SD;F&".AKL[6WG;3!!J3QW$TBL)]JX0[LY4#^Z,X&><#F@#CO &EVN
MO^#+36]<MK?4=1U56GN);B,/P6.U%!SM11@!1QU/>N3U"[DE\%?$GPU=DW4&
MADFS>;YV2-U+HN3R=F" >N,>E=UX>T76?"&E'1;"*UU#3X7<V3S7#121HQ+;
M'^1L@$G##J.PQ5&Z\"WA\%^([&&>WFUK7F>2ZN)"T<09A@*N QVJ. .I_&@#
M:_MMA=VFA6-K%=7K6*W,RS2^7''%]T;B%8DL<@#'0'/;/)>!M=M]!\)&.6&"
MWGNM;O8(+=YA''&PD=B"^,!5"GD#T '-;,GA_7K#Q5:>(=-2PF>33TL+^SFN
M&1?E)*NCA#TR005Z5E0^!_$EMI,4UM=:=%K-CK%QJ-H2SM#(DI?=&_ (RK]1
MF@"_<?$DVNBZK>OH[2RZ9=102K!<!XI%D8*CQR;1N&6Y&,@@BNKTNYO[^VN/
M[4TH6+"5HTB,ZS"6/ PQQP,Y(V^W>N9U_1/%/B3P?=65U_9<5_<2P,L*3/Y,
M2QR*Y^?869FVXZ #CT)/:H7,:F155\?,%.0#[' S^5 'DMIIVF:.WC_PE>VD
M9M74ZG:*J#<\<J[0J>Z2#:OH2*L^&)(M8^&NF>&;RUA%Y'>?V3>0[00I@),A
M^IC3[WJXKJM>\(+K'C#0M<67RQ8[TN4'!G3(>-3[+(JM1I?A!=-\>ZQX@67,
M%]$AC@'1)2 )6QZD)'S_ +U %F37)!J=YH^B:?#<S:;#&TZ//Y"(7!*1KA6Y
MPN>@ !'//&1_PL5+JTT"XTW29[D:Q+);JCRK&T,J*Q*,.>A0@GICGGI5P:%J
MFD^--4US2UMKFWU:*(7,$\QB:.6)=JNI"ME2O!'7C//2LN#P/J.G#PPMF]G-
M_9M]-?7CRR-&9'E#A@@"G@&3C)' % %*/4C8?$YM1U#3DL;^X\.IOLTD$C/,
M;A@J!E'SDX R!T^E=5>^)GTR'3XM0M[2UU&^W%()+P"- H!8M)M[9 X!Y([9
M(P_$_@6[\2>+)]2D-M% --6WM)TG83P7"2&1)5^3 P3CKTSZXI^H:%XON[?0
MM76;2E\1Z3O1T\QS;7<<@ <$[04)VJ1P<$4 #?$=ETI+K^Q99)AJJ:7+'%."
MFYF 62-R!YBG/' ]#BKZ^+KY-0M])N]*MK/5IXI9H[:?4 %D57VKL<(=S'KC
M P.M5M;T/Q-KFD:>)SIHO8=3M[UXA,ZQ1I$P;8K;"6)P<D@=?:K7BOP[+XC#
M6MYI6GW]@UO\@EF,<MO/D_.C!"0,8Y!!XZ&@#H8"-0TR)KNU">?$K26\HW;2
M0"5.>N.E>(:%+H5K\$&FGT>YDU%4N1%=V]BZLDGFN$?[0% 4+\N6W8 &/:O9
MM(L[W2_#EE937 OKVVMDB>:5BOFN% ))P3S^)KD?#OAOQ5H/@ >&Q!HLDP69
M/M+7<A0"1V;.SRN<;L8R,XZT :%AXE?3/#WAZTOKVRO-6O+(2-/)=!(7V*N]
MS( <\LH& <DYZ9Q67XC,VFV-RNB3O+/JW]E2QI,NU9.S(Q $B$<@\ ^U5(_
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M^+)_^$ECTG4M+^PQW%F]Y;3FX#[E0J'#@#Y"-P/4C'>N<OO!/B&[L/&5JO\
M9,:ZZD7DA99 (2L:H0?DZ +P0.?1>E;-_P"&M2U/Q-IE].EHMG#IL]E<*MPQ
M?,NW)7Y,$#;W(ZT <_XNU:3Q!I'A;58]+B&GS:Y9/:W#RYF"&488IM^4,!V8
MG!&1UQW?B+7H/#NFI>7&P*\\< :639&I=@ 7;!VJ.YQ7$IX1\6KX8TCP\_\
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M016\0EG>8$\N&4A8@ .<KDDC-8C:CJ6MZ]\.KPZA+;+J5A-=2P0JNP2>0C9
M8'_GHPYS@=.] 'I0()(!&1UI:\VT:YUBVA\>7D6KQO<6VHR)"VH%4@3$,6&8
MA00%'&!QQZ\U*WC6[T?4?$*W$EQ?65AHZ:E UQ (9&;+J5P%7Y25&"5SUZC%
M 'H4DBQ1-(P8JH)(52Q_ #D_A5+1M9LM?TF#4].E,MI/N\MRA4G#%3P<$<@]
M:S-.C\0_;M-NI-2MKK3[BV+7<;1A2DA *F':.5Z@AB3C'-<#X4U+6-$\$>$+
MR"^B^Q7.J"QDLS /F26>1=V_KN!Y&,#M@]: /8*BN;B.TMI;B;=Y<2EFV(7.
M![ $G\*X:ZUWQ+K$>KS>'893/87SVD$)$'D2F,@.)"S!P3\V"N,#'6K0U?4?
M$5_XAL[6Z.GII4:0[51)#),T>]MQ(/R#(7"X)^8YZ4 =1I6J6FM:5;:G8R&2
MUN8Q)$Y4J64]#@\BKE<I\,O^29>'?^O&/^58VL^)]8TR\\Y;Z.;;K<-FUM;Q
M!X$MW=4P[E01-\V<!CCCC% 'HE17$\=K;O/+O\M!EMB%SCZ $FN(O_%5S:>+
MY-)U"]ETEGNX5T\RP*;:\A^0NOF;21(?W@QD8^7@]^WN?^/67_</\J .=M?B
M'X8O=/EO[2_FGLHB1)<16<[QH0,D%@F!@$'\:Z&TNH;ZS@N[:0203QK+&XZ,
MK#(/Y&O"?@7=ZO%X<L+>VM8FTR?6YENI_-.\?Z+D+LQC:2%YS[8[UW/Q&U#6
MO"?A6TU;PQ<JNGZ:Z0W=HL:/F$';\K$$@@C:>OKV.0#L]:UO3O#VFOJ.JW/V
M:SC(5Y2C,%).!G ..<#\15NWN(KNVBN8'#PS()$8?Q*1D'\J\J^(=Y+JGP%U
M357OC=1WP@N(1M4"*-IT*I\H&2!@$GN#1X8\1:[8>//#WAFYU!+G3K_P_%=+
M&(%3R&"MC:1R>$_B)ZT =O\ \)[X9_LV_P!1_M5#9Z?<?9KJ41N1%)G&#\O3
M) ST]ZWK:XBO+6&YMW#PS(LD;C^)2,@_E7@.H:S=ZM\(/B&MV+?-MJHB5H;=
M(B^)H_F;8!N8]R:Z?3_$>M^&_$'@72YK_P"VZ9K=@B&!H$4V[A%P48#)'*_>
M)[_@ >D:1XBTG79[^'3+Q+B2PG-O<JJD>6X[<CGH>1QQ6E')'-$DL3J\;@,K
MJ<A@>A![UX6WB+6)O!7Q+:.\2VGT[4'B2>VMXXI)%WE26*J,L1_%U],5Z;\.
M8)X?A[H)FNY+CS-/MW0.BKY:F)<(-H&0/4Y/O0!:O/&F@6&M?V-<7DJZD5+K
M;+:RN[*,G< JG(X/(XX-7-%\0Z1XBMY)](OX;M(FV2>6>4;T8'D'ZBO*O$KW
MB?M+:&UA#!-<C26V)/*8T/RS]6"L1^52_")K>#QQXQMM0:6+Q-/<-/=VRJ!
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MQOW7%S!(J$A9/[WR@C=UZY/:NR\0Z8VL:6;'[-:7,3NK21W3,%.TAA]WG(8
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MR[U'\+A2 X]FR* .62;4/$VMZGH<FIH9K73[5H98II(-YD0EKA A&?FQUSC
M'<Y[?0$N8]!LH[R_2_N8XPDMTB[1,PX+8]\53UKP9X>\0W5O=:GIJ37%NNR.
M57:-@O\ =)0C*^QXY-;4,,=O#'##&L<4:A$1!@*HX  ["@#SG3K:TT_QIX_O
M7OKFT6TAMY/M#7$D@B!MV)=E+$/CJ 0<8XQ2:%/>0>,O#UNL]Z+._P!&F>0W
M-RSO<,ACQ*R$D(QW$\$G!P<8Q79IX7T=+O4+G[(S2ZBFR\WS.XG7:5 92Q!
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M^8X*AA\L@?)Z_P!T'/M5Y+K1[S^WO"_BF]OX]1DU269+%% :[4R;X6B8)N/
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MZ$^A[=1W K#\!:ZW_"N=#N]3N;B[O;H.BDYDEG?>YP/7A2?0 =@* .U  S@
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M1?R4.<%L>NT],X R<"DU;Q-I^CBY:<7$BVD8ENF@A:00(>=S8]@3@9..<8H
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M,$GFHW[SYN!M!/?TZ\5WE% 'D\N@ZU=Z#KKVEC<+=P^*/[8M[>53']JB5D8
M$\<[3@'N!G&:Z.>VEUKQGIGB"*TO+>TTVPN$D\ZW9))7EV@1A",G:%8DXQDC
M!/..UJ..>&9G6.5'9#M<*P)4^A]* /*['2]3@\"> K&33+T76G:G!+=Q^0Q,
M2() S'U'S#IG.?8UT7Q,D,.F:#*(WD*:_8ML099L2= /6NU=UC0N[!549))P
M *R->T.TU];&*ZNIX?L]REW"(64%I$.Y3R#G'7'YT <=XE\,7WBS5=;U'3XI
M+8/H?]G0-<1F(SRF7S.58 A1M"Y(_B..E7M G2_DCNYO TNDWMI"XGGFM4RK
M%<%("I+-D]\ 8'J:[H#  ))]SWI: /-;'3-13X!R:*^GW2ZG_9DMK]E,1W^8
M00!].1STJU;VNH:5XOTG7GL[N;3IM$33IUCA9I+656W@E -Q4Y(X!Y [5Z!3
M4D23=L=6VG:<'.#Z4 >4W7AK6K$CQ%:V$TX'B1M5?34QYA@,?E[@N<>9C+[>
MO..HKHM#-[=?$C5=4.DW]O8W.FV\<<UQ&(_F1I"003D'YAQC^E=M10!YWXPT
MFZN-6OM1T:/5+'7X8$6UN+:,O;WXQD13+@I@$D9;& <Y.,""XM;S2?%VK/JW
MA*77+/6!#+%-:0I+Y4@B6-XG#D87Y003QS]<>ETTNBNJ%E#-]T$\GZ4 <1%I
MU[IGQ TB[31RMD=%-B19JOE6TGFHVT\C"A0<''..!VJU\0+>ZNK+1DM+2XN7
MBU>UN9!#&6VQQR!F8_0=NIKKZ* .)ACO-#^(>K:K+:7=QI>L6MOY<L$+2-!)
M$&&QD W $-G.,9SG%8%OX=U'2;7PPKV-PS+K\VIW$449<6L4@EPI(XXWKD#/
M.<9KU6B@#C[VWO;3XI6FJ+I]S/92Z2]H9H5!$;^<K_-SP-N3[XP,FN4?2]4;
MX:7>GC2[W[8^N&Y6'R&W&/[6)=WI]SG].M>MT4 <WX\@GU#P!K5K9V\T]Q=6
M;Q0Q(A+,S+@#';\:R4@NCXY\-WOV&[%M;Z1-!-(8&Q'(QC(4\=?D:NZIJ.DB
M[D96&2,J<\C@T <I\/[6YL],U2.[M9[=Y-6N[A%FC*[HY)"RL,^H/X5B:=I-
M]9>*+2]T.+4K&.XOI#JFF7*,;4*=^9XV(PK,=IPIYW<@8->D44 >/WNGZU'X
M+USP_'H.H377]MFZ1T0>7)$UVLH96)Y^7J.V#G%;\,^K^'?%^N^=X>U#4K#6
MGBN+>2V5'\MQ$L;12Y8!1\HP<XQ7H-% '%107L7Q.AU">RE6W30?LTDL,+-$
M)O-#E%.,G@''Y=>*L?#>UNM.\$V]I?6L]M<13W#-'*A! :9W7'KE6'2NMR,X
MSS10!Y19^#9-=N/%AGM+C3M0DU;[?I.H20%60JJA&!QTR#E3U!Z5?UJ3Q!X@
M\*:9=S>'Y?[7TF^CN;O39%&RZ50Z/Y3'Y2"&+#G/'TSZ110!YY?VZZKX*\2R
MZ;X1GTN>]T][:-)+5([FXD*, "%)PHR "Q[GH!DU+VUO=,UC1M:F\.7.KZ=)
MI$=A<6\4 >>UE1BP;8V,@[B#CTSZ9].HH \_GBO[.[T**U\,S66D2BX::#38
MT6:%V(**[*1L#<EBI'. 3@<XVD: \G@S3=(UK1]8LY+:^NY([VS)\ZU<RNR2
M*4)8J5?'0YST(YKUFB@#RF>P\2VUOX?UG5=+DUY;"2\M[B!85%Q+;R,OES>6
M>-^$4E>OS<\YKN_#,,*V,UQ;Z$NCQW,ID$!B2.5^ -\@7(#''J3@#// VZC:
M>%)DB:5%E?E4+ %OH.] 'F5MI&JVO@'7O!<^G7$U[,]U'9W C)AG29F99&DZ
M*5+DD$@_+QGBMC1],NM/^(P+07+VD6@P6*W;1'8\L;L2,_0@YZ=LYKN:* .2
M^(MK=7OAR""SM9[F;[?:RE(4+$*DJNQ_  U'=1W#?%33;];.Z:R32IK=[@0M
ML61Y(V4'CT4\]!WKL:* .2\=VEY.GAZZM+.>[%CK,-S-'  7$85U) )&<%A6
M?!!>#Q9XQO)-.O$AO=/MHX#Y).]T20,HQG)!<#T/;(KO:;)(D2%Y'5$'5F.
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M/#Y<[%2)79@&)0$8W8X!H 9HGB:Q'A[PS!I6F)!+JMOOL[$2;4AC5=S%F .
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MFF^;<: 1Y\5O<AT=2@<%7(';((QD$=ZS9_"?B86NN?9FL5:^UI-0\G[2X6>
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M'&TF=H;J,X[<5EOH^O7?BOP[K-Q!I\:6%M<17$<=R[$&4(!MR@W8V=\=?;D
M=:>/+:70Q>75LMG>?VA)IC6TLZ[5G0G</,QC: I;..@Z$X!N^'/%*:]?:G8M
M;I%<Z>Z!VAF\Z&57&59),#/0@C P17+GP3XA73;J:VGL;?5H=?EUFQ)D9XG#
MY!CD^4$95B"1FNST,Z[+%)/KD=G;RL J6UI(9%0#.6+D DG/3&!@=: .,\90
MZ>OQ5\*->V(N(9K6\\Z-;4SF0JJ;<JH).,^G%:]M?:1HVF>(M>TG1)8!9+LG
MMU@^S>:(H_,W!&"XXD(SCG ]J=KNB:U=>/-$UVQ@L9+;38;B-DFN6C=S*%'&
M(V QM]:FU>Q\1:QI.LV36VG6R75A);PHERS[Y9%*EW;RQ@*,8 !SD^@H K)X
MYO#>Z- _A^4)K-NTEDRW*$EP@<JXP-HQD[LGIT!XJ*?XAM9^'=5U*[T65;G2
MKY;*ZMHYU<!F*!6#8&5/F+VS[4X>&]9^V^"IO+LMNB1NET/M#98M#Y7R?)SZ
M\XKG/&.C:GI7@[QI=726H74=2M;JW\N5F('FP)ALJ,?=SQGK0!UUGXKEN?%!
M\-ZSH<FGR75N\UHTDJ2I<1CAE.WA6 /*\\=_7"\!:Q!HGPZT.V2'S+F\OKFU
MM+=3M#-Y\I.3V4*I).#TZ$X%=&='OM1\56.N7T$,']FVTT5M"DN\O)+MW,6P
M,* @ [G<20,8KF[+P+K=IX:T%0]DNL:)J$MW$!,QBG21W+H6V@J2KXS@\CWH
M WG\87$4^L:>^D%M8TVW%V+2.?*W,)S\T;E1DY!&"HYX[YJW9>)QJ-AH%U9V
MT<HU=0^U9O\ 4ILW,Q^7G'"GI\S 5#:Z8T'B>\\5ZNUO9L;*.QCC\[*QQARY
M9V( R68#'8 <\\4/ ^A16.HZS=6USY^F"ZDBTU!C;"C$/,$/]TRY'_;,4 !^
M(MF9M/EBAAGT^^NA;))#=!YDR2%D:(#A"1UW9 (R.P-2^(MG8I)=1PPW-C#=
MFUF,=T/M (?8SK#C+*&SW!P"0,=8O"^B>+?#L47A_P W3I-$MI#]GOM[?:!!
MNR(S'C;NQ\N[. .<$T:3H?BW0+R\TJQETV30[BZEN(+J5V$]JLC%V0)C#D%C
M@DCKSZ4 ;P\.6J>,F\1HGEW#6AMI&5V)E&01N7.T;=O&!D[CZ5!X>\4MXBCM
M+NTM(FTZZ1V6>.YWM$1C"2)M&UCGIDX((],]$<X..M<-HWA"\M_%-CKKVEII
MEV(735/L4Q,5^Y7"G9M &&RV2 <\<]: (OB[;PR^$;9Y(D9AJ5JH8CD!I5!'
MT(.#3/B!HEOX?\+77B+PXB:5J6F 3H;4>7',H(W)(@PK@C/49SBM?Q_H.I^(
M]"AL-,6U\Q;N&X9KB9D&(W#8&%;DXQ4?B+0=;\7V*Z1?FST[2975KS[/.TTT
MZ@@^6"44("0,GD^U #;SQS-;:/-J<>D,UK;Z;%J$TD\WDJP=2WEQDJ0[@*<C
M(Y*CO23^)M3G\:Z#8V-O =.OM/DO,R3%78#9U 4XP'Z9Y)ZC'-/7O">N7U_K
M<-LFG2Z?>Z7]CL3<2,IL#Y;(P1 I!W;A\V0>.^ *FMO#>O6^J>%M1"Z>9-/T
M^2QNXS,^%#>7AT.WY\;.AV]>M #[GXBV<#07$4,-QI\EW]D+Q70:=?F*>9Y(
M'W-PZ[LXYQ72ZYK-KX?T>XU.\W&*$ ;4&6=F(55'N6( ^M<KH&A^+?#SR:'!
M+ILFA"=Y+>]9V^T0Q,Q8ILQM9@20&SCO@]*W/&7AUO%/A>ZTN.X^SSN4D@F(
MR$D1@ZDCTRHS[&@",>)9[;Q#::)J=@EM<W\+R63QW'F1RL@R\9.T%6 (/0@C
M//:N<\)V1\2W^O3:[IUM,UKKTC0S>>S20R1",(J_*#M '7(SDY')K;&CZGK&
MOZ+JVKV]M;/I*2LL4,QD\V:10A.2HP@&['<DCICE_@_1M3T9];_M".U"WVIS
M7L1@F9\*^W"ME1SQVH A\:>'M*N-#U[5KFRAN+T:9*L<DR!S$$1R-F?NG))R
M.>GI6?X2TS0M)\"Z#XFEMH+6:UTE+BXN8HPK2*807WX^]Z\\Y%=3XDL[K4O#
M6I6%DL37%U;20)YKE%!92N20">,^E9=AX9GF^&L7A;5&BCD_LT6$DENY=>(]
MFX9 ^N,4 06OCI9];LM-:RB<W\+R6[VMVLQ5E7=LE  $;$=.2"01FL^#XC7T
M_A:;Q(OA:X_LR*UFG:0W<>=T;E2NWK@@$Y]B,'@G3\.1>-(8H;76_P"RS'9I
MM$]M*Y>\(7"[@5Q'V)(SR.!BLRS\(ZW#\([OPK(MC_:$L-Q"CK.QBQ([,"3L
MSQNZ8[4 :#>,[Y-8L-/?P_(&U.V>:Q872'>4"EE<8^0 ,#G)X[9XK.U;QC:W
MOP_UN^U7P]]H73[IK.^T]IE9-ZLO.\@97YE.<9]JT)=!UB7Q'X4U#RK,0Z5;
M317(^T-N)D1%^3Y.0-N><=:Q[WP7K]UX2\7:2JZ>L^LZB]W QN'VHC;.&^3.
M1L[9ZT =%?\ BF[MO%3>'K+17N;G[";R.1KA8T8!PF#U(&3UQGIQW$>G>,I-
M7T/2+^RTF=I=1EDA:-WQ';-'O#F20*<#*$ XY)'2E_LC5C\08]?,-H+4:2;(
MI]H;?YAD#Y^YC;QC.<^U<]8>$/$UAHNAV933;F.ROKJ>[LGN7$5PLKNR$MY?
M5"^=I4@D9["@"QJGCR^N?"46I:3:0)/_ &NFFW >?<J'SA&Q1@OS ]C@8!S@
MXQ6R=3MAX_M+*\T>./4?[+DG%_Y@8)&'0-&#@$C)!R<=.E<^?!/B#_A&M4L2
MVG&Y?7?[5M=LCJD@\X2E6^4[.F!C=6Y/H.J7OC:TU>ZBLQ9C2Y;*=$G;?ND9
M6.T;.0-N,Y!.<X'2@!DOCQ(-&M?$$FGD>'[F98Q=B;]XB,VQ96CV\(3C^(D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQC#JWC+5_#_DF,V<:R6\IZ7"ABDA'LL@*_6M+Q'JO]D:/)+&\:W<S+;VBR'
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M,<(F?=B!^->=>+-'U;POH6C^)&O+.XE\/7'VB4Q6[1R3I*V+C+%R,MN+=.M
M'J<]Q!:Q&6XFCAC'5Y&"@?B:0W, @$YFC$1P1)O&TYZ<UPOBG6].M_$G@_6S
MJ=H;%EN62.6=(UD5HUQ*K.0NY<@8)!PYQWKE-4T31[+X97UU'+I4S76NQ7(D
MLW1Q KW2E8Q(O=48_3)QQ0![$U_9I;O<-=P+!&Q5Y#( JD'!!.< YI[75NMM
M]I:>(6^W=YI<;<>N>F*\ZU]=(\+^,M%BE:+1=#N8;@I-#%&L(NV*<ON4JI*
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MY'T-/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML8F9V(4N1@'!S_\ 7J3PK/:ZM<:4;KPQJ]MJVG(1+)?K+Y=JVS:QC9B0V[@
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M_57<#1$_W<C@CW!P?PKCD\!ZA*WA^]N[U&U*/<FM2CI=1,H+1^XW1QJ/;)H
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MA(;@8.,=>>);OPUXMN;KQ7>6\UC8W.KVEM';O%<.6A>,-E<[1P0Q&X8(Z@4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$,)4.W^C]MQ _,U'\/@NHZKXC\:[DMK;4W2/["I.^ P@JQF&!B0GD@=/4YH
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MQFC\UL1'!7&Q057:#QU'4T >L4455U.:YMM+NY[*%)[J.%WAB=PBNX!(!8]
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MDB11M)(ZHB LS,<  =235*UU:WN;"*^;,-O.ZK TG!D#$!#CMN)X!YQC..E
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MM:DLY;VR=Y[-/*AF2XD20)_=+JP9A[$GO6];V\-I;16UO&L4,2A(T08"J!@
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MJIJ5I+)<?$Z]AU"^M9K+9<0FUN&BQ(EHK G;RPXZ'CVKU :;9KJSZH(%^VO
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MMX/']KX7:$@3V[NMQ_#YR@-Y7U\L[OH1ZUN:EJ-MI.F7.H7D@CMK:-I9&/8
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M[Q'-KVA1W6HFUANWN;B!8HB0&$<K)P"<GA<FN@ENK>"2..6>*-Y#A%=P"Q]
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M%"<;I'"C/U-2UQ'B2]TT>.K&SG:WAO/[-F<3WS9@6)G4,JH2 TAQZC"YZ]*
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M6#@=5!V8ST8CN:Y&33M,M_ACJVHPVUNEW:>(V%O<!1NA OE "'^$8)X'')H
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M[2R):2&2./)&YTVY495NO)P<9P:LGQ)I;6]G-;SFZ%['YULELAD:5 !E@ .
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MH/*<-))NVXQMR!GC)P*T]:\4Z-X?60ZC>;&BA-P\<<;2.D8."Y502%SQD\4
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MQ8-MNX[B%XI(3U&Y& 89[<<_6K-AXBT_4-4GTR-IHKZ&,3-;W$+1.8R<!P&
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M0!T']DZ</+QI]K^[^Y^Y7Y><\<<<UFZ+IFL+>OJ&OWEG<W:HT-N+2%HTCC+
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ME90I.'!.01_#CBNQHH \S*>(()/!&M:SI]S=3V;W<=Z;.V)<>8I6.0QKR,@
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M>6H965AMVD@GKGD\'-<G!X UC1M TZ;19+./5K#4Y]0BM&9OLX27<K6X;&0
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MVLES.R/9R.!ORH4^8N1D $?4=:ZZ[T^+4-)GTZ\S-#<0-!-G +JR[6Z=,Y-
M'*^#-"M-5\)Z=K&N01:EJ>HP+=S7%R@<KY@W!4S]Q5!  7'3/6K\$T7A2+3]
M!@:6]O+V>X:U2:8YV;FD8NYR=JA@,\DY'6JGAFR\2>%]*AT*2SM]2M;0>5:7
MJW/EL8A]T2(1P0.,KG..E/UK0-6FUK0O$-J\$]_IS3)-;%MB2PR@!E5L?>7
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MOIUK;&8$Y<Y9F8# '"@8SQD^U;'A'3[O2?".DZ9?(B7-E:1V[^6^Y244+D'
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MT=JQ\Q5!.,<@>F1W[4 =717(WM[JUD^G69U&*.*2TD?S8X-]Q)*-NU5B&?D
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MY#8Z??ZE<3VUTKQ^8!LC=ED7:Y&"%!V]<\9% 'H=%5=-CO8=-MX]1N(KB\5
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MS!M6ZMAT>*0_>8CGKZC'>@#N:*\XO/&&M6_@?Q9JBS0&[T;4IK:!C#\KQH4
MW#/7YCR,5NS:MJ>KZYK>DZ1<Q6DNEV\1#R1A_-FD4LH.>B  9QR<GD8Y -I]
M:T]-<CT5KC&H20M.L.QN44@$YQCN.]:%>=WZZQ/\0O#*N]K::H^BW/GNJF6.
M-]T6[:,C=STR?SZ'H?!&LWNM:#))J)B>\M;RXLY9(DVK(8I"NX+DXR .,T :
M^IZI::19_:[V1HX=Z1[E1G^9F"KPH)ZD5<KFO'6LZAH/AY;_ $YX%<75O$XE
MC+96254..1@_-WS5"ZU/Q'=^.-4T&ROK*U@AT^*ZAF:U+LI9W7!&[!^[UXX[
M=Z .THKRQ=?UCQ%%\.M06\6S;4993/%'&&0R+!)\W)SC@X&>_? K7N_$/B74
MHM5G\.6AFDT^]:UB@98O+G,9 D#LSAE).[&!QQUS0!WE%<,-5\4ZCXSU/1[6
M[L+.&UM[2Y7S+4R, [-NC.'P3A3\P].G.1%;^(_$^L6=GK.BV#7%K+=E6MF$
M2HUN'*%@Y<,' &>F.V.Y .^HKAH/%L\WBZ71;J]73KY+PK%97,&U+JV'1XI/
MXF(YZ^HQWI_@"349[SQ1)>Z@;D1ZU/" T87[J1@$8Z   8H Z>VT;3[/4KG4
M;>W"7EUCSY0S$R8Z;N><=O3M5^LSQ#=WECH%Y=6#6BW4<>4:[?9$O(RS'T R
M?PKDXO%6J?:_%%E!<+-_9^G1WMI<75H4)+!\AE&W*Y3@C'7O0!W]4-9UK3_#
M^FOJ&IW'D6J$!I-C-@DX'"@GK7&Z5XD\0?;/!<U]<VDUKK]M^]@C@*F)_L_F
MA@V[G)!!& !GVS6-XOU>_P#%'PDU;78;F.*PEF*0VOE [H4N!'N9NN\E=W'
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M-;WVFHZ23K$";M7.7$O/(+9;_>.1BNJHJFEW.VKRV9L9EMTA61;LLNQV)(*
M9SD8!Z=Z ,(^#F6768K?598K#69FFNX?*!<,RA&\M_X054#D$CL0:H>*+?2=
M:AA\#PVMT)HVMY(S% Z);1(P.]9<;00JD#G.2!ZX[BB@!L<:11K'&H5$ 55
MP !T%8_B3P^OB&VLD%Y+:3V5Y'>031JK8=,CD'@C#&C5O$/V"];3[.REO]06
MU:[-O$RJ?+#;>I[DY '?!Z5H:=?Q:G8Q742R(' W1R##QMW1AV8'@CL0: ,2
M+PK+#J^KZBNILTFI6L=LX>$':(PP5A@C)^9L]L]A6:WP[\K3=#CT_6[JQU+1
MH3;VU]%$I+Q'&4D0Y5AP/QYKMZ* *6EV#:=9"*6[FNYV)>:XFP&D8]\   <
M  8  K-\6>&CXIT^"S:^:TCBN([G<D89BZ'*]3C&?:M^B@#&.DZE-=VTEUK+
M20P/YA@2W5%D8 [=QR20#AL#'(%8DG@#S/"E]H#:J_DWEZ;QY1 -ZL91*0.<
M8W ?A792,4C9E1G(!(5<9;V&2!^=<DOC^U?PC8>(AIMY]GO+L6HCRFZ(F8Q
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MR!USG&#TQR/6N?C\?6EQXMO_  S:Z3J=SJ5C&))A&(0@4A2"&:0#^(<=?RH
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MSUH ZR)&CB1&D:1E !=@ 6]S@ ?D*?110 4444 %%%% !1110 4444 %%%%
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M:7:A)_,NY6>11T4N6W;1D_*#CD^IK>M;:*RM(K:'?Y42A$WN7.!TR6))_$T
M<[XPU:6QN_#]@L[6\&J:B+:>=&VL%V,P0-V+,JKD<X)QSS6/XCN+WPE92Q0:
MU<31:CJEI OG,7?3X96VN0[$D@[6P3T)XZ5U^N:%IOB/3'T[5;5;BV<AMI)4
MJPZ,I&""/454B\(Z)%H5QHSV9GL[G_7BXE>5Y3Q@L[$L2,#!SQ@8QB@#(\V\
MT3XDZ=I=O<W,^FZG8S220SS-,8)(BN'5F)(!#@$9QG!KC8/^2'Z1_P!AF/\
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M\(,K'"ELR-M! ],<#%6?#FE'3;.YFFMXH+R_N7O+E(N0';H,]R%"@GN03WH
MUV&Y"H8J2,9'45Y)97NJ6'@+5?%4FMZG<7=A/>P11RS;HMOG% SKCYBHY![=
M.G%>MLH92IS@C'!P:RM.\,Z3I>F7.FVUJ39W3.TT,TKS*Y?._P"^3UR<CWH
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M=H4#B51P%'."!@5-XY\(1OX2\01Z)I]S<:EJ[1F91<,WF,K+R=[;5PJXXQT
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M95VO(PY" X)]0,=ZX6:ZBO;CXGP17T%]/=:/%)']G4!92()02@!.0/E&<GG
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MN-S3V\A&Q@>^V3:1ZAC0!W(U*Q;&V]MSF3RAB5?O_P!WKU]JA_MO2?LC7?\
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M<Z_:*#)C[I8[ASVQUKF]:4VNJ?$:UT.-5E_L^QD^SVH + ;_ #-JCOLXZ>E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:+;/,R?:(8'61 )BJ8;:02=H!QD MCBNIO\ 7+'3KC[/*TTEQY9F,-O"\KA
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MG$$C1P[P"OF,%PG#*><8!!.,T ;$D$4T)AEB1XB,%&4%2/I2K#$@8)&BAOO
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M2&:,8Y3:IW'D<#GVH VGM;>2$PR01/$>2C("OY4K01/C=$C;1@94'%<MJ7Q
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MI1)YDTARS$2./Y 5@Z%XYLM%;7XO$6K7,GDZW-!'-)"SB&(! N]D7:BY)QG
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M[:17:)C@.JE<L,C'&3FH].\7Z)JT5E)874DZ7KR) 5MI>3&</G*_* >,M@4
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M!5>-I));'KCH?"D4T?C+QA++:7445U=PR02RP.BRJL*H2"1@X8'^==C10!Y
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M]B@4F2:VD5%8;225( P>G7O7G$$=])X:^'=NVD:G'+IEW;BZ5[-\QA(&1F(
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M04R.J!F"C<<9)Z#ZT^@!L;B2-74, PR RE3^(/(IU%% !1110 4444 %%%%
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ML)!\HPORD'K@@BN:;P9XI>"T25])FN;36UU$WDDLGF7:!V(#_)\A56"@ D8
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MK$0@#N%XW-C)]SC^E<3X5T3Q-X;T[4+62RT>Y-U?3W8/V^10!(V=I_<'IZT
M7KK67\-ZIH?A>PTE[E;BUD6VD:X"!1"JC#<$]"N3]< ]*RI/B+?Q:!J.JOX<
MPFD73V^I)]M'[LH1DQ';^\X8-R$Z]<UH2:%KUSXF\-:M=/8.=/AN1=[97!+3
M!>(QLY5=N!D@D=:RKCP;KT_A/Q?I/_$M6;6[V:X@;[2Y6-9 HPW[O.1M[>M
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M*\6E:W(D$5PUP#(DKH6 ,8'W?E(W;L^U&J?$."PCN;JWM8KNTM;HVTZQW/\
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M2>>)?^P5=?\ HIJY_1?"DVO:-X,O=3U!'L]+M[>[M[6"W*;I1&NTNY=L[?0
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MZ=TE7[(7'R$[00P!R "><DDUEZW.?$WP8UGQ!>7%Q]O>YDW1K.P6 )<;%BV
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MDJL4_P![!X_&O/I;S3-+\>>.7OE&YM,MYDAC(6:95CF+^7WSCN*S=!U/3O\
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MQDX#<X#<8!H ]&M]1L;M7:VO+>98QES'*K!?K@\=#3K6^M+U2UI=07"CJ8I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-NX,0P!P5Y!KG[G7)KKXG>&[>!]2M[>XM+J22WF5HXY %38VWUY;@\CC('%
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M.T:M<[AA))%Y50N2.0"3SP* .W-M ;<VYAC,)&#'M&TCTQTH2V@CMOLZ0QK
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M=>:_8 K;0O/<RRV_V@+9)O983TDR.@/;N<' .#0!I26EO+<1SR6\3S1_<D9
M67Z'J*KKI< UE]4*J;@Q>2I"@;4)!.3U))5>O3 QCG//_#&^N-2^'FEWEW=3
M74TOG%IIF+.P\YP,D\] *T/&7B/_ (17PQ=:L+:2X>/"HB+D!F(4%O1<D9H
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M5U#J&VNN",^H[&GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_BM'8+)<)&V64\X4G.0#S\HS@G HZ_H-YXQU>:^L8[BRC31+JR66YB:)GFF
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M0-C,:/@*#CH2%W$=MV*Z>B@#!\9OJD?A.];1[075Z FV+8KDKO&XJK<%@N2
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MZTW59$FECO9'1[:8(J%AM!W@A0<<<CMUH ["QO(M0T^VO8-WE7$2RIO7!VL
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M 3CDG)Y''%1>%-*\8:-;VFAWTVFR:78[8XKZ-F\^6%?N(8R-H.  3D\=.>:
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M'G++P#@-N7CD<^V:YN#5=3U3QOXBT.[L[-]+M;6W^4REB1()3N*E,$G !&0
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M9%'E2J&. 3]X';D'@8(/M1JNA>*(-8TWQ#I4]A<ZG';/:WUM<%HXIHV?>-C
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M 4444 &!G..?6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L#0/".G^']+OM.AW2VUW-+(
MR/T1')/ECT4 D >Y/>M^B@#D?#G@V^T PVC^)+N\T:U.;2RDA0&,#[JM(/F=
M5[#CH.PQ4UKX2D_M/1[_ %+4$O+C24=;>9;;RY7W(4_>-N.X8)X '.#7444
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M$^XEI$ R$&,# Z^@P*M7VDZC+\1-+UB*"-K&VLIK:1C+AMTC(00N.0-GKWH
MI:K\1+33+>[G-LD@L"JWD)ND696(4LJ)_&5##/(&00,XK5/B7[7<S6^C6GV]
M[>".>8F7RE4.-R*"0<N5YQ@  C)&:Q8-,\6>'_$6JKI%OI][I6J7)NU>YG:-
M[25@ ^0%.]>,@#'U'6G1:/XCT/Q?JE[81VE_I^KI"T\D\QB>WECC"%L!3N!
M!P,<\<"@"UIOCN#4QX:D2PE2'7Q+Y#,XS$45GPP]PO8GFJVL>*[&Z\+^*CJ.
MBRW-MI3O;7ELLBD2KL5B021QAA[^U<YX6TG4[KP)\/\ 5]+@AN9M+\QWMY9?
M*WI(CQDAL'D9!K2G\*>(I]!\;V<EO9>=KLK/;[+@X7=$J'=E>@V]>I]!0!M7
M_B]]-U&RT>PT"ZN[BXL&NK=(Y8T5@FT;,D\8W#DX]LYJ'5?B)::9;7=P;9)!
M8%5O(3=(LRL0I943^,J&&>0,@@9Q3DT;5CXRT+5&M(UMK/39+2?]\-P=RARH
MQR!L]NM5X-,\6>'_ !%JJZ1;Z?>Z5JER;M7N9VC>TE8 /D!3O7C( Q]1UH U
M;GQ#%J<EWI^F6(U(16J37(:01KMD4E$&0<NRC.#@8QDC-4OA4?\ BUWA\\_\
M>W_LQJ*#1-?T/QEJNHV,5OJ-EK$<)F,T_DO!-&FS=PI!5@ >.0>U:7@'1]0T
M#P3IFDZFD*W5K&4;R9"ZD9)') YYZ<_6@#*TCQM=+8^)=2URU6"TTW4)+9!#
M(';*B-5C P,EF;KZMCI6U'XE:'Q#::+JEB;.XOHGELW642)+L&70G PX!SC!
M&.A-<O=>!M7O](\5:.[VT$5_J3:E8W8D+$29C959-O !3!.3UX%;G]D:EKGB
M#0M5U6TCLO[)65_+282>;-(FSY2.B ;CSR21P,4 4/B-MAN_"-VMLT\\>N1*
MBQ@;V!CE.T$D#D@=2!QS5JV\?V\9U>'6M.GTJ\TN-)I()'1_,C<X1D8'!RWR
M]L$U<\8:/?ZHFC7&GI%++INIQWK122;/,55=2H.#@_/GGCCK6/K7@J]\3'6[
M^>5;"^O+."ULE#;_ "1%)YRLY'!)DQD#. .IS0!JZ3XSM]1\2-H4D42W)MOM
M,4EO<K/&Z@X*E@!M<<<>G0FK&M>)CI&NZ5I*Z9<W4NI>;Y3QL@4&-"Q!R<YZ
M>@]^U-\/S>*KIE/B"RL+$1)M(M9S+]H?^]RHV+UXR2<]1CF'7=)U"\\9>&M2
MMH8WM=-:X:<M(%;]Y'L&T=\=3TH S7^(<\>D:K?-X<N]VCS/'J,8GCQ$% 8L
MIS\_RD'  _#C.KJOBMK(3M::=)<Q6]A_:$DSOY49C.<*K$$%SM)P<=N>:P9O
M#&MRZ)XYLQ:PB37997M29QA0\2Q_/QQC;GC/6DO/#?B2[G,4MM97%G)I"VD*
MSW! LIPK!G"A2'+9&&X(QCCF@#HE\507O]E0Z; ;FZU.T^VQ12/Y8C@PIWN<
M''+J, ')/H"1R?@K6K70=&\0374"VK2^);BWBMFD50)"%^7=T  !.?0<>E2Z
M;X8\2Z)=>&]8@MK.XNK/2%TB^LOM)4&-<%71RN,Y&2".AP">M1?\(;XF.FW\
M\7V"WU2/Q ^LV*F9GC?*[3&_RC *EAD>O04 =7X=\66^OZCJ6G")([O3RGF>
M5,)HI%<95D< 9Z$$$ @U8&OD^*[CP^+3_2([$7L<AD^1U+E #QD'(/K3]#EU
MVYC>XUNTM;%B L=K;S>=C'5F?:.3Q@ <8ZG/&5J&E:S!\0(M>TZVMKF";3OL
M,HEG,9A(D+A_NG<.2,#GB@"O'\0XIM'T'48]'O'76+IK6-%=,HZEQ@Y/?RS[
M>I%6;?QS;)9:Y+JME-83Z/*D=Q!O64OO4&/81P2VX #UKGM,\(^(;/P]X2L)
MK:U:72-4>\G,=Q]Z,^;P,C[W[SIG''6I-9\$ZQK4WB\J8;5M2FM+FPE:3<!)
M;JH < < E>V>#^% $MQ-<'XNZ%/?:?'9.=+NV:19@X9<Q\$X&"O.>HYX)K0B
M^(NGRWNE(L2/::K)Y5M+%<*\@8C*>9'U0-V.3C(SMJO)I'B+6_%&D:EJ6F6=
MG;PV-S:W2)>%V_>[!E<)_LG&?QQ4GA2R\9:1:6F@W\6GM86 6./4HYB9)H4X
M1/**\,0 "2W'.,GF@"[H7C"YU[4'AM_#]Y':PW<]G<7,DL>(7B]5!RV3Q\N0
M,CGK@\0Z_JFG^,/#NE65I'+!?F=I&:7:6\N,G;T.!R#GVQ3_  7I.HZ/!J\>
MH01QFZU2XO8C')O^21MP!X&".]'B31]3NO$OAS5]-CMY?[.>=98YI3'\LL>W
M<" <X(Z=Z .3TW76\)W7CF\@T>:ZL[75?.N#$Z((H_)C+$ GYCU.!^8XSUEQ
MJ>FR>.M&MWTQY+R>RGEM;\D;5C^3>H&<Y.5Z@5AW/A?6Y]'\<V@M81)KLKM:
MDSC"AHEC^?CC[N>,]:T5T35F\5^&M2:UC6WT_3Y;:X_? MO<)RHQR!L]NM &
MCHOB@ZZ+6YM+,/I]TTBI<),&,97/$BX^4G'3)QWP>*H?$5-4&C6=Q86$NI6M
MM>)+?V$)P]S  V5 _BP2IV]\8JEI'A*\@\5:?KBV,6DW060:M]EFS#?$J0I"
M#ON.[) (Z?-UK:\3ZQ)I=QIK6]_ID++,7G@O;P0>;#L8?*3GG<5(XQQU% &/
MX2U3PE?RW6OZ!=);6T%JR7EB08_LQ!W%C%T0X!!(&#@=<5;M/B!8W&L:99/%
M&L6J*QMI8[E9"A"[MLJC[A(Z<D9X.*YV6#P_K?BC4=8N=3T?2X[O2I=-D2._
MA:6<R'EWVG;\H&!R2>^,"K'AOQ#>QV4&BZYK/AI;2UC\E[^WU-&>Z0#:H$9'
MR$C&22>^!SD '26_BU[O^S+JWTBYFTO4IO*@NHOF91@[9'0#Y8VQPV>XR!FL
M6U\47>H>'?&%SK>CB>PL+BZMWMX9E),4:*&3G&<C<2<]\ =*S_"&L76A65KX
M=NM<\-MIMBVV+4EU-#)+"#E4\KLV,*3NP!TR:B2>"#1?&FEKK&@21ZO-=S6D
MHU- 29T"@,/X0O.3DY["@#L+3Q!;K!HVF:79*UU=6"W4-J9-B00*%&6;!(&6
M51@')]@35&?XB6MOHLU\VF79GM=073KNU!7=!*S!02<_,IW @KG.>W; M[BS
MTS5O#^NVVLZ-+<6NE#2[^T_M*(%D&&#1L3@D,.AQD'M535+>PN-+U.6#6M#;
M4-4U>WOY8SJ482*.)DVIN[MM3TQECV&2 =]I'B5[_P 07VBWFF36%W;0I<H)
M)%<2Q.64-E20""I!'ZFJWQ&3=\.M?<231O%8RR(T4K(0P4D<J1D>W2LBVU?3
M1\1[G7)-8T=+&73([,'^T8BX=9'<DC/3YL=>U7/&.MZ/K'@_5M+L=<TA[F\M
MI+=-]_&JJ64C).>@H Z33$$N@62,6PUM&"58J?NCH1R*YSX7%O\ A"$#R22%
M;V\7=(Y9B!<2 9)Y/XU=TWQ3H=OHMK'-K.E"XB@5&C6_B.6 QP=WM6-X&OH=
M+\-2Z6-0TB?4_/N9K>&'4$<2EY'D5<CD=0#Q0!WU<*/%.G:1;^,=5@T&XCFT
MVX!OE5TWSL(E(?[V -N.^?;-=+X;U&]U70+:\U&VCMKM]XDCB?>F58KN5NZD
M ,#Z$5R%_P"%M<NM-\=6R6T ?77S:DSC"CREC^?CC[N>,]: -VS\7F;7[;2[
MS2Y[%;RT>ZM9Y9$(D5-N\$ Y4@,#SVZX/%.M?%DEXVEW$.D74FEZG(4M[J/Y
MBHP2KR(!\B,!P<GJ,@9JA=Z!J5]XC\/7<MJBVEGI]Q:77[X;LRJ@^4=P-A].
MM,\(:;XNT6QL_#]['8'3[#$<>I1S$R30J?E3RMORMC )W=,XR>: ,C2=9B\(
MV'CW55L_-MK/6F=X8V"G:8HL[>W4].*[2;Q%';>*HM#F@*^;927BW&\;0J,J
ML".Q^85RESX.U?4/#_CC39$@@?6KE[BT<R[@/D10'P..4[9ZU9ET'Q!K?B>T
MU+4;*SL[5M*N+"XCCNB[IYA7Y@=N"?E/''U[  S/%VKMKMCX3U*+3<6$VO6;
M6MTT@W[3(,,4QPK 9')/3(%;Z:[86?B'Q;-%HDXOM.M8);J563==)MD*;?FP
M  IZD'GI6 GAKQ?_ ,(QH.@2V6GN=%O[61+O[656>&%LK\NPE3M !Z\],]MB
M70=8;7/%]XMK"8M6L(;:V_?C.]$=26XX!+^_ Z=J +&F^.3?7F@1S:/<VMMK
MD'F6MP\B,-_E^85*CD#;G![XZ4E_X_@L]-O=5CTZ:YTRROOL$TL<BB3S P0E
M5; *AR%R6!ZG&*HP>&]9BA\!H;6'.@H%NSYPYQ 8ODXYY.><<5B6\&I72ZE?
M6N@6.IZ#=:E)?+Y>K"&*0H_#LC(><H&/S;2>2* /5H7:2&-WB:)F4$QN02AQ
MT."1D>Q(I]065T+VPMKL1O&)XED"2##+N .#[C-3T %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 50D
MUK3XM;AT9[@#4)HFFCAVGE%QDYQCN._>N>^*-Q>6OPXUF>QNC;2K#AG5<DJ2
M%('ID'K_ /KK.UJ'4O\ A8_AB&&\A^V'3KX&X>'*J-T7.P'D]NOO[4 >@T5Y
M[I_C75)-(M;6=(YM6EUBXTHRPQ@*WD[R9 C,!DJF,;L9/?I71>&[GQ!+=:G;
MZU9E+>&1#973;%:=&&2&5&8 J>,\ Y'% '044URPC8H S ' )P"?K7!Z5XKU
M5O$?AZPN[BWN1JD-P;D0Q'RH98U#8BDZ.!DJ>3R.HZ4 =]17"^'/%UQJ^L"Q
MGNTMM3B:7[9H]Q#Y<B*,[&B8_?7ID\YSGCI3?"_BRZ\03FW?44MM2BMG-]IE
MQ;>7-;397&P'[T8^89YSE>1TH [RBO/+/QEJ]SX4\%:NQMA+K%[#;7:"([=K
MAR2O.0?E'KUIE[XC\4&W\9RV][I\7]@2,\6;1F\U%A$NP_/QU()Y_#'(!Z-1
M7#6_B'7%\0>&EN)K-K/7[>5E@2 @VS+$)%._=\_<'@>V*Q)?%OC)/"%]XG2;
M2WATN\GCGLQ;,#<11RE&(<N=A &0,'IR>U 'JE4],U2SUBR%Y8RF6 NZ!BC)
MRK%6X8 ]0:Y#2+G4[[XF:WMU$?94TZTDAA>#(17\T@<$=^2>IZ<8%5]*\;ZE
M=^&]!,YMO[5U?4Y[(2+&1'&L<D@+!<\G;&  3U(SF@#T.HYH(KB/RYHU=,@X
M89Y!R#]0><UPVI>*-9T?4/$.CO);S75GI#:M8W3PG#HN59)%4@9##@C'!Z<<
MKIOB+7UUGPDM_<6<UKKUH[-%% 4:%UA$@(;<=V>01@8XH [RHU@B69YEC42N
M &?') Z#/IUX]S7%>'/%L^KZZNGW-XEIJ44DHO-)N8/+D1!NV-$Q^^O"Y/.<
MY^7I7<T %%>?)JM[IWCWQC>WE^TFGZ9IUM<>0(AQ'MF;:ISP<@G/.?; J2X\
M4:QIFB>'O$5T\$UGJ<MNEU:I'CR%GQL9&SD[20#G.[G&WI0!WM4/[:T_^W1H
MOV@?VB8#<"':?]6" 6SC'5AWS5^N!UV+4)OBQIT>F7,%K<MH=P//FB,H0>=%
MR%!&3]2/7GH0#OJ*\YT[QQJ\D*:1>6\3:VNKRZ7)+;(-CB.(RF559@,E<#!/
M!.><8KIO#5SX@EGU*#6[/RX895^Q7)V*T\9&3N568!E/&> <CB@#H**9*KO$
MZQR>6Y'ROC.#].]>?6/C/6+GP?X,UEC;";5[^&UND$1V[7+@E><@_*/6@#T*
M218HGD<X5%+,<9P!63_PE6B_9=*N3>8BU5U2R)B<&5F&5&,9'XXKF-$N-:/B
M#QQ(=2CE:TG585EM\JH\A748# X&X\9YZYJA?ZK<ZYX4^'6J7FS[3=ZO9S2;
M!A=QCD)P* /0H=4L[C5+K38I2;NU1))DV, JOG:<D8.=IZ&KE<G;:OK-YXL\
M3Z-'+:#[':V\EDQA/RM()/O_ #?-@J.F*S[;Q+JTGB#4S'=P76A:+!(;^Y%M
MM,DZJ3Y49W8^4<L>><#WH [RJ&K:UI^A6JW.I7 @A:18U8J6RS' & #U) KE
M].UOQ3=7&BWXL/-TR]CWWJL(T6V5EW*\;!RS =#D9/48Z5SOB?5=0\2_#&+7
MQ<1Q65W?VS):>5DB'[4@0ELYWY )[8)&.] 'K-4[[5+/3I+2.ZE*-=SBW@ 1
MFW2$$@< XX!Y.!5RN:\5:SJ&D:CX=2T:#[/?ZFEG<*\9+;2CME3G ^YZ'K0!
MTM%><ZAXB\4Y\:&VO-.B70,2Q9M&;S5\@2[#\_'7!//L!7=Z7>'4=(LKXIL-
MS DVW.<;E!Q^M %NBL?Q)?7EA8026DMM"'N8XYIIS_JXR?F*#^)^@5>Y/0]#
MQ5[XWUNW\'>*[ZW>!KO1;T0127%JRF2,B,C<F1M;Y^N,<?=H ]-JG)JEG#JL
M&F/*1>7$3RQQ[&(*J0&.[&!]X<$UR&LZEXNT:_TBW;4-+E&J:F;=<6;CR4,3
M,.=_S8*GTSQR.UF'4_$%EXNT?0=1O;*X%SI]Q-+-!;&,F1&4 C+$8P_3U% '
M95335+-]7DTI92;V*%9WCV-@(Q(!W8QU!XSFN2TOQ'K$]GK&FW<]N-?M-2%G
M&$APA1\-')MSD@Q[F//\+>E7/[:U?_A-M5T436IA@TJ.[MW,!R'9W4[_ )OF
M^YVV]: .MIDL2SPO$^=CC!PQ4X^HYKSC2?%OB.73/!NLWL]B]MK<Z6L]K';E
M2I='8.'W>J=,=#WZU-K/C'6(=+\5:A9F"&?1+U;:&QEBW^>I"89N0V7+G;M(
MZ#K0!W&F:79:-8)8Z= MO:QYV1*3M7V /0>U7*BM1.+6+[4Z//M&]HXRBD^R
MDG'TR:RO$E]>6-O9M:S6\$<MTL=Q-+RR(0?]6O\ &Y(4 <]>AH VJ*\GUOQ)
MK&I_#O7)1=^1-8ZTNGF00;&FB,L2_,I^Z2LG/3IVS7JD"2I BSRB64#YG"[0
M?P[4 245SGC'79O#^GVMV$G%FUR$O;F"$RM;1;6._;SQN"@G!P"3@UD/XHOD
MM_#%S:ZE8ZA;:IJIM'FAC^5XB)&4C!^5P$4$>N>!0!W55[Z]M]-L9KR[E$5O
M"A>1R"=JCJ>*XJ]\:WVE77BV.=8)UTR>S@L\J5RUP%QO.>0&<=,<"M'5H]?@
ML=<CO)[:ZTMM*E9)0GERI-M8,NT<%,8(.<CISUH Z2QO;?4M/MKZTD\RVN8E
MFB?!&Y&&0<'D<'O5BO-/"^K:SI=KX M99[673=5L$@\A82'B*6P=6W[OF)VX
M(P!S^->ET -DD6*-I'.%4$D^@JII.K6.NZ9%J.FSB>TE+!) I7=M8J>" >H-
M8S:O>:KXLU+0]/N$M%TRWADGF,8=GDEW%% /&T!<GN=P (QSR'@C6[NQ\%>%
MM(MXRUYJ#WSL\2J2JQS.6VAF SEUQD],\&@#U6BO+]?U#Q:="LH]2/\ 9\H\
M0VMNDJHA-U 95V,RJQVG/4 \X[ XK;O]<UVYO]6TO1U9[O2XH@9%AC*RSNF\
M!@SC:F"O3GD\\<@':T5P$VM^+[OQ!INCQ_8-+N;S1Y+N5)83,;>9612,A\,,
MMQTQG/.,5'-KGBN2Y\76D=_IT4FB1Q212"S8B3,/F%2"_&3QG)^@H ]#JG9Z
MI9ZA<7D%M*7DLY?)G!1EVOM#8R1SP1R,BN-L_$^NM>^$+RYDLS8^($PUI'"0
MT!,!E4ARWS=,$8'7\:KZAXOU^U\.^-[Q);$W.B71CMS]G;84$:-R-^=WS=<X
M]J /1J*XZUUG7+;QK8Z7?SVEQ;:CI\MS&D4)C,#QE/EW$G<"'ZX'(Z#I5#3?
M%>KMXA\/6-U<6TYU1;E;E88B88)(TW@12#AP,%6Y//ITH [>_O[;3-/N+^[D
M,=M;QM)*X4MM4#). "3^%30RI/#'-&<QR*&4XQD$9'6O,=+U?7M.\#^,M9&H
MPW-U8WU\4-Q;Y!\HX'1A_"H ';WKI(O$%YJ6OV6@VTRV\S:4NHW-QY88_,P5
M54'@<[B2<\ #OD '6T5YI/XXUY=**(MDNHV7B"+2+HM$VR97=0'3YODRK#(.
M['-=#H.K:L?&&LZ#JMQ;W0MH(+J":& Q860N"A&YNA3@Y[T =5116)XLU:[T
M707OK2WEFV2QB8PQ>8\<18!W"?Q$+DX_'G&* +FJZUI^B0Q3:C<"!)I5AC)5
MFW.QPHX!ZDBKQ4'J :\O\3:P-;^'_P!MM-4M=3MSK-F+::-=AV^;%\L@_A8-
MNSP.,<5NP:YK]IXBU[1KB6QO9X--34+-_+-N@9BZ^6Y+-\N4'.>A- '8OY:(
MSL%"J,DXZ"L3_A+_  ]_8::S]N3^SWF,"S>4_+A]F,8S]X8Z5C^'_$U_=>,(
M='GN8[RWGTDWWGK 8P)%D5&$;='C._(//3J:Y!_^2%W/_89/_IR% 'LFQ?[H
M_*L^^U?3-.OK*RNYECN+Z3RK=-A.]L$XX&!P#UK1KA_B +@ZIX/%HT2W!UC"
M-*I95/D2\D @G'ID9]1UH [?8O\ ='Y4;%_NC\J\Z?QGK?AZYUS2M:^RWUY:
M"VDLKF"(Q+*L\GE+O0L<%6_VN1W'6N@T>Z\2_P#"1S6U_9N^D-;"2.[D6-'2
M;=@QE4<Y4CD''&,'- '2[%_NC\J-B_W1^5+7F5YXI\5)X?\ %FJ1W>G*=!OY
M8U3[(Q$\:(C;3\_R\,>>>3VQR >F;%_NC\J0QHRE612",$$=17(0:WK5MXTT
MFPO9[6:RU>SFGCBBA*-;M'L.-Q)W@A\9P.1G Z50L/%FKCQ#X=L[N:VF_M.2
MXANHX(R8H'1&=1'+T<C;M;D\YZ=* .QUC6=/\/Z9)J&IW M[2/ :0J6QG@<
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MA= UB\U7PMX0%[JEW-=W'V@26L!*2WHC+(&:4,NP+\K,<\G Y)P<Z\O[V_\
MA!*;^=YIH-<2W#R/O;:E\JJ"QY;  &3R<5W,?@'P]%:Z=;PVUS$NG/(]JT=Y
M,KQ[_O@.&W;6[C.*=_P@7AT:7/IJV<J6<]S]J>)+F51YF[>",-P W( XSVH
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MS:"6PDT&4:F00T3_ ##R=W8M]_!/8'M7.Z1#IUIX8^%MY"EM%=27D2/,N [
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M:\SO-0TNR\7W^F^(=1ETC3[S2K>.Q^U>7L>$*PDC+R*V&!(R,Y/'7 J*#1]
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M=1M-)T^>_O[A+>U@0O)(YP% KF;GQ?))K'A/[!+:MIFL-*)RPR\>V!I!\P;
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M)9HIOA;H/E2(^RWV-M.=K!CD'T-9TUIHES\5=?778;&2(Z3;,BW@4J5#2AR
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M#B503\D8'3 /0G(Z5T4-OH>H_%K5WDBL;B&31+>7YE5E8EY,MZ$[2.?0^AH
M[Y]0LHY(HWO+=7E ,:F507!Z$#/.:D2Y@DG>!)XVFC&7C#@LOU'45Y+I%E-=
M_!KPSKVGJ)]5T%?M5N <ET0LLD6?]J/(QZ@5Z#X6(O[.;7FC9'U5Q/&'7#+
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MY\8:#:MIPDU!#_:2,]FT:,XF 4L=I4$9P.!U)P!R: -J.-(HUCC1411A548
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M4 &LZ-J=_)#:V%_;V.ER(Z7L2V^99 <#Y&!&TXR,X.,YK<1%C1410J*,*H&
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MS"#A3(5'()QN"]1@Y%9>D>'M:'B/X>:9/HE]%I&E6GVIPT6 MP<Y:1NBMO\
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MPR+Z!F\IQ[1D4IAN5\2^/Y6L;WRKNRMX[=Q:R$3,L3JP4XYP6 X]:] CD25
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MJNFW%R$%PMK*A27:, E9$8 XXRN*V+&QBL+?RHB[$MN>21BSR,>K,3U/3Z
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M86C3D-&P9@X8[>JA&)&.BG\572[BX\26WB76EM;)=.LY(HXTGWA2Y!=V<JH
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M ##(-F,9)R/W:\'WYK9UKQ"NC:EH]F]G+*-3NOLRRJRA8VVLW/<\*>WXUM4
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M.0:3->:5:G4Y4<QK!%*J%V5]CC<W VD-_P!\UHT 4=:T]M6T2]TY9A#]K@>
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M!)/;+#IF@#'TWP+<:1?31V7B&[CT&6=ISI7E(0K,=S*LA^94)ZJ/4\\FK?\
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MQ-*L*D;F4$ ]>.I Y]: ,1_#$UMXCOM:TC4!9S:A&B7D4D'FI(R#"R*-R[7
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M:KI\UC>(TEM,I21%D9-RGJ"5(.#Z4CZ=;2:8VG.LC6K1^45,K[BO3&[.[]:
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M+*ZQ3D="\8.UCQW!SWJ?^PM._MW^V_)?^T?)\CSO.?\ U><[=N=N,\XQUYH
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M13N)^;& ?>KL%U;W)D$$\4IC;8XC<-M;T..AKQ006#_#"T4I!Y<7BK9&1@;
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MSG>)A%<$#.$;ITY&<;AR,U:US7;'P[IQO]1:5+8.J,\<3/M+' S@<#) S[T
M7XX8HHA%'&B1CHJJ /RJ#^S;':5^Q6VTG)'E+C^55(_$%C)X@DT,>>+^. 7+
M(T+ >63@,&Z'GC@]:S+G7M)OK[P\YO=2MWNKAS:1QQO&ER0C9$GRX*X!8 D9
MP",B@#H6LK1RA:UA8H $S&#M Z >E-_L^R^;_0[?YOO?NEY^O%<3JGBZ75M
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ME ;EK>&Y^RO_ *.X<2[PFW:1G.X@=* -9+*TCFEF2UA6688E=8P"_P#O'O\
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M#[7:JPC\SS55T+CV+ D<9XSGBNJU7Q-I^CK<M<?:)%M8Q+=-!"T@@0\[FQ[
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MB2T_>IDE83&=W/')S]/?BN@\)V5SIGA'2-/O(O+N;2SBMY%#!AN10I((['%
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M>VD^PVA9#)O5CF3YE/IT[#H>*U-=\1:CI_C+0-'MK#S8+Y9Y))!(H+>6H^4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUS2X-2TZ<36DX)C?!&<$@@@\@@@@@^E8=[\1?#%@;H3W\H^R3>3<[+65O);
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M+MMT$EPT4#RB%#_$Y4':.">>W/2DN_%&DV<<DK3R2QQVZW4CV\+S!(FR5<E
M>#M)'L">E &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!QTD<_\
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M.3CL0:PY_B?8064]^^BZQ]@M;M[6\N?)0K;,K;"6^;)&?[N<#KZ567PQ?_\
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MYMN"P)RP4''\.[Z5@>*?"MS:ZKH.M>&-->74+"[S*#< ![=E(D0EVZGC'N*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !114=P[Q6TLD49ED
M5"RQ@XW$#@?C0!)17GOA[Q;=ZQ#X?N+343?75Y*4U.P,2*+,!&,AP &38X51
MN)SN]2#7H5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 45#<W=O9QK)<S)$C2+&K.V 79@JK]22
M /K2/>6T5TEK)/&L[QM*L;, Q12 S8] 67)]Q0!/165IOB70]8N7M]-U6SNI
MD7<4AE#';G&X>H]QQ6K0 456M=0L[Y[A+6ZBG:VE,,PC<,8W&"5;'0\CBJ47
MB?0I]4_LR+5[)[W<4\E9E+%AU4>I'<=: -:BN>/CKPH+C[.?$.G>=NV[/M"Y
MSG&,?6M6'5M/N+H6L5[ ]P3(!&K@L3&0'&/]DL ?3(H N45FZAXAT?2O-^WZ
MG:VWE%!)YLH7:7SM!^NUL?0U'I_BC0M5<)I^K6ERQ<1XBE#?,59@..Y",?\
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MKS(MQ,K-'&6^9PN-Q ]!D9^HH FHJ&XN[>T5&N9XXEDD6)"[ ;G8X51ZDDX
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M'5+)55)VE2'-RF=I( R1_%M!QQTKMJ** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tardioagreementa01009.jpg
<TEXT>
begin 644 tardioagreementa01009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS5FW\6Z/<V\\J3R![>X%K+;O"RS+*<;4V$9R<Y!Z8YSB@#;HJGI^I6^II,T
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M\Z6Z;W5/+D7=CN 6%4=)^V:!X@\3IJ.F7MQ;ZI,M[:R0P-,'S&J-"Q7(4KM
M&X@$'K7>T4 <[X%T6Y\->!=)TJ];=<VUOB7:=V&)+%1CKC./PKE-.T/4]1^&
M?B?2(K:>UO[J\O)(%N(FC\P/*73D@<,,#VSS7IM% 'F]O;+XKTRZAC\)7FCZ
MJ;">W:[OXMH@>2,IB)B26!)!R!C YYP*O^%=2U#4=+T[2;SPW?6%_8P>1/<W
M,($415-A:%\_/NXQM[$Y/'/<TSSHO.\GS$\W;NV;ANQZX]* /,?!]F\=GI7A
M_5O!MU_:FE21K]MECW6G[LX$R2$_>VC@ 9R>PR1N>&-.:XU'QG;W]C.MIJ%^
M6430LBS1&%$."1R,AA7:T4 <9X$TO5M/LFCUI6+Z6K:=9R'DRP*V1+_P)1&,
M?],_>N5;3]1/@&>T_LN_^T-XD^UB+[*^[ROM8DWXQTV<_IUKUVB@#@;ZW\[Q
MWKMU<V-TVF3^'EMVD,;1HY#2,R;V  .UAR3C\JQ/#5[")O"G]M6>NP'281;V
MCSZ2\<:O(@B'F2@D'@[0<*"3D^WIVJ:;:ZQI=SIUZADM;F,QRJ&*DJ?<<BLR
MP\+I:/&;C5]5U&.)@T<5[.K*I!R"=J@L0<$;B>0#UYH @\;S:A!I%H]A8R77
M^G0_:## )I88LY:2-"#EQQC@XSG'%<>MCJ"V?Q&A32-55=1MP;,S(TC3$VP0
M#.222W;^'OCI7JM% 'GDEO=G4/AW(+"]V62/]J/V9_W.;8QC=QQ\W'Z].:V/
MB#IFHZAH-K-ID37%QI^H6]^;92 9UB?<4&>,]Q[BNKHH XW[,^L^/=,\006]
MW!9Z?I\\<KSV[Q/*\A7"!& 8[0K$\8R0!GL[X<PW%MH5Y!=6ES;2G4;J8+/"
MR$H\K,I&1W!%=A3$FBD=T21&:,X=58$J>N#Z4 <A<Q7=G\5UU$V%U-93Z,ML
M)X8]RHZS,Q#'M\IS[]!D\5RD6G:BOPRTZQ.EWXNXM=%R\/V5]RQ_;#+NZ=-A
MS^G6O7:8\T4;QH\B*\APBLP!8XS@>O )H \S:WDTWQ'KMAJWA34-8M-4NC=6
MEQ;Q>9&ZNBJ8I<D!,%>K<8KM]4CN[3P?=QZ?86\]W%8LL-GC,3L$P$P>J]L=
MQ6JDT4DCQI(C/'@.H8$KGID=J'FBCDCC>1%>0D(K, 6(&2 ._ )H \TT5+X>
M-M#U:32M:\@Z/+!/+<0;=DNZ-B/+'" !3@!1G' -4;;3M1C^%OA^P;2[\7EO
MK,<\L'V5]R(MT9"Q&.FT@_IUKURB@#S/Q)H>HZ]XD\46]G!<Q+?^'X[2"X>%
MEC:4/(Q0L1@<,!^)JW/!>>*8/"$0TZ\L;K3;Z&[O3/ T:PB.-@R*Q&'W,0!M
M)&.:]!HH \>U:RU9/"'C/08]#U*:\N=7ENX6C@)CDB>9'4J_0G'! Y'? R:Z
MRV\]?B=J.I26-ZEI)H\,2R&W<@NLDC,N0#D@,.E=HS!5+,0% R2>@I(I8YHD
MEB=9(W 974Y# ]"#WH \FT;3=4T_PS\/I9=(OV?2[N5;N!8#YD>Z.10=IQQE
MASTYK1NM.OX?$K:EH$>J6=Y-J2"^T^>%GL[J/> TP8C:C;!NW YRN,'(SZ.D
MT4CNL<B,T9VN%8$J<9P?2GT <7\6#CX9:N=I;'D\#O\ ODJ'6+6ZUKQ9INLZ
M9I\Q_LJPO,_:H6A$\DB*L<.& )&023T''/-=)XCT"W\3Z+-I5W<7$-O,5+FW
M*ACM8,!EE/<"M2-2D:JSM(0,%VQEO<X 'Z4 >6:/%J<WB3P7J,NC:NIAMKB"
M\,L'E1V\C(@"K'D!$&" 0!D <L:UET2[MOB'<Z?;[#H=^R:Q<)GF.=#M*@>C
MN(W_ .V;5WS+N0KDC(QD'!K)T'P];Z!;R)'=7UY-)CS+F^N#-*P&=JECV&3@
M#U/<F@#SWQO;ZSJUEXQTX:+J+2,(S8BSBVQ7"!4R[N"/,?(*[3G "X7J:Z'S
M+BS^(TFM7&FZ@ME=Z-%!&\=LTI61978HP3<5.&!YX]\UW%% 'E4GA[4-,\.Z
M%&;"X,K^)UU26W@B,GV6%I6;!VY'RJ5SCOG&:F:VDTSQ'KVGZOX4O]8M=4NC
M<VEQ;Q>9$ZNB@Q2Y("8*]6XQ7I]% $-G#]GLH(?+CB\N-4V1_=7 Q@>P[5-1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% ',?$+5]0T'P+JFI:8(OM,,7#R,1L!.-PP#DC/ .!_(S
MR:_=C5H-%BL[9]6>U:[E0W+"**,-M4[]F26/0;>S>@R_QEH<WB7P?J>CV\L<
M4]U#MC>3.T,"",XYQQ69)H&MQ^*+'Q/"+!KXV1L;ZT,KK&R;]ZE'VD[E.>JC
M(/:@#6\->(H_$5I=,;=K6[LKE[2[MV;=Y<J=<-_$I!!!P,@US&H&YM/C&TNF
M:?#<7DOA\Y#R"%6(G'+O@GH,< GIVY'2^&M!;1EU*XG9&O-2O'O)_+)*H2
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MDFGD<(L6W QDD'=Z<X%7Y-"U+4=<37+Z&SBNK:PDM;6WCG9TW2$%W9R@(^Z
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M59F\P;&9MQ&S'._IGM4_C70[GQ)X2O=*LY8HKF7RVC:;.S<DBN <9.#MQ^-
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MQ1Y)-JLR1J%.XA6'4CGBN?EEN[?XM7L^DZ5'-=S^'X)&BFE$ W>=)R[ ,<X
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MM_)!S\Q'.>@HU#Q!XAU&37%\.6S/+I=Q]FA0I&4GD"*[!RSJ5!W[1CIC.3G
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M&( !6@9PH.>,%C]:I>%-6UG2='^'\3W%K)INIVT=J;=82'CQ;EU??GD_+R,
M<^V: /4:*X%/$GB?5K*+5]"T]KB#[:T0M6$2I) DIC8[RX8/\I;ICM@]3WU
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M+235IM+20F\AB69TV, $8D [L8/*G@'-7*Y%M<U?_A,==TE9;00VNF17=J3
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MFFQN^I:O/JMY( IGEC2,!1G 5$  ZDD\D^O  UZ* *>K:;#K&CWNF7#.L%Y
M]O(4.&"NI4X]\&LFQ\+M')I;:E?_ &Y=*7%FHA$8#;=@=\$[F"D@$8')XSC'
M144 <=I/@231;QXK37[Y=",QG722B%$8MN*B3&X)GG:/QSDY6;P*9M(\1Z<V
MJ-Y>NSO-.P@&8RRJI"\],*.N:["B@#C[[P1<R:K;:OIFOW.EZDMLMK<RPPHZ
M7,:_=W(^0&&3@^]7-0\)M>3:(\6HR1_V3.;A#)&)&FD*LI+G(Z[FZ8Y-=)6)
M-XA\GQE:^'C9O_I%I)=+<EQM^1E!7;U_B'7% %>7PG%=>(=1U.[N1-%J%@+"
M>U,>%,0W'KG.?G;\ZA\.^$+K05@@E\0WM_96:E;&VGC0"$8(&YE 9\ X&3CV
MX&.IHH XG_A7Q&EK:IK,T<\6K-J\-PL*_),Q8L"I)#+\QX_6DN_AW]KL_$-J
M^N73)KA1K@O%&2I"JI(P!R=H]@,\=ZZO3KF\N8IFO+ V;I,Z(AE63>@.%?(Z
M;ASCJ*N4 8&N>')=<L=,@EU#RGL;N&[\Q8<^8\9RN1G@9Z_TJA=>"K@>(KK5
M])\07NE?;]OV^WAC1TF91MW+O!V-@8R*ZZL3Q/XA_P"$;L+>[-F]RLMU#;':
MX4)YCA QS[GL* *>J^$#JME?Z9)?_P#$IO8TB>VDA$AB"J%S&Y/RD@#DAL'D
M<]>EC18HUC0850% SV%*Q(4D#) X'K573+B[N]-@GOK(V-TZYDMC*)/+/IN7
M@_A0!B7>F-I_CF+Q%&A:WN;/[#>!1DIA]T<F/3EE/IE3T!(J_P#"#2V^N7UW
MIOB"^L+#493/>V$2(RR2'[S(Y&Z/=WV\^A'&.PKF],\47.KZ7K=Q9Z/(UWIM
MY+9I:-.JF=T"G[WW5SN]Z ,S5/ATFI)X@MTUJ[M['6BKS6Z1H=D@55R&(SMP
MJ_+QTZXXJS>>"KE]<36M-\0WNGW\D"V][(D,3BZ5>A*LNU6&3@@<#C%;&IZV
M-..G6Y@#7^HR^3;P,^T;PC.VY@#@ *>0#V]:GT>^N[^P$U]ILFGW(=D>!Y _
M0XW*PZJ>H.!]* ,P^%=GB'3=6AOF4V%K):I'(F_>'(+,S9R6)4'/U]:RY/"N
MK:1HDMKHVMSQW<^IO?!TMUPS.Q9D?.0(\G.>N!CDD5V'VJ#[8;3S5^T"/S3'
MW"YQG\\_D:ATVYO+JU,E[8&RF$CJ(C*LF5#$*V5XY&#CMG% %RN2U7P.-1U+
M6[F/6+JV@UJS%K>0(B,#M1D!5F!*\,<@=:ZVB@"EH^GMI6CVE@US)<FWB6/S
M9% + # X P*NT44 <MXY\&#QQI<.F7&HR6MFDJS.D48)D89P"2?N\]/UJ%O
M%M?>*;'Q!K.H7&H7.GC%G 46." ]=P51DG.#DGL/05U]% '&:5X!?1=>U>^L
M==NX;+5;DW5Q:+&F=Y))VR=5!R>G/H0>:DE\ 6LVI>*-0DU"X-SK]L+5G  -
MO&$*X3].OI71R7-XNK06R6!>S>)WDN_-4"-P1M79U.<DY'3%9$_B>X>^NH=+
MTI]0BL;M+2\9)@CHS*K$HI&&"AUS\P[]<4 8=W\+;67PWH.EVVKW=O<:).MQ
M:W917(=<=4X7' ./SSDYR?&L-WXETH^"[&[OK[4+G4(HM2N)8#&D,"@2,XP
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MV%Y';"SG)03+<1 Y&\-_&#D[NO/.:O>%O#@\,:7)8K?3W:O<2S[I55=I=RQ
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MEW8>(KNWUB6224Z;=:$LL\;LQ/E-)M5B!D+NW  #J ./7XC(84,H42;1O"]
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M*!,[57U)R2?4DDDD\DG-9G_"(Z']AO[(V;&VU"0RW<9GD(F<]2WS=3@9]<4
M<MXDL8;SQ3X!>9KC=++*K%+B1.!;.>-K#!SW')Z5 8K_ ,63>)K:+6!I]WIU
M\8()/-D#VB*JE'"A@"&^8DGKD@G  ':S^&=)N9;"6:WD:2P&+5_M$@,7&,@[
MNN.,^G%5M1\%>&]6UA-6OM)@FOD 7S22-X'0. </_P "!H YO1["&;XK:I-)
M-+)*VC6DC2QS2('8M("VT-P.!@=JP5N;YOAO8S#4[\7"^)/(\X7+EV0WA3:Q
M)^8;>,-D5Z?/H&EW&L)JTMFAOTB\E9P2&"9) X/8DD'J,\53'@S01IRV L6^
MR+<?:1%Y\F!+G=O^]USS]>: .9AT:-_B-JNA-?:H=,FTN&\>#^T)O]:9)$+!
M]VX<*. 0#W' K(T'7M0O]%\#:=>7V1J,-V));B1@9WB8+&C,I!)*ECUY*CK7
MI \/Z:-4DU,12B]DA\AYA<2;C&.B_>Z DGZG/6J4W@?PW<:#'H<VE1R:;&_F
M1P,[GRVSG*'.5ZGH1U/K0 GA6PNM&M;VRO-7%^%NV,(8L3;HP#+#N8DMC.1D
MYP1[57^(FL76A>";V^LW:*0/%$TR]84>159Q[@$X]#3M2\#Z/>:%9Z/!910V
MUM<+<1$.P:)QGYP0<L_)Y8]3DYQBNBNK6"]M9;6ZA2:WE4I)'(NY74]00>HH
M XO4(9=&\>^';73I[DV.K17,-Y UP[C"1AEE!))5L\%@>=P[XJ'X8:<USX=L
M=<NM1U*YO,W4!\^[=T*_:' RI."1MZGGGZ8ZNP\.Z9IN/LL$BL(O(1WGDD:.
M/^ZC,Q*#@<+CH/05+I&BZ?H5E]CTV P6VXL(_,9@"3DXW$XR23]30!SM_)-'
M\6='A6YN!!/I=RTD'G-Y997C ;;G .">:J?#[3H+?6O%TB&<M'K4D:[[B1AC
MR8CR"Q!/N>?>NLFT33Y]8AU:2!C?0H8XY?-<;5/4  XP>,\=J;IN@Z=I%Q=3
MV,#Q274AEG)F=O,<]6(8D9X'- '+ZM:M??%6SL);V_2RGT:>26WANY(U9EEC
M /RD;>#U7!/T)SSND:W?+I/AC2+B\N3:76N7=C-<M*WF-'$TOE1E\Y^8JHSG
M)"X[UZ7+H>GSZPFK/"_V](C"LPF=2$/)4 '&,X/U%55\(Z$NE2:9]@4V<DWG
MF-I'.),[MZDG*MGG((.: ,?17NM.^)&K:)#+-+I3:?#?(DCEQ;2L[(44G) 8
M+NQT&#C%9_CF?4;'4+N]DMKF_P!#%B(Y_L%R8[G3FRY,RH"-P(([Y&STSGM[
M#2[/3?--M&P>4@R222-)(Y P-SL2QP.!D\57O?#NEZA=37-S [2S1"&;;/(@
MEC&<*ZJP##YFX(/4^M '-:==B\^)%_%'>7#Z=<:%;W2(9W"9:20;U&?E)4+T
MQ7/>%M<N;W3/ .F:E?7#V^I6]W)-*\S;[B2,_(C/G)&"QQGG:![5Z'>^%]%U
M#4+:_NK"-[FVC\J-P64>7G.P@$!ESV((JK+X&\,S:##HCZ1 =.A?S(H@6!1_
M[P8'<#[YS0!RGBG3!I^DZ3I\>K75T!XIM2K2/N>V#.&$88YR%##&<G!%:_A9
M'T_Q[XHTB*YNI+***TN(H[BX>8QO() ^&<DX.T'&:VW\)Z&^GV=A]@"VMG*)
MX(TD==D@.0^002V><G)R:M6VB:?::M<:I#"RWMRJI-*97.\+]T$$XXR<>F30
M!Q_C..:7XG> DMY_(D/]H8DV!L?N5[&L]7O-#^,9&H.-7O+_ $F0V<RIY9M8
MXR6,90<$,P^]USQ7=:CX9TG5M0M[^]MY)+NV#""5;B1#%N&&V[6&W('..M2:
M?X?TK2[N:\M+-%NYE"R7#DR2NHZ NQ+$>V: .%\.0W^O:/X;\3Q^((X9'>-K
MQE>1OM!?Y7@92^T'<<# ^4@8K#O1=0^"/%6L+JNIF]TK7IELW:]D(C59D4*1
MG#C:<?-GBO2;+P3X;T[6I-7L])@AOI&+F1"V QX+!<[5)R>0 >33F\&Z"^G7
M>GO9,UI>3&>XB,\A$LA.2S?-R2<$^I ]* .:O?M?B?Q7XFT,7XM9+**%;4"6
M1'C#QAO.4(PR0Y(R<_= [G-74].%QXI^'PO;^6^G=+E);N&:2(3%;<_.H5OE
MR><CKGTKK=6\%>'-=N;:YU/3([FXMTV1RN[[]O\ =9@<L/9L]3ZU;NO#VEWM
M[97DUL?/L01:LDKIY((P=H4@#(X^G% '":KK&HZ'J?Q(NK*XN)7LM.M)K:.6
M1I%A9DEW,JL2 /XL=.*Z?3M)LA>Z;J5GK5XT%W9F+RC<,ZW>5#"0DG(8 'YA
MCK6M%H&F0ZC>Z@MMFYO4"7+,[,)5 ( 92<$ $@#'&3571?!WA_P\TS:3IL=J
MTRE69'8D*3DA23\HSSA<#@4 </H%\\_@7P]!=:E?RW5SJ]S&L0E)DO DTW[M
MY"<A  "3GHN,'.*S[V\U)?AUXM!OKJWGT_Q +>W,-V[&&,R090,<%E_>,,$8
MYZ5Z(?!/ATZ9#IQTX?98)_M,*>:^8Y"22RMNRI))S@\Y-(_@;PT]M=V_]DQ+
M#>2++<1HS(LC+C!(!'H#CID ]: .>\4:*_A:RM_$6GWVK31:?>_:[ZWDOI9!
M+;MA9/E+8.W[X'3@^M=)X<<:C)?ZVD\LEO>RXM5,K%/)0;0RJ3@;F#-D=05I
MFOKK,D<6D:7IT4UG=PO#/>SW7-L",9V$$R'!/?DCGUK;M+6&QLX+2VC$<$$:
MQ1H.BJHP!^0H XVXFN(OBGJ$"7\T,)\/>>!)*S112><R[PI.!P!G'I57PA>W
M5KXB@T?7;*[LM86Q?$BW+3VNH*&3=,I)X<=P1G#<GI77S>'M+GU274Y;8M>2
MVYMGD,K_ #1'JF,XQR3C'7GK2V&@:;IDL<MM XDCB\F-I)GD,<?!*KN)VC@<
M#'0>@H P-4OFO?B78>';F1TL/[,DO0BN4%Q+Y@0*2.H5=QV^X)Z"N-L+Z30=
M+O[."Z:&WNO&<MG-<32L2D97(#/G<,E57.<X/6O3]8\.Z5KS6SZC:"66U<O!
M*KM')$3UVNI##/?GFJR>#/#B:;?:<-(MS:7\ADN8F!(D8\Y.3G/3IT[4 <W=
M:)KNG6VM0:?K<#R7+VTUKI\DDBK%AQO02%BRK*%88XP<X[UAZSK!G^&OC P1
MZMHVJV)5Y[22Z;=;,54 1NK<QL 2,<<GBN_M/!GA^QTAM+M=.6*T:19659'W
M%U(*MOSNR"!CGC%33^%M&NM/NK&XM#-;W;!KD23.S3$  ;V+;F  '!..* ,3
M6I9SXYL[>]%S-HTFERD16N]F6<.OSLJ?-C:<*>@.>A(KFI;#6].\*>#4U/4M
M4BU.YUN*.Z8WKLQC?S"%;)(SM5,CH"#6OXE\+R7WB))[KPTNLZ?':I!;/#?F
M&>$@DOO+,I<'Y<?,<8/')K5TGP78IIT4-_;2B.&[^UVEL;Z67[(P4 8<MDG(
M9O0%B!ZD YJ2X71)O'VG-K.H6>GVR6;P3>:]Q+ \RD,$+L3EF QSP3GBG[;C
M_A(/%6D3I+;V3Z%'<"T^UO)L8F4$Y_A)"C<%)!QU-=G<>$="O'U%KFP$QU)%
M2\$DCL)@OW<@G'';'3MBEL_".@6%Z+VWTR);D0?9_-8EF9.>"23D\D9/.#C.
M* .!TBY:R\.?#S2(KCR;?5;,/,TTTFUY%@0K'G=E0<D[00"5QCJ#:OFU'PU_
M9^B3ZX\]KJ>NI"SHSAK2%T+B 2%BWS%0 <Y ;CM772>!_#4N@_V))I$#:<'#
MK"2QVL.A#9W @<#!X''2I3X0\/MX?.A-I<+::3N,)R<MG.[=G=N_VLY]Z .>
MT.R@T[XM>($A+K$VE6K[7D+!/GER!D\#C./<UW3*LL17)*NN,JQ'!]"/YBN?
M/@G0(X[QH]+CEFNK4VDKS3R,TD>"-K.26[D9Z_E6EH6DQZ'HEIID+;H[9-B]
M< =<#)) '0#)P * /*=&N6T+X=Z7]DEG@CU#Q$UC=3+._P"Y@-U("5R<(2 %
MW#!^;.<\UV,/VC1_B?;Z992S/IE]ILD\UN\C.L,D;J Z[B=NX-@@<$C/6MM/
M"6@):7]J-+MS;W[E[F-@2KDG).#TYYXQSSUJWI^C6.F.\EM$_FNJHTLTSRR%
M1G"[G).!D\9QR: .2\46%O<?%'P<\GF@O#? E)G3A40CH1CJ>G7O7+:E:L-
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MS.%%NA^4JL6WYODSCG&<9X%;%[I&G:CI+Z5>6<,U@Z",P.N5VCH,=L8&/3%
M' :[_:?@W3M8NQK:BUNI+3_1P786*-*L<DBLS$J&!/I@C(Z&NAT71[O3?$\M
MS_:\;65Y9Y&GJSN"ZL/WRL[''# $#@Y!ZUHZ=X1T#2M)N-+L],A6RN!MFB?,
MGF#&,,6))&.Q/%.T'PKHGAB.1-&T]+42XWD,S$@=!EB3@9/'3F@"AXLM=0BT
M6SAT&&W:2*Y5C8-+Y NXPK%H@PZ$_>]#MYX)I? ^I6VIZ/<O!%?6\D5W)%/:
MWS%I+:08)CR2<J,@CG&"*VM1TNSU5(4O(V;R)1-$R2-&R. 1N#*00<,1^-/L
M=/M=-A:*TBV*[F1R6+,['JS,22Q]R: /.$74?%=CK=W%KB:9?:=JDT?G[Y,V
MBQ2?*"@8*59 ,Y&#N)J;6K^]TCQ%-=ZO#<SZ--?VY@U.QN&!LB#&/)EBR/D+
M Y(SG?R,XKJ[GP5X;O->&MSZ3 ^H@J3-R-Q7H64':Q&!@D'H*LOX:TF2ZEN'
MMF9IIEGE0S/Y;R+C:S1[MI(VKU'8>@H X*W2RTK4?B5?2:A<Z<L,J?Z4DCN8
MMULAW!"<,V3QGZ#%7-+2X7QW-I$ZW,%C<^'Q,]L]X\C,PEV[VY^5R"0=I.?4
MUU]SX4T*\N[ZZN-,@EFOXA%=,V2)5 V\C.,XXSUQWJ.Q\'Z!IM[;WEIIL275
MO$88YBS,P0]B23GIQG..U 'G/AN[;3? /@*TBN#;P:M+Y=S++-)M)$;E$SN^
M4,P'"XSC'0FN^\,Z9=:+=:K;W6K+=0/*DT%M\Q^R!@05#,Q)4D9 [<U*?!/A
MHZ)-HQTBW.G3/O: Y(SG(P<Y7!)QC&,G%.3P;X>30'T-=,C_ +.=UD>'<Q+L
M"""S9W$Y4=3V Z4 ;M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI(<;E$JJBX;/0'G@]@:QK>STC_A&_A9(T-IYDTL*2MA<NIMF#*Q[@D $'V%
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M [FBD!# $$$'D$4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)IHQ'U1L[2IZ'.T_E6+<^/K4S^&?[/M+FZMM;9V258CPBQLW /.[(''IGVH
MTM7T74M2N8;6#4+>VT-HO+N[1;;,DHSRJOG"@CY3QTSCKD;;Q1RJ%DC1P.@9
M0<4KOLC9\,<#. ,D_A7E^O>,+G6_AG?ZS;B^TN2WOTC1U8Q_(+H1$%@>3MSD
M=!F@#TW[+;YSY$6<8SL'3&*/LUOY3Q>1'Y;\,FP8;ZBLFP\5:9?ZE>:>#<6]
MQ:PBX<74#0[HB2/,7<!E<@C-);^*]-GU6ST]A<02WT;2V33Q%%N549;8?4 Y
MP<''.* -?[+;^4D7D1>6@PJ;!A?H.U*MO"C[UAC#_P!X*,TV[NH+&TFN[J9(
M;>%#))(YP%4#))K*M?%.G7&J?V;()[6Z-L;N-;F/R_,A!P7'ICN#@CN* -22
MRM981%);0O&/X&C!'KTJ95"J%4  #  [5A0^+M+FN+"-O/ABU$XL;B6(K'<'
M&0%/8D<C=C(Z9JC<?$70;>&^F;[>T5A<FWNY%LI,0$!<L_'"_,.>_.,@4 =,
MEG;1R/(EM"KN,.RH 6'H3WH^R6V,?9XL=<;!6;J'B2RT][E3'<7'V2 7%R;=
M-_E1G=M)&<G.UN!D\9Z4:KXELM(%R98[F<6D0FNOL\1?R(SGYF_ $X&3@9QB
M@#3-M Q8F",EUVL2@Y'H?:E,$+/O,49?^\5&:P)?'&BI>PV<+W5U/<6?VV!;
M:V=_.B) !0@8;.X=.G.<51U#X@6B:/HFHZ;;7%W#JM\EHI$1!C.\APP."&&U
M@!ZCTH ZZ.&*+/EQHF>NU0,TV2V@EECED@C>2/E'9 2OT/:GQOYD:OM9=P!V
ML,$>QK"O?&&E6"W$TS3FSM9O(N;Q(RT,,F0"&/7@D D @'J1@T ;<UO#<Q^7
M/%'*F<[9%##\C3\ # ''I7%>)M;D/C#0]"$=\;*[BN)9S:ED:7:J;=KJ0<#>
M2<'L*ZC2[$Z1I,-I+?7-YY"D&YNW#2,,D_,V!G XS[<T 6/LEMM*_9XL'DC8
M*46T"L&$,88="%&16)8>,M*U&ZL88?M"KJ$4DMC*\1"7*IRQ7OT.<$ D=*IC
MXBZ T7G WOV<79LY9S9R!(9-VS$A(^7YB!SSSSB@#ITMH(]NR&-=K%AA0,$]
M3]:1K2V:5I6MXC(V-SE!DX.1D^Q JA:^(;*[\07FB1K.M[:1K+*KQE5V-]UE
M)^\#@]/3G%6=,U*'5K%;RW658F9E7S%VDX."1[9!Y[]>E %B6W@F>-Y88Y&C
M.Y&902I]1Z4]E#*58 @\$'O7/:GXUTG2]4GTR1+Z>_A@%P;>VLY)'9"2,K@?
M,.#R.!CKFHO^%@>'CINEW\=S-+;ZI(8K5HK=VW.,Y0X'#?*1MZD] : .A^R6
MV /L\6!SC8*<L$2.72)%<]6"@$US-IK^E:MXDT@I-J]O>36DTD5I-%)#&R!E
M#%U8 %@0,>F?<5;E\8Z3 $FD>86+W'V47WE_N/-W;=I;L-WR[L;<\9H W&AB
M:19&C0NH(#%1D ]1FF26MO+ ()((GA&,1L@*C'3BL*Y\;Z1;:Q<Z5LOY;RV>
M%94ALY&VB0D*W ^[QRW3D5T$L8EB:-BP##!*,5/X$<B@ EABGB,4L221L,%'
M4$'\*#%&8O*,:F/;MV8XQZ8]*\@T+Q"K_#*?5;[QA<6^MQ&Y\MGNE9BR2.(U
M\ILAL@*,8R<UZ#I.OW)\-:-<:Q:21ZM>VZLUG$GSE]N6PI^Z!U.2,9 )S0!N
M):V\< @2")81TC" */PI?(B\DP^4GE$$%-HVD?2N</C_ $!;&"[>:X59;[^S
MRAMWW17&<%'&/E(]^O;-6K#Q=I5\NIY:>U;3 &NDNX6B:-""RM@C." <?2@#
M8CMH(5*Q01HI4+A4 &!T'TH%M;JH401!578 $& OI]*R(?%-C+J<FF/#=P7R
MVYNHX)H2K31 X)3U.>W!&>17!1:G#KGA*\\1ZUJGB+3%M[FZ\V33Y)%4PB1X
MUC"C(& %RV 01G/)H ]3^R6V /L\6!T&P4XV\+3K.88S,HVK(5&X#T!ZUFW.
MN6ECY-NBW%U<-;^>(85WR>4.-[9( _$Y)SC-94OB30M6G\,74&HWVR_F9[+[
M.'2.<[&RLO&,  G:><B@#IY+>"66.62&-Y(SE&902OT/:I*Y^3QEI,5T8BTQ
MA%\-.:Y6/,2W)P!&3USD@9QC/&:BN/'.DPZO<Z6L6H3WEK+%%-'#92-L,F=I
M/'W?]KIR.: .C,:$."BD/]X$?>XQSZ\4DD4<H DC5P.@89K#M/%^F7N@W>LP
MK<_9;61XI0T)60,IPPV'G(/&.OI6ZC;T5MI7(SM;J/K0 AAB;&8D.%*C*C@'
MM]*9]DML8^SQ8ZXV"J6O:_8>&M*?4M2:5+9&56:.)GP6( S@<#) R<"LX^-]
M*&I3Z=Y&H_;8XA-'!]BDWSIG&Z,8^89[\8H Z,J"NT@%2,8QQBH_LUOE3Y$6
M5 "_(. .F*Q(/&6D76DV&H6\DLBZA,;>VA$9$KRC=N0J<;2-C9S@#'6HIO'6
MC6^C/JDGVH6\5V;*<>02T$P;;M<=N2!GIR.>: .A6W@16588U5QA@% !'O2P
MPQ6\2Q0QI'&O1$4 #\!55M3A35H--,<OGS0M,,+E552 <GMRP'OGCH<27]_:
MZ7927EY*(H(\9;!)))P  .222  .22!0!.8T,@D**7 P&QR!]:8MM DTDJP1
MB608=P@RP]SWKC_$WB6&[\,>*+.UFO+#5M.TV2ZV']W(HV,R.K D$97L>.AQ
M5OPYXLL;I=)TF5KL7L]@LL<L\+JEQM5=Y1S]XC()^N>: .E%M JLH@C"M]X!
M!@_6D^RV_'^CQ<=/D'%8MIXRTF]NK&*)IO*OY)(K.X,?[N=X\[@IZC[K8R #
MCC-4YOB-H$$%W.QOC!971M;J46<FV!AMR7R/E7+#D^_:@#IOLMN0P,$7S?>^
M0<_6G0P16\0B@B2*,=$10H'X"LZ_U^TL;UK+9-<7:VYNGAMTW,D0.-QY'?(
MZG!P#@U!9^+=)U'3+6_L'N+F*[8K;*MNZ/,0,DJ'"Y7'\7W?>@#7FMH+AD::
M".0QG<A= =I]1GI2R00RD&2)'(Z;E!JCHNNV.OVTTUD[Y@F:WGBD0H\,J_>1
M@>AZ?G7-^*M2ETOQ]X3;[5=BVG6\$UM"6992L0*_(OWCDG'_ -:@#M0 H
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M\8^#UCMKJXM-+T^>UGNEC)4,R1JN>YSL/3..]=M=&9;28VR*\XC8QJYPI;'
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M\+)O -SI\_\ :"L;9+K9F!XO-W";?TX7G;][(Z5ZM437-NEPENT\:SN,K&7
M9AZ@=30!RFAVEU;?$;Q#<R6ERMI<VMI%!<.GRR-$) W/_ ASWKK99!%$TA#,
M%&<(I8GZ 4^B@#ROPSI]Q9_#*30]5\)WMW>.US_HSPIM??([+\Y; X8<YXJ*
M/PUX@\/:)X/N]0T\^(9-+@GMM0M$*R2!)2K*4W<,4V*ON.G'->LT4 ><:OI\
MUSI>C3:?X8?3U_MZVOI+:*!%D6)#\TDH0D;O;).,=\@0Z[X?U76=6\;1VEK)
M']OLK-;.:9,1RR0EF923T!) YX.37IM,>6.(H))%3>VU=QQN/H/4T <?X:F6
M^NH[R3P0VBW%M$PGGGMX]VXCE(2A+,#US@#@#!SQS\6E:HWP8UK1CI=XNI3M
M=B.W:/EO-F=DP>G1AGGBO4Z* //IVU?0/&,.NQ:+?:EIU_ID-I-';*IFMI8V
M8C*L1\IWGOP?ULZY;ZE=ZIX.N#I<B?9;][BY2%=PMXS&ZJ&(X)^90<9YSVKN
M** /)M;L_$.I17'VC0M0DNK77HKB,0LBP&V692K(NX;V*C))&<YR0,"NI\/0
M7D?Q \47D]C<P6][':>1*Z?*YC1@XS[$CZ]LUV%(P#*5.<$8X.* .#.A7,/Q
M'GMK9D_L6_$>JW<6>4N(SM&!V#L(V]S$U=-;ZXTOBBZT233KJ'RH1-%=.!Y4
MX^7=MP<\%@.??TI=!\.V7AVV>*T>ZF:0C?-=W#32,!G W,2<#)P.@R?4UHI;
MQ)/).J 2R !GZD@=!].O'N?6@#F/B39W>H^!KZRL+66ZNIGAV11+DG;*C'V'
M"GK4<D5RWQ3M=4%G=?85T62W:?R3@2-*CA<=?NJ>WMUKK4ECEW>7(K[&*MM.
M<$=C[T^@#RO3(-?TW1-/M_['O_L[:U=RWJP(!<+#(TC1LA)& =P#$$,!GI6I
MX6\.276B>*]$UC2KFUM+_4;B1/.=6W1R!<$$,26&,Y]>YKT"LS6]#MM>M8K>
MYGO(4BE$H-I<O Q(!&"RD$CD\4 8?P_M]3;2#J&M2I-?,!9K*AR'AA+(K_\
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M+:U9[*[T5/\ CV9G),#JGRL#\I/&TG=R,\^A1RQS)OBD5UR1E3D9!P1^=/H
MX!+77)?$G@6[U.R=KBTLKA=1EA3]W%+)&@ XXZJ>G ^E<\NWR]3TR?0?$$VA
MRZQ)>!;*U2='VR[OED#YV,Z[BNW(R0#7L%<S9^!M,L/W5M=:I'8Y)%B+Z3R
M#R0%SD+_ +.<>U &=8&67Q[JVM1VER^FW>D6Z6]PL1(E92[$ =>CK6%X?M=?
MTS0?!^FW.C:A]DAM98;U;8*LR39&Q2Q8%8R,DE3R0,G&17J:JJ*%50J@8  P
M *6@#R2QT76[3P1X>@?0[L3:3XA-U- I0LT7FS'<GS<@"1>N._;FMS4=(O\
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M6\FN+A(%5,A8\Y)=V .U  ><'G [T>'X+^UT*SMM26W2YAB6-EMW9T^4 =2
M3G&>@QG'.,G.\8:3JNK6VGC3&MI%M[Q)KFTNI&2.ZC (V,RJW<@X((..: ,F
M?XBB#PMK.L#3!,^DWWV.>*&Y#(QRF'5\<C]XO;/6M*W\4:A)XCNM#GT4078L
MC?6@-V&$R!MA5R%^1LD=-PYZUS=[X'\1W.@>*M-5M*!U>^CNX2)9%" >5E3\
MAQCR\#'7.>,8KHI=+U"/Q['XDN#8PZ?#I3VDNZX;<I+K(6Y0#:-N.2/6@!--
M\8OJGAFPU2#3U%U=W?V3[$]QAHW#E7#';U4*S$8Z*:ZJN(\.Z/:R>.M9U;3[
MQ9]+++*D49#1K>2(!*ZD=3L"<^LC5V] '))KFL/\2KO1A;VS6%OIT=PH$Y#M
MO=AN(VXS\F,9 QSGG S+3QE;:7X0;5;+PX((FU=[.6VAE48D:?RV<G')+'./
MUK:DT35(?B$^NVIM'L[C3DM)EE=ED1DD9P5 4@@[L<D8Z\]#SQ\%:^?!TND?
M\2W[0^L_VB&^TOLV?:/.VY\O.>W3WH V!XMU=M?O="'AU/[1BMDNX ;X>7)$
MS,N7;;E&!7& &Z]<<T6GCZSO="T>^6**WN-4$GEP75P(TC,9(DW/@\ C P"3
MD<#G%A=&U5?B!-K_ )=G]E?2UL@GGMOWK(SYQLQCYL=??VKFK/P1XFTK0?#\
MEA<::NM:+-<D1O([07$,[EF0G:&4_=P<'D4 =?X7\2#Q':W;M:FVGM+EK>50
M_F1N1T>-\#<A!X.!]*N:[K-KX?T6YU2\W&& #Y4'S.Q(55'N6( ^M&CKJOV5
MI=9:V%U(V?)M26CB&.%#$ L>I)P.N,<53\8>'?\ A*?"]YI(N#;RR[7AFQG9
M(C!U)'<949]J (#XGN+/Q!9Z-JFG);SZA#(]D\-QYJ2.@RT9)5=K8Y'4'GFH
M/"OBS4?$\<%T- :UT^3SU:X:Z5BLD<A3;MQD@X)SV((]"5.C:KJVM:-JFKP6
M<$NDI*Z1P3LXFF=-F<E1M0#=ZG)'IS-X&T74/#WAI-,U'[,98YYI UO(SJ1)
M(TG=5P1NQ^% '1.7$;&-59P#M#' )[9.#C\J\EM=0>+P]XE\1:SH=MJ#Z5K=
MS<QLMT1(DD3A5 )0?*JC .>0/NUZVV=IV@$XX!.*\];P=KTG@CQ1HC#31<:O
M=W,\3BY<HBS-G#?N\Y'L.: -D>++U)K:WNM$-O=:A.(M.B:Z5O/7RS(SO@'R
MPH!R,'G&,YJ"[\=MI]MX@CN]+(U+1;<74EM'."DT)4D.CD#C@@C;D$=ZDUOP
M[J5__P (]JEHUM'J^C2EQ$\C&*5639(F_;D9'1MOX53U?PCJ.L0^);UEM(M2
MU;31IL$1F8I#'AOF9@N22SDX _A S0!8_P"$TU%=5TNQ?P^1_:UL\UBPNU)9
MD5699!M^08;.06X'3/%:OA?Q"_B"UOC/9?8[NPO)+*XA$OF*'4 Y5L#((93T
M%93^'M8?6_"-Z4L1'H\$L=R/M#Y8O&J?)\G.-N><=:N>$]%U'1[K7Y+X6NS4
M=2>]B\B5G*JR(NULJ.?DSQGK0!H^)+^ZTKPUJ6H6444MQ:VTDR),Q53M4GG
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M59"!N56W 'N <#/Y"N'73+'5_B2FJ:9J$<UH+59=0C@8/'),C$6Y)'<9D/\
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M?JBPKJ%C;78AD$L0GB5]CCHPR.#[U;HH **** "BBB@ HHHH **** "BBB@
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M\P!XS4GAZWO[V.YT^Q\06VHZ7<V\B231Z0+=86( !5E(5R03QCC&3CH?1**
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MC5/(C(&(QCJ!@\GGFKU%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 444BLK@E6! )'![T +1110 4444
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MD3[L-O['*D8P>>^,D0ZYI'B37=)TTSPV27<6JVU\]NDYV11Q,&V!]N78X/.
M.?;)N6^E:I!X]U/7#;0M:W%A#;1+YWS[T9VY&, '?CJ>E "V7C$:MI>B7FF:
M=-+_ &K"\RF9BD< 09;S' ;!SP..>:ICXB02>']%U:'2KJ5-3OOL'EI(F8Y-
M[(><_,,H<$<'C)%9&C^$O$VEZ/X5L)(-/N[?38YHKRSDN66*1F.8Y<[#NV\_
M*1P3D>H2T\'>([;P_HVFO#8.VGZ\=19DG8!XO-D?@%>&._ 'MUYH Z"#QS!$
MFO\ ]L64FG2:(L<DZ>8)=Z2*2A4CJ3@C'K6/J$EW/\5?!LUYI<=G(]O>D.LP
MD8CRU^1N!@KGH,CG@T:WX(U/7KOQBCM#;0:S;VBVLHD+,DD!)!=<="Q'0GBK
M8TWQ5J?B?PSJVHZ?IUO_ &:MPET([QFWF1%7<@V>V0#^)'< U]"\4'Q EI=6
MEFCZ==!]EQ'/N:,K_#(N/E8^F3C'/OI:SJ;:3IK726<]W)YB1I#"N2S.P49]
M%!.2>P!KD]&\)7EOXIT_7/L4&E70B<:M]DFS#?L5PI"  9W?-D@'MSG(W?&.
MGZMJ6A>1HTD8N!<122122&,3Q*P+Q%P"5W#C/X=Z ,^;QTMM9^)7FTUGN= 5
M7N(K>=75U*;P58[>P.01D$=ZFL/&$EQKNG:==Z1-9QZG:O<6<[RJV_8%+*RC
ME>&!&>OL>*Y^;PAK[Q^,HXK+2X(M<L(X+>.*=@L+")H\'Y!P,YR![8[C4F\.
MZK<ZWX4N9((%M],LY[>[Q/\ ,3)&B?)\O(&S/..M &'XYUG_ (2#PA9:C;:<
MCZ:VJVHM[MI1OP+A5\P)CA&P0#NSR.,'CU!W6-&=V"JHR23@ 5Y</"'BR'P/
M#X26#3IH["[A>VOFNF3S8DF60!DV':P P>3[9KTNXMUO+&6VN!A9HC'(%;H"
M,'!_&@#F'\=10Z98:W-8.FA7LRQ1WGF?.@=MJ2.F.$8XYW$C<,@<XSY]7U'6
M-0\;:1?65O\ 8+"W6-1YN[[T+2!B"O).1WXP.O6HH/!^L3^"+;P7J*V[65O+
M$C7Z2<RV\<@=0$QD.0H4\X')R>E7WT#6H/$'BNYMXK26TUF"/RV:<JZ.L/E[
M2NTC&<'.>G8T 9_@KQ/+8Z#X*TJYTN6.VU#3XH;>\,JD&1( V"@Y (4X/MTK
M0O?B/I]H8[A8XI]/-W]D>2.Y4S*=Y0OY6,E PZYSCG&*J6WA?6H;#P+;M#;%
MM!*_:B)SA@(3%\GR\]<\XJ30='\7>'I)M#MQI\NBFXDEMK]Y6$T$;N7*&/:0
M[ L0#D#IGTH T+7QA>7WB&]TJT\/74@L;R.WNIFGC41JZ!A)C/S#!' R?ITK
M;UG5[?1-/-W<*[[I$ABB3&Z61V"H@SW)(_G61X=TC4=/\3^);Z[BA6VU*XBF
M@*2[F 2)8R&&!C.W/!-3>-- NO$7A_[-I]PEOJ%O/%=VDD@)02QL&7=CL<8_
M&@".?Q:=+&K-KFFS64.G6ZW!N(R989E;(VHQ5<OD8VX[CUIQ\42VFM:?IFJZ
M:;234D<V;I,) SJ-QC?@;7QR.H.#S6;J>AZ_XS\):EIFNI9Z6]Q"$BCM9C.!
M(K!A(S%5XW*,*.V<D\8G;1]7US4-!N]9MK>W;2':X<0S;Q//L*#;P,)R6YYZ
M#'>@"BWQ(==%.LMX?NETZ&^:SNI#,FZ(B7RLA1][YL9 ]>">:UK;Q7</KUYH
M]WHL]O=1V?VZW03(YFBW;2.N%8''&2.>M<W+X/UZ3X?:EH0AM!>76IM=HWV@
M[ AN!-@G;G.!CI6]/I.K-X^&NI;0&U&D-9;#/A_,,@?IC&WC&<_A0!1MOB,\
M^G:%J9T"Z73]8D6"*19D+B5@VQ=G'!VXW$C!]N:LMXYE@M?$9N]'>"[T*%;F
M>#[0K"2%D9@RL!UPC<'N.M9-KX0UVW\&>$-(,-HUSHU_#<7!$YVLD>[[IV\D
M[NX'2KU[X4U/4-5\9LX@BMM<TZ.SMY/,)9&1)%RRXZ$R=B>E &P_BE4U?0['
M[$[#6+:2>%UD&5V(KE2#[,,'/KTK%C^([MIL>J/H%U'IRZ@;"XF:=,PMYOE
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MN[BSAB>WL9;QGF2-DB9045C@N=Q' '/K0!0TOP^=-\0:QJWVLRMJC1M)$8P
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M((R?XN!Z\4 9VF^%;BU\3_V_>:U<7=VUDMFZ>3''&RABV< 9')]?7MP+6O\
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M BN)(B<['1@00#R/0FB7PB9-0T.]&ISF729)90TJ!FG>12KESQU#' 4 #MP
M!TU1P3Q74"3P2+)$XRKJ<AAZB@#F-4\&2W/B-]<TG7;S1[NXC6*\$")(EPJ_
M=)5P0& . WI3KGP6JZW9ZQI6IW&GWL-M]DF?:LHN8LYPX;JV<G=UY.<UU-%
M&)X7\.+X9TZ:S2^GNUEN9;C=,JC:78L0-H'<_P#ZNE5Y/"TJ:WJFI6&JS6IU
M58UND\I7(*)L#1M_"<>H8>U='10!PWB.VTA-!3P!:65SYEQ:*EHL<#F.$!L"
M0R8V@H1O.3DX'<C/965I#I]C;V=NNV&"-8HU]%48'\JGHH P!X;D3Q+J.MQW
M^);VU2U,9A!5%0L5(YSG+&LFP^'W]F+H9LM;NX9=)MY+1)%B0F6%R"5(8$!L
MJ/F _ UVM4WN[A=7BLQ8RM;O"TC789=B," $(SG)R3TQQ0!RUM\/%M-+TO3X
MM8N&ATW4CJ,'F1*3NW.P4XQE?WC9[GU'2K%]X#M-5G\1'4+J26#7(XDFB5 O
ME&(8C9#SR.O.>0.G2NMJ-9XFN'MUD4S1JKN@/*JQ(!/UVM^5 '+VW@Z\&LZ/
MJFH>(KN\N-+CECC_ '$:"17"@[N#DX7D]^V.^AX6M-4LM,FBU34)[YC<,T$U
MPBI(8B!@,%X'.XCO@C.#P-RB@#DKSP3*?$=SK&DZ_?:4;X+]N@@2-TF*C 8;
MP=C8XW"KL7AC[-XG_MNWO-C#3UT](&CW*L:L64YSDG)]>GYUT%% '&)X $?A
M6ST!=5D\BTO1>)*85WEA*90#SC&XGMTJ/4/ATM_;ZY:_VY>0VFK7"W<D"1H0
MDPV$L"03C*+\N>U=O10!@)X;D3Q5'KYU%Y)TL/L.R2(89=P?<<8^;<.V!CC'
M>I?#/A__ (1O39;);MKE'N);C<Z!2&D8NPX[9)Q6M<3Q6MO)<3R+'#$I=W8X
M"J.234E '/2>&&A\0WFLZ5J#64]_&D=XAB$B2%!A7 )&UP#C/(/&0:KIX(MK
M6X\//873V\.A^9Y$90/YAD4JY<]R02>,<DFNIK&T#Q#'K[:HJ6DULVGWKV3K
M,5)9E56)^4D8^;UH V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y+XG7%U9_#K6;NRO)[2Y@A
M#I+ ^U@<@=>O?M69=V5U#\1K#3%UK5OLFI:;/+<Q_:FY='3!3_GG]X@[-M=C
MK.C6'B#2YM-U.%IK.; DC65X]P'."5(./;-0-X;TQ]5M=4:.X:]M8C##*;N7
MY4.,C&[!S@9SGH* .&TK4[IO#R6%SK-^TD/B.>PA56+W-[%&[XB\S<I' !+D
M]%]ZJW&IZO'\//'N=0O(+C2[Z=+61;EGDB41QN$\P_,0"QYZ^]=J_@+PZ]J;
M?[).%^V&_#"\F#K.<Y=7W[E)R<X(S2GP+X<-IJ5K]@<0:DP:[1;F4"0X /1N
M,X&<8SCG- &5JC%OB+X&9B23:7Q)/?\ =Q5EZ/-KGB;1+#Q%;:I'93+>-)<,
M][(8_+61E:!H,;!Q@9Z\ YR:[9_#6EOJ&G7[Q3M=:<C1VLANI?D5@ 1C=AL@
M#.<YQ5*'P)X<M]>DUF'3REW)+Y[A9G$32_WS'G9N[YQUYZ\T <3K%U)XH^'?
MCG4[F[NDEM9;RVB@BG9$B2$8"L@.&+#).X$_-[#'>RV$VI^"EL[:[FM+F6R4
M0W$,A1HWV#:V1Z'''>J][X#\/7]SJ$\UI,IU%2MY'#=2QQS\8W,BL%+8[XSW
MZUO6EI#8V<5K;J5AA4(BEBQ '09))- 'E%MXMFW^$]:EN+N.TMP+'74>Z?RX
M9F)C5G!.,B1&SGLRDYR#6QX@EU"S\,:3J$=_?P37NM6TC)Y[<12S#$1R<@!"
M 0.,YKKY/#&C2Z=?V#V$1M;^<W%U'VED)!+'WRH_*I=8T+3]>@A@U&*26.&5
M9XPDSQX=3E6^0C.#SS0!R>D6,0^+/BN;?<;DL[-P#<R;<L)LY7=@CT!&!VQ7
M+>&!=:5X-^'>I6VI7H:ZO8K.6#SCY#1.),CR_NY!4$-U]Z]/F\,Z5/J[:JT$
MHO7@$#RI<2)N09QD!@"1DX8\C/6JJ>"- CT[3M/2TG6UTV83VD8O)OW3C."#
MOR<9/7CDT <M?7NHQS?$R--4O1]AM8YK0B7F _9F?Y/0;O2G:=)?6/B/P/+_
M &MJ%P-7L91>1W$Y>-RL"NK!>BD'N.3GDFNLD\(:+-)JTCV\Y;5T$=]_I<P\
MY0-H'WN...,<<4Y?"FCK/I4X@G\S2D*61-W*?*4C:1][YN..<\4 <]XTL8KK
MQUX)\Q[A=]U<H?*N)(^!;N>-K#!]QSCCI6#J-I*]]\3KR#4;ZTELA'<0FUG,
M7[Q+-6!8CEAQT)P?2O1]7T#3=<^RG4(&D:TE\Z!TE>-D;!!P5(.""01T-5#X
M/T0C50;:;&K+MO0+N;$HV[<?>X^7CC''% ',Q:OJ'B#6[32'EV[]"M[[:E[)
M:M(\A8.P:,9.W"\=!N/7C&Y93ZKH/P^N)]0O8M5U/3[6=FFC!Q,T>X@'WX"G
MW!I^H^ _#NJ6VGP7-G)_Q+D\NUECN94EC7&-OF!MQ&.Q-;EI96UC91V5M"L=
MM&NQ8QT _K^/6@#D]$@EN=-\/>(X]?O)#+:^9=0-*9([UI(\X"$[8R&R1M Z
M$=*YJ36M3E^$L'CJVU"Z.KJPN6B$[&%P9MC0&+.W&#M'&[(!SG-=QHO@CP_X
M?O6NM,LFA<EBB&9VCB+?>\M&)5,Y/W0.N.E2P^$-%MYG>*U=8GN/M1MA,_D>
M;G._R\[<Y /3&1GKS0!R-S#?:CXE\<6LFM:K#!:6=M/;QP71C\IVCD;@K@@9
M XZ'OG JI;;]<UOX9ZA?3W+7-YI4\DS1W$D>YO)C;.%( )+'..O0Y KO3X7T
MDWNI7GDSB?4XQ'=N+J4>8H! &-V%P"1QCJ:A_P"$,T'[-I=N+.01Z5D6>+F7
M,2D;2N[=DJ0 "I)!'&* ..U&^U**U^)RIJM\&T^-9;1Q+S"?LPDPOH-Q[5:M
M9;[2_%?A-AJ>H72ZKIUPUW#/.71FCCC=2J]%.21D#GOFNHE\':'-_:WF6TS?
MVN +X?:YOWP VX/S\<<<8XXJ0>%M(%YIEWY,YGTQ#':,;J4^6I !&-V&R !S
MGI0!QN@2:YXBT7P_XF@U:.V:29);PM>R/'*C,5>#R2-BD$A01R".IR36/J$^
MJQ^#_&FKKKVJ_:M'UB86>+DA55/+PK <,N"1M.1[9))] LO GAS3M:DU:TL#
M%<O(9B@F?RA(>KB/.P-[XIS^"- DTW4=/>TG:TU*8SW<9O)OWKG&23OR,X'3
MC@4 82VL ^,MW<R33H%T**<G[3($!\YP<C=C;@#Y>G?&:S-(U&_C\0>#'BU*
M^N[74_M2SW5Q*P6] B:176$DB-<@$8P<<8Q7<R^%](GU.WU&6V=[N"#[,KM/
M(=T><[7&[#@'GYL\\U1M?A_X:LC8F&QE'V"0R6NZZE;R<@@JN6.$P3\OW?:@
M"GX%_P"0MXS_ .PZ_P#Z)BJOIOR?&S75;@R:1;.@/<!W!/YUU&F:#IVCW%[/
M8Q21R7LIGN"T\D@=R -V&8@'  XQT%,U/P[IVJWD%[/'+'>VZE(KFWF>*15/
M5=RD97V.10!6G3SO&J1J[*5TN0,R'E=TBX/_ (ZV/I7G>E7>JIX/\':])KFI
MS7D^LQVDPDN6,<D3W#QLK)T;CH3DC'! P*]2L=%LM/2<0+,9+C_7323N\KXX
M&7)+<9. #@9XQ6:G@?P_'I-GI:6DZV5E<"YMXA>3?NY VX,#OSP23UZT <W>
M/<W.L_$6PN+Z[DM8M,MY(8_/91$6CF)V;2,9*C/KC!S532;N:ST7P#HEM+(L
M6J:=YTADO98R[I#&1&KC+*/F+;5Q]WTR#WD7AO2H=2O]06W<W.H1K%=,\\C+
M*@! !4L5X!/0=S6?-X!\-W&@0Z)+8,UE XD@#7$A>)@, K(6W+@<  XQQ0!S
M5Q<:SH,FEZ!?:N94U/6C$)DF9Y;>W*&00F5L,6)  8_-@^N#5_PY9I8_%7Q1
M%'+/(AL+)AY\S2%>9> S$G'?D]ZW)?!>@3Z -%EL2]F)!,-TKF02#I)YF=^_
M_:SGMTJ;3/"VE:3J<NI6T=P;V6)8I)YKJ65G5<XW;F.>IY- '/\ B3PQ>7_B
M"37/"FM#3O$%M$D-Q%*NZ"Y3EE61?Q.&'_ZN9UG5Y?$_@6-]1L7T[4K'Q%;V
M=[#;SLJ&431[F!4C((8$9S@]#QFO2+GPWI]SJ4NH_P"DPWLJ*CS6]S)$65>@
M(4@$#)ZCN:9+X2T2;07T62SS9/)YSCS7#M)NW[S)G>7W#.[.: .2\6S30KXC
MCT_4]0EETW2!*D45R\2V3!9'#O)NS*[;1A2#PO. U,2+^T_B#X/O;F6X,UQH
M4LTA2X= 6_<G@*0 "2<@<'OG KJ+CP-X=NKF:>:Q=GN+<6TX^TRA9D ('F -
MAR,G#-D]\YJ4>#M#7^R\6C@Z6A2U87$F54XRK'=\X.!D-D<4 <AIDVN>)]%A
MU^TU2.QN(;Z1IG>]D,:QI*RM"\&-GW0!GKT.>:FFU:]TWQ8L&N#4(K:ZU,+I
M^IVERSVK@MA;>6,'"'^'..3SGK71IX$\.1Z_)K4>GE+R2032!9G$3R#D.8\[
M"V><XZ\]>:MKX7TI;CS?*F8?:C>>4]P[1B8MNWA"< Y.<= ><9YH P/B'"UQ
M=^$(5FDA+ZX@\R/&Y?W,O(R",UFP:9JW]O>)?"=MKVIO;FPBO+.[EN6::TF<
MNNWS.I4E,X/:NYU;1;#7((8KZ)G\B43PO'(T;Q2#(#*RD$'D_G52YMF\/:7=
MW6C:3+J5[(ZN\1N )9SD+DR2'LO0$]!@8H Y_P *:S+XH_L=#)<P3Z7"W]J1
M"=\BX!,0C?GYAN61^<]%]:7XC645Q=>$V=YU+:[;QGR[AT&"LASA2,'_ &NO
MO70^'=+:PM[NZN+:*"^U&X:ZN4C((5B JKD=2%503W.3WJ;5O#^FZY)9OJ$4
MLC6<RW$&RXDCV2#.&PC#)&3U]: .>0W2?%.72EU"\^Q'01(L1F+!'\[9N&?X
ML <G)Z^M<]X:M->O_AK:Z[;:YJ%UK$\'E"&ZO2D,@^T<@?W9&52@?.1N^F/0
M&\.:8VM-K!CG^WM;_93,+J4?NLYVX#8Z\YQG/-0V_A'1K3P\NA6]O-'IRNLB
M1"ZEW(P<."K[MRX8 \&@#S?Q)J-OK'P\\2QLNL6=[:7%J;C3[ZXD+VS,Z 8;
M<=Z,,D<D9YQTQZ!XNU&;PMX#U2_T_>\UG;,T1F=I2#_>)8DMC.>3VJS-X4T>
MZL+^SNK9KB/4 HNFEE9GE"_=^;.1C'&,8Z]:OQZ;:1Z8=.\KS+4H8V29C)O4
M]=Q8DMG)SG.<T 9&GZ6+;5;'4;;7KN:TGMC&;:>9IEN6(#+*I8_*< \* "#[
M5QGA>XV?#[PU;+?7,,EQJ=R!:VO$MX!+.3&'W+L P&+9Z+CO7;:'X,T/PYYG
M]F6LL6]#&N^YDD\M#R53<QV#./NXZ#T%1#P'X=73+33TLYT@LYS<6VR\F#Q2
M$DL5??N&=QR <<T <IIMYXCN?#6LP6CO=7=CX@D@2VDO6$DL";7,*3'#;L$X
M)YP*ECU>^U+PZ\^@1ZE-/;ZKB^TB^NFANE41?-"DA;/!VR#!Y&1ZUU,7@C0+
M<3?9[22 S7(NV,5S*I$P&-P(;CCKC@]\U8;PMI3(H\N=95NOMGGI<2+*9MA3
M>6!R?E.W!XQQC% %7P7JMKJN@R3VDE^WEW,J20W^[S[=P<F)MQ)^7( Y/&*P
MO##W'B?PSHOB<Z[=6EV]UYURHE9HG7>RFW\LG:.R@XW9 /)-=KI^FVNEP/%:
M1E1)(TLC,Q9G=NK,3R2?\!VK)L_ _AZPUJ35K6Q,=Q)*9F03/Y7F'JXCSL#>
M^* .4MYM<\4:3>:K9:HFGWEIJ4ZF1[V01P)%*1Y<D &P@Q@9)Y^;.>U6]/L+
MO6?'OBBUN-=U=+73[FSD@A@NC&OS1;F4X_A))X&/SP1O2>!/#DFOOK9L"+R1
MQ)+LF=8Y7'1GC!VL1ZD=>:T++0-.T_5K[5+:*5;R^VFY=KB1Q)M&%^5F*C X
M& * /++9)M+^!FMW^GW]];74=Q=E94NG)&VY<<9)QD'DC!/4FNH\4Z?#=?$7
MP69)+H&7[8&\NZD3&(,C&UAM/J1C/>MQ_ WAZ33K_3VLI/L=_(9;B$74H5F+
M;CC#?*">2%P">U6[GPSI=Y?Z??3QW#W.GAA:R?:Y@8]PPW1N21P2<YH XK4M
M?U+0]1^(MQ%=SSC3[.TEM8Y6WI SI)DJO3&<$^N.:NW']KZ%O\1P:BDNG)IL
MTC6;WTMT+MUC,B.A<#:?E.=O!!Z<5U,?AO28M1U&_%LS7&I(([SS)G=)E (
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MB5Y58%%7OUW%AP<5VZ^&],75;K4UCN!>740AFE%W*-R#.!C=@8R<8QU-48_
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M0:C-.TD@&Y9(W;!3C@A3@BL#1S-IG@OX;2V=W>1&\N[6*=?M,C*Z-"Y*[22
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M XXSCD]Z .NHIL:>7&J;F;: -S'D_6G4 %%%% !1110 4444 %%%% !1110
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M)+%=-6\CFB8LQ8R%""<X_A-=#-/#;QF2>5(D'5G8*/S-<%ITFE)\:KO[#):
MSZ%&6$++\["9O3J=H7\,5>\57NGQ^+]!M;AH8[OR;F6&:\?%O&N%#DKD;WP<
M 9& 6.>Q .ODN(8H?.DEC2+ .]F 7GWIR.LBAD8,IZ$'(KQ[PPD^H>!?#D.C
MZK8)JUE>WC6]M=KNAG DE7RV .5.QLKCD >E=_X%O4OO"\;II@TUH[B>*6U5
M@R)(LK!]A'!7=G&/IVH @O\ Q#J5WK>J:/X?^P&\TZ"&5A>;BLS2%\1@J1MP
M$^]SRPXXKI8KF.1_):2+[0J@R1*X8K_7'OBO/+>U2/QYX^DTRTMSJ4.GVLEJ
M!&NY9C',<CT).W/K665@N_AQX-U#1]O]N)=VBI(O^M:8D"X5SU.?WA<'T)-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5XUH\32_LT7FV>2+9;7['R\?./-F^4Y!X/M@^]>Q2HTD3(LCQ$C
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M(^S'&"X?=G?_ 'ATQT_.N@K'\1>([/PQIZWU_'<-;F18BT*!\,QPH(SGDG%
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ML(_$,LV@V\ADMK)K<"1!NW!&ESED!YQ@'MG'!Z/3;:_MC>?;M1%X);EY(!Y
MC\B(XVQ\?>QS\QY.:O5G:CKFGZ5>:=:7DXCFU&<P6ZG^)]I;^F/J0.] &C14
M<\\-K;R7%Q*D4,2EY)';"JH&22>PK%C\5036/]HQ:;J;Z;MWB[6 89/[P3/F
M$=^$YZB@#>HJ"RNXM0L+>]@),-Q$LL9(P2K $?H:GH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@B-S9Q3"*!2J1JR A1DGH#C\*V*@LK.WT^QM[*UC$=M;Q+%$@).U%& .?0
M5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*VMXX((UCBC4(B*,!5 P * //_ /F^!])D\*:Y'+#'93R&RO3&QAN(68L/G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.!R#\WN/<@'H]%<[%KUY+XNU;0A% /LMG%=0S<\[V<;6&>VSJ#WK#/CO4O\
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M8G/Z<=:73/"&MV>KZ)J,NH:;G3;"2Q,$-JR(RG800=QP24Y.,#/ [UW%% '
M0^!=4A\'Z3H?VVS+Z?J2WWG;& ?;,90NWMR<9SVJ_<>#9-2UCQ)-?S1&RUNR
MCLVCCSOB"!P&!/!/SD].,#K7844 <MX=TCQ38+%#K.MVE[;VB%8#!;M%).<8
M!F8L1P.P'7!SQ46A>'=<T'PW'IMK?V0G%^UPTK0LRM$\ID=<9X/S$ YKKJ*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 9>JZ!8ZS<V-Q>"8R6,OGVYCF9 CX(W8!Y."1SZUJ444 %9FM^'].\16L-MJ
M<+RQ12B9%29X_F (Y*D$C!/'2M.B@!D44<$*11(L<:*%1%& H'  '84^BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDUO#'JMBTMP6$"+<(6E*DAMHSS@@@XZ8-6KFY@L[=[BYFCAA09:21@JK]2:
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ME89\M%#+T'5B>"<8[UI6$VLIK%S:ZDMK):+ DD%S C)O;+!U923@@;>_.3]
M :]%4[35=.OY)([/4+6Y>,9=89E<J/< \5&->T<RP1#5K$R7#E(4^T)F1@<$
M*,\D'C H T**IV^K:;=M<K;:A:3-:G%P(YE8Q'T;!^7H>M-AUO2;F[CM(-3L
MI;F2/S4A2X1G9.NX*#DCWH O453.K::M\+%M0M!>$[1;F9?,)QG&W.>G-,N=
M=TBR\W[5JMC!Y3*DGFW"+L9ON@Y/!.#@=\4 7Z*JMJ5@MZEFU[;"Z<;E@,J[
MV'J%SDU)#=VUQ+-%!<12R0MME1'#&,^C =#]: )J*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** //O$-[:Q_&;PE&]S"KK:
M7@92X!!94V@_7!Q]*M:]=MIWQ/T"ZU%Q'I+V5Q!#*YQ''=,RGD] 2BD#/7)
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M&V?>))/.><M7>^,]$?Q!X3OK& [;O8)K5^Z3H=T9]OF _ FMP1H'9PBAVX+
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M]C<WDEPLTI&V1FP6:/  ";LXP,9SCBNB=$D0HZ*RGJI&0:<    , =J /-]
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M9Z5::-,=%EGFL)[J2=)I2-LA;!9HP  $W9Q@ =2."*Z%XTD0HZ*RGJI&0:<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO;I-->:4W<AWGS(U^[NQ@AR, 8Z<<"M@:7I\OQGU$S6\9+Z) [$]V,TBY_(
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MUZWTW5-/U28/.(&:XM!'*=B ^8/D*!1MVX;)ZGFO0_$G_(JZO_UY3?\ H!H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9*^(K-_%1\.B.
MX%Z+1KS<T1$>P.J<,>IRPZ9'!YJ74]:M-+EMK>3S)KNZ8K;VL*[I)<=2!P !
MW8D =SS7/2?\EIMO^Q>E_P#2B.LBSL=1UGXE>,YHM6FT^[LH;6TLV2*-]D;1
M^9T=6^4ODG&"<=>* /1H7:2)7>)XF(Y1R"5^N"1^M/KGO VMW?B/P7IFJW\2
MQ7<Z,)5084LK%21[';G\:Z&@ HHHH *CGFCMH))YG"11J7=V/"J!DDU)7.>+
M)Y)DL]'@M9KIKV3=<10E QMT(,GWV488E$//1SZ4 :>A:U9^(M#M-7T]R]K=
M1AT+#!'8@CU!!!]Q5B_NQ8:?<79ADF$,9D,<6-S #)QD@9_&N#\"3R:)XLU[
MPK/:S6<$KG5=-BF*$B*0XD4;&9<*_09Z-4&BVVH:G%XGN[S7M4E73=3O8(H/
M-41O&(@ KC;R!NR,8P1[G(!WFAZK%KNA6&K01O'%>0).B/C<H89 .._-.M[Z
M26[OHIK*:WBM64+/*5V3 J"67!S@=#G'2O*]*CU/0_!G@77+'6;Z0S-8VDUA
M(X,$D4H"D*@'##.0W7@YJ[KDUW<Z3\4K.YO[N:*RA#6X,I7RP;42;1MQQD].
MXX.: /4HI$FB26-@T;J&5AT(/0TZO-;J"\BU'P+IEIK&HVMK?P3K<+'.23BW
MW @MD@YZ=AV /-5_%$]]I6E>(DL=<U.]N=(T^(QR>=Y?V1E0MNE8$"9WX.-I
MXQG&<D ].,T2SI 9%$KJSJF>2!@$_AN'YBJ]A>2WANA+8SVOD7#0H9MO[Y1C
M$BX)^4YXS@\=*XE+<7OQ<TNYEFN0[^'FG(2X=5W>=%_"#C![CH>^:S/^$EU7
M3= UW?J$\LC>*O[,2ZE()MH6:,$CC P"V.,9.: /5:*XBY>^TCQ_IVCVM]>/
MIVKV5P7628RM;R1;2)%9]Q&0^,=,X-<QHFH:POA?P%K\NMZA/=:A?Q6MS')+
MF*2.3S,@KCD\ ACS^&  #UZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF4600:M#9_9$1I'^SR,JB1I%;",2V0K <#'/6KGB.\?2/'OA>YBX346FT^Y
M_C&S?&3[JP./9V]:J7/P[NYK6^M(_$+QVT^J#5(5-HK-')Y@D*LV[YUR..A'
MJ<8K3O=,?6O&.C3EF>TT02RO*P'[VX==BJ,<?*-Y..A*CUP =31110 4444
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M0_D!N2&!(PY '&.ISVMW?BO6+9?'6R.P,F@1)+;DQMB0&#S</\V2>W&*GMO
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M>=CY^H1_O+AW&%F8#AB1GU/4]R:ZG7+F;P]K'AW7Y;VY71Y%6ROX3.PAB9U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4K&>RO8$GMIT*2Q.,AE/4&L2R\"Z#875A<Q0W;3:>K+:O+>S2&)6 !4;G/&
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M7$UH1S'4%M_LPE:XD/[O.=I4M@\\].M+J?A_3=7O+*[O;=GN+)F,#K*Z%=P
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M%FO @C>1)Y$\Y1T60*P#C_>SZ=*W_/AV;_-CV9QNW#&:>6"J68@*!DDG@4
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MC[#O0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$RI+Y8):50-[\[4SC<<'C/!KCK6YB.O_ !"MTUFQMI)M*A=;BU^5(F$4P9P
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M?937*7,MI ]PF-LK1@LN.F#C(H Q?%<5SIWP_P!5AT.-HI[?3W2U2$8*!4P
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M5I!'._#2+& Q^IQFHX=(TVVBFB@TZTBCG.942%5$A_V@!S^- ')?"S1],M_
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MC\* 'V*E-/ME+3.1$H+3_P"L/ Y;_:]?>IZ** "BBB@ HHHH **** "BBB@
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M>ZM@JC*!@-QSD@=?E^E '266ORS?%#4+8W5^+&'1DG:UFA9?+D,I!*KMRV5
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M+=74R0P0H7DD<X55 R23Z5FVOB73+K4$L!)-%=21&>**>W>(RH.I3<!NQD9
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MV4>EWYNKS6II[:'[*^Z5&F1E8#'3"D^U 'KM%-C<21JZA@&&0&4J?Q!Y%.H
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M)P,GI7%:;\0A?Q:!=OHMU;Z?K3B&"Y>1#ME*LRJ5!S@[2,^OMS6?\0-:&K^
MO%266GBZL[*.6WEG,@4B51\Q1<?,$)Y)(Y!QG% 'HH.1D=**S[.!+GP]!;R
ME);148!BN04P>1R/J*YVR\!6]I;^'T6617TB>26)Q<R,8T=BWE#)^<8PN6[
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M7#W=TGVA)6250LK!=K@[A@ 8P>U4;7Q,8/ _BO3O%%K-KT.A7QLY&+*&GAW
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M^8J,N=I*Y)Z$\9J/P[X+N= :&V/B*^N](M3FTL)D0>7C[H:0#<X7L. ,#T%
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M4Y8[AR#GBJWBZ74AXU\'VUIJ'V>">XN-T?E!@66!R">1G@GC\>>,;"^'I?\
MA+XO$4EZIE2Q-D85API4L')SN)!W ?AQ[TNO>'?[:OM*O8K^:RNM-G:6*2-%
M;(9"C A@1R#U[4 <--=ZSINI_$?4M)NK6!K&6.Y830&3S=EJC;/O#:"!UY//
M;'/12>)]0U6^33]+BDBD&FPWTDD<:2%6EW;%P[*,#8<]SD=*GD\%O)'XF0ZF
M<:^NV;]QS$/+$7R_-_='?OS[5!=>!)S<:9?Z9KUQINJ65HMB]S%"CK<0KT5X
MVR,CJ#ZD^V #=\.W.L7OAVUFUNR2PU5D(GA5@ZJP)&1@G@@ XSQG%<-X>\0:
MIIGA>ZN[BZ^W7=WKTMA!OB .\SE-Q^8 @*.%XZ 9'6O1M/LQ86,=MYTL[+DO
M+*06D8G)8XP.22<  #L *Y5_AW:S:-JFE3:G=FUN[Q[VWV!4>TE9_,W(P&20
MW3/;B@"GJ>N>+](TKQ)=26L8MK*R-W97=U$F6902\;(DG/3(;CW!INHZUXMT
MNPTB^DO=+E34]1LK=81:LIB27 8;M_//?;Z\"M1_!]_>>'M0TW5?$=QJ$][;
MM:FY>W1/+B888*BX&X]V.>@JSJ?A:74])T:Q?4=C:9<P7*R"#/F-$<H",\#U
MQU[8H R(=1\5S^(]<\/C4]/62UMX;J&\^Q'($F\;-F_'5/O9Z=CG(IK\0;@^
M&?#.L:CNT^QU*V9[N^A@,J03#:$5ASM1LOR<] ,CK73Q>')X?$NI:VE^OFWU
MM';F,P95 F[:1\V2?F.?Z54TGPA=:)I&FZ;9ZNKP65O);&.XM0Z3(Q!&]0PY
M&",@XP3D4 ;NCSRW6BV4\]Q;W,LD*L\UL?W4A(^\O)^4]N37&V?BS5UU_P /
MVEU-;3'4I[B"ZB@B+16[(CNHCEZ,1MPPR><_=Z5UFAZ%:Z!X>MM%M2YMX(R@
M)."<DDGCIR3TZ5S5A\.I+&'0HAXAO'31)F>T'D1C$95E*GCDX;&[],\T 8]Y
MXO\ %-OX<\1ZU]IT[9H>J26YA%JW^D1HR#&2_P G#$YYY]!75#6+W6/%.K:-
MIUS':+I4,)EE:+S"\LH+*,$\(% SW.[@C'-.?P";CP[KVC2:J?*UF[>[FD$
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M+(4YY3(((//0Y[5@W'B_Q3!X;UG7&N=.,>D:O):/ MJW^D1K,L9Y+_(<'/\
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M&@)=O%:2B/$AE"Y4@9'UZ^^"0<K1O$>ME=-\/7MVUR_]L7VGF\EG:![E(!E
M9%!(8D]1R=F,\F@#U6:>*VB,LTBQQC&68X')P/UJ2O)_%6E:G:>&GMM5U-KA
M!KEG):QQWDCR0Q/,HV.YP7P<E2V2/J!6W=27^K^)=:\.VEQ)$-/M(/(/]I2P
MR R!CYN54F3!P/F...G- '>U'-/%;Q^9-(L:;E7+' RQ  _$D#\:\[":U+XL
M\.:3?^(+AS-I=R+QK&3RTEDC:-=PP,@\G)Z@YQBL.[>YU#PAI\%]?7EPUCXO
M6Q29KAP[QK=;5WD$;F Q@GD8SUH ]DJGJ%Y-9K;F"QGNS+<)$XA*CRE8\R')
M'RCOCFK,4:PPI$I<JBA078LQQZD\D^YKE/'EU>6:>'I+2\GM_,UNT@E6)L"6
M-GP5;OCVH ZZBO/S>7G]K?$.U^VW7E6=M!+;#SVS"S0,Y*G.1\PSCI^%9T<^
MJ:K/\/K9]<U&"/5=%E>[,$H5G=8(CN!Q][+DYY]L=: /15O)CJ[V1L9Q L E
M%V2OELQ8C8!G.0!GICFKE<%"^I6/CK4=)BUBYECA\.Q2PM>R!E27>Z>8V  3
M\H)./6L:+Q==Z'I^JG4+74[/Q!IVD23-97<[3P714K^^C?)! /4#& WM0!WV
MJ^((M)UC2-.EM9W;4YFACF7;L1@C/\W.>BGH*N6=Y-<W%Y%+8SVR6\OEQR2%
M2)QM!W+@GC)QSZ5Y_J-ELUKX>7QU"[NI)[HM*\L[.DK-;.V\*3M7OPH P?85
M#=>)-2T;3O&DS:C._P!FUF"UBGF(;[+'((0S 8P-N]B.,9QG- 'J54+C4F6"
MQGLK26^ANY47? RXCC89\TY(RHXZ9/-<QXBT5[32M?==:O6LY](E*V4EP[,L
MB DRK(6W 8*@J./SK'#7.E>#_AXUE?WD2W-Y81SIY[,)$>+)4YR0ORCY00/:
M@#TZBN!M+F[\4_\ "7LVH7=E<:;>R6=F()FC$(2-2LA4'#[F)/S C Q65I>K
MZMXEU/P9)<ZC>V::KH\\UU!;OY:LR^7AEXR,[B<]0#P10!ZG17)?#V[N[C1=
M0M[N[FNC8ZK=V<<T[;I&C20A=S=SCC-=3-$L\+Q,SJKC!*.48?0CD?A0!AVO
MBD7]Y;"STR[N-/N)Y;87T0#(CQE@Q89R$RK -ZCW!/05X[H%]+H/PRT1[2>X
MB;4];^P2S&9F$$;7<H9E#$A3@8R!U.>M=->RW^D^.!H]K?7C:?J&E37&))C*
M]M+$5&]6?) (8#!XSR,4 =Y17%?#>VN[GPQI6NWVL:C>7-Y81B2*>;=$#G.X
M+CANQ.>:["XD6&UEE>58E1"QD;H@ ZGV% $M%>9:-J6H1>)?!P2_OKFUU.UN
M?/N+F0[;PK&KK*L1)$0R<C&#@XQTKTV@"/SXOM M_,7SBF_9GG;G&?IFI*\[
MDC6S^*OB"_4W,CV^APW*Q"XDVLP>7Y=N<8^4<=,\XR:70EUW5K/PYXBAU:**
M*=$>]+7TDJ7(D !58BH2-@QXV]",'- 'H=%>.75WJ\7@+7=;77]3-]I>M316
MQ,_R;%N0FUU'#C:<8/'ICG/4*M[I_P 1I-*35]0EMKW19;IQ-,'V2I*JAD!&
M$X8\  =.* .[HKQNTN=>M_ /A;Q@FOZE<7SSVT=Q:RR[H;B.20(5V8^]\P.[
MKU]L;T5]>^(M#\7:DNHW=G?:;>W5O:"&9D2 0*-NY/NON/)W \-CL* /1J*\
MNM;O5?%?B#0HI]6U+3H=3\-F\GALY1'LDW1?,AQP?FSDY/;H33/$>IW]C8ZI
M?Z?J]]=R6.K6T'VCS3'#"N^*-H"@.)6^9BS%0,MURN* /5**X V=]K'Q'UW3
M9->U6WLX+6SN(X[:<1[6+29 X^Z=N".^>>@JK'?7VEZAKWA&XU"\DU"\E232
M;B2=B_D2_*2IS_RQ*N3Z@#/6@#TFBF11B&%(E9V"*%!=BS''J3R3[T^@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** *NHZ?;ZKI\]A=AVMYT,<BI(R%E(P1E2#R*SI/"6CRZ/9Z6T$O
MV>Q9&M&\]_,@9!A2CYW# XZ]*UYIXK:%IIY4BB099W8*JCW)J(ZC8K#/*;VW
M$4#;)G,JXC;T8YX/(ZT 9MQX3TB[TN]T^YAEEAOR#=LT[^9/@ ?,X.[& !C.
M,4[5O"NCZYHL6DZC;-/:PE6B+2OYD;+T8/G<"/7-:']HV7V(7OVRW^R$9$_F
MKY9&<?>SBJ&H^*=&TR&REGU"W*WLZV\!652'8G!(.<8'4GMB@# \1>%DM?#%
MOIFEZ3/J%H;R.>]C%XRW4BKSO65V!+AE3JPX&!CC!X:\/&*^:=+76[2P>%XI
M[35[_P"TB;=C&$WR  <Y.0><8(-=:^I6$;!7O;92=@ :51]_[O?O@X]<4JZC
M8O>FR6\MVNEY, E4N/\ @.<T 9NF^%-)TIK7[/%,4L\_9(I9WD2WR"#L#$XX
M) ] 2!@'%0R^"="GMM5MI(+AH=5?S+U3=R_O6P!_>XX '&.!6A;W%PFHZG]K
MO;%K2+884CXDA7;\WFDG')R1P.*LQ7]G<7!MX;N"28()#&D@+!3T; .<'UH
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MP,A<]P!3K&^>)+DZGJ.G,?M;I 86V!4_A1LDY<#KC\JOK=VS3R0K<1&6,9=
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M7=M++$2A*L)!&_HP!_3(K%\&^(I=:\#6&NZJ]O;R3QL\S*=D:8<CN>!P.IH
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M:>+BR.D7.GSW1F'56C9!]_=MV_,>W:@"2S\ >'K&33I(;:XWZ:S&T,EY*_E
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M>HV,UV]I%>6[W*9WPK*I=?JN<BLZP\6:)J3WRV^I6Q%G<&WD8RJ 6"J3CGD
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MQ74TTX?#+QVBBV$</B20QA=H$9\V'[OIQGI[UUZV]A9?%W[-8>1:+-X=<MY
M5<D3KM; ZD G!KNOL5IM*_98<'DCRQ4%[ID=S97$-N1:3R0M''<Q(-\1*X#+
M[CM]* /)?#C:'K]AX,TZ?5M#=])F:1M]U&TMT"K*JB(_,&8E68, 01W/3T;Q
MZ-2/@+6QI'F?;S:/Y7E_?Z<[<=\9QCO6;:>$-0EMXK+5VT.:UB"J9;?3BDT@
M7&.6<A#QR0#[8.".TH \VOGL=4NO -YX<:$R"8 B''RV7E-YJL!T4$(,'HV.
M]8^DZ=;_ /"$^-+_ $2RMGUFTU'4ELYH44RPY) $9'*_*3@#U]Z];BM+:!Y'
MBMXHVE.9"B %S[^M.BMX8,^5#''GKL4#- 'E,VK^&[J[^&L^FW5ELBG,8"NH
M:)3;L-K=U.X 8/>H-*FT76-.DT?Q!K-Y!KUKJTDK6">4D[W E+1M'E-[ J5Y
M!P!QD 5ZU'96L3EX[:%'+%RRQ@'<>I^OO3OLT!N1<F"/SPNT2[!NQZ9ZXH \
M_P#"NEZ)<^._&4DEG92R6NHP2PDHI,+>0A++_=.[.2.X]J[?2-9T[7M/2_TJ
M\BN[5R5$L1R,@X(JREO#$S/%#&CD<LJ $U7TS3(-*MGB@ _>2&61@H7<Q]AP
M.  !Z 4 >7>/-2TZ0>/;*-X+6\73HEG$[%Y;O$;.GE(3A57/) /.>F,GT_1K
MB&_T*RGCE2>*6!/G!W!N.>>]6VMX'D+O#&SE=A8J"2OI]/:G8V1XC5>!A5Z#
MZ4 >(G1M"NOAUXR46ML=2AU>]CLS&H\Z.43'R4CQRN6(P!ZGWKI-.TC3+_XI
M:A:ZM:65U<_V):/-'(BN&F#ON;'=NG/7'UKIO"GAF30UOFO5M)IY[Z>[CFC3
MYD$KEBF2,\9Z]_05T0MX!+YHAC$G]\*,_G0!Y%ILVBZQ87&C>(=9O+?7;;5I
M)6L8_*2=YQ,6C:+*;V!7;@@X XR *Z"S:TF\>_$"&X:%XS966])"",".7.0?
MJ*[PVT!N1<F",S@;1+L&X#TSUQ2&TMBS,;>+<WWCL&3]: /'-/BT^X\*?"K[
M0MO(3<+&V_!)7R9,J?;.,BK[Z=HS:E\3XFM;(QPP(R(57;&6M?F*CHI+ 9([
M@>E>I_8K7 'V:' Z?NQQ2_8[7+'[-#EOO?(.>_- 'F%G+;2ZG\)KEWB:XDL)
M%:0D;F'V0<$]3R?SK"U"STE?AW\1;B."T$T&LW'DNJKF/!B*[3_#SGI7M@L[
M4%2+:'*_=^0<=^*3[%:;2OV6'!Y(\L4 >6>,]5TR>3QI:1RV]O=G1$$KSOO>
M['ER,BPJ3@*,G+#/)Z#&:?;PZ)K?C;PE]I2RO4N?#THD#A7$Q!B #?WOXNN>
MA]*]2^RV^X-Y$60FP'8.%]/I[4@M;<.KBWB#+@*=@R,=,4 <!K5O<^$/%RW&
MB6@6#Q%"MAMBC&V"[0'R9"!_#LW9_P!RN\T^Q@TS3;:PM5VP6\2Q1CV P/QK
M+MM)U237GO=5U&"XM()7>PMXK?88MPVY=LG<P4L!C'WCZC&[0!X_JL>G_8?B
MY"$MMBQJZH N _V4<@>N[/X^]:4$&FV7C/P UG';1/=:;=+*8\ S#RXR-Q_B
MYR>>^:]'-G:G=FVA^;K\@YJGJ=A<-9C^R5L8+Q&4H]Q!O3 ;)& 01D9Y[4 >
M57L,5O\ #/Q@(XUCAM_%#/A5P(T6ZB)..P !_"MVYU+1M2^*-]MN[.YMY?#)
M3=O5DDQ,Q(!Z-@=<=*[30M"BT>PNH'99GO+J:[N#MPK/*Q8@ YX ('T%:*VE
MLB;5MX578$P$ &T=!].>E 'CFD0Z=:>$OA=>PI;17;W\*/.N [ PR!@6ZD?=
M&/H*U=&U+P_>V6L:%XH93K2:S+*UHSE)[AQ+N@:+!#,-H0#'  YP*]-^Q6F
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M5D2]^$.O6.H'_BI8;RX,B9Q/]L,Q:$KWR08PI';@<5Z['9VT)!BMX8\$L-J
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M6-@RL/4$51OO$FD:9/Y5Y>K%AUC=RK&.-FQM5W VH3D8#$=1ZUD?#W2KG2M
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M>GW*2L]NZ^662(*&R/E)*G&<5B7]G=WG@/XC6]O9W+S3ZK+/#&(&#2QXB^9
M1\P^1NGI0!Z5%XCTJ;4H=.2Y87DT9EC@>)U9D!P6P0.,]ZN6NH6U[+<Q6\A=
M[:3RIAM(VO@''(YX(/'8CUKD/&3/-HVG>,-*AF:[TB7[0D<D9B>>W;Y98]K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<,T'VDY6-)'X+XS@@<].<>E %FBN=\&>(V\1^%=*U&[:WBO;V#SC!&<8&2.
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M"]144=U;S2R113Q/)&<.BN"5/N.U(UW;*ZHUQ$&9_+ +C);^[]?:@":BBB@
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MPEN4\.RR6^K6 VQW%NH*J'3^%LG(P<')QTI-,LK&PU/X77-K!##<75G(LTJ
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M[3]-MOAGX:U*&WMTNX_$4:I< #>J_;77:&ZA=I/'3DU[C5+^Q],\L1_V=:;
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M)_L\P4;H-MQ'@(?X?PQ7M-OIMC:2RRVUE;PR3<R/'$JE_J0.:C_LC3/+:/\
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M==5B>>.:.VD9?+"YR,+R<E>.P.3CC-^[\3Z/8W2V]S>>66F$'F&)S$)#T0R
M;%;D<$@\UQ<<FL?VIX!U;5=*G26.WNX;I;2V9A&[J@3*@?(&VYYP!WQBJ6GP
M11C4?"OB#P_J]]=-?S2P$><UI=(\QE1RP.Q,%AG/3'<\4 =U+XU\.PZF=.?5
M(_M8N$MC$JLQ$C_=4D#'/KTY'K4__"3Z/_:$%D;S$UP[10LT3B.5USE5D(V,
MPP> <\'TK \/Q2GQ]XU?[/=0+=&U\BXDMG1'VP[258@ X;T-8'A&."2PT?P]
MK/AS5VUG298P3.9C:HT9P)T<G9]W) '))P!B@#:^)'BM=,\':N^EZG/;ZA:[
M4\V" NB.2/D9RI520>F0>1ZUW8Z5XM>&_M_A9XC\*7>EZE)K:SSLICLY)%NP
M\_F"17 *G(;N<Y&,5[+!*)H$E574.H(#J58?4'D?C0!PI\7PZ#XZ\2P:YJ[K
MI\%O:26\;1[O+W^87P$7<1P,DYQQDUTP\4Z*USIMNE\LDFIH7LO+1F6=0,DJ
MP&.!R>>!UKGXY1I'Q)\0W=]:W7V:]L;5;>2.U>592GF;U!4'GYEX/)K(7PI?
M:5\)K/:JV^L:-+)JMJC,,1$2/)Y1/3!1BAYQS0!Z+!J-K<WUS9Q.S3VVWSE,
M; +N&1R1@\>AK-\5>);?PMH_V^>&:7=*D*+'&S?,[!1D@' Y_'H.2!4GAJ"=
M=)%Y=Q&*]U!S=SH>2A8#:A_W4")_P&LGXE6UQ<^"YA;6\UP\5U:S-'"A=RJ3
MHS$*.3@ GCTH IW/B@Z?\10EUJ%PND2:*;E+9[<AA+YP7*H%\PG:#P<GK73Q
M>(=*N-)MM4@NUFM+K'V=XE9VE//"J!N)X/&,C!]#7,QS-/\ %B+4?L5\MH=!
M:,3/9R!0YF#!2=O#;1G!Y[$9XKD=.@U'2_#'A?49M)U:2UTZ]OUOK6"*6*X1
M)I7*2*HVL0 1G'9J /6=*UBPUJV>XT^X$R1R-%("I5HW7JK*P!5AZ$ U>KGO
M"D6GF&\OM.TNYLH;R42,]V'66X;&"[*YW#T&<$XZ8P2_Q9>2PZ2+*W2[\Z_=
M;82VT#R&!&(#R$J#MVJ203WQ0!C^&?%]WJ?C/4]+O8UCM9X5O=(8?\M;<$QL
M<]\L X]G%;]]XHT73M1;3KJ^5;U8#<&!49W* @9 4$DY(X')]*XSQGHE[H']
M@>(--EU/4KK1[E8TM([5'+6SC9(@$48/W<$9X&*TVE,WQ8L-06TO?LG]ARQ^
M>UG*%5VEC8*25X;"G@\T :L?COPS+%92QZM&T5XXCA<(^W<3M"L<80D@C#8Y
MJ[JGB/2M&\S[=<M&(E#RLL+R+$IZ,Y4$(.#RV!P:\RFM;L_";5[--,U'[5)K
M;31P"QEWLAO5D#!=N<;!G-:=U)'IWBOQ!:ZYH^M7NGZRZ36DMFDSQRJ84C:&
M14("GY?XAT/.* .OU+QOX;TF9X;W5H8Y$@%PRJK/^[) #?*#D<_ED] :=INJ
M6$NKZY)'KAN4M_*,\#X6.R&P]&P/O %CDG'M7/Z;:&T^)UD%TRXMK6'PZEHI
M6%VBB<2@^4),;3A??M61K6E:GJUS\2;:PM+D37D=H;5I('1+CRXQO56( ;."
MO7O0!W]MXGT>[NI+5+S9,D'VDI/&\68?^>@W@;E_VAD4VR\4:-?SB&"\/F&W
M^U*)(GCWP_\ /12P&Y>1R,]1ZUSX\0IX@TF\O[+PG=2:A!I\RO'J%D8CN*Y^
MS@L,ON8<A>,#GDBL/19IF\9>&=2-EJS0_P!DSP2N]@\4<$F8CY:IM 15 (''
M., L: .RMO'7AF\DLDM]5CD^VR&&!A&^UG!(V[L8!)!P"03VS715X[:VUW'\
M,/#UJ=,U%;F'7TGDA^PR[T07;.7*[<@;"#FO80<@$=#0!SGCC5M2TOPY,-#C
M$NL3AEM$(R,JI=CCV56Q[E1WJ]HWB&RUCPO9Z^DBQVMQ;B=B3]SCY@?<'(_"
MLJ**?7_%%Y=)<ZEIZ:>GV2W(M0@EW8:1P98R""0BC']P]C6'X,\_PQJ?B/PS
M+;:E)IL,S75A=-92;&#KNDC!5 N0V< =<G% "^,?'MA<^#[^?PUKI6^AABNE
M:&/K$TJH>77'\7;!'%=7IWB_0-6U"YL;+4XI;FV3S)(R&7Y/[ZD@!E_VER*X
M*/2[^X_9WBTN+3;L7\=M&KVC6[)+N6568;" 3P">.M='/$NO>.]!UJQAF6UT
MRVN3<7$D#Q[_ #%54C 8 L1AF(QQCU- !_PF.G:+X9LKZ/4;O6H[S4?LL5QY
M!)RTVT@[5'"\@<?-M &<UJ7OCGPWITKPWFIK#+'&DCQM$^]5<X7*[<CGL>1W
MQ7 06EZGPTT_.FZ@)+/Q&MW-";202B$7C/N";=S#:0> :ZFQ9Y_BW<WOV&\2
MWET2&))I;5U3>)78KN(P#@J<9_44 ;Y\4Z*+U+0WO[Q[DVBMY;^69O\ GGYF
M-F[KQG.1CK5.T\8V%[KFLZ9MN(!I@19)Y('5=Q4L3DK@ #;C/WNV1C/ ZC+>
MWD5L\FC:E;SV?B>.>:SM;!Q#'$)B?-RJ_O6888L"W)Z#OU.DO-8^._&!N;&]
M6.\%M/#(+9V1E6 *WS $$AAC:#GVQ0!M:1K&GV_A?3KIM8DU&&8!(;N2,F2Z
M8YQA%7)/!X Z#/O4C^+M!BTJ[U.744BM;-S'<&1&5HG'\+(1N!]B,UYWH-GJ
M>F:%\.]4FL+T6VE+/!J%N;=Q+"9$VK(4QN(4YR0.C$^M3>)]*N[VS\?:M96E
MW)!J=C!:VT4=NY>YE13EPF-V/F"@XYP>U 'H5AXGT;4]4DTVSOEENTC\XQ[&
M&Y,XW*2,,,G!*DXK7KA9=\GQ&\,7,=I=_9X]+N(I)?LL@1&8QE58[<*?E;@^
ME=O-*L$+RN&*H"Q"(6/X 9)^@H XSQMXON_#FIZ8UO&K:=!/&^KR'_EE#*3'
M&?\ OK+?\ 'K777E];6%OY]S)LCW*HPI8LS'   R222, 5QEOX?;Q3X<U2XO
M[W4[1-8\QKBT:V12B8VHNUXRX(15Z'[V2.M9.EW$NM_#6QTWQ'9:W;7EI/';
M27,-M-'-&T9/EW"97)'"DG'&3F@#O5\0Z8]N\PGD 2?[,4,$@D\W ;8$*[B<
M$'@=.:5?$&F-8->_:2L(F\CYHG5S)G&P(1N+9XP!FN"%K?7VAR67B"XOYEBU
M918:Y8VS13<0DK.ZJIX!S&6QM.?3FH2GB41:'JVI127\.D:U+YTL%J4DNK=H
MO+6Y,0&<J6/0<@9&1S0!Z)::_I=]%=R0W:J+(XNEF4Q-!QG+JX!48YR1TYJ*
MW\3:/=7,MJEV4GC@^TF.:)XF,6<;U#@;ESQD9%<#XIT#4O$5YXHU31(9/+FT
MFWMHU=#']KE24R, &QD; $ST.XCL:ZW1/$%IK]PFHQZ#>VL\-N5GGO+%HY(N
MA,*DC<_/)VY''J10!+H^NZ9;>&M-G;6Y=3CNF:.WNGB+2W398\(BY. #T'1<
M^]1:MXZTK3]!AU6W,MW%-=K:*(H7)60R!"'&,J0<\$ Y&!R:XKP_+>Z7X+\$
MV]QI%]"(YITNKD:<\EQ9'Y]NU"A*[]VW=@\$^N1 +.^7P5K,0TK4PUOXI%Z4
M>W=I&A^TJ^Y>ID^49)&: /1DU.RN?%EM!'J\ZW!L7E_LPQ;0R[E_>,"NY2,@
M8)'7I4Y\4:,+J*W-Z 9IC;QR&-Q$\H)!028V%L@C&<Y!'45S=YY][\3=.NH+
M:^BA?1+B$7#6L@6-WD0J&.,*<*3@X([X-<ZFG7VH?"2#P8]C=0:]!)%;$&%M
MJ%)@WGB3&W;M!;<#R>.O% '>WOCCPWI\U[%<:F@DL=OVE$C=S%D$Y(4'C Y/
M0=\9K=AFBN8(YX9%DBD4.CJ<AE(R"#Z8KSTQRCQ#\1)&L;TI<V<"0/\ 9)")
MBL+J0AV_-@D#C-=/X(62/P)H$,T4T,T.G6\4L<T;(Z.L:A@0P!X(- #]0OK2
M/Q1I-H^LO;W+),RV"@%;D;>2QP2-N,CD=>]5SX]\+@_\A:(C[1]E9@CE4DR!
MACC"C)QDX!/?BJ'B)96^)'@^9+:YDA@6\\Z6.W=DCWQJ%W,!@9(/4UR%_:W<
MGPW\;VT>F:@;FZUN>:"(64N^56F1E91MR1A2<^U 'L-8^H>*=%TN:>*\O?+-
MOL\]A&[)!O\ N^8P!"9_VB*UHW$L:NN=K#(W*0?R/(KR;QS]NU&V\;::ND7\
M<S01FV6SLVVWH"#]X\H'S%>5"9' QACT /2M2UW3M))%Y.P98S,R1Q/*RQCJ
MY" D+[GBFR>(-+CMK:X6Z\Y+J/S8!;(TS2I@$LJH"2.1SC'(]:XL:K-H7C6^
MO]0TG4[C2M;L;9;>2*R>5HVC#@Q.@!9=V_<,CN<]\+<W-QX8\9:?J\VAW4>B
MW.DBR$5C;&4V4BR%U5DC!P"I .W(RN* .QC\2:1-IMIJ$%ZD]M>'%LT*M(TQ
MY)"JH+$C!R,<8.>E0R>+] AT>759=2C2SAE,,KLK!HY <;&3&X-DC@C-<O=Q
M3Z?XE\,:[%H\MKHL45U;R6T,'S6GFD,LC1H.-VWYN/EW<]ZQ/$^D7D^B^/=1
MMK&\E@U>>S6TMH[9V>4Q; \@0#(!YY(YVYZ$4 >B0>+=#N8)9H+\2K'<_9"$
MC<LTN-VU5QE^#GY0>.>E<_X:\4J^H^+[C4=4D?3;"\BCA>XC\LQ!HU)3;M!S
MO8C!&2<#DT>*YKBR\5^%?$*VEU<:1;"XBN1! [O 944)(8P-V!@@\9&?>N?N
M+N[CE\:WEOH5W<Q7.H64L?GZ=(P\L)$&E5&7YV3&X+UR 2.#0!Z#_P )5HHM
MM0N)+T0IIV#=B>-XWA!&065@&P1R#CFDL/%NA:GJ,5A9Z@LES-#YT2[&42(,
M9*L0 Q&1D Y'<"O/I4N#<?$(QV.LSKJ6C1"UEFLY-T["*53@;1@[F4;< \]
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MR1QTR,CCIG-"'QK%-9^&+P6,@@U]E2/,@W0LT9<;ACD84]#6+HM_8^'?$'Q
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MT<N]@%CC(4# W%BV?J<>] '<45SA\426FM6&FZKIK6DFHHYLW282!G4;C$W
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M2*2)),>60^=I4@YW>@)J[H/BV'6=9O\ 26ACCN[-$EWP3B:&5&Z%7 '(/!!
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M^3&AVN9#@XPQ"C .2?3)&=\, 5MO% -J+4CQ!<@P @A#MCX!'44 =T64,%)
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M\.1VZ:MXABLQ%9!ML]R!\@;@CWSCIWK0.JV(U*#3C<H+N>%IXHN[1@@%OU%
M'GLO@?Q'-INI.&L(]07Q"-<L<2L4=@%'EO\ +P" >>>O05HRP:O;^*+KQ9K-
MGI]CIT>AM;3H]T92A#F0D@)AAVQZ'N>*[VJVH36EOIMU/?F,64<+O.9!E1&
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M]E'3G)/&-JB@#D_%6CZV^M:5X@\/?9I;VQ66"6TN7*)<0R;20& .U@44CC_
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MQVY! 7' /6O2J* &QLS1JSIL8C)7.<'TS3J** "BBB@ HHHH **** "BBB@
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M?)!&+:%F)C*QEG9<Y8JKDD#&0N..M-O?&%V? FM^(=+OM)U2&UB\RVD2-@K
M+EED3=D,#VXX(XK2MO"NH6<NN3VVM)%/J=['>*XM3B(IL&TC?\RE4P>G4U5N
M_ *W6G>)(1>06]QKZ)'</!:[8U"J1D)O^\<G+$^G'% %T^(+N_\ $4>A6#V\
M,Z:<M]<3RQ&0#>VU550R^C$G/0 =\CGW\>ZRVEVQBM+%=0A\0)HE]&^_RV8L
M!OC.<@$$'G.,]\<]!)X4N(];L=<L=1B@U*&S^Q7!>W+Q7$0.1E-X*D'D$-W(
MYJK<^!/,L;6&#4%CG35UUBYF:WW>?.&W8P&&U> ,9)P!SW(!9\/:UJMQXFUS
M0]6-G+)8)!-%/:Q-&&24-\I5F;D%#SGG/058U+7)QXILO#E@8H[J>UDO)9ID
M+B.)650 H(R2S>O !ZTZP\/SV?BW5-=>]CD%_##"8! 5V"/=M(;<<_>.>/2D
MUGPVU_KNG:[87@M-3LE>(,\7F1S1/]Y'4%3U (((P?6@#DM?\1:GJ?@3QQIT
MYM[?4]'BEAN'CC8I-$T1960;LH64]RV,'KFNV\/VTB:18S71MY+G[,B"6*#R
MR$P"%Y9C^N/:LJ[\%FZT#7K+[<JWNN%C>7?D9&"@0!4W< * !DGN><UT.G6T
MMGIUO;33),\,:H9$CV!L#&<9./SH \TGN=6N_"WQ/^WWT,\4!NX$00%2H%JA
M&T[B H!Z8))R<\ULZ-KFKZ=JGAG3+[["^GZGISM$(D820-%&C?,Q;#@ANRKC
MW[V[CP1<21>*+:#6!'::]O9XFM0QB=XQ&YW;AGA>!Q@^M6/^$3N3JGAN]?4H
MF_L6"2#8+4CS@Z*A)._Y>%'KWH S;'Q;KVJ1Z-JFGZ;]ITZ_F42P"V=7A@?.
M)?-+;6(X)&WOQTR>H\07E[8:)<7.GQ6\ERFW'VB0)&BE@&=B2.%4EL9&<8KG
M]!\$ZAH$JV4'B.9_#\4OFP:>UNN^,;MPC\[.2@/;&<<9QUV?%6@-XDT-K".]
M:SE$T4\<P0. T;AQN4D;AD=,T <T/&FI_9_&*Q&SN)-#M([NWG:"2-9E:-WP
M5+9/,9PP.""*RO$5WXAO_#_A[4-0&FLMSJVES6D4(=2K,V6$C'/&2,$#CGK6
M_+X&OIY_$,\NO!GURQ2TN!]C 5"JNFY1NSC#G )SG&2>E7K[PE+?>%]*TIM1
M"7.F2V\T%RL'RL\)&W<F[D''(##ZB@"A:>(O$5KXCU'P_JR:;)=#3SJ%C<VT
M;I&R!MK(ZEB<@D<@\BL=_$&N:OIWP]O8;JUM/[4G#3PK;ED+>2[#^,':,=,]
M<'/&*Z^/P[,]]>:I=7D4NJ3VGV..5("L<,>2<!-Q)RQR26YP.F*RHO D\&@>
M&]/@U<)<Z#,'@N#:Y$BA&0ADW=<,><]>U !9ZUXHU'Q?K&DVYTE+;2[BU$CO
M')NDBD3>P&&X;'0]..G/%>T\8:NNOZ%8WRV.[4IIX+BW@1F^R,B,ZCS0Q1FP
MN&'!YSQ6WI?AN?3_ !!K>IR:B)EU41;HU@V-&8TV AMQR2.O YZ8Z5AZ?\/+
MZQA\/Q'Q&730YW>WQ9*I:-E92&.XY?#?>Z?[)/- &?IGBG4]&T;Q7JVI7,-\
MT&M26<$0B,>9,QQQC.XA4Y'&">IR370W&NZMI'BO2]&U!K2XCU:*86T\,+1^
M5-&NXJZEFRI'0@@\8]Z@F^'T5U8^(=.NM2D?3]7N6O%B2(*]O,Q4[@^3G#("
M!@=\YK1A\.WDVI6&HZMJ$%W=Z=%(EJT=J8E#N K2,-YR<#& 0.6]1@ S_ ^M
M^)/$EA:ZM?C2X[&07$;Q0H_F;TF9%())&W"G(Z\9SS@2^*/%G]@ZU96-Q=6^
MFVUU"QCO[N!GA,P( C9@RA.,G)//MBM'PEX?E\,:!'I3WJW:QR2.D@A\L_.[
M.01N/=C^%+K.BW>J2SHMY;&QN+;R)K.ZM3,C').\?.N#SC'? H Y:\;5)_B5
MH;6[V<6H2>'YC)(ZF2)&,D1)"@@L,]!N'7KZV],\6:Q?^%K*^D2P@N/M\MG?
MW#G$40C=T+HA8%BQ50%R3EN^*N:;X*;2=7TB\M-1!ATS3#IL<4L!9G4E3N+;
MASE!VQUJC#\/KRUMM/\ L^NHEU8ZE/J$4C6>Z-C+NWJR;^?OG!R"* ,7Q)X@
MN?$'PA\7-=I&);&ZDL]Z1-&) CH0VQLE20PR#WKHM4_Y*UX:_P"P9>_^A15!
M/\/+B;P[XAT<ZZS1ZS=M=-(]JI,18J6'##))4<\ >E;4_AVZN/%>EZZ^H1!K
M&VDMS"ML<2>9M+'._C[HQU[]: ,OXH;QX5MC&JM(-4LMH8X!/GIC)P<55N/&
M>K^&=9U"S\2Q64\":9+J5K/8HR9$9&^)@Q//(PW3^G2^)] 'B/1_L/VEK:1)
MXKB.4('"O&X=<KQD9'(R/K527PE'JD]W<Z[/'>37-B^GXAB,21POR^T%F.YC
MCG/\(QCG(!6T_6O$4FOZ?#-8"?3;N%S/,EJ\/V20#*\LQWJW(X .>>^*K?%@
MW2_#K4VMYHXU_=B0-&6+*9$& 0PQUYZY'%7?#?AG6-&,$.H>)IM3LK1=MK$U
MLL3 8VCS'!)? ..WJ<G&+OB[P_)XH\.7&CI>K:+<%-\IA\P@*P;@;AW44 9U
M[J6H:9XR\.V$B:=-_:@N$N+A+=DD_=1LZ@?,<#GN3WZ9KG[OQMXGM_#_ (@U
MK9I7DZ)J<EM)%Y4A:XC1D!P=WR-AB<_-D\8&.>MU#P]=:AXAT+5WU"%'THRD
MQBV.)3(NP\[_ )>.G7FLBX\ 7%SX:\0Z,^L1A=:O'NWE%H<Q;RI*@;^?NC!^
MO6@!_B[Q/J^A+JT\'V**&RL?M5LDB--)=$!BX*HP,:  #<1C+9SQBH=2N1>_
M$#P%=[-OGV=])MSG&Z.(X_6I=2\"WNH7>O2#7?)AUNR6UNHQ:!BI5"@9&+?*
MOS$E<'O@@G-6X_"5VNI^&[V35DD;1;>2#!M<>=YBJI/#?+@*,<'WS0!K>(;V
M]T_2&N+!+8RB1 TES($CBC+ /(V2,A5R<9&<5Q\_CC58M'\92PK:33Z"J2PR
MO;R1K,C1>9\R%LY'(R#@\&NH\4^'Y/$6F06\-\;*>WNXKN*7R_,7?&VX!DR-
MR^V1VK#NO -Y=KXF$NO;CK\$<4^;,8C*IL)7#=,=!V[EJ )+?Q+K%IXFTRSU
M8V!L=3L)KI/L\;A[=H@A8,Q8AP0_8+TKGO$NJZGXA\$Z+K9:UBL+S5;.1+;R
MF\Q8S.NPE]V"QX)&W'..V3UTOA2>XUK1-0GU"%UTRUEMFA%L0)ED50QSOXX0
M>O>L5?ASJ$6@0^'XO$8&E6MW'<V:O9!IH@D@<(S[\,H(X^4'\!B@#I_%_P#R
M).O?]@ZX_P#1;5Q^D:]X@T&P\'?;HM/ET34X[:Q40JXG@D:(>6Q8G# XYX&/
M?OW^HV":GH]WIT\C!+JW>!W7 (#*5)';/-85AX3G2'1;?5-0BO+?1BK6L<5L
M8MSJA1'D)=LD*3TP,G/H  85_P"-=;L_"_C+44AT_P"U:)?-#$/+?8Z!(SEO
MFR6^?U'2M0>)=4TSQ;_9^LFQ-C-ILM_&UO&X>#RF4,K$L=XPV<@+TZ5#=^ ;
MB[T7Q-IK:O&JZ]<F>1Q:',.0JD#Y^>$'ZUI7?A66_P#$5IJEW>PR1PV,MC+;
MBV($JR;=QSOX^Z/7O0!R7B#4=4UO0?!VLS&UCL[[6["=+98VWQHT@*9?=@G!
M&?E'7CISOR>)=535_&5HL5E_Q)[."XM6*-\^])&(?GG[@'&*IQ_#S4X]'TW1
MO^$D#:?I=[%=66ZR!E58VW*COOPP'3(45JR>$;E]3\1WHU2,?VU:QVQ4VI/D
MA%90<[_F.';T[4 9FE^*]?DN_!\NH+IQL_$%ODQP1N'AD\CS0VXL00<$8P,<
M<GK4.H>-]731-4UBRBM ECJ_]F_8Y8F:1QYBQ;LAA\Q+!@,=./>M6+P9<Q)X
M44:I$1X>7:G^BG]^/*,7/S\?*??G\JXJSO!=:K>:A:^*-,MM3EO))5T[4-&$
MMY&0Q5$X97.%  P. < GJ0#V"+S/)3SBAEVC>4!"[N^,]J?4%D]Q+86\EW$L
M5RT2M+&IR$<@;@#WP<U/0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !17+^/\ 6KG0O#'VBUD,+S74
M%LTX /D+)(%9^>,@$X]R*H7AO-&^(&C:9:7EZ^GZQ:W*S1RSM*8'B"D2(SDE
M<[MI'3H<9H [>BO'M'O-53PEX(UZ36]2FO+O58K2=9;@F.2)Y'4ADZ$\ @G)
M'8XP*]+\4Q+/X3U>-FD4&SE.8Y&1N%)ZJ0: (-1\46UA=:)$L$MQ#K$PA@N(
MBOEC*%P3SGD*<8%;M>2"R"^$_A?%%/<1F:YMG,GFEV4FT?.W=G:/0#@=A4UQ
MKVH>&H/%]DFH7$L%EJ=E##/>3EVMX[@1;R7;)P-S8)SC/>@#U6BN7T;3=6T_
MQ/-+-J"?V;<VN4L7O)+EUE5AF17D (7# %>F<'O5/QH]]_PDGA2UM=4N[.*\
MO)89U@8#<ODNWIUXX].N* .THKRO[7J&B77BS09_$5^+.W:RDL[R;,]PAG;#
M0 Y!8MMPISE=V>U2/?ZK"?B%:"ZOK1+'38;NT1[HS20.T4I/SG)&2BG ) YP
M: /3)YXK:+S9I%C3(7<QP,D@ ?B2!^-5VNYQJ\=F+&8V[0-*;L,NQ6! "$9S
MD@YZ8XKR_7='=O!7A_4KO5]6NY[V]TII%EO'"(2ZY*JN,9W>_(!Z\UTMS=76
MF_$R*UBNKN6S70)YQ:/,64NDL8!YY+8R,G)Y- ';T5YQX?.MZWIGAKQ+#JT4
M*S&.2^+7LDD=PK\-$(BH1&#' QT(QSUI='U:\M?%-CI_B :A!=SW$S6E[%<-
M+9:@A5RJ@9Q&P4@@8_@Z\T >C445YUXTO+G=XG:QU*]DN-/TH3)%;S- EBX6
M1P[L&_>,V 0I!P%YP&S0!Z+BBO.FFU#5?%_ANWEU:^AM[_0Y)[B*WE\L,X\K
MD8Y!^8\CD=B*S=-\0ZBFE:/HL^H7+"Y\0W.F/>R2'S3#$[E5W]=S;57=UQG'
M/- '?V7B".]\3ZGH8M)XIK"**5I'*[9!)NQMP2?X3UQ]*V*X3PY9I8_%7Q1%
M'+/(AL;)AYTK2%<F7@,Q)QWY/>K_ (SGU:UETZXL+.XU"SB\QKRRL[DPW#KA
M0KI@@MMR<KGG</:@#K**\O%^^LZEX)BTOQ!JHTW48KU96W[)7\M>C9Y#@Y4G
MVR,'!JH-<UCP]/J_A^34I[NVAUNSLX+Z[G/F)%.GF%&EP3QPN[&1OSQQ@ ];
MIKL4C9E0N0"0HQD^W->;Z[<ZYX-TW6+V35$2SN&MU@B>Y>Y>RW2K')*'D&=N
M&R <@$#MQ72OH\MA>7LMOKMZ+>XL2$M))FE9)%/,R.Y)'#*"!QT/6@"[-X@2
MQ\/0:KJ-G/:22F-/LCE6D$DC!53@XR6('7'KBH=-U[4+S69=.N?#M]:)$&W7
M;LC0L1M*[2#EL@GMP00:X"^,FK_";P7>W]S=37,E[I_F2&X<%RTRY)P1D^A/
M([8KJ+N>ZT[XE:99PW=Y)9'1[F0VKS,ZLR/& ><DMR>22>: .UHK@O#!N/$/
MASP_XG_M^X@N9I1-=J)"T,H8E3!Y9.U<,0H(&<KW))K6^(EQ=6?P^UN[LKN:
MUN8+5Y(Y86VL"!Z]OPH Z>BO-[G^U?#OBSPU=0:OJ.H0ZLDL5Y9W$N]"5A,B
MO&N,)@K@XZBDT!]<U_2/#GB6#5HK?SI(Y+TM>R21S(YVO"(2NQ&#$!2.01CG
M)- 'I-<];>*?MM[ ++3+JYT^6YEM#>Q8*I)&2&++G(3<K+N]1Z$$\]X0TZZU
MB\UFXOM=UB1;'6KRVBA6Z*(T> H#8P3C.1@C! (QSGG]$OI/#_PUL9K2:XB?
M4-=:PEG:=W$$;WCJSJ&)"G;D9QU.3DT >Q45PMVU[I/CVUTBUO;U].U33IY'
M22=I6MY(BN)%9R2 0X&.F<'K7)G^UE^"1\5?\))K)U*33$)_TGY ?,'S 8R&
MQQG.: /9J*\_NK.[B^(UEIBZUJOV/4M-FFN8_M)^^CI@I_SSR&(.S;5#2M4N
MG\/16-SK-\TD/B*XL8E5BUS>Q1N^(O,W*5. "7)'"\]: /3Z*\@OM5UF+P!X
MO(U*\M[C3=;$%NZW!D>.,M#\AD/S,!YC>_OQ6S?ZA?\ A;Q=K*P7U[?0KX<F
MU/R+J4R#SXWP"H_A!!P57 ]J /1J*XS28)7L=!\11:]=RB2T+W,#R&1+YGCW
M#:I.(R&!(V <9'2LKP^^N:]I/AOQ-!JT4'G21RWI:]DDCG1_E>$0E0B,&("D
M<@C&3DF@#TBBL7Q?/J5KX/U:XT<HNH1VKO SD !@.O/&0,XSQFN>TN*_O/%]
MA-876L)HPTW?<BZ:0#[1N&P?O!G=MW;@.!@9]P#K].NY[R*9[BQFLV29XU25
ME)=5. XVD\'J.]7#P.F?:O+[5-<U;X>^(&L]4OWU6QU6\^RR?:&#.L4IQ&<$
M9!5=N.V<BNFT/48O%KIJUC=W,=@+)(T$<Q_ULBAVR.A9%*C..K-Z4 ;^F7<]
M]IL%S<V,UC-(,M;3,I>/GH2I(]_QJW7D5AJ>KWG@7X?73:S?I<7VI)!<RK)\
MTJL)2=V0<_='7CVK2%WK>F1?$'3M*O[BXFTZ.*:P:]F\QHC)#N8;W[ @D \"
M@#TNBN$TF._N_&&G3V-SK"Z,--\RZ6Z:0 S[AL'[SG=C=N X&!GMG4\<:Q/I
M&FZ>('6+[;J,%I)*TAC"(Y.?F .W.-N<<;LCGF@#I7=8XVD=@J*"68] !7*'
MQW!%91ZG-I=ZND3VOVFWOE"LK@D!589RC-N7:#USVP<4Y-'U.UMO$45_J);3
M[BS,MO9B^FEE@95.XB1L-L)Q\N<=NA(KF-2TV!?V?](E$EUN-OISD&[E*Y:2
M$'C=C'H.@ZC% 'INF:G=7MW>VUWI5S9/;%=LCD-',K D%&'7&,$=N/6M.N&O
M9;BY\8R^%X)91!;Z8ES&K:E-#+(7D=6;S &=MNU1@G W=^,5=-NM4&NZ'X4U
MS5_M#C3[B>:YM9&B-U*DH14W+ALJI8L!C)'/2@#OYIXK<(99%0.X1=QZL3@
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M:&)I @ZL0"<?C7F<^K:E%\,]'\:VNHW4VIO);S3Q><QAG$LJH\(CSM &_ (
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M);R%T W';@D _=QGCK0!C/X \-R6M_:M8R""_E6:Y1;J50[KC!X;@Y52<=2
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M1R+@C8(Q+(#SCDXQC(]*[+5M(L-=TN?3=3M4N;.<8DB?H>XY'((/.1R*NT4
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M201W?F2NZ2J 0 4)*X )' [FM6B@#&T[PKI6EM;&VBF*VJE;5);AY%MP1@A
MQ.WCCU X''%5G\#Z!)I-[I;VT[6=[<&YN(S=S?O)"VXMG=GD@'@XXKHJ* &H
M@CC5 6(48!9B3^)/)K%M/"&BV4B_9[9UA2<W,=MYSF".7.=RQD[1R<@8P#R
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M[0<DD<8!Y&#4.I>!?#VK:T=7NK%OMC*$E:.9XUG4=!(JD!Q]0>..E='10
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MYOY-/M7O#$83<-"ID*?W=V,X]JB70-'32VTQ-*LEL&.6M5MU$1.<YVXQUYH
M\U\269L)/B!I]D#'HZZ&MYY,9*I!=%9/N@<#(4,0.^#WK0L]/M=)\;^"9K)#
M%+J&FW*W;[B3.%CB9=Q)YP2<>E=X-$TH6$EA_9MH;24YD@:%2CGU8$8)X'6D
M70M(6>VF72[(2VHVV[B!=T(]$./E'TH M6]U;WD9DM9XIXPQ0M$X8!@<$9'<
M'@U-5>RL+/3H&ALK6&VB9VD*0H%!9CDG [DU8H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ.M:DFC:%J&J.
MAD2SMI+AD'5@BEL?I0!>HK@V\1:II=EX5UBZOA=VVM3P6]S!Y:*L33KE&B(&
M[ ; (8MD'L:[R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **AN;NWLXUDN9DB1I%C5G; +LP55
M^I) 'UI'O+:*Z2UDGC6=XVE6-F 8HI 9L>@++D^XH GHK*TWQ+H>L7+V^FZK
M9W4R+N*0RACMSC</4>XXK5H **K6NH6=\]PEK=13M;2F&81N&,;C!*MCH>1Q
M5*+Q/H4^J?V9%J]D][N*>2LREBPZJ/4CN.M &M17/'QUX4%Q]G/B'3O.W;=G
MVA<YSC&/K6K#JVGW%T+6*]@>X)D C5P6)C(#C'^R6 /ID4 7**S=0\0Z/I7F
M_;]3M;;RB@D\V4+M+YV@_7:V/H:CT_Q1H6JN$T_5K2Y8N(\12AOF*LP''<A&
M/_ 30!K45"]W;QW45J\\:W$RLT<18;G"XW$#N!D?G5./Q#HTM_-8QZK9M=PA
MC)")E++M^]D9[=_3O0!I45C6/B[PWJ=Q]GL->TRZFVE_+AND=MHY)P#T%3VG
MB'1K^TN+NTU6RFM[<9FE2=2L8QG+'/ QSDT :5%9D7B+19M,EU*/5;-K&$[9
M+@3+L0\<$YX/(X]QZU'-XK\/6]A#?3ZYIT5I.Q6*:2Y14=AU )/4=Q0!KT5C
M/XM\.1Z?%J#Z]IBV4KF..X-T@C=AU ;."1Z4Z[\5^'K&WM;B[US3H(;I-]O)
M+=(JRKQRI)Y'(Z>M &O15)=8TUHU<7T!1IEMU;>,&1@"JCW(((]<BIWN[>.Z
MAM7F1;B96:.,M\SA<;B!Z#(S]10!-14-Q=V]HJ-<SQQ+)(L2%V W.QPJCU))
MP!4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %17$<,MM+'<JC0.A617^Z5(Y!]L5+10!YM;^$+>]US1;336OAX=T6?[6
M#<3NT;RKGRXX0W5%))+'(Z 'KCTFBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YGQZ&7PVEQM
M9H[6_L[F7:I)6..XC9VP/103]!6'J>IZ5XB\22W&GR'5]/M=!O8KO^SG$A)E
M:+$:L#C>51\#.>*]"I%55&%  ]A0!YOX?U6&3Q%H=G::UI_B.W5)$C9( EUI
MZ",_-(4.T X"$%5.2.N*[C7]530]!OM3="_V>(NL8ZR/T51[EB!^-7)X!-!)
M&LCPF08,D6 P]P<=:H6NC/;7*3-JVHSA?^6<TBE6X[@** //M)L=>\,WL-M=
M6T%J^LV+VC7$5T9/,OP'E61OD7:6W2>O11VK3T;7?# \*:#HK1)<:A";:+^R
MD -S#.A7<S(2"NU@6+' P"<G//H5)M&[=@9]<4 <R1_Q=!?^P*?_ $<*YN*,
MVNEWNOQ@^9I'B*[N'P.3;M(4F'X(Q;ZH*]+HQ0!Y3JS-%X=TSQ#/>1:?/JFO
M17IN;E<K!$4=8@P)'2-4R,CDFMJ35$U+P[?W4'B33M<N=,>*^7[ BJ8Q&VXJ
M0';[RJZ]NIKO, ]12;1Z"@#D+NPLH_B3HFI6\8,]W:77F3;BVY0(=H&3PO4X
M&!DD]2:R-(UKP_X@\3V%KI]_IUK8Z7=3/:6JS+Y]W.5=68+G*H-\A]6)SP ,
M^CX [=*3:!V% '&V?V;47\2^(-2MFN[9#/I\,"Q[S]GBRLH5>Y>0/GU"J.U<
MKK5Y!?R^(YK&\M]5L[C3[9!=6R_)8()_E5MN0VQ7:0@\X0@@ UZ[2!0HP !W
MXH \ANKCS&U21=6M[V)]3T^5M?C1?)MRH/4*=AV;%R<X_>C.,5K:?JEQI_A3
MQ'-874=Y=3ZKY%IJ,:CR[F6?RD5U XPC/M..#Y9/4FO2 JA=H4 >F*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tardioagreementa01010.jpg
<TEXT>
begin 644 tardioagreementa01010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBN?N]6>[\7P^'K:0QB*U^VWDBGYMI;:D8/;<0Q)ZX7WR #H**Q-0\6
MZ-I;2_:KEUBAF6"><1,T4,C8VJ[@8!^9?ID9QFH;C5I-)\7V.F3R%[35TE-N
M6Y,4T8#,F?[K*21Z%2.A  !T-%%% !1110 45S7CH:HGAJ6?1=0DLM122)(7
M 4HS/(J8<$'CYNW-9%OXOFUWP'KDV9-+\0:5;2B\MUQNMYT0D$ Y!0XR#R"/
MI0!WE%9<VJ6NE"WLY9;BXNGC+K&B&65U7&YB%' R1SP,D#VK(U7QYIMII&F:
MC8B6]AO[^*S4Q0N=A:0*^X8RK ;OE(R3QCK0!U=%< _B8Z7\0]46[N]0EL/[
M)@N8K1;=Y&0L[AB(U7<.%&<CCN:V;_7M'O8O#MTFKW<,-_=1O9M:JP6Z)4XC
M<[2 I&20<'Y?:@#IJ*YF\\?>'K%]026XN2VG,%NQ'9S.801NW-A>%QSNZ>]:
MEQKMA;R6L0E:::ZC:6"*!#(SH "6 '\/(Y]P.IH TJ*S=%U[3?$-E]LTN=YK
M?.W>8709'! W 9P00?0C%6KV^MM.LY+N[E6*"/&YCSU.  !R220 !R2<"@"Q
M16-;^*=(GDU")[DVTNGQB6Z2Y1HC'&02'.X#Y< \TMOXFTRXOUL=\\-U)"9X
MHI[=XVEC'4H&'S8XR!R,]* -BBN7A^(/ARX%JT5W.8KFY-JDQM)1&LNXJ$=B
MN$)88 ;';L:?:^,+6?Q3K.D20SP1Z9%$[W$D+!,L'9B6QA5 48)QGG&: .EH
MK%T_Q5I6IW<5K;RS"6>V^UP"2!T\Z'CYTR.1R..O(XK+L?%6@:9H4VHR:Q>W
M%D^H20F>ZB<F.4OCR_NC:JD[1G&/6@#KJ*QM/\4Z3J=W>VL,\D<UD@EF6Y@>
M B,YPXW@97@_,..*+7Q1I=WJD.G+)-'<W$1FMUG@>,3H.I0L &QD''7!STH
MV:*\_P#%WBE96\.G2;Z\CCGUNVMS+%$PAN$,F'7?C!'!Z'!YZUZ!0 45P4OB
M,Z+\1M;BO[R]GLDTVWGBMHHFF*$O(&*HBDXPHR3^)KJ!XBTR33[*]MYFN(KY
M/,M5@C9WE7&<A0,X (SG&,C- &K17.-X[\.K86EZU\XANKDVD?\ H\F1,"08
MV&W*L,'AL'BIHO%VEW%A%=P"\E$B.XA6SD\T*C%6)3;N R".1SVS0!NT5S$_
MB#1=2N/#EQ;ZS=*E],7LQ;!O+NOD;*2';C Y."0<CVI+GX@^'+1;UI+FY*V,
MWDW16SF;R#@'+X7Y5Y'S'CTSB@#J**165U#*05(R".A%4;[5[6PN([>3S9)Y
M$:410Q-(VQ2 6PH/ ) ]\\9H OT5P6I>)/(\<^';F._NVTJ_TNXN%MHXV;S"
M/+*$1JNXMACQR?I700^+]%N-'MM4BN7:"YG^RQ)Y3"1ILD>7L(W!@5.01Q@G
MIS0!NT5P_C#Q&MY\-_$.H:)?W%M<V"21NR*8Y(I4QE2&&1U'3U&#4U_>WL/C
M_P )6Z7LXM;NTNFFM]PV,R(A4GC)/S'J: .RHHK%O_%6DZ:;DW$TOEVC!;J:
M.%WCMR0#\[*"!P03Z @G H VJ*P-0\9Z'IE]]AGN97NC;_:DB@MY)6DCR!E-
MJG?U[9X!/0&I;+Q7HVI:-;ZK97?GVMP_E1!(V+O)SE-F-VX8.1C@ GIS0!M4
M5SDGCOP_!IL]]/=R0Q6UP+6X62!P\,I( 5UQE<Y&">#GK3X?&>CW!1(6NGGD
MEEBCM_LDBRN8P"Y"E0=H#+STY Z\4 =!17)ZEX]TZWT_0[VQ2>\M]7NTMX98
MX'(49.[(QG=A6&W&<CIP:TM2\5:5I,4LMT\XC@57N'2W=Q;JPR#)@?+QR0>0
M.3Q0!M44V*6.:))8G5XW4,K*<A@>A!K U3Q5%IOBO2]"-K<N]Y'+*94@=U"H
M!P,#DY89/0#KUH Z&BL2\\6Z-8&9KBX=8()A!/<B%S#%(<#:S@8') )Z G!Q
M6V#D9'2@ HK$U7Q;H^C:BFGWD\PO)(6FCACMY)&D4$ [=JG<>1P,FJJ^/_#;
MZ)!JXU _8IK@6H<POE)20-CC&4.3_%B@#I:*PX/%FEW5JLT NY&9I%6#[)()
MCY9 <["H8 $CDC'('4XJ./QMH$T6ERQ7CO'J<AAM66WD(>09RA.WY6&#PV#P
M: .@HK.FUS3[>:\BFE=#9HCS%HFVC=]T XPQ/H,GIQS5%O&>BQ#4/M$T]O)I
M\(GN8I;:172(YQ(%VY*\'D9QCG% &_16!8^,]$U'4+>RMYYS+<P&XMR]M(J3
M( "VQBN'(!&0":3PKXIB\46]Y-';7$ @NI8 LL++PC;>21C.0> <CO0!T%%1
M7%Q#:6TMS<2K%!$I>21S@*H&22:R[?Q1IEQJ$MANN(KM(/M(AFMI$=XLXW("
M,MSQ@<CTH V:*X:+QCI^C^&O#TEE<:EK%OJ5XMM#>3Q.[L"[;BV%!S@,%&,G
M XX-01>*5TCQSXF&HWE_-8Q6EI/#;K \AA#"0N0B+E0,#)(XXR>E 'H%%9C>
M(-.^QV=S#*]RMY%YULMO&TC2I@'<% SC!')]0.I%9S>//#JV5C=_;G,-]*T$
M!6WD),@SE"-N5;@_*<'C@4 =)15/2M3MM9TV'4+3S/(F!*^;$T;<$@Y5@".0
M>HJEJWBK2-#OH+*_N)$N;A'>&-()',@7J%VJ<GD<#GD<4 ;-%<]:>-M OM&_
MM2"])@%R+0H8G$HG)"B(QD;MV2.,?I2S>--$M]*U'4;BXFBATV3RKQ6MY-\+
M8!P5 S@@@@].>M '045QNH_$73+>6TBM(+VX:?4([(N+.4*-PW[@=OSY4';M
MSGKTK=L/$>FZEJM[IEM).;RR5'N(I+:2,H&Y4Y90#G!Z>E &K1533=1MM6L8
M[VS9V@DSL9XV0G!QG# ''OWK!\?^()O#WAA[BU\T7$LL4*2)"SA \B(QR 0#
MACC/4XZT =317$Q>(]%\,ZC>PW6K:O-]HA^VQ65S;3RO#&N%;82N\@DYP2<8
M)X&:VKOQ;I%DD\DLTS16RJUS)';NZVX8!AO('R\$$CJ 03@4 ;E%8EWXMT:R
MOX+&2XD>YN(#<P)#!)+YL8QRA4$-U' R:HK\0_#;64-X+J?[.\ODR2?9)=MN
M^[9MF.W]V=W'S8_*@#J:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9YT
M7G^1YJ>=MW^7N&[;G&<=<9[T^@ HHHH **** "BBB@ KB[*VDLOC!JDDH/EZ
MEI4+P,>A,3E74>XWH?\ @5=I5:[L8+PPO(")8'WQ2J<,C8QP?<$@CH0>: ."
MT6;5-#NM9\/7OAR]OC<ZC/=6=TL(>VE25]X\QR<*5)Y!YXX!XK2\5VTFH>.?
M!EM",M;W$][*1_!&D>W)^K.H_&NTJM#8PPW<UV 6N)@%:1CD[1G"CT R>/<G
MJ: +-%,EFB@0/+(D:DA078 9)P!3Z "BF&:)9UA,J"5E+*A8;B!C) ].1^=/
MH P_%I?^P]L<$\[FYMV"01-(<+,C,< 'H 3^%<Q\1/"5]J%I/XA\,@IK!LWM
MKB#:0+VW92"C#^^,Y7OD8],>ATF]=^S<-V,[<\X]: .+O(+W2/B5%KDEM<W&
MEW>EBR9[>%I6MY5D+C**"VU@QY /(YQ7/77AW4K319M12PN9!/XMBUC[)&FZ
M5+<2+D[.NXA=V.O//(->JEU5E4L 6Z GK2T <39F<?$S4M3ET^^CM)-'@B5V
MMF(WJ[LR9 () 8=/PKF=,T[48/ OP]LY=,OUN=/U2*6[C^S.3"BK*"QXZ?.O
MY^QKUGSHA.(/-3SBN\1[AN*YQG'IGO3Z /-KBTO&D^)6-/O3_:$(6T_T9_WY
M^RB/Y>.?FX_7IS56>:XT>]\)7T&FZH;Z#16M[@0V1N"J_NQL>(,K#Y@2&SCY
M<<YX]3K!U/PM!J&K_P!JP:CJ6G7IB6&22SF $B*25#*P93@LV#C/)H J> 3I
MT7A\V5BM\CP3.UPE];-!+YDC&0DH1P"6XQD8XSP:3X@6&I7GAZ"?28#<W>GW
MUO?"U!P9Q$X8H/?N/<5OZ?I\6G0LD;RRN[;I)IG+O(V,9)^@' X'85;H \]\
M1QZAXZ\%:Q%I>BW>G7,L$>PZA"()9W20/Y>,YVX!&3QEN.,U:NTF\4>(?"VI
M16-[9KICRW-T;FW>-H]T97RAD#>23_#D87KR,]Q10!Y'_9^H_P#"L?L']EW_
M -K_ +=^T>3]E?=Y?VSS=W3ILY_3K6Y*FJV/B[QA<6NC3W9U'3H'LB\?[F1X
MXI 4<DC&6*C;UY].:] IBS1/*\2R(9$ +H&&5!Z9';.#^5 'F6BQZ@WC#PSJ
M<FDZR(QID]O<R7$&Q8I#Y9P(\@1J-I P!G'&XU2ET_46\ ZE:#2[_P"T2^)#
M=)%]E?<8C=B3?C'38"?TZUZT\T43QI)*B-(VU%9@"QQG ]3@$T^@#S?Q'H]_
MKGBOQ!#:6]S&E]X:^Q0W+PNL9FWR-M+$<<,/S]:728SX@M4A;PC>:3K,%M+$
M]Y>1;4MY&C*$PODELDC[O&,Y[ ^CT4 >1*VJR^#/">BOX=U6/4-&U*R6Z06Q
MV;(6P9%?[K @9X/?FO7 <@'&/8TUIHDF2%I4660$HA8 MCK@=\9%/H XJ*.>
M'XF:Y?/9W?V1]*@A286[E7=&D+*"!R<,/K7(:7IVJZ+H7@W4;K0-0OH+&QFL
M+^RBB;SX"[(PD5."PR@!QV->R44 >:ZM8AK'P_-IWARZLHCXABOY8$MB9!&%
M(:64+G#$D<9SC'?(%GQ''<Z5X\&L3Z'?ZMI-[81VQ-C&9);:6-W890$':PD/
M/8BO0:* //+_ $UH)_!2V.A2V5M:ZC)<26UO 66VC9) "VW(!)<9 )Y)Z@9J
MC=V-])H/Q)@73KXRZC+(;-?LS_O@8$0%>/[P/\Z]1HH I:/N_L6Q#(Z,($#+
M(I5@0H!!!Y%<QXRTN/4-5M)$?5]/O[>!VM=5TZ%Y=A)&8I$4$,IP#@C'!Y'?
MM** /.K!-:D\5>#[W5]/E2X@TF>.]>&!C%%*_E[5RHP,[3P.!^59MF-8T[2I
M NCWQBE\3W,\SI9EIXK=V=EEB5AWR 2!E03T->KT4 >0RZ9J8\%_$'3DT;5%
MEOKN22T61#(TH>.,+ALDL<J<G) [FNGOH[B?QUX-NX[.\-O;VMTL\GV=P(C(
MD84-QQDJ?IWKMZ* "O.+*VO](LO&.B7NFWET^HW=U<V4D4#21W"3KPA<#:A4
M_*=Q Q@]*]'ICS11O&CR(K2':BLP!8XS@>O - 'F.DV[>%_'?AS3KSS[B2U\
M+&WD>"%Y<,LL8)PH)QQC./2J<OAW5=+@CU^/1[B\@.OW6HRZ7&,3?9YD\L,%
MS]\8#[>OS$>M>BOX=@?Q7'XA^UW0NDM3:"(%/+\LL&(QMSU .<UJPS17$2RP
M2I+&WW71@P/XB@#S+Q#9KJ'@N_FTGPO>V<EY>6;^4UJ1<3^7,C,[J,D *"!N
MYX/MGH?$5S??\)+HP33;V73)8)?,N+.']\LAV[8RW#1(1DDY'(&2 #77T4 >
M0Z=INK6O@7PI'+HNHB72?$!GN8?*W2>67G^91G+#]XO/OGFM"2&;3?$^N6^K
M^$]1U6RUB5;FVEMHQ*HW1(C0R_,%7&SJ3C!ZUZ=10!7L(!:Z=:VXAB@$42)Y
M47W(\ #:OL.@KE_$,%Y#\0?#.IQ6%S<VL4%W!(T";O+9Q'MW>@.T\GBNPHH
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MBN>2>!DC'?'I%% 'G:6UV=8^'<GV"\"6-K*ETQMG A+0! &XX^88_7IS6IX
M@O+"WU?3[RPN8'35+N99)$PDB/*64J?XL@]NG>NPIB3122R1)*C21X#J&!*Y
M&1D=N* ,+QQI=[K7@O4[#3MIO)(PT*L<!V5@VTGWVX_&LGPW<VNI7L>HGPA?
MZ7=6T+":>]MR'3/6.+DLX)YR!C ]3BNS>:*.2.-Y$5Y"0BLP!8@9P!WX!-/H
M \DL-,U2V^''@Q7TJ^,^EZS'/=VX@;S40-+E@O4CYU/&?TK>MTNAXR\77DFG
MWR0W>FVT<)-NQ#NBR;E! ()!=1QU[9KO:8LT3RO$LB-)'C>@8$KGID=LT >1
M6%CJ6B:?X0U*[T#4;^TM])_LZ]M((F,]M)E6#A."P^4@X^M:^I6&!X6ET_P[
M<V5NFN"^E@CMB7CC,;J9) N0&+,#C).",\@X]&>:*.6.)Y4623(12P!; R<#
MOQ3Z "N&\5W*6GQ+\%RO',ZB+4 ?*B:1AE(^=J@D_@*[FL:_\/07_B/3-9DO
M+I+C3UD6")"FPAP ^05).0!WXH X>ZL=6L)=:URRTJX:WU36K9S$EL'GAMT0
M*TZ1L.'+ D9&0#G&:S]1TS4WT;XB6D.BZMG4A$UF94:1I?W*+C.22<@_3&#C
MI7L-% '$^+X;FYT[PM>VMC=SI9:M;W,\4<)\Q(PCJ3LZ\%AQ47B_3]237-'U
MG1?W%[?*=*ND9@&$4BEP_&06B*LW';/:N[K'M?#EM;Z]<:N]W?W,TI)CBN+@
MO%;Y !\M.BY _GC&30!IVMM#96D-K;H$AA18XT'15 P!^0KE?B3!<W?A/[-:
M6EQ<SM>6SB.")G.U)D=B<#C 4UU]% '&S)-)\5]/OUL[LV@TB6W,YMW"+(TJ
M,%)(XX4UG6$%]H;>,-+OM.O+L:E=SWEE+# TB3K*@'EE@,(5(V_.0,8/2O0Z
M* /-M$T.^T+Q%X-M9X;B9-.T66UN+E(6:-9&\LA=P'3Y6 ^@K,O=.U&;X:^,
M;&/3+\W=YK$\UO#]E<-(CS*RL!CI@$^W>O7** &QN)8UD4, PR RE3^(/(IU
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 4-:U";2]+DNK:QFOI@R(EO".6+,%R3@X49R3@X )KG
M!X]BAB\2_:[6+S-"6-Y3;7'FQR*X)'S;05P00W'&,\UJ>,-)U+6O#TEGI5Q%
M%<F6-RLS,L<R*X+1N5!(5@"#@=\5AVGAOQ)9:SKNHPC1D&HV]JD=N"Y1#%D&
M,_+RA5B-P&?]D4 :-UXO;3]$O-7N[:U:QA6%H;JVN_,AE$C[,EMHVA3@DX/!
MS[5)-XJ-CILM[?6]NL;310VDD%UYD5R9,!2'VC !)SUP 3SQ63I_@V]T>369
M](M=.LXK_P C_B5F5GMB5<^<Q^3Y=Z';@+C@$^@I'X;W$>G:K'I<T&DO)>6]
M_IUM$[2P6L\7);! P')P0!@ #KTH OS_ !!FM;;7GDTE9I-*M?MBO;W):&>/
M!SB0H,,,<K@]JK:UXL\3I::3-%HUO907VIV<,<DEYN:6.0AB,*AV=-ISG@\
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MB+3;:\WRQAV:2=69%(/ 4!>>YSQC'*R:[KLE_9Z') L6J?V<+R\>R"2!6+;
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M>ZFE$5W;M \J$!\$8STQG\,5B6?@V[MM:LM8D\07,]Y;6+61+6\81T)5A\H
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M&#E1C'0#OUI9M,M_#>L:UXJDO[H6MS''+=6L<(D&Z--@88!8_+C@=QFNFHH
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M JX 3<=ORCM^/-3^"=!@T32;B2&VDMOM]U+=^1)UB1V)1,?PX7!V]B6KI:*
M*.LZ5;ZYHE[I5T,P7<+0OZ@,,9'N.OX5DIX+TU+_ $&\W2F;1XGC1B<F;<!D
MR'^([AOY_BYKI** ,2;P^TOC&V\0_;"K06CV@@\O(*,P8DG.<Y45B/\ #S/A
MRXT)-9N!927GVJ-6A0F+]]YVT'C/S]SGCCBNVHH PHO#TB>,#XB>]#2-8K9-
M"(L+M#%\@Y)SN)_#CWIWB#PZ-<N-+NH[Z:SNM.N3/%+&BMG*%&!# CD,?I6W
M10!RK>#7:3Q*YU,_\3Z-8YLPC]T!'Y0*\]=OKWY]JJW'@*7.D76FZ]<Z=JFG
M6:V/VN*%&$\ Z*\;9!]<^I/MCM** *NGV8TZP2!KB6=ERTD\Q&Z1B<EC@ #D
M]  !T& *\\\*Z8^NVWC&P_M(1V%[K5T)HDC!D:)MH)1\\*PR,X/?!%>FT4 8
M$'AD6WBU=<AN@B+8+IZVBQ#:L2L6&#G.<GZ8[=ZI_P#"$K"-8M;+4I+?3-8D
M>6ZM1&&*LXQ(8GS\FX=<AL')&*ZNB@#DK_P.#K-OJNA:M<:)<QVRV<@@B21)
M85^ZI5P0"O9J-5\#_:KK3]0TK6;S3-5LHF@%XJK*9HV.YED5AALMEOJ2:ZVB
M@#E+_P $_:FTJ\@U>ZAUG3G=TU!D5VEWC$BR)@*5.!P,8P,8Q5=_A]%<Z?XC
MM;S5[J?^W&625A&B>4ZJH#* .Q0<>WXUV=% '*VWA*\C\00Z[<:_/<7\=DUF
M2;=%C8%@V=HZ<@'@Y]\<5 G@&-/ 4/A7^U)PELZ26]TL:AT9)!(N1T;##\OS
MKL:* .5@\'3P:KJFI-K=Q+<:E:);3AX4VY4, P  Q@.<#/US6MX=TC_A'_#]
MEI(N#/'9Q+"DC+M)51@9]\5J44 >:>&-/EUN3QK9)J8AL[S5YEE1(P7:)HT4
MM&V> PRN<,..,&NJ@\+):>*;?6;:Y$45OIXTZ.T$7RB(,&'.<YR![8[=ZZ&B
M@#E3X,\F;6$L-2DM;'6':2[MQ$&*R,-KO$V?D+#KD-SR,5<UKPEIVL^&H="(
M>VM;<PFW:$X:'RR"NT]C@8SZ&MZB@##\1^'%U_2[;3TN?LD4%Q%.NR,-S&P9
M1C/ R!576/"3Z[%?V=]J ETZ^DCDDMV@!:,J%'[M\_+G9GD$C)QBNFHH YR3
MPE#<Z]J^H7=QY\&J6:V4]J8\+Y:[L8.<Y^=L_P!*BL?!Q@MM*LKW4I+ZQTF1
M9;.-X@K[D!6/S&!^?:#Q@+R 3G%=110!QLW@(W&@^(-)?56\K6[I[F=Q -T9
M<*&"\]/E&,Y[U;U3PI<:O97UA=ZFLEC?Q+%/"UL#MPH4M&2?E8X!Y# $ @5T
M]% %2YTVTN])ETR>(26<L)@>-C]Y"NTC/TK"L?!Q@MM*LKW4I+ZQTF19;.-X
M@K[D!6/S&!^?:#Q@+R 3G%=110!A:9X>ET[Q+JVLF^\TZGY7FPF' 3RU*KM.
M?0\YSGVIWB+P\->.FR)>RV=QI]V+J&6-%;G:RD$,,8(8UMT4 <N/"$@O/$-R
M-3);6X4AE#0@^6$0H".>3M)SGOZ=*9!X,:!_"Y&I$CP]&8H 8!^]!C\KYN?[
MGIWY]JZNB@#F3X3:YNM/?4+_ .UQZ=>->6V8 LJL=V%+YY0;N@ )VKDG'-CQ
M3!-=6=O# FI"19UF6:P$1="AR,^80,'IT.1D5O44 <.L5_<ZY8ZMJVF:I=RZ
M>L@M(XK:&)$9QM9V_?,6;;QU Y/%9NC:#>Z'<^1:KXD_L)9C-%I1CMML;;MV
MT2;]^S/.W/USSGTJB@#S:ST*[T[4[MK*+Q'!H]Y<-<SZ6L=L4+L<L%<ON5&/
M51[\U?BM;RV\0ZOJUK8:Y'_::IYMNT5NR"1$\L-GS,_= XSU'X5W5% 'FEOX
M=>TT30K2#3];2]T)B;&]\F#<%(PR.OFX96!P<8Z#I4VI:++JNE:W;W&F:P+S
M652.[ND@@&(T&%1%\WY0.>I)RQ_#T6B@#AC!?/XETW6I--U8RV-J]L(Q;PA7
M5]I8G]]P?E&*VKK6;V:UEBBT+58W=2H<QPMC/MYHK?HH X72]/6R\%+X5N]"
MU>]L%MS;$M'"K-&1CG$O7W&.U2Z=:7+7VD-J-AJUU_9N4M7EBA386&SS)")#
MN8+D9  Y)QG&.UHH Q?%6@#Q/H$^D-=-;1S,A>1$#-\K!QC/'51^%1#P[./%
MC^(?MZ_:&L!8^5Y'R;0Q?=][.=Q/?IQ[UOT4 8WA;0!X8T"#2%NFN8X&<I(R
M!6PS%CG''5C6>?!OD3ZPNGZE):V.L.TEW;B(,5D8;7>)L_(6'7(;GD8KJ:*
M.<A\)QVOB33]5M+D00V%B=/AM!%E1$2IZYSGY5Q].]4+KP&QN=<_L_69[*RU
MM7-Y:B%)%\UEVLZ$\J2.HYS[<8[*B@#BY_A_(ATFYTOQ!>V&IZ=:+8_;!%&_
MGP#HCH1M.#R#V]ZO3>$GDU+0[T:I*9=)>60-+&&:=Y%*N7(QC()P  !] !73
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 <5\6HEE^&.M%FD79$K#9(R9.X#G!&1ST/%#SM
M-X_A\*FXO(["'23?#;=2"29VEV<R;MY"C/&?XO85U6J:99ZSI=SINH0B:TN4
M,<L9)&X'W'(^HK/E\)Z3*+$^7<)/8AA;W*W,GG*&^\#)G<P/<,3F@#-\"ZAJ
M%Q'KFGW\\ER-+U.6T@N9.7DB 5E#'NP#8)[X]:YKQOJM]:V/BG4=,U2\FGTY
MX-C12&*&R("$QD XE9MV3E< ,!D8%>D6&G6NF6OV>TB\N/<SMEBS,S'+,S'D
MDDY)/-8M_P" _#NISZE+=64C?VD!]JC6YD6.1@  VP-MW8 ^;&: .?\ &6J7
MVDZK>W-^NH_V"T"1I?Z9<-NTZ3DLTL2D;@=RG/.!QWIGB/6KK2]=NKG4S?KH
M4LD'V75-/N&*6?"92>)2/E8DG<0>' ],=7+X1TF83JZ7/E7,:Q7$7VJ0I,H&
M '!;GCJ>I[DTZX\+:5=3W4DL<Q2[='N(//?RI2BJJY3..B*, #..<T <K))K
M/BNX\20:???8KS3[XVUM(+Z2/[.%52&:)5*R!B6/S9R#CC%-6VU#6_'MWIL_
MB'48K;^R+6[_ - G\M?,,C@E..%.WIW!YKH]2\"^'M5ULZO=63_;'4),T4[Q
MK.HZ"15(#CZ@\<=*T(O#^G0Z_)K<<<HOY(1 S^>^TQ@DA=F=N 23T[T <O\
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MM<Z1<221+(=N]7C"L%.0" QYQ6T?#>E/IM]836QGAOP1=F5V=YLKM^9B<]
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M,YGO/*D9,= B*PP<*JJ,\9P3QG% '344B@*H4= ,"EH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV.&.\\]NPK9U75O$]IX@T30[.YTMGU&TN9//DM7 C:,*0=OF'(^<#&>V<]J
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M'H?:L.Y\9^*(/#NM:V6TORM'U:2TDA%N^;B-9%0X._Y#AB?XLGTH ].HHHH
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MW]R8!+#$#Y2[R@D<9R%)'UY'&>* .JHKG4\6I]IU>&;2[^ :6RF9Y8QAX6W
M31X)W+E&]\#H3Q701R)-$DL3J\;J&5E.0P/0@T *VXJ=I ;'!(R :Y_PMX:F
M\-OJI>_6Z74;Z6_<>1L*228R!\Q^7CCO[U8TKQ"FJ:[K.E"TF@DTMXD=I&4B
M3S%W C!/&,=>>>U;- '&3>!9I](\2Z<VJH$UZ=II7%KS%N55(7Y^>%'7WIU[
MX*OSJ]OJ^D>(9-,U#[,EK=LMJLL5RB_=)1C\K#)P<FNQHH I)IJC1VTYYYW#
MQ-&\S-^\8L#N;(X!))/ P.PKE-/\ 7ED_AUV\122'0E>*W M$4-$R;-IYZX
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M<C)4@X]J-0TFSU72I=,O8WEM)H_+D3S7!=<8(+ Y.>_/- '->+[K4XY]-O\
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M]C4] &!@=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 9+-% H:65(P3@%V R:!-$9C")4,H&2@89
M ^E<?\5XQ)\,=;^3=LB5^F<8=23^ !-9TU]H^I?%ZS$=Q9W44^@SQ'#*ZR$R
MQG;GH3C)QZ4 =\MY:O*D2W,)D<%E0.,L!U('>B6[MH9HX9;B*.63A$=P"WT'
M>O$-,T73IOA)X3U+3((1XB%[;K:W,?\ KF<38="W4J$W$KT 7VKI;8VE_I?Q
M#M/$ C%['=SLWG8WK;^6/L[+GD  97'\6>YH ],DN(83B6:-/E+_ #,!\HZG
MZ"G1R)-&LD3J\;#*LIR"/4&O*=(TW[9XS\)IX@M8IM0D\-.;M9T!:1P\6-X/
MWB.>O<>U='\+O+3PI<V\.T0V^J7L42+T1!.^%'H,&@#H+C5_^)]%HUJ$:Y\G
M[3<,W*PQ9VCCNS$$#_=8]L&[]NM-F_[5!MSC=Y@QFN0\.B1?BMXU$^<M#8-#
MGO'Y;@X]MVZN;U?P^\FH^)? UK;(D6LE=6LI3'E+<_\ +4GTQ(B8'_37T% '
MJK7$;?)'-%YK)N0%LY]#CTK(3Q!%IECI,>N7MC_:-\PA'V5L1R/@EBFXYV@#
MJ?ZUA>&[A/%>@SZ_J=BB,]C]B,4T8P"@/G=>QDRO_;,&N2L/L*>#?A9<WGV<
M0+<JDDLVW:!Y$O!)XZ_K0!Z!I7B6>?Q/XCT[47LX;;37ME@E4E=PE0M\Q)QG
MH.,5T<]Q!:Q&6XFCAC'5Y&"@?B:\MO+#2]3UOXF/<V]O<"*QMVC\Q0PC_P!%
M8Y&>AX'/6I?#U\\OB7P:NJ,'LKCPQ&;-I>5>[.PR=?X]F/?&[U- 'IAN8 (R
M9HP)/N9<?/\ 3UJ.?4+.U@GFGNH8XK=2\S,X C ZEO2O'[R#[#H%_)\JZ+:>
M,+>2S=ON0Q"5/,VGH$#EQZ#FM:]NM.O_ !IXTC@EMKCSO#T>T(0PD9?.SC^\
M1QTZ4 >CZ5J=KK.E6NHV;[H+F))4]0&4, ?0X(XJ:2\M8KA+>2YA2:3[D;.
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MQC.:Z*6ZMX)8XI9XHY)#A%=P"WT'>O([=+<_#SX73LL9E74[)$<XR,J^0#^
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M4O"$^EW%@4ETZZC5H'7#+B/RUX_X%@?6K_Q9BMG\&1RW*H%BU"T82,<&,&=
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MC"KSUX'%8DGCCP_%I5EJ;WCK:WEQ]EB?R).)=VTJW'R$$$?-CH:YJY\90_\
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MHUO<K9RP/$RRK,Q 5-F,DG(QC@]<XI)?&FB6^EZE?W$TT46F2>7>(UNY>%L
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MM?\ !=SIUU-J$TEU':3B)FAG69V993)C:N"^2&((V\9XKU$$, 000>01WI:
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M"/YE(]1GJ:Y[3/"?B>&\\+WEW:Z8;O3)YC>W'VIWDN]\;(922F<\YVGZ944
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M,V-W)(C+(^W=L91RF1TSU]!SC*\)ZG8^&M+\53RJD<(\2SPQ1@A 7<QJJY.
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M012Y!6,_)&3C')0;O^!4 =1J.MBVU:UT>T@6YU&YB><1M)L2.)2 7=L$@98
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MQ0O)%?V]TYFE*#;'('(& >3C% %>QDM=*UF_T_0]&@75)8DOK^%;DI"A;*H
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MUK5BT2:]U6TUJZU"VNI[6WDCLFA@*QH9,;I"-YW$A0." !GUKH:* ..M? ,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
MUH **,T4 %%%% !1110 444=* "BBB@ HHR,9S10 44=:* "BBB@ HHHZ4 %
M%%% !1110 444=: "BBB@ HHHH **** "BBC- !1110 4444 %%%'2@ HHHH
M **,T4 %%%% !1110 4444 %%'2B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMI>L:3IQN;"[N0)+<Q*NVV+$>8)"_+@ $C&#R.V: .]J.*"*%I&CC56D;<[
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MVWES'<9\/L4=8MA ^T+D$9(//3Z^V2 =[15/5OMXTFZ.E&$7XC8P><A9"X'
M(!'!Z=:X:V\>WDS>"[EIK46>L@Q7J_9VWPS8P #NPH,@*<YY'?F@#M]1UG3M
M)>T2_ND@:[G6W@5@29)&. HQ[FKU>;^+[N^OM(T:Z9H'5_$]J+,!"@\L2E5+
M')SG&<@=".*M/XQU/0YO%5OJYM;Q])AMY[>2"(PB3SMP5&!9L891SGH: .^J
MCJ&LZ=I<UG#>W20R7DP@MU(),CGH!BN:_M'Q8NH7$#0#[#)9/(M\UNJ&VG'0
M;/,.Y2.GH1SFN2$NI7/P]^'MU/<QW%U/J]E(C.A7DHY^8Y.XYYSQ0![!17 G
MQEJ>C?\ "4V^JFVO)])>U^SRP1&%9/M'"*REFQAN,YZ5:;5O%EM>7ZO:1O8K
M8/<17<UN$\N=?^6;()"64CD$$$=\T =I17+^"K_7]8TBQU?59[$VU]8PS1PV
M\+*Z.RY8EBQ!!R#C QTYQDU?B+<:A;V&BBPO!;";6;.&7]WNW@RK@=1QD<CO
MTR.<@'20ZSIUQJ]QI,-TCWUO&)980#E%)P"3TZBKU>=S1:N_Q3U*/3[NTAN_
M[!MMUQ- 77(EEZ(&'4^K<>]3:5XYO=9TCPV(K<1W^JV<EU,8H]XC$956VJ6'
M5F&,DX /6@#OJ*P_"UYK=YIT_P#;UBMM=0W+Q(Z@ 3Q#[DFT,VW(/()Z@U1\
M4ZUK.G:]X>T_2S9;=3FEA<W$;$H5B9PP(8<<=,<XQD9R #JJ*\^M?%/B2#_A
M)-(OO[,DU326MWCO#F&!X)3]]@S<%0&)&[G 'O1_PF.JK;>,TAD@FDT2T2[M
M9I[5X_,5HW<JR9'=#AAC@CKW .RU?1=-UZP-CJMG%=VI8/Y4HR-PZ&KD,,=O
M"D,,:1Q1J%1$&%4#@  =!7F6O7_BR3PYHU_<:G8PPW]_INR*WMFW*'=2RLQ;
MD9P> ,\C@5TC:YJFF>.+72=6N+,Z;>V;R6LZ0F,F:/!D1B7('R_,/;/IR =9
M167X>NKV_P!&AO;XQ[[@M+$J1E-L1.8PP)/S;<$^Y-8WB+6=<M?%VBZ+I;V"
M1ZE!<L9+B%F,31A3GAAN'S]..G6@#K:*\ON/''B6QT+6(KB/3VUC1]3M[.9Q
M$PBN(YF0(ZC=E&P_/WAQ6[+K.O6>K0Z%<S6]Q?3QS7?GV=J?W<"LBJNQG^]E
MSDY(P.G.0 =G17G]QXPUS2-%L;CQ)9'34:\E@NKZ.#S42,#,<I16;8'. <DX
MP?4$7?\ A*+V0Z1I]O/;W=U?PSW)N[*,21F%'"J44OC)WKU)Q@]: .SHKSRY
M\3>+['3=+-Y8V=O=W&N+IK>:AQ/"V2DJA7.PD#!4Y[]*BU3Q!XABTCQWI\U]
M;"]T>S6YM[RWMRF5>)WV[2S8(*$ Y/4&@#O+S5++3Y[."ZG$<EY-Y%NNTG>^
MTMC@<<*>M7*X;^V-7T>U\%V_G6DT.HS1VTY,#*P7R6<;3O(S\N#QS[50O_%'
MBE+7QC<6\^EHOA^4L@:V=O/01+)M/S_*<$C=S]!0!Z117)OXCN[[Q'IFD6Q2
MR6\TIM0$\B;]S;E C49 XW;CWQCIUJQX%UK4O$/A:WU74UMDEG9]J6\;(H56
M*Y^9CD';N!XX(H Z2J-EK.G:C>WMG9W233V3*EPB@_NRPR 3TZ>E<SXTGU./
MQ)X1M[*^6WAN+]UD1HMX8B%V!/(R!CIQSSVK"FN-9L?$WQ%OM)N+.*2T2UN&
M-Q"TGF%+4-M ##:#CKD_2@#U&BN+'BR]U6:PL].B:&>XTF+4I72$3%/-R$4
MLO&5;)^GKFMWPS>:M?:!;3Z[8+8ZD=RS0JP*Y!(##!/!&#C/&<4 6[G5+*SO
M[*QGG"7-Z76W3:3O*KN;D# P.>:N5S>LZU?Z?XS\-:9";<V6I-<+,&C/F QQ
M%QALXQG';MUK,T?Q=/J7B<Z5-=P6=]#=3)<:9<0%)&@4/Y<D3$_/G"$D9&">
MF* .WHKAO#WBZYUS5OL#WMO::C$\JW>EW%N4FA W;&0D_.OW<D9SG/R]*J6_
MC769? VA:VPL_M-WJRV5P@B;84-RT.5^;*G SR3S0!Z)17#:AXEU^].L-X=L
MQ-)IMR;:.%H0RW#J%+AG+KM^]@8'&,G.<!FI>,[NVUXZ7<S0Z-<RPPO8K>PE
MHKIF&73S00H8'Y0,]>?F!Q0!WE%%>:Q>([_0M0\?:OJ-VMW:Z5)&$@$6TD>2
MK(BG/RC+XZ'J30!Z539)$BC:21@J*"68] *Y"\U[5]"U/P__ &D]M<V>KSBT
MD\F(H;>=E+)M.X[D.T@YYZ'/:NQH IZ5JMCK>G1:AIMPMQ:2E@DJ@@-M8J>O
MN#4.CZ!I/A^"6'2-/M[..5S)((4QN8]S7EGA_6O$/ACX8Z=KT#6$NCVMQ(+F
MS,3><T;7+JSK)NP"">%V]!U[5UFH>)?$%[_;#>';,32:;=&VCA:$,MPZA2X9
MRXV?>(&!QC)SG  .YHJ*WD>:UBEEB,,CH&:)B"4)'()'''2I: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0NO.M]:M8[6:!(MI01[MK*V3SEB>G4"NHBFCG4M$ZNH9D)4YPP)!'U!!%/H
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M/I]F4NKZ6^NI&WS7$BA-[8 X5>%    'XY))KD?'4N/%_@I(KR*VF6]F??(
MP4>2X&X9'!/R]1UX.:[QF"J68@*!DD]J2.1)HDEC8,CJ&5AT(/0T <EJ7@1=
M4M-1:74GCU2]N8+AKN.(!4,!!B41DG*C!."3DL3GIB.7P+<S3:_-)KTKOK=D
MEI<[K9,+A67<H&,<.<#/U)KI]5U :5I=Q?&UNKL0)N\BTB\R5_95[FG:9J$.
MK:7::C;!Q!=1+-&)%VL%89&1V/- &'J'A)M0\)Z?HS:B8Y[![>2"Z2$??A(*
MDH3@_=Y&:RO$L6F>*KFV\)2/=7.I6=S!/<3"!T$2 ;G8N%"_.A9, ]7]CCNZ
M*      8 [5P/BN5F^*'@]+:]@@G2&]R9%WCYEC #+D'G!QR.1WZ5V6F7LNH
M6"7,UC<63LS P7 &\88@$X)'.,CGH:;K6J1Z)HMYJDL$T\5I"TTB0A2Y51DX
MR0.@/>@#G=0\"B_TB]M3J.RZO[V.]N[KR,EWC*E%5=WRJ BC&3P#SDYJUXC\
M*3:U=Z=J=EJTNEZS8!ECNX8@ZNC8WHT;'!4X! SQ6[I]XFHZ9:WT:LJ7,*3*
MK=0& (!_.IHYHYBXCD5]C;&VG.&]/KS0!AIH6HPQVS)K;2W"^9]J>YMPZ7.\
M*.44J% VC&/QSDYQ9/AO#!IVF+I&JS:9J6G33307<,2LH\YBTB&(\>62>%SQ
M@<^O;--&LR0M(HD<$JA/) QDCZ9'YT^@#E;WPA=7]GIB7&M/+=6>H1ZC)<20
M ^=(@P%V@@*F.,#GCKG))/X,%W>^)9KB_)BUZT6UEC2':8E5&0%3DY.'.<CT
MZ5U5% ')OX/NYH/#Z3:R99-&G6=7:V \TA"@& PP-I/J<]^U-E\%2RVOBBW.
MJ*%\0$^:?L_,68Q&=OS<_*!U[_E7744 >6>)8TM];T[3+W7AIB6&GK'%/=Z8
ML]M<LQP2H;(5U"*#\V3NX &<]KX2DU%]+D6_N8[M$EVVUREH;;S8MJ\^62<8
M.X \ @ @8Y.]10!A^(?#K:Y-I=S#?/9W.G77VB*18PX.49&4@^H8\]JH'P=,
M9_$TO]J G7HEBDS;_P"J"Q^6"/FY.W]?;BNKHH XF;P%<H-&NM+U^73]5TVR
M6P-TENKK<0+C"O&QQG(SG/4GVQUFG6;6%DD$ES+<RC+23RXW2,3DDXP![ <
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M96,IEL]2&,[HCG"D#G;@8![UO67@+0K"?3)HDO&DTS<MJTEY*_EJ0!LY;[N
M/EZ<5<T_PMIVG2631FXE%@K+:+/,9! "-IVYYZ<<YP.!@4 5_&,NK0:7;RZ3
M;O=,ERK7%K#/Y,L\(5MRQMD8;.UL C(4CO7.6NO6VIZ5IHL=7U,";5)8I+"5
M&6\<JC,;<L6!39PQ8G[HY///;ZEI4&J+;><\\;VTWGPR0RE&5]K+GCJ,,PP<
M@YZ5EW'@G1;F.#?'<+/#=->+<Q7#QS&5AAF+J0>1P1TP .,"@#SW5;F]U+X>
M:K'?W5T7L/$RVD7^D,6$8N(P%9A]_ 8C)ST!ZC-=G/->67Q,T73H[^Z:QETR
MY=H)'W*61HP&)ZD_,>I-7/\ A _#_P#9NI:>+:86VHSBXG7[3)D2 A@RG/RG
M<H.1U(YS5U?#.G+JUGJ@^TF[LX6@A=KAVPC8+ Y/S$D DG)H Y'PWK%V=?L]
M(\0-J5EJ\L<V&\YI+341C.^%@<*0/FV@# /?C%'0K:6Q\(>/;RSO[V&YM]0U
M+RY!,6P4^8-ALC=QUQGWKN;#PMIVGM9F-KF06*,EF)IB_D!AM.W/.<<9.<#@
M8%1V_@_2K;3=3T^+[4+;4WDDNU-PY+M)]\Y)R,^V* .:M=8U#4[GPYHIE+&X
MT%+Z5FO'MWGD^1?]8BEN,DD#&<Y/2DAO=<L=3\-^$]7U59IKN:Z:>ZMY")'B
MB4.D1? (;#KD@ D+[UT&H>!-#U+3=-LIXKA?[, 6RN(KATFA&,8$@.[& !SZ
M5+>>"]$O=,L[%X)D%E)YUM/'.ZSQR=W$F=Q)R<DDY[T 8W@FV^Q^-/&\ FFE
M"WEL0TSEVP;=2 2>3C.,GGBFZ_9K-\6?#),]RH:QO"52=E7Y3%C !P.ISZ\9
MZ5T>D>&=.T2_O;ZT%R;F]*&XDFN9)-Y50H)#$C.!UZ_A4FI^'M.U;4+&_NHY
M?M-B7\EXIGC.'QN4[2-RG R#QQ0!Y;=M?:?X6\=ZY8ZI=VMQI^O7$T,<+A49
MAY6=XQ\P(XP>*ZN_NM4\0>)M?T6SG^SM800B I>O;LCR(6\W"H=XS@8/'R].
M:UY/ VBRZ7J>FR)<M::G.;B[0W+_ +QSC)SG(S@<# XHU7P-HNL7UM?W*W<=
M[!%Y(N;>[DAD>/\ N.R$%A]: -30_MPT2S74[F"YODC"7$UO]QW'!(Z=Q^=<
MCX=FO?%/AS3O$JZY-8W)O6EG3):$0K(RFW,>0H^4 ;L;L\^U=U;V\5K;16\$
M:QPQ*$1%& J@8 %<_:^!="L]:EU2W@GC>6;[0]NMPXMS-U\SRL[=V><XZ\]:
M .<34=0U_P ->*M9BU&YL[[3;RZBM%CD*I"(!\H=/NMNQEMP/WN,8%,T_4-4
M\2^*]'CFU.^LK74?#0OI;6W<($D+Q@[3C(^]UZ^A&:ZR?PAI,]W?3[)HUU#'
MVV"*9EBN3C&74<9(X.,9'!S5AO#M@VNIK*B9+U+8VB,DI"K$2#M"].H!Z=J
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MW));)^;C&!79V_@+0+37)=5M[>>.26;[0]NMPXMVESGS#%G:6SSTZ\]:;>^
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MXCW6G3WEVMG/H$=Q]F#[/)D:5E)4K@@X'7K6O%X.TB%Y52.?[++<&Z>S:=C
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MMJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?PK9?1-)DBFB?3+)HYWWRHT"D2-ZL,<GW-7Z* *2:-I:74=TFFV:W$2A8Y1
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M"&UM+:RA\FTMXH(LD[(D"C)ZG KG]0\*OJ5S)+<RZ;-N8D>=I:2$#H!DGG@
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MUG@8]2KYR,^@X]JM7G@?1K_0HM*N!=.(IA<1W9N7-RLP_P"6GFD[MW;/IQT
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M0YSLVX]1G/7\.*K67@S2K!(;>$W!L()_M,%B\F889,[@5&,X!.0I) /( P*
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MO'_C#[+JES9;=+LW$EKM#,0)BO)!X^G7U]>L\%ZG<ZSX)T74KQ@US<V<4DK
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M5I'B'6M;T77)+>/3(K^QU*6SA\UG\@HA7+,1SD@MTQVKJWFCB!\R1$PI8[F
MP!W^E>(7D>F'X6^.8;86QBM_$$CPJA4B,&:(*5]!C(&.W%=C=Z1I>H?&::*\
MLK>X230%>2*1 RN?/(!93PQQCKZ#TH [\R1K%YC.HC SN)XQZYH62-XQ(KJT
M9&0P.1CUS7CFEW*6WPY\$7$UY"+>WU>16MIYE19T5Y@JAF(7* !@&('RCG.*
MTX=!LIM(\4WT&HZ?8G5+^(V\D1CF$&7C"I(5)&'D&2N<88^IH ]/BFBF7=%(
MDBGNC BG$A5))  Y)/:N%\-:['I<NOKXDM-/T:\LY8#>74,H6UG+KA'4M@J2
M  0>>GK7<.D5Q"4=4DBD7!5@&5@?YB@#D]:\:"+P_8ZQHGV:ZMKC48K-GD8X
MVM-Y19<=><D'/3!KK4ECDW;'5MIVMM.<'T->(V2:?_PIO18H?(6<ZQ;+<B(A
M7_X_& W$<@X!Q]*U]9@?0]?\;P>'+=;61O#T-PL-H@3]X&E!< ?Q;>_7I0!Z
MLDT4K.L<J.R'#A6!*GW]*R_$^NQ^&_#UUJDD?F&(*J1[L;G9@BC/8989]JY/
MPW#X9U'7M'UK1M<6:X^R/&MM:+$F8B,XF51D!3C&<88X[U;^+4%M)\/[N2XB
MB9HY[;8TB@E<SQ@X)Z9% '06%UJD-S=KK,FG?9=R?9+B F/S,@[E9&)P01U#
M'.>@K6DDCBC,DCJB#JS' 'XUYUXF.BQ>)+K3$BL[::+0W)^U8$"Q.[<1Q<9<
ML.3D8^7KTK%\/:]9H? 2ZU=PMI4FB,D<D[@Q"\ CX<G@,$W 9_O'UH ]2O\
M6;#3?L8N;A%:\F6"W4$9D8^GL!DGV%6VGA618VEC#L,A2PR1]*\MUW3O#=I9
M^$5T]89-*3Q'M$LS!X]K)*656/'E[N,=,BI-9>32]6O-7AAL=:T!]1M6GA4;
M;JQF7REC,9Z,OW"%X/S<=2: /4JCBGAG!,,J2 '!*,#@^G%87CJ[LK+P/K$^
MH"Y:T%LRRBV?9(0WRX#=NO7L,UQ5F]BWQ U2SDFTIH;GPXFZWM"/*++(^%Z_
M.P7O@<8X% 'J2SPLZHLJ%F7< &&2/7Z5A^,]?F\.>%M0U*T%M)=VT#3)#.Y
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M%9M>J)99C;QL5;RWE&<QA\;2_!^7.>#Q0!<BTZQ@NGN8;.WCN'^]*D2AV^I
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M;MZ\CM6=H6DWFC:[\/[+4(9I)K'2KF&>01,Z0NXCVH7 P. RCGM7JE!.!DT
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MX9&Y&0PY!ZB@"I\,L[/%8-L;8CQ!.#"6!V'RXN,CJ/3VK2U;QA/8>(9=#L]
MOK^]2R^V((I(U61-X4X);COUP?0'.:3P9I.K:7-K\FIV]O$+_4Y+V(13F0A6
M1%P?E']SK[]!3CI6H_\ "S1K0MU.G_V5]B+^8-V_S=^=O]W''KGM0!4U;XC:
M;I,=Q<M&LMG:7'V>Y9;A/-1MP5BL75@K'!Z'@X! S4EWXYDBO]<L[30;VZET
MB*.:4B6-5='5FW*2WHO ZGT%4M.TSQ=X?U/4M.L+:PNM)O;R6[M[V6<H]GYK
M%G5H]I\S#$D8(SW([3KHFK1Z_P",+S[(K0ZK:PPVI\U<EHXW0EAV!+Y[\#\*
M -1/%=M?)I,>F0M<W.J6GVV&)VV!(,*=\AYVC+J. 22?8D<IX*UJUT/1_$,]
MW#]F:7Q)<016[R*,2$)A=Q.   3G/0?A3],\,>(M!N/#.JVEI!<W%EHZZ1?V
M;7 3**5(DC;&/O#H<<5%_P (?XG.G:A<1+8V^IQ^(&UFQ0SETD!7:8W.T8!4
MMS[]J -2X^)MG::;KUQ)8237&BA'GBM9DD1T<?*Z/D CL>,CTK3D\8&V81WV
MF26$T\YCLUNYXT6= H8R$Y.P#."#SD@8K+\0:=XI\4^!=7L+K3K2RO+R$0PV
MJ70D"'.6=Y-H_!0#CU.>+GBC2M=NI]#U[18H#J>F-)OL;F3:DT<B@.F\9P1M
M4@]./PH +'X@Z?>Z?+*L$GVV._&FBT1U<R3GD;'!P4(RV[T!XXQ5#P\9C\6_
M$7GV8M9?[-M2P63>KG?)\RG XZ#D#D'ZU)KNC>)M;L-+U806=OJ^FWZ7D.G^
M>6C*!2K1M+M'S$,3G&!P/4FWHVFZX?'E]KM]86]K:W6GPVX07/F2*R,YZ!<'
M[WK^?8 H^-7^R^._!5Y#:27-P)KM%BB(#/\ Z.V!DD <GJ3QS4S?$41:+K-W
M/H5['>Z*ZC4+ NA>-&&1(I!PRXYR.P-:'B;2=0N=>\.ZQ80I<#2YYGE@,@1W
M62(I\I/&1G."1]:72]$$.J:YK&K+#&^L>5";9F#*D2*556/0L=S$XXY YQD@
M&E_;&[4M/LXH5F^UV[7!ECD!6-%V\].02X ]>?2LOQIKVH:%%HXT^U68WNIV
M]J[,X7:K,,@9[D C/;.:J?#K1I-,TB:26[-W$)&M;&4]19Q.XB'OU8Y[@K5[
MQIH]_JUCICZ;'%+<6&IV][Y4LFP2+&W*[L'!P: .<6\N=+^)GB&XL](EN[E]
M)M)7MXI54 [I=V68X[ <=?S(Z!/'.G7&EZ1=VQ3S-5MS<P1W,RPA4 &XNQSC
M!8#C))/H"17MM+UB+QIJVL3649AN]-AMD$<P)\Q"Y/7'RG?@'VZ"L#3?"GBG
MP_I/A>]TZWM)]3TFTDL+RREGVI<1,RME),'!!4'D?_7 .U\+^);7Q3I<EY;1
MO$T,[VT\3D'9(AP0".&'(((Z@BL_6_&J:*NI7$NFSM8Z;+%%<SLVPDR;>8U(
M^< ,,\COC-;FDG4GLO-U2.&&YD;=Y$+[UA&!A=^!N/&2<#D^@K@/%/A3Q-K<
M/B>T-K97?VQD;3KJ:X(,$8V9B5-IVG*ME@1G=ST H Z/4_&,]GXBN=#L_#]]
M?WD-JEV!')&JO&SE,@LW;!X."<=,<UR>A>(9/"EMXMGAT*\O=/MM>N9+F6W9
M ((PL>2%8@M@<D#H.]=59Z9JW_"Q)-<N;.*.UETJ.S8I.&*R+(SGC ROS8SP
M<CI6?'X?URUM/%6DQ6T#1ZW=SSPWGG#9$DJ*IWI][<N"0!D'CD=: - ZSI5W
MXUTP0Z;)/>3Z5)<V=_N 1H24)4#.>25Z@5DZ=\0;V#P5<^(M6TF1XTOI(,6T
MBMM'GF)1S@D#Y1D D]<5H6_AJ[T_QAH$]I"&TO3-)?3_ #&D&_G9M..X 3GZ
MUAS>$O$8\ ZCX<2TM'D;43<6\HN<"1#=>?E@5^7CC'//H* .J7Q-J#7$-H_A
MV[M[N>681+/*OE^7&JGS&=-P7.X #KG/89K&OO'MS=:%X<U/1[ F/5=32SD$
MLBAHR'8,HZ@Y,;#/IS6EXAT_6[[6M'N+>T@N],1)!=V%Q/Y8\P[=CM@,'"X8
M8YZY&3C'.VG@_P 16OA#1K'[-9-=Z5KAOUC6X(6:/S)&/.WY3B3IST_"@#K9
M_$LK7-]:Z?IKWMQIT:/=QK*%VLR[A&A/WGQSC@<CGFLZ3XA6DJZ$VEZ;>:@N
MMQ2O:M&44;D4L4;<W!R,'/ YYXI+#2=:T#Q/K.H6UI%>VNL"*=HUG"&WN%3:
MP)8<H< Y'(Q]TUG:=X+U#0KGP7#;1QW,&C?:GNY0X7<\ZG.P'J S$\XXQ0!W
M%M=SS:3%=RV$T-P\0D:T+*75L9V9SMSVZXKD;;XDI/IFBZJ="OUT[59A;QS;
MT++*Q(1=F<G)7&>@)[CFNVE9EB=D0NP!(4$#)].:\WM/">NV_@7PKH[6D1N]
M*U.&ZN,3C:4CD+G:>Y(. "!T/X@'10>-5#:[%?Z3>6MUI$*W$ENA69I8V#%2
MFTX)^4C'8]ZDM_%4TFK7>D2:6RZE#8K?1PI,&$B,2NW<0-K@C&",<CFL;5M
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MB,[0D$B2-@=K# /Y&K_B[2+_ %&;0KW3XHYGTS4!=/"\FPR)L="%)&,_/GG
MXZTNFZ2Z>(M3\1ZFL=N]W!%:1P,X/EQ(6/SGH69G/ R  .30!;BU];AM&%O
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MAN50IP>XXKSO0K#4==\%^)="@M56.^U>^A-VT@VQHTS!R5^]N S@ 8/&2.<
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M;RY\E&"J200.O2N?N-2UFX\=>%X(KVWBM+K39KEX#;EAO CSSO&>'('ISU[
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M470 LJF59&,R>3YI7@C!P<;N@]#V .UEU;3X-3M],EO(5OKA6:*W+C>X49)
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M7<Q ]!0!@OX:O)_%6G:W<:E#(;6TDM9(?LN!+YA4L0=_RC*C P>.I/6LVV\
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M[;GB5]V-I)."5R 3UX(Z#0=?M?$-K<W%I'/&MO=26KK,@5M\9PW&3QFK)O\
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MKBT8V/[UDC#!4<^9@X!QD =*ZGQ'H5OXE\/W>D74DD<=PHQ)&<-&RD,K#W#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSM'(SD9/.<G/)- 'FT$6LVGA3Q=KNEZ[/9RZ;K&HW*6PC0PRA)"S"3(+'(!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFH>)]22ZOM.L8HI-0T^WCDFQ9S3)+*ZEA&NS[@P!\Q)^\..#0!V%%<'+XO\
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MLH8IW1Y40*S(I"D@=0"3BJVK6M]=0P"PN(8G24-(D\9=)H]K H0",9R#GG!
MX-237S0ZI:V0LKF19T=C<(H,46W'#G.03GC@]#5R@#@3\.WBTX6UC=6MF&UJ
M/5VA2$F*,H5(C09& 2N2?4G %6-8\#WNKWOB*?\ M5+9=8L([,>5$=T6PL0<
M[OF!W$$<<5VU% '(V'A?6+?Q1!KMQJED\BZ;]A>"&S,:</N4K\YP,]>OMCM0
MC\ W\?@6P\.#5+8M:7JW7VC[.V&VS&8+MW<<G&<]*[VB@!%SM&[&['..F:Y^
M?0+M_',/B*.Z@$<5@]D+=HSD[G5]V[/JH&,5T-% ' 6O@'5;&STE;?6+4SZ=
MJ-Q>J)+5FBD\XOD,F\'*[SM.:VO#?A>?1H=:M[Z]BOK?4KR6Z*>1LQYGWE;D
MY'Y?C72U32^9]7EL/L5RJQPK*+IE'E.22-H.<[AC)&.XH P=(\$6FG^"KGPS
M<W$MU!<QR0R2L<,8R-B >FV,(H_W<TOAK0O$>F>1!J_B"*_M+-=MN(K8Q22#
M&T&5MQ#8'8 9."2<4M]XVAME:2TT;5M3@6>2V\ZPA60&5,[EQN# 9!7<1C(Z
MUTT;^9$CE&0L =K=1['WH =7!7G@#4+CP[XCT2/5[=;75[N6YC+6I+0^8X=@
M3O\ FP1@=.O.:[VB@#E[SPO<:CXI@U:[N;=K==-ET^:V6)LNLA4L0V[C[N,8
MJOX9\,>(-#2WTZZ\0I=Z-98%L@MMD[(/N)(^[!5>.@!.!DXR#V%% !7F?ARS
MOM7/CO3[6\MHK:ZUF>&1RI:2(-%&K,O."2.!G&",\]*[W5-6M]+%LDBO+/=R
M^1;P1XW2OM+8&2 ,*K$DGM4.@W-M?61NH=*FTV3>T4D-Q (W!4X/3(8>A!(-
M &1%X/?1]=AU3P_/# HL8[">UN%+)(D?^K8$'(91QW!'IUJ3_A"K5O!NIZ#+
M+YCZDT\UQ<;<9GE8L9 ,\8;&!GC:.3UKJ** .33P- NJZ#J#74C3:=$\=PQ'
M-X6(?<_TE'F?4TW5/"VL)XIEU[P[K$%E+=Q)#>V]U;&:.79G:XPRD, 2.N#7
M744 <P?#-Z/%6DZQ_:*2K8VLMM(LL1+S&0J6;<" O*C  QVKIZ** .<N_#,\
M_C/^W([R);::P%C=6TD)8N@=G&UMPQG<0<@\5EVO@2YC\-Q>%;K4(I]"AF1T
MS$1.T2R"18F.<<$ %@.5&, \UV]5+[48-.\EKG<D,CB,S8^1&) 4,>V2< ],
M^F10!;KR[Q5=1WGCJ[B&N:%826EG' 8-:@($@?+L48.FY""H(Y&5Q@=_4:CE
MMX9RIEACD*'*EU!P?:@#B;;2M7\11^']0EN--@_LB[>1#;0/Y-TFPH"@+91<
M,<=>F1D$58UCP=J.H:OKEQ;ZO#%:ZQIXLI4EMC(\.%9?W;;@ #O)((/-=E10
M!QUAX1U*TU7P_?2ZE;2G2=/>R95MV7S=P09!W'&-@]<\_A4/@*^.@W5D-4MQ
M<OK7]LP2_9SL1_-\S8R[LD9XR"*Z;1_$%OK-[JEI#!<12Z;<"WF\Y0,L5# K
M@GC!'7%:U $<"RI BS2+)*%&]U7:">Y R<#VR?J:YK5?#&H7GBHZO::I%#%+
MIYL989K<R%%W%MT9W *QS@Y!' ZXKJ:* .%M/ VI6VD>%+%M5MI#H,ZR[OLS
M 2A49 OWN.&////8=*VM)T"ZT_Q7KNL274,D6J>3B%8R&B\I2H^;)SD'T%=!
M10 C;MC;,;L<9Z9K@(_AY?0^%-.T^#6D@U72[V2\LKZ.W^4,[.S*Z%CE2)"I
MY]*[NYF^SVTDWEO)L4MLC&6;'89[U3T#6K?Q%H5GJ]HDB6]W&)(UE # >X!(
M_6@#D/%:W^G^"YX]?UJU^TZC/#:O<"T(M($W9(9"QPI 8%B1DL!D<8J:1%?Z
MB+[2(-7\/W<&HVLD4U[HJ.)K<["$=F,C @= "0?3@&O2F574JP!4C!!'!IL4
M,4";(8TC3^ZB@#]* .,TSP;K%GJVA:A/JUDQTRR>R,4-D45XSLQCYS@_(,GI
MZ =:U_">@7/AVQO+:XNHKDW%[-=AHXRFWS'+%<$G.">M;]% &)XMT*;Q)X<G
MTVWO!:RN\;K(R;U)1PVUER,J<8(ST-8<G@S5Y[[7KN76+0OK&G)9RJEFP6-E
M#J"OSD[<.3@\D]P.*[>B@#D(_"-\D_A*0W]N1H$;1L/(;]_F+RLCYOEXY[\U
MCR?#K5H_"M]X4L];M4T6282VOFVK/- OFB0ID. P!!P<9YQ]/1Z* &QAQ&HD
M96< ;F5=H)]ADX_,URFM^%]6?Q,GB#P]JT-C>/;BUNH;FW,T,Z DJ<!@0RY/
M.>_Y];10!QU]X2U8:OINMZ7K4::M;P/:W+W=N9([F-VWD%58%<-R #P.*YW0
M]"D\2>'/%^F)J")>+XDDF2X\L%1)&8G!*@]"5QC/2O4$ECEWA'5]C;6P<X/H
M?SID-I;VQ)@MXHBW78@7/Y4 <U8^'-9A\6S>(;K4[.6:;3DLV@2U94#*[,"I
MWD@?-WR3STX SK?P#?6OA#P]I$6JV_VO1+U+J&X:V)23&\89-X/1ST;M7>44
M >?ZO\/]5U*W\26BZ[ +;6MCLTEH6E1U51MW;L;/ESC'&3CUK8?P]JL/B?\
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MXWE>0LC*T31>7@$*/O9SGG..*W/"?AV*+0= EOOMCW-A:HL4%T>+:3RPKX&
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M!I8\YV.5(R/U]ZL7?A?3KB[L;R$2V5W8Q&"">U8*RQ''[L@@AEX'!!P1D8H
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MSVTVTG8Y5E*D,I!'(((!_"LH>!M)%S=7/FW[7%W:"TGE>[=FD3GDY/7#$9[
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MI)9R*YN+@S;3"0!M 7'S9.>XQBHYM2,UC?R:2D=[=6I>,0F38K2J =A;!QU
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MVGA]K,>7<V<MTMSYO/R,H*[<?[77-8/A2RMK#XF>,X+5!'%Y-@PC4_*N5ER
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M ]#6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7YLJ%./EX^4 <4W4?#YU%M&TL^8VG:9/'<R22XS*T8_=H, 9YPQ./X0.23@
MZ:BBB@ HHHH XGXO?\DIU_\ ZXI_Z,6MB!==6\LGO)K!M.6-C-Y4;(P; V$E
MF(QU_'%6?$7A^U\3Z+-I-_).MI/@2K"P4N 00,D$CD#I4)\-B0VXN-6U*XB@
MD2187D0*Q4@KNVJ"1D X)[4 <I?ZEK.F>//^$?GUR7[#JK1/:796/?:$;BT/
MW,$R!2%+=L]2.=B2]N];\6:UH,&HS6*Z=9P-&T6W?))*'.\Y'(7:O'0DG.>*
MNW_@W3]3TFZTZ[GNY$N;H7;S;U$HD!!4JP7Y<;0!CD 8Z<5%JG@BPU34K;4V
MOM2M=1@A\AKNSN/)DFCSG:Y P1GGH#0!EMJ.M3ZW:>&I+U9;N'2A<W5Q:R"
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MBN+EKG4 @G5V4H0@(3 QQ@$]^<\YJC%X)TN!)K:.2Y&F37'VE].WKY'F;MW
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M6X53$$@)^1U(R2X4DG.1NXQBD34-;\2^*K:SMM;N]+M+WP]%J0CBBB9H9&D
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M/_+7S/,_+^'']WBIM<T>?4]3T>YM[N\MVLKCS6,4^R-TR-RNG\>0"!Z9)]B
M,\<"3_A!->:*XE@D33YY%DA;:P*H3U[=*XR>TGW_  SACOIA))O(F959HP;-
MN%&,<#ID'WSTKTJ^LX-1T^YL;I-]O<Q-#*N<95@01^1K"A\%6,!T8K>Z@S:0
M2;5I)@Q!*;.<KS\GRXZ?CS0!R\7B?5M*L=8T^6^>[F@U^'3+:[N-@=8Y1&WS
M$+MR-S $C&2,@XQ74:%;>(;37KU=0N8Y-*EB5[:.28231R X<9"+E#D'G)!^
MM)+X%T>ZM-9M;S[1<P:O*)KE)''^L  #*0 5(VKC'I5W0?#=OH"/LO=0OIF
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MNC'9O%)!.L@65'C.48$#&1CTH Q;K6+_ $KQ_<VDE[/<Z?!X>>]^SNJ F1)
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M8@8+'&3[\4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'IWK O-'M-2\2?$2*[,\L<-I;2Q(UP^U',,C;@,]0>1Z=J /4Z*P?",DFI>
M="ENY9));C3+=I9-Y#,S1J2=PYR2>M>566E[/A3X=\3V5S=MXABNH5@E-P[&
M7=<[#$5S@J03D8[$GO0![G17FVF:+;7OC?QC-*MQ<RZ=>6UQ91M<R827[.K=
M W.2>AR.V*I^&+>#7M)\->(?[?MH;]98_M300$7%Q(WRR02GS#D9)_A^7 (
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MHH **** "BBB@"&ZM;>^M9+6[@BGMY5VR12H&5AZ$'@U!I^CZ=I086-I% 6
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MRN64"3*LV& ;.%(Q@\9^E;]EKVD:E:W%U8ZI9W-O;DB:6*=66,@9.X@X''-
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M%_M&R7;%>_NT^?'(W  *<'&1CM6-XGL_!_BB[O%UBZ71]8TV4QV^H+-]GF
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M-+^(^I6KHVEWUM;I 5.4GN57#LG8G&T$CJ0>X->R44 >>:];6L7B?P#J%E%
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MX=3;2H-KN2 !LQD\G!R!R370_$&\?2KWP[JUQ]J72+2ZD^VRVREF@WQE4D(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEJ=[9G4M! B26>TFVW.E%5!)"_Q*=P8X.<'G(H [Y)[TZO+ UDJV*PJZ77G
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M@)9_LT>Z0#=-Q^[Y_BY'R]:?+K&FDWT U.UBGM$W7&Z1<VX.<,X)X'!Z]<4
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M/MEI87@E$G)A+*GEJ3V.!M'NIQ7H?_".Q_\ 04U;_P #7H_X1V/_ *"FK?\
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M\3,+F P!%1" <[<$$>Y]Z]1HH \;TW4H]$B\'ZCK U&WT=_#\=D;B%)5^SW
MVDAPHR P &<8)45HZ[!I.F^#=#BTJWGMK%]>MKF))RY=D\X,\FUOF5>K<] 0
M>,UZG10!YGK&I6&E>.]3/B%[Z/2]6LX%LKJV\UHG"A@\1\O/)+%A_O'UHMK3
M3=.\=^#[:VM6M;2UTNZ6**X8LT(9HR@8MDJQ ;@G(Y':O3** /(-.CL[G0;F
M(ZM+I-PGBB\EL;V)05@8F0HS \&-E+#G .[K2W&J:I%8Z)K.MVKFPL-4NHKV
MZTM7"RJR%4NE4<[22P)&>IQUKUZB@#F?!\6BLFH:CH<5S]GOIA+)<SF3_2),
M8+*'YQT&<#)!]*Y/4H;Z?6/B3I=BLR:EJ%M"UGA&'F 6VTD-C Y!7.>I%>I4
M4 >:3S0>);7P,NCC9?V%]#+<1!=KV<*1L)4D'5,\)@]21C-;WCO4(M/CT1Y[
M96C.I(/MCQM(MD=CXDVCOR5&> 6R<XP>MHH \/U&5#X'\>V;_:I)9=;CE3S[
M=D:52;<YQM R0K' '0$XKMUDM6^,4!A:(PMX?:(%,;2?.5E7(XSMR0/2NYJ"
M]AFN+&XAM[EK::2-ECG50QC8C 8 \'!YP: ."\-Z9>V/B.;PI)"W]C:3<?VC
M:R]C')GRH?\ @#^:?^V:5O>-X+6YTBUCN=0N--;[9&UO?0@'[/* Q5F!X*\8
M.>.>W6M+0](DTJU?[5?RZA?3,&N+N5%0R$ *,*H 4 #@#W/4DUJ4 >1ZC>:I
M/X5CN]6C@F&F>);26;4;*(B.ZA1H\S[1GH/E.,C*G'2M2SU.UNO'7BN[0R?9
M)M'MO+F:)E1P/-R02,8^88]>V:](HH \AT^5;3PI\,+N99!!9S".X98V8Q,;
M=U 8 9!W$#\:])T_Q%INIZM?Z7;2N;RPV>?&\3)C<,C!(P?PZ5JU7BLXH[R:
M[RS3RJ$+,>BC)"CT&23Z\_2@#SOQA?1OK?B73OL\MI<2:)MCEBMVDDO_ )9/
MD!P0%4GGC/S9R *HZ5KT6@ZIX8U?5$N4T:?P[%9)<F!R(+A2"P88R-P"C..=
MHKUJB@#S;5/L&FWO@>]L].EL-(@U"X(1;=AL$D4@4E ,KO8Y (S\PS@\53U:
M"[U/6?B3::2Q%]=:9:I !P9&5) Z@^O(4^A(S7JM% 'FUU<6_B;_ (0A]&^2
M\L;V.:Y0#:]G L3"5)!U3)VK@]?PKGK\V[?#/QT(U0S3:]-)&%7YY 9T96 Z
MD8!((]#7M5% ',>/;6^U?X>:S;Z,WF75Q:'RA&<^8."5!'7<N1^-8=[<VOB?
M5O!EYHK 2V5PT]S@8-I!Y1#QR#^ D[5VGT]C7H=% '"_#2.T?3]8=8XC,-:O
M9 VT;MKR':P]BN,'N*CUJXL+3XQ:/-?O!&@T:X"238"JWFQ]SP.,C/OCO7?5
MA3>'YI?&EMXA%ZBB"T>T%OY&<JS*Q.[=URH[4 >9W.G16.BJS1"/3;SQI%>6
ML+)Q]F#J&<+V0X8^F"#WKKM0E71/BA8:E=A(=%N=+DMHKC $45P91(VX]%WJ
M!R>I7%=W10!XY/;WVCQS:_';3RZ"GBDWY@BC+'[.8RC3!>I7S#O&.N P]:V/
M$EU9ZIX?N]=\.:=<7$(OK.ZO9K>)XY+U(G!8(" 6**%.>G&.H->ET4 >4:K'
MI?B'P]KFK^$H-1O[Z2TCCFFD:9?-1)5<P@/C<Q4..!QG'>GW,FE>*]*U34?"
MJ:G/KHTF>V$TYF4PAAGR3OX+EN@&<8SD<9]4HH \F?7=,U,_#TV,<H>SO%CG
M@%N^^V(MW4HPQ\N#@8]L]*@U:2)] ^*<:$,T\W[E1R9"8$7Y?7Y@1QW%>P44
M >>F6T'Q!\&M;M$(QI5S&3'C:,B+8IQTSAL#V-<KI6IZ"-.T?0=0UN&T@TG6
M7NTDN8I8YGVRR%4?<@122W+;CQV!/'M,T?G0R1%G3>I7<APPR.H/8UR^G^$]
M2M=.32;GQ%+=:2D7D"%K6-96BQC8T@Z\<$A0?<'F@"QX_*_\*\\0H<$R:=.B
M+W9BA"@>I)QBN8CEM9?&?@*0M$PBTFX!8X(1BD04$]B<,!]#7I0    P!10!
MY#8QV5SHNH1-JLVE3+XKNY;&]B *P,1(4=@>#&R[ASP=W6I;V^U&?PWH][JT
M$.;'Q3$9KRSC;RKB)<C[0!S@$G![9!]:]9HH X:WN(9OC)+*APLGA^- 64J=
MWG.VTYZ-M(..H%<A8SB+X2^$S)%.G]C:M:O?AH7!@"S-N)X[9&<=,U[110!Y
M9-<KJNN_$ V45Q*MYH4*VS"!P)2(YA\IQ_M#'KGC-5Y-8AL[3P3K5S]O_L.#
M3GLKJ>W213;3%(L,P W%?D9<C(!R*];HH \FOAI^D/H&NZ9:7H\-C6IKR^DD
M$CEWDB*K<%6^8(')[8XR.H-;OA2]M;SXE^+;BUWO!<V]BT<RQ,$DVI("0V,'
MJOUKO** .(U6:&/XNZ&S.JA-,ND=B>%):,J">Q(#$?0UQ>;9/A5.J!%G_P"$
MB\X*%P^/MH8-CK]SG/I7M=% ',^/;R*V\#W]RU@NHPXC)A*LZD%U^<A>2J_>
M('4+^-<5]MA;Q%XOE:ZN+J.\\/QF*XDMBB2X$P.W"@8R0!USG&2:];HH \IL
MGMH8OA3L\M#!$1+@8\LFT*G=Z9?@Y[^]:-UI=Y8^-KO0K: MHWB,_;IF'2!H
MRHN%(]) 8Q]7->BUB:'H5UITTMUJ6KSZK>.#&DTT21^7'G.U50 =>IZG ]!0
M!MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ2+S$#[)1AESV([&N*US09Y/B#:-92(MGK%OMU:$]72!E97'KG=Y1_V6KNZ
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MMYV*D,OD+&2 &)!R"><5F>#K#4[2#3M&U+P9:P7>G;(VU;$312*G D3'S[V
M]!@G)/:@#K+7Q/:WCP-#:W;6UPTBPW2H&CD*!B<8);^%L9 SCBL:/XGZ"]O9
MW9AU)+"ZG-O]L>T988I-Y0*[?PY(_#(SBL[1-!O['Q-87^E6E]I,,\DC:QI\
ML@:U)*G#Q#)PQ?:?E[9SCH<30["Z\3?!_P#X1N"QF#7=Y,AN6 \I(Q=LS29S
MU&" .N0.,<T >A:OXML='BO)Y8+J>VL2!>SP(&6WR ?FY!. P)V@X!&:6_\
M%=A9QSO#'<7RVUL+NX-HJMY41!(8Y(SD D 9) Z=*Y,Z7J.C^*-9BF\(1:[8
MZG<_:K6[!BS$S*JM'+OY"@KD$9X/0GBK,4&O^%?&.HW,&AOJNGZM#;X^PO''
M]FFBC$94J[#"$ $'M0!IKXT^U>+-*TRQL9[BROM.:_6Z7: REHPI + @ .2<
MC/3 /-;/B36#H'AS4-66UDNOLD#S>4A )"C/4D<<<]\= >E8%S8ZQ%X^T35V
MT\W$9TR6SN&MW4+!(SQOD[B"4PI&0">.E;GBNPN-5\(:UI]JH:YNK&:&)2<
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M*O-<O/'+)L#%720D8)XXP1FMSQO:W5_X(UFQL;62YNKNSE@BC0J"692!DD@
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M.>%)8G#QNH964Y# \@BGU%;1F&UAB(C!1 I$:[5&!V'8>U2T %%%% !1110
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M2CF-RNY<\@$8.#TH UI-0LH;Z&QDNX$NYP3% T@#N ,DA>I  -6:XSQ&J_\
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M6;:.27&3C@#OBM0>(+RP\66.@:O#;L-3ADDM+BW! +Q@%XV4D_PG(;/// H
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MK8V,-HLDB6UO%<7#"6Y:!-HDDP 6/<]!R>>*M4 %%%% !1110 4444 %%%%
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MS!6CG09:*16#*P^C 5EKX:UG6]#O=-\6:E:W*7%LUL%L(6B&#C]XVXG+\#&
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M#GOS7;44 %<[H'A6+0=9UB^CG+Q7UP9H(".+?< 9 O\ O.-Q^@KHJ* .$F\
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M17*AS(H49() 8,#V%6]/_P"1X^(/_7K9_P#HF2K*_#;3H[6WM4U75EMK6_\
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M53<5![],9K#TF37;FUT/7&U>*6RN;;S[^V>)0N'0,GDE5W<,<?,QR/>NH-M
M;0VIB0VY3RS'CY=N,8QZ8XKG/#_@>T\.R1K!J>IW%E 2;6RN9PT5OG/W1@$X
M!(&XG'UYH YJ?Q9K(^&T7CV"\) 87$FG&-/*,!EV% V-P<+SNW?>!XQP+VJ>
M*+NQ\5O8:G>7>DP374 TZX:!&M+F,A"\;N5)60GS!R5Q\N/?7M_ NG6UH^FQ
MW-W_ &,UQ]H_LTE#"K;]^T';NV;OFV[L=NAQ5B_\)V^I&[BNKZ\DL;N=+B6S
M;84W+M("G;N )0$C/KTR: .8T\ZU%XC^(,NGWMQ=WML8A9V\_E[&<VX9%^Z,
M ,W ! ]<G)K8\&^(H]<O+Z,:C>M-!'&)M.U&W6*XM9,MN)"JN5(VX(R.#ZU<
MG\'6DVIZO?)?ZA VJQJMQ'#*JJ&5-BR+\N0P7W([XS5VQT"*TU>35IKF:[OW
MMUM?.E"*1&K%L810.2<D_P J ,[4M8N9_'%GX9MKA[17L)+^:=%4NP#JBHNX
M$#DDDX["N1U_5=2U#P'X\TB_NW-SHPDC^TQHB_:8FBWJ'&W .&P=N.@QC-=Y
MJ_ARVU74K'4UGGM-1L=PAN8"N[8PPR,&!#*>.".",C%5KKP=8W?A_4M(>YNE
M74W9[VY4IYLQ8 ')*X'  X P ,4 :6B0R0:-:))<RW#>4IWRA <8''RJ!C\*
M\U:.Z/A/XIR3ZE=7(CEO(@DNPCBUCP>%!&!P "!CMGFO4[*U^Q64-MYTDPB0
M())=NX@#'.T ?I7/7'@:QG77HQ?ZA%;ZWN-U!&Z; S($=ERI()50.2<=L4 8
MNF:CJVD:[X6M)]2-U8:IIDK-;&!%$#11QL"A W'(8@[B?P[+I&L>*=<LM"U[
M3]_V:[E22[MYS (!;MG.PC]YO7CJ>2#D#@#H1X2M_P"T=$OFU"]:71XGAMP3
M'M=74*V_Y.<A1TQTJEI/@"PT6^,EGJ.IKIPF,\>EF<&VC?.[*KC=@-R%SC/:
M@"YXTU^7P[X>-W;A/M$L\-K$SC*HTCA=Q]@"3COC%9UW?ZII'C72M$EU*>ZL
MM:M[A4E>.,2VTT2AMP*H%*D'H0<$>G%=%K>BV/B'1[C2]1B,EK<+A@#@@@Y!
M![$$ @^U5K'P\EO?P7]W?76H7=M"T$$MSLS&K8W$!%4;FVKDGT[<Y /+[<7<
MGP=\/7$M_-<3SZS;,#<!6"M]L.3P 3D\G)/X5TEYXIU7PO?^+(;V].IQZ?IL
M5_;&6)(RC.74H=@&5RH//(&>36JGP[T^/1(=(34]36S@NUNX$\R,^45<R*HR
MGW0Q)YR3T)( K0F\'V%UJVHZA=SW-S_:-F+*XMY"GEM$,X'"@@_,W.>] &?;
M#Q6-;A_TB5M+GMG69[L0;HI<91HA'U!Y!#9['UJ+X=7.O:UX?TW7]5UG[0EW
M:'=:+;(BJ^\X?<.<X&,=.?:KNA^"HM"C$::WJ]VD2&.U6[G606JD8^0;<$@<
M MG X'4YT_#>@V_AC0K;1[2XN)K:V!6(W!4L%SG&5 SU]* .?UB\UVX^(<&@
MV.KBRLY]*EN2RVR.Z.LJ+D%L\_-WXY/&<$9>D^)-=GTF2SU'5(([RPUQ]-N+
MJ.'][=QJFX>5&%8>8=RY&, !CQ5[5+:YN/BYI\L+WUM%'I$L1N8;<M'O:5"$
M9BI7D G\!6E<>!-/E@LA#>7UK=VEX]ZM["Z>:\S@AV;<I4[@2,;<8P!@<4 <
MK<^*_$4?@37KV.],=[IFMBQCDGAC+M$98E <+\N0)",@=A5S6K#6;?QCX1M[
MOQ+>3_:+^[=3'!%&(P+9R!MVD,1\PR<\-Z\UK2_#G3I=-U2P_M/55M]2O%O9
MAYR,1("K9!9#U**><]/3BM?6/#<&LRZ9/+>7D%UITIEAN(&57)*%&!RI&""<
MX ]L4 <^WB#4=#\1Z]INJWLMPIM%O-(Q'&I=2=C1C"C+B0J!G.0PXZUV&FPW
M4&FVT5]<_:;M8P)IMH7>^.2   !GI7,20P>*_%-@\NC7T":!<RN+F\A,8D?&
MU1&2?G4GY]WJB^M:MWI=[-XNT_4H+^]CMH872>V\T?9Y 0V/DZ[]Q4[N@"X[
MT 4OB'JFHZ+X-NM1TRY%O<0R0C<8P^0TJH1SQT8U3O;K7+SXBW6@VVLM9V1T
ME+M3';QL\;F5DX+ C^$=0>_'<;_B30+?Q/HLNE75Q<002LC.;<J&.U@P&64]
MP*B7PU&OB5]>&H7OVQ[,61'[O9L#%@<;.NXD_P!,<4 <IX?\7ZGK6G>$;*>Y
M6&]U:*Z>XNHT4,1 =IV @J"Q()X. #@="#QK!JUMX NX=7OH;R1=6MO(E10K
M&$W,6P2  #>.02 !TK4/PVTL:#INF1:AJ44FF3/-97T<B+/ SDE@"%P0<G((
M-7;WP9:ZAX?_ +(N-1U%E>=+B:Y,B&::1&5E+$J1P57@ #  H @@U+49?'VM
MZ.;YQ:1:=!<P@1INB=VD!P=O(^4=<UA^'O%VJ:W8>#K"6[\N]U:TEN[NZ2-
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MA@W>2ID9EBW==BDD+GG. .I]:DU;0],UV*&+4[..Y6&02Q;L@HX[@CD5H44
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-=0T_P"U0R1MO "S+\X!)R W'J:[F\TF6[URPU WA6.SWE;;RP59F&TL3UR
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M0HHC4JNW/(X)ZDU"OP[T=]&UBPNY;J[EUB02WEY*X$K..4*[0 NTCY0!@>]
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M><8XOWA<GD9)(7&,8R<YQ6G#X 6#PYH^BIJLODZ5>K>PR&%=[LKEU#=L98]
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M .'\,>(+CP[\-/#LUQY\6GO<7:W]]:P>:;?$TFTE<'"ENIP<?CFO2M NVO\
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M:F+R05B1 P7;SU^8]: .276M5\0:A\.+Y;TV@U*&>::&.,%/,%NQW<\D?,P
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ML)HP",'Y3SVQG'.1D$ [^BO+TM[SQ3%XCB375TZ\TO4'@CG9I#):1QXV/]\
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M>ELVM9--1H6N?MF#(Y(F[R YR&.3DCKWIR^#O#JV]_;KH]JL.H "Z0)@28
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M[XV*7UJUV,Y@$RF08Z_+G- &;?\ @WP]J=]<7MWID;W%S%Y5PP9E$RXQAP"
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M<Z1;2:BI4^>0<L1T+#.&(P,$@XP*?J'A+0M4U(ZA>:=')=M'Y+R!F4R)_=<
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MAAZ$9IODQ9!\M,CI\HH \5M]2BTW0A<QW#1Z+8^+[O[6UJJN+>(F01MM(8;
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MT*YTMX+:_A$;0BXW NI9E91E0.?]DCUKU C(P>E1O!#)#Y,D4;1<?(R@C\J
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M]5-U8$&XM!9MYJH1N#XZ;2,\Y[>M37'CK0[?^R]KW,YU2 W%F(+9W\Y0H;C
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M'AS^QKHWS7%P(<%"L_F3LZE2&Z;3R3CTYH ]#N];M[.Z2QCBN+N\,/G_ &>
M!G$8.-QR0!SP.<GG&<&LZ3QWH,>FZ;?B>:2WU"X%M"T=NY(ER0488^5@01M/
M/' -9PM[_2O'\FN_8KFXTS4M.B@?RDW26TL;$@,G7:0QY&<'KZUA/X9U.RLM
M-D%A.\D_BMM9GAC ;[-"Q;@D'!(!4D#/).,XH [S1?$=EKL]];V\=S!<V,BI
M/!<PF-UW#<IP>Q'(J]J$?FZ=<)OD3,;8:-RK XZ@CD5S>@VMW#\0O%-Y+9SQ
MVMXEH+>9UPLAC1@^.XP2.O7M72:@YCT^X98Y)&\L@)&N68XX % 'CEKXBUBQ
M^'?A7Q!:ZW=W>M7UU'%)932^:MX&=@RA#RI  .5QC\:]0U#Q58:>;TM'<SQ:
M?@WLMO%O6WR-WS<Y)"D$A02 03C-8_PRT0Z3X)TJWO\ 2Q::I;1&.8R1*'^\
M?XAU&".]5=/L]3\/W?BRPFTVXO8=4NI;VRFA 99#(@4Q.<_)@J.6P,'KVH M
M:O?M+X^\%2V5_*UE?1W;,D4Q\J91"&1MH.#UR#[U<TO7=%A_X2&^6]OO+M;S
M;=_:]^(I-B_+&K#(!RN !R3QG(K L?#>H:'J'P^L_(FN8M(MYX[RXC7*(SQ!
M1[D;LCCH.N*J7OA[7+_3_&*V=E)%=S:O#J-@)\*EP(A$<9SQDQD<X[4 =A)X
MST^"6_@N+:]ANK&V%Y+;M#F0P$D>8H4G(X.1G(QTJW%XBLYK#2;R*.=XM591
M;;5!)W*7!(SP-JD^V.:AT+5K_6R9KK0;K2XECVNM[LWN^1PH4GY!SR<9R,#K
M6#X*T.ZTW6=2LI9$DTK1YY(=+ .2JS!9&4^Z A ?0D4 =W7+:5KKZK+K>K!9
MI++3;B2TMH(>LK1C]X_4 DL2HR< +GN:ZFN(\ V4MAI.OZ++Q<6VJ7(&[^))
M#YB-]"''Y'TH QM2\5W.K^&/!^O@WFGBYUBU$L<;L%DB<L2N%/SC@=N2.G-=
ME8^+]+O8]49S<6C:81]JCNX3&Z*PW*V.X(Z8YKAK33-:3P/X+TV71+V.YTG4
M[5[E2$;"1;M[C#'(Y&.Y["K.M^'=6UC4O',=K:/'_:%O8FREF7$<SP$LRGT!
M.!SUR: .ULO$MG=ZTVCR17-I?^1]I2&YC"F2+.-RD$@X/4<$=Q5[5/MO]DWO
M]F[/M_D/]F\S[OF;3MS[9Q7->%F-]>1W3^"ET*>&,K---%$&+'^"(H<E>Y8X
M' X.>.PH Y.SN?%#7GA]I]$,5K)%(M\AU!7:U?\ A9CC][D=AT+'/05QOB#Q
M&9/C.^ER^(9],T33].\_4 +LQJTA!V@'/!P\9P.N#Q7K<L@AB:0J[;1G:BY)
M^@KPC_A =:\1>'_'MYJFDSP:UJ=RMQ8QR[2=D;%E4,"1D@[<9["@#M/AEX@U
MIO!=]JOBZX>*SAN':VNKY1$[6X PS<#OT/?\JZ6R\:Z)?7M_:">2!["W2ZG-
MS&8E6)AD.2W08YP<'VK@O%MCXHU[P)X32;2;YY+6[@;6+./:97" 9*@G:P)R
M<<\D9Z'$OC/PMJ%_X%OFT31+K[7>WT-Q?1W,RFZO8EZAL$@8.W"@\ =!TH [
MNP\8:/J.HBQBG=)FM/MR><FS=!G;YG/(&?[P&1R.*BM?'&A7E_I]K#<N?[2\
MT6,QC(CN3']\(?;L3@'L37/^-[76/%'PZU8:/H<]CJ$\$<2)/Y:3R1!P73Y2
M<#&1@GG)XZ9AL_"5U?>+=$U+[(]OHWAO3_)T^"0;)+B8I@L5/*J  .<$E<]*
M .A7X@^'3!KEPUS,D&B.([Z1X'4(Y)&T C+'(QP.XI]_X[T/3KC2()WNC-JT
M?FVB1VLC,ZX!Z 9S@CCK[5XX/!WC&Z\"0:=<Z+=(^J:]]JU5%=/,D0G))YX4
M8!&3R?0 $]9]NFU#XS:E>P:?+=CP[I:VEM;VXROVJ09V[C@+P67)P/EH ZU?
MB9X8;PK/XD^U3C3X+@VTI-N^])./E*XR.H_.E;XE^&([O4+:2]D26PM?M5P#
M"WRKQD#CEAD9 SW]#C@KCX:ZPGASP[X9>-ITO=6;4M=N86 2,X'RC//3@8[K
MFJVJ>"_$ESIOCG5;?1I!J6IW"6%A;[U!2S4JNX#.!E %]0,^] 'K,7BW1I?#
MMGKOVK997NT6Y9#OD9CA55,9+$]@#69/\2O#EKHU_JEQ-<QP6%ZUC< V[%DF
M'\/&?SZ5Q^N>'=9L_$W@IX]+U"71-*L6A\NP:-Y()MI4,0W&<;.>QS@]S9\2
M>"KC4[?PKX=T_19++1CJ#7NI$3!F4+R-[YRSMELD%L'')P#0!V5EXXT/4-<N
M]&MIII+ZTMC<S1K YP@(! P/F8$@8&>>.M5O!7C:+QM_:5U9V=Q#I]O,(K>6
M:)E,V!\S9Z=>,#D8YQD"N1L]$\266J?$+6H]&=+NX@-KI6UT&8T4K'L /<;3
MSCH!R2<=?\-='FT#X?Z3IMQ:/:S119DCD(W;V^9B<9Q\Q..>@'3H #?U:\@T
M_1KV]NF9;>W@>60JQ4A54DX(Y!P*^?H/%7B6W^&VEZO#XAOKCQ-J6IE;.S$@
MEWP@E=IC.<C*DYQGYAS7JGQ8AUG4/ MYI&@Z?/=WEZ5C;R\ )'G+$DD#D#&/
M>MWPOH-AHN@Z=!;64<,L%K'$SF$+(2% .X]<DB@""_\ &FEZ1'.E_(S7-E;I
M<7Z6R&06JG'+$=/8=2!G&*YKQOK5SJ/B3P5H^A:E/$-4N#=326LI7?:JH8].
MS#.#[5S=IX-\2W7A?Q#H,MJ\6JZYK+/?:A+_ *M+4$$,I_BS@@*.?F.<5MZ=
MX?U;3_BA>7T>D32:=I.BQZ?I4CNH1P$!..<[MV5Z="<D<9 -C0M=L+SQ)XGU
MM?$=VVF606VGM+J(Q06DB#YRI;J>#G@=>_&-&7X@:! MR9Y;B/[/9B^<&W<M
MY!. ^T L!_O '!STYKRY/"'BA/A#;6QT>XDOI=9&H:I:,ZB2Y3<21C/3B/@\
M\'CCGTO7I#J?@;Q'=RZ1)I[RZ7.@^TA!,R^6WW@I. ,\ G/7@=P!U_XDTO7;
M:VT>QO[^&ZUC3S>6<UFNQS'P?E=AM5O8]/;BEM= UD:CI$UWK-](L6G"VOXQ
M*!#,^T_.  &$FXYW<<+[U0^%^FWB>#M#NM4MS#/!8B"VB<?,B'!+'T+87CL%
M'0DBNZH Y[PSK,MY<ZOI%X_F7VD7(A>0@ RQNH>)R!QDJ<''=2>,XKH:\[L+
MBZTO7O'GBBVTZ>_BDN;:VA@A(#2F",)(P).,!F8$_P"P:[ZSN4O;*"ZC5E2:
M-9%#C! (R,CUYH S-4\366E7DEFT=Q<7,5J;R6*W0,8X0<;SDCN#@#).#Q5:
M?QMHT$FDHKW,QU: SV?DVSN)4"[N..N"..O/.*R?$T6M7?B*YM!I=U<Z7-IA
M2W>UD5%,Y+9$S%@=H&W Y')X)Z9.B:;JT4OPY^T:1>0C2K.6"\+!3Y1,*QJ3
M@GJP/3D#KB@#K[3QCI%WHD^J[YH8K>X-K-#-$5E28,%\O9U+$E< 9SD5B:;J
M=Q<_%V[M6_M""%=%65K2Y?Y%<S8WJ 2O*@#(]#WS7/W.@Z])9ZI=VFF3M/;>
M*EUF&VDPANX%55PI)P#P2 <'@5T6G'4;_P")HUDZ+?VMA)HJVWFW(12L@F+8
M*[B>G^<8- ':RRI#$\LK!(T4LS'H .2:PM/\8Z9J-U9P1I=1_;K9KNR>2+BY
MB7&67!)Z,IP0#@]*U]1-T-,NS8I')=B%_(23[K2;3M!]LXKS?2[/6G\1>$=5
MN=#U,/;VMQ#J$D[Q_)(R(,J@;"Q@JV H'L* .EA^(NA3Q6TZ+??9I[K[']H:
MT=8XY=^P!R1\N6&/;(SC-:UEXAM+[7-1T>**X6\L%1IED3:,-G:5.?F!P>1Z
M<XKSTZ/JY^&LNF?V3=_;FUO[4(=@SY7VOS=V<X^Y[YSQ6_XSTJ]EUW1=3T>4
M07=[NTJZSE6:WD5G+#_:CVEA]30!UNEZE#J^G0W]NDBPS#='YBX)7L<>A[4S
M4-6MM.EMH'$DMU=,5@MX@"\A RV,D  #J20.G/(JW!#%;6\<$*!(HE"(B]%4
M#  KE/$=AJ%OXUT'Q':V\MW:6L4]K=PQ<NBR;2)%7^+!4 @<XZ T -USQ_:V
M/A+4]7L;>>>YL9?LTULZ;7@E) 'F GI\P.1G(/%4M1UJ6S^).ERM_:7V>?2;
MAS8*&8M(LD8!$8)&[!//IW%9NO>%=4U+2/'&HVMG)Y^L/:&VM&(5V2 +EB">
M"V&P#S@#.#Q6VZWUU\1=(U=M*O(;1-,GAD9U!,;NZ,JG:3SA3TSC.* -FR\6
M:9J&BVVIVQF9+F5H(H#&1*TJE@T>T]&&ULYX !.<<U2G^(&AVFFWMY=&Z@^P
M7"VUW"\!+P.Q 7=C( .X8;.#GK7%IH&MP:):WRZ$UW+I^NW=Y)ILX4&XMYBX
MRN?E+ ." ?2M+Q#I]QJO@;41I?A%].FO+BU9+988TGE$<R.S2;3M "@@ G/!
M]: .[TG5XM8@FEAMKR 13-"5NK=H68C!W ,,E3D8-5M;\3Z;X?N+*"_-P)+U
MS' (H'DW,%+8R!UXX'4]A6NCB2-7 8!AG##!'U%<3X\G-OXA\%RB*27;JKY2
M,9;'D29('? YQUXXH U-.\<Z)J%AJ5TTL]I_9C!;R&[A:.6$G[N4ZG=VQG/:
MK=MXAL[K5?[(FCN;.^DA,T45PH4RQ]"R$$@D9&1G(SR*XCQ#X0U7Q!)XFU?3
MX3#-<_8OL<$_[LW!MVWDL#]W<?E&[!^7)P*WI;2X\0^+O#NM?8;JRATB*YDE
M%PFUR\J!!&!_%CDDCC@8)[ &)I6K6\'PVU&;7=1U7R$U6XA^TP2R-.H6Y*H-
MXY X"\D#!QWKMM3\16>F23Q&*XN9;>#[3/';H&,47/S-DCKM; ZG!P#BO/I]
M&UB3X4ZUI2Z3=_;[C5))HH-HRR-="4-G./N@]_:MN9]9\/>.]1U2'0[W5=,U
MJW@Q]EV"2WEC!7:RNRX4@YSG@T ;UMXPTJ\U/3;&W,TC:E;?:[241XCEC !)
M#'N,C(Z\]*T['4HM0EO(XHY5^RS&!V=<!F !.TYY'(_EU!KE_&EC?/X8LM8@
MCABUO29H[JVC5OE+$[6@SW#*Q3W..E=+HNGMIFD6]K(XDF +SR#^.5B6=OQ8
ML?QH DU+4[72;3[3=R%4+K&H4%F=V("JH')))  JC:^)+2YO;NP,%S#J-K$)
MGLY$'F-&>C+@E6!(QD'@\'%9OCS2=1U'3]+N],B-Q<:5J<-^;8,%,Z)D,@)X
MSAB1GN*CAL9M1\>1^)OLMS;VEIIC6H$L9629W<,1LZX4+WZEN,XH S_!$D_B
MJUM=?NKG5;>[BN[DL%E*P31^;(BQ%"2I"@+T .1G/)KK/$&O6/AK1I]5U$RB
MU@ +F*)G(SQT'3ZG K%^&]I>:=X/AL;^SGM+J*>X=HY5[/,[J01D'AAWI_Q(
ML;S5/A_JVGV%K)<W=S&(XHHQR3N![\#@'K0!=@\5V5QO6.VO_-\\P0Q/;-&U
MP0N[='NP"N.=Q('Z4VU\8Z1=V$ERCRK)'=FQ>V:,B87'_//;Z]\],<YP":Q?
M&EE?SWGA_7[313JL%B94NM-=5\QHY54;E#<%E*#COFJ&JZ9J366E^(-$\+I9
M26&I"[;2U6.*:XB,;1NS;3M\S#' R>!UR<  ZF'QAI+V^HR3/+;2:=,L%U!,
MG[Q';&Q0%SN+;AC:3G-21>)[-[VYL)(+J#4((/M)M94 =XLXWH02K#/!P<@]
M:YWQ);:WXI\.QWUEI$UG/97]M?6]E=LB37'E-E@V&*KD8V@GJO.,U;DTVX\0
M^,].UM;6XL[:QL)X2;A-CR22[1MV]<*%))Z9(QGG !IQ^,=*FLM%O4,YMM9D
M6*TD\O@NP) 8=1D*?RK.N_B5H-FE[(R:D\5A<&WNY([&0BW( )9^/E7YNO?!
MQG%<II^GZ^OAGP1I;>';Y9M$U.(W9+1@%4252R'=ROS Y..H R:MZ7+--#\0
M],@T^XN9KO4YXH0J9C=G@C7#-T4#@DG'!XR>* .PN/&6E0ZHFFQ"[NKJ2S^V
MQ+;V[.)8LJ 5.,-G<.G'J15.+XB:%-96=ZBWWV2YF$#3FU8);R%]@24G[IW<
M=\9&>"*R]%T.\T+QEHJ-;SS6>G^&QISW:IE3*'C.!WY"'MCM6/)HVKM\+K[2
MAI-W]ODU@W*0;1DQ_;!-NSG'W!Z]>* .]U;Q38Z.EW)-%<S162A[R2WCWBW4
MC.6YSTY(7) P2,$57G\;Z1%J/V"%;R[NC:+>QI:VSOYL3' *'&"#Z]/?-<Q-
M8W>E^+=9:Z\'MKVGZQ*ES;7"11,T3&-4:.42$;5^0'/3FM2SL;NS^(T=XVFM
M%8Q:"EGOMHOW*RK(7*(!S@#IQCMUH EOO'UL++P[=Z9:W%Y;ZU<B%)%3&P88
ML""0=_R,,>Q].>P5MR!L$9&<'J*\HT[1=:M/!WA -H]VUSI6M/<7-LNWS!&Q
MGPPRP!_UB]_7TKU9"S(I9=K$ E<YP?2@#*O_ !%:65Q<VZ0W-W+:1":Y2UCW
MF%#G!/(R2 3M&6P.E<]XL\6*-'T&?2'GN+35K^VB^T6W\43-EE4Y!#$#'8C)
MZ&GV5OJ'ASQMXBNI;&YO+#5O)N+>6W4.4D1-C1L,\9P""?E]2*P_^$8U/1?!
MO@_24LYKFXLM8BOKI8 &6%/,=V&>,[=X''7'% '>Z%IBZ9:RB.YOY8KB4SI%
M>RF1H P'[L$\X!R<$G&36I2*P90P! (SR,'\J6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BL[7-
M8AT/3?M<R-(S2QP0Q+UDE=@B*/3)(Y[#)K)NO%D^C1ZM-KNE/:VMA;+<+=02
M&6*8'(V*2J_/G QCN.: .GHKFG\475AK6FZ=J^F);?VF'6UEAN?-'FJN[RWR
MJ[21G!&0<$?7%?XC7T>@RZVWA[%A:W[65V?M@\Q,2^5N1=N&Y/()7\: ._K)
MOO#]M?Z[I^KRS7"W.GAQ;A& 50X ?(QSD #GIVQ67%XKOE\07FCWNC+#<)8&
M_MO+NA)YL8;:5;Y0$8$C@%ASU-9-K\2;M[+0M5N_#KVVBZL\<(NQ=J[0R2<+
MN3;]PGC=G\.F0#T"BN*U3XA1V,=S=6ME'>6EI=&VF6.X_P!(.U]CLD04[@K9
M_B!(4GTRMYXUU)-0\0V=CX?6X?1HHYF>2]$:RHZ,_'RDAL+P,8ZY(XR =I17
M)CQO!<R:/#910>?JM@+ZW2\N/)#J0N$4[6W/\W3MBI-2\47]C;B3^QMFS3A>
MSR75P88D;_GB'V$%\Y].WK0!U%,2:*262))$:2/&]0P)7(R,CMQ7#7'B[5+[
M5O!3:5;0"QUJ"2Z9)YBCG$.X(<*P &X'C.2!T'6PGBG3-+U'QC=W>EI9-I7D
M-=W$9#/=YCRF< <X(4 D]>U ':45S,GBBZL-:TS3M7TQ+;^TPRVLL5SY@$JK
MN\M\JNTD9P1D$@CZXR_$6]_LG^UY/#XCT^'43873F\!>,^=Y6Y5"_,-Q&<E?
M;- '?T4V1_+B>3:S;5)VJ,DX[ >M<IIWC.:XUW2=+OM,6SEU2UDN8H_M&Z:#
M:%.V6,J-A(;U/(([9H ZVBN9\/>*W\1BWN+.UMWL96=7DCN=TENRYPLL>T;2
M<>O'OQ5[Q)X@@\.:?#=7'EA9KB.W5YI/+C0L>KM@[5]\>E &K+-%"H:61(P6
M"@LP&23@#ZDT^O.?'5Q/>:-H]U>:;&MQ;^(;(0>5()?,4R*0R.0OWLX[=*VK
M?QA>"YU^SO=$D6^TFW2Y2WLYOM!N8W#%0ORJ=V4((Q^)H Z#5--AU?3+BPN'
MF2*==K-!*8W'?AAR*BTR#3-)TF*&SF06BL5$CS;R[EN2SDDLQ;.23G-9.F^)
MCJ7B.Y\.7]C;I.MBMTPBN//7:S;61P57# XXP<@UY[;V\)^"?AQC$F8=9B\L
M[1E/].(X]..* /::JQP6EQ=+J,!1I"GE^;&W#J">#C@X.<>ASZFIY8HYXGBF
MC62-QM9'&0P]"#UKR7P5XLO/#/P[\.2W.AL=#)%O+?K<KNB+RE0QCQ]S) SG
M/MTR >NT5QFL>/DT];^:SLHKV+3Y_(GC6XVSN1C?Y<>T[MN>Y&2I]B>O6=7M
MA<(&92F\ +\Q&,]/6@"2F2S101F2:1(T'5G8 #\37*:?XTFGUS1],OM+%G)J
MMO)/%&;C=-!L ;;+&5&TE3ZGD$>]<UX]UE_$?P^DU&UTV"32S?P+!=/-^\PM
MPJ^8J;> 2"!\V<'/M0!ZG17/3^(KJ?4=4L=&T^.]ETQ4^T>9<>4"[+N$:85L
MMMP><#Y@/7&2OQ$%]_PCS:/I,MZNN13/ 7G6(QO$/F1L@XP>"?8XSP" =O17
MFFK_ ! U9_".MO!ID>GZUI=W#:7<$MQO$8E=562-@OS9#9&0,<GG&#TFH^*Y
M;*[DT]8+$ZE#;+<312WICC&XL$57V$L3L;^$8_$4 =/3(YHI2XCD1RC;'VL#
MM;T/H>17+:?XU768M)BT_3I!?ZA;/=-;7;&+[/&C!&+G:3]\@# YZ\"J'PO1
MDM/$RM:QVK#Q!= P1'*H<)P#@9'X#Z"@#M[B:*W@>6:9(8U'S2.P4+[Y/%8?
MAKPQI>@RWU]IEQ/,=3D^T3R23"02.<G<#CW/3BL;Q=<ZF/'?A&S@M[:6VDDN
M9!'+<,@D=8#]X!&QC<2.N3Z=:;HFN26&HZAH.D>%XK:PTN]5+J07BJD22+YK
M2*I'.-V=H_#TH [NBN-D\=F#1;'Q!-IH70+R5$%R)\RQ([;4D>/;@*21T8D!
MAQU 2[\::FE[XCM;+0$GDT18Y)#)>B,2HT9?C"'#8' Z=<D=P#LZ*X^T\;SW
M%]X?,FD&'3-=3_1;@W(,BMY9D >,+@ @'!#$^H%:?C/5+W1/!NK:GIR0M<VM
MJ\J>:Q"C )SP#DCTXSZB@#:>:*)XTDD1&D.U S %CC.!ZG )I]<7-J[1S^#X
M]6T:VN+F]FVQ7(FW_9W\EFWC* Y(!].O4U#=^/=2AM?$5Q!X>61-!F9;G?>A
M"\:QK(67"'+8/W3@<=>U '=45RMMXON)/$.E6%SI7D6FKP22V5Q]H#.=BAR)
M$"X7*G(PS=.<537XA122:;/;V4=SIU_<BW62"<O/&&)"R-$%X0D<G=D C(Z@
M ';45C>+-2O-'\):MJ=A'"]S:6LDZ"9B%^52<\ YZ=._J.M9FG^)+Q;/0=/E
MMH9M8U"U\\+]H.P1JBEI';9D$E@,!3R>N,F@#K*Q-1\*:3JNNVNL7D4KW5M$
MT*@3,L;(3DAD!PPSV/![YXI/#_B,:U<:E8SVQM-2TR<0W4&_>HW#<CJV!E64
MY&0#UXK.U36M8A^(NDZ/;0VK6,]G-.^^9E9BK(.<(>F[@=\\D8H ZJ.:*5I%
MCD1VC;:X5@=IQG!]#@C\Z61/,C9"S*&&,J<$?0]JX,^+X=)T;Q?J]OX=CCFT
MN]9;F..95-RPC0^8S!>N& []*OR>+M5B\0V^D/H""2^MGN+%_MHPVPKN$OR_
M)@,#E=] '3#3[1;%;(6Z"U QY6/E(]"._OGKWJS7'VGCR*71?M-W9I:WXU*3
M2VMFN,QB="<_O-OW=JEL[<]L$U?\.>)FUN^U.QFLQ!-8NG[V*0RPS(XR&1RJ
MY(P01C@^M &\9HEE6)I$$C@E4+#) ZD"GUY_XC,]I\5=$N=.TZ.ZOI-+NUVF
M01!L-%C>^"0!D]B>>E.;XC7$?AVZU.70C%/IU\++5+:2ZQ]ER5'F!@AWIA@<
MX''TH [ZBLU=3ED\0'38[>-X4MEGEG$O*%F(5=NWG.UCG/;ITK&\9ZSJVE7?
MAZ'38K=DO]22VE,LK(3\K/M&%. =G)_#'.0 =0LT32O$LB&1 "Z!AE0<XR.V
M<'\J?7F4%[>Z+XZ\=76FZ/!<RK;6-Q-']H$*<1REOFVDECV^7G')%=&?&]K/
M;:6UFL'GZC8K?HEW/Y*I&0N-S!6.26Q@#L?3D ZJL>V\/:;I^LW>M;YVN9\D
MM/<,Z19 !V*QPF<#./Y4>&->_P"$DT2/4#9RV<F]HY()>2K*<'!P-RGJ#W!K
MEM%=?%OQ$\2-J:+/9:))%:65K(-T:N5+/*5/!8G ![#I0!WZR(ZAD=6##((.
M<BG5SE]9:-X6EO?%!1;2""R<7*0KA7 (8,%'&[@CU.1Z"HG\5W-CJ.D6^K:8
MMK#JQ\NWECN/,V3;=PCD!48) .""1D$>] '445P%Q\1;Z#1-2U@^'A]CTN_D
ML[S-Z-X".$+(-GS')S@E>.A/;8@\47__  E#:)>:,());-[RS9+H.9%5@I5Q
MM 1OF'0L/>@#IZ*\[M_B;=OH^D:[<^')(-#OY5ADNOM:L\#,Q56*;>4S@$Y!
M]NF=36/&TVC/+-<Z5Y=E'J$=B&FG\N6;<4!DC0KAT!<?Q<X/3% '85DZKX?M
MM7O]/O)YKA)=/E,UN(V  <@J200<\$CGCFL:\\7ZFFMZWI5AH*W$VF6\5QOD
MO!&LJN'/]TD'Y.!@Y[D=TC\<F;_A%KA-. T[7PH6YDGVF"1D+A&7:<DX('/)
M':@#KV944LS!5 R23@"EZU@7 3Q1;:WI-UI\$MC&_P!F#22L5G;:K'( ! 4D
M#@]01QBJLFIV_A)= \-1-"\LMLT5O)>7!B1_*"+MW;6RYW# ] ?3! .II-P]
M15?3YY[K3[>>ZMC:SR(&D@+;O+;NN<#./6O,[2WT6'XK>-%OM%%Y']GLF5(]
M/-Q@F-MW"J<$\?7'M0!WUSX;T^\U^'6;@W#W$*!4B-P_DY!)#&/.TL">"1Z'
MJ!6O7EW@?Q'#H_A'Q#JL\LATV'4Y%L=/:3=/;JS!4A8$_(2QX4],UUP\33VG
MB2RT75[".VEU"*22SE@G,J2-&,O&<JI# '(Z@C- '1T5Q]EXVGFUG1M/O=)^
MR/J\<LD,33_OX=B[@)8RHVY4'N<$8]ZAL/'EW=)?7MSH8M=)TVXNH+Z[:[5C
M%Y(/(3;E\D8XZ9'6@#LWFBC9%DD1&D.U S %CUP/4T^O-=;NKS4/%G@*^NM*
M@MEFO)&CD$V^55,#D(XVC!Q@\$C(/L3W.NZS:^'M$NM5O-QAMU!*H,LY) 51
M[DD ?6@#1J&2\MH;B.WEN84GE_U<;. S_0=36"?$US9^(=/T?5M/BMI-2C<V
M<L-P94:1!N:-LHNTXY!Y!P:Y_P *6DGB/4O$W]NZ=9SI!KA*OY[.T3Q1Q;%3
MY!\HZYR.IXY.0#T,D#J0*7K7GWQ6L[6ZM?#'VBVAEW>(;.-O,0-E&9@5.>Q[
MBJ_Q'TNW\)^&W\5^'H8M-U#3)(W9;91''<QEU5HY%7A@0W<9&.* /1O.B\_R
M/-3SMN_R]PW;<XSCTSWK,T?0+;1+B_FMIKAVOYS<SB5@09" "PP!C@ 8''%9
M,&LPS^.I+6/1(_M_]CK=1WA=0\D1DP(CQD#=D]?PJAI?Q"N;WP_#K]WH7V32
MIXAY4IO%9FF:41K'MP, DYW=!@\=Z .[HKC!\0(+2YU.+5+18XK*R^VK<V<I
MGBE7.TIN*KB3./E[Y!S6B=:UQ+U[6704C+6;7$-PMR7A#@_ZN1M@VGG/&[//
MI0!T5%<'X:\8WTWA#P]<ZA!#-J>LL%M8TF($A(9V9LK\BJH/3=V'>K=WXYDT
M]-?@N]+"ZEH]I]N,$=QE)X,$[T<J#QM((*\'UZT =C17%GQQ=VUI9W6IZ1#I
M]MJ$L,5G/<7PV,7C9SYA"_N\;<#KDL.G..HTRZNKNS\V\M%M9A(Z[%D\Q2 Q
M 8-@9! !Z=Z +E%<]/XBNI]2U.PT;3XKV;3%3[1YMQY0+LNX1KA6RVW!.<#Y
MA[XR1\1/ML?AR31])>\37%F\G?.(C')&C%D88/0J03VP2,]" =O15;3YKJXT
M^WFO;46ET\8:6W$@D\ML<KN'!QZU9H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@# \8^'IO$OAY[*U
MNA:WL4L=S:SD9"2QL&4D>F1C\:R[[P[KWBWPMJ.E^)IK"U:Y@\J--/+NJN"&
M$C%P"?F5<*.@SR<\=D2%4LQ  Y)/:LZ77;"'7[?1'>07UQ"\T:^4VTHN,G=C
M;W'&<T 8O]AZQJ]YH=SKJV2-I#M/_HTS/]HGV% W*C8OS%L<G.!VYQ9O!6O2
M^ ]5T'.FBYO=2>\1_M#[%5IQ-@_N\YXQT]_:O1J* .2O-%U-O&C>('6T6T71
MY+)T$S&0,7#Y V8(&W'4>OM7.>$-%O\ Q%\-/"=C=);1:?#]GNI)%E9GE6,[
ME3;M &2!DY/ ..O'ID\$5S \$\:2Q.-K(XR&'H16+;:IH&D-)I6FPD"U.)(-
M.LWD2$GG#>6I"GOCK[4 8EAX?\5Z'J>H6>EWFFMH=[=27223[_M%H9#N=54#
M:XR21DCKSGI4_P#PCFKKK/BZ\46)CUBVBAMP9W#*4C9,O\G&=V>,]*Z;3=5L
M=8MWN+"X6>))&B9@",..HY[CH:N4 < ?!M_<^%=,T#5=-TC4;2UTV.V(:=U:
M.9!M\R-_+R 1C/0C'?NB^#_$<%S9JVH6>HP1Z.M@TMZS[X)@"&F10"&+ @')
M!X'/KZ!10!Y_8^#_ !!967@MEETUKO08GMY4+R>6R-$(]RG;DD8!P0 <XR.M
M27_@6\UJ?QG#?RV\5IKRP"!X9&9XFB0*I92H'50>#[>]=Y10!R7]A:QJ]WH4
M^NK9(VD.9_\ 1YF?[1/L**W*C8OS%L<G.!VYQI/!6O2>!M0T/.FBYN=5-\K_
M &A]@4W FP?W><\;>GO[5Z-10!6O(KBYTR>&&;[-<R0LJ2K\WEN1@,.F<'FN
M%TGPAXCM=0\*W5Q_9"'28YXKKRI)':?S%4&7)49=BN2#W.=QZ5Z'29&XKD9
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MCO4=IX@TZ]U$:='+*EZ8FF^SS0/$^P$ MA@.,L!G_ T :2[BHW !L<@'(S7
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M0Z7'J6G2/):R.Z*SH4)*,4/!P1RIZUH4 %%%% !1110 4444 %%%% !1110
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M<K-&@6.?9Y@5G SS&&;'4$#L<58OM6U[38_"32WG.IZDL-U') N\(Z.X3(
M*A0#QDG//:KR_#W0E\/P:*(G^RPWPODRW.\/NV_[NW]WC^[Q6EKGAV+7;G2Y
MY;RY@.G70NXEAV89P"HW;E/&&/3'6@#BHUO'NOB69]3NIXX$,:1R!-NTVH8#
MA00!N.,$>^3DT_PYJ.L:6? %L]^DVGZMIXA:U\A5$6RV#JRM]XGY<')QSP!7
M33^#+>6^URYCU*^@768PES#&4V!O+\O>N5)SM&,$D=\9QA(_!=O&WATC4KT_
MV"A2V!\OYQL\OY_DY^7CC% '35Q 6\?XS2Q'4[H6Z:*DRP838,S%64?+G!V
MDYS[XP*[>L2Z\-17'BB/7XKZ[M[I;7[(Z1%-DJ!BZ[LJ3PQ)X(ST/'% 'G/A
M[4=8T3P1HNI6M^@M&UQ[66S,"D2))>.C$L>0P)R,8''(-=+>:UXCUDZY_P (
M\)DGTZ\-K;IM@,,CHJEA+O._DL1\N,#!YJXGP^M$\.6VAC5=0^S6]Z+U'_=;
M_,$AEP3LQC>2>E27/@2&37[C5K+6=4TXWNW[=!:2JL=R5&-QRI*L1P2N#]#S
M0!T]L\LEK"\\8CF9%+H&W!6QR,]^>]2TV*-(8DBC4+&BA54= !T%.H ****
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M(UVQ@@@J&RS;1@$C&,<5FZYI^IZ'HD-LWB&YE8>(;01""9P;>*61<PL2QW@
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ML"<8P2.G<TD-\MSXB5(-9LI;=K+S!8IM:4DL,3;@V=F"!C&.0<U836=+DO\
M["FHVC7>2/($RE\CJ-N<Y'?TH I0^$=$MHK6.VM)(!:HT<+0W,L;*K8R-RL"
M1\J]2?NCTK5L[.WL+2*TM(4AMXE"I&@P%%4;GQ-H-EYGVK6M.@\N01/YETB[
M7/13D\'VK4!!&1R* ,<^%M%-Y/=?8@'GE$TT:R.(I9!C#M&#L9N <D9X'I4T
M^@Z=<:S#J\L#F_A0QQS"9QM4]0 #C!QR,<U/J0U!K0IIC01W+G EG4ND8[MM
M!!;Z9'7K7,:7XGU+3]'\27'B58)!H<CC[7:QE$N4$8?A23AAG:><9X[4 =1J
M.FV>K6,ECJ%NEQ:R;2\3C*M@AAG\0*J6OAS3+2]BO$BFDN(5*PO<7,DWE \'
M8'8A<CCC''%84'B;4[*3PY-JXM_(UTB+9$A4VLS(71<DG<" 5)P.<'H<"3Q5
MXKNM)U71[#3X8Y/M&I6]M>2OR(DD/"C_ &R 3[#D]10!?/@GPV?$!UW^R8/[
M29Q(TH+ ,XZ,5SM+=\XSFG77@SP[>ZZ-:N-*A?4/ES+E@'*_=+*#M8C P2#C
M K=J&ZN[:R@,UU<101 @%Y7"C)Z#)H IR:!I<NLG5VM%_M Q>29U9E;;SCH>
MHR<'J,\&JZ>$M"CT3^QET]?[/$GFK"78['W;MRDG*G=DY!')S4MUXBTNVT*X
MUA;ZVELX48^8DRE69?X0<XSGC'K61X2U/4]=@L=8&JV5Q875FLEQ:1J"UM.P
M5@JLO8 D$-DY ]<  USX<TIK"[LWMWDBO%VW)DF=WF7&,,Y;<1CC!/2FKX9T
ME9].F%L_F::I2S8SR'R5(P0/F[CCGMQTJSK&KV6@Z3<ZGJ,RPVMNA=V/MV'J
M3V%<Q>>,'.O>%'M;ZS&CZDEPUT<ABACA,G,F<  ]>.W6@#L+FVCNH3%(90IZ
MF.5HS^:D&H!I.GKI3Z6MI"MB\;1- JX4JV0P(]\G/UI+75]-O=..HVNH6L]B
M 2;F.96C '7Y@<<4ZQU2PU1)'L+VWNEC;8YAE#[&]#CH: *^D^'M+T- MA;,
MFU/+5I)7E94_N@N20O X'%6;_3;/4XXH[V!9DAF2>,-GY9$.5;\#S5JN TWQ
M/KGB/P]J.KZ)=Z?]JMI)D72Y(&9T*,P578."'8#/3'.,'K0!W]8]IX6T6QG6
M6VLA&$E,Z1>8YBCD.<LL9.Q3R>0!U/K5J^UC3=+"_P!H:A:VI92P$\RIP.IY
M/09'-)=ZWI-@5%YJ=G;EHS*OFSJN4 R6&3T [T ,BT'3H=:EUB.!Q?S($DF\
MY_F4=%(SC [#%2ZKI%AK=B;+4K9;BW+*^TDC#*<@@C!!!'45RUAXT@C\4:_%
MJNLZ;%I%O%9R6,[.L:,)ED;[Y;#$[1R.W:NJNM6TZR@BGNK^VABE&8WDE50X
MQG@D\\<\=J *L7AK28+][Z&V:*Y> 6YD29U_=CHHPV !SC'3.:J3^!_#5SH,
M.B3Z5&^G0/OAA+O^Z;U1L[EZGH1UK3;6=+2*VE;4K01W7_'NQG7$W&?D.?FX
M]*6QUC3-4M)+O3]1M+NVC8J\L$RNBD=02#@8H =IFEV6CV$=CI]NEO;1YVHO
MJ>223R23U)Y-49_"NCW&K/JKP3"_=/+:XCNI4;9G.W*L,+GMTJW::UI5^)S:
M:E:3BW&9C%,K>6,9RV#P,<\T^SU73]1>1+*^MKEH@#(L,H<J#G&<'C.#CUQ0
M W3='T[2(Y$T^SBMQ*V^0HOS2-ZLW5C[G-5+?PMHMI<^?!9!/WQN!$)'\I93
M_&(\[ V><@9SS4'BSQ*OAK3[9HX/M-_?7,=G96Y;:))7.!D]E'))]JI:]J6O
M>%]%DUNXGM=1M[4"2\MHK<Q-Y?\ $T9W'E1SALY ZB@"_?\ @W0-3U">_NM/
M5KFXB\F=TD=!,F,8<*0'P.F0<4D_@SP]<6VGP-IJ(FG#%HT,CQ/",8(5U(;!
M[C/-7+?Q!H]TUND6IVAEN85GBB,RB1XRNX,%)SC'/2L3Q7XDFM-%T[4=#O;2
M:&?4;:WDD4"4.CRA&VL#@'D^M &YI&@Z7H,<Z:791VRW$K32A,_,Y.2>:;J7
MA_3-7NK6ZOK=I9K1_,MV$SKY;?W@%(P?>I;[6=+TMD74-1M+5GQM$\RIG)QW
M/KQ3UU73GU%M/2_M6OE7<UL)E,@'J5SG% "ZAIUKJNGS6%[&9;69=DD>]AO4
M]02#D@_K5&\\+:-?Z=9V%U9^;;V3*]L#*^Z(@8!5\[AQQUZ5HVU[:WHD-K<P
MSB-S&YBD#;6'53CH?:IZ .>;P/X::WN[<:3$D-W*LTZ1LR!W7&#@$=" <=,@
M'K5R7PWI<VH-J#PRF[:W^RF;[1(&,779G=TSS]>>M8UYXR-I\0[#P^T'^@W,
M;Q&Z["ZVK(L7M^[Y]]PKJ+FZM[* SW4\4$0P"\KA5&>G)H R%\':"D6G1)8E
M5TTDV>V:0&#/7:=V0..E;M8&J>,M"TK2[?4'U&VE@N+A+:)HY58,[,%/(X^7
M.3Z8-;D,T5Q"DT,B21. R.C JP/<$=: (HK&UAOKB]C@1;FX5%FD Y<)G;GZ
M;C^=%E8VNG6Y@LX$AB,CRE$Z;G8LQ_%F)_&G7-U;V4!GNIXH(EP"\KA5&>!R
M:IRZ_I4>CSZJM_:R6<(;=*DRE=P_ASG&<\8]: ,U/ /A9%15T:#:EQ]I126(
M23GE1G"@Y.5'!]*O#PUI(FU&46SB34E"WC">3]\ ,#/S>G'';CI6-X0U;4_$
M5OI^M+JEE-8W5H)+FR106MI6 955ASP#@AN>,\9P.GOI+F*RE>SA6:YQB)';
M:I8\#<>P'4]\ T -T_3[72K"&QLHS%;0*$BCW%@BCH!DG@>E9TGA+19'N6%M
M+%]J=I+A8+J6)9F8\EU5@&S[YXXZ5C6&L>)=-\:6FAZ\VGWEOJ-O+/;W-E"T
M1B:/;N5E9FRN&&#FJC>.;P^%I_&*+ =$BNS&+?RSYCVZR^4TN[/WLY8#&,#'
M4YH ZN]\-Z-J$-C%<Z?"\=B0;55&T1<;<#&.,<8Z$=J?8:'IVEWEW=V<#1SW
MC;[AC*[>8W3)!)&<<?3BL9]>U'5O$.L:7HKVT8TF&(R231EQ--(I94&",*%
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MR4V\RR;&]#@\&N;O_%F[QQX;TO3-3L;BTO6N%NHHB'<;(F93N!X&1Z=CSVH
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M!<CG!)&<\#I0!U\:"*-44L0HP-S%C^)/)IU%% !1110 4444 %%%% !1110
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M6..7>4"NQ'RDL,<^HSC-<QI5KJ[^)/"&JW&B:L&@M+B&_DGV 1R,L?W4#85
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M&V692K(-PWL5&22,YSD@8% '9WOCS1K&ZU2V9+^6?3 K720V<C%%8%MW3[H
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M%10!';V\5K;I! @2)!A5'85)110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$5U]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%M!QQTKMJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tardioagreementa01011.jpg
<TEXT>
begin 644 tardioagreementa01011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **KWM[;:;92WEY,L-O$NYW;H!_GMWJC;>
M(].NK^6P#3Q7L</VC[/- Z2-'TW*I&6&>.,D'@\T :U%<#X<OKCQ=?WEY_:&
MJ6<UAJ\T:(D;I"]O&P3RG5AM);DG^,$]L8KJ=3\1:=I5S]FG>5[@0-<M#!$T
MC+$IP7(4<#/'OVS0!JT57L;VVU*PM[ZSE6:VN(UEBD7HRD9!_*N>G^(?ANWC
MNI'NKCR[.X^S73BSE(@;CE_E^5?F')P#SCH: .IHK&U/Q3I6DS3Q7,LC/;V_
MVJX$,+2>3#S\[;0<#@^_!]*IWGC&UM_$ND:3%!/,FH0/<+<1PNZ; %QM('.=
MP)/0#KUH Z6BN<TS6=)23Q!=C5[J2*UN/]+%YE4M"$7*H&487&#WY-7+?Q+I
MMQ?M8[IX;OR3<+#/;O&\D8ZL@(^;'<#D<9% &O17,6OQ \.7GV%H+N9HKV<V
M\,QM91'YNXJ$9RN%8D' )!Z>HJU>>+]&L+B>*>X<+;31V]Q,L3-'#(^-JNP&
M 3N7Z9&<9H W:*Y);N\7XMM8F\G:R;1/M MR1L63S@NX #KCUS717VI6VG>0
M)RYDG?RX8XT+/(V"Q  ]E)_"@"W164OB'3WL8KI6F(FE>&*+R'$KR(6#*$(W
M9!5L\=!GI45MXLT:ZTY[Z*Z;9'<&T>-HF$JSYQY9CQNW>V/?I0!M45SS^-]!
MAL[RYGN98ELIUM[I7MY-\#L0%#*!D [A@]#GK5V7Q!IL&K3:7)+*+R&V^UM&
M('.8L[=P(&&YXP,F@#4HKC+KQWX;U;0;UX=4OX+4V+7!O;:UE!CC)VET;81N
M!_$=^AJW)XMM[/Q!HNAI#>3B\M&G^TF!WRJA0.@Y)W D]!WZT =117.:5K&E
M!]>NDU:[FCMKO;<K=!@MLX1?W<8*@XZ' SDMQUJPGBW1S-?0S3R6TUE!]IGB
MN87B81?WP"/F7@CC//'6@#;HJA8ZO;7]U/;1I<1SP(CR)-"T9"ONVD9&#G:W
M3ICFEO\ 5K73G2.0323NK.D,$32.57&3M4'@9'/J0.IH O45SW_";^'S:Z9=
M+>LUOJ<H@M95@D*O(3C82%^5L@C#8/!J\GB'3&L+J^,[):VLK12221.HWJVT
MA<CYOFX^7.3P.: -.BN-\3>)H+GPMXFATV]N;/5=.T^2Y*&,Q2H-C,C ,.0<
M=1^AJWX<\6:=?+INEM<3MJ$MBDRM+"ZK/A5WE'(VN02,X)ZT =/16%:^+]&O
M;NTMX+AV^VO(EK*86$<[1YWA7Q@XP?K@XS5.7XA^&X8[B1KJX\JVN?LMQ)]C
MEVP/P/WAV_(,L!EL \XZ&@#J:*S+_7K#3KHVLKR27"P&Y:*")I&6('!<A1TS
MT[G!QG!J&V\5:1>Z;!?VEQ)/!<MLM]D#[ICC=\JD9(QSGI[T ;-%9^CZW8:[
M:27%A,76*5H)4="CQ2+]Y&5@"I'H:IZEXOT;29KN.ZN' LO+-VZ0LZ6^_P"[
MO('&>OL.3@4 ;E%9FHZS9V<WV-I)VNGB,HCM83+(J#C?@ X&>F>IX&:YGP%X
MD#_#S2K_ %2^FNKBZN)XHG<%Y9R)I-H"@9)VKZ< =@* .YHK E\::%;Z7?ZA
M/=210Z>^R\1X'\R!L9&Y,;@",8.,'L:;9^-M"O\ 5I-+@N93=K$9T1K>1?.0
M=6B)7$@_W<Y[9H Z&BN8\.^-;/6_#O\ :\L4]K&9WB5)('RW[UHT"\?.QVC(
M7."<5=M_%>CSQ:B[71MSIN/MD=Q&T;PY&02",X(Z$9SVH VJ*X:/79KOXK6%
ME%<7\=J^E33/:3Q-$NX/&%< @9X+=<XZ<5N^*KVQLM-@^WZC>6"274*)-:!M
MQ?>-J$A3A6/!SC@]: -RBN?OO&FB:??WEC++<O=V<:RS00VDLCA#G# *IR.#
MDC@=S6OI]_:ZII]O?V4RS6MQ&LL4B]&4C(- %FBL)_%^C1W@MVN'P;P6'G")
MC$+@_P#+,OC&<\>F>,YXI^J>*](T?[2;R>0):[?M4D<+NEONQC>5! Z@^H!!
M/'- &U16/J7B?2]+69IYI'$$'VF8P1-+Y47/SMM!P."1ZX..AI\OB+346V,4
MKW37,'VF%+6-I6>+CY\*#\O(Y/7.!S0!JT5S\WC;P_#IMAJ+7^;2^F$$$JQ.
M09"<;3@?*<@\-@\'TI\/BS2[NTMY+=KII+KS/*@%K()L(=KL4*Y !XR1C) [
MB@#=HK@?!/BF,>&I[O4]0N;DS:S<VEH948RR_O"$0+C(.T=,#&#G&*W9?&V@
MV^C7&JS74D=K;7!M9RT#[HI00-C#&5Y(Y/'(YYH Z&BL;3_%&E:GJ5UI\$TJ
M7-M&)G2>!XMT9) D4N!N3((W#(I+7Q7I%WJ-I8QSR"6]C:2S,D+HERJ@%C&Q
M&&P"#[CD9'- &U16(/%FCF^M+4SR*;QS':S-"XBF<9^57(VD\''/..,U:UK7
M+#P]IYO]3E>*U#JC2+"\FTL<#.T' R0,].: -&BLQ/$&G2:\^B+)-_:"0"X,
M1@<#RR<;MQ&TC/'7K69=:]I-[>:"PU+4+8W-TPMHXX9(TNF"L"K[D^[P2.1G
M (S0!TU%<'J?C!]4T3QG!8B]L9](AF6*<0LI+)#OSD@@<D8'!QSWK2\,>+=/
MO;;1],EN9VU&>P257EA<+.51=Y60C:Y!/.": .JHJGJ>JV>D6JW%[+Y:-(D2
M *69W8[550.223C K+F\::);Z7J.H7%Q-%#ILGEWBM;R;X6P",J!G!!!!Z<]
M: .@HK#M?%VCWNI2Z?#+<&Y2W-RJFUD'G1@X+1DK^\&2!\N>M+:^+-'O/#ZZ
M[;W$LFG-)Y:R"VDW%M^S 3;N^]QTZT ;=%1S7$5O;27$\BQ0QH7=W.T*H&23
MGH *R[7Q/I=WJ%O8K)-%<749EMEG@>+SU')*%@,X!!(ZXYQB@#8HKS^SU&?Q
M=XBURSCO]5TYM/NH4LWABDC50(U=_,#+M)8L1A^V,>IW]?\ %46AZWHNFO:W
M,K:E+(I>.!W"*L;-QM!);(' SQDG% '0T5YY8^+HM"\1^,%UF_O9[2SNH#'B
M!YOL\;0J[$A%^1 6/) KL;S7;&S6,[I;AI(C,L=K$TK&/^]A0>.?Q[9H TJ*
MJ:9J=EK.FV^HZ=<)<6EPN^*5.C#^GI@]*XJ34Y?$_BW7]%6_U335L8[<6D]M
M%)'Y<C!W=WR-I!PH ?@@<=<T >@45AV_BS2)I[* 7,F+T[;2>2%EBN6 SA'(
MVDD D>HY&14,/C?0KC5#IT-Q</<K=?9'46LN(Y-N[#';A1CH3@'!QT- '145
MB0^*](GU"TLEGD5[T,;21X76.XVC)V.1AN.1SR.1D5'<^--#M%\R:YE\@W)M
M!.EN[QM,#CRP5!R<@CTR,9SQ0!OT5CWOB?3+$S"1YY#!$L\XAMWD,*')#.%!
MV\ G'7 SBJM_K&E3ZCX>*ZO<QF\E,EFMKDQ78\MCAV"D%<?-C(Y H Z*BN7N
M?B%X<M5O&DN;C;8S>1=,MG,1 V <OA?E7D?,>.N,XK6O-<L;*YCM6>2:YDA:
M=88(S(_EK@%\#MD@>YX&: -*BL_1M<T_Q!IZW^ESM/:L<+(8V0-]-P&1[BM"
M@ HK#UNPOY7N;R+6+NT@BM3LAMPF#(-Q+,64GIM  ([USW@B/6=<\)Z#K5SX
MBOFEN(2]U&5BVN"K ;<)D$-M(Y[&@#O:*\]\ >-;67PMX>M]6OKF;4;[=&+B
M6%V1Y=S$(9<;=V!PN<\?2NGU+Q9I&DF0WD\B0PRK%/<"%VBA=L8#N!A>HZ],
MC.,T ;=%5M0OH].TZXOI4EDC@C,C+"A=F &> .M8NB>+K75/#.FZM-%-#)?1
MH4@$#EG=DW;4&,N ,G(XP"<\4 ='17./X[\/1:=]NEO'CA%W]BD#P.&BGR!L
M<8^0\CDX%,C\>Z \UO!YUVDUPTJQ126,RNYC^^ "F2>G'4Y'% '345RI^(OA
MM=/>]:YN1#%*8;@_8Y<VK X/G#;^[Y_O8K4U'Q'IVF-.)WF?[-")YS!"TOE1
MG.&;:#UVM^1/2@#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#E?B%I6H:KX59-+C\ZZMKF"[6
MWW8\\1R!RF3ZXX]P*JRP2>(/'&@:Y;VMY;6VEVMR9VN;9X6=I555C"L 6QAB
M<9' YYKM** ./^'T5Q;VNMI<VEU;--K-W<QB>%DW1O)N5AD=P?K4'B1M1D\5
MFT_LN]DL)=,98KBQCPTDQ8_NY)<@HH&"!D DG)/2NWIDLT4$9DFD2-!U9V '
MYF@#F_AW%<VWP_T6UO+.XM+BWM4A>*=-K J,'CKC/K7(7MA?S>$/B):IIM\9
M]1OIGM(_LSYF5HXU4KQTRIKU:B@#S+7?[5OY-7L?[&U$P3Z(J63VL!3SY-CA
MEF?@C:2,(2 <MP<@4^Q@U&WU/P%?OH^H>7;Z7+9SH(OFAD*1!=XS\H.QN3^.
M*]*HH \HU/0=7U73O'<%E9W"7%QJ4%Y:+-&T:W*QK$2H) ')C(_+M70W,<GB
M/Q9X9UB"SO;6'2DN9KDW-L\3@R1A!$ 1ECG).W(^7KR*[:HS<0!Y4,T>Z)0T
M@W#* YP3Z#@_E0!Y/;Z=J*?#/1+%M+OQ=P:ZEQ)#]E?<D8NVD+=.FP@_IUH\
M6PZSJNF^*+0Z'J9G%[#):):0;89H5:(^8Q&/,D(4@@Y(PN ,$UZU'(DL:R1N
MKQN RLIR&!Z$&D6:)Y9(DE1I(\;T# E<\C([9H X^)+F7XL1Z@;&[CM6T/R#
M*\)VK*9@^PL,C.WWQVSFK?C73K75+>P@NH=27$Y>*^TT.9K.0*<.-H)P<E3P
M1SSZCJ** /*+BU\306F@ZQJFG7.LQZ==7<$\<$/EW$]O(0(Y_*&/G^7)7KAO
MK5K5+&Y2TTSQ'H7A>X@CL]4%Y/8&,)<W,9C:-Y"F?OC=PIYP/?%>FT4 >?\
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MYR #JKO6GO-6OM$T^P@OI+2!'NQ<3>6@\S.R/[K9)"DGC !'K7#^$M1M]/\
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MX> T..]TV3P_#*S6]P=_VI(BV[R]N-I/.-V>!SCM0!W#(KH4=0RL,$$9!%>
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MU>P)!/ QC)R(CI^GZW\1[;5-+U&*>W2U#:C';NKQR/&_^C[B/X@3(?\ @ H
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M71T4 16UO':6L-M$"(X46- 3G@# J6BB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)0D<J2/3I4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#&_X2'_ *@^K?\ @-_]>N+U?0I=4N/$7ER:Y;VNNPJD\(TY7*.J; 58M]W
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MCY%X^M>F44 <_9ZY/!:1QW-AJ]S.!\\OV,)N/LH/ _SDU/\ \)#_ -0?5O\
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M6>K)IU[8:G-$LQNI MLL,F KPCY&!09.[KNSV&.L7P3X>2QTZR73\0:<Q:U
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M=Q>NLEPXZR,JA03] !6(OP^\+JB(-,^2.Y^U1IY\FV*3))*#=A0<G*C /<4
M<3J2W\FD?$.[_MO5EDTBY>2RV7CJ(BL".!P>5R?NG(]L\UT-KJ$GB3Q7=:-?
M7=Q;I%I%O<PQV\S0M(\N[?)E2"=N$ '0$FMYO!^AO!J<#6LIBU1BUZOVJ7$Q
M(P<_-QP .,<<5'J/@?P]JHL?M=B[/8IY=O*MQ*DBI_=+JP8CV)- '/&YO7\0
M:7X5DU0WP32WE:X>X>V:ZE63RV.Z/DE0#P#W).<#'3^%+34+#1%LM3U-=2N;
M>1T,X)+;<Y56)ZL 0">^/6FZOX-\/ZY9V=K?:<ACLO\ CU,3M$T/&,*R$$#
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MZ8&%H1<2#R]W#'[WS$Y.2<D]Z /.[B&]3PKXZ9=;U@-H-U.=/;[=)NCVQ)(
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MR1\_>;=DGDC<><'&<4 <=I+WMK<?#J].JZC/)J]KY=ZDURS)*/LID!VYP&#
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MLH+8Z9QCGKS[US^EVMG!X*^&6IQQ1+?R:E:Q/=8'FLICD4J6ZD8 &.F !VH
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MXD!"GT)[&G?:K?8C^?%M<X1MXPQ]O6O/[;PQI7_"QM5L=/L+>/1+G1A%J5M
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MO9UNV/W!(3((-W;&\]^,@>U 'L*WMJ]NMPMS"8&Z2"0;3^/2G?:8/W?[Z/\
M>?<^<?-]/6N!C\/VVK>,_&&E>4K:%>V4 N8U V+=L&!*CH'V!&..<[2:3P>]
M_JX@L]0M@+OPPCVC,R826ZQM1U_[98;_ +;>U '?"[MFNC;"XB-PHW&(.-X'
MKCK0;NV6Y6V:XB%PPW"(N-Q'KCK7D_A1M UW2_#AO=<N4\0Z?=JTEDGDI<_:
M02)0XV;RARQ;GD<D\4S2WT37-.DL==URXM?$%IJTDDEI'Y*7)N!*2ACRF]@5
MV@8.,<< 4 >KZCJ-II.G7%_?3I!:VZ%Y)'. H%-M]3M+C3(]0$\:6SHK[W<
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M]J\JUG2/#]OHNFG3+UK^TF\5VT@F9D,:N[CS%A9  %]=O&<^AJU?V%E::O\
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M[OQ+X3O-'LY(8I;G8/,F)PH#!N@!STQVZUK65E;V<1\FSMK9Y/FE6!0 6^H
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M!]7CAN$C/RR1E)&(( R>5''?TJ_9^.O#]Y8ZE=_;'MTTSF\CNH'ADA!&02C
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ME020/04 ;E%,AE$T*2J'"NH8!U*D9]0>0?8T^@ HHHH **** "BBB@ HHHH
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MI;36[7X4W_@Z;0]3GU6VN/DEB@+17*&Y$GF*_3D'D=1Z=<>Q-+&C!7D56()
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M+12HEPK>8DG1@5&?4'.0!S7L=% %>Z1Y]/F14(>2)@%.,@D=/2O-K#1[W5/
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M.]MXS"RF:)6@)*YQD_NWXZ\>]>IVLYNK6.<PRP[QGRY1AP.V1V^E34A( ))
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M7>EE#!2P#'H,\FLC0_#EKH7GO'=7UW-,?FGOKEIG"Y)" GHH)/'O0!L4444
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MR.8H,NA.T%6 (/0C'>N=M? NI7'PEB\+7<L%MJ5N?,AFC<R1^8LOF(3P#C.
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M(5LDTM[-QYV7#M(KY Q@@;<=:N^,-&G\0^#]6TBV=$GN[9XHVDSM#$<9QVH
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ME@"3>L@V@AE; R#GT[&LG7_%,NC:UIFE0:1<7UQJ*3& I(B*6C7<5))X[<G
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MDS"VA#Q!Q--L#G?GHF6"X7!X)SVH ZZBO-;;QIKGB(^$6TJ2TL8]=M+II!-
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MUK&[RC3VC&'MED*'+]1)@%L]!TP>M '4:R-"LM2MM4U")GU")'-NT222RA
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MHK=Y9;6*2:(PRL@9XBP;8Q'(R.#CIFI: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R_$6@6?B;0[C
M2KTR+%+@B2)MKQNI#*RGL00#6%+X%FU'P]>Z7K?B*_U&2YA$*7#)'&85#!AA
M5&"257);.<=J[&B@#DE\#K/J\VHZGJ]U?M<Z:=.NHGCC1)HR6/15ROWCT_.I
M/#_A"ZT*.*"3Q#>W]K:(4L8+F-,0#!4;BH#2$ X&3C';ICJ:* .,B\ "'PUI
MNAKJLGDZ??+?1RF$;V<2&4 \XQN)Z#IBNEU?2;37=&NM*U!/,MKJ(Q2@<'![
MCT(ZBKU(3@$@$^P[T <G9^"9AH]SIFK>(=0U2WDM7M(?-5$,,;+M)RHRSXXW
M-GOZG+++P++;7^D7LVOWL\VFVKVBYBC4/$P7 ("\?<&3U/J*V/#GB"/Q%:7<
M\=K-;?9KR6S>.8J6W1G:WW21U]S5S[7<?VQ]C^PR_9OL_F_;-R[-^['EXSNS
MCG.,4 8D/@Z.:[L;C5[L:B]C:R6L3M"$>1)%"MYA!^8X'; Y)QGI%X=\%3:
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M),B;MN21D?>(.#S_ #JV/@>.UTZRTB;4);G1[&=9[:VD0;AL;<B._P#$BG!
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M8LP0\JKL>68 @9[\56N_ /AN]TBPTR:Q?[/I_P#QYLMQ()(.V%DW;@.!QG'
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M1^8(C)N7!&<L^1PN.]5+[5-9C^'_ (O8:E>6]QINN"WMW6Y9WCC+0?(9#\S
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M)X<TO6'U2RT\Q7#R&78)G\I7/5UCSL#>X% 'GNOW4GBCX,ZUXANKNZ6ZDGD
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M[F$*ZV\AD80EMRL ,;E!QQNK??3]'_LZ.?P[XD>WFN=:-U:7TX1[::Z,3[U
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M)VNS*6@9!U.08PI'8<<"@#V*BJ]BMPFGVRW;!KD1*)6'0O@;OUS5B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** &NB2##JK#K@C-(T,3Q&)HT:,C!0J""/I6'XUU/4-'\':EJ&EQ-+
M>01AE")O91N 9@O<JI9L>U9GA^Z369-,U3P_XFGU+2RS"\AF9&/,;;2?E#(P
M;;E>!ST&* .N\B+RUC\I-B\*NT8'T%'D0YSY29QC.T5DW7BS1[.YCBGN'1)+
MC[*)_)?R?.SC89,;0<\=>O'7BDU+Q;HVDF8WERR16\B17$RQ.T<#-C:'<#"G
MYEZ],C.,B@#7^SP8QY,>/3:*&MX7D21X8VDC^XQ4$K]#VKG[;Q=;W/B[5-#^
MRW2_8(8G:7[-(0S-O)Y Z808)^\2<9HT+7-)A\*6M]%J]W?V<TSQPW-RK--,
MYD8; H4$D$$ 8Z+^- '0R0QR[?,C1]K;EW*#@^H]Z3R(2NTQ)C).-HZGDUC_
M /"7:,MGJ-S+<21#3!F]CD@<20#&02F-V".00,$ \\4FG^,=%U/4K>PMKB4S
MW,)GMR]O(B3( "=CD!6(R,@$X_.@#8EMK>8*)8(Y N"-Z XQTI98(KA DT22
M*#D!U!&?7FH=3O/[.TJ\OO+,GV:!YM@ZMM4G'Z5P)\1:E8>%_"_BIM1DN1J4
M]LE];D+Y>V?C" #*E"1CGD YR>: /16BC9@S1J6'0D<BD^SPX(\F/GK\HKSO
MQ5XCE_X2]-(EU[5/#5L D4%T+!6@NI6Y(\UU*C' '3G=STKKM>U&XT_3A:V+
M"34I8V$+2#(4*/FE8#LO'IDE1QF@#5>V@E14DAC=%.55E! /J*<T4;,&:-2P
MZ$CFL'P+?76I^!-#OKV9IKJ>SCDED;JS$<FM6_U2TTWR5N';S9V*0Q1H7>1@
M,D*HY. "2>@[T 6!!"%91$FUAAAM&#]:1[:"21)'@C9T.59D!*GV/:L"_P#&
M%BGA75M7L&DG>P257A\A]\<J*3MD3&Y>V20!@YSBH/!\4][:V6MMJFI2"XL8
MUN;6Z5A&TQ"L94#@%>I&%^4Y]J .KJ)+>",Y2&-3N+950.3U/UK#U;Q7#I7B
MC2=$:UN7>^660R) [JJH.@V@Y.2N?0=<9%<WH7C*WT:7Q*NO:G=S1V^MR0)*
M\+2""+9'MWE%VQKDG!.!G/O0!Z#]G@QCR8\?[HH:WA?R]\,;>6<IE0=I]1Z5
MGZGK]AI/F"X:9VBB\Z18('E,<?/S,%!P.#]<'&<&KME>6VHV4%Y9S)-;3H)(
MI$.0RD9!% #S!"T'D&)#%C'EE1MQZ8H\B$HJ>4FU1A5VC 'M7%:Y<ZF?B;HN
MD6^KWEK8WEG/-+%"(^63;C!921UHO-9U;PGXRT?3]0OFU+1]9D:WBEFC19K:
M<#*@E H96Z=,CU]0#N0,# Z5"UI;-*DK6\1DC&$<H,K]#VK*NO%NC6;OY]RZ
MP1S_ &>2Y\ES#')G&UI -HY."2< \$@U+JNM65HTMFT]P+D0&5A:PM*\2<C>
M0%..0<9'.#@'!H TI8(KA DT22*#G#J",^O-++#%/&8YHTD0]5=00?P-<9X&
M\1Y^'>@7NK7DMQ>WJE5.TR2SON8\ #)X!/H .P%/\#:M<:IK'BM9;RZN(+?4
M5C@6Y4HT2^4A*[<#&&)[?G0!V+(C*%9%*C& 1QQTI!%&'WA%#_WL<UQWQ(U*
M^TC2M+N;#49;)I=4M[:5DV$&-VPV=P...]7K>XAM;^:\3Q+<7MI9VY:[@8)*
M%W<JP,:9R-K<<\'ITH Z)+>&.5Y4AC61_ONJ@%OJ>]'V>'!'DQX/^R*YRV^(
M'AN[MS/#>R&'RHI5<VT@$@D;:@0[?F8L<;1DYX['%F3QCHD-AJ5Y/<2PQZ8V
MV\1[>0/"2H897&<$$$$<>] &Z%55V@ +Z <4R&WAMU*P0QQ*3DA%"@G\*Q[+
MQ7I&JZE_9=K=3+=20&>(M;NBR)P"T;,NU\$CIFL+P1XC*>$;&35[RZNKNYO[
MJWC;RFEDD*S2 <(#@!5ZX  ':@#MFBC>1)&C1G3.UB,E<^A[4^@'(!KA=,N]
M3C^(>O\ AS4-6NFBFLX[S3&P@,<9)63!V\D/C&<\4 =R % "@ #H!3#!$Q<M
M$A+@!B5'S#WKSGP9XIO-0^'.J7%[J,UWJUE--;F8!4:5R?W)08  8,@''.:Z
MW^U[;0+>UT[4+VXO=06V,TA2$R2.JX#R%47@9/IWP,T ;)@B+%C$A)ZG:.:1
MK:!XC$\,;1GDH4!!_"N.\2:T\[^#=0TC4Y/L.H:I%&WE'"3Q-&[<\9_A''YB
MK.@WEY)\0_%EE/>336UO'9/!%(1MBWK(6"@ >@]^* .K2-(\[$5<G)P,9--:
MW@>99FAC,JC"N5&X?0UD>,-0U#2?"&J7^E0&:^@@+Q(%W'/<@=\#)QWQ6+X=
MO8]<.EZIX>\47&HV D(OX)V1F(,;X)&T,C!]ORC ]J .T=%D0HZAE88((R"*
M$18T"(H55&  , "N2LOB!ILT6O7-W%=VEII-R\+RO:2_=5$+,<*<'+'CK@ D
M"M"T\8Z+>I,UO/,WEO&@'V:0&1G4LHC&WY\@$_+G@$].: -N.&*$,(HT3<=S
M;5 R?6E=%D0HZAE88*L,@BLBU\4Z1=VEU<1W+*+686\\4D3++'*2 $*$;B3D
M8P#G/&:S=7\?:7IVA:U?1)<2W.E)F>S:!TD4L,H6! PI_O=,9^E '3K!"D(A
M2)%B' 0* H_"G)&D8PB*H_V1BH+"[6^LHKE4D0.,XDB:,_\ ?+ &N0\276I)
M\1O#>EVVK75K9:A!=//'$(^L2J5(+*<=3F@#M6BC8DLBDD8)(ZCTI/L\/'[F
M/CI\HKCO ^NZEJ6M^)=-NKO^T;#3+E([34=BJ9=RDNA* *2AP"0!UK;C\5Z/
M+J%I9BXD5[TL+61X76*<@9(1R-K<<CGD<C- &L8(3.)S$AE VB3:-P'IFGD!
MA@@$=>:\^@U:3Q1KNOP?VGJ>E+IES$+::.*2-$18UD<RAEVG<21A^P&/4]3;
M>*=)NKVVM%FECENT,EKYT#QK<*!DE"P ;CG'7'/2@#4CM;>*5Y8X(DD?[[J@
M!;ZGO2F"(EB8D)<@L=HY(Z9KG(_B!X<EG:&.[N'9))8GVV<Q"/&-SAOEX( /
M7K@XI8OB!X;F-B5O95COTWVTSVTJQ2_+NVARNTOC^'.>V,\4 =&(HU<NL:AC
MU('-(+>$3F<11B8C!DVC<1Z9K/T;Q#IVO?:ELGF\VTD$4\,\#PR1L1D91P"
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MTPP^N:]=HH \VDT^_MO% U#P^NIVLMQJH&HZ;<0.UI/'OPUPK,-J-M ;(/)
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M\3/$,\]A=M;7]I:-%<QQ%H_W2R!P2.ARPPO4YZ5V=% 'D6D:5K%EX5\&W_\
M9MZ6T;4KF2\LC"PE\N5I1O5",L5#@X&3R>]:/B#2KK4[GQ?K=I9W?DW>@?V;
M;Q&W=9+F8^8=VPC< -RKD@=^PS7I*312 E)$8 X.U@<'TI] 'GP@N6\0_#^8
M6-[Y=G9SQW+FV<"%FA15#<<?,I'_ -:N]FE6"!Y65V5 20B%V/T Y)^E244
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MK223F3:H&'&<D D<FK47A_5X/$WB+4E%F\&HV<-O &G<.&C#C+_)@9W]L]*
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M![)Y9(I'2YW2V[+NP)(]ORD[?7C(ZU1\*Z1XPT>"TT;4+O3)=*L0(XKN+?\
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MQ"8OD_=^^><>GO0 L'BW3],M?%.HMH\5BUAJ*07+"0?OW81@2NP7Y0 ZY/.
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M)IDFFR2L]E=S3.LD:-+YA1T"$$@Y^8-^% 'J%%,B\PQ)YP428&X(<@'V)I]
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MUI\^M3Z/'<AK^"(320[3\J$X!SC'7WI^F:I9ZS8)?6$IEMW9E5RC+DJQ4\,
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MR74#(Z#@YH [BBN$OO$?B345U>7PY9&:33KQK6*!DCV3LFW>'9G!7)) P.,
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M=T5YO<^,M<DT5M5LFMXY_P"V_P"R_L$L!?:OF^6"0&5C)C#]0,<8[UH7^O\
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M  SD#&< 9-8[?#N&7PY-I,NISB3^T&U*VO(4"26\[,7W+R01EB,>A/UKM:*
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M44DX +,W).2?3 '2T4 <;?>!KFY32KNW\0W=KK6G1F%-02%#YD9QE'CQM*\
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MS_:.-VWTFTM=6O=3B6075ZL:S$R,5(0$+A2<#J>@YH O4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** 0>
MAS10 4444 %%%% !1110 4444 %%%% !1102!U.* "BB@$$9!R#0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%% (/0YH ***,C.,\T %% (/0T4 %
M% (/0T4 %%%!( R3@4 %%%% !1110 4444 %%%% !1102 ,DX% !1110 444
M4 %%%% !1110 4444 %%%&0<\]* "BBB@ HHHH **** "BBB@ HHHH ****
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MN><_(%"DG=@X[9XK$^S:M>:;XDT>?PY]DU?6K"5OM+:@DXF.P1#>0J[ H9<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M.9\?W:VO@V]5IY+9;C9;M<)%Y@A5V"EW']P G/MZ5SGAC=-?"QM=7\-ZWIEW
M&T-ZNF67E-''L;:69'9<9PH4X/S<=#7I-(JJHPH 'H!0!QUGX'GBT6QT"\U-
M+K1K&>.2%#!B9TC;='&[;L$*0O(49"@<<UJ:QX6MM7\0Z1J[RO'+I[-N5>DZ
M'#!6]@ZHP_W?>MZB@#E-=\*:A=^(X-?T+61IFH"#[+<"2W$\4\08L 5R,$$G
M!![XI\_A6\EUGP_J)U<.^E&9G\ZWW-<-*N'.0P"CT !QP.E:</B"TG\37&@+
M'.MW!;+=,S)A"C,5&#G)Y![=JLZ9?_VG8)=&TNK3<S#R;J/9(,,5R1D\'&1[
M$4 9*^'+N/Q7J>N1ZA"/MMI':K"UL3Y>PL0V[?SRYR,#M6%%\.KVQT?0(],U
M\6VK:)&\,-X+7*31-C<DD9;GH.<\$5W]([K&C.[!549+$X 'K0!R&I^#;[4+
M?3+O^W&&OZ?<FYBOFMP8R678R>4",(5 & <\9R23FYH7AR_TSQ'J^LWFIPW,
MFII )(HK8QJAC4J"I+L<<G@Y^M;%SJ M[RQMUM;J<7;,OG0Q[HXL*6RYS\H.
M,#W-7* .>USP[>:CX@TG6+'4TM9K!98S'-;^<CK( "0-R[6&W@\]>AK#@^'M
M[;Z1I^GKKJ.ECK']IQM)9Y+?O&<(<..<N<GZ8 [][10!QFI> 5UB[\2M?WZM
M:ZY;PPM%% 5:$Q9V,&+')R<].PIT'A379=:T'4]4U^VN9=($R#R[$H9Q(H4E
MLR'#8&<CC/:NQJAJ6K0:8UM$Z237-W(8K>WBQOE8*6(&X@#"J3DD#CZ4 5_$
MWA^#Q/H%QI<\TD'F%7CGB/SQ2*P97'N"!62OAC7KS0=1L-8\1QWEQ=6DEFDJ
M60C2-7&&8H&^9SQSD =AR<[VCZHFLZ<EXEM=6N69&ANHO+D1E)!!'U'4$@^M
M3:A>QZ;I]Q>RI(\<$9D98UW,0!DX% '.)X1NUO/"UP=4A/\ 8,3Q;?LI_?[H
M_+)^_P#+P/?FFP^"?,7Q-!J=['=6FO.7EBCMS&T7R!.&WMG 4'IUKHM(U.#6
MM&LM4ME=8+R!)XQ( &"LH89 SS@U<H Y6U\*7DB:-#J^I17L6CR"6WV6YC:2
M14*(\AW') 8G  R>?:C3?!@@T;7]*U*\2\M=9N;B>01P&(IYWWE!+-G'8UO&
M_P :PFG_ &2Z.Z S?:1'^Y&& V%L_>YSC'0&KE '*:%X6U:QM$L-9U_^U+""
M(PP1"V$3,A4K^]8,=Y"DCMZG)QB+PWX1UC0A!83>)'O-$M#_ *+;-;!90H^Z
MCR@_,J\= ,X';@]A10!YV_PWU%/#%UX7M-?BCT5KA9K5)+,O- !,)=F_> RY
M!QQGGK7?2P-/9/!)*P9XRC21_*02,9'I4U8,WBNUCOQ;Q6=]=1"\%C+<V\0>
M.&8@'#<[L#< 6"D GD]: ,'3/ .I6+>&C)X@BD&@F1(0EB$\R)D*$-\Y^?'\
M73_9JSHG@K4=!G>RM/$##P]Y[3QV/V8>;'N;<8Q+G[F2>-N<$C/>MZZ\06EG
MXCT_0Y(Y_M-]'+)"X3]WB, MDYZ\CIGK6K0!QEKX+U'3=6U#^S?$#6^BZA<-
M=3V1M@TB._WQ')GY0WT..V#S5M?"UYI^MZM?:-J45M%JN'N(9K<R!)@NWS$(
M88)&,@YY /M7444 <C;^!UT_4O#4NG7B0V>A6\MO' \!=I1(%#$ON&#\H/3J
M323>$+^W\0:MJ&D:M%;6VKH/MMM/;&7$@7;YD9#+M)'7(([UU]% '%6G@6[M
M=/\ "EK_ &Q$X\/ON5C:']]\A3'W_EX8^O-.F\#W<VF^*K(ZM"!X@D9V;[(?
MW&Y!&0/WGS<*/3FM[6O$%IH4FG)=1SL;^[2SB,29 =SQN.1@=?RK5H \J\2O
M%%XCL=.O?$>E:9)I^G*B/JU@&@N"YPS1[G&" @!^8]<>M=OX1GOI]'9;Q[.5
M(I/+MI[.!H8IH@JX94).!DLO!P=N1P:W656QN ..>12T <[<^%WG\7R:VMZJ
MV]Q8K8W5H\&[S$5F88;/RYWD'@\=,'FLVT\"S1:#;>'+K4UN=#M9TDCC: B9
MHT<.D3/NP0"!R%!(&..M=I10 V1!+$\;9PRE3CWKAK?P#J$'A[0=(.NPO'HU
M[%<PN;'[ZQYVJ1YG7GD^PP!SGNZ* ..OO :ZI>^)7O[\/;:Y!#$T<4)1X#%G
M8P;<<G)STZ@5H>'M&UVP96USQ#_:AA39"$M1!G_:?!.YL<=AR>">1T-% &%X
ML\/S>)='33XKU+3%Q%.7:$R9\MPX&-R]2HK$U?P)?:G<>(]FN+#;:[;)%.AM
M-[QLL>P;&+\(>I4@GDX(SFNXHH YG5_""ZWH>EV%[>L9[&:.7[3$FPN "KJ!
MGY0R,R]3C/?%6+#PM:Z?XMU+7H78->Q1IY &%1@,,P]V"QC_ (![UO44 <I/
MX0GU#4M.NM2O;>X.G7S7=O,EL4G"DL5B+[C\HW 'CD*.!UK7\1Z#:>)_#]YH
MUZ76"Y3:70X9"""K#W! /X5J44 <Y;^';V?4=+OM:OX;R?3$?[.8;<Q!I&7:
M9'RS<[<C P!N)],/\->'KK0;G6))K^*Y34KY[TJEN8S&S*JXSO;(P@KH** ,
M'Q+X?FUQM*GM;U;2ZTV\6ZC=X?-5OE92I7<O4,><U1'A&\%]XENO[5B8ZW!'
M"0UH<P[(R@/#C=D$GH.:ZRB@#A6\!:C:1:'<Z1KZV>JZ78KI[3FTWQ7, QA7
MC+<$$9R&ZYKK]-M)K*R2*YNWN[@DM+.RA=['KA1PH[ =@._6K=% &"=+UJVU
M74;NQU2V\F\D606]S;,XB(C5,JRN#SMR0?TYSDO\/Q'X>LK"SU$17EKJ@U4W
M+V^Y))]Q9LQAAA3N( !X ')KM** .#U7X?W^I+XBA'B );:Y$BS![,-(CJ@0
M$-N V'&=N.YP16J/"UXOB:PUO^U4,L5A]AND-J,3)O#Y7YODY&.=W!]>:Z>B
M@#C/#_@S5?#[I80^(WD\/0R^9;V1M@)47=N$9ESR@/MDCC.*Z+7]$M/$>@WN
MCWP8VUW&8W*G!7T(]P0#^%:-% '-6WAJ]FN=(FUO48KXZ22\!CMS&9)-I02/
MEFR0I/ P,G/H!+X?\/76BZIK-Y-?Q7"ZG=?:3&MN8S&VU4QG><C"CM7044 9
M>MZ9=:I%:I;7<5OY-S'<,9(#)NV,& &&7&<=>:I>*_"%CXLM+1;L^7=6<RSV
M]R@^9&!!(_W6 P1_A70T4 <EJOA/4V\3OKV@:X-,N+F%(;V*6V$\<X7.UL;A
MA@"1G/\ ]>WKOA./7- M=-FOKA9K>XBN$O ?WN]6RS<8P6!<<<#=P.,5T5%
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M_O'&<]*L/X/U:T\0WVH:)XB-A::DXEO;5K19?WN IDB)/R$@#J&&?7I7944
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MI[R"[C@^SN;><QB:+=NV/CL#D\8/)YH X :G>ZQX!\!7^H7#7%W+K]MYDK
MMB20#@ #H!6U<7GB/Q+)X@70[M+2YTZ]-K:[IPJ(R*A)D3RVW!B3WZ8Q@@DZ
M\/@'2;?1=,TJ">^2VTVZ%W;_ +[<1*"2"<@\ D_*,#GI2WW@/2;[79=7$^H6
MEQ<*JW:6=VT*7048'F*O7CCC'% &!KWB/4=*U%VUJ:ZL=/FA@%KJEAB2U@E(
M&]91C(!8\,1C:1C!R:]'!R,BL&]\)V5]]MCEN+H6=\%%S9JZ^5(%4+C&W*@A
M0#M(S6A;Z5%;:M=ZBD]RSW*1H87E)B0)G&Q.BDYY]: +U%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%!8;B%!Y(XR16M0 444Q)8Y=_ENK;&VMM.<'T- #Z*** "BBB@ HHICRQQ%
M[JI=MJY.-Q]!^1H ?163I?B"WU75M6TV*"XBGTR2..;S5 #%UW K@G(QCKCK
M6M0 4444 %<I-IYTGXAG7#Q9ZE9+9SOVCF1LQEO0,&9<^H [BNKH(!&",@T
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M #(5D2!%FD$DH4;W5=H8]R!S@>V33Z** "BBB@ HHHH **** "BBB@ HHHH
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ME@T]Q*<O(0,#/0  =   .>.34.J^';#6+^PO;H3+<6#.87AF:,X< ,IVGD'
MR/:@#S*Z;4+'0?B#K-AJMU9S:?K,T\20[=KLL<1^?()8$<8X%=1=W^J^(?$6
MKZ/8SBV-E9P/'MNV@822JQ\SA&W 8 P>.#D'(QK2>"-*ET[5K!Y+MK?5IC->
M*9?]8Y !.<?+D # QTINJ>!=)U6\M+Z26_M[ZVB\@7=I=/!*\7]QV7&10!JZ
M"-1&AVB:O/;7&HHFRXEMC^[=P<$C@>G(P,'-<9IFMW:>*K;2]??4;&^FN9S!
M*'+6>H1$/L6,CA&52IQP?EY))KO[6VALK6*VMXQ'#$H1%'8"LFV\+6-O+:EI
M;J>*SF:XMH9Y-R12$,-PXST9@ 20,\ <4 <,=>U<?#0ZE_:5Q]MAULVPFR,M
M']L\K:W&#\G%7$TBZUCXB>-(+;6;W3&$-@1):;0Q;RY,9+ \#T&,^M;D_P .
M]"N8[N&0WWV:ZNA=M;K=NL<<N\.60 _*2PSQZG&,UH3>%;&34KB_BGO;:>ZB
M2&Z,%PP\]%!"[LY((!/S##<]: .+TKQ+K>I:=X O;F]>.2^O);:]CC50D^Q)
M0'Z9Y* X! YZ59%WXE\36&I:CH]_;6=U9ZE-!$9KMEBC2&3:4DB$9!W*,DDY
M&X8( Q6E-ILFHZ]H-K9Z1<:=8Z!>.^Z1%6-XQ"R)Y>"<@EAZ$ '..,WI? .A
MRZ]/JRB[ADN6#W5O#=.D%RP[R1@X;WSP>^>: ,VWGU'Q;+XFBM=7ETV[TZ]^
MR6?E'*Q;41O,=?XPQ9A@\8 P,Y)BL+=I?C!=R&^GE']B6TPV2'RV)ED!P.0%
M. <5LW_@71M0UV35V^V07$ZJETMM=/%'=*O $JJ0&XX^G!J_)X<TZ3Q##KFV
M9+R. 6_[N5E1XPQ90R@X."21GUH R/B)>W^G^'[:YTZ^EM)?[0M8F*!2'5Y5
M4@Y&<8/8BLU+;4V^(.H>'3XBU,V,NEQ7V[<GFI(9'0A&V_*IV@X ZCC R#UF
MN:%:>(+..TO6F$*2I,!$^T[T(93GV(!J,>';4:])K8GN1?O;"T+[QCRP2P&W
M&/O$G/K[<4 <9H6N:AJOA7PH][JDSW-S)<)-;VZ[9[X1ET&'! 0#"LQR!T&>
M<''NKS4-8\%:.U_>W1F@\51V98289D6ZVKO(X8@ <^HSUKN(OA]HD%MID$+7
MT7]F22O:R1W3JZ"0YD7<.2K'K^F*>/ .A+I5QIJ)=+!->"]!%R^Z*8/O#(<_
M+AN>/6@#"\MM/^*6KW'VJ]F6UT&&<1M,3N(>3C'H=H_'FGZ*WB;5K3P[X@@U
M.V2"Z5)+Y7NV=)4D7[J1^7A'5B ,'M@ENM=1_P (OIHUN#5P+@7<5N+;/VA\
M21@EE#C/SD$DY.>M4=(\ Z)H=^US8?;(X@[2169NG:WA<]62(G:#R>W';% &
M5X'CU75)[S4+[7[^=;'5;VU6W(C$<L:N57> N<C&1C XZ=<R^/HY)=7\&QQS
M-"[:Q@2* 2O[B7D9XS]0?H:Z/1- M- BNH[-YRES</<R"63=^\<Y9AZ9/;I1
MJN@VFL7>GW-R\XDL)O/M_+?:%?!&2._!(YXYH X.3Q'JGA^'Q38'4);D66JV
M=K;W5XP+0I<"+<6;;C"[V()!QQP>E:.IV_B?2+7Q!=?VJD%C_9,L]M$+HW$\
M5Q&"2RF2,?(1C(.<'&,9K?D\&:/<?VR+J*2YCUG;]MCF?*N5 52,?=( &,8Z
M#O4-EX&TNRTF[TX7&HSQW4)MWDN;MY76$C!C0MG8N/3'Z"@#FTO=6TW1O#D[
MZU=74_B%[6!_M,BQQPGR7<B-@A*ER O.3SGKS3M5U#Q)X3LKX75_ UO>W]I;
MV+>>9Y;))6VR,S.@W 8)7.>>N<5U=YX0TC4?#$7AZ\BDGL8518=TA\R/9]PJ
MXY!'KU]<U'%X+T==#NM(NEN;^"[ $\E[</-*^/N_.3D;>HQC!Y'- &9//?:/
MX_TS1H[RZGTW6+.X)660N]O+$%.]7/(!#XQT!QC%0_#&T\G3]9D^T7$G_$YO
MDVN^1Q,><>OO72V6@6]G<_:FN+JZNUA^SI<7+AWCCSG:.,<D DXR<#).!1H?
MA^T\/PW$-E).8YYWN'663?F1SEFR>>3VZ4 8_B.XGDU]+&&_N3_H$DHL;,^7
M(&W "9Y,@!!R IZDGAL<<U8ZWKFK6/PYF;6+B!]621;SRD3$A$#MNY7KD?3/
M:NWU#PKINI:W%J\WVE+M(#;,8+AXQ+%G=L<*1D9)/XU4LO FCZ?'I$=L]XJZ
M2S/:!K@ML+#:>N<C:<8Z =* .2/B;5-%T[6]..HS3R1^((-+M;RXVL\,<PC)
M9CC#%=S8R/3.:UK>Q^P_&>W5;JYF1] E(6>0R%3Y\><$\\^G3TQ6U-X'T6ZM
MM7MKJ.:XAU:0372R2'F0  .N,;2-JXQCH*=8>#M/L-7M]5-SJ-S?06YMDFN;
MQW)C)!P1G!Z#KZ9Z\T ,\97.JV=E9SZ;:7%["EQNO;:TDV7$D.UO]6<@DABI
MP""0,=ZYJ/Q$UQ!X1N=*UB\G@N]9DM;@7 VOLVRMY4BD<,F%7/7CJ<UW6HZ5
M%J3VLC3W$$UK(9(I('VD$@J<@@AA@G@@BLVZ\%Z3=Z9'9,+B-H[PWZW,4I28
M7!))DW#N=Q'I@XQTH XWQ%K>L6=A\1OLNJW,)TO[.]FPVL8@T*LR@L#P23[C
ML15^^NM:\+^,=%D;5[O4[+5HK@7-K,JXC>.(R*T6T#:.",'/N2:=XP\&V]IX
M0\3G1[:^N=2U>!8V3S7E,C* H."<9P,EC[\]JZC2]$M4DM=0D>[N+B* Q0&[
M/S0(<;@!@<G R3ECCK0!RVB2>)M9L?#OB*WU*UCANO+DOEDO&:.6.0<HD?EX
M1U8@+@]1@ENM0:$GB/4[#7[^+Q'=O>:?J&H6MG#+Y:POM!6/S/E['!XP..G7
M/1Z5X!T31=0:ZL?MD<7F&6.S^U.;:*0]66(G:#R>W';%6K3PGIUGIFJ:?&]R
M;?4Y)9;D-,<EY/OLIZJ3[=.V* .*_P"$V?3M&UV<_P!I6.L65E&9--U,EQ$Q
M?;YZ/R'3+#../EZ#-:M_-XA\,?;=>>[@GTF'3997M);QIWDF12ZLA,:X! .0
M#C'('%=&/"^G2-<-?"74'N+7['(UT0Q,&<E. ."3DGJ>,G@55T3P/H^A120P
MF\N86B,"17MT\Z11'K&BL<*IXSZXH Y/5()Y5^'FJ3ZC<7,UUJ4$DVY\QNSP
M2-N5>B@<@ 8X/.3S5B*[\3>)=+N=7TB_MK2YMM1FC7S[QEB2**4J8Y(A&1RB
MY)SG+9! XK;M_AUHEO%8PK-J36^GW N+.%KZ3; P! "\YQ\Q[^W3(J9O .A_
MV[/JT8NX7N9!+<VT5TZ6]P_]Z2,'#'USP>X- &'J&NW>F^*VM];?4+*VGU"(
M:?J,#;[1X\J#!(!]QB0PRPZGJ ,5UOB>Z>R\,:C<QZC%ITB0,5NY4WK">@;;
MW/H.YQP>E0R^%K&>67SI;J2VEN5NWM7DS$90P8'&,@!@#M!P2.0>:O:SI%EK
M^D7.EZC$9;2Y3;(H8J>N001T((!_"@#BK/4=33Q7JVDI<ZC;VQT-+V'[4ZR2
MQR;W4N-V[&0H^4],=!TK.T?4M:BTWX?ZQ/K=Y<R:M(EO=P2;?*97A=LX SN!
M4'.?7MQ781>"-+BOS?B?4'O#:&S>>2\=V>/)/S9.">3CTSQS2IX*TN.QT>S2
M2[$&D2"6R7S?]6P! R<?-@$CG/6@#GCJVHZ+JWB+P]=WUQ<7ERJ3Z+)*_)20
MB,(,?\\Y#DGKM()Z5WUO%]ELXXGF>3RT :64Y9L#DDUS5G#-XB\36NJW^A36
M TCSX[=[HH7D=\*63:3A=H/7J6&.E=2Z+(C(ZAE8$$'N* /---UG4UUWPB5U
M.ZO(-4EN8[FZ;Y8+K$;NK11DDH%*@ @#(_O YK-OM3UZ#PAXJUL>(;XW&C:S
M-';)B,(R)(@VN OS#!(P,#OUKM+3X=Z%9KIRQ&_QILK26@:]D(A!!!1>>%P2
M,=^AR*ED\#:3-H^IZ5(]VUIJ=PUS=(9N7D8@L<XR,D#@8''UH JPWT_B'QIX
M@T@WEQ:P:1%;I&MN^QFDE0N9">X P #QP<@\89\)\CX7Z$"<GRGY_P"VC5J7
M7@_3KG68]7\Z]@OQ"()9K>X:(W$8Z"3;C/UX/O5S0-!L?#6CPZ5IPE%K#G8)
M96D(R<GDGCGL.* .$\4:WJ5C!J^HV.IW%Q+9ZK;Q*T/R6]NA>)6@=2?WC'<Q
M) .-PY&,5N+_ ,EIE_[%U/\ TH:K%Y\/="OAJ2RB]6+49Q<S0QW;K&)@0?,5
M0<!B5'-:4?ANSBUW^V8Y;D7GV0688R[AY0.0,'.3GG)YSWH Q?A;_P B-%_U
M^WG_ *4R4L-[<>(_&/B31VO;FSATF.W2$6S[&+RH7,A/?'  /R\'(.:WM"T*
MS\.Z=]@L3-]G\QY LK[R&9BS<GGDDG\:BO/#5E=:Q_:T4MS:7[0^1+-;2;3+
M'G(5@00<<X.,C/!H \XMM1U#Q+)X!NM2NIX[K^T;RUF:W?RTD:*.5?,"CC)V
M_AD@8JQ?07G]L?$V\L]5N[&6R2"XC-N5!9TLU8;B0<CCIQG)SVQW5UX0T>YL
MM,M!#+;QZ9)YEJ;:9HVC."I^8')R"<\Y.?6F'P?II.LGS+K_ (G*!+T>;]]0
MFP <?+\GR\8X]^: .?AUO4_$.J66E)((R^AP:BX2Z:V9WE)!(*HQPNT<<#YN
M<U4F/BF+4/!ND:EXA*W5T]Y;WTMAM*R;(G96RR AP,9XQD9Q71W_ (!T;4(-
M,5GO8+C3(O)M;NVN6BG2/&-A=<$C '7^IJVWA+3#<Z3.AN(WTHN;7;,>&<$.
MS9R7+ G);.<D]30!J:?:R66GV]K+=37<D481IYL;Y"!]YL #-6:** "BBB@
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MT-G8.96R;4,P"AL\@,&&?;BNJMM,TVS^(T7AB2QB718]):>PM)1OB:5IB92
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M?"8E@C_MRVS/*88V^;:7!*X+8P.00,D9QQ4,.H7X^*ESI;WDCV']CI=) RJ
MDAF9"00 3PHZD]Z -RWT/2;2\:\M]-M(;EV+-+'"JL6/4Y ZGN>]9UE8:U=:
MX;W6SIX@M))/L$=IO)(;@/(6Z,$RN!Q\S>U6HO$VCSW<%LEZ-]PS) Q1ECF8
M=0CD;7/!X4GH:?9>(-,U!KY;2X:1K%BERHB<&-@,E2".N.PYH DU30])UN..
M/5=,M+Y(VW(+F%9 I]1D<4:AHFE:M9)9:AIMI=VJ$%(9H5=%QP, CBH)?$ND
MQ6,-X;AVAFB\^/RX)'8Q_P!_:JE@O(Y(QR*D;7]+%C;7B70GAND\R VR-,TJ
MXR2JH"2!D9P.,T 7K>WAM;>.WMX8X88U"I'&H55 Z  < 54N=#TJ]NC<W6FV
MDTY4*9)(59F4= 3CD>U9&LWM[KGAB"^\(:NB2O*KQ2I )EF R#&V?N#/5NJX
M/>M34=?TW2FE%Y.R>3%YTNR)Y!$G.&<J#M'RMR<=#Z4 :5%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(F10?F&YLD$[01UQGO?2RU"/XH7FK'3IS8-I$=LDX9,-(LCN0!NST8<D8S0
MMM\0]'NH=*N8H-0^Q:E*D$5VUOB))6.!&Q)SG(QD C/&:>FMZ1:^(O$<H&I&
MZL+:%[Q2KM'LPY4QIGKPV2!SQS7)VWA_7HOAQX=TMM&N/MUGJ\5S/$)8OEC6
MX,A.=^#\I' .<UM2Z;JO_"4>,+Q=*N&M[_388+5P\?[QT60$8W9'+CDX[T :
M>G>.],U*[TB%+6_A35X?,LYYH-L<AV;RF<YW!<]L'!P34B>-M,>YMT$5U]FN
M;YM/BN]B^4TZE@5^]NZJPSMQD=>E<W;:-K,6G?#N%M)N-^C[!?#S(OW6+<Q'
M^/YOF/;/%4;K2_%-^-,GOM!N9]2L=?6YEE%Q$(F@#OM\E=_ VE<Y"DD<Y/0
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MEW':5.X@X/O6O-I6I_\ "2^#[N+0TM[:R:[>Y2U:,);B5"J+C(W'U*@C.30
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M-D?>?ND*#D$XYZUIVFEZE;_$:QOFTL)8QZ(;)Y;<H(DE,BOM5=P;: I&<>E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% &7IF@6>DWU_>6S3^=?R"6X,DI8.X  .#TX '%:E%% !63!X;TN
MW\07&N)"[7\X 9WF=E7"A<JI.U3@8R /U-:U% !1110 4444 %1^1%]H\_RU
M\[;LWXYVYSC/I4E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF6R/$($)0-\X!WD@,/FZ\8KN6U:RL;"T>YO?-,L0*.J$O-A02P11GW.!@9H
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MO-)MY("?2-V5P/H64_\  A7:U3O=-AO)[:Y),=U;,3#,O50>&4^JD=1[ \$
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M% 'GFHD3^./"ILFV :5=Q"54.V-F6/8"<8'*G /I67X1;2;VPT+1=4T?5_\
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M(WVM7,JD*0P8'.>Y.*[>"=&^,%Q<X=83H,:>8Z%5W"9V*DD<,%()'4"NWHH
M\HLW#_"?QI;[)//FGU,Q1&-@[^8SF,JN,G=D8Q5E=6/AWQ-H>LZA!=-HUSH4
M=D+B&!Y?L\ZMN(95!(W# Z=5QVKTZB@#SN\N[6PU/PW%;:)+I5A*ET8;J&Q+
M2P[B#Y:H%/EM)]XY&>,8!SCG-/$UOX \,^;9WR_V;XG,MT&MI"T:>=,=V,9(
M^=<D9ZU[/10!YSJ4=QJ7Q!UE+ R0SW7A?[/;RNA0+.7D(4DCA@&4D=15#8VN
M^!/">B6MO-;ZUI]U9B6%HRKVA@P)';CA=H;!Z-N &<UZK10!Y->*CZ+\4E6)
MC+=NX@'EG,W^CJJ[./F^<$<9YKI_$-C?:U\)+JRTHL;R?3%2-<X+':-R>Q(!
M7GUKLJ* //;R5/%6H>#)]*BDBN+&Z^T70:,HUI$(F5XWR/E)8JNWOC/09JYX
M.F1O%_C(_,!-?QO$64@2*(44E2?O %2,BNVHH XF[E-C\7X;J>&<6]QHGD1R
MK"S)O$^X@L!A<*<\XXKCD7;\+8XA!(+D>(A.8Q$WF;?MF_?C&<;.<^E>ST4
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M]O(RE0)LRG;GH&&Y21U%5V!\0^%?!NF65O+!JNGWMF\\+1E7LQ",2ELC@8!
M_O;AC->HT4 >0WR+)X1^)T:PLTUW>RF!1$=TP,484IQ\PW!L8SWJWXA\P23Z
MIHFI26^J+IL2R6-Q 9;?58PK$1!<9\S)9?E.1D9'->IT4 16TDLMK#)-%Y4K
M(K/'G.QB.1GO@U+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %74=1M=*L);Z]E$5O$,LQ!/4X
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M9S@MSSD*QP,G Z=*YCQ%H-UHWBWP_P"(-"L]1OIHG:UOT-P\I:U<<G,C?PL
MP ZDU2UR2XA\7Z\]CI&L36^H64-M>2Z?%%-EMK=0[J8Y%1P.AX()'2@#IIO'
M^B1KIC(+^7^TXWDLPEC+F8*N[Y05&<C&/7(/3FIY_&-A#IS7WV6_>**W6YN5
M6W(>VC89!D4D$' )*C) YQC%<W!$MSJ_@6XTC2K^/3-*6YMYEFBVO;#RO*57
M!.2<KSC/K2:A87>D^-]8N+GPD=?TW5_*DAEACB=X)%C6-D<2$84[0<YP,]Z
M.LG\3V"VZ36BSZ@'MENPMF@<^2WW7Y(X.#@=3@X!P:J#QYH4C:6MO+<7/]J0
MO/:&"W=A(JC+ <?>&<$=1WQ7,WNE7NA>*$U"3PE%J^F7EA!;O;V,4;&REC+8
M5%? \LA^HQT[5??3+N+Q9X/GAT06EI9Q7GGQVJ*(K;S0NQ>.">#DJ,9R>AH
MNM\1]#73);]H=1$-M,T-YFT;-FP.#YOIC(Z9XYK9U+Q#:Z:95$-S=R00BXF2
MU0.8XSG#')'7:V ,DX. <5P=UI&K3>"O'UBFEW7VG5-0N);.,J!YJ.B*IZX'
M*GKBI[NRO=,\5R:G<>%)=<TW4[.!"J11M-:2Q@J5*R$#:P/7.,B@#IF\=Z&9
MK"*W>YNGU"V:ZM?L]L[^:@QTXY/(R.W?%4=2^(-M'X>LM5TVSN;@76HQV#1M
M'M:!S*$<.I((8<@#N<=N:@73;N#QKX:N8]'%K9VEA=1S+:QCRK=I"A5!CK]T
MY(&,\\9K#?1-9/A>^"Z3=-/'XJ_M18,*'E@^T!\KDXSMSP2#0!Z>]Y%#8->W
M&8(4C,LGF#!10,G/T%<_J>MIJ&A:C%%%?V<K:=)=03?<)4+PRLI.#DCC@CN.
M:V+YY9M!NG^P&65[9R+.0@[R5/[ML''/0\X]ZX+3]"U#2TU2UTA-5.@S:5*J
M:?? L]M<M@+'"6YVX)SR5''/H :O@SQ?:2Z+X6TR[-Z;V]TR(QW,T3;)Y%A5
MG <_>;J3ZX/-:T?C/2I;JVC7S_(N;Q[&"[V?NGG7=E <YZJPR1@D<&N7M=,U
M..U^&\;:;=!M)C5;[Y!^Y(MC%SSS\Q[9XYK/N++Q)?KI%Q>Z!?R:C8Z^+BXV
M21B$0AI,>2N\#&&4EB 2<Y)H W+.6Y?Q1X_M6OKPQ0P6S0#SV_<EH78[.?EY
MYXK:\ W$UW\/M N+F:2:>6PB:221BS,Q49))Y)K)M;._B\4>-[I]/N1#?06Z
MVKA<B8I$RL!^)'7&>M:_@2TN;#P+HMC>6\EO=6UI'#+%(.590 >G!H Y30_&
M=MX='B4:O+JMS;V^N3QFX\J2X2UBVQA=[\[5!SQ^E=K?>)+.S1VBCGO3' +F
M1;1 Y2(YPYY'!P< 9)P< XKDH=.U2UT[QIHQTFXDN-7O;F6T? ,+I-&J!F?/
MRXP20><#@&J?]@W?A/78_-\-OXDTN?3K6T$D4<;RP2PH4Y60CY6&#G/!H ]&
MT_4K75=+@U*PE%Q:W$8EB=/XP1QUZ'V-9EGXNTZ^T6[U6".Z,%K,T$J-%B02
M*VUEVDYR"<8ZGMFM'2+?[+I5O#]BM[+:N?LUN $BR<[1CCC/)'!.37+P^'+^
MU\?WC1(O]@7QCU&89Z7<?R[0/]K]W)GUC]Z -/4?&NE:8][]H6X,6GF(7TJ(
M"MJ9,%0W.3P03M!P#S5&XGGB^+EE +JX^RR:+/*UOYC&/>LL8#!.F<$C.*YK
MQMIWB+6[/Q=IK:->7!D5/[-:"1$@:,*N2WS M)D$<@XP,8'-=&T-]/\ $O3-
M6;3;J*T72)8)'8 ^7(\B,%."><*<XR,]Z +.C:_HMOH=_J,-Y?R6JZA+$YN]
M[2><7V^6BGYL;B%5<5GZ9J=Q<_%R]M6_M""%=&21K2Y?Y5D,Q&Y0"5Y4 9'H
M>^:Y]M U\^'IKBVTR8W=EXJDUA+.0A6N8#(Q 4YQG#9P>X^E=%IO]HWWQ-.L
MG1;^UL)-%2V\VX"*5D$S-@KN)Z'_ ""#0!TMYKEI8ZUIVE3B47&HEQ;L%RK%
M%+L">QVC/-9EUXZT:QTS5+^Y^U)%IER+6Z'D%BDA"D=,C'S+SG'/6JOC"UO4
M\0>%]:M;"XO8=.NIOM$5L 9 LD+1A@"1D D9KD]3T?7KOPSXYMAH5VL^IZE'
M/:)N0[UQ%GHW!&PY[>A- '?V/B;3]5U>YT5$O(+I(//430M%YL1.W>A/. >.
MQY%87@+63#X L)]0N;F[N9KNY@CWL9)9F$\N%!)Y.U3UX 4DX JS)#=-\4+;
M5A8W/V!=&DMVF\O@2&5'"XZ]%/;KQ7)VWA_7+;P7H$XT)KN[TC4[FXN-+G"Y
MGAE>7E<Y4L%D! ]<]Z .\@\9:7/%<_Z^.ZMKI+.6SD0"83/]Q<9P=P.0<XQD
MYX-3_P#"26JQ9>WNH[@W?V-+9T D>79OVCG:?ER<YQ@'FN9N--L]6T*8S^"9
M+.RO)XA)!%&D5V-H8B8^6W&T[<#);&[CD"JB:%>S^'WTO78=4U;31J@-E=L2
MM];PB(E9CC#;E?*@XW$'D=J ._T[4(]2MWECBFB*2-$Z3)M964X/_P"OH>U8
M<>MZ1;>(/$4IN-2:>PMX7O(621HXUPY4QICDD Y*C!P*D\%VVL6FBS0:O<SW
M)2ZD%I/<J!,]OQL,F/XNO7G&,X-8LUCJ \4^-+D:?<M!?:;!!:N$XE=%D! Y
M]7')P.M &QIWCG2-2O-+MX4O$&J1>;:32V[)'*0F\J&/&X+SZ<'FM'7M>M/#
MFG?;[Y9OLWF+&SQ)NVEB%&?09(&?>N*MM+U..P^'$3:;=!]*"B^&P?N<6[1\
M\\_,>V>.:[K7-)@UW0K[2KD?N;N!H6..F1@$>X//X4 01^(+67Q%-H0BN%OH
MK<7)#( IC)P&!SSR,?SK-N/'ND6W]GJ\.H&74(I);6)+1V:54&3MQU)&, =B
M#TYKE5\,^*KBWT'6ICY>O8.G7^U^$M&386![L&42CW8CM70ZSI]POCKPC-9V
M$S6&GQW4<LD:C9"'C54'K_#VSB@">TU[3+OQ+)+!_:YO_P"R4N#921O&GE%L
M@A&P/,))&?;!/%9:>,;'6_ -IK&JIJ>GP75Q'L:TW*V3+\@WKV.%!)P#D^M:
M"V=X?BO/J'V.86+:,EJ+@K\AE$K.5]>A'.,=JY2/1]<7X.V/A]]$NUU"TN;=
M6CRAWB.X#LRD-]W:."<9H [>^\9Z;9:K=Z7Y&H7%]:PK.\-O:.Y*$D97CD<'
MGIVSGBIX_%>E3Z=I5Y;2O<+JV/L4<:_/+\I8\'&, $G.,8K)@ANX_B5JFJ-8
MW7V&7288(Y?+X:17=BN.O1AU%<C:66HZ-X3\#1/H]^VM:9)*QBMQ&TL:;6#_
M ",P#H=R D,,9'.<"@#TC1?$EAKTEW%9BY$MG*8+A)8&3RY!U3<1M)''0G@@
M]ZAU;Q9I^D7%W#(EQ.]E;"[NQ @;R(3G#-DC/W6.!DX'2LWP1/:[]4A&GZI9
MW\]P;VZ&HP"-I&?C<FTE=HV;<9R,<]<G+\6VNNZCJ/B#3SI-W<V5QI?EZ>]M
M(B1M*5<-YQW D@E=H.1UXSS0!T=WXRTFTO[.R'VJ>>]MC<VRP6SOYJ#!^4XY
M/S#Z=3@4ZU\8:3=Z$FK(\RQ/.;40O$1-YX;9Y6SKNW<8_'IS7,Z59:FNO^#;
MJ?2;N"*QT>6VN2RJ?+D81!0<$]=AZ9QQG%9 T/7X+)=1@TJXDEL/%-QJGV)M
MJM<6\A<!DR<;@&R 2#U]J .C\/ZE<7?Q0\06[F_BABL;9OLMTY*QN6DR5 )7
M! 7E3^HKI[[68;*\CLUAGN;IXFG\F  L(U(!;DCNP&.I[ US>B+J%Q\1M3U:
M31[VUL;K3;>*.6X"+\R-(2"H8G^(=OKBG>,M&BU;4;9GM]4MKFW@9K35M,SY
MD,A/,; ?>5L X(QP<D9H NRZSI5YXA\-YN-1CN;R"6>TB4.D4B&,,WF#[I(&
M, \@FGWOC;2+"&XN9?M+65M=?8YKJ*$NB39 V8'S'DA<@$9.,YK"2RU^77?
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M11C:A!]&^:3_ +:&F>*+/4/^$P\+:K::?->06;74<XA*@IYD8"D[B.,CD]J
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MPTF2H&<Y )! 8@*3T/(K&;2-1MO'D$RZ:5LKC04T\RV>U8K:19"3P2"% ;C
M[8K&C\/:O>_"^+P)=:?-%?1/';-= #R/*24-YROG^Z/N_>W=L<T >IT51MKZ
M>?5;ZS?3YX8;81F.Z<KLGW D[<'/RXP<U>H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y^?P=ITNJ7&H07&
MHV<URP>X6TO9(DF8 #<R@XS@ 9&#Q7044 0VMK#96R6]NFR).@R2>3DDD\DD
MDDD\DG-3444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MND;OB9U7"#V4 >N.]=/?Z]I.ERB*^U"WMW)4$2.!MW'"Y/;)X&<9H T:***
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M5NC2R2Z;<+&J#)<F-L >N:W** /+3?65]??#1U.Z*'?O,D94*1;%03N''SX
M/J,=16?J<D3>$?BA"A#&>]D:%%Y\PM%&,J.^6!Z=P:]BHH \Q\32;+L:EHVM
M16FIQZ1%NM;M ]KJ,.9"(\==X.[[IS\X&.:[VUOUA\/6]_?Q?80+9))HG/\
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MYD.K0SM!$,M/ JP^8%'\0(5AQUP17L=% 'G)US3-:^)OA>^TUWN(&T^[0RI
M^%),1"L<<$<Y!Z=\9K2\?N+:\\)WLBO]GMM91IG5"VP&*103@'C) _&NTHH
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M4W3<D;QJ[%25B5G53(P')502QQV':LJ7Q?)::0EVS6-\;R_BLM-EM)/W5R9
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M&^2!;AH>XC+%0WY@T 9EIH=S-XCBU[56M_M4%JUK!%;Y*(&8,[9."2=J@#'
M!Y.:/%NA7FO:?9QV-W%!-:WL5WMG0O%-L).QP""1R#]0*WZ* .,M/"^OV.H:
M[>Q:M8M+J<]O.%-JP4% BNI^8_*54CU^;.>*T/#'A>/P_>ZM=Q1P6RZC*DIL
M[7/DQ%5P2.!RQY. .WID]'10!SWB'P_>:GK6AZK87D-O/IDLIQ-$75UD0HW
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ME,0(V>8VXJ<]<>O?TKH:R]5U^TTEO+DCGN+@0M<&"VCWR>4I 9L>@)'N>P-
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M=6T^0DR!MRL&&2K*<]CD''%2:=X3M;?0M4TZ\(N#JTT\]\P7:':7A@HYP ,
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M /<9[USUYX#M+C7YM7M=5U73YKI56]CLYQ&EUM& 6&WAL<97!KIT@CCMU@1
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M;RF 6SPQRE&#$_O Q52<\8/;%0ZAJGB66Z\<I!KIMDT1$FM=EK&2?W'F[6W
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M3)6.,8&3U/N?>KM% '/R^!_#$\EP\NBVK-<S"XERO63(.X>A) )QC/?-6?\
MA&-'$E^XL]K7Z!+HK(X\Y0, -ST X [#CI6O10!B7'A#0;JTL;6;3D:*P_X]
M,.P: 8QA6!W 8P,9QP*MZ5H6EZ&DZZ98PVHGD,LOE+C>QZD_YXK0HH RY?#F
MDS7DUU):;I)Y%EF'F-LE=0 K,F=K$;5QD=AZ4UO#.D-)J$AM#OU%=MX?-?\
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M#&;&/,SNR&]^M2R>&M'FM$M9K%)(EN5N_P!X2S&93D.6)RS<#DD\#'2M6B@
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MCQAIE\\;)9Z,LK1[ACS9W&S@>BKNY[EACH: .CHHHH **** .'^,/_))]?\
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MTX) "@9)P,L<DX%2:SX>35=3TW4X[R:TOM.,GD2(JLI$@ =65@<@@#I@CUH
MX:_\6>)]*\*^,+>:]MY-6\/R1[+T6P GBD567*9P& //4>U;]_J&NS_$)-"M
M-2BM;.72&NPPM@[HXE1,@DX)Y[C'/0U<U#P39:CX>U/29;NZ4ZI)YE[=KL\V
M4\#NN  %4  < ?C5H>&A_P )-%KQU&Y-U'9&R";4V%"P8DC;G.X ]<>U '+:
M/XSU34-)\-6$TT:ZKJMY=6LMTL8 "6Y?>ZJ>-S!% '0%B<<8J"S?4=*\1?$B
M>*^$MW;VEK-#/-"I^[#(P#*N >F.,?2MH?#FR31K.RBU.^CN+&\>]L[U=GFP
MR.Q9A]W:RDL<@CI5B+P0JS:Y/+K5_+/K-NEO<NRQ  *I4%0$X.&;VYZ'K0!D
M#Q!X@N9O D4-_!$-;L7DNF:V#'>+</N'('4]./Q'%0CQ=K=AX/\ $,\\J7=Y
MI.K&P^UF$+B$M'F5D7C*K(2<<?+D]ZZ&#P9#!-X=E74KLG086AM@1'AU*!#O
M^7D[0!QBL7Q%X?.B:!J:P7&L7$>KZFES=RVD:O); E2SJBKEEQ&JE<-UYR,T
M :6DZGJT_CN_TQ=02]TBVM(I_.,*EA(^X>673"]%#=,X/TJSXCU6^TWQ)X9M
M[:?%OJ%X]O<1E 05$3N"#C(.5'>LOPFM^-2C-GKNI:EIFUO.6^TQ;54./E*-
MY:%FSVP1C.<'&>@\1>'4U]+%UO)[*[L+D7-M<0!24;:5((8$$$,1C% '&Z[X
MLU[3](\<RVUY%YNC7,*VSRP*Q".B,0<8&<N<$@].AJ[>Z]KWA;Q?90ZO>PZA
MI>I6US*$BMA&UJ\,?F$ Y)92H(YYS5#QQX572?!/BV>WO-0O;K5Q$6B<!RTB
M[%RH5<YPI.!P.P %=C:Z%!=7MMJE[=OJ+PV[PV_F(JJJ/C>2 .68  GTX &3
MD Y>X\4ZS9>"]'\9/<K+;W3V[W=@(UV)#,P4"-@-V]=R\DD'!X':/4-:\3O)
MXX%OJ\%NNA!9K?;9JV\>0)=C9)X[$]?3'0[]EX&M+.PMM*-]<S:/:W N+>RE
MVD(5;>J%L;F16P0#Z#)(XJ23P9#(WB,G4KO_ (GR!+GB/Y!Y?E_)\O'R\<YH
M V=(O6U+1+"^=0C7-O',5'0%E!Q^M<1;>)]8BUOP]'-?1W2ZC>SVMVL$0-LF
M%=D$4FT,Q&P \L,[AP:[C3-/73-'M=.$LDT=O"L*O)@,RJ,#. !G [5RMG\-
M[:SM](MTUS5&ATBX,UDI,?[M2&!3.SD88C)R1V(H P;[Q+XJA\.>+-775;<'
M0M3EBCB6T7$T:",[&))(&&/(YR>O:NJ35[S7/%FJ:-97C6,6EVT#R2)&CO)+
M,&91\P(VJJ^F26ZC',<W@&VGT77M*?4[TP:U<O<W+ 1[E9@H8+\O PHZYJ>;
MP</[>CUJRU>]LKYK=;:Z>%8R+I%^Z65E(##LP% %+X3AA\--*#D%]T^X@8!/
MGR5!/X@UM-2\=VZW<&-)LX9[+,'"%HY'.[G+'Y1W_"NC\+^'H?"VA1:3;W5Q
M<PQ,[*T^W<-S%B. .,D]<GWJE+X.AEO?$%U_:-VK:Y EO.H"8C55*C9\O!PQ
MZYH P=,UWQ NH^#'O=2CGM]?M&\Z%;=4\IQ;^:'5NI.00<\<\ 57N/%FMQ?#
M_6M66\4WFG:Q)9QN8EP\:W*Q ,,==I/(QS72IX,AC?PXPU*[_P")"A2VXC^<
M&/R_G^7GY>.,>M4+WX<6UY::M8?VSJ,6GZC=_;&MH_+ CE+J[%6VY.2O0D@9
MZ'B@!EQ>>);_ ,>ZGHEEK%O96UO:6]U&QLQ(PW.X93EN<A>O;L*K0:]XHUNP
M@UG0[>5XS>NGV:3R! ]NDK(WS%O,#X7.>F>,8YKI;3PVMIXHN->_M"ZEGN+9
M+:2-PFPJA)4\*#G+$]>_2LRU\ V]CJMS-::QJ4&F74YN)]*5U\AI"<MC*[E4
MGDJ" ?IQ0!<\?27,/@#7I[2ZEM9X;&:198L;AM0G'(.,XQD<^A!K)L=4O$OO
M#OAB&^E5[C33>S711-ZHH151!MVYRW4@\+[Y'6ZMIL&LZ/>Z9=;Q;WD#P2%#
MA@K*0<'UYK#/@J()I$RZI>?VGI0*07S!"S(5"E'4*%*D <8!R,YSDD /"FMW
MUYJNOZ)J3+-<Z1<H@N50+YT4B!T) X# <'&!["J %X_QEEA.I7 MDT5)U@PF
MP;IBK*/ES@[ 2>OOC KI=)T:#2C=RJ[S75Y-YUS/)C=(V HZ   *H 'H/7)-
M:Z\-1S^*8O$$5]=6]RMK]D>./;LE0,77.5)X8D\$9Z=* /.?#VI:QH?@C1]2
MM;Z,6;:Y):RV9@!\Q)+QT8ESR&!.1C XYS72WFM^(]8;7/\ A'4F$^FW9M;=
M-L!AE=%5F$I=@X!+$?+C P>:N+\/K5/#=OH8U6^^S07OVY'Q'O\ ,\TRX)VX
MQO)/2GW/@6-_$%SJUAK>IZ:;W;]N@M74)<%1C=RI*,1P2N#]#S0!U%L\LEK"
M\\8BF9%,D8;<%8CD9[X/>I:9%$D,211*%C10JJ.@ X I] !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 87B_P 02^%_#5SK$=F+OR"FZ,R^7PS!<YP>A(XK=KC/BN,_#/6!G'RQ<_\
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M;3H3#>OYEU&<[9F]7&?F/UI-.U=GUN]T.\*_;;:-+B-E&!- Y(#X[$,K*1[
M\9P-&\O[/3XUDO;J"V1FVJTT@0$]<#/?@T 9FJ>#_#VM1VL>IZ1:W:VHQ!YR
M;B@] >N/;I6S'&D4:1QHJ1H JJHP% Z "JG]L:9]GMKC^T;3R+I@EO)YR[96
M)P IS\Q)]*6PU;3M5CDDTZ_M;Q(G*2-;S+($;T.#P: +3HDD;(ZAD8$,K#((
M/8UG:?X=TC2I%>QL(H2@*QA<D1 ]0@/" ^BX%85YXLW^.O#VE:9J5A<V=Z+C
M[3'$0\BE(RRG<&X!/MVZUM>(O$>G>&-.%[J,Z1H\BQ1JS %W8@ #\\D]@":
M&-X2\//KPUQM'LSJ@.1<^6-^?7Z^_6I#X:T9OMV;"(_;^+OD_O\ C'S\_-QQ
MSVXK#D\6?9O'3VMSJ=@F@_V/]N2<D* WFA,F0M@CTQCK73G4K!;!;\WMN+-U
M#+<&5?+8'H0V<'- &=J'@_P[JUA:V.H:1:W-M:#%NDBY\H>BGJ!P..G JQ<^
M'M(O(;.&?3X6BLBK6T87"PE?NE . 1V(Z5;L[ZTU&U6YL;J&YMVSMEAD#J<=
M>1Q4=SJ^FV=PMO=:A:P3-C$<DRJQR<#@GN>GK0 Q=&TY=5&J"U7[>(O)%P22
M^S^[G/3/./7GK573_"?A_2=4GU.PTBTMKV?/F31Q@,<]<>F>^.M7/[8TP)<N
M=1L]EJ<7#>>N(3_M\_+^-.GU73K6TCN[B_MHK:4 QS/*H1P1D8).#QS0!1?P
MGH$EE=V4FE6[VUW+YUQ&RY$DF<[S_M<#GKQ3?^$/\.XN -&LU^TQ"&;;&!YB
M#HK8ZCV[]ZT'U33X[%+Y[ZV6TD *3F5=C9Z8;.#FA=5TY]/&H)?VS61Y%P)5
M,9YQ][..O% $%QX?TJ[TV'3KBRCELX"ICA?)5=OW<#V[>E5]6\(^']=N+>XU
M72+2\FMP!'),FY@/0GN/8Y%78]9TN;3S?Q:C:/9@[3<+,ICSG&-V<9SQB@:S
MI;69NUU&T-L'\LS"92@;^[G.,^U $-WX>TJ]N7N+BR1Y'B$,A!*B2,9PC '#
M+R?E.1R:A3P[9KXJ_M]8(H[D6QMMR+AG4D'YCZ#;@#_ZV+JZKISV'V];^U:S
MSC[0)E,><XQNSCKQ]::NM:6^GOJ"ZE9FRC)#W G7RU(Z@MG Q0!>JA+HVG3:
MHNIR6JF^6,Q+/DAU0]5!SP/:FC7]'99F75;$B%Q'*1<(=CD9"GG@D=JMVMW;
M7ULMQ:7$5Q ^=LD3AE;!P<$<=010!FMX4T%M)GTIM*MFL)W,DENR91F)R6P>
M^><]<TD?A/0(M"_L2/2;9=,)W-:A,(QZY8?Q=NOH/2K<FLZ7#?+8RZC:)=LP
M00-,H<L1D#;G.2.<5'=^(-%L//\ MFKV%OY!43>;<HOEEL[0V3QG!QGK@T *
MFA:8FIQZDMHGVV.+R4G))<)_=SGI[4V/P]I,5V;I+)!*9C<'D[?-/63;G;NY
M^]C-6KC4+*TMEN;F[@A@? 6220*K9Z8)ZYKG_!&OW6OPZW)<W-M<I:ZK+;6\
MMLN$:)40J1R<_>/.30!U-9^J:'I>MI"FIV$%V('\R+S5SL;U%/O=9TO3I%CO
MM1M+9V (6:94)!. >3Z\4M[JNG:;M^W7]K:[@6'G3*F0.IY/2@"@?!_ATQ2Q
M#1[18YIQ<2*L>T-(.C''<=O2K::'IJ:C)J M$-Y)%Y+S-DLZ?W23U'M3[O6=
M+L"HO-1M+<LH=?-F5,J>AY/2H5N)&\3- -4M#"MIDZ>%'G!]W^L)SG;@@8QU
M[T 4[;P/X8M)(7@T.R4P2&6+]WD1L>Z@\#KT%;]9[:[I"3F!M4LEF!(*&X4-
MD'!&,]CUIEQXCT.TW_:=9T^'9((6\RY1=KGD*<G@^U $NH:-IVJRV\E]:I.]
ML_F0,V<QO_>7T/OUJMK?A?0O$?D_VSI=M>F YC,R9*^N#UQ[=*N7NJZ=IVW[
M=?VMMN!8>=*J9 ZGD]*M*RNH92&4C((Z$4 <=K/AN6^\;>'[N/3A_9>G6T\)
M:.01F,OL"E ""  A!QC@\9K>G\-Z-<Z='I\VG0/:1OYJPL/EWYSN/JV><GG/
M-3IK&F27_P!ACU&T:\R1Y"S*7XZ_+G/'>N8U+Q0]_P"*KOPWI&L6-G=P6BRI
M+(5D\R=G91$5)Z#;\P'S?,.F.0#H=8\.Z/X@LH[/5]/@O8(R&19EW%3Z@]0:
M0^'-'^SV<"6$44=DI6U$.8S"#UVE2",XYQUJOJ_B6S\-:?82:W<V\5Q=316X
M"MM5I&(5B,]%&223T K*3Q:+;QKJ-KJ.IZ?%HL6G07<$[$1K^\=UY<MAL[1C
M&.M &U?^%M"U/28]*O=*M9[&([HX6C&$/J/0\GGW-*?#&B&SLK0:;;K;V+![
M6-5VK"PZ,H'1N3SUY/K5R;4K&WLDO)KRWCM7 *S/* C \C#9P<U):7EM?VL=
MU9W$5Q;R#*2PN'5A[$<&@"F/#^DB>^G-A"TE^GEW;,,^>N,8?/WA@D<]!Q58
M^#_#A2R0Z+9%;'(M@8A^[!Z@?7WJC_PD-YK'BN_T+1C!%'IB(;Z\F0R8=QE8
MT4$<X&2Q.!TP:T;.36XM;:UOC;3V)MR\=S%$R-O# %6!)'0Y!'7G@8H ;_PB
M/A[^S5T[^QK+[&L_VA8?*&T2?WOKR?PXZ5;AT;3K?4Y-2AM(TO)$$;S+G<RC
MHI]AV':G6NL:9?3O!::C:7$R+N:.*9691G&2 >F:A/B30UDA0ZSIX>:4PQ*;
ME,NXZJO/)&1Q[T 7([.VANI[J.%$GG"B60#E]N0N3WQDUFR^$O#TVO+KDFCV
M;:FI!%R8QNR.A]R/7K5NWUK2[N>Z@M]2LYIK3_CXCCG5FA_WP#\OXU'#XAT6
MXNX;2'5["2YG7?%"ERA>1>>5 .2.#T]* $'A[21>-="R3S7F\]N3M:4='*YV
MEAQ@XR,"M.J,FLZ7#?+8RZC:)=LP18&F4.6(R!MSG)':H[OQ!HMAY_VS5["W
M\@J)O-N47RRV=H;)XS@XSUP: +&H:=9ZK9O9W]M%<V[X+1R+D9!R#[$'D'M4
M<&C:?;6TUO%;A4G_ -<2Q+2<8^9B=QXXY/3BG-JVFI=PVC:A:+<SJ&BA,RAY
M >A5<Y(^E2Q7EK/<36\-S#)- 0)8TD!://3<!R/QH BTW2['1[-;/3K9+:V3
M[D4?"K]!V_"KE%9FHKK<E[;IID]C;VWEN9I+FW:8ELKM"A9$QQN))SVH BF\
M*Z#</?/+I-JS7Y!NCL_UW^]Z]!]<"IUT'2UO;:\%FGVFU3RX)226C7NH.>![
M5ROA#7?%?B;P]9:R9M("2W+Q2VZV<@(196C+*YF//&[&/:K?@_Q<FH::J:WJ
M5A'J4M]<VT,098C*(Y60;$))/3WH U[/PEX>T_6I=8M-'LX=1ER7N$C ;)ZD
M>A/<CK6S5*]UC3--D2.^U&TM7DQL6>94+9.!C)]>*MR2)#$\LC!8T4LS$\ #
MJ: *.J:'IFMI&FIV<5TD3!T27D*PZ,!Z^]1P^'-(M[N.ZBL(UN(PP27DL@88
M."3QD>E8_A[6=7\7:=_;-E+;V&F3.PLTEMS+)*BDKO?Y@%!(.% SCOS6KIM_
M>0Z?<R^(#:VKP3LGF*VR)DR-C L>X([]<CM0 W_A$]!_LYM/_LR#[$TOG&#!
MV%\YW8SC.><^O-)J6A696ZO[:P$NJ-:-;1R[_G*D8"[B?NYYQ^/6KB:SI<EA
M)?IJ5HUG&2'N!.OEJ1U!;.!BHU\0Z*T\\"ZO8&6"+SID%RFZ-.NYAG@<CD^M
M &-X)\+1:+X;T>&]L5CU&RMQ$29-ZJ^W#,@R0N[G) !.3FMN#0],MKB\GBLH
MEEO?^/IB,^=QCY\]>..>W%+'KFD36$=_%JED]G(VQ+A9U,;-G& V<$YXQ3K+
M6-,U)YTL-1M+I[=MLRP3*YC/HV#P>#UH AL=!TW2!NTZQBCD2,QQ L<(O78N
M<[%R!P...E4=!L]5N+U]8U^UM+:_,(MHH+:0RB--VYCO('+';QT 4>]:=KK6
ME7SR)::E9W#QIO=8IU8JO]XX/3WJ.+Q#HDUQ;V\6L6#S7.[R(UN4+2[20=HS
M\V""./0T 0:GX2\/:UJ,&H:EH]G=7<& DLL8+ #D ^H'H:76?"F@>(IH)=7T
MFTO9(/\ 5O-&"5'IGN/;I5RWU;3KN6>*WU"UFDM_]<D<RL8O]X \?C4UK=6]
M[;I<6EQ%/ _W9(G#JWT(X- $J(L:*B*%51@*!@ >E,G@BN;>6WG19(94*.C#
MAE(P0?PJJNK:?<7#V=MJ5FU[\P6(2*S CKE0<G!ZC^5<[X)\71ZMX?TYM8U*
MQ35[N2X5( ZQM($F=!L0G)&%]^E &C:>&K<^'D\/ZI#'?:?;A8X?-Y\R-?N!
MQW*@ 9YS@'@\"\-!TP:@-0%J/M@A\CS]S;_+_N[LYQWQZ\]:?/K.EVUXMG/J
M-I%<L5587F57);H,$YR>WK6-_:^I?\+)DT,RP?83I'VR,>4=RR>:$^8YY'TQ
MU_&@"[)X1\/RZ*VCR:1:OIQ?S/LS)E V<[@.QR3R/4U(?"^AG14T;^R[;^S4
M(9;4)A,@YR1W.>>>_-4? VL7VN^&S>:B\3W(N[F$F)-BX25D&!D]E'<UJ7&O
M:/:3M#<ZK8PRHR(R27"*RL^=H()ZG!QZXH CO/#FCZA>VMY>:=!/<VJ[(99%
MW,J]<9/49YYSSS4#^#_#KZ/'I)T:S^P1OYJ0B, *_P#>!'(;WZU>?6-,34%T
M]]1M%O7.%MS,HD)QG 7.>G-)>ZWI6G2B*^U.SMI" 0DTZH<'H<$T 4X_"/AZ
M**\CCTBT5;U0MSA,&90 ,,>XP.G>IU\.Z2ES:7"V2":SC\JWDR<Q)_=4YX'M
M5A-5TZ2=H$O[5IEB\\QB92PCX^<C.=O(YZ<U1U'5(9]-MKG3M=TZW26YC1;B
M1EDCE&_#1J=P&X\KP>M &-XD\(I)I2VNCZ/IUS;27HNK^QN6*+=<'G=AL/NV
MMG'.W!-)X4\(P:1J?]H6^AVVACRFC:WMKII?.R0<L,!1C'&,GGJ.AZ.XU[1[
M29H;G5;&&5&1&22X165GSM!!/4X./7!I[ZQIB:@NGOJ-HMZYPMN9E$A.,X"Y
MSTYH NU0NM$TR]U&'4;BQ@DO84,<4Y7YT4]@>O\ A5R66."%YII$CB12SN[
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MP02/:L"RFTV+X7>'9UDM5G7Q*DC."H88O&.2>OW"/P]J]P"J"2% )ZG'6EH
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M(\JV N.OW1WBET'7_P#A6/B7PX-&F:[FN+K[.PEBVSB69G5E^;@8/.[!]CV
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MSRETDAW[MCH[(P![C*G!J7Q!KD6@V4$K1^=/<W,=I;0[MOF2R-A03V'4D\X
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M/B"6VEN@ORV]BK>6"/NJF[YF=B<=L\ #C)WJ:R(S*S*I*G*DCH<8X_.@#G_
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M$OK'QGK^KS-;&VU);=8U1V+IY2LO(*XYW9Z\8[UT=9D.O65QXBN-#3SOMMO
MMQ(&B*KL8D @GKR#TXXH RKGP_?VGC1_$>DM;2&ZM5M;RUN9&C#;"2DBL%;!
M&2"",$>E94W@:^CL]-6TEM'N8]=.MWCR,R+)(2Q*( #@88 $_P!T<<UWM% %
M:_2ZETRZCLI$BO'A=89'&520@[2?8'%<?!X$WZCJ]X8;/2_[4TQ[*X@L'9HY
M9&_Y;$%5 8#(''.XY-=S10!P-AX4\2B[\)37MSI2C05>)EA$C>:IB\K=R!R1
MSCH/4YXDC\&ZJ-$UGPZ\]I_9NIW<\SW2LPF6*9RSH(]N,X)4-N[YQQBNZHH
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M&5PQ&3\P[,*YRWMKN74;]WN_&FDZE<7<LAM+:W$MN3NPI61HV3!4+U<#MP*
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MZ>K)#>V<^)BK<L'+ [\GDY!YR>YH T?#!UO^PXD\0F!M2C9DD>$C#KGY6('
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M);D$=2>*PK&.:P\ Z_XFAN]0EU/3KG4(K=WNI)!''YK+DJ3ABH&[+9/'7@8
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MT00<>4,;1D_PYVCK4MYIZ7UU\2%GN[YTLE26U O)!Y+_ &4/E<-V;D#H.PH
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MTW1C)IL@W0O-<"*6=.S(A4C!ZC<RY]JK?$BSO=0^&NNVUB&>Y>T)"H.6 P6
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M.>!3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGS$ Y[FBRDTFXBU+PIXGAU1]6_M&:6.T0RA;O=,9(Y$9> .5Y)&,<X%>OT4
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M[VOVI8UFMY[99T&P8&SD%>IXR1DDXYK7TZP73X77S7FFE?S9IG #2/@#)
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J[7]FE^EBUW +QU+K
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M,E4"J?F//)P.G7/&Y!X[76(+(:/"1+<Z>E^QE@EF$8<D*A$8)R2K@GMM[YH
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M ^R1=K+D9P1V/M4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMLQ0#*_O(QOX?"[23U'ITKO:* //M,\!ZMIVE>&+%M0LYAH=X]P&\MD\Q2'
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M,0?=MVY)^;&<$XQP0R?P;J<^F>+[,W-H/^$@D9U;YOW :-8^1CYN%SVKN:*
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MIB_\[#88"<S;=OU.,YJX/#'B+3/$.H7>A:Q90:?JDHGNK>ZMVE:"7:%9XB"
M20!PW&17:44 ,BC\J%(]S-L4+N<Y)QW)[FGT44 %%%% !1110 4444 %%%%
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M@PEU6"."1#$"L80,%*\]<,<YKD+O1CH/B?P#H]GJ)_XET-W$L\D0;"F- @D
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MZ9_;5[Y6J7ZWTS,B%E<,C?+QW,:Y[>@%0>,/-/CCP2J7BQ312W+/-Y>57,)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKE_&NK:G
MH\.CRZ?/%&EQJMK:SAXMS-')(%(!S@<>Q_"@#J**R?$]W>6'A?5+W3Y8H[FV
MM99D:6/>N54GID>G_P"NI/#MW-J'AG2KVY;?/<6<,LC  99D!)P.G)H TJ**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BH;F[M[.-9+F9(D:18U9VP"[,%5?J20!]:1[RVBNDM9)X
MUG>-I5C9@&**0&;'H"RY/N* )Z*RM-\2Z'K%R]OINJV=U,B[BD,H8[<XW#U'
MN.*U: "BJUKJ%G?/<):W44[6TIAF$;AC&XP2K8Z'D<52B\3Z%/JG]F1:O9/>
M[BGDK,I8L.JCU([CK0!K45SQ\=>%!<?9SXAT[SMVW9]H7.<XQCZUJPZMI]Q=
M"UBO8'N"9 (U<%B8R XQ_LE@#Z9% %RBLW4/$.CZ5YOV_4[6V\HH)/-E"[2^
M=H/UVMCZ&H]/\4:%JKA-/U:TN6+B/$4H;YBK,!QW(1C_ ,!- &M14+W=O'=1
M6KSQK<3*S1Q%AN<+C<0.X&1^=4X_$.C2W\UC'JMFUW"&,D(F4LNW[V1GMW].
M] &E16-8^+O#>IW'V>PU[3+J;:7\N&Z1VVCDG /05/:>(=&O[2XN[35;*:WM
MQF:5)U*QC&<L<\#'.30!I45F1>(M%FTR74H]5LVL83MDN!,NQ#QP3G@\CCW'
MK4<WBOP];V$-]/KFG16D[%8II+E%1V'4 D]1W% &O16,_BWPY'I\6H/KVF+9
M2N8X[@W2"-V'4!LX)'I3KOQ7X>L;>UN+O7-.@ANDWV\DMTBK*O'*DGD<CIZT
M :]%4EUC36C5Q?0%&F6W5MXP9& *J/<@@CUR*G>[MX[J&U>9%N)E9HXRWS.%
MQN('H,C/U% $U%0W%W;VBHUS/'$LDBQ(78#<['"J/4DG %34 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QGQ&W-8:(J1
MRR,FM6<S".-G*HD@+,< X '>NSHH Q/%KAO!>LA SF6PF2-44L79HR  !R22
M:7P@?^*-T5"K*\=C"CHZE65@@!!!Y!!K:HH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tardioagreementa01012.jpg
<TEXT>
begin 644 tardioagreementa01012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[=Q*L9Z,$QEAP>5STQUI]OXETN[TJQU.WFEDM+YU2W=8)"7+=/EVY XZD8H
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M[3\/)X8;[4Y;Z*/[9!A6RUV#OW"/;D$N3]-QJ34@?%.CZ#/J=AKFEZDL;O\
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MC^#]"D*E[$MM.0#-)C.<@XW=>.O:@ \6E_[ =(H)YY#-"0D$32-@2HQX /0
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MZW=)+B5VW!50C<0N!SC&6]C5:ZTK59/AMX.>TLKAKO1);&YN;%D*22")-LB
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MQ,N"5C'RMDE1DYP!D>O'+^!?$4.D_#SPI8+Y!N[JR>1!<3>4BHC $EL$]74
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MC=,X.U<G R0..2.M01^)-)EN(8%NB))VV1!XG7>V,X!( SQ7._%__DE&O_\
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M_%?BNW\):_JIO-/:7P]?2V\@^RG_ $Q8RIY^;]WE6QQGF@#U&BN-U'7]7O\
M5=4TW0XI%EL+>)]ZQQONED4LJMO=<+@#IR<GD8YJC7?%D_B#0M*F2RTV>_TV
M:>XC:+S3!*A0'!#X8?-P.,9Y)QB@#O**\IU'7]<U3PGIIEOHX;N'Q/'IMS)#
M#A9PER%#8)^4< D \_3BO4XE=(465Q)(% 9PN-Q[G':@"M'JEI)JTVEI(3>0
MQ+,Z;& ",2 =V,'E3P#FKE<A)K^LQ^+O$&F1107*6>EQWEG"B%6>1C( C,2<
MY* 9&.M'@[Q./$4\GEZHLYBA'VFRGM_(N;6;/(9>NWL.O3J: .OHK!\:ZI?:
M)X-U75-.:%;JTMWF7SHRZG:,XP"/\]C6-%XAUG3O%.F6VJW-K-8ZEITUULA@
M*-;M$$)^;<=X(?T'([=* .WHKSJX\9:O;>!K/QP6A>QD>.6>P$?*6[N%&U\Y
M\P!@3G@\C J_X>DU*;XE>+$GU RV]L+14B,0 "M&S!0<\8+'ZT =M5.\TC3=
M0N(+B\L+:XF@.89)8E9HSZJ2./PJ/7+F[L]"OKFP%L;N*%GB^U2;(@P'5V[#
MU_I7*67BG5#KNK:9;G^T_)T==0M&> PM+(6==@X&Y"5&#COU/6@#NZBN;F*S
MM)KJ=BL,*-([!2<*!DG Y/ [5PNE^,;O4]'U2[TFZ&HWMI9%VTR:W\FYAN1_
M"R<$KV ]B-QS4EAXMDU+P_KNHZ1K%O=FRL_,2*ZMMDUO,H<NDL8*G'"@=._7
M% ':6=W!?V,%Y;,7@N(UEC8J5RK#(.#R.#T-,L--L-*MS;Z=96]I 6+F.WB6
M-=QZG '6N3B\4:A/#X)MW987UVU\VXNP@^1Q"LFQ0> S$G&<\*>/3'N/&'BB
M#P=K&K>;IS/8ZL+"%OLKJ)D$ZQ%]WF$9.[L, J>#V /3J;)(D,32.<(H))QG
MBN/@UG7K3Q?J>B74UE>G^RO[1M2L1@5&WLGEL=S97(!W=>M5]"\3ZC/XKTW2
M[BZBO(;W3'NI)(X"B),C("(GZ/'\YP>>@^:@#K=)U:QUS3(=2TV<3VDV?+D"
ME=V"5/! /4&FVNM:?>ZM>Z7;W&^\LE1KB/8PV!\[>2,'.T]*\H\/:OXA\,_"
M_2-?MY[*72+:8I<6)@/F-&UPREQ)N^\"W VXQZUT-QJZ>'_&OCO5Y(S(MGI-
MG-L!QO*B8@9]^E 'HM07M[;Z=937EW)Y=O"A>1\$[5'4X'-<UI][XJ_X2"Q2
M>S,VE7$+FZE=8H_LT@&5*;9&+(W(P02.#FMKQ%_R+.J_]><W_H!H M6%];ZG
MI]M?VDGF6US$LT3X(W(PR#@\C@]ZL5Y7HFK^(O#WAOP/=2SV5QHU_'96#VJ0
M%98/,C 20/N.[G&1@=>/6MJ#Q-JUJ_B;3-1FA?5K)T.G!(MBSQRX6$XR<DR$
MJW88H [JBH[=94MXUGD$DH4!W"[0Q[D#M7!^,_%>K^'X=<O(9[8#3DBEMK6.
M,RF5#C>9B/\ 5Y.0O(^[GGI0!Z!17&WNJ>(+CQ]/X>LKVRMK8Z4MXDSVID=&
M,A3&-X#=/;KT-9">,];;P/H'BB5[:.U-R(=7"PYVQ^:8C*G/ # $CG@GTH ]
M)HK)TZ\NKW6M3(E0Z?;LD$0"<F4+N<[NX&5'U#5G^/-:U+0/#1U#3#;^<MS!
M$5G0D,KRJAP0>#\W7!^E '345PJ:YXETGQ@VBZE)87Z7UA-=V,D41@$<L>,Q
MOEF^7YA\W6FZ-XGU2X\3:=I<MW!=+?:7)<M*MN1''.A0'RFX\R/Y_4]!\U '
M>45Y2VM^+]6^&&I>(7U:RME2RO@4M[4A]\<CJK*Q8[>$(Q@XZYSTVIM5UCP]
M:>%+B>\ADT>X:*VO6^SX:(NN(FSG 7=A23ZB@#O**R='N[J_NM2G>56L4N3!
M:@)@D( KDGO\X=1_N^]:U %:^T^RU2U-KJ%G!=VY()BGC#J2#D'!XJ"\UC3=
M*DAM9Y@DSKF*WB1I)&4=U1 6P/7&!6A7GWPYE;4?$'C;4KOF^&LR60W=4@B
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M)&.O\0]* *EUH^JVTVBII^L79:&X,EZ9(T9;M21O,AP-O&0H7N1QA>.GHHH
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MM!)RN3U '2V>@ZIJEUH.M:GJ.+S3#/L'V3R_/63*[G4ME"4"G'&#G/H.OHH
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M\<UT%% '%KX *>%[?0AJS>3!?"^64P#<7$IEP><8W'\J[-<[1N()QR0,4M%
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M2.=LF<[U;.5;))R".I]:DM/".@V4MW+#IL1DO(A#<O*6E,R 8PQ8G/'KU[T
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MSI)N;&X-O)YUA&8[5_M$F8E(P0/F[@ 'Z#TH \O@^UP^ [/7?[4U-]0MM?\
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M//>L>:336^#WC2SD:V-U;W=^7B;&Z-O/;9D=CSQ^E 'L$]_:V-JDU_>6T"$
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MW?+_ +P"Y([ BO*_$^L:9)IVN?9I[>R:V\20//!(Y:=Y$FB5IB2?DCP.,#&
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M*7\/Z.\NGW=@;^.:!6MICN<H\BH2%# @@-G/(KE/"=QX=UVU\,,NKW;Z[I@
M73QY:2PR[=LHD 0-LZY)//J216%<:OIL_P %S!J5Q;IKUOJ4;WT,[ 3)<?:U
M+L0>?ND\_P!WCM0![9<W]G9LBW5W! S_ '!+(%+=N,GGJ*+B^M+2V-S<W4$,
M X,LD@51^)XKS/Q!JFF6GBWQ/:W.JZ6RZOI,$48OKM85A^60  M]Y#NW$KG!
M['-1M-IWA2_\(0W&KI!H0TI[:+4[98S UU\F68E64;E5OFZ]>>30!ZK%-'/$
MDL,B21N-RNC AAZ@CK3R0!DG %<;X:O?#'AK2+6TM-5;['J%\ZV+W#C;/(YR
M1%@ ;-Q.. ,].HS/\2)+F'P->S6R2NL;PO<+"H+M )5,H .0?D#9!XQF@#H+
M?4]/O(I9;:^MIXXN)'BF5@GU(/%+#J5C<7 MX;VWEF,8E$:2JS%#T; .<'(Y
MKS>]_P"$5UFQU_6]/UEM5FDT*6*=LQ^2B %D\P*BXDSG;GG /I4&FQ:;9WWP
MJFMEMHI9K:022)@-)FSYW'J?F Z]Z /4#J-DMZ+)KRW%VPR(#*OF$?[N<TW^
MU-/\AI_MUMY*-L:3SEVJWH3G&:\U\)ZEH&I:#9Z/KY5_$MEJK32V9<K<-=B5
MB)  067!!S]T+UX%9^L7]C9^'_BEIUQ<0QWLUS++';,1YCJUO'A@O4C@G/L3
M0!Z[-J%E;Y\^[MXL1F4[Y N$& 6Y/3D<].:8-5TXFV O[7-US;CSE_>_[G/S
M?A7GUFFD7WQ1TB1ELYUE\,ER3M8.1+'@GUP,X^E<P8-*@^$5[=PI:)/;Z]B"
M5=NZ,"^&T*>H 4G@=B?6@#TBQ\3R)XN\1Z=JUU8V]EIXM3;RM^ZSYJN2&+,0
M3\H'&/I7237MI;!3/=0Q!P67S) N0!DD9] ,_2O/5MO#]S\1_&(U^.PDA:RL
MG3[6%(,>R0.RY[=,D>U<_I&E0Q3_  RLM<@C:8I?+Y=V!O,.QC$C@]<*5X/>
M@#UU]7TR+R/,U&T3[0 T.Z=1Y@/0KSSGVJ2>_L[4L+B[@A*QF1A)(%P@(!8Y
M[9(Y]Z\B\:7&CVUEXYTBQ2UTZ2WT^&-X6Y>X"Q%HQ"F<(B@\D \Y/&,G9M1H
M^J?%/3)W%G<K+X;,A9MK"1A,F&/KQG!]* /13>6HL_MAN8?LI7?YV\;-OKNZ
M8]Z2*^M)[3[7#=026V"?.20%,#J=PXKQK1-6M])\/^$+NZD4:!:ZS?QW+#F.
M!B\H@+8Z*">">!P?2MSQ'>:+9:5'K&B/)_8TFNQW6K7EJ?-C;*D&1<[E*J_E
M$X!&1Z@X /2K2]M+^#SK.ZAN8LD;X9 ZY';(J>N%T?4?">DRZ[XFM]>:XM9_
M)-]>%T-N''RJ!L4#?@C..>5S75ZE)//H%Y)I;A[B2U=K5U.07*G80?KB@"5=
M0LYKJ2SAO;9KQ 2T(D#.ON5!S7/^$/%#ZKIK-J]S917IO[FUBC0^7Y@CD*C:
MK,23@>IK \&ZGX4UG2?"R*RR:YIL6W[,'*SV\NS;,TBY!QG<26X)(ZDBN7E3
M35^&6J:BHMOMD?B4M'<?+O7_ $X8PW4?*2?H2: /9Y]2L;6XCM[B]MH9Y,;(
MY)55FSTP"<FEN=1L;,L+J]MX"J[R)957"YQGD],D#\:\A\?:KIT^G>/;:WE@
MM;I%@\Y)&+SW3*B%612?D11W .2">.^ZUKH&N_%XK/#87T-QX>5]KJKK*?//
MS8/#';T/I[4 >@RZA96]PEO->6\<SXVQO*H9L^@)R>AHNM1L;&)9;R]M[>-S
MA7FE5 3Z DUY'K4VESGQMX8NM;TF)]1OT=9[ZZ6)H/DBR-C<D(%&W'!/''6M
M;4+_ $G2?&UQ8ZOJ::9I-WI,,>G3!8A;R("_FH&9"H)W*<#&1CK@4 >G AE#
M*001D$=Z221(HVDD=411EF8X 'J37,^'+[0=#TW1/#UMJ$FZ:%_L$=XW[V:)
M22".!QCITXQZ57^);)%X1$\EW%;K!?6LN)CMCEVS*0CGLI[D\#O0!U%O?6EX
MI:VNH)U!()BD##(Z]*;:ZE87QD%I>VUP8_OB*57V_7!XKS1[GP]=3>,_%7GZ
M?J"S:8(WL]/NDDG$:(P=BR'*%MP7(Z!03Z!NBZAID_Q&TW??Z;/:S^'&A5(,
M&$ 2H1'DD[R%R3GMDX% 'I0U?3"&(U&TPL9E;]^O" X+'GIGC/K4L-]:7%Q+
M;PW4$D\0!DC20%DSTR!R*\5M]+T0_LY3ZB+.Q:\%A+']I**9 ?-.%W=>H&![
M"NM$.EV?Q.\.+:):Q+<Z-<K((]H\T;HB-W][^(\^] '8Z?>R1:?/<:GJ-A($
MGD'G0'9&B;L*K$D_,!@'GK65XF\23V$6AW&DSV<]O>ZK;V4[8\SY)&P2K!L
M_4'K7%:'%;W'@M(++6(-+N8_$MT;&4JKQ>:'E*HZY VLN0/?;CM3=3U ZAH&
MEQ:M8V=G<IXN@@NA!)F"X8,-\B9_A.>1Z@Y[T >KPZC8W$,LT%Y;RQ1$K(Z2
MJRH1U!(/&*:FJ:?),T*7UJTJQB5D6920AY#$9^[[]*\NU:+38+_XH6B):1P?
MV-!((0%"B00S#('3/W?TJ3[%HYU;X8CR+/%Q;S"7A?WH^RY^;^]\X!Y[T >H
MV][:7=K]JMKJ&:WY/FQR!DXZ\CBHX=4T^YM9+J"_M9;>/(>6.961<=<D' KR
M*ZNDT[3_ !:;0E=.M/$\$UY':JK%+?;$9&"8((W#)&,'!SWJ[XAC\,:AX8\8
M:SINK-JLMQI)6XEW1F$.JGRL[5 \WDX[@=<<4 >HIJ5C+-)#'>V[RQ())$65
M2R*>0Q&>![U4T+Q%IGB.TDN=,NHYXTE>,E'!^ZQ7/'8E3@]Q7$0PZ;9^.? O
MV-+:)KG3+I93'M!E&R(C=C[W.3SWS4G@+Q#H>@^"9VU'4+6T-MJ-U'<;S@QL
MUS)M# <C/;/;F@#TBBD!! (((/0BEH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!KQI*C)(BNC#!5A
MD$4PV\!SF&,Y 4_*.@Z#\*9>WMOIUH]U=2;(DP"<$DDD   <DDD  <DD"LA?
M%^G^=J%L\%Y'>6$0GFM&AS*8CT=0"=XX/W23GC&: -H6MN"I$$0*_=.P<4IM
MX6#!H8SN.YLJ.3ZFLC2?%.FZV;/^S_.F2[MOM2.$^58\D L?X22" #SP?0X9
M)XOTJ&ZM(Y#.D%Y<?9;>[,9\F2;D; WN00"1@XX)H V)+6WEC6.2")XU(*JR
M @'U ISPQ2,&>)'8="R@XK$O?&.DV#DS/-]F6Z%G)=K'F*.8G 0GZD D @'@
MD&GMXLTU(]9=EN =&P;U/*^9!LWY']X;>>* *OAWPU+I>I:Q=WHM)VOK]KV(
MJI+0ED5=N2/1!R,?2NC:&)I!(T:%U! 8J,@'J,US$WC2,^)-%TRULKF:#4K1
MKL3B/C9A< #K_&"?3C\'Z9KNBPCQ%?#4;TPVEV1>?;-X6!PB_+&K#(7&. .2
M>,YH Z00Q!441)MC^X-HPOT]*$ABC8LD2*QZE5 )K)@\36,FI'3IH[JUO# ;
MB.&>$AI8QU*8SN(XROWAGD5FVGQ#T&]33I83>?9[^?[-#<-:NL8EW%0C,1P2
M5.!],XH Z6*UMX XA@BC$ARX1 -Q]\=:/LEMC'V>+'7&P47=W;V-G-=W4R0V
M\*&221S@*H&2367!XHL)=1@L)4N;6XNHFFM5N(2OVA%&6V>X!!*G#8[4 78=
M+MX=4FU *#/)&(@0H 5!VXZYP.3Z#TJTT4;NCO&K,ARK$9*_3TK TCQKI.N7
ML=K8)?2%WEC,IM)%C1XSAE9B,*?8X/YBJ7BR>YM_%7@\07=Q%'/J#Q31)(0D
MB^3(V& Z\@=: .J-K;E54P1%5S@;!@9I5@B60R+$@<]6"C/YUBZEXOTK2A)+
M=&<6<,XMY[Q8R889"0 &;ZD D @$X)!JQ9^(;.^UK4=)A2<7FGJC3J\>T8?.
MTJ3PV<'D>G.* -%+6WC,A2")3*<R;4 WGW]:3[);8 ^SQ8'.-@K&M_&&FW&H
M:79".[275(FFM"\)"R(HR3GITP<=<$5IV>I0WMW>V\22AK.412LRX7<5#8![
M\,I_'UH G-M Q<F&,E\;R5'S8Z9]<4YHHV;<T:EBNW)'./3Z5F7_ (AM+&YG
MMEBN;J>WB$UQ':Q[S$AS@M[G!PHRQQP*Y[Q9XN1=#T2YT>2:>UU:_MH1<VRD
MYB=QN"GJ&(!'8C)Z$4 =F+>$1M&(8PC?>4*,'ZBD2UMXX! D$2PCI&J */PK
M,TBRBT:QNIWOK][65C<A;^4N;9=HRH+?,%&"<$G&:@L/%^F:C=6T$:W,;7EJ
M;RT,D) N(1C+)C)_B4[2 W(XH VA:VX*D01 K]T[!Q]*KZ=ID&FBX,0&^XE,
MTK!0NYL!>@X PH'X<Y.36#;_ !$T&YCLYHS>_9KJY-HMPUHZQI+O*!78CY26
M&,'U&<9K5L?$-GJ&LZCI4*7 N]."F=7CV@!LE2"?O @'D<<4 :#6ELUPMPUO
M$9E^[(4&X?0]:5K>!V=FAC)< .2H^8#H#ZU!IFHPZOID-];"58)UW1EUVDJ>
MAQZ'J*X[PCKILM/U47]Q>7LG_"075G;J29I"JMA5 /. !] .3QF@#N?(B\WS
M?*3S/[VT9_.A+>".9YDAC663[[JH#-]3WK!_M/3O^$TE@-QJ0U"+3/->TVN8
M1%O^^% PSYXRN> 15>R^(6@Z@-,>!KS[/J4OD6]R]JZQ&3) 0L1@,=IP/SQ0
M!NZ=ID&FBX,0&^XE,TK!0NYL =!P!A0/PYR<FK30Q.VYXT9L;<E03CT^E<CX
MW\110^&/$45E)??:;*TD\RXLP?\ 1I=A9 6'.>5)QG ()P#6_P"'9'F\,Z5+
M*[/(]G"S.QR6)09)/<T 7OL\'E-%Y,?EM]Y-HP?J*0V\!SF&,Y 4_*.@Z#\*
MBO\ 4(-.B1YRQ:1Q'%&B[GD<YPJCN< GV ). ":YG5_%FAW7AG7&N[K4K%;'
M]S?"!'2YMB1D$;<XR,$,/E]Z .K%K;@J1!$"OW3L''TI([2VAD>2*WB1W&'9
M4 +#W/>N>G\4^3XRLO#D=G=.DUB]RUP%ST9%7!ST&XDGZ>]<]X5\86^DV&H1
MZO<ZA<*NNW-H+J1'E2%?.V1J\G11T'MD=,T >B1P0Q$F.*-">"54"FI:6T4;
MQQV\2(YW,JH &/J1WK,U;Q-8Z.MTTR7,R6<8ENVMXBXMT(SEOP&<#)QSC%4;
M[Q]H=E<BV#7EU,]F+Z-;6TDE\R$D ,N!\W7/'3!S0!LZAI=OJ&G26$B*EO+Q
M(JJ.1W ]#[]1VP>:NJJJ@10 H& !T JAJVL6VBZ--JMVLQM8$\R4QQEF5>I)
M7KQW]*:NM6SC32D<S#41NAVKG V[LMSP,=_PZD4 74MH(PH2&-0@(4! -H/7
M'UI([2VA,ABMXD,GWRJ ;OKZUC'QCI*FWD9YELKB?[-#?&/]P\F2NW=V!((#
M$;2>A-9%OJ4UC\1/$WGW%W-96^FVUP(-Y<1Y:3<47.!PHZ=<4 =A':6T*R+%
M;Q()#EPJ ;C[^M8>OZ#?WLUA<:3=VEN;1G+6MU;>;!-N &6 *D,!G!![GBIH
M_%FER1Z)(K3&+6@#9/Y9PY*%P#_=.T$\UGS?$;0((+N=OMQ@LKHVMU*+.3;
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MK;:245[B9<+]S>S,<\#!&/;F@#HOLMOY3Q>1%Y;\,FP8;ZCO3EBC6$0K&@B
MVA HQCTQZ5C6_BO3I[ZRM'6XMWOT+V3SQ%%N !D[3V..=K8..U7M6U:ST6R%
MU>R%4:1(D55W,\CL%50.Y)(% #KC3H)M.>QC1((7&,1QKA1GL", _A5BWMXK
M2VBMX$"0Q($1!T50, ?E63!XJTN6#4Y)I'M&TM@EY'<+AHB5##ID-D$8VDYS
MZU5N/&EA;?VC"]M>K>V5G]N-HT6))(<D;EYQC(P<D$=P* -];:!)))$AC5Y?
M]8P4 O\ 4]Z3[);8Q]GBQUQL%<[H_C.WO--\/R7UO<6USK$:>4#$=C2&/S"
M?3&<$]<5:D\8:1#!JTL\LL(TJ5(;H/&<J[XV 8^]G<N,>HH V3;0$L3!&2R;
M"2@Y7T^GM2B"$2>8(H]_][:,_G6#/KEOJMAKEC"UU9W]C!F:-ODDCW(61@P)
M!!P>0>QKD8M0U!O"7PTNSJ-YYUW=6D=R?.;]^K0NQW\_-DJ#S0!OQ^%];ANK
MI#?:/>6D\[S"2^TXR3H&.=N0X5@!P.!@ #'%='::196FEVNGB!)(+9%6,2(#
MC X.,8!^F*K6'B2RU&^U2S@2<7&F$+<I)'LVDC(QGKD<@]/>K=A>Q:OI4%[
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MX%.H 9$[21([1M&S $H^,K['!(_(T^BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .)^+<,4OPTU5
MI(E<QF)TRH)5O-3D>AZU9B\7Z@GB1-#U#06LI[N"2;3G:Z5TN"@RR,5'R, 0
M?XA[U?\ &>A3^)?".H:1;2QQ3W"KL>3.T%75N<<X^7%5SI=W?^(-/U[64M;-
M-*@F\J**<R#?( '=G*KA0JD#CN2<8Q0!%IOC*34_#$&J1::J7DM[]B-B]Q\T
M<@DV,&.W@J 6(QT!-:OB?4;O2/"NJ:E910R7-I:R3JLK$+\JDGH#GIT[],CK
M7.Z'I-I/X_U75].O5GTLK'-Y41#1"]="KNI'?RMF?^NAKJ->TYM7\.ZGIB.(
MWO+26W5VZ*70KD_G0!Y]?W%Y/J?PWU2YLHIM2<RX,<@+2!K1CRQ5<9)R1SCM
MFNBM?'<?]EZC-J=DME>6.H+I[P?: Z-*VW81(0/E(<$D@8 /'%5(O#?B%Y?!
MTMPFF*=$+>>J7#G<#"8AM)CY/.[G'ISUJK=^!]:O(O$#K<V=I=W6J1:IITR2
M-((Y(U0*) 5'!V<XS][OCD Z#0O%?]KZW?:3+;1)-;1K,D]K/Y\$J-QP^U<,
M#U4CN*Y[XGP69U/P=-<VBS@ZRD<@\GS&=-CDK@ EAD#BNJT'_A(Y0TWB!=/@
M<+L2"Q=G4GN[,P![< =.<DYXSO&.@ZMK6H^'[C34LBFF7ZWD@N)VC+X5EVC:
MC?WNM "Z3%HW]N7D^DZ"UI=VEHJY^R?9?/$K$XP5&<&(<]LFLRU^(]U<:1H6
ML'P](-/U:=;92MVIE21BP0!2 "I(QDL,9Z8Y/2(?$,M_&\MKIMO;(C%A'=/(
M\SXPJDF)=J\DD\G(''6N3M?!6O6W@GPOHO\ Q+FN=(U"&ZF?[0X1TC<MA?W>
M<G..1Q0!J/XXN;2+Q&E_HICO-$MENVAANA(LT3*S ABHP?D8$8^F:;:^.[DZ
MMHUOJ6@RV5CK*@6=W]H63,FS<$=0/ER,X.3GN!SC/\4Z+J5M%X[UJ86HL[W0
MFAC"2L9%,<<O)!4#G?Z]JN:9HU_KNG^$9;^*W@M=+2*['EREVFD$6U.-HV@;
MBQZ\@#WH S_"^J67AC3?%UP8<(/$LT$%O$ I>1Q$J(O898_AR:Z/_A)KN#7Q
MH5[IL45_/:O<6)2Y+17&S[R;B@*L,@_=(P<Y[5@2^ ]5O-&UVVFGL[>[N=:_
MMBPFCD:18W&PJK@J/[G.,]?:MS^RKN]\1:?XAUM+6S&E6LRQQQ3EQND"[W9B
MJX4*F!]23C% #--\92:IX9M-4ATY5N[F\^Q_87N,-'('*L&.WJH5F(QT4U5U
M;XAV^G)=W%O;0W=M97/V:=$N@+DD,%<QQ;3N"DGJ03M/MEF@:1:R^/-7U;3[
MU9]+.R98HR&B%XZ8D=2._EA,_P#70TEEH7BS0]7U*VTJXTR31=0NY+M9;@N)
M[1I#ND"J!M<9)(R1UYH LZSX\AT\:BUE!;WG]G$">)KL132':'*Q)M.\A6'7
M&3P.:Z>WOX+C3(M0#%+>2$3@R#:50KNY';BN1_L/Q5HGB74KC09=,N-,U659
MY8[YG5[:;:J,R[1\X(4'&1SW'6NMDLEN=+>QNI&F62$PRN>"X*X)XZ$T <R_
MCKR-*T[7+C3?+T*_E2-+D39DC60XCD>/;@*3CHQ(W#CKB2#Q;J5YXFU#1[3P
M\\@T^ZAAN9VNT4+'(@?S ,<X!!V@YK,M_!NKS>#[/P?J3VCZ=:RQ*;Q)&WRP
M12!T7R]ORL=JJ?F( R1GI6UH6BZEI_BWQ)J=TMK]EU.2%X1%*S.OEQB/# J!
MSC/!- &IK&I3Z;;P-;6$M[-/<) J)D*FX\N[ ':@&23@]JI^&O$B^(3J<9A2
M*;3[LVLOE3>;&QVJP96P,C##L,$&H?&.DZKJUA9)I;V[>1>1S7%K<R,D=U$,
MYC9E!XR0>A!QR*@\*:%JNCZQKUQ??8?L^H7*W$2VS,2I\M$*D$  #;U[]<+T
MH P?'L%@/B-X&EO+);B-Y+U94%L9C(!!\H*@$M@X/0XZU'X>N[;_ (6S?6^C
MH^F:9'IH-S93H;?SIM_$L<+8( 7@N  ??K6]XDT+6=0\8>'-8T^.Q>#2&N&=
M+BY>-I/-CV<8C8#'7WJ-O"NH:OXYL_$6L&SMXK"UEM[>VM9&D+F0$,SN57C!
M.% Z\YH 9'\0[>:XTJ2&UBGL-3G6&*2"Y#SQ[L['DB"_*IQUW<9&1Z5KCXC7
M<&EZKJ9\//\ 8M)OVL[QS=KN"JR@N@"G<?FSCCCN>@F\+:)XOT&"WT*>YTV7
M1K-@L%XI?[2T*G*QE,;0<?*6ST[9YJC=^"]>N?!WBO1Q_9RSZQJ,MU"_VA]J
M([*<-^[SD;>WK0!NZWXRCTVZO[6TCM+BXL85EFBGO! S%@6"(-K;FP,]A\R\
M\G&'KFN7NL:QX&DL;.,V-_+)<>1=2M&S,+=R%D78<;2<]^0.!@&K]SHOBK3?
M%5UK.A'3)H=3BB%[:7DKJ(I8UVAT95.1MP""!T_*SJNA:U=Z[X8OXY+.<:5)
M+)<O+(T;2,\90[%"L !NSR>V/>@"AI%[X>\+ZSXIAAT.#2H]-MH[RZN8F#&9
M7\QN!C@ AL#WQ@5NVNN:I)J5K;7.@RQP75LT\<\4OF"-A@^7+\H",0>,$C(/
M/&:Q[_P9>:OK/BMKQ[>/3]:L(K.-HY&:6,H'^8J5 ZOG&>WO5_PW;^+X88(-
M>?3-EI'L$EH[LUVP& 7W* @[D#.3Z 8(!2\/^(HSX5M+K2/#A@^TZC+:_983
M\D3"5P\LC*ORKE22<'D@>]1S_$80>%=8UD:8)WTJ^^Q3Q07(9&.4 97QR/WB
M]L]:HV_@[Q):>&+#3U;397M]6EO+BU:X<0W4+N[[&;R\C!<'&T@[>?2HKSP1
MXCN/#_BG3$;2LZO?I>0MYLBA /*RI^0XQY6!CKG/&,4 ;MUXNU;3;RP35/#J
MVEK>WXLH[AKY7V[AE&8*IQN.5QGJ.N"#6]9ZE)=ZOJ%H+=1!9E$\\29+.RAB
MNW'& RGJ?O#WK)\:#3;SPC>Z=K%S#;2W%LS1HLH+^8N"IC!P6(;;C ZX]:8(
M=8\/> MUO)92ZV$$T\MZ6$3S.P,A.SGNP4#T44 =57(V?C:6;5]%L;S2FL_[
M8$Q@22;]_%L4L/-B*C;E5/0G!XKI('N+K2XGD0VMS+""R_>\IRO(]\'^5<!I
MG@[Q/;S^&9[G^R3<:5<RO=3B:1WN]\;(96)0'?SG:<Y_O#I0!TFC>*GUVX0V
M5I#)9_:I;:9TN<RVY3?S)'M^7)3'7^(5JZSJ,VF6<<EM837LTL\<"1QYPI=@
M-SD [4'4G!P!7*P^$+V7Q1IFN2VUE8ZC;RN;R\LI6_TV(JP".FT DDJ23G&W
MC/;9\8Z5JFKZ5;PZ5)!OBNXIIK>X=DCNHE/S1,R@D \=B#C!&#0!D77Q$%IH
M?B.^;3%FFT*81S1V]T&1P55@RN0/[V",9!!ZU:C\9WD?BBWT74M!EL_M\4DF
MG2_:%?SR@W,C ?<;'/4CWKD?%V@ZMI/A'Q]?7@L%M=1AAEB2V9B8RJ(FW! &
M!MZ]_1>E=K_8U]JOB+1M5U**WMTTJ.5HDAE,ADED4(3DJ,*%W8[DGMCD PX?
MB=<'1=-U^X\-S0Z'=3"&:[^U*S0$R% Q3&2N< G(Y/ /!-C2D2U^)?C5X+57
M9K*QD:-<+YC8FSGMD^IK#\'Z-?\ B;X3:5HTT=O'ITLY>:<2DNT27!?:%V\,
M2NW.< <]>*ZZTT35;7QEX@UC99M;ZA;00P+Y[!PT0?[PV8 ._L3C'>@"IX>\
M3V3^&?#::3I,=M)JL;FSL%DVQQ(F2Y9@O ''0'EA]:OIXEU,V0,GAVZCO?[1
M-CY98F+ &?/\S;GRL#[VWKQBN:M? _B+2_#WA22QGT_^V_#XDB\MY',%S%(
M'4MM!4\*1P<$5KZSHWBC5=/T^2233I)X[Y9[K3C*ZV\D(4CRR^TEL'#<K@GM
M@"@#GO&.OV_B;X<:S,UG$+C2]6@MCY<@F7>L\/S1O@<%7QT'4BNJL_%-Q<>)
MSX<UO0S8/=6[S6C-.LR7"*0'5L#Y6 (RO(QW]<*;P-KMSH7BC3Y)M-1M3U&.
M_MBA?:"IB;8W'RC]UC(SG.<#&*Z--'O]0\26FO:C#;P26%M+#:VT4Q<%Y-N]
MF?:.,*   >I/L #F? FN6N@?#;0H6\E9;JZNH+=)91$@Q-*Q+-@[5"J>QYP,
M<UU?AGQ,/$#ZA ]J(+BQF$3F.3S8I01E7CDP-P/T!!!%<K:^!_$5AX3T2.TN
M=/BUW1;R:Y@)=W@F25G+(QV@C*OC(!Z>_&WJ%[XNT_PU<:B\>D'5-R;+/S)#
M"$'55; 9Y&S@< =!@]P#JYI/)A>3:[[%+;4&6..P'<URMAXSFGUK3-,O-*^R
MS:E9O=PQ>?NECVA3LE0JNQL,.YY!';-='>Q7-UI5Q%;R_9;J6!ECDZ^4Y4@'
MWP>?PKA=*\)>)+74O"][-%I$;:7#/#=>7/(S3F14!EW%!EF*9(/3.<GH ">+
MXBW3Z5!JTGA]H]..H&PN)#=J6B;SO*#*H7YANQGD8SQFK^O:RVIVGB'3+'38
M;^.QMREV9IMBEV3=L4;6W,%()S@9(&>N,8^"M?/@670_^);]I?5?MP?[2^S9
M]H\['^KSG^'I[U='ASQ!IFM:_)IJV%QI^N#S76>=T>UGV;&(PAWJ< _PT :O
MP\_Y)QX;_P"P;!_Z *K77C:6QOK-+K2F@MKO5/[,B,LVR9CN*B41E>8RPZAN
MA!]JT_"&EWFB>$=*TJ_,!N+.V2!C Q93M &02 >WI7'S>#/%$L2+(VE3W$&N
M1ZDMY+-)YES&LA94?Y/DVJ<  L..,=2 :M]XZU"WG\1Q6OAYISH.UYR]XJ!X
MS'YF5^4_-MZ#\R.]\>+RVN:%9BQ LM:MS-;7;38^8('\LKM^]M.1SS@^E9S^
M%];>;QLY%@?[=A6.W_?N-A$'E9?Y./7C/I[U6\0:<%\!Z7H<M]:P>([!+5K$
M0R[V%PA"(R@@$J<$$XZ%O2@#L-*U*74C>L;=8X(+EX(I%DW>;L.&;&!C# KW
MY4UEW'BI_P"W-0TJPM(;FZL!&987N?+E=7 ;<B;3N4 ]<CD$?7;TRPCTS3+:
MQB)9((PFYNK$=6/N3DGW-<AXL\(7OB6YN"UM91W$<D;:9JL<K)<6@ 7=G"\_
M,'(&[!W<XZT :9\5R_:_$UJ-/7S=#CCE/[_Y9E="XYV_*<#T/-%GXM.J1:1'
MI]DKWVHZ<NI&&:;8D,3!<;F"DDDM@87G!/&*S=0\-ZZNO^))].%A)::Y9QQM
M)/*RO Z1LG"A2&!!'\0QSU[TK?PEXGT;_A'=2TM]-EU'3]+32KRVFE=89XEP
M597"Y#!AGE>_Y@$&OZA-J.H^!=7ET.>UU'^TIHS:S "1<12@KN./E) (/<8.
M*Z[PWXAEUN34[6[L197VFW/V>>)9O-4Y575E; R"&'85G:GH.O:A?^&[R22Q
MDET^\>ZNOWCHOS(R!(QM.0 W4XSCMGBUX>T74=-\1>([^[%KY&IW,<T(BE9F
M4+&J88%0/X<\$]: )==\0W6E7$T<&FB6."S:[DN;B8PP\' C#[6!<X)P<<8]
M:Q+CQ?J5]JG@MM)M8!8ZU%)<LL\Q1SB$L$.%8 #<#D9R1C@<FWKF@:W?>*3>
M6[6,^GR6!MD2Z=@;24DYE10I#$@@=5/'7'7-L/"'B&QL/!;!M-:\T%)()4,K
MA&1HO+W!MN21C.,#/3/>@"SIWB^^@N_%MUK,5O'I^DW/E+Y,Q9@!&A"@%0"6
M+=21@G'09JU!XW=]8DTUK"&:0VC7,$EE=B>-BO6-VVKL;N.H(SS5*[\$:C?'
MQ=827%M%8:W(MQ#<(S&:*4(B@%, 8#(#G=R.,#J-+2HO&<UG)'KG]D"2.%D3
M[)(^+ER,!G)7Y%[X //IC! ,VW^(=W-I_A_4G\/.MAK3K#$R7:M(LK*S*NT@
M#:=I&XL/IZSS>/;BRL/$KWVB%+W04266"&Z#K)&ZEE8.5'8'(QV[U2@\':[#
MX5\'Z5_Q+FFT.\AN)V^T.%D6-67"_N\Y.[OCI57QAHNHV6E_$/5[@6OV34=,
M181'*QD7RHW'S J!SN[$]* -N'QM>+K^G:=J&@O90ZK&S:?<M<JXD=5W;' '
MR$CIU_/($W@'6M5U[1)KW5(K=&-W<1H892V DKKMP5&  H .3GK@5%:Z-?ZS
M<^&KW48K>"#2D\]5BE+F:5H]@ZJ-J@,3ZDX].;7@S1-2\/V%WI]Z;5K<7<\U
MO)"[%G621G^8$ *1NQ@$_6@"";6]7'Q.BT5(;7^SETQKHDS,&.954L1M/(P0
M%SSDDGL(I_'JP:#'XD.G[O#SS!#=+-^]6,OL$ICVXV9Y^]G!!QV%N^T+47\?
M6VN6QM'LVTYK"Y25V5U!D#[E !#9P1@D8Z\]*P[?P1JR>"9/!$\EJ^E>9Y:7
MHE;S?LWF;]I3;C?C*YW8Z'M@@'=WM[;Z?I]Q?74HCMK>)II9#T5%&2?R%>>>
M(+VZU37? >HS:3%;13ZD'AE,VZ55:&0A'&T;21@X#$9'TKNM<T>+7/#M_H\C
MF**[MGM]ZCE RD9'TKC5\.^+[J#PO!>QZ3NT.\21YTN9#]H18V3=M\OY3AAQ
MD\^E %R/Q5IVEGQ=?/HZ6<FG7,274@<9N&9$VNQ X #+D\X&35G6/&5UHOAR
M_P!9FTF.XM[81-&]K=AXYE<XW!BHZ'' !J*W\/Z[:7WBFZCBTR3^U;J&:&*6
M5F5D541TDS'QN56Y&>M<IXJ\*MX<\ >,)K:**QLKW[,T.G12EXX7$@WN,@!=
MQ(X''RCUP #L(O&LMMXF&CZYI#Z6D]O)<V=RUPLBRI&,N& 'R,%YQDC'>D;Q
MPT&GZ3J]UIOE:+J<L<<5R)\R1"3_ %;2)M "MQT8XR/P?J'AFX\2ZQ:W>LQ0
MV]O:6EQ;I%!,79WG4([9*C "@@=SNYQCG.M_"&L7'A73/"NJ-:/8V$T.Z[CD
M;?/#"P9%V%?E8[5!^8XYQG/ !L6OBI]0U2ZM;"TAG6SO?LEROVG$\7(!D,>W
M[N3P<\CFL[4/B);6:-=06\-U8Q79M9?*N@;D8?RV=80IW*&![@X&<8IFH^$+
MW5/$%IJDEM96NH6FH"5-4MI6662U#Y\IU"C<2OR8)([Y[%-)T'Q9H-Y=Z787
M.FOH,]S)/#<2EQ<6JR,7= N-K8+'!)[Y.>E '7:MJEKHND7>IWK[+6UB:61@
M,G &>!W-8A\5SV>I:1;ZMI@M(=6/EVTR3^9LEV[A'(-HVDC.,%AD$>]:7B70
MXO$OAK4-&GD,:7D+1^8HR4/8X[X.#BL-?#^L:N/#\>NK9H-'G6Z>2WE9S<RH
MC(A *C:/FW'D\C'O0!E:59R>)?%_BZRUW3;.XM([BVCP;AF,(6%74)\@/WF+
M9RN"3UKL=7U6YL+FRM[6P:X:Y+[IG8I# J+N)D<*VW/ '')K-\/Z-JFG>)O$
M6H7B6@M]3GCEB$,S,Z!(UCPP* <[<\'O2^)M(U?4-8T6[L/L=Q9VCR&YLKN1
MD20L $?A6R4() ([]CS0!FCXB!_#NEZM#I,DWVW4QIKQ1SJ?+D\PQY5CC>,@
MD=,\9Q5J'Q?J3R:_9OH(&IZ3%'.+9+O<+B-PQ7:VSAOE88QUQSWK#A\$^(XM
M$M+!GTN1K;Q -4#B61 \8F:7&-APQSC'(&.IKH+73KK2O&>M^(=0EL8--N[:
MWB#FX(9#&6Y;*@ '?Z]O>@"Q8^*/[3T[P_=V=M%+_:XW[1.?W*;"S-G;SCA2
M./F8"IO%WB)O"OAZ;5OL3WBQ.BM&KA3\SA >_=AVK&\$:'#9:GK5[:W/GZ8;
MN2/35&"D*,0\P0C^$RY'_ *TO'6B7_B+PG<Z5IWV83S/$P:XD9% 217[*Q_A
MQT[T 9NJ:Y,MQHJZ[X51#-K*V]HSW*2^4VPE)A@<-C>,=L=>:L:IXV-DGB":
MTT[[5!H(7[83/Y;,=@=@@VG.%(/)&3Q[U-XHT;5-:D\/R6J6BG3]2CO9Q+.P
MR%5E*J0AR?GZG'2N4N[2_P!:\0^)+G3++1M0T]YEM;J.74);8L8D 99552&^
M;<,GJ!CD=0"S>7DTWQ'\.:I9Z4C7MWHUTPB,JKD;HBN]\'C!]"1GI4VH>.=4
MNO#>E7VGV,-M<S:Y%IEW#-.3Y3"<(RJP4Y!P1NQP#T)J]9V>J:SXDT+Q,EI9
MV]K!836[P&X);<[+RA";63Y.#D9# \5G?\(5KH\.R6P.G_;8_$/]LPKY[^6Z
M^=YFQFV94XXR : /0XC(84,RJDA4;U1MP![@' R/? I],A\WR$\_9YNT;]F=
MN>^,]J?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% "$A022 !R2:;+%'<0O#-&DD4BE71QE64C!!'<
M5R/Q4DN8?AKK4MK=RVTBPC+1XRRD@%>1P"#VYJ5]3O9?%T7A6+4)8VBTXW\]
MV(XS*^Z38BJ"NT 8;)V^GO0!TEC86>F6<=G86L-K;1_<A@C"*OT XJM=:Y86
M6M6&D3R.MY?[_LZ^4Q5]BEF^;&T8 Z9STK*\&Z[>ZM%JUGJ01KW2K^2RDFC7
M:LP #*^.Q*L,CUK+\9QW4OCGP5'9SI!<-+>A97CWA/\ 1SD[<C)QT]Z .ZHK
MS6/QCKFD3:MH>IR1WVHVNH6=K;7D<2Q^8ESRI*9"[E ;N 3BK.JZIXPT?2/$
MMVV5M+6P:ZL;F\2%I1(H):-EB;:1P"&QQSG- 'H-%<);:YK=CXGT&'4+^*ZL
M]7T^:=XEMPGD/&J-E2.3D,0<_ACI3-*UOQ3K-MH.MV%M(]G?2(]W;R^0L,=N
M_P#$C!O,WKQUZ\\#I0!TFK^*M*T,S?;99<0*CW#10M((%8D*S[0=H)!_+/2K
MVF:I;:OID.H6WF"";.SSHVC;@D<JP!'(KC/#=K>_\+$\:XU*0E'M!B2)"K9@
MXR  <#/8C/>L636=9UWP7X'U&XU.2&XO=:CBN/(C15?#R;3@@]/+7 Z>N: /
M4KVRM=1M)+6]MX[BWD&'BE7<K#T(/44MK:P65K';6L*0P1C:D:#"J/0#L*X?
M5/%%UIOBA])U'4)M+WRP+IUQ-;J;:\4A3(K/M.V0G>,94#Y3@]^].<'! /8D
M9H 6F30Q7,$D$\:2PR*4>-URK*1@@@]017ELWB'QFWA77/$$&J67_$EO[I&M
M?L8VW,4+D$%LY7Y0<8Y]2<\:'B;Q5JUKINK:E97J1"VTZ*]M+6&(2MRI9C<9
M7Y%.,+AE)P<9- '>V-A::99QVEA:PVMM&,)#"@15^@'%6*XZ[US4=/\ %F@R
M7-R%T/5XC"$\M?W5UM#("V,[6 ; Z[AUP<4UM6U1M,L+W^TXX;:_OF*L8P9O
MLQ#&-84"G>[ *W(.%)],T =%K&N6&A0V\M_(\:3SI;QE8F<%W(502 <9)ZG%
M7II5@A>9]VQ%+'8A8X]@ 2?PKR;5]:U'6O TWVM@US9>*(;..22,*6"7*;2Z
MKQG!&<8Z5U&GZEKVF^.V\/ZO?0ZC:WEB]Y;3I;B%HF1E5D(!(*_,"">>W- '
M3:/J]GKNDV^J:?(9;2X7=$Y4KN&2,X/(Z5>KROP;K=S9>!?!.D6B2^=J,$S%
MX1&75(\D[?,(7)++USP#Q7;>%Y-?:"\BU^$!H[AA:S$QAY83]TNJ$J&'(.,
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M7,B!I+9I%<QGTW+P?PH YT>'%T75&\476K:K?W5KI[03((T8SHI+C"(@YSG
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MJ T:@(Z[5&&&,CMTX-=?10!RMIX-EBTN[L[[Q#J>H//;M:I/<E-T,3##!0%
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M);R:5+'$[.P/F;T#@C'08([T 9UEX&M;33H])>_N9]'BN/M"64BIC=O\P*S
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MC/\ 9TD2+>5SG &]FX]*N:RNL>%K/5O$%CJL;P_V3*\5CYLEPKRJ,B=2Y.,
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M6AE1YY#N0@@IN))5>?X?RK2T#2(]!T*UTN$YCMU*J,DA023M&23@9P,DG %
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MYZ]Z +^GV:Z=I]O9I-/,L$8C$D\A>1@!C+,>I]ZLT44 %%%% !1110 4444
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M **** "BFR.R1,ZQM(R@D(N,M[#) _,US^D>*6USP]I>L6.DW4D5]<>4T>]
MT";V4R-S@@;>0,GGO0!T5%%% !116&/$T5SJ5U8Z797&HR6;^7<R0E%CB?&=
MA9F&6QC(&<=\4 ;E%9NDZS'JSWL:VMS;2V<PAECN%"L&V*W&"01AAR#BM*@
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M8;68%3Z@_P Q0!OT5G66KB]U2^L!9743694/+)LV-N&1MPQ/3U K1H ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9P]U*7EQT#/NW$#TSCVJZWAO3'U:VU1H[@WMM"8(I3=2_*AQD8W8.<#.1V%
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MAEML$^<D@9,#J<CBO,9I_#.CVVG2V-R;BUOM>:XAU*\E M(;@QL6D&S:K+U
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M9:>AN)[F2Y@#P*(VDFF0*,N54>XR< 9(]0* -8@,"" 0>"#3!!"  (HP NT
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M#I^&:YGP_::OH%OX'U2YTG4);6RTZ;3[V".V=I;9V*D/Y8&Y@=N"0#Q7K]%
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M &5&"'<N&#= <9]*HV7@SQ)8^&- TX/ID[:=>RSW-H\\@@ND=G9<GR\Y4N"
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MCO["XLYL^5<1-$^.NU@0?YT <I:>/!<ZCI$8L$>TU3B*6"X\V2$E=R^<@7"
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M,_WMXW9]:EC\):;#XDL=:A5HY;.R-G'$/N[0?E/U4%P/9S6]10!R5WX+N/\
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M(8!ND*$E5;YL8^8YQCMT[]G10 5R,_@FXC\0WFIZ1XAO=+AU!@]]:Q1HZRL
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M:UN$$D$R-'(AZ,I&"/R-4;3P_IEDY>*W9V,/V?=/*\Q$?=!O)PIXR!P<#TH
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M:+O8E5 P!DG/ZT >;>%-,DO?!U]K%QJ^KR7<+:A#&QOY,!1*X7C/)&W@]?P
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M *,9!^[SM7##C:![YJH-0N!<^&=3L+^[N8+S7GMWOI9V7[5&WFY01 E?+7:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZBO-6M(=2^%WA[6]"$%QJ>A6]O=P^5@[V2)?-B)'=DR"/7'I77^%6&HVDWB
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M3'(DL:R1NKHPRK*<@CU!IU(JA5"J % P .@I: "BBB@ HHHH **** "BBB@
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M@5+10!%';6\4TDT<$:2R??=4 9OJ>]2,H92K $$8(/>EHH A@M+:V $%O%$
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M5;6ZMW>"$OY;OY97=_=!VGDX'K7944 >?ZEHMY#\0&M+0*=)\01"XU!,\QO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF-K*$92X0!25^9MQ VCG)Z4 =316$?%^CI;:I/-+-#_98#7L;V[[X5*[@Q4
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MT'2X8;C584NXFD*S6]M$Q(=V;[SQ[A]['4_TKMX;:*%WE$:>?(%$LH0!I,#
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MR+(44NH*AL<@'&1G\!^0IOD0F)HC%'Y;Y+)M&&R<G(]R3GZU5UG4?[*TBXO
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M)9RQ1I;QM/*9I5MH1%$&("_(G.!A1WY.3WK3DC26-HY$5T8896&01[BN:O\
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MCR2R'+,Q'))K%O/$O]@_$G4XK^\OIK$:5#/':Q0M,58R2!BJ(I.,*,D].YH
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M60G]F36]Q)<Q>6L4I,9QLR!&HVD#  ..-U;_ ,-H+S3_  L-+OK"YM9[2XN
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M$>Z<NA"KY9D+-@YY!&  >GK4\'CBTDUN#29+.>.ZNX'GM%$D3^=L&63AOE<
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MXT]BNLPHEF?-C^8BW\KYOF^7GGZ>_%=/X?LIK?PEINGWD30S0V4=O*FX'!5
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M,F8W?9R5)SM <9/UP#BN-M/"^O0>"/#&EMII-WIVLI>W"B>/'E+,\G!W<G#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#+UCP[I.OB'^T[))W@),,@9DDC)Z[74AAGO@U/IND
MV.D0M%8P"(,<LQ8LSG_:9B2?Q-7:* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHK N]6>Y\6P^'K5RA2V-[>2+U";MJ(/0L=Q)[!>.2" #?HKGK*XM=2U
M?7K:RUR[DN8FA62';\MDVWC9E>=V-Q!)!_&I_#&N'7=+DDE14O+2XEL[M$^Z
MLT;;6Q['AA[,* -JBBB@ HHHH **YKQMXEE\-:/;M9Q)+J-_=Q6-DDF=GFR'
M +8YP "?PQWI;[1M=CT6X-AXANWU7RF*/-'%Y;OC@;0HVC/3!R.,Y[@'245E
MZAXBTW3))8[F63?#$)IEA@>4Q(<X9]@.T<'KZ'T-"^(M)>\TZU2\5Y=2C:2S
M**S),JKN)5P-O3GK0!J45@S>,_#]OI]W?S7_ )=M:7/V2=GAD!CEX^4@KG^)
M><8YIT'B_1KJ6^AM[B:6>RB\^6);:3>T9SAD!7]XIP>5R* -RBN<T'QA8ZQX
M:L]9D2>W6ZQY<30/N8G)"H,9<X&?ER.#Z4]_&_AV+3I+Z741%!%<"UE\R)U>
M*7(&UT(W*>1U ZT =!17,CX@^&-R(=2*N[R1HC6\H9FC&6 !7)ZC'KD8SFK%
MGXS\/WVC/JMOJ*O:1S"W<F-PZRD@",H1NW$D +C)S0!O45AOXPT.+3]0OIKQ
MHH=.?9=B2&17A. 1E"N[D$$''(K*U#XD:+;&W2S-S>22WT-F?+M92J^9SG.W
MYOER1MSD].] '8T5DS^)-+MW9))9LH8UD*VTC"-GQM5R%^4G<O!P1D9QFM:@
M HHHH **S-2T_4+V\MFMM8N+"VC1_-6WCB9I6)7;DR(V  &Z8SGVKC_ LWB+
MQ'X8L]7N/$MV9_MDJ2Q&"W$;QI,R$<19!VCKGK[4 >AT5Y]X0\:6L&FM;Z[J
MLTMV^K7-I'-)$Q Q,R1J[*NQ"<# .,]JZ1-2T_\ X2V]B.L3>?;V*O-8L,0Q
M)N/[W.WJ>A^;H.E &[16;8Z[8:C<K;V[S>:T/GJ)+>2,-'D#<"R@$<CIZUI4
M %%8OBJ_O;+09DTL*VJW7^CV2MT\U@<,?90&<^RFH_!GB >)_">GZHR[)Y(]
MEQ'C!293M=<=OF!_#% &]16#/XRT&V$;2WQ6*29K>.;R9#&\JD@HKA=I.01@
M'L?0TR3QOX=BU-].;4";M)X[=HU@D)5Y/N X7 !XYZ#(YYH Z&BL<^*='6_M
M[-KIE>YE,,$C0N(I9!G*+)C86X/ /8^E%UXIT>RND@N+IDWSBV$IA<Q"4\;#
M)C8&SQ@GKQUH V**YR[\=^'+)K]9KYRU@P6Z$=M+(8<C.6VJ<+CDMT&1S5BV
M\6Z'=ZM!ID%]ON;A&> B)_+F"C+;),;&('4 DB@#;HK'G\4Z/;7D5M-=,AEG
M^S)*87\HRYQY?F8V;L@C&>H(Z\52N?'_ (9M/M?G:B<6<OE7)2WE?R6P#EL*
M<+R/F/'O0!TM%<]/XMM8?&5KX>$%R[S6C7)F2W=D^^BJ 0""/F.6Z# R>:Z&
M@ HK(U#Q/I&EZE'IUW=%;R2)I8X5B=V=5QG 4')Y' Y/I5 ?$'PP;2&[&I-Y
M$DGE%_L\N(7W;<2_+^Z^;CY]M '345CZGXIT?2);B.\NF5K:-9;CRX7D$",2
M SE00H.#UQP">E2CQ#IAUR/1A<,;^6'[0D8B?#1_W@V-I'([T :=%5;+4;74
M&N5MG=C;2F&7=&R@..H!(&>O49%3S(TD+HDKQ,P($B8W+[C((_,4 /HKSOP'
MX_TZX\,Z!;:SJY?5[U2OF2QMMDD+'"[P-@;&/ESGIQ76:EXIT?27D%[=-&D3
MK'-*(7:*%FQ@.X!5.H^\1U'J* -BBCK5>\OK?3X!-<R;%+!% 4LS,>@51DD^
MP% %BBL!_&N@1:;>:A+>21V]E)Y5UNMI0\#?[:;=RCD<D8]ZT+76K"\NWMH)
M7:2.%)WS$X54<94EB,9([9S0!?HK'MO%&D76HV]A'=,+BY1I+;S(71;A5Y)C
M9@%? Y^4GCGI2#Q7HIO;>U^UG?<R-% YA?RY77.563&UCP> >Q]* -FBL-_&
M&A1Z3<:H]XRV5M<&VGD,$G[J0,%*L-N1@D#)&*C3Q7;R>-)O#@M[H2PVRSM*
M;=]I+,0 #C&.#\QXSQG(- '045CQ^*='EU"VLENF$MT6%LS0NL<Y7DA)"-K'
M'/!.>U<S\0_%:6?A>\;2=2N8;R"ZB@\V"!FCW>8H>,R%2H.">A!!&.O% '?4
M45B>*[VSL=$9[W5KC2XVEC47-NN7!WC"CY6^]]WIWH VZ*PK_P 8:'INH3V%
MQ>/]L@B$SP1022/L)QD!5);H>F<8-:FG:A::MIUOJ%A.L]K<()(I%Z,IH LT
M57O[V+3M/N+V996B@0R,(HR[$#T4<FN?T?QUI>H:3HUW<_:+675MJP1O:RX9
MV7=M#;<'COG!P?2@#J**R(?$VDSMJ:QW$A.F?\?@-O(/*XW=UYXYXSQS3KCQ
M'IMLL>^2=GDA^T"**VE>01_WF15+*/J!T/I0!JT57L+^TU.QAOK&XCN+69=\
M<L9RK"IR0H))  Y)/:@!:*Q[?Q3H]U=VMM'=L'NP3:L\+HEQ@9/EN0%?CG@G
M(Y'%5[?QMX>N]273X+\R71N6M-BPR<2JNXJ3MP..A/!P<=#0!T%%%8=[XOT2
MPO[FPGNW-Y;1":2"*WDD<(<X("J2W0],XP<T ;E%<]!XY\.7,NGI!J(D&H%5
MMI5A<QNS#(0OMVJY_ND@^U6M0\3Z1I;W"W5RZBV -PZ0O(D (R/,900G'/)'
M'/2@#7HK!U/QGH&CSK!>Z@%E>W-RBQQO(7C&,LNT'/4'CG'-.O/%^B6-O]HN
M+MUMPJ-),L$C)$' *^8P4A,@@_-C ()H W**16#*&4@J1D$'@BEH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XNQMY+/XQ:L\H.
MS4-)AD@8]#Y3E74?3>I_X$*[2JMYI\%Z\$CAEFMWWPRH<,AQ@X]B."#P: .8
M\-QSI\0O&,\EK=1PW#6AAEDMW1)=D6UMK$8.#Q3/AY;R ^)[\@B"^UVYE@/9
MD7;'N'U9&_*NON(?M$#Q>9)&'&"T9PP'?![?7KZ8HMK:"SMHK:VB2*&)0B1H
M,!5'  H EHHHH **"<#FB@#C_B)X?OM:TG3[O2HUEU'2-0AU&"!FVB8H>4R>
MA(/'N*T[3Q1#?P*+;3]3%VPQ]FN+*6'8WHSLNT >H)]L\5HW^EVNI>7]I$W[
MO.WRIY(NN.NQAGIWJE_PB^E>EY_X'S__ != '/Z>UUX>\<>)9-2M+N:TU3R;
MBUN(+=YE.V,(T1V@[2". >H-<_INB:AX3LO $U[97<L6GR7@NDMH6G:W\]6*
M*50$D#(4D9 KT#_A%]*]+S_P/G_^+H_X1;2_2\_\#Y__ (N@#S;4;;4;CP?X
MUM_[&U,3WFO1W$$7V1V,D>^ DC:#G C;/TKJYHYY_BHUS':7?V:30&MQ.UM(
ML?F&7<%+$8!QSS_.M[_A%]*]+S_P/G_^+H_X1;2_2\_\#Y__ (N@#S:S@U6S
M\$^#;IM#U65=#8Q:A9)&\4Y#1LA>,9!?:2#QP0>#UQ?\16L%[X-O;C2/#FI0
MM>WUG(RR6LK7%QY<J,SLG+ !00"V"<'CIGNO^$6TOTO/_ ^?_P"+H_X1?2O2
M\_\  ^?_ .+H YWQ9=Q0?$#P-<R1RM'F]/RPLS+F$<E0-WUXX[UCWMIJ%C<^
M(=>L](FEM-3U:R*I]C,DT44:A9+E(2"=V[)7(SP&P:Z:^^'FE7NLV&I&\U2)
M[+?LB2\<JVX8.2V6''H16I_PB^E>EY_X'S__ != 'F]_:7S67Q'AATK67&I6
MT)LWEMI':<^0$]SG=GC^'H0O2NF\517$WASPK=6]C>2I9:G9W$\4=LYECC4$
M,?+QNXR.,9KHO^$7TKTO/_ ^?_XNC_A%M+]+S_P/G_\ BZ .+\06U^-<O]6\
M.IJEIJS20++83VS26FI+L3EN"JLH)4L&XV<^M=_;:F+G5;ZP%I=QFT$9,\L6
MV*7>,_NV_BQC!]#53_A%M+]+S_P/G_\ BZUT01HJ+G:H &3G]30 ZBBB@!DD
MBQ1M(P8JHR0JEC^ ')KBOA5%<67@9+:]L[NUGBN;AVCN+=XVPTKLI 8#/!'2
MNXHH \?EL[YOAAJ=FNEZE]KDUXW"0_8I=[1_;%DW ;<XV G/X=:Z*\21_B'K
M-VVEWMS92>'5@Q]FD5)G#R,8@V,9*L/S]:[ZB@#@/!UGJ.F:^MG:W6H7GAW[
M$6B_M.V9)K)]RXB#L 64C/'.-@YZ9[^BB@#E9HI==\72+YFI6,.EQ8AE6W*+
M-(^0Y#.A4A5"@$?WF[5C^%K>Z\,>/M=T86^HSZ3J#+?0W;VK>6EPW$J%PH7G
M ;(P.W6O0J9+$D\+Q2 E'4JP!(X/'44 >-Z7=Z=;Z7INFZE'K-MI&EZH]] S
M:3*X4+*[)NG7*% 3DL!TXSU)[/P_'-_PL'QC,;:ZBBNA:>1</;NJ2;(BK;6(
MP<$^OTJ[I_@Q+"V2Q_MW5[C2XT$:6$TD9C" 8"%@@D*XXP6Z<'-=/0!Y5X1M
M@MCI?AS6?"^J2:MI<R#SYA(UI^[/RSI(3M^[R .<\8IND6ODI=>%]=\,:I?7
M:WLLD$Y$C6=PK2M(DC/G8N-V2,9XXR>*]7HH \W:&Y^W_$IO[/OMM[%&+8_8
MY/WY%J(R$^7YOFXX^O2HXH+I5^&?_$OOP;%,77^AR_N/]%,?S_+\OS''/UZ5
MZ910!Y1X?M/*M_\ A%]<\,:I=ZA;7;M'<,)&LYAYA=)M^=BX!R1UR.!DXJ6[
MMKN32/B;$NFWYDOV<6B_8Y<SYMU0;?EY^8$?KTKU*B@#SZS2ZM?&WAN_?3KY
MK>306LBZVS_NY?,B;$F1\G"GEL=*]!HHH X[5XYC\4?#URMI=/;PV5W').EN
M[1HSF/:"P&!G:W>N1O[*^F^&OCFSCTO43<WFKW$MO#]BE#2J\BE64;>00"<U
MZ_10!Y;XN>_U-_%MBFCZB%N-*'V%K2S9?MI,39\V3 .4)P(R1WX8G%:&OP7D
M?A/P]XET^TE75='$16VF'EO-&X$<D)!Z%@01GG('&:]"K&N?#L5YK\>J3W]^
MZ1JNVP\[_1MZDE7*8Y8'GKC(!QD"@"UHNGMIFD06TKAYP"\\@Z/*Q+.WXL2:
MOT44 >1Z=I%YJ/PKTCPBVGWD&JPW,0F,ULZ+;!)][2;R-I^4'&TG.[ZXLI!]
MBUC7M#UWPUJVII?WTES:26ZR/;7$<A!".0VU"IX.[ P!7J='3K0!'!'Y5O''
MM5=B!=J]!@=!7(_$&WOA%HNJV=C<W\6FWWG7-I:L1*\31O&63!!++OS@=>:[
M*B@#A[.;3_[+U/4++PQ?J-2\NW9;NVE,MTQ!7,JG<PC4'!9NV[ Z9RM#T?4M
M)TCQ#X#\JY</:R?V=JOV=Q&X>/:$=\$!DX Y^Z%';%>FT4 >:^&Q'K$.GVES
MX8U6RUJQB*/<7JR>5:OL*EXG9B&SV"]CSP*F\$7MU'HND>&M2\-7B:GI16)Y
MIK;_ $= G'G)*>"2O3;SD^F37HE% 'C>KP:A'X/\:Z"FCZG-?7&L2W4(BM'9
M)(GF1U97QM;CC )/M@$UU%U!>2?$6^E2TO4AU/0H[>"Y6!MD<@>0D.W1" P.
M#CVR>*[RB@#S#P@D=Q:Z-I&I^%=4CUC23&K2W(D-M$T8V^;&Y.TY X"\Y..F
M36+(NJ6_PEO/"5UH^J2:U:7*AO+LY'2X7[4)/-20#:<@YQG.<\5[310 V-_,
MC5P&4, <,,$?4=JY+XG07%UX&NK:UM;FYGDGMBL5O"TC$+/&S'"@] I/X5U]
M% '%1&0?%B[U V=Z+0Z'%")_LDFTN)7<J#MZ[6''X=:F^&%O<6GP\TNUN[6X
MM;B$2*\5Q"T;+^\8CA@.Q%=?10!6U&)Y],NX8QEY(751ZDJ0*\\M=+OM3^#.
MGVL-C=VVL:/;P36Z7$+1L+F  X /)!P5ST(;BO3** /-5T+6V\4V]\UNXMO$
MEN!K$1;(MO+8,BGZQ$PG&,GFM2+[5H/Q*UF^O;>ZET[5K2W^SW$$#S")X0P:
M-@@)&=^X<8//>NVHH Y;X?Z/<Z+X::&ZC:%I[RXNDMVZPQR2%E3V.""1V)-:
MOB73[C5O"VK:=:2>7<W5G+#$Y.,,R$#GZFM2B@#S1[>[\1>'/".EKIUY9ZAI
MM[:370FMW1;80#YR'(VMG&%VDYW>F<;/@:.6+4_%9FM+J#[1K#SQ-/;O&)(S
M'&H92P&1E6KLJ* "N,A$L7Q9U&]>TO!:G1X81.+60HSK+(S*&"X)PPZ5V=%
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M;AE#8['&*R]5TCQ!XV\(:GI>L6EOHS7$ 2*..X\\F4,&#LP PN5 P,G!.>U
M&J/%)@U>QTW4=.FLIM11VLV=U9791N,;$?=?'..0<'!-4_\ A/;8>&%UTZ?<
MB 7WV&2/<N]'\[R<]<$;O?I3'TK5?$.H^'KG5[%;(Z3*;F<B57$TVPH!'M.=
MF6+9;!X QU(YRY\*^*!X6U#P]!I]JZ#5_ML%R]T )8S<B;&W&5(&<Y].,YH
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M..%;D\<C@T =/IVHSWD\\,]D8/+2.1)5D$D<JON^ZP]-O.0.H[<UH$A5))
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M;/(NY0=Y+R$$J/F<< GA?4X !KV'C);O6M.T^?2KNT74[9KBSGE9"LNT*6&
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M/%).9&\P.CO@@$<G;C/;_:SP =U17&1>-9-2AT>.RC$%S?Z6FI.6M9;D1*V
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MCX?WNK:A;:Q-J=Y#<%-5N8!LA*$>6^P8RQPN%&!^IH [&BBB@ HHHH ****
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MY..3C&:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%F)(X498\C.,5RT'C34#)XH@C@BU*32K2*ZM7M8'C^T!U<XVDG=@IP5/(/%
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M1;JRFMGM;FR:^O',392-0.%^;Y6W$C!S]UO2@#;?1-+D1D.G6H##!VQ*#^!
MR*J:7X1T#1K3[+8Z7 D.XL%DS+@DY/+DGJ:P=/\ %6O:@VAW]MIOVC3=2*&:
M);61'M8G7*R>:S;7 XW  =>.E,B\8:WJ%O9:II.G?:[&>[\M[86L@<0;ROF"
M4MM)&-VW'?&>,T ==_8^F?\ 0.L_^_"_X4?V/IG_ $#K/_OPO^%<]\3;S4-/
M\ ZC<Z==+;RKY:,Y3<2C.J$#D8/S=>?SY$[:UJ,WB3_A'+:>S%Y!9"[N;IK=
MBGS.515CWY[$DECT'KP 6M+\&>&]&^T?8-%LXC<2&24F/<68^[9P.3P.!3[!
M?#FJ/<I80Z=<FUD\J;RHD8(^ =I..N"*@\(^(9O$%A>B[@2"_P!/O9;&Z6,D
MH9$Q\RYYVD$'GIG%<?:7'B2TU7QU=: FFN;?4A*\=X')FQ;QDHNTC:<#J<\G
MH.M 'HG]CZ9_T#K/_OPO^%']CZ9_T#K/_OPO^%<I:^.)]>CMDT>,02RZ;#?N
MTMK)<A#+N"IA"O0HV3GTP/3H_#VHW^H^';6]U?3VTZ]9#Y]LQSL8$@D>QQD>
MQH L?V/IG_0.L_\ OPO^%']CZ9_T#K/_ +\+_A7/:5KNOZW8:1K6GVUE)IM]
M/^\MV!66*W.0)-Y;!;@$KM[XSQDTYO&&JW'AG5?$VEQ6;V&GS3 6TJ-YD\4+
M$2,'#84G:Q VGH,]> #N54*H50 H& !VI:XA?%&M:MXG33-'_LZ.UN='CU.W
MN+F-W90[X 90PSTZ9'7J<8./+XHUO7='\#W\$]M9/J.HF"ZB$+.K.@E_V@=F
MZ/.WKTYXY /18]2LI=3FTU+E&O8(UEDA!^948D*3]<&K5<A_PD&J+XHU_3/*
ML2;'3H;J"38P+EB_#\]/EZ#UZUF:7XQ\030^$-0OHM-^Q:]MB>*%'\R*1HF<
M,&+8(^4C;CCU- 'H5%>?77C76+?P=XKU81V+76B:A+;(#$^R5$"=1OR"=_7/
M;I6GJ?B74)-2U'3M'1/M-C;QR,9+22<22."RI\C#:, <DG[W3CD ZTD*"20
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCM<&V^TJNV8)NV,K!@<<9Y4<5GR>%KU=>M/$%MJD2ZJMJ;2[9[;,-S'NW#Y
MP*E3T.X\<'/6NHHH RM!T2+0[6X19/-GNKF2[N9MNWS)7.20.P P .> .3UK
M)/A.]AOM<>RU9(;767\R=6MMTL3; A,;[@.548RIP?7I75T4 <9>^!9K;4-/
MO_"^K?V//:6:V#(]N)XIH%Y4,I(^8$G#9SS74V%HUI81V\UP]U( 3)-(!F1B
M22<#@#)/ X XJSN4N4##< "1GD ]/Y'\J6@#C?#_ (*U#P\RV$'B&1_#\,QE
MM[$VX$B#=N$9ESDH#VQDCC..HG@>:WLM8TBSU18M%U62222!H-TL/F_ZU8WW
M  'G&5.W)ZUV59@UZR;Q*?#X\[[<+4W9!B(3RPP7ACP3EATS0!G0>%I+3Q8-
M:M;R&*%--73HK3[,2$16+*=V_GD],=/SK*MOA_<VGAW0]-BUJ,7.CW[7D%P;
M/*MN+Y5DW_\ 30\@CH*ZW3-1CU6P2\C@N85=F41W,1C<;6*\J>1TR/;%7* .
M8/A:\_X2#5=575(BU_8I9['M<E-F[#$AQD_.<C [=*I0^!KJ'2O"UB-7A*Z!
M*DB.;,YFVHR ']YQPQ]>:Z'6M>LM!2T>]\X"ZN8[6+RXBPWNP5<D<*,GO6G0
M!P>I_#Z\O;/Q'IT&N+;Z;K<S7+Q_9-TD<K!0WS[L%3MSC /OZV[WP=JHUY=:
MT7Q#_9][-;I;WP>T$L5R$SM;:6&UADC.3Q^.>QHH Y*Z\'7<>O6.N:3K!@U&
M&U-G<O=P>>EU&6W_ #*&3#!B2"".N,8J]X5\.S>'+:_AFU#[9]KOIKS=Y(CV
M&1BQ'4YK?HH Y:7PG=/J_B*_74X5_MFTCM?+-J3Y(164'._YOOGT[5!%X+NH
MH/"<0U6$CP\ JG[(?WX$1BY_>?+\I]^?RKKV947<S!0.Y.*S8M>LI?$<V@KY
MWVZ&V%RX:(JNPMM!#'KSGIGH: *_BK0&\2:,+*.[^R3)<17$4QC\P*\;AQE<
MC(X]15:'PW?1^+F\0/JD,DK:<+$Q&T('#E]^0_\ >)XQT[YYKI** . B^'%U
M:Z!HUK9:^;?5=&EEDM+]+48*RL2Z/&6(8'..HZ"NOT>QO+*T(U#4#?WDC;I)
MO+$:], *@)VJ,>IY).>:J3^+-)M];DT9FNVU".(3M#%93.?+SMW952",\9J]
MIVJVNJB?[-YX,$GE2+/ \+*VT-T< XPPYZ4 <T/!FIV6O7]UHWB.2QT[4IO/
MN[,VRR$2$ ,T3D_(6QW!YYJ_;^&KJU\3ZGK,.H0@7EI%;+"UL3Y8CW;26W_-
M]XYZ5T=% '#P> ;JW\,^'-&36(BNB7<=TDILSF79G"D>9Q]XY-9?AR"XUC5O
M'=G9:K;10W&I-')B+S)%!A12R'<!Z@9! ([]*]$OKV'3K">\N-_DP(9'\M"[
M8'7  )-1Z3?VVK:39ZG9@_9[N%)XRRX.U@",CZ&@#$_X1 0Z[H%[974<%GHM
MK):16I@+%D<*I^?<,$!%QP>]48/ +6^A77AI-27_ (1Z>9G%L8#YL<;/O:)9
M-V-I.>2N0"1Z$=K10!PGB2/1/%^MV/A^"1WO]+O%DN1$C+Y$)0[T9L8*NI"8
M!YW>QK=U?P_/J?B/0]6CO8X5TIY7$+0%_-,B%#\VX8X/H>:WL44 <=)X*NY+
M#Q5:G5H<>(&<NPM#^YW1B,X_>?-\H'IS^517'@C4XK[3]3T?Q MAJ4%DEC<N
M;,20W,:?=)C+?*PR><]\5VU% ',2^%;J37-!U,ZMO;2EGW"6#<UPTP <DA@%
MZ< # Z=*SYO $\^A:YISZN@?4]2&I1S):8\B0.C ;2YW+^['<=375W>HQV=W
M96[P7,C7<AC5XHBZH0I;+D?='&,GO3-6U>TT72KO4;MG^SVB&2;RD,C* ,G@
M<]* '3:<M]HTVG:DXNDN(6AN"%V!PP(; [#!..3]3UKGK+P9<)I^DZ7J.J+>
M:=I,T<MNOV?9*_E_ZH2-N(.WCHHR5'N#U%I<QWMG!=19\N:-9$R,'!&1_.IJ
M .?TWP]=6'BW5];;4(I4U)(4:W%L5,8B#!<-O.?O'/'Y4[Q#X>FUF_T>_M;\
M6=UIEPTR,T/FJP9"C*1D<X;@]O0UO44 <A)X,NY!XK!U:+_BH$",?LAS#^Z$
M61\_S?*/;G\JKS^!M2AN-*U#1_$ L=4L[%+">4V@DBN85^[NC+<$')!#=S7;
MT4 5=/M9+*QC@EN9+F49,DT@ +L3DG X R> .@P*YZQ\*7V@:A>R>'M3@M["
M]F-Q)8W5L94CE;[S1E74J#U*G(],5O66IQ7J7;B*X@6UG>%S<1&,,5ZLN>J>
MC=#4)UZR'B5- /G?;GMFN@#$0FP,JGYCP3EATS0!G:WX3.NZ7'%<ZA(NH074
M=[;WB)Q#,GW2J$_=Y(VYY!/.>:'\,W-W>76I7M[ ^I2V+6$4D=N5CA1CECM+
MDDDX_B'W0/7/244 <:G@BZCTKPM8+JT.- E21'-F?WVQ#& 1YG'#'UYK"\?Z
M&^D^%O'>KSZC"ZZO;Q@0^3L*,BA% 8L=V1[#FO3Z;E),@%6VG![X- ',PZ ^
MKSZ;J6H:C%<BTMI%M#:1^6 TB;6DSN;)VY Q@#)Z\8R]-^'^HV/_  C>[Q"C
MC06D6 +8A=\;(4(;YS\^#][I_LYYKK-2UFPT@P1W4I$UPQ6"")&DDE(Y.U%!
M)QW.,#OBHK;Q#8W&I1Z:1<07LD;2I#/ Z$JN,D$C!QN'0GK0!S<_@"ZG\+:W
MHC:S$!JNH/?-,+,_NRT@D*@>9SR!SGI3/$ZZ1XNU.S\->>TNK6%W'-=&"-T\
MF(H3)D]-KHQ3&3RX]#7>48YS0!AZW'K)U/1VTJ]\F!9_]+MC;!UFBXSE_P#E
MGM&XC'4D#IFG>*/#D7B72X[9KA[:XM[B.ZM;E%W&&9#E6P>HZ@CN":VJ* .;
M;PU<W5]/J=]>V\FI-8M8PO';%8H48Y8[2Y))('\0X 'J3>\,Z/)X>\-V&CR7
M2W7V.%85E6+R]RJ,#(W'G'O6M10!P^L^ +O5)/$J1Z[Y%GKL:B6-K4.\;J@0
M8<M]S@?+C/7!%6]5\(WVLZ7=Z7?:I;7-E=VZQ.D]EN,3@$&2/Y\*>> 0<$ Y
M/.>MHH BMH%M;6&W0L4B144L<D@#')]:EHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\4W=S9>
M'YY[2^M[*8-&HGG!8*"Z@[0 <N02%&#EB!BLCPIK&H7GBCQ'I=W+<26]D+62
MV-U&BR@2HQ(.P#C*Y&1D9P:VO$.@6OB32OL%U+/"!*DT<UNX62.1&#*RD@C(
M([@U6TKPK;:3KEYJZ7U_/=7D4<=QY\H*N4!"M@ 8.&/ X] * ,OQ/_R43P-_
MUVO?_2<UCW_B+7K?1?B#+'J>)]&E)LY/(3Y%\E9-N,8/)/)S79:EX>@U/6]*
MU62ZNHI],9V@2(IL)==K;@5).1QU%9\_@:RN+;7X)-0U#R]<;==X:/CY0OR_
M)Q\H [_G0!CRW?B&'Q3X?L?[?D:#6K*=I5-K%_H[1JC;HOESD[B/GW#OCM6;
M>>)?$%I\.?%-RNJEM0T74Y+2*[:"/=)&K)C<N-N</C( Z5VC>%8'U31]1?4+
MXS:5$\4 S'M97 #;ODY)"CICI5"?X?V%QHNL:5)J.HFWU>Z-W<G=$&WDJ3M.
MS@':OY?6@"I+%=2?&B)!J5VL"Z(9A"-A0?OU!7!4\':,GKQU XK/L_$>LQZW
MX:634_ML6HW=Q;W3PQ(+4X1V40L5#G;M W<@\\DUUEQX7MKG7K367N[Q;N"V
M-J^QU59XRP;#@+_>&?EV^G3BLFT^&^FV<.E0IJFKM%I4YFLT:X7$0(8&/A1E
M<,1D_,.S"@#"T675++0/B!J$.LW;W-IJ%X8FF2-QNCB0JQ^4<X 7'W<=JU=/
M\17^JZEX<T3[6\$MUH8U.ZN41-\A^10JY!49+,QX[#&*UO\ A"[()KL<=]?Q
M0ZT9&N(ED7:C.H5V0%3@D =<X[8H;P99"+1C#>7D-YI$7DVMXA3S/+VA2C@K
MM92 .J]LC!YH Y#4O%?B*ST;7;5;]1?Z-J]M:B[,"'[1#,\>W<,8#!7P=H'0
M8Q72:3>ZK:?$*_T*]U-[^V;3H[Z(R1(AA8R,C*-@&5X!&<GW-6KWP1I]]I$^
MGR75XGVF[6\N9T9/,FE5E*EB5(XV+P !A0*N1>'88_%#>(#>W;W;6@LV1BGE
MF,,6' 4'.XDYSW]* *6M:S<?\)AH_ARVG:V^UP37,TZ*I?;'M 1=P(R2V2<=
M![Y',ZGJ>IW>@?$'0+V]E>31[1GBO$1%:>*2!G5'&W&1@@E0,\8Q7:ZSX=M=
M9NK"\::>UO[!V>VNK<@.FX89?F!!5AP014$OA.SFTG5;%[FZWZL&%[= IYLH
M*;,9V[0 H"@ #'UYH ?X0@D@\(Z4)+J6X+6D+ RA 5!1?E&U1P/?)]ZX$Q71
M\-?%.2?4KNX$;W<02780?]%3!X4$8'  (&.V>:].TO3UTK3+:P2>::.WC6)'
MFV[MJ@ 9V@#H/2L.X\#V,YUU5OM0AAUL-]JACD78"R!&905."5 '.?;% &'I
M5_JVD:WX1M9M3:YL=5TV3?;&%%6%HHD92A W="0=Q/X=ETC5_%.O:?H>OZ>Y
M%O=2K)=6\S0B 6[$Y"$#?O7C&3R0<CH!T*^$;87^AWAO[YI-&B:*W!,>&5E"
MMO\ DYR !QCI532_ &G:/J#2V=_J:V'G&X32S<?Z*DF=V0N,XW<XSC/:@!_Q
M%U/4=&\$7^I:5=?9KN QE7,:OD&15(P01T:L_7)_$'A^71"VOM=+?Z[#!(K6
ML:;874YC&!T!4X/7!ZGK71^)- M_$^B3:3=W%Q#;S%?,-N5#':P8#+*<<@5'
MK'AN+6TTT7-]>*VGW*7<;Q^6"\B9P6RA'<\# YH Y7Q!XEU2"[\60IJ!T^YT
MVWCETN#RT;[7E-V<,"7W/F/"],>M1WT.J7/C;P;'/>O;W\FEWAFF$2%XR?))
M !&W(SC)!''0U!>P3R^*]7FN+GQAI-Q+.%A&G6YGMYHU0*KAO+=5)Y)!*XSR
M.I/3Z?X9N)[O2=9U74;UM3L8985XB *.?XP%(W[53.TXR#CB@#BM1U/5]3\'
M6\=WJUP;BR\5)ISSQ*B&X1+H*K.-N,C@X  R.0:]+U6__L'PW?:C*9+G[#:2
M3L6P&DV(6YP ,G'8 5C'P!IS:/>:<U]J!6YU#^TO.WQB2*XWA]R$)C[PZ$$5
MT@M(S8FSFW7$31F-_..XR C!W>N: .$NM>UK2]#\,>(7U W<>HSVT=Y:&)!&
M%G P8B!N!4D8R3D=>>:FT&TG'Q8\5.=2NF5+>R8H5CPX(EPI^3.!VP0?4FMC
M3_!=E806-H;R]N+#3Y1+9VD[*R0L,[>0H9@N3M#$XX]!BU9>'(;'Q)J&N)>W
MCW%^L:31.4\O" A  %!&-Q[]^: ,+X@)<MJ/A)8-0N;99=92)UAV8/[N1@2&
M4Y(*C&>/;.,9$L.I'QEX\?3]6EL9K>QLI/.2&-W=EBE(SN!7''( R>Q%=QK_
M (>MO$$-FL]Q<V\EG=+=P36S .DB@C^($$88C!'>J:>$+:.^UB[34+\2:M D
M$^6C("HI5=N4SD!CR2<YYH P;#Q5J>NC0;*+SHKB\T1-3N'M?*#EFVKA?,R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;>2WN(+2**2-\95E0 ]"0>14?BW3[C5O!NMZ=:*'N;JQFAB4G&79" ,GIR:
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M1D4Q_&6FQ7%@LL=REI?S_9K6^*#R99><*"#N&<'!*@'L>16+<:;J5QXC\%W
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M-8/(5HSPI8$R_*^2P]@0,"NBL[?4D^(FI:O+I5REI-I4$"-N0YD5W8KPW7#
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MZ?I-NS:_'*<2W)7RG2-F(X7[N1UZX[9K+\0>(KW6/ GCK1]9L8+;5=)M2)1
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M0\LQR?<]: /3Z*Y[PIKUWK2:I!J%O!#>Z;?/9R^0Q,;X56#+GD9#C@^E=#0
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M))VDDYXXX.>*-CX^.HVEG;16:1:W<:C-ICVSN2D4L(+2MNP"RA1D="<@<=0
M=;!J%E=75Q:V]W!+<6VWSXHY S19SC<!TS@]?2K->96&KR>'O%_C[4=2BBD>
M&+3P!; J)BP=4X.2I)8#O^-=-I6OZK/XE.F7FFR-:/;>='?1VLT2(X.#$WF#
MKCD$'GT% '3T5EZ[?WFG6<4EG;)*SSI'))(X5+>,_>E?D9"@= >>.G6N1N?B
M'>V_A/Q'JD-G9W4^BW?V<LDK+%.A"$.O!/1Q\N>WWJ /0JK76H65B\"7=W!
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M %[:&2SU!;WS]C8<"<S!=O;DXSGM46CC5)?'WCN/3Y+16=[1"TNXF)C;K\P
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MN<L\X9LREB,99^03VSP. *F7QKHSZ5H^I*]P;;5YT@M&$#?,SG"[NR_C70T
M<YXR\-/XH\*3Z3"\-M/(4:.<@GR75@P9<8.01[5M:>MXEA"FH2127:H!+)$"
M%<^H!Z9]*JZYKUCX>L5O+\RB%I4A!CB9_F=@JYP,#DCDXK3H Y.'PSJ6DZQK
M5SHUW;+:ZP_G217"L3;S[=K2)C[P( )4XY'6H)O!,EM:>%;'2IH8[309EF G
M!+3$(R$9' SN)SSSVKLZ*  9P,]>^*\^D\!:J?!]YX<34[,V\E_]J@D,#!E7
M[1Y^&^;DY^7C''//;T&B@#DM0\(S:OXEO;^^EA^Q7NCMI4L$>=X#,6+ANG\1
M&,>_M3O#.B>)],%O::OKEK>6-DNR PV[1S3 #"^:Q8C@=@.2 2?7JZ* ,W7]
M#LO$NA7FCZ@A:UNDV/M."IZAA[@@$?2L[3++Q396<=A<ZAI]RD2A%OC$XE91
MP"T>=I;WW8SSCM71TBLKC*L",D9![C@T <Q/X9N[3Q5'X@TFYC:9[,6=W!=D
MXG53E'W#D.#GL00>U9ES\/IH[>SO=-U".+7;74IM3^T21$Q2R39$B%0<A"N%
M&#D!17=T4 <'/X#O]6G\2/JVI6RIK=O;QE;2%@T#PY*,K%N<,<].<=JV_#VG
M^)H&4^(=7L[OR4V1"TMVB\P_WY,L<M[  #)Z\8Z&LP:]8MXE.@ R_;Q:F[(,
M3!/+#!<AB,'D]LT 4O%FA7NN6VG_ &"[A@FLKV.[V7"%XI@N?E< @]2"/=17
M.7W@'6+S2O%%BVK69&N3I/O^S,OE,%0-QN.1\F /?))KT.B@#E-0\+7.J^)U
MU*[DM_LCZ5-IL\";MS+(5+,&[?=QC%8\?@CQ'_8^B:1+K.GO;:+?03VTYMG,
MDD<6=JN-P&0,#CK[=_0Z* ,/1Y=:?7-8COYK>;3U=#9O%$4*YW;D8D_,1A3D
M=V([8$'B'0=1U+6M$U/3[VWB;3GE+07,321OO4+NP"/F7!Q_O'I6@NO6+^)'
MT &7[>EM]J(,3!?+W!<AB,'D]L]*TZ /.Q\.]4CTA8X=:ACU*SU:74["Y%N=
MJEV8LD@W<A@Y!QC'O6GJOA/5_$/A\Q:GJ\46L)/%=6L]I"5AMI(SE,(S$MU.
M23SGV%=+/J,=OJ=I8-#<-)=*[+(D1:--@!.YAPN<\9ZU<H X^]\*:IXE\,WV
MF^)=3@,]RBK$=/A:..!E8,K@,Q+-N )R0,# QR3:30=2OM4TO4M9EM)+C2HY
M/(6W#!9977:9&S]T8SA1G&XG)P*Z7<N[;N&[&<9YQ2T </;> 9)?AU>>$M2O
M(V6=Y72YMU(*,TIE4X/]UB._(':I(O#?B6ZU[P_JNJ:GIK2:4LZ.(;=_WXD5
M5)Y;Y2<9]![YX[2B@#@+CP)JEQX7UW2/MMFKZIJAU 2[&(B!D639COR@&<CK
MTXK2U&PNM.\2W/C"XEB%M;:.]M)!$C/)PWF%E]>1C;W]:ZVB@#R'PS-?:?#I
M4]IJ/A'52 !'#;F07!\PCS/+ =E1CDEL*HX.<#IV=O:+X6UCQ)XCU?4+.#3]
M0D@D+,2HAV(L0!)X.>/3D]ZZ*WL[*&1YK:WMXW<D.\: %CGG)'7FII88IXFB
MFC22-AAD=00?J#0!R/@;1K.TFUC5K&5I+&_NF:Q!/R)%G<Q3T5I#(PQP1M/I
M6KX7EUF6QNO[:EMYY%N76">WB,:R18!!VDYX)89[@ \YR;*Z[8?\)'_PCZ^:
M+Y;4W6TQ,$\L,%X8C!Y(Z9K3H YW5?#]Y=>+=*UVRO(83:P2VTT<L1?=&Y4Y
M7!&&!3OD<UD0^!KRUT#4O"\%[!_85[+(4)4^=;Q2-NDB7LW5L,<8ST.*ZVXU
M&.VU*SL6AN&DNPY1TB+1IL )WL.%SGC/6KE #(88[>".")0D<:A$4=@!@"GT
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!QOQ5:=/AIK4EO=36[K",F(@%E+ %3D'@@\XP?>J&M6
M=V?B/X8MH=2F68Z=? W;QHT@&Z+H H3/894CU!KL-=T6U\1:'>:1>F06UU&8
MW,;88>X/J#@U03PG$-8T[59-5U&:ZL()(4:1HR'#X+%ODZG:.F ,<"@#EM.\
M7ZO_ &39V%Q,USJ$NN7.E&[1(T=DB\QMP!P@<A /3G.#TKJ/#?\ PD"7>IPZ
MR3):+(C6$LIC\\H1\RR"/Y>&'!'4'FJ,OPZTJ?1;K39KS4'$U^VI)<"15EM[
MAB27C95&.2>H/6MK1-$&C0.'O[W4+F3'F7-Y(&D8#.!P  !D\ =R>IH U:\X
MO-2\1SW?CF&'76MET4)+:&.UC)YMQ+M;<#E<G![^X[^CUSI\'VQGU^7^T+[=
MKBA;KF/Y0$\L;/DX^7CG/YT <_9Z[K@U3P7>7&I"6VU^(B>S$"+'$?LYE4H<
M;\Y&#EB#GH*BF\2:S:ZEH\G]I"[2[UQK"X6")?LBQGS-JHY4.74(,D$C<&![
M"NC7P9:J/#X&H7^-"&+7F/YOD\OY_DY^4XXQ^=9\?PVTZ*TM;1-5U9;:ROOM
MUI$)D @?+$JOR9*G>?O9([$<T 4-5UC7=*\<)H,NL8M=8$9L+HQQ VC DO&P
MV_,7 (0GJ01S@UL:EJ6I6GQ!\/Z7'>9L;VTNFEC,2Y+QA-K$XS_&>!@5/J7@
MNRU?2[^QO+R]<WEPEP;@,@EB9"-@C;;\H7;QWY//)J>7PQ'/K6EZM-J5\]UI
MT,D41/EX<. &+ )R3M'3'2@#A+GQ%XHA\&:SKXUO,VE:O+;K#]ECV3QK.(]K
M\9Z'C:0?<]NDBO-9M/'[Z'<ZQ)<VUWI4EXA\B-#;R)(JX3"\J0_1MQXZU/)X
M L)?#NHZ(^I:B;74+MKN9MT6_>S[VP=F "P!Z5IGPW"WB:#7GOKMKJ&T:T"'
MR]C(2&.0$SDE0>"* ./L?%6M7'@WP+JKWO\ I.J:A#;W@$2;94??GC'!^4=,
M4E[JOB62#QT\.O-;G0W,EKY=K$<@0"78VX'*Y)'K[]JUX/AO806=A9KJ^JFT
MTZ\6[LH?-3$!&XA1\GS+EOXLG P".<WSX+M6C\0(=1O\:Z"+KF/C*>7\GR<?
M*,<Y_.@#'M=9UN+Q%X2DN-2$UKKUO*9K3R$5(66$2J4(&[U!W,<Y[5WM<Z/!
M]L+C0)_[0OBVB(4MN8\,"FP[_DY^7CC'YUT5 ',^(M9NK?7])T2S$RR7T<\S
M20>7YFV/9\J^9\N27R>O"GUR,>\;QM;^#=2N'U".#4;">26W9Q"?M5L,,%E^
M4JCXR,K@9Q70>)?"EGXF2T>:XN[.\LI#+:WEG)LEA)&#@D$8(X((YI8?"\4=
MM:POJ-_/Y5P+F9YG5FNG&,>9E>@P,!=H&T>E '-S:O>:[\,/$'B"#5+B!9[.
M>6VAC"![0(A^0G;G?E3N],X!XW$L-4OK:W\,Z!;7%Y*]UI1NWF00"4*BQ*$7
M< N/G)R03Q[Y&]#X,L(9->"W-V;;6]YNK3<@B#.NUF0!05)'4YYZFJ=U\/;&
MZTO2[8ZKJL=YI?\ QYZC',JW$8VA2N0NTJ5 !&WG'J22 8]]J?C+3-/T2*]O
M8(;J?7EL3(8DD,ULP9D9PO"O@8(7'L>:J:SJ.M)HGQ#TFXUFXF;2[-)[:[6.
M..7;)"S%#M4#&5/( .#U[UUMQX+M;FUTZ&74M1:2QO%OA.TB-)-,HP&<LISP
M<8  Q@=A3I?!EC<7.OS3W5Y*-<MUM[N-F0*%52@V84$$!CW- &AX>A>'P_8+
M)<2SGR$.^0*#]T<?* ,#Z5>N1(;640R".38=KE=VT^N.]5])TX:3ID%D+JYN
MA$H42W# N0!@9V@#H!T _/)JQ=2+#:RR,&*JA)"J6/X <F@#RFV\2>+8/!?A
MWQC/K$=S#/+!'>:?]E15=))-FX,!N#@D=,#VXYVI=9\3Z[;ZG=>'C(EQ9:C)
M:PPOY'V=Q$^UA)N_>9;#'(QC*^Y+/A[X::X\!>'X=6DOP+(K*;"YB$8256)7
M(*AB <, 3C..N!6Q+X L3KEWJ5MJ6J6<5\_F7MC;SA8+AL8)88R"1UVD9H S
MX+GQ)JWCC7=,AUT6=K8K93QJMK'(</O+ID]00N,]>F,<YP[GQ%XHA\&:UKPU
MO,VDZO+;I#]ECV3QI.(]K\9Z'^$@^Y[=_9>'(+'Q%J.M17ET9[^...6)MGE@
M1@A-H"Y&-Q[]^:RY/ %A+X=U+1'U+43:ZC=-=SMNBW[V?>V#LP 6 /2@"*VO
M=9LOB'_8MSJIN[:[TN2[0/ B>1(LBKA-H!*D/T8D\=:Y6ZU35]:\!>'+N[U6
M=;F3Q+%;RO"B()%6\*KD;2.-JD#ID<YKT%_#4;^)(-=;4+S[7#:-:*/W>PHQ
M!)(V=<J#U[>E9R> -/3PS'H:W^H>5#>"^@GWQ^;%*)/,R#LQ]XDX(/6@#)#W
M5A\3]6EFU6^G@L]#AN#$PCPWSR;A@(,9V \8.>^, 3:1J/BK4T\/ZS S-97B
MI)?0SF 0K'(N08BOSY4D8#$Y'7FM_P#X16U_X2"/6?M=[YXM%M)D,BE+A%8L
M-^1G.6/0C.<'CBJ.A^ K+0+E?LNIZH^GQ.9+?39K@-;P,3GY1C) /(!) //7
M!H XSQ)J5]XI^$4_B,W\D5O<W4;)9+&GEB(72HH)QNW<!B<]>,8KUZN)F^&>
MG2:;?:3%JNJ6^D7<PG^PQ21^7$^\.=A*%@"PSMSCD\5L6FDWUOXMN-0_M&_D
MLI+58FMYY5:+S!MP\:@?*<!MQ/4M[4 ;U</-'=2?&>%!J5TD"Z(TP@&PH/WZ
M!EP5/#8&3UXX('%=Q6+>^&[>\\26VNK=W=O=P0&V(A=0LL98-M8$'HP!X(]#
MD<4 >;Z9?:OHG@Z76;+4C'##XBEB>S\E"LR27A1MS$%@?FR"I&,=Z[*35M:7
MQ[K.E031SQ1:,EW:6[(% F9W4 MU(.T=^]//P_L6\.RZ(=2U+[++>?;6;=%O
M\SS/-Z^7C&\9QC]*NS^$K:YUF^U22_OO/O+#[!(H9 HC^;!&$R&!8G.>] &3
MX-\2MK.I/:7.H7L>H06P-YI>H6Z12Q29'SKM4;D/(R"1T]:[:L:R\.Q6VK1:
MI<7EQ>WL5L;6.6<("L98,?NJ,DE1R?3C&3G9H YWQ?=J+&#2MLSG49/*E$$;
M2,(!S*<*"<%?DSV,@KG?AS=)I6LZYX0V3106TIOM-2:)HS]FE))4*P!PCY&?
M>NR&CK_PD)UAKVZ:3R/(6!MGE(I.3CY=V20">><#T%4[_P *V]]XJLO$7VZ]
M@O+.)H46$QA&1N2K H20?KQVQ0!Q^K>*M<^PZ]):WIM]8LM66TM-+$:,9H2R
M!3M(W-N5F?<#@8] :T;R7Q+=>.Y_#UKXB^RQ+I$5V)A9QNPD,K(>#V(7]>*Q
MK:"[EU&_<WWC/2=2N+N64V<%F)H,EL*5D:)DP5"]7 '3@5VNF^')(]:@\0WU
M]</JK:?'9W$:;!"0#N.!MS]\L>O>@#G1K7BC7=/GU30=XDAOY(H[>4P"V>**
M4HP<G]X&*J6R,8)';DRW6K^)-<.N'P^TL5QI]ZUI;IB PNR!2WF[OGY+'[N,
M#&.<UHCP!81:U=WUMJ.IVUK>RF>[TZ&<"WGD/WB5QD;NX!&>_'%.N_ =G/X@
MN=7M=3U73VO-OVVWL[@)%<D# +#!(..,J0?YT 4%O/$.I^-=0T8:P;"$:5;W
M2^1!&[12.S@@,P(8?+W!XZ8ZUC:?XF\1R^&O"'B*?558ZA?P6-S:+;H(Y%=S
M&7SC<'R-W! [8KMXO#%O;^(;C68+RZBGFM4M/+7R_+2-22NT;,Y!8]2:SHO
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M6I+58!:QA9XEG6/:YQD<'C;@^I/;T"_\.PW_ (ATW6GN[J.?3UD2&.,IL(D
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MR><!)9N&+*8F"C&"S<G)YP3P,6)O MA>Z!<:7J=]J%^\Y1FO9YAYZLARA0@
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M7.=H]!GL.*=9:-IFFS336-A;6TL[;I7AC"F0^K$=3[FDU#6]+TD@:AJ%M:Y
M/[Z0+@9QDYZ#/&3Q1?:WI>FC-[J%M;C9YA,D@ "?WCZ#W/% #=7T#2-?ACAU
M?3;6^CC;<BW$0?:?49Z4LFAZ3+):2/IMHSV0VVK&%<P#&,)Q\O'I6A5*_P!7
MT[2P#?7L%OE2P$C@':.I^@[GH* (?^$<T0I=I_9-EMO.;D>2N)O]_CYOQKGI
M_"1D\>V5^--MAH]KIC64:JX5HW,BL"J@<  %>"#SZ5=\7^+;;0-!@O(;JU,E
MY-#%;LT@*E7=5,@Y^8*K;O3I6CH:7P6YDN-7BU.SE</9S+&JN$QR&*85N>A
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MVW2VX@78[=<E<8SGO6I7(>)?&3Z#XHT6P$ :QN)EBOK@_P#+ RAA!^;(V?0
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M>G:YKNE37EW<?V+-:S75P9%5%(RL1#  ON)X&2/Q&:L?V#[-\*@1;_NE!D!
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M7+6.TC>'6(%"N5W,!#+M)4L,EN.QR>M=!XMCLIO"NHPZB\\=G)%LED@^^@)
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MM8C &XY)'\/O@ 2S^(VFWMOI=VNFZI'8ZC=?9([J2)0B2EV15;YL\E>H! R
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M21SI]EO;4,?F= Q)<IC!V@ACSZT =CJ^M0:/]C62*:::\G%O;Q1 9=R"W4D
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M3*Z7<DV"&=5<Y .=N0".@'05V=OXL2Y,%NFDZBFHS))+]@E1$E2-&V%VR^T
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MT@$>=JD2$ ':-VX@'N>: /1M5U>VTB&%YP[R7$RP00Q@%Y9&Z*,D#H"<D@
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MBAT8=&!&0:?4<"-%;Q1L5+*@4E%VC('8=A[5)0 4444 %%%% !1110 4444
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M"MA2  ) >^2.V.9(_%FG:7/XPO+K28[-M+FB%Q)"0SW;-&I3/ YPRJ,D]>M
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MRSH+S_6-E>5.SIAU/(]16_)X@EC\9KX>^Q*WF:>]['.)NNUU385V\<MUR>E
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M/2)_D8C;NP<]#7'6OQ&O6M_#^I7OAXVVC:RT4*70NP[Q2R#Y=R;1\A/&[/U
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M!#PPM&JNO/3+ MW[5WM% ''VWA?4;J3P]'K$ML]OH1\Q&A9BUS*J;$=@0-F
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M6*)A&"B!2(UVJ,#L.P]JEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5&,;,CAL,.H..]35YKX4UF#PYX?U39 'DN/$]U96ENIV!I'F(49Q\J@9)..
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MDG!X%9OAOQ/_ &YJ.L6#);^;IDT:&:VE\R.570,"#C@CD$<\CK0!T)90P4L
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M.(9555"N"HR,*<_[W3CGJ-"A\0[6F\0SV!GVA$AT]7\L>K$OR2>/I[YK9HH
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MW!:RVZ'$Z3CS6S)NB\KY?E[=>?I[UT&M6U[=6<<=FEI+^\'GP7>?+FBP0R'
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M>\DCD>;[.LS6\@@,N<>7YNW9NSQC/7CK0!K:3#J,5GNU6>&6\D;>XMU(BCX
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MWY;Y>OR\=#6WXTUZ;P]H"W%MM%Q<7,-I$[C*QM(X7>1WP"3^ KG_  ];7O\
M:5H^F:SXJF@1P+B'6;,11"/'(RT2,6Z8VD\]>,UV6MZ+8^(='N-+U&(R6TX
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M$CQ'<3 @6-E8P6Z'^!94,K_F=H_X"/2K_BW2X-=TV+PM!&H6>2*6<J.+>%)
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MS*C;-I&SCYL#/ ]\WYO$-[]G\&7.GZXE]::EJ/V>:=84'VB,K(PSP-I&P @
M<@UL:5X*M]$L-/M-.U74H5L1*L9+QMN61@S!@4((R,CH12_\(/IRVVD00W-W
M"FEW37D/EE/GF8L69LJ>N]N!@<\#I0!RVHZMXE:W\=30Z^\']@N9;54M8CN
M@678V5.5Y(XY]^U;-SXCNY=;T2VNKO\ LO3K[2VNC=+L&^X^3]V&<$#"EFQU
M./0$'0D\%6<D6OQ-J%_MUW(N^8^,IL.WY./E '?\^:YO7M.>SUVQMI9_%-K:
M66GK;VVH:7%YYE);YED5(VVD!$P=HSGKQ0!TG@*\UC4O"EO?:W,9+J=G(S"(
M_D#$*P [,H#?C6:(KI_C/,G]I78@318YA#\A09F8%0"N0#M!)!S[XP*V_"L.
MHP:?,M]>7MU&9<VTE_&B3^7M'WPH'\6[&0#CK3[KPU;7/B6+7EN[RWO$MOLK
M"%U"21ABX# @]&)/!'H<CB@#S?0+W5]%\#Z+JEIJ;);G77M9++R4*21R7CHV
M6(+;N<@@@<=#UKI;K5?$>O-KHT"62"XTZ\-I;K^Y\EF15)\W<"V&+'[N,#&.
M<UH+\/[!/#UOH@U'4?LMO>?;4.Z+?YGF>9R=G3>2<8_2G7?@*QN->GU>WU/5
M;"2["B]AL[CRX[K:, N,9!QQE2#0!TUJ\LEI"\ZHLS1J75&W*&QR >XS4M-C
MC2*-8XU"H@"JH&  .@IU !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 5[^6Z@T^XELK475TD;-% 9!&
M)& X7<>!GUJ2)I&MT>2/9*4!:,-G:<<C/?ZUSWQ"WK\/=?ECFFADBL99$DAE
M:-E95)'*D'\*Q+:]_M/QMI6@Z@Q:R30$O(X68A;B4L%);^]M4< _WB>P( .E
M\,>(&\16=[.]G]E>UOIK-D\S?DQMM)S@=36W7C6F7K:/I":>EV+:PN?%UY:3
MW$Y9QM_>%%<[@3N95!.[GOD$U=\6Z1=:#X/\4>7K\CAI+6>"UM0\(LMT@1@#
MYC95^3M/ YXYH ]8K,FU.6?2X[W1;>/4=\JJ!YPC4IOVLP8@YP,GWQQ7)+I\
M5E\3+O2XY;E[*^T%Y[F*6X>022+,%W?,3@[6(XQ7,6<*VGP.\-W-K-/#,UQ9
M%S%.Z[MTZJ00#@@C/!XH ]-U77)+35+;2;&VCN=2N8);A(Y93$@2/:"2P5L9
M+J!QZ^E2:!J.JZE:R3:KHITIPP$<37*S,PV@DG;P.<C'MFN8U+3;2;XRZ6TD
M;%GTBXD/[QA\RRQ 'K6#>ZQ=Z)I7CJ:.\NA'#K<$+3-*SM;P.(0Y4DDC 9L>
MF?:@#UNBN'UJUTC0++6-3BUR\L+>?2F)CMGWJF#CST'/[P[U&<\\?6L[2X9(
M_'MQI,L/V>QN?#PEDM!<%]S"7:'?&!O()!QG/J: .VFU.6?2X[W1;>/4=\JJ
M!YPC4IOVLP8@YP,GWQQ6G7C%E"MI\#_#5S:S3PS-<61<Q3NN[=.JD$ X((SP
M>*ZZTV>)/''BO2M5,ACL$MH[2(2%-B/&6,JX(^8MD;NHV@<4 =S17CVDW.I:
MRGP];4[Z],EQ<7UO-)'</']HCCCE".0#C)"CYNO.0:Z[P"&MKKQ1IJ2RO:V6
MK-';I+(SF-&BC;:"Q)QEB?QH [.BN"O-/CU'XM7%A<SW;64NA+*]NMU(J%O/
M*Y #<< <# .*Y2S6:/X=>'==-]?/J4&L);),]TY_="\:+85S@@H,'(R: /:*
MK27T*W36<;*]X(3,(<X.W. 3Z GC\#Z5YY+!/XNO_%=G+K46G7FGWGEPN4?S
M;.((C)*A$B@ G<2<<\@D@ "QH]E;GXLW5Q))Y\QT.TE,_*>8YDD7?MSQG X[
M4 =5X3U\^*/#5KK!M?LIG,@\DOOV[9&3K@9^[G\:VJ\4T6V%EX$\':Q;W%RE
MX==2WR)W"^4]U(KILSMP0>>,UTMICQ-'XV.HSS0WNGWTMO:LLK(UI$D:F-TP
M?ER<MGOT.0,4 >BDD*2!D^GK6+X7\0-XBL;NX>T^RO;7LUFT?F;\F-MI.<#J
M17%>&=:O/$^N:%IWB$'#^'8[_P AOE6XF9]I<COA0"!VWDXZ8RM)O)-+TRST
MN.66.PO/&%U9W,OF'<4#N50OG/S,%!.<GD=Z /7;^Y>ST^XN8X?.>*-G$>[;
MNP,XSVJGX<UC_A(/#>G:QY'D?;;=)_*W;MFX9QG S^5<H%GTOQUK>D6C/_9$
MVA_;6A+$I;S[V3"?W0R@G XRI-8WAV^=M.^&NB3EETV]TV225<D+-(D2E$;U
M&"S8[X'I0!ZQ17E6H3:UI]K\0-)TJ\DCMK%;:6Q>28@PF1=TL2.3QP/E&>"X
MQVK<L=#>]\:27D,%_::"=-$;6SRRP*UR6()\L,,D)P6(QG!!)&: .YHKS'03
M.9&\!7<L\EY87_G27#2-OEL@?,20MG)+$K$>>FZNT\5P7EQX:NX-.NXK6\DV
M)"\K%4+%U 0D<@-]S(Y^:@#:JGJ]\^F:/>7Z0>>UM"TOE;]N[:,D9[=*\PN?
M$TECH^IQ/8S^'[V*^L8=2B>0R0V\,C[?-B92/D8 @XVD<]#S6]+HLFDQ^(9T
MUJ&2VO-)D==.@A98T95(\U29&QD'! P#U[4 =;H6I_VUX>TW5?*\G[;:Q7/E
M[MVS>@;&<#.,XSBM"O*]+O))K;P%H4US!!9W?A]9$6X1F2XF5(@$(#+DA2Q
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M33F"*(1*S3,9-H&/OYW9]\YH S;KQ!+I/A1]9UJP^R3Q@![6.82X9GV(H<
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MX=NM9^VQ7$$#^45B;),O01D?PG)'7H.: -)=#TY=434Q;DWR1>0L[2,6\O\
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MM;H8G2/(\P=,$YR1@D8SCD^M8VK>+?\ BKO#-AI6J6TEO>W,L=S$BABZK$[
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M-WH]K-J,>"L[)\Q(Z$]B1@8)SC K-G\177AW7[?3=9G6ZBN[&:ZBG2((1)"
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MG.=N<=>?KS6LL*K#Y0+[<8R7);\\YK/O/$NAZ?++%=ZO90R11>=(CSJ&1"0
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XWXK -\,M<CQN>2$*B
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M+&8],\I-ID0Y#M)C<><-CU /M714 >7Z;-<:=XGLUTB_34]+NM4F\W2[E/\
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M;(SBH;FUOO$NN>&M1FTRYL!I32W-R)MN[S#&4$28)W<DDD<8'7FN<_L/6_\
MA6PTO^Q[K[=_;7VKR<IGROM?G;L[L?=[9SF@#OIO$EK'=S01V]U.L%S':SS0
MJI6*5]N%/S;NDB$D @9]C698^+6OM:\16$^FWD-MI96,R(H9CF/>3A23R",
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M$8!+G./EP1[]< BL1=&U?6?!WA_PU>Z9-:76GW%K]JN"5,02 CYT8'YBX4
M#(W<XQ3+K2-7ET?XB6ZZ5<F35GD^Q#Y/WH:!8P?O<?,#UQQ0!Z3'(DL:R1L&
M1P&5AT(/>L34?%=CIRW\GD75S!IPS>S6Z!EM\+N(.2"2%()"@D C-4H?"PU"
MWTZZN-1URQFBMXD>UM[YHHP5'.44X/OZURNH1ZUH&A^.]+N-'N+BUO1?7UOJ
M,<B>4$DC)*OEMP*\@8!SQT'- '<VOBBQN]3M-/CBN!/=V/V^#<H >+Y>^>#E
M@,&H(O&FESZ;!>1K<,;B]:PA@V 2/.I8,O)P,;&.2<<=:YNTMM0L]4\'ZY;:
M9<W]J-#^Q2"V*;HV81,I(9E&T[2,YXJGIUEXITS0K> Z-=B)M=N9KR.VFC\Y
MX'=V4QL6! R5R?E;'3&: -+QMX@CU;X7^([S3IKRSN; O!(%<Q2PS(1E25//
M!'0D$&MZYOM.'C'1[.:6_746M9GA1"ZP.N%W%OX6(XQUQFN'G\/:Y_P@WCG2
M8M"N$FU&_DFLT$L;;U=8P.=W4;3DG\":ZF^M;^Y\?^&-1CTZX^R6MG<QSRG:
M!&T@CV@C.?X#G&: ,:.\?Q1JWB9=1_MRRBTVZC6WELI2CVZK$CD81CEF+-G@
MY! [#'2Z'K>F1>%]&;3C?7<=W#_H<<K;[B50,DL6..!U)('('<"L[0+;4+34
M_&,]QIEU''?77GVI(4^:HA5.,-P<KWQ7-6_A[6].\->"[U_#_P#:$NCVTMI?
MZ7(8RY5POSIDE25* ]>0: .ZMO&>DW6F/>(TP=+LV#6K1XF%R#CRMN<;N^<X
MQSG&36/X9OY[KXE^*89/MT4<5M9D6UU(6$3'S,E1N*@'@_*<50U72=4>'1=?
MTOPTEHVGZE]J?28_+2:6)HS&S':=AD&20,].^>*U/#\6I2_$'6]5GTB[M+*]
ML[5(I)S&#N3S,@J&)'WA_7% &]J.LV\%VVF)!=7=V8#,\-K@.D><;B2RXR<@
M<Y.#@<&N8^'FN[?AYH\UU+=WMY=SW*0H[%YIL32'DN1T4<EB ,8]*F>WU;0?
MB/J6J1Z7<ZCINKVL$>^V9-]O+%N 5@S#Y2&)SGK7+67AW7[#PWX:O9/#GVR7
M2KF\%UIDK1EIH9Y"P=,DC<ORG!P>M '2>)_'0'P_UW4]&CN4OK+S+:5'10]I
M,,#+@G'&001D'CK6A8_9M'O7GMX]:EN[Z'=_9DDXDVB,X:4;VPI.Y0?FYXXS
MFL?Q%IE[JGPVUJVTWPN+"YU!0L-C&L22GD?-(5.T'@\9. !W.!)XDLM0C\3Z
M;XCB\.-K-DUD;.ZL66,S0'?N610YP>X(SZ4 :O\ PL/0FL],N8C>2KJ,KPPK
M';,6$B [D8=FRI&.OX<U&_Q%TQ)5M_[,ULWAM!>?9!I[^<(]VW[OJ#GVXZ]
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M /$WA^UL)GFO=5OH(YF \I0T[9<MGC;R<=3C@&MXZ=J>B^,]1DM]*N;ZTO\
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MJ'CDC8,KJ>A!'44L\\-K \]Q+'#"@R\DC!54>I)Z5SWP[_Y)QX;_ .P;!_Z
M*P&U#5]0U'Q]97SVTEE90"*.-0WRJUN7&,\$_-R?;VH ] M[B&[MHKFWE2:"
M5 \<D;!E=2,@@CJ"*@U33H=7TNYTZY,@M[F-HI1&VTE&&",]L@XK@_"/B'4]
M.TOP+IUS96PT_4]/C@AE24F5'2W#@L,8P0IX!R./I5Y_'-]-';ZAINDSWNGR
M7AMVCAM9FE\L.4,P<+L(R,[?3OG@ '8:?8Q:;IUO8PL[0V\8CC\PY(4# &>^
M!5FN+MO%>N7>MZO;+INGQ66D7BQW<SW3$^28PY9 $Y8 ]#@=LGJ&V?C+5+RY
MT>:'1YI=/U3 )2UFW6@9<H[L5V,IXS@C&>"PYH [:BN$D\=WT?@N\UTV-N9+
M/4VL9(=[8<"X$.X'MUSBK5WXFUY_$FLZ+IVFV!>PM8KF.6>X;:X??P0%R#\F
M,=.ISVH [&J]K?V=\9A:74%QY+^7+Y4@;8^ =IQT."./>N7T_P :MK5KX>CL
M+>..^UBT-X5E)9+>-0-Q.,%OF8*!QGDY&*P/#6M/H \6375O&;N;Q&+:.* ,
M5:1XX@", G&,L0 3U')H ]/HK@[WQMK6G:?XAFFT0R?V9:BZ@N7BFMX;A<'<
MOSJ2'7'3)SZBNET&\UB^BDGU2SM+:&0(]L()B[%2N2'R  0?0D?S(!K,RHI9
MB H&22> *AL[VTU"V%S97,-S Q*B6%PZD@D$9''!!'X5RK:EK$GQ5;2?,MCI
MJ:4+@1$-D[I=K$]BWR<=@"?4URWA+7]1\.^#=,F2QM7TJ369K25C*1*/,NW4
M,J@8P"1P3D\].X!ZU17$^)O&E]X=6_NI;.V2VM)HHXX9I/WUXC% \D>#P%+X
MY!SM/(J:'4]9E^*EWI9EM_[.@TV*=8_FR-\C GW;Y/H!^- '57=W;6%I+=7E
MQ%;V\2[I)97"J@]23P*E5E=0RD%2,@@\$5@>-]4?1?!FJ:DMA;WRV\)=[>X;
M".O?/!S]._K5'5O%S6.LPZ/"UE;7<MBMU;"\8HETY+#RD;@ C:,]3\PXH ZZ
MBF(TC0*S(!(5!*D\ XZ5YS-\0?$4>@7VOKH-DVGZ9>36]Y&MVQE*1R;&:/Y0
M#C&?FQGG@8R0#TFBN)\2>-;S1;/4-1BM;865I;QW$'VB3#7X(W.(\'*[1CD@
M\GH!S6A)XDNX/&6FZ5/;PII^I6KRVMSN.]I5 )B(Z [26!SR 1B@#IJKW=_9
MV B-Y=P6XE<1Q^;(%WN3@*,]22>E<]_PD6IO8P74=K;+;7%Y+&+R1\106Z;L
M3/DC.XJ, '^('-<GX@\0OXC\&VMVUK$;FR\306F(V^61H[A1N4GH&&.O3- '
MJ<DD<,322NJ1J,LS'  ]2:QO#VEZ99K=W^E7;W,6I3&YDE\X2)(Y !92..B@
M<<<5EZ?XBU23Q/=>&O$&G6D,TEFUY:RVLK21RQA@K*=R@[@2.V#GM6'X)U_^
MROAUX/L(4+W=]:N8SY3R!$3EF*H"Q^\HQQUZB@#TND9@JEF("@9)/05A^%]:
MO]8M;O\ M'3)K*>UN6A#/$Z)<*.5D0. <$'H>A!IMUK=Q<^(YM!TQ(#/;VJW
M-S+< LB!R0B!1@DG:Q)SP .#F@#8L[VTU"W%Q97,-S 25$D+AU)!P1D<<$$5
M/7E?@O7;K0_!OAU/LL!74=<N+&5 Y_=%IIFRIQR!L(Z"NDN/&S:?>>)XKRU1
MDT<VRQ&(G,YG'R*1@X.XJ.,]<X[4 =A17,:3X@U2Y\2/I=YIDIM6MO/BOX[6
M:*-6!P8F\Q1\W<$'D=A4'CW4]5TVWT0:9+#']JU>UMI2^<E6<' QT!Q@^V1W
MH ZZBN9&O:C?ZKJ6EZ5%9M=:7%%]I:8ML>9UW"-<<@8P2QSC<.#S5[PMXAA\
M4^';75X(GA$P97A<Y:-U8JRD]\$'GO0!JRRQP1/+-(D<:#+.[ !1ZDFF6]S!
M?V:7%I<)+!*N8YH6#*P/<'H:XRUU#5[[QIXNT^Z>V?3K2UMPD6&RJNDK9]"Q
M.,^P'I6/X)\0ZGI'A;P-;SV5L=+U&-+-9!*3,LGELRL5QMVG81C.>A]J .]T
M/0;3P_;SP633&.:9[AQ*^[YW.6(/N3FM)W2-&>1E5%&2S'  KB+SQS?>1)?Z
M5I,]_9PWC6S00VLSRRJLAC>1&"[."&.WN!U!X'<T 9_]O:/_ -!:Q_\  E/\
M:O(ZR(KHP9&&593D$>HKRGP/?G3_  =K3KX>N+Y8]2O3O182A'F'@@N&P.^%
M/'3-=9?ZO>Z)X@T7PQI>G6K07-G+Y$DL[+Y?DA!@@*>,,.F2?;K0!UE%><R^
M/M=@\,ZGK$FDV&W1;R2UU!1<-^]V. 3%\OHP/S?3'>M:_P#$NOOXKO?#^DZ7
M822PV,=Y'/<W+*I#,RX8!<@Y7H,^N1TH ZBYO[.R>%+JZ@@>=Q'"LD@4R,>B
MJ#U/L*L5Y=J?B%?%6@>#]3DL_LMTGB6"">!CN,4J,ZLH/<9'ZUT\OB74+YM<
M;1+6VG31Y3 ZS,P-S*J!W12/N8# 9(.3G@ 9(!U5%<7;>.7O+SPS<06\2Z+K
MR$1W$A(>*8*6$3#IDX8 YZJ?:K-SXMFM5=F@1Q<:DUA8>6KL9-JL7=@H)PI2
M08 YV]L\ '5TUW6-&=V"HH)9F. !ZFN+3QO>VD6HIJ6DSI+!=06UG,+>6.*\
M,QPI4,NX%3G<!NZ<9R!5[2M8O]7U/4M&U/2F-L( \5X;26."=6RK1LL@^\/3
M)R#VH Z2WN(;NW2>VFCFAD&Y)(V#*P]01P:DKC[RZL?AWX?TNRC-O:V<UXT+
M7,D96"V+[Y"2H/RKN^4#( W#)XYZ+1[JYO--2>[6 2,[[6MWW1N@8A'4_P"T
MN#^- %ZBN2O_ !=)'XEO-#M6LH[ZWCCDAMKMBCW@89)B.0..1CG)!Z=:BU?Q
MC?1/JPT;3FO7TN01/"+>9S<R;%=D1D4A2 P )SD]@.2 =E17$R>+/$%YK\NC
MZ5HUJDW]FPZA&U].\>T.S#;(H7*L"I&.?<CI1I?C:\UG0]/O8K"*Q:2>:WU"
M6ZD!BL7BR"#R-VY@ .1UY]* .VHKS\?$&^D\+Z9JL&EV\LMSJPTN:/SRH#>:
M8]R?+R#C/.,9[UISZYXCLD2/4+/3+-_*ED:Z,[/ 6#8CB7.UMS Y]L=#T !U
MM01WMK->3VD5S"]S %::%7!>,-G:6'49P<9]*X"7Q=J^LGP'>::L%K!K#N\T
M,A9CN$#MM)'\((STR2!TK3;Q;#IFL^+WU"PMX(M&M;>=[B [I+A660@'('(V
MX YZ]: .SHKDI_%&HZ5>Z&-6M+9;76)!;QM"[9MYV4LB-G[X."-P P1TK'G\
M?ZW#HNJZPVD6*VFDZF]E=)]I8NZK(J$I\H&?FSSCTQWH ]%HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"IJ.EZ=J]N+?4["UO8 P<17,*R*&&1G# C/)Y]ZYS3/A_H^E^+-1U>
M#3=-C@N;:.&&"*T1#"0'$A! XW!P#CKCFNM9E1&=V"JHR23@ 5C:=XHT_4]1
MCLH%N0T]M]JMY'A98YXL@;D;IW'!P>0<8H QK;P3*NFZ3H=S=1R:/I5TMQ#P
M?-E"$F*-^P"DC)&=VT<#FM;6]#F\1@6-_)''I </-!$27N@#D*Y(&U,@9 R3
MTR!D'=HH QKC3+RX\2V=XYMCIUI"ZQP$'>)&P/,].%#*!Z,>>U9NK^&;^?QO
MI/B+2Y[6W-I!);W*2*V;F)R#M)'3:1D'GDUU=% &=KVFRZQX?U#38+M[26ZM
MWB2X3K&6&,US6F^%-<L]>TO5I+W3-UGIKZ>UM!;NB%=R,-IW''*<\<#H.]=M
M10!Y_;>!=4MO"/A[11=V;/I&HQWIFPP$H20N%QVSNQG)Z>_#Y_!.LV\/B?3]
M+U&R72]>\^9DN8F:2WFE3:^T@@%2>>>GH>_>T4 4-%LIM-T.QL+B9)I;:!(6
MDC0H&V@#."3CIZURUSX+U-K/Q=8P7]I]DUYY)$WQ-OB>2-8VR0<$ +D#'.>H
MQSW%4]-U&+5+9IX8KB-5E>(K/$T;95BI.#VXX/>@#GF\,:A+K/AF]EEM/+TB
MVEMY8QN/G>8BH2..,; <<]<>]5_#?A;Q%X?$6D#7+:7P];2;K<>0PNA&#E8B
M^[;M'3."2...W:T4 9OB'3YM6\.ZCIMN\:27EM);AY,X7>I7/'7&>E8.I>$+
MZ_\ ">C64.H1VFL:.T4EK=HA9-\:%/F4_P +*2"/?O7844 <!XH.J67@B^'B
M+5=.6ZU!XK,,ELWV.$,V#O#,3@@MN8D8XQR!EOA>;4(-<2W>;PWJ$5TFR:;3
M))6GB158H6+L_P F?E R,%N.]=\5CGA(8))$Z]#@JP/\Q3+:SM;*,QVMM# A
M.2L2!1GZ"@#@+3P%KUOHWA_2FU:P^SZ'J"7%NXMG+21H'QO^;[V& P,#J<]J
MNZCX*U._E\7E-1BMAKT4*1/&&W0^6FWG^\&'7&, D<UW%5KZ_M].LKB[N&;R
MK>,RR>6A=@HSSM4$GH>W:@#E['PKJR>*$UB\OM/$;:6-/EM[6V9 H#%AL)8X
M'/?Z8[U13P/K"^"-)\/-J%B[:=<V\B2B)E#)"X901D_,<#)Z#T-=KIFH0:MI
M5GJ5J6-O=PI/$6&"58!AD=N#5J@#EH_#NI:7XFU35](GM?+U58VN;>YW8CF1
M=HD0CJ",94XSCJ*IVG@:72[KPH+"XB-MH?GF3S00\[S*0[<<+RQ;OUQQUKM:
M* ..L/#6M:<^KR17-@QU#4S?-%(K%&C9 C1-QSPH.[U[=JT/"GAF/PU'J(A6
M*".]NS<K:6^?)M\JJE4R!U*ECP!D\ 8KH:* .>U+0KR\\::-K<<L"V^GPSQ-
M$V=S^;MR0>@QL'USVK-A\'W<^O:5K%^UDFHZ>LBO>VJLLEV&0H%D&. ,@]6Y
M'&*[)65AE2"/4&EH X_3O"-P/$FGZ[?_ &)-0M;9X+BXLU*M?%@!F0$# &,X
MRW)'(QBLFT\ Z[;Z+H6D?VM8"VT348[FW<6[EI(T+X#_ ##GYL8&/7/:O1J1
M65U#*05/0@]: .*M_"OB+2=9U$:/K5K%HVI7+W4L4]NSS6\C\R>4P8#DY(W
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MDXSVQWK;U/P]JMSXMMM:M+^VCB%BUG)!<1-)Y>6W&2/!'S'@'/8#Z5U%% '
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MA-GW=I4J "".>_/-;&F:-!ID]Y="22>\O'5KBXEQN?:-JC    '0 =R>22:
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MMO$WB_[ 6"OX0#S;?[PF=0?KL+UZ-9WMCI/A.QN9I5BM(K6(*?7Y0% '<G@
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MF-'/<$DG!ZE1UIE]<+X:G^(#:<1:VT>HZ<)FC!/DPNL8E( ((&"PX(P.F,4
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M\QMTRIZ@X]*NT4 0VMK;V5NEO:PQPPIG:D:A0,G)X'O3$T^SBLC91VT26I#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !117+^-=6U/1X='ET^>*-+C5;6UG#Q;
MF:.20*0#G X]C^% '445DZW;:S>K%;Z3J":<IW-+=&%9G&,;556XYR22<],8
MYR,SP/JNKZA9ZG:ZT\4UWINH267VJ)-BW"J%8/M['YL$#C(H ZFBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HJ&YN[>SC62YF2)&D6-6=L NS!57ZDD ?6D>\MHKI+62>-9WC:58
MV8!BBD!FQZ LN3[B@">BLK3?$NAZQ<O;Z;JMG=3(NXI#*&.W.-P]1[CBM6@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tardioagreementa01013.jpg
<TEXT>
begin 644 tardioagreementa01013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M34-,>_TR?3[AX8Y!$T;8214.6(P"3NX!R.*[:P\4:5J6K3Z7;S2B[AB\_;+
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MA$BC=)*5&,GG"J, D@=!B@#L**YV&9;_ ,-/>:!K#7UPFYX[AI0ZRR*.4<#
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MU<#&!["IJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6J>+M0N<LPU6334&?NPPJ  /3+,[?5J +:_$?P:]VMJGB*Q:=I/+"*^26SC
M_&I;KQCIT-U;1PRP2PM?O8W,S3!! RQ/)D\<C]V5ZCGUJ+6+2WN-<T#0[>"*
M.".0W\R(@ 6.'&Q<#I^\:,C_ '#4(\-:DNIPR@V;00ZU)J0)D8,4>%TVXVX!
M!?/7H* .CAU.QN9($@NHY//B\Z%D.5E3U5NC=NG3(]15NO.?%%K>>%OA0+DM
M%_:&C2I=PO$Q*Y$W(R0#@HS*>.A-=_*\LEB\ELR)*T>Z-I$+*#CC(!&?S% $
M]%>7V7B[Q3+X<\):Z]QI[+K%S':2VOV=@ 9-P#[]V>"HXQTXSWJY<^-=2\-K
MXO35W@OSHT-O/;R11>3O\[< C#)P P'/H: /1**X^^UC6- \0:':7MQ#>6NK
MNULSB'88)PA92N#RAP1@\CCDUSZ^+_%">&&\037.GF*TU@V4ULEJP\Z/[2(<
MABWR$ @CKTY)S@ 'ID\\=M!)-,VV.-2S'&<#\*@TO4[/6M,M]1T^;SK2X7?%
M(%*[AZX(!KDM+DU*7XG^*(I=0+VMO:6FR Q# 5A,< YXYY)YS^5<WX,U;6=%
M\&^ I1<6KZ;?S1V#VODG>N]7(?S,]05Z8Q@_C0!ZY61!XHT>YU6'38KLFYG5
MVA!B<),$.'V.1M?'?!-7=2$[:;<"WF$,VPE9"N[;^%>;>$=7NM)\ ^"K-)HI
M+K5C';V[O%Q;IL9G;K\QP,#IR10!Z;=W4%C:2W5R_EPQ*7=L$X [\5F#Q5HI
MMM)N!>CRM695LF\M_P!Z6&5[<9'/.*PWUN_AUW7/"^HNEQMTHW]I<JFUFC)*
M,K@<;@W0C&0>G%<Y#_R(7PJ_["%C_P"D\M 'K%%<6-?U?6K;Q'=Z//!!_8]U
M+:00RQ;Q/)$H9]YSD D[1MQC&><XJO9>,+V_U#PO>!T@T?7[1]JF/+PW03<%
M+9P00'QQR5]Z .\JG;ZI:76HWFGPR%KFRV>>A1@%WC*\D8.0.Q..]<7X<\6:
MIK>D- UU"-775/LN1;[4,./,$@4G.&A^8$G[Q J:Y\2ZW%=>.H5EL\Z+;13V
M9,#8^:)I"'&_)/ &01].U '=45P6F>(M?76/"(O[BTFM=>M'9H8X"AA=81*&
M#;CNSR",#VJI=^,=<?1KC5+)[>.YCUO^S!I\L&_"^8(P2 P8O@A^H&.W>@#T
MBL_4];T[1VLUO[@0F\N$MH!M9M\C'"KP#CGUXJQ*EPU@Z+.J7)CQYRQ\!L?>
M"DGOV)/XUY%!-J-W\+_!%Y<W8N;FXUNQE5I%Q\QF).XCKDG.: /9:*\_D\8:
MIH,WBR#59+>^;2H;:XMI(HO)#>=N4(PW'@,HYST-;&F77BA?$J07EF\ND2VY
M9[B18HVAF!Z *[$H1^(]30!U%9NGZMI=YJ&H:?8RHUS9.OVJ-8RNQG!(R<8)
M.">,U1\0:W-9:OHFBV91+O5II%65UW"*.-"[L!W;H!VR<G.,'D[";5=+\2?$
M.:&XLYKZ%+)HIKLB*,#RCS)CC@=<8!QVS0!Z5)''-&8Y45T/56&0:=7GW_"2
MZI/<>*-,AOF(L]+2\M+R2U\N0%@^?E( 893(.._>H]"UO4;3PQX-TM))+F[U
M/3UG\U(TWQQ)#&2 &8!FRXY/OQ0!Z+16%X7N=>GM+I/$%F()H;ED@E&P>?#_
M  N55F"MU!&>U4AJ^H:WXBUS2=,NH[/^R5A0R-$)#)-(A?D$_< V].22>1CD
M Z.\O+>PMFN+J41Q*0,GG))   ')))  ')) JMI6N:?K:W!L)F=K:4PSH\3Q
MO&X&<,K@$<$'IS7G&KZ]?>*O!WA/4PR64TFO6T%Q $WJ)DG*D@D_=W+D#Z<U
MZ@L,JVC()5^T,F#,(P,MC&[;_3- %;5=;T[1(89=1N!"DTRP1G:S;G8X4< ]
MR*T*\8$VHW7P<TV\N[S[7/-K,+@R+M.[[<<DD=<GVXKJ;GQ=J?AS4O$MOJ\M
MO?1Z?IB:E T,)A/S%U,9^9N,H,'W[T =]5'5M9T_0[,W>IW*VUL" 97!VJ2<
M#) XR2!S6%I]YXJ'B*SCN+-IM*N(7-S,ZQ1FWE RNP+(Q9&Y&#DC@YJA\9/^
M25:SCKFW_P#1\= '31>(]*FNH;9;HB:=BD2O$Z;S@G R!S@$_A6I6)'-K$^L
MVT%]I=I'9")Y?.BN#*5E4J%'*+C@OS[5Q=YXK\51^&O%.KI=Z<IT+49HEC^R
M-B>.,(=I^?Y>&//)SZ4 >GT5QJ:QKMMXTL-,NKJSEMM5L9YX52W(^S/'LP,[
MLN"'YZ<CMTKFE\9^+H? MEXTGFTV2RCG*7EE';,&>/SS&65RW!'&%P>F23TH
M ](MM:T^\U:\TNWN-][9JCSQ;&&P-G;R1@YVGH:OUYW<:O%H'CGQMJ\R%X[/
M1[28HO5MOG''X]*NW?B'6-&7PW?WLT%S::O<0VEQ%'%M\B25<HT9SDJ#P0V2
M<YXZ4 =O17"P>)M6M6\3:9J,T+:O9.G]GA(MBS1RX6$XR<DR$JW88J6]UO7;
MG4-3TG2MSWFF6\6Z5(8RLL[H6 8.XVIC'3GD\C'(!VM8GB2X\-Q1V4'B,6+1
MW-PL5LEW&'5I3T R" ?>L-?$>O7]W#I)L9+'4X].CN[Q81%,8Y'9E"C<X!4%
M&)QD\@9%:VF6VH:_X9L1XHL$M+]7#W%M&RNA9&.,'+8!P&P#GG&>N0#H%540
M*H 51@ =A2UPVN>+9]/\43Z3<7BZ4SB/^S9;F#-O>$CYU,G0,#\H&1C@_-G%
M=?J<]S;:5>3V5O\ :+J*!WAASCS'"DJOXG H =?6%GJ=H]I?VL%U;/C?#/&'
M1L'(R#P>14T<:11K'&BHB *JJ,  = !7GMG\0(_[!U75TU!;S[!:!Y[">'[/
M<07&<;77LA) !P<8/)K32^\7PZH5:U#Z?):2.UQ<11K]GG49&%24ED;D8ZCC
MF@#L:*\MMO%_BN#P[X9\4WDVGS:=J$D$-W9Q6[*\8E.T2*^[D@D?+C&#C)ZU
MI:QXKU?2[Y7:>V?_ (G4-D;6&,R(MO(RJ"\@^[+\V[;GIC@]: /0**XFWU/Q
M-J7C;6]*M[[3X+33);1P6M69GCD!9D^_P<#[WL.!S56#Q7J\.MZ#!<SVTQU"
M]GM+J&",M#!M5V0)+_$PV ,,GDGA: .ZNKF&SM)[J=BL,$;22,%+84#).!R>
M/2BTNH;ZR@O+=B\$\:RQL5*Y5AD'!Y'![UYYHE_KEMIGCS4?[2BGGLK^Y\H3
MV^5S'#&5X## P,8_'FM2P\47NJW'AS28Y4AO+_1QJ=W<! =JX080'C)9SUS@
M+TYR #M:*\SU+QOKUCHVO0C[&=4T74;>UDD:([)XIF38P&[Y&VOS]X<=.>.A
MTO5=8A\>7F@:G<VUU$VGI?PR0P&(QYD9"A&XY' (/6@#I;JZ@L;62ZNI5B@B
M7<[L> *J:9KNG:Q/=P6<SM/9N$N(987B>,D9&5< X(Y!Z&N9^*JW)\' P7 B
M3[;:!UV;MV;B/'.>,'GWINI7WB=?&<7A^PU#3HS/I4EU]IELR6#K(JC(#X(^
M;&.,9)YQB@#N:*XB+7M:UBP\0W>F7-M$^C7$EI'$\.Y;B6) 9-_.5!8D  Y&
M,DG.*K6GB_5]>U?P]'ILEK:V>L:3)>8E@+O"ZE >=P#?>('3UYZ4 >@45Y;+
MXN\4V_@_4M;DNK!GT349+.>,6I_TP),$+9W?N\@]!GD=><#TZ=Y([>5XH_,D
M5"43.-QQP,T 245YWI'CX3:;?ZA<WH>;3=.EN=1TJ:W\BX@F4*<*#R4^\,\]
MN3FM*QU#Q=+JNFM]D$FG7<#FZDD2)5M7VY1D"R%G0G@@\]#F@#LJ*\[T#4_&
MWB#PC_;<%_IBSM#<K%;"S;#S)*RIDE^ 0N,=N#DUL:#XAN/$5CH%Q97"C[1;
M&XO=T6=N/E*8S\I\S(^B-WYH Z#3]4M-42=[.0R+;SO;R91EQ(APPY SSW'%
M7*\^L_&FI_V5,+HVK7\OB.31;>18RL:@.0'*[B3A58XSR<#-:6J:OKOAFSU.
MXOC;7EN9K:'39 -LC/*PC(D487"LP(P1D<<=: .OHKF=&NO$O_"1SVVH6;OI
M#6PDBNY1$DB3;L&,JCG*D<@X&.0<U)K.MS1>)M(\/6CK%/?QS3R3E=QCCC X
M4'C<2PZY  /!H Z*BO,]9\;:[I6C^+;8-:-J>@O R7#0G9/#-C:2H;Y7'()Y
M''3FN[TF'5H5N?[6O+:X9Y=T/D0F,1I@?*<D[L'//% %VXGCM;:6XF8K%$A=
MR 3@ 9/ Y-96GSZ#IFA17^GPVUGIUUMF3R;?RO,,F-OR  EF) QC)) JSKES
M<V>@ZA=6;1+<P6[RQF5"ZY52>0"#V]:X#Q!>:EK'A3P!J+7:12WNH:?)*%BR
M/,==V[KT![4 =_I.MZ?K<4\EA.TGV>8P3(\;1O'(,95E8 @\CJ.]:%1P1M'$
MH=E>7 \QPNW>V,9Q^%24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!E^(M L_$VB3Z5>F18I<%9(SA
MXW4@JRGL00#5:U\/S?VG;:GJ=\M[?6D#P6SB 1JF_&]BH)RQVJ"<@8' &36[
M10!A^&O#S^'8KZ,WINEN[R6\;=$%*O(VY@,'IGIW]Z-7\.#5-=TK5XK^:TN-
M/$J#RU5A(D@7<IW X^Z,$>];E8_BG7?^$9\-7VL_9'NUM(S(T2.%) ]S_P#7
MH Q)_ 1N- \0:1)JK>5K=T]U.X@&Z,OMW!>>GRC&<]ZEU#P7=3:XFM:9X@N=
M*U"2!+>\>"%'2Y5?NDH^0&&3@\UT#7EV;VQCBT\R6L\;O-<^:H\@@ J-IY;=
MDCCIBKU $%G:I96D5NC.ZQKC?(VYF/<D]R3R3[U@1>$3)>:3/J5_]M_LIW>U
M9H LF64IAWR=R@-T &< G.*Z:B@#C]#\"R:#.MO;Z_?-H44OG0:6Z)MC.[<%
M\S&\H#R%R.G.><ZUUX9LKOQ98^(G+B[M+=X H/RN&((+>NWY\?[QK:HH Y35
M?!L]QXD;7='UV[T>[GB6&\$,22I<*OW25<$!@#@-Z597PMY7B.QU>&^8&SLW
MLTCD3?O5B&9F;.2Q*@Y^M=%5>2\A2X^RA@]T8FE6$'YF4$#/H.2!S0!R@\
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MK8VUQ&F(>"!N90&DP#@ D#\ACJZCGGBMK>6XF<)%$A=V/15 R30!D^%?#_\
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ME@5SM #9  'RXP.]>N8XQVKFD^'_ (6CVA=(C$:7 N4B\Q_+CD'.Y4W;5Z]
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MP/04 =!I4,UOH]C#<<S1V\:29_O!0#^M7*C@\[R$^T>7YVT;_+SMS[9YQ4E
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ,EEC@B:6618XT&6=S@*/4FN7\7^)Y=,\*R:OHES8W'E7$
M$3D_O5P\J(0"K#!&_/.?I5GQM##<>&VBFU/^S&:X@,-V5#+'*)5,>X'@KN"@
M@^M>>^(M2NIO GB>SUJVLH;^#4[%;BZLW(ANR9("&&>0P11N';% 'KL%[:74
MDT=O=0S/"VV58Y QC/HP'0_6H[?4K*^:6.ROK:>6,?,(Y%<H?< UYUJLFE:-
MX^USRK9!:?\ "*-+-;6>$:4+(_3;CYMIP#VJMX?U2P;Q]X6DAO[$PR:%+;Q1
MVK92,!HBL6XDEV SG.#QG H TI_&NN1?#C5=> L?MUEJ$MKCR6\MD6?RN!NR
M#@YY)KT642&)A$RK(0=K,NX ^XR,_F*\7N[JW/P4\4,)XR/[9GYWCO> C].:
M]I5E=0RD,I&00<@T <OX)\4_V]X:TRYU*YLX]3O%D;[/&P4L%D9<JI).,+[U
MT$^HV-K<16]Q>6\,\QQ'')*JL_T!.37BMCI.FWGPCTM;""V_X2<7ZBU>,#[0
MDXN3G)'S !,DYX"BMBYNM$O-1\6>'O%FKSV,]Q?;T@(C!N("J^28B4+,1C "
MG((X&30!ZV2 "2< =2:J1ZII\UQ';Q7UJ\\B>8D:S*69?4#.2/>HYK>.30'M
MYXVDC-MM9+C#,?E_B[$^M>/Z9I6FW7PV\#7.E16_]OB\M3%-#CSB5;]Z&(Y*
MA V0>  /:@#V5M2L4O5LFO;9;MND!E4.>_W<YJ&*6Z.O7$37=FUH($*6Z@^>
MC9.68Y^Z>,<=C7DFNZSI<MK=/;W%O9"V\5Q23V\C[I]ZSHKS.2?W:$= !@#'
M/.*VM1ED3QIXT?0BG]HR>'8I(!#C>TO[W! [M]W]* .E\0>*7L-=T*QT^[L)
MA=ZB+2[BSOEC!1VR,-\OW,<CO76=*\?EUCP[<Z5\-9;*[LPT%_"C+O4/#F%P
MX;N#O SGJ:[+XFF]7X?ZDUDDDA7RVG2,99H!(OF@?\ W9]LT =+:ZC97WF?8
M[RWN/+.'\F57VGWP>*(=1L;B988+VWEE92ZHDJL2H.TD 'H#P??BN)U'['J7
MC_PK?:-+;S6[6=R+YH2"C6A0; ^.-N\C:#_M>AIGPCTW23X,L;^WM;0WB2W<
M?GHBEU4W#_+NZ@8"\?2@#N[B]M+3'VFZAARI8>9(%X R3SV ZU'-JNG6X@,U
M_:QBXQY)>91YF>FW)YZCI7%>+;32[OXH>#X;V"UE\V"^61)54^8-B;0P/WAG
M. :QKF70;?7O%/AKQ'J7]DVMPD26D.V)(Y;3R554B+(>58/PIX)R!G- 'I,L
MMT->MXEN[-;0P.7MV!\]WR,,IS]T#.>.XJ7^U=.,D4?V^U\R9BD2^<N78'!"
MC/)!Z@5P<,%C:_$WPY ,Y/AZ6)_M6/.=0T0 D]6P#G\:Y(VVDK\'IKE([19H
M]>Q'*NT,@%]QM;J/D)Z=B: /8;W5(VTS49-,N[26ZM(V++N\P(X!.'"D$=/4
M52\*>(H];\/:1/=75J-3N[&*ZEMXW 8;E!)"YR!S7+74-C:?$S4K6PCMX1+X
M78F& !0["5L<#J<'\JPM.TO3+KP;\/I='AM?[>2XLW,MN%\T(H'G^81SM"@@
M@]\#T% 'K?\ :FG_ &<W'V^U\A6V&3SEVAO3.<9]J6XU*QM"1<WMO#A=Y\R5
M5PN0,\GID@9]Z\?UJ_L;3P9\3M,GN(8[Z34YY4M21YC*T<1#!>I'!.>G!K>^
MQZ#K7Q9BCN(+"]BN/#BN4=5=9#YW!(Z$[>_I0!Z$=2L5N_LAO;87/'[DRKOY
M_P!G.:5M1L4O5LGO+=;MQE8#*HD(]ESFO.$GN-*\0PFUFL]8T.ZUUXS;L-MU
MI]T78,5(^\@(8X(!"GTK.TRXT75]/GT3Q#K%Y!KMMJTDK6">6D[SB8M&\1*;
MF!4K@@X XR%% 'H?BW7ET+P_J%S!=V45_#:R3P0W+9\PHI;&W<"<XQQ6AH]X
M][H.GWLY423VL<TA' !903^'->7W.J6)T'XF:?KDT$>K-+=%(KE@'D@\K_1R
M@/4 #C'0Y/4UZ+X3FAN?!VC212)+&UC"-RD$'Y #0 _1O$FE:_%<RZ=>0S1V
M\KQ,RN#G:<%O]W.<'OBKUIJ%E?JS65W!<JAPQAD#A3Z'!KQPW:P>!-7A@*O]
ME\2RR:K!&,R+:"Z)<,HYVD?FN>V:[.58[KXJZ/?Z-+')"VF3#47@8%&CROD9
M(XSN+X]@>U '2:UXATS0%M/[0NHX6N[A+>%68 LS$#//8 Y)]!6/9^*7'C#6
M[#4+NPBTRSMK:>WGSL_UI?[S%B#]T8QBJGQ)>""'PS<W+1QP0Z]:M++(0%1<
M."23P!TK+$>D:E\0?%K7"VEQ$-'M2@D"D $2Y(!Z<$?G[T >B7%[:6EM]IN;
MF&&#C][)(%7GIR>*DAFBN(4FAD22)QN5T8$,/4$=:\:T36XM.T[P#=:MJ<EG
MI+Z,]NEX-C1Q7/R<.75@N44@$X[CH37HO@JQTJPT.1-$N9[G3Y+F26*60J48
ML<MY>T ;-V<8&,YQQB@"FVNZW/\ $"[\-V\FGQ10V"7JS26SNQ#.5VD"0=,9
MS^E;=C=WD%O=2:S/8JD4VV.>+]VCIA>2&8X.[<N,]JX:Y?2YOC=?I>ZAY"IH
M<2Y2]:W.[S6X)5E)X(.#5?QL^A)\,=5T^RNTO([&\A;[0\WF[9)+H.5$A))8
M*W)SG!&>IH ]).JZ<!<DZA:@6O\ Q\?OE_<_[_/R_C4HO;0PPS"ZA,4Q B<2
M#:^>FT]\^U<$^GZ*/C);P"UL1&V@NYB"+M9A,NTD="0"V#Z9KD($TN7P9X4%
MP+9K:'Q;+!EB-J1&2X^3/92,<=",4 >N:EK"GPWJ.HZ/=V=Q);0R.K!O-CW(
MI.T[6'IZTW0]:6Z\'Z5K&I3P0-<V<,\KLP1 SH"<9/ R:X>;3K33?$GC>?24
MAM]);0U%TL("Q"ZQ)T X#;-I./[PSUJ+1;[[->?#B:\D4:2^B>3#(Q_=I=F.
M/&3T#% RC/JP% 'IC:GIZ6T=R]];+;R_ZN4RJ%?Z'.#4AN[831PFXB$LHW1I
MO&YQZ@=Q7G-EX8C\0)X[TN-E71[J\1]/D7E8[D1J9'3V$N,X[AAZU+IUYK7B
M;PQJNLFTDM]9L]-GTZWCQAA=@'SF7V+K&!_N&@#OH=1L;FZEM8+RWEN(O]9%
M'*K.GU .10FHV,EZUDEY;M=J,M )5,@'J5SFO-?#UQX=\0#0+S2]8N)M;L+6
M1(+)1$C6Y,>UUF54!" @#DXSC&2:K>$KCP_KFF^&8+O5[S_A(-+G0MIX\M)X
M[A?EE+@('*'+%B3R.I)H ]0U:2XBTB[>TN;:VN%B)CFNAF)&[%N1Q^-.-];6
M\2?:KRV23RO,8EPH*C&YAD_=YZ^]<Y\3T@?X9^(//6,@6<A3>!PV.",]\]*P
MI(-*N_B7X8,T=I-YFAS,=P5MY!BVY]<<X^E 'HT$\-U D]O+'-"XRDD;!E8>
MH(ZU#<:E8VD\<%S>VT,TF-D<DJJS=N 3DUR7PN>'_A'=1@MV3R8-8O4C1"-J
M)YS$  =!@\5R7C_4]/FM?'UG#)#:7:00B=)F+S716,,AC4G"HH[@')R>.I /
M8SG:=I ..,BN7\)^)9=3TV[EUB>SAGBU*XLDV?NU<1N5& S$Y./6N@L+J*\T
MZWN89EEBDC#+(IR&&.H/<>]>/S30M\-=:N!(C16_BMII'!!"(+U26/H,<Y]*
M /8EO+5II85N83+$,R('&4'J1VJ./5-/FFCACO[5Y9(_-1%F4LR?W@,\CWKS
MN[U+1]1^(NN;;JTN+>7PTH!WJR2;992<'HV.,XSC'M6+;6FD?\(?\+Y6AM/-
MENX(Y7(7<ZFWD#JQ[@D*"#QT% 'K\6IV$]H]W#?6TEM&2'F252BD=<L#@8IT
M-_9W%S+;07<$L\6#)$D@9DSTR <BO'O$L-@MK\5[2&.W$4<%K,D**N$?R>6
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M.^D>]@F8"7SOM&58 \D>7M (XP,=!0![I13(I8YXDEBD62-P&5T.0P]0:?0
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MQDN07)4?,1TSZXIPAB$AD$2!S_$%&?SKD/!OB2(^'O"=A?RW$FHZCIB31R2
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M ?C*VD\,^%[+49KV2]O[<*MW-$[1RRA2Q7S3P6P#^1'7B@#O&@A=][11L_\
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M23DDH.:7[-;[-GD1;,YV[!C/K69J/B*TTI)1)'<W#6\ GN%MX]YBCY^9OR/
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MD8LSL5Y))Y)H U;[2K:^L9K1HTCCF&V0H@R1[<<'W[5<CC2*)(XU"H@"JHZ
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M<1H6CCDEV$#/<9##(]!G%:VG0W_AOQ9XE>XL+J\LM5E2[M9K>/S,N(PC1/\
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MC+YBE8GVOMDZ@G*AB.#P1G!K-OM;O];MO'FFWM@B6FGP/%&1*#C]QO!/?)W
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M_B#.FGZO.?#EZ9]&D8:A")H\1(%#[E;/SY4Y 'H<XXS>U_3-1U#Q)X7U"WM
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MVDN++>XWX0 E9%XV,001U'O68^F^*M3\5V6M-I]GIS1:7<6AW7?FF.5RI5@
MN" 5Z>GITJCI/ACQ)%J_A34;K3K%+C3UGCU"<WA>2X9T"F4MLR>02%SWQP*
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MW^LV4=C;V[RC]TB@_,[#C)+'@9X YY..YT\2KIULL\7E2K&JNFX-@@8/(ZT
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M!&Z?)Z_>SSCI6I9:?K^EZIXNU.UTZ"6;4)HIK**2X"AMD:QD.1G;]TD=?PH
M[.BFH6,:EP%? W '(!^M.H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6JZ
M38ZW8/8ZC +BUDQOB9B%;V.#R/:K442PQ+$F[:HP-S%C^9Y-/HH .M9VCZ#I
M7A^T:UTC3[>R@=R[)"@4,Q[GUK1HH **** "BBB@ HHHH **** "BBB@ HHH
MH SXM%T^'6)=6C@(OI4$<DWF,2RCHI&<8&3@=JT*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBN>NM6>\\81>'K9VC6&U^VWDBG#;2VV.,'MDAB3UPOO
MD '0T5AZAXNT?2VE-U<.L,$RP3W"Q,T4,C8 5W P#\R_3(SBHKC59-(\86&F
MSR,]IJZ2FW+')BFC 8KG^ZRDD#L5(Z$  '0T444 %%%% !16=JFGW6H/;+#J
M5Q911L6E^S[0TG& N6!P,G/KP*XKPFFLZ['XA+^(M06;3];GM+?)CVF.,J55
MQLYSD@GKS0!Z-16'?>+=(T[[0UQ-)Y%K((KFX2%FB@<XX=@,#J,^F><5MJP9
M0RD%2,@CH: %HKGO$GBF/P_?:/:-:W$S:C<^3NCA9P@"ECTZGY> /<]JYVV\
M5IHGB_QA_:MY?SV=L+62*)87F\A&B+.=J+\JCN2* /0Z*S)]>L88;>2-I+DW
M,7GPQVT;2,\> =P [<CD^H'4U-I.K6.N:9#J.FW GM9@2C@$=#@@@\@@@@@\
MC% %VBJ][>V^GVK7%U)LC!"YP2220  !R220 !R2:R/^$RT=8M2:1KF.335#
MW<#6TGFQH1D/M )*X!Y&1P: -^BL>R\3Z7J1A^QR33B:T6]0I;N1Y39VG.."
M<'"GDXZ5G^'?&MIK?A]M6FAGM(_M$D*I)"^6Q*T:!>/F8[1D+G!.* .HHKFY
M_'6A6MEJ=S=3SP?V85%Y$]M)YD.X94E0,[3V;I[U8M?%VDWFI3:?"]R;F.W-
MRJ-:R+YT0."T9(^<9('RYZC% &Y16!X/\3)XKT)-22VFMP[R ))&R_*)&5>3
MP3A1G!.#6O?7UMIMA/?7DRPVUO&9)9&Z*H&2: +%%8MOXJTNXGN(-UQ%/!;+
M=M%);N',)R ZC&6&01@<CN!52P\>:!J4^FQVUQ.RZED6LS6TBQ2-@G8'*[=V
M 3C.>/6@#I:*QK'Q1I6H1:G);RS8TQVCNP]NZ&-E&XC# $\<\9ZUIVEU'?6<
M-U#O\J9 Z;T*-@\C((!'XT 345DZSXETO0);2+49I(WO)/*@"P.^]\$[<J#S
M@' ZGMFJZ^,-+?3H[V);R16A,YB2TD,J1@D%F3&5Y5L9Y.#C.* -ZBN9EUW1
MM0U?PV\&KW8-[YDME';AO)NU\LD^8=N/E R 2"#BF3_$/P[;V]W<//=&&RN3
M;73K92D0,-N2_P ORK\PY/7G&<&@#J:*P[?Q1I6HZLVCP3W$=U)"TL+M Z+*
M@P"T3LNU\9'(SUSR*Y+P3X]L+?PQI4&N:C=R7EQ<S0&[GAD:/?Y\@1&EQM#8
M P,\#'08H ])HK&/BC2@VKJ99M^D!6O4^SOF,,NX$#'S#:,_+FJMWXZT"S6Q
M,EQ.QO[4W=JL=K*YFC"ALJ O)P1\O7GD4 ='16&GBS2Y$22,W+Q%H49UMG(C
M>4*45^,J2'0G/3<,XI=4\5Z3HXG>\EE$-NZI<SI"SQP%L8#L!@?>!/H""< T
M ;=%<_=^--&M+Z[L2]U-=VD2S2PP6DLC;&SAE 7YAP>1Q[TRW\=>'[N735@N
MI7BU(JMM<"WD\EW(R$\S;M#X!^4G/&.M '1T5B:EXLTC23*UY-*L$,JQ3W"P
MLT4+MC =P,#[P^F1G%5[WQSH=C=ZA:2274ESIZ*]Q%#9RNRJP)#8"\KA22PX
M''/(H Z.BN6OO&UG;ZMX?M+:&>Z@UA'G2XBA=U\H1E@1@9))*]N!G..*ZF@
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M0RK/#'*F[8ZAEW*5.#SR#R#[&GT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(S*B[F8*/4
MG%+0 444@92Q4$$CJ,]* %HHHH **** "BBB@ HHHH *XNSMI+'XP:G+*#Y>
MI:5"\+'H3$Y5U'N-Z'\:[2JUW8P7AA:52)('\R*13AHVQC(/N"01T(.#0!P>
MBRZMH5WK/AZ\\.WE]]IU&>ZL[M8PUM(DK[QYKD_*5)Y'7C@'BM'Q7;2:AXY\
M&VT(RUO<3WLK#^"-(]N3]6=1^-=I5:*R@@NI[L M<3 !Y&.3M&<*/11D\>Y/
M4DT 6:*:DB2H'C=74]&4Y%.H **** $9@JECG &>!D_E7$_#JWNK1_$ZW=G=
M6QNM<N;N#SH60/$^W:P)'?!XZ^U=O10!YG:V&I:=X8\6>&+K3;NYNKV>\:RF
M2%FBN5GR5+28VH06(;<1C&1FN]T/3WTGP_ING22^:]I:Q0-)_>*J%)_'%7Z*
M .0\;VUVU_X8O[:RN+N.QU02SI;IN=4,4B[L>F6&:RC;WAU?X@S-IUZJ7]G"
MEM_H['S66!D8+@<X8@?J..:]$HH \F@M-0T5O#&J7?AZ_P!2L1H4&FW5O!"6
MGM9H^=VPX)!R02/3/IGT3P[;0VND((-*32HI':1;1552@)SE@O&X]3CIG'-:
MM% '*?$'3]0OM MYM-M/ML]C>PWAL]V#<(A^9 ?7!)'N*JZ7?6RVU[K=EX.O
MK.3R1%MN+79<W#9X3:,G8.Y/'/&<5VM% ' >#],O/!VOW6A?9)9]*O0+R&[A
MMV"6\IX>$^B<97T!P36#%I&N1> [.U30[J6[T36I+R6UD 47<1EF)6,Y^;Y9
M P/3([GBO7:1F5!EF"C(&2<<F@#S#7[5=:\">(I=)\)7MA<WMJL"K-:[+FX?
M/0J"2%7U/J<=.=R:.>;XDZ%?)9W?V6/2YX9)C;N%1W:,JI)''"GZ5VE% ''_
M  U@O-/\'P:7?V%S:W%G)*C^<H"N3*[ J<\C!!STY^M:_BUM03PEJC:591WM
M]]G;RK>5 RR'T*GAN,\=^E;-% 'FFG1WB>.CJO\ 96MM:3Z"8#/=QY?S1(6(
M*@_)QT4 <]!CFJ=EIVH0^"OA[9OIM\+C3M1@DNX_LSYA18Y%8GCIEUZ>M>KT
M4 <#K^B78\=PK8;/L/B"#R=5C)P0L)!W@=]R$Q'_ 'EKOJQ])\.6ND7EU=K=
M7UW<7#,=]Y<M+Y2D[BD>?NKGL/09S@5L4 <?XUAN)M6\*/!:7,Z6NJBXG:&%
MG$<?ER+N.!ZL/>LS7(KG1_'EUJ-WX>O=9TK4K2&)7LHO->WEC+_*RY'RL'SG
MUKT.B@#@+K3I;?7_  ,;71'L[2SENGEAMH<I:K)$ZJ&*_*#EAG&1G)Z<UE7&
MGZA)X,^(EHNFWQN-1O[B2TC^S/F97CC52./53]*]4HH X:XBN9O&_@V[2RN_
ML]M974<\AMW B9UC"ALCC)1OIWK M]$U"^^%S>"I=.NX=2DNG5WEA811(;DR
M^:)/NMA>0%).<#%>L44 ><:C#J%CXC\;QKI-_<C6+&(VDL$6Z-BL#(RLW12#
MV/)[ ]*BTFTOX]4^';3Z7?1#3]*EM[HM 2(7:*)5#$9 R4;Z=\5Z910!YMK^
MF7Z^([W5/#R:G9ZQ]IA22$PL]EJ4>$&Y\C:I"Y&[((V>XJ%;273=>UW2]6\(
MW>LP:C>O=6=S#$LD+K)C]W*6.$VD8R>WX9]/HH XC3K>>R^(FK74EC.EH=)M
MH$DBMW,;/&7+*F!S@,,5S=EINHP?#KP/8R:9?"ZL-6MY;J+[,Y:)$=BS'CH
M1TZ]J];HH \N@LY;#5=;T75_!]UJZ7U]+=6=TD2O;R)*VX+*Q.$VDX.1T' /
M&=.WMKFW\6^,9FL+H6]QIUM#;NEL^R1HTD#!>.Q9:[ZD9E1=S,%'J3B@#R[2
M[#4["T^'%R^DWS_V;;36UW$D7SQ.T(49!QQD$;NGO7J5%% '%+%>:#\2-6U.
MXM;JXTS5K2!8YK>%IC!)%N&QE4%@"&R#C&<USUWX>U'3OAZEH+&YDN;K75U
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M!VFHZC:Z58RWM[+Y5M$-TDA4D(!U)P.![UGQ^*]%E6!UNV\N=D6*1H) CER
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M3@9!"'/;/:TA. 2 3[#O0!S?B+PBVL:K9ZQI^K7.DZM:HT*W,"JXDB8Y*.C
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M<\?,AYX&.A]3SZ;NAZ/=Z9&[ZCJ]QJMXX"F>:-(P%'151  .I)/4]SP,:]%
M&'>^&UNO%-IKT5]/;SPVS6LD<84K-$6#[3D$CE1R.<>E85G\.!9VFD6J>(+\
MPZ1=F>S7RXLHI# J3M^8X<_,?RKN:* .5U3P4NKZ?+'<:C(M\UZEY%?QQ@2P
M,A^0)V  ROT)SDDFNC9_LUD7NIT_=I^\E(VCZ^U3T4 >9_#O06U;X<^'[;4+
MPR6=JRS-9F+:_F(Y94D.?NAL-C / R2.NYJ7@3[=<Z^8=9N;:TUR+;=6R1H1
MO\OR]P8C(& ,CN1UQQ7844 <S:>$3::WI>IC4YI6T^Q-BJ21+^\C)4DL1CG*
MC& .G0US^BV]QJ/C?QS'::F+:*YF@7(B#L5$"JSQG/!!R,D, 0.*]&JGIUW<
M7D$DES82V3K,\8CE96+*K$!QM)X(YH Q#X+M+2]TJ^T68Z?=:;:?88SL\Q)+
M?@^6ZY!.",@@@YSUJ:'PNUE AL-1DANS>O?7$SQAA<R.I5@Z\?+@C !&-J\U
M8@\0QS^+;KP^;2:.:WM$NO.<KM=68J-N"3U4]<=*V: .+N?AS93::([>]GLM
M12_?4HKZU4(8IWX;:G(V$<;3G(ZDGFM.'P[?Q6L#-K]S-J,<XFDNY8DQ* K+
MY9C7 "88G P<\YSS70T4 <;<^%KW3=.==#U&:UO[K4_M]PT$*B.5B &4J<[8
M\ $\DG'<FNGU.S?4-.EMHKJ2UD?&V>( LA!!!&>.W>K=% '+7/@FUU+^V9-2
MG$ESJUDMC/);Q"(",;L$#)R^6ZDGH!@ 5':^"IEU?2M3O]=NKR>PMY+?!AC1
M)4?:"" /]GGN<]<<5UM% '(Z!X'?0'2VAUV^ET:"0RVNFR*FV(YR 7QO90>0
MN>PSFHIO  N/#FLZ*^JR>3JUZ]Y-((1N1F8.P7G&,J.H/&?P[.B@!L8<1J)&
M#.!\S 8!/T[4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** .1^)US=V7P[U>[L;R>TN8(@Z2P/M8
M'<!UZ]^U9^J"ZT;Q!H^C1ZG>W*:U+<3R-=WK1_/'&F(T=1E%.2VU<<KCIQ77
MZSHMAX@TN73=3A::SFQYD:RO'NQS@E2#CVS5;6?"VCZ_I46FZG:M<00L'B9I
M7\R-AT829W ^^: .)\01:]H'@?4_-UZ5YH=2@:V,-PS20PR31KY3R-\S<,V"
M><$9K4N;>YU'XGZAI,NK:E%8-HT4_DV]RT6US*ZY4K@KPHZ'/X<5MR>#-"ET
M$:+):2M8^8)67[3*&D<$$,SAMS'('4GH/05:7PYIBZQ)JPCG%_);BV:;[5+D
MQC)"XW8ZDG.,Y.>M 'FEA?:K_P (3X2\0R:UJ,M\^JPV<H:<^7+$9VB(=!PQ
M*C.XY;/>M&/1)-8\4^/?+UG4=->*X@:-[.?R@K_94(9L<L!Z$XZUUR^!_#Z:
M1:Z2MI.+&UG%Q!$+R;Y) VX-G?G[W/7K4UQX3TBYO;J[>&99+Q56[6.YD1+@
M*-HWJ&PW''N.#D4 <;X7US5-5UOP?/>W$ZG4M"FFNH1(P21U,85]N< D,3QC
MK6?+J.K/X35X]8OXI8_%QLED$Q9O)^U; A)R2 O8]>^:]%U/PQI.KRV,US!(
MDMCD6[V\[P,BD %<H0=I &1TXJF/ 7AP636:V,B6YO/MWEQW4J 3;MVX;6&,
M'H!P* ,#78-3\,R0M$=:UO1HXI7NTAU!OMEN7;(D&"ID0 , N>,'K3+75I/$
M.L6VCV=_)<6@T2WNX)C>RVLMP7+*TN4!8D;5X)X+'.>W9W>@V5[=K=R&Y2<0
M^1OBNI(RT><X.&YY/4\^]9^I^!?#FK0Z?'<:?Y?]GIY=J]M*\+Q)C&T,A!QC
MM0!RYBURWUGP3I>H>(KBXEF^VP7LMI)L6?RXVVYX^\.A/J,C!YK,N%U&/PKX
MY==>U@/H-W.;!_MC[D"Q)( [=9!EB,.2,5Z*?"VC&ZTRX%JZ2:6K+9^7/(@B
M###?*& .1U)!S41\&Z&UKJELUM.8=4<O>J;R;]\2,'/S\9  XQP,4 <ZVHZA
MXC\17.C><8O*TJVN8UCO9+5F:7?OD!C&6 (48/ ]\\5&BUI?$7@[2=0\17,S
MSVM]%?26<AC29HMH!]FY()ZYSC!KJ-3\">'M6%B;NSE,EBGE6\T=U*DJI_=+
MJP8CV)-6SX7T<WVG7BVKI-IL;16GESR(L2L " H8*<@#.0<XH \QU/S[OP-?
MVMY>WMR--\5I9P227+F0Q"XC #MG+D!C@G)'!ZBM_P 77=]H=Y=2W"ZI)X?%
MJD0O=/O)&ETZ0;BSRINS("&4[CG 7WKISX*T!M-O]/:SE:VO[C[5<*UU*2TN
M0V\,6RK9 .5(Z5)+X2TB;S@T=QLN(A#/&+J7;,@!&'&[#=3DGDY.2<T ;,4J
M31)+&P:-U#*PZ$'D&O/O&>I7^DZI>W5ZFHMH+0)&+W3+E@^G2#)9I(E(W*=R
MMGG '3FO0U540(BA548  P *R;WPSIFH7%U+<1SG[8@CN8UN)%CF4# #(#@C
M'!XY'!R* ..FL5UCXB^)52_O+>,Z/:.KV<YB8G,I4[EYXZX!P>^:;HNK7>N:
M'X.^TZC=S7MUISS36=O(86N" J^=)*K HJD]!G)?@'%=F/#.E+J=WJ*PS)=7
M<(@F=+J50R#.% #87&3C &,U23P'X=BCTY(K*6,:<K1VI2[F!1&ZH3NRRG'W
M3D>U '#"_O-3^&'A&YOYWGN?^$@MHWE=MS,$NV09/<X4<]ZZNU_Y++J7_8"M
M_P#T=+5]/ GAR/38=.CL9$M(+K[7%&EU*H27=N!&&S@$D@= 3TK0BT#3H==D
MUI(I?[0DA$#RFXD(,8.0NTMMX))Z=Z -.O$=%@U#1_A1X:\2Z=K&HBZ@D@C^
MQ>=FWGC><1F/R^F?FSN^][],>W5AV'A#1=,\A;6VD$-O(9;>W>>1XH7.>41B
M57J<8'&3C% ')&36_%<?B![#4QI]YI^I26\,WVV1%MUB(QNA V.&&2=V<[O8
M8]%@8O;QNS*S,H)*]"<=O:L"]\">'-0UUM9N+ F\D"B8I,Z)-CIYB A7Q[@U
MT= '"7%O<ZE\3M2TF75M2CL&T>&<0V]RT6US*ZY4K@KPHZ'/KQQ7-:=?:K_P
MA?@[Q#+K6HRWTNJV]G*&G/ERQ-.T1#(/E8D#.X@MGO7IA\/:;_;<VL>7,+^:
M 6[RK<RC,8)(4*&P,$D\#J:I+X'\/II%II2VDXLK.<7,$0O)ODD#;@P._/!Y
MZXS0!QOBG5+VWM-:U33M4O;B2RU:WB\Y9FB@MQYD2- (P2)3\QW$J!\W7*XK
M;BNI/$GB?Q787%W=6\6E+%!!%;SM$07CWF0[2-Q).!G(PO3DUI77@#PU>F_\
M^QD9;^037""ZE5&D!!\P*&PK_*/F&#[\FK%SX-T2ZU)-0:VEBNEA%NSP7,D7
MFQCHLFUAO'^]F@#@?".I74FA^"/#\;A(;K1Y;C'VI[<S.C( H= 6X#,V!C/'
MISW_ (4L]2T_3)K/5-22_FAN7$;AR[I&<,B.QY9@#U/48JK/\/O#-QH5EH[Z
M>WV2Q;?:E;B020GU5]VX?GBMS3=,M-(L([*QB\J!,X!8L22<DEB222>I)S0!
MC^++CRSI-LM]<PR7%Z%%M:\2W8",3&'W+L' 8MGHN.]<IIMYXCN?#>MV]G(]
MS=V/B"2".VDO6$DL"A',*S'#9P6P3S@=:[O6?#^FZ^ELNH0N[6LHF@DBF>)X
MWQC*LA!'!(ZU1B\$:!;B?[/:20&:Y%VS17,JD2@8W AN#ZXZ]\T 0^"-6MM5
ML+YH#J,<L5V4GM-1+&:U?8N8\L22O\0.?XJG\8?VL-&C.C()KD7",UL+CR'N
M(QDM&C_PL0,_@:U-/TNUTQ9OLR,'GD\V:1W+/(^ ,L3R> ![  "DU+2[758H
M8[H2_N91-&T4K1LC@$ @J0>A/'3F@#SM/%BSVVEV=E/JEJM_KHLKV.^=A<6?
M[O<8=Q)/S$## ]&..>:/$GB'5O!FJ^)+:PEGN[5-#&I6XN9&F-M-YGE$;F))
M4_>P2?NG&!7<3>%-&N=.GL9[3S8KB87$KO(WF-*,8DWYW!AM&"",  # J>VT
M'3[9+H&$SM=H([A[ES*TJ $!6+$_+@GCIR?4T <IJ<EWH6J>$KG3M1O+J'4[
ME;*ZCFN&E697C9Q* Q(4J5S\N!@XQBN9N+G58/!6N:X-=U5KS2]>DBMP;D[/
M+6Y5-KJ.'!4XP<@=L<Y]*T[PMI6EM;FVBF(M4*6RRW$D@@4C!"!B=O'''...
MG%5F\#^'WTF[TMK2<V5W<&YGB-Y-\\A;<6SOS]X ]>M '15YSXTO+G/BE['4
M[V2XT_2A,L5O,UO'8N%=PS,K?O&; (4J0 O. U>B(@CC5 6(48&YB3^)/)K#
MU#P9H.J:A=WMW9,\UY!]GN0L\BI,@! WH&"L0"<$C([=!0!RNO:MJT%M8ZI<
MP7]YI$FE1M=-I=R8[BSE;),QC4C>I&/7&P\=:[W2[B*[TFSN8+C[1#+ CQS<
M_O%*@AN?4<UF+X.T:.-(X8[F)%M5LR([N4;X06(5OFY^\W)YY/-;4$$5K;Q6
M\$:QPQ($C11@*H&  /0"@#B-8@O-1^)\&D_VQJ-K83Z-+,\5M/Y?S"9%!!'(
M//4<]LX)KF$O]>31K:PEUR_,ECXO32DNQ)^\N+?<I^<_Q$9P<\''.:ZW4M%N
M[[XHV>H-:7BV$.ER6_VN&81[96D5@.&#$;0>Q&<5LW'A#1+JQM+.2TD\BTN!
M=0A+B5")LEO,+*P+-DDY))R2: .<O[%['41HUOK>L7TD>GS3"V>\='CW2<32
M3@AB!@HJX8\=.,U2\/>(;S6AX*TW4;V95U#2)+N:6.0QO<RIL 7<I!'!9C@C
M.!VZ]G?^%='U/58M3NK9WNXX3;[UG= \6<[' 8!USSALBJ,OP^\,S:+9Z2=/
M=;:R?S+9EN)!+"WJLF[<.,#&<8 ]!0!S'B?1VMHO"UG=:Q>:@\7B2.(2F=T=
M(W1W",5;+,HVX<_-],FKNI:M?:'XS\0F&XN;B"S\-B]AM99"R"16D'3U(0<]
M?>NFG\):)<Z1;:7):,+6VF6>'9-(KI*"2'\P,&W9)R<Y.3FIHO#>E0:P^JQV
M[B\>W%JS&>0J8AT386VX&3V[T 8>B6S36OA[Q OB*ZV36N^ZCEE+Q7A>/=D*
M3MC*D%OE X!'2N?TO4K]->\&2PZE?7=KJ4MRD]U/*RI>CRG=76 DB-05&#P<
M=L&NPT;P/X>T"Y>;3K$Q[MVV-IG>./=][8C$JF><X ].E0VOP^\,V?V(0V$@
M%C*9;4-=2L(20057+<(<G*_=/<4 <$MA=IX0\9:Y9:YJ%A=Z;J^HW,"PS;8B
M4<MATQA]V,?-GV]^A%_/_P +%M=1DMR+C_A$I)VA']_SHV*_GQ73CPAHHN+B
M46TFRYG^TSV_GR>3)+G)<QYVDD@$\8)&35IM!TY_$"ZZ8I/[16#[.)1/(!Y>
M<[=F[;C(!Z=: .,\/KK6L6'AKQ+#K$<4<PCDO=U[)+'<B08:,1$!$8,<#;T(
MQS7HM<YI?@3PYHVJOJ-A8&&9G:0()G,2.>K+&3M4G)Y KHZ /++K5+V.ZTC4
M;'5+V[BN/$@M9+MIF2&2)G=#"D.2I5<;=^!DKD9S6I:Z5;R_&#6MTMX,Z5;R
M?+>2KRTDN1PW3T'0=@*V#\/?#)#+]@D"?:A>*@NI0L<V=VY!NPF3UVXS6E#X
M<TRWUR76HH95OY8Q$\GVF0J4!R%V;MN!D\8[T >9^'+V30_AOH MII4.J:U)
M9322W<@"KY\Y&&.=A8J%+*,G=G.<&M#Q7;:_H'A'Q9<#7)HD^SI<6<,5W)+-
M;$':W[UQNVL>0.V#BNP/@;PX=)O=+;30]C>N9)8'E=E#%BV4R?D^8D_+CDYI
ML?@3P\FA7&C&TFDLKG'GB2ZE+R@= S[MQ ],X]J -'2-*.F"X9M1OKQKF02M
M]JFWA#@ A!CY5XS@<<\5S'Q*M8[A?"^]YE_XGUJG[N9X^&)S]TCGC@]1VQ7:
MP0I;P)#&7*( HWN7./<DDG\:IZQHEAKUFEKJ,+21)*DR%)&C9'4Y5E92""/4
M&@#B)M)%]\1_$5J+Z^MD31K0![:X9)"0TN"7!W<=>O/?-5-#\1ZGK5GX-T^Y
MGW/J&D27,KM=/;M<2H44#>@W9P68@8SU[8/<Q^%M(AO[B^BAG2YN(%MY76ZE
M&8U^ZN-V!C)QCU-4KGP!X:NM#L]'DL&^R6+;K3%Q()(#_L2;MP^F<4 6?"EG
MJ6GZ9/9ZIJ27\T-RXC<.7>.,X9$=CRS 'J>HQ6#\9/\ DE.LX];?_P!'QUV&
MF:9::181V5C%Y4"9P"Q8DGDDL2223U).:KZ[X?TWQ+IK:=JT#SVCD%HEF>,-
M@@C.QAG! /X4 5T@U>VU:"YOM6MY+!8GC:)(/*S(S($.2S9_B&/]JO.K^74_
M^$.\<:F->U876D:K<?8V6Z90@18R%('#+R1M.1[9)->D+X8TP7%O,YOIFMY!
M+&L^H7$JAAT)5G()';(XZU7;P5H+:=J5@UK.;74I6FO(S>3?O7.,DG?D9P,X
MQTH P\7FG_$+1K=-5U"6'5M.N7N8Y9RZ!T\LJZ*?E0_.1\H ]JY%)M<A^%EC
MXQB\0ZK-J=I<G]Q).3%<)]J,9C=.C9!X)Y' &!C'J4GAS2UO[/5#;W,EWI\3
M1VS?:I254XR,%L-G ZYS@5S?@'PE]D\*6$&M6-S#=V]Q).;::XWQA_-9D<*K
M%> 0?8\XSS0!1U35)]#\6^/-4MHQ)/::';31J1D;E$Q&?;N:EO;F]TFT\&ZO
M8ZC>73:C=VUK>)+.TB7"3(27"DX0@_,-H QD=*[&/P[I<>L7>JBW<WEY&(KA
MGF=ED09PI0G;@9/;N:AT[PII&E-;_98)=EJ6-M%).\B6Y((.Q6)"\$@8Z D#
M .* .0^W7NBZOK_A::^O);O42DVC3RW#LPCDPC*"3G]TV6..2O)JS<-?ZSXC
MUOPY;7<L7]G6L"V['4989 70GSB5!,AS@?,<?+TY.=G3K>_UK7X=7U?1%TXZ
M<LT-HKS)*[ER 9 5^Z-J@ =3N.>@S8UOP7H/B'4(+_4+1S>0KY:SPSR0N4SG
M:2A!*^QH YF"\U?4->@\-7M_'<SP:1'.\MO>26GVB0R/&\@,8R<;%XX +'@\
M8ZWPO!J-KX>MK;5M1CU&^@W1RW4?1\,0,_[0& ?<&J^L>"O#^N)9"\L=K6*[
M;62WE>!XEQC:&0@XQVK9L[.WT^SBM+2)8H(EVHB]A_7ZT <CXR:];Q9X2L[;
M5+RSAO;B>*=;=PH=1 [>G7CCTZ]17'ZY=:WH>B^/M*AUS4I(M+CM;FQNY)RT
M\?FYW1F0\D#''< UV?C#2;O5/$WA:2*RNIK2RN99;F:"41F,&)E4@[@WWB.G
M;\JU[KPCHM[I-WIMU;22VUZ_F76;B0/.W'+.&#'@ 8S@  =!0!SNHK/H_BO0
M="_M74Y;?6[BXGN)9K@[@8X@1%&PP8U)^;"XZ$#@XJN+?5[S5?%_A6UU2]1(
M+>&YTZ[-P_FV\DBM\A?.67<N<$G@D>E=EJ'A_3=4LK>UO(9)%MG62"3SG$L3
MKT99,[@??/UJ>PTNTTT3&W1O,G??-+(Y=Y&P "S,23@  >@Z4 <KX3U9O%=M
MI-PLMS";.T(O8Q,V1<D["C<_-M*2'YO5#WKGK+Q#J,'AJQM9=0N6?4/%$NF/
M=R2$R)")7X#=B0@48Z9XP<5Z78Z58Z:MV+.W6$7<[W$^S(WR-C<WU.!64?!'
MAYM$N=':P9[&YF-Q)')<2.?-)W%U8L2K9YR"* .+UB>7PKXR\5ZA8//--;^&
M4N(A<2M-L822XY8D[01G&?6MRTLM7CO[#5K;7(8K">TD619[Z2Y2X8QEHY%W
M@!",%CMX*YXXK;L_!VBV5^]\L$\UU);?99);FZEF,D62=K;V.[J>M0Z1X#\.
M:'YXL+%XUF1H]C7$CK&C?>5 S$(#_LXH P_!^J72>((=)UV+4['6DLGWQS7+
M3VU[ADS-$Q) (_NX! ?VKNKM#)9S(LCQ$H0'0X9>.HJC8>'M.TZXAGA29Y8(
MC! T\[RF*,XRJEB<9VKGOP/2KUTS):2LD;R,$.$3&6/H,X% 'C]I-KEOX \+
M>+X]?U2XU!Y[:.>VEG+0W$<D@0H4Z%OFSNZ]?;&]IZ7TVN^+;N;6-6E31;X2
MVUK'<E4<"W5S&PQRI)^[5_X?^$QI_@_1(-7L[B.^L%W?9Y[@ND<O/SJH8KWX
M],G&#73:=H&G:5?WU[9Q2I<7SB2Y9KB1P[ 8!PS$ X ' ' H \_GU34H?AQH
M7C*UU&ZFU*62UDN(C,S17 FD5'B$>=JX+X& "-O7KF4Z?J6MZGXVMSXEU>U_
ML^X0V9AN2@B8P*_..JY/W>F,]\$=E9^$=%L9$-O;.D,<YN([8S.88Y"2=RQD
M[0<DD8& >1@US^D>&9+OQ3XMN-4L;V"TU&>,Q$7.Q)XEB5"&5']0>H'!_"@#
M*T+Q#JWBN72=/NV,<LV@0WS*MY):-*[NRLX,8R<!5.. -_?C#IK;78M3\%:/
M?^);J66=[VVO)[*4H)@D3E<\??' )]1G@\UV.M^#=!\0"S-]98>R&+:2WE>%
MXEQC:K(00,=NE2-X3T5I],F%JZ/I>[['Y=Q(@BW##' 8 D@G).<YYH T=/L_
M[/T^WL_M%Q<^3&$\ZY??(^!U9NY]ZLT44 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A(4$D@ <DFN
M4A\4O=_$*VT>SO+"ZTV73I;DM =SK(KHN"P8C&&SC J'XH37%OX)EEB21[9;
MF WRQ@DFV$B^:,#MMZ^V:P-1U73[_P")-M<:!?64UW-X<NHK:6&12&DWH8UR
M._4XH ]'34K"6]:RCO;9[M<EH%E4N,=<KG-$^I6%K<Q6UQ>VT5Q+@1Q22JK/
MGT!.37E0DAU3X8^$X-,8+X@M;NU1(\XFBN%<"X+CJ./,+9ZCD]:MV>IZ!/)X
ML\.>+B/MT^JO(MJ[,LMU%E3;^5@AFP%4 *>,>] 'I?\ :5CB<_;;?_1_]=^]
M7]U_O<\?C0VH62K$S7EN%F4M$3*N' &25YY '/':O/I]0LM,\=>-8K^>*WEO
M=,M6MXI&&Z?"2J0@ZN0<#C-8>BG2KMOA,)#:2L;&:-PQ4D[;<?*?HW;UH ]7
M_MS2?L\-Q_:EEY$[[(I?M";9&]%.<$^PJ:]U&QTV-9+Z\M[5&. T\JH"?3)-
M>/W5MHQ\)_%+$5D3%=7'E<+\A,"$;?3Y\].XK3DUNQM?%*KX@UAK&PU'1+=;
M.Z81F&4#?YR%G5@"2RD],C&<X% 'ITM_9P;?.NX(]ZEUWR ;E R2,]@.<UG:
MIXJT72=(BU2?4+=K6:18H7256$K,VT!3G!YZ^@!/:N BTK0;3Q;X!L(%\VU2
MTOEB^W8,DD8V&/=D#(ZE01P,=ZRYY+./P/XB$3PBUM/& ;Y2-D,?VF(D^BKU
M]J /7YM9TNW2)Y]2LXDF&8F>=5#CU7)YZ]JJWOB;2;#7;31KB]A2]ND:18VD
M PHQR<],D@#UY]*\_P#%FLZ1=77BNVMIK:WGDT$#S9&+M?(4E*+ N<;1DY8
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MJ06X48)[X./6K=>;:5IFBWOQ5UZWN[6UN)%TZR?R[A4=MX+DL1T+CY<FO2:
M.:O/%UC-_;EEI5]:/J6F0%RLAWKOVLVW 8$X"\X/&?8U/X6\01:SH&D2W-U:
M_P!IW=A#=2VZ. PW("2$SD+DUR(N[*T\4_$>">:&*>2"&2-'(#,@M<%A[9X)
MZ9K+TI=-M+3X47$'V6*=U"R2*5#-NM&# GJ?FP/KB@#U8:GIYOOL(OK8W?\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (R,'I445M!  (88X\#
MV(!@=>U-O;VVTZSEN[N98H(AEW;M_B<\ =S64OB_10=0$]VUJ^GPB>Y2YB:)
MDC/1\, 2#CMGGCK0!L+;PI,TRQ1B5QAG"C<1[FAH(FF69HD,JC"N5&X#V-9M
MIKMCJ]U<Z;;S7$%['"LK1R0M'(J/D*ZAQ@C(/K@C!K!\":^[_#K1;_5KN:XN
M[G>NXJ9))GWOP !DG"D\= #T H [!X(I)!(\2,Z@@,5!(!ZC-'D1?+^Z3Y1A
M?E' ]JP'\=>'HM/:^EO6BA2Z%G*)('5HIL@;'&,IU')P.>M6]-\4:5JMU>VU
MO/(DUDJO.EQ \)5&SAQO RIP>1QQ0!J?9X<$>3'SU^44CVT$J*DD,;HIRJLH
M(!]17#:OXG^U>+O!\>FWMZEK>W,FY#"R17,8A<A@Q4;AG:>OH<=ZZ)?%VBO>
M0VZW+GSKIK.*;R7\IYUSF,/C;GY2.O4$=: -EHHV8,T:EAT)'-(((0K*(DVL
M,,-HP?K6$OC?07U9M,2YF>[2Y6U=%M93LD89 8[< $=">#Z]:V-0O[?2]/GO
MKLNMO A>1DC:0A1U.U02<>PH F,4;.',:%@-H)'./2E\J/"#8N$^[Q]WMQZ5
MF1^(M,ET[3K^.65[;461;5E@D)DW E>,9 (!.2!Q45QXLT>UNHH9KAT66X^R
MI.87\DS9QL\S&W.01UZ@CKQ0!KK%&A)1%4GJ0,4V.V@A5EBAC17.6"J &/O6
M1-XNT6"[:![E\+=K9/*(7,23MC$9<# /('H"<'FHKCQOH-KJL^F27,QO()(H
MI8DM96*&0D(3A?N\?>Z#(YY% &[]G@QCR8\>FT5)C P*CGF2V@DFDW!(U+-M
M4L<#V')_"N?L?'GA[49M.2UO)77425M9C;2+%(V"=F\KM#8!.TG/M0!OO;02
M2K*\,;2(<JS*"0?8TYX8I)%D>)&=00K%02 >N#61J'BS1]+=A=W#I%'*L$MP
M(7,,3MC"NX&U>2!R>,C.*9/XPT2VO]0L9KF6.YL(/M-Q&UM)D19QN7Y?G&?[
MN: (-9\.3ZEXFT+48VM5M=,$P:WD0GS1(FPCT& ,]\^U/\7^'I_$/AMM(LI8
M+4-+"^]T)"B.17  &.NW%1ZEXPM[#Q#HNE?9+QCJ222[_LLAVHBYQC&=V2N1
MC@=<<5TA.U23G &>!F@".W@2"(*D,41/S.L0P-W>E2WACE>5(8UD?[[A0"WU
M/>O/].UEO$M]K=U-JNHZ4NDZD5BD$;QPK;Q)&SK*&&S+;G)W?,!C& *ZVU\2
MZ9>:A%8++-%=3Q&:!)X'B,R#J4W ;L9&1U'<4 :B11QDE(U4GJ0,4A@B(P8D
M(R3C:.OK7EUUJVL1_#GQW=+J]Y]KT_4KN.WN-R[U1-NU1Q@#Z 5Z#+K5I9):
MP3-++=2P^:L,,32R%1C+84$@9(Y/<XZT :'D0YSY4>>GW16#KN@ZC>7UE>Z5
M?6L!MED5K6[M?-@EWX^8@,I##& <G@D=S4I\9:%]DTZZ6]9X-1G%M;.D$C!I
M2<;&POR-D$8;'0^E3P>)=+N+S4[2.68SZ8H:[1K>1?+!&1R5^;(&1C.: &:+
MHC:?<37MT;-KV=%C<V=MY,8522!C)).6/)/T K895==K*&![$9KG/[9TN[\2
M:7LU._CGELY9X;/RG2.:,[278%/O+Q@9!&[I3(_B#X;E$+)>3&*6Y^R>;]EE
M$:2[MNUVVX0EN!NQ^5 '2B- A0(H0]5 XIJ6\$<(A2&-8AT0* H_"LW4/$NF
M:9+<Q7$TA:TA%Q<B*)I/(C.<,^T' X/O@$]!5S3M1M=6L8KVRD,EO*,HY1EW
M#U 8 X]Z )O(A!!\I,CI\HXH^SP8QY,>/3:*P+CQ5$GC:/PR+>Z#O9-<-.L#
M, 2ZJN" 1CELL>!@#/6N>\'>-+:UTGR-;U&ZFN9-6N+1;B2%W53YS+&KNJ[$
M)P  2/RH [^2V@E""2"-PAR@9 =I]O2G2Q1SQF.6-)$/574$?E65JOB?2]&$
M[7DLH2V :X>*!Y%@!Z%RH.WCGGMSTYK6BD2:))8G5XW4,K*<A@>A!H 0PQ$$
M&)"&.X_*.3TS39+:":/RY8(WC_NL@(_*LK5/%>CZ.;@WEPZI:[?M,B0NZ0;L
M8WLH(7J#ST!!/'--U'Q=HNEO<K<7+D6D:2W+Q0O(L"/G:SE00 <$_3GIS0!L
MO#%+"89(D>(C!1E!&/I088F55,2$*,*"HX'M7*:E?7<?Q,\.VT-],;&[LKMW
M@!'EL4\O:W R?O'J36I)XLT>&\M[:2X=1<SFVAG,+^2\W(V"3&W=D$=>2".O
M% &MY$.2?*3)ZG:.:1[:"2$PO#&T1ZH5!!_"N<G^(7ANW2Z>2\GV6EQ]GN7%
MI*1 W'+G;\J_,/F. ><=#6KJ.LV=G*+1I)VN9(FE$=K"TLBH.-^ #@9Z9ZG@
M9H T&AB8 -&A"C RHXH$,:DD1H">I"CFN&\">*4;P)H]SJE_/=WE]<7,<!*E
MY9RLLF, #LB^@  [5N2>-O#\.DP:G+>LEI-<_90[0N-LN[84<8RA#<?-B@#?
M5510JJ%4#  & *22-)8VCD171A@JPR#5/2=7M-;LVNK(S&-9&B/G0O$P93@_
M*X!_2HDU_3I/$,F@K++_ &BD/VAHC X'EYQN#$;2,\<'K0!HI&D48CC1411@
M*HP /I38[>"$*(H8T"@A=J@8!Y.*SE\1Z:\!E229A]H>V5!;OODD0D,JKC+8
MVMDC@8//%5XO&&B36 O$NV*FZ^Q>48G$HN/^>1CQN#=\8Z<].: -Q45,[5 W
M')P.I]:&574JRA@>Q&:P)?&N@V^C7.JS7<D=K:W!MK@M!)NBE! VLN,CDCD\
M<CGFM#2=:LM;CN)+%Y66WF,+F2%X_F !XW 9&""".#0!<\B'(/E1\=/E'%*D
M4<9)1%7/7:,5BZC?6,?BO1[2;4KR"\=9VAM(U/E7("_,7.W!V@9 R#D]\U4;
MXA>&U5W-Y-Y<=U]DFD^R2[(9,A<2';A/F(&6QS]* .G9%==KJ&'H1FF""$$$
M1)D=/E'%25@2>,]#BMM5N)+B=8])?9>DVDN83C/(VY(QSD9&.: -O[/#Y_G^
M3'YV-OF;1NQZ9J2LN35K2Y6VMHI[B.6_@:6W=(&R% &6R5(7&Y?O>HKD_ 'C
M6UN/"WAVWU6^N)=3OT*">2%RDDN6.PRXV;\#[N<\4 =Y+!#.H6:)) #N =0<
M'UYI[*&4JP!4C!!'!%8%AJNF?VUXAD&KW+FT\HW<-SE(;,!"<IE1@,!N)R1W
MH?Q)I^HM<:9;7=Q;7[6;7,0>!HW:/IO3>N#S^7I0!OD!E*L 01@@]ZC6V@2%
M8DAC6->B!0 /PKB/ GC2SNO#GANTU&]N)=3OK88FEA<I+(%+,OFXV%\ G&<\
M5W3N(XV<AB%!)"J2?P Y- ""&(,&$2 CH0HXI514SM4+DY.!C)]:\SUWQK-K
M'PYN]:TZ6]TR2WOTBR8S'F/[4(B"Q&.5R2%/!X-=MI_BC2=3O[NR@GD2XM$$
MLB3P/#^[.<.N\#<G!^89'% &NR*Z[74,/0C--\F+*'RDRF=IVCY<^GI63;>*
M=)NM3M]/2:5+BZC:6V$L#QK<*O)*,P ; (/'8YZ<UK2RQP0O-,ZQQ1J6=V.
MH'))/84 'DQ[%3RTVJ<@;1@&D:"%Y4E>)&D3[KE02OT/:LF'Q5I4]^+$/<)<
MO ;B*.2VD0S1CJ4!7YL<<#GGI3-/\8:)JL5I)8W,TRW<TD$6+:4'>GWPP*Y4
M#N6P* -H11A]XC4/_>QS3ZY6]^(WABP-UY]]-_HDWDW.RTE;R6P#E\+\J\CY
MCQZ5K7?B#3[2)'\R2XWP_:%6UB:9C'_?P@/'H>_;- &BT4;$EHU)(P21U'I2
M?9X>/W,?'3Y1Q6$WCCP\HTXK?F4:E$TMH8H9'\Y5&3MPIRW;;][) Q4UIXLT
M>^TL:A;SR-%]H-KY;0NLHF!P8S&1N#>V.G/3F@#7\B+)/E)DMN/RCD^OUH^S
MP\_NH^>ORCFL]/$.G/:27!>90D_V8QO ZR&7 .T(1N)YSP.G/3FH(/%FCW%O
M<R)<2![:=;::!X765)6QM781NR<C&!@CGI0!M*JHH55"@=@,4UXHY#EXT8_[
M2@U6T_4[?4UG-OYH,$ODRI+$T;*^T-C# =F!ST.:R_$?BF+P_?:1:/;7$KZC
M<^2&CA=P@"EC]T')^7@#GOT% &^J*@PBA1Z 8IDD$,KH\D2.T9RA902I]1Z5
ME7_BC2M.-QY\LQ%JBR7+16[R"W4C(+[0=O'.#R!R>.:U8)HKF".>"1)(9%#H
MZ'*LI&00>XH 62&*;;YL2/M.Y=R@X/J/>B6&*XCV31)(F<[74$?K7"7?B<:#
M\1]6AU*^O)+%=,@GBMHX6E*,7D#%412<849)Z=S740^)M)NM+L]1M+K[5;WO
M_'MY",[2XSD!0,\8.<CC'.* --HHW(+1H2.A(Z4GV>'G]U'SU^4<U4TC6K#7
M;-KK3YC(B2-#(K(4>.13AD96 *L/0BJVL>*-)T*[M;74)Y(Y[L.8$6!W\S:I
M8@;0<G Z=3D #F@#3DMK>6(1201O&#D(R @'Z4]D5T*,H92,%2,@BL.3QCHT
M>G+?^9<O ;=;IS':R,T41SAG4+E1P>O/!]#4<NL:5<^(]%$6KW(EGMI9K:WA
M!,%U&54EV.W!VC!&"/O>] &\+>!8EB6&,1K]U HP/H*> %    '0"N8;XA>&
MD@:<WDWV=+DVLLWV279#(&VXD;;A/F.,MBK<'B33-8O;O2+2[N(;U(#,I:W>
M,M'G'F1EUPZYXR,B@#9F@BN$V31)(F<[74$?K3U4*H50 !P .U>=^ _'^G3>
M&/#MKJ^I3/J=]$$\^:)]DDI)^3S<;-_^SG/:NJ;Q;HR6>J737$HBTIRE[_H\
MF82%#'(VY(VD'(R,4 ;"11QG*1HI]0H%/KG=0\<:!IDR0W-U-YKVOVQ$CMI7
M+Q<?,H"\]1P.0,DXP:M#Q/IC2*J/.ZM,D'F+;N4$CXVJ6Q@'YAUZ$X//% &H
M]O#)*DKPQM(GW'902OT/:E>&*0Y>-&/J5!K(O_%>CZ9(1=W#I$DRP27 A<PQ
M2-@!6<#:O) Y/!(SBJOBGQ!;66DZM;PW5REY;VC2O):PM(;?*DJ6(4A<XSSS
MCGIS0!TE-:-&(+(I(! )'8]:QO!MS/>^!] NKF5Y;B;3;>261SEG8QJ22?4D
MT[5/%6DZ1-<Q74TA:UA%Q<^5"\GD1'.&?:#@<'WP">@H U?L\&,>3'CTVBAH
M(7D21XHV>/[C%02OT]*P]3\:Z#I-PEO=7<GG26QNHTBMY)#)&,9*[5.[J#@=
MN>@I][XPT6PMVN9YYA;H$::9;>1D@#@%?,(7Y.&!P>0""< T ;M%(K*Z!T8,
MK#((.012T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!RWQ!T_4K_PP'TF#[1=V=W;WJVV<>>(I%<I^
M./S%9VJ:S?ZQX7U:_P!*\*7(N1:!!%J=F%DF.X?((SRX4%C@\$X SS7<221P
MQ-+*ZI&@+,[' 4#J2:4$,H92"#R".] 'GFB+<Q_$>35#IVMFRGT1(_M5Y"=Q
MD65V8%?X3@C"!1[+CFL#3]-U?3?!7@Z^?0[^Z&DRW"7^G)&RS[)"P#HIQN*\
M' ZY/OCV.B@#S'7;-;SPN9]*\-7MF;G5+.=HVM6\^41RJSR2*,D  $#=SQ[B
MG>)M'U+6_$OB>&PM[F/[=X=2T@G>%TC>4/(Q3<1@9# ?C7IE% 'F3WU]J]YX
M'D7P_JT$FGW1%['):,BP'R&3[QP&7)X89&/0\5G7*ZS>QZ1-<:!JJ7EEXC6>
MXM[>WV6\40>3#1@$"3((8OSR6R0"!7KU% ''>$XIX_%WB^::SNH8[J[AE@DE
M@9%D5840X)&#A@?Y]*[!E#*58 @C!![TT2QF8Q"1#*H#%,\@'H<>E5]3L1J>
MFW%D;FYMA,A3SK63RY4]U;L: .,\&Z->6&N7NE3;7TG0IW&FG=D_OE#A3Z&-
M691[25D^'[)[:$^&-:\)7MY>P73M#>O&7LY5,A=)2Y.%(!R1C.1QR<5Z-I6E
MV^C6"VL#S2<EGFGD+R2L>K,QZD_X <"KN1ZB@#R/Q!'K&H6NIQR:%J8N+;78
MIHXK6WVP/;K,A$HQCS791DYW$'LH%=5X?2X'Q'\3W<MC=PPW=O9"&26!@K&-
M9-XW8QD%AWP>V:[/(]:9'-%,&,4B.%8HQ5@<,.H/N* $N'$5O(Y5F"J3A%+$
M_0#DUY18:?J$'@'P!9R:9?BYL-4@ENHOLLFZ%%\P,QXZ?,/KFO6/-C$PA\Q/
M-*E@FX;B!P3CTY'YT^@#RRULY+.]UGP_K/A*^U0W5_/<6ERL>^UGCED,B^:Q
M.$*D\Y';C/%7O&.FWNIWPUO2["3[;X=*F&-[9_\ B89(9HQQR@P-IYP_/ &3
MZ+10!PNKS75WXK\&Z[#I.HM;1QW<<T?V<B2!Y$3:'4XP,J1GI[XYKNB<#-%%
M 'E4FAZIK7A#Q_I5M:W-O=ZAJDMS:?:(6C69,18P6 'S;&7GU]*W+M)_%FM^
M%+V&PO;-M.G>ZNS<V[Q&+,97R@6 W$L1]W(PI.>F>YI&8(I9B H&22>!0!Y3
M<6&H2_#[Q]9IIM^;F^U*ZDM8C:N&F63;M91CH<'Z=ZVXUO-+\?0ZY-:7DVEW
MVDQVF^*W=WMI4<MAHP"P5@QYQU'-=TCI+&LD;JZ, RLIR"#T(-.H \WB\'7M
MUX)\2QA'M[S4-4GU73T88:!PRM%D?PDE 2.V\@\YJ+^PM>N=<T_5WMVC_P"$
MAMS;:U 6.+:,8=!['8'C)_O/FO3:* ..U:*<_$_P_=):7+6MO8W4<LR0.R(S
MF/:"0,<[37)RV&H-\,=3L5TO4/M<FNFX2'[))N:,W@EW8QTV G].M>NT4 >7
MZ]<-:>+O$'V6RU@PZG800W4EKIK78+;7 ("L#&P1APP.<@X]>X\+2:>WAC3X
MM+$XL[>$6T:W",DB>7\FUU8 AAMP<BJLOA"+^U;J_LM7U:P:[D$MQ#;3KY<C
MX"[L.K;3A0/EQT%;=I:0V-LMO I"+D_,Q8DDY))/)))))/7- '*WT5U9_%6T
MU+[!=36<VD/:>=#'O5)/.5_F/\(VY/OC R>*Y)[#4#\,KRQ&EZA]K?7C<+#]
MDDW&/[8)=V,=-@S^G6O7J* /,IHY-,\4Z];:KX8U+5[#6)EN;6>UB,BD&)$:
M*4$@)C9_%Q@\XKT33X!:Z;:VX@C@$4*((8ON1X &U?8=!5FB@#SNQGU#P_KW
MB+2;[P[?ZG;ZI?->6<\$(DAD5U4&.1CPFTKCYNWX9H>,(=8U!/%NF-HU\3)I
MR+9-80XCNF\H[B\@P6*L2H0GIT4DUZ@LT3RO$LB-)'C>@8$KGID=LTKNL:,[
ML%11EF8X 'J: .#"7<_C/P==G3KZ.&#3KB.9GMVQ$SB,*&(R 3L/T[XK)\*V
M3V]G:>&=9\(WMQJ-A. E[)&6M'"ME9PY. 0.<8SG]/4D=9$5T8,C %64Y!'J
M*=0!Y3>V-_+X0^(MJFFWYGU"^F>T3[+)F96CC52O'3*FM.REOM#\=W.HW6FZ
MC<:=JVG6L<,T%L\AMY(@P,;J!N0'<3DC%>ATQY8XV17D16<[4#, 6/7 ]: /
M)]!&LZ9X<\,VL^A:C% M]>_:Y8K7?<0!GD:/;U**P?#..@[C.:KKI^IQ>$Y[
M%]$U19$\5"["-"TC-#]H$A;(W;L*.N3GL37L=% "*P90PS@C/(P?RKC/'EG?
M6TNE>(]%2-M5LIQ;"-VVB>*=A&4/T8HP_P!TUVE8D^A6::Z^O7>H7K+&H9;>
M:Z/V6%@I&\)T#8)Y/KGK0!S'B?2+K1&\,7UKIUUJUCI8FAO8+8$SN)%7]\%!
M&YMRDD?[1J.]:6WT^RO=)\+75G:76II)=,MF'O$3809O+Y*L3A<\L%R>XQZ,
M#D9'2B@#QJ^TW4_^$.\;Z<FB:MYMYJT=Q;+)$TK2H?(/WLG/"-DYXQ@G/%>Q
MQR"6)9%#!6&0&4J?Q!Y'XTXG R>E,BECFC62)UDC895E.01[&@#DO$,,[_$3
MPC<1VMS);VPN_/FCA9DCWQJJY(&!D@_UKDK[3]0F^'7C6RCTN_-U>:S/-;1?
M99-TJ-*C*P&.F%)]J]=HH ;&XEC5U# ,,@,I4_B#R*X?6O#M[-XVD%K"3I.O
M67D:JP.-GE'@_5T9H^/KVKNJ* .)\#Z;JFEZ3,-:21I--5M.M&"EFDMXV.V0
M #.6&P8'7RQ7,Z?I^H0> / 5G)IE^MS8:M#+=1?99-T2*9-S'CI\P^N:]<HH
M \NUG0]4UBZ^(MM9VMQ')?Q6ALY)8F2.<Q(-RAB,<D;?Q]*Z/3]?FUVU>YD\
M-:C83PVKK.]W:E75B/\ 5Q?Q."><@8P!W-==3(IHIT+Q2)(H)7*,",@X(_ T
M >5V-C?P^$/AU:OIM^)]/OH7NT^RR9A58Y%8MQTRP_.O5Z8)8S,81(GFA=Q3
M/('KCTI] 'D$UCJ:?"S4-";1]1^VQ:L7"K;,PD4WOF[E(ZC9SGIVZUL^(=*O
M=;\9:Q':07,<=[X7>QBNG@=8Q,SL0I8CCA@?TZ\5Z-2,P52S$  9)/:@#@/"
MDB:E<:8+SP=?6.J6"D37-Y%B.%MNUC"Y)W;C@?+VSGH,]+XPTNYUOP;K&F6;
M!;FZM)(XLG +$< GT/3\:UK>YM[N$2VT\4T9. \;AA^8J6@#@O#MY!J-U:WU
MQX.U&PU"PC<SS7=NQ\HE<,L!R2^X_P!T<CKS@&EI]M?:#XPB\0Q:7<M9>(=Q
MO+6*U<O8/QMD( XW  2#NP!&0*]*HH \QT^Z3[9\1;'[#=74MQ>,D<<5NSK*
M6MD4(6 VK_P(@8.?6JMMI%_X+U'2_P"T='O]8L'T:UL9)-/1I7MYX=W&T$'8
M=YY]J] T?P]!HM]J=Y%>74SZC/\ :)EF*;0^T+E=JC'"@?A6K%+'/$LL,B21
MN,JZ,""/8B@#S_\ LYK7Q1X)-GH4UC96JWIDAA@)2V$JC8&*@J&)ZX) .><<
MU0M]+2ZT_P 06NJ:9K"0W7B22YAGMH)4FA4HNR=,+GAEQP._3U]2IC2QK*L3
M2()'!*H6Y;'7 H \JNK'Q0FD6=]=6]UK<>D:PTB+Y/DW-Y:&$Q[RG!,BER!T
M+!<_75N+#2=7T:ZG/A;5;*VO;B 23)"\=Z&3)6;:N7 0[<9Y^]P1C/H=% '+
M>"8]9@M=0M]5N9KR"*ZVV5Y<P>3-/%L7F1< Y!RNX@$[<],5#XW@NO[0\+W\
M%G<W45EJ@DG6WC+NJ&*1=V!VRPS77T4 >?Z6MYH.I^++74=-O;B+4[EKZTDB
M@:42AXU4PL5!"E2H'S$#!SG%=#X)T:Y\/>"M(TF\</<VMLJ2D'(#=2 >X&<?
MA6_10!Q<OG:5\3KW4[BRO'LKK2H8(IK>V>8&1))"5.P$J<,.N ?6N57P]JOA
MFWT+59=&N;ZUCN+Y[S3[/YY;9+F173:JGYBNT @>IQZUZ]10!A^%X;9;&XN;
M31GTJ*ZF,OE2ILED) !>1<G#$COS@#/H,KQ1%._CCP=<1VES-!:SW#SR10,Z
MQ!X6122!@?,1_.NQHH \WU..;2/'.L2ZEX=U'5M+U=(6@EL8S+Y;*@1HY%!&
M < @GCD^^+<UA+;>,_!9@TF6VM+*TNTE2WA9HK;S%CV)N Q_"1QQQ[BN]ILD
MD<,;22NJ1J,LS'  ]2: /)+W3]0F^&?C"Q32[\W5YK%Q-;P_99-TB/.'5@,=
M-H)]JZJX2>?XIZ=?1VEV;3^QYH#.;=PBNTD;*I)'!PIZ]*Z^&>*YA6:"5)8G
M&5=&#*?H14E 'D^FZ-?:C\,M"\)2:=>6^I6UQ!]H>:W9$MQ'*'9Q(1M;(&!M
M)SN],XEU>WU&U3XBZ:NCZC<2ZK$TUG)!;EHY%-L$(W]-P92-O4]@:]3HH \^
MTV&['CCPW<RZ=>QQ1:"]M*[V[;8Y2T9"LP& <*W?ZU7O=.O[?Q-)J/AY=3M;
MN74D6^T^:!GL[N/> 9PQ&U&V#=N!SE<8)(SZ310!Y79V<EI=:OX=UGPE>ZHU
MS?SW%K<B/?:SQRR&1?-8G"%2><CMQDXJR@U'1+[QIIMWI6H7(U5Y+JQNK:W:
M5) T(3RRPX0KM &[ KTNB@# \#Q3V_@70;:ZMIK:XM[""&2*9=K*RH%.1]17
M*^,$U2^O?%.G#2+]HY])V6,EC#A;IS&^?-D&#\I. A."">&)%>DT4 ><Z7'=
MMXL\(7,FF7\,5OHLEO,TELP$4C>7@,0,#.QOIWQ5=K>33/$6OZ9K'A;4=7MM
M3NS<VEQ;1^9#(KJH,4F2 F"N,MQC]?3J* (;2+[/900^7''Y<:ILC^ZN!C ]
MA4U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8D)2W/2-70>=_P!]MR?H* +*16.N>+8=22&&XCTZS!AFV@DR3888/8JBJ?\
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M7Y3D';][KZX^HI>)=<FUOPIXGMK728+B&QM9(;LS3XQ-Y6]E0;2&*!AR2O/
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M?E) ^;J ?IZ:'A;7_P#A)-#2_:U-K,)9()H"^_RY(W*, V!D9'7%9JZ%J_\
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M3N([D=5V80X*'(4D#Y>#GK69HD.JWE[X^L;".TV7.IO$)II6!B9H(P3M"G<
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MK5FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQFO;R416T"%Y)""0JCJ>*XF3Q+XGU.REU3P_IS720WSP):,L06:*.4QN2[2
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M*^\/B>UTVSL9H[*RL98Y%MUA#*XCY13R,*" >.X%;*G<@8J5R,X/44M '/\
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MV'V5)QM<I*Y? Z ,6+ #)X! I!X.T$:!_80L3_9>0?LOGR;/O;O[W3/..F:
M,!K&!OC:\I,P;^PDEXG<#<)R.@.,8'3I[53\*ZA>6?B+3=+U^&[CU&6"7[/?
MPW+2VFIC 8OC/R. ,@$<#..,"NUF\/:5<:G:ZE-:"2]M8_*BF9V+!<YP>?FY
M&><X//6F:=X:TG2FMVM+9U^S(8[<23R2"%3C(0,Q"\ #C''% &+XGEGA\>>"
MQ%<W$<<]S<QS1+*PCD MW8;ES@X/M6/;ZA>:9XMM8==ANC%=:G*+#5K6Y9X)
M]V\)!-'GY"H.!P1E ?4UW%[HFGZC?V=]=0L]S9,6MW$KKY9(P2 "!R./IQ4,
M'AK2;:X6>.V?<D[7"(\\C1I*Q)+JA8J#EFY [F@#!\>>>-2\*+!>W=L+C5UM
MY?L\S('0Q2,00.#RHYQQVKE]2UB^\*V7CJUL;R[^S65Y9+!)/,TSVJ3K'YC!
MG)/&XD9/!->F:CHFGZM-:2WL+2/:2>= 1*Z^6_3<-I'."1GW-1+X:TA9]1F-
MF)'U)0MX)79UG & &5B1P..G3B@#F]1AET?QYX=L]/GNFL-6BN8+V![AW&$C
MW+*I))5L\%@>=P[XH^$EI%;^ +-XS)F2:X!#2LP&VXE P"<#\,9[UTVF^']-
MTET>T@<.D?DQM+,\ICCX^12Y.U>!P,#@>@IVE:%IFB"<:;:);B>0R2!22"Q)
M)QD\#))P,#DT <.U_>:9XLCBUR&[:TN]59;#5K.Y9HB68JMM-'GY<?=S@C(!
MZY-96HW]]#\-/'$ZZE?+/8ZU<1VTOVJ3?$HD0*H;.<8)XSCFO2(_#6DQ77VA
M;9RWVAKH(T\C1B9B27"%MH;))SCJ<U4N_ WAJ_GOIKK2TD:^(:Y4R.$=N/FV
M@X#<#+  GN>: .=O-&AUSXK:M:W%S>0Q?V+;$_9;AH6)\V7!+*0>/3./4&L:
MUU#5G\+^%'N=2O)98O$PL/M'G,OVN!99%!< X?.P<GT]S7HMQX8TBYNH[IK5
MHKB.'R!+;SR0L8^H1BC#<O)X.:QM1T>\U34-+TV/25L-,TC48;N&X25"DL<:
M-A50?,IW$#!&, G/:@#%==1\73^)X(=773[S3[\P0R":16M$55*/L#!2&^8D
MGKDCH !9LI'\5ZYXETB^U.>*:R@MX[5[:5H=@DA#&X4 C)WDXSG 4#N<]%J/
M@GPWJVLIJ]]I,,U\H"F4EAO Z!P" X_W@:=J_@WP]KVHPW^I:9%/=1+L67<R
MDKUVMM(W+[-D4 <O;6,$OQ9TN5KN>Z;_ (1SS/M/G,OG%9HP&(4@8/4K]TYZ
M5;\=64-UXJ\%&4R@G49(\I,Z8'D2'C:1@Y Y'-=1=:!I5YJ-GJ$]E&UU9J5@
MDY&Q20<8'!&0#@YP1FG:MHFFZY%!'J5JLZP2B:++%2C@$9!!!Z$CWS0!QMBT
MGB<^,5N[RZMKG3KQ[6T\JX>,VT:1*4D !Y+,68DYR..G%=)X)U.]UKP1HVI:
MBNV[N;5))>,;B1][';/7\:FN?"VC7=Y+=R6>V::(0S&*5XQ,@X"R*I < <88
M'CCI6IY,?D>0J[(]NP!#MP,8XQT_"@#R#399[?X/^$9K>YN('&K0(WDRL@=6
MNR&5@#R".QKJ([G_ (2'6?%\-Y<W$9TIE@MH8KAXO*4PA_-^4C+%B<$] HQW
MSO#P;H*Z3;Z4MBPL;:430PB>0!'!W CYNQY^O-0ZWX1T:^N)=6;21<:HMN8D
M99"ID&. P+!6_P"!9H X_P .W]]+-\,I9+Z[=KZPN#=!IW(G(A# N,X8@DG)
MYJIJEY>K\.OB%)'J5\LECJTZ6TBW<F^)0L7RALYV_,>.G-=7X=\(07'@;P_I
MOB'362\TR)%7$VUHW"[25>-LX(]^>XK5/@KP[]@OK$:7$MK?2>9<Q(S*)3QU
MP>G XZ<4 9/VLZS\1[S0KR65+6RTR*>*!)6C\YI&8-(2I!.W"@>A)/7&.8\+
M-'%X3T+3?MEVTLNLWRI:1OAKP)),2)'R"%'#$\YQC!SBO0K_ ,*:-J=Q9W%U
M:,UQ9KL@G6>1)57NI=6#,/8DBJP\">&5LX;5-)B2*"<W,7ENZLDASDA@<C.3
MQG% 'G.H&>^^'^H0W\LTAL?%2VT(^TN_EH+E %W'!8 ,0">1QTKL;MIM/^)^
ME6]O/=O;G1[ES;-<.ZLR/&%.&)^;DC/6MD>"O#@L+ZQ728%M;^02W$:Y =P0
M01@_+@@'C'-64\.:5%J-MJ"6I6ZM8C#"XE?Y4/48S@Y/)SU/)H \XDU2_G^$
M-OXVMKVY.NJZW!Q,VQV,VQH#'G;MP2H7'4 ]>:OW5E)J7B7QY;SZCJ:06MG;
M3011WTB"*1HI&RN"".1G;]WU!P,=K%X5T6"Z>XBLMI>?[2T0E?RC+G._RL[-
MV><XSGGK3CX:THW>H77V=Q/J*".[<3R#S5 P ?F[ D#'0$T 9>DZS??\*IM-
M;8&ZOQHRW1!Y,L@AW<_4_P ZYB>ZN[7P9X2\3:??W4^I7,]F+G=.S+=B8@2(
M4SM'+$C ^7;QBO1].TZUTG3X;"RB\JUA4)''N+!5'0#))Q[51LO"VBZ=+'):
M67EB*1I8HO-<Q1.<Y9(R=J'D_= ZGU- '+>&M,;4?%WB.2YU/5&73=74VT7V
MV38H,*$J1GYE);H>!VQDYNZ]>SWGCRS\/-,D=O+ITERD;RO&)Y-X4C*$$E5Y
MQG^(GL".CT_0]/TN\N[NSA:.>\??<,97;S&Z9()(SCCZ5#KWA?1?$\,,6L6"
M7(@??$VYD>,_[+*01^![4 <;J>C:Q8^"X4A\17-[K>FWG^B&.:11=$-N%M(-
MWS\?*6/3&20 U,G\2"W^&L>MVU_<J]]?0QZA-+(VZRWS!9E 8GR]@)4 =.#R
M>:[JWT#2[4V/V>U$0L RVRH[!4W##< X).3DG)YJ"/PIHD46I1"P1HM39GO(
MY'9TF8]25)(S[_2@#G_$FDPZ9H7BF6WU.Y:*ZT2<BPDE,B*5C8&12Q)!.X ^
MO6LO28I-)U[P"T%[>%=3T^5+N.6X9HW"0*Z80G:N#_= ZFNNL?!7A[3=)NM+
MM-.$=I=)Y<Z>:Y:1,$;2Q;=MP2,9QR?6K"^&-(6;39A;/YFF*4LV,\A\D$8(
M'S=QQSVXZ4 >?VFH7 U#PCJ%E?W=S;7^J30O?33LIO(V65O]5DJ$&T;>A&WH
M,U3U&.Z_X17Q_J U;51<:3JDS6+"^DQ#MCB8#K\PYQAL@#H!DY[^+P#X6A6)
M4T>$+#/]HB7<Q$;\YVC/"G)RH^4^E6&\(:&]IJ%HUFQM]1D,MW&;B3$S'J6^
M;O@?D* ,/4[BYG\8P0W_ -KDTF71R\<=EYA9)]_S,PC^8':1M8\ AL<UC6DF
MN:78>#=$UJ\E6\U0SO>/=7+L6D504B+ALC(.=H."5QSD@W?$'A1[OQ'YUUX7
M.KV"6L=O:2V^H&&:$ DL'+.I8$G@[C@#IR<[%GX(TVZ\-OI&LV7GV;S^?%:S
M7+S&VX "K*3NSD$Y!XW$#B@"WX4TV]TA-0L[O51?*+DR0QDLQM48 B(LQ)8#
MJ,\@$=L5RD$8TKQE\0=2M4N);FQLK:XAC-Q(P=_)E."-WS#(X!SCMBN_TK2+
M#0[!;+3;9;>W4D[0222>I).23[DYJ*UT'3;/5;K5(('6\N]HGD,SGS-HPN03
M@X!....U ' SW5W:>#_"/B73K^ZGU&ZGLUN=T[,MV)L"1"F=HY8D8'RXXP*O
M^&=,;4?%GB.6YU/5&73=84VT7VV38H,*$J1GYE^;H>!VQDYZFQ\+:+ITL;VE
MEY8BD:6*+S7,43MG+)&3M0\G[H'4^IJ?3]#T_2[N[NK.%HYKQ_,N&,KMYC=,
MD$D9QQ]* ,+Q 5O/%5KIJ7%Q/-]@EE-@DQAB"EE43/(O.1RJ@!N23QC-<?IM
M[J.J>'_AM-<:K?B6]F>&Y>.Y93,HBD^]SR?E'S=>^<\UZ3J/AO1]5U&WU"^L
M4FNK=#''(6(^0\E6 .&7V.156V\%>'K.*RBMM.$*6,K36PCE=?+<]6&&ZXXY
M[<=* .!O-9OO#6G>+;&UO;K[+:ZQ:6\<\T[2O:PS+$9"'<D\;FQD\$YKI+Z"
M72OB#HNFV<UT^FZO:727ENUP[!#&JE95).5)W;201G([\UT2^&-&!U+=9+(-
M2_X_%E=I%FXQ\P8D=./I4VG:%IVE2"2UAD\P1B)9)IGF94'.T%R2%]AQP* /
M)+"T1/@SX6,4DR/-J]IEO,+;3]J(!4-D#\!CUK9U34;WPEJ/C>/3;F[DCM])
M@O85N)WG\J5C(K.N\D] &(Z<5V:^"/#B6@M$TU4@%P+D1I*Z@2 E@1AN,$D@
M= 22*NKX?TM=2N-0^S%KJYA$$SR2.XDC&<*5)((Y/&.Y]: .:L]&N?[4L]2@
MUX#3KRT>)X(KB5_M65W+(K,WRL "=PZBH_A=8//X3TC7KK4=1NKVYLMDOGW3
MNA^<D'83C=QC/7KGK6YI'@CPYH)N#I>FK:F=2CLDKY"DY(4EOD!/9<=!6GI.
MD6.AZ='I^FP>1:1YV1;V8+GL,DX'M0!P*:!#K_CKQS#-J%_9A/L91[2Y:$HW
MD<.2I&<>AR/:J/AS7M6\1CPWIFJW"B2ZT9KK]Y(\7VIQ)LW90@D[ &Q_MDXX
M&/0KOPQH][?SWLUJPGN$$=P8YGC$Z@8 D56 <8X^8'CCI3=;\*:%XBMK>WU3
M3HIX[8Y@P3&T7^ZRD$#@< ]A0!P]U8ZGI]QX/TNY\1WEVYU.>VFF@G="\?E2
M,$?D[F7@;NO'4$56GUB[\-V?BJRAOKA;*UUJSMTFN9WD:VAF$1D^=B6 ^9L'
M.1NR*]"/A;12NG*+((NG'=:+'(Z"(]R ".3DY)Y.3ZTH\+Z-_P 3(-8K(NI_
M\?BRNSK-QCD,2.F!^% &-8:#=6NLWWGZOG3[VSW+I\4\I*NK#,J.6RH((! Q
MG@UQ5K$^G_L_:7?6=U>07'^B'='=2#[UPB$8W8 *L1@<5Z3I'A#0M!LI[32[
M'[-%. LA65RY Z#>6W #)P <#)H_X0_0CH2:)]B;^S$8,MMY\FT$'<,?-T!Y
MQZT 8$%A ?C7?RYF#_V+!+Q.X!;SI!R,X(P!QT]J[I6##*D$>HK-F\/Z7/JL
M&J2V:R7T$/DQS,[9V9R >?FP>1G.#S4'A?P[;>&-(-A:1K%"96E6%'9DBW?P
MJ6Y(XZGJ23@9Q0!P3ZA<"X\.:II]_=W,%WXA:W>^EG9?M,;&4&,1 E?+7: "
M<'*9 YS46I6\\VG?$:X;5=5#Z5*TMELOI5$++;I(,8/(SV.1Z"NX_P"$!\+8
MQ_8\.T7/VI5+-A),DY49PH))R!@'N*M-X3T5HM1B-HY34CF\7SY,3<8Y^;TX
M^G'2@#F]/U.3Q#XT32=0FD6"#18+Q(4D:/SI)"0\AVD$A<  = 23UQBQ\*XA
M#X->(.[A-1O%W.VYCB=^2>YK:NO!^A7AL6FLF\RP3R[:5)Y$DC3^[O5@Q7V)
M(JYI&AZ9H%J]MI=G':PO(TC*F>6)R3S0!RWPR#7_ (,NIKEI!<7>HWCW#*Y5
M@YF8=1R"  /;%<W97]_+\+O M\^H7ANI=6M$FE^T/F96G(8/S\P/OFO0=-T3
M^RKS4H803IVH3-=$*Y5H96 W@$8.UB-V1R"3VQA!X.T%=*M-,6R9;*SE$]O"
M)Y (W!R&'S=CR/0T 8WC.22W\9>!YX,^<U_- P'>-X6W_A\H/X"H_'ME#=>(
M_!9D,H)U1H\I,Z8!AD/&TC!X'/6NA?1S>^);75;H 1Z?')'9QYR=SX#R'_@(
MV@>A;/7 LZMHFG:Y##%J5JLZP2B:++%2CC(!!!!Z$C\: /.[[34O/$'Q'<W5
M[";:UMI(C;W+Q$.MLQ5B5(+8(Z$D>H-6+'5[W7[_ ,/:5=W*?Z5X=AORKRO'
M]HE; <Y0@DJ #C_:)[ CM!X6T<2:A(MJRMJ*".ZVSR#S5 P 0&X ' QT''2J
MU_X'\-ZGIECI]YIBRV]B,6H,KAH1C&%<-N P!QG' ]* '^&+>ZTGPV+;4]8&
MHRVC2*]X0<[02<,23DJ."?;GG-<3I%Y=)K_@B:WO;R:TU,72RW5Q.P>^7R6=
M7:+)5!D KSD#C Z5Z9:6%I8V$=C:V\<5K&FQ8E7Y0/3%8EMX"\+VAM3!I$2F
MTD,MOEW/E$@@A<GA>3\O3GI0!YWJ NX_ 7C'5EU;5/MNDZS<BRD^VR?N@DB
M C.'&.,-GBNEO&N/#GC]197%[<K<Z+=7,MO/</*LLT;(5(4G"GYB,* ,'I72
MMX.T)]-O=.:R9K2^F,]S$9Y")7)R6;YNI/7UP*M?V!IO]J6^IF&1KVVB,44K
M3R$JAZCEL'.!G/7% 'GDM]>Q_#;P_P"+[&_N9M8DEM7F_?,5N3+(J21%,[<9
M8@ #Y=O&*LW5U=1V7Q0C%]>*+%#):G[2^8#]D#C8<Y7YN<#BNUM?"NBV4XEM
MK+RPLQG2+S7,22'.76,G8K<GD =345_X.T#4[Z[O;S3EDGNX?)N#YC@2KM*C
M<H."0#@-C([$4 <C%'/J7BOPK;3ZCJ(M[S0'EN(X[N1!(P\KG@Y!^8Y(P3Z]
M:PYD>^\(Z/!>7-U/]B\8K90R27#[_*6Z*@%LY) X!/([&O3X?"VC6UU:7,%F
M8IK.$V]NR2NOEQGJH .,' _*HCX.T$Z9-IK6&ZTFG^TNC3.?WN[=O!W9#9YR
M"* -J*-884B0L510HW,6.!ZD\D^YI],AACMX4AA0)'&H55'0 =!3Z "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH "0 23@"JUOJ-C=QR26U[;S)%_K&CE5@GU(/%<O\3I+J+P3-+ CO
M EQ UZJ#)-L)%,HP.HVYS[9JM=+#=_$[P_>Z-+#)"^G7 U%X6!1H,+Y.[''W
MRVWV#>AH L:7XDU+Q'J$TFC7.F?9;34GM9[>;)DDA0A7E5E/!SG:-N".]=9=
M7EM8P&>[N(;>$<&25PBC\37&?#,VKV?B!H#"Q&O7PRF/N^9D=.V,5!XLU6'2
M?'^DOJ^HR:=I4UC+%!=$)Y:W!=20Q=6"Y0<'CH1GDT =NVHV*"(O>VZB8 QD
MRJ-X/<<\_A2_;[/9,_VN#9!Q*WF#$?\ O<\?C7G-QH.@S^";71M$O)IIY;UI
M]$N9'7*3!MYEC(  B4[B<#!&0,Y7.5K5_8ZK\$O$,$T$2:O8LRZE$Y#.MT)!
MNDS_ +74$=C@=,4 >N0WMI<3RP0W4,DT)Q+&D@+(?]H#D?C38]0LI;Q[..\M
MWNHQEX5D!=1[KG(KSS5=(MH?'6@W?A*&WCNFT^\:Y:U Q)$8QY3.1US(1@GD
MX/7%4?"<OAO7K'PP)=8NWUO36 .G#REFBEV[9A(NP.4^\6+'GU)- 'J!U.P$
MD<9OK8/(YC1?-7+..J@9Y(]*6;4;*VG2">\MXIG&5CDE56;Z G)KQ6>UTJ'X
M7^(KV&*T2XM_$3^1,H7=&!>KM"GL-I/ [$^M=)XGN;C2]8UO4[":SU;3_M%L
M-3TB;B:-]D?EO PZD@H0I')!QS0!Z-/J%E:SQ07%Y;PRRG$<<D@5G/L">:+C
M4+*TF2&YO+>&5QE4DE52P]@3S7EUW<Z+>:MXNT#Q;K,NGRW%T'CA81C[1;E$
M$1B+(6)!!&%.0>@R34GB"2YTB35=0L9X=4M(H+:/5M'U @7. B['C<?QD,."
M,%@<<T >K56CU"SGN9;6"\MY+F(?/$L@9D^J@Y%0:V;QO#NHG3@POC:2_9P.
MHDV';^.<5Y[X3G\,ZZ?#%S!K-U+J^GQE4L$\I)(#LVRK*H0-L&#DDX)QU)&0
M#H=(U_6-5\.:],UQIMK?6.HW-G%/*C+ !$P4,PW9YY[]ZZFXO;:RB62\NH(%
M/&Z1P@)]LFO'-4:TN/A)\0BYAD":U>LA)!PWFC:1[^E=1XAUG3]&^(6FZA>:
MA9&";1Y81!<W"1*N9%(=6<[3NQ@C.<+GGI0!V6J7%P+2&2PO+*%C/&&DN>49
M"PW*,$?,1P/>L:Q\3RKXO\1:;JMQ9066GK:M;RG]V3YHD)#%FP3\HQC%<+<Z
M/I.B?##PY%#<Z9=/'K5JYN[1D9"[7 +!7'7:ORYZX7M6W]CT"Z^)/C!=?AL9
M(38V3(+P+C9MD#LN[TXR1TH Z7Q#KE]I>N>&[:V^SM:ZE>&WFWH2X'ELX*D'
M ^[Z&MN74+*"[CM9;RWCN9?]7"\@#O\ 09R:\HTV*XT[0OAE;:B[QS+J<GEK
M.<.(BDWE@@\\(4&.W H\_1-4'B/0/$^LW5GJ/]JR2"T3REFF7S-UNT)*%V.T
M(!@YXQP* /7G=(XVDD95102S,< #U-<?H_B34O$=T;O2KG3/L$%_+;SVTN?-
M,*,4\U6!ZDC(!7&#U[UU^!Y.V3E=N&WX_6O&8YMGPIU.XL566"/7IFOA  6-
MJ+LEQQSMV]?]G/:@#V&UO[.^5VM+N"X5#AS#('"GT.#Q1#J%E<RB*"[@ED*;
MPB2!CMSC. >F>,^M<5?1VM]\2M#N],>WFM)-,N!J;(0T;V_R^3O['YBV,]@W
M;-1_"'3=+7P%H^I6]I:_;3#)$]RJ R%?,/RENN.!Q["@#NY[RUM<?:+F&'(+
M#S'"Y &2>?0<FHI=4T^!8&FO[6,7&/)+S*/,STVY//4=*XKQ=9Z9=_$[P;%>
MP6LOG17RNDJ@^8!&FT,#]X9S@'O6-=/H-OX@\4>&O$6I?V/:3Q0I9Q%8DBDM
M/)50L1=#@JX?A3P3D#- 'I4LMV-=MHTNK-;1H7,D#@^<[@C#+SC:!G/'<5+_
M &GI_F11_;K;?*Q2-?-7+L.H SR1Z5P45M8VOQ)\+P+N).@3Q,;K'G.H,042
M>K8!SGWKDGM-)3X07UTD5JLT6O$13+@-&!?#&UNH^4GIV)H ]CO-21M/U!M.
MNK66ZM8V+*6WA& )PX4@CIZBJ'A+Q$FN>'=(N;JXM5U*[LH[F2WC< C<H)(4
MDG%<Q<06-E\3[ZUL(K>!9?##DQ0*%#L)3M.!U."?PKGM-TK3+GP1X!GT>&V_
MM];FT836X'FA5QY^\CG:%!# \=!Z"@#U[^TK#R#/]MMO)#;#)YJ[0WIG.,TM
MQJ%E:9^T7EO#A-Y\R55PN0,\GID@9]Z\@UF^L;3PC\3]-GN(8[V34)Y4MF(\
MQE:*(A@O4C@G/L36VMEH.M?%6U2X@L+V&X\-!BKA764^< "1T)Q^E 'HAU&Q
M6[^R&\MQ<G'[DRKOYZ?+G-#ZA91WJ6;WENMTXRL!E =A[+G)KSCSKC2=?C:U
MDL]8T.ZUTQF C;=:?=%RI*D?>0$$X."%/I6;I\VBZO8W>B^(=9N[?7;?5I)6
ML8_*2>283%HFB)3>P*[0"#@#CA: /6)]3L+7?]HOK:+8P5_,E5=I/0')X)[4
M\7MHUX;-;J$W2KO,(D&\+Z[>N/>O+9K#1Y=1^*8DMK-Q'$C ,JD(3: DCT);
MJ?446<=A;3?"R[A6WCN9XR)9EP'DW6AW;CU.6QU[T >H'4+);U;)KRW%VPR(
M#*-Y'KMSFDEU.P@)$U];1D.(R'E48<\A>3U/I7D^C3:+K.FII6O:S=P^(+/5
M7E?3T\I)VN1*S*T>4WL"".<X ZD 4R_L-'DTCXK.UM9L\+2&(E5_=M]F4Y7T
M.\=NI'M0!ZA/XCTNW\0P:')=Q+?S0M.(RX!"AE49]R6X'?!]*U:\UM;NS3XB
M^&KJ[FA'VKPZ5CDD(_>R^9"0%/\ $WTYKN]*UK3=<@EGTR]ANHH96AD:)LA7
M7JI]^1^= $]W?6EA&)+RZ@MT)P&FD" GTR:?)=6\21O)/$BR$!"S@!B>@'K7
M%K=+!\6M0@U<HL$^E1C33-@(RAF\]1GC<25)'7 '85Q0L;>/0_#$5ZL36)\7
MNFG>;CFR/F[%!/\  >,#H05[8H ]JM[B"[@6>VFCFA?[LD;!E/T(JA:7<T7]
MI2ZC?V#00W!$;1';Y,>U3MD).-W)/;@BK=C86>F6B6EA:PVMLA)2*% B+DDG
M ' R23^->,ZQ'IX^'OQ/B5+8)'J\C1H N%;9" 0.QSG]: /9XKRUGN);>&YA
MDFAQYL:2 LF>F0.1^-9/C/5KW0O!VJ:MI_D&YL[=IE$Z%E.!G& 0?UKF9(+.
MP^*VF)I*6D$L^A7(&T +(WF1E"V.6YR?7K1XQ/B./X<>*#XAFT@QFP<0_84D
M4[B#UWD^V,4 =O;:A \=LDMQ"MS-$K^5O 8Y'8=:@T^[F2TGDU._L),7+HDD
M!VHJ[L(K9)^<# /O7(>#-4B76[G2M=^SG6Y(%EM;G(V75F?N"//W=O(9>Y^;
MG.:Y"=-./PQU%<6XCB\5L(L$#8/MB_=]/EST[4 >U07EK=/*EO<PS-"VR01N
M&*-Z''0US>N>*7L_$F@Z=875C-'>7K6UW'G=+'B-V&,-\O*XY%<IKJ-IGB_Q
M3!X;BB@O&\++)%%:J%)E$D@!"CJP!&/PJ&;5_#ER/AK/I]U9 0W2I@.H>(&!
MP5;N#N !SWH [[QIJU[H/@[5-6T_R#<V<#3*)T+*<=L C^=:5CJ-M>*(TN8)
M+E(U:6)'!9,C/(SD?C6%\259_AKXB55+$V,O &>U<W+I>GGQ3X0O/"\5HMXL
M,SW4MKMVM;F(X,A7KF0K@GJ<GL: /1%U"R:]:R6\MS=J,F 2C>!Z[<YI&U.P
M1U1[ZV5VD\E5,J@E_P"Z.?O<CCKS7E7A2;0=<TOPY;:AK-X/$.FW:L^G#RDG
M6Y!(E+#9O*'+,Q)P1U.:R]0L])3X;_$"ZB@M%FM]<G\F157=%B2,J%/\/.>E
M 'M=WJ%E8!#>7=O;^8=J>=($W'T&3S6)XC\3Q:3J6DZ5'<VT-UJ4SIYLQ!6%
M%C9RQ&1G.T*.1R?;!Y'5M2TK_A-O$.F^)=8.G6=_9PBS>3RA%/;["'57=#R'
M+' (ZBI;ZWTVRU_X;VBN[0HUQ'&;W'FM&+9@F[('J.H[CO0!T^DW^KV2ZA+X
MHU/1!!;1AP;3<A1,M^\DW$X# +QZ@\FM#3_$>E:CH=MJ\=[!':7$:.'DD5=N
MY0P5N>&P>E<4(K4^-_B#!#'#ODTJV9HT RS[)LG'<]/TJEI+K?\ @[P0WA_6
M["VUFUL5\J.=0\$[B&-9(GP<AP".GS#F@#U2*:*>)989$DC;HR,"#^(I9)8X
M8FDE=4C499F. !ZDUR/A3Q1IAT'1H;R.WTF[OY9XH++S,J[I(P?RSW4GD>S#
M%2?$V&*;X:>(1+&CA;*1UW+G# <$>XH Z2&_L[BXDMX;N"2>, O&D@+*#T)
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MA)0NQVA ,'/&.!5]=3L5U+X@6'B":&.^D7$"73 >;:>3B,)G[PW;\@?Q-ZT
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MD X^E &Q);PS,&EAC<CH64'%(UM;O<)<-!&TR#"R% 64>QZBLRS\2V%WK/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $9
M0RE6 ((P0>]9^C:#I7AZS-GI%A!96Y8N4A7 +'N?4UHT4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% &=I.@:3H*SKI6GV]H+B0RS>4F"['N3_G%:-%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1:=KS3C3WF<0!"S/ Z*P<94J6 ##'<9JEJGBN+3O%FF:";6Y9[R*24RI [J
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M1@RGH5.0:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5"^'BQN9B  .>?YUHV7Q!L;G26GN+9[&_2^.G265S(JE+@#<07Z;=H+;O0<
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MG8 =\<UI4BDE02-I(Y'I2T %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQT-7Z* "J.JZ-INN6JVNJV-O>6ZR"01SH'4,.AP?J?SJ]10 BJJ($10JJ,
M8 %+110 4444 %%%% !1110 4444 4=2T?3]7\C[?;B?[/()8@S$;''1A@_>
M'8]15X#  ]*** "H+VSM]0LY;2ZC\RWE4I)&20&4]0<=CZ5/10!!965OIUG%
M:6D?E6\*A(XP20BCH!GH!Z5/110 4444 %%%% !1110 4444 %%%% !1110
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MD1^7&3\L>!UVCC=U-7J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!<@H7+9W?(  <[L'H,9.*H:O:^*?$G@K6;.[TBVL+F[M&MH;6.Z67+,,%V?
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M'>'WCRR"S<[E !SWJ#54U;_A._ <NHW-M)YDMRS)#"4\M_LS9 )8Y7Z\\>^
M =]]DMO^?>+_ +X%'V2V_P"?>+_O@5Q%OXJ\1:K:Z?J^D:=]ILKBZVO;&(*1
M;[BOF"0O]\8W8QCMVR9-,UKQ5J>LZU%$VF&VTG4# T8A</<1^4KA5.["MEAR
M<@YZ#'(!V?V2V_Y]XO\ O@4?9+;_ )]XO^^!7#Z%XMN_$-C<M:ZK:)=PV+M=
M6DEJT=Q97 VX!1FR5^\/J!R<XJ+PUJNM0_#_ ,,7,M[:%;Q(S<74R?/&K(2
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MO53F-!@#=TR<Y[5"VH:K??$K0UBO8XK.?1I+K[.T)8 EXMW.X9;!P#V]#DT
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M<YXDO_$NNWSZS'H%IF?3'6)(I(-XGF\M9"C-O7:/G"\=P3G'% ';,P52S$
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M1QDBM>@#FD\+3Q:QK^H1ZA&#J\,<)C-OD0B-652/FYX8Y_#I5-/!$T6D^&;
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M57=\J@(HQD\#KDYKL:* ,#5_#3:AJ^F:U:W@M-5L%:,2^5OCEC<?,CIN!(R
M1\V0:LZ1H46F/J%Q*XN+S49O.NI2FT.0H15"Y.%"J !D]^3FM:B@#"\,^&8/
M"NB/IMA,S R/(CR@MM!/R+C/(50J]1PO:J.B^$K[0=#TW3+/649;(R@F6TW+
M.CDL5=0XZ$\$$?SSJZ+X@M];EOXHK6]MI;*<P2)=P&,MZ.OJI[&M:@#C/^$
MCATO2[&SODMTL=4.J'%OE6DW,VQ5W#8GSD #)P!SUS;_ .$2GM-4U:ZTG4_L
M<.K?/=0M!YFV7;M,D9W#:Q&,Y##(!Q6BGB"!_%DGATVUPMREG]L\U@OELA?9
MQ@YSG/4#I6O0!R\/@R*RU?0KJPN5@MM'M'M(+8P[MR.%!);<.?D';UZYIFG>
M$]0TJ*86NM(LDVJ2ZDY:TRK>8&W1LN_E<L".01M'6NKHH Q_#GAZW\.VEU#
M5)NKJ2[E\N/RT#OC(1<G:, <9/?UJK-X9FA\3W.O:3?I:7%["D-Y%+!YL<VS
M.Q\!E(8 D9R1CM5M_$$$?BR'P\UM<"XFM7NDF(7RRJLJD=<YRP[5KT <C=^!
M8W\/Z7I%C?&WBL;U+XR20^8\TJR>9EN0.6))Q^&*ZU P10Y!;') P"?I2T4
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MBN[HH XKPSHK:KH/A:[OM0BNK?3[>*>WBBAV_O?*V!G;<=Q4,PP O//:GO\
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M,LL(E$_FR3NTWG#!$GFD[MXP.<]L=.*LV_A^QA%V95DNI;R(0W$MP^]Y(P"
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MQ+<JO $JJ0'&..>HX- '06;R265N\KQ/(T:EVA.48D<E3Z>E34BJ%4*H  &
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M6U0P^'-0U'3);:XDMH))$);<A9 3@[3[5Y'ITEC=> /!EK<30RP0^)WBG1F
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MVWL8K#6E1-TKI(J_-ZEEE _!C7=^'M.;3=(C2=$6[G9KBZV=#,Y+/]0"<#V
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M-0>]@D0;WAW*J[<LH_N9R/7I7544 8-[I>KZAKBBXO;0:$ACE%LL+><\B'<
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MM7N;>[-R<2;" R;=GWAG/7I^59?Q:_TCX>7VF1)YM[J+Q6UI /O2R&12 ![
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MR[# \89"OH5/&*9;:1IMEIYL+6PMH+,Y_P!'BB58^>OR@8JY10!3T[2=.T>
MP:986UG"3DQV\2QKGZ 8J"^\.Z-J5U]JO-,M9KC;L,K1C>5_ND]2/8\5IT4
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M;5'U.YCF2*WE:0(%B2/!8JO/RYZ=ZZ*B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHKE_&NK:GH\.CRZ?/%&EQJMK:SAXM
MS-')(%(!S@<>Q_"@#J**SM7MM2NX%AT[4ET[.2]P(5E<>@4-\OU)STZ<Y&?X
M*OM6U'PW'/K#12W(FEC2XB38MS&KE4E"]@P /ISGO0!T-%%% !1110 4444
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MA:?J<$,<L&FS:A)-I]O*"#%"57C!Y4%@Y /8CN:ZRB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
0 !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tardioagreementa01014.jpg
<TEXT>
begin 644 tardioagreementa01014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6\NFM[Q_DS.!&6R?E^4DCMC@U#X\.MZ!X=GU2V\07JW#W\2)&JQ>7'$\P4*
M4SG:>I)YH ]#HKC/$>FZSIGA[6[RT\27^^.T\VV,@B)BD0,3_!@JWRY!R>#B
MF^'_ !1<ZWHFIZ9J>[3_ !+ID92\BC(!R!E98\]4;J/R],@':T5YQXBU34M/
MTCP3-'K5S =1O;>WO924^='C9F)RN%.1U&*Z;3BK:Q+]BU^741!;?OK5Y(W
M9S^[;*J"#\CCKWH Z&BO,/#6N77BK19#;>([JV\5PL?MFG2[%\LAOFC$;#A<
M<!QST).<BM'7O$L5GX_CT;6M3N-(TZ:T1[&9&$:3S%F#AI"."HVX7(')SG(H
M [ZBLS0K?4+6QDBU*]:]E$[F.X954O&3E,A0!D# . ,D9K3H **X>UO-1M?B
M?J.A7^I7+V5]8+=::#M'E%6VRJ"!DG)##.<"J'@KQ1<3^%?$9U34KB^O=)NI
MHFEPJ-+&!F)D  'S#IQR: /1Z*\\\1SZSH47@RWDURY\^ZU"*TU"7Y,2@HS-
M_#A>1QC'%6O%^J75OXB\*6VG:M)%%>WYM[F.)D;>@0MW!(.1U&* .YHK@+O4
M+I?BK/HT^O7%IIO]D)>(F^-<2F4H<,RDXP.E3:Y=W5G\//$.K:;X@N+HPI--
M:7/R,8S&-K)D+AEWHW4'K0!W-%>:3:YK&DZCX+2UU>;4I=7:-;VPG2-B(V0%
MIE*J&4+[\&M#Q-J-W:_$7P_IPUF>RT^^MKEYU5D W1A=N"RG'6@#NZ*XV]U^
M#PUH6OZ\-8EU:SL8U41.Z'9,!G:&51][S(QWQBK.G:7K&H>'X+V[URZ@U>XA
M$VZ$*(8689"",C#*,X^;)/J.P!U-%>3ZGXXU+4_AC;:[;W+Z;J4&HQV-X(=I
M0-YH23[P/!!R.XS7;:<J3:TOV+Q+/>I;IFYMF>.12KA@ARJ@@Y0]^F?:@#HJ
M**1B%4L<X SP,F@!:*\Q\1^-9]7^'&OZGIKWVF3V-R8D<1M&V%E5#EB,9/S9
M .1Q7;6'BC2M2U6XTV":474$0G*S0/&'B)QO0L '7/&X9% &Q16+!XKTBXU&
MTL5FD66]5GM&DA=$N HR=C$8;CGW'(R*VJ "BLC6/$VDZ#<VEOJ-RT,MV6$"
MB%VWE5+$ J#S@<#J>  <U4L_'/A^]TF\U*.]9(+*40W*30O'+$Y( 4QD;LDD
M #'- '145AGQ=HZ6VJ33330_V6 U[&]N^^%2NX,5 R00"<C(X/H:QM1^)6DP
M6D4MC%>7327-K""+24)MF8 ,&*X;C.-N<D8H [6BL"+4M/N/&45NFH7Z7O\
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MD*QRJY+2;068[<8 P./<UH'2]3/Q%37OLJ?8AI)LR/-&_P PR"3ITQQC.>M
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ME,= R YW=.._&B=&UC7KCP\^MVT%L=(G^U3/%-O$\RH479P,+EBQS@\ 8[T
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M9:1J\6GI:Z>@B^VP3%WND480>65&PXQN))Z<#G( !?'L3>%[?7?[.D$,E_\
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M2S'[P&W /'7IFK_P_P!-NK'PK;3:A<M=7ERJNTSKM+1A0L61V.Q5)']XMZT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 9NK>'](UY8AJNG6]WY1S&TJ
MLA[[3U'X58T_3;+2K46UA:0VT(.=D2!03ZGU/O5JB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH H:IHFEZVD":II]O>+!()8EGC#A6'<9J_110
M4444 %%%% !45S;0WEK+;7,22P3(8Y(W&5=2,$$>A%2T4 5--TRQT>PCL=-M
M(;6UC^Y%"@51Z\"K=%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$%Q(UL8VT:W^:0 =Y-PYZ<%<CT(S7HM% 'C&F7-L/!/PN\R:,2Q:C$'W,-R
M1R@Y] "5'XBK3W6CRWGB3POXLFU!+J[U&2:&T16_TV)F!B,9"Y) "KUXVCTX
M]=HQSF@#A;*:)?C)<Q>8N\:!!'M+Y.X32$KGN0"#^.:[.]LX-1L+BRNHQ);W
M$;12H?XE88(_(U/10!YU\.[350YTS5XW*>&'DL+>9O\ EX)P4D_X#"4 _P"N
MAJZTMNOQN0!XQ(= 9#R,EO/4@?7&3CTKN** /%;:ZB7X-Z;$Q82:9J\+7JE#
M^X O23NXXP.3Z CUKV:WGCNK=)X6W1R#<K8(R/7FI** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *.J6$NHP10QWL]HHE#R/;MM=E /R@]LG&?;-<+HUG?:M
MXH\9:4VO:M%'8201V;K<G,6^'<3S][YN>:](KB?"=K>0>.O&%Y<6-S!;:A/;
MO:RR1X$@2+:WTY'?% %Y=8L+;Q#K&V;4[C4+*PB>XM &\K;EL&-6P"Q.<D<<
M#GBN<U7Q+>:WX)\,ZW";O3Y;G5+'>D;E%=))%RO!^9<''/6M==/O9/B'K]S]
MDF6UNM*AMH9V7"-(ID)&?^!CGI7/IIVL-\,_"^F/HM['>:=>V7G1$*3MA<%W
M&"?EP..Y["@#N=6\46&CI=R3)<RQ62A[R2"+>+=2,Y;OTY(&2!@D8(JS'KEG
M-J5K90B:4W5J;J*=(B83'D#[_3)R"!Z5P]Q8W.E>+M:^V^#VU_3]7E2XMKB.
M&)S&WEK&T<OF$;5^0'/3GZUVEG<3VEW8Z2-):.$6>YI[<*+>%EPOE =1[<=!
M^0!K4=!FB@C(P: .%\'WL_CNRN/$%W=W46GRW,D6GVMM.\(6)&V[W*$,S,0>
M"<#C [U4\9Q:KH/AJZN'UN]:,:M:-;R>;M9(6>)&C8KC</O=>N[G)YJ7P?:W
MW@*UG\.7>FWESIL5Q))I][:1^:#$[%MCJ/F5@2><8/K5KQQ#J>L>%EC@TR<R
M-?VLD<"@&01I*CLS8.!P#@9].YP #9LO%>G:A=:A9K'>PW%E&LLD4UJZ.T;9
MPZ+C+ X(X&<CI5;0-;TN/PII,UC<W]]#=*5M#<$R7%QC).2WL"<G  ZXJFD-
MTOQ.OM5-E=?87T6.W681'#2+*[E0.N<,.WM7)66@ZSIOA#P9=R>'WOY-&6:"
M_P!+=5,C))_&@;Y6*X!Z\Y/O0!TOB?QW''X US5M&$XO;+S+=U>+#VLPX^<'
MTR#GD'CK6]H>EK;3W%]%=:KY=RBJ;2]F9PC+D%UW$E2>,X...E<KXCTV?4OA
MIKL&E>%FTZXU%0L-G'!&DTAR/GDV':#P>IZ#KDX'H,$PFMTE"2)D9VNI5A[$
M4 >;Z+JMFWB/Q7:ZWXEFMHK&^$=LDVHF+9'Y88]6!(R3R<UTP\0V/AW1=+>_
MNKRY@OI52"[D3=GS6)C5V_AX(&3@<5B^&1=Z9XA\67%YHNH&WU"_$UNP@#"1
M!&%SC.1R.AK0OK>77_#L6@SZ+-:65\S6Y5T#&UMTX!;D@.=HV]=N03]W! -U
M/$%BUG>7;F6.VM)6A>1T.'<-M(3'+?-\O'4\#GBJT/BW2VO+ZSNVEL+FRM_M
M4T=VH3$'/[P$$@KP0<'@]<5QKZ5XBOOA[<^'GT_??Z1<1&RDF0)#J,4,JLF1
MT!95P0>_/0\27NCR^+O"^K0Z?X17P_>RV1A$MU#%')))N5A&I0D^7E>2<9R,
M#K0!UB>+M/:^:R>&\BNC:F\BBEAVM-"#@LO/4<?*<-[4L?B_29;31;I'F-OK
M+K'9R>4<,S*6 /=> 3SZ55T;5M6\06_EWGAVZTJ58&2XDN]F"Y&-L6UB67/.
MXX& .N>.,T^QUT>'? VFMX=U!9M%U"+[66\L#"QR*64[N5Y!SQU&,F@#J[/Q
MC#JD?B9+NTO[2TTR5X&FCC8N%$:EF&W)#?,2,#@ 'BK.G^)M*M++PW9I)?S+
MJMN@L9YU+M* F[YW/\6WDYZ\XS6/:6.IV3^.K632[IEOYY;FVF0*4E#P(BJ.
M<[MP/; [FFS>']0O/A)I%K#;O#KND6MM/;1N,,MS H^7WW89?3#4 =;+KUE
M]XLWFH+21(G;9D-(^-J+CEF.Y>!ZBFZ7XAL]4U"\TY5FM[^S"F:VG3:X5ONL
M,$AE.#R":YKQ)H&JW7@RUDM[.&[U6&]CU.XLI&&VX8-EXLGC !V@GLJUJ>%O
M)NIY;^'PG_868Q&S3V\<<\ISG'R$_(/?J3T&.0"IJVM7>H_$&S\(6<[VL*V3
M:A?3Q'$C)NV+&I_AR3DD<XZ$5!XCU"?P1JFB7<-U<SZ5J%\FGW5O<S-,8VD!
MV2HSDL,$'(R00>@/-3ZQHEY8>/[+Q?86[W49LVT^_MX\>9Y>[>LB _>(;J.N
M.F>E,U_39_&NIZ+;+:W%OI.GWJ7]Q/<1F(RN@.R-$;#=3DD@# XS0!3O+^;Q
M%XSUO0I6U>UM[.S@,$ED[1/'(QD)DR#S]Q0N<C@\<FLNVOEUW1]<U'5]2\16
M*:7?W"&YLW="((@$*%5R,D98G;D'D$8KI=+ANH/B5XAOI;*Y2SN;6UBAG,9V
MNT?F;@._\0ZCGM61I]AJ*^!_&UE)IMVEU?W6H26L31\RK-GRR.PSGOC'>@#J
M[?6[*VT[2XK<W5Y+<VJRV\7WYY(PJY=B2!W7))')QU-%GXMTO4=+L[^P>6Y%
MXSI!#''B1F3(<%3C;M(().!TYY&>0C@UKP_J7AS7HM&O+^V714TR]M8 OGV[
MJ0P8*Q&X9!!P??TJQXEM-6DO=!\1GPV+Z"V^T176D@(\J12["' )VLX* D _
MQ8!/)H VV^(&@)I\-X\MPJR7W]GLAMW+17&<%' 'RD>_7MFMK2=4BUBP6\A@
MNH%+LGEW4#1."I(.5;GM7#:QI\]SI.D3:=X7?3U_MVVOGM88$601(06DE"';
MN]LDXQWR!Z,#D \\^HH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@>.O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !14-Y=16-E/=SMMA@C:5SZ*HR?T%<[8ZLVDP0:9):7%WJS6S:A<P0LFY=[D
MMC<PS\Q8 #L.W&0#J**PK^Y_M-]&M8@Z+=.MY(IX811X?G_@9B!'H36K?0K/
M8SQ.6"LAR4<J1]".10!8HKSGX?:]]B^&_AJ>\-[?ZAJCM$FZ0R/(^7.2SM@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI#/<:$VDVMH]Q%O=F+,68ARH&2H'.>&]J[1M$T5!EM+L%'J;=!_2F?V5H/\
MSX:;_P!^8_\ "@#C8K6[6]\ R&W0+I$#I>G[5#^[)@\H8^?YN>>.WOQ7>MJ-
MF%)%U 2!T$J\_K4']A:/_P! JQ_\!T_PH_L+1_\ H%6/_@.G^% '+>!HY]+O
M?$K:A'';)?ZM+>P,;F)LQL% !VL2#\O_ ->N=UJQUW5$N_M-G;7EW!K45U:W
M+:A$%-JDJLJ1*3\A"CYL[<]<MTKTB;2-"MX7FGT[3HHD&6=X$55'J21Q3?[+
M\/\ G1P_8=,\V12Z)Y,>YE&,D#'(Y'/O0!S^AB:#QSXDU"[CBAM-0BM5AE%U
M$PS&C!N V[JW!QV[5R!TS7K;X;OX,%A!<2V=S%]GOEOH5BGB6X60'!;<K8'(
M(QQU/ /JG]A:/_T"K'_P'3_"C^PM'_Z!5C_X#I_A0!QVH:=)J_C+59IO+M]/
MO_#_ /9AN!<Q'9(6=CQNSC#]<=152/3[[5?">@^&M3B@MFTZ>V-Q>"ZB:*2.
M @@QX;=EMJCE1C)]!GO/["T?_H%6/_@.G^%']A:/_P! JQ_\!T_PH L?VA9?
M\_=O_P!_!_C1_:%E_P _=O\ ]_!_C5?^PM'_ .@58_\ @.G^%']A:/\ ] JQ
M_P# =/\ "@"Q_:%E_P _=O\ ]_!_C1_:%E_S]V__ '\'^-5_["T?_H%6/_@.
MG^%']A:/_P! JQ_\!T_PH L?VA9?\_=O_P!_!_C1_:%E_P _=O\ ]_!_C5?^
MPM'_ .@58_\ @.G^%']A:/\ ] JQ_P# =/\ "@"Q_:%E_P _=O\ ]_!_C1_:
M%E_S]V__ '\'^-5_["T?_H%6/_@.G^%']A:/_P! JQ_\!T_PH L?VA9?\_=O
M_P!_!_C1_:%E_P _=O\ ]_!_C5?^PM'_ .@58_\ @.G^%']A:/\ ] JQ_P#
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M-%\S:EUYC>>+?S-_EE-N-W5=V[ISCC%=^ %4 # ' % "T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEDD6)"[ ;G8X51ZDDX J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_A3Q'-874=Y=3ZKY%IJ,:CR[F6?RD5U XPC/M..#Y9/4FO2 JA=H4 >F*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tardioagreementa01015.jpg
<TEXT>
begin 644 tardioagreementa01015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH \,OM$M]4^.>O7.LZ)?7&AW5@(%N&TZ61/,\N,94A#@C#8
M([CK7H]EXJ2&SOV_LS56L=.BBBB8Z?,LMU)AMVR,KDCA1G &2><<UUE% 'B'
MCKP]K-M/I/Q%T*.YD\0B93<6<-NYW1D8";0N[Y0-K$@9R3Q@"KGQ=N+SQ?\
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MEOY<]S':2-'&Q,G!8+C^(?G7K]% !7%S6LGBS5=6#23VMI%"VGK'<6+8EC8
MR.I8#(8X7C/^KSWKM** /)/@S_:OA]]7\):E97XM+6Y=]/O);61(I4R0P#$8
M&<!@.^XUZW110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSNM6TVQG6"[U"TMY7&5CFF5&89QD FK1D18S(74(!N+$\8]<UX-XK7[3\8/
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M[*X-C=QM]Y;5<EB?; ,7L2*I?!%1_P *F\4<#FXN ?\ OPE 'KW_  DV@?\
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MT5% 'G_@;P#J?@:XU=;74[6:POI3-%:&%E%NV3C!W'(Q@'CG:.E1^!/ .N>
MM'N]/L]7TZY6XG,^^:T<;6*A>@DY'RBO1** ,OP]IMWI6C1VM_>"\N_,DEFN
M%38'9Y&<X7)P!NP!GM7+Z9X$U#3_ (H:GXS;4;:3[?!]G:U$+#8H$8!#9Y/[
ML=NYKO** ,G1M.O+."\AU"6VG2>XDE41QE0%=B2I!)SUZ]_2L;0O L'A?3->
ML-&D2.#4IVFACD4E8-R!2O'4 @D>W'O77T4 <9\.O!$W@?P\^CW%Y!?1_:&N
M$D6$H5) &,$GTZU)K_@@:AXKT[Q7I=TMEK5D#&6>/?%<1D$%' (/0G##IZ'
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MD''X  L?937/?"7Q8_BSP):RW,A?4+,_9;K<?F++T8^Y7!)]<UJW=C>:OXJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=P0!  3GDD$\#TH H^![:VO/A3H5M>1I);2Z5$DJ2?=93&,@^V*X70I[B?\
M9JU7SG>2*.UNXK9WZM"K,%_ =!["N\@\#11^'H- DUS59-+BA$'D!HH]\8&-
MC.B!L8X.",U!XZMH;/X<ZCH>F:?<,9;"2WM+:SM)) ,+@+\BD+U'7% '76__
M ![1?[@_E4E1P K;Q C!" $'Z5)0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 45#<W=O9QK)<S)$C2+&K.V 79@JK]22 /K2/>6T
M5TEK)/&L[QM*L;, Q12 S8] 67)]Q0!/165IOB70]8N7M]-U6SNID7<4AE#'
M;G&X>H]QQ6K0 456M=0L[Y[A+6ZBG:VE,,PC<,8W&"5;'0\CBJ47B?0I]4_L
MR+5[)[W<4\E9E+%AU4>I'<=: -:BN>/CKPH+C[.?$.G>=NV[/M"YSG&,?6M6
M'5M/N+H6L5[ ]P3(!&K@L3&0'&/]DL ?3(H N45FZAXAT?2O-^WZG:VWE%!)
MYLH7:7SM!^NUL?0U'I_BC0M5<)I^K6ERQ<1XBE#?,59@..Y",?\ @)H UJ*A
M>[MX[J*U>>-;B96:.(L-SA<;B!W R/SJG'XAT:6_FL8]5LVNX0QDA$REEV_>
MR,]N_IWH TJ*QK'Q=X;U.X^SV&O:9=3;2_EPW2.VT<DX!Z"I[3Q#HU_:7%W:
M:K936]N,S2I.I6,8SECG@8YR: -*BLR+Q%HLVF2ZE'JMFUC"=LEP)EV(>."<
M\'D<>X]:CF\5^'K>PAOI]<TZ*TG8K%-)<HJ.PZ@$GJ.XH UZ*QG\6^'(]/BU
M!]>TQ;*5S''<&Z01NPZ@-G!(]*==^*_#UC;VMQ=ZYIT$-TF^WDEND595XY4D
M\CD=/6@#7HJDNL::T:N+Z HTRVZMO&#(P!51[D$$>N14[W=O'=0VKS(MQ,K-
M'&6^9PN-Q ]!D9^HH FHJ&XN[>T5&N9XXEDD6)"[ ;G8X51ZDDX J:@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tardioagreementa01016.jpg
<TEXT>
begin 644 tardioagreementa01016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCO;73;HPVNIQ1!%N!N8=OE)P >/7Z5Z+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAX@C[6R?+ZC&2,=.]='?:W<P:?IEQ9VEO=27\L<:)]I*KAAN+*VPY 4,W0<
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MN",?[)[XK0F\0/>:IX1\-Z)#):6&JVSZQ<0//Y32*Y9U@W]DW @X'W0 .."
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MM;L(C;N(Y@TZ_NV.< \\'@\5'?\ B[2=/U[3M(EN4^T7R-*AW?*J <'/0Y)
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M14C0855& !Z 4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** ,'QK(D?@?70[ %["=$'=F,;  >I)
M[5PLDMM)X3^&$;M&Q@NK3SE;GRMMLRMN'\.&(!ST.*]8HH \T5K,>)OB3(WE
M?O;2!58@?/B!E8 ]^< @=\"J.C20/J'PL$A5GM]*F27<.8G\F)0&_NG*D#/<
M&O6:* /&KP6S^ /B6D:QF6XU.X,2JHW2@JFTK_>!;=C'?-=$=3MM.^)UG?W3
MN+:]T!(+>5(V<2RK,6*#:#EL,#BO0Z* /%-(>%O!WP^BN(BK0ZZ[RI-&1M7,
M_P QR/NY9.>F2*U[Z6'SOBL@9<3VB"(#_EHWV38=OJ=WR\=^.M>J44 >60:S
M'X=UGPMK&IB7^Q9= 6R6Y2-I%M[C*,0P4$KN"@?5<=C7566N^']"L]*M(K9]
M-M]3N7CL8OL[J'9FSN88^3<S9&['WATZ#J:KW-G%>-#YQ9DB<2"//RLP(*D^
MN",CWY["@#D/BXP/PPUJ!?FFFB58XUY9SO7@#J:K:K<6=U\0O TZR12QI;7A
MW\$*62,+SV)(('N#7H%% 'C'VB:UTZ_U&W@EN+.P\9R7MW# I9C;$?ZP*/O*
M&(;C^[GM7=V?B+PVEKJWBBT@=;1DC:ZOTM9 ;@J"H 7;N;:"!D#'..QQUE%
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M$#Y\M53'RM(IXW @9/!->AIX?F7QM)XB-ZA#V0LOL_D=%#EP=V[KDGMTK=H
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MB5GQC=Z-C/K[<U@:7X3NCX T+P_KWAQ[M;?S//$5Q&LMN^XE)(WWCU(X(/\
M(@'H%A=C4]/$[6T]OO+HT,V ZE6*G.TD=NQKQV&_M4T#QA&^N:D->BUB\@TF
M"#4)FG)7'E(D08[ESP>",9S7J'A*RU72_#,5KJUQ-=W,32;&E</+Y6\^6KMT
M9PNT$YQGN>M<AIW@>_U#1?$-GJ-M)IM[/K<^JZ9>+(CM [$&-OE8X/!!'3!Z
MT =;::S<Z9X9T:37ESJ]S%%$\,>T%YRFY@,D*,;6)YP,'VKE/&OB:UU_X=>+
M88!<VE_I:!9XC)M9"<%2&1B&5A[_ %%6=7L?%>L:-HNI2:-;C7=(N?-ELY)T
M,%XI1D<(V3MR&R-P&#ZU)KVFZ[K_ ,/]:M$T"&PO+Z$0P6231E@<\L[C"_@"
M<8]\  Z*_P#$4.G2?9(K>6\NX[87#PQ.BE4.0.78#)*M@>QZ54M/'&GZK;:;
M+I%M=7[:A;27421JJ;40A6W%B #N(7&3S[<UCZGINO6'BQ==L- BU:UOK**W
MNK.6>..6W>,L5=68E2,.00#[U9O+'Q$^L:6)M+M[K23:R">S@N%CBAN&?*E\
MX\Q OR\ \Y;;G% &G:>,]/U&QT>XL8IIGU>-Y+:$[4?" ;\[B!D9 P"?RR:F
M?Q1 L-F!:7 O+I)'2SD*)(BH0&+$MM&"0.IY/&>:XO2_"%ZW@C0] U_PVTZV
MBS!I+6[036\@8&.1&W+C(+=">@R.U/\ ^$>\6:8N@:NUK'K][:VTUG>VMS,B
MR/$\FZ-@[?*9%"J&/?GGO0!V_A[Q'9^)=):_L4E'ER/#+!( 'CE0X9#@XS]#
MCD<U2L?&5K?Z+J&I1Z??I]AN6M);5Q&)C*K!=H ?&22,9(SD8ZUIZ*MV+#?>
M64%E+(Q?[+"0PB&  "P #-QDD<<XYQDX"^%[N'X@7&H0L@T6\2.ZN8L\F[BR
MJG'H5*L3_>C% &G=>)XX9[V"UTZ\OIK"-9+M+?9F+<-P3EAN?'.!GC'/(SSN
MN:G::QK'@'5M-NGDM;N^;85=@KH8)#RO3(([C(Q5VRT[5O#OBW7[NWT^34;#
M5FCN8S%+&K0RJ@1E<.P^4X!!&<<C%9-KX.U+1-/\#V%O;_:UTB[DN+R2-T55
M+K)N"AB"0&DXXZ#\* .AD\<6,6D:[J+V%_LT29H;N/;'O^55<LOSX(PP[@^U
M.N?&4,.M1Z1!I6HW5Y+8_;HEB5,.FY1C<S  Y;O@<=22,\OJWA_Q$+/QSI5G
MI(N(];9[BVNOM,:+EH50H03N#97CC'/45L66F:O%XYT_59M,<6T.AFRD9)HV
MQ*9$? &X$C"D9QU]N: ([[Q^TNB^']2TG3;F6/5=12S=7V*\)#,'0@MC=\C+
MUQWSTSHZIXXM-)749)M/OFATP1&^D54Q#Y@! Y;YL @G;GVS7+V_AG7X/".C
M0_V63>:=X@;47MS/&#)$996^5MV,@2#@D=#1XLT#Q5X@M?$UE/I4=T+F!/[,
MD-VHB@&P;D"GGS-V[YR!D'J ,4 =3JOC6'3=;ET>+1]4OKU+07BI:QHWF1[M
MN5RPZ'/7'3C.15%[O3+^3QK!;6U];7\,*"\>25EW'R28RF'.T;0.F,]ZDL[#
M5V^(T6L7&F-#:-HPLW<31MLE\W?C&<D8XSCK[<U##I.K1ZWXWNCILGE:I%$M
MF?-C_>%(?+(/S?+SSSV_*@"/POXFBTOPMX'L+NUO)'U2R@BBNEV&,2>4&VN6
M8$$@$C@Y[<UUMIJB7FI7]DEO.OV)E1YFV[&9E#;5PQ.0&4G('45QMUH$P^#5
MMIVH V.H:78121R[@QAN(%!5U*DY^9?J0<5KF75?#7@A[Y=/CU#5L?:KN'SU
MA4NYW2'>V0%4$@>R@4 ;>L:K;:'I%UJ=V)#!;(7<1IN8^P'<FLM?%T*7.IVE
MSI]Y#=Z?:K=R0?(QDB;=@J0V"<JP()'3O4GB4ZU>^#;IM 4PZK+"C0I(P1AD
M@LN3PK;=P!['%<K;Z#K,7B+5K^'P^+>UOM%6V"?:T>7S@9.'.?F8[ASDC'.[
M/% &YIWCVSU&YT1/[,U&WM]9CWV=S,B!&;9OV$!BP. >2,''!/6L'XE>($O_
M (>^(#86U[)!;,8&O8) B"16 ;HP9E!RIX(SZX)$MMH&M1:7X MVTR3S-%9/
MMF)HL*! T7'S<\G/';\JR[GPUXHMO .O>#(=(^UK+)*UC?K<QJCI))YF'#$,
M'&3V(/K0!WWBK6IO#WA'4=7M[4W,MI;-*(]P4<#.22>@Z\<UR6JZE<GQ;X%U
M"2TOQ--%=[[574F4^2,$*'*#DGDD8SSBNJ\3Z;>:YX&U738HTCO;NQDB2-GX
M#LA !;Z]ZPO[.URZU[P9?3:.\,>FQ3K=#[1&QCWQ!!_%SR"3C/&._  -.V\<
M65QH\E\;*]CGCU ::]FR*95N"P4+D,5Q\P.[=C!JEK?CMK/POXDO;33I_P"T
M=%S'-;RL@",4#*^02"N&!XY[8%9(TCQ79V.M?8M/E0WGB'[:\274<<D]FRJ&
M57#?(_R^HXZ'-03>$-;N--\>64.DV]G%K$4;V2K<*1N$*KL( X.0<D\9/4]:
M /1[2[EFTQ+F6TGBE*;C"Q0N?^^6*\_7\JX6'Q;;Z9X/\-S^'-)O#8ZCJ2VJ
M)/*IDC!F;<#O<Y9MK <X&>HP!7;Z=-=MI,4EW8M;W CYMQ(KL"!TR/ES^./>
MO/;3POK]O\/_  W9G3,ZAI.L)>RVWGQYDC$LC':V=N<..I'0T =KXHO;.U\'
MZC=:I9W4ED+5VN8(6 E";?F&0PY SR&^AJ)?$5K;BTL+*RN;F8V"W:V\;KO6
M'@#[[#<>W4].3TROBVSOM5\#:M86UKOOKRRD@6)9%P'="/O-@8!/7]*YS6O#
M4^L6%A#=:%=K=6FGH+6_LKJ.*XM;@ AEW;QE>%/<=: .SGO8GT%[Y[>=X7M_
M-:%.)-I7)'4<X]ZYG3O%VD:9H/A>*QTW4C::K$$L4 $C* A8*Y+$YP/4CU('
M-;T$&I1>$([>^(O-4%D(YFC( EEV88C.!R<^E<;I_A[7+;3/ %O)I<F_17_T
MS$T7RCR6CX^;GE@?I0!>UKX@R6_@S7]3LM*NHM1TJ0V\UK<F,&%R 5<D,0RX
M93P3GI[UOW7B1+9X[?[!<-?O"TYM#)$KH@. 68OMY/3!.?P../U;PKK>IZ7X
M^MH['RWU>6.6R,DJ8DV(BX.&.TDH>OJ*N:M8^(H_$]IXFM?#L.H+<6(L[S3)
M+F,20[79T=7;Y2?G8$ _3- &A!\1M*NXM$DL[/4+E=8\U;<1Q+E7C5BR,"W#
M94CT[YQS5JT\;Z?/H]]?W%O=6DEC=_8I[255,OGY4*B[6(8MO7&#CFLZ\TK6
M9_$'A&_.EQHEC-<3726\B!81)$R*HR06(R,D#UQZ5BW_ (2\07<.NSVUF(KL
M:_#K%@DTR;9Q&J#8Q4G:3M/7V_  T(-0=?C!++>075C%'X?>61;B8-'@3)\P
MPQ48 P>G3\3MV_C?3Y=7TVPEM[B :HK-932%"LA4;MI 8LA*\@,!Z<'BL*[T
M;6_$GB>>[NM'DTVRO- GTR1I;B)WB>1\YPC'(Q[_ )5/X:L_$;6<&DZQX>LK
M$VT7DRZG#.C^> NT-&H&Y2>"=V,<_@ 4/''B!=6\/Z;=V%M>_8WU>UCBO4D"
MQR 3JI)4-DH<$ D8/T()ZCQSX@NO#/A6YU*TM#<2JT<8^90(][A QR><%AQZ
M^@R:XI= \61^ [#PJ^AB6;3+RW*7B742Q3PQS!@P!.X-M'(([=3TKLO'FDWV
MN^"+VPL(5>]<PR)$SA0Q25'*[CQR%(R: +DOB$)>1V$6G74NHM ;E[0-&&BC
MW;06;?MY(( !.<'T-3Z'KEEXDTK[;9&0)O>&6.0;)(I%.&1AV8'_ .M7.C3]
M9L?&_P#PDL>F//;ZA8+;75I'-'YMNZ,61@6958$,00#P>F16GX/T*;1+/4I+
MD!+C4M1GU"2)3D1&0C"Y[D*%SCC.: .,\->,(O"^B:F][I^JW%A!K5Y'-?(O
MF);KYQ5=Q9MS #&2 <?6NSU?QC9:6MXT=O->BRA$]S]G>/Y$(W#&YAN.WYL#
M/&/49YN/P[K?_",^(_#+:?M_M2]NG2^\V,PK#.Y.XC=OW!2>-O7'..0YM$UO
MPYXIO9M-T"WUS2]0C@QYEQ'%):R1QK'SO'S*0JGC)'/'J =@_B#3D\,GQ"LK
M2:<+7[6'1"2T>W=P.N<=JKZ;XEBO]:?2)K*YL[P6B7JI-L(>)F*Y!5C@@C!!
M_6DUJWUO_A#+JWTB2"/6OLVV%D 5!)CG;GIWQGVS7/:%HNK6_CR#6&T,65G+
MI/V68R7BRRK*)-V7(R7)]<GW(Z4 6]?!3XH>#RLDH$D5\'3S&VG;&N/ESC/)
MYQWJS=^/=+LWMY)(IC837?V-;U2A02;BN2N[=MW C=C'?IS1K>FZA<^//#.H
MV]F\EG8I="XE$B#;YB*JX!()^[SQ^=8GAO2/$>A9\/RZ!8W%G%.YM]9:9.(6
M<L-T>-Y< X]#QSWH WM3\<6&FP:M=?9;JYM-(D$5[- %(C8@$@ L"VT,I..F
M>^#A]YXPAM2Z)IE]-+%8_P!H31J$!CBR0.2V"QVM@ GIVXKCKRSO[W5/$B6?
MAV[U'1K^["SBQU""..<HJJ^X288-N4JVT@';CKDG1U&'6_$<[R0Z2;C1+W20
MEI#-.D:VLYW!C*F3N/W<$!@,<8SF@"QK5]#J7BCX?:G9S3?9[V:611O8*R-;
M.RY7.,\CMFH--U0:!KWQ O7@OKRWL[BWE,,+>9(J_9U9MH=AP,DXS]!3++0]
M>CMOA\LVE,K:*NV\"SQML'V<Q#N,G)SQGCOGBMOP]IE_;>+?%5W>6316FHSP
MO [.C!U2)8SD DCD9Y'2@#3B\16\\6C20VMQ*NK -#L*'RTV;]S_ #?=QW&>
M2!W%<YXQN6L/'W@ZZCCNYR6O%-O;L29"(3@!20N<GJ<8[G%2> ]"ETN[U)&N
M%FT^PGELM* _Y9PE@[KGOA\1_P#;*KWB;3=0E\2^&]9LK-KN+399_/ACD59"
M)(]@*[R%.#UY% &=J'C31M5\':_)J6F:G&FG@PZEIY 2XC!&<Y5P,$<@AN16
MK<^++>PU>UT6'2]1N;J:R-U L2H0ZJ5&W<S#!^8<M@>^<9P-:\*ZI?Z)XTNH
MK/\ XF&OQ1P0VGF)F-(TV*7;.W))8G!.!@<UI+IVJ'QUH^JG3)1:6^DR6LK>
M;'E9&9& QNY'R'D>HH NVGC;3KS0;34XX+D275R;.*S95$QG#,K1XSMR-K$G
M.,#.:YS2[_9XU\=RWMG?K#%8VC26QEWL05E+&,[L $>A'X&J4'A7Q):6&GZA
M;Z=F_P!,URZOQ9O/&/M$$S/D*P) <*_? ZUKP:=KLWB#Q3J<FBR00ZGIL,-O
M&]Q$9-Z+("" Q Y<=\<=: +ECXNTK3-)\+6MEINI-;ZM:C[ B@2,JK%O",2V
M=V !G)'<G&35J#QUIS:%J>IW=O=61TRX^RW5M,JF19?EVJ-K%3NWK@@XYK"L
M- UNWA^'J2:9)G1(F2]Q-%\I^SF+CYOFY.>.WOQ535M(OHM%\9Q7NEACK.I1
M-8127"*9F(B10"I)5P4+#/' SQG !V5MXHCF\3'P_+IUY!?" 7)+;"GE$D!L
MAO[P*].OMS5J_P!;CM-073K>VFO+]H3/Y$)4%8P<;F+$ 9/ [GGL"1S/A^:]
MA\4I<:UX>U.VOKR$6<5]<W5O,NU TGEXBQMSAFSMY/&>@J76['7]+\<Q>(]&
MTY=5M[BQ%C=V@G6)TVN7212_!'S$$4 :=KXQL;ZRTN:TMKN2XU-7:"T=!'*
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M<8(R*+?3]3@\=>(-4;393:7=C!# PDCR[Q^9D8W<9WC&?0]*P=/\-Z[;>&/
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M'!(IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWGA#[PDD;E&PV!D9&1QWH VZ*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,K4/#>CZKJMEJ=]8I/>66?L\CDX3)!^[G!Y (R#@CBM*
M2*.90LL:NH(8!AD9'(-/HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/:Q)W-CL,#.>>#EWOAW7[CP/XWTU-&G^UZKJ4T]HAGA^='V8)._ ^Z>#STH
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MMI:6$\%Q(TL7[MW\O P'R?N'. >U &;_ ,)C;:Q\-+K6/$&FZE;V+S.C?9'
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M?[:OH8H]R:I.TGG-P"4\S''4@C& :]#UM9I-#OHK:W>XFD@=$B1E!8E2!RQ
M_6N2\-+K6B^ =+TFX\*7L]]96Z)L-Q;",R*<J=WFY R <XS[4 ;-WXQM;;6;
MW28=-U.[OK2!;AHK>$'>C$@;2S ?PGKCVR:K6OQ"TJ[32)XK74/L.JR)#!>-
M %B$K9Q&V3NSD$9 *YXS4=G8ZM;_ !$U'59M.EDM9-+@MUGC>,"25&=F 4OD
M [AC-<Y9^'/$$'P_\(:6^C3_ &W3=5@N;F,3P_+&DK,2#OP>#P <T =%??$?
M3+(ZF!IFL7 TN7R[PP6F1$-H;><D?+@Y]>IQ@57U"^CO/B#X)O+&\EDL[ZUO
M) %E;RY%$:%&VYQGYCSC/-9^E3W?]N_$"UMM+FNWGNT6/:R!-YMD&UB6&!T)
M.#QGOQ5BS\+:EHVK^!+>"UDNK31K*>WNKI70*&>-%!"LP8C*GH#@8H W;KQM
MIMI:R7[PW3:5%<&WEU%%4PHP;82?FW;0WRE@I&>^.:MVWB.VN?$]SH MKF.Z
M@@6YWN%$<D9. RD-DC.1TX[UQ5KX:UNV^'VI>!7L'E+O-#:ZAO0Q-#+(6WO\
MVX,NXY7') QG.:U/&&A747_"/7.B70@U2WD&G)(W)D@D7:_U*A1(/]PT ;L/
MBFVN+:VDAL[MYKII?(MAY8DD6,X9P2^T)DCDD9R/45%8^,],U*P2XMDN&G:Z
M>R^Q%5$RSIDNA!.T$ $D[L8[\BL7Q3H%[9:IH.J:-HL.K6FG6\EC-IKL@;R6
MV;6C+_+E2@Z]1576]$UBXM=(UJR\-V7G6-W)*^B%HQYD,D81LM]SS!C=Z=LG
M'(!O-J-KXTT+5].M6U&SN[>3[-<11S""XAD&&&'4L ",?,"003]*MQZDVCQ:
M;HT_VC4]4^Q[W\K8&D$857D.]E'+,.,YY]C3_#B3FVEN)M$AT<2D;;5=ADP/
MXG*?+DYX )P!UYP,KQCH4>N7=JEQI=[((8W>WU+3YECN+27(X!+ X8?4<<^H
M .GL+Q-0TZVO8TDC2XB654E7#*& .".QYK A\<6=SJ]QIMOIFK32VUT+6X>.
MURD1*[@S<Y"D=\?A6GX;BU6#PWI\6MRK+J:0*+AUQR_X<9]<=ZQO"]CJ5EXB
M\57-WITT,%[>+/;.TD;>8HB1.BL2#E3UQ0 W1?$FAV?A8ZA:B^6VEU"2WCBN
M"7FDN&F*;%W,>KDX!( '7'-)JWB6WU*R\1:*D&HVE_963RRG[AC!0LC"1&/7
M!Q@]B#7,2:1J5G\/_P"SKO2)AJ<FNM<6<*W,0E),[2AXR&*[U3)PW'!SP*T+
M9[F=M?2X\.ZQ!K>K6+(DET]N5E"+M6-2C[5QOSSC.3ST% %WP=XM@&C^%=)N
MK:_6>]TV/R+J6,>7/(D(9U#$[LXR<D ''!-:GA+Q+=>(GU8SZ;-:):7\MJA=
MD('E[5*G:Q.[.3TQSC)K MM%UJ.+X=JVD3@Z.FV^_?0_NO\ 1S%_?^;YCGC/
M'Y5L^#=/U+2;SQ!;7M@T4,^JW%Y!<^8A65)""H !W CG.0.V,]@";Q#XFNM(
M\2:!I=OIDURNHR2AWC:,<)$S;5#,.<A3DX& >IJ:_P#%]E8QZA,MK>7-KIK;
M+VXMT5D@( 9@06#-M!!.T''U!%4_%6GZE+XC\,:K86+7J:?<3>?&DB(P62)D
M#?,0, D9[^@-9=EI.M:)!XJTD:9)>Q:I<W%W9W"2($S,OS))N(*[6[X.1TYX
MH [NWN(;NUBN;>198)D$D<BG(92,@CV(KF[3QW87NH3VD.GZH5MKM[6YN&M\
M16[*F\L[9X7'&?7KC(SK>'-(_L'PUIFD>;YIL[:. R?WBJ@$US.C:!J,]CXU
MT^^LY;%-8O+A[>9GC;*21+&#A6)!!4G!QVH V(?&-@^J:=8S6UW;#4U9K&>9
M5$<^!NP,,64[>0&"_GQ2)XST]Y]/Q;WAL]1G-O:WH13#*_..C;@#M.&*@''7
M!!K \+6&KM;6VEZIX1L]/GM8_*GU-&B990%VAH@OS;FX/.,<]^*E\%+XIT?3
M++PS?:*J)I^(?[4$Z&&6%3\I5 =^XK@8( '7/8@&Q>^-=-L/+FFANO[/>Z^Q
M_;U53"LN[9@_-NQN!7=MQGO4$.MZ9;:WXIFM[35);RPC@>]CY(9=K%?*5FQ]
MT$G &>.IKG_#^BZSHTLN@W'A2SO(UN9'MM:9HBGE.Y8&13\Y=<XP!S@<@<UT
M&AZ?J-OX_P#%%_<6$D5E?):K;SM)&0_EHRMP&+#EAC(H T;7Q+:WNF:/?VUO
M<R1:L5\@#9N4%2^6^;@;5).,GMUJK<^-=-M'MGFANA87-U]CCOPJF'S<E0#\
MVX L"-VW'O@@U1\'^&;W0M0OX+@J=,M)Y%TA0>5BE(D<'_=;Y1[ ]C6-X8T7
M6=%"^'[KPI9W"V\S>1K;-$4:$N6#,OW]X!QC') Y YH ] U2];3=*NKU;>2Y
M-O$TGDQE0SX&< L0*\YU'Q!=ZEHW@'7;B*\M9+K48#+%$Y*S*\#N<(C'<,@8
MW#/'05Z/J5N]WI5Y;1XWS0/&N>F2I KSR#1_$#>&_ MG)H,Z3:-=P-=#[1"<
M)'"T98?/R"6! '.,YQ0!UEEXRTZZMM3EG@N[&73)5BN;>YC D5F *8"E@V[<
M,8/)-36'B:UO=>FT26VN;+48X!<B&X"?O(B=N]2C," >",@^U<;K'A77-6N_
M&IALA ;Z:RN=/DN'C:.9K<(2K ,2 2F.0.#72>%_MMS/]HNO"4&@E(RC_-$[
MR.2.%,?\ P>N">..* *7Q#N6L9_"UVLMTH&MPQR1P,Y\Q"DA*E%^]RHQP:T-
M/\=:5>#5%N8;S3;C3%#W-M>P[9 C?=90I(8'H,$G/'<4SQMIM_?1Z'<V%JUT
MVG:M%>2PHZJ[1JKJ=NX@$_,.,BL/Q#X0U+Q3+KVI1QBQN+C3X+.RAN"I+&*7
MSMTFTD %L+CDX!)ZXH Z%O&=E#J%SI]Y97UK=PVAO5AD1&,T0."4V,P)!Z@X
M/MBH=.\>Z;J5QHZ)9:C##K$>ZSN9X0L;MLW["=V0V >V#C@FJ&G)JM]IMVTO
M@J#2+E;22-@CPL\TA7&V,J<!>Y+$=N.IK/M="UR+1OA];-H\_FZ/)&;T>=#^
M["P-&2/G^;E@>,\4 =+?^-=-TY5GGANO[/-U]D:_55,*2;MF#\V[ ?Y=P7&>
M]86HW$NO_$#4/#]]9:A_9\.FQLAAE1#&[R.#."'ST4;>"PP>!GFKH>BZSHUQ
M<Z'/X4L[Z$W4LEKK+M$4$3N7S(I^<LNXC '. ,@<UNVMEJ<?Q.U+5'TR8:?-
MIT-M'<>9%AG1W8_+OW8PX[=J ,9/%%KX?\"S7FA6FJ7@74S9R-?2AI%E:4([
M-O;/WCP!WZ@#)KJ;OQ5#:&Z3^SKZ:>SMEN;J&+RB\*-NQD;^2=C<+GI[BN,?
MPUKTG@+6;+^R9%O7UUM1A@::+,L7VI9>"&(!V@\$CFKOBG0K[7+F74+;1[_3
M]<AME_L[4;.YC5@QR?*F^?!4'&<@C!.">X!Z)145L)EM81<LK3A%$C(, MCD
MCVS4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA)($D3AE)!P1D>A!'X5-7DW@[Q!?^'?!>CNNFV[Z5+JTMG))YY$BF2ZD565
MN-H) Y(/7CN>FU?QM<VW]IOI6FF_&FS>3)"JR&2=@%+B/:A (W8YZD$<#!(!
MV=%16\PN;6*=4=!*@<+(NUER,X(['VJ6@ HHHH **** "BBB@ HHHH ****
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MNM,BNKB6^M>9[>*RG=XQZD*AXY'/O6EI&LZ?KMD;S39S- )&C+&-DPRG###
M'@\4 <WX6\.^)]"MK;1[G5;*?1K'Y;:1(G6YDC7[B.<[0!P"0#D#'%7?#&AZ
MEH=AJ\4[6DDEY?W%[%L=L+YK;MK97MZCKZ"NFHH X"R\#ZI8>&?"UG'<V;WO
MA^X\U=Q81W"[77!.,H</Z-TJUJG@637;?6KB\NUMM4U$0"&6WRRVGD-OBP3@
MM\^23@9SC Q74ZIJEGHNFSZCJ$WDVD"[I9-C-M'J0 33].U"VU73;;4+.0R6
MMS&LL3E"NY2,@X(!&1ZT <K+X:\0>(_#FH:5XKU&QQ<6QMT_LZ)P,G!$K;CR
MP*C"C Z]<C$,?AOQ3=ZGX:O-3O=*+Z-)(7>))&-P&C,>[!QM.#G'(SW[5W-%
M !7-OH>HCQ[+X@C-JT!TP6*Q,[!LB0N&)VD8R<8_'VKI** //K7P/J]MX1\,
MZ-Y]DTFC:A'=O+O<"549FV@;>"=V.^,=\\>@T44 <WJ&@ZA)XVL-?L;BV58K
M.2SGBF5B2C.KY4COE<<^N>>E8,W@?5YO!FK:'Y]B);_4VOQ+O<J@:<3;<;>3
MQC/OGVKT*B@#BYO#OB73_$][JOA_4--CM]4$;7MK>QO((I54)YD94C.0!D'&
M<?EU]O$T%M%$\KS,B!3(_P!YR!U/N:BL]2L]0>[2TN$F-I.;>?9T20*&*Y]0
M&&?RZ@U:H YCQSX>O_$VCP6%C+;1%+J*Y9YRW_+-@P  '?'7-72GB&XNK;S?
M[/M[9'WS>3([O( #A02H"@MC)YXR.];5% 'GTW@?5YO!&L:#Y]B)M0U%[Q9=
MSE4#3"4J1MY(QC\<^U;%UHFH/XR7Q"YM5MX]*DLGB$C%LLRN6!V@8!7&/Q]J
MZFF30Q7$+0SQI+$XPR.H96'N#0!YGX*T2]\0_#+PK97AM4TV+R;EV1V,DHC;
M<J%2,+\P&3DY / SQL7O@:75[KQ?'J$T*V6OQPJGE,2\)B3:I.0 >0&_#'/6
MNPM+*UL(!!9VT-M"#D1PQA%S]!4] '*1^']4U&XT277Y;-AH[F<-;LQ^T2A"
M@=@0-@ ). 6Y(YP.<^RM-)\0_$-=?T?48[JTBM5^U_9I \,LX++"21P656DR
M.WR'TKNZAMK2VLH?)M+>*WB!)V1($7)ZG H Y^'0]2M_&.L:TIM6BO;2*WCC
M,C!E,>\@D[>^\_3'>L6W\$:M;^$_"VC">R:31+V*Y>3>X$HCW8 &W@G=[XQW
MSQM#X@^%CIZ7W]K1_9FO?[/$AC<8G_NGCCCG)X]ZWK:]@NVF2)\R0/LE0C#(
M>O(/J.0>XY% '(6GACQ-H^KZC%I&K6*:)J-R]TZSPLUQ:O(<R"(@[2"<D;NA
M/0][2^&]2CUSQ1?(]HT>KVT,$2M(V8_+1E!8[><[R?P[]:ZVB@#A;7P;JUG#
MX.:&[LA<Z#;R6LF]69)4>-4W#H<C8#@\<]:[JBLZ_P!<L--U'3["ZDD6XU"0
MQ6X$3%68 L06 P. >IH K2Z9=W7BB.]NDM)-/@MVBAC))=78@LY!&.B@#T&>
M><5F7'AB_A^(-MXBTLV4%O\ 9#:7<#%@9UW;E/ P"IZ'G(XXKK"0H))  Y)-
M9YUVP7Q"FA&20:@]NUR$,3!3&" 2&Q@\L. : /,K>:XOKO5-6L;WPI/9S:B\
M_E7\TL+AHVVKYD:DKN&P$$KGH3ST[/3-+U.X\81^*+B*"WANM)BM7M2[&6)@
MQDY^7'5RN/;/M6GJ46BZ7*NK7.FQ-<&5(Q/%9^9+N9@HY4%L9/6MB@#B-.\+
M^)=$O[RRTW5K$>'[NYDN )8G-S;>8Q9TC(.TC))!/3/0TY/#7B72?$&I3:#J
MFGII6J3_ &F:*\A=Y+>4@!VCP0&SC.&XS^O7W5S%9VTEQ-O$4:[F*(SD#Z*"
M36):>./#EXEI)%J!6*\;9;330211S-V"NZA6/L#0!#;:#J-IXSOM:5[>6&:P
MBLT1Y6WYC+,&8[>^[GZ=ZQ;?P/JUOX.\-Z()[)I=(U"*[:7>X641N7"@;>"<
MX[XQWSQZ#6=JFN6&C2V,=[)(C7UPMK!MB9@TC= 2!@=^I'0T <U;^&?$VD:W
MJ7]BZK8)H^I7+74J7,+/-;2/]\Q$$*<GD;N >QYS;B\.ZE!XDU_4T>U>+4;.
M&VB5Y&W(8PX!8[><[S^7>NKHH X*S\%:O8V/@\07ED+K0$DA<NK,DJ/'L+#H
M01P<=/>N]HHH YJ_T34D\:1>(M.:TES8&QDM[AVCP/,WAPRAN_&,?C6/=^ ;
MZ"SL[S1]3AB\06U_-J!GFB)AF>;B5&4'(0C &"2 H[\UWM(2 ,D@#IS0!Q^K
M^&]>U[PP]O?7]D-5^TP7,8BC<6\9BD5PN"2QS@Y;KSTXJUXB\+3>(HM(DFNU
M@O+*<M++"I >)U*2QC.2 RG&?8&M:#7;"YUVYT6*20WUM$LTJ-$R@(Q(!!(P
M>0>F>E:- '-Z-X4CT?Q1J^JQS9M[UA)#; 86%V"B4C_?,<9_ ^M9FC>%_$N@
MW$VF66K6)\.O</-'OB?[5 KL6:-"#MQDG#'D9Z5V]8LOBO2(=5FTLRW+WT*"
M22"*RFD95)P&^5#P?7I0!AV_AGQ-H^M:DNC:K8)HVI7+W4B7,+-/;2/S)Y6#
MM.3DC=P">AYS:C\.:E#XA\1:BCVK1ZI:0V\2M(VY#&K@%CMYSO)_#O70:=JE
MIJL<SVCR'R9/*D62%XF1\!L%7 /1@>G>KE &-X4TFXT'PKIFDW3Q22V5ND!>
M(G:X48!Y''TJ+QCH4_B/PU-IUK/'#<&6&:)Y02FZ.17 ..<';C\:WJK:A?V^
MEZ?<7]VSK;VZ&21DC9RJCDG"@D_E0!S\6AZN/&T7B"9[)PNF&R:-&9<L9!)N
M'!P,C;^OM6%!X!UNRT'2!8ZC9P:UI%W<7%O*RL\,J3,S/&XX(&&QD?W<_3OK
M"]@U+3K6_MF+6]S$DT1(P2K $<=N#5B@#-T:#58[9I-9N;>6\D.2EJK+#&!T
M"[B2>Y)/7/8 59U"PMM4TZYT^\C$EM<Q-%*A_B5A@C]:LT4 <GH.D^)?#NG0
MZ/'/I^H6-LHBMKJ=WCF2,<*KH%(<@8&05SCM3M2\,WS:[I.OV%W')J5C')!,
MMQE8[F*0Y*Y )3# %>#Z'/6NJK.UK7;#P_9I=:C))'"\J1*R1,_S,0J@X!QD
MD#)P* .5UCP->ZGHVO*DUJFIZW=033N2WEQ)"4V(O&6X3J<9+$^U:S:+J3>.
MX?$/^BB%--:R,/F-NW,ZONSMZ97'Z^U=+10!Y/JVB:CX=T;PO8R26DERWBM;
MB,JS;#YGG/M/&1][&1GUQVKH=:\&ZCKB:Y>M>PV>J7]G%90&(LZ0Q(Y<JS84
MMO)(/ P..>_6W>F6%^T;7EE;7+1G*&:)7*GVR.*-1U"VTG3;B_O&=+:WC,DC
M)&SE5 R3A03P/:@#D8_"NN_VY=ZF\^E(+G2!IYMH8W58RI<KM/\ =^?KCMC
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MP <D@G/'4'/?.>:9-\-]+FN=:W7-T++6KA+B^M58 2,O.W=C<%)Y(SGW XH
MYJ#X@>(7T_X?:A<):Q1:[<"VO(?).22=JLISP",-C'XTWQ1XP\5:'HD8BN[6
M74-0UYK/3VBMMV^VZ9VD\D-D9YSQZYJ_J>EIX_OM)LK6PU'1[3P_J9:1YH/)
MW+&,((3W!.,$= .W&>IO_!VGZAXBT/6)'F4Z,CK:VJ;1$"R[<D8SD #&#V%
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M %[?:C]H-Q?%Y(1$JHCM;R'Y"!G:,D?,6/3GUZ>Z\'VE_K=YJ5[<SW O-/\
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M,T)D0IYB $KGTR"*YJ+X?Z:O@>/PI-<W4]G"!]GG8JLT+ [E964## ]#C\Z
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MZ>V95$;PY)/09SECW[U6T#P6=!$<8U[5+RVME*V4%TZ,ML"" 1A06(!(&XD
M=J .9TKQ1XD3P+!XLO\ 4K><2@VRV:VBJ/-:Y$22%]PX /*\ C'.>:T=7?Q*
MFG^(HKV.:317T:=DEN_(6:.<(V5 B."A7G)&016O9^!=.@\$R^$[F>XO-.D#
MC,I4.NYR^05 Y#'(./2ETWP<+:PN;34M;U+5EFMWM5:[=<QQ,,,!M498\98Y
M/'UH Y?3M1\1>']-\%7,FHP76DZFMK8/9K;!&@+Q?(ZODEB,<YX] .VA;^(=
M8MAXCT6^O=^MVUPB:>_E(HDCFP(7V@<X;<']-IZ5NZ=X2BM%TN.[O[B^ATH#
M[%',J*$(78K-M W,%) /N3C/-9VG1V?BKQ?:>(TTR]MO[,MY;=)+R!H6D=V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD9IT4L5$IC"8V9&?O9 (/J  =O17(Z7XKU?5M<O;&#08Q!8:A]DNIVO1\J[
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M2LY 5=O7&[..,<UZW-K,WAS2-$L=1ECN=6N(U@9W<JCR)'F1R<$XX/;))'U
M!T$\\-M"TT\J11+RSR,%4?4FI*\K\9Z[_P )'\,_$B7FFB"XT^>) W+QR?O$
MVR1.5&002.F1R*ZW6?%AL;^\L+&&WGN[2!9I%GG,8);=M1<*V6(4]< 9'7/
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M;*VH^(K*^L8K671XUF&+@OY\;*65Q\@P.".^""/J =(UQ"D\<#S1K-("4C+
M,P'4@=\9'YT33PVT1EGE2*,=7D8*!^)KEY-78>,/#MGJ&A6R7UW:7$J7/FB1
MK8J$WQJ=H/.Y03QG'2N7\>ZS)XC^'-SJ-KI]O)I?VV%8+AY?WN%N%3S57;@
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MU73=.LH[B?3+-+N?S9C&&W[BJ+\IYPAY/ R.O.,M?'U]<0>&I;70ED_M]7:
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M"MB6=(4=W+':I8JBEFQ[*,D_A5/1-9L_$&CV^JZ>[/:7 +1LRE20"1T/(Z4
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M:*)8=OEJ3@$YP23C^+IQSU]SI.G7EW#=W5A:SW,'^JFDA5GC_P!TD9'X5<H
M@L_M7V2,WHA%R1F00DE ?0$\GZ\9]!TKSZ\\$^);B&[B^U:7*QUF/4HKF4R>
M;*BRAUC?CY0H&!C(Q@8'6NUU;7]/T7[%]L>3_3;I+2$QQLX,K-M ) PO/J1T
M-:= '#ZWX/O]>O8I[J+3H[NVNXYK358'9+B&-6#,FW;SG##!;&&]1SUVI_\
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M4H(=6L/B3H5OLLI[R'PY)',OF-&A FC'RG:3Z=1SSTKTFLO4;;1[!IM?N[&
MSVT19KI;;S)E0=<$ MCV% '*W'@?4?L5L8)+-KQ]?76[PO(RID,#Y:84D_*%
M7)QTSCG VM+T34+3QOK>LS?9OLNH06\2*DC%U,6_D@J!SO\ 7C%;6F:A!JVE
M6FI6I8V]W"D\188)5@&&1VX-6J .3\9Z=(;_ ,/Z_$I;^Q[TR3@#)$$B&.1O
M^ Y#'V!J+6-#U^/Q4GB/PQ=:>S7-JEM=VM\7$<BJ2R.K("0PW$>A!KL:;'&D
M2!(T5$'15& * .-\9:=?:GX*'AR2=9]2U61(7=%VJJF0-*X'.$5<@9_V1DD\
M]E&BQ1K&@PJ@*!Z 4>6@D,FQ?,("EL<D>F?3DTZ@#@+;P5JG_")S^$KN2S.E
MS7,CR7<<C>:\3S&4IY97"L<[<[C@<X[59/A_Q1H_B74KKP]=Z6VF:I(L\T-\
MK[K>7:%9DV_>!"@X)'(ZBNVHH Y2;PU>S^,[?4Y7@FL$TE].EWR$2R;V5B^
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M6VNI5@RD'GD$ T <E;^(-7_MOQ!IJ7MP\4&DQWUI->VR)(K$N#\JA?E.P'#
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M4;77/KD''0'UZ4M_XCU/1=:72M;U:YLMQMTLM2-H@M+P[5\P2':WENS;QC(
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M8>%-WFK)&H8D 9X8\# KEK/Q)XG'A31_$,^L+(7UC[%/;"UC5)8C=-%R<9#
M8P01TY!ZUW/_  B\7_"0VVMG4KXW=O:-:+N,95E8AF)^3.25!X('' QQ6<OP
M_L4\.6^AC4]2^RP7@O4;,6_S/,\WD^7C&\YZ4 9FO^)M3M[[Q9 NH#3I=+M(
MYM.B,:'[62A8G# E@7'EX7&/J179:&U])H=E)J1S>R0J\P*!-K$9*X'IG'X5
MY_J$<TGBW59;B_\ %FDW#RI' +*Q-S#/&B *X81.%));(RN,\CJ:[[0DU"/1
M;==4E:6[ ;=(ZJK,NX[=P7Y0VW;G'&<XH YC3DNG^+NN!M2NVABT^U=8#LV
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!&*O>&;"VC^*/C.90X=39L/WK8):)LY&<'\>G;% '>44V1UBB>1V"HH+,Q[
M=Z\JTFZF37?!%S:W5U+:ZD]TLEW/.1+?)Y+N&>,<*,@%><@<87I0!ZO3)F=(
M7:.,R. 2J @;CZ9->,W\<\/@CQ?JZZEJ1O=*UV863M>R'R@LJ #&[YA@X^;/
M%=E:S+XA\?\ B72M0DE$6FPVR6L*2M'Q(A9I1@C+9PH;^';QC)R ;_A77E\3
M^&;'6EMS;+=H7$1?<5PQ'7 ]*V*XSX3\?"[01G/[EN?^!M2?$8S+:^'_ "+R
MZM6DURTA9[>8IE&?!!'0]NH- ':45Y3J-E<Z!KWB?2K#4-1.FR^'9-1 >\E=
M[>X5F4%7+;ANP3C/)4]J5@=#\+>%KT:E=*VN/96]_<75S(Z*/)9A@;ALW-M4
MD$<4 >JT5Y[=:#K6G6VLVVG:[;R2W,MM/;:=(9$CBPWSQARS,JR[6&. #G'4
MUDR^*/L^DO;B"[T2X?7+>VU*WNY2ZVBO&,;'5A^Z;8O((^^W2@#UBBO*_%FD
MWV@^$_%TT>O2!)+-;F"SM7DC^RL."RMO)"OS\O0D'WK5CL_[/^)&FVD=U>O!
MJ>D7#7:2W3N)'5H\, 3A3AF'RXP#QB@#N;6[M[V#SK:598][Q[EZ;E8JP_ @
MC\*FKAOA):06_P /;!X@P:1Y]P+L1Q/(!@$X'X5O^+(;^X\-W,6F7$4%ZS1B
M(S.45SYBYC+#D;QE,CGYJ -JH+VX>TL9[A(3,T2%Q&& +8'3)Z5Y/J^KE_!7
MB(I:ZCHFKV-W9F>T:Y8B#?)&N8G4X,;*&X&!UXYKIKV>1/BC>6RW$ODOX<>9
MH/-)3?YVT-MS@''&<4 =+X;UD>(?#>G:PL!@%Y LPB+;MF1G&<#-:E>+Z9IT
MVE^ ?!'B#3;Z_74VELK=HC<NT4\4C!6C\O.T  DY !XR3GFM[[;=Z7XMA76K
M>::TN]69;'5[.X++EF95MIX\\ ?='49 /7)H [ZSN+R:XO$NK'[-%%+LMY/.
M#^>FT'?@?=Y)&#Z9[U0N?$)M_&-CH#63$7=M+<+<^8,#RRH*[>O\0YXKS^_U
MR^T+1O'4T-[<CRM:AMTGEE:0VT4BPAF4L3C =L>AQ6W/I5G8?%CP_P#9?-"2
MZ7=@@S,P.#%\P)/WCGD]3@>E '::=<7ES!(]]8_8Y%F=%C\X2;D#$*^1TW#!
MQVSBKE>5Z3>_\4DEO=ZC?M)+XEGMH8UE+27069\0L['(0JO)ST4CG.#FZM=7
M\'@7XAP_:I[=M/OA]F6WNY#Y 9(B45N"5RQXQCD\4 >M:A<7ENMN;*Q^UF2X
M2.4><(_*C)^:3G[V/[HY-7*\]\5Z2NA+H<ME?ZEONO$=F9_,O9&#AF 8$$XV
MG:#C&!VQTJO+%>>+]0\567]KII]Y878B@;,@DM(Q&C)(H5U&"2QR1ST)P
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MO+K>E/J(TY=1M3>$L! )5WDK]X =R.X[4J:SIDE\+)+^V:Z9F181(-S,H)8
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M^@U6RELX"1-.EPICCQUW,#@?C1>:]I&G+&U[J=I;K(H93+,J@J> >3T/KTH
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MP])IS:>^FHUJ;C[5L,CG$V<[P<Y#<GD=<TC^"/#3Q7D1TBW$=[M^TJF5$NT
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MEW!3CG(.!ZYXKV"B@#ST:QHWC'2I[CPU;LVN1Z5/;Q2")HVLBR<1L2  V\*
M/8D<"F>%-9T'7].T*VM;-O[>TJV,(B>!U;3W\O8^XD8 .,#UR/?'HM% 'D7A
M*XT35=/T'1=4_M,^(](GC9[!]ZF*:/AI20,;""6R3@YQR2*NZ+<SZ?XCTR#3
M-0AU?1KJ^F/V*91]KTN0B0NP(ZIDL/F'\8P3D5ZA10!Y/H$U];7NFZ=HNI0:
MMI5U!<-9^:H%WI+>6Q <CJF2%^8 Y(]*JJ1JOPGT?0+7]UXGM+FVC%LW$\%Q
M',-\C#J!MWL6Z$'KS7L5% ' >&X].N?B3XU+QVTL@FLWC)4$_+" 2OT8<D=#
M6=X+N9[+6=%T^QU"'6M"EM9#:NZ@7>F*%!$<A'53PO(!R!Z5ZA10 $X!.,UX
MI9:Q9W+>"KJ%7M(8-7E5].B@<BS+)-\CL06,A)Z9&<\+WKVNB@#Q:_-B_@3X
MG;/(,TVIS>7C&YQLCV8[GY@V/<&NCLM=MM+^)%_-K5RL=KJ.FVHTNZD.8W"[
MO,C5NFXLP..IX]J]&HH XGX2O&?AU81QJR^7+<*5*%<9F<C@CT(JQX]U&VTV
M+1)+J"/8=20+>3!C'9MM?$A (R>JC/&6R>E==10!X]I[6-Q8>*;.ZU:\L9&\
M1+<0:@8=AA?9$T<C J%VEEZ$#(YZ<U=^TW.I:/-!K.J6^GWUOK*"TU^P0>1/
M,(,K(RM\I&T>6PSC/&>*]4HH \AUG4KJ\^'TS:M'9+=Q:];H+FUXBO DL1,R
M ^V0<<95JN^)=9T[1/&^LFXU&TC75-(AB87WF+&O,@4HRJP9<%MPX[<G)QZC
M7-S>']8BUR]U#3/$ @BO&1I;>YLQ.%*J%^1@RE1@9P<C))[F@#C%BT2"[^&5
MK9W]KJ%G;-,@N05*OMMV4,?3YP ,]#@=14<?]FW/_"86\NJ-IROXABFM[N J
M?)DV1E9"#P5WJ0<\=<XZCU#3M/CTVU,2.TCN[222, "[L<DD  #\*MT >?Z%
MXN&BZ5JMUXIN+,)#?I!_:ME$QBO2T:8? S@@ *V. 5QVKT '(R*K7UE%J%H]
MK,6\B0;9$4XWKW4^Q[XQ5F@#S+QCJ-L=>\1Z=Y9L[N30]JRK$TDM^,28C08*
MA5).[C)W=0%S532;FPNM>^&KLT;&/1IE8R+@J_EPA>O?*MCZ'%>L44 >)B\^
MRZ5/=Q@RZ59>-);F^2$;MEON)60J.J!MK<>F>U=9HFIZ?J/Q=U*YL)DGAGT:
MWVS1 E'(DDS\PX/&!U[8[5Z!10 AZ&O$K6[LW^$_A&PG9?,MM8M8[J&52-FV
M<EPP([#D^@(SU%>W44 >2^(4GN]?\?6NC[9+J?1[79%$1F8J9-ZC'4[3C\16
MUX<U+PMXBUJTUFPGOKB^M+9XYFN-Z"TC(^9),@+G(''/0D<#->@44 >(V4MB
M?AGX(AG:$K'XB0R(^/E03RDDCL,,"<\8(]:]J@A@@B"6\4<<9)8+&H R3DGC
MU)S4E% '">,#9GXA>!UNO)(6>Z+"3'&8"%)STRV />L?4;O2=%\9:[I7B*2Z
ML--U*"%+ PQMY,T0CV/"-JG!#;CM_P!OWKU.B@#RC6H$T91)H6HK875MHT4<
MFD:J-\=[; R;(\D[A(,L."?O 'K5N&[TL?%,W&L0VMDTWAJW?RKO:!&QEDW*
M2W&0./< UZ96!%X>N(_&\_B)KZ-DELDL_LPMR"%5V<'?OZY8]J /,K&.;PGI
MWAS4+Y;VU\.)?:@0T2MFTBE<?9W9<$A=H?MP)/?%:5_)IFD0:7XCTB&]G\/C
M7#>ZC,RNPD+Q,GGA2,[%8@Y ZC(]:]:HH \P\7SZ/J?P_P#$6J:%:EXKB:UF
MGNXXV N"DL>Y@",D*JC) QU[@UI:GJ%E=_$_P?<V\R,CVE[A^F=PCV]?7!QZ
M]J[VB@#SR+3;K3_'&I>'8[=SH^L2+JOF ?+'@@3QG_?81\>DC5GZG?Z98^,/
M$VD^*[B^MK;5?+-HR*YCNH3"J-$-JD[@P;CK\V1UKU.B@"EH]M'9Z)8VT,,L
M,4-NB)%,VYT4* %8]R!P:XWQ-)IUO\5O#$NHFW2/[#>8>? 4-F+&2>!WQ]:[
M^L"]\/7%WXQT[7EOHT2R@E@%N;<DN)"I8[]XP?E&.* //$-KH,%Y>_9(DT>]
M\4++87$BMY-I^[P;@*I&5+A@O1>0>F,K9/87%OXNM+O5;VT+Z[#<0W_D[&B;
M9$8Y6!4+MW*.H&1D^]>PT4 >0:O>ZG<^!->74UM;I[+5;)WU.Q0B.\19(29,
M#/*J &QP-OM7K5M<Q7=M'<0-NBD&Y&P1N'KSVJ6B@#AO$>IVMMX\M;.539SS
M:7($OQ$9'F!D&;>-<%=V5#'(8XP .]<;X?GLI]'^%D<^PFWFE643+C:1"X'7
MMNVC/3/'45[710!XOJTLGV?QFUBAN+:+Q!:W5W! -QEME6(RD =1E3GZ&NDM
M=:TK5_B[IM[IMS'=0RZ'-&)X5+*3YR,%) Z@9X/2O1**  C(P>E>'06FF:I\
M(;[2;1+=]<EU*<6T48 F$WVIMC#N %ZMT"@^AKW!PQ1@A ?'RDC(!^G>L/PE
MX?E\,Z*=.EO4NP)Y9ED6 QX\QV<C&YN[&@#G=#BL+CXJ^*TG6VGF^SV(4NJG
M+('+8]P=A/H<5SWAN?1]0T^P\.:^VI-XCT^^\QK#YUS.LA83JP&-AR6+9QR>
MO?V"B@#R^UN9].\40+I6H0ZIIEUK,JSZ7<*/M-A,7?S)8R.=F=S88=&X/-9^
MB3Z1?68\,>(FU(^(+34'E^P#>/-E\UG29& QM.=Q;.!SGBO8** /(+TV#Z7\
M5S_HYDEWB/IE_P#1E  ]?G!''?WK7LKV&#QYX6NYI"8;GP\UO%(%+!Y?,B.T
M$=\ G\#7I%% !7D\4T*>$/&WA_6P/[8FNKQX[=Q^\NQ(,PO$.K?P@8Z%0.,5
MZQ10!YM,[Z?XK^'-KJETAOK:QN([MV<<2&",9)]V!QGK6AI5Y:_\+;\2*;B+
MG3[1!EAR5,I8?4 C/IFNYHH \5LKTV/@[3=22-Y].T_Q1/<7\<*[BD)DEVR%
M1R54LC?@#VK=\27FGZCX?OM?\-6<US";VSN;^XM8V#7<<3C<$!'S%%"G(X[=
M0:]-HH \HU6X\,ZOX7\5ZWH]S<WLT^BRVTMW,7"$[3Y<8#  ODGH,CH>HK2O
M[32W\*>&9K35(]%O#Y36FH11H4$JP,NV7/!4J77!/4XKT6B@#A_#OB^&QT2T
M_P"$B^S6=U=ZE+9PRVJ.8+N3<?WJ'!PK')R3C.>:[BJUW917RQI,6,2.LAC!
MX<J05SWP" <>W.15F@#@K>[MK#XH>*$OG$0N]/M&A\Q3M=4$N\YZ8&1D^]<M
M;V$,_P"S>39VL;WB6 67RXP9!ME#L#W[9Q7LU% 'FESKNE:I\1[>]MI7NK!_
M#URGFPHV'_>(2%;&,X!^A'K4?AJ6]M[^/2(-0M]?THZ5-]BO50"YM$&P"&;'
M!S\H&0&)0Y'!KT^B@#Q>QU9++P3X#U&1KL:7I@,&IO;QMNMI#$45B,=%.X''
M3=[U>U8Z9;:1'XAT!=2N=*.LPWFI7,>\F50C*TB*1R%)C)(&"5_V:]:HH \P
MGC\*:KI>K:MI^IW\4=]-:>;K +;5FC<>4P#  ["%W'&,'D\'%[0O%AT33M9N
MO%%S9O#:W<47]KV43&.\+(H#%5SA@-JMC@8]J]!JO>V<=_:26LK.(9!MD"'&
MY3U7/8$>F#[T 3JRNH92"I&01W%+2 !5"J  . !VI: "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K:
MAJ%KI5A-?7LHBMX5W.Y!/L  .22<  <DG%<6FKSS?%JU@9=2MH#HLTSVLQ)1
MB)(PKJJD@G&1Z^HYK4^(.DZCJ_A<II4:S7EK=07<<#-M$_ER!]F3P,X[]\5F
M02ZEJ7Q$TO6_[!U*VLDTJ>"5IU13&[.C %=V3]TCC/Y<T 6=.\7>'])\+VVH
M+=:G-8W-^]O'+<QR22>8TI4AB1E5#9 SC@8K5@\56MS C0V.HFY<R;;1[8QS
M%4(#-M<@!<D8)/.>.:X2+1]83P'IUB=(O/M</B$7KPA1D0BZ,N[.<?=(XSG-
M;GBJSO;3QA8^($\/MKNG/9&SN+5$1IH3OWK(JO@'J01D4 ;]KXOTF_TVRO+&
M22Y-ZSQV\")B5G3.]2IQMVX.2< >O(SDZC\0K6/3K&YTZTN;EKC5DTR5"F&@
MDW@.K G[V,XQD$X[5FW]AJNE:EH'B33/#06WMOM$5UI-F(UECCFV$. "%9P4
M!8 ]\9.,U<\30ZOJ^BZ3?QZ+.CVNM6UZ;(%//$*'DM\VW?R3@'ICOF@#H;KQ
M+:VTDL*6UW<SP0+/<PP1AG@1LXW#/7@_*,MQTJI<^.M"@32GCFGN4U5&>S:V
MMWD$NU2Q P/O<8V]<]JR].AU+0?&FNZA<:;=SV6LI!<1- !(T,J1[&B< \=
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M*DT9BD;#+WY4<'IBIO''B*)/"OB2*Q-\9[&TD\RYLR0+:7R]R L"#GE2=N<
M\X%85OX6U/1M"\%6 LY9I++5FOKL0X98$<2DC/?:9 .,YP339;#7-,T?QSH#
M:->7AU1[VZL;NWVLCB9#\C98%64\8[]J .OT_74M=!TN-HKJ^O#I\5Q)% N^
M39M&7.2.ISCG)(. <&H'^(6@>3I<L$EU=+JD4DMI]GM7<R[ 2RCC[W&-O4'K
MCK7+G3M4T?5M,U6Z\*2ZM9W&D6]E<VRK%)/:31;L$ MM*G>>A[<UJ2Z;=Q^)
MO!L\&A?8[2S-XUQ%:1J([82IA =O!.?O;<C.3TYH WD\7V,L!FBM;YXXUB:?
M]SAK<R ,JNI(8'# G . ><5T%><^*-%O[C7;_4]!M]0T_7T>)(+B'FVU"/:O
M$X^[A<L,G!P!C/2NOM-<DN/$E]H\NFW-N+>-9(KE]ICN%.,E<'(P3CGKSZ4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEC=:E]O@D>)S(,SK,4;G'!!P1UXZ5Z-6;J&NV&EZAI]C=/(L^H2F*W B8JS
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M0"5/TZ5/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M294RCD, -P )4!C@?3).*Z*@ KS.SNIM!\4?$35Y;VYN$TZ*"=H66,";%L6
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M)-&FTN^WB"4JVZ-MK*58,"#V.0*B3PUIL?B6/78XMEW'9_8E"\*(PV1QZCD
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M1OMXD1925^ZI^4*L8YR .YZD\@'6T4V,,L:AVW,  6QC)]:=0 4444 %%%%
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MMM GE;88U\E=L>$ V#T'H.!7%Q3?9?C1J6'$=HWA^&:Y8G"AUF<*2?\ =W4
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M)O2\K.)?+6)E8@DC(R<8' XZ5EZ3.B:[X%O+.5_LNH-=A[F>7-Q?1^2[[I@
M!]X @'...G2@#URBO,XHCI'B37?!V'*ZRZ7=A(224A?Y9U![>7M9E';<*?=P
M)K_BSQ%X<N+RTM%M+:!;&.:)F:.)H\F6(AUPP<D%AR-J\T >DT5G:"KQZ!8(
M^H'466!5^V,NTSX&-^.>O7/?K7/^(OLE_P"+[337_P!*N%TZ:9K2X<+;1QEU
M7SFX)+@@A<=BW*]2 =C5-YKX:M#"EI&U@T3-)<&7#(X(VJ$QR",\Y[5Y-IKR
MZOX9^&;7=]=R/<7#P3LMRX,B"*7AL'D_*!GK[UT\.FP:)\3M#T^Q>X6T31;D
M+%)</(!B2/!^8GGD\T =]17E.D7NH:)>6MMJ&G)/J,EC<2:;J]F^Z/4\)O\
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MS6[^S[2T32^7P6"YS@]"1Q7"Z/:K83_#*_@FN/M.H6HBNG>=F\U/LA<*03C
M8 CTK*U:2#Q#\%];UW4 'U@7<@F8M\]N5N=JQ#^ZH3;\O0YR>3F@#VRBBB@
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M,,!<\]<9]K<:/>1:IX5\3W&HKJ_]IS3+8H"K769C)%)$P7.,;1G/&WG KV#
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M[K,656VAC\J98 #@#TK9L/%=E?:U=:2]M>6=S!;BZ'VN(()8<[=Z\DX!X(8
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MPR*V5^;S>!D YQ^%7;6RU:'XCW>JSZ?(]JVCPVWGQL@5Y4=W8!2VX [AC(H
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MQ\COM $G_;,TWQ5X>N[*]\/:EI&BPZO::7#)9S:=(4#-"X3#(7XW*8QUZYH
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M^U?)>4D@#[VX D$!BN#ZX(-4KCXC:7;V>I7?]GZK);Z9=-;7CI;#$. I+G+
ME?F'3)X)QCFL/PCHNK:-%;>'[WPC92-92;8];/E&.2$-D.1]_P S'&,=><@4
M3Z'KDGA7Q]8KH\_VC5[R>2S4RQ?O%>)$!SOXY4]>U '60>+[&?6X]+:UOH9)
MX'N+666'"7*)C=LYW9&X'! SGBLE/BAHC6EI>M::I'I]Q.;<WKVN(87WE '.
M>,D=0"!D9P>*)]/U2;Q=X.O1I<XMK"TN8KIR\?[II$C"C&[)Y0YQGM7+Z%I]
MWXF^$3>'(;&91=WLZ&Z8KY:1_:V9GZYR,$ 8SG';F@#J;*X^R_%+Q#YUW*+2
M/2K:<K+,QCC^>7<0"<*,*,XP.*U(O&-@\^FK-;W=M!JA"V-S,BB.=B-RKPQ9
M2PY 8+GZ\5A:GX;U'5_%'BB-K:6WL=3T5+"&\+H5#CS,_*&W8^<=NQIG]CZQ
MKNA>&=(U#3)+*?2[NVGNYV=#&?('!C())WD#' P"<X(P0#H;+Q=97MKK4_V:
M[@_L=VCNHYE16!5=QQ\W(VX(/0YX-12>-+5-4&EKI>J2:@;(7HMU@&XH6"XR
M6VYSZG'&,YP*RM;T&:7XA6CV<J+::K;_ /$VA/5UMV5D8?7<(SG^%JNO9:@O
MQ2.K#3YFT\:,;7SU>/!D\W?C!;=T[XZT -@^(NDW%EIU\EIJ0L;V9;?[2UOM
M2"5FV!),G(.[@D @'O6AJ_BVST>*^G>UN[BVT_'VV:W166WR WS L"<*P8A0
M< BN)7P]KX^&5OI']BW'V]-7^U-%YL/^K^UF;.=^/NGIGK5TZ5JND>*=7+>$
M8-<L=4N!=V]RSPAK=RBJT<F_G:"N05SUZ$\4 =%/XXT]-3ETZULM1OKE;1+Q
M%M8 PEB8D J20.QY.![YXJC>>/5DC\+W&D6%Q>6NMS%5D&Q2H",Q7#,/FROT
MX/.<4MGIVIVGQ$FU%],<V0T6&S66$QJC2H[,0J[L@88 9%<]I7A[7]/\+>"0
M^C3/=:/?R/=6JS1;]C+* RG?M(^=>^: /2K_ %"UTO39]0OI1!;01F25V_A
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MLI$2>R(4!)=RL 7SG.TG@CK@T = OB:W9+-5L[O[7=O,D=H0BR?NF*N3E@N
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MEKHNL:UX8\.:!J&F26D^FW-L]U<%T,96#O&0<DOM&.!C)SC'->ZT+7)O#OQ
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ME#$*P; X88/XUS&K>.+BV74I=+TTWZ:=/Y$D*B0RSL,;Q'M0C*YQR>2#TX)
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MB-?W=M$<-(20 ,]ASDGT!KFXO&LYN/$-H+:SNKC2+1+M6M[D^7,I#94G:=K
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MF8[E&9K=B22\8! RP(!R1]T<GI7644 <#I/@W6K#_A#1-<6$@T"*2*3877S
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M$VA2ARNUE*@ @KV]>:+[P3IVHZ->Z=/<W?\ ITZ7%W<*R"69U*E<G;@ ;%
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M2TM1:+\\;[XQTW!D(R.Q 'ZFM2PT>UTO0X-(L-]O;00B&(J064 8SD@Y/U%
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M(R,G*JN<L .G %=C'X:EO+W1-7U/4+G^U=.MC'^Y\L1EG51(<;><E1W[<8H
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MHHC)Y9\H[7P"I(\P\CGI6]J]UK7AZ?3(KS69)K*_U(K<WK01Q_9(S&2L8P,
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M0/</->)').TT[R;F" 9 8X7Z# H VJ*P?&NHWND>"-:U#3A_I=O:221'&=I
M^]CVZ_A6+]GT^RL;?Q%H5]/)</I<I@MTEWK?L(]ZO(.2S C[V<_-C/.* .XH
MKRB265/A_P"%/$^EW,LFLS3V?G2AR6NVE8++&_\ >&6;C^';QC%0:GIZ7%E\
M2YI;J^9].=IK,_;)/W+K:K("/F_O=,Y [8R: /7J@-[;B_6Q,J_:FB,PC[[
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MY\GCMZUYUIEC;6_PS^(,L4>UQ/J\6=Q/R@O@5JN7CUKX9E)IE62&1'C$K!&
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M.Z@YZ'OZU<@GBN8$GAD62)QE74Y!%4K77M)O;M;6VU"WEG92Z(KC,BCJ5_O
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MBF]TS5='LM,2-EEU.VMKZ9QD(LAX1?\ :(Y/H,?WA0!V-%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 <?\ $R.]?P:[V=O+<K#=6\US!$NYI8$D5G4#OP.GH#6!?:I;^(/']K<Z
M%,\IN/#]W!#<I"X596="@+8XQ@]>E>GT4 >6>$+C0=8B\/V4]EJO_"0:.$5K
M28SJ+-U7:[$GY-N <#/.0,>B17\,6F?$F06(U,/=O(MGS_I$?DQJ2,<E<@Y(
M]#7JE% 'EVDZC;M\1H[UKN:YM9_#Q1;@VC10Y$NXJOR\*!ZD^F2:R+)+9?AE
M\/8)8XP\6KVS31LG* %]Y8=@,C)/J/6O:** /*-<NX;;7?B%-_9RZE&^G68^
MRX)68KO#_=Y.T,"<<X':I].NA>?$*]DBN+J^6\\.JD4YM&C1V$DA(7Y0 HR,
M9)ZXR37J%% 'CHNX9/A/X-@Q(LMI?Z>DRO$RE#'(OF=1_" <GH*Z+3KV'2/&
M7BV'7V5(=1:*>TEE&4N8!$$,:>I4@_*.3NS@YKT"B@#R#0=-N-*N?AE8ZLI%
MQ;1WK.LHR8 ZYB5O[I VJ,]UP.E=5\/GC-UXM5",-KLTJ ?Q*R1_,/4$AN?8
MUVM% 'G.GW,.EZCXVTSQ$,/?73W-OYBY^UV[Q*BI'_?*[2NT<\].:SDM[K1M
M)^&=AJTF+RTN5:X#')B7R)%&X]@"RKGIFO5Z* .3^(T5[-X+GDT^WDNF@G@N
M)+>(9:>))5=U [Y4'COTK+U+6M \0^'M?U;2K9I)GT>:WDO7MWC/*G9#\P!8
MY)X&<''J*] HH \NM'MX[_X7>7L416LJR;1CR]UL%PWIEQCGO[UCQ:I%<Q>$
M[A+:XLUMM>?SM-ALWVV>1-PQVDLY+9ZX.[@5[310!YUX;-J+GQ[.+)+R4:C)
M/'"%&Z=1 H 4XYR=ZY'<FL31[]+KQ%X$N;=IA']ANK<116;K#9N8XPL0RN3M
MQ@EB?NYX%>P44 >8>"=3TZ?0M'\-:MI<\GB'2K@&2VEMW/ERJQS<;\;<8);=
MGG.!DD51N%O3X?\ '>G6=K=2:@NN&^^S)&P:6W#0L0K8Q\RJP !R>:]=HH \
MS6\\,:Y9ZMKFEKJ$]VND36TUS=&91&I&1"0_#,6[#.,=>1G4\/ZUHWA?X9:%
MJ5]^XB6RMK>5XX"S*^T A@HR,-NSGIS7<57O;.._M7MIRWDR#;(JG&]>ZGV/
M?% &'X[N4M_ VJ3MIHU.,1#-L5+*X+ 9(7DA<[CCLM<;%?PR>,M=N6N[B[AN
M_#B[+F2U:.-R&ER%^4#;R ,YY.,DUZMTHH \DL#!!H?PL50D;P2)YP P8\V[
MJV[T^8@'/<UF7^H"+X6>*_#FIQS#Q MS<220M"S-<;YMZ2K@?,N"HSVP.G%>
MW44 <YXLO$7P!J=TNF-J49LV/V-D93*".A'W@,<GO@5R&FZC;O\ $,WC7<]U
M;3^'-BW+6C119$I)5?E&% /<GKC)->I44 >-Z;Y-OX$^&B;5CE@U.%IEVX:/
MY) Y8=N2,D^HKH=:TV^T_P :RVFGQ,=/\51B.Z*''V>6,#S)/;?#N&1_$JUZ
M'6)I6A7-GJ4]_J&KSZE,2ZVPEB2-;>)F#% % R>%Y/\ ='3G( _Q/HG]N>$=
M3T6%EA-U:/!&>BJ2N%_#.*P/!OBFQM?#6G:3K$@TW5[&W2UGL[D;'9D4+E!_
M&#C(*YZUV]% '">-+L37?@V5XWAQK:2E9!AEC$<HWL/X1RO7ID \UR?B?4([
MC3O$$"6\]E+;:]#))9PVK-YJK-%FXD?:?O 9&T@8 ZFO9Z* .$BN[;_A;=[<
MLX2%O#\0+R J,B5V*G/1@I!(/(!KD+".V7X7?#^"6- \6L6S31LG* .^\L.P
M (R3ZCUKVJB@#S#41IT_BSQS#?/,MG<V%E&\EMG?D%PS+CJR;E)ZUM>"KK53
MK&IV5]>VVL6\,,)@UB",(95)?]U)CY2Z]>.SC/6NUHH \F\<7JS2^.--2VFM
M+AM-3;Y-LSOJ'[IB&+8(")DKQ@YSD]JOV,ME?_$70)9$5XV\.R1?OHB/G+QX
M4AAP2H; /4>QKTJB@#S.==/D\4_$.&^$ILI].M(Y/LX.]E5)0^S'5EW#@9QQ
M3;&[U**S\26%[J-MK=BFDDP:NB!9#D.%@EQ\K.,Y&.?FY'S5Z=10!Y18- TG
MPG64(?L]HXE##_5-]EVC=_=.\8&>X]:JWHMY?"_Q 4S21*-<6YB:*(R X\C:
MQ4<LA=3N(SP#U(KV&LKQ!HKZY81017\]C-#.EQ%-"%;#H<C<K AESV/H/2@#
ME/"^LZ+KGCNZU6+5K5M0FL([5+*(2#*HS,SY=5+'+8P!P![\6/%=U%I?Q!\*
M:G>%H[)8;R!I@A95D<1E%. <$[3CUQ6_8:/>I<17&K:J=0F@),(6W6%$8@J6
MP,DM@D=<8)XK9H \4NI8Y_!VNQ202@R>+_-$<T#+NC^T(2<$<@*#GTQS6QXF
MCNKWQ9XJ@T5LW=QX82* Q'&^0/(=JG^]M(_,5ZG10!Y0^O:9JMU\/GL8Y@UI
M=&.>%;9]UL?L[J488^7!P,>V>G-0:0VDW-K+X6\26NJR:Y!J$DJVH,X2X8S-
M(DR,ORA>02Q(Q@YKUZB@#A?"26DWCKQHYCB=VO;>2-BH.X+ JY4]\-N&1T-=
MM//%;0/--(L<:#+,QP *DHH X3X/L(_A;H\,GR2P+()8W^5HSYKGY@>1QS7*
MR?-\,];:-'80^)FN65$)(B^V*^_ YV[><^E>RT4 <'>W<5W\4M"G@D(1])NE
M5V4KAF>,KG/0D*2 >H%<_P"$WT>_T_1= UFTU5O$>DW,;-:.TX5)8S_K]P^3
M9@ELYYSCG(SZY10 C*KJ58 J1@@]"*\W\%:-J.G:]=>'+F%O['T*Z>ZL)6Z2
M+,"8D'KL#2Y]ROI7I-% ' >,KB)/B-X&9G 6">Z:9NT8:':I8]LDX&:+&XB/
MQOU-@XV-H\4*M_"9!*Q*@]"P!''6N_HH XKQ;)-I_C7PKJ]P&_L>W-S#<2 9
M6"21 $D;T'#+N/ W>]9+P;7^(NKP.!I5_:(ENR_=GF6!E=D]<DJN1U(/7%>E
MT4 87@J1)/ ^A!6!,=A CCNK"-05([$>E>;ZE*$^'GQ#TMXYEO&U.[D6(Q-E
M@\BE,'&#N'(QU /I7LM% 'G6J;9OB!IBZ9+&CR>'[J"*2,X578QF,9' Z$@>
MU9_A"?0M6M_#^G75EJO_  D&CF,-:3&=1:2(NUG)^YLQG SSD#%>JT4 <+\0
M],O#>^'/$EE;2W?]B7IEN+>%=SM"XVNRK_$PP#CZUT%KXJTC447^S+M+Z9\8
MAA.77_?'5 .^['Y\5M44 <1HWDR_%'Q=&X5DFM+-,$</M$@<>^-P!],U7\$Z
M??VEY+H%Y%)]B\.W$BV<S])DD&8<'OLC=U/U7TKOZ* /*C+'_8'Q356&9I;@
MQ ?\M-ULJC;ZY8$<=Z[[PW-'_P (EI4AD4(ME%N8G 7"#.?3&#FM>B@#P_2O
M#\NK>'-2U+3D^TZEI^OW5['I]PQ,-Y%OSM,;?+R.5?'4#FNH\7:_8>(/!VCW
MMH6&[5;*1X)$*R0[95+!EZC: <GIQZ5Z110!Y9XDU:PT?QCXBBFOHXEU?2X(
MG-U#*44XD4,A1&#+@G*G;ST/7#U.DC6/AI#I]]'?V%I'<1K<]0=L&Q6;^Z2R
MXY[C'45U<GAO5(=9O;[3?$,MM%>R"6:WFMDF"L%"_(QP5&%'!R*V["QCT^U$
M$;NY+,[R/C<[L268X &22>@ ]* /)-1!E\&>/U@1I/\ BH4N56-2Q,8>W+.
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M24#&,MM7!ZGIW-5/$OA[Q=8V>@P-K.G77_$\MY-Z:8X?S2Q/FR'S3D9ZCCL
M0!7K=% #(1(L$8F=7E"@.RKM!;') YP*?110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &+XMUX>&O
M#%[J@C$LL:A(8R>'E=@J ^VYAGVS37U&+P_'IUA<O<7VI7SLJ*F-\\BH6=OF
M(50 "<9 ' %9GQ-T^XU#P-=-:QM)-:2PW@C49+B*178 =SM!_&I/$LVJW%YH
M,VF6MQ?:-*SM>BRE1)6!0>40S,OR9)S@CMVR" 7+;Q?IMYIMK=P).SW-T]G'
M;%567STW;T.2%! 1SUQQP3D5J:;J"ZE:M,L$\!61XFCG4!E96(/0D8XX(/(K
MSC3O#5R?#,^CZUX9N&MFUNXG!MYUWP(QD9)HBK _*2H]?F/%=AX+L]7L-$DM
MM7N9[EDN9!:R71!G-OGY/,(ZMU]\8SSD4 :6KZS:Z-#;O<"1WN;A+:"*, M)
M(V<*,D ="<D@<5CW'CS2;30M2U:XBO(X]-N#:W</D[I(Y..#@E<?,ISG'/6I
M/&)UD6FGG2;6>YB^VI]NCMG5)S!@YV,Q&#G;D@@XS@CK7#7OAS7F\*^-],M_
M#\Z/J5\D]F@FB.Y2L7&=W4;&R3WZ%J .X;QM8IJ\NE'3]4^VB'SX(OLO-RF=
MI*<]B1G=MQFI['Q=INHZ-;ZC;K<$W$[6T=JT>V8S*6#1E2< C:Q.3@ $YQ6=
M<6M_+\2]-U9=-N/L,6ES022DI\LCNC 8W9Z*>@Q7)CPUK\6CQ7J:$+BYL-?N
M[_\ LZY>/%U;S%Q\IR5W /D9[B@#L+CXA:-::?J%U=17L+Z=<);7=LT.9(7<
MC83M)7:=PPV<&KUAXKL+[5KO3'AN[.XMH!<D7<7E"2$DCS%R>F1@YP1Z5RFO
MZ9J&K^!M0CT[PE_9T]W-;&.T00I,PCF5V:0JVT# ( R3^>!8U_0=3USQ;J1B
MM)H+2]\-RZ<MVQ7:DSN6 (!W8P>N* (O$?B ZAJG@RXL4U*"VN]60).6*0W,
M)C<\J&SR0I&]02.G>NCU+QEINEH]Q<1W/]GQW M9K]$4PQ2;MN&YW8#':2 0
M#P3P:Y)H?$=]I?@VTF\,WD5SH^HP-=D2P^65CB="Z'?R#D'MUQ2Z9HVIZ3?:
MAHMSX/M=2CFO)I[/57$31A)'+_OMWSY4L>@.<<>M '1>+=?A&B:_:6D=_--9
MVCF>:R;;]F8H67+;@<@88A<D#&1R,Z7@Z22;P1H$LKL\CZ;;LSL<EB8UR2>Y
MKD?[/UW1I/&6EKH]S?VVLR37=G=0/'M#21!#&X9@5P5&, Y'Y5UWA&WNK/P=
MHUG>VSVUU;64,$L3LK$,B!3RI([>M &!XOOWTOQYX2G#WSQ2?;%DMK<NXF(B
M^7]V#@G)ZXX[G JU_P +&T<:%>:LUOJ")83B"]MW@"S6S'&-ZD]#D<@D<_6G
M^)[&^/BKPQK%M92W5MI\ER+E82N]1)'M5@I(R,]<<^U)I?AK[9?^*;_5+7RX
M->\N$VKD%A"D7EY;&0&;+''88[] #??5(TU2TT\P3&:YB>8%=I5%7:#N.?5E
M'&<YJY(YCB=PC2%5)"+C+>PSQFN.^'FG7]OI<D^J7"W,T1.GVTR_QV\#LJ,?
M=CDD]_EKLZ /*M9\57>O_#6/7##>Z:ZZI$JE)MH:/[7Y94[&^;Y1@@C&>F:[
M>R\7:==7NHVDT=U8RV$(N91>1>7F$YQ(.?N_*>N",<BN%&A>($^&J^'SH=R;
MNVU5905EBVRH+LS%E^?IMQUP<\8K5U_PYJ6O^*->5+6:WM-0\/?V?%=.5VB;
M>[8(!W8PPYQZT =-;^*[.76K32I[:[M+B]B::S-P@"W"J 6VX)((!!*L <=J
MW&(52Q. !DFN(\)I?SSV@O\ P5;:1=VBD7%YMA*NVTK^Y*?-R>3G  R.:[<@
M,"",@\$4 <+X+N)O'6ER^)-0NKM+6YN)%L+6WN7@6*%&* ML(+.2I)))QQC%
M3ZW';^'?#6KMKNH:K<:;+=QM"\$CF:%#Y:JF]<$#>IY)Y#<DDG-7PC9:GX#M
M)O#LNEW5[I<4\DFGWEIM?$;L6\N12P(8$GG!!]JM^.K36-<\":A:6VF.]U<2
M0^3;*Z;U59$8EV+;<X4\ GMUH W!XAMCXI/AYH+A+S[,;I695\MHP0I(.>>3
MC&,_A65J^O:5<0Z2]['J<"RZNEM;&$E0\RN5&XJV#&2#P3SCH:;XQT?4[]]&
MUG0E6/5K&?:!+C'DRC9(&]=N5?\ X!47BW1KK^SO#5GI5C-<QZ?JMK.X1ERD
M,1Y)+$9/ZF@!VE23+\5O$%N;B=X!IUK*L3RLR(S-(#M!.%S@=*Z]U#HR'(##
M!VD@_F.17*Z?97\?Q-UC49+&9+&XL+>"*X)7:SHSEAC.1]X=JZIVV(S;2V!G
M"]30!XK#K$D?@OQ#=#Q)J*^(+;4[J#3HA>O+)(4?$<8A)(<'H?E)QDYXKO\
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MMX3;VT4)EDE,:!/,D.6? QDGU-<I)<7D?Q<M;3[=<-92Z---]F+#RU<2Q@,
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MN&D!^?<N[& .<#D=:Z'PU9W]KXN\67=SI\\-M>W$,MM(Q0B0)"J'@,2#E3U
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MC&6CDRHP<'.0,>QKF->U7^W?@Y<WSV%M9N-3CC,,'*J4OE4D' R3@DG SDT
M>G&^M!J"V!N81>-$9A!O&\H#@MMZXR0,U8KF9=7N!\0_[%6PM S:1)=0WC$F
M3(D1=A&!A<G/!.<#I6)X4\0^(9_ =KJEPEM=SW-[(C2DE$MT\^0/(^3]Q0.
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M],O)ECEN.@  R>O&*_BSP[J&O7VB3V=S;0#2[U;S$R,WF, 1MX(P,'K7444
M<_<Z3JVK^9:ZK=6JZ;+;RQ2PVJ,'D+J4Y8GH S<8ZX/:N(U72=;T&P\'Z=JN
MJV=W:VFO6<%JT<!CD= &"^82Q&0!C@?C7J]07%E:7A4W-K#.4^[YL8;'TS0!
MQ>J>"=6N3XJM;+4[2*PU]"S"2!FECD,0C(!SC:=H/3/4>]/D\&:R=0,Z:Q:,
MDVDKILWF6K$QXSEHAO\ EW9&0<\@'GI7<=!@44 </:^#=5M[;P?$]_:2-X?&
M&(B91,/*,0 Y..#G/<]A70>*M)N->\,:CI%M+%"][ \!ED!(0,""<#J?RK75
ME=0RL&5AD$'((I: *&B6<^G:)96-R\;RVT"0EX\X;:H&<'IG'2N*B\ ZY%8Z
M;:'6K)ET[5SJ,4KVC&2;)<GS3OY;]X1QCH*[C2]4LM:TZ+4-.N%N+67.R1>A
MP2#^H-7* .$O8-&\6^.=+N--OEGFTOS4U'[.V5*JRE(I/?S55@/1&KN)?,\E
M_)V>9@[=^<9]\4V*.")Y%B2-&8[W"  DGN?KCK[5+0!D:%I=QIVA_9+UK>YN
MF:22:15(65W8LQ(.<9)/'.!7)6GPZU"/P.?#<^K1(;6Z%WI=U#&=UJROO12"
M?F )([<&O0F=5(!(R<X'<_05GZ+KMEK\%S-8F4I;W,EK)YL9C(D0X88//7UH
M QY?#VN:SX:U33]?U2U:XO;1[5#90,D4092-Y#,2S$X[@#&!C))2.+Q-ITWA
MZT6]L9XTS'?11VS#<@4 ,K%CM P>O4D#Z=710!A>+]!E\2>'I-/M[A+>?SH9
MXI'0LH:.17 (!!P=N/QJK%H&J+XS3Q!+<VDI&F&Q:)49,MO\S<.N!GC'/'.:
MN7/BO2;36SHTCW;:@(?M'D164TA,>[;N!5"",\9J[IVKVFJ&=;;SP\#!9$GM
MY(6!(R.'4$C'<<4 <3!\/M5L_#^CQ66KP0:SH]U//;7/DEHI%F=F>-TSG!W8
MR#V!KL]'MM3@M6?5[R*YO9#E_L\9CB0=E122??).23Z8 T:* .;D\-SV/BBZ
M\0:-+"D]]&D=]:S@B.<IPCAARK $CH01VSS3[/P[,_B-O$6J2Q3:@D!M[6*(
M$16T9.6P3RS,>K8'   '.=N[N8[*TEN9M_EQ*7;8A<X'H "3^%0:1JEMK>D6
MFJ698VUU&)8BZX)4],CM0!Q9^'M^_A\VG]I01:C;ZP^L65RD9*I*SLVQU)Y7
MYB.O?VYLS>"M1UC6=0O=;O;(P:AI TR>"UA<$?,[;E9F[;NX_#C)[BB@#E/#
M^C^*M/CB@U;6[2^@LT*VYBMVBDG.-H,S;B.!V Y.#GBKG@O0;GPSX6M-'NIX
MKAK;>!+$I4,&8MT/3KCK6_10!F>(M&A\0^'=0TBXP([R!HMQ&=I(X;\#@_A6
M#J?P_L]2\.:#I,DS?\2J>*4RG.Z8 8E#'_;!;/KFNP9@JECD@#/ R:YD?$#P
MX8;N<W5TL%G.UO<S-83B.&13AE=MF%QD9R>] %GQ7X</B*QM!!<_9;ZPNX[V
MTG*;E65,X##(RI!((SWJG<>&;S4+R^U6[DM5U&;3FTZ!(]QCA1CEF)/+$G'8
M8"X[DUT\4L<\*30R+)%(H9'0Y# \@@]Q3F944LS!549))P * .+O/!VHW7PX
ML/"PO+59;9+:,W!1BK+"R,#M]3L //&:=:>"9K9M;T[SX1X=U>-MU@N=UM(Z
MXD,;= I))VXX/(QTKIY]1C@U.TL&AN&DN5=ED2(M&FS&=S=%)SQGK5R@#D_#
MNB>*=,BAM=4URTO;2R3;;>7;M'+-@87SFW$8 [ <G!)XY-!\-ZOH/@J/18+^
MU^V0S&2*X\IMC S>8RLN<X()7@]#7644 <WX;\+QZ'JVK:BD5O:G4C$6M+3/
ME(R @N.!\S;N>!T'7K4&K>'-5O/&VG>(+2YLXUL;>6!8949B_F8R201C&!ZU
MU=% '()X*:_\37>NZ[=QW,TU@VG16]O$8XXH6)+9))+,<GGC&>E)X:\.^)M%
MBM].O-=MKO2K(;;;;;E+B15&$21]Q&!QT&3CDXR#V%(&4L5# E>H!Z4 <"W@
M34V\&3:#]NM-\FI?;O/V-@?O_.V[?J,9STJY)X7\0V'B2^U+0=8L[:UU0I)>
MVUU;M*(Y0H4R1$,O) '!XX_ =-JVK6>AZ9-J.H.\=K I:61(FDV*.I(4$X]Z
MDT^_M]3L(;VU+M!,@>-GC9"RD9!PP!Z4 85YX=OY?%>AZM%=1-!I=O- 4FW&
M2;S H+%AP"-@['//2JC^#KJYF\8_:+N%8O$,(C7RU):#$/E G/WN.>WI78T4
M <D/#NKR:19Z=J#:5J5JEK]GN;6:%DC<@*%8'YB" #VYSVQ6OX<T8^'?#-CI
M"3M<&TA$8D?(W8_/ [#K@8K6HH YGPEX=OO#]UK<EU<6\R:GJ$E^/*5E,9<*
M-G/484<\?2I9]"O)/'MMX@2> 6\-B]D82#O8,ZN6ST&"H&/UKH:* .0B\*:C
MIEWKJZ3>VZ6.LRM<.DZ,6MIG7:[KCAP< [3C![T)X+?3M4\.W&CW<4$&DV3V
M#1SQ%R\3;#D$$8;*=3D<].U=:[K&C.[!44$LS'  ]36%'XRT>3[*V^Z6&\D2
M*VG>TE6.9G("[6*XYSP3C(Y&10!D:-X2U_0KB73K+7+<>''G>9(6MS]IA5F+
M-$CAL!<D_,02 >/6EM/"6NZ3J^I)I.M6\.BZE<O=RQ26Y:>!W_UGE,& &X\\
M@X]#W[6B@#FX/#]]9>,M3UNUNX#;:A;PI);R1G>'B#!</G !W<\$\5B6?P^O
M+3PYH5JFH0+JNAW<ES:W(C/ER!V8NCKG(!#E>#G@'VKOZ* ..U/P?=:M!K]S
M<3VR:EJVG_V:I4,8[>'#=.A8DN3V[#MDRCPSJ!UCPO?-<6H71;>2&1 &S-O1
M4)!_AQM!QSUQ[UT%SJ,=MJ%E9-#<.]V7"/'$61-JY.]APN>V>IJV&5BP# E3
M@@'H>O\ 44 9'B'3KW5+:WMK66W2$3QR7*S GS45@VP8Z9(&3SQD8YJCXV\,
MW/B;2+:WL;F&SO+:[BN[>Z="WE.AR" ,9SR.O>NFHH XW4/#.O+XDB\1:+J5
MC;7\UJMK?P7$#R03!22KJ P8,,GOT/YV=0\,:A<:KX?U*WU2,W6F>>LSW$)8
M3"8 ,0 PVD$<#H!QVK=GU2RMM3M--FN%2[O%D:"(]7" %L?0$5<H P]#EUE]
M3UA-2FMY[-;C_0I(HC&57G*')^8J OS#@DD=J@N?#]]_PG">(;.[@5&L!930
M2Q$E@LA<%6!XR20<@\5T3,J*69@JJ,DDX %+0!P$?@34X_!UGH/VZT+VVI"_
M\_8V&Q.9MNWZG&<]*M_\(MXAT[Q#?WFA:U:6UAJDHGNK>YMC*T,NT*SQ$,.2
M .&XR.AZ5VE5=0U&VTRV$]T^U6=8D &6=V(55 [DD@4 3Q1^5"D89F"*%W.<
MDX[D]S3ZSM(UJWUF.Y,,5Q#);3&":*XB*,C@ _0C!!!!(.:T: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-G"1ET^Z.,9 XQG%9/A^TU^XT?QF^EZ[=_VG'J]TEL9TA=6=%3;NRG< +Q@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\PR">>3U S5_Q)HL&E>%-0AM=8:>,ZQ9R+#:YCBLR\R!D3#$ $'.W/&<X&:
M/7*P?$^OSZ!_9+16D<Z7VI06,C-*5,8D;&X#!W=^XKG;_1M"L/$NGZ)9V^^1
MX;J]:TNYBUJ Q0/*X?)9AV48ZL>.M<W8W3W7PO\  C2W!GD77[5-S-N.%N75
M>I] !^% 'LE%0QW=M+<S6T=Q$\\./-B5P6CR,C<.HS[UROC6UU*XO=,ETN&Q
MU&6W2:232+T[5ND^0%E)! =20 2,?.: .GN-0M;6[M+2:55GNW9(4[N54L?P
M '7Z>M6:\DA&B:OK?P\O%TY8[9XK^-H[U%9T\M/N,3U"L&Q^=0ZS<VTA35M.
MD^9?%44)O+B0&X9O-5'B3 &V(#( ).1GCO0!ZQ%J%K/J%S812JUS;(CS(/X
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M*>!\[9(G#JW;@CBO/XO#^G:U\4?$T&H)+/#';V$Z1&=PHDS(=V >V.G3D^M
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M1KR^@A#H77>XY4=6^@R,GH,UG:GXPT;2[_2+2:\ASJA8PN)!L$8C9]Y;I@X
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M:SAU.TFOH(@]Q"DJEX_4D#IS^5 #K/PWH>GZI-J=GI-E;WT^?,N(H%5VSUY
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M^Y3@J IY/!)W=@,UCZ)/:7-S\*=^TFWTZ9'\U"-CB"-1U']Y2 >Y''2O7:*
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M5KTI>0A3+ .LB;2<@>G!]NM<3X@L-3TOPIX@DN]/DB-WXG@O+96DC/F(TT(
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MUB#SK*XFC14D(3S"GWLAMN>2,'!P34]GXRL[S2-8U'[%>PC299(;F"54$N]
M"0H#D'@C'(SGBN?M]#UJ.'X>HVERYT9 M[^]B^0_9S%Q\_S?,<\=O?BK5_H$
MK_$N*2UF06%_;K<ZG;XY9[=QY+>V20#ZB.@#MHG:2%':-XF902CXW+['!(S]
M":?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% $-U=VUC;/<W=Q%;P(,O+*X15'N3P*D1TEC62-@R
M, RLIR"#W%<W\145_AQXC#*&QITY&1T(0\U5'B.2UCT_1[&,-=C38KIW>&65
M44_*HQ&">2K<\8QWZ4 =A17&VGC2\O(?#MO+I,NG:GK$DT;0W:,!!Y2EF."
M6S@;1QD'/:FV'B_6;ZPU=TT6![C3M1_L[]W<DJS!E#2L"HVH%8-U)X(XZT =
MA/<0VL#SW$T<,*#+R2,%51ZDGI1!/%<P1SP2)+#*H>.1&RK*1D$$=017#3^(
M_P"W] \:Z;,MK,=-M'47%N<Q3J\!<$ YP1R.IZ=:Z+P;_P B/X?_ .P;;_\
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M\P:TRNY#(Q7:5/0D="?XAS0!OP>&](MM?N=<BLU&I7("R3EV;@ #@$X7@ <
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MO([>\,L<XDW$(&C5RHE P =F[..IZ^QU673K%;PWBV=N+H]9A$N\_P# L9H
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MNV'+?N,Q"+GCYN!GMSQ[UVE94>OVDGB>3P^$G%Y':B[+-'A"A;;P>YS_ "H
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M#[)=MYL3R_:$BS$FTCY6;LQSP.^#6')X\TF+P[JNN-#>_9=,N)+:=?(^?>A
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MP(QE3CD=15#_ (06XTJ#PO\ V#=P";0Q,G^F(2LPF7$C':<AMWS#MSBNXHH
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M]F5V.?,.U^4X<#''3.>*W[6]O-;\5Z[H*ZG=6L>CP6R+)%L$DLDJ%S(Q*X.
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MU$;*RLI /(XR.U17G@S2KO1;;3%-Q;+;7(O(;B"7$RSY),FX@Y8EFSD'.XT
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M9GE;=EG)4YX8C'0#CL* .4:77C)XUTX>)KX+HJI/:S^7#YI+P>9M<[,%0PZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+*FX8.U@",_@: +%%5K*^@OXG>!B3&YCD1AAHW'56'8\CZ@@C@@U9H ****
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M=R;"X$8N57[N\$'D#@$8..])JG@33M0U&TU"TO=1TF\MH!:B;3Y@ADA'1'W
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M](DREL_F* .1<J.<R#<!NSSD?6@#M7+!&*KN8#@9QDUQ/_"P)?\ A!H_$O\
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MFBNF6+#-(6SM5<AL*#EL?+QQQ\J?;_ MC'>N9S:>+EMXLRLVR,76T*"3G '
M)[4 >UTC$A20,D#@>M>=7$/_  D'BS7_  V]]#;+9VL"V4<BNS(C(298R)%^
M8-P6Y(VCGU-)G;4/&5IX=U74?[3MK71(YXI&&Q;V0N4:8KD[L!1CD_>)'4&@
M#J_"WB!O$FES7CVGV5HKN:V:/S-_,;E"<X'7%)-X@>'QK:>'C9_)<V<ETMSY
MO]QE!7;C_:ZYK%^%L2P>%[R%&9ECU:]0%V+,0)F')/)/O46OV,.H_%71;:X,
MGDMI-WO6.0H6'F1<$J0<?0_I0!W=%>0:=K%S::#HVF3WQBT]_$-YI[SW+,X\
MM#+Y4;MN!(+!1UZ#!R,BK'BO2+G0?!_B%8M?E?-W9S06]MOB%D'F1&4?.V5;
MD[3P/3F@#U>J>HSWMO!&UA9+=R-,BNC3"/:A8!GR0<X&3CO7#ZG:0:/XLTCP
M_%=&&PU,75RPOI9)UGN1Y8"<N#]TNVW.,\XSBJ.M:=<Z'X7MK7^WI[UH/$=L
MJ&-GC$,;RH?(/SG>JAN-Q/! [4 >I45YO<:7%JOCOQA9W=S>O;)IUK*D(NY%
M57(EY&&XZ9P.,\XZ5TO@"\N-0^'^@7=W*TUQ+8Q&21SEF.T<D]S0!/IOB![_
M ,5:SHCV?D_V;'!()O-W>:)=^.,?+C9ZGK6Y7G!T"R\0_$CQ=;7[W2PBSL2!
M!</#SB7#$J1DCMGCVK(M9=3B\ ^&O&5W/<W4VD3/]KR[?Z59>8Z>8RYPS*FV
M0$^A/>@#UZBL'PT%O%O=<4DIJ,V^#YB1Y"@*A Z?-@O_ ,#'I6)XSM?M?C;P
M=:M<W<<%U-=1S1PW#QAU%NYP0".??KSUH [FLG6-:73+K3K&*)9K[49FBMXW
M?8N51G8LV#@ *>@/)'UKB5TY=3U_7/"8U!;=-.M(([%;@R22I&T>3,C>8I+!
MR06Y(V@9I-2TR&?Q)\/$O+PZG(WVB.2\^9/M 6V;#X!XSUR#S]* .^T>[OKW
M3EEU+3CI]UN97@\X2C@D!E88R#U&0#STJ_7F!@F\6/XHADUN'3;W3K]HXY2C
M>;91(%*.I\Q0%8 DG&#DYSVGM](CUKXC:O:WU]?RP)I]C<JJ74L2^9ND.X*&
MRH^7[O3GIF@#TBBO*])BN/%&B+K;:_#I^I6>HR&XD$3M+"5E8>0P\P J5PH7
M;SD'!)R:NIV N++XE327FH%]-=IK/_3)1Y+BV5P1\W][H#D#MC)H ]>HKSVQ
MOU\0>+8]&UF0M&VA6]U;PEMHE=RPEDQW884#TY(ZU T@&OZ%X7?6/M=B=.F,
M,VH R?;)DD"D$JR[F5<XZ]<\G!H [G4]5321#-<IBS>18I)P?]4S$!2P_NDD
M#/8D9&,D:%>?ZAI;:=\(O$NFW6KG5!;V=V%G92#& A94R68MM.!G/;':NK\,
MSW%SX4T>>Z)-S+8PO+GKO* G]<T :M%>:&YNM+\5P_VS:-<V5YJSK8ZS9S$E
M69F5;>=.H"G*@C(R < \UAS:5]J\$^,M6;5=3CO](U.^>QF^W2?N?*;*KC=A
MLX"_-DXH ]GHKS*)[SQ=K>KZ-J=Y#9W<5A:M#%(C[X]\6YY8\.N&$A(SR1M
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M=."#\@0D?]=%/45R%A;R?\*\\'ZP+^__ +1?6(K=KC[6Y8QO<LC+@G!R#W%
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M<SR,0H4-&R '>?=B,#% %?Q+X/$O]E6MIX>T_4]$LTD'V"6<Q/$YV[71B",
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MD^Y)))/<FJEMK^D7FE_VG;:C;366[9YR2 KNSC;]<D#'7)J2+6=-FLY;M+Z
MV\+^7+)O "/Q\I]#R..O- $-SX=TJ[NYKF>S5Y)]OG?.P6;;]T.H.& QT(-<
M]:>&)+GQWXBU+4M/?[%?16\4$BS[=P16#JP5LE6R.#D''(%6?%'B4+X$UO5O
M#^HV[7-A#(V\*)/+=1DJRGH?J/PJ'7?%R::_A[3WOHK:XU1P)YR5W0QB)G+
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MVYU[2;.\2TN=0MXKAW$81Y /G/W5]B>PZFJ=GXNTF]\1:EHL=S&)[!4,I9L
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M6FW(Z,^Y-R*VTLN.X..,&NPN[RVL+=KB[GC@A4@%Y&P,DX ^I)  [U@^(?$
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M19?.$;#I)DG?GKNR2=V<G)]:IW.CKH$-Q?>%] L)-2G:-9$,GD!T&!]X*<8
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M 'DL"V%U#XJ@GU&;3P_B43VUY;X_<OY:%92#P4W*02>.N2.M1WNH:V-'BO\
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M 6?:?G";@XZ=&R!\PRFK#3K.RT_7]$M;Z30SKT5]J4S"5C-\A!F"-R45MI)
MY*Y[9KUJB@#RF[O='U;Q=XJE=KB;2[O08$DGM8F^9=T@8JP&"0",=>F.<8K>
M\%W6J#7;^PN[^VUNUCM8F@UB% KL-SXAEQ\I89)X[')ZUW%% '">)=0AA\<)
M9/#):RS:2X2^CMVEDGR_^H3@J,8#'@GD8QUKE?#\UO+9?"I)EYMO.6431D;"
M+=E!.1_?P ?4<<BO9:* /.-#TJR\1#Q_HTY7[/>ZDQ&WWAC'F+ZX=<Y]5K3\
M"RZKJL9U#7(3'>V"-I8)Y$CHV)I1[.RI_P!\&NCUJQU#4+%8=-U:32YQ(K&>
M.%)25'5<.".?6I].L8M-L(;.$NR1CEW.6=B<LS'N2223ZDT <QXQU&&PU_PV
M)H?*$DLX74O*:0VIV8VJ!D;GR0"01P>#7 QR0-X-M[.X64M%XP#R+<0E3L^U
M%B2" ,;>3QQGG&:]OHH \E\417=[K?CVWT4EKRYT2V2(1'F4J9-ZKCJVPXP.
M>15J7Q!I.L^*O %UIH<QP/<I(BP/FVS;E0C#'RD' Q^/3FO4** .4\?W\6G:
M3IT\UHDR?VE //DC9ULSDD3E5Y.TC [989KBOM"?V3\483+=2M/"7BDG@*&7
M=:JHQ\JC)/  &3[U[!10!YM/<PG6_AHXE4JD4V\YX7-MM&?3+<<]^*ZOQO(D
M?@77@S %]/G11W9C&P 'J2>,5O44 >8:A=P6NC_#K597Q96<T:W,P!(A+6S(
M-V/N_,0#GH36)KUU'=Z#\3PD<W^DS0- 'A9?,_<Q 8R.3QG'7O7M5% 'G&K,
M'^(&G#2)(4F?P]=0P/&0%#EHS&N1P.A('L:YU=8L9_ G@S3?*F34M,U:Q2]M
M6@<RPNC8=F&,\\G/?->TT4 >7S3W&G^)6FT6_6]M;K6%6]T*[C_>QR>8 9X3
M]X 8#\Y7 /(Z5T'Q-CO7\%S-9P2W"Q7$$US!$N6E@616=0._ Y'<9KL** /.
MX=:TW6/BMHM_ILK7%O)I%Q'YT<+E03)&0I..",'@].^*Y33M0AC\!^#-**3F
M^TW7H%O(5@<M 5EDSNX].<=QS7M]% 'DAGT@W_B/PSXLAU1I[W4))[:WB$Q2
M^A<@Q["G&1A5.2,;1SP<>BZV5M_"6H!SL"V4B_,V<'80!D]3V]ZUJ* /)=/:
MW@TWX4A/+1X !, ,&,FU96W>F7.#GO4&J21/X8^*,:%6:>Z8PJ.LF88U&T=_
MF!''<5[#10!YY=-8M\0?!#Q^08X]/NEW*!A,K'L'MG#8^AJ]\.9(V7Q.J,,'
M7KJ1 .Z,5(8>QYP>AYKM:* //Q+IVG?$[Q)+K(ABAN]/M4@:X3B<+YGF(F1\
MQY7*C)/'%9=OX:U'2_A3I=W% T6KZ'+)J5I#(<,L>]V,#=QF)MI'KCTKU2L3
M6M#N]8O( =8GM],V%+JQCB0BY!/0N1N48X..H)Z4 +X8CDDTQM3N(FCN=3D^
MUNC_ 'D5@!&A]U0(#[@^M85Q<1V'QC\ZY#I%<:&D44FPE699W+#(&!@$$YZ#
MFNWHH \4MFMX_A9I&-BSKXC69AC#C%XS;R.OW,'/I[5ISW6D1:WXFT'Q6FI$
M:G=F>U6$2M'?0LB*JILZL-NWMVKUBB@""QB$%A;0B-HQ'$JA&?<5P ,$]_K4
M]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 <UX]\3/X2\(7FJ01++=#;%;QMT,CL%7/L,Y_"I(/#
M$HTT+/K.IMJ;1_/>K=. ),<LL6?+ ST7;C^=-\<^&3XN\)7FDQS""X?;);RG
MHDB$,N?;(P?8TNFZ]JTUI'#?>'+Z#4@H610T9@+=V63=]WOTW8[9H EBU8Z9
M!9:3,EQJ.K1V22SQV^TM@ *7)<@<L#C)R><#@U6?QYH:Z;IE^LES+!J-R+2+
MR[=B5ER04<8RK @\=>. :HFQU71OB!-K;VLE[9:CI\5O.;4 M!-&21\I.=C!
MCR,X/7UK#?PMJUG8::\>GRRS3^*CK5Q#&R'[-$S-P3G!(!7(7/).,T =+_PG
MVG_\3&(:;JYN]/P;BT%KF54(W!^N-I /?/'3-2W'CO1H?[)V?;+@ZM;M<68@
MMF?S5"AL#CK@CCMGG YK/@LM1B\8^+KYM-N#;7MG;Q6T@V?O6C60, -V1RXZ
MXKFM/BO=#O?AC:7NGW"W5K9WD,\*[692(D!(P<$?3F@#L[/Q]HMYI$E^OVJ-
MXKQ;%[.:'9.MPS!5C*D\$DCG./?@T^?QSI=II>KWMU#>0G2'"7D!AW21DJ&!
M^4D$$$'.<?2N;N])\06LFM:YIUA,&U75+5YK2)D$XM(T",RY.%D8@GKD ]0W
M3.O?#^MOIOC^UM_#]T@U>.(V0:>-BY\E4(8[S\V0223CW- '=6OC"QN]7.F)
M:WZ7+6S75OYL&P7* @'RR3R02.N.N>G-%GXPT^_\-C7;>"[:U,WD",Q@2E_,
M\O&TG@[^,'FLN6RU";QWX;U :=<"TMM/GAGD8KB-W\O (W9/W#TS4%CH-Q;?
M$:_@AD0Z*YCU=X>Z73!H\?[K;3)_O** .Z!R 2"/8]JR-3\1VNFWXL!!<W5Y
M]F>[,%NJEEB4@%CN('4@  Y/I18ZW-=^(M2TF;3)[86JH\5P[*RW"-GD <C!
M!'/7!]*QO$,6M7'BF. :;<7FBR6#*OV>5(P+@M_RV)8$IMQP,CD\$XP 7)/'
M6C(FBO']KF768S)9F&W9MP"%\'C@X&,=<_G4EGXSTJZT>^U*3[1:I8SFVN8;
MB+$J2\83:,Y)W+C&<[A7&Z#HVN6UK\/([G1;F(Z/YRWF7C/E@PM&#PW.6/;)
MQ3-1\-^(+J+Q!<6FG2+<)X@M]7LXI755NTB6,;<Y."2IZX[4 ;=GJ5Q<_&(6
M[QZA:Q_V$\K6MS)E"WGQ@.JJS*#C(XYXYK7\3^)IM"U#1+2'3YKDZC=^073;
MA0%9B!DC+';].O/0'+L?[4U#XDVFMOH5]:6)T=[5VN#$&20RJ_(#DXPI''Y8
MYJYXTL;^>\\-WUC8RWHT_4Q--%"R!]AC=,C<0#@L.] &);>)!H/C'QI)=)JM
MW;6ZVDP@B#3>0AB9G(R<*,\X!^@.*ZJ?Q78*]K':1W%]-=69OHH[95R8!M^?
MYBH_B4 9R<]*YS^SM5.K>/)VTJX":G:0QVA#(1*RPLA ^;CYB.3CUJO86?B&
M"#PYIUUHUW+IL.BQV\L4,T:%+M0JD2G<"8]HXQD')R#Q@ V+WQU&9?##:793
MWMKKCL4E0*,((F? #$'=D#KQ@'G.*M^/WEC^'NO3PS3V\T-C++')#*T;JRJ2
M.5(-<?I&B:_8>'/ 32Z'<M/HMPZ75LDL6_:T3H'&6VXRP[YQVKM?&UI=ZCX&
MUFQL[9I[NZLI(8XD(Y=E(')(&,GK0!7T'Q79W-QIVCR17L=U-9":&6>$JEP%
M"ARC'DD;AU SG(R*G;QEIJ7.GI)'<I:ZC-]GL[UD'DS2<X4'.X9P<$@ ]B>*
MQ)],U*Y\2>#Y_P"SKE+>SL+F"ZER@\EI(XU4?>R>5/3/:J'@_2M1TVWL- U'
MP9:_:=.=$&L%(3#)&A^61?X_,*C@8X/)(H [;Q!K]KX;TS^T+V.=K82+&[1*
M&V%B%!.2,#) S[TV/Q#;2>))M!^SW*WL5N+H[E4*T9.T$'///'MWJSK6E6^N
M:)?:5=#,%W \+\=-PQD>XZ_A7G:^%/%$]KH.KSR*FOC.GW[*_"V;)L9@>[!E
M$H_VF(H Z>?7M*O]2\,O*-3AFO)9'LE7<D;_ +MB?,P=I&T$@'/8XK%BDN/M
MWQ)M_MMYLMEC:W/VE]T)-J'^1LY4;B3@5K>(],NG\1^$)+#3Y)+/3KF1YFCV
MA8D,+1KP2">2.F>*H1Z;JBZEX_E.F7&S4T3[&<I^^*VXC('S<?,.^.* .A\%
MS23^ _#TTTCR2OIEL[NY+,Q,2DDGJ36;)\1]%BM[JY-OJ1M;2\-G=3_96"0,
M"!E\]!EA[^V*U/!]M<V/@O1+*\MW@N;6QA@EC<@E71 IY!(/(KA;[0M;N/ 7
MC73H](N?M>I:K-/:1EH_WD;LA#9W8'"G@X- '?WNOP6M[-906UU?74$(GFAM
M55FC0YVD[B!D[6PHR3@\5B7_ ([@SX;DTBVEU"UUF<HL\6T *J,Q7#$'?E<8
M/3!SSQ45I;:EHGCK6-6.GW5UI^M6]NP,04O;RQ*4V,I/1@<Y' .<XZUC0>%-
M7T33?"TT=A)=S6FKSWMU;6\B9B699<!2Q .W>H//J: /1-1U*VTK39K^\8QP
M1+N;C)YX ^I) JG_ ,)#;1)>->VUU9&U$9=9E4EMY(0)L+!B2,8'?CK2^(H/
MM?ARZ@DTL:DLJJDMD&'[Q2P# $D#(&2#D<@5P$_A#7GT+6-.TR6ZN-.ADM+K
M2K;5VW-YD4F]X23SY9VJ!N[^W) .VB\7Z:+Z^LKU9]/NK*V%W+%=*N3!R/,4
MJ6!&1C@YSQBHY/$=I>WLVASPWUA>S6C7$ E_=F6,<%D9&.".,@X8>E<Y<Z->
M>*O#&JV]MX4A\.W4MH8E>=(M\DH96"@IG]WE<$G&<CCBKNA-=W49GG\#1Z/=
M00.LLFR$M(Y&-L)4YP3R6.!CCG.0 +X"U]F\&>&+><7=]?W=D)792'90.KR,
MQX!/0GJ0:V?&OB&7PMX2O]7AM'N9((_E12, G@,V2/E!(SCFN(\":+XB\&QZ
M2/[,NY[2]MEBU.V:1&>SFC 59$);E&'!4'C&1Z5V/Q TJ\UOP%K&G:?%YMW-
M!B*/<!N(8'&3QVH O2^((HI;>V^QW3ZA/&TJV2!/,"*0"S$MM R1U;G/'>IM
M%UNRU^P-W8NQ5)&AE1U*O%(IPR,IZ,#7+O;ZK;^.;/Q3_9=TUG=:9]AN;8%&
MFMF$A='*AB"#D@A22.*T_!^BW&EG6KVYC,,FJZE)>" D$QJ0JJ#C(W$+DX/?
M':@"Y?\ B:TLIKV)+:[O&L$$EY]E0-Y (W#.2"3MYVKDXQQR,\OK7B"%/&WA
M/4[&YO+NPOK&[D$-H7D6?"QE"(QQGYCS@8[XQ5S3K34_#?B?Q([:=<7]EJLR
MWEK) 5)$FP(T3Y(V_=&#TQW%9.E>%=2\*GP03:R7L6E6MW#>&V(8QO-M88!(
M+*""..>G% &IJ/Q'M1X4EU;2[*ZFFCO$L9K>:,1R6TK.JXD5B/[PQC.21VR1
MKW_B^STY[B.2SO7FM;3[;=11HA:WAR1N;YL$_*W"DGCITKD]9\*ZM<Z)XDU&
M"Q8WNIZG:7D=B'4.(H&B')SMWD(S8SW SFK/B*#Q%K%YJUM+HEW)976E;+%(
MYXU2.8APPG^?D\K@#<HYQSS0!O7FL:1<>(?#(,]\9[U99K$P[UAD7RBQ,G0'
MY>0#D@D<56F^)&BPVUY<FWU(VUC=FTNYA:,%@8;06;.,+EA[]\8YK)M--UC[
M3\.Y9-(N8UTN"1+S+1GR2;?RAG#<Y;TS@=<=*H7VA:W<>!O'6G)I%S]JU34I
MIK.,LG[Q'" -G=@?=/7!H ]0GGBMK>2XF<)%&A=V/0*!DFL+3_&.GZA=VENL
M%W";VT-[:-+&,7$0QDKM).<,IVD \]*TKU[U] N7L(0+\VSFWCGQCS=IVANV
M,XS7 :5I^N'Q/X7U>XT'4%:&RN(+^6XGC9Q(PCYP'("95MH7'^Z* .@M_B-H
MUS!97*0:B+2ZNC9BY>V*QQR[R@5R>F6'OC(SBM>Q\16M_K6I:3'!<I=Z<$:8
M2*%!#Y*E3GD$ \]..<&N 30M<7X;VNEG1[G[='K0NFAW1\1?:S-NSNQ]T],Y
MS6YXQT:[N/$.C7VERB"XOP^EWH/#-;.K.6'HR;6(]VH Z[2M1BU?3+?4((Y8
MX9T#QB4 ,5/0\$\$<UD6OC72[NYL4CCN1;W\\EM:7;(/*FD3=N4<[A]QL$@
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MC=0RLIR&!Y!%/J*VC,-K#$5C4HBJ1$NU!@?PCL/05+0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M65X@UJ/0=+^UO&TLCS1V\,:@_/)(X11P"<9.3@$X!P">*Q[/Q!K]UJ.HZ<NE
M;I(K87%I>26TT$$QS@Q-O&58''()R#G'&* .MHKDO"7BN]\3HLILX[6.V1H]
M120,'@N02#$/7 P2?0CU.%L/$FL:M:Z7J^G:9%<:5?W&PH'VS10$D"<DG!'
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MX:R[/Q?JUU?:05T::6QU)22R6TRFS)7<AD<KM93T)&,'U% ':45YU'X_UO\
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MC0PE#&F,Y*@1@$]3DGCI7;52N]3AM);*-HYY?MDOE1M#$753M+98CA5P.IH
MGM5N%M8Q=R1R7&/G:-2JY]@23C\:X_XHEQX;T_RW1)3K%EL9QE0WG+@D<9%=
MM4%S8VEZ%%W:P3A3E1+&&Q],T <[=>&KS4=0OM5NGMDO9-.?3[:-"S1Q*YR[
MEB 6).WC P%QWS52?P5=W/@+2="_M%;;4M)\A[.]B3*K)",*Q4]B,@CWKLU4
M*H50 H&  . *6@#C;[PIK/B3PU>6'B'5K=;R4(;>33X62.W=&#J^&8EFW 9Y
M P,#')-ZPTWQ+)I]R-:U*QGNFMV@B6UA:.+GJ[Y));@=, <^M=)10!PB>"M4
MM= \+6]I>V?]H^'W'EO*C&*9/+:-@0#E3AL]^14-S\.[^_M=?2ZUB%9]1O8;
M^VFAMR#;SQJ@!P6Y7*].N.Y->@UF7^O6.FZIIVG7)E%QJ,C1V^V)BI(4L<MC
M X!XSF@#GAX4UK4O$-OJFM7FG,@TV;3[B"VA?$BR%22"6X^[Z''3GK4GACP[
MXFT6.VTR^UVVNM'L@%MRENR7,B+]Q)&W;<#CH,G')ZY["B@ KG+G0+[_ (3E
M/$-G=VZQM8"RF@EC))"R%P58'C.2#D'%='10!P$?@75(_!MEH7VVS+VVIB_\
M[:V&Q.9MNWMR<9STJV/"_B+3?$.H7>@ZQ9V^GZI*)[JWNK=I6AEVA6>(A@,D
M <-QD=.U;>L>)]/T4SB=;B9K>)9[A;:(R&&(D@.P'./E;ID_*3CBK6EZM;ZO
MIJ7\*3Q0NS*HN8FB;ABOW6P>2./7(H N11^5"D>YFV*%W.<DX[D]S3Z** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH P?&_P#R(/B/_L&7/_HIJQ_"C:Z_A7PI&;:P.G-9P"X82,S^
M5Y'R_*5 ^]MSS73ZUI4>MZ-=Z9-<3P0W430RM!MW;&!! W @<'TK)A\(&'1H
M-('B#5S80Q) (O\ 1QNC4 ;"PB#8(&#@@^] &)/?^(;[Q#XPT^#73:0Z;!;S
M6C16L;,I>-V()8$$949SSP,$<YK67B+7VM_!&LSZDLD.N/'!<V*VZ+&N^%G#
MJV-^05_O8.>@KJE\)P)JFM:@FH7RRZO$D4ZCR]J*BE5V?)Q@,>N>M55\#6<>
MG:#9+J6HB'0Y%EM>8LDJI4;OW?(VDCC'6@#EI-4\8W>B>*]2M-?BBDT/4+E8
M8?L496>.)%;8Y/(!&<$8.3UZ 7X=56_\?>&]7>,QK<>&I[ID')4,T+8_6H_"
M^A2:M_PEUK>3:E:V5]K$[/;M#Y2SPLJC*LR;L, 02IZ#C'6NL?PS:MXDL];2
MYN8I;2U:TBMTV"+RV()&-N?X5[]J ..N/%FM1_#BV\>1WA=2RW$VF^6GE&!I
M-FQ6V[PX4@[MV,@\8.!K3>(+S0/&6HVNLW\DFFW%@UYIO[I 5,>?-CR%RS#*
MD>Q[FKMMX%T^ULSIJ75V=&^T?:%TUBAB5M^_:#MW;-WS;<X[=.*KZC%;^+/$
MEE93:/>I'HM]]I:[N8#'&Y5"%$39^<%F!/;"G/:@"#^U-<&I6'AV:XNGU Z9
M]NNYK98!)N+A=J[QLVJ<]B3\OOF"'7/$T$FBZ#JJ[=5NEN9)9K,Q;WCB*[<!
M_D#$2 GK]TX'/&[XB\(6OB"\L[];V]T[4K/<L-Y8R!'V-]Y#D$,I]"*@U/P)
MI^IZ?8PF]U&"]L96F@U**?\ TD.WWR6((.[H1C&    !0!<\+'7A8W,7B#8T
M\=RXMY04WR0<%#($^4/U!QQQ4_BB.27PMJ@CN)(&%K(=\84GA2<?,".>G^%3
MZ1I::39^0+FYNI6;?+<7+[I)6P!DD #H ,   "I=2L5U/3+FQ::6%+B-HVDB
MV[@",'&X$=/:@#S:SN]:TCP'\/UT_5W4:@]E:R":"-PD;P$X7"C@;>_/O6[8
MWFKS>)W\*SZY,\ME8"ZGOH[>))9VDD8(-I4J JCG Y..G(-YO ]JVDZ'IW]J
M:D(=%EBEM6!BW9C7:@8^7R "1^-7=0\-07FN6^M075Q9:E#";<SP;3YL1.=C
MJP((!Y'<&@#B3XO\12Z59QB[ABOK7Q.NB74OV<%;E-P^?;_#E2,@8YSC';1@
ME\23^)?$6@?\))*J6EO!=077V2$RH9 _R?=VE<IGE<X.,]ZVKGP1I]Q8V5JM
MU>0BUOQJ1DC9-\UQN+;W+*<Y))P !VZ "K*>%XH]=U+5TU&^%S?P)!(/W6U5
M3.W:-G4;FZD]: $\%:Q<:_X*T?5;L+]INK5'EVC +8Y(';--\8:EJ6E:3!=:
M?;74\:W*_:Q9QK).D&&RR*P(8@[<C!X)JYX>T.#PWH5KI%K//-;VJ;(VG*EP
MO8$J /TJ75-,.I"U*7MS:26T_GH\&WD[67:P8$%2'/'TY% ''0>,&N[31H-+
MU234_P"U;R>-+E(XTFCCC0N4*L%42#@<CIDXZ4LVM^)M$MQ:ZF#(]]JL=I87
M!,/G^4ZLQWJ,1[QL90>AR,@X(.G>_#[2;[2Y+5YKN*Y>^.HB^@<1S)<$8WJ0
M,#@ 8QC ]>:DN? NGZAX?ETO4KW4+V22193?RS 7"2)]QD8 !=O8 8Y/7)R
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MOVJWUVT<SVYMT18W6 2!E(&[)Y!R2.> .E)INM^*-?T[2]>TK?Y$]SOFMYC
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M2G.-,L]9C:Z8_=C+#".WH >_O0!T5YX@U/3=/;4+W09!;C!*P7"R2Q@G&77
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M=F['3(XZT >JGI6)X:\0-XABU)FLS:M8W\MDR&0/N,>,MD#C.>E<T;J4>+_
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MNOFO$KD=^0,G%<CX<>1/BGXTMTS]G,=C,P["0QLI_$JJ_D* .VHHHH ****
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M)'Y4KH[)YJ?W7"D!U]FR*U:* ,Z;0M-GU&TOY+8?:K-2EO(KLOE*>"% . "
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MF*9)P2<YSDY/4YYJ/1?!_A[P[=37.D:3;VDTP(=XP>A.2!G[HSC@8' K;HH
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M61W169&0DHQ4\, 1RIZUH4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW^Q_MS7,$VC?;8[BXM0H$HD"$H $+1G=D9';@D57U30)=8OM5N;S1O$##4[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMN681RQJD>#@QA< $@Y_VL&N*M+$)I'PUOTN[U;K4%AMKJ474@,L36S,5//
MRHZ8(ZYSS0!Z_2,2%)49..!G&:\;U]'TS0/B9IUE<W<%K8-;S6JI<R Q%X49
MP#G."23C..:Z*72VT'XD>&IM+NKQEU6.Y348Y;AY5E"1AEDPQ(4AB!Q@?, ,
M4 =/X5\0/XDTN:\DM!:O%=S6K1B3?S&Y0G.!UQZ5N5X]9ZE/8>%K6%9'BM+[
MQA/:WDJ,5*Q-/(2,CH&(52?0GUKHWTT1_$2ZT"W\Q-%U#1C/<6\;E5@E$@17
M3'W"03TQDKGM0!WU%>:^%)IM1%CX5O@QO?#UP_V^3)'FJ@Q"Q/4^8'#\]=C
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MV6G^!K;4EB6$Z[</:Q7 &Y;4B7RP0?X>5P#Z@5MV]Y8P7/Q01+BWCB&'"JX
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MO[@UL>+[?08;+P;)##IZ1SZU:,SJJ 2((W&2>XZ#GVKTP *    .@%+0!YE
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M,=Q+CG)&.I[59N;#6KS1?!"?V'=1RZ;?6\MU&TD1,:1PLC-P^#RW &3CTZ4
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M$^XC;]T8/3'<5E:-X2U/P_>^ [46LES#I-O=K>7$;+LC>8 @ $@D!LC@=,4
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M*9$[21([QM$S $HQ!*^QP2/R-/H **** "BBB@ HHHH **** "BBB@ HHHH
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M10!DZ'X;TSP[%,FG0R*9FW2/+,\KGDD#<Q)P,G Z<GU-:U%% !1110 4444
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M%(LI8-%(=H(RKD9&:[71#K<D,D^N):03/@);6KF18P,Y)<@$DY],# ]ZU:*
M./UK1-;N/'^DZ]96]E):V%M-"R37+1NYDQR,(P&,5)K6G^(];T77+%K;3K9;
MNQDMH$6Y9]\CJ5+NWEC 48P #G)SVKK** .+/A[66U;P;=&*S":-#)'=#[0V
M6+Q"/Y/DYQC/.*YGQ9HVJ:3X-\63726H_M'6K6\M_+F9L S0*%;Y1C[F>,]:
M]:JGJ6DV&L6PMM1M(KJ ,&\N5=RY'(./:@#&_L>^O_%=KKU[!#";"TE@MH%E
MW%WD*[F9L<#" #KU)..E<WI_@;6['PWX;VM9#6-!O)9XU$S&&>.1GWH6V@J2
MKX!P<$>]>CHBQHJ*,*HP.>U.H YFTTPVWB2_\5:N]O:/):164:>;E8XU9F)9
MB ,LS8QVP.3FL_P-H$-C<:Q/!<>?IGVF6#35'W882VZ55/IYI9?I&M=;?Z?9
MZK8R66H6L-U:RX#PS(&5L'(R#[@&I8((;:"."WB2*&-0J1QJ%50.@ '04 <5
MX6T7Q=X?@@\/R2Z;)HUH^(+X.WV@P Y$9CQMW8^7=G@=B:31=#\6^'[BYT>S
METV30I+F2:WNY'87%LDCEV39C#$%C@D@=SGI7=44 4;1]4;4;];R*U6R5D^Q
MM$[&1QM^?>",#YNF.U7J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **AN;NWLXUDN9DB1I%C5G; +LP55^I) 'UI'O+
M:*Z2UDGC6=XVE6-F 8HI 9L>@++D^XH GHK*TWQ+H>L7+V^FZK9W4R+N*0RA
MCMSC</4>XXK5H **K6NH6=\]PEK=13M;2F&81N&,;C!*MCH>1Q5*+Q/H4^J?
MV9%J]D][N*>2LREBPZJ/4CN.M &M17/'QUX4%Q]G/B'3O.W;=GVA<YSC&/K6
MK#JVGW%T+6*]@>X)D C5P6)C(#C'^R6 /ID4 7**S=0\0Z/I7F_;]3M;;RB@
MD\V4+M+YV@_7:V/H:CT_Q1H6JN$T_5K2Y8N(\12AOF*LP''<A&/_  $T :U%
M0O=V\=U%:O/&MQ,K-'$6&YPN-Q [@9'YU3C\0Z-+?S6,>JV;7<(8R0B92R[?
MO9&>W?T[T :5%8UCXN\-ZG<?9[#7M,NIMI?RX;I';:.2< ]!4]IXAT:_M+B[
MM-5LIK>W&9I4G4K&,9RQSP,<Y- &E169%XBT6;3)=2CU6S:QA.V2X$R[$/'!
M.>#R./<>M1S>*_#UO80WT^N:=%:3L5BFDN45'8=0"3U'<4 :]%8S^+?#D>GQ
M:@^O:8ME*YCCN#=((W8=0&S@D>E.N_%?AZQM[6XN]<TZ"&Z3?;R2W2*LJ\<J
M2>1R.GK0!KT5276--:-7%] 4:9;=6WC!D8 JH]R""/7(J=[NWCNH;5YD6XF5
MFCC+?,X7&X@>@R,_44 345#<7=O:*C7,\<2R2+$A=@-SL<*H]22< 5-0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% ',^/0R^&TN-K-':W]G<R[5)*QQW$;.V!Z*"?H
M*P]3U/2O$7B26XT^0ZOI]KH-[%=_V<XD),K18C5@<;RJ/@9SQ7H5(JJHPH '
ML* /-_#^JPR>(M#L[36M/\1VZI(D;) $NM/01GYI"AV@' 0@JIR1UQ7<:_JJ
M:'H-]J;H7^SQ%UC'61^BJ/<L0/QJY/ )H)(UD>$R#!DBP&'N#CK5"UT9[:Y2
M9M6U&<+_ ,LYI%*MQW 44 >?:38Z]X9O8;:ZMH+5]9L7M&N(KHR>9?@/*LC?
M(NTMND]>BCM6GHVN^&!X4T'16B2XU"$VT7]E( ;F&="NYF0D%=K L6.!@$Y.
M>?0J3:-V[ SZXH YDC_BZ"_]@4_^CA7-Q1FUTN]U^,'S-(\17=P^!R;=I"DP
M_!&+?5!7I=&* /*=69HO#NF>(9[R+3Y]4UZ*]-S<KE8(BCK$&!(Z1JF1D<DU
MM2:HFI>';^Z@\2:=KESICQ7R_8$53&(VW%2 [?>577MU-=Y@'J*3:/04 <A=
MV%E'\2=$U*WC!GN[2Z\R;<6W*!#M R>%ZG P,DGJ361I&M>'_$'B>PM=/O\
M3K6QTNZF>TM5F7S[N<JZLP7.50;Y#ZL3G@ 9]'P!VZ4FT#L* .-L_LVHOXE\
M0:E;-=VR&?3X8%CWG[/%E90J]R\@?/J%4=JY76KR"_E\1S6-Y;ZK9W&GVR"Z
MME^2P03_ "JVW(;8KM(0><(00 :]=I H48  [\4 >0W5QYC:I(NK6][$^IZ?
M*VOQHODVY4'J%.P[-BY.<?O1G&*UM/U2XT_PIXCFL+J.\NI]5\BTU&-1Y=S+
M/Y2*Z@<81GVG'!\LGJ37I 50NT* /3%       Z"@#@]9TW2=#N= MG\03Z'
M%9VUPL-P5BVR.=FXM)*&7><$XQELL<]:R)-5>2&TUC5?$<VBZN='_=*;:-4N
M?WC$$"13DMM0F-<,,KZUZF5##! (]Z"H.,@''(S0!P,EA>:Q;7MC<QBTU#5]
M,M]2B7IY-[$%#'_@+"W_ "-3>'M0O/$4U[XJM+%7F6WCLK.VN)#$ 1AY\MM;
M'SG8>#S#7<8&<XY]:6@#B?%EC]KLM"U/4;*.+4H=4LE54G:5(<W*9VD@#)'\
M6T'''2NVHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tardioagreementa01017.jpg
<TEXT>
begin 644 tardioagreementa01017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGEN,)SYDBJPQMP!@^E=I;>4VMV<5IXFGNI%#S2VK212"2(#:<[5R,,Z'.>U
M'1T50UO5H-"T.^U:Y!,-G \S@=2%&<#W/2L+PW;:IKGA^SUG5-4NH;N^B6X2
M&U8)';*XW*H!!W$ C)?=DY[<4 =917!7VLZW87WA_P )F]#:OJ<UP\]_Y:YC
MMXV9MRKC:&9=H&00.>#4OB[4+SP+IL/B"&^NKK3X9XX[^VN6$F8W8+O0XRK
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(2!U.* 0>A!H
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MWA^=&Y?[P_.@ 4AE!&<$9Y&*R/%8=_"6KPQ0RS2S6<T4<<49=F9D(  'N:V
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M7CWH Z2RM(K"PM[.'=Y5O$L2;CD[5  S^53T44 %%%% !1110 4444 %%%%
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MM+[3H]0M)UN+25/,CEA^<.OJ,=:33]2M-5M!=64OFP,2%D"D XX.,CGFO+]
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M(!8Y;C)XJOX8#^(_B9JGB29%T^;3;?\ LI].)S,?FW^9(>FT_P .,@CG/&*
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MY^G%=$Y98V**&8#A2<9_&N7T7QC<^(-.EOM/T"Z>*.:2 AIXE8NC%6 RWJ*
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M&\\V[%P+FX:XXBV;"V,@<GCCZ^]4M*\&Z/H\>LV]M;K]BU:8RSVK >6"RA6
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M*W1PT".P#$/N(<KG!^5>A/;%=)JM['INCWU_+&9([:WDF9!_$%4DC]*\MO\
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MR%;9XVV-@MM8R$$@9.,<X-<Y\1=>TS4_AGXI%E>0SQ0P>4TT<@9#(<'8".I
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M>I50,TW[-!N+>1'N.<G8,G/6I:XC0]1N/&NNZY(UU<0:/I=XVGPPVTIB::5
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M%LG\$:MW49HM7\)RWME=S1QS6AN+>XMY"C#*;E8?X'(H UHX8H<^7&B9Z[5
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MWMW/?M;P&+F02[MF"..<]SQWK?\ %WAJ;Q#96FL:,YLO$.GYDLII%*Y_O12
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MNLM?#UU>^+8_$FL>2DUK;M;V-K"Y=80Q^=V8@9=N!@#  [YS47C'0=4UN_\
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MK_PJQ/W<5?\ $-C?ZOX2U'3H([9+R\M)+?#S-Y:%U*YW!<G&?2@#@+F]TL_
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M*!5E5HV3:P'!QN!!/3!'<UC7_A?5TUO3/$^G7-K)KEO:?9+Z.8E(;N,G<0&
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MFRVBR(T[*"2<#V&<#VKGI-!U5OB=%XC"V?V!-,:P*F9O-R90^[&S';&,UUE
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MSR22>2V<YSSG.>:\_P#!5QK\'A[Q0='L;*=UUF_,;2W+*V_?V01D'V^89]J
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M<2(K@$!@"-RD'\0>13J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ$<X ..^*2/Q1;)_:G]I6\VFKID237#W.W;M;=AE*D[A\I_'C&>* &GPNO\
MPF9\3#4+D71L_L7D[4\ORM^_'3.<]\TOA_PPGA^\U2YBO[BX.I7+74R3*F%D
M( .W:!@8 &#FH7\5S1:3_;$FAWRZ6$\UI,IYJQXSYABSG&.<?>Q_#GBHO$7C
MO3/#FF:;JL\<UQI=_*D:7=L59$W@L&;)!V[03D9Z4 =+/&\L#QQRM$[# D4
ME?< \5A>'_"D?ASPFGAZSU"Y:WC1DBED5#(@8DGHH!ZGJ*VKN\@L;&>]N) E
MO#&TKOV"@9)_*N2B^(UI-X!D\9+I5\--3<=A,8E(5RA.-V/O ]Z %D^'5I)X
M 7P:=4OO[-4!?, C\W:'#@9VXZCTK9?0KN>2W^U:[>S0Q2K*T/EQ()2IR Q5
M <9 . 1G'I56W\96QURQT?4+"\TZ[OXVDLS<;&2?:,LJLC-A@.<'%7-?\2Z=
MX;&GG4)"GVZ[2TBQV9NY] .Y]Z (_%7AF+Q7I::?<7MQ;0K,DQ, 7<61@R\L
M#QD"F:KX6AU/4]-U5;VYM-4L,JMU;A0TD;?>C<$$,I/.,<'IBM#6=2;2-)N-
M0%G-=K;HTCQPE0VT#)(W$ \#IFJ^A>(['Q+X?AUC229X95R(R0KJPZHWHP-
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MGK-]J37LTS7:HGE.JA8E3.U5P <?,QY)Y)JG%X5C@\9W'B:+4+I)[B!;>:W
M3RI%7[N?ESN'KGVJMK/C3^PO#EWK5[H>HB*SE\NXA0QLZ#C#_?P5.X=#QW[U
MK7^L+I_AV;6'MY)(X8#<-%&REBH&< YP3CWYH QQX*<^'QX?DUV^ETDQ"&2*
M18_,:/H4\P+D*1QTSCH14^H^$([[7M+U:'4KFSETR)X;6*%(RBJZA6R&4YX
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M%93WC1*6\B#;O<#LNX@$^V: +=<]:^#-(M- U;1HHB+35)9Y;@<=9<YQZ8&
M/H*71/%EIKOA$>([>&2.U,;R;)70, F<[N<*>#U-4-7\>Q:#X8M=?U/1=1@M
M9W56C(C,L(89#.H;@8SD#)'<4 =%8Z;%IFBVVF63&&*V@6")@ 2H4 #VSQ7-
MV_P^MK;P-<>$DU6]-A/O#2,(_,"NQ9@#MQR2>U=6;JW6S-X9D^S"/S3+GY=F
M,[L^F.:Y2P^(=IJ7@V^\46^F7WV"S\PLK[%D98\[B%W=L="0: +J>%KH6=M9
M2>(]2DM(=BM%Y<"^:BX^1F$8."!@X(R,TP^#W7Q/>Z_;ZY?6]U>1)#(B1PE
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M2Q'[0Y3S')(\HN "0%(XYKV/Q)=S6>A?9M,'^FW9%K9JA (9@?F&>/E0,W_
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M)/XT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,GQ/J-SH_AC4]4M!"TME;27.R525<(I8KP1C..M
M<S?>,M7T7P79>++^VLKC3Y8H)KF&#='+"DNT94DL'(+#CY<UM^/72/X>>)"[
M!0=,N1DG')C8 5YIK]OI,?PFT2^M=7EDU6WMK26TLGNVN4N)\+^[,#%@W4\
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M]>T9)HVBNM/O8<\X*R1L.A_ UP_P@AMTT/4Q'.TYM=1GL87>3>4MXF/EH#Z
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M9"66G71N[>PQ:_:-V\.549^;)W$9P3ZY]#0 GBK6W\/>&[S48;<W-S&F+>W
MR993PJX'.,\GV!JQHVK0Z_H%GJMBP$5Y LL989VDCH?H>#]*QKN2XUSQ:(--
MO;-%T9-\HEB,P,\BD 85U(*IG_O[[5A_#Z?_ (1WQ!KG@>[N8&:VE^W6.P;%
M,$OS,BJ22 C$\9/WJ -WP7X@U'Q%'JTM\EK&MCJ,]@JP(V7,9 WDDG&?3'XT
MGBWQ!J>B:AH5O8I:.NJ7HLR9T8F,E2V[AAGIT_6L'X;:SI=M:>)Q/J5G$?\
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MAT72]5$S6M_:ZC#'!<QOL=$D;9( ?0J3GZ5W]M!#:VL5O;1K'!$@2-$Z*H&
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M: +I=L!Y=Z\!SN;()1ESU'!]: -_7M=UO0?!^L:O+'82SZ>6>,(K>7/& O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+PV\4;$8)1 #C\*FHH BFM;>X(,\$4I'3>@;'YT]HT=65D5E8;2",@CTIU%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,4+R!'D*@G8G5O89H ?169X>URV\2Z#::Q9QRQV]TI9%F # !B.0"?3UK3H
M**** "BBB@ HI"0 23@#J321R)+$DD;!T<!E93D$'H10 ZBBB@ HHK)\0>(+
M?PY90W=U!<2QRW$=N/)4':SL%4G)'&2* -:BBB@ HIB2QR-(J.K-&VUP#G:<
M X/IP0?Q%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=2RLT9P=I&?F VC QCOC-8OP]\+&+P5HUOJ\=ZDMDYE-C<\)',')5L8R<9!
MR5!Y R. #'OXKP:E\3;ZSU2[L9;+RKF+[,5&YTLU8;L@Y''3CJ<YXQZ/I=]+
M=^'++4)%#2S6B3LJ]V*!B!^-47\(:<YUK=+=?\3I=M]^]_U@V[../E^7Y>,<
M5K:?91:;IUO8PL[0V\:Q1[SDA0, $]\#B@#@/"=_-%\$DU4ZG%8WEQ#/<R7\
ML?F!)9)6)8K_ !')P!SV&#TK1\/ZC?)\0+W2)&O5L3I4-Y'%>R!Y%<R.A;.2
M0"%'RD\8Z#I5JR\(6J:!?^$[VW,NBRO));E6QM1WW["1R&1R<'T [@U<M?"F
MFZ5JBZU$=0N+^.U^S%Y+IY&E4$D!@QP3DG&>!GM0!E^#9Y(_%_C;3 3]FM]0
MBGC] TT*NX'_  +GZDU2\::E?0?\)))9:G=/-I^F"XAAM#L%FX5VWRDG#[L#
M"8/ Z#.:Z?PYHK:5'?7-QM-]J5TUW<E3D*2 %0'N%55&>Y!/&:KZCX(T;5-0
MU"\N!=*VHVXM[R.*Y=(YE"E064'!(!P* ,%[S5=4\8Z#9_VQ=6UK?Z))<S1P
M!!AP8N5)4D'YCR<X[8ZUG:7XGU1M*T71Y[^5I[O7+K37OFQYAAA9SUQC>P55
MSCN3UYKL[7PAIUE?6%Y!->">QMC:0,TY?$9P2#NSG) .3Z#&!59_ .B2Z/)I
MD@N6B:[-\DGGD20W!)8R(XY4Y)/IS0!F>&K3['\4_%<0GFF0V=BR^<Y=E'[W
MC<>2,YZY/-37T[W/QDTBQD)\BUT>>[C'8RM(L9/U"Y'_  (^M;.E^%;#2=7N
M-5BEO9KZXB2*66>Y=]ZKG&1G'<]N.V*36='>36],UZT3?=V(DB>/(!F@D W*
M">,@A6&>.".,Y !RB:1=:Q\0_&D%KK-[IC"*Q(DM-H8MY;X)+ Y ]!C/K5+5
M=;U#6/@"VN7CJNIP1K.)D&/WL,X"N/3.P'CUKN;CPQ8W.J7.IQS7EK/>Q+%=
M>1,4$ZJ"%##L0"1E<'GK4&N>'HM4TBU\-P6RP:2&B-P% "B&-@PB4>K%0#Z+
MGOC(!HZC>-%X:NKW[3%8N+1I1/,,I VS(9AW /)'M7(^']3U!/'-CISW%])9
M76BM<M]L.3+*LB#S54DF,$.?EX_W1BNVU+3K75M,N=.O8A+:W,312IDC<I&#
MR.E8UAX)TG3]1L=022_EN[. V\<LUY(Y:,D':V3@@;1@=._6@#S;0SJ^A?"G
MPYXEL-9NR8'AC?3B$,$L3S^65 QNW?-G=D_RQUL&H:AXDL?%MW#J5Q8W.EWT
M]I9+$V%C,* AG7H^YB2=V1C&,=:WM/\ !FE:;%;6\/VE[*TE\ZVLY9B\4+Y)
M! /)P22 Q(!Y&"!3[CPCIL]]?72-<V_]H*%OHH)2B7( Q\P[''&5P2.IH Y6
M+Q'J+#P5XHN[B:#3-5C2WOK8-B*.:1/W4@[A2P(ZX^9:N7FKW\":+'%<./[?
MU"389IBGEP"-WC16VDJ6"KV)^8@8X(ZK4]!TW5]#?1KRU1M/=%3R5&  I!4#
M'3&!^5,U_P .:9XETO\ L[4H"\*NLD9C8H\3K]UD8<J10!3\,VFMV%UJ=OJM
M[!<6QD62R03M+-"A!RKL54D;@=I.3U!/%4(;Z?Q#XT\0Z0;RXM8-(BMTC6W?
M8S22H7,A/< 8 !XX.0>,;VBZ':Z%:M#;RW4[N<R3W<[32R'H,LQS@#H.@JI?
M>$M-O==76@]W:WQB$,LEI<-%Y\8Z*^.N.QZCUH X#P/JLXT#P%X=6:2&&_M[
MN:>6,[7<1$X16ZC);)(YPO7FKMYXJU;0KWQ!HK71F2VOK"*TO;AANBCN6PP=
ML'.W#88@]1G..>I@\!Z):Z/I^FVZW,2Z=*9K.<7#&6%SG)5CG@Y.5QM.>E6Y
MO">D76E:AIU[;F[BU$[KQYFR\S   DC&,;5QC &!C% &!<67C#3SK'V.]MGC
MGLPUC:S7C2RI<!@&VNZ#Y6! YR Q'8U;\%ZY!JMYJ4(;4[:ZMUB$^F:EDR6S
M?-\P8D[E;C!R>G;(%6K+P1I=EID]B+C4IQ,%7S[B]DDE15(951B?D (!XQ6I
M8:-;V-[/?&26XO9T2*2XF(+%$SM7@   LQZ<YYS0!S6IMJ5W\3H='CUF\MK"
M?1I9VB@V JZRQKE3MR#@]3GOC&:Q-'\4:I/I?A?2KF]E:74-4O+*>^.!(T<!
MDP,XP&;:HR.>N.>:[R7P_:R^(DUWS;A+Y+=K565QM$9(8C:1CJ <]>*ST\"Z
M,FCKIFVX,,=T;V%S,?,AG+%BZ-U!R2?3D]J .0\47FH6L7C?PZ][=2V<6A'4
MK28R'S(<AU,9?JRDID9YQD9(KO\ PU!]G\-:<GFRR9MHVS(VX\J./I3!X:T]
MK348+E9+IM2B\F\EF;+RIM*[<C   )P% ')/4DU;TG2X-&TV&QMGG>*)0JM/
M*TCD 8&2?8 4 >?7&MZE!>Z/>6VIW-XESX@^Q2W"_+:O"S.OE(A/)7:!O ZJ
M?F-#1>(-7E\9I%XHU"U?2KL_8O+6, $0HX#_ "\KDXP,=3G/&.B'PYT 1)"O
MVY88KS[;!$M[(%@DW%CL /R@DGIZFLO0O#SWNO\ B[[:NI6MGJ%VI5,&-+F$
M1(AY(R.0PX*DCVH SM*U76_%6N:%#)K%Y80:EX;^VSQVRHI63?&"R$J2,Y[Y
MP"<8SFL^]U#4[KP#?V.JW37D^E>)H+%+ME :9%GB*LV.-V&P?I73WNCS2?$_
M3IK:*]M+&VT>2U2XMH\(CF1"J<@J1M!Z@@<="!6W=>#M)N]%32F6=+9;@73;
M)2'DEW[][-U)W<T 8^J:O-X6\=+/J=_<-H>HVDGDJ[96WN(QO91_O("1G/*D
M#K72:!;WEOHEN-0EEDNW7S)?,;<49N=@/HN=OOC-8VIV\WB/6(='N]$G%AI]
MU%=M?W!39,4&Y1& <[MV <@# ;U KK* /(;?5+GPMX9\<ZO;W=Q)<1:[);(T
M\AD5-YA02$'J5#?3@#I75WMQ?>'O&_AVS@O+FZL=6$\%Q%</YA1TCWK(IZC.
M""!\O(P!6H/!NBE]7\RWDEAU8LUW;R3,8F9@ S!<X#':O(YXXQ4^G>'+33Y[
M><S75W+:Q&&V>ZEWF%#C(7CJ<#+'+''6@"UI=A-I\$T<^H7%\TD[RJ\^W**Q
MR$& .!T%7JHZ7I4&D6\L,$EQ(LL[SDSRM(0SG) )Z#T%7J "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *BN+F&U17FD"!F"*.I9CT '4GV%2UQT%X^
MI?%F\M'/[C2--C:-#T\V9CN?Z[4"CTRWK0!T']NZ;]HU"W-T!)I^S[6"K8B#
MC*DG&,8YST ZXK0!# $$$'D$=ZYO0]9O[_Q9XFTF\^SM!ISVX@,494E9(RYW
M9)R>W;ITJG\/;R1[76])<DQZ1JT]G!GM#PZ+_P !#;1[** .QHHHH **** "
MH8[NWFN9[:.9'G@V^;&#RFX9&1VR*2\NX;"RGO+E]D$$;2R-Z*HR3^0KRG2]
M170_B!I6KRS2?\5,AMM21U8"&YR7@&2,<*3$,?W<]Z /7:*Y+6-7UQ/'-CH6
MGS6,5O=V$UQYLT#.T;(R#. P##YNG'U.,'%;QAXB7P,VMXLFETS49+;5-MNS
M!X(Y2CR1C=\I"C=@Y'6@#T>BL>SU&XO]?N8[>6%],MX(\LJ99IG!; ;.,!"A
MZ?QCFE\4:XOAOPW>ZLT7FF!1L0G 9V8*H)[#<PR?2@#4EEC@B>65@D: LS'H
M!5?2]4LM:TV'4-.G6XM)@3'*H(# $CO[@U0LE\0PZWY=[)9W.F/;;C-&AC>.
M?=]T+DY0CD'J,=ZXSP5?WMA\,/"@MI+>""9WCN)Y?F9%W2$"-/XW9@  ,]3P
M: /0=4U2RT;3I;_4)Q!:Q%0\A4G&Y@HX )ZD"KE>;S^.-:7X>:KK40M/MNG:
MD]DQDMW594681[MA8%&PP.#GD=/39O=6UZ7Q[/X>LKBP@@.EB\CFDMV=T8R;
M,$;P&Z>W7OB@#KZ*\SMO&?B1_"NC>(IVTX0R:@EC=6J0N3)F<PLZN6^7D9"X
M/U[#5G\73KXPFT.6[@TZZ6ZA6UM[N A;RW.PNT<F0"_+@ =" ,&@#MZR]6\0
MZ5H:,^HW7E*J>8Y6-G\M,XW-M!VKGN<"M2O.[::YM?B3XONKVZA>SMM-M9)D
M-N3F$"9MH^;@CG)P<YZ"@#T*.1)8UDC=71P&5E.00>A%.K@)O%VK6'A;1?%<
MRVK:;>O ;BS2,AH(9B A5\\LNY<@C!YQBK6G:MXGU3Q;K.GQW&F1V>E7T*/F
MW<O+$\8<@?/\K#=UY!]!W .REEC@A>65PD: LS'H!5?2]4LM9TV'4-.G6>TF
M!,<J@@, 2._N#5L]*\;\,ZUXA\,_#'P_K<;6$VB1.L5S:>4WG>6\Q3S!)NQD
M%A\NW&.] 'LE%<)?>)O$-\FJS^';$7#Z?>-:QV[1 K<%"!(&<N-ISNQQQ@$Y
MS@++KGB>]\2ZYI-G-I]HMG8P74336S2,I</E& < G*XW \>ASP =U45S<P6=
MM)<W,J10QKN=W. HKB-/\;7NM6/A^.V@\N\U+3#?SM%'YGE@%%PJEAU9NI)P
M!T.<C*\67?B2]^&Y;5X(K"[CU.WAD CR+A/M,>R0 .=@/4J2>A'% ':V7C#0
MK_6?['M[[_B9#=FUDADCD7: 3E64$<,",]>V:W*Y.YU35-/\<:+I+/921:C:
MW,DTJ6Y1R\07;_&>/GZ>W7FN=T37=<T[PCKFK3S-J#Q:S-#(8[4L\<:SA'D"
MAOF"H,A0.,=Z /3J*PO"NL+KFGSWL.IVFHVAFQ;SVZ[3LV+PZYX<,6STXQP*
MA\9:U?:#IUC=V7D$R:A;VTBRH6RDDBH<8(P1GWH Z.BN.OO$6K6_B3Q!IL)M
M"EEI*7]LSPL2&)<%6PPR/D[8ZUGZ5XI\0/)X,NK^2P>T\00 20PPLKQ.8/-#
M!RW.2#Q@8SU.,D [/5]9T_0=.DU#5+I+:UCQND8$XSTX')J]7DWC/6;_ ,3_
M  FU[6;::"+3F=XH8#$2SQ1S>66+9X8E21Q@# YZUU&J^(=7N-3UC3M"A_?Z
M9''@F 2"29TWA6RZ[5P5&1SR>F.0#L:*X&;7_%UWKVFZ1!%I^FW-[I$EW(ES
M$TIMYE9%*DJ^&&6(&,=<\XP>[A$@AC$Q5I=HWE!A2V.<#TH ?17"7OB?Q%?1
MZG<>';'[0UA>M:QVS1#;<>6P63,A<;3G=CCC SG/$C:SXEO_ !/KFCV<^GVB
MVEG;W,#RVS2,IDWY5@' )RO4'CT.> #MZ*\XL/&6OSZ7X1UV?[ ++6KB*TFL
MXX6W(75OG$A;^\OW=O0XR>M$WB+QG=6_BB;3Y-(4Z'>2(L<ENY-RBQH^W[_R
MG!//.21P,9(!W,FLZ?%K,.D/=(+^>-I8X,$DJO4^@ZCK5ZO/$U:/6_&W@35T
M0QI>:1=W 0G)7<L)Q^&:)O&NJMX$/CBU%N^GK(TAL3&=[6PD*$[\\28&[ICM
MCO0!Z'17(KXFN[+QG-8:I/:II5Q8&]T^81%20G^M5R6()4%6X X/M4">(]8:
M72]+DC"ZE=V4E],8;?)AC#*JIL9_O?.,G)'RGCG@ [6BN%@\4^($ATS3=3TW
M[-J]Y/<)NC0,&AB /FJF_@MN7@MQR><8.YX7O-<NK>\CUVR$$D%PR6\P 47$
M757*AFVGL1GM0!H:CK.GZ3):1WUTD+WDZV]NI!)DD8X"C%7JXGXD^;]C\.>0
M$,W]OV>SS"0N[<<9QVJC<>--9\+ZCK6G^(!9WK6VG#4;.>UC:$2*7$?ENI9L
M'>5YR>#0!Z)17'Q:EXL35VA>T22PDM'?[5+;B,6\Z\@%1(2R$?B/6L?2?%_B
M*;3O!VL7KZ>UIK<R6TUM% P9&='8.'+>J?=QT/4]: /2*SM5US3M%B,E_.8P
M$:4A(VD8(N-SE5!(49&3T&17)S^*?$>H6EQJ/A_3C=I!?/;I:&)0)XXY3&Y\
MPN-K?*S#C'0$&E$>H/\ &>9?M<'EC1$;8UN3\AG;*_>Z\?>_2@#J]&UW3/$%
MH]WI-XEU;I(8C(@.W<,9 )Z]1R.*T:\IUSQ!K5U\-_$<BW-M:S:?JYTX&V@*
MJT(ECCP 6.W(8YY]ABO4K=9D@1;B1))0/F=$V _09./SH DJCJ6LZ?HXMCJ%
MTD'VF9+>$,"2\C'"J /<BN;U35_$<OCI_#NESZ=!$VE_;$GGMW=HV\S9@@.
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MOH3AF&>F.HHH *YZ#PPR>)M6U::[2:'4X([>:U,& $0,  V[_;.>.?:NAHH
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M*YW5/!DE_K>IW\.L3VL6IV*V=W L*OD*&"E6;[OWSD8YSV/-=710!PY^']S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSG/WOFQG&:YG4=#GG\4:G<7NC>(Q)-(BV]UHVI>7'+$J *7'FIA\YSD8Z<T
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M-8/B48$C.DFPBE*X!C6]VMN*]@VW83CG)%;:66G6/Q%\)BS@MXOMFD72S[%
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M+X8C:SEG8;&NCM\SD\;]F/?!/K0!V/A'Q#<ZU8:K<:@;5/L6I7%H'ARJ%(R
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MT'B76-0LM&^V:#'8WLZ3*KQ33$;U[JFW.9"<  ^M;%Q?6EHR+<W4,+/G:))
MI;'7&>M5-"TTZ5H\-M)L-P=TMPZ# >9R6D;\6)_"N'\;BZMM1UO4K&6QU"WC
MTY$U;1[SY6: ;V#Q/_"?F?@C!(]<4 >E45%;3?:;6&?8\?FHK['&&7(S@CUJ
M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 0HZ+]/:HSIUBT:1M96Y1,[%,2X7/7 QQ50^(=-%XMKYTA=I_LX98)#'YO\
M<WA=N?Q[8J]=W<%A:2W=U*L4$2EW=NB@=Z &S6-G<RQ2SVL$LD1S&\D88I]"
M>E+)9VLLPFDMH7E'1VC!8?C6'9>//#.H:A9V-KJJ//>QB2V!C=5E!&<!B N[
M!^[G(]*SM#UV2TUCQFVL:FS6.FW<8CDGV@11F%'(^4#NWU/N: .N@M+:UW?9
M[>*'=][RT"Y^N*+FTMKV+RKJWBGC!W;)4##/K@UFIXIT=UOBUTT1L(UEN4GA
MDB>-&!(8JR@D'!Y [5#8>,_#^IWME:6>H>9->P^=;?NG595V[CM8J%+ ')7.
M1W% &S/;07,!@G@CEA88,<B!E/X'BG0PQ6\2Q0QI'&@PJ(H  ]@*SXO$.FSW
ML5K'-(TDTKPQ-Y$GENZ!BRA]NTD;6[]C5G4M2L](T^:_OYU@M85+R2-G"@?2
M@"PB)&"$55!)) &.2<D_G4*6%G'---':0++-Q*ZQ@-)_O'O^-8]EXW\.ZCJB
MZ;::DLEV\1ECC\IQYB@9.PD88CN 21SZ5+_PEVAC2AJAO2+(S_9C+Y,F%DW[
M-K#;E?FXYQS0!J1V5I#&\<5M"B2##JL8 8>X[U6O=*CFTR>VLF6PG>W>"&YA
MC7=!N'!7Z'G'M5"\\;>';#4)K"YU$+=0-&DD2Q.Q4R'"YPIX)&,]!QG&15J/
MQ'IDMS'!'-*S2,Z1LMO(4D9 2P5MNUB-K=#VXH YZS\'7LT<%MJT'A\PPE/W
MUI8%9GVD$8+$[#P.1D^F.HZ]K*U>[6[:VA:Y0;5F,8+J/0-UK+'BW0VTNWU,
M7I^Q7$_V:.7R9,>9OV;3\N5.[CG'-.O_ !7HNFSSPW=X4-NT:3N(G9(2^-H=
MP"J9R.I'4>M &S58:?9"1Y!9VX=W$CMY2Y9AT8G')'K69?\ B_0M-OY["YO2
M+R"(3/!'"\C["<9 523T/ ST/I5/4?'6F6J:%):B>\@UF4+!-!!)(NS:6)^4
M$YXQMZ]>.#0!OG3K$L[&RMR9/ODQ+\W.>>.>:233;&6W6WDLK9X%;<L;1*5!
M]0,8S4[2JL)E(?:%W8"$MC_=QG/MUKG- \:Z=K6@2ZQ(LUI;QS21YGA=,@2M
M&N"1AF.T?*N2"<=: .A%K;B&2$01"*0DN@088GKD=\]ZC&G6*VJ6RV5N+=#E
M8A$NQ3[#&!5>PUS3]3N[BTMIF^U6X5I8)HGBD53T;:X!P?7&*J>+/$D/A70I
M-2F@FF^=(D6.-F&YV"C<0.!DCK]!R0* -J.-(HU2-%1%& JC  IDEM!,X>6&
M-W"E0S*"0#U'T-<5=>)FL?B/"MQ?W:Z3+HDEPMHUNV[S1,BY6,)YA;&>"">O
M:NF@\1Z3=:/;:K;W8FL[HX@:-&9I#S\JH!N+##9&,C!ST- %G^R]/V!/L-KM
M!SCR5QG\J?)8VDLT4TEK \L/^J=HP63_ '3V_"H-*UK3];@EEL)_-$,K0RJR
M,CQN.JLK ,I]B*P_$GB"[C\2Z/X7TIUAO=1$DTURRAOL\"#E@IX+,>!G(')(
M- '5U6N].L=0"B]L[>Y"'*B:)7Q],BLJ;3-8M;BRDL]8N;B)9U^U0W*1G?&>
M"5(4$$'!], X%37/BK1K29HY[S8JS"W>;RG,*2$XV-)C8#D@8)Z\=: -811B
M+R@BB,#;L XQZ8]*@AT^RM[=K>"SMXH&.6C2)54_4 8K+OO&6@Z;>W-E<WQ^
MU6T8EEACADD<*<\@*I)Z'IG&.:LCQ%I;VEG<PW)GBO8S+;_9XGE:1  2P503
M@9&3C@D#J: +1TS3R@0V-L54Y \I<#]*RO$_AX:QX<U33[&&TANK^W> SNN-
MH<8)) R?I5L^(=,^QV=TMPSI>+NMUCA=I)1C)(0#=P.O''>N;\;^(_-^&FJ:
MSX>U1XI+? $L2@,K!PK(RNN5/)R, B@#I]&TR/3;")/LMM%<^6JS- H =@,9
M)P"?Q]:LK8V:?=M8%_>>;Q&!\_\ >^OO69/>V?\ PF%G9G5YH[O[+(XT]5^2
M5<K\[';U7MR.M<[X]\5I;:(ITG4KB*Y34(+<R0P$QN3*JO&9"I7(!;@$'(([
M$4 =E_9>G[2OV&VVDY(\E<$_E67+H^IW.N+Y]W9KH,#1RP6<5N5D,B#(W-G&
MT-A@ .H7T.9K_P 5Z+ID\\-W>%#;E%N'$3LD!?[N]P"J9R.I'4>M0-XKMAXU
M_P"$;%O=>:MJ+AY?L\A7E@J@$#&/O9;ID8SG. #H*K3:?97$Z3SV=O+,ARLC
MQAF4^Q(XJ@OBC1VU"WLOM9$MR[1P,T3B.9EZJDA&QCP> >QKFOB/XK33_"&J
MMI6I7%O?6SI'YT$!9%<LH*-(5*@X/3((..] '>T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(?$
M>-6\-03".Z>>WU"VF@-M%YK+(L@(8QCEP.<J.3[=1@6VH6%\WBJ[ U(ZSJ6G
M%!;2:7/!E(T90$5@2[9?G![C@ 5W&NZ!#KL5KNO+NSN+2;S[>XM) KQOM*YP
M05((8C!!ZT[3=&:RE$]WJ5YJ5R%*+-=>6-BG&0JQJJC.!SC/'6@#A[O3]2;X
M:^"YK2QNFET::QN+RQ\EDE98DVR*$(!+ G('?;QGBK]YILWB#QC/K&GQ3);+
MH4UB9)8FB\Z21LJH#@$A<$DXP"P'KCO:* /)--FNIM/^'-N-(U97TF58;W?9
M2*(66W:,]1R,_P 0R/>BS:.]\+?$'1H[*>YO+S5K^&"-(&*N[@*IWXVC#8))
M/RXSZ5ZV>0<''O6-X?\ #T?A_P#M#RKRXN/MUW)>2><$^61\;L;0..!P<T 7
M-'LY-.T2PL99/,DMK:.%G_O%5 )_2O+[^TO)O WQ%MDTS4&N+[4IGM8_L4NZ
M966,*RC;R,J>?:O7:* /,KV9]+\8WEUJ>D:U>Z5J]I;B"6QCF8Q.BE6BDC0@
MC.<C([GWQ)<1RV6J6FEP^'KNPT]M(98#8VY=RY<D6[S#/EJ!AOO $D_-@<^D
MT4 >2Z=#>CPI\-X7TO4DDL+R,W*M9R9B5870LPQD#<P'./7IS6A-'=VMS\1K
M5].OV:_0RVSQVKNDH-JJ#:P&"=PQ@<^V,FO2J* /-+>&Y6\^&1^P7P%E;R)=
M'[)(! 3:^6 _R_+\W'/\J[70]?M]>2\,-K>6SVEPUO)'=PF)LC!W 'JI!!!K
M6J&WM8;42")<&1R[L226;@9)/)X 'L !T% '&^()+O1_B/I.NS6EW<Z2VGRV
M+M;0-,;:5G5PY106PP4+D#MS7*O:ZL^F:Q?6NCZE)]F\5'4S;>4\,ES;% I\
MOH2W).!SE:]BHH \K\00VNL>!?$MYHWAW58[F]M%@WW-O*;BX8'A0C9;"^IX
MYXZ&MV422_$OP_=QV=Y]F32IXGF-K($1F:,JK$K@'Y3P?2NWHH \DTF;4M*\
M :+82:'?^;9ZJ4NY3I[2R6JF65O-A4J=Y *_,H8 /W/%->TO1X7^(]FFE:N9
M+V1WM?-MY':8/ BK@\DDD'C^'OCI7KM% %+2&W:-9$HZ'R$!61"C X'!!P17
MEOBW^T=0TWQ1:?V+J4=Q'J4,D$%G9,(IXEDB/GLZC]ZY"D8R2,#Y>":]?HH
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M-E3"Z;'C\S !?&3DC&3CIS0!<G\<6UG!K8N]/NDO=&@^TW%JA1F>$@D21L2
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ML=<F^(4^O7FF1V=G-I4=KM:Y5Y%=9';&%!'\7KCISU 7Q#9/;>/_  SKV/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 85UX.\/WNI2:A-ID?VJ7!ED1F3S<?WPI ;\<UM111P0I##&D<2*
M%1$& H'0 #H*?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% #5C1&=E15+G+$#&XXQD_@!3J** "BB
MB@ HHHH **** "BBB@ HHHH *9-#%<0O#-&LD3C:R.,AAZ$4^B@!$4(BHN<*
M,#)R?SI:** "BBB@ HHHH **** (YK>*XV>;&'",'4-R PZ''M3C&AD$A12Z
M@@-CD ]1G\!^5.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHK"O-7>;Q3!X?M'V2"V-Y=R@ E(]VU5'NS9Y[!3
MW(( -VBN=BU6Q^V>(G_X20,ELJ"6,A-NGG8>C8Y)QNP<\BJEUK;:-X0T_P 0
M)J3ZEI\,41NIG0 SPM@&8  889W8Z$9&,X( .MHI%(90RD$$9!'>EH ****
M"BBN*T/QA<W_ (\U#1[J)8[&:#S])D_Y[+&QCEY[_,-P_P!G![T =K163?\
MB;1=+OOL-YJ,,5UY1F\GDN4! S@>Y&!U/:H?^$PT Z?8WZZBC6M_+Y-M(J,1
M))G&P8'#9!&T\\'TH W**J_VA:_VE_9WF'[5Y7G;-C?<SC.<8Z^]9NJ^,?#V
MB7,UOJ.JV\$\,0FDC.2RH3@$@ ]S_,]!0!N45AZ9J5E/J^M-%KJW:0>49;<[
M0EE\AS\P'.[!8Y)Q[4Z/Q5H<]S!:+J21W%T@:W612AF4\!H]P <=.1D<CUH
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ML((I(WC*,KJ@# @@$'.:Y.>*]L?$[76@3W3+<ZLJW^B7D!:-OW@#7,3$?(
M'R"5S[\5Z92$@#)('UH \EU+3-5O=#^(>B6=G=#4+G43>0!H66.>+;"<!R-I
M+!&7 .:W=0SXM\1>%;[2DN(&L6GFN99(6C-NK1%?+;<!\Q8K\O\ LDUWU% '
MFO@B_0:'I/AC5O#]TVM:5*JN)[1C%&4)_P!(64C;]TD@@Y).!US6+ISZEHOB
M+5/$0M+R[TY=>N%EL?LKEQ'*$"W4(VY8C!!QGY<XQSGV2B@#G?&%T_\ P@VI
MW-GIBZJQMR4M)(BPE!QG*=3@9..IQBN.@E:7QI?WBKJEQ;77ALQI=W-F\2LR
MNY(QM 0 $8! S[YR?4ZKW]LU[I]Q:K+Y1FC,>_;G:",$XH \JTNVB\0?#_P!
MI^GPN;RTN+*Z=A$5^SI&-TCDD<;AD#^\6&,T^TDM+C0?B-I36SW%Y=ZK>1PP
M+"6,S-&@0 XQPW/7Y>IP.:]'\/Z2N@Z!9Z1'<-/'9Q+!'(R@-M48&<=\57\/
M^'_[!DU-A>-<?VA>/>R!D"[)& ! Q_#A1P>?>@#E=#L)M.^(>EVUU'+*UMX8
MBLGN?)8QF59 2N_&,D#.,UF0):I/K?ACQ)HFL7L]SJ$\]LD?GFVO(Y)#(AW*
M=B[20#NP!MKUB@D 9)P* /-K6^70_$'B;1=>T:]O8=5NA<VC1V;7$=TC1(GE
M$X(!79CYL#'.0*NS^=#\4+:9=/D*Q^'I(=D<9\KS?,1A$'QMZ X]J[RB@#R#
M2+B:XUCP'>G3M1B%NUQ%<6R:=)%#9,T)41*NT< \;B3TR2!Q5G;<1> _B#I3
MV-Z+N6[U%XD^RN1()23'L.,-NSVS[XKU:@D#J<4 >=6KW&E>,M$UF[BG_LFX
MT%;$2^4Q^S3JX<AQC*AAQD]U K%O])N;?2;NX^R7)M]0\6PW\$ @=F6$2)OD
M*XRH.UFY X(]:]?HH XS3-Q^+&M3"&802Z9;(DIB8([JTA(#8P2 P_.FSKGX
MR6TS6\K0C1)(/.\EC&)#,K!=V, [03UKM:* /.6@CG\1?$=+NWO!:75A F^.
M)E,JK!(KB-B,%AG'7K6=X;U?3+S5?"KZI?3P7FEVC6MO&^FW$"RR2(J?,[J%
M'"X"@\DYST%>DZSI4&N:/=:9<O-'#<IL9H7V./<&L^R\/WD;Q_VGK]]J<43*
MZ131PQKN4Y4ML0%B" >N,C.* /.;R&=_AGXN@CLKLW%QK\L\40M9-\B&Z1U<
M#;DC:"<^U=-*_P!G^(NM336%W/;7^BPB$QP.4EV&4NI<#"G##J0>1BN^HH \
M[\'17^G:_:V%G>W&I^'S9.T9OK<I<:<04VPLY )!_NGD;/0<Z&O&2T^)GAR_
M:VN9+8V=U;F2&!I LC&,J&V@[<A3R<#@\UVF1G&>:* /'-0@GE^'/CV".RNV
MN+K6II8(Q:OOE4R(591C+#"DY'I5[QA<SW[^,;"+3;V)IM*7[*UI9,3J'[IC
MEY O 0G:%R#UZYQ7JM% 'G5I++%XT\+:@]C?"WET.2T#?99,K+OB(5QCY.%)
MRV!Q6_X]TNXU'PK-+8KNU+3Y$O[+ Y,L1W #_>&Y?^!5TU% 'F2:3K3^*HKI
MK:46GBFV']IQMTM?+(*JWNT),1Q_%S4FL3IHWCS56UNQU:?2]5MX5MI[ 3NH
M9%96B=8CG)SD9'<UZ302 "2< 4 >=6UE!8^/?"L5OI4]I9V^EW,2QF-G6W+L
MA1&?D!B W&?49JC(;:QU_P 1Z+XDTC6;N+4[LSVC6HG>&ZC=%7RR$.T,NW!W
M8&,<XKU.C(.<'I0!!90BWL+>$1"(1Q*@C#%@F!C&3UQZU/110 4444 %%%%
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MRPDTNZ@M]5A>6QNG9,2[%#D%0<K\IR,_I61)X=UE[+QY"+1-VN;Q:?OEP-T
MB^?TY&>,\5/_ &%JYU3P3<?9%$>CPR)=_OESEH?+&WUY&>W'OQ0!!%XOTO0_
M#WB36K70;J%;359(KR)73?)-\@:0_,1@EE'&>G2MNU\6;_$-SI%[I=U9RQV9
MOH68J_G1!MK<*20P)'R]>:Y:]\)Z]=>$/%VEI9Q"YU?56N[;=.-HC9HS\Q['
M]V>!GJ*VM2TC7+KQF=7LHDME_L6:QCEDD4F.=V5U8J,Y4%>?Y4 6K#QC]JU+
M3;*?3)K:35+-[RS#2 L54*2LB\;&PPXY'7GBN</BQM2^&>M:MXDT,W5BDT\<
MEO!,IW(LK)MR2IP-HR>IZ@4_2/#/B&'7?"^I7.FV,4EC!/!?R?;#)),SJ@,I
M;;EB2AP">_44R7PEX@_X5SX@\,"VM6DN9[@VLHN.'664R;F!'RX!QCDDT =C
M<:Z(]372-.M1=7RVPN7C,@C2.,G:N6P>20<#'8Y(K';XB61TO3KV'3KV4W>H
M_P!FR0@('M[C)!1QNZ\'ID=.1FE.CZKIWC0>([2U%Q#>6"6M[:>:JR1NA)1U
M).UAR01D>HSTK*F\&:I!9V#00Q2W,GB3^W+U5E 5 2<HI/WB!M'8$@GB@#J=
M!\2'6-1U33;C3YK&^TYH_-BD=7!212R,&4D<@'CMBH/&=[I]E8Z=_:>F27T,
MNHV\:;6 $4ID 1SR#@'T!IFC:5J%KXZ\1:I/;JEGJ$=LL#"0%LQ*P.X=L[N/
MIVI?&^DW^LZ986^GPI))#J-O=/OD" )'('(^IQ@4 0WGC2:'5]8TNTT&]NKG
M3(8YWQ)&BR(X8Y!+?[/ ZDGIP36]HVJV^N:+9:K:AA!>0)-&'&& 89P?>N<C
MTC58_%OB34_L8-OJ%E!!;_O5W;HP^=P[ [_?I6GX*TR[T7P9I.EW\:I<V=NL
M,FQMRDJ,9!]* *>N^-%T-=4N)--G>RTLQ"ZG+;"=^#^Z!&'P&&>1Z#)J[J'B
M)H;R\L].L7O[JRMUN+A%<+M5L[5'!R[;3A?S(R,\CXK\*>)==3Q1:&VLKM+V
M-1IMS/<$?9T"C,:IM."6!.[(SGD\ 5H/IGBK2/%MSKFF6%C>Q:M;PI>6DEX8
M_L\L8(5E?8=R[3@\9XH VT\4"\:TM]/L)I+ZYLQ?&VN#Y!AC/ \S(.&)R ,'
MD'H!FH[;Q?'>VVDK!I]U'J&II(\=E=+Y+Q+'P[29SM .!D YW# ],K4=(\3Z
M;XJM/$FF16FIS2V(LM0M))OLX)#EU>-L' !9A@\XQU/-37^AZX/$&A^)8Q!<
MWUK%-;WMHC[0T4A! C8@ E"!][&X#M0 MY\0[6QT/5;Z;3;O[3I5PEM>VBE2
MT3,0%;.?F0[@00"?;K5X>*9Q/#9SZ+<6VH75Q)%:6TTJ?O8T4,TI92=J@$ ]
M3G P<USFO>#=5U'2/%%Q!!$-2UVXM66%I0%AC@V;0S=V(5B<9Y8#G&:U_$FD
M:Q+XAT'Q+I-O'-<6"RPW%C-*$\R*4#.U^0&4J#Z'UH Q/#&JG1[[QQ>2:9<"
M1=5AC%I!^\8NT<:C!_NDMNR<<') Z5T$OC=+6W\1FYTV8W.@QK+<Q6\JN'1D
M+AE9MO93D$ \=#6!-X>\7E?$UQ:PVMO)J5_;W*1)>$-)$BHLD1<+\FX*1N'O
M]:'\)ZZ/^$R6#2]/MX=;TV.WMXH;CB)Q&Z8/R@8^?)/Y9ZT =#8>,_M>LZ98
M7&DW-I'JELUQ9SR.A$FU59E*@Y7A@1GKZ"GP^+_M/]G75MI=U/I=_<_9H;N'
MYB.H$C(!\L9*_>SW!(&:SCH.JRZOX-N'LU$.E6LT-W^^7.7B6,;?497/;@^O
M%,\(:7XL\/6=OX;F@LGTRR?$.J"?+O &R$\K;]_'RYS@=><<@$^H_$?3-.S<
M%4EL$N_LDLR7">8C;]A<1=2@;@GKQD CD]A,TB0NT4?F2!253=C<?3/:N&T3
M2_%WAZXNM$MK>PGTB2ZEFM=1><K);1R.7*M%M.]@6..0.F?2N\H XQ/B##)H
M>CZM_9LB0:E>_8=KRJ&MY2[(!)Z<J1QGM4_BG7+6+0?$:ZCH\M]IMC#MN5CD
M7]Z&0,R\D8PI!//<8S65??#R6_D\36LDZ#3;XM<V$8ZP74BC?)[8= PQ_??U
MJ_J?A_5;KX8WNC'RY]9O[5UG<L%0S2#+'/\ =!.![ "@!9O$-_'XQT31+/3T
M_L^YT][@GS0#@% !TX"AOQ_#GF_#OB,>$],\13G2KB;38/$=RD\\;J! C2*@
MP"<MC(X'05T<VBZPOB?P[J]O:P.MM82V=U')/M,98QG<, [ON'CCJ.G;%N_"
M6O7'@CQ3I"V<0NM5U66[M\SC:$>17&X]B I' /44 >F44V-F:-69"C$9*D@D
M'TXIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7%A9WC*US:03LOW3+&&(^F:L4 <5!X,OK+_A&[ZTN[<:IHUG]@DW*WE74&T
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MO?[9EMYV6[<6\T$1C62+ (X)[$L,]\9YZG<HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!&7.%#.A49]LFN;@T/4M6MO"UIJ%@UC%HDL=Q*SRHYFECC**$VD_+EBQ+8/
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ML9$H)##!7/RALBH;?PG>:1J_@F&SA:XL=$M9X+BX+JI)=%4$*3GJI)] >,T
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M!_*IJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4WVZ.Y+7*JP9#&H.%4YP#D9Y.<&@#J*RSX=T<^(/[>-A"=5$8B%R1E@O(X[
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MRB@#BO#WA#6_#[)ID/B!'\.PRF2" V_^D(F[<(O,W8V9[XSCCBM+3- O]/\
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M45T]% '+7^E76MZWHWB+2-2AB6VBEB:&ZMS(,/C)"[E*2#;CGW![UF1Z!?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#1HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKDY+ Z3\1SK)XL]4LEM)7[)/&Q*9] RLP!]5 ZL*ZRD95=2K %2,$$<&@#G]
M'T*\T_Q7K^KS2P-#JAA*1IG='Y:;.<\'/7MCWZTWPWX4C\.ZAJT\<YDAN[EI
M;>$CBW1OF=5^LA<_3;Z5T=! (((R#0!RFEZ>U_\ $#4O$O\ R[QV4>F6K=I
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M9 V9&1QW/&3FMG_A'M47QC:Z^M]:%O[.%E=1F!ANQ(7!3YN,DD<YP/6NHHH
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M **** .)^+W_ "2G7_\ KBG_ *,6MBW?7)+RQ6\M;!=/V%I6BE:1@P *<,@
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M]EE)3S)(#]TR!/E##D''!Q64?AKI@\/6&E1ZCJ<<FG3O<65\DB+/ SDE@"%
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M-J%F/18S\O#;DESC'*>]:4R6OA*UO=7>#4=2NKN6/[0]O!YLSXPJX1 ,*H[
M>IY)-)X3T&WTS3;V4V(MGU2ZENYK=N=@<\*1R!\N,@< EL4 9&D:CXJU$Z!J
M\.]["\19+Z&;R!$L;KD-"5^?()'#$Y'H:KZ9K?BC7]/TC7M*63[/<W >>VF,
M @^S%B#M(_>!U ')."0> .!K:%X#M/#]P@MM5U273H7,EOILTX:" YR,<;B
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MJ(OH'$<T=Q@#>I P. !C'3KD\TFH>%;Q?#-Q9V>MZP^IS.K?;_/19B5^Z"<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO-;=N5V?<3MQ@EL?AGVK7TC5(M9TY+V&"YAC=F4)<PM$_#$9VMS@XR/8U>H
M\\T[P1K-CI'A>Q::P=M%OY+MW$CCS0WF< ;>#^\/Y>_%RZ\):K<#QJ!)9 >(
M(A'%F1OW.(?*RWR\\?-Q]/>NWHH XZ^\-:M<P>$TC:R#:+-'--ND?$A6-H\+
M\O&0V<GZ>]/O?"=QJ?BC5[V\:#^SM2T@:8\:.WF*,N2WW<?QD?A7753U;5+;
M1=*NM2O/,^S6T;2R&.,N0H&2<"@#G/#FB^*["R@TS5=6L9+.SB\J">UC<3S
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M\0ZHMO'<Q6?V.&"WD:14#-N=BQ5222% &. #USQT--:15(!89() [G'7 [T
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ML63S#*A0A!@[54'C)).!GUKHM4U!-*TV:]D@N9TB )BMHC)(V2!\JCD]:MT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!S?BW6Y]+.CV-I((KC5;]+-9RH/E*069@#P6PN!G(R
M0<'&*P+*VN[7XG>)$&HS2R_V+;M%-*B%H_GEXX !Y!/([UUGB+PY8^)M.2SO
M3-&8IEG@G@?9+!*OW70]B.?SJE:^#H;;5;G5'U?4[B^N;1;22:5X^5!)!VA
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MF3P;9_;=1GM;R]LX]3 %[! Z[)CC:6^9258KP2I!/7KS4P\*V4>N:?JD$UQ
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M0=@H9E  ()VJ<DG!'&* *=WJ&IZ!XTT#3Y+^74+#5Q-"XG1 \,L:;PZE%'!
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MP)# 5#$ @XR0<<@56O\ PO'J(O$FU._\F^MQ;W4(,>R50"I/*?*2"02N/T&
M#=1UD171@RL,A@<@CUI:C@ACMK>."% D4:A$4=  , 5)0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*]W(WEJ+Q4Q@MALJ2#G)/Y4 >UT5SWC>YM[;PM<?:+NZMEEDBA5K0@2NS2*
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MSQ+<^68PI(#'GD@L#\W<D&L6[MXYO!4EI.TDT.G>,!:VWFR,QCB%RH"Y)R<
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M/8Q*3+LV;S@?-M[9ZX[5/0 4444 %%%% !1110 4444 %%%% !1110 4444
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M4_#^E:S+!+J-FER]NVZ$N3^[;U7G@^_6F0>&](MKAKB*S59VB:'S=[%@AP2
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M%AW Y%8]QXPL[RYU[2M-NXTU#38,[V&X&3:S$!3C. HR??VH ETGP?IUI:6
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M<76G7%O:W;6=Q)&5CN$0.8F/1@#P<>AJMHNE-I5HZSWDM[=S/YEQ=2JJM*^
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M \N6YLM,^%GA&Y_L^"0J;&*6X:$L+)E&3*ZK@DJV>#_$W/>LB_62[T+XH6L
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MQ/PG@@C^&^B;842XCMS'+\F'5MQ)4]QSSBNLU)&DTN[1%+.T+A5 Y)VFK5%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI-_:(PGN;J!%",5P5A8$ELGO@# YYQ69H7AR_P!0^#2^&[NQN+'4K2#9$TP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2 8XSFIM/\3ZA:^,AX7U^&V%Q<0-<6%Y:AECN%7[RE&)*N.N,D$4 ==1110
M45R&EZ_JUQX\\0Z1</;/9:7!!+&(H")9/,5C@G<1QM].<U0T3Q)KGB3PK%X@
MTF^TZ=Y"#+IX@+& ;OF3<&SYBKSR,$C@ &@#OJ*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** .&^%;"Q^&MI%>.L4MI-=171D.-CK/)NR32?"VZM_\
MA5NG%I4(ABE\X9Y0>8YY';BNLM=+CLM0NKFV;RTNV\R:''RF3 &\>A( !]<
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MUW'+)I-TQLV!_P!9 _S@#GDH201VXKT6B@#S]KRV_P"%](//CS_PCQA^\/\
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M8Z==7BV.JQW=QY" [(PK GD@$\]* .NO;N'2]+N+R8MY%K"TKG.3M523UZG
MKE/"4=WXM\,V^O:M>WD4^H S0PVER\*6T9)V* I&\XP26SDGTXK4FO9M>=M(
M;1[^"RN8)$NI[E%10A4KM7YB2Q+#MC -9?A$W_A+PW!H&J6%Y<2V :*WGM(3
M(ES'DE",?<." 0V.1U(YH IZ3?:KXJTGQ'X=EU2:TUS1[IK>/4(#L,@(S%(R
MCCD<,,8XXQVBT3Q%<ZSX-70S+<6_BE)#I]RIE8R0S*/FGSGE,?..Q)"]ZV_!
M?AZZTJ36-6U%5CU'6;PW,L*L&$* 8CCR."0.I'&2<>M4=+L+F+XN:WJC:;/'
M:75C#!'=&+"NZ$[AZ],<G@X^E %;QS+)H'_"*1IK%[;P3:I':W<\EVP,D11B
M2S$X!R!R,?E6[I!TR\UB<:7K\]]'#;[;B%;TS(#(?D;=DE6'EOT/1JS?'UK>
MW>H^%GLM/NKI;'5H[NX,*9V1A6!/)&3DC@<UM0ZBTNLAX-%O(A)%FZNIHMOR
M)G8@&<EMSG''3/M0!P_A;7-.ET75IM?\4W$=S;:A=0HK:D4D$:.0@"9Y..G'
M->FV,$MMI]M;SSM<311*CS-UD8  L?<GFN!\&Q7&F>'M7T_5] U%EN]1NIO*
M$(8/%(V1WXR#7>:;/<W6G0W%W;&VGE7>T!.3&"<A6QQN P#CC.: )YIH[>&2
M:9PD4:EW9C@* ,DFN'\&>)-4N_%&KZ5K8\N2XCCU334/!%JX"[#[J0,^[&MO
MQ4LU[;6VD+:W4EM?3".\EA4XC@'+ D<_-@)QR Q/:N=\6Z!<Z7K/A_Q!H5MJ
M-_?V=T8YXC</+OM7!$@R[8!'!'O0!:U6:Z'Q9T73TOKM+*XL)YY;=)V".Z%0
MIZ\=>@XKH?%5SJ=GX4U2XT6+S=2CMG:W0+N)<#C [GT'>N8U@7W_  LW1=9A
MTG4+BQM]/FAEDCBY5W*D#!()Z<XK:N=;UFXM[V33M#NT:WB5HDN0J-<R%ONK
M\QP  <DX^\/0T 8GA?4=/\1C3K[P[XBOY3!)G4;*[N2\C#:P(=&Y0AB#\N%.
M#UJ?0-1G\:ZSKTTES<0:3IMZVGV\%M,T1DD0#?([J0QY(  (&.H)JCJ^@Q:U
MXMT+6='T>\TW6+>]22^NWA\D&W /F1N>DA;A1MW?7%7M!TVZ\%ZYKL36L]QH
M^IWC:A!-;1F1H97 \R-T7YL9 ((!&.N* )=+UF[TOXAW'A&\N)+JVFL1?V$T
MIS(B[MCQ,W\6",@GG'!)KLZX_3-%NM2\?W'BV]MWM8HK(6%C;R8\PKN+O*P'
MW<DX ZXZ@'BNO=@B,Q!( S@#)_*@#A_B)X@U;1[:*71EWG3MFHZBHZM:JX4I
M]6&\_2)JU?%?BVW\/>!;OQ-"%N8D@62W&>)"Y 3\"6'X55TS1(]<CU+4-7@U
M&VGO97C>V-Q)$! N5C4A&P<K\QZ\NPKF-,\*ZEK?PRU?P-J-O<VHMY'CTV\N
M$XEA63?"QQR,8 (ZXH [+3_#]X^EQ2ZAK&H'5I(PTEQ%.52-R.0L7^KV@\ ,
MISCG-<KXDU&Z\.:KX'CU?6YX('CF3591.R),8H VXX/&6&>,$YQS73Z/XAU)
M["&WU30=1AU5$"2HD8:*1@.667.W:>O)!]JQ?&&E7.L>*O"1N])>]LK9KG^T
M?+B+Q*LD.P#GEAD]AVSQ0!O:3:7NI:F^NW5Q>6]M*BBUT[SB%"_\]) #]YLC
MY>@ &<G-<K>>(=3\'>-;Z>]GGNO";RQ6\SRN7;3Y&0%7R>?+);!R3CCZ&SH4
M6N>"=??0([&_U7PN5#VERHW26.<_NCDY=!V(R1G'/;?L[9-0U7Q#;7VGRM97
MAC \^(A)D\H*PY]\CG'M0!!>ZC'I>N:QJ<MS<26-EI"7ODK,Q0\S%F SCE4&
M.U0>%K:\\3>%[36]6U"]CN]0C%Q&EI<-%';(W**JJ<-@8R7#9.>W%9GAWP/?
MZ=/XBT'4+A[G0;BP2TT^9CF1(6,NZ(GN4W\'T(^@TO"L^H>&?#%KH>J:;>3W
M6GQ_9X9+2$R1W*+PC*W1#C (<K@@]N: ,,:OKOB/P-XGL8;V:#Q)H-Q+;K<V
MQV?:#'\RMM''SJ"".F>1BH/$'BD1Z1X)\36NI7D5A=S1+?6Z3L5,+ !F<YR-
MCE03GG=@]JZWP1X=N=%M]4OM1"+J.KWTE[/&C;EA#?=C![[1U/J37.Z/\/)O
M[/\ %.B:AC^S)&FMM)!'^IBEQ*Q'T<J/K'0!ULD;WWC HES<I;6=I^^CCF94
MDDD/R9 /551C_P #7VK&^&]Q=WMOKTM[>W5T]OK-U:1&:4L$B1@%4#I^/7WK
M0\#6.HZ;X1MY-;R=6G437F!D[@H11@=PB(#[@UA>"9M0T&VUR.]T#50UUK%U
M>0[(5;='(P*G[W!]C0!9^(E_+IM]X8D74I[&WNM42VNF6X,:F(HQ.3G Y YZ
MUK:0=-O=7G&F:_/?10V^VXA6],R@NWR,&!)5@$?H>C5A>*5U?56\(7@T:[,E
MMJBWMS"B F"$!P QS@M@KD GG-=+#J+2:R'@T6\B$D6;JZFBV_(F=B  Y+9<
MGITS[4 <MX%M;_Q!X=OKBYU_5DNDU"YMXIEN,[%1RJ_*P*GCU!JBOQ(U33/#
M&MVVH)!<^(M,U!=,B<+LCN'D/[J0@=.,D@?W>V>-#P-)J?A_P]?6USX?U-[J
M34+FXBB5$&]7<LOS%@HX/<U0F^&>I:GX5UJ6\N((/$>I:@NIH4):*WD0_NX\
MXY &03COWQR ==-HRV.D&6^\27T-[LPVH276Q!(>XB)\H#/1=O\ C7-^+-4E
MLK+P9,-=9([F^AM+ZYM[O$4J>6Q<[LX^\O7@UIZYJ5_K7@75-,FT+4(=8N[&
M6W^S"'?'YK(5XE'R;<GJ2..HK+UG2-3M](^']G'IMQ<2Z1<6LMX(%#"-4B*-
MSG!Y/04 =)I,MC/JUP^C:[)J'V>VQ+;F\\^/<YRASDX/[MA]&KD?#&L?\)-I
M9MAK^H6/C*!LWME/,4^8-ED6)OEV$< J,@8).>O:IJ$T^JDV>C74+R0GS[J>
M,(,(&V(.<EMSGMC&?:N.\5Z1+XP\/6K/X=O++Q@@B,%T(POV:0$$L9E.TH.3
MC)/H,T >H44U PC4.VY@!DXQDTZ@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &2S10)OFD2-.FYV '
MZU7_ +4T_P#Y_K7_ +_+_C1?Z99ZI'#'?6Z3Q12B58Y%#*6 (!(/7&<_4"O/
M_#>@Z3J'CCX@65UIMI);F:UC$;0KA08!G'''X4 >B"^M#-Y(NH#+G&P2#=GT
MQ0M[:--Y*W4)ESC8)!NSZ8KSYI(M.^.%RZV<T[?\(]$/W$0=O]<PR?P &:?H
M<D=U\:]:N!:20/\ V/!Q-'M?_6-S^@_*@#T1G52H9@"QPH)ZGK@?D:;+-% F
M^:1(T_O.P _6O-/B5?3W$DMQI^H10W'AKR]06 RA?M$V=Q0CJ<1;N._FBNXB
M72_%FC:=?-%'=64H2[B210RG*_+D'TS^!'M0!;_M33_^?ZU_[_+_ (U8EFB@
MC\R65(T_O.P _.O-_#>@Z3?^.?B!976FVDEN9K5!&T*X4-;C.../PKM/$<*?
M\(AJT+*'06$RX;G/[LT 7Q?6AA,PNH/*!VE_,&W/IFFG4K$*&-[;[3P#YJX/
MZUYKI>HQ+\"H[3^R[TJ=!8%Q;CRR3"?FSGIGG-4M>BB7X)^##Y"N%ETMM@49
M).W.,]SD_G0!ZS%?6D\FR&Z@D<_PI("?TI\US;VP4SSQ1;NF]PN?SKG[3[%<
M^([:/_A'I;&:WA>>.XDBC3)X0J"A.>')(/\ LUD?&6-)/AAJ6]%;$MMC(SC]
M_&/Y$T =I-?V=O;"YFNX([<\"5Y %/XGBI8IHIEW12)(O'*L".F:X7QI'J^D
M^(=+\266CG6=-L[>2"XL(@#+#N*GSHE/#-A=N.N/J2-+P)>^'-3L+_4/#3HL
M%W=>;/;B/RV@EV*K*R=C\H/N23S0!TC7UHDWDO=0K+G&PR -GZ4-?6BS>2UU
M )<XV&0;L^F*X'Q%)%:_&7PY<&TDG<:9=<0Q[G^\N#^&3^=-,\5]\<-+F-E-
M ZZ+/_Q\1!6)\Q>1^9_.@#O/[4T__G^MO^_R_P"-/:_LT1':[@5'^ZQD #?3
MGFO-_#S6]OXY\=[M#EOP+V%OW,4;;?W()'S,.33?'D-D/AAHTL5@L$$NHV=S
M]F$>?+,LH=E QZNPP/I0!Z=%/%.F^&5)%]48$?I4+:E8HQ5KVV5@<$&500?S
MKS[1(H=9^*DFK>'[?[#IVG6[V6I@IY+7$W55,7#?+G.Y@,]!F@>3'\9]=+:2
M]]NTJV)6.-&(.YN3N(H ]#-_9B(2F[@\LG ?S!@GTSFG0W5O<DB"XBEQUV.&
MQ^5>=>,X[.;X-^)+J#3/L(N!)(]NZ!2KJX3) X!Q&"<=ZS/&%S:K:>%OLVF2
MZ-=B\MRNKS0B**!/XE9US]X<;3P>_2@#U<WUH)O)-U )<[=GF#=GTQ2O=VT<
MPA>XB65L81G 8YZ<5P_C[1I-/O+/QWI-JDFI:0";J(*,W5J1\Z_[RC)!^M:^
MA1VWB.^C\6O;J8WA\O3#(F'6$\F3GD%S_P".A>F30!T]('5F958$J<, >AZ\
MU'=7,-E:375Q((X((VDD<]%4#)/Y"O,/#6K2:9\18VN[])HO%5L;CRQ*K?9K
MF/D1<=/W15?<I0!Z9+?6<$ACENH(W'57D /Y5-')'*@>-U=3T93D5P/BZUM[
MGXK> UG@BE5EU#<'0,#B)2,Y]#57QG;0^$/$_AC7=%B6T>_U2+3;ZW@&U+F.
M3.&91P67'!Z\T >AQ7MK/)LAN89'Z[4D!/Z4/>VD<C1O=0JZ\LID (^HK@VM
MX?"7Q=2Y2)([#Q1!Y3L% "7<62/IO4GZL*Z+1+6WU#6-3U]H(RTS?8H)-HR8
M8B03GWD,A]P%H VXKNVG5FAN(I G+%'!Q]<4RWU"RNTWVUY;S*#MS'*K#/7'
M!KRCPOHM]JOP+-GHRP"[:\FD$4GRI.$NF)C8^C*NWZ<'BMSPUX@T+Q!XJM4N
MM*DT+Q58PNCV5Q$%:2,CD(PP'48!!]CQ@YH [G^U-/\ ^?ZU_P"_R_XT]K^S
M149[N!5<94F0 ,/;UKS7PP]O;>)?');09M0"ZJ6_<PQOC]TIQ\S#D_UI_CBT
MLF\$>%A%91102ZU92B#:"J>8Y9E ]/F(QZ4 >EPW$-PI:&:.11U*,&_E3I)$
MB0O(ZHB\EF. *\[^*&DVNC>%I_%.CQ1:?K&E-'+%<0($\Q=ZAHWQC<I!/!KM
MG@MM?T2)+VW#07*1RO"XR#T;:1W&1@CO0!+_ &II_P#S_6O_ '^7_&IWN(8[
M<W#S1K"%W&0L N/7/3%>>6ND:8_QHU.V;3K1H!H<)\HP*5R96!.,8I+&&&\^
M*K>'Y(Q_9/A[2XFL[1N4\QL 2$=RJ_*/3MS0!Z%:WEM>Q>;:7$,\><;XG##/
MU%35Y]XRE/AWQIX3U73U$3ZC?C3;U$&!<1N/E+#N4(R#U&3VJS\4-4N[+0]+
MT^SGDMWUG5;?3I)XSM:..0G<5/8D+C\30!URZG8-<26ZWUL9XP2\8E7<H'7(
MSD5-/<0VL+37$L<42_>>1@JCZDUDWWA31;[P[)H36$$=BT1C1$C \OC 9?0C
MKFN8TF5M?^+7B"'4,2P:!!;16<+C*AY4+/+C^]Q@'L/K0!W<-Y:W%M]I@N89
M8,$^:CAEXZ\CBGQ317";X94D3.-R,"/TK@?$,A\/?$_PQ-8*(XM;,]I?PH,+
M-M4,CD=-RDGGKCBL2)KOP%K6I^)+56D\-W.HRQ:I:1K_ ,>I#86X11V[,/QY
M[ 'JT5W;32-'%<12.O54<$C\*9!J-E<NZ6]Y;RLC;66.56*GT.#P:Y"?3VU[
M3O&D.BW,45QJ 18+J,\-NMH]IW#L<]1ZUCZ%KFD7^N:-HWB#0QX>\3:<^;6-
MH@(I@$*D0R#@J03\OJ!U(H ])COK2:3RXKJ!Y/[JR G\J1K^S21HVNX%=?O*
M9 "/J*XKPI#$GQ8\?LL:!O\ B7\@<\P$FMZ""$^/M1E,2>8=,MEW;1G'FS\9
M_ 4 ;,-W;7)(@N(I2.H1PV/RI)KVUMWV37,,;8SM>0 X_&N)^#T,<7@)?+C5
M,WUUG:,9Q,P'Z "M+QMHNG-X6\2ZC)9P27CZ9,/.DC#,H6)MH!(X ))^IH Z
M2&]M+A]D-U#(^,[4D!/Z4LEY;0RB*6XA20]$9P"?PKF/!&BZ:/"?AC44LH([
MR/3(,3)&%8AHEW D#)!X/U K/^*%L+*RTKQ9%"'GT&]2>3"Y9K=CLE _ @_A
M0!VR7EK)-Y*7,+2@D;%<%N.O%-.H62E@UY;@H<-F5>#[\UYR][;Z;\:X-1MX
M8QI^K6PTV:X7&&N@HF0_BA5<]_PK4OK:"X^'GBS5S#'NU6UNKD-M'S1B(I$?
M^^$5OJQH [(ZC8A YO+<(Q(#>:N"1U[^XH74;%V"I>V[,>@$JD_SKFO"&B:9
M>>"_"US<V4$TD&DPI'YD88+OCC+$ CJ2HYK#^%>AZ9>^ K">:Q@,\-_/+',(
MQO5EN'QAL9[8^G% 'H4=]:3%A%=0.5&XA9 <#UIT-Y:W#%8+F&5@,D(X8@?A
M7G7@:\BT_7/&JIIUU*6UV7+6\ 88V)P3^)/XU:^%@C;_ (3"5(#"7\1W7RLF
MU@-L9P1[9/% 'H--61&C$BNIC(W!@>"/7-8WBG4?L&C&..X2WN;V1;2"5F"[
M&?J_/]U0S_\  :YOX87RVUKJOA-[I;B30[DQP2APWF6K_-$V1U(!*GTQ0!W<
M-Q#<*6@FCE4'!*,& /X4U+NV>8PI<1-*,Y0."PQUXKRV^AO_  AXM\0>+=)B
M:;3$O4AU;3HE',7V>%_/0#^-2[$^H)^M=EH=S8ZCXIU'4K!XIH;G3K*1)XQ]
M]2T^#F@#IJ175QE&##)&0<\@X/ZUF>(M5_L?0[BZ5HUG.V*#S#A3*Y"ID^FX
MC/H 37'?#>Z72M7UOP<^H"^%I)]ML[@R!S+!*<MR.ZR;L_[U '>/J-C&[(]Y
M;JRG!5I5!!_.C^T;(QF3[9;[ <%O-7&?3.:\^^).AZ99:'IK06-NLD^OVTDL
MGEKN<O,6;)QDY)-=@WA+0GO!<G2[7=O60H(EV%U5U#%<8)Q(PS]/2@#0&IV#
M$ 7UL2> !*O^-275Y:V47FW=S#;QYQOE<(,_4UYSX)T#2=2N?&UM=:?;/&-=
MF1/W2Y0;$QM..,'D8Z&KG@68^(_$?BK6M042SV>J2Z9:(XR+>&(#[H[%B<D]
M\#TH [M;F!K<7"S1F C<) PVX]<]*;%?6D[[(;J"1O[J2 G]*X6WE.A_&1M&
MLU":;JVF&\EME'R).KE2X'0;EX..IYKSZQ6POOAM!X<L].!\0ZAJ%RNG7!B\
ME8W2<MO$QQRJCHI)[8H ]]>Y@CF6%YHUE;[J%P&/T%$US!;*&GFCB!X!=@N?
MSKC/'/AS^V_#VC:==7+)?"[A5+^-0)(Y0C?.I[?, :RXO$,^K:!=>'?$<,2>
M(=-NK1;F,J-EPGVB/;.GJK=_0^G% 'H3:E8J<->VP.,X,J_XTX7]D8S(+N Q
MJ<%O,& ?KFN \1+"GQDT-VTYKS.D7 ,<:(Q/SK@_,0./ZUT6FV&E:U;ZPDVA
M"TCN'%I<6\T:J955<AB%R/XS@YZ8H WUN[9X6F6XB:)>KAP5'XTZ&>&X0O!*
MDJ@XW(P89_"O,/#[:AHC7?PR9&:5 7L+S8"/L#D[G;MO3E/=BO&,FO2M/T^T
MTK3X+&QMT@M8$"1QH,!0* )9KB&W0//+'$I. 78*,_C49OK00B8W4 B)P',@
MP3Z9KGOB2BO\-?$8=0P%A*1D9Y"D@URGBG48W^"-S:C2[U%&DQA6:W 12%7!
MSGI[T >E'4K%0I-[;@,,@F5>?UI\-Y:W#E(+F&5@,D)(&./PKS?QM%#'I7P]
M(M!,$U:U41(BDL/*?Y0#@<X%=;I/V.Y\17#IH4FGW%I;(%FDB1#(LK-N VDY
M ,2T ;DUW;6S!9[B*(D9 =PN?SI)+ZTAV^9=0)N&Y=T@&1ZCVKAOBNL?V'PQ
M))!YNWQ%9_*%W$C+9 'OZ53^(%[%J%YX-C?3;J+'B*U^:X@"C&'XS^7'M0!Z
M7O4IOW#9C.[/&/6A6#*&4@J1D$=ZYWQC<Q'3(M(:[6U;57^S-*7"&.+!,K G
MH=@*@_WF6LOX7ZL]WX8?2+J=)K[1)VT^616R)%3_ %;CV*8Y]C0!USZA91W7
MV5[RW6XV[O*,JA\>N,YQ4[NB(7=E5 ,EB< "O'9[FV\.V>H^%_'VDXL+^XF:
M'7UB\R.4R,2K2'JDBY ![;1T S7L,91X4*,KH5&&'((]: (8]0LI7"1WEN[G
MHJR D_K4DUU;VV//GBBW=-[A<_G7C7AZ33H/AUXA2Y\,7&I(M_? ""U5P?G.
M,'.1CU XQQ4VN%I?@/H+W-]%JLJW%GFXC;>'/G 8!/4@?*<^AS0!ZY'?V<S[
M(KN!VZ[5D!-,_M33_P#G^M?^_P O^-8EK]BN?$=G$?#LME+!%)<Q7$D4:\\1
ME05)SQ(<@^U<IX9>WMO%/CDMH4VH!=3#?N88VQ^Z4D?,PY- 'I0O;1F11=0E
MI!E )!EOIZTZ:Y@ME#3S1Q \ NP7/YUP/B7PY8Z[X-T&TMX_[.:>[CFMY(5
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M>F-XPT183<?:I#:*<&\6WD-N.<$^:%V8SWSCWK;5E=0RL&5AD$'((H XO2/
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M)>VZAI88K*>1D4]"=J'@]C5[3M3M-4BDDM'<B*0Q2+)$\;(P ."K $<$=N]
M%'Q=I-UKWA74=(M&A22]@:#S)20$##!/ .?IQ6;K/AS4M4^'#^&U>TCNI+1;
M1IB[%   -P&W)Z=/UKJG<1HSD,0HR=JDG\AR:Y^+QSX>GLY;R.\F-I"[)+<&
MSF$<;+PP9RF%QWR>* ,W7/#&LZK:>&4B:PCDT>[BNWW2.1*T:E=H^7@'.<]O
M0UNPQZ[-J4$EVUE;V<09GCMW=WE;&%!)4 *,D^N0*=J?B32-(TZ'4+R\"V<Q
M41SQQM*C;ONX* ]<C'K1%XBT^:\@M?\ 3(YIR1$)[&:(.0I8@%T S@$XSVH
MS/&?A_4/$*:0EE);1BPU*"_8S,WS^62=@ !QG/7]*3Q=X?U+Q ^A-:M:1?V;
MJ,.H.)7;YR@/R#"]#N^]^E6XO&.C7$UU#!)>326LABG6+3[A_*<<X;"<&K;>
M(M)32;?4VO%%I<[1 VUMTI/153&XL?0#/M0!6BTN\G\2SZAJ,5G);"W6"U0,
M6:+DER<K@[CL^FP=:SH/#-_8?$.XU_3S9Q:=>6L=O=6V6#2,A.V48& 0#MQW
M'<5M6FOZ=>WWV))9(KLH9%@N8'A=U'5E#@%@.Y&<=ZJS>,=$M]0NK![BX^U6
MBA[B-+.9O*4\AF(0@ ^O2@#*NM!\1WOA6X\.W<FEW,5Q"T!O)"^Z-&R!^[VD
M.RCH=RY(!P*Z:PL5TK1K73[7+K:6Z01>8V-P50HR<'T]*C37--ET7^V(+M)]
M/,9D$\ ,@*CJ?E!/&#GTQ5"+QGHDUBE_'+=M9NH=;G[!/Y14]&W[,8]\XH Q
M_#GAWQ-X<T6[T^";26DGNIKE9V,A$9D8MC9@;L9]1FJ-Q\-KBU^'=CX4TJ[A
M8P7*7,MU<Y7>ZR>8<*H. 3QUX'K7HM9^HZW8:5-!#=/-YUP&,4<-O),S!<;C
MA%)P-P_.@"J4\0W%U;"3^S[:V23?,897>1P!D*,J  3C)YXR*Q]$T'7]$U?7
MKY!IDRZK=BY"--(IBPH7&=AST'I6C:>-_#]\(FMKN=TEF^SI)]CF"&3.W;N*
M8SGC&>M7--\1Z7J]S>6UC/)+-9OY=PIMY%\MO[IRHY]J *$^F:[<6]@T\ME+
M<Q7WVJ7YW5 HR%1!M)^Z1R>^3CGB+Q9X+MO$MUI>H+)]FU+3KF.6.=?XXPX9
MXFQU4XX]#^.;]KXKT>]2_>VN)I!I[,EUBUE_=,.JGY>H]!S4,7C70YM/74(Y
MKM[%EWBY%A<>5M_O;MF,>^: .@HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@_C'>7-E\-=0:W
M=XTEDBAN)$ZI$S@/^8./QKJ-0N5T/PQ/<V%K#+#96I>.#S/+4HBY ! ..!QQ
M5R^L;74[">QO8$GM9T,<L3C(93U%8$?A&>#0Y-#AUV]&F/$8%25(Y)8XB,;%
M<CH!P-P8CUH Y'Q!?+J?@?P!>Q6264$VMZ:\-LDID$<9SM&<#MCM6U\28)-,
MCTKQE:(6GT*XWSJHYDM7^65?? PWM@UI:AX&LKW1M$TJ*]N[6UT:6":V$>PL
M6B&$W%E.?TKHKBUBN[&6TNE$T,T9BE5APZD8(/UH QM-FBUKQ!/JD+K)9VD0
MM;5UY#LX5Y&'J,>6OL5:N6\+RZK'XS\=_P!FV=G/_P 3"/FXNFBPWDKC@1MD
M?E7;>']#M/#?A^ST:QW?9[6/8K-]YCU+'W))/XUEV'@]],U/5+^TUV_274YA
M-.#'"5W ;1C*<#&* *?B+2XM:\):1IVLVR8O+B 7D2C;\[ E^G0[B3GUKFQJ
MU]X?M9?!'B&=I9T>%])OW_Y?8!,GRD_\]$'!'<<^Y[@^&&:UMHFU>]>6*[^V
M/.XC+S/G@-\N H&!@ < 58U_PWIWB2VMHM0CW-:W$=S!*O#1R(P((/OC!'H:
M ->J>K:C'I.DW5_*K.L$9<(@RSGLH'<DX 'J:N5F:QHYU?[(#>SVZ6UPEQLB
M"$2LIRH;<#P" >,<@>E 'G&CS+X6^(.FSM]K$7B*'[/J,DUI+"GV\$NK NHS
MNW.@ Z "NQ^(<:)\./$[*H!>PF9B!]X[,9/X #\*N>*O#$'BS2X["XN[FU6.
M=+A);;:'5T.5(+ XYJ?6M#&N^'+C1KF]G6.YB,,TT:H'92,'M@$_2@ \.1HW
MAK1I"@+K8Q!6QR 47/\ (5K54TNQ_LS2[:Q$\DZV\2Q+)( &(48&< #/'I5N
M@#A?#/\ R5GQY_UST[_T4U)\8S_Q:O60""08.,_]-XZTXO!KVWB'5-;M=>U"
M"YU(1B=5CA9,1KM3 :,XP">_>F:KX'CUKPY>Z-?ZSJ,J7LPFN+@^4)&VE2JC
M";54;%X ]?4T :,4FMS:Q;QWVGV,5@(G=GAN&F82@KL^]&N."W/-<WX[MK3Q
M/-/X>NA=FVAM6E9[>UEF"W+@K%GRU.-HW-@_WD-=(^A74\EN;K7;Z:&*593#
MLA59"IR Q5 <9 . 1G'I4^CZ0=)-ZS7L]V]W<&X=Y@@(8@# V@< *H&>@ H
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M#D[AR:]$H Q-2UY[?7+?1+"U2ZU&:![HK+-Y4<<2L%W%MK')+   'OG%0?\
M"2W:Z-K5[/I#PSZ2SB6!YQB4+$LA9& .00W&0.G.*H^+/#6G^*-5MXX=1N-+
M\0V,/GVE[;-AU1B001_&N1R/<<\FL:QUC6[GPOXVT7Q"MO)J.DVKH]Y;+M2Y
M5X"RL1V;&,CW% '1Q^-+5/!]AXAO;=X5U!8C:VL3>9+*T@!1%& "QSTZ#UJ6
M\UO6=-T]KZ[T)&A4 NEO>>9)&/5@448'4X8XYQFO.;MGL?#?PFUJXS_95BL"
MW;G[L1DA54=O0 YY[9KM_B7J^HZ%X*GU32KSR+B*6%0?+1U8/(J'(8'LV>*
M+&I^-;?1/%UAH>JVWV>/40?LMX)0T;." $88!4G/'4=.:U;W4[BUUBPL8[1)
M$N]_[TS;=FT9.1M.>.G/Y5AZ]H-CXAUI='U13<6\VE2JS-@/D21X<8& P/((
M%8/AW4M7M/&6F>%/$&^:_P!/29[>_P ?+>6Q7"N3_?'1AZ\\]: .FT[Q3>:G
MK.NZ7!I48GTAHT<M=864NN]=IV>GKCFG^#_&5CXRTF2[LD:&Y@<QW%I,PWQ-
MVSCL1R".OX5D^#_^2C>/_P#KZM/_ $0*QO[#O]/T#0O&?AJ+?JEM81)>V:\#
M4+<*,K_OKU4^V.>!0!V(\606OAZ]UK5H5L[:VGE@PDAE:1DD:+"C R69>!WR
M.E%QK>N6NDRZE)X=W11Q&7[-'=AKG &<;-NW/L'/MGI7G.O7XU/X=>'_ !-:
MI*^E6_B5M2NE*G<(/M4IRP]MPR/\*]!\=:M=:;X!U+6=(O!'-;V_VB&5%617
M'&.H(((/:@#I(I%FA25?NNH8?0U0\0:JVA:!?:LMN+A;.!YY(_,V$HJEC@X/
M.!TJ71WEDT6RDGE::5X$9Y&4 L2 3P  *R_'O_)._$O_ &"KG_T4U #;7Q#J
M=_9:;<6>B"07MJ+HEKH*L2L%*J3MY8Y/ &!@\U3\.^,[WQ%I=AJL.A,FGW<Q
MB,@N0SQ8<IN9=HXW+V/?-:WA#_D2M!_[!UO_ .BUKGO@[_R2[2O^NES_ .E$
ME '=45G:-86&GV]PFGS-+'+<R32%IS+B1FRPR2<8/;M6B2 ,G@4 <V/%@F\=
MR^%K2R,TMO:K=7-RTNU(@QP%Q@DMC!_&J6@^.GU_Q?K&@6^E;3I+;+FZ^T9C
MW9P ORY)X/7'0USWP_U"+[!XS^(%W_J;V[EDB8][:W4A,?J/PKG?A]#?Z-\+
M];\<3ZM-:SWSSWSJD4;"0J2%!+*3R^[O_%0!Z'X6\=2>*M<UG3K;2O*329C!
M-<M<91W!8 )A<G[I].*K^'/'][XJ_M4Z5H(=-.N#;.[W@42N,_<.WD<#KCJ*
MY/P+(W@KX"ZAXBG;%[>)->[VZF1_DB_,A3_P*I/ 'AL^'OAQH.IWVNSV5F\X
MU*\MFV!)MP)C (7>6.(N-QS@C'2@#U/1K^75-'M;Z>SDLI)TWFWD(+1^Q(JW
M*S)"[*%+*I(#MM'XG!P/PIXY%<?\4=<_X1_X<:S>*^V:2 V\7KOD^3(]P"3^
M% $/A'X@GQ=X?U#6K?2OLMG:%U#SW'^L90&;&%X7!ZU=\"^,7\<:*=7CTQ[*
MT,C1QF64,TA7J0 .F<CKU!XKS#6K&]\!_L_P1+JMQ')?0)$;3RH\%Y_F==VW
M=PI?OVKT?0;9_!W@71="LX$FU7[*%BMV;:&EQND9CV0,Q)/N ,D@$ T]2\6Z
M?IWBG2/#I;S=1U(N5C4_ZN-49B[>QVX'KSZ53UCQF++Q?9>%M.L1>ZK<P&Y8
M23>3%%&,\LVUB2<'@ UYVEG=0?M#>&H[Z&-;L:=-/-(LWF&9V68%B=HQV 7H
M  !5_P"(=A#KV@V_Q*\+ZA]FU32$<K*",2Q(S!D/N/F^H)!ZC !Z+X?UNYUD
MZ@EUI<NGRV5S]F=)) ^]@JMN4CJN&7![^@K:K%\):O)X@\)Z7K$]N+>:]MTF
MD0#C<1U'L<<>V*T=1OH=,TRZO[@[8+:%YI#Z*H)/Z"@#AIOB>Z:CXDM8=!DN
M$\/)YEY+'=+M*]?ER!DX#<''W36O)X[L'^'9\9VD+RV(@,WE2-Y;X!*E>XW;
MACT/K7A-D=2M?"%AK6I7,D>C^+=;==7$8"LT6[C#XR!D3$^HQZG/H7Q?@@T[
MP;H'@;1(EMQJE[%:PPKT$:D$^Y^8H23UYH ZZR\9:M?^'=/URW\,N]K>F,HB
MW8\U5=@H8KMQCD'@GBKFN>-++2M:M=!M8)=1UNZ&Z.RMR!L3^_(QX1?U] :@
MTK3(O#WB"VM9M=GNE>S6UT^RFV!HE3)<@(J_+A8QD]QC/(%<3\+(VG^*GQ O
M-2/_ !-$N1%&K_>$)=^G^SA8_P ,>M 'H=MK>K'7HM)O=%CA:6VDN$N(;OS(
ML(5!4DHI#9=>V,=S6+X;\?WOBR'4Y=*T 21V%PUNS/>!1*X_N';@CIUQU%:G
MC7Q'#H?@G7-5AF4RVD#QHP/W9F 51_WTRUPW@+PW_P (Y\._#NHWNNSV=FTH
MU"\M6"!)BX)C PN\MGROEW'.",=* .J\0_$#_A&_ ]IXFOM)E19R@:S:8+*A
M?H.F"<#)Z4SQ'\0)O#-IH4MYHC--J\JPI ER-T3MC 8E<=^<=ZYKXH'_ (2/
MXA^#/!R_-$UP;^[3U1<XS_P%9!^-+\9/.D\2> 8H+:6YD_M0R^3$,LX0QDX[
M=,]>* /1=7U>YTYK""WL1=W=W+Y?DK-MV*!EG)(^ZO<^X[D"L&+QW<7?CO4?
M"=EHXFNK&$32SFZVQ[2%(&=I.[YQQCUYK?L;0V27&IZG(AO)$W3.#\D*#D(N
M?X1SSW.3QT'D/P\TF^\3:3XL\7IK5SI$VK7L@25/+ $*\\LRDJ!N(RI!^7VH
M ].;Q1>6_AW6M4O]':S?2C)OADN ?-1$#[E8#'(.![]<5@6WQ8MET#2_$&JZ
M-=V&CZC*8H[OS%D$39(!D48(!VG!&:SOC!KT)^%]O9Z0XD_MJ:*UM=G&^/.[
M*^Q"@9]&%9OQ0L-O@WPY\.-%07.J3-"BQ)_!%&N#(W]T$X.3_M>E 'LRL&4,
MI!4C((Z&EJMIUI]@TNTL]Y?[/"D6\_Q;5 S^E0:KJ7]GP(L,7GWL[>7;6^['
MF/C/)[*!R3V [G (!1UKQ;I^BZWI&C2-YFH:I-Y<4*GE4YR[>@&,>Y_'&]7A
MVHVE]'\<?!<>IPPB^=)IYI8YC)YC;6_V1M4;<!>< =2<D^XT 4-;U(:-H=]J
MC1K(EG \[*S[<JHR><'G KA[7XMVYL= U#4-%N;/3];F,-M,)5<HP;;EUX(!
M/.1GBF_'#5)+/P =,MN;O5[F.SB4=2"=Q_\ 0<?\"KG/#6CQ-\5%\*>(W-Y%
MX>LHIM$0@)&  NYBH WMDCD_W30!WWB[QQ_PBVL:)I@TUKV?5YO)@"3!2K94
M98$?=^8<_6M.TU?4WUT:=?:*;:)K=IUNTN!)&2K*"G0$'YL\CM7G-S#)XR_:
M"DCBNYK>W\.6.!-"$8B9O3>K+GYSU'\%;6OR7-E\*?$]I8ZI)JFJVL<PNKI3
MEMS'+ D  ,L9' Z #IQ0!M6'C<>(M0N[;PQ8#48+-_+GOI9_)M]_]Q&"L7/T
M7'3GD5!J7CR72/!^I^(-0T9X!I]T;>2W:X&Z3#*NY"!@@LW'3@9]JK_"-+#3
M_A-H\L,L2PF%YIY"P #EB7W'VZ?A6!\9I3KDWA;P=;.RG6+]9)MHP5B7 R0?
M]XG_ (!0!V%MXIU>XT[2=0'AM_LNH-#RMV"\"RD89UVC@;AG!-1:GXY>Q^(%
MEX0ATLW-W=P^>LRW&U(T^;)?Y<C[AZ9[>M6M*M$TCQ--;7.N37T]Q;I]DMI0
M@:"),[R%C50%)*C)'. ,UQ7P^/\ PDOQ<\8^*3\T%JRZ;:MU! X)'_? /_ Z
M .ML/'!O_B)J/A!=-*S6$0GEN3,"A0A",#&<_.O'UY]=&77[A=2U*"*Q1[2P
M@\R2\:XVIOQDQXVGY@.3V (]<5YOH<>I7'QX\:O81LN^&&W>[*Y6W&R/)YZM
MA>!Z\G@&N@^*]_!X3^$]_;6>4>Z LXLG+.TA^<D]2Q7>2>I- %G0OB#J'B/P
MG+XCT[PS(]JA?$37:B639U*C;@]QU[5:\7>/3X2M]'DFTF2XEU2188X$F D6
M0@<8(P0,@9SU[5G^&_#@\'V'A>&]UV=;>"'R5T]P@5KN3 ^0*H9L%Y?O$XSG
ML36-KO\ Q5/[06AZ4/GM?#]JU[,/21L$?J830!V>F^-K6Y\5R^%]0M)M/UA8
MO.CCD8.D\?\ >C<=>AX(!X/H:ZBO'X(9/&/[0,>M:=\VE>'[8VLMTOW))2'R
MBGN09#G_ '3ZC/L% !6#HWBW3]>\0ZSI.GMYITGREGF4Y4R/OR@]=NSD^IQV
MJ/7+R_OY7TK1HUD="/MTOGF+RD(SL5@#B1ACME5.>"5SP7P7B">)/'S+!' H
MU,1B*(Y5 K2C:#@9 SCH* /7ZY/Q3XV'AKQ!H.D?V<UU+K,IAA=9@H1@5!+#
M!X^<'(ST/%=97D?Q"BU"^^,?@NVTV 33VT,US\WW(P3C>W^R"H^O0<F@#K[/
MQO\ ;/B+>^#TTXB>S@%Q+<^?E-A"XP,9S\XX^O-0ZUX\;1/"NH^(KC3 UC:S
MB*+;<_-<KOV;T^7ID\9Z@$],9X3PIH5Y<?&/Q@EN9OL(2.VN[YFP[95&=01_
M&Y4YQC:"<8^6M/XOHNKZAX1\#6N(TU"]$DR1@#RX8QCIZ8+$?[E '26'Q&BE
M\1Z1HFI:3/87.KVBW5HWF+(I!!.UL8*MP>Q&>]3ZAXY>T^(-IX/ATO[1=7,'
MV@3+<82-/FR7^7(/RG@9ZCUKD_AK$NM^./$-[XB_TKQ)HER;."0X5(K<[@NQ
M!P,X?GT;WY7X<'_A)?BGXS\6-\T,,@TZT;J"JX!(_!%/_ J -KQ'\39?#D(N
M9_#MS):S7QLK1Q<*'N6!(W*F,[<C@GKD>M:C>+-76>6T/A:X:\6X2&.-+E"K
MJ4+M)OQ@*HP#GG+ 5R'BG_BJ?CQX;T,?/:Z)"VH7 ]'."N?Q$7_?5>@>,M;'
MAOP;JVK[@KVULS1Y_P">A&$'_?1% '+Z5\3KO6AJ+Z?X9GGBT^\6SF=+M<%V
M;;E>/F X)]B*T6\=32>/KKPA9Z0+B\MH!</,;G;&J$#&?E)!^9>/?K5+X-:,
M-"^&.GR3?++>[KZ9F_V_NDG_ ' M<;X TV^\6CQIXPMM9N=*FU&YD@MIT$>!
M&HR-Q=20 "HRI!^4T >H1^(K\:3K-Y>:*UI)IC,#')< B950.65@.F#QQUR#
MBJW@SQS;>--%O+VUM7M;FTE:&:TN'PT; 9&X@< ^N.Q]*GNKFRU'1M(LM.E$
MEI>SI'&XY#0QY=C[JRQ[<]#O'K7G6NZ5?^%OBZ\.F1,=-\9PM;S!.!%+_&X]
MP"6_X$WI0!ZQH6HSZOHUKJ$]G]D-S&LJPF3>RJPR,G P>>E:-(JJB!% 55&
M!T I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH K7^GVNJ6<EG>PK/;2##Q-]UQZ$=Q[50@\*:!;&
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M8M)RQFCY_>D_>+GJV>^<YKCYO%^OW7Q9G\(Z8^F"SMK,7-Q<36SN\1(&%XD
M/WD].I]*Z?09];FN+QM3FT^XLB(WL;BSA:/S%8$L6#.WMC!_^L 7K;1].M-+
M_LR&SA6PV[/LQ7='MZ;=IXQ[=*I)X2T)4BC_ +/1X(B&C@D=GBC(Z%8R2HQV
MP.*L:Y)JR:=MT2.V:_DD1$:Z!,4:Y^9F"D$X4' !ZD5YYH_C+QOX@UCQ38:6
MVA2C0SY<<K64H%S-R"@_??+RK#//;UH ]).EV3:F-2, ^V!/+$VXY"_W>O3(
M!Q4TEI;RW,-S)"C3P[A%(1\R!A@@'WP/R%<#?>,/$(^*MAX/L/[,>%[,7-[,
M]O(6AX.0,2 <X7&1QN'6G?\ "8:]=_%Z;PC8?V<;"UM1<W4SV[F2/('R@B0
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MKE%06=W#?V-O>6[;X+B-98V]589!_(U/0 4444 %%%% !1110 4444 %%%%
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M#GYR7;+LPSVSD<5Z782Z9XGU77P)H+NV1%TUXU<,"NTLYX[$R;?^V?M73T4
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M<-TK"\1>"-6N-5\'Z/:Z9=7>BZ7<K<ZC>O)$#<R#:,[2^2,*1TX! '2@!_Q
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M/-<2R.&*B- Q&%Q]T #C%2:CH=YK'AR_U6]L=0&NW%K+%#9PWIB$((.V/Y)
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MK'P]!%:W@F99%MT"9MRR JP'5<+)^1K+\:ZYHW_"[&O]8MS-I7AS3QYX2#S
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M#<;<6DIPO7=NV[<>^<56N_B'X:LM5OM,GN[D7EA'YUU&EC._E1X!WDJA&W#
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MVF&Z-Y(7B+#L0' ./?%7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWCR<G\A4G_"$0O#JJS:UJ\\^IQ"":XEEC+I'A@4C^3:@.XYP* .(^$,RWO\
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M\O*C"EPB*7(''S$CVH \NN=+O-"_96G@O0R37+1S"-NJ*]PA4?B.?QKTKPE
M=:\,Z$KJ1I-I9VX12/\ CZD5%^8_],U(X_O$9Z ;N@U_P_8>)=,&G:E&9+0R
MQRO&#@/L8,%/L2!FM'RPL/E1_N@%VKL ^7TP,8XH \G'_%4_M&'^*T\-V'U7
MSG'\_P!Y_P".4:-_Q5/[0NL:D?GM?#UH+2(^DK9!_4RC\*['P_X$LO#>I:OJ
M%EJ.HO=:J_F7,D[1L2^6(8?)Q]X\=/:J>D_#/3]&74DL]9UI5U.0RWG[Z,-*
MQSD[Q&&7J?ND=: ..\!78;XK_$#Q! =NA0AEEE7[C2(021Z\+(?^!>]5_A;;
M>);S1-4\46*VBRZ_JH::27<9$A\S#,G;*[GQGCC\*]-G\%:2WA.3PS8B73=,
MD0QNEF5#,I^\"S!B<]SU/K6=#\.;>W\.1>'X?$&N1:7$I0012PH2I))!=8PQ
M!R<\]Z .=^-E[CP98Z!IFSS]>OXX8UCZ."V\L,=<N4SZ[JR/C#8K;V?@;PQH
MRDZG'=(MF$^\B1J%S[#.TY_V3Z5W^M?#[3]<UO3-5FU#4()M+P;*.!HA'#C'
M12AST'7/05HZ=X3TRPUF767\Z\U:1/+-[=OO=4_NJ  J#V4#K0!N5Y-\8?-U
M[6O"G@RVVL]_>&YG5LX\N,=\=L%S_P !KUFN4O/ =K>>+5\3G5M3BU-(3;Q.
MAA*Q1G/"JT9]3SUYZT <CX.%OJ_QAUVYUIBWB/2HA!"D'_'JD!X!3^+=\W.?
M[QQ[5?$"W5M^T5IRZ+(BW=_I)CNF89$2_/\ .?4@(I /4@>M>A^&_!ND>%I;
MVXL4FEO+Y_,NKNYD,DLIR3R?Q/  JM9^!;&T\:3^*_[0U";4IXO)?S6C*;./
ME "#'W1T.>OJ: .AL+&#3K**TME*Q1C R<EB3DL3W))))[DDTE^UK!:M>7@7
MRK0-/O89V;5.6_(FK-9FOZ+'XAT:YTJ>ZN;>WN4,<IMBH9D/!7+*< CTH \Y
M^"M@=6T7Q!XFU"$-)X@OI"RN,@Q D8^F6<?A5+0WU#Q+\<O$FO6$%K<0Z-&-
M.A^TS-&JMR&*D*V>5D_[ZKTW0/#=OX;\-PZ'I]U<BW@4K%(^PN@))_NX/)/4
M'K6;X;\!6/A33]0M-,U'4E^WR&66:1XVD#D8+ [.OUS0!Q7PS,WB;XG>+_%M
MVL8$#+IUOY;%D 7 ;:2!QA%/0??K-\%/KVO>(/&_C;0DLI9IYS969NMQRB8Q
MC'7Y1'^(KT;P_P" -/\ #'AR\T/2]0U&*VNG9WD+QF12RA20VSN .N<8XJMI
M7PWM=#T%M$TOQ!KEI8,S,4ADA5LMU._RMP_.@#KK6**.(F-E=F/[R08S(P 4
MDX[_ "@?A1>7D%A:275R^R*,9)QDGL  .22<  <DD"F:;I\&E:9:Z?:@B"VB
M6)-QR< 8R3W/J:KWVC+J&J6%[+>72K9.9$MD*>4[8(W,"I)(!XYXZCF@#QWQ
M=?7&K_$OP!-<QWL$CZ@SBUG@DB6%%:,J!N #/U+$9[#H 3L_%#_BH_B%X,\'
M+\T37!U"[3L8USC]%D'XUVNM^"+'7O$NF:[=7M\EUIC;K5(F01J<C.04).<#
MO^55I/A]:/XOD\4+K&JIJCQ>2'5H2JQXQM53&0/YT <;XK,FH_M#^%;?3 6N
M;&V,EXZ?P1$L<,>W!_\ 'QZU!8G4O$_QQ\1:SI:VLO\ 8%L+&W^U%M@D((/W
M>>OFC\:]-TCPIIFAK>/8"5+V\;=<7TC^9/*WJ6<'IV&,#TK%T;X;VOA^*^CT
MO7];M_M\IFN'#P,[N>IW&(D'GL: -VPN?L&@QW^L21"^6!/MKHO/F8SL '/#
M.0J\GD=2:\C\87UQJ_Q)\ 37,=[!(^I%Q:SP21+"BM&5 W !GZEB,]AT )]1
ML?!MK8)ID<>HZB\6GRO,$ED1_/E8L3)*2N6;YC@Y&.,=*9K?@BQU[Q)I>N75
M[?)<Z8VZU2)D$:G()R"A)S@=30!TU>;>-)IO$7Q&\/\ @K)&F^4=3U)1TFC1
MB$0^JEUY'?(]*])KG9M!*_$*T\1QIN#:;)I\WJO[Q9$;Z<.#]10!Q'Q+T[4;
M74]/^)/AF6.YFT:-X+JW/*O"K.'Q]"7!_,=*3QUXNL)?@G>^(-,A,$GB )$0
M?O%V C<$^H2-E_"NGB^'<,&A76B0^(-:73KLN9X2\3%MY)<!C'E0V3D ]SC&
M:O:IX"T#5O!\7A>:U:/3( HA6)\/$5Z,"<\\GDYSDYH JZ9IDGA3X8V.DV_[
MN\2UCMD([7$I"Y_[[<GZ5PWBJW&M_&KPKX.F7;H>GVPNOLQ^[(RJQ&1W'R*O
MTW>M>FZ=X>:T>"2]U?4-4>W_ -1]K,8"'&-V$1=S8)&6R>3ZFJWB+P5IWB'4
M['56GNK'5K'/V>^LW"R*#G*G<"&7D\$=SZF@#?GMH;E%2>-757610>S*05/X
M$ UXWX"EU'7OB'XP\9V4%G/!YWV""2YN&C C3'(PC?PJA[=:]1BT!EM)TFU;
M4)[N:,QF]<QB1%/9 $"+^"Y.!G.!65HOP^T[P_X4N_#FG:AJ,5G=%R[[XS(-
MPPV&V=QWQD=L4 <?\&!+KVJ^*O&MR@$FHWOD0X)(6-.< D#(P4'_  &O7:P_
M"GA:R\':''H^G37$EK&S,GGE2P+')Y51GD]ZU;RW:ZM)8$N9K8NI7S8=N]?<
M;@1G\* /*OARR^(?B;XU\82L/L\,@T^VD)^78N-Q]N$0_P# C6-\,M7?2-$^
M(OBM%*:.UU)/8J1A68&0X ]]T:__ *J[W2OA=I&D:%-H4&I:LVE3R&2>U:9%
M$I( (9T0/@@ $;L5IZYX'TK6_"Z>&]]Q8:2H4&WL2B!@I! .5/&1GCJ>M '!
M_"?2O$&E>"])NHVLTM=4O&OK^>3=YRQX)!Y^7#;%&?1S6O\ $OPQ=:[I]AJ?
MA::-=6\,7!D@MU'RGY48ICIG 0@?AWK>/@."2PL-.FUW69=.LO+5+/S(DC=$
MQM1]D8++@ $$\U)'X+^RWFJ7-AK^KVCZG,TUPJ-$RACQE0T9VD# R.P&<XH
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M=KDEAE0.Y//6J$?PXTXZ/9Z+>ZEJ-]HUFP,5A.Z"-@IRJN50,ZCL"<<#.<4
M<5\*=)O++X3I:W896\0:A^ZC;C]PX4.?;,<<C#\*K1M<_#KXFZSX>M%=+#Q/
M%YNF%1\L-RQV_@ 2<^P6O7;C14N-4L+T7ES"MCGRK:+8(CE=O(*D]"0,$8S2
MZAH5AJ>IZ9J-U#NN=-E>6V?^Z60J0?;D'ZJ* +MM;Q6=I#;0+MAA18T7T4#
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M:[_[%R/_ -*&H V])\5VVHZU<Z)<VMQI^K6\8E-K<A?WD9.-\;*2&7/'J#U
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MGZ4 =1;:'IMGJEQJ=O:JE[<@":;<2T@'0')YQV].U5(_"&@PZI/J<6G)'?W
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MNBH++[2;"W^VA!=>4OG;/N[\#=CVSFIZ "BBB@ HHHH **** "BBB@ HHHH
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ML8QCKQ7+>*?#6FSZ[X!\*W\[/:6NGW5I<2QN4*'R8U1B?X267(SUQCFO8**
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MLK1$.>'90VX ]R,C/I7?T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M06;6D4NJ20A=\1:3;\XSS@]\>U6O#T'B'P=KDN@+I][JOA@*&LKS>ADM,_\
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M?:,!U<L,9 SAL$53\7V6KW^J>$IH]-DN#9:D+J[,!7;$FUEP"Q!8C<.@YQG
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M"WCN((Y1*(I%#(S '&0>N,Y^H%>>>'/#&A:CXV\?6-UI%C);":VC1#;KB,-
M,[>/EYYX[T >F^;&6V^8F[.,;AFCSHLD>8F1VW"O-V^Q:9\<;B1K*25O[ B(
M:"V,C[O.8;CM&<X &:=H@LKWXU:U<)9&,G2(<^?;&-LF1@3A@#R,<]\4 >B_
M:(?^>T?_ 'T*>"" 000>XKR#PH^E:=I_C.>X\-MJ'V;7;]E\NR60;5(P@)Z=
M.GO7J^GV5OIVG6]E:QB.WAC"1H.BJ.@'L.E $OVB'_GM'_WT*4S1  F1 #T.
MX<UY=H,.F0>._'*SZ$;U5O("HBLUEV_N02.>F32^/;+3F^$5B]OI\=O!+=6M
MPD#(/W/G3*[*!CC[Y&/PH ]2WKLW[AMQG.>,5'#=6]PNZ">*5<[<HX89].*X
M2_E77OBM!X7N$7^R--TS[>]KCY+B4N%7<O0JH.0.F?H*TM;;P]IOBC0//M'A
MU-YG%D]O;_ZW]VRLA(XQM8GGTS0!U:RQLVU9$)] :!-$>DJ'_@0KS;0IK+3/
MBWXW?[!*S%;':;:T:0KF([ON@XS^M,\*Z;IFL^.?B%#)8[;:=[)&CD@\MBIA
MRRD$9 8YSZYH ]+^T0_\]H_^^A09XAUE3_OH5YO_ ,(_HO\ PNTV?]D:?]E_
MX1OS/)^S)LW?:<9VXQG'&:C\3:9I>B?$#X?116&ZWA%^JQQ0>8P41 J  ,D*
M3QZ8H ]-,L:MM:1 WH3S3Z\TUB6RU/XP>#9!8RHX@OMS7-JT9;$:[?O 9QS]
M,UT_CS7)_#_@^\O;0@7CE+>W)&0LDCA%;\-V?PH Z$S1!9&,J!8^')887C//
MIP12+/"\:2++&4<X1@PPQ]CWKBO&ME/H^@:/<:="MY'IE['))82M\U]D,N!G
M[TFYMXSG+#/6E\%-IWB:PUS48F7[#J5S@Z?C:UJR($8./X9"1N..G&">I .X
MIGG19QYJ9Z8W"N;\!ZS<:QX<9;R0R7MA=36%Q(>LC1.5W'W(VD^Y-<_::/IE
MY\:?$"W6G6DZ_P!EVSXEA5AN+,">1U( H ]'I"P! ) ).![UYS:+_P (G\7+
M70]-+)H^L6,D_P!B!_=V\T9Y9!_"".,#C-0_$34+P77]KZ==87PK-'<R6X<#
M[2S#]ZI'^S"V?^!GTH ]+9T09=E4>YQ1YB;-^]=O][/%9.IZ9I/C/PRUM<HE
MSI]] '1\#(##*NI[$9!!KA?#TEU>:3/\-=2M5^V6.+>ZG6+$<ECCY95[;W7"
M>H.6[8H ]15E<95@P]0<T%@HRQ &<<U%:6EM86L=K:01P6\2A4CC4*JCT %<
M/\1UO-8M)-(TN]%M=V4(U/<& +R(V8(^?[S*Q]M@]: .]9E098@#U)I@GA)P
M)4_[Z%8-AJ]IXL\ )JBQH\%[9,[1L-P5MI#*?HP(_"N&\ 6^BW_@7PQIMUX<
M:22[C*&]:T4!&57<.),9SE ![T >KF>($@RH".H+"CSXL9\U,>NX5YK\2/#F
MCV.D:9+#IMKYUQX@MGFE,*EY#),68,V,D'.,'MQ5OXC^'=(T[X<>*+BRT^VM
MVFM5+K%$JKN0\-@#[WS=?84 >@":)B )4)/8,*!-$6VB1"?3<*XNPAT6>30[
M8>&G@F8I*EV;-8PC1KO&' SDXQCN,URU_<>&=(^(GC>ZU_38I[,6MEQ]B\T
MLK \XPA)VC)('OQ0![!3&EC0X:1%/H3BN6^&^EZOH_@FSL]:=C<JSLD;2^88
MHRQ*(6[X&/Y=JR_&MI;3?$;P$TMO$[-=70)9 <XA)'Y$ T =X9XE)!E0$=BP
MIRR(^=CJV/0YKS/XE^'-'LO#]M/#IMKY]QK=O)+,T*EW,DV6!;&2.<8].*[W
M3]"TS2;NYN-.LH+1KE4658(PBMLW8. .OS'GV'I0!>,L8;:9$#>F>:1KB%)E
MA::-97&50L S?05P>K6ELWQOT"1K>(N=+N6W%!G(9<'ZC)_.L.]OK3PQK.M6
M7CK1?.TK5+QY;?6Q%YJ!&^Y'(1\T908 (],CUH ]7EAANX=DJ)+$V#M;E6]/
MK2FX@6<0--&)F&1&6&XCUQ5;1X8;?1+"&WG6X@CMXTCF4@B10H 88]1S7E=Q
M=V/AZZU;1?'VC_Z'J5W+);Z^(O,C<.3L#L.8V48 ] HQ@#) /7C-$N,R(,C(
MRPHDECBC,DCJB 9+,< ?C7G7C&RM&U_X> I#<*+_ &"7:"'40D@_3@&I]$D3
MQ7\1?$;:BBS6NA216EE:R#*(Y4EY2IX+$C /8=.IH [V.X@EC$D<T;H1D,K
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M9'! P* /1GD1,;W5<],G%"NKC*L&'J#FN"^,L,,GPYN9)85D,=S;%<KDC,R
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MB8%FO8&AWSN55 PQG@$GZ5>T:VN+/1;*UNA$)H(4B;RG+*2J@9!(![>E7J*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>tardioagreementa01018.jpg
<TEXT>
begin 644 tardioagreementa01018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0C((R1GTH 6BO-
M]!U&ZO;[Q9%J/BNYM$T_4G@MW9X5\J,*K G<F#@D\GTJ?1KSQ-XR^&7VN"_?
M3]:S*+6[CB54N K$(Y1@<*X']1QQ0!Z#17 :7XFN/$?@NSM+*ZN+7Q#+(;.<
M-M,MK-'CSG<$8PHY'&#N0<9KNK:$V]M'"TTL[(,&24@LWN< #\A0!+17EVB:
M[>>*-.U.VC\0W6G>,8'F5M.?8JQD$[56-EPR;=OSC)YSGM6YXDO=0M_B-X1T
M^WU"XALM1^U_:84VX?RH@R\D9')YP: .UHKC-,U6[\7^)=:@@O);31](N/L1
M%N0LES.!F3<V,JJY  7!)R2>U:-M;3QZQ<6P\0236DD&R.%I$,UO*#S@XRV1
M_>SC!]: .BHKSGP/XNU(7X\/>*)2UU<^9+IE^0%%W$&(*'  $BXY '(Y]S-K
M-[J=C\/O%&I0ZK=B\LY;DV\IVGRQ&Q"KC;@C'J": /0**\[\07/B:S\.^&M0
MT&^FNM2F=/.M9RNR['D/*ZGY<JQV$#&.36D_B6'Q+X3T_6-'O;BV\R^MH)47
M >,M.B21N"#@@,1^1% '945QL>K7?B+QKJ.@V5W+::=HT<0O)HL>;/-("50,
M0=JA1DD<D\9'?3MX9;+Q'$J:XTUD8'C>RN)59UE)0JP/WCP&&"3U&* -^BN,
M^)^I7^C^#WU'3KZ6SN([F!-Z;2"KR*K9# CH3536-:O-%\3^';32]:?51J%V
M(+FPD\N1DAP2TX95#+MXSG(.: .^HK@+G4;H?%2\T>XUZXM-.&E1W:1[XUQ(
M964X+*3C Z5-KMY=V7P[\0:KINOW%R85FFL[KY&*&,;2F0NUAO1^W>@#N:*S
M/#QE?P[ITMQ<27$TMM'))))C+,5!)X  _"N>TO5KKQ=XHURVBNIK32='G%GB
M A9+B?&7+-U55X "XSR2>U ':45Q=OJ]YIGCL^$KZ[EN+>^LC=6%TV!+&5.'
MC8@8; ^8,1GL<]:P+/5==D\#>+;2XUNY3Q#H=Q,JW.Q,NH&^$[ N,.I QC.:
M /4Z*XBPUJ;Q!X%\.7%CJ%Q%>:F\*F92I<%<M/G(QPJ2#IUQ7;*-JA<DX&,G
MJ: %HKA_&^H7MAXC\*PV^JSV5M?WCP700IAE$98<L#@Y';UI++7+V#XDQZ#:
MZF=7TZ6R:>X+!&:R<'"Y= .&_NMD]\XH [FBN(\*:E=>.[2[UI[VYM=,:YDA
ML+>V?82B';YCMC)8D'C.  .#UJ/3=5U6_P!9UWP;<:E)'?6#03P:BB());9R
MK'(VE=X&4SC!R#B@#NZ*\]L%U:\^(&OZ$_B/4UM;.TMY867R=X:3=N))CYZ"
MI)+W4['XDZ)I%WK,IM7TEY[E/D5)9D95W9QD Y)P#0!WU%<.VIW<OQ>M]*AU
M25M-;2'O&MT92OFB4*.<9Q@],UT^IV%W?R6RP:E<6,4;,TIMPN^3C 7+*0!S
MGUX% &C17G7A(:YKL.OL_B._$VGZW/:096+8T<97"N-F3D$@D8/-7?#^J73?
M$7Q;I][JLKV>G_9/LL,K( OF1%FYP">?4\4 =Q17#>%[V]U+QEXOL9M5N9[.
MQEMTM5#+^[#Q;FY R>?7-9/@S5Y=8\!VVH:MXONH=0F>6(E7A!#>:R)A-G7A
M>.] 'I]%59+@:?I37-[*"+> R32 ?W5RQ_0URWA*74?%VA1>(;^^NK5+TM):
MVELX18(LD)DXR[$#)SQSP!0!V=%<'K.M:WX>BTW1#>K<ZMK&IM;VMY)&O[N#
MAC(4  +*IQC !//3BK'BR34?"/AZ;Q!8:C=W9L=LEU;73AUN(\@/V&Q@"2"N
M!QR#0!VE%>:>*_%>HZ-KNA:]97DC^'984FU"W95($,C*BRCC(VEU)&:VOB1X
M@OM%\(W3Z-,$U%X))HI<!O+CC7>[X/!XPH]W6@#L:*\WU_4=6M?#W@B:WUB[
MBGU/4+.VNY%V$R)*A+<%2 <CL*T-!UG5(OB5JWA>>^;4K""QCNTN)$026[LP
M'E,4 !R/F&1G'K0!W%%<)K_BV^TKQQI2*%_L 3C3KZ3TN9E#1_0+A,G_ *:U
MI>/?[8B\._:= OWM=26XMXX00ICD,DR)M<$'CYNV#0!U-%<*GBY_$/P_U6]M
MWFTS6=.B=;NW&/,MIT!X(((*G&0<<CW%-\;SZQX:FTWQ!;:E>R:):RA=5M%"
ML3$>/-!V[OE."0#R/3F@#O**YOSYM=\10/INIS1Z99Q;K@P%2EP[@,B D'HI
MW$@C[R^^.DH **X2S\6WQ^)7V"Y"KHFHPR0Z:_\ >GMV/F_GEL>HC&.M2^/K
MKQ%I<NE7WAR62>?[0PFTYMNRYC6-W91QD/A.,'KZT =M17(2>(8/$?A_1]7T
M74)X8;F]ABD"8# ,X#QN"#@CIZ^AJD9=3NOBM>Z(-:OH=/32H[M8HO+XD:0J
M>60G&!TH [RBN(L]<U71/B#!X7U:[_M"TU*W>?3[MXU2563EXWV@*W'(8 ?C
M4GQ,U*^TCPY;WNGW\MG+]NMX7=-N"CN%;.X$=#UH [.BN<M1$^M6T5IXFGNF
M57DFMFDC<-'C;GY5!4AF4CGL:Y[POXBU6V\?:CH.L7CW%I>/,^DRR*H*^2Y6
M2+( R0-K?2@#T2BO._%'B+53\0?#VD:?=O;Z:UV;>]:,+NED,9DV9(. JA"<
M?\]/:I9)=4N_B;JNC+K]]:6,.EQW<8C$1\MV=E)RZ'(XZ&@#OZ*\>?QCX@U'
MX5VNL_;WMK]=52R^U6Z*$N8S*$+A6!'(/;N/PKUZ)/*B5-[/M'WG.2?K0 ^B
MN(\)ZC=^.[&ZUR2]N;737N)(;"WMGV'RT.WS';&2Q(/&<  <'K2:3JNHZAJ_
MB+P==ZC+'J&GJDMKJ42('>*1<JS+C:64\'@ ^@H [BBO.O#/BB^3P]J6CZU/
M--XIL)S:R)D*UP[Y\EX\# 1A@YQP%8FG^,Y=8\+^!+.9=?NGU!+NWBGNV"#S
M [JK_+MP!R<<<>M 'H5%<Y:B)M:M8K3Q-/=,JO+-;-)&X>/&W/RJ""&9".>Q
MKG-!U.:[UWQ3;:IXGN+>'3[_ ,JW5I8DVQ[ W)*\X)/)H ]&HJAHHD_L>W:2
M]>]W@NEQ(H#.C$E,X &=I Z#I6#\0-8U;3-":/0$5]596N$4\XBBP\AQWS\J
M?604 =;16(/%.GGP7_PE(8FP^Q?;..NW;NV_7M]:S/#T>H:UX>MM=UG5+BVE
MO8A<I!;2".*UC895>GS$ C);/.> .* .NHKSGQ?J>KZ+\+-3OK?7O.U2RERE
MY#Y9W(TX"[E VYV,!TZBK-UJNJ:/\1=!T6TU6;5+:_BF-[;3K&SVRJH*R[D4
M%03QAN#VYH [VBN!U/4;I/BNFCRZY<6>F2:,UWL#QJ/-$P7AF4G[I/'M5S49
MYX/!OB/4=/\ $%Q=B"VFEMI\HQBDCC;(!"X9=P'7/.10!V5%<'H=VVH^'=!G
M;Q9<?VI>P02>5YD+!Y"@=U*A<@$!L^@KL-4M;F]L&M[2]DLY6=/W\84LJA@6
MQN!&2H(Y!ZT 7**\]L%U:\^(&OZ$_B/4UM;.TMY867R=X:3=N))CYZ"I)+W4
M['XDZ)I%WK,IM7TEY[E/D5)9D95W9QD Y)P#0!WU%<.VIW<OQ>MM+AU25M-;
M27O&MT92OFB4*.<9Q@],U)\0_$.JZ)IB/HD0EN;?%]=+_P!.L3+Y@^K9Q] W
MI0!VE%9EPS:[H,4NE:@]LMTL4L=U$%+>665CMW C)7(Y!ZUR%@NK7GQ U[0G
M\1ZFMK9V=O+"R^3O#/NR23'ST% 'H5%064<\-A;174PFN$B5990,;W &6Q[G
M)J>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "D)P"3GCT&:6B@#S+P];6MOJ7
MBY]9\/7D\=]J;S6XDTMY?.B**./E(&2#P<5M?#/2-6T;PY<PZHDL$<M]++96
M<LF][6V)&R,D$].3C/&:[.B@#@_#ED]O\5?%E^VFW$-O>Q6HM[AK9E61E0^9
MAB/7;UZX[UWE%% 'EGBG3[?Q=X82:Z\/:E;>+XX1]DFAM'1TG'W3YP&P)GGY
MFX!Z UIZQ;:C_P )UX$N)[:ZN?[/BNEO[F&W=HU>2%5!R!W8'IT[XKT"B@#@
M=%L+WP3XKUX26=S<Z)K%T;^&XMHFE:"9O]8CHH+8)P00"..:?I-G+-\4M7\1
M+87$>GMID5NL\MLT;/(')8!& <\8YQSBN[HH X9?#$/BKP%;Z?=)<V-[;NTM
MM.T31RVLP<E77.#W'U!K+GL?$#?![7+#5;.277+HW49CMHBPE=F.&4 <*W7/
M Y[5Z;10!R DD%GX.!L[W-O*K3C[+)F("UEC^;CCYF4?CGIS67X@\(7]EXKM
M=8\/C%GJ%_:G6+,#@E)D<3J.S#;AO4'/J:]#HH X.'3;[PE\0M7UB.TGN]%U
MQ(FG:V0R26L\8QDH/F9&!/*@D'MBE2SEU3XMV>N6]A<"QMM*DMY+B>V:']ZT
M@( #@$\9Y Q[UW=% '$_%6TN=1\%/8V=E<7<\MS PC@A9_E6568G XX!ZUE>
M*=*;6]3T)_"^CW-EJ-O?1RS:D;1K58H!G>K%@I?/'R@$&O2Z* //9H_+^+M[
MJ=WI=[+IYTB.U6<6$DJF42LQ PI['KT]ZD\1%KWX?^)--TG1+V*%X)(;6+[*
MZ/-+)N9BJ8R%RPY('.?2N^HH Y+3?$$MKX=TZTAT?57OU@A@\N2QD1$? 7+,
M0 %!Y)ST!Q5/1M/N/!WBOQ \MM<3Z3K%Q]NAGMX6E,4Q&)$=5!89."#C'8G-
M=S10!Q=KI5QKGQ%C\436\MM8:?9-:V:SH4DF=SEY"IY50/E 8 GDXQC-?4O#
M%\_Q0MM0M5QI-_;(VI#'!EMW#0G/J2RCZ(:[RB@#@_!OAB^T7Q1KB3KC2;>X
MDDTL8X N-KR@>RLH ^K5TUMKR7'B6\T1K&]ADMXA*EQ+%B&=>,^6V>=I8 ^]
M:U1);0QW,EPJ?OI  SDDG Z#GH.3P..3ZT <1X\MI+KQ)X3D&G75W;6=Z\UT
M8K5Y51#&5!. <\D<#)JL-(GN_B;I.JZ!ID^F:=;PRC4YW@-NEWD8C3RS@L0<
MG<1QZ\"O1:* .#\&6DW@2QN_#]]:W;V<-S)+875M;/.LD+G=M8("5=22#D '
MC&:M^&=%NI/%^N>++Z![9K](K:TMY/OI"@^\_H6/..H&,\\#L:* .'T:&Y3X
ML>(KQ[*[2TN;2VBAG>W<([(&W $C'&1]>U1:M8&\^+FEW4^ESW&GQ:9+ \SV
MK/$LK."HSC'0'GH*[VB@#@5TX6?QDMKRUTJ:&P&CO:O/#:,L7G&4, 2!CH.O
M3WKO68*I8YP!G@9/Y4M% '$?#FWNK4>)EN[.ZMC<Z[=7</GP,F^)]NUAD=\'
MCK5;0=+2X^)7B^\O](D:VO/LGV2:YLSL?9$5?!8<<X],]LUZ!10!P'A&W;3/
M&GC*Y.FW=K8W4MN]J19NJR*D6UMH"_WNW?-9W@2"VTOX?6FGZWX?U#[=#)+(
MT7]F2,^?.9TPP7&>5QSQ7J%% &>T#:SX?>WOH3 ;VV*31 Y,>]<%<^HSBN3\
M%7=YX5T&W\-:YIU^)]/S##=6MG)/#<QY.Q@8U;:<8!#8Z5WE% '$>+M&U/5S
MH?B"RLS]NT:]^T)9LX#RP, KKG. Y R.<=J=XNEN?%GAFXT#2;.]2?4 (99K
MJTDACMHR1O9BX&XXR %R22.W-=K10!Q\^C6DVJ1Z#+:7+Z;_ &,U@TAA;9@E
M0!OQC.T9S[5S">']?M_AEKEMJ\4MWJBV,ND6"P1EV>%=P1\#."_!)/95S7J]
M% 'F/B2SN+_PSX%M1I5[/]DU&RFO(39NWEQHA5]PQV)Z=^V:[LQ6&@:7<7.G
MZ6$7:93!96V'E;' VJ.IZ<_C6G10!Y[?^#5UGX>W<-W=:B+J\A:YEC 8!;DG
M?D1[=V ^,#T JQ#JNI:IX#TE]2TO4(M56ZLC=0FT<L#'/&SOP/N[5+?IUXKN
MJ* /._'_ (1OKDR^(?#0*ZC-;FVO[;;@7ENPQR/^>B=1WXQ[5W6I>6=,NEFA
M::-HF5HUC,A<$8QM .<U:HH XWX5V4^F?#G2;"[LYK2[@1EFBFB*$,78]QSP
M1R*W/$E_=6&AW#V,$\UY(/+A$,+2%&;C>0!T7.X^N,=36M10!YOXQ\(/:^#[
M2?0Y=2N-0TB6&XTZ%MTF70CY2H&>5W Y]>:Z"ZU![^]\,W0T^_B_?/+,CVLF
M8,P2+A^./F8#]>G-=110!YYJWA"_TSQG9ZIH(_XE>H7T4FJV8'"2*V1.@[$X
MPWUS[B7?-9_%Z^U26PU V#:1':K/'9RNIE$K,0-JGL>O2N^HH X>WTG4/$/Q
M$M/$M[9R6.G:5;R0V,4^!+-))P\A4$[5V\ 'GOQ2_%&UN;[PS;6MI97-W+]O
MMY3'!"TGR)(&8G ]!^-=O10!S:7MC_:UJ^G:+=BYDS$\[6$D"1Q<,VXLHS]T
M  9Y(]ZYC6=&O]4\.W-]I=I<)K>DZO+J%@LT+1F4>825&X#*NA(Q],UZ710!
MYMK&D7EEJ_@K_1;FZDM;Z6[U&X@MW=0\B-N;('3<V .P ]*G&DQ:C\7-2N=0
MT9[C3I-+BMXY;FR+1&17)(!9<=#UZ5Z%10!POQ,L9I?"-K8Z9IT\[)>VTBP6
MD!8*B2!CP!@  5O#Q";F[MK6STS4BTTF'EGLY(HXD RQ9F [# QGDBMRB@#@
MO!=I-X$TZY\.WUK=O9P7,DEA=6UM).LD+MN"L$!*NI)!! SQC-7?#&B73^+=
M=\5WT#VS:@L5O:VTF-Z0QC&Y\="QYQV&,\YQV%% '!WEDY^-&GZF--N&MX]*
MDMWNQ;,4$I?*C=C^[NYZ#/7FI?BE:W-_X5AM+.RN;N8WUO(8X(6D^1) S$X&
M.@_&NWHH YM+VQ_M:T?3M%NQ<R9A>=K"2!(XN&8LS*,_<  YY(]ZYOPW'#:>
M(/%LVJZ+?-#?:AYMNSZ9+()(]@4]$.!D'KBO2** ,W0IC-I49%E+90(3%!#,
MI601K\JE@>F<9 ]",\UC65F^O:YJ6I3MJ=CY1%I;+L:'="!DO\PYW.6_!5S7
M5T4 >8>'/#\W]C>*? 5U;7T6DN\HTR\D@8)Y4@R5!(QE')ZXSGBMSPGJ5YHW
MANUT7Q!IM['>Z?$ML9+>TDN(KA$&U75HU/4 9!P<YXKLZ* /&9_#FJVOP$O]
M%&D7/]I7=P\D=K%#N<J;@.,[>%^0=\=,5TQTV;PGXFBUW0=,GDT;5@L>I6,%
MN5>!P/DG6/ ..S #T.#7H%% 'GEZ-WQ;AU:?2[Z;3%T,VQF^P2NHE,P<+C;G
M.WOCVJ[JTBW/A'Q-8:7HMY#!)9S)"OV1T:>>5'R%0C(&<9) &6]J[:B@#@=$
MEM=/\(Z'&WAZ^DUBQM(42/\ LZ1"LXC"',A4*!R<G/3/6N]&<#/7OBEHH X?
M1H;E/BQXBO'LKM+2YM+:*&=[=PCL@;< 2,<9'U[5%JU@;SXN:7<SZ7/<:?%I
MLL#S/:L\2RLX*C.,= >>@KO:* . _L\67QBM[ZUTJ:'3UT9[9YX;-A'YIE#
M9 Y^4=>GO6CIVF'Q!=:IJ5XVI6;7$AME@96B_P!'3(7(8<[B7?\ X'@]*ZZB
M@#AOAHE]I6FWOAR\M+U(-.NI$T^YG@91-;%LIR1U&2,>F,4NC0W*?%CQ#>/9
M7:6ES9VT4,[V[A'9-VX D8[CZ]J[BB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"CJNDVNLP
M16]ZAD@242F/) <@' /J,G./:O//#_AK2-3\9>.M.N+-#;PRVT<"KD>0&@!.
MPC[O//'>O4:Y'PUHVJ:?XP\3ZG>6\26VJRPR0;)MS*(X]A##'&>O&: ,,O9:
M9\;+CSHI63^PHY (K=Y?WIF8%]J X8@8W4[138W_ ,9=9>*W;R1I,+[)K=H_
MG+L&;:X')  SCFMJ'1M57XI7'B!K>(:?)IBV*D3?O-RR%]VW'3GUS26NCZM!
M\2]1U][6(V%Q81VD>)AYFY&+9(QC!SZT <?X8GT"RL?&$^JZ3+>&SUN^$>W3
MY)PL2D80.$(4#GC(Q[5TGC'P3]M\,6;:*N=4T?9+9B0Y$ZISY,G]Y2!CGO\
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M''FQ'[\+XZJ1G'H?QI?$&CZS=>/- UJRLX);73(KA)!)<;&<RJH^48/3;WH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **H7VD6^H2K)-->H57:!;WLL(_$(P!/O57_A&;+_GZU;_ ,&MS_\
M'* -FBL;_A&;+_GZU;_P:W/_ ,<H_P"$9LO^?K5O_!K<_P#QR@#9HK&_X1FR
M_P"?K5O_  :W/_QRC_A&;+_GZU;_ ,&MS_\ '* -FBL;_A&;+_GZU;_P:W/_
M ,<H_P"$9LO^?K5O_!K<_P#QR@#9HK&_X1FR_P"?K5O_  :W/_QRC_A&;+_G
MZU;_ ,&MS_\ '* -FBL;_A&;+_GZU;_P:W/_ ,<H_P"$9LO^?K5O_!K<_P#Q
MR@#9HK&_X1FR_P"?K5O_  :W/_QRC_A&;+_GZU;_ ,&MS_\ '* -FBL;_A&;
M+_GZU;_P:W/_ ,<H_P"$9LO^?K5O_!K<_P#QR@#9HK&_X1FR_P"?K5O_  :W
M/_QRC_A&;+_GZU;_ ,&MS_\ '* -FBL;_A&;+_GZU;_P:W/_ ,<H_P"$9LO^
M?K5O_!K<_P#QR@#9HK&_X1FR_P"?K5O_  :W/_QRC_A&;+_GZU;_ ,&MS_\
M'* -FBL;_A&;+_GZU;_P:W/_ ,<H_P"$9LO^?K5O_!K<_P#QR@#9HK&_X1FR
M_P"?K5O_  :W/_QRC_A&;+_GZU;_ ,&MS_\ '* -FBL;_A&;+_GZU;_P:W/_
M ,<H_P"$9LO^?K5O_!K<_P#QR@#9HK&_X1FR_P"?K5O_  :W/_QRC_A&;+_G
MZU;_ ,&MS_\ '* -FBL;_A&;+_GZU;_P:W/_ ,<H_P"$9LO^?K5O_!K<_P#Q
MR@#9HK&_X1FR_P"?K5O_  :W/_QRC_A&;+_GZU;_ ,&MS_\ '* -FBL;_A&;
M+_GZU;_P:W/_ ,<H_P"$9LO^?K5O_!K<_P#QR@#9HK&_X1FR_P"?K5O_  :W
M/_QRC_A&;+_GZU;_ ,&MS_\ '* -FBL;_A&;+_GZU;_P:W/_ ,<H_P"$9LO^
M?K5O_!K<_P#QR@#9HK&_X1FR_P"?K5O_  :W/_QRC_A&;+_GZU;_ ,&MS_\
M'* -FBJMCI\.GQM'#)<N&.XFXN9)C^!<D@>U6J "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
ML?Q5K<OASPU?:Q%:)="SB,KQ-+Y>Y1UP=IY_"MBN.^)E]:#P)X@T\W,7VQ]-
MEE6WWC>R#@L%ZXR0,T =+I=Y+?Z3:WD\*0//$LAC23>%W '&2!GKZ5<Z5YY>
M1V,VK:+I-W&DE[#H;220WS#[+#'\BM(4(RTF00.1A=V2.,X>AC4]5\!>#I]/
MEL=3O;:UF:33-0;*W2 JI(8Y"NH*@$]G- 'K^:*\KTC5+35M<\(V,EC);Z'<
M6%V8;*ZPP-U'(%*-V;8H?;]<UE:_;26_ASQG81M(-*L=9LAI^UR!$7>$RQKZ
M*"Y '09- 'M-9>H7FKQW\=OINF6]Q&8R\DUQ=-"JG. HQ&^XGD]L8]ZYC2["
MUT?XO7=II\?D07.B)<31JQ(DE$[+O;/5L'&>IKNZ ..\+^+]7\2Z-IFLIH-O
M'I][(R,4OF>6$!F3<4\H C*]FZ'-=CGG%<#\(94B^$6D2NV$1+AF(YP!-)FN
M;T>:RCU[P#>V4D<5K>F[S++*&NKF,PNVZ=Q@$[@#CG!'7- 'L58&O:_<:/K&
M@V<=K%+#J5X;9Y&D(:,[&?A<<_=]?PK@--TV&S\/>,]?L[9I=8TG4]3-@YD9
MC"0N.%S@\'H<YP/05//;Z+GX;:G8>0TD]XNZY!&^;,#EB[=6;=U)Y!)]: /2
M[1]0:[O5NX;=+=9 +5HI"S.FT9+@@8.[/3-7*\?U6[N]'TKXE3::TRM%J%ON
M>-B7CB:.+S64]00K.<]NO:NCO;.#3/'OA.;P]'%#!?1W"7D=N (YH%C#*[ <
M'#%<-U^;&>: .]HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG4?^A9U+_O\ 6W_QVC^V=1_Z%G4O^_UM_P#': -FBL;^V=1_Z%G4O^_UM_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW36O$?AMR632+F,VY)^[!,@=$^BG<H]@!VKK: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFTKQ!J2&TN ;F$C,=S&74R-*PPH^7< ,8R0% KH?$ND2:_X<O](CNEMA>0M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $&--_\ !:__ ,>H V:*QOLGB/\ Z#&F_P#@M?\ ^/4?9/$?_08TW_P6O_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!1U;5[+0]/DO]0DDCM8ANDD2%Y-@[DA02![U)'J5I-IB:C!+Y
M]H\8E22%3)N4C(("@D_A6?XQ&?!&O@]/[.N/_1;5QUNS?##6Q83,?^$/U.4_
M99&/&G7#<^63VC8]#V/XF@#T'3]0MM5L(;ZS=WMYT#QNT;)N4C(.& ."*M5P
MME>WD'A[P?;07XMH)].3S$@0274K")-HC5E9=HR2S' 'R\C-95OXM\0W?A#P
MEJ"W<,5U?ZQ_9]T6MP=ZB25,X!P#^[&<>IP10!Z?17GD=UXFFUCQ1HH\1%?[
M-AAN;>Z^QQ&7]XCG81C;M!3^[G!ZT[3/%^I:[;^'K6-9X[J_T?\ M&X>S$6_
M.47"B4[0,L2>">GO0!Z#17+Z3#XLN]%M$U*]ALK^WOLS.L*2?:K8$X4@'",P
M(R1T(XZUU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %'6=,76='N]-DN)H(KJ)H9'AV[MK @@;@1T/I27^CVNK:
M+-I.IK]LMIXS'+YH +CUX  /?(Q@BK]% ',R^"[8SZ+<6VHW]I/I5K]CCDA9
M,RPD*"KAE(_A!R,&JEO\.[&VTS3]/BU34A!I^H'4+<%XV*ON9@I)3E<NWN<\
MG@8[&B@# 7PK$FKZQJ2:C>";584AF7$>U%0$+M^3J QZYZUER_#BQ_LO1K:U
MU34K2[T=#%9W\+H)EC( *-\NUEX'!';ZUV=% &*/#NRQL[>+5M1C>"Z6ZFN!
M*/,NB.JR'&"IX!  X  P!6U110!FWFI7EM<&.'1+V[0 8EBD@"G\'D!_2H/[
M9U'_ *%G4_\ O];?_':V:* ,;^V=1_Z%G4_^_P!;?_':/[9U'_H6=3_[_6W_
M ,=K9HH QO[9U'_H6=3_ ._UM_\ ':/[9U'_ *%G4_\ O];?_':V:* ,;^V=
M1_Z%G4_^_P!;?_':/[9U'_H6=3_[_6W_ ,=K9HH QO[9U'_H6=3_ ._UM_\
M':/[9U'_ *%G4_\ O];?_':V:* ,;^V=1_Z%G4_^_P!;?_':/[9U'_H6=3_[
M_6W_ ,=K9HH QO[9U'_H6=3_ ._UM_\ ':/[9U'_ *%G4_\ O];?_':V:* ,
M;^V=1_Z%G4_^_P!;?_':/[9U'_H6=3_[_6W_ ,=K9HH QO[9U'_H6=3_ ._U
MM_\ ':/[9U'_ *%G4_\ O];?_':V:* ,;^V=1_Z%G4_^_P!;?_':/[9U'_H6
M=3_[_6W_ ,=K9HH QO[9U'_H6=3_ ._UM_\ ':/[9U'_ *%G4_\ O];?_':V
M:* ,;^V=1_Z%G4_^_P!;?_':/[9U'_H6=3_[_6W_ ,=K9HH QO[9U'_H6=3_
M ._UM_\ ':/[9U'_ *%G4_\ O];?_':V:* ,;^V=1_Z%G4_^_P!;?_':/[9U
M'_H6=3_[_6W_ ,=K9HH QO[9U'_H6=3_ ._UM_\ ':/[9U'_ *%G4_\ O];?
M_':V:* ,;^V=1_Z%G4_^_P!;?_':/[9U'_H6=3_[_6W_ ,=K9HH QO[9U'_H
M6=3_ ._UM_\ ':/[9U'_ *%G4_\ O];?_':V:* ,;^V=1_Z%G4_^_P!;?_':
M/[9U'_H6=3_[_6W_ ,=K9HH JV-U/=Q,\^GW%DP; 2=HV+#U&QF%6J** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **;)(D2[I'5%]6.!47VVT_Y^H?\ OX* )Z*B6YMW
MN7MEGC-PBAVB#C<JG."1U .#S[43W,%JJM<3QQ*[A%,CA06)P ,]R>U $M%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **AN;NWLXUDN9DB1I%C5G; +LP55^I) 'UI'O+:*Z2UDGC6=XVE6
M-F 8HI 9L>@++D^XH GHK*TWQ+H>L7+V^FZK9W4R+N*0RACMSC</4>XXK5H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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6BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>vtl-20250630_g1.jpg
<TEXT>
begin 644 vtl-20250630_g1.jpg
M_]C_X0!.17AI9@  34T *@    @  P$:  4    !    ,@$;  4    !
M.@$H  ,    !  (         +<;    G$  MQL   "<0     /_M $!0:&]T
M;W-H;W @,RXP #A"24T$!@      !P & 0$  0$ .$))300E       0
M                 /_B#%A)0T-?4%)/1DE,10 ! 0  #$A,:6YO A   &UN
M=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94     $E%0R!S4D="
M              #VU@ !     -,M2% @(
M                                    $6-P<G0   %0    ,V1E<V,
M  &$    ;'=T<'0   'P    %&)K<'0   ($    %')865H   (8    %&=8
M65H   (L    %&)865H   )     %&1M;F0   )4    <&1M9&0   +$
MB'9U960   -,    AG9I97<   /4    )&QU;6D   /X    %&UE87,   0,
M    )'1E8V@   0P    #')44D,   0\   (#&=44D,   0\   (#&)44D,
M  0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C
M:V%R9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0
M            $G-21T(@245#-C$Y-C8M,BXQ
M                                          !865H@        \U$
M 0    $6S%A96B                      6%E:(        &^B   X]0
M Y!865H@        8ID  +>%   8VEA96B         DH   #X0  +;/9&5S
M8P         6245#(&AT=' Z+R]W=W<N:65C+F-H               6245#
M(&AT=' Z+R]W=W<N:65C+F-H
M                         &1E<V,         +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@              +DE%
M0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M                          !D97-C         "Q2969E<F5N8V4@5FEE
M=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F
M97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M                            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,
M  03"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S          $
M                       "CP    )S:6<@     $-25"!C=7)V
M!      %  H #P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &,
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M(#!08'#!XE*R0&*"(Q3QDG/"TE.#@*!#8\,D%?_:  P# 0$"$0,1    ]_
M
M
M
M
M        "OUUEW-'+6         "N/&2Q_>,                "M_'NR/?
M@                "LO'NT??CC                !6WCW9GOQ\
M          B,]99,Q8                                     !(M;:
MVBQY !4RP+K<:2>X         *$PY;[S8@                *!Q9;^RX2@
M               #7C#EV.S8>!0               !K]@R[#9\/$H
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M7WY         %!8,]^Y\                 &O^+-L!EP@
M   :[8<VQ^;#P@                U]PYMA\V'B                !5OC
MW)TE?OR                                     !!^;TMI<&P *G*+]
M^9>@         H-ZOQY                 B=LLD                 B*
MR]/P                $167I^                 @&SJYK'EDN+*
M                                !@//O;R !4:YY)\         #5M=
MI$                 B-2Z                 (A4O@
M "'5,8                 J[<T9!BRS'!L@
M             :WKL@@ J-<\D^         !JVNTB                 1&
MI=                 $0J7P                !#JF,
M  5=N:,@Q99C@V1KOU>/8W,ZNI/G)=AL8@  U76R##D<,&7\E3+2!=9LLFN:
MW"FHR[!E<EOIV2?E8%GE9F5,06<#69?TA);Q!28$8,Z;"(    -;EN%)@:0+
MMNDH   !'2OUN)( 3\%3+,$E)K>NR" "HUSR3X         &K:[2(
M         !$:ET                 1"I?                 $.J8P
M             !5VYHR#%EF.#9\Q/L/AMX/G?J8[H]'019V2PA!\%CIJ&]>P
MKQ'EJ(K==BD\Q%VW2++31)BU2'$E(V6<G&7Z:;KDS*&92E%]"4I,U77=Q->U
MZY!"WTU.>KU3,%N)8Q2YWC6)=W4U<7K$M*\.N2,M9,X:G+;Y:*9\_37I:S).
M3DX#\*J,\<1S&<(2>F;S9)K>NR" "HUSR3X         &K:[2(
M      !$:ET                 1"I?                 $.J8P
M          !5VYHR#%EF.#9CN7#(L6:M#E*Z4443$X2/F\Z:#KM*5^<Y^D!)
M*6>1<^2+F+(&MSIA":& ,62XJPQYMFE7KTS+G4,690C!%C-G ?!L.FO*UX9$
MM@IHG)9I1!EB7'&80PYG3.$[(45&N82WCG-/EV%2.EC$0!89K(MF)N\FMZ[(
M( *C7/)/@         ><75X^F7VOY^                !TU[B
M        =)>Z@                '17OI^                 PN3%[L?G
M'ZK+,&P                            !&21GV  "-$E   .L=DUO79!
M!4:YY)\         #RD^@^9\>?U#\@SN'9P.;7_4DN'9C6;6 &3QY<9DQ #N
M^,O3]8^U/?4]8Y+AV(SFP9/'DQN3%)L.S&,VO^I]2Y;'GP^77DN'9C6;6  [
M?GW\)U_7F0X=CKUT/>/[EZ7O%W/&7O><G?\ -BV?5 RV//\ B=7UY^4R/C-C
MO>'].>>^%,EXR8[WBZ?O'VO.3J^L8 $DP[.&R8LICRXOWB^;,AXR]'WCZM\9
M#SD^IZ_$Y9<1EP9G%LX;+K27!MX_WC^+YQWO%^RR'%FCF;
M              !_5O\ BO[[*L.P!@RG5C)@BQC.FCRU\>CR8 XSJG:*L($N
MZ[SERJ5B1;R:3/6]+SPE.+("RT\W7KU;>?,IZW72&&*,Z8(OU-4EN$E"0M<:
M1PMTP)'C9E!JJMKI$%ZY(S%E@)'%A9B2PB%G5.^9\[QDDBJ\Q@BV4^CS\>MA
MTE)L>@&MZ[(( *C7/)/@         >4GT'S/CO\ J'Y#ZN?$_HE#]+D038PY
M#RQ_KSC<F#-8MCI^O.'R8I#BR]+UYG.MN:4?1?)>MGP_Z/I3]!\S>W.Z>LO7
MX5C:F_;NCT:5Z',E^#8D>'-K;UN1S/-C:NUA?;)>;G,66O-K7[4\YK'ED.+/
M6.YH=[QDS'CW271Y%^<SL3'7VI-AV+8T]W1WZ'YC9GC]_L)2?0Y>IG=^:R^/
M-C_>+?\ ^6^TI/H\S:KB][6_J\C9'E=;7CJ\7\OB5:^_*<.:7Z^UY^?4_&83
M)@W*X'TVA_TWR&VO!^HC.?5R?C)Q$[U]K&>\/%,NT''[FK?9X5Y<[IUEN:&G
MG>^<].?D/MNE;6VWHT7TN3K]U.+Z/?)_;^;GUOQ'HA\K]E36_H2?#L:^=3C2
MC#L;'<KK:?=WYVM=WF                           #^K?\5_?95AV *=
M6AS1UZV?23)]&KRWL28L5-9EM0QQ,4U26V39E*U*/60$B,XFIJ^EZ:++'BW#
MTA>?/1ZH@VL351=G4PYE#D*56U4R9IBNZ*4PMPI7"^A#S72Z.+)"Q$QA'%D1
MW$UT7:)-5EL(M)-5EVH2G5VT2H3"K-DKU<TG:6NR[4B*^@;R!K>NR" "HUSR
M3X         'E)]!\SX[_J'Y#OE\S]C9NET,5DPT-TN5N'POHX1L:D&V=:58
M-FF]_FX?+K;!<KN9#QD\N_M/SW>WYG['O>,DBQ^IE@VM:.MQ)QK[$$V=;87E
M]CO^,M=;6G7&YSJ3Z/*VYX/U'+<==;6G>?-ZU9;FC ]K2LC3WXSFPV?I[]>[
M6C"=G4R?C)P)E_&;J7Q=7/Z=1[VC<.COTIT.7JAV_G;QYW4J[=Y^T_$^CIK?
MYMU\_J9CQ[D6+/!-C5D^+)56YJ9GQZFFMMZY];AX++K[G<#ZCS:^L^(]A_@_
MTO6OK<2M]S0L74WXSFUL3DP0C8PS37VMC>3V-?>IR+CT.E6FYI3W6V8#L:^4
M\^J/Z/)_$W%X/TWFI]?\'M1Q?H>G7P3;6W,_CS93Q8'LZFDWT?R0
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M_%_4'&]<CR/E>1YXWK[0?"_AR)P/?.\?@ /P_%^D^D
M         ']6_P"*_OLJP[ $>.^9(  KLL0 AA,P 8<KA;?0"N"0D3,^3,
M   $-)B?H                !K>NR" "HUSR3X         &@/0YM'?4?'@
M                8I<J@                &*7+)^
MQ!F(_*                $7S8/6GXC]!EV#8 HY:'.R;DIHPO 24U]7=-,<
M4Z6N:\K9Z8$WG3S5>N<N5+=*Q-7EM0[9.$U:7:9-JDU/6+K)D[Q72YA+*/@H
M%9(6"G(4^NY"6\@               UO79! !4:YY)\         #5M=I$
M               B-2Z                 (A4O@                "'5
M,8                 J[<T9!BRS'!L@:]+KRM@IM2FM2Z$KLB1@FQA3IET)
MCC3!ZN=/0EY\XGKND[*M.X=@Q9=R2@K5:%/8]Y\HGKK%X)U2;FKZR(O!/PU6
M7;E.,\Y7KV4>+2               !K>NR" "HUSR3X         &K:[2(
M              !$:ET                 1"I?                 $.J
M8P                !5VYHR#%EF.#9       %)K7YM8@    %)+=J
M#@-+EV?2<@               UO79! !4:YY)\         #5M=I$
M          B-2Z                 (A4O@                "'5,8
M              J[<T9!BRS'!LCKWSP6=_S[
M            UO79! !4:YY)\         #5M=I$                 B-2
MZ                 (A4O@                "'5,8
M J[<T9!BRS'!LX+)BU1[?S]S\#Z6"+WB@EV@3,$"(H2$R!L8FHJW4D,7#E3F
MU:=%8J8,RAL$FIBT>NXR:?K.$F)J\NUB= Z97Y+"EU]*GFIES!7AU"Y$IQ<@
M?)897IVS9%-6%G9D2G#-EM)7BU@3(A1=QQ&%*I-Y4U(6AUMM-;EW.2FS'+NR
M\S, UO79! !4:YY)\         #5M=I$                 B-2Z
M          (A4O@                "'5,8                 J[<T9!B
MRS'!L^8'V'POI?\ (_;TCYR:(+?Z=0K!;32=GGB];;)(TW83R0>K1+).DFE;
MUN@\P5;22M5G"6$18I!?4UY\KWJT3''3(D64G"L%)@5&>LSSYZ+V##K,TT/>
MMX7GX,D:6+M"2Y-UDT@7'KVT@:XLZ!;:0Q8J9PE!/DC1CC?]-+%$5774O(IL
M]&DM=,Z :WKL@@ J1<ZD^         !JXNT:                 1&I=
M              $0J7P                !#JF,                 5?N
M:.?Q99C@V0,$0LS1!%_3ND]2O%F2?I-35!;K3(%3+*"O"STP"Y\C)?2:KK?*
M38U@62%P)5"X@D1R$K3@-=5VJ329=I$D!12Q,I9?0AYJA902I.0FYJPL\,ZG
M:. UP6UBSDH1;H2*KAS\,87,GV40NP2=$ZIW"@%V?3+@&N"['H *C7/)/@
M       :MKM(@                $1J70                !$*E\
M            0ZIC                 %7;FC(,668X-D        0XSQDS
M\(:3,     '$10F   !#"9E=E@GV  "N2Q@  "O2?GZ5X6* 5P6.   :WKL@
M@ J-<\D^         !JVNTB                 1&I=
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MXR#5M=I$                 B-2Z                 (A4O@
M       "'5,8                 J[<T9!BRS'!L@:]KCSS[795/U8:3 GZ
M?!@"+E;K8Q9*46L7)6<9*2O21DW2:E[II6]8\W/35!>$ZQ;:?A5BT<;BI"3$
MKK2OJZ\:=O5@IR&JJX8VR26E%+BR*'I.\^7KU8IBS$%ZG DO-1EN$K,WI2_T
M\EWKNDK)<2I,J;CH  -;UV00 5&N>31KZSXOY3M3U1W1Y=:[>C:.GOXGWCM;
M2W\YCS5UM:4 VM3*>/<_UMN ;.I9&IN\DL.V-:S=/>],?D?MQJVNTB
M           1&I=                 $0J7P                !#JF,
M               5=N:,@Q99C@V0                        !A"(ED@
M  %>EA      &MZ[(( *C7/)U=O2JG=Y^;QY:*Z7*G.MMUGMZ-^<WK=SSZK/
M;TLKX]U+O<^T=+?F.#9[_GU^&OO4Y%G:>]SR[8\3Z :>[.">];E
M        8 SX                !'R0                 &+Q9=F>+UP
M               *NW-&08LLQP;($!-3ED):!'R2F6,":L+?:=<VU2J2TRM"
MRC6I=ED^S2I=U4UE7]-F4'P?1\GV?)\FM"_ILLGZ:UK:B3@[!A#5U<J7VDL.
M0&HZRTU_789(H5JN[#S(@         #6]=D$ %1KGDGP         //ON\75
M#]'_ #T         #\K]@?E?L  ?E?L   #\K]@ #\K]@         #\K]@
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MD=7](]L8,GBR9K#FQF7%2G8Y(                  $KYW1]B/RS]+
M            J[<T9!BRS'!L@           #'F0         !CS(
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M3EE'5]><]@S?2XC+BPF;"                  !*^=T?8C\L_2P
M        *NW-&08LLQP;(J+>YUFZ>]K1YR;))!#. F17Q2*VF1XB9LHG8.^5
MN6088C1/@    :TKLLE4A;60   "J2UCB.([0*J+5 !5):P.@=\ Z!!BR"/&
M+)J    :WKL@@ J-<\DCR8LSCR_0    .GZ\]#UXZOKS)<.< #0GL\F@_O/A
MP                ."N>                 ."SGE
MSNCO>JOYQ^@                 5=N:,@Q99C@V="?I?D[QYW4CO+[,S(@:
MM+<R=8WB3S0>J)+)-\D\V5W92@%M),2MWI2Y;15A+"4E='>)4:G+:9/DRAKB
MNPZ:N+>R9 N\HL^3 KV4AZR0BI(DXECQ^D5-ADIE?3QYU+7MF"* 6R4CJQ V
ME2#E%KBRS2_THU=@TV+0   #6]=D$ %1KGDTC^K^,_35KL\+?OYCZV@.IR)O
MK;7Y7H9\M]AXF?H7YCM-QN]0/3Y$WU]J8:^QP6;9<3Z"^>;U@ -6UVD0
M            "(U+H                 B%2^                 (?4P@
M                "KMS1D&++,<&S2G0YEU\_IU<:AO7*D:7.G3+T2L"["K2
MX2IC+F*.@2LI=?@V@2H2HUR9)3O)/#5A=LDI=> N!-;5[)L@FGJ^NKSH$O$O
M5+93Z-:EQI>B54NRZ:YKU"TDP:W^F7-4%K,L\[I79<J0!<L3U*U66)$EXC;Q
M+O0   #6]=D$ %1KGDT5^M^*ZM\]>^=8NQP]ON%]%5F[H2/%GV5Y';\Z?JOC
M-@N9V* Z?(M?2Z$VU]G(^/?I3\E]L  -6UVD0                "(U+H
M               B%2^                 (=4Q@                "KM
MS1D&++,<&R                 *E6VD  $*,P9T  'P1,EX           -
M;UV00 5&N>2C>W\_L?R>UR2_-GZN*]X\WCRYC'DKK:TY5ASX#+BYY>"^:GW=
M#9+D]H  :MKM(@                $1J70                !$*E\
M             0ZIC                 %7;FC(,668X-D#K&-.J9@U37:M
M/TQ13"R,GR9PQIQD@*D69I*C%&L2VH3M.$U_78I*Z76-;_2ZD[( ,*9PQ1S'
M5,R8TKM9XF4,<2,              &MZ[(( *C7/)/@         :MKM(@
M              $1J70                !$*E\                 0ZI
MC                 %7;FC(,668X-D#6==>%UH781/@LY-:EVX36I9$=XUJ
M78!,@;Q/.LRZW+MZE4K'R+%FFL18)*2T4TE>MDDEAGT_3699>2HI$V>2"+0)
M>Q(3!E2DC+6/1AY              &MZ[(( *C7/)/@         :MKM(@
M              $1J70                !$*E\                 0ZI
MC                 %7;FC(,668X-D"O3OFJBVF0D^S/$1).3TU]+8)>E?K
M=R1)>J9,A)@#(G$5>6"=(MDJ$L,H(VH).FMRVF:\E\$@(&5R7B=DCIVS0U;+
M/2)Y              &MZ[(( *D,\3T         &KR[0H
M  !$:ET                 1"I?                 $.J8P
M      !5^YHR#%EF&#9               _#]      /P'Z
M #7)=C4 %1F>)\         #5M=I$                 B-2Z
M       (A4O@                "'5,8                 J[<T9!BRS'
M!LBHM[G333WJ!\Y+1+60  :[K<*9<UC6^DRAAR)KT2PDHM;;3 K4!M2GP8DE
MA]'&0DL JD[Q9 ,"=@CQ22[&)F   "J2UCK'(<H*K6U$ UK7C-F$'&1H^25@
M%;ED   UO79! !4:YY)\         #5M=I$                 B-2Z
M             (A4O@                "'5,8                 J[<T
M9!BRS'!LZ$?2_)7ESNKV.7V?-1;G+=3E(2MXIIVOIN\XDU77&+N<\ZF+Q'6/
MM<28$O--;%VT315?3UYB"T*3HJTRIW2&DH+ (.=LL\D)YPKO\ES)IDO8,6=!
M8V94QY+TAZQ$G9!B_P!*G7TL>=5%I!:M(\2XV,3IFNJVR6FFKZ^B[S3JZSKN
M8EZ( -;UV00 5&N>2?          U;7:1                 (C4N@
M           "(5+X                 AU3&                 *NW-&0
M8LLQP;-*]#F75S^G3:\15Y]&J"W&D)6/'J$\^;SUNVE6$6("O:(>34ZA.$@:
MWNE7%;+NZF#-<5VW>=5EO\T47+FRR?9^'R7^FD#U/D@Z[O/.E#USH6S$^S4%
M9>7NFOZ[)I1R]@FJ=,N\KPZ9)"E%C9;Z6F:^KGD[91:^G;SK>O3,J;6H -;U
MV00 5&N>2?          U;7:1                 (C4N@
M   "(5+X                 AU3&                 *NW-&08LLQP;(
M                      KLFYW0  =(Q!)         #6]=D$ %1KGDGP
M       -6%V=]>                 (I4K@                ")DL
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M;.M7V_H[(?/=^@N[Q)KI[?%9PV9W#FXTQV7Q7V]H@
M      "5\[H^Q'Y9^E@                5=N:,@Q99;AV-3.W\_LER>U$\
M.?6M=S4S !2ZYE+/ !7A("1D=)$#6)=D4[@*86YT CI7*W0E.+#20DM2E%L\
MG:5:L=,B2 LI)"00DYE"EUNA    (Z2($/. ARW0@     &MZ[(( *C7/)/@
M         >??=XNJ'Z/^>@          =[Q[Z/OP!^5WL?OI>_
M                             E?.Z/L1^6?I8                %7;
MFC(,6608\W\G7[7_ #__ $C_ )/^T['\GM:!O6)(^=<VO2DS@*:6XDB*[O//
MFX];3I5JP(D9O(GGVMMIPKDD[17"V<F'*;7\-L$JM=CT\I'K;YYA2RHV531I
M<\2HW7>=(WJ8ICRURJBDEW!3-FD2WND%7) _25)1ZST[A79O0FH2_!+TW^3O
M@    UO79! !4:YY)\         #4W)YO7:U                 (R28
M              C!)P                "-^?5PZ>V                !
M5VYHR#%EF.#9 &I"U&L1. ]$GFBUKLD)&2U"TDT(>ID9Y.0HU=]D@A5)DB_R
M"E!K8:=PP)90,(3 CI02SY.N8A;*3N$4+](&5L7>:]F7/HZ)=Y79AC6E;I)(
MEG%0+ETZ);!K&N\;SJZLL-7E]<'D    #6]=D$ %1KGDGP         -6UVD
M0                "(U+H                 B%2^
M(=4Q@                "KMS1D&++,<&R  (@9TR0
M   !7Q8(    !7!8X    !K>NR" "HUSR3X         &K:[2(
M      !$:ET                 1"I?                 $.J8P
M          !5VYHR#%EF.#9 %3DL.B8PI1=F4C1H$]>C;SH ]7:F*,(2T^3;
MU                            !K>NR" "HUSR3X         &K:[2(
M              !$:ET                 1"I?                 $.J
M8P                !5VYHR#%EF.#9 U"76!9Z9M(DL\3HKCCC/15Y\[7J0
MI]G>*S7IGIV\@                           #6]=D$ %1KGDGP
M   -6UVD0                "(U+H                 B%2^
M        (=4Q@                "KMS1D&++,<&R!A#4M;\04>MV&*(X3Q
M,T:IK<1VRE2["LS<)                            !K>NR" "HUSR3X
M        &KB[1H                !%*E<                 1.I9
M             $1J70                !5^[H9_#FF.#9
M                         UP78] !4I1*S(         &OZ[ (
M         !'JD,                 1VI%                 $;J20
M             ! -K3S./+)L.<
M   "-FX2 "HUSR3X         &K:[2(                !$:ET
M         1"I?                 $.J8P                !5VYHR#%E
MF.#9                                      UO79! !4:YY)\
M    #5M=I$                 B-2Z                 (A4O@
M         "'5,8                 J[<T9!BRS'!LC7GJ<>Q>;U=2_.2[#
M8E  !JTNR2:ZKA";FP*"!D\*P+/-?EOM*]+(!K\NP* 5H1=>B; H  -?EV!0
M"!$]    !'2!K;R :^+-DLT &OZS)+.   !K>NR" "HUSR3X         &K:
M[2(                !$:ET                 1"I?
M  $.J8P                !5VYHR#%EF.#9\Q_K_A]VOGOI\!H]+0)9Z2X@
MY^%DIJ OL&\ZSKM(FHRQQ<\E2KZ;O/E<]94V 31EZVF3T%>?'1ZM,]/WGQ]>
MI$1\V#2E%B9<IQ%B),S E"+(#O%MI7JT090LHBQ%#/DY)@FU">7;U>1VBMS;
M5*K(VM4FR"5^M0EY&Z+SI\]10BY;2:A/6TR1HA!G2Y4WK36]=D$ %1KGDGP
M        -6UVD0                "(U+H                 B%2^
M             (=4Q@                "KMS1D&++,<&S&\V"28<]9'*5T
MHHE9DG5,&;TIIJL)7;]YT_>IXD./01-*5L@Q!K*NQ2;8)YWKL0;&IK:M*+9*
M1,QQ(C\+!-4%]*'G7]8V50MTI!3E)>1TXB?E9$R+3*,+/*#+Q,64,NV24Z=8
MDYGS7-9*F2-H4UX7KGR?)%"5'(0=9ZEXEMIK>NR" "HUSR3X         &K:
M[2(                !$:ET                 1"I?
M  $.J8P                !5VYHR#%EF.#9      ZQV0          10E8
M                   -;UV00 5&N>2?          U;7:1
M    (C4N@                "(5+X                 AU3&
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M21ZQYCS-)4"V20$MU*479)-TT    UO79! !4:YY)\         #5M=I$
M              B-2Z                 (A4O@                "'5,
M8                 J[<T9!BRS'!L@=(UI7.$Z3\7M)JXM^$H2AEM ZQDRN
MB/FXR0<C2YQ("OV60FCCUNR\]LJI<D3!.\3$U26_$G)3:\9!BZ$%(+/#B--E
M]!'G!&: ,885:H+]3\*#6XSY.\D)66I"5$E(6?A9:1!=@4    UO79! !4:Y
MY)\         #0OL<JF/N/B@                .LO90
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M8\'FP@ 2'!GCV?    )KI;GH9\#]N                !C\>38+E=4
M           "KMS1D&++,<&R-:.OQ+.Y79U)\^]Q4G0  -;UV00  #6]=D$
MK L\K L\     &H*[6)D@ :WKL@@    $%-5EL0V?3SQ>MTGG$D.6W4XR5
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MTZ.AB,N++8LE1]7F ":Z6YZ&? _;@                8_'DV"Y75
M           J[<T9!BRS'!LXSWXR?CW7QJ0MQ%,EXE8DP-J4T^7D(B5VMRIQ
M$K,@8LC1T24DS(:;1IJ\N7(T<A<Z:SK/#&D/)V6T8 ITN$O%-'5M<S15YV2O
MBM5E9/4GY*"#F<*9)^2$M!-6ESY8AF2^4K$UP7:-->UL,L!/,IZV\3"DJ(*;
M6I,0:WKL@@ J-<\D^         !Y[][BZJ?HWYZ!^5^P%(  4@*"/ROV%(
M4@#\K]@!2 I 4@  *0    I  'Y7["D  372W/0SX'[<
M#'X\FP7*ZH                %7;FC(,668X-D#\/T    &(,N   ?!]@_#
M]   /P_0  ?)]   PYT"3@ _#]      !Q'3,B   :WKL@@ J-<\D^
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M+H                 B%2^                 (=4Q@
M "KMS1D&++,<&R!K0NNB_)(#KF]3SI>NIB["%DI4RP,E9CRXTI]?3UYT(76A
M?6]YT<>NVF=-<%S19!71>2;SIYUO7V9 VK>=<5FYITN5+\3Z.F<Q-R<&@:Y0
MN X32U?9EXI1=>5S!Q%;FR":U+-3#',>F[SE       :WKL@@ J-<\D^
M     !JVNTB                 1&I=                 $0J7P
M          !#JF,                 5=N:,@Q99C@V0,(8HX3!&'6W4J19
M&F6(\=\[A02S8M1*L6_$H1;33/FI:W4DK, 19>H6LE:K;R:]+:"<!994"V(D
M6(JMD(/P_22E%KVR1IG"OUG:09;H2@%M!*U6RDB2X<[)8:4XNQR       :W
MKL@@ J-<\D^         !JVNTB                 1&I=
M    $0J7P                !#JF,                 5=N:,@Q99C@V0
M                                     -;UV00 5&N>2?
MU;7:1                 (C4N@                "(5+X
M     AU3&                 *NW-&08LLHPY_)'[C\]]+?D?M\AJ;NJ:[S
M(!6!7B[)( !K6MB):!6Q81S@UN6VTSIF05B"S@ 5>6@     "L#Y+1
M        -;UV00 5&N>2?          U;7:1                 (C4N@
M              "(5+X                 AU3&                 *NW
M-&08LLDQ9_Y\_P!/_(/:_P#/OT[&<_J:UK-4C9 ECQ\&(($NQ2;[/.@KUWTL
M0UL6,&QR3TTJ7;Q,L:]K5A=17I.#-F://I?>!XTJ>M;3TY33I<N5L4TMCI("
MV2K"0FJ*[*IW3L$:(*>LKS+P           #6]=D$ %1KGDGP         -6
MUVD0                "(U+H                 B%2^
M   (=4Q@                "KMS1D&++,<&R!7AR&OB\Q:I4Y8I6YUBT"^T
MTM7.DZ/PH<LTAQT"["=)K>N0)25>34FY#CSW7UB>:]7Z++30UZV724E-E?K+
MDF1\$Z-:%V#3J$1,X2 O-)*            :WKL@@ J-<\D^         !JV
MNTB                 1&I=                 $0J7P
M  !#JF,                 5=N:,@Q99C@V0              ($3T &*,J
M 8DRP                 -;UV00 5&N>2?          U;7:1
M       (C4N@                "(5+X                 AU3&
M           *NW-&08LLQP;(
M &MZ[(( *C7/)/@         :MKM(@                $2J6P
M       !$JEL                 1"I?                 %7[FAG\6:8
MX-D                                     #6]=D$ %3%#+,@
M   :_KL @                $=J10                !':D4
M        1NI''Z                "!;6GE\>638<X
M                    $>-P4 %1KGDGP         -6UVD0
M    "(U+H                 B%2^                 (=4Q@
M        "KMS1D&++,<&R                                     !K
M>NR" "HUSR3X         &K:[2(                !$:ET
M     1"I?                 $.J8P                !5VYHR#%EF.#9
M                                      UO79! !4:YY)\
M#5M=I$                 B-2Z                 (A4O@
M     "'5,8                 J[<T9!BRS'!L@
M                 :WKL@@ J-<\D^         !JVNTB
M  1&I=                 $0J7P                !#JF,
M      5=N:,@Q99C@V0                                     -;UV
M00 5&N>2?          U;7:1                 (C4N@
M  "(5+X                 AU3&                 *NW-&08LLQP;(
M                                   &MZ[(( *C7/)/@         :M
MKM(@                $1J70                !$*E\
M   0ZIC                 %7;FC(,668X-D
M              #6]=D$ %1KGDGP         -6UVD0                "
M(U+H                 B%2^                 (=4Q@
M   "KMS1D&++,<&R                                     !K>NR"
M"HUSR3X         &K:[2(                !$:ET
M1"I?                 $.J8P                !5VYHR#%EF.#9
M                                 UO79! !4:YY)\         #S#[?
M \V?T'\P                 W)^<^L]F?AOT(                "(5+X
M                AU3&                 *NW-&08LLQP;(
M                           &MZ[(( *C7/)F<V#'^O$TU]J&[&MW_'HL
MDQ9JQW-&P-7;@>SJR_!L=WSZ[WGV   /*3Z#YGQY_4/R"38-KZ2+Y]8  2+#
ML1W-KC\7]0#N>,G8EQ>3$)+AV,+DQ337VHGFU^]Y]Q[-K@   #?WY3[7WD_.
MOU                 "(5+X                 AU3&
M  *NW-&08LLQP;(                                     &MZ[(( *
MC7/)H3]?\1K]T^/LMR>W6.WHV1J;JO0;Y?Z_R+^X_/+$U=VA>ER=KN+W]J>+
MW[RYW4   'E)]!\SX\?I_P"0^@GR_P!K4&]S<OCS8#+KY7QERWC)\IW_ #[P
MV3#C?4Q_I=NAOP+8U\'EP8?W-B>5UZPW-# 9<, VM2^>;U=/N[\UM1Q?H<WC
MS5OMZ'6L[,]Q[-K3#7V_A8%M:.?Q9Y5@SZA]_P"6&_ORGVOO)^=?J
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MEF'+3V]SKQYW3KS:U,/DQQW+AM[1Z/F-]C\#]O._ORGVOO)^=?J
M        $0J7P                !#JF,                 5=N:,@Q99
MC@V0                                     -;UV00 5&N>2?
M    \I/H/F?'G]0_(/E1^*3Z/D^CY7Z0#\/E?I/T^5_4_3Y/T^D^'K[>?Q?E
M1])\J/I/E1]O(W]^4^U]Y/SK]0                 B%2^
M    (=4Q@                "KMS1D&++,<&R
M               !K>NR" "HUSR3X         &C^UJ8[M_/@
M     331Z.WO([0                $0J7P                !#JF,
M              5=N:,@Q99C@V0
M    -;UV00 5&N>2?          U;7:1                 (C4N@
M          "(5+X                 AU3&                 *NW-&08
MLLQP;(                                     &MZ[(( *C7/)/@
M      :MKM(@                $1J70                !$*E\
M           0ZIC                 %7;FC(,668X-D
M                      #6]=D$ %1KGDGP         -6UVD0
M       "(U+H                 B%2^                 (=4Q@
M           "KMS1D&++,<&R
M !K>NR" "HUSR3X         &K:[2(                !$:ET
M        1"I?                 $.J8P                !5VYHR#%EF
M.#9                                      UO79! !4:YY)\
M   #5M=I$                 B-2Z                 (A4O@
M        "'5,8                 J[<T9!BRS'!L@
M                    :WKL@@ J-<\D^         !JVNTB
M     1&I=                 $0J7P                !#JF,
M         5=N:,@Q99C@V0                                     -
M;UV00 5&N>2?          U;7:1                 (C4N@
M     "(5+X                 AU3&                 *NW-&08LLQP;
M(                                     &MZ[(( *C7/)/@
M :MKM(@                $1J70                !$*E\
M      0ZIC                 %7;FC(,668X-D
M                 #6]=D$ %1KGDGP         -6UVD0
M  "(U+H                 B%2^                 (?4P@
M      "KMS1D&++,<&R                                     !K>N
MR" # FNJ]P         &&,R                 <9R
M'&<@                !QGV?H                .IZ\<D]<\H
M                             $W+E0
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MM37Y<X5*7.1<V"2&+0QFS?U-%UP!'B]RIR-FXR8DWI3*
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M1ACOF#).3E.T5^OX=,R1\G.14D969S%M$V2A%^3/DD,&8T^2(&Q:50L6+#.
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MZN9*W.8@2W:E,+>B5 7R4<3(U=79).F5PNVJ1(PA4BV^E>&4.$FYM(F9
M                                                       !&"3@
M '3.X   #I'=     .J00L4                '2.Z     =$[P   !TSH&
M;!@S('<.D=T    Z1W0   #I'= .F=P
M
M
M
M
M
M                                                        _]H
M" $"  $% /\ \]I2V,-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@
M-T@-T@-T@-T@-T@-T@(E\([I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I
M ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I ;I
M ;I ;I 3E^Z-T&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z
M0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0&Z0$Y?NC
M=1ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!N
MD!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!ND!4+]V&Z#=(#=(#=(#
M=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#
M=(#=(#=(#=(#=(#=(#=(#=(#=(#=(#=("8MA"4M",-T@-T@-T@-T@-T@-T@-
MT@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-
MT@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-
MT@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@-
MT@-T@-T@-T@-T@-T@-T@-T@-T@-T@-T@*DG<CV9/A[I-_O4=;4E80U&8_P Z
MCJ?YI_#]&F/]=F3X:9)(SQFM]:6'MYO]^RHEYZT:Q2I1AV))>]&8E/"K-+&2
M(D+SSRZ2Q68Q&$<?95O:T2E2M"L7GHQJ%9J<G;DH3SR^TK"'M*)6I6%8M4HB
M)::%/MR6ZO/",,/:&/\ /M*)>>L*Q2I1A M-&GVZ5OK5832QEC[.I_FG\-,L
ML9HU*<U.-6C-1CV.&UQ&$81]G"E-&622,\9I8RQT%BTQB.L#'^NS)\--M\>-
M:MOE0I*:-U2E/&8H6DFX;/MRY$M7F)V^0S">E0C/(3HF($2$IF22W4C$DQ*E
M4I]B;_?LK3&,)+14GGE*V^2>C3)R5IX%*->4J3EFIQITI9Z]*-4Z4M^\STR-
M&O M0C/0+DY(TZU&EC1*%J\UGEC+/+\/8UO:T9XRDJ<\\Y.I2DF*G"<M.22D
M6EA5MLTM<Q2+RPIE*<E,T5EIR@N<G,4?:5A#VA&:,I4G//.6I4I9R9DG)"G3
MIEI93-OC3JF"Y>E&@4DA3,E)(4P7-5JM:\S2S&/9F/\ /M+5&,*=JJ3SR$Z4
M*A2L3IS4J-.A"4X3A2C7*%Z$2I26:2L4IS4Q1HFC,;S7EK5_9U/\T_AI*^(;
MIP*U:%&<]5I%*!F,I2$]"D5A-1%ZJU):]UI0JUSA*D6%0E1+ X1C0FA;Z$M2
ME;I:M>O0HR"B4+5IB1#;U*-NI&!2M]&M$4_D[7X\"F]&J)&A5F*$(U9[91HQ
MF*TZ<PJE*4]*I3+[M0*21DKE:<:<2=&A+/"$(ZI,?Z[,GPTVWQ[C=*\*EB\>
MTU84J]>V5MK-5EG/1H5"X(P_^-:BTIBI;9YYP1^5(_+VWP^Q-_OV5FJ1IRF+
MA6,PF^2L]2.S@;,0A+2B8)R%9Z4W_P#($/\ =B\8C\K-2F,%"]OFC4)]^!BV
M^-+\/8UO:DS,Y<H8.5#$3ORM3Y*O1B6FNTL\3,TL3=.>O/$N<,5IZ8(%:DM*
MI3FIQ]G6$/:6RO-0+F3U4R*GR=/Y.I1W:2\R3S5*<)CD*5:>8J:,5IJ0D*5"
M$E6C/2C[,Q_GVEGJQI2&+A5,PD^2)?*RTH4*-VDGC(7A.;F)U)HE:QJO&D-V
M-48W[#:>SJ?YI_#25\2L8EFKVNE,5K4S)F6:TU835+E+N\@N]RK4*A*>,]<]
M-"0S=RE2>L>ALX&2\TM:U1FB8)485JA:$\I@A\U8?'L/S$WQ(T]X+VPC4EJV
MJIM39"W59#%":!H6<I4DFMI>6:E&:>8I&C-5*%JDVZF#5:-(K-6!RE+2JZI,
M?Z[,GPTRS1EC--&:-.I-3B(':L);89D+U"\*):>J9FGFEFC+&<Y5GC+4FEA+
M4FEA+4FE[,W^_925)I-&TF[LLT98U#E6K"E6FI1J5IZD=M-WI:LTHIU)J<9:
MDTL*5:>E&I5FJ1F.59A+5FEC[*M[7:3=T35)IH;2;NRFJDLL:LT8U352M"E7
MGHBK7GJQ&_UA4J35(^SK"'M(5)I8#:31EA4FA"F:J4X1J33"J;JU84JTU*-4
MQ/6T;_6%2M-5C[,Q_GVDM2:6 VDW=EJ32PI&JE*$U2::$YRK/+3J34XU3-2M
MHD.U9(1CC[2I_FG\-,(X1GGC/&>M-4C,>K30(1DEJFS$3%05*DU2,LT98S31
MFC2-U:4"]6$E2M+1JU#QZ-:L)CE682UII8TZDU.-.I-3B)9HRQJFZE6%JKRT
M*N]5.[)/&2,QJI/&E5FI1G,U)Q2,U*(IU9J<:IFI6$IRK++JHQ_KLT_A[I-_
MO4=;4E80U&8_SJ.I_FE\/T:8_P!=G:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:
M3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:
M3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:
M3#:3#:3#:3#:3#:3#:3#:1B-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-
MI,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-I,-
MI,-I,-I,-I&(VLPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDP
MVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDPVDP[\8
MC:S#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3
M#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3#:3 G_ .[5KQC)/M)A
MM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)A
MM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)A
MM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)A
MM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)AM)A&:,=?PU)#4D-
M26[QS7B?L9#4D-20U);O'->)HH$Y:<D\W>C^Q$-20U)#4EN\<UX@*VDO7IW
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M'(@Y$'(@Y$'(@Y$'(@Y$'(@Y$'(@Y$'(@Y$'(@Y$!I%;"F4CC2TP$(##1&&
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M1G=S-<ON$AC8P+GC4M>%O\*E0@=A+7C7H&?E#DD9*4/GBT9MRACN,N&^4#E
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MP]V4/RWZKM'S&H[I\N3\+L0_D?U#X0$/XT1$-$!"(B("$1_6C^HB(B("'\B
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M5XT[A K5I$:U2-26$:TNYSFJ,3$AJ,@I1D-4#%*6G,4[E0O3J4B,NUEW4O/
MO*6,QJT*E3NU:1ON5B$DTL)3]*0S7C4EDDPA&!N$M:A6EED+U992]6$AV2Z5
M:<XMU>2$*4)",I?N5BU:K+$M4-2RTC%::M,5KRRP!0Q3GI$Z5(E-;ZL(4+A6
MDK2SU=G0C&0P6-UI9Z,O<-T3562G3WNGOMJK2TIBL9*Q8F9[U$S",T:U7N4*
MG<,%YZ\D1&O+OA6O)"<\8A$M=*TM6-KJ22@M+1)S%S$-E;H[ 4JU*M)-&0I1
MN%66I+-"0Y2,FJ=*->I-4F+5Y84B,D8QNM:6K/V+?XVHZ/\ K4=T^7)^$-E+
MWA 8C$8Z,=.(C$8B Q&(Q$(B$1B,1"(A$0CHQ&(Q&.C$8C$8C'1"(Q&.C$8B
M$1B(Q&(AHQ$(B$1B(Q&(Q$8B$1B,=$8XZ8QQT8B$1 1B,1CHQ]C#W90_+?H>
MW^-J.C_K4=T^7)^%^DH>[&RDIJGRU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!
MRU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+
M5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4
M!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'
M+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 <M4!RU0'+5 4D]1I3;K*-UE&
MZRC=91NLHW64;K*-UE&ZRC=91NLHW64;K*-UE&ZRC=91NLHW64;K*-UE&ZRC
M=91NLHW64;K*-UE&ZRC=91NLHW64;K*-UE&ZRC=91NLHE+0ECJ.Z?+D_"TP&
M A 8##1@,!@(0$8",!@,-&&C 0@(B$!& C 8# 8# 8:(_"'PC 0$8# 1& C\
M(# 1AHP& A\1@,!AHA#1@,!@,!@,!A[K#W:'[(73Y<GX6F A\1#X1T8#^X?'
M 1$8_P Q_@?$?U\=$1_8A\/ZB,-$! 8Z/ZA\/Z@(_&(C#&(C\)=']0T1']P^
M& _L0$/CH@,1AHP_GW6'NT/V0NGRY/PNUB,=&(QT8C'1&(QT8Z,=,(C'1B,1
MCHQT8C$8Z,=&(Q[6(Q&.C'1CHQT8Z,1B,=&/NL/=H?LA=/ER?A?I*'NT/V0N
MGRY/PIH]V'/D1;CF]T1AV,!'M0[>'O&&I(>[0_9"Z?+D_"GAC#E(X+,6G+EX
M"(_H1B(Q$8C#^1#1\! ?U&. _N QT?U ?&(@("$1_4>QC_,1_4?Y$8CX#^X1
MQ$!$1CHA$?U\-&/\^_P]VA^R%T^7)^%IAHQ$8B(Q$8C'1CHQ&(Q$8C$0B,1B
M,1 8Z<1B,1CHB,1B(C^HQ$8XC$0&(Q&(Q&(A$8C$8C'4$/=H?LA=/ER?A>_X
MZSA[M#]D+I\N3\+])0]VA^R%T^7)^%^DH#$8C$8C$8C$8C$8C$8C$8C$8C$8
MC$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8
MC$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8
MC$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8
MC$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$7&?NT"T_>IXC$8C$8C$
M8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$
M8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8B/9A[M#]D+I\N3
M\+])0]VA^R%T^7)^%^DH>[0_9"Z?+D_"_24/=H?LA=/ER?A?I*'NT/V0NGRY
M/POTE#W:'[(73Y<GX7Z2A[M#]D+I\N3\+])0]VA^R%T^7)^%^DH>[*<S.7*<
M>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CC
MQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>-CCQL<>
M-A(W*N9K?JNZ?+D_"_24-$YFG)-4.TJ<PH':5>-$S3K"!FG&<5KG0HS1J0A"
MA<J%>:M7DHRR3PJ0]@K_ )(%R=0Q$R3J%X]J@5GK0T1AAV*=*:I-6HS49M!4
MK,9GJ4XTYJ%MK5Y:U">C&J4GI2^R0_C_ *KNGRY/POTE#1>?J5\)[T=-WOOV
MU.D]S/(W_-+ZO*8DFC?(D"\ANWUHVNG/1N%966V$]*Q_*^P5_P E" NE2J6F
MN-$[1I%"!*M,1L\LTQ&F5WN\T"]0T?LY>C/-;"=.H6MDU"8M:J&[F;;0I14M
M*A&:-I*EYRUAA"J5IE(&;A3*1-RV>4R8J6LO7HDJ)2,A.WP)'[AXU4S/0(%:
M\US*&",9Z=S(EBPDMA<M3-VN0M7C;2QBE+:RY>E;;9(8!FVT:E$_;"Q*&A#^
M/^J[I\N3\+])0T78O//<*1:?BA"S593A(O/+<R=6M8ZME+UC1LNG"M"I<KS,
M8I5[.9IV\[#B4RG-SSTTZ<FJ4O8*_P"2A' &I*=XE-]PJ3DK;*M1A4F,7*O1
MIF+D7A(;-G9:1^K::=0Q+<:9BJ9K2Q(UZ\FYW;NU <-US$Q6%:>O=:]*2I<Z
M,L#<#,FVL]:62B4FP+US=.8^>FA-5IEY3A*>I2MA<Y-+6HUYXP+P/53-&C4A
M,<B8GDI6>6>E+:#].2-QJ&ME0A&G2FPQ"'\?]5W3Y<GX7Z2A[LK_ )(0C& C
M&,1WHB$T8",<1&:,1&.([T1". Q&([T1":,!",8",<1&:,1C$8B$T8#'1":,
M-&(C-&(A-& Q$9HQ'>C 0C@(S1B(S1CI0_C_ *KNGRY/POTE#W8^0D/4N3"@
MY,*#DPH.3"@Y,*#DPH.3"@Y,*#DPH.3"@Y,*#DPH.3"@Y,*#DPH.3"@Y,*#D
MPH.3"@Y,*#DPH.3"@Y,*#DPH.3"@Y,*#DPH.3"@Y,*#DPH.3"@Y,*#DPH.3"
M@Y,*"VV&A;YOU7=/ER?A?I*'NT/V0NGRY/POTE#W:'[(73Y<GX7Z2A[M#]D+
MI\N3\+])0]VA^R%T^7)^%^DH>[0_9"Z?+D_"_24/=H?LA=/ER?A?I*'NT/V0
MNGRY/POTE#W:'[(73Y<GX7Z2A[M#]D+I\N3\+])XC$8C$8C$8C$8C$8C$8C$
M8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$
M8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$
M8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$
M8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8C$8BI)"I++"$L,1B,
M1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,
M1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1B,1C^I,!@,!
M@,/=L.W'MX##1@,/:X##L8##V6':P[. P&'8A[# 8>RA#5U2>$DO.10%E46,
M3B$!A[E,H:$L95#0FCHP[<>U'MU*D)!O4HIU83^]1]A&'LX:(Z8Z8]N AHQ$
M!CHA_(CIP$.Q'1'M1$.Q'1#VD-$1'XQ[<.Q 0AV,1$8]B P$?C&.B/QAV(=B
M(AV(B.C'3$0U<<\(6'YOL?'3#^=$8C#V1C_='_0AH^ B(Z(#XZ<1 1T1[9OX
M IHCHCICI^(@,/YQT8Z,='QT8Z(Q$!\1'3$1B,-'P$?=<>QC["$1CVHQ]EC[
M/'W;'W* Q[&(Q[>.C'6=>GM).1:HMR/J%:PA'1CHQ'PTQT?'V-1-3SS2)FI+
M$0B/XT1&(Q$-&(_@0TXB/;K4]I#=(BA1C3T8C$1']8B.B&G$0TXZ,1#3CHAH
MQ[$1CIC'VD1& A 0@,!@,!@,!AHP& P& P& P& P& P& P& P& P& P$1@,!
M@,!AI@(P$8# 8:<!AHP& PT8# 8"(P$1@,!@,!@,!@(P& P&&C 8# 8# 8##
M1@,!@,!AI^ P$(:(C 8# 0@,!@,!@,!@,!@,!@,!@(PT8# 8# 8# 8# 8# 8
M:(P& P& P& P& P& P& P& P& CHP& P$8",!@,/<\>UC^D8#$8Z,1B,1CHC
M'1B,1B,1CHQ&.B,1".C'$8C$8C$0B,1'1B,1B,=$1 8C$1B,=& QT0&(Q$-&
M.C$8Z(B$1B,<-&.G$8C'1'1B,=&(Q&.C$0&.C'1$?$8C'1'1$8C$8Z,1"(C'
M1B(:8QT1@(:,1".C'1B,>Q'1B,1B(QT8Z(C$8]C$8B(C$8C$8B,1CHQ_9;'_
M /5<_]H " $!  $% /\ \]79OQU*H=/V)R+M:>4W$'*;B#E-Q!RFX@Y3<0<I
MN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B
M!5G'.3RLY3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3
M<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$
M'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q X9USD4:Y3<0<IN(.4W$'*;B#E-
MQ!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0
M<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*
M;B#E-Q [=Q<YM['52#B4Y^4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!R
MFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN
M(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@>$\YS8HJ=(N))'E-Q
M!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<
MIN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;
MB#E-Q!RFX@Y3<0<IN('!H.4C$JG+,Y%[L_*;B#E-Q!RFX@Y3<0<IN(.4W$'*
M;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX
M@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.
M4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-
MQ!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0
M<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(.4W$'*;B#E-Q!RFX@Y3<0<IN(&2O:KI
M+;L/WZ9(S[;]T<KU-U&^GU+4>:#[-->-J+-9Z0U_]ZB?+TT0?VM^C6I]7NP_
M?IDC/MO3=+F3LA.W/\V-W-1A&6/MG*]3?9*U>)M T$DZB+7U?L72XT;.1MKR
M)4ZA;9<BEZ)B]+].)V]Z7&<VS-<5JTXT9_8OI]2]HK751:!,I-=II>ET\Y-H
M4RG[=X7"=3UU]IF@^S37C>S5[E))OIDBXR3<"!1R+0=6G:A",8WK,&V"=N5*
MK3,4_9YK/2&O_OV:N7Z90%%).DC%]6,N/:"JT[:G?MMD7<+?<"EW*^S?+TT0
M?VMI.G*%M+V!0VM56U*K&Q+HEIA",1/F(:RG5+&:)VC[.LJK,7O5[O=O35OM
MUQ*W@IH<9R+.UMMGDC3F&,,=6M3ZO=A^_3)&?;>G,3Z52)-N(Y>4\[%^9S+P
MFW:6-(H2==[5%8Y<Q":JM:N7L>9NK([#]*!HC=L53KD4U>'@<MKKB]3W7)I5
M-<\PR];._6QY%^EUGV'*]3?99J"U XH<V"?3-ANKF/VHTTXJD>%3H).576<)
MM[VYCN7VS*LFH5W<DZA5-21>5IT'SJM,F+V^+D-P><5944^YCA.^H"JN2:P7
M\;<L7;>5MK+FY.T+HF#WS/L7T^I>T5UKM]WS)WJU6"R9D+,J519'R9]V[\JU
M%=5.]]S,)[,7:[LU"#5#NW@PH'65RB5K5NI=U1>IL8RK]H["U[B>TS0?9IKQ
MO9O80)W-\W:LR=L3SJ947Q-YBFV=U4G%HH+^\ERNS;OU05J(;]PG<6A9;NJH
MJBN;QU%";5D?Y@NVT;1"MQE"M]SMC/>SS6>D-?\ W[/,Z5+G5GF@L":L*D>%
M37)*9A4B[ZSMRZ5U_=<Q>FA>(TN"R(=AV''MCE.K>+*I4BZJKMJRDGC3F5RQ
M8=H2F4%%WM"MC[-\O31!_:VEROLYJ5!<7E0*W5B<RXH=1.TZC4%K@ZQNS.JI
MG2-VUR)!E 2R.NS897U&81C3-(\KANY/9'F<IV@T3V%G(LU5^G4NR.4F8._H
MIJ4,N'*ODJM=5ZD#8WF?&1LD6K,P#A-G!4O\XZ"+1[L0HO\ R3S-^DEQ=2LS
M#'*Y\'51]J=1\BR(L.9%6./"QN;?EG:*B4=E:6E=6&_._3>M=NLH"2D0SI*F
MFLRSNN(XEVM!DV<(:I:GU>[#]^F2,^V].8F/=:MB<M+7GD=G:FA!K<U";N*P
M:A%YD6XD0=O3-RL&56@KTLY8>NMWWHS2N+?&Q1.8>W)FPTWGF[K\/E-W78S'
M30@L9_\ 6ERO4WV6;VR$%-=$(PC?-8>M\V&9C-O:2Y96'VO:$Z9N*C(-CF,N
MSFI5:6J$T.CE[Y^ZGL\<80;IYHP@^))2VQK\PKAOY:RJ0>*>PF&?S&30@W![
MYGV+Z?4O:.N@$^YN85OVH1[5T&@F_P#[PL,LLV9I!+6@Z]NRNW)+$F-)&Z#&
MK6R))/DG::1$-U958'Y<A(71?V2_VM3%/9YH/LTUXWL\QJ1LZ]>-OF80[53)
MZ?#,HH82S9E4XL9G64.4V^)RVHQ0UK4P)M2I>QVQ^VZ0#:VM<SSR4I;JZ"1S
M-*)-JJQ*\K[/-9Z0U_\ ?L\VEAMZJ4J"8AOVL.7B;#,N\,80>\TJS#CN1E4O
M=B*7YP#"98^T.O9+61?5*-RUY)<0A&8>93(.#;LCL34R6]F^7IH@_M;2Y4<$
M<C4%=[8U&9166IWVR43>LQ>+-FK3=>U)++H8D<Y4R#*GE\;MR46[]M)61K&2
M(5;TRF4YTDK8&X9 Q45Q]O5O;3;=9HB]C(,V\JLN2%1KDFK'<6=?B>$K(9ZY
MNZV.>";!GR/RCU7RBUCQYF7G1]R;[-!9*R,8-\LP:"O[3+FUUV:CFY=5*7ZS
M9BEY=[4M"M!/6W,!05=E168IPK)9"S\(9N6T)KQR23=PI-$J;HN$/JEJ?5[L
M/WZ9(S[;TW&W%+N5($"UJ+7NP6M2E831A&LSZ",73,BWM^=-%N',Y#NIA.H"
MU62VG[>5NQ:UM,AK(4.V*V7(^>L-LNAJXV*V7BMV'*]3?97.P6N]58QQ$MAM
MDES.DBUR+IUHT*D#:D2MD69*Q(^P)>W<HV+@QY-6>Z4[W8K8IBYVPVRY'E.C
M["MBE@3-F2A&W-"@[1&XIBS7@M--&:/L7T^I>TGL-KJ7,%+!:[>>DL5LIW(Z
MV2.N5Y+)>RDR25;)'(6NJD.FUU032.3Z++_$095NH"Q)ZTI8I[/-!]FFO&]F
M;L%K/GQ3L-LI7*I8K;6N-];)'*FXE+!:B 3C5(E''E*DK$M"B60:90U.:66>
M6+*MU,$\EK*D2_L\UGI#7_W[.XV"UWBO\1/8;94N1RPVRX'5.VR06Y@A8+5:
MC%I:5#6"YWY/6E5DDJW"20LT(X"\LZ@5&>HT:9:E[-\O31!_:VDP7I'*-GM1
M).E+*E[*FZ%M9AO;.>?*@HSZ":I"T&R1L(X"R6"UIDJ=)%KF6MUN*6<HI6J1
M*S.+Y+&E&CD>?<E&)-EF1+H)O(QC$6]HD)::IY*V2Z$;Y8K8J"M\L5M4Y.$(
M0A<+>4NY5,-:BT2:S1H>^N(@X-LCZ=\NEL)7PI;&N1=EMZE2]F69*TH!+6""
MI;Y*KF:_I>RJPBE6\2B%%Q:1"W>Z1CCJIJ?5[L/WZ9(NC4BF]A4&PJ#85!L*
M@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ!RZ<\'.V%
M0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"
MH-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85 ^U*>6Y;"H-A
M4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&P
MJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@S14IY48:H5-ML*
M@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%
M0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&:ZG/(T%>A4[^PJ
M#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85
M!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0/G1J2MF@J-29*["
MH-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A
M4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&P
MJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#8
M5!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L*@V%0;"H-A4&PJ#85!L
M*@:N6,KO]A^JL:+9-]EB3EX2O2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=
M**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<.1E]L5G<G
MI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N
M.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12
MXZ44N.E%+CI12XZ44N.E%+CI12XZ44N%%E.1U:X=**7'2BEQTHI<=**7'2BE
MQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**
M7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTH
MI<=**7'2BEPL,IB-,48Y4DQ-'I12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.
ME%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12X
MZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12X7F4Y'5+!
M'*BEXCI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI1
M2XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E%+CI12XZ44N.E
M%+CI12XZ44N.E%+CI12XZ44N.E%+CI12X=C+&FK,B$7E=3-Q3W2BEQTHI<=*
M*7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQT
MHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'
M2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<
M=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BE
MQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**7'2BEQTHI<=**
M7'2BEQTHI<=**7'2BEQTHI<,<CBB!=7L9@/2]J?LGW1W?5_4:@^J:C5_PU&O
M_H.HWP].6[^U/T:AO6SL9@/2]J?LGW1W?5_4:@^J:C5_PU&O_H.HWP].6[^U
M-"O=&Z*51J]3EFC1)#/>5)6MP7O,I-P^TY&9*ZI2_L:]J>S )7,$^Q1@;(W+
M\JQ;J!#9P4PMG6<QP[0TZ69K,K:7C0%KSZ4HV%4OY-;G#&97,E9<M%@LBUL]
M_3=JSH'%"4<1XB#=*1P<SD; KVJ<2+GV!7N>FT)=0XR[O"+,AYUR9;%!MDJJ
MRZ1]K7=X/KK0^&8_R>4#1YG;0YRD4.;HX26319@$P]"6RQ9LTYF?+YA\P%FR
MZIM29JTVG$ UCV7M<7SV68AZ;PUDJ",J<U8A;LU%Z/-4A[_45:<]@K[U43=B
MR_.2;>!NP2<]-W!8:'V<0TTK?(905%:FPAO6SL9@/2]J?LGW1W?5_4:@^J:C
M5_PU&O\ Z#J-\/3EN_M0+_,FZ3?*5DVDMS,IC-7#%FK6J5\^#"9D&]N-%P4@
MG;AE\?Q\?+ PI:[ANBY>5MJG#;I"H"@J9+VW[7**YJY'/<\EC8M*9+&@O#1M
M]_T*G/TT\UUR>(Y=5-9[B2HO.J">8=79:9]HT+;+Y=.%EV=AG[JG5TA;!<6!
M?YP'4;Q4YC<BM^M"Z;:RJ5T<A]FS&7,K>G(<MGW.:]Q,O;]6O,"G<Z#7EK^[
M.85+*=.*YWDB:8:GF0G;2HLV[<*ZKC++EY]+$2H;J9S,9>6<43_MGDX<2\NJ
MS>:.[*:R/[E^.WAY'S3RX<Q$/!D]M)$^U[!FYF;LKS3Q>E<V-B;L\C#LSF/4
M]Q6&:>*Z@U^4DXVMUN62)1W=1- E7F6MLRMMMEKD:6^,6W=US>II\'(K'W1R
MWJQ2T%1E@.)\\HG$N!"BZ.;)J"=^<^,MQ1686FHKMU7V#_QLOE^N[2WY$J"[
MNCF%SF.4H6Z0J-R[4F1/,BSMVS4(A5/>O5!E>?QO5IE\/'T==LMCQ4T@H'H?
MUKKG?T)<Y7;NS<Y:4FIZ*%<&UL$04&:!?.E;7-=I!/PK6V:QWLNE[L3!,U]@
M!#>MG8S >E[4_9/NCN^K^HU!]4U&K_AJ-?\ T'4;X>G+=_:@KI*S&;T'G1)M
MR4$SR,--TA'.9NZ+AS5<SMU4#QIW+^\38W!O6:=1EFC;S+<H+W?46VN9!J++
M:Z1HN3<Y@WI4;M-%2=.E0S5LPI'HL3>4,PDB@:-BC2+/90LJ1W+G%H6!O3?(
M7+XW=P:5N'$9NZ+!UE2SUWO3R9?<LQ5 6,]ELOB?<]7L]F,>*RN(PII0*%8V
M',;9[_ES8VJR5FS,,LI7/GNC-+M;JI^F=NKK7)1,JZB+<Y'95U4G&T:]*F$*
MC4VSUULKSY:V5N[+M[E<:6YL6V"Z9VZ*EW%BR-Y,/*T[.W1 . U3!WQKU!9\
MJ)NKER:S+6?;YE"K4/ WZ";ACW OCAN<161ZQ-HRR_N3FI/+H\[:"WY-KA68
M1L+*_AJ^IEA'P9&*]8-?6U5H.VO.=*7)CGD>%0O$V3].435>7(\;.OVRRUOR
MQ:I@7"LKM6W*TI"+2YF$';"67')2WQ]#-;F-9.F_:+;M-OU=;ND&-?AC+:JL
MG%6FQ^8]EKH\TKNL[=7!796T.0;S(-1ES42?(SY2+H>9M#%LPYR].,R;F6]U
MU0R3CH)?EVS6;FH2]9=<PJT;M>W]:(^YA#>MG8S >E[4_9/NF?QQ[NT5Q_(Z
M[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z
M[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z
M[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8_(Z[8,_\ 0]UC
M5;\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CK
MMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CK
MMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKM@[_T
M/=8_#\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC
M\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC
M\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMC\CKMB
MY?\ 0YUKH6C_ -'G;B/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R
M.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R
M.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R.NV/R
M.NV/R.NV%+G_ '15=H0,D*:8UVL$78G M=.G)1D[5N1MCM%X[<"9>!@(;UL[
M&8#TO:G[)]T_ZF_2!32]\K%X30F@.3KWR]V"5EN-R+]BO;3I2C"$9HGK>;M=
M86Y'7J[V:$T(Q,V:XDB@22-O:\N$(PF@)))JDUV3MW3\1:$=>K];.R0MYJZF
M316N1K!)I2[+F\T4[=#9HZ0-6RK-;3DI6,< =MQRV"JFKS0(5$5>J:;TVVPW
M6\RW&Q72SQ.D#5LK5B1DM3HIJ\F"%$D9,429(S<:UOL]PN]0];S=KJDDM?+G
M1/VXY:JPJ$C-&AV;RD+RGB)(@:N=8VD[];Z-6WFZ!>F3,5:-I3EX4$"I T>K
M2PC/'@]P@<N5DN=FA;;+<KS&XIZ[6:2,80A63EX+$?@)46HZDMRL-TLT+39K
MC?S/P$DDU296I&\H.[:Y0OVUI4RFM2-M36YFF_>.Z,4MK'9$.6SX,T8,K_,X
MVK7W-L'K1SYV1>9A"+8Y:$>Y;,IY)NT_:'9&F0S3-=<48V&:5N7=O2US:-:W
MY^IF=;\XW.5#-S:<Q"8R5//9TLRRV<Y.-X96BQM+>V)#YG6W<E51SJL]"ZNH
M\*096S3/VGW??]*N6G5K=DDZB76\R9SH- K[^Y6:5N6IO%I<U*7Q+9K\X"!<
MMJX?!M<Q:6:!<61^D(HT+8<W+3J:\(_.BTBXO=SN5"5[51G2:%)3(A;V)Q['
MF-N9TD[[GYDD T5R3CSHA6)!L,T#>._=<O=_M\;#:L\S+WBZ..^B%:,XT>99
MO7P.JC-^U:0OVB?.JSU.ZN*]:):4PT^:)MWKNCH9K&S9^\*;,.W212#5YF6\
M>2XI)RTZN+F5?9$G;/8<W33J:\)#.DT:WO;IO\B6;KI7,PW3WVIOW?23=-6A
MLWC4N.IG0S)H!H+DS^8-!OS3<E[T0T)BS9H6UO2';',NW[N75;YO6L;V^'G/
M3=M5-5S$[16+2/I(T;?Y9,UZ<?1*M_FQ;-SK]I0WK9V,P'I>U/V3[I_U-^D3
M_P"7#KOM3M;]HLH]CYE&5;Y=PFGQRL(UI6D49UN<MQY;+"=A$8K$Y395#)2Q
MM78;P>0UE8!*4&_566JO25B:R\M4KZU;N0C?:4'/:_*_;"A"[/\ )6L];UM(
MSE)SG/;"2-)AUJWK/TV=?I*Q3:"666EN&M4+ -C<V<?MLVGM=\3#DM39[ G,
MEMVLUJ7CX71\D:0@PZ(15L:ZV4;*VEE:1)6!*7#+W(2<!;9>$^G[L3R\-E=%
M(WK&37P^CTPGJSE$&<IJV_KZTI2U'<KM.9.6S*+%4ET&YUU5T6/:$X24#,9>
MFS@IW%?AR+>O+GF.OS[(:^9<R,5DA"U*H<FY9O8-D#=OGRZ%7$-L>X1AVRZP
MS@VTL]4KU5"M-#9@E"\J>N[*3[1D<A7KAE4J*>G95[=%?Y'R6][#K0NM<E>9
M4R*4!!.7G-"L;DOVBFC&$$>S#3*^ZM1EZK.+=5$QZ0N**33)).V(_->GZ"52
M&1:!N9T'7CF3L*63<]K7;2(NTGK R,?,%2--E95=Z7#XH?ZZF,(YVFXO#JDR
M64*@LS#6/R8>FW4;3=8VP]E-?)P71<(U$O4K917T<-3J-L"*USA7)IF]L,[H
M-\G4+=RSI-';4%1?9J)G?S&KVT((D7UPA?MK2_K9V=Y$(U[HN&B'$-2E*^51
M.F%EF+<5-68@?S<M&6I$<QB0_P# /.9Z)VBJ5ES>YAGELK2VE6^817,5E]L=
MOKYB<N!.F3ON0$Q2K9=VM;0TYN2EGEX5S<.]G']$#Z=F2^5)N6P<=UV"6%B@
MD7H<JJGY\VV6:XE2;NE[[.I&7;4VA9&WRS$72N"B?5G[TRN7#_HA61WDC#X9
M4IT_!YK'NU5&)51IO+]EBS.7IT[VC[__ .7&2*RV^%Y_Y^49"J!S+>LS6$W(
MN+U)_*UBDVS<EPVQ<"ZSW*3+!FF,(2&651I^O=G#79>F7S6JNDK\F]OHK:Q5
M#.9:-U@TS9MBX[K,"\J%+D58[M&2CF=R75RO-2\.IBOF%S%;H8?_ "O7(H2<
M]O+T14;+(Q1)M@,L.9V^.G?$4Z3@GVYS+,X@[PF6U5) M=LJ><2WEK?>+NZ-
MV;/,/E(;6X-HA<U%AMRF>?/-&ZRJ\PQKE*9PEO:ECE2BK%,2NN8WF&V7K.(R
M5.:JU.7NPV5;98D(JW!RUJ72AO6SL9@/2]J?LGW3_J;](G_R_+J7]OC-OO"-
M;-]KG1S(H<O,;H=+U%,7%&*-N2A:]OBUS9W?*_96%2+C269KYK020[IF:%5B
M4%,5-W-2)11F2<W^7&<BHV=SS>12S8)M=*^T)5^F18*]M:^C;&J--D*J*NKQ
ML \IR@88S,]EH5+N./95[85AF8RZJR]J!H,P)]X+6G&Q:6Y.^84-K4K2,8\C
M0W[,N;;0@733<612+MRVX+7A>^=J07MK;C,98LK:D2[CHR^N(XCF*"S6*PNZ
MCK>Y]9R<V%DL-FO&7*K->6_8.\36IJ[?=ZC[,LME'6L#+9CU.DT^BG)L5%;)
MC+PVZ[RV7C*N<H6$BEU%<T;<>K=Y NW*5+GG&>1%Y<MB+TSBO:10+YVHM%F6
MS=)).6D,$R;G,(LF@4*67%1CVF4&5I39?[U5)(-/7:=]F;4C1JQX&HHW%=Y8
M%(?N2KS#JYX&&6=P9PM&C4J6E-79$."DC1>6_,<8HTFHOS<WC,@V^:6U$D\D
M,D_=G<E3Y8G,1%B>:ZS%&S<M6IIQ6'0V6=UB5:Z/*A[9F:L&397)I2,HX]K<
M+-CEO6-1R3F79(793M:JFE<)AJJE=M9OS5<#+^N$FEKU:#2?N&2\S1+*_)V8
MHEC^1HS1)NWER24;LWV:4Z=JH)VBBUO.9/-)9*)1-:X0OVUI<!O4ZZ=B:K+4
MW3+GLPV7<S(UM[92NY]T)MPG""JMC;)NS*(NP:"*(-8M,DU_97>R^H%]:);*
MVU91%(C*>U;>7!/MRG$M?$JW"<1%P;[+$V;5J!,(BQLRD<D+,GF>;Q8I"T+^
MR6:S$D];KCD59&YW!R621#N)]"97&O;4\YV5%K'AOJ.:9(("BDLES-(=1.9E
M4;!W+REF81"+2=HR+L?9BOP"UR?-$X-2ULHB+(BY4(GX)JQY(F6L$##<)PTK
M$8W*<;V9!-PG&Q)*1N$XK[PZF65N'FN%HRSMC8T:UF6-MV9N23:I)HBVIS)&
MRR5O5\;E.*10W!N$Y=%1-DK9J>_>3US5#V"Y9%F1NMQO#6)6_7"[MRG+\I'2
MREM4\MY5>7QNELDVFRY-XR59RLI[5N[?[<Q2$M%DIH1/TTU9,D3+6&#N-I>J
M;OY9&,/V6^UF#05=+K%N4XOZJR;*[6ETLGS0W]MHJ%N4XJ[VO6^3CH65MLI3
M6M/>KKDL9J]WYV6*0[WVQO\ +DW#6GDBV*70E!&Y1FD0$C:93VN:.\:4-ZV=
MC,!Z7M3]D^Z?]3?I EDED$))91L9!W8=[92!FG5IM-/2HRTI8T9(B,LLT822
MPBS[F'&<5:>?-OFS/?S$2R2R"226F)9)9(;&G&$9)8QFI23QC3A$/NY]%Z5A
M-)+-":26<2R2RQGDEJ0A)+",U*281DEC&,D(S0I22RPA"$-C) 320FCLY(2[
M.42R2R09]S330JLU O4KS22S1A)+",))98[.40I20!)T)[4W>FI1IU8R4:=,
M2RPDA+3DD$*-.$)I83PA3EA&,DLT9I)9Q,6I3QDIRTX322SP@5H0B-C((TY8
MB,DLT9J<LT99)9!/)+4A*6HR1A)++'9RQFC1DB,,(;&2$)I99X32RSPGHTZ@
MIT*=*,80FANE 0A"6$TDL\)I)9Q/)+4A-)+-&6G)(-E)W99(2QUPA?MK2JU7
M:$-:+->"2BM_97;I)]MS6DBX:;N2E["BOI-+6J@_*&G36EO'53SHS+%961OK
M-?'D2U@NEG<--*"_>T7;A)ML;7+-":&HT-ZV=C,!Z7M3]D^Z9U&M@]BE_%K*
M/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6L
MH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:
MRC\6LH_%K*/Q:RC\6LH_%K*/Q:R@_P#\R)"1K\6LH_%K*/Q:RC\6LH_%K*/Q
M:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_
M%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC
M\6LH_%K*+M_S(DMD/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC
M\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*
M/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LH_%K*/Q:RC\6LHOW_,F6RD(_\
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M@FKO)FC:]$7M7IAE'"33I(C4"&];.QF ]+VI^R?='=]7]1J#ZIJ-7_#4:_\
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MPV27N7%UGH1[I.ZB+*MUL_U)M$@::)/.=?#]@3.7])KQE$8PS<W*N\F5-O5
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M$(2PA&6E))&>G)4$)80A+2DE$:4DT8PA-"2G)3$*4DL='_.+U2U&K_AJ-?\
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M#N;(O50MJ:S#)<PL$Y<B+G-\JY6*<2%E<IBW%>NVJQOKZ=<LEER<%0)JFB7
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MI(@"P;BD>9?.R23$%B#6.JFA1^=*3R#C" P'/K1 +C0=?X5RUG[J'F"G 28
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M& HC(Q9ZL2 =H!0C(61X6)!&PA'*P]TUJY.LFKK% 6ZR3(MJM30#.2?>:HF
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M,8B DP TDQ%LE.1)>)82MB2'#&ZJ,YYDL4HVDGNQTO$:&499&9.1Q '%B,9
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MT(@_,!-KQZ]S-:L9L%(C^F.@?KM#S1WA2VG?[#E@G"2Y&A_UWAYH[PI;3O\
MUYAYH[PI;3O_ %YAYH[PI;3O_7F'FCO"EM._\TB,PX8V>Y< Z5P#I7 .E< Z
M5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7
M .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .GK7
M .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E< Z5P#I7 .E<
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MCEL2:XK!4:,+T!M7SXQAA9Q$DXS';2T+*S!$$3G$=X/A=[1SA'(RH@G""Y<
M:S+FU 6J>5(1&9!M> O0ZT3+#@Q2>TXGYM#.CG948X+6$GQR TZ@^AUERR@'
MS"PQ<(VM=SJ>(0Q &T$L8M;SB70@0,LQ$3Q&3D6UL994X0'?(&$65%(^]1AG
MQBTW8Q)L.J3U]R(RA  :9$][8(TU6J<B&(<$<X*CL&Y9@F >[&H!WK+EE6#,
M.&413F+:.7.LXX0,#%P.]+NO;KYE',D(8)6V$XHZN8ZC12C].(M L3)[9:0!
M'5K1E&/?B3$Q>S$*VZM/0HQSQ!IG"#%[#H=ZJ<,D0:!8XG<[&H-1*C" !G.@
M)L#6DDZATH9.>(O($Q,78M4$&UU\R A@=F).-@6?4^EO;'S?L?S9#S1WA2VG
M?^5<V)(!)+![38-"C$$8A*CVU.BJ^;$CYDXB)M[W/9S6]"RX AQ(V/;66A0E
M&<8RB&(D6Y<RC]+ER$B"Y(II.\]:.7*5A#&P=2CFQSHX1;5BVHBG,=RE-P!A
MPB1H^O\ 9^;G69+ZC-C,2!L!Q&1V<]++-=%'/E.(8GNDM*C?NCF1G&6*1+1+
MD;?N8[);O9++G&4LLDF,HC$SZ)!'.A$B(AA>0PN7=2CF0G+.[SOB858BW#A&
M@::++AGPE(&(=@3A( JW>B5FP[V$N,O'Q,1SVL]'1RL,A*,&+@BUB&&M#*-A
M,&MT%M*&483^8!A;#82S/BHRR,MG,9Q):UJD^X/52DQ;  ^AWUK-D06(@QT&
MQ3^FG&0)E*UNZQTO1?+^HRI&8>T"1$M1#6*,)Y<L!T,^#3:UH-M0LR(Q8#9E
MXZT+UMPO1'),9"482!<%GML!TKZ<,;)0>PV6:=2R2 2TB_-9I4_^3&<A9\L1
MQ&+<V%N]M69#"0<4FCIT7[5$'4-RG.49$&,0#&)-%',E$PA!R,5DI2/-H Y<
MV?,Q)'=(LXFCHUJ)^EC.()_W 08P;8;,6IE,?499D)2,HR )#'1W:$*7_%A*
M#FC-,BQR*FT4TK*ED0G9,8I$2_\ 5TF@UJ30F,T61E$$/J.(6&.V@65FYL<>
M$-.(K:!:&JQ0.3ER! />(( YGEI*$OIX3AF&0Q6&,6TX_"V_VQ\W['\V0\T=
MX4MIW_FF.R6[\$CYOV/YLAYH[PI;3O\ S2,R#.'KSKPW=J\-W:O#=VKPW=J\
M-W:O#=VKPW=J\-W:O#=VKPW=J\-W:O#=VKPW=J\-W:O#=VKPW=J\-W:O#=VK
MPW=J\-W:O#=VKPW=J\-W:O#=VKPW=J\-W:O#=VKPW=J\-W:O#=VKPW=J\-W:
MO#=VKPW=J\-W:L&8S O8/S9#S1WA2VG?^O,/-'>%+:=_Z\P\T=X4MIW_ *\P
M\T=X4MIW_KS#S1WA2VG?^O,/-'>%+:=_Z\P\T=X4MIW_ *\P\T=X4MIW_KS#
MS1WA2VG?^O,/-'>%+:=_Z\B4;""X/.$Y_P#Q-$1IL7AO[$9R9@'-O^%!#6\Z
M<M9S_P"'8>RW]28[1O\ 9/RG_"QV#<CL.[_$C]21+405P2Z%++$2'#:/\*!A
M-@ T(C";1S?X=U3_ /35_P#_V@ ( 0,"!C\ _P#SVHJ!4"H%0*@5 J!4"H%0
M*@5 J!4"H%0*@5 J!4"):BH%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@
M5 J!4"H%0*@5 J!4"H%0*@5 J!&R@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0
M*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*BHJ!4"H%0*@5 J!4"H%0*@5 J!
M4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0)F5 J!4"H%0*@5 J!4"H%0
M*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0)F3,J!4"H%0*@5 J
M!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%
M0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5
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M@:PS-[SSHF4 9.& .CGM--MU4/G1CAD6>+V;;>SG=0@(XL3V"KBG36PH0SH
MXAW<.O4;3[]6AU&&=$ 3H1HYC:=8O?[)]V_[O*!_KT[8J'R@!/%9A86<X'.S
M>_0Z^1".(D CK-M -FU1$HO.181%-M3933IJ Y 'U BTBP,7L.AWY,Y<H9.4
M'D0Y>D1S_P#6RRKJ<<V(!$3:.$V';RT#3B(!%MA#@O-K0LN8B^)@PYP[1_;<
MHRS8 1D6L/>CMM_8>XV++@8@F3L2+8MJ.A?)R0#)G)/#$<].;3I%AT2^9"T"
MQC9/97EH7S)PCALL![P>RVUMZRR*&8-\3]V=GWH$@",&D CQ:U 9+"PXQ&C6
MZK-3_P"EUG1RXN2UIX0P%IZ.5BEE9H E'50C6*ZQI3PA$ /Q'O2'-:*\[;2O
MG$,U1S]KC8A*<8X9,0Q[P!#N;6N='*R "8U,GP@ZK.VT&RQU++S THZJ$:Q>
M-==H"RF<DRMD;2;8\M[_ 'ON.[[W)$@"+:TH=:R_DL)/WA%F:RK6.V+W(B$<
M1,6U <-IYAR*.1G "3."*$=/(&Q$948@ UD>(<S$-[[U+,D&,'$ALY<['24,
MS#'!)F8G$ ];;+*Z^8+Y62 9 .2>&.WHO# VL<G. $@'LX2.;EH-@;V2!B&
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M"%CAAH NH-"&5\D%AA=XL?\ ,=Y[R&5F-*U]8?EIV^PM"-MAL%#4>]") (%
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M0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5 J!4"H%0*@5
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M0;.8UT6Z@C+N1B >\V6'#:" ]O-<$SA_F_\ ]:A+)&6,H8>^<+Z'<R>6)W
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M91C.0!D6B#I*D)3 ,6Q.:/1?-QQPNS\^IJOS,L>600=(^ZEMCO\ 9 2RQ+%
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M/3&,-UK=*RW_ * VUBR,Q&9E:"#(6O5['3!#Z?.CCB[,1WH[#6SD5]1#+M(
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MVR.Z(YH_E+)^F-'Q'GY &]9$02 6< V&U9L\N4A\O#)G+-W135;;[U\Z!MF
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MY1D14 @[D<$A)K"Q!8^Y?+Q#%7"X=ME?9AG.(.HR"Q$AJOH6&$XDZ@02L4R
M-9+!"42X-"*'[F6V/]WL;+B3L!.Y-F1,=H(W_;)@"6#EM 'VQ&(<FQD83#$5
M'M&7"TE&)J%BA"1&L1)W!-,$'GL0G($"3L6JWW<O*=X_-F9Y);BH^4;ORKD;
M!O*S0*QRQ(?Z1']G0S!Q3&#GQ4ET FY3RM66'VD0)Z2LWSJ7D_\ 2$PD'VA3
MR8Q)S'K:^(VOB.CF48 N1WBQ%L;2SNQPV76+)A]+'!*-LC8*-_W'GKTM//E(
MEA$1B_=C: 2VDE9?DCN^YEMC_=[(?1_3N+ [6&4RUI/O  IT,(_4/@Q:>\Q8
M[6L>P,%'*$IF4F&)@(.>8G%6RHN69\TELNN%G-N&Q[+&+DZ-"@(X\),6! ?%
MB#/HP^YVT+!#$"9D2L#5T,=M0-".1"4I9AD *8;2S'3B;2.Z]FM?\>4I8Z&0
M P [.*PUM%RSLLR(,(2-A;$S5U@]2'U&=(@8B" SFP$-SUM-G,ZR\Z!D<N9Y
ML08@$:!^RB(XL>&+6#"W/:[MS(9&=*6.QR&PQ)Z2VEB.9RLR.:2V6Y.'B.Q[
M.=S05"AAQL=! =^@-[@>9&).8)F0X<( +UJ]>9UFQS)GNB1Q&WAD YJ:>]2G
M]/*3P9Q("T.SQ:GO<H'-,S(FD0+-3F57K9[RH1B7!:0/,5+:LLP)'>E0D:M2
MS(YUIRQBC(VG_,'K37IV!9 Q$X\08FR/>$;-57*EEQ,\<2UH&$VWAZBV5FI1
ME]09/,.!!K :$XM>BG.0HQG+N2 D),3W32S7HKSJ<L@S!@'./#:!5L.KG=0G
MGF;SM&%F%NEZ\[,VMV4LR9(A"I:TO8 '+.3K+#2CG?3F31($A)GMH0S"MC,"
M_,OES,\>%W &!R''.VAWKX?;+RG>/S9F>26XJ/E&[\JY,XQ)  <@%A::E3F8
MG"8,[=VD=-%\F0/RX2,Q8<.AK:6]T7\ZS9D'"8ABQ8V1TTT+,A/+E*$BX,0_
M*RHYE+ZS,B8 AH@U-!N%YL0S81.(%Q::WJ63/(GC-E'#Z""SV5##WJ,&).+%
M* KAT"SGM(&OF67'Z;)E Q(>1CA$1MYJVVZA:I?31RYR) [P#QJ^C8AE2A*)
MA$!Y!@=%GW,ML?[O9'-A.,<P "0D<+D:8O87U/VC)G.,I',Q-$@L,+6Z 749
M94X1R;*87-'!\>*KO2I(M69F9&9&)Q2;O 8@9&C]V6NNHL5E3[N(&)GAX;)/
MHLQ-Q-I0SL<2)3>R0-CN_3I1S07 F]FH2='.&9'Y9)D^(/:79N+%;1NSZC,<
M 2RY /8_"![R!11B"'^82SVMA&A90<.)2</:.\-"A]5"42!&(9QB>A#5LV47
MS/I\V(@6+$Q!A9XL5M5.<,V.,:<38]%CL#058$-85E3.'&'.9A9JV4LQ-Q-I
M]RC]0)Q,93B;)"C@OS-I=?4G$+89C6BUS8VMUG"1 <6.:VBB@?II0B;<9EA$
MJV/BMPM3#<2LJ>($88O)P _/JV6,I$:U#+$X1(E(D2D!5M94LJ,A.<V!PVQ$
M1SV.^EO^OT\!( ]][>%YBK.VO8I#ZJ4)D-@((E.N@Q<X=>+F4#]-F")C$1E$
MD1+QLQ=[0=ME%'_E3C.RKO"A82T,YM9Q5RSK-CGYD+82PQ!C_P"GH#N=5BB)
M3@<HL91D8D!ZAC:)5;"+2UI6;E9<L&(O"1I8382:."SG2B,W-BQ([HD"3I=H
MOJTM:RE#ZF<)Y8B<-HD7:S!XP::@ ]BL]DO*=X_-F9Y);BH^4;OS3+;'^[V6
M*W[3?8;V6?<6>VU6>UO9:F]LO*=X_-F9Y);BH^4;OS2<K,=BU+*%UXK^Q>*_
ML7BO[%XK^Q>*_L7BO[%XK^Q>*_L7BO[%XK^Q>*_L7BO[%XK^Q>*_L7BO[%XK
M^Q>*_L7BO[%XK^Q>*_L7BO[%XK^Q>*_L7BO[%XK^Q>*_L7BO[%XK^Q>*_L7B
MO[%XK^Q>*_L7BO[%XK^Q>*_L1GENY#6E]75^;,SR2W%1\HW?KSF>26XJ/E&[
M]><SR2W%1\HW?KSF>26XJ/E&[]><SR2W%1\HW?KSF>26XJ/E&[]><SR2W%1\
MHW?KSF>26XJ/E&[]><SR2W%1\HW?KSF>26XJ/E&[]>3&0<$,1K!JF L'_P")
MID= >Y>*[M0RXXGD6%G^%8O9S)@]W^'<^RS]29>4[O9E^8?X66T[T-H_P_O]
MA_4DQU@B\+CC<5'-,XD1(-#_ (4G$+2=:!Q"P\_^'95__35__]H " $! 08_
M /\ ]/7)LGLJPU<;;9;C,C.%(4$NL1EN(5M4"#120:$$'PZMUW?ZI7E+LR%&
MDK2++8R IYI*R!_RHX G7TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(E
MB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E
M.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q
M>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=8=A
M<?J7=78V3OW5E]Y=FLH6R(,/RE); BT.\]U6[P=E#KZ4[U\B6+S77TIWKY$L
M7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TI
MWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+
MS77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[
MU\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%Y
MKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z
M^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\U
MUBL.%U+NL@9#D,:R/%VS65):;>8>=+J-L7BL%H !7=H37P:^E.]_(EB\UU]*
M=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB
M\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.
M]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>
M:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>
MOD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-
M=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7
MR)8O-=1<BM_4JZRW)%ZM%J4V_9K*E(1<):(ZUC;%KN0%%21V$@ \-*;_ /52
M]]TD? EB\'_U+KZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.
M]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>
M:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>
MOD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-
M=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7
MR)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FN
MOI3O7R)8O-=?2G>OD2Q>:ZO/4"V]2KK,DVIEIU$=^S65+:][[;5%%$7=P"Z\
M/"-;?_52]GL__DEB]3]EU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)
M8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI
M3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L
M7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TI
MWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+
MS77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[
MU\B6+S77TIWKY$L7FNOI3O7R)8O-=7W,X?4Z[R'[/;)EP;9=LMD"'%1VE.!"
MBF+4)410D<:=FK;?'^J%Y:<G08LM3:++8RE!?92X4@F+6@W4%>.OI3O7R)8O
M-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O
M7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7F
MNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWK
MY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S7
M7TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\
MB6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKK
MZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1
M+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(EB\UU]
M*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E.]?(E
MB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q>:Z^E
M.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G>OD2Q
M>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O-=?2G
M>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S77TIWKY$L7FNOI3O7R)8O
M-=?2G>OD2Q>:Z^E.]?(EB\UU]*=Z^1+%YKKZ4[U\B6+S7678!F>1R<DBVNVX
M_/B/RX<**XVJ>9H=32(TTE2?R""-VXCC0_6YI_EN[^XW-6/XIM_N9O\ JO2C
M]LR;_I7V$Z:_Y\M_N25]A+=_F[%?^IM:<_[ZO[?L'EW['']V,:/W!_9]@\T_
MRY=?<R]8_P#$UM]RM_\ 8[/O\OX?_P"*Y_6YI_EN[^XW-6/XIM_N9OZR1>;R
M^W%M\1M3TB0\K:VTVGM4H^ #3=KMN865V6\H(;;\K2DJ4>P5505/VSJA[?Z?
MI1^V9-_TK^C9GYS=HEHC2%J;9<F.;$K6D;BE/ U('$Z7 P?(;9=I;:=ZF(LA
M*G D=I"#11 \- :>'ZV7>9F[R>%'=DN[!56QE!6K:/": T'JZ8ZUSI2[=B;\
M<2B_,;*7&T*<+8"VV]YW%0H G=74:\VEY,B#,9;D1WD5VN-.)"D*%:&A!!X_
M4M.$WRXM1K[?=_O;$6%E<CE^-M(!2.P@;B*G@/K+=<LG3)4S=+E'M3'DS8<(
M?D5V%0*DT0*<3Q(]0Z4TOQDDI-/5']%TU_SY;_<DK^E;MN<W^WVB6\V'FV9;
MNQ:FR2 H"AX$@@?<TY/P>\0;O'9(2ZJ&^EPH)[-R1WDU\!(H?!K(.G5M3(%V
MQH1C.+C82R?*15'*6%$J_P!ZJ4T^W_00,2OEUB1;Y=5AN#!<<_+OJ5V!*!4B
MO@*MH/@/]+;O\W8K_P!3:TY_WU?V_P!(PWG=[@V=<I*EL)F.["XE!HHIX'@"
M:$Z=."WRWW<L"KJ8<A*UH'JE'!5/MTI]O4WI*RF1[^V^W,W1Y2FP(Y8>5M2$
MKW5*ZGB-H'VS]?0<2=*QJ]Y=:8]S0OEK9+Q7L7V;5+0E2$D>&JA3PZ1)C+0Z
MRZE+C;C:@I"T*%4J2H5!!'$$<#_29=^QQ_=C&C]P?V?TC,O.KO#M#$E2D,+F
M.; XI(JH)X&M :G3D/!\@MMVDM)WK9B2$K<"?"=AHH@>$@&GAU$Z2.ID>_LV
MVNW5I0;!CAAI12H*7NJ%U!H-I'V_Z!6/97E5KA7-LA+D=3JEK;4? OEI6$'[
M2B"/#IFZVB0U+@R4!UB0PL.-N(5V*2I-01_29I_ERZ^YEZQ_XFMON5OZQZXW
M!Q+,6.VMYYU?!*&T J4H_: !)U'R;&YC,VT2FR\Q+:5^26V*U4"JE *&I-*4
M-=*OF%W%BZ6Y+SD<R(Q*F^:W3>D$@5(J.(X>H?K*#1B.9E94O!104JDT(4#0
MCB*=O^C3<V"ZV_&>0'&G65I6VM)[%)4DD$'U0?Z1C"GYS*+_ "HZYC$$D\YQ
MALT6XD4IM![>-?M:DY#D,EN';(39>DR7B0AIL=JE4!-/N#4>\6EY$B#+:0_'
M?;-4.-K%4K2?4(XCZL;(,I$@Q)4^-;F_)FPXOG25;45!4FB1^,:\/4.BA7:#
M0_4VU&X=HJ*C_1V_8[/O\OX?_P"*Y_6YI_EN[^XW-6/XIM_N9OZS-/B25_8-
M0KGG\"SLM'%D.F668Z)7E7)/)4AQ(#BG2YMX5->.[A76*]0<@C"=<FTPHSC<
MQ2PKR1]]24*.WO%:60-@/:-M>&KKU)ZJ8_%QSIRQ;7+E#<,@NW,(2H<I,AFN
MT+>2:@"FTE(.D]3L9PFRC&W6%3(ULEW!T75^*!N#@"1L"E([R4TXCL!X57_,
M"RT^JTML%1A\.>)06&O)B>S=S"!N[-IW4\&H&<91B^,M6FYR(L=+:9\E3L)4
MO\UY40*4-0%*17:>!&L.LMTQ]FYW?(V9")<*W/+<4F:VE(:9BK( 6A;BP"M8
MX(J::N%SRW$;?)RQ$IEJWVVUW <AQIT=YQ]YPG8&3X].)'B^KJRR.M5@LB<6
MOEP:MGEMDEO.NPGW^#?,2Z %IKVD4J :&H%<:PZU6%=^<R%$U*&(RR)*I#-$
MLH;_ ! A2C5Q:O%0"H=FHF*=9<1C.OWR.XNQ)QF2J4MZ6D@)B++G"M2 I8\7
MQJ*3JP8-UNQVUVV%E:W&+7+M,Q<@,2D 'R>05<">(!*:<2"FHK];TH_;,F_Z
M5_1]*8L]MIZ,YEFUQMY*5MJ24-U"DJJDI/A!X:P:3TZBP8'4561Q40$VAMII
M]<;=^5YB& *M@TH5#PJ'B[M/]%L&QQJ]7>5;8\NV*YJFT!YU2BZN4KQ41VFT
ME51WB:"O'5CC9;88TOJ=D$URW6^QVZ36,ZZE5>:7C4I:2BBE^$$TX<2++:^O
M%DL\>Q9#-%NC76QR7G$19:Q^3:D(> JE78%I^V?!34+HWTIL\>\YI*BJGR3.
M?+$*!$!H''EI!42HC@D?:[2H#6763JQC\6URX=EEN1[A;))D09B5QW I*-W?
M0X@BJDGP$'[L#*Y5MB7AJ!8N:JWST[XS]993M=3QJ.-?NC6%Y1%LR)<:_/PX
MST&*%;VFW8P="(B$T"E@D(;2KN]FK/>NK^)VVW8;>YS-O"H$Y4B=;G'^#?E(
M("%'_:">'!0!J #@6%/V:WSG[TJX!NY2$;I,'DHJ3&53AO\ QN(TST;Z/V:+
M>,K\B%QN#]P?4Q!M\97B%TH!4I:ZB@'J@<2>%\1U"Q-#5]M+2782;3+2[%NV
MY)(1'6Y0MN!0HL+X)J#ISJ;F^(V#]UHO*7/A0;B\[/BLK4$E964\M:DU%0*@
M'MX<1@UU@**XLO++)(9410EMU)6DD> T(KI[_P""+_M/]%TU_P ^6_W)*_I;
M'#OL:++BG#Y*BU,:;=;*DN+VG:X"FH\'#6)1ND[46+.=M4TY0Q; A# C@'EE
MY#7<2H]WA0&NP^-KJ99.FMC1>;Y<A;-KLQ_R>!#:9:!4[)< *N)4$MH2-RU5
M]35\Z4=4;5&L^86%MB4M4)Y3T.3%>H$NM%7>%*BHXU!\!!&ILG"L0L<6V0WG
M41VKQ<'#-G(;) 6E#(V-!RE4!1KQ%=2^OEQ@/1FK:W(1-MJ5!3B9<=8;4RA9
M [JEE-%$<$GB*C5IO&98]C[6,7AMMY1M]P=5,@LNM[VUK#@V/#L"@@U%>&KE
MTNZ&6>!<)UA;:5>KK=WG&H45UT51'0EH%;CI'C> <?4)U>^F74>TLV7-L?0R
M^^S%>+T25%?IRY$=:@%4)("DFM*]O: I*%%*BD@*':DD4"A]L=HUTEDV<R9U
M[N>3N.7.[W%Y3\V:M*6]I<6> 2FIVH2 E/\ 2V[_ #=BO_4VM.?]]7]O])TJ
M@W=AB3#<BW8.-2D(<:4 %$;DN I/'B*CMUTS'2UB%#S!Z:\+HS:T-MI5;-HJ
M9*&J( IO'$ E/;V)U?8^!60WV^W'&+?&BLN/!B,R H+6_*=XE#2$CP#<I1"1
MQ.IG1CK%9X-KR5N +I!DVM];T27&K15-_>2I/^NB@0#2LZW].,7LK%IAO%IB
M7?)ZTNSZ =YEID$-MJ/!*EFOJZOG4'+;<NTS\5=FQKY;VE<WEO0T[E!I1IN"
MQP%>Q5:DCCJRYV[C6/IPV^<EU##-Q=]\8\1U5 ^HK2&G%)'>4V./@''AH]'>
MC%IB7?)H\-,^YR[D\MF#;V'/S07RP5K=<X$('@([>-)G1WJ[:8MIRV/!3<X;
MUN>6]"GQ-VU2VRX M*T'QDGU#V$<2GP$$'[A%#J_PIEAM</'8MLE.N'R='-Y
MA0>6L/*!=+I=*=JMU=U/!K&(V0A:9"VI#S*7"2I,5UY2F!Q[!M-0/4(_I,N_
M8X_NQC1^X/[/Z3I+$N+33T9S)'4N-OI2MM22ANH6E8*2#X0>&NG\CIK%@P>H
MJ\B81%1:6VFGEPZ_E"ZAD ; : %0["L>+75BG8G9W;]=Y&*RXD*"RL-(4XZ^
MX MUP\&V4 %3B_ D<-1.D'6VRVVWS[S$>FV>=9Y*WXSW)J5LKW\0H 'CPX@5
M%% ZDV+IACEH%KBI;(NU]FK0B4M20I26&&05!*3W2I=./VM9);\]MB;'DN'R
MEQKQ%CN%]G:EM3@=94>)"DI5P/AI0T/"'U-Q#%["O"I[ZDQHC]Q<1<UQD.\M
M3Q53DI6 "KEGU*>I6W=).E5I9OF:7&,Y/6)CQ8AP82#MY\A205$J/!*$]O\
MI U&Z/\ 6VT0+=>;G#=G6>X6E]QV',2S^=:*70%H<2.-/#_I!(6@T4""#]L:
MO.*Y#[Q,S'0^[/M28PD3I+TE)716Y*EE;FX%)*P$U!&VFH%KRME<5Z5*E3XT
M5Q86IB+(4"TDD$@$T*Z#LW<>-?Z3-/\ +EU]S+UC_P 36WW*W]9D?Q/</<Z]
M8I_+'T^E*A1&[4).979O@N-"6^JD1@'BIQZH"B. !"2:;M1O>BW*5!AEBUV:
MTQ*!R3)>-&F@H_C*-5.+()[3Q) U&S7K-C%F;PYZ2Q'G*L\QYV7;/*#M0MT.
M#8X$J-%[3V\ >S5OZ076)'39;Y:%3[/<T+7S'Y#7%QE23W:4!*:<?%KVZQKH
M[CT-B6[=(DFY75]U:@J'#9J$J0$\"I:@0-W#L]71_P"ZK^PZE3,[MUF?C&\7
M9,M^XL1RH,)<%=SK@WI2!6E%"GXNLXRG'T*EXY9KI=I6.-R5*#;D9E)5M"O&
M#952M/QMWAKJS99;\7@6_ )*4HN$^7*4F25I02^]%:)XQVUC:DJ!*@"?N3+_
M -"L;LZL1BR78L:??YCC#EP6R:+4PVV*(17@"H_=-:@7BXY%!78;YC#ST>_6
M]Q7,\F6RE2RMM7 K0I*5;:\:BE3P)E=<<3Q2RC"FV7I<:--FO>^;T-I1!D%*
M &Q4 JV UIV5\-KZU9-:[6I^Y3X:1'@R'7F/>^4:I=2HA*^<$A56SP"A0ZN6
M29;B,>!8%P%S;)#8EA5T>6#5J/(0H[$..H[U> 030Z?ZGY7A^/IQJ$A#\ZWQ
M;DZY<([!4 I97MY:E)J-P34 _:U:>J%CB)N4"YS;<V&W-P7Y-,07"I"4]KH2
M*)2>&[@=0,\ZHX?$MW3VX2D1E)CRU/W>$EVI:5(;X-\Q0'%L>&J-P534+J5F
M^&PX/3J9+9CK1Y8I5XBLR%4:?D-@<M)4./+XT\4D$UT%-J"D* 4E0[""*@_Z
M1K%_\H7'](K69_%#O_B3K$L[BQ&IG+@V&*XTZ5 !I]"4N*3LH2M*02D=A/;I
M75>Z8/"9P%I2''HCDY1O3,-Q0"9#K:1RT*(()1QV5 5X3JQ7?#(1R"]Y:ZPQ
MCT *Y8D*>0E86XH5*4(2I.ZG'<:5 !.K)B?5_'8$02<BM<F)=;+*5(B;VG>_
M'?"QN0Y0U01W5@&FHL'I=8(]ZGS'74O2)\L18<)" "%.D K65DT2E \!KJ%T
M?ZV6>VPI]Y@OS;1<;.^XY'?,>I<:6ET;DD 'CX#X"% ZRN9:\=L#N5+L<!$N
M"[<W4PVXJ5)Y+C;M*J6KAN33NU.K?T@Z76>-=\YE0!<IQEOK:M]NC=G,=6D%
M:RI=0A( )%*\54TGHUUEM$&VY%+@KN-JF6M];L*<RV:.I < 6AQ%":'U/!P)
MR!CHE9+&_8\8N"K7(>O4QYE^9);%5I:2T"&D5X)4OM_U"+,N\7R*>ZPVN3%#
M@=##JD@K;#B>"PDU 4.WM^Q6??Y?P_\ \5S^MS3_ "W=_<;FK'\4V_W,W]9F
MBNREDE?^S6*YS<\=8FWB5;(LMUR6\\\TIY2:E?)6LMCCX-M/M:76@ O5G [
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M=H0H\2!P.FLDR;'[7<+LSMY<N5$;<=&SQ:J([U/!NK34T08$5E-R=4_.2AE
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M7M54;DGB#X#IRS9+#CW"WNE*G(\IM+K2R@[DDI54$@BH]0Z"4B@   '8 .
M^YIVUW>.S+A/IVNQY#:76ECU%(4"#][2KKAN.VNUS5 @R(L5"'0#VT70E/\
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M-0'I:Q7E,UVCQW>XE23<LPO2Y=RBX[:WYDA:BA4F0F*T5J)("$;U[? $IJ>
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MX[0>.H;M.8J9\KWD_P#3E,OR'G+\FY_OJ4<WE5V<S;W=]-U.%::Z[_YKRO\
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MGHM2Z%,Q<1Y,<@]A#I3L-?NZ;ZC&*3CCL]=L$M*T*"9:&PYREI!W()0:I*@
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M:'U#HP[K&?B2  HM2&EM+ /8=JP#0^ TX_49G/L/-QI&XL/+;4EMW::*Y:B
M%T/;M)IX?KK7?;W#<C6^],+DVYY>W;(:0K:I2:$F@/#B >PTH=)A6R.]*D*J
M4M,-J=6:"IHE )-!V\-+FW"TW&/&;%5NO0WVVTBM*J4I  X^J=-7!^.\B(^5
M):?6TM+3A3VA"R-JB/" 333DUEEU<9DI#KJ4*+;97P2%J VI*O!4BO@TZK'[
M;-N"6?SIAQ77PC_O%M*MO^G1AP8[S\@!1+332UN (XJJA(*AMH=W#AX=!*!N
M)(  XDD]@'JZ]Y3#D^^.[9Y+R'.?NI6G*IOK3C2G9I)O,&7""S1)DQW602?
M"M(KI:+-"E35-@%8BL./%(/85;$JI7P5TEZ\V^9#;6K:A<F,ZRE2J5H"M(!-
M/ -5/ #2;_)MLYNUKIMF+BO)CFO91TI"./W=<=)<;LET4A0"DJ$"000>((.S
MB".S2%WJ!,A)<)"#*CNLA1':$E:4U(\--)M=@AR9\U:5*2Q$96\Z4H&Y1"$
MJ(2!4FG <3JA[1I+2!5:U!*0/"2: ?Z3J1B>80W(%XB;.?&=*2I&](6FI22.
M*2#P/A^S5F^+HGZ%/UDO*LIELP+1 94_)DOJ"6VVTCB2?[!VD\!4G2L9PB=*
M5<_)#<&F9EOEPR_$"DHY[)D--AQ&Y215)KQ[*:OV7WS/'LGLUNO-U5+O-T95
M$$0,K 7&HOM0R>"5#@O=W !M2(MM<O$^/(GE'D27[+<T&4APT2XS6/WD$_C=
MGA-!J=C.;WQN'=[?'BR'(?)><?<3+6I#*6&T(4IY:BDU0T%J2.\L)3QU+O\
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MR*E2Q3QR=7>P=%,SE7K*[/$D3A%G6Y,6-<F8PJ\8;@<4H$#BD.#O#[55!#B
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M+KR'5.2H+%Q?9<25-C8M:>4I5"D+IWJ<%<.W4:ZQ TZ]$?:D(0ZD.-J4TL+
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M$A,93ZR&F$[20$MM)31->Z2H:GX7ET83+-<XZXLN.5K1S&EBBD[FU)6G[J5
MCP'43'K.T&+?!CM18[()(0TT@(0FJB20$@#B2?5T_>'\72VF4]Y0_#CS9K$)
MQVH.XQ6GDL^#Q0@)_P!W3."=0+.Q.LL8MJBL@K95'4VG:A3+C10MLI3W>XH=
MWNFJ>&K7?\-QYB)=K.J8N+.+K[DDKFH"'U/.K6I3REI% 72O8.#>W3.;=0<?
M;F7EI"&EOH??CE]M'BH?2RXA+R10"C@5P&WQ>&KM"P^T1X,2^252[A';!++K
MBFDLG\DHE"$%M"4\M"4MT_%XFK6>8UB[+-UC/F5%"Y$EV/&>)KS&8[CBF6U
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MZ7$N$@1BU1$0H H&A,.W:3Q[:>'ZDW"<2LLN7@O5@XZO(I[#3JF(2K-+W/\
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M"$E%$I4JA(*N\:4HFEVZ:]65C_U)PR6(-V)2A!E,N#?%F)0F@"7FB.P#B-U
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M-2$/LJ0X$DBI3NVD\2-28W2^R,VU<PA4J05N/R7R"2.8^\I;B@"20DJV@DT
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MH2K;XJ3M-5'@/Z";U&SMYR/9+?R>>XTTIU0YSJ6D40@$GO+'9]W27FS5"P%
M_:/$:*U=@%3J+U"P5UUZS3%OMM+>:4TLJ8=4RNJ%<1WD&GJ_5IH]%><[^](L
M_OYRN4KE^2<_D;N9XN[?PV]M./\ 0=0_B'$?TET^MS;_ "U>/<;NL:^)K?[G
M1_5>D7[5DG_2E?82R_M+OZ!?V$MGQG%_M/V$F?<;_2)^PF7_ !!=/<KFK%\5
MPOT"?K,FZBX\VP]<K-;7Y<=N2E2FBXA-1O"%)44^J I-?5&I'7SJ[;K)8>E7
MO"[=FH32I#EY;2TTEU#KE:,D/)"U);!WI"FDD[MVC_,D];L43AB8B;RK&BY)
M]]A:2D+YAEE89\HY9YFSE;=O=IS.[K"<*Z#0X=RR_J!'5/MKEU4XB'#MZ& ^
MN5)#7?5W2 E"5 DA7$D!*\KS7^96%99-ML,1J5;[CC[CC29RW5%L1EQY!4MI
MWF<L;P2V0X*<4JT.O>867%'\789;GW#'(BI:;G&@KH21*6HLJ>;0=S@V;."M
MH/9KII;^B]GB9"SU#C3GHK4IU3"N[%:>CN<P$I0V@.%Q_NK44)*445QTK^7_
M "6PXU>,TO-O3<['=+>Y)C6N.P%E$A<U#JEOE+)' -T6Y5*>U>Y.2]!^M\:U
MC*+%%BW.+/LH>1%F0I)VUY;RE*0M"J)/&AJ:#N[E7;.^GECQ:%$QZ7=&GG+B
MJ4LW0Q'5E+,1IM8Y6UH!"W'7*..GN!"0JB_YE>GN-X_;L'MT$SG[?=GGWKA<
M&X]?+'&%,E+;+:-JPUS-SB]A64T4E!PB=TMMK-QRWJ.8R+!$G.EJ.TEYA+[C
M\E2:*+;"% K2COJ) 3K'^E?7C]W[C"R]$M-HN^/I?9#4R(V'7(TAEY;E0I)_
M)N)4.- I/$[<YZ4=)K5CT5O%;HTP+Y=U2"PAAR.%(9+#2BMV0M>Y6\%#3;8H
MI*E%-<PZA]7+<U R'I_-N%KOD6 I19>E0@D@QBY4A+Q4E*0I2J*[32FK_G'4
M"R8VK$,@LQ<5;K:](;N=K9D;%,/.K=*FGPE)'.0@(4"H*30)4D83;.A\6R&5
M)M,/RVX7UQ[D1&T16MNUABCCJW"33OI2C;WJA7#*N@&7,XROJ%;+*Q>K)<XR
M9:;7)9><Y5)+)47DE"Z [%\? .&Y5S7TX?PGWM_>2[\[WY;N:W_*2Z"]L++@
M3RBHU0#WNW=QU<NNV7V2TVE%JEW-#MMQ]CR2*](1,4P@-I4546^X4[EFIJHK
M(\&AUVSVS8I)Q9A#4RYX] 5+1<XD-PCB)+BBRMYI*@71LV<%;.&NG..=&+/#
MR%OJ!!N$F*F4ZM@CEL,O,/%P$A#*$.*<>&Q:U(3M;HKM1T%_F!C6-Z7=K0Y>
M+/<\?3(;84&5[7H[K<A2E;D\2E7 4 K4J[N6N]/UVYMU%IGJN"K@'C_R B.\
M_P G+)!$BE.45U;K7<-0.H765^QG!+3B<.=;3:T2S<>2TQN(E<Y1;4X4!"4A
MN@*R1V4U_P#7#6VRXFWBZH1O#6-.JFFZ+MH1S:F4"&@^IKOI2&]M*#;O[FK-
MU(QX*3 O,-J6VA?C-[QWD*\&Y"JI-.%1PU=>B7\NK%D9=QB+%D7^\7\2'66W
MI:2MB*PU'4E2EE'>4M2MH&Y- I(W6*TY9CEL>ZNY)>%6*U6^',4;;(6#^O;U
M?E6XX11:FUGFBH2HIJ2G&8/\Q#&-W+$\JN+5F1<<>1+9<M\]\'DI=1(4L.-+
M(H%#:H *4JE E62] >D=HL:Q;(%LFM7BZK?2S#0^@J>+[;2BM]:R0EA#?+"2
M%*<44]F==,;I$Q^)U;PN5&C!X^5*L\E$M'-8>*$GGI"FPJJ0JM=I[M2@,/=-
MWL)583<;H0+XW<W)1<\H47=Q86&]I57;PK3QJFNK3U[QC'++!GN7015VBVQE
ML0@A5U7&<Y+2%@A:TI)!*B.8K<0H=W6,Y5UBLN.LX)E%XC69<"VNR';E:G)I
M/DY>?40R^4T/.Y: FHHBE03&Z$)CQ?>)[$'+^I\I7Y3Y0F=Y.$A6[9R]O&FS
M=NX[J<-7WHK,9B-X_:\9B7EN0 L2.<Z^6UA:BK9L">P!((I4J->$[JUT3CXK
M#PIIZ4BSP;UY4JX75J&M2''2XTXAN.'2@AI)2JAXN'911LO52R-*CQ[O'YBF
M%J"BRZA:FW6RH4KL<2I(50;@ :"M-3(N)2,43>?W,=7;TSD7 P_>KWQ/+YZ6
MUA9F;_&4C\EM[!75EZ#=+K-:+E=+YC:K@F5,4\VQ#E)DE#DAXI54QFVT*HVE
M/-6XI "O >C^!]4;1C4[*K\UD7OA<HD=Q9BJAQPX@V]UZCC0=20'0H'=XHI3
M5R7TR9PZV6"&K;;TW@S),J>4H"BI184VVPA2B4I'>6*$GA35UZF2(7O=,EJA
M,2XH5O2W(C7=IEP(5X4E2-R:\0" 22*ZQ?H%TL79+;>+W:W;HNZ9 'EL<MI7
M+$>,RTILNR%$%125@!L5H? PGJPBV(R9"W42%6=3IAN)"R&UMA[\HG<BA4E1
M.U50"1J)9^B;..Q+>6%.S;K?E2'=J]U$LLQHY22JG>*UKV4X4J./47'.K]NA
M+R[IJ@/S/>,N^3SF'8JY3*F4/;EH6I*""DD]XC@.S5AZI7)[#7\%OB7'9$&V
MF69\!M2"6D<]2E-.O(5M1(04-[3NV]E-7;(H*4+DP($J4TERNPK9:4M(52AH
M2.-#V:B]?,0L&+0[)%M@G/V^<N4N;=/)TDRG(_+5LC-JVJ\G0XIQQ5-RC120
M>@?4VQMJ9AWG/;%*2RLA2FE*0Z%MJ(X$H6%))';2NEVSI WBULQYAAM7OA?3
M*DOR7UUJAMB.4!M"*44I:E%504#MIGW4"]VV!$SS '+U;IT=DNN0')MM9Y@6
MW4ASDKJ.[OW<#WA4:A?S-2<=QR/@C<6%,EV5QV0J[/1'M@7*0Z"&6MQ4'&VB
M%J0V>^5+%-=.H'2JRQK^<X>EM(BR7%1W#2*AQA27:E+:4J6%O%25_DTD) 4:
MZM/13^8*-CTA.4V^7.L]PQX2FT-O0T[WX[J))4I0".*5C;^+6I40C)<8Z _N
MY;+!B,PVJ9=,A$A]4RY(0%N,,-1W&^6VU7:XM94HDU0#0@95U8SZV(BY'A-P
ME6.[VR(]O:<N3+B&FTL.J%2T\IQ!"J** 5>/LJJ\2NL=JQQS'KVW;U/)LRY+
M4NS+,MEUL2 ^5H?2:!I?+(*755!+8KIC_P"!(_\ "-+_ .Z?[-01T5M>.,6:
MS.W9;;E[7(>D7=WRUYU2(R&"A+"$U+6YQ1*W1PVHJ=8]UGQNSJEY/E,UFQVR
MQ%W;NN[CJF5-*<(!Y:%(4K=M&Y.T=TJJ++E'\P,;%KGA-VN$:VSW\?3,9?M;
MLD[4.'RA2@\RD\%&@7]SA6ULX@]BJ;G^Z\\V43DSS'%O+ZJB6&UA1D%8[6Z-
M[0GA4:A1^G=NMMQS.=TT8BONRG7&K;"/OBI;LIQ(J\XT%)V(;20XHK350 4=
M9-T*ZWQ;8C*\?8BW!B?9@ZF),A2JA*MCQ4M"T*HE0)H23043N5]=U#^(<1_2
M73ZW-O\ +5X]QNZQKXFM_N=&O_K?,DMD>/ F1!(MEP2ZHK>)9Y@"D$4%2AU'
M ^,D=M=6&%C=N:NV09#<1"BQ'G2V"D4"E=T$D[UMI'_>KX*&9C-PM=M3TW;@
MI<8G(?09:G^6@FK?-W@<PK30LA.T!6^OC(M+LIA%P=25-1U.)#JP!VI17<1P
M\ U=LASQQAR;#O+\)HL,AH!I+3:P" :$@K/'MIVU[=*M$:?%<GHKNCH?0IT4
M[:H!W#[VK:C!6XSF17N>B#'5*[R&4E))<**BIK1(KW14DUI0X)@G4B]V*Z6_
M*+BAEQRW1N\6PZVVZA2BAL C?W2D=M:^II<%MYM4EL!2V@L%:0>PE/: =.18
M[S:WF2 XA*P5()[-P'$?Z=91>\6EQ59!9K7(F(9*D.*;4A%4J6U6M*T[>&L<
MZD]/H-LNV9W%P"6F8MN,SR4NNH*TI6ZRC=W$"G,':2 >P0F[X66+K(80IQA#
M@(YNP%Q+=3502:\1X..GA;9<>08ZBE[DNH7RU#P+VD[3]HZ,FSRF);*5%"EL
M.)<2%#M!*214>II4B&\VZTDE*EMK"D@I[02#2H\.O*XCS;K''\HA84GAV\1P
MX:<%FFQI?*-'/)WD.;3ZBMI-/]/U>D7[5DG_ $I7V$LO[2[^@7]A+9\9Q?[3
M]A)GW&_TB?L)E_Q!=/<KFK%\5POT"?K,UL>/1'Y]RE6:4VQ%BMJ=>=64\$H0
M@%2E'P  D^#2.DTC=;[I<<0CVW_F$E)8DF$E #B>T;7!18[>WPZ@89U2Z!W^
M5U$ML9J'-;@8^J4Q-?:2$&0U+2YR5-N4WJ65 ))5XP2">G7\P6"XO-N..8[:
MI-CN]AM+*'9D2%(:3RE,,H-%\E7!:4&E$CB$DJ&:8!BN*7K'HJHL-VTS,A:3
M <GS&) D%I$==5I:_)(2'EE*5*<I0!!.IG0_'>G&51.HE]MRK+.3<+>8]LA%
MY'*D2%35_DU-;2HM$"J^' <*_P O=AL4*5/L^'PKQ GW!EE:F6=MJ;8;6\L"
MC?-4D[=U*G@..L9RYBWREV)C#+C%>GI968S;RI04EM3M-@60:A)-2.(% =95
METBW2T6*1A]MC,SU,K$9QY,DE3:'2-JE@"I2#4#B1Q&K]8<BMDR!<WKMD;C4
M64PMIU:775\M24* )"_Q3V*[14:>P29:9S.2KQ&]QDVQR.XB67G1(Y;?)4 O
M>K<FB:5-1PUT4S&X8H_DO[BV^&B^XLMO_FGHLB$RW("&5T*WF5-)(:X**N'@
M.K8]TRZ.WJR3V$O/&^7&PJM\>"M+:NZ7'EU4ZHG8$MI52M:T!.NL-VO=NEPX
M-SO\%Z"_(96VW);3%HI;*E !Q()H2FH!X=M1KK_T]>@2+?.R3,+K*LZIK:V&
MY0 9>86A:@ IIQ: GF"J>WCP.KET5L'3/*T9HW8Q"O'E<$L0XXBI2EU<=TFL
MI;NW_EV64E2]V[Q4][I2SF]ER"[]*(=L#646>QH?5(\J$1M,8RV&"EYQEM==
MR4F@(.X5*4JO>9X7@5UPK Y^(MLP!<(RF>>ZB:C<M:"I99<6$DI960YRTI<*
M$A>KS_+WF.*Y#'N2LBO-P:O'D!-H5%=/,:<\KW;:N4VI2 H[B :'<$WSI2B%
M(M>5.W>Y3X46>TJ.I:V+H9+22'0*!T(HA1HGO)57;QU-Z(8KTZRJ%G^00O>F
MX>^=O5%MD#F@(D/+F+[BFMNXM%(W+%#0&@/02UV*%+G6+$;/>[;,N#;*U,L[
M;8TPTIY8!2V75([H41N/ 5UA&61;=+<L<3&;PQ(GH968[3KBQL0MT#:E2OQ4
MDU/@K0ZRS"[* JX7:QW*#&22 "Z_&6V@5- *J(%2=3OY99>.9!C.0VO%&;.[
M*O=O5%AN3$-EM"67%&KB=S84HI3W4*![33371%73;+3U49LPL :][@+87TL>
M3IEF<5<CR>@"R:TW=RNW\IK&NF<UU+\NTP&VI#B/$+ZB7'=O^Z%J4$GPBFLT
MS:\8S?<AP;/6[;+CR[!!,YV).AL\A;+[2"%)2L&J5=GB@5._;@7\RN/X5<XU
MPPN_RYAQF2I NDFTR$AI3H9%=D@I2"(Y*E)J>*B!7$,$PW%,BL>+6>_0L@OU
MVR&WJMZ$HA;E(B,)<)4ZZM1VJ*!1'=-2DDCJ+E4VW2V;).L=A:BSG&5ICO.-
M((6AMTC:I23XP!)3X:5&NLN17:W2HUJNLC'# EO,J0S)#,!2'"RLBB]BC16T
MG:>!XZD?RTYCBF11+S;Y]XD*NJX!%I<96Z7&U(E[MJBX%40$A52#QU8\$./W
M7]Y6K\AURV>1O>5H;]_7'-ZF=N\)V$+W4IL.[Q>.L1BXO;I=R?C9Q8);[<1E
M;RFV&G%[W5A )2A%1N4>ZGM) U8OYA%8]=\@Q*1B\C&YIL<4RY,-XRO*6W%L
MI(44+X)KV#CQW;4JRKJ1E^)W7&<>O>&1H=O-P;HZ6O*: /E.Y#4E0"EJC[E+
M:1MW\=.=+/Y@>CMXR#*+7)E(BWJT6)RY,7>,IU2V%H=:50.;"$EM>W: G<02
M4IM,7&L=<Q.W%DNM65YM#;L7F+4LI<0VI20LDE2AN)!5QXUU;>O3V-7[(<8F
MX:[CZCC\!4YYF6B89"0MM)!"5IH$DT%3V\#3'LZ;M<Y%B&!2H[LQ;"N2U(7-
MWAAQP50EW::[-U?"*@5UT>R>UVZ5)L]J1DXGS&F5*8C<^$A+7-6!M1O4*)W$
M;CP%=9NW_,GT^RG.[Y+NJCAWD;,A^U>]BP$QV6G$NHCQE)X&0XY3;Q6HUW;K
MGTS.-W)O*A<G-MH1'<7)VIOB7.X@#<M(0"H+ (4@;P2GCJ'@76SIQD&3V0PD
MR8=UM%M<FAB024+9#D927XSW=0000EP'QN[IN%U/3<FG#<9J[1'O*PNXL6I2
MQY*U*-2>:D5JE1JD%*>%-HL]PZQ8]D.4]'!9%-QX-B:DR66[SSRHN38T8I6L
M%JB6RJJ HB@\>G5S,;)T]NU@L,V/9IUAL+Z4(>D--17R6T*4M;8?6>\MHN$L
MK<#:Z'6*Y;_+-@^68,\N<I[-!<+<[:K6N"4'<RZPXHLJD;CW RG@3OXTW)R2
MO_Q&N'N=>K+TOA=/<DN.23[&Y%L$JVQDRK9+;D[T-/.R4JHP6R3SFW %)"0J
MNU8*>@?3J'!D7&;C>8VB7=UPFUOMQ@><](<6I((2TA;A3S%43V=E0-7ZX?S%
MX?E&9X0[ @##H]EC2IL%EQ#=)2'6&%H2F2XZ3M4[^+X0D)(ZX8DK$9]AEW6X
MY Y:+&4*><Y,BWM!AIA2-P? _-A396%+24I)(.OW(A6N:]D0PVUQ3;6V%KE<
MYME@+;Y*05[TE)JFF[@12NOY?YL.U378]E<E>^;C;"U(A[K8V@>4* HW50*1
MNIWAM[>&NE&46ZW2W[-;8.2IFS6V5JCQU/14I;#K@&U!6K@@*(*CXM:'6;)Z
M\=,KCF%DR2]OWVR7^VVM=TV(EG>Y#?2T=[2D.$[*COU4>RA.28MT/P>5@TR7
M-;N$"U7**W"DRGH3K3B5N-;U;"\ELMH#I!! *MJ375SZ<X3TTRQF\N,PG+X;
MA;UQT1E,2&UK;B@U7+<4XD;4MIX-$N+VTVZP'I6Q:7+E/S%V4RI;;X0J$S#9
M0MQY;>U16D;N/%  "CN)HDK2GB2DT'^C4+IUF/3/+)%X*K@_8C MZI#<E4B4
MZM+<L I7$6EQ1J%IXLT=16M-8!+LT--RS[#,E;S&;9VU)K(+KSCCT5M7%/,0
MA:1P)"BE>S<2BMJZ*8-AN46:W2[I!F9#=,AMJK>S!B17 ZMI',)YKY4  E'W
M]I44XGU]_=R]Y#C+6.S[))%@A&;(9D+=4ZV5-)((2O=M"C05\/@U'ZE*L]PB
MX_)Z:-1_*9$=2$-2EW+F^3.+%4!]*#53>XD=O9QUF&6R;=+;L<G%+5'8GK96
M(SCR'B5-H=(VJ6D<2D&H\(XCZ_J'\0XC^DNGUN;?Y:O'N-W6-?$UO]SHUA?\
MP]A03-QRYM,2"FE5-*7SF@K_ '=R%H_^BZMTR H2,;P:SLSDJ!!0J1(0EUL^
M$;MSR#P\+)X\-9&Z 5;<90K:.TT8BF@UF75KJA,FJREVZN-19+$E;3D%26TN
MI=0 :=TJ"4)55"4MT2!VC*YN,2G&9T[+/>]4MI1#B&W8[)<4E0-05A)34&O>
MX&O'5LZMX6Y(B9A;VK9--T1*=W27)*FPJ@W%*:%>YLH"2-HJH\:]+NKM^C+&
M3Y*W;(ER=YBP'&E,)60$5VI)4M1JD \==#<%P]E4>SP+J^([2W%.%(=FL.*[
MZR5'O*/:==0_BCS'7\PF66(TN$"$^['6..QT*6$J_P#</>_T:G]=94N8<T=B
MW&X.3D2E\>6ZXVJ.X@JVJ2X$G>3WRI7C4[IP_P",&OTTK71[&(\Z3;C<HWD2
MY4190\VV^6FW-BAV$H4I-?M\01PU:.A^'3KE:\3R6SAVYL1Y2][S38>6MA2R
M:E#A825 UIN52G"F7=*<'=?:QA['U2O)''%+ 7RV7$\5$DE!6L)4>]M402>W
M6<E1H!.N=232G_PN9U,Q;INI1NKUUD+6PEWEJDL(=27&0HD#O#C0D!5-I[=)
MQ2/B5QPCJ9%M2XDF)*=?4U,:!0M:AS37?5',%4)[M=JU@</J=(OVK)/^E*^P
MEE_:7?T"_L);/C.+_:?L),^XW^D3]A,O^(+I[E<U8OBN%^@3]E;ACDA:FFKA
M$?B+6BFY*7FR@D5X5 -175FZ96R2[,BV:*F*W(>2E*W "3503P';X/Z)_JXZ
MAU_(G;<W:FG'G"IN/%2X7%(81V(+BR"X>)5M3V 4_INH?Q#B/Z2Z?6YM_EJ\
M>XW=8U\36_W.C5TZ=WM99CW%H(#R4A2FG$*"VW$@TJ4J2#2HKV5XZND6%<5W
M:;=76ENRG& R0VRDA#82%+X J4:UXU[.&I_\P2;FXI^=;4V\V\L@)1M2VG?S
M=U3P;'=V^'MU=IF&9A=K%A]_=YETL<(;0\DDE327@L (.Y21N;44H)350.K_
M -%[O,?N-EOEP<GI<V):>BDI0&N6JJZJ;Y8.X\%<04[21J!AN>=0;O=\%MCB
M5QK,&0R-J."$%SF+X)!VBB.ZDD(V>#&[,S/-GBXW-:E,-LL!U*D-I"0T 5IV
M@   \:>H=8=U&?N;D-S$I2I*(Z60X)%7&U[2HJ24<6P*T5P/9K_UAP+*Y^)W
MV0RAB<N&WO+J4H#=4*2XV4$H2E*@=R3M"J UKE#C$^3=+/E$%$"1#FI"EA!2
M0\I;P-5J=*E*\5&VOAX:F85,SJ\O8*ZXZ_'LJ4\M"7U#\FMU0<*7 A5%$!#>
M]0![IU:/Y?'+ZZTU:GT/BXB*DJ<*5NK(+/,  /-('?-*#MUA.>N75R,O#"DH
MCA@+$G:4*%5;ALXHX\%:LO7U=S<:?L\!<$6\,I*'-R7D[N9N!33G'AM-:#B-
M3_Y@??-:WIUM3;C;RP E-$MIW\W=4U#?B[/#VZND6V9A=XF!WA\OS<?C5:#H
MJ2&U/!=%(36G%K<4=TJKWM-](\6RVXVZ;&N2KG'N\-L-.)655#:V@L[VZ<%)
M*Z*\/#AISK#U(R>5EF6B*8<:0['1&;8:(H:-H4JIH2!Q"1N4=I4=P^ITJR:]
M%28$:7D =4A.XCF6Q24]WM/$^#7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O
M:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K
M*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK
M7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?
MK$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM6V6U(D[(SSBU_\NKL
M4TI(_P!9U^L2O:R]?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM
M?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^
ML2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ
M*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$KVLK7ZQ*]K*U^L2O:RM?K$K
MVLK7ZQ*]K*U^L2O:RM?K$KVLK4+D2)/Y":P^JL=7BH)KK]8E>UEZ_6)7M96O
MUB5[65K]8E>UE:_6)7M96OUB5[65K]8E>UE:_6)7M96OUB5[65K]8E>UE:_6
M)7M96OUB5[65K]8E>UE:_6)7M96OUB5[65K]8E>UE:_6)7M96OUB5[65K]8E
M>UE:_6)7M96OUB5[65K]8E>UE:_6)7M96OUB5[65K]8E>UE:_6)7M96OUB5[
M65K]8E>UE:_6)7M96OUB5[65K]8E>UE:_6)7M96OUB5[65K]8E>UE:_6)7M9
M6E8Y9WI"ILQ;;;06PI(*MX/$GLX#["9?\073W*YJQ?%<+] GZR_]1%1O+!8[
M9+N/DX7LYOD[2G-FZBMN[;2M#3U#JT9?9^E-M59+Q'BS&'SE#"5>3R$I6E90
MID*!V*KM/'P4KPUC5CF6!Z[6J[MRI5QEL/%+D*+&6TAQT-!M?,VAS<05(X"E
M>-0OJY9HC=ZCEVW(CMI?Y3;K<Z0VTEP.!*^ 2YO'#O=E16NK-T<Z7X]^\N<W
MN*]<$L/3$0HL6&RK:I]]Y25DU55*4)34T/$':%7YWJQB'[N7.R(YC19G(F1)
M[9;4O>P\E*5)H4[5I6G<FJ3X:"Q=5'X(MKEX8<>,1+O.#90ZMN@64HW5V5\4
M=NL_PEVVB(WA,Z-#2^'MYE!Y@NE13M3LH4TI55?5U_ZXVWI2F9@83)>7(AW]
ME4M,>*ZMMYQ,9;*5+*-BNZ*%5*CAH_S-8;"5>;8\Q">BQ77/)E*\JD(8VN*V
MN;5-J40H *[R2 :=[5NA97TQMULL<A]M,R<WDK#ZX[*O&<#0:!64C\4&I[.'
M;]1KJ%A2)3=K>D28R4S&TMN[H[A;4=J5+%"14=[L[0#PT$J4 5&@!/:?M:O[
M74:Q1[+%B71UBS.,2T23-@I'<D+"2>6I7A0K:H?[/"JE-)4DK33<D$5%>RHU
M;.BC/D_[N2\1D7IRK9Y_E+<SDBBZT"-OXNWM\.@T5#>14)KQ('AI]3)H&&2;
M+;,$PN^,V69%EQ7GIDXI2%2EI=2M*6B ?R7=4#PWZX:7G&%^3FY)N=MB#REL
MN-\N3)0VON@IX[2:&O#6*]'H?D_[OWBQ7*XRMS9+W.C* 1M76@3ZHH:ZJ-<-
M%QU02@<25&@'^G51Q!TE"E *7XH)XFGJ>KKCH["#0D&AK0CP:4AM25*0:* (
M)!^WZFHW1!(C_NV[ACE]4>6>?Y4F=R!W]U-FS\7;V\:ZS*3E@CA=BS*\6*)Y
M.V4#R6&I ;WU4JJ^\:JX5]319"@5I )37B >RHT7'5!*1VDF@UE'1R6(_O!:
M+#;KE&*6R'^=(60O<O=0IIV#:*>KJ==NE-F9O^4-!OR2W2)*(K;M7$A=75E*
M1M05* *DU(I7CIAVX-I9E+;0IUI*MP0LI!4D*\(!X5\.B6U!0!(-#7B.T:N6
M2*;YPM\.1++05MW\EM2]M:&E:4K0TU<1=[(O';[;1%D*AJ?YZ7H<Q!7'D-K*
M&R4JVJ![O=(''C00KC;[2;]?KFY(\EMZ7PP.1#85(E2%KVKHAEM-31-25#5D
MSE#!BIO-MAW$,%6\M^4LI=V;J"NW=2M!7U!K>RI*TU(JD@BH[>S51JHU=K?T
MIZ9.7BSV56Q<^Y7-J 9RP@+4F$R4+4XD T#A(2I54@52=+Z].!RTVB$Q*<N;
M,GBN(Y#!+R"0!OH!5! !6"GNA1VAGKM=^FBV>E;O+D&0FZMJNK=O=4 B8J(&
M]NT@A7+#E0DU*MG?U8QT.Q)W,7;]&,YJ:J6B#;H\;:A2''I"TJ)4X' 6VDIW
M*2%'AMU?^CG4S&UXMGN.M-27XB929<=^*[MVO,O)2GAWDU%#XP[U=R4Y$.E7
M32%=;)8;]<+#Y7(R%F*MQV"L)4KE+9J*@@]I'&E334"XY=;T6J]/QVUS(*'T
MR4QWB.\V'D@)6$GAN H?ZMU#^(<1_273ZW-O\M7CW&[K&OB:W^YT?U7I[^VW
M?W%_5@I)!!["/JU0016G#ZVIX :"DFH/81_0D U([?M?7=XTJ:?U:J"".SA]
MB+7^U-_83+_B"Z>Y7-6+XKA?H$_69_7L_=F[>Y5ZZ?SW<CQI6%>\]H682;7(
M$SR'R=!#?.YVSFA% 5[ G=QVTX:Z8XKD#*9-JN=@RV'+87XKC+L0)6D_:(.L
MS_E*SJ07+IA-WL4BQR'E#?.L4FZ,F.M/^TI@GEKIP15*!XAU9^KO2;(%8QU(
MQYEV-$F+:#T63&<)4J-);(-4%1)"@%;=RNXH[2C-.BG6NS1[1U#QFV+D/KMZ
MU.09T5]I01(C[B5I!-*I43XP[%;D(PDMJ"@(<@&AKQ$MX$?=!UUY6.*??R *
MCLJ(:ZBOJCPZC7?$DV%/3&EQ9FR(K3[V01H#LYY$MY#;BT1%%%5[:&H1M5P(
M4I)Q_IK(5*QAF'8E6^2LA2GFG9S#@>60 *N%6]0"1Q)  [-1)74K(L:N&-AE
M8>CVZUR(\A2BW^3*7%O+2 %4*JIXBHX>";@^:1?++)<6PU*C\QQK>D*"@-[2
MD+'$ ]U0U;NL3-MIEXE7>%Y=Y1(/Y#R@HV<HN<KQ4I%=F[AVUKH]7.H3\^[7
M2R95<U8^RY-D-L6SR>:75%IMM:4K4\Z2ITN!04-J:"A*NOTC.;O(L]B1F]^3
M+N+$A3+T9CDMI4IEP54E8'!&T%6[:$@F@UAG4G^77"<QQ2Y#)K4VC))\>2S#
MN4*4YM<0ZN1(6XZF0"%)*VDE8\(2:&Q?_,[F?]2U,5_./CUV9RV=DJI=HZA)
M?DN6]U*G]T-H2&7 (>T=SDK0$; 2NB1PDV2Z-\V%,9<COM[E)W-NI*5IJD@B
MH)%001X#KJ)?H%HY<[$<QE0;*YY7*5Y,P(X3LVETI<X+4*NA:N/;V:?<<6M2
MO?3(3N4HD_K;OA/'MX_=UB+CRU+6;M"XJ))X7QP#B?4U@33@"D*Q*]@@]A!6
M*ZZP]+KTZ2OI](>NN/!TD\R#=QN@M@JKN"9"@A9XT4Y2FL>Q:\%Q5Z=CFX71
M;JBI:ILU1D/[B>TI6LH_]VO;QUD>!]1L4R7-\1PVVVT0K%9 TJ+Y7-;#ZY<M
MM<B/O4$JY;7%:0 H[0>.NIV/1<=R#&^EZK<)F-PL@6DOPWE17$RV&=K[Y#.\
M!:$[Z)[>"E*JWUARV5=+AFL+&9L^T7)R<^E5K$ .KCLPVT+2AMM);&[@5+*E
M*W#N[>@US<N\FWY#D.1XPV]=(RBEYMZ5#=0M]/JKJHK%>&[CPU;.G70MV;C[
MO47+K/8KG<TS7W9*1)"@](2X\M6QUQ+=%J1M'>) '#3'7[H*Q(L&5XQ/MZW'
M6YLA?OFP](0RZQ*2XM:70YOW'A7@1V<-6Y_:4[^F+BMI[16Z@T.NNN=8FXIF
M\1^H5_8BOIIN97*E1H_-36HW(#A4G_> U!O?0CIEU"MW5Z"J',C93-+)5-?Y
MB%23.6)[G,:?1OJCE[:E(VI1N&KQTYZQLO2,3PO';;)9L7E#C49V?<$AQQ]S
ME*27"VD\M/>H"!]O=G.%6.9.E6B-BUI,%$^0N0Y%CJ=JF,AQ9*RTUQ#842I*
M*))52IS-QE2D*#,'BDD'C/8!XCU1KHC@INEPM<.ZP<A;F/6Z0IA];"(;#CC0
M<'%(=">6I0[P2H[2#QU8L%Z0H>M>+95C,Y^XVKRAYZ.9,)8Y;Z0ZI:@X11)-
M>S=_M*KDOQ-</<Z]=!_Y@&R4V>^V=K!\@5Q"4HD.*<@.KIP[CH(4M0X)"4UX
MBG7#K(YWL?PW%+OA5B)-4JD^3J<N;R12@4%E+(4"=R.'@IKI[#ZV2KDFR2;9
MC[3-LM+LA,FZR%04I;A!N,0Z\EPFI;"D@J2DE0IK'\-Z8X?D>#8KE./79B\V
M:^-N1V9I9;WMO--&0]1:1W5*!04@T JI1/5#I+-><<R7IQ/>M-E*JK<<8O"O
M_A2L"FX]YPD)\"4@ T'#'.G;RBN7;X#8F+))WRG:NR%5))H75KIQ[*::@V%A
M5TSV_*5 QNS,44]*EK% LI\#+1(6ZM5$@=VH*AK(\"??$F^F&F;=7T<4KDRI
MC2Y 2:"J4I.P&G>2G=05IJ_$D>]AP63R]NVFSWM/+IX/4I_JUB&:]1)C=OM5
MNQ>WOR'WB0$MAA/+ !XJ4H%*4(2"I:B$H!) UE/\VN=PW+7(S!N/#L-M>H'8
M]FCA/*6\*<'']J'-M> X]BA3)[QT4ZAP&XUVO=QR)NR7"PM+:6_+5O4TN7S2
MZD&@3N2D=E:"IU9^I\Z(F!/F!YF9';)+:9$=U33A;)).Q13N2"20#M))%3_5
M>H?Q#B/Z2Z?6YM_EJ\>XW=8U\36_W.C5FZ2=)8#5RSV_E!92_P!YN.VXLMH4
M4A2:J6H*IN4$(2DK74<-6MGJH[9+]C%P6MN:N D-O0?R:E)7XC.X;P$F@<[?
M!XVE8Y><LMC5P;66G$)=+B6U@T*5K0%(00>!"E"GAIJ/E73N[O0GI-SA!N;;
MW]I<8<;<7W7$'BE5$FH-"/M:A93U!NL>W1%QV-S\IP)WN*;!HD=JE'B=J03V
M\-7S).BF:VNVR(G)2N[/*/+B%3J:AU)0I;9<35*"6R:GNCPC%I75/*+?*N%U
MCL,MW-"MC,YY:0=S5$IJ"".]M2/"0FM-6RQ9/<X\&?>7N1;V7E[5/N52-J!X
M3521]T@>'5TM^09! B2;*AI=P;=="5,AX M@CPJ5442FJC4<..OW_P#WGMWO
M#SS&\HYAKS@-W*Y=.9OV][;MW;>]2G'3.3X9/8N5K?J$2(Z]R24FA2?"% ]J
M2 1X1_1=/?VV[^XM$CU-8\Q<<59N:KC9HUPE2?+'FG=RQ1>VA(KPJ.P>#AI.
M/8*AV9%F6Y-VBM.J3S4,%)4M*B2*E-.'XRJ@<3VP'+];W&%70TB-@I6ZM7 [
M"V@E25]X=TBO'U:Z<NTRTJY+* X\VV\RX\V@BNY;2%%8%.)X&FG48U%YZ(Z0
MMYY3B&F6P>S>XX4I!/@%:GU--W')H'DT9UU++:P\RX%K4*IVA"R2#X%4I]O5
MPO-TMBV(5K-)3BW&P!0 DH&ZJP-PJ4U [/ =-W>#:U%EYLNLMK=:;?=; KN;
M96H+4*<1PX^"NE6;'HBY$MM*ENI)#:6DH-%%Q2RE* #P.X]O#4;'[C"49\T)
M5%;86A\/A1H"VILJ"N/#MX>'7OID<5,>*7.0IUM]E[END5"%AM2BE5/ ?OZ:
M@6+'6[4^S9VISD5J0A9=92*JD5)%5*KX@JOAQJ=*@8^SY0^EAR2H;DH"6FQ5
M2BI1   ^^> TY<<=A\R$VH(5)>=;89WG\0+=4D%7$<!4CPTTY9<@C.1)S--[
M3E*T/8H$$A23X% D'5\N.>Q/*X%OC1U@;U)+?-=V*6-I'$#CQ]35RQF5N/D;
MR@VH]JV5=YM7^E!'^FNIZY,7=F-NCVZ5,D%:ZM+G.DAG;P2-K8%13PUU$R24
MSLML]QUJ,]N2=ZVO'&T'<*>J0 ?!JR7BXL;+?=9#:HKA4E0=2AY*5\ 21QX4
M4!4?:UD-OA6%B\--LO*3!+B6&VPEAM1>![*H[=O:2>''2)^.079S"Y"886T4
MUYI1S*$$C:D)XE9HD>$Z1^\\,QT24++#R'$.M+('$)<;)&X>$=OAU:(ELCI2
MIZR6VC;#8!6XL*'!*1Q4HT'JG3EYN5L*8[" X^EMYIQUE!%=SK2%%:13MX</
M#30VD"I W'L%32I^T-,83.Q9%UCHC,N/7)^4\V_)+B:J7'*:( 2>%!PJ*<.W
M0LV+1'I4AY:RRRFA6&P>!6HD)&T4W*) K]W5A&5P0W$E7*,VAQ+C;[+AYHW(
M*D%0K2M4GP5U>L>QJ(I^2NY/H8C1T#L%":#@$I XDFB1X=)N=_A!$);G*Y[+
MS3[:7/\ 86IM2MJOM&E?!J+)L5M4]'FLK?8=+C:&RA"]A*E*4 DE7!*3WE=H
M%..I+6/P5.IAJ*)+KBT-,M+!H4J<60G=]H$G2;9D\-R*^XG>UQ"T.I[*MK02
ME?$CL-?M:<OUWM_)B,MI=>27V2\TA? *<9"BM(/VQP\--8ZZBR(A*DH?V3VW
M.8Y<2%A-2V.*2D\ #Q->'#3E]O5OY,1D-J?H^RMQD.>*76TJ*T5)IQ'W::1&
MC"KSJDMMCU5+.U/^LZLO3:.A)M=G][[6X$5'-6ZI*Y"E'MJHKI_9I_I6_BXA
M(7.7;F+C#F.\U#GXBRVJJ2">!!K3MH=95;^H49-QA8^RH*(4I [C_+4X-JAQ
MV\>WAQU<<;<)+,5TJ86>)6PL;VU?;[IH?M@ZN+\V+OS"# @W&1(+BJL>6OT;
M9VUV\&QQ!%>-?4UCUWN&/M7Z3?6%2GI<MYU##7$48:#? + /:>/ GCV"-[W0
M3&QZ[+-N<A2%AXMM2D!!&\U)VN4*3VA/ ^'4[')!W.0)+L8J]4-J(!_TBA_T
M_5;L3CQC0D-.2ID@"I:CM"JB*\-QJ *]E:^#1MS6(*-E_-IFIF.B>4]G.XG;
MN([VPFG@/J:3'N25KL,%$F?,W<"8D<%0"Z$4*NZDT([30Z@WK$FN3C]\@,SX
M3=2>74 .-U-35*J&E>%=8]DD=@)N4V=/:D/ FJT-$[ 16G#[0UE#UW8#R[?8
MWI<4DD<MY)X+%"*D?;J-6N!,3OCR)L9IU!X;D+<2E0X>J#JZXE-@H=LD15P+
M<0K6$T9;W(%0=U ?MZN-HM-B_=Z]1(#MPBR(TIQYESDTW-NH<X &HXC[_"A<
MZ@9'9&+O,7>1 2'WW&@EM3(6*%!IP-?!QKVZLT*RV-BT1%S&6)*(\AQT/I<=
M2""5>+05'#CQ^YI[I0[BJ8J5SEV]J?#FO!Y"P*ASEJJDCAQ!K0<:'4^P\T/&
M%*>C<U/8OEK*=W^FGW]6W![MB<4N.LN!V=Y4^5K4RT5E114"JB.(KPKH8Q@6
M*1[==$N.N\UB6XM2VF$J*TT<(3Q KZM0 .W5AEY'81,8NC^V-;WWVVS).PJY
M;G$\HT.[OCP<?4U/@8Q;"%L/.J>92XE+45.]0"%.K(2 FA2#7CMX:2C)HACI
MD-K4P\AQ#K3FT<=CB"02/".W4%J&TVRA5EMRREM(2"I2%5) \)\)^Q%K_:F_
ML)E_Q!=/<KFK%\5POT"?K+]T[=D&&B^6R7;C(".86A(:4WOVU3NV[JTJ*^J-
M6K$+'U@BMV:T1XT..Q^Z,,D1XZ4H2@K5(*CW$TW&JO#6O'6(=:!<>0,6B76*
M8/(W>4>7MAL*YN\;-E":;%;O5&K)>C<UV.^69T)\K;8YXD1"XEQ4=Q&]NH"T
MA:%5.Q6[NG=P3FG1[J [CI7&;C2;3/@-W&WN<M2B'6T+4E3+AW46I!._:FO9
MJ^=0<ZOK^5YYD@91<KJ^PB,T&&!1MB/'05):;2.T5.X@'AV:GV7^7/J*,=PV
MX2793=HN-H9N0M[CQW+\D<6M)"*^*VH;1VJ*E%2C,QRWS)-SNMVE/W"[W>;0
MR9LR1X[JZ< / E X)':5**E*B]!KS-%\@MM7"/)?+'(2\U.>=<6DM[W*#:Z4
M^,:]O"M-/_RL7+*E/-)>3Y#=5P05LQVIB93+2VN:-^W;LW;T\*4  IJW3\GZ
ML1;I98TAI<N C%8D<R64GO-!Y+RE-[APWI%4]OVOJ2+/9\P3+Z:>4SI<2PKM
MC27VG):]X2J9O*BEM52*)3NKQ '#3^%*N/OH7KI/N7/Y'(IY6\7 C;O7XH--
MU>/;0=FNI> Y'=G9,#J+?)EY4MED-+A*?Y:FT"JUAPMN-A52$A0[I2..K+C?
M5+J2)L#&YUNF6]B#9FXR'U0G =\S\JI3BRV"A 0I"$*/,4'"*:@=?/?':F%C
MCU@][N17<7)//YW.W\*>+LV'U=P[-?\ IKU6ZCIO'3M<QJ3)CILS+%SDLLO!
MUN.Y*2YL 24IJZEH+5MXCCH-H%$I  'J :S7(#<?+OWOOSM[#?(Y7DP<0E/*
MKO5OI3QJ)_[NKOA&%=0I5IZ5WN?)GR+1'@->^# E&KT>-.*B6FUD^.$;TC@G
MO%2S:/Y:!D !M<QF5[Y^15"PU/5+V<GF\."ME>8>(W4/BZQ_KD+CRA8[3.M9
M@<C=S3*4"'.;O&W;_L[#7U1KIYB5N==\K-N7<<HCMKVLNVNWR0_$2^$FJM\@
M*0 H<*I(I0'ZB>MW17)OW6S!V$FW7),B&F=!N$=L[FP\R5(*7$'@'$JW;0$T
M'$F_VWJQF*<BFWI@L,>3VQF#&@(4TM!#3:%*6X5%6Y2G'"3M2 $\:C^795U\
MH4+'-LYN0C[.,I#B>9R=Y\7F>+OXT\85UTQZ=JOFP].KK9;F9(B5\M][&E(*
M-G,_)<S=6NYS;ZBM/X%D+[\-7.:F0IT16U^)+8.YI]L^JDU!'A25 %)HH6B%
M_,1GR<EQ6R2V9K=J@6INWB?(CFK2YKB7%E24GB6D@(4>-0173'\P/OC0,XPO
M'?>[D=I5+\IYW.W\*>+LV?;W>#6==,<PFJN]HSF^W:\O[&O)UL)N!04MH.YR
MJV2@*2YP!4 =@'#4/#&.K#?[M0.4TS(_=^.NZ*C-$ ,J><=4WNV#;SBVI9\8
MBNH_7'HMDXQ;+S ]ZKD)$),Z'.B!6Y <:*T%+C9XI6#4@)3PXDWGJYD.63,F
MO.06N-$N#DV.AI2I+3A4IQH-G8TSMVH:82FC24^.O5ZZ3HG^]:KNAA F%GGA
MODR&WJ\O>C=793QAVUU@'5,7,LC!V+HSY)R-WE?E\9+%>9O'+V;=WBKW=G#M
MUCW7'WQY0L5JG6PP.1NYWE9!"^;O&W;_ +.PU]4:N6-EWD^^$.1$YNW=LYS:
MD;MM16E:TJ*^KIC^6*[7,/*C6UN(Q=1'VEN2ROFM2$M<RHV+ .T.5*:C<*ZE
M?RV6NX[5S;1-@2+LJ/53DF:E?.DJ:WU-5K)VERNT!._A76#XICN0KM65=/\
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MXPTS[)(VN&T7)@E+B7>(+.X5&^M4T"DDFNVNK?9<7;6PQ(>MTI$59*EQUO.
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MX:4KX=(N>2R?*7VVPRW1"&T-M@U"4(0$I K]K4^VVU[EQKFR(\M.U)YC:3N
MJ02GCX10ZGXS;9):METV>6,A*3S-G9Q(JGAP.TC<.!U.QR&]LMUR4TJ4UM2>
M8635'>(J*'U"*^'3UOQN8&XCZPZIEYIMYL.#\=*7 0E7 <1VT%0::AB_S7):
MK>XX['6Z$E:5N+#BB54JKO 4!X "@H.&I68IETO$UMQI]_EH[R'$A"AMIM%4
M@#@.%.&I<+'KCY'?_?J.^RTD@K6P&@E9*5 I4CP*!J-,_O1*Y[4=)2RRVVEI
MEL*[2E" !4^$]O@[-1KO<I2E38;3+,=YL!M3:&/S>TH XI_VNWU=+CO7!L+=
M;Y+DA$1A,A:"*$%T(W=GA%#]O25,DH4@@H*30I*>((/@(\&C#-UHHM\HR$QV
M1)V^IS@G=_I[?MZ3?L<E.19Z=P+@HK>%&J@L*J%@GB0H'CQ[=0Y5VF@^][R9
M,5IEEMIIMY)J'-B0 I7VU5\(\.EYM%F+9OCKJWER6PE)4I?C52!MVGPIIM^U
MIZR724RF#)*52&X\5ECG%)J.8I"0I7'C2M/M:@6*>]O@VM+B(;>U(Y8=5N7Q
M JJI_P!HFG@T_$QZ4$1))W/1GFD/,J5_M;%@@*X#B*5\.F<CO,YQVX1BDQG$
MA* QL(*>4A("4T(!X#CX:Z>L]VFH\EDD&2&([3"GZ?\ QU3:05#U1V'PZM,5
M$M2$6-2E6XH2E*F"M6\D$"JN/^U7U.S3EFN\QL0WU!<AN/':8YZ@:@NEM(*^
M/&AX5\&JMG:L4*5#P*'$'_0=6WJ!87PFZ/Q8KLUK;QCSHU$U((H0JB5#MKX=
M2+W=7.;-ENJ>><VA.Y:NTT30#[@&IT.UO<IFY1_)92=J5;VJUVU()3Q\(H=7
M#'[5)4S;[JA*)C0"3S$I[.)%4\#0[2*C@>&I^/PGMEON@:$QK:D\P-*W(XD5
M%#ZA%?#IFTP;D%1XR=D<OQVGG&D@4 0M:2H #@*UH-,9IG4Q:TPR[<%N.E2W
M)$AM/Y)L$ \2JE*T2 GP:DWFXFLJ8\Y(=/\ ON**C]ZM/JMRHKBVGVE!;;C:
MBE:%)-0I*AQ!!["-& J\* *.67D,,I?V_P#P4)W _;''[>H-HN;Y=AVU"VXC
M>T#8'%;EDD"JE*/$J54GU=2_>-\,B?&7#D@H2L.,K[4D*! ^T1Q&D8_C5P$>
MWMJ4M#2H[+E"LU5WEH4>)^WI[,F;B$WB1'1$=>\G9HIE!W)3LV;.!\-*_;U&
M8OUP2\B'):F, 1V&]KS7%"JH0":5[#P/A&I&9QI6V\RN=SG^6@[N<-J^X1M%
M1Z@X>#02GL&G+3C$U,>&ZZ7E-J89=&\@ D<Q*B. '9J#<[_+2])MKG-B*2PR
MWRU;DJK1"4A7%(/>K_K.G,FF/%5S=D"4IY("3S00H* 2 !0@< *:?O\ >W [
M/DJ"G7$H2@*(2$UVI  X =@TUD&//>3W!@+#;FQ*Z!:2E7=4"#4'PC0R"PO<
MBX)#J0[L2O@Z"%\% CB"?!P\&H]\L[G)G1'.:RYM"MJZ$5HH$'M/ C4NY664
M$.7 J,MMQM#K3Q4HJ.]M0*3Q)I0"E2.S7O1DDTR80>#Z&>6A"$*".6 @) VI
M">Q([M>/;QTW/OKW/D-,-1D*VI31IH40FB0!PKV]I\/V(M?[4W]A,O\ B"Z>
MY7-6+XKA?H$_5AX7CL4WG-;JE2H-J:6$4;3P5)DN4(8CH/C+(*E'NMH6JH$<
M7TLJN/*1Y28P4EGFT[_+"R5;:UVU-:=NG,,R',(;=U9<++R66I$AIIP&A2X^
MRVMI!!X*"EC:>"J:C9!CLMB=;)C27H\F,XEQIUM0JE2%I)"@?5!U=6.G%X9N
MKEDE>1W -)<3R7>-!^42G<#M51:=R%4-%&FH/3.;.2C)KE$?G1(90X2XPP0E
MQ>\)*!0GL4H*/&@-#21F^?SD6VQQ%-)>DN)6M*"ZXEM HVE2C5:@. \/'AH+
M0:I(!!^T=7R[8_=&I,/&YDNWW9P)<2(TB&G<^A6Y(KL!J2FJ3X"=-66T9K \
MK?4E#8DMR(J"I1H!S'VFT"I]56H4WJO>6K.S<5N-Q2XT\Z7%- %= RA9&T*%
M20!Q&G\7Z6Y"W=KI&C&6ZRB-*:*64K2@JW/-(2:*4D4!KQ[-3,-OV818UW@2
M'(DEI<>44MO-**5I+@:+?=(()"J5\.HV18S,8N%KF-AV/*BN)=:=0>Q2%I)!
M'W#J/$G2667Y2RW';<<2E3JP*E* 2"H@<:"II]2+D74*88,"9.8MK#B677MT
MB1NV)HTE1 (2HE1%!3B?J3LDN 6J+;XKTMU+8!64,H*U!() )H.'$<=6CJ3C
MK3[-MO,5$IAN4E*7DI57@L(4M((IX%$?;_HY/2?%[#D-W][YR;9<KU!@!RV0
MI:DE1:?>*PH;*46H(*4$BIXU^I"R7*&93\:==(5I;3$0A:P],7L0I06M V#M
M402:=@)X:A]#'691OLVS.WQMY*$>3!AI[DE*E;]^\JX@!!33M4#0?T6)]-;L
MS*<N>8.SFH#C*$*9;,)D/.%Y14"D%) 3M2KCVT''ZBY4I:6V6TE:UK(2E*4B
MI))X  <23INX6YYN1%>2%MNM+"T+2>(4E2:@@^ CZL+H<\U*-^G6=Z]MNI0C
MR8,-/<DI4O=N"RKB $%-!Q4#0'ZS%\9OK,IV5EMS]ZH2HZ$*0V]L*]SI4M)"
M.%*I"C7P4J?JLVI^2RB;(2M;+"G$AQQ*/'*$$[E!-14@</#]8)5WDLQ65+0V
M%ON);25K-$I!40*J/ #M)[-0KWU!FF%#N%PCVN,L,N.E<F1NV(HVE1 (2HE1
M&T4XGL^I<\PNB7%PK3"DSWTM %PMQVU.+"02 5$)- 2./AU9^HEB;>9MUZA,
MSF&Y*4I=2AY(4 L)4I(4 >-%*'J$_P!%U#^(<1_273ZW-O\ +5X]QNZQKXFM
M_N=&O?;*;A%ML'>EOGS'T,-[UFB4[W"!4GL%>.@M!!214$<00?Z-ZZ75]N-#
MCH4Z\\\L(;;0D54I2E$!( XDDT&F\FASXKMG=0'&YJ'T*CJ030*#H.P@G@#7
MMT;AB\UJ8R"0KEFBDD+4CO(512:J0H"H%:$BH^NZ<VFT,N29KTR\EMEI)4M6
MR 5*H!Q- *G7P#<?:SGX-? -Q]K.?@U\ W'VLY^#7P#<?:SGX-? -Q]K.?@U
M\ W'VLY^#7P#<?:SGX-? -Q]K.?@U\ W'VLY^#7P#<?:SGX-? -Q]K.?@U\
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M8+X]'C*\G>8D!WFEE#AW-E6U)K6J36G#73/&\;=91!R?(5VZY)<:"U+8#!4
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M0XE(!W52>VH']FNK.19#!<BVV^WN!(MKZRDID--Q=JE)H2:!1IQ XZZ],YC
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MU.U))C,1<'>SK'YJW6+Q"C*CK>;9V50I,611$@*6-JD;@4^-Q[-=4HUOL4K
M\#S.%Y'8L>GO)6Y&><B.,R):F4+<3'#BU@\H*KW:4"4HU)_E<@]-Y4>_6VQO
M6B7=94MCWO>BL-E*3#*%%;TA]*0A"*)0A:MZU[1371%SIS9&YF0XB[!E38LQ
MY+3+*HUN2E3;SB2=NY22V%)"@%D$\-8/,R/"[AAN(8/<C?)[UW=94[*N#2:,
M,QDM+5O;2KB7>"5)KXI"4K=QV+T?N-JZK,3&TVK+FI45$2(VS(&R5[XM+0\I
M/*&[D*;*DE1"1O2#KIMUTQJQ2\N8QF+=+?=XMN4TF63,CI;2\VVXI(4-VXJ
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ML'>!))UT,NG6"'*R[&W,2<O%VL\6$]<E(DKB,)%REPVTK+K 4X4[E)4$J*J
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MCQPXD^!2.9N!\!%=6#%+-#CE$FV1G[@X6TE4N1(:"WG'B15>Y2C3=6B:)'=
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MX+;NUDU0E*TD[D@;3V4VI2!FW4*-CMN7D%@S3(X]ME^3(Y[##"$I0RTNFY*
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MW8,AC<]Y;X ;C?E$H)J.)2 :FO'AJ1A^)O,WAYGFJ;?CK2EMYMI(4M:"I5*
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MA9NR0FL5]UQI0*TA205%) J"*>KIVPY+',:8T K;4*2M"O%6A0X*2? 1X>!
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M)L=J2VEY!0XE+J L!:3Q2H \0>P\/J2<PM\%VWMQKI.MA:><2XHJAN\LKJD
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M)4OO_E5@;*BHX5UB>$98RF/>;7:8T66REQ+@0ZA-%)WH)2JGJI)'J$ZN/3_
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MS35I$**F0A3035*PO=VD]G9]>Y$O8E7?(&V!+5:;6WSGVHY4$\^0K@AAJJ@
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M0&G X^MRI0EQ7Y-/XBDJ%.I,J]SKVBXXW+F6^R7^8R_;[A-MZ7&E1I"]Z6G
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M/*:4IV.XN2VVXZ8[B=J5*3N*34]W8!KJ'\0XC^DNGUN;?Y:O'N-W6-?$UO\
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MOQ;R>WW!*YL9:*I6^I:%);62#^<Y-!VH%*F5?+JX&84-AR0^X02$-M)*UJH
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MJ&MZX)@(MO,++326R@1.6A"TJ0BO,2JAH-M N5*6EIEI)6M:R$I2E(J22>
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M _+;+B L-2T32GFHK4!0W*VJ\%:CCK*/>M(;=E=.XC[@2  Z^B<&T+7X"H)
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MMX;!51XU2E/0;.L%,"T0;U:[G,M"+_&=D06;@Y'31M;;#C57DIHEA6X=_:I
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M.!Z:AF7*8CRG$G<%OL-.(:6K=Q55/?-2O=4ZM]OS>RM.^] ";:_%<<B/Q$@
M!++L=3:T(  [@.S@.[P&KO\ ^F]L6Q/NS0\ME/RGY<F2IM"@V%O2''%4&XT2
M"$\>S6+'KGB:HV81&I#=P9\H>C*?2F:\XRF4B.XE#U$%)25[E;:)KMX:>Z99
M#;([^+/QD0U6\)V,AENG+0@(V[-FU.PI(*"D%-"!IW%^F\-R' ??,ET.R7Y*
MU.%"6ZE;ZUJH$H2D)!V@#@.W4;JO(A!651+<Y:F9G-<&V(XYS5-\L*Y9JOCN
M*2H<0#0ZN[V'0A#7?;F_>+B0XXOG3)  <=[ZE;=VT=U.U(\"1J59L&A"##FS
MI-R?;#CCFZ3)5N=75Q2B-Q_%!"1V) &ABG4VUM7.WH<#S04I;;C+H% XTZV4
MN-JH:52H5' U!IJ:ST[M0BO7(I,Z4^\[*DR-@(2''GU+64BIHFH2*FB>)T_,
M5CJVHDE[RAZW1[C.8MZW:@[C%:>2T!P'="0CP;::Q[*[I;T+N>*%\V9Q*W&Q
M&\H:#+@"$*"% H 2 M*@FE4T/'60Y?;[:V+KE:8Z;RXM2W$RDQFBRVE3:U*0
M &R4D)2D*KWJG4N&YC//A2D/-IBOSICK$8/J"G#%;4\4QUJ(\=H)6D=U*DI)
M&H^)=1;2W/@0U)<B'>XT]'6D4"F7FU)<0: 5HJBJ#<#J7 Z:VL03/<2[-D./
M.R)$A: 0DNO/*6XK;4[4[MJ=RMH%3H8IU,MC=R@-NID,U6MIUEU/8XTZVI+B
M%4-*I4*BH-02-6O)<2L*&+W:%S'8]P6^^[*4Y-;#;ZGG7%J4\5)%$\TK#?'E
MA%3K*>=:&G4YJ4F_H=<=6F64-<I-4J60BB>SE[./>\;CIO,L1M#IO,9I3$23
M.FRIRHK2AM*(_E+K@:!!()316TE.ZA(T<YR>TN-9 XV&7YUNFRH#S[8  2\8
MSC?,X "J@5!("0: #3O1)BP1OW*>W<RWK4ZL*4I>\N%U:RZ7-P"@YOW@@$*%
M!J!?;58E.W>URV9L.?+FRY,EI;"5(:2EUUU2@T@*-&:\HFBB@J (EYEDUE=7
M/N3B';@ABX3(\>8M  27V&G4-+/ 5[O>_&W:9Z=9M9(LS'HH:$6*$EH1N4C8
MV6%-%"V2A/=26U)(35/BDC2LPP^VOF_J85%\OG3I<UY+*B"6T&0ZL(3P_$ )
M\)/]%U#^(<1_273ZW-O\M7CW&[K&OB:W^YT?U7IM?+(\J/.8EWOE.I[4[X&U
M7 \#4$CB-?#<G[R/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y'
MK=?#<G[R/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y'K=?#<G[
MR/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y'K=?#<G[R/6Z^&Y
M/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y'K=?#<G[R/6Z^&Y/WD>MU\
M-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y'K=?#<G[R/6Z^&Y/WD>MU\-R?O(];
MKX;D_>1ZW7PW)^\CUNFGW;S(*V5%2#1' D4/XOJ:^&Y/WD>MU\-R?O(];KX;
MD_>1ZW7PW)^\CUNOAN3]Y'K=?#<G[R/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7
MPW)^\CUNOAN3]Y'K=?#<G[R/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CU
MNOAN3]Y'K=?#<G[R/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y
M'K=?#<G[R/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y'K=?#<G
M[R/6Z^&Y/WD>MU\-R?O(];KX;D_>1ZW7PW)^\CUNOAN3]Y'K=6>VW>[/OQE3
MFBIM010D5IV)U^?5_J_!K\^K_5^#7Y]7^K\&OSZO]7X-?GU?ZOP:_/J_U?@U
M^?5_J_!K\^K_ %?@U^?5_J_!K\^K_5^#7Y]7^K\&OSZO]7X-?GU?ZOP:_/J_
MU?@U^?5_J_!K\^K_ %?@U^?5_J_!K\^K_5^#7Y]7^K\&OSZO]7X-?GU?ZOP:
M_/J_U?@U^?5_J_!K\^K_ %?@U^?5_J_!K\^K_5^#7Y]7^K\&OSZO]7X-?GU?
MZOP:_/J_U?@U^?5_J_!K\^K_ %?@U^?5_J_!K\^K_5^#7Y]7^K\&GX\ETK;5
MLJ#3_;3]A,O^(+I[E<U8OBN%^@3_ -CNH?Q#B/Z2Z?6YM_EJ\>XW=8U\36_W
M.C5OP*^71B-D%U3NA0UD[W@24C;04XD$"I%2.&D83E.0P8-[7RZ1GG-JAS?$
MW&FU.[@1N(X$'L(TI]]24-H25*4H@!( J22>  &I%CP*_0[I.BMEUUJ.LE0;
M"@DK%0 I-2!5-1Q'JC4QW![FQ<D6]\QI19W?DW1^*:@??'#[>G>F35S85E#+
M DN0!NYJ6B H*[*=B@:5K0U^HYC.6Y-"BW1H[76!S'5-J_V7.4E80?M*(.D=
M1[E>(B,8<#91<$N;V5!Q6U.U2*UJKAP[#P/9J+C6.9/"EW.:X&H[".9N<614
M)%4@5-/5TB\=0+M%M45Q10V9"Z*<4.T-H%5K([3M!H.)T_<NG=U8ND>*L-OE
MK<DMJ4*@*2L)4*@&AI0T-.S^AZ=_MEX]Q#ZCAQ6V2)R&CM6XV$I;2K_9*UE*
M:_:K77O9D<)^#*IN#;Z-NY-:;DGB%"OA!(^I^_BBV+5Y:;?XWY3FA&_Q:>+3
MPU_T:CQ\@C&,Y*CHE,A2DJW-+\57=)I]P\1X1]8[(Q:VOSFF%!#JFM@"5$5
M.Y0XTX\-(:R>W2H!<X-J?;(2LCP)6*I)^U6NDY>J.19ER#$3(W)H7@*E.VN[
M_32GV_Z2NK;)N?+V76(F='Y:MQY2C0;N HK[7'[OU>;M5RR:!6T[:^I7LK]K
M4+,'BW[WSY#T5D!1+F]FN[<FE .'#B?]'UK=LL\=V7,=J&V6$%:U4[: > >$
M]@\.E72\6.6U$0-RW$A#@0GPE0;4HI \)(X:J/JA:DJ"%5VJ*2 :=M#V&GAI
M]5##0W..*2A*1VE2C0#_ $DZ=L&0L&-<&-I<:*DJH%#<GBDE)J#X#]3F;5;*
MTW;3MKZE>ROVOK M25!*O%)20%?<)X'_ $:@76ZQU,Q+HT7X;A4D\UL4J: D
MCM'!0!H:_5*SV 5U#CW<ME4Z&S.:Y2BH<IZNW=4"BN'$?Z]+M^,0G9TEM'-6
MAK;5**TJ=Q I7AVZ\MR2T2X<:H!>6W5L$]E5I*@*_;(U/O=MCEV#:T)<F.A2
M0&DK- :$@FM.Q(/J_76N\SN7Y->&%R8NQ55;$*VG>*"AJ?M_T-E_;6__ &_8
M1W_W/_&G["9?\073W*YJQ?%<+] GZLGI)T;?#";<H)R+(@E+C<"O_P"2Q0JJ
M')BO"5;FV!4K2M?<%UR]Y$BXQ\;M#\Q27GBI^0F(R5D+=74E:]O%1!XFM/!J
M+U/OW1N[)PV5#:N*9MKO,&>_Y(Z@.)=$0!MTC8=Q!VD#QMNH/4# IB9UEN#9
M6RZ 4J!!*5H6D\4K0H%*DGB"/K\]Z07!B*BS8O#LDB$ZVE8?6J>PIQWFJ*BD
M@$#;M2F@[2JO#Z^Q]$6&(IL5RQN9=WGE)7Y0'V7^6D)4%; BG:"@DG\84H?J
MPNB4A3_[RS[4[>&0&JL^3-N%L[G*\%;@:"G@[>RNLBA9OC@L<"W7)<:T2?+&
MY'OC$%:2-J.+5: [%<1NIVI/]+8N@?1!JS,WRX6F5?9EPOJ'W8[45ESE(;0V
MPI*BM;G DJ[J?!743]X>1[Z\AKROR7=R.?M',Y6_O;-U=N[O;:5X_6]2>GMX
M8BMV[#YUKCP'&4K#JT2XI=7SBI2DDA0[I2E/ T(/;_23^H.>2TPK+;FPMYT@
MJ422$H0A(XJ6M1"4I':3IO+<6Z+W%[%GDI=97,OD*)<7&2*[Q"6DJ2:<0A2]
MRO!6NL8ZG_N_<$#)+Q;;1[VW(>0RXBIKJFU*>0I*Z*;*3W/Q^%% &OU)W4&P
M=))\_";?)FLNW"'?(;CY3#<*'5)AJ0AU1%"=HK]HD"NK9U'PE]3]FNK/.94M
M.U:2"4K0M/&BT+"D*%2-P-"10EB[Y&B7+ESI AVVVVZ.J3-G2E)*DL1VD]JB
M$DU44H2/&4-2<V=L[EB=BW69:W(3KX?6E44I!*E!" "=W%-#M((W*[=7*[XE
M;O?B]1HCSL*W\Y+'E+Z$$H:YJ^ZC>J@W'@-6V\9C;/>:^28K3LVW!Y+_ ),\
MI-5-\Q'=7M/"H^OQRPY,7Q*RFYHM-OY+6]/E"TE0YAJ-J?!7CV]E*D?5ZA_$
M.(_I+I];FW^6KQ[C=UC7Q-;_ '.C73#]GC^Z7]=0K*A)5/A8HW=(03XQ?B1X
MR]@_[Z-Z?].K?<H#JG,IR!#>+E*">89 _)OJ]6JV4E7W74ZR+I]#HKWKQ:(T
MZL?COK:@N/*_TN+5K.OC[_YU6KS\0H]R1]-X_9\GLTJZ/.*:;BL7".X\M::U
M2E"5E14*&H KP.NI/3'J1C\'+;O<EO+BW5!9D%"G]P2)"E J:H5A:@FCB71M
MIQ2M*,<Q]\9'-GSHUP2+2%2D(#LE)+;>P$JY=/RE -KF\>"IL6,7KI](P[+%
MAA,&;<K<A@*D%/+20=V])6NH2LIVU\923J\N9CCERS)C'(3<2SV.#&\J27@A
MM2G'6SP"$J6XHDI7WMG#@*7RW8/C@Q3(H;C?OM;5Q&H[BBFJ$K/+"=VPU0=P
M2M!X%(!!/]!T[_;+Q[B&B$<%'@#]LZMO2^S.N1;/:;?'6IEE90EY]X%2W5[2
M-Q^[PJ2?#JV8;<+@\J-'0^I+KQ+ICQT@+=V5J36@"4DD5IX-3;#BEJOMJN+$
M9Z3!F7 J6S*Y(J4NH*$AHK'B[3_937- X_O0HT/[-X=6*-<Y,XVJ5:H4R8X7
M.>^@.)45)9YG "H 2GQ4UKJ\?NI;KO:KC:[>Y<67IKW.8D-M>,E7= 2HCLVG
M[=32A8Z@YZW,EHN,ER-;;?#=#)6&OSCKCA!( (( 'VNVO!+N&&6+>XTA:FIN
MTNLNFN]O<G@M(X%*OMT\&KZY'<6VOW]A#<VHI/B#PI(.KKTNR)]R99Y]MD/M
M(D++GD[[%"EQM2B2GMK0&E0#ZM8V9%U_RQR]+AEM3JO)P@-;MW*\4+KVK[:<
M-?NU<X%W?EN0T/,7I#Z1&>><;W -M$;2V%=U7>WCCV]NH><9= N5V<NKSK<&
M!;BIM(;9-%O/.I2HBJN" !Q^WQI8\GMIG1<>OB5*4U+0#+BJ96$O((--] 24
M$TW>'AQT_C.,V^^091C/OPKE*>2XTZIE.ZCJ G8D*'^R?M5U-ZAY!"G7<1IJ
M(7D%O=Y1:24!1?>6$J5LXT%!3U>WA+9L:YL7&841=PDEP)=EH:;2-S:-M0M:
MEDI0:'AQ()X:N\O$[3>;+<[1$,]*+BI3K4IA![X)4A.QT#B DD?=%2 0>!IQ
M^UZNH^(6J!?TF85,LWAQQ)2'0@J!6RE)0E!(I2M>P&G;K)Y.9RGXK5@;0KGQ
MAN/=>4A=$'QBH)VHKP!-3JX9M@S,^ _9I##,R-.>2\'6GS1#B5)[%5[0.':/
M4.K1.S]BY3[K>V#,2Q!>2RF+%)HE7>\=9[0#P[1PI4XC'L\A4J"BPH##ZT;%
M+;YG=*D^ T[1ZNKC=\D?=BX_98OE<YQ@ O+!-$--U! 4L@\3V?ZQ=G,$C7"U
M7VTQ%3TQYDA,AJ2PWX_'@4K'J#AV=H[+<]/M]S<@&]+!;;EMI<,GE'>X%%-
MV>-$4J-6*=F)EN,,W:XF/"AE*')"U%0HIU7!M*1Q40*GL3K'+[@(D>]^3!3<
M>++6%NLR$.!M2"L=J:GM[>'V](Z<SK??Y,OFMQ'[XR%)8;D.4%4,\LI4TE1
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M 4G_ $C3D/"[1;[1'=4%.-V^*U&0HCL*DM)2"?N_6U/ ?TZXTE"7&7$E"T+
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MZVN,\MMC<0A:WG4@&,0"I 4O:I+@V\%#3EQZ58_=K$_(9@-71=UC3(ZIC[;
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M]=FV&ITU" '7T1T[6DK5X0@<!]K3F+YM;X]SM+RVW'(TE 6VI32PM!(/A2H
MC[FH&<3[?'=O]K9>8A35(!=8;?%'$H5X H<#IGJ ];XZLCCPU0&IY0.<B,M>
M]305_LE7&GJZ4TZD*0H%*DJ%00>T$>$'7[\XIA]H@WQ*RXW):C)!:6?QF4FJ
M6CQ[6TITW?>HV+VZZW)M*4"4ZUM>*4^*E3B"E2TCP)42!ZFE]*F\?MS>'N"B
M[4W'0B,K\H'*EM( )W@+)[2KB375IRFXVV,]=[$EY%LE+;!<BI?0&W0T?Q0M
M "3]K3?4/*\4M4_(FU(7Y8]'!4M2  A3J?%=*0  7$JH *=@T_A5IM,-FP2E
M2%/P RDQW#*4I;VYL@I(6I2BH$4->RFG,EZ>XM;+5=70I)E,,CFI2OQDH4JI
M;2?"E&T$<*:4TZD*0H%*DJ%00>T$>$'5RDVG#+.PY=V7(TS;&%%LN^.VD'@V
ME7A#82#X=66Y3[7%=E8X5&T.*;!5#W-AL\K_ &:H 3]P#U-'/<EP^T3+ZMSF
MNR'8X/-<_P!MU'B.*]4K2HG2L4SVTP[M:%%*O)I;*7$)4D42I-1W5 '@I-"/
M =.R^F6-V^SRGVRT[(8:J^MLJ"B@NK*G"FH!V[MM0#3@-/\ 4%[#[0N_R2XI
MV2J,D[UNUWK*/S?,54U<V[R23NJ=6S$\KQ:VS+79F1&MS2VMJHS( '+:<20M
M*3052%4-!6NFL2P>V1;59F-VR)$:2VV"HU42 .*E'BI1J5'M)T<L&#V3WR4O
MF$F*DM;ZUW!C\R#7C4(_J'4/XAQ'])=/K<V_RU>/<;NL:^)K?[G1_5>D7[5D
MG_2E?82R_M+OZ!?V$MGQG%_M/V$F?<;_ $B?L)E_Q!=/<KFK%\5POT"?^QW4
M/XAQ'])=/K<V_P M7CW&[K&OB:W^YT?U7I%^U9)_TI7V$LO[2[^@7]A+9\9Q
M?[3]A)GW&_TB?L)E_P 073W*YJQ?%<+] G3LJF[E-J72M*[16FN.$HK\;'S;
M5GZAKB""JZQ^>8P<YO+[Q33?M3N[.W:-7WJ'*CJE-6.VRKBMA"@A3@CM*<*
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M:Q#KEU NEVO&3^226;>7)S[;$*#5V+Y*VTA02I*D[EK4H%96:@C;4]3)@B3
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M=9->.K-VO-R9CY/?HEGAIN$AABVK3(*C);2TM/,?*UD[G=Z0D)2$=M7<BO\
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MRQX2/!V:O6 6>7E2<XL3P8+MRCQ4V^<M*@'"VA%'FD;25M+)4E8IZH.K#?\
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MH6HJ4.P  GAJYXQ_,)E&*91TFCVJ2+6[[X,S9OE&P"*+=0"2A8-!L7P; H*
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MA54T[0==.IO1@MMV:_6+)%2UP[@]*CR5Q1#V<5NN));*U]G$5XZZ;]0,9O\
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M=2V 65E1WAON!0*01EG37KC+1:L3Q&R688? F75^&PQ;UL+5*F1U%Y"G'D2
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MJ%I*DJ%%'3753/\ (CD%\AVUVUP>3;H]N99:?6A;REI9W*=6LMHIN7L0*[$
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M;V[G-6VY*E(B,I>>6TK<VIQP)W+*"*I*B2D\1IB_9'9+;<+G% $>5+ALO/-
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M.)\KWZM]ZBEF;%#Z=T<EIM3@6'Q^9Y:E\P]T=[AJYQ<K@7K$Y=KM3U]<CY!
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M4B/(5;"320U5(+24<HN#<EP Z_?"SXZC$; [+N3V1/Q;V9,*_)=:4W&<%O"
M&I._8ZX\4M+&U:"MX+U@_26^VB)$=P/,;',$Y%P;=;N%O@REO.R6T!(4T=I
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M))*#5:6UD\,+Z;/8BS>\IL,6XICW:VY ;5+L\Y]U9;>COA(6II:5@N442K8
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KHA*0 *J))]4DGM^L5!NC#4F,LI*FGD)6@E*@I-4J!!H0"/4(!_\ U@G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Immunic, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2358443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200 Avenue of the Americas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-9818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMUX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,650,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001280776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 55,310<span></span>
</td>
<td class="nump">$ 35,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets and prepaid expenses</a></td>
<td class="nump">4,532<span></span>
</td>
<td class="nump">3,664<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">59,842<span></span>
</td>
<td class="nump">39,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">991<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">61,429<span></span>
</td>
<td class="nump">40,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,893<span></span>
</td>
<td class="nump">7,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">18,113<span></span>
</td>
<td class="nump">12,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">1,416<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">27,313<span></span>
</td>
<td class="nump">22,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">27,518<span></span>
</td>
<td class="nump">22,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 20,000,000 shares authorized and no shares issued or outstanding as of June 30, 2025 and December 31, 2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2025 and December 31, 2024, and 98,650,590 and 90,150,869 shares issued and outstanding as of June 30, 2025 and December&#160;31, 2024, respectively</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">595,069<span></span>
</td>
<td class="nump">525,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">2,525<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(563,692)<span></span>
</td>
<td class="num">(511,399)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">33,911<span></span>
</td>
<td class="nump">18,429<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 61,429<span></span>
</td>
<td class="nump">$ 40,868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">98,650,590<span></span>
</td>
<td class="nump">90,150,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">98,650,590<span></span>
</td>
<td class="nump">90,150,869<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 21,369<span></span>
</td>
<td class="nump">$ 18,323<span></span>
</td>
<td class="nump">$ 42,902<span></span>
</td>
<td class="nump">$ 37,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">5,714<span></span>
</td>
<td class="nump">4,491<span></span>
</td>
<td class="nump">11,006<span></span>
</td>
<td class="nump">9,636<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">27,083<span></span>
</td>
<td class="nump">22,814<span></span>
</td>
<td class="nump">53,908<span></span>
</td>
<td class="nump">46,695<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(27,083)<span></span>
</td>
<td class="num">(22,814)<span></span>
</td>
<td class="num">(53,908)<span></span>
</td>
<td class="num">(46,695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="nump">2,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts', window );">Change in fair value of the tranche rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,796)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="num">(1,658)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">1,434<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
<td class="num">(4,269)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (26,820)<span></span>
</td>
<td class="num">$ (21,380)<span></span>
</td>
<td class="num">$ (52,293)<span></span>
</td>
<td class="num">$ (50,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in shares)</a></td>
<td class="nump">132,175,202<span></span>
</td>
<td class="nump">101,272,580<span></span>
</td>
<td class="nump">116,844,985<span></span>
</td>
<td class="nump">99,607,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">132,175,202<span></span>
</td>
<td class="nump">101,272,580<span></span>
</td>
<td class="nump">116,844,985<span></span>
</td>
<td class="nump">99,607,158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Change in Fair Value of Tranche Rights, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (26,820)<span></span>
</td>
<td class="num">$ (21,380)<span></span>
</td>
<td class="num">$ (52,293)<span></span>
</td>
<td class="num">$ (50,964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(1,399)<span></span>
</td>
<td class="num">(505)<span></span>
</td>
<td class="num">(1,684)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (28,219)<span></span>
</td>
<td class="num">$ (21,885)<span></span>
</td>
<td class="num">$ (53,977)<span></span>
</td>
<td class="num">$ (50,941)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>May 2025 PIPE Transaction</div></th>
<th class="th"><div>April 2025 PIPE Transaction</div></th>
<th class="th"><div>January 2024 PIPE Transaction</div></th>
<th class="th"><div>At The Market Sales Agreement</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>April 2025 PIPE Transaction</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>January 2024 PIPE Transaction</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>At The Market Sales Agreement</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>May 2025 PIPE Transaction</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>April 2025 PIPE Transaction</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>January 2024 PIPE Transaction</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>At The Market Sales Agreement</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,177,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 28,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 436,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,759<span></span>
</td>
<td class="num">$ (410,892)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(29,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,584)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign exchange translation adjustment</a></td>
<td class="nump">528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of pre-funded warrants and common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,751,286<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of pre-funded warrants and common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,364<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,360<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity', window );">Conversion of tranche rights liability to equity</a></td>
<td class="nump">28,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,079,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">83,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,287<span></span>
</td>
<td class="num">(440,476)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,177,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">28,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,759<span></span>
</td>
<td class="num">(410,892)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(50,964)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign exchange translation adjustment</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,079,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="nump">63,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,782<span></span>
</td>
<td class="num">(461,856)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,079,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2024</a></td>
<td class="nump">83,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,287<span></span>
</td>
<td class="num">(440,476)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(21,380)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,380)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign exchange translation adjustment</a></td>
<td class="num">(505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,079,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="nump">$ 63,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,782<span></span>
</td>
<td class="num">(461,856)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">90,150,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,150,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 18,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
<td class="num">(511,399)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(25,473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign exchange translation adjustment</a></td>
<td class="num">(285)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(285)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,150,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="num">$ (5,287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="num">(536,872)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">90,150,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,150,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 18,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
<td class="num">(511,399)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(52,293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign exchange translation adjustment</a></td>
<td class="num">$ (1,684)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="nump">98,650,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,650,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="nump">$ 33,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">595,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,525<span></span>
</td>
<td class="num">(563,692)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,150,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2025</a></td>
<td class="num">(5,287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="num">(536,872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,820)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,820)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign exchange translation adjustment</a></td>
<td class="num">(1,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of pre-funded warrants and common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of pre-funded warrants and common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,661<span></span>
</td>
<td class="nump">$ 4,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,661<span></span>
</td>
<td class="nump">$ 4,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Exercise of pre-funded warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,613,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Exercise of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued in connection with the Company's employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued in connection with the Company's employee stock purchase plan</a></td>
<td class="nump">$ 123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="nump">98,650,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,650,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="nump">$ 33,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 595,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,525<span></span>
</td>
<td class="num">$ (563,692)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Conversion of Tranche Rights Liability to Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PIPETransactionMember', window );">May 2025 PIPE Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 4,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025PIPETransactionMember', window );">April 2025 PIPE Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PIPETransactionMember', window );">January 2024 PIPE Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_AtTheMarketSalesAgreementMember', window );">At The Market Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PIPETransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PIPETransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025PIPETransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025PIPETransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PIPETransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PIPETransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_AtTheMarketSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_AtTheMarketSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statement of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (52,293)<span></span>
</td>
<td class="num">$ (50,964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign currency gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,941<span></span>
</td>
<td class="nump">4,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses', window );">Non-cash lease expense</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_GainLossFromChangeInFairValueOfTrancheRights', window );">Change in fair value of tranche rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Fees expensed as part of January 2024 Financing</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Other current assets and prepaid expenses</a></td>
<td class="num">(429)<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(896)<span></span>
</td>
<td class="nump">2,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">3,447<span></span>
</td>
<td class="num">(4,420)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(231)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(46,385)<span></span>
</td>
<td class="num">(41,008)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(83)<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(83)<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from public offering of common stock through At The Market Sales Agreement, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from shares issued in connection with the Company's employee stock purchase plan</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">65,518<span></span>
</td>
<td class="nump">74,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">592<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">19,642<span></span>
</td>
<td class="nump">33,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">35,668<span></span>
</td>
<td class="nump">46,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">55,310<span></span>
</td>
<td class="nump">79,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares', window );">Conversion of tranche rights liability to equity upon increase in authorized shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PIPETransactionMember', window );">January 2024 PIPE Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from offering, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">74,273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PIPETransactionMember', window );">May 2025 PIPE Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from offering, net of issuance costs</a></td>
<td class="nump">60,661<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025PIPETransactionMember', window );">April 2025 PIPE Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from offering, net of issuance costs</a></td>
<td class="nump">$ 4,734<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 850<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLeaseAndOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of Tranche Rights Liability to Equity Upon Increase in Authorized Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_GainLossFromChangeInFairValueOfTrancheRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) From Change In Fair Value Of Tranche Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_GainLossFromChangeInFairValueOfTrancheRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PIPETransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PIPETransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PIPETransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PIPETransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025PIPETransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025PIPETransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Financial Statements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business and Basis of Financial Statements</a></td>
<td class="text">Description of Business and Basis of Financial Statements<div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Immunic, Inc. ("Immunic" or the "Company") is a biotechnology company developing a clinical pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The Company is headquartered in New York City with its main operations in Gr&#228;felfing near Munich, Germany. The Company had approximately 90 employees as of July 31, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is pursuing clinical development of orally administered, small molecule programs, each of which has unique features intended to directly address the unmet needs of patients with serious chronic inflammatory and autoimmune diseases. These include the vidofludimus calcium (IMU-838) program, which is in Phase 3 clinical development for patients with relapsing multiple sclerosis (&#8220;RMS&#8221;), and which has shown therapeutic activity in Phase 2 clinical trials in patients suffering from relapsing-remitting MS ("RRMS"), progressive MS (&#8220;PMS&#8221;) and moderate-to-severe ulcerative colitis (&#8220;UC&#8221;); the IMU-856 program, which is targeted to regenerate bowel epithelium and restore intestinal barrier function, which could potentially be applicable in numerous gastrointestinal diseases, such as celiac disease, inflammatory bowel disease ("IBD"), Graft-versus-Host-Disease ("GvHD") and possibly weight management; and the IMU-381 program, which is a next generation molecule being developed to specifically address the needs of gastrointestinal diseases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business, operating results, financial condition and growth prospects are subject to significant risks and uncertainties, including the failure of its clinical trials to meet their endpoints, failure to obtain regulatory approval and needing additional funding to continue and potentially complete the development and commercialization of the Company's three development programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Condition, Liquidity and Going Concern</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Immunic has no products approved for commercial sale and has not generated any revenue from product sales. It has never been profitable and has incurred operating losses in each year since inception in 2016.  The Company has an accumulated deficit of approximately $563.7&#160;million as of June 30, 2025 and $511.4 million as of December 31, 2024.  Substantially all of Immunic's operating losses resulted from expenses incurred in connection with its research and development programs and from general and administrative costs associated with its operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Immunic expects to incur significant expenses and increasing operating losses for the foreseeable future as it initiates and continues the development of its product candidates and adds personnel necessary to advance its pipeline of product candidates. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Immunic expects that its operating losses will fluctuate significantly from quarter-to-quarter and year-to-year due to timing of development programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From inception through June 30, 2025, Immunic has raised net cash of approximately $496.3 million from private and public offerings of preferred stock, common stock, pre-funded warrants and tranche rights. As of June 30, 2025, the Company had cash and cash equivalents of approximately $55.3 million. With these funds, the Company does not have adequate liquidity to fund its operations for at least twelve months from the issuance of these condensed consolidated financial statements included in this quarterly report without raising additional capital and such actions are not solely within the control of the Company. If the Company is unable to obtain additional capital, it would have a material adverse effect on the operations of the Company, its clinical development program, and the Company may have to cease operations altogether. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in conformity with United States generally accepted accounting principles ("U.S. GAAP") and include the accounts of Immunic and its wholly-owned subsidiaries, Immunic AG and Immunic Australia Pty Ltd.  All intercompany accounts and transactions have been eliminated in consolidation. Immunic manages its operations as a single reportable segment for the purposes of assessing performance and making operating decisions.</span></div><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Immunic has prepared the accompanying interim unaudited condensed consolidated financial statements in accordance with United States generally accepted accounting principles, (&#8220;US GAAP&#8221;), for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals which, in the opinion of management, are necessary to present fairly Immunic&#8217;s consolidated financial position, consolidated results of operations, consolidated statement of stockholders&#8217; equity (deficit) and consolidated cash flows for the periods and as of the dates presented. The Company&#8217;s fiscal year ends on December 31. The condensed consolidated balance sheet as of December 31, 2024 was derived from audited consolidated financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto included on the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the"SEC") on March 31, 2025. The nature of Immunic&#8217;s business is such that the results of any interim period may not be indicative of the results to be expected for the entire year or for corresponding interim periods in an any subsequent year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements. The most significant estimates in the Company&#8217;s financial statements and accompanying notes relate to stock-based compensation and the valuation of the tranche rights. Management believes its estimates to be reasonable under the circumstances. Actual results could differ materially from those estimates and assumptions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is United States (&#8220;U.S.&#8221;) dollars. Immunic AG is located in Germany with the Euro being its functional currency. Immunic Australia Pty Ltd.&#8217;s functional currency is the Australian dollar. All amounts in the financial statements where the functional currency is not the U.S. dollar are translated into U.S. dollar equivalents at exchange rates as follows:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; assets and liabilities at reporting period-end rates;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; income statement accounts at average exchange rates for the reporting period; and</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; components of equity at historical rates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from translation of the financial statements into U.S. dollars are recorded in stockholders&#8217; equity (deficit) as a component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses resulting from foreign currency transactions denominated in currencies other than the functional currency are reflected as general and administrative expenses in the Consolidated Statements of Operations. Foreign currency transaction gains and losses related to long-term intercompany loans that are payable in the foreseeable future are recorded in Other Income (Expense). The Consolidated Statements of Cash Flows were prepared by using the average exchange rate in effect during the reporting period which reasonably approximates the timing of the cash flows.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash on hand and deposits in banks located in the U.S. of approximately $47.9&#160;million, Germany of approximately $7.3&#160;million and Australia of approximately $0.1&#160;million as of June 30, 2025. The Company maintains cash and cash equivalent balances denominated in Euro and U.S. dollars with major financial institutions in the U.S. and Germany in excess of the deposit limits insured by the government. Management periodically reviews the credit </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">standing of these financial institutions. The Company currently deposits its cash and cash equivalents with two large financial institutions. Cash and cash equivalents in the U.S. are held at JP Morgan and are primarily held in a U.S. Government money market fund account earning interest at a rate of 4.1% during the period ended June 30, 2025. Cash and cash equivalents in Germany are earning interest at a rate of 1.6% to 3.25% during the period ended June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Quoted prices in active markets for identical assets or liabilities. Level 1 assets consisted of money market funds for the periods presented. The Company had no Level 1 liabilities for the periods presented.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs other than observable quoted prices for the asset or liability, either directly or indirectly; these include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. The Company had no Level 2 assets or liabilities for the periods presented.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The Company had no Level 3 assets or liabilities for the periods presented.  The Company did have tranche rights that were at level 3 during the first quarter of 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximates fair value due to the short period of time to maturity.</span></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost. Depreciation is computed using the straight-line method based on the estimated service lives of the assets, which range from <span style="-sec-ix-hidden:f-310">three</span> to thirteen years. Depreciation expense was $43,000 and $31,000 for the three months ended June 30, 2025 and 2024, respectively, and $86,000 and $57,000 for the six months ended June 30, 2025 and 2024, respectively.</span></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company records impairment losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets&#8217; carrying amount. Impaired assets are then recorded at their estimated fair value. There were no impairment losses during the six months ended June 30, 2025 and 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These costs primarily include external development expenses and internal personnel expenses for its development programs, vidofludimus calcium and IMU-856. Immunic has spent the majority of its research and development resources on vidofludimus calcium, the Company's lead development program, for clinical trials in MS and UC.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist of expenses incurred in research and development activities, which include clinical trials, contract research services, certain milestone payments, salaries and related employee benefits, allocated facility costs and other outsourced services. Research and development expenses are charged to operations as incurred.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into agreements with contract research organizations (&#8220;CROs&#8221;) to provide clinical trial services for individual studies and projects by executing individual work orders governed by a Master Service Arrangement (&#8220;MSA&#8221;). The MSAs and associated work orders provide for regular recurrent payments and payments upon the completion of certain milestones. The Company regularly assesses the timing of payments against actual costs incurred to ensure a proper accrual of related expenses in the appropriate accounting period.</span></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain collaboration and license agreements may include payments to or from the Company of one or more of the following: non-refundable or partially refundable upfront or license fees; development, regulatory and commercial milestone payments; payment for manufacturing supply services; partial or complete reimbursement of research and development costs; and royalties on net sales of licensed products. The Company assesses whether such contracts are within the scope of Financial Accounting Standards Board (FASB) Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and ASU No. 2018-18, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2018-18"). ASU 2018-18, clarifies that certain elements of collaborative arrangements could qualify as transactions with customers in the scope of ASC 606.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Daiichi Sankyo Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company entered into an option and license agreement (the "Daiichi Sankyo Agreement") with Daiichi Sankyo Co., Ltd. ("Daiichi Sankyo") which granted the Company the right to license a group of compounds, designated by the Company as IMU-856, as a potential new oral treatment option for gastrointestinal diseases such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea and other barrier function associated diseases. During the option period, the Company performed agreed upon research and development activities for which it was reimbursed by Daiichi Sankyo up to a maximum agreed-upon limit. Such reimbursement was recorded as other income. There are no additional research and development reimbursements expected under this agreement.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#8217;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%">Ludwig-Maximilians-University Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Government assistance</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Government assistance relating to research and development performed by Immunic Australia is recorded as a component of other (income) expense. This government assistance is recognized at a rate of 43.5% of the qualified research and development expenditures which are incurred. We also receive government assistance from the German Government  for reimbursement of research and development expenses up to 3.5&#160;million Euros per year.  We had recognized <span style="-sec-ix-hidden:f-324">expense</span> of $7,000 and income of $3,000 for the three months ended June 30, 2025 and 2024, respectively and $1.0&#160;million and $39,000 of <span style="-sec-ix-hidden:f-329"><span style="-sec-ix-hidden:f-330"><span style="-sec-ix-hidden:f-331">other income</span></span></span> related to research activities performed during the six months ended June 30, 2025 and 2024, respectively.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and related costs for personnel in executive, finance, business development and other support functions. Other general and administrative expenses include, but are not limited to, stock-based compensation, insurance costs, professional fees for legal, accounting and tax services, consulting, related facility costs and travel.</span></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the cost of employee and non-employee services received in exchange for equity awards based on the grant-date fair value of the award recognized generally as an expense (i) on a straight-line basis over the requisite service period for those awards whose vesting is based upon a service condition, and (ii) on an accelerated method for awards whose </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">vesting is based upon a performance condition, but only to the extent it is probable that the performance condition will be met. Stock-based compensation is (i) estimated at the date of grant based on the award&#8217;s fair value for equity classified awards and (ii) based on the final measurement date for liability classified awards. Forfeitures are recorded in the period in which they occur.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock options using the Black-Scholes-Merton option-pricing model ("BSM"), which requires the use of estimates and subjective assumptions, including the risk-free interest rate, the expected dividend yield of the Company&#8217;s common stock, the expected volatility of the price of the Company&#8217;s common stock, and the expected term of the option. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. If factors change and different assumptions are used, the Company&#8217;s stock-based compensation expense could be materially different in the future.</span></div><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases office space and office equipment. The underlying lease agreements have lease terms of less than 12 months and up to 60 months. Leases with terms of 12 months or less at inception are not included in the operating lease right of use asset and operating lease liability.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three existing leases for office and laboratory space. At inception of a lease agreement, the Company determines whether an agreement represents a lease and at commencement each lease agreement is assessed as to classification as an operating or financing lease. The Company's leases have been classified as operating leases and an operating lease right-of-use asset and an operating lease liability have been recorded on the Company&#8217;s consolidated balance sheet. A right-of-use lease asset represents the Company&#8217;s right to use the underlying asset for the lease term and the lease obligation represents its commitment to make the lease payments arising from the lease. Right-of-use lease assets and obligations are recognized at the commencement date based on the present value of remaining lease payments over the lease term. As the Company&#8217;s leases do not provide an implicit rate, the Company has used an estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The right-of-use lease asset includes any lease payments made prior to commencement and excludes any lease incentives. The lease term used in estimating future lease payments may include options to extend when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or changes in expectations regarding the lease term. Variable lease costs such as common area costs and property taxes are expensed as incurred. </span></div><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Accumulated other comprehensive income (loss) has been reflected as a separate component of stockholders&#8217; equity in the accompanying Consolidated Balance Sheets and consists of foreign currency translation adjustments.</span></div><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to corporate income tax laws and regulations in the U.S., Germany and Australia. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment in their application.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes the asset and liability method of accounting for income taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the audited consolidated financial statements. Deferred income tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. Deferred taxes are reduced by a valuation allowance when, in the opinion of management, it is more likely than not some portion or the entire deferred tax asset will not be realized.  As of June 30, 2025 and December 31, 2024, respectively, the Company maintained a full valuation allowance against the balance of deferred tax assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">It is the Company&#8217;s policy to provide for uncertain tax positions and the related interest and penalties based upon management&#8217;s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense.  The Company is subject to U.S. federal, New York, California, Texas, German and Australian income taxes. The Company is subject to U.S. federal or state income tax examination by tax authorities for tax returns filed for the years 2003 and forward due to the carryforward of NOLs. Tax years 2019 through 2023 are subject to audit by German and Australian tax authorities. The Company is not currently under examination by any tax jurisdictions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants and Tranche Rights</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for issued financial instruments either as a liability or equity in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (&#8220;ASC 480-10&#8221;) or ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock (&#8220;ASC 815-40&#8221;). If financial instruments do not meet liability classification under ASC 480-10, the Company considers the requirements of ASC 815-40 to determine whether the financial instruments should be classified as a liability or as equity. Liability-classified financial instruments are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the financial instruments after the issuance date is recorded in the Consolidated Statements of Operations as a gain or loss. If financial instruments do not require liability classification under ASC 815-40, the instrument is classified in permanent equity. Equity-classified financial instruments are accounted for based on allocated proceeds on the issuance date with no subsequent measurement after the issuance date.   </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of common shares and, if dilutive, common stock equivalents outstanding for the period determined using the treasury-stock method. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#8217;s net loss position. The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2025 includes 8,580,507 pre-funded warrants from the January 2024 Financing and 86,666,667 pre-funded warrants from the May 2025 Offering that remain unexercised as of June 30, 2025.  The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2024 includes 11,193,564 per-funded warrants from the January 2024 Financing that were unexercised as of June 30, 2024.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities, which are not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive, are as follows:</span></div><div style="margin-top:12pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:73.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.955%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,853,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,819,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Placement agent warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">283,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,136,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,819,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued and/or Adopted Accounting Standards</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The new guidance is expected to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information by requiring 1) consistent categories and greater disaggregation of information in the rate reconciliation and 2) income taxes paid disaggregated by jurisdiction. The guidance is effective on a prospective basis, although retrospective application and early adoption is permitted. The standard was adopted by the Company for the annual period starting January 1, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 2024, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures to improve the disclosures about a public entity&#8217;s expenses and provide more detailed information about the types of expenses in commonly presented expense captions such as inventory purchases, employee compensation, depreciation and intangible asset </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">amortization. The disclosure requirements must be applied retrospectively to all prior periods presented in the financial statements. The effective date for the standard is for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text">Balance Sheet Details<div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets and Prepaid Expenses</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Assets and Prepaid Expenses consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:74.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.255%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid clinical and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Payable</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounts Payable consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.474%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Legal and audit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,893&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued legal and audit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,913&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Liabilities consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.740%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-385"><span style="-sec-ix-hidden:f-386">Lease liabilities</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,416&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space under non-cancelable operating leases. The leases terminate on July 31, 2026 for the New York City office, December 31, 2025 for the Gr&#228;felfing, Germany office and November 30, 2028 for the research laboratory in Planegg, Germany.  These agreements include both lease (e.g., fixed rent) and non-lease components (e.g., common-area and other maintenance costs). The non-lease components are deemed to be executory costs and are therefore excluded from the minimum lease payments used to determine the present value of the operating lease obligation and related right-of-use asset. The New York City lease was extended on November 8, 2024 for an additional 12 months resulting in the new lease termination date of July 31, 2026. The New York City lease has a renewal option, but this was not included in calculating the right of use asset and liabilities. On April 7, 2020, the Company signed a five year lease for its facility in Gr&#228;felfing, Germany. On March 1, 2021 and August 1, 2022 the Company added additional lease space at the Gr&#228;felfing, Germany office. The lease term has expired, however, the Company is currently operating on a one-year monthly rolling lease and the Company needs to provide one-years notice to terminate the lease. Renewal options were not included in calculating the right of use asset and liabilities for this facility. In February 2023, the Company leased space in Germany for a research laboratory. The leases do not have concessions, leasehold improvement incentives or other build-out clauses. Further, the leases do not contain contingent rent provisions. There were net additions of $448,000 related to the extension of the New York City lease and Gr&#228;felfing offices during the year ended December 31, 2024.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The leases do not provide an implicit rate and, due to the lack of a commercially salable product, the Company is generally considered unable to obtain commercial credit. Therefore, the Company estimated its incremental interest rate to be 6% for the original leases and 8% for the New York City extension and German laboratory, considering the quoted rates for the lowest investment-grade debt. Immunic used its estimated incremental borrowing rate and other information available at the lease commencement date in determining the present value of the lease payments.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Immunic&#8217;s operating lease costs and variable lease costs were $312,000 and $270,000 for the three months ended June 30, 2025 and 2024, respectively and $591,000 and $527,000 for the six months ended June 30, 2025 and 2024, respectively. Variable lease costs consist primarily of common area maintenance costs, insurance and taxes which are paid based upon actual costs incurred by the lessor.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the operating lease obligation are as follows as of June 30, 2025 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:85.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.945%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Present value of obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following fair value hierarchy tables present information about each major category of the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:50.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement at June 30, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:50.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement at Fair&#160;Value&#160;Measurement&#160;at&#160;December&#160;31,&#160;2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level&#160;1, Level&#160;2 or Level&#160;3 assets during the periods presented.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s money market funds which are included as a component of cash and cash equivalents on the Consolidated Balance Sheet, realized gains and losses are included in interest income on the Consolidated Statements of Operations. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our money market fund account is held in our bank in the U.S. and was earning interest at a rate of 4.1% in a U.S. Government money market fund.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has cash balances in banks in excess of the maximum amount insured by the FDIC and other international agencies as of June 30, 2025. The Company has not historically experienced any credit losses with balances in excess of FDIC limits.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded tranche rights of $23.6&#160;million at January 8, 2024 as a result of the January 2024 Financing (see note 6).  The fair value measurement of the tranche rights associated with the January 2024 Financing was classified as Level 3 under the fair value hierarchy.  The fair value of the tranche rights was determined using a Black Scholes Option Pricing Model. The inputs to this model included a risk-free rate range of 3.93%-4.36%, a stock price volatility range of 105-115%, an expected dividend rate of 0% and remaining term of 1.81-4.81 years.  This liability was revalued on March 4, 2024, upon stockholder approval to increase its authorized shares of common stock from 130&#160;million to 500&#160;million, which resulted in the reclassification of the tranche rights from a liability to equity.  This revaluation resulted in an increase in the tranche rights liability of $4.8&#160;million using a Black Scholes Option Pricing Model. The inputs to this model as of the date of the reclassification included a risk-free rate range of 4.16%-4.63%, a stock price volatility range of 90%-105%, an expected dividend rate of 0% and remaining term of 1.66-4.66 years. The inputs used in the determination of fair value of the liability are level 3 inputs. A rollforward of the fair value of the tranche rights is as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"></td><td style="width:66.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of January 8, 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value through March 4, 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,796&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to equity in March 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28,396)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The carrying amounts of other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximate their fair values due to their short-term nature. The fair value and book value of the money market funds presented in the table above are the same.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">Common Stock<div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shelf Registration Statements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In December 2020, the Company filed a Prospectus Supplement to the shelf registration statement on Form S-3 filed on November 13, 2020 and declared effective on November 24, 2020 (the "2020 Shelf Registration Statement") for the offering, issuance and sale of up to a maximum aggregate offering price of $50.0&#160;million of common stock that may be issued and sold under an at-the-market sales agreement with SVB Leerink LLC (now Leerink Partners LLC) as agent ("December 2020 ATM"). The Company used the net proceeds from the December 2020 ATM to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The December 2020 ATM terminated in May 2024.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a Prospectus Supplement to the 2020 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $80.0&#160;million of common stock to be issued and sold under another at-the-market sales agreement ("May 2022 ATM") with Leerink Partners LLC (formerly SVB Leerink LLC) as agent. The 2020 Shelf Registration Statement expired in November 2023. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the Company filed a shelf registration statement on Form S-3 (the "2023 Shelf Registration Statement").  The 2023 Shelf Registration Statement permits the offering, issuance and sale of up to $250.0&#160;million of common stock, preferred stock, warrants, debt securities, and/or units in one or more offerings and in any combination of the foregoing. This registration statement was declared effective on May 31, 2024.  Unsold securities from the expired 2020 Shelf Registration Statement can continue to be sold under the 2023 Shelf Registration Statement.  As a result of the April 2025 Offering and May 2025 Offering, the amount available under the 2023 Shelf Registration Statement was reduced by $70.1&#160;million to $342.2&#160;million as of June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2024, we filed a Prospectus Supplement to the 2023 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $80.0&#160;million of common stock that may be issued and sold under an at-the-market sales agreement with Leerink Partners LLC as agent ("May 2024 ATM"), which rolls over the $80.0&#160;million of unsold common stock from the May 2022 ATM. We intend to use the net proceeds from the May 2024 ATM to continue to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The May 2024 ATM will terminate upon the earlier of (i) the issuance and sale of all of the shares through Leerink Partners LLC on the terms and subject to the conditions set forth in the May 2024 ATM or (ii) termination of the May 2024 ATM as otherwise permitted thereby. The May 2024 ATM may be terminated at any time by either party upon ten days&#8217; prior notice, or by Leerink Partners LLC at any time in certain circumstances, including the occurrence of a material adverse effect on us.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, $80.0&#160;million in capacity remains under the May 2024 ATM.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The Company has agreed to pay Leerink Partners LLC a commission equal to 3.0% of the gross proceeds from the sales of common stock pursuant to the May 2024 ATM and has agreed to provide Leerink Partners LLC with customary indemnification and contribution rights.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any ATM activity during the three or six months ended June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June 30, 2024, we raised gross proceeds of $0.2&#160;million pursuant to the December 2020 ATM through the sale of 150,000 shares of common stock at a weighted average price of $1.31 per share. The net proceeds from the December 2020 ATM were $0.2&#160;million after deducting sales agent commissions of $6,000. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">April 2025 Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2025, Immunic entered into a securities purchase agreement with certain institutional and accredited investors relating to the issuance and sale of an aggregate of 5,666,667 shares of the Company&#8217;s common stock, par value $0.0001 per share. The purchase price per share was $0.90 for aggregate gross proceeds to the Company of approximately $5.1&#160;million. The offer and sale of the shares is referred to herein as the &#8220;April 2025 Offering.&#8221; The April 2025 Offering closed on April 10, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on April 9, 2025, the Company entered into a placement agency agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (the &#8220;Placement Agent&#8221;), relating to the April 2025 Offering. Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the April 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">therewith. Additionally, upon the closing of the April 2025 Offering, the Company agreed to issue to the Placement Agent, or its designees, warrants to purchase up to an aggregate of 283,334 shares of common stock, representing 5.0% of the shares sold in the April 2025 Offering (the &#8220;Placement Agent Warrants&#8221;). The Placement Agent Warrants will be exercisable, in whole or in part, commencing 180 days from the date of the Placement Agency Agreement and expiring on the five year anniversary of the Placement Agency Agreement, at an initial exercise price per share of common stock of $1.125, which is equal to 125% of the price per share to investors in the April 2025 Offering. The Placement Agent Warrants and the shares of common stock underlying the Placement Agent Warrants were offered pursuant to the exemptions from registration provided in Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds to the Company from the April 2025 Offering, after deducting commissions and the Company&#8217;s offering expenses, was approximately $4.7&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The April 2025 Shares were registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on the Company&#8217;s Registration Statement on Form S-3 (Registration No. 333-275717), previously filed with the SEC, and declared effective on May 31, 2024.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">May 2025 Equity Offering</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2025, Immunic entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Leerink Partners LLC, issuance and sale of (i) pre-funded warrants to purchase an aggregate of 86,666,667 shares of common stock, par value $0.0001 (&#8220;Common Stock&#8221;) of the Company (the &#8220;Pre-Funded Warrants&#8221;), (ii) accompanying series A warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#8220;Series A Warrants&#8221;), and (iii) accompanying series B warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#8220;Series B Warrants&#8221;) (the &#8220;May 2025 Offering&#8221;). The price per Pre-Funded Warrant and accompanying Series A Warrant and Series B Warrant was $0.7499. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.0001 per share and will expire when exercised in full. Each Series A Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.75 per share and will expire on December 31, 2025. Each Series B Warrant is exercisable on the earlier of (i) October 1, 2025, (ii) the first day following any <span style="-sec-ix-hidden:f-491">five</span> trading days during which the volume weighted average price for the Common Stock of the Company during such <span style="-sec-ix-hidden:f-492">five</span> trading day period is $1.25 or greater (the &#8220;VWAP Target&#8221;), or (iii) immediately prior to the consummation of a Fundamental Transaction (as defined in the Series B Warrants) for one share of Common Stock at an exercise price of $0.75 per share and will expire five years from the date of issuance. Each Series A Warrant and Series B Warrant will immediately expire in proportion to the extent that the corresponding Pre-Funded Warrant is exercised prior to September 30, 2025; provided that this term will not apply to the Series B Warrants immediately as of the date of achievement of the VWAP Target. The holder of the Pre-Funded Warrants and Series B Warrants may also satisfy its obligation to pay the exercise price through a &#8220;cashless exercise,&#8221; in which the holder receives the net value of such warrant in shares of Common Stock determined according to the formula set forth in the applicable warrant. Holders of Series A Warrants may, provided there is no effective registration statement or prospectus available which covers the warrants and shares of Common Stock issuable upon exercise of the Series A Warrants, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Series A Warrant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is prohibited from effecting an exercise of any Pre-Funded Warrants, Series A Warrants or Series B Warrants to the extent that such exercise would result in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding 4.99% (or 9.99% at election of the holder) of the total number of shares of Common Stock outstanding immediately after giving effect to the exercise (the &#8220;Beneficial Ownership Limitation&#8221;), which percentage may be increased or decreased at the holder&#8217;s election, not to exceed 19.99%. Any increase to the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. If a holder is not permitted to exercise a Series A Warrant or a Series B Warrant for Common Stock due to the Beneficial Ownership Limitation, then the holder may exercise such Series A Warrant or Series B Warrant for an equivalent number of Pre-Funded Warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The aggregate proceeds from the May 2025 Offering were approximately $65&#160;million before deducting underwriting discounts and commissions and offering expenses payable by the Company in connection with the May 2025 Offering. The Company may receive up to an aggregate of $130&#160;million of additional gross proceeds if the Series A Warrants and Series B Warrants are exercised in full for cash.  Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the May 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection therewith. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The May 2025 Offering was made pursuant to an effective registration statement on Form S-3 (Registration Statement No. 333-275717), as amended, previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on November 22, 2023, and declared effective by the SEC on May 31, 2024, as supplemented by the preliminary prospectus supplement, dated May 28, 2025, and a final prospectus supplement (the &#8220;Prospectus Supplement&#8221;) filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on May 30, 2025. The closing of the May 2025 Offering took place on  June 3, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement of up to $240&#160;million (the "January 2024 Financing")</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2024, Immunic entered into a Securities Purchase Agreement with select accredited investors, pursuant to which the Company agreed to issue and sell to the Investors in a three-tranche private placement shares of the Company&#8217;s common stock, $0.0001 par value per share or in lieu thereof, pre-funded warrants to purchase shares of Common Stock. The Pre-Funded Warrants are exercisable immediately for $0.0001 per share and until exercised in full.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first tranche, which closed on January 8, 2024, resulted in the purchase by the Investors of an aggregate of $80&#160;million of Common Stock (or pre-funded warrants) from the Company at a price of $1.43 per share;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The second tranche is a conditional mandatory purchase by the Investors of an additional $80&#160;million of Common Stock (or pre-funded warrants) from the Company at a price of $1.716 per share, equal to 120% of the price paid in the first tranche and is subject to the satisfaction of three conditions:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">release by the Company of topline data from its Phase 2b clinical trial of vidofludimus calcium (IMU-838) in progressive multiple sclerosis, which data was announced on April 30, 2025;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the 10-day volume-weighted average price of the Common Stock is at least $8.00 per share during the 6 months following the data release; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">aggregate trading volume during the same 10-day period is at least $100&#160;million.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The third tranche must occur no later than three years after the second tranche and is conditioned on the same volume-weighted average share price and minimum trading volumes as the second tranche. The third tranche provides for the issuance of $80&#160;million of shares of common stock (or pre-funded warrants) at the same price per share as the second tranche, but permits investors to fund their purchase obligations on a &#8220;cashless&#8221; or net settlement basis, which would reduce the cash proceeds to be raised by the Company in the January 2024 Financing.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The volume-weighted average share price and minimum trading volume conditions of the second and third tranches have not</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">been satisfied as of June 30, 2025. Any of the conditions in the second or third tranches can be waived by holders of a majority of the outstanding securities (including the lead investor).  The fair value methodology used by the Company assumed the conditions will be waived if the trading price of the stock exceeds the purchase price.  Through June 30, 2025, the investors in</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the first tranche have not purchased any additional shares of common stock from the Company pursuant to the terms of the January 2024 Financing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The January 2024 Financing resulted in gross proceeds to the Company of approximately $80&#160;million in the first tranche, and an additional $80&#160;million if and when the second tranche occurs. If the second tranche is completed and conditions for the third tranche are satisfied or waived, the Company could receive up to an additional $80&#160;million in the third tranche. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of the closing date of the transaction of January 8, 2024, the Company did not have enough authorized shares to be able to issue the potential shares for tranche 2 and tranche 3 (collectively referred to hereafter as "the tranche rights").  Therefore, the Company recorded the value associated to the tranche rights as a liability of $23.6&#160;million and allocated the remainder of the $80&#160;million received (or $56.4&#160;million) with the common stock and pre-funded warrants to equity.  On March 4, 2024, the stockholders voted to increase the Company's authorized common stock from 130&#160;million to 500&#160;million shares.  As a result of the ability to issue shares in satisfaction of the tranche rights, the instrument was reclassified to stockholders' equity.  The Company allocated the transaction costs across the instruments on a relative fair value basis at the grant date. As a result $4.0&#160;million was netted against the equity proceeds and $1.7&#160;million was recorded in other expense in the Consolidated Statements of Operations for the six months ended June 30, 2024.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company registered for resale by the investors in the January 2024 Financing up to 55,944,850 shares of common stock issued (or issuable upon exercise of pre-funded warrants) in the first tranche. The Company will not receive any proceeds from the sale of these shares of common stock. These shares are registered on a registration statement on Form S-3 (registration No. 333-277040).</span></div><div style="margin-top:12pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:12pt;padding-right:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2024, the stockholders of the Company voted to increase the authorized shares of the Company from 130,000,000 shares of common stock to 500,000,000 shares of common stock, par value of $0.0001 per share. The voting, dividend and liquidation rights of the holders of the Company&#8217;s common stock are subject to and qualified by the rights, powers and preferences of any holders of preferred stock.</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Board of Directors, if any. Through June 30, 2025, no cash dividends had been declared or paid.</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice of Non-Compliance with Nasdaq Listing Rule 5450(a)(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2025, Immunic, Inc. received a written notification (the &#8220;Notice Letter&#8221;) from The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that we were not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price for our common stock was below the $1.00 per share requirement for the last 30 consecutive business days. The Notice Letter stated that we have 180 calendar days, or until December 24, 2025 (the &#8220;Initial Compliance Period&#8221;), to regain compliance with the minimum bid price requirement. If we do not regain compliance by the end of the Initial Compliance Period, we may apply for an additional compliance period as provided for in the Notice Letter. Nasdaq&#8217;s determination of whether we qualify for an additional compliance period will depend on whether we will meet the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and a written notice of our intention to cure the deficiency during the additional compliance period by effecting a reverse stock split, if necessary.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Notice Letter has no immediate effect on the listing of our common stock on The Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we can regain compliance if the closing bid price of our common stock is at least $1.00 for a minimum of 10 consecutive business days. In the event that we do not regain compliance with Listing Rule 5450(a)(1) prior to the expiration of the Initial Compliance Period (or additional compliance period, if applicable), we will receive written notification that our securities are subject to delisting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to actively monitor the closing bid price of its common stock and is evaluating available options to regain compliance with the minimum bid price requirement. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or that the Company will otherwise remain in compliance with the other listing standards for the Nasdaq. If the Company&#8217;s common stock is delisted from Nasdaq, it could have a material adverse effect on the trading price and liquidity of the common stock.</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-funded Warrants</span></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued 11,193,564 pre-funded warrants in connection with the January 2024 Financing, 2,613,057 of which were exercised in the quarter ended June 30, 2025 and 8,580,507 of which remain outstanding as of June 30, 2025.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue 20 million shares of $0.0001 par value preferred stock, with such voting powers (if any), designations, powers, preferences, and relative, participating, optional or other rights, if any, and any qualifications, limitations or restrictions thereof, as shall be set by the Board of Directors. No preferred shares were issued or outstanding as of June 30, 2025.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Reserved for Future Issuance</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares reserved for future issuance at June 30, 2025 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock reserved for issuance for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2021 Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">708,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-funded stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,580,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Placement agent warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">283,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,853,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the second tranche of the January 2024 financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,620,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the second tranche of the January 2024 financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,620,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Pre-funded warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,666,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Series A warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,666,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the May 2025 Series B warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,666,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options available for future grant:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2019 Omnibus Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">596,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total common shares reserved for future issuance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">389,308,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation Plans</a></td>
<td class="text">Stock-Based Compensation Plans<div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On April 25, 2021, the Company adopted the 2021 Employee Stock Purchase Plan ("ESPP"), which was approved by stockholder vote at the 2021 Annual Meeting of Stockholders held on June 10, 2021. The ESPP provides eligible employees of the Company with an opportunity to purchase common stock of the Company through accumulated payroll deductions, which are included in other current liabilities until they are used to purchase Company shares. Eligible employees participating in the bi-annual offering period can choose to have up to the lesser of 15% of their annual base earnings or the IRS annual share purchase limit of $25,000 in aggregate market value to purchase shares of the Company&#8217;s common stock. The purchase price of the stock is the lesser of (i) 85% of the closing market price on the date of purchase and (ii) the closing market price at the beginning of the bi-annual offering period. The maximum number of shares initially reserved for delivery under the plan was 200,000 shares.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">An increase of 1&#160;million shares to 1.2&#160;million shares was approved by stockholders of the Company at the Company's Special Meeting of stockholders held on March 4, 2024. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The first enrollment period under the plan commenced on August 1, 2021 and the Company has issued 491,839  shares life-to-date under the ESPP.  The Company recognized  $22,000 and $48,000 of expense related to the plan during the three and six months ended June 30, 2025, respectively.  The Company recognized  no  expense related to the plan during the three and six months ended June 30, 2024, respectively.   </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Programs</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Company&#8217;s stockholders approved the 2019 Omnibus Equity Incentive Plan, (as amended, the &#8220;2019 Plan&#8221;), which was adopted by the Board of Directors (the "Board") with an effective date of June 14, 2019. The 2019 Plan allows for the grant of equity awards to employees, consultants and non-employee directors. An initial maximum of 1,500,000 shares of the Company&#8217;s common stock were available for grant under the 2019 Plan. The 2019 Plan included an evergreen provision that allowed for the annual addition of up to 4% of the Company&#8217;s fully-diluted outstanding stock, with a maximum allowable increase of 4,900,000 shares over the term of the 2019 Plan. In accordance with this provision, the shares available for grant were increased in 2020 through 2023 by a total of 4,408,871 shares. At the Company's Annual Stockholders meeting on June 28, 2023, stockholders voted to increase the allowable shares under the 2019 plan by 4,440,000 shares as well as to eliminate the evergreen provision.  On March 4, 2024, the stockholders voted at the Company's Special Meeting to increase the allowable shares under the 2019 plan by 9,100,000 shares.  On June 4, 2025, at the Company&#8217;s 2025 Annual Meeting of Stockholders,  the Company&#8217;s stockholders approved a proposal to amend the terms of the 2019 Plan to, among other things, increase the allowable shares under the 2019 plan by 7,000,000 shares. The 2019 Plan (as amended on June 28, 2023 and </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">March 4, 2024) is currently administered by the Board, or, at the discretion of the Board, by a committee of the Board, which determines the exercise prices, vesting schedules and other restrictions of awards under the 2019 Plan at its discretion. Options to purchase stock may not have an exercise price that is less than the fair market value of underlying shares on the date of grant, and may not have a term greater than ten years. Incentive stock options granted to employees typically vest over four years. Non-statutory options granted to employees, officers, members of the Board, advisors, and consultants of the Company typically vest over <span style="-sec-ix-hidden:f-575">three</span> or four years. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares that are expired, terminated, surrendered or canceled under the 2019 Plan without having been fully exercised will be available for future awards. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Repricing</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2024, the Company's stockholders voted to approve the repricing of outstanding stock options having an exercise price above $3.00 per share to $1.72 per share.  All other terms of the grant remained the same. There were 3,317,596 stock options that were repriced to $1.72 per share.  The repricing resulted in $1.2&#160;million of stock compensation being recognized by the Company over the remaining term of the repriced grants.  $52,000 and $0.1&#160;million was recognized in the three months and six months ended June 30, 2025, respectively and $17,000 and $1.0&#160;million of this amount was recognized in the three months and six months ended June 30, 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction Option Acceleration Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2025, the Company established a Corporate Transaction Option Acceleration Plan, pursuant to which in the case of a merger or consolidation of the Company with or into another corporation or a sale of substantially all of the stock of the Company each option award held by an eligible employee will become fully vested upon the occurrence of a Corporate Transaction.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Movements during the year </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the six months ended June 30, 2025 and 2024, respectively, for the 2019 Plan:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:52.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,136,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,937,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(219,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,853,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable as of June 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,042,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.04</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:52.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,196,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,810,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Repricing Modification</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(186,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,819,558&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable as of June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,606,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the BSM option pricing model to determine the fair value of the employee and non-employee stock option grants relating to the 2019 Plan were as follows:</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free rate assumption is based on U.S. Treasury instruments with maturities similar to the expected term of the stock options.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has not issued any dividends and does not expect to issue dividends over the life of the options. As a result, the Company has estimated the dividend yield to be zero.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected volatility based on the historical volatility of its own stock. The historical volatility data was computed using the daily closing prices during the equivalent period of the calculated expected term of the stock-based awards.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The expected term of options is estimated considering the vesting period at the grant date, the life of the option and the average length of time similar grants have remained outstanding in the past.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of stock options granted under the 2019 Plan during the six months ended June 30, 2025 and 2024 was $0.67 and $0.98, respectively. The following are the underlying assumptions used in the Black-Scholes option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six  Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.14%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">116.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.91</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.95</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense for all stock awards recognized in the accompanying unaudited condensed consolidated statements of operations is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.391%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br/>&#160;Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months<br/>&#160;Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">761,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">842,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,592,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,005,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,138,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,040,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,349,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,627,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,899,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,882,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,941,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,632,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, there was $15.6 million in total unrecognized compensation expense relating to the 2019 Plan, to be recognized over a weighted average period of 3.16 years. There was $28,000 and $24,000 of stock-based compensation expense during the three months ended June 30, 2025 related to the repricing included in general and administrative and research and development expense respectively. There was $56,000 and $49,000 of stock-based compensation expense during the six months ended June 30, 2025 related to the repricing included in general and administrative and research and development expense, respectively.  There was $9,000 and $8,000 of stock-based compensation expense during the three months ended June 30, 2024 related to the repricing included in general and administrative and research and development expense respectively. There was </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.6&#160;million and $0.3&#160;million of stock-based compensation expense during the six months ended June 30, 2024 related to the repricing included in general and administrative and research and development expense, respectively.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Equity Incentive Plans Assumed from Vital Therapies</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Upon completion of the Transaction with Vital Therapies, inc. ("Vital") on April 12, 2019, Vital&#8217;s 2012 Stock Option Plan (the &#8220;2012 Plan&#8221;), Vital&#8217;s 2014 Equity Incentive Plan (the &#8220;2014 Plan&#8221;) and Vital&#8217;s 2017 Inducement Equity Incentive Plan (the &#8220;Inducement Plan&#8221;), were assumed by the Company. All awards granted under these plans have either been forfeited or expired.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are no longer any shares available for grant under the 2014 Plan as of June 30, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 2017, Vital&#8217;s board of directors approved the Inducement Plan, which was amended and restated in November 2017. Under the Inducement Plan 46,250 shares of Vital&#8217;s common stock were reserved to be used exclusively for non-qualified grants to individuals who were not previously employees or directors as an inducement material to a grantee's entry into employment within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules.   </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No expense was recorded for the plans assumed from Vital during the three or six months ended June 30, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Chairman Agreement with Duane Nash</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2020, the Compensation Committee of the Board of Directors of the Company independently reviewed and approved entering into an employment agreement with the Executive Chairman of the Board, Duane Nash, MD, JD, MBA (the &#8220;Executive Chairman Agreement&#8221;) and pursuant to such approval, on April 17, 2020, the Company and Dr. Nash entered into the Executive Chairman Agreement. The Executive Chairman Agreement establishes an &#8220;at will&#8221; employment relationship.  On October 17, 2023, Immunic, Inc. and Dr. Duane Nash entered into Addendum Number 5  to the Executive Chairman Agreement to extend the term of Dr. Nash&#8217;s employment as Executive Chairman of the Board of Directors of the Company to December 31, 2024.  In connection with  Addendum Number 5, the Company increased Dr. Nash&#8217;s monthly base salary to $32,368 from $30,250 (which includes the cash retainer payable for serving on the Company&#8217;s Board or for acting as the Chairman of the Board). On August 29, 2024, Immunic, Inc.  and Dr. Duane Nash entered into Addendum Number 6  to the Executive Chairman Agreement to extend the term of Dr. Nash&#8217;s employment as Executive Chairman of the Board of Directors of the Company to December 31, 2025.  In connection with  Addendum Number 6, the Company increased Dr. Nash&#8217;s monthly base salary in 2025 to $33,986 from $32,368 (which includes the cash retainer payable for serving on the Company&#8217;s Board or for acting as the Chairman of the Board) All other terms of the Executive Chairman Agreement remain the same.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, the Company has non-cancelable contractual obligations under certain agreements related to its development programs for vidofludimus calcium and IMU-856 totaling approximately $2.1&#160;million, all of which is expected to be paid in 2025 and 2026.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments and Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Daiichi Sankyo Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#8217;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%">Ludwig-Maximilians-University Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently a party to any litigation, nor is it aware of any pending or threatened litigation, that it believes would materially affect its business, operating results, financial condition or cash flows. However, its industry is characterized by frequent claims and litigation including securities litigation, claims regarding patent and other intellectual property rights and claims for product liability. As a result, in the future, the Company may be involved in various legal proceedings from time to time.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Disclosures</a></td>
<td class="text">Segment Disclosures<div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision making group, in deciding how to allocate resources in assessing performance. The Company has one reportable segment: life science. The life science segment consists of the development of clinical and preclinical product candidates for the development of the Company&#8217;s proprietary new therapies. The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is the Company's Chief Executive Officer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the life science segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the life science segment based on net loss. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM allocates resources and assesses performance on a consolidated basis, focused on the Company&#8217;s cash resources and an assessment of the probability of success of its ongoing research and development activities. Resource allocation decisions are informed by forecasted cash expenditures and actual expenses incurred to date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not generated any product revenue. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances product candidates through all stages of development and clinical trials and, ultimately, seeks regulatory approval. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the significant expense categories regularly reviewed by the CODM for the  three and six months ended June 30:</span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.596%"><tr><td style="width:1.0%"></td><td style="width:46.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical product candidates</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,931&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-clinical product candidates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs- research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs-general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,083&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other segment expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,513&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,083&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,814&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27,083)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,814)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(26,820)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(21,380)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical product candidates</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,491&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-clinical product candidates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs- research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,881&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs-general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,704&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,632&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other segment expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53,908&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,695&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(53,908)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(46,695)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of the tranche rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,796)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(52,293)</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(50,964)</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 7, 2025, the Board of Directors (the &#8220;Board&#8221;) of Immunic, Inc. (the &#8220;Company&#8221;) authorized grants, subject to the final approval of the Compensation Committee of the Board, of up to an aggregate of 35,000,000 stock appreciation rights (&#8220;SARs&#8221;) to the Company&#8217;s employees and executive officers. This includes an aggregate of 22,015,000 SARs to the Company&#8217;s executive officers. The SARs could be settled for cash, but it is the intention of the Company that these SARs will be settled for shares of the Company&#8217;s common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;) provided the Company obtains stockholder approval to amend the Company&#8217;s 2019 Omnibus Equity Incentive Plan, as amended (the &#8220;Plan&#8221;), to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock. The Company intends to seek stockholder approval to increase the number of shares available under the Plan. The exercise price of each SAR is $0.77, the closing price of the Common Stock on July 7, 2025.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Of the 35,000,000 SARs, (i) 5,000,000 will be exercisable beginning August 1, 2026; (ii) up to 10,000,000 will be exercisable beginning August 1, 2026, subject to the exercise of the Company&#8217;s Series A  warrants by the holders thereof; (iii) up to 10,000,000 will be exercisable beginning August 1, 2026, subject to the exercise of the Company&#8217;s Series B warrants by the holders thereof; (iv) up to 5,000,000 will be exercisable beginning August 1, 2026, subject to the Company&#8217;s issuance of Common Stock or pre-funded warrants to subscribers in connection with the second tranche of the Company&#8217;s January 4, 2024 private placement (the &#8220;January 2024 Offering&#8221;); and (v) up to 5,000,000 will be exercisable beginning August 1, 2026, subject to the issuance of Common Stock or pre-funded warrants to subscribers in connection with the third tranche of the January 2024 Offering.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in conformity with United States generally accepted accounting principles ("U.S. GAAP") and include the accounts of Immunic and its wholly-owned subsidiaries, Immunic AG and Immunic Australia Pty Ltd.  All intercompany accounts and transactions have been eliminated in consolidation. Immunic manages its operations as a single reportable segment for the purposes of assessing performance and making operating decisions.</span></div><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Immunic has prepared the accompanying interim unaudited condensed consolidated financial statements in accordance with United States generally accepted accounting principles, (&#8220;US GAAP&#8221;), for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals which, in the opinion of management, are necessary to present fairly Immunic&#8217;s consolidated financial position, consolidated results of operations, consolidated statement of stockholders&#8217; equity (deficit) and consolidated cash flows for the periods and as of the dates presented. The Company&#8217;s fiscal year ends on December 31. The condensed consolidated balance sheet as of December 31, 2024 was derived from audited consolidated financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto included on the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the"SEC") on March 31, 2025. The nature of Immunic&#8217;s business is such that the results of any interim period may not be indicative of the results to be expected for the entire year or for corresponding interim periods in an any subsequent year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements. The most significant estimates in the Company&#8217;s financial statements and accompanying notes relate to stock-based compensation and the valuation of the tranche rights. Management believes its estimates to be reasonable under the circumstances. Actual results could differ materially from those estimates and assumptions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Presentation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is United States (&#8220;U.S.&#8221;) dollars. Immunic AG is located in Germany with the Euro being its functional currency. Immunic Australia Pty Ltd.&#8217;s functional currency is the Australian dollar. All amounts in the financial statements where the functional currency is not the U.S. dollar are translated into U.S. dollar equivalents at exchange rates as follows:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; assets and liabilities at reporting period-end rates;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; income statement accounts at average exchange rates for the reporting period; and</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%">&#8226; components of equity at historical rates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from translation of the financial statements into U.S. dollars are recorded in stockholders&#8217; equity (deficit) as a component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses resulting from foreign currency transactions denominated in currencies other than the functional currency are reflected as general and administrative expenses in the Consolidated Statements of Operations. Foreign currency transaction gains and losses related to long-term intercompany loans that are payable in the foreseeable future are recorded in Other Income (Expense). The Consolidated Statements of Cash Flows were prepared by using the average exchange rate in effect during the reporting period which reasonably approximates the timing of the cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash on hand and deposits in banks located in the U.S. of approximately $47.9&#160;million, Germany of approximately $7.3&#160;million and Australia of approximately $0.1&#160;million as of June 30, 2025. The Company maintains cash and cash equivalent balances denominated in Euro and U.S. dollars with major financial institutions in the U.S. and Germany in excess of the deposit limits insured by the government. Management periodically reviews the credit </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">standing of these financial institutions. The Company currently deposits its cash and cash equivalents with two large financial institutions. Cash and cash equivalents in the U.S. are held at JP Morgan and are primarily held in a U.S. Government money market fund account earning interest at a rate of 4.1% during the period ended June 30, 2025. Cash and cash equivalents in Germany are earning interest at a rate of 1.6% to 3.25% during the period ended June 30, 2025.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurement</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Quoted prices in active markets for identical assets or liabilities. Level 1 assets consisted of money market funds for the periods presented. The Company had no Level 1 liabilities for the periods presented.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs other than observable quoted prices for the asset or liability, either directly or indirectly; these include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. The Company had no Level 2 assets or liabilities for the periods presented.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The Company had no Level 3 assets or liabilities for the periods presented.  The Company did have tranche rights that were at level 3 during the first quarter of 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximates fair value due to the short period of time to maturity.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div>Property and equipment is stated at cost. Depreciation is computed using the straight-line method based on the estimated service lives of the assets, which range from <span style="-sec-ix-hidden:f-310">three</span> to thirteen years.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div>The Company records impairment losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets&#8217; carrying amount. Impaired assets are then recorded at their estimated fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These costs primarily include external development expenses and internal personnel expenses for its development programs, vidofludimus calcium and IMU-856. Immunic has spent the majority of its research and development resources on vidofludimus calcium, the Company's lead development program, for clinical trials in MS and UC.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist of expenses incurred in research and development activities, which include clinical trials, contract research services, certain milestone payments, salaries and related employee benefits, allocated facility costs and other outsourced services. Research and development expenses are charged to operations as incurred.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into agreements with contract research organizations (&#8220;CROs&#8221;) to provide clinical trial services for individual studies and projects by executing individual work orders governed by a Master Service Arrangement (&#8220;MSA&#8221;). The MSAs and associated work orders provide for regular recurrent payments and payments upon the completion of certain milestones. The Company regularly assesses the timing of payments against actual costs incurred to ensure a proper accrual of related expenses in the appropriate accounting period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaboration Arrangements, Daiichi Sankyo Agreement and Ludwig-Maximilians-University Agreement</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain collaboration and license agreements may include payments to or from the Company of one or more of the following: non-refundable or partially refundable upfront or license fees; development, regulatory and commercial milestone payments; payment for manufacturing supply services; partial or complete reimbursement of research and development costs; and royalties on net sales of licensed products. The Company assesses whether such contracts are within the scope of Financial Accounting Standards Board (FASB) Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and ASU No. 2018-18, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2018-18"). ASU 2018-18, clarifies that certain elements of collaborative arrangements could qualify as transactions with customers in the scope of ASC 606.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Daiichi Sankyo Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company entered into an option and license agreement (the "Daiichi Sankyo Agreement") with Daiichi Sankyo Co., Ltd. ("Daiichi Sankyo") which granted the Company the right to license a group of compounds, designated by the Company as IMU-856, as a potential new oral treatment option for gastrointestinal diseases such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea and other barrier function associated diseases. During the option period, the Company performed agreed upon research and development activities for which it was reimbursed by Daiichi Sankyo up to a maximum agreed-upon limit. Such reimbursement was recorded as other income. There are no additional research and development reimbursements expected under this agreement.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#8217;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%">Ludwig-Maximilians-University Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistancePolicyTextBlock', window );">Government assistance</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Government assistance</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Government assistance relating to research and development performed by Immunic Australia is recorded as a component of other (income) expense. This government assistance is recognized at a rate of 43.5% of the qualified research and development expenditures which are incurred. We also receive government assistance from the German Government  for reimbursement of research and development expenses up to 3.5&#160;million Euros per year.  We had recognized <span style="-sec-ix-hidden:f-324">expense</span> of $7,000 and income of $3,000 for the three months ended June 30, 2025 and 2024, respectively and $1.0&#160;million and $39,000 of <span style="-sec-ix-hidden:f-329"><span style="-sec-ix-hidden:f-330"><span style="-sec-ix-hidden:f-331">other income</span></span></span> related to research activities performed during the six months ended June 30, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative Expenses</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and related costs for personnel in executive, finance, business development and other support functions. Other general and administrative expenses include, but are not limited to, stock-based compensation, insurance costs, professional fees for legal, accounting and tax services, consulting, related facility costs and travel.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the cost of employee and non-employee services received in exchange for equity awards based on the grant-date fair value of the award recognized generally as an expense (i) on a straight-line basis over the requisite service period for those awards whose vesting is based upon a service condition, and (ii) on an accelerated method for awards whose </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">vesting is based upon a performance condition, but only to the extent it is probable that the performance condition will be met. Stock-based compensation is (i) estimated at the date of grant based on the award&#8217;s fair value for equity classified awards and (ii) based on the final measurement date for liability classified awards. Forfeitures are recorded in the period in which they occur.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock options using the Black-Scholes-Merton option-pricing model ("BSM"), which requires the use of estimates and subjective assumptions, including the risk-free interest rate, the expected dividend yield of the Company&#8217;s common stock, the expected volatility of the price of the Company&#8217;s common stock, and the expected term of the option. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. If factors change and different assumptions are used, the Company&#8217;s stock-based compensation expense could be materially different in the future.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases office space and office equipment. The underlying lease agreements have lease terms of less than 12 months and up to 60 months. Leases with terms of 12 months or less at inception are not included in the operating lease right of use asset and operating lease liability.</span></div>The Company has three existing leases for office and laboratory space. At inception of a lease agreement, the Company determines whether an agreement represents a lease and at commencement each lease agreement is assessed as to classification as an operating or financing lease. The Company's leases have been classified as operating leases and an operating lease right-of-use asset and an operating lease liability have been recorded on the Company&#8217;s consolidated balance sheet. A right-of-use lease asset represents the Company&#8217;s right to use the underlying asset for the lease term and the lease obligation represents its commitment to make the lease payments arising from the lease. Right-of-use lease assets and obligations are recognized at the commencement date based on the present value of remaining lease payments over the lease term. As the Company&#8217;s leases do not provide an implicit rate, the Company has used an estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The right-of-use lease asset includes any lease payments made prior to commencement and excludes any lease incentives. The lease term used in estimating future lease payments may include options to extend when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or changes in expectations regarding the lease term. Variable lease costs such as common area costs and property taxes are expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Accumulated other comprehensive income (loss) has been reflected as a separate component of stockholders&#8217; equity in the accompanying Consolidated Balance Sheets and consists of foreign currency translation adjustments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to corporate income tax laws and regulations in the U.S., Germany and Australia. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment in their application.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes the asset and liability method of accounting for income taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the audited consolidated financial statements. Deferred income tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. Deferred taxes are reduced by a valuation allowance when, in the opinion of management, it is more likely than not some portion or the entire deferred tax asset will not be realized.  As of June 30, 2025 and December 31, 2024, respectively, the Company maintained a full valuation allowance against the balance of deferred tax assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">It is the Company&#8217;s policy to provide for uncertain tax positions and the related interest and penalties based upon management&#8217;s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense.  The Company is subject to U.S. federal, New York, California, Texas, German and Australian income taxes. The Company is subject to U.S. federal or state income tax examination by tax authorities for tax returns filed for the years 2003 and forward due to the carryforward of NOLs. Tax years 2019 through 2023 are subject to audit by German and Australian tax authorities. The Company is not currently under examination by any tax jurisdictions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Warrants and Tranche Rights</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants and Tranche Rights</span></div>The Company accounts for issued financial instruments either as a liability or equity in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (&#8220;ASC 480-10&#8221;) or ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock (&#8220;ASC 815-40&#8221;). If financial instruments do not meet liability classification under ASC 480-10, the Company considers the requirements of ASC 815-40 to determine whether the financial instruments should be classified as a liability or as equity. Liability-classified financial instruments are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the financial instruments after the issuance date is recorded in the Consolidated Statements of Operations as a gain or loss. If financial instruments do not require liability classification under ASC 815-40, the instrument is classified in permanent equity. Equity-classified financial instruments are accounted for based on allocated proceeds on the issuance date with no subsequent measurement after the issuance date.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of common shares and, if dilutive, common stock equivalents outstanding for the period determined using the treasury-stock method. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#8217;s net loss position. The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2025 includes 8,580,507 pre-funded warrants from the January 2024 Financing and 86,666,667 pre-funded warrants from the May 2025 Offering that remain unexercised as of June 30, 2025.  The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2024 includes 11,193,564 per-funded warrants from the January 2024 Financing that were unexercised as of June 30, 2024.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and/or Adopted Accounting Standards</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued and/or Adopted Accounting Standards</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The new guidance is expected to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information by requiring 1) consistent categories and greater disaggregation of information in the rate reconciliation and 2) income taxes paid disaggregated by jurisdiction. The guidance is effective on a prospective basis, although retrospective application and early adoption is permitted. The standard was adopted by the Company for the annual period starting January 1, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 2024, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures to improve the disclosures about a public entity&#8217;s expenses and provide more detailed information about the types of expenses in commonly presented expense captions such as inventory purchases, employee compensation, depreciation and intangible asset </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">amortization. The disclosure requirements must be applied retrospectively to all prior periods presented in the financial statements. The effective date for the standard is for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities, which are not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive, are as follows:</span></div><div style="margin-top:12pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:73.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.955%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,853,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,819,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Placement agent warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">283,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,136,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,819,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets and Prepaid Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Assets and Prepaid Expenses consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:74.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.255%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid clinical and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounts Payable consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.474%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Legal and audit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,893&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued legal and audit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,913&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Liabilities consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.740%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-385"><span style="-sec-ix-hidden:f-386">Lease liabilities</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,416&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Obligation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the operating lease obligation are as follows as of June 30, 2025 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:85.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.945%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Present value of obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following fair value hierarchy tables present information about each major category of the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:50.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement at June 30, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:50.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement at Fair&#160;Value&#160;Measurement&#160;at&#160;December&#160;31,&#160;2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value of Tranche Rights</a></td>
<td class="text">A rollforward of the fair value of the tranche rights is as follows (in thousands):<div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"></td><td style="width:66.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of January 8, 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value through March 4, 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,796&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to equity in March 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28,396)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Shares Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares reserved for future issuance at June 30, 2025 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock reserved for issuance for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2021 Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">708,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-funded stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,580,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Placement agent warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">283,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,853,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the second tranche of the January 2024 financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,620,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the second tranche of the January 2024 financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,620,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Pre-funded warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,666,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Series A warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,666,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the May 2025 Series B warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,666,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options available for future grant:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2019 Omnibus Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">596,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total common shares reserved for future issuance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">389,308,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the six months ended June 30, 2025 and 2024, respectively, for the 2019 Plan:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:52.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,136,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,937,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(219,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,853,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable as of June 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,042,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.04</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:52.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,196,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,810,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Repricing Modification</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(186,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,819,558&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable as of June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,606,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions Used</a></td>
<td class="text">The following are the underlying assumptions used in the Black-Scholes option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six  Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.14%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">116.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.91</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.95</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense for Stock Awards Recognized</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense for all stock awards recognized in the accompanying unaudited condensed consolidated statements of operations is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.391%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br/>&#160;Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months<br/>&#160;Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">761,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">842,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,592,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,005,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,138,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,040,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,349,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,627,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,899,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,882,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,941,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,632,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Significant Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the significant expense categories regularly reviewed by the CODM for the  three and six months ended June 30:</span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.596%"><tr><td style="width:1.0%"></td><td style="width:46.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical product candidates</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,931&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-clinical product candidates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs- research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs-general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,083&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other segment expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,513&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,083&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,814&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27,083)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,814)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(26,820)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(21,380)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical product candidates</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,491&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-clinical product candidates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs- research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,881&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee costs-general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,704&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,632&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other segment expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53,908&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,695&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(53,908)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(46,695)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of the tranche rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,796)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(52,293)</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(50,964)</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Financial Statements (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">114 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>program</div>
</th>
<th class="th">
<div>Jul. 31, 2025 </div>
<div>employee</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_NumberOfDevelopmentPrograms', window );">Number of development programs | program</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (563,692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (511,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="nump">496,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 55,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,668<span></span>
</td>
<td class="nump">$ 79,698<span></span>
</td>
<td class="nump">$ 46,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_NumberOfDevelopmentPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Development Programs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_NumberOfDevelopmentPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>financialInstitution </div>
<div>lease </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>financialInstitution </div>
<div>lease </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;) </div>
<div>financialInstitution </div>
<div>lease </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 55,310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,668,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits', window );">Number of financial institutions used for cash deposits | financialInstitution</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation expense</a></td>
<td class="nump">$ 43,000<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 86,000<span></span>
</td>
<td class="nump">$ 57,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Government Assistance, Expense, Decrease (Increase), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Nonoperating Income (Expense)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceExpense', window );">Government assistance, expense</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceAmount', window );">Government assistance, income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Nonoperating Income (Expense)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_LesseeOperatingLeasesNumberOfExistingLeases', window );">Number of existing leases | lease</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PreFundedWarrantsMember', window );">January 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares) | shares</a></td>
<td class="nump">8,580,507<span></span>
</td>
<td class="nump">11,193,564<span></span>
</td>
<td class="nump">8,580,507<span></span>
</td>
<td class="nump">11,193,564<span></span>
</td>
<td class="nump">8,580,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PreFundedWarrantsMember', window );">May 2025 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares) | shares</a></td>
<td class="nump">86,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in months)</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 47,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Investment interest rate (as a percent)</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Investment interest rate (as a percent)</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount', window );">Australian research and development tax incentive | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany | Money market funds | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Investment interest rate (as a percent)</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany | Money market funds | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Investment interest rate (as a percent)</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent', window );">Government R&amp;D assistance rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income from government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease (increase) in expense from government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes decrease (increase) in expense from government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes increase (decrease) in income from government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Assistance, Qualified Research and Development Expenditures, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Assistance, Qualified Research and Development Expenditures, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_LesseeOperatingLeasesNumberOfExistingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Leases, Number Of Existing Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_LesseeOperatingLeasesNumberOfExistingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_NumberOfFinancialInstitutionsUsedForCashDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Financial Institutions Used For Cash Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_NumberOfFinancialInstitutionsUsedForCashDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_January2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_May2025PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (in shares)</a></td>
<td class="nump">26,136,939<span></span>
</td>
<td class="nump">10,819,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (in shares)</a></td>
<td class="nump">25,853,605<span></span>
</td>
<td class="nump">10,819,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vtl_PlacementAgentWarrantsMember', window );">Placement agent warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (in shares)</a></td>
<td class="nump">283,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vtl_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vtl_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Other Current Assets and Prepaid Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_PrepaidClinicalAndRelatedCostsCurrent', window );">Prepaid clinical and related costs</a></td>
<td class="nump">$ 2,467<span></span>
</td>
<td class="nump">$ 1,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">VAT receivable</a></td>
<td class="nump">594<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">861<span></span>
</td>
<td class="nump">948<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 4,532<span></span>
</td>
<td class="nump">$ 3,664<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_PrepaidClinicalAndRelatedCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Clinical And Related Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_PrepaidClinicalAndRelatedCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Accounts Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ClinicalCostsPayableCurrent', window );">Clinical costs</a></td>
<td class="nump">$ 7,015<span></span>
</td>
<td class="nump">$ 7,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_LegalAndAuditCostsPayableCurrent', window );">Legal and audit costs</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Total</a></td>
<td class="nump">$ 7,893<span></span>
</td>
<td class="nump">$ 7,846<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ClinicalCostsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical Costs Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ClinicalCostsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_LegalAndAuditCostsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Legal And Audit Costs Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_LegalAndAuditCostsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_AccruedClinicalCostsCurrent', window );">Accrued clinical and related costs</a></td>
<td class="nump">$ 16,227<span></span>
</td>
<td class="nump">$ 12,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_AccruedLegalAndAuditCostsCurrent', window );">Accrued legal and audit costs</a></td>
<td class="nump">353<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_AccruedCompensationCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,457<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 18,113<span></span>
</td>
<td class="nump">$ 12,913<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_AccruedClinicalCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_AccruedClinicalCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_AccruedCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Compensation, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_AccruedCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_AccruedLegalAndAuditCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Legal And Audit Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_AccruedLegalAndAuditCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">$ 774<span></span>
</td>
<td class="nump">$ 740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Total<span></span>
</td>
<td class="text">Total<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,307<span></span>
</td>
<td class="nump">$ 1,416<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Apr. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_OperatingAndVariableLeasesCost', window );">Operating and variable lease costs</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
<td class="nump">$ 591<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=vtl_NewYorkCityMember', window );">New York City</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal option period (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Increase in operating lease, right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_OperatingLeaseIncrementalBorrowingRate', window );">Incremental borrowing rate on operating leases (as a percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=vtl_GrafelfingGermanyMember', window );">Grafelfing, Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Increase in operating lease, right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=vtl_PlaneggGermanyMember', window );">Planegg, Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_OperatingLeaseIncrementalBorrowingRate', window );">Incremental borrowing rate on operating leases (as a percent)</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_OperatingAndVariableLeasesCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Variable Leases, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_OperatingAndVariableLeasesCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_OperatingLeaseIncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Incremental Borrowing Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_OperatingLeaseIncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=vtl_NewYorkCityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=vtl_NewYorkCityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=vtl_GrafelfingGermanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=vtl_GrafelfingGermanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=vtl_PlaneggGermanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=vtl_PlaneggGermanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Operating Lease Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2025</a></td>
<td class="nump">$ 415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">1,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Interest</a></td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of obligation</a></td>
<td class="nump">$ 979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">$ 47,190<span></span>
</td>
<td class="nump">$ 14,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">47,190<span></span>
</td>
<td class="nump">14,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">47,190<span></span>
</td>
<td class="nump">14,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">47,190<span></span>
</td>
<td class="nump">14,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 04, 2024</div></th>
<th class="th"><div>Jan. 08, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_TrancheRightFairValueDisclosure', window );">Tranche right, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement', window );">Reclassification of future tranche right liability upon settlement</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">4.16%<span></span>
</td>
<td class="nump">3.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">105.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">1 year 7 months 28 days<span></span>
</td>
<td class="text">1 year 9 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">4.63%<span></span>
</td>
<td class="nump">4.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">105.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">4 years 7 months 28 days<span></span>
</td>
<td class="text">4 years 9 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Investment interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Reclassification of Future Tranche Right Liability Upon Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_TrancheRightFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tranche Right, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_TrancheRightFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Schedule of Fair Value of Tranche Rights (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">December 31, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value as of January 8, 2024</a></td>
<td class="nump">23,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value through March 4, 2024</a></td>
<td class="nump">4,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity', window );">Reclassification to equity in March 2024</a></td>
<td class="num">(28,396)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">December 31, 2024</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag', window );">Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag</a></td>
<td class="text">Fair value as of January 8, 2024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Reclassification To Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Shelf Registration Statement (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>d</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration', window );">Maximum aggregate offering price of common stock, preferred stock, warrants, debt securities, and/or units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_December2020ATMMember', window );">December 2020 ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration', window );">Maximum aggregate offering price of common stock, preferred stock, warrants, debt securities, and/or units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (in shares) | shares</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Issuance of stock (in usd per share) | $ / shares</a></td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForCommissions', window );">Underwriter commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2022ATMMember', window );">May 2022 ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration', window );">Maximum aggregate offering price of common stock, preferred stock, warrants, debt securities, and/or units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025AndMay2025FinancingMember', window );">April 2025 And May 2025 Financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration', window );">Unsold securities to be sold under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 342,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2024ATMMember', window );">May 2024 ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration', window );">Maximum aggregate offering price of common stock, preferred stock, warrants, debt securities, and/or units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays', window );">Shelf registration, termination, prior written notice (in days) | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SaleOfStockRemainingCapacity', window );">Sale of stock, remaining capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SalesOfStockCommissionsPercentOfGrossProceeds', window );">Commission, percent of gross proceeds from sale of common stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Aggregate Offering Price Of Securities Under Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SaleOfStockRemainingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Remaining Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SaleOfStockRemainingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SalesOfStockCommissionsPercentOfGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales of Stock, Commissions, Percent Of Gross Proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SalesOfStockCommissionsPercentOfGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shelf Registration, Termination, Prior Written Notice, Number of Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unsold Securities Rolled Over To Be Sold Under New Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_December2020ATMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_December2020ATMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2022ATMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_May2022ATMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025AndMay2025FinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_April2025AndMay2025FinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_May2024ATMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_May2024ATMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - April 2025 Offering (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 28, 2025</div></th>
<th class="th"><div>Apr. 09, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Share price (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PlacementAgencyAgreementMember', window );">Placement Agency Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_PlacementAgentAgreementBrokerageFeePercent', window );">Placement agent agreement, cash fee, percent of gross proceeds from offering (as a percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction', window );">Shares sold in the offering (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Initial exercise price per share of common stock (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Initial exercise price per share (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_OfferingMember', window );">Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses', window );">Proceeds from issuance, net of offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_PlacementAgentAgreementBrokerageFeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Placement Agent Agreement, Brokerage Fee, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_PlacementAgentAgreementBrokerageFeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock, Net Of Offering Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PlacementAgencyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_PlacementAgencyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_OfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_OfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - May 2025 Equity Offering (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 28, 2025</div></th>
<th class="th"><div>Apr. 09, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember', window );">Pre-funded stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares)</a></td>
<td class="nump">86,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,193,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_OwnershipLimitationPercentage', window );">Ownership limitation (as a percent)</a></td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder', window );">Ownership limitation upon election of the holder (as a percent)</a></td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate proceeds from the offering</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember', window );">Pre-funded stock warrants | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_OwnershipLimitationPercentage', window );">Ownership limitation (as a percent)</a></td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember', window );">Pre-funded stock warrants | Series A Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares)</a></td>
<td class="nump">86,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember', window );">Pre-funded stock warrants | Series B Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares)</a></td>
<td class="nump">86,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance', window );">Expiration period from the date of issuance</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember', window );">Pre-funded stock warrants | Series A Warrant and Series B Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 0.7499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember', window );">Pre-funded stock warrants | VWAP Target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod', window );">Consecutive trading days</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PlacementAgencyAgreementMember', window );">Placement Agency Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_PlacementAgentAgreementBrokerageFeePercent', window );">Placement agent agreement, cash fee, percent of gross proceeds from offering (as a percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Exercise Price of Warrants or Rights, Consecutive Trading Day Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Expiration Period From The Date Of Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_OwnershipLimitationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership Limitation Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_OwnershipLimitationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_OwnershipLimitationPercentageUponElectionOfTheHolder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership Limitation Percentage Upon Election Of The Holder</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_OwnershipLimitationPercentageUponElectionOfTheHolder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_PlacementAgentAgreementBrokerageFeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Placement Agent Agreement, Brokerage Fee, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_PlacementAgentAgreementBrokerageFeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesAWarrantAndSeriesBWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesAWarrantAndSeriesBWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=vtl_VolumeWeightageAveragePriceTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=vtl_VolumeWeightageAveragePriceTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PlacementAgencyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_PlacementAgencyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - January 2024 Financing (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">114 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 08, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 04, 2024 </div>
<div>USD ($) </div>
<div>tranche </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 04, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 03, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement', window );">Reclassification of future tranche right liability upon settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="nump">130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts', window );">Change in fair value of the tranche rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis=us-gaap_EquityMember', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts', window );">Change in fair value of the tranche rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts', window );">Change in fair value of the tranche rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SaleOfStockPrivatePlacementNumberOfTranche', window );">Private placement, number of tranche | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Common Stock | Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Common Stock | Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Common Stock | Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Pre-funded stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement', window );">Reclassification of future tranche right liability upon settlement</a></td>
<td class="nump">23,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_CommonStockAndPreFundedWarrantsMember', window );">Common Stock and Pre-funded Warrants | Common Stock and Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_TrancheRightsLiabilityRemainderAmount', window );">Tranche rights as a liability, remainder amount</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_TrancheRightsLiabilityReceivedAmount', window );">Tranche rights as a liability, received amount</a></td>
<td class="nump">$ 56,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=vtl_AccreditedInvestorsMember', window );">Accredited Investors | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=vtl_AccreditedInvestorsMember', window );">Accredited Investors | Private Placement | Common Stock | Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_CommonStockNumberOfSharesRegisteredForResale', window );">Number of shares registered for resale (in shares) | shares</a></td>
<td class="nump">55,944,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=vtl_AccreditedInvestorsMember', window );">Accredited Investors | Private Placement | Common Stock | Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SaleOfStockConsiderationReceivedPercentage', window );">Sale of stock, consideration received (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SaleOfStockNumberOfTrancheConditions', window );">Number of tranche subjected to condition | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation', window );">Threshold trading days for weighted average price calculation (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_WeightedAveragePriceOfLast10Days', window );">Weighted average price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation', window );">Threshold trading days for aggregate trading volume calculation (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days', window );">Aggregate trading volume of last 10 days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=vtl_AccreditedInvestorsMember', window );">Accredited Investors | Private Placement | Common Stock | Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SaleOfStockEquityOfferingsPeriod', window );">Third tranche close period after second tranche (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_CommonStockNumberOfSharesRegisteredForResale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Number Of Shares Registered For Resale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_CommonStockNumberOfSharesRegisteredForResale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Change in Fair Value of Tranche Rights, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Reclassification of Future Tranche Right Liability Upon Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SaleOfStockAggregateTradingVolumeOfLast10Days">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Trading Volume of Last 10 Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SaleOfStockAggregateTradingVolumeOfLast10Days</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SaleOfStockConsiderationReceivedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Consideration Received, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SaleOfStockConsiderationReceivedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SaleOfStockEquityOfferingsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Equity Offerings, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SaleOfStockEquityOfferingsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SaleOfStockNumberOfTrancheConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Number of Tranche Conditions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SaleOfStockNumberOfTrancheConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SaleOfStockPrivatePlacementNumberOfTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Private Placement, Number of Tranche</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SaleOfStockPrivatePlacementNumberOfTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold Trading Days for Aggregate Trading Volume Calculation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold Trading Days for Weighted Average Price Calculation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_TrancheRightsLiabilityReceivedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tranche Rights Liability, Received Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_TrancheRightsLiabilityReceivedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_TrancheRightsLiabilityRemainderAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tranche Rights Liability, Remainder Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_TrancheRightsLiabilityRemainderAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_WeightedAveragePriceOfLast10Days">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Price of Last 10 Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_WeightedAveragePriceOfLast10Days</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis=us-gaap_EquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis=us-gaap_EquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vtl_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vtl_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_CommonStockAndPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_CommonStockAndPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vtl_CommonStockAndPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vtl_CommonStockAndPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=vtl_AccreditedInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=vtl_AccreditedInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 04, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 08, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_NumberOfVotesPerEachShareOfCommonStock', window );">Number of votes per each share of common stock | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common stock, cash dividends paid (in usd per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Common stock, cash dividends declared (in usd per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_NumberOfVotesPerEachShareOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Votes Per Each Share of Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_NumberOfVotesPerEachShareOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Pre-funded Warrants (Details) - Pre-funded stock warrants - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>May 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant exercised (in shares)</a></td>
<td class="nump">11,193,564<span></span>
</td>
<td class="nump">86,666,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Shares exercised from pre-funded warrants (in shares)</a></td>
<td class="nump">2,613,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares issued from exercise of pre-funded warrants (in shares)</a></td>
<td class="nump">8,580,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vtl_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Preferred Stock (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Schedule of Shares Reserved for Future Issuance (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">389,308,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Second tranche</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">46,620,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">25,853,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding stock options | 2021 Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">708,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vtl_PreFundedWarrantsMember', window );">Pre-funded stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">8,580,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vtl_PlacementAgentWarrantsMember', window );">Placement agent warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">283,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vtl_May2025PreFundedWarrantsMember', window );">Shares reserved for the May 2025 Pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">86,666,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vtl_May2025SeriesAWarrantsMember', window );">Shares reserved for the May 2025 Series A warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">86,666,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vtl_May2025SeriesBWarrantsMember', window );">Maximum shares reserved for the May 2025 Series B warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">86,666,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vtl_EmployeeStockOptionsforFutureGrantMember', window );">Common stock options available for future grant: | 2017 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">46,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vtl_EmployeeStockOptionsforFutureGrantMember', window );">Common stock options available for future grant: | 2019 Omnibus Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common shares reserved for future issuance (in shares)</a></td>
<td class="nump">596,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_May2025PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_May2025PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_May2025SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_May2025SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_May2025SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_May2025SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_EmployeeStockOptionsforFutureGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_EmployeeStockOptionsforFutureGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_A2017InducementEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_A2017InducementEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Plans - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 04, 2025</div></th>
<th class="th"><div>Mar. 04, 2024</div></th>
<th class="th"><div>Jan. 08, 2024</div></th>
<th class="th"><div>Jun. 28, 2023</div></th>
<th class="th"><div>Aug. 01, 2021</div></th>
<th class="th"><div>Apr. 25, 2021</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares', window );">Options repriced (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,317,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice', window );">Stock-based compensation, exercise price (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Repricing cost during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">$ 56,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 7 months 28 days<span></span>
</td>
<td class="text">4 years 9 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 28 days<span></span>
</td>
<td class="text">1 year 9 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2021EmployeeStockPurchasePlanMember', window );">2021 Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum annual contributions per employee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Purchase price of the stock, at discount from market price at purchase date (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares issued under the ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember', window );">2019 Omnibus Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 10 months 28 days<span></span>
</td>
<td class="text">5 years 11 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted in period, weighted-average grant date fair value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period over which compensation cost will be recognized (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 1 month 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember', window );">2019 Omnibus Equity Incentive Plan | Incentive stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember', window );">2019 Omnibus Equity Incentive Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember', window );">2019 Omnibus Equity Incentive Plan | Maximum | Non-statutory options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember', window );">2019 Omnibus Equity Incentive Plan | Minimum | Non-statutory options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember', window );">2019 Omnibus Equity Incentive Plan, Evergreen Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,408,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent', window );">Additional shares authorized (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease', window );">Increase in other share (in shares)</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_TwoThousandFourteenEquityIncentivePlanMember', window );">2014 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2017InducementEquityIncentivePlanMember', window );">2017 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other than shares newly issued, the number of additional shares issued (for example, a stock split) or canceled (for example, to correct a share issuance), during the period under the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-Based Payment Award, Additional Shares Authorized, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation By Share-Based Payment Award, Options, Repriced, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Plan Modification, Option, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_IncentiveEmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_IncentiveEmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtl_NonStatutoryEmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtl_NonStatutoryEmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_TwoThousandFourteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_TwoThousandFourteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_A2017InducementEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_A2017InducementEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details) - Outstanding stock options - 2019 Omnibus Equity Incentive Plan - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">16,136,045<span></span>
</td>
<td class="nump">6,196,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">9,937,100<span></span>
</td>
<td class="nump">4,810,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod', window );">Repricing modification (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or expired (in shares)</a></td>
<td class="num">(219,540)<span></span>
</td>
<td class="num">(186,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">25,853,605<span></span>
</td>
<td class="nump">10,819,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable, ending balance (in shares)</a></td>
<td class="nump">7,042,889<span></span>
</td>
<td class="nump">3,606,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in usd per share)</a></td>
<td class="nump">$ 1.52<span></span>
</td>
<td class="nump">$ 7.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share)</a></td>
<td class="nump">0.78<span></span>
</td>
<td class="nump">1.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice', window );">Repricing modifications (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired (in usd per share)</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="nump">2.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in usd per share)</a></td>
<td class="nump">1.24<span></span>
</td>
<td class="nump">1.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable, ending balance (in usd per share)</a></td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="nump">$ 2.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted-Average Remaining Contractual Term and Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted-Average Remaining Contractual Term, Ending balance (in years)</a></td>
<td class="text">8 years 9 months 7 days<span></span>
</td>
<td class="text">8 years 5 months 4 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable, Weighted-Average Remaining Contractual Term, Ending balance (in years)</a></td>
<td class="text">7 years 14 days<span></span>
</td>
<td class="text">6 years 11 months 19 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value, Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable, Aggregate Intrinsic Value, Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Repricing Modification in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Repricing Modifications Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Plans - Schedule of Valuation Assumptions Used (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 04, 2024</div></th>
<th class="th"><div>Jan. 08, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember', window );">2019 Omnibus Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.14%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116.00%<span></span>
</td>
<td class="nump">99.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 10 months 28 days<span></span>
</td>
<td class="text">5 years 11 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtl_A2019OmnibusEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Plans - Schedule of Stock-Based Compensation Expense for Stock Awards Recognized (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,941<span></span>
</td>
<td class="nump">$ 4,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=vtl_EmployeeMember', window );">Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">$ 1,899,000<span></span>
</td>
<td class="nump">$ 1,882,000<span></span>
</td>
<td class="nump">3,941,000<span></span>
</td>
<td class="nump">4,632,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=vtl_EmployeeMember', window );">Employees | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">761,000<span></span>
</td>
<td class="nump">842,000<span></span>
</td>
<td class="nump">1,592,000<span></span>
</td>
<td class="nump">2,005,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=vtl_EmployeeMember', window );">Employees | General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">$ 1,138,000<span></span>
</td>
<td class="nump">$ 1,040,000<span></span>
</td>
<td class="nump">$ 2,349,000<span></span>
</td>
<td class="nump">$ 2,627,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=vtl_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=vtl_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 29, 2024</div></th>
<th class="th"><div>Oct. 17, 2023</div></th>
<th class="th"><div>Dec. 28, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=vtl_DuaneNashMDJDMBAMember', window );">Duane Nash, MD, JD, MBA | Executive Chairman Agreement | Board of Directors Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_SalaryAndWageOfficerMonthlyBaseSalary', window );">Monthly base salary</a></td>
<td class="nump">$ 33,986<span></span>
</td>
<td class="nump">$ 32,368<span></span>
</td>
<td class="nump">$ 30,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_SalaryAndWageOfficerMonthlyBaseSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Salary and Wage, Officer, Monthly Base Salary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_SalaryAndWageOfficerMonthlyBaseSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vtl_DuaneNashMDJDMBAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vtl_DuaneNashMDJDMBAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=vtl_ExecutiveChairmanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=vtl_ExecutiveChairmanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual obligation</a></td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures - Schedule of Significant Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,941<span></span>
</td>
<td class="nump">$ 4,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">$ 27,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,908<span></span>
</td>
<td class="nump">46,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(27,083)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,814)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,908)<span></span>
</td>
<td class="num">(46,695)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="nump">2,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts', window );">Change in fair value of the tranche rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="num">(1,658)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,820)<span></span>
</td>
<td class="num">$ (25,473)<span></span>
</td>
<td class="num">(21,380)<span></span>
</td>
<td class="num">$ (29,584)<span></span>
</td>
<td class="num">(52,293)<span></span>
</td>
<td class="num">(50,964)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtl_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_ClinicalProductCandidates', window );">Clinical product candidates</a></td>
<td class="nump">17,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,491<span></span>
</td>
<td class="nump">29,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_PreClinicalProductCandidates', window );">Pre-clinical product candidates</a></td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="nump">1,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,941<span></span>
</td>
<td class="nump">4,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation expense</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees and other segment expenses</a></td>
<td class="nump">2,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,641<span></span>
</td>
<td class="nump">5,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">27,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,908<span></span>
</td>
<td class="nump">46,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(27,083)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,814)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,908)<span></span>
</td>
<td class="num">(46,695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="nump">2,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts', window );">Change in fair value of the tranche rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="num">(1,658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,820)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,380)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,293)<span></span>
</td>
<td class="num">(50,964)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtl_ReportableSegmentMember', window );">Reportable Segment | Employee costs- research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employee costs</a></td>
<td class="nump">2,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,761<span></span>
</td>
<td class="nump">3,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtl_ReportableSegmentMember', window );">Reportable Segment | Employee costs-general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employee costs</a></td>
<td class="nump">$ 2,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,643<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_ClinicalProductCandidates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical Product Candidates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_ClinicalProductCandidates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Change in Fair Value of Tranche Rights, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtl_PreClinicalProductCandidates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre Clinical Product Candidates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtl_PreClinicalProductCandidates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtl_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtl_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jul. 07, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Series A Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Series B Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | January 2024 Pre-Funded Warrants | Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | January 2024 Pre-Funded Warrants | Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs) | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable (in usd per share)</a></td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs) | Subsequent Event | Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">22,015,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=vtl_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=vtl_January2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=vtl_January2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>248</ContextCount>
  <ElementCount>283</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>76</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Statement - Condensed Consolidated Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows</Role>
      <ShortName>Condensed Consolidated Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Description of Business and Basis of Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatements</Role>
      <ShortName>Description of Business and Basis of Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Stock-Based Compensation Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/StockBasedCompensationPlans</Role>
      <ShortName>Stock-Based Compensation Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Segment Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SegmentDisclosures</Role>
      <ShortName>Segment Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/BalanceSheetDetails</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/Leases</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/FairValue</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/CommonStock</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Stock-Based Compensation Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/StockBasedCompensationPlansTables</Role>
      <ShortName>Stock-Based Compensation Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/StockBasedCompensationPlans</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Segment Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SegmentDisclosuresTables</Role>
      <ShortName>Segment Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/SegmentDisclosures</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Description of Business and Basis of Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails</Role>
      <ShortName>Description of Business and Basis of Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Balance Sheet Details - Schedule of Other Current Assets and Prepaid Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails</Role>
      <ShortName>Balance Sheet Details - Schedule of Other Current Assets and Prepaid Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Balance Sheet Details - Schedule of Accounts Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails</Role>
      <ShortName>Balance Sheet Details - Schedule of Accounts Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Balance Sheet Details - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails</Role>
      <ShortName>Balance Sheet Details - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Balance Sheet Details - Schedule of Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Schedule of Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Leases - Schedule of Maturities of Operating Lease Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Operating Lease Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Fair Value - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Fair Value - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/FairValueAdditionalInformationDetails</Role>
      <ShortName>Fair Value - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Fair Value - Schedule of Fair Value of Tranche Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails</Role>
      <ShortName>Fair Value - Schedule of Fair Value of Tranche Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Common Stock - Shelf Registration Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails</Role>
      <ShortName>Common Stock - Shelf Registration Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Common Stock - April 2025 Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails</Role>
      <ShortName>Common Stock - April 2025 Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Common Stock - May 2025 Equity Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails</Role>
      <ShortName>Common Stock - May 2025 Equity Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Common Stock - January 2024 Financing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails</Role>
      <ShortName>Common Stock - January 2024 Financing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Common Stock - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockCommonStockDetails</Role>
      <ShortName>Common Stock - Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Common Stock - Pre-funded Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails</Role>
      <ShortName>Common Stock - Pre-funded Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Common Stock - Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockPreferredStockDetails</Role>
      <ShortName>Common Stock - Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Common Stock - Schedule of Shares Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails</Role>
      <ShortName>Common Stock - Schedule of Shares Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Stock-Based Compensation Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Stock-Based Compensation Plans - Schedule of Valuation Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails</Role>
      <ShortName>Stock-Based Compensation Plans - Schedule of Valuation Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Stock-Based Compensation Plans - Schedule of Stock-Based Compensation Expense for Stock Awards Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails</Role>
      <ShortName>Stock-Based Compensation Plans - Schedule of Stock-Based Compensation Expense for Stock Awards Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/RelatedPartyTransactions</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/CommitmentsandContingencies</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Segment Disclosures - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SegmentDisclosuresAdditionalInformationDetails</Role>
      <ShortName>Segment Disclosures - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Segment Disclosures - Schedule of Significant Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails</Role>
      <ShortName>Segment Disclosures - Schedule of Significant Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="vtl-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vitaltherapies.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vitaltherapies.com/role/SubsequentEvents</ParentRole>
      <Position>57</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="vtl-20250630.htm">vtl-20250630.htm</File>
    <File>vtl-20250630.xsd</File>
    <File>vtl-20250630_cal.xml</File>
    <File>vtl-20250630_def.xml</File>
    <File>vtl-20250630_lab.xml</File>
    <File>vtl-20250630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>vtl-20250630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="608">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "vtl-20250630.htm": {
   "nsprefix": "vtl",
   "nsuri": "http://vitaltherapies.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "vtl-20250630.htm"
     ]
    },
    "schema": {
     "local": [
      "vtl-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "vtl-20250630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vtl-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "vtl-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vtl-20250630_pre.xml"
     ]
    }
   },
   "keyStandard": 229,
   "keyCustom": 54,
   "axisStandard": 22,
   "axisCustom": 0,
   "memberStandard": 28,
   "memberCustom": 39,
   "hidden": {
    "total": 15,
    "http://fasb.org/us-gaap/2025": 8,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://vitaltherapies.com/20250630": 2
   },
   "contextCount": 248,
   "entityCount": 1,
   "segmentCount": 76,
   "elementCount": 555,
   "unitCount": 13,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 608,
    "http://xbrl.sec.gov/dei/2025": 31,
    "http://xbrl.sec.gov/ecd/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://vitaltherapies.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-34",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-39",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
     "longName": "9952157 - Statement - Condensed Consolidated Statement of Cash Flows",
     "shortName": "Condensed Consolidated Statement of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatements",
     "longName": "9952158 - Disclosure - Description of Business and Basis of Financial Statements",
     "shortName": "Description of Business and Basis of Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952159 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://vitaltherapies.com/role/BalanceSheetDetails",
     "longName": "9952160 - Disclosure - Balance Sheet Details",
     "shortName": "Balance Sheet Details",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://vitaltherapies.com/role/Leases",
     "longName": "9952161 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://vitaltherapies.com/role/FairValue",
     "longName": "9952162 - Disclosure - Fair Value",
     "shortName": "Fair Value",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://vitaltherapies.com/role/CommonStock",
     "longName": "9952163 - Disclosure - Common Stock",
     "shortName": "Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://vitaltherapies.com/role/StockBasedCompensationPlans",
     "longName": "9952164 - Disclosure - Stock-Based Compensation Plans",
     "shortName": "Stock-Based Compensation Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://vitaltherapies.com/role/RelatedPartyTransactions",
     "longName": "9952165 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://vitaltherapies.com/role/CommitmentsandContingencies",
     "longName": "9952166 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://vitaltherapies.com/role/SegmentDisclosures",
     "longName": "9952167 - Disclosure - Segment Disclosures",
     "shortName": "Segment Disclosures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://vitaltherapies.com/role/SubsequentEvents",
     "longName": "9952168 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://vitaltherapies.com/role/BalanceSheetDetailsTables",
     "longName": "9955513 - Disclosure - Balance Sheet Details (Tables)",
     "shortName": "Balance Sheet Details (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://vitaltherapies.com/role/LeasesTables",
     "longName": "9955514 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://vitaltherapies.com/role/FairValueTables",
     "longName": "9955515 - Disclosure - Fair Value (Tables)",
     "shortName": "Fair Value (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://vitaltherapies.com/role/CommonStockTables",
     "longName": "9955516 - Disclosure - Common Stock (Tables)",
     "shortName": "Common Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "vtl:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "vtl:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://vitaltherapies.com/role/StockBasedCompensationPlansTables",
     "longName": "9955517 - Disclosure - Stock-Based Compensation Plans (Tables)",
     "shortName": "Stock-Based Compensation Plans (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://vitaltherapies.com/role/SegmentDisclosuresTables",
     "longName": "9955518 - Disclosure - Segment Disclosures (Tables)",
     "shortName": "Segment Disclosures (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails",
     "longName": "9955519 - Disclosure - Description of Business and Basis of Financial Statements (Details)",
     "shortName": "Description of Business and Basis of Financial Statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "vtl:NumberOfDevelopmentPrograms",
      "unitRef": "program",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "vtl:NumberOfDevelopmentPrograms",
      "unitRef": "program",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "9955520 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails",
     "longName": "9955521 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails",
     "longName": "9955522 - Disclosure - Balance Sheet Details - Schedule of Other Current Assets and Prepaid Expenses (Details)",
     "shortName": "Balance Sheet Details - Schedule of Other Current Assets and Prepaid Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "vtl:PrepaidClinicalAndRelatedCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "vtl:PrepaidClinicalAndRelatedCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails",
     "longName": "9955523 - Disclosure - Balance Sheet Details - Schedule of Accounts Payable (Details)",
     "shortName": "Balance Sheet Details - Schedule of Accounts Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "vtl:ClinicalCostsPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "vtl:ClinicalCostsPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails",
     "longName": "9955524 - Disclosure - Balance Sheet Details - Schedule of Accrued Expenses (Details)",
     "shortName": "Balance Sheet Details - Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "vtl:AccruedClinicalCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "vtl:AccruedClinicalCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails",
     "longName": "9955525 - Disclosure - Balance Sheet Details - Schedule of Other Current Liabilities (Details)",
     "shortName": "Balance Sheet Details - Schedule of Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails",
     "longName": "9955526 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "vtl:OperatingAndVariableLeasesCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "vtl:OperatingAndVariableLeasesCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails",
     "longName": "9955527 - Disclosure - Leases - Schedule of Maturities of Operating Lease Obligations (Details)",
     "shortName": "Leases - Schedule of Maturities of Operating Lease Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "longName": "9955528 - Disclosure - Fair Value - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "shortName": "Fair Value - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-97",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-97",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
     "longName": "9955529 - Disclosure - Fair Value - Additional Information (Details)",
     "shortName": "Fair Value - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-109",
      "name": "vtl:TrancheRightFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-109",
      "name": "vtl:TrancheRightFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails",
     "longName": "9955530 - Disclosure - Fair Value - Schedule of Fair Value of Tranche Rights (Details)",
     "shortName": "Fair Value - Schedule of Fair Value of Tranche Rights (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-38",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-38",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails",
     "longName": "9955531 - Disclosure - Common Stock - Shelf Registration Statement (Details)",
     "shortName": "Common Stock - Shelf Registration Statement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-120",
      "name": "vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-120",
      "name": "vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
     "longName": "9955532 - Disclosure - Common Stock - April 2025 Offering (Details)",
     "shortName": "Common Stock - April 2025 Offering (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-129",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
     "longName": "9955533 - Disclosure - Common Stock - May 2025 Equity Offering (Details)",
     "shortName": "Common Stock - May 2025 Equity Offering (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-134",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
     "longName": "9955534 - Disclosure - Common Stock - January 2024 Financing (Details)",
     "shortName": "Common Stock - January 2024 Financing (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-71",
      "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-157",
      "name": "vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
     "longName": "9955535 - Disclosure - Common Stock - Common Stock (Details)",
     "shortName": "Common Stock - Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "vtl:NumberOfVotesPerEachShareOfCommonStock",
      "unitRef": "vote",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails",
     "longName": "9955536 - Disclosure - Common Stock - Pre-funded Warrants (Details)",
     "shortName": "Common Stock - Pre-funded Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-161",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-162",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://vitaltherapies.com/role/CommonStockPreferredStockDetails",
     "longName": "9955537 - Disclosure - Common Stock - Preferred Stock (Details)",
     "shortName": "Common Stock - Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R48": {
     "role": "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
     "longName": "9955538 - Disclosure - Common Stock - Schedule of Shares Reserved for Future Issuance (Details)",
     "shortName": "Common Stock - Schedule of Shares Reserved for Future Issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtl:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtl:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
     "longName": "9955539 - Disclosure - Stock-Based Compensation Plans - Additional Information (Details)",
     "shortName": "Stock-Based Compensation Plans - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-116",
      "name": "vtl:ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-116",
      "name": "vtl:ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
     "longName": "9955540 - Disclosure - Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details)",
     "shortName": "Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-192",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-192",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails",
     "longName": "9955541 - Disclosure - Stock-Based Compensation Plans - Schedule of Valuation Assumptions Used (Details)",
     "shortName": "Stock-Based Compensation Plans - Schedule of Valuation Assumptions Used (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-116",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails",
     "longName": "9955542 - Disclosure - Stock-Based Compensation Plans - Schedule of Stock-Based Compensation Expense for Stock Awards Recognized (Details)",
     "shortName": "Stock-Based Compensation Plans - Schedule of Stock-Based Compensation Expense for Stock Awards Recognized (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-208",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails",
     "longName": "9955543 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-229",
      "name": "vtl:SalaryAndWageOfficerMonthlyBaseSalary",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-229",
      "name": "vtl:SalaryAndWageOfficerMonthlyBaseSalary",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://vitaltherapies.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955544 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractualObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractualObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://vitaltherapies.com/role/SegmentDisclosuresAdditionalInformationDetails",
     "longName": "9955545 - Disclosure - Segment Disclosures - Additional Information (Details)",
     "shortName": "Segment Disclosures - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails",
     "longName": "9955546 - Disclosure - Segment Disclosures - Schedule of Significant Expense (Details)",
     "shortName": "Segment Disclosures - Schedule of Significant Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-230",
      "name": "vtl:ClinicalProductCandidates",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://vitaltherapies.com/role/SubsequentEventsDetails",
     "longName": "9955547 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-244",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtl-20250630.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "vtl_A2017InducementEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "A2017InducementEquityIncentivePlanMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 Inducement Equity Incentive Plan",
        "label": "2017 Inducement Equity Incentive Plan [Member]",
        "documentation": "2017 Inducement Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_A2019OmnibusEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "A2019OmnibusEquityIncentivePlanMember",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 Omnibus Equity Incentive Plan",
        "label": "2019 Omnibus Equity Incentive Plan [Member]",
        "documentation": "2019 Omnibus Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_A2021EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "A2021EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Employee stock purchase plan",
        "label": "2021 Employee Stock Purchase Plan [Member]",
        "documentation": "2021 Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "AU",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Australia",
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "totalLabel": "Total",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r731"
     ]
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableOtherCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails": {
       "parentTag": "us-gaap_AccountsPayableCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Accounts Payable, Other, Current",
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "vtl_AccreditedInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "AccreditedInvestorsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accredited Investors",
        "label": "Accredited Investors [Member]",
        "documentation": "Accredited Investors"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_AccruedClinicalCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "AccruedClinicalCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued clinical and related costs",
        "label": "Accrued Clinical Costs, Current",
        "documentation": "Accrued Clinical Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_AccruedCompensationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "AccruedCompensationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Accrued Compensation, Current",
        "documentation": "Accrued Compensation, Current"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_AccruedLegalAndAuditCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "AccruedLegalAndAuditCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued legal and audit costs",
        "label": "Accrued Legal And Audit Costs, Current",
        "documentation": "Accrued Legal And Audit Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r61",
      "r110",
      "r503",
      "r533",
      "r534",
      "r931"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r11",
      "r19",
      "r371",
      "r374",
      "r432",
      "r529",
      "r530",
      "r857",
      "r858",
      "r859",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r731",
      "r991"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r870",
      "r871",
      "r872",
      "r873",
      "r932",
      "r997"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of tranche rights liability to equity",
        "label": "Adjustments to Additional Paid in Capital, Conversion of Tranche Rights Liability to Equity",
        "documentation": "Adjustments to Additional Paid in Capital, Conversion of Tranche Rights Liability to Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r77"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r774",
      "r784",
      "r816"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r777",
      "r787",
      "r819"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r812",
      "r820",
      "r824",
      "r832"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r331",
      "r340"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potentially dilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "vtl_April2025AndMay2025FinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "April2025AndMay2025FinancingMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April 2025 And May 2025 Financing",
        "label": "April 2025 And May 2025 Financing [Member]",
        "documentation": "April 2025 And May 2025 Financing"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_April2025PIPETransactionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "April2025PIPETransactionMember",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April 2025 PIPE Transaction",
        "label": "April 2025 P I P E Transaction [Member]",
        "documentation": "April 2025 P I P E Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r90",
      "r106",
      "r129",
      "r130",
      "r131",
      "r164",
      "r177",
      "r195",
      "r199",
      "r208",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r361",
      "r363",
      "r405",
      "r492",
      "r493",
      "r498",
      "r589",
      "r694",
      "r695",
      "r704",
      "r731",
      "r743",
      "r744",
      "r755",
      "r889",
      "r890",
      "r950"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r112",
      "r129",
      "r130",
      "r131",
      "r208",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r361",
      "r363",
      "r405",
      "r731",
      "r889",
      "r890",
      "r950"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total assets at fair value",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r724"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_AtTheMarketSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "AtTheMarketSalesAgreementMember",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At The Market Sales Agreement",
        "label": "At The Market Sales Agreement [Member]",
        "documentation": "At The Market Sales Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Consolidation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Board of Directors Chairman",
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business and Basis of Financial Statements",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r844",
      "r863"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r105",
      "r675"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "terseLabel": "Cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r67",
      "r126"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r67"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r107",
      "r108",
      "r109",
      "r129",
      "r131",
      "r155",
      "r156",
      "r158",
      "r160",
      "r166",
      "r167",
      "r208",
      "r234",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r248",
      "r249",
      "r251",
      "r252",
      "r254",
      "r257",
      "r260",
      "r261",
      "r264",
      "r267",
      "r274",
      "r405",
      "r538",
      "r539",
      "r540",
      "r541",
      "r546",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r577",
      "r598",
      "r620",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r842",
      "r866",
      "r867",
      "r874"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails",
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r166",
      "r251",
      "r260",
      "r261",
      "r262",
      "r264",
      "r267",
      "r272",
      "r274",
      "r369",
      "r538",
      "r539",
      "r540",
      "r541",
      "r705",
      "r842",
      "r864",
      "r866"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in usd per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r132",
      "r275"
     ]
    },
    "vtl_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consecutive trading days",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights, Consecutive Trading Day Period",
        "documentation": "Class of Warrant or Right, Exercise Price of Warrants or Rights, Consecutive Trading Day Period"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance": {
     "xbrltype": "durationItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration period from the date of issuance",
        "label": "Class of Warrant or Right, Expiration Period From The Date Of Issuance",
        "documentation": "Class of Warrant or Right, Expiration Period From The Date Of Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant exercised (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued from exercise of pre-funded warrants (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_ClinicalCostsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ClinicalCostsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails": {
       "parentTag": "us-gaap_AccountsPayableCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical costs",
        "label": "Clinical Costs Payable, Current",
        "documentation": "Clinical Costs Payable, Current"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_ClinicalProductCandidates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ClinicalProductCandidates",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical product candidates",
        "label": "Clinical Product Candidates",
        "documentation": "Clinical Product Candidates"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementAccountingPolicy",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration Arrangements, Daiichi Sankyo Agreement and Ludwig-Maximilians-University Agreement",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for collaborative arrangements."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 9)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r83",
      "r500",
      "r576"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r228",
      "r229",
      "r660",
      "r886",
      "r888"
     ]
    },
    "vtl_CommonStockAndPreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "CommonStockAndPreFundedWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock and Pre-funded Warrants",
        "label": "Common Stock and Pre-funded Warrants [Member]",
        "documentation": "Common Stock and Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total common shares reserved for future issuance (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockDividendsPerShareCashPaid",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, cash dividends declared (in usd per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, cash dividends paid (in usd per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r745",
      "r746",
      "r747",
      "r749",
      "r750",
      "r751",
      "r752",
      "r870",
      "r871",
      "r873",
      "r932",
      "r990",
      "r997"
     ]
    },
    "vtl_CommonStockNumberOfSharesRegisteredForResale": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "CommonStockNumberOfSharesRegisteredForResale",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares registered for resale (in shares)",
        "label": "Common Stock, Number Of Shares Registered For Resale",
        "documentation": "Common Stock, Number Of Shares Registered For Resale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in usd per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r577"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r55",
      "r577",
      "r595",
      "r997",
      "r998"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2025 and December 31, 2024, and 98,650,590 and 90,150,869 shares issued and outstanding as of June 30, 2025 and December\u00a031, 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r249",
      "r256",
      "r502",
      "r731"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r114",
      "r116",
      "r121",
      "r490",
      "r511",
      "r512"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Income (Loss)",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractualObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractualObligation",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual obligation",
        "label": "Contractual Obligation",
        "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments."
       }
      }
     },
     "auth_ref": [
      "r865",
      "r869",
      "r959"
     ]
    },
    "vtl_ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of tranche rights liability to equity upon increase in authorized shares",
        "label": "Conversion of Tranche Rights Liability to Equity Upon Increase in Authorized Shares",
        "documentation": "Conversion of Tranche Rights Liability to Equity Upon Increase in Authorized Shares"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r129",
      "r135",
      "r136",
      "r243",
      "r262",
      "r438",
      "r451",
      "r497",
      "r677",
      "r678",
      "r679",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r927",
      "r928",
      "r929",
      "r930"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "DE",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Germany",
        "label": "GERMANY"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_December2020ATMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "December2020ATMMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "December 2020 ATM",
        "label": "December 2020 ATM [Member]",
        "documentation": "December 2020 ATM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum annual contributions per employee (as a percent)",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r30"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r123",
      "r164",
      "r182",
      "r199",
      "r680",
      "r694",
      "r695"
     ]
    },
    "us-gaap_DepreciationNonproduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationNonproduction",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation, Nonproduction",
        "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r30"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation Plans",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r294",
      "r325",
      "r326",
      "r329",
      "r714"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_DuaneNashMDJDMBAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "DuaneNashMDJDMBAMember",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Duane Nash, MD, JD, MBA",
        "label": "Duane Nash, MD, JD, MBA [Member]",
        "documentation": "Duane Nash, MD, JD, MBA"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, basic (in usd per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r122",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r153",
      "r155",
      "r158",
      "r159",
      "r160",
      "r163",
      "r247",
      "r330",
      "r355",
      "r360",
      "r382",
      "r383",
      "r491",
      "r513",
      "r685"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, diluted (in usd per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r122",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r155",
      "r158",
      "r159",
      "r160",
      "r163",
      "r247",
      "r330",
      "r355",
      "r360",
      "r382",
      "r383",
      "r491",
      "r513",
      "r685"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r162"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "vtl_EmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "EmployeeMember",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees",
        "label": "Employee [Member]",
        "documentation": "Employee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period over which compensation cost will be recognized (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "vtl_EmployeeStockOptionsforFutureGrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "EmployeeStockOptionsforFutureGrantMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock options available for future grant:",
        "label": "Employee Stock Options for Future Grant [Member]",
        "documentation": "Employee Stock Options for Future Grant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of employees",
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r98",
      "r99",
      "r100",
      "r118",
      "r119",
      "r120",
      "r137",
      "r138",
      "r139",
      "r141",
      "r148",
      "r150",
      "r152",
      "r165",
      "r209",
      "r210",
      "r221",
      "r246",
      "r276",
      "r330",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r359",
      "r360",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r421",
      "r423",
      "r432",
      "r510",
      "r529",
      "r530",
      "r531",
      "r546",
      "r620"
     ]
    },
    "us-gaap_EquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity",
        "label": "Equity [Member]",
        "documentation": "Trading in a derivative instrument whose primary underlying risk is tied to share prices."
       }
      }
     },
     "auth_ref": [
      "r721",
      "r723"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r774",
      "r784",
      "r816"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r771",
      "r781",
      "r813"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "vtl_ExecutiveChairmanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ExecutiveChairmanAgreementMember",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Chairman Agreement",
        "label": "Executive Chairman Agreement [Member]",
        "documentation": "Executive Chairman Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ExecutiveOfficerMember",
     "presentation": [
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Officer",
        "label": "Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r397",
      "r724"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r397",
      "r724"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r396",
      "r397",
      "r399",
      "r404",
      "r443",
      "r444",
      "r445",
      "r673",
      "r702",
      "r703",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r724",
      "r726",
      "r730"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r389",
      "r724",
      "r936",
      "r940"
     ]
    },
    "vtl_FairValueChangeInFairValueOfTrancheRightsTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "FairValueChangeInFairValueOfTrancheRightsTransactionCosts",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in fair value of the tranche rights",
        "terseLabel": "Change in fair value of the tranche rights",
        "verboseLabel": "Change in fair value of the tranche rights",
        "label": "Fair Value, Change in Fair Value of Tranche Rights, Transaction Costs",
        "documentation": "Fair Value, Change in Fair Value of Tranche Rights, Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/FairValue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r392",
      "r394",
      "r395",
      "r396",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r488",
      "r724",
      "r727"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r278",
      "r283",
      "r285",
      "r386",
      "r397",
      "r404",
      "r443",
      "r673",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r724",
      "r730"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r278",
      "r283",
      "r285",
      "r287",
      "r386",
      "r387",
      "r397",
      "r404",
      "r444",
      "r673",
      "r702",
      "r703",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r724",
      "r730"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r386",
      "r387",
      "r388",
      "r389",
      "r397",
      "r404",
      "r445",
      "r673",
      "r702",
      "r703",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r724",
      "r726",
      "r730"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of Tranche Rights",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r393",
      "r398"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r389",
      "r724",
      "r936",
      "r940"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value as of January 8, 2024",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r398"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value through March 4, 2024",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r939"
     ]
    },
    "vtl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification to equity in March 2024",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Reclassification To Equity",
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Reclassification To Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "December 31, 2023",
        "periodEndLabel": "December 31, 2024",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r398"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r396",
      "r397",
      "r399",
      "r404",
      "r443",
      "r444",
      "r445",
      "r673",
      "r702",
      "r703",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r724",
      "r726",
      "r730"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Measurements, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r940"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "vtl_FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of future tranche right liability upon settlement",
        "label": "Fair Value, Reclassification of Future Tranche Right Liability Upon Settlement",
        "documentation": "Fair Value, Reclassification of Future Tranche Right Liability Upon Settlement"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFairValueofTrancheRightsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag",
        "label": "Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag",
        "documentation": "Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized foreign currency gain",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r596",
      "r753",
      "r943",
      "r944",
      "r996"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation and Presentation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r820"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r820"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r820"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r820"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r820"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "vtl_GainLossFromChangeInFairValueOfTrancheRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "GainLossFromChangeInFairValueOfTrancheRights",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of tranche rights",
        "label": "Gain (Loss) From Change In Fair Value Of Tranche Rights",
        "documentation": "Gain (Loss) From Change In Fair Value Of Tranche Rights"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r600"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "verboseLabel": "Employee costs-general and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_GovernmentAssistanceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceAmount",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government assistance, income",
        "label": "Government Assistance, Income, Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in income from government assistance."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_GovernmentAssistanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceExpense",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government assistance, expense",
        "label": "Government Assistance, Expense, Decrease (Increase)",
        "documentation": "Amount of decrease (increase) in expense from government assistance."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Assistance, Expense, Decrease (Increase), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Government Assistance, Expense, Decrease (Increase), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes decrease (increase) in expense from government assistance."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_GovernmentAssistancePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistancePolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government assistance",
        "label": "Government Assistance [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for government assistance."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r420"
     ]
    },
    "vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Australian research and development tax incentive",
        "label": "Government Assistance, Qualified Research and Development Expenditures, Maximum Amount",
        "documentation": "Government Assistance, Qualified Research and Development Expenditures, Maximum Amount"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government R&amp;D assistance rate (as a percent)",
        "label": "Government Assistance, Qualified Research and Development Expenditures, Percent",
        "documentation": "Government Assistance, Qualified Research and Development Expenditures, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Government Assistance, Income, Increase (Decrease), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes increase (decrease) in income from government assistance."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "vtl_GrafelfingGermanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "GrafelfingGermanyMember",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grafelfing, Germany",
        "label": "Grafelfing, Germany [Member]",
        "documentation": "Grafelfing, Germany"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r72"
     ]
    },
    "vtl_IncentiveEmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "IncentiveEmployeeStockOptionMember",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive stock options",
        "label": "Incentive Employee Stock Option [Member]",
        "documentation": "Incentive Employee Stock Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r224",
      "r225",
      "r365",
      "r366",
      "r367",
      "r368",
      "r391",
      "r393",
      "r398",
      "r406",
      "r407",
      "r408",
      "r526",
      "r528",
      "r605",
      "r672",
      "r673",
      "r716",
      "r717",
      "r722",
      "r723",
      "r725",
      "r730",
      "r924",
      "r925",
      "r961"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r365",
      "r366",
      "r367",
      "r368",
      "r391",
      "r393",
      "r398",
      "r406",
      "r407",
      "r408",
      "r526",
      "r528",
      "r605",
      "r672",
      "r673",
      "r716",
      "r717",
      "r722",
      "r723",
      "r725",
      "r730",
      "r924",
      "r925",
      "r961"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r537"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r843",
      "r862"
     ]
    },
    "vtl_IncreaseDecreaseInOperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in operating lease, right-of-use asset",
        "label": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset",
        "documentation": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other current assets and prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r812",
      "r820",
      "r824",
      "r832"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r836"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r836"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r836"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "verboseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r180",
      "r199",
      "r694",
      "r861"
     ]
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment interest rate (as a percent)",
        "label": "Investment Interest Rate",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r630",
      "r631",
      "r633",
      "r634",
      "r636",
      "r637",
      "r642",
      "r643",
      "r747",
      "r882",
      "r883"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Type [Axis]",
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r561",
      "r562",
      "r564",
      "r566",
      "r629",
      "r632",
      "r635",
      "r639",
      "r640",
      "r641",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r747"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments [Domain]",
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r561",
      "r562",
      "r564",
      "r566",
      "r629",
      "r632",
      "r635",
      "r639",
      "r640",
      "r641",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r747"
     ]
    },
    "vtl_January2024PIPETransactionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "January2024PIPETransactionMember",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2024 PIPE Transaction",
        "label": "January 2024 P I P E Transaction [Member]",
        "documentation": "January 2024 P I P E Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_January2024PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "January2024PreFundedWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/SubsequentEventsDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2024 Pre-Funded Warrants",
        "label": "January 2024 Pre-Funded Warrants [Member]",
        "documentation": "January Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee costs",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r683",
      "r860"
     ]
    },
    "vtl_LegalAndAuditCostsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "LegalAndAuditCostsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails": {
       "parentTag": "us-gaap_AccountsPayableCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccountsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal and audit costs",
        "label": "Legal And Audit Costs Payable, Current",
        "documentation": "Legal And Audit Costs Payable, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r431"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r431"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Operating Lease Obligation",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r865",
      "r869",
      "r959"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r865",
      "r869",
      "r959"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r865",
      "r869",
      "r959"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r865",
      "r869",
      "r959"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Renewal option period (in months)",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease term (in months)",
        "terseLabel": "Lease term (in years)",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "vtl_LesseeOperatingLeasesNumberOfExistingLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "LesseeOperatingLeasesNumberOfExistingLeases",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of existing leases",
        "label": "Lessee, Operating Leases, Number Of Existing Leases",
        "documentation": "Lessee, Operating Leases, Number Of Existing Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r129",
      "r130",
      "r131",
      "r208",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r362",
      "r363",
      "r364",
      "r405",
      "r575",
      "r688",
      "r704",
      "r755",
      "r889",
      "r950",
      "r951"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r84",
      "r505",
      "r731",
      "r743",
      "r744",
      "r864",
      "r868",
      "r884",
      "r942"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r104",
      "r129",
      "r130",
      "r131",
      "r208",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r362",
      "r363",
      "r364",
      "r405",
      "r731",
      "r889",
      "r950",
      "r951"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r50",
      "r51",
      "r52",
      "r53",
      "r129",
      "r130",
      "r131",
      "r208",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r362",
      "r363",
      "r364",
      "r405",
      "r889",
      "r950",
      "r951"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long term liabilities",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManagementFeeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ManagementFeeExpense",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fees expensed as part of January 2024 Financing",
        "label": "Management Fee Expense",
        "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r600",
      "r753",
      "r992"
     ]
    },
    "vtl_MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum aggregate offering price of common stock, preferred stock, warrants, debt securities, and/or units",
        "label": "Maximum Aggregate Offering Price Of Securities Under Shelf Registration",
        "documentation": "Maximum Aggregate Offering Price Of Securities Under Shelf Registration"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r172",
      "r230",
      "r231",
      "r232",
      "r233",
      "r289",
      "r320",
      "r321",
      "r322",
      "r341",
      "r389",
      "r452",
      "r525",
      "r527",
      "r535",
      "r567",
      "r568",
      "r630",
      "r633",
      "r637",
      "r638",
      "r642",
      "r655",
      "r656",
      "r658",
      "r659",
      "r670",
      "r671",
      "r699",
      "r705",
      "r713",
      "r716",
      "r718",
      "r719",
      "r726",
      "r727",
      "r728",
      "r729",
      "r740",
      "r891",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957"
     ]
    },
    "vtl_May2022ATMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "May2022ATMMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "May 2022 ATM",
        "label": "May 2022 ATM [Member]",
        "documentation": "May 2022 ATM"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_May2024ATMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "May2024ATMMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "May 2024 ATM",
        "label": "May 2024 ATM [Member]",
        "documentation": "May 2024 ATM"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_May2025PIPETransactionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "May2025PIPETransactionMember",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "May 2025 PIPE Transaction",
        "label": "May 2025 P I P E Transaction [Member]",
        "documentation": "May 2025 P I P E Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_May2025PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "May2025PreFundedWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "May 2025 Pre-Funded Warrants",
        "verboseLabel": "Shares reserved for the May 2025 Pre-funded warrants",
        "label": "May 2025 Pre-Funded Warrants [Member]",
        "documentation": "May 2025 Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_May2025SeriesAWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "May2025SeriesAWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares reserved for the May 2025 Series A warrants",
        "label": "May 2025 Series A Warrants [Member]",
        "documentation": "May 2025 Series A Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_May2025SeriesBWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "May2025SeriesBWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum shares reserved for the May 2025 Series B warrants",
        "label": "May 2025 Series B Warrants [Member]",
        "documentation": "May 2025 Series B Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r172",
      "r230",
      "r231",
      "r232",
      "r233",
      "r289",
      "r320",
      "r321",
      "r322",
      "r341",
      "r389",
      "r452",
      "r525",
      "r527",
      "r535",
      "r567",
      "r568",
      "r630",
      "r633",
      "r637",
      "r638",
      "r642",
      "r655",
      "r656",
      "r658",
      "r659",
      "r670",
      "r671",
      "r699",
      "r705",
      "r713",
      "r716",
      "r718",
      "r719",
      "r726",
      "r727",
      "r728",
      "r740",
      "r891",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r893",
      "r894"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r69"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r69",
      "r86",
      "r100",
      "r102",
      "r113",
      "r115",
      "r120",
      "r129",
      "r130",
      "r131",
      "r134",
      "r140",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r157",
      "r208",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r247",
      "r250",
      "r253",
      "r258",
      "r330",
      "r355",
      "r360",
      "r383",
      "r405",
      "r509",
      "r597",
      "r618",
      "r619",
      "r681",
      "r683",
      "r684",
      "r753",
      "r889"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued and/or Adopted Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_NewYorkCityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "NewYorkCityMember",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New York City",
        "label": "New York City [Member]",
        "documentation": "New York City"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r778",
      "r788",
      "r812",
      "r820"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "vtl_NonStatutoryEmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "NonStatutoryEmployeeStockOptionMember",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-statutory options",
        "label": "Non-Statutory Employee Stock Option [Member]",
        "documentation": "Non-Statutory Employee Stock Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense)",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_NumberOfDevelopmentPrograms": {
     "xbrltype": "integerItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "NumberOfDevelopmentPrograms",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of development programs",
        "label": "Number Of Development Programs",
        "documentation": "Number Of Development Programs"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_NumberOfFinancialInstitutionsUsedForCashDeposits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "NumberOfFinancialInstitutionsUsedForCashDeposits",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of financial institutions used for cash deposits",
        "label": "Number of Financial Institutions Used For Cash Deposits",
        "documentation": "Number of Financial Institutions Used For Cash Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r698",
      "r876"
     ]
    },
    "vtl_NumberOfVotesPerEachShareOfCommonStock": {
     "xbrltype": "integerItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "NumberOfVotesPerEachShareOfCommonStock",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of votes per each share of common stock",
        "label": "Number of Votes Per Each Share of Common Stock",
        "documentation": "Number of Votes Per Each Share of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_OfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "OfferingMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering",
        "label": "Offering [Member]",
        "documentation": "Offering"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_OperatingAndVariableLeasesCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "OperatingAndVariableLeasesCost",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating and variable lease costs",
        "label": "Operating And Variable Leases, Cost",
        "documentation": "Operating And Variable Leases, Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "terseLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "verboseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "terseLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r681",
      "r684",
      "r689",
      "r875",
      "r877",
      "r878",
      "r879",
      "r880"
     ]
    },
    "vtl_OperatingLeaseIncrementalBorrowingRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "OperatingLeaseIncrementalBorrowingRate",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incremental borrowing rate on operating leases (as a percent)",
        "label": "Operating Lease, Incremental Borrowing Rate",
        "documentation": "Operating Lease, Incremental Borrowing Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/LeasesScheduleofMaturitiesofOperatingLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Present value of obligation",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r731"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "verboseLabel": "Foreign exchange translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r11",
      "r81"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Liabilities",
        "label": "Other Current Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r731"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "verboseLabel": "Other income (expense)",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r720"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Expense",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Sundry Liabilities, Current",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r48"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r776",
      "r786",
      "r818"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r779",
      "r789",
      "r821"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r779",
      "r789",
      "r821"
     ]
    },
    "vtl_OwnershipLimitationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "OwnershipLimitationPercentage",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership limitation (as a percent)",
        "label": "Ownership Limitation Percentage",
        "documentation": "Ownership Limitation Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_OwnershipLimitationPercentageUponElectionOfTheHolder": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "OwnershipLimitationPercentageUponElectionOfTheHolder",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership limitation upon election of the holder (as a percent)",
        "label": "Ownership Limitation Percentage Upon Election Of The Holder",
        "documentation": "Ownership Limitation Percentage Upon Election Of The Holder"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_PaymentsForCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForCommissions",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriter commissions",
        "label": "Payments for Commissions",
        "documentation": "The amount of cash paid for commissions during the current period."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "vtl_PlacementAgencyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "PlacementAgencyAgreementMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Placement Agency Agreement",
        "label": "Placement Agency Agreement [Member]",
        "documentation": "Placement Agency Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_PlacementAgentAgreementBrokerageFeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "PlacementAgentAgreementBrokerageFeePercent",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Placement agent agreement, cash fee, percent of gross proceeds from offering (as a percent)",
        "label": "Placement Agent Agreement, Brokerage Fee, Percent",
        "documentation": "Placement Agent Agreement, Brokerage Fee, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_PlacementAgentWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "PlacementAgentWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Placement agent warrants",
        "verboseLabel": "Placement agent warrants",
        "label": "Placement Agent Warrants [Member]",
        "documentation": "Placement Agent Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "vtl_PlaneggGermanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "PlaneggGermanyMember",
     "presentation": [
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Planegg, Germany",
        "label": "Planegg, Germany [Member]",
        "documentation": "Planegg, Germany"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "vtl_PreClinicalProductCandidates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "PreClinicalProductCandidates",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-clinical product candidates",
        "label": "Pre Clinical Product Candidates",
        "documentation": "Pre Clinical Product Candidates"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails",
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded stock warrants",
        "label": "Pre-Funded Warrants [Member]",
        "documentation": "Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockPreferredStockDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in usd per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r260"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockPreferredStockDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r577"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockPreferredStockDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r260"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockPreferredStockDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r577",
      "r595",
      "r997",
      "r998"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.0001 par value; 20,000,000 shares authorized and no shares issued or outstanding as of June 30, 2025 and December 31, 2024",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r249",
      "r255",
      "r501",
      "r731"
     ]
    },
    "vtl_PrepaidClinicalAndRelatedCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "PrepaidClinicalAndRelatedCostsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid clinical and related costs",
        "label": "Prepaid Clinical And Related Costs, Current",
        "documentation": "Prepaid Clinical And Related Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets and prepaid expenses",
        "totalLabel": "Total",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r676",
      "r700",
      "r885"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from offering, net of issuance costs",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from public offering of common stock through At The Market Sales Agreement, net",
        "verboseLabel": "Proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "vtl_ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance, net of offering expenses",
        "label": "Proceeds From Issuance Of Common Stock, Net Of Offering Expenses",
        "documentation": "Proceeds From Issuance Of Common Stock, Net Of Offering Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of private placement",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from shares issued in connection with the Company's employee stock purchase plan",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r16"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees and other segment expenses",
        "label": "Professional Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r683",
      "r694",
      "r753",
      "r994",
      "r995"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r430",
      "r496",
      "r508",
      "r731"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r95",
      "r96",
      "r507"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful life (in years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForLoanLeaseAndOtherLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProvisionForLoanLeaseAndOtherLosses",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash lease expense",
        "label": "Provision for Loan, Lease, and Other Losses",
        "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r85",
      "r91",
      "r683"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r172",
      "r230",
      "r231",
      "r232",
      "r233",
      "r277",
      "r289",
      "r320",
      "r321",
      "r322",
      "r329",
      "r341",
      "r389",
      "r446",
      "r450",
      "r452",
      "r525",
      "r527",
      "r535",
      "r567",
      "r568",
      "r630",
      "r633",
      "r637",
      "r638",
      "r642",
      "r655",
      "r656",
      "r658",
      "r659",
      "r670",
      "r671",
      "r699",
      "r705",
      "r713",
      "r716",
      "r718",
      "r719",
      "r726",
      "r727",
      "r728",
      "r729",
      "r740",
      "r747",
      "r887",
      "r891",
      "r936",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r172",
      "r230",
      "r231",
      "r232",
      "r233",
      "r277",
      "r289",
      "r320",
      "r321",
      "r322",
      "r329",
      "r341",
      "r389",
      "r446",
      "r450",
      "r452",
      "r525",
      "r527",
      "r535",
      "r567",
      "r568",
      "r630",
      "r633",
      "r637",
      "r638",
      "r642",
      "r655",
      "r656",
      "r658",
      "r659",
      "r670",
      "r671",
      "r699",
      "r705",
      "r713",
      "r716",
      "r718",
      "r719",
      "r726",
      "r727",
      "r728",
      "r729",
      "r740",
      "r747",
      "r887",
      "r891",
      "r936",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957"
     ]
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r771",
      "r781",
      "r813"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r133",
      "r134",
      "r207",
      "r284",
      "r288",
      "r436",
      "r437",
      "r499",
      "r506",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r594",
      "r628",
      "r993"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r133",
      "r134",
      "r436",
      "r437",
      "r949"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r133",
      "r134",
      "r949"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r133",
      "r134",
      "r207",
      "r436",
      "r437",
      "r438",
      "r601",
      "r602",
      "r605"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r133",
      "r134",
      "r207",
      "r284",
      "r288",
      "r436",
      "r437",
      "r499",
      "r506",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r594",
      "r628",
      "r949",
      "r993"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r434",
      "r435",
      "r437",
      "r439",
      "r543",
      "r544",
      "r545",
      "r603",
      "r604",
      "r605",
      "r625",
      "r627"
     ]
    },
    "vtl_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r129",
      "r135",
      "r136",
      "r243",
      "r262",
      "r438",
      "r451",
      "r497",
      "r677",
      "r678",
      "r679",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r927",
      "r928",
      "r929",
      "r930"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r672",
      "r681",
      "r682",
      "r694",
      "r958"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "verboseLabel": "Employee costs- research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expenses",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r762",
      "r772",
      "r782",
      "r814"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r763",
      "r773",
      "r783",
      "r815"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r780",
      "r790",
      "r822"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets",
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r77",
      "r504",
      "r532",
      "r534",
      "r542",
      "r578",
      "r731"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r137",
      "r138",
      "r139",
      "r141",
      "r148",
      "r150",
      "r152",
      "r209",
      "r210",
      "r221",
      "r246",
      "r330",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r359",
      "r360",
      "r370",
      "r372",
      "r373",
      "r375",
      "r381",
      "r421",
      "r423",
      "r529",
      "r531",
      "r546",
      "r997"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "vtl_SalaryAndWageOfficerMonthlyBaseSalary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SalaryAndWageOfficerMonthlyBaseSalary",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly base salary",
        "label": "Salary and Wage, Officer, Monthly Base Salary",
        "documentation": "Salary and Wage, Officer, Monthly Base Salary"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SaleOfStockAggregateTradingVolumeOfLast10Days": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SaleOfStockAggregateTradingVolumeOfLast10Days",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate trading volume of last 10 days",
        "label": "Sale of Stock, Aggregate Trading Volume of Last 10 Days",
        "documentation": "Sale of Stock, Aggregate Trading Volume of Last 10 Days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration received on transaction",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SaleOfStockConsiderationReceivedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SaleOfStockConsiderationReceivedPercentage",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, consideration received (as a percent)",
        "label": "Sale of Stock, Consideration Received, Percentage",
        "documentation": "Sale of Stock, Consideration Received, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SaleOfStockEquityOfferingsPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SaleOfStockEquityOfferingsPeriod",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third tranche close period after second tranche (in years)",
        "label": "Sale of Stock, Equity Offerings, Period",
        "documentation": "Sale of Stock, Equity Offerings, Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails",
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in usd per share)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SaleOfStockNumberOfTrancheConditions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SaleOfStockNumberOfTrancheConditions",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of tranche subjected to condition",
        "label": "Sale of Stock, Number of Tranche Conditions",
        "documentation": "Sale of Stock, Number of Tranche Conditions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial exercise price per share (as a percent)",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPercentageOfOwnershipBeforeTransaction",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares sold in the offering (as a percent)",
        "label": "Sale of Stock, Percentage of Ownership before Transaction",
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, price per share (in usd per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SaleOfStockPrivatePlacementNumberOfTranche": {
     "xbrltype": "integerItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SaleOfStockPrivatePlacementNumberOfTranche",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private placement, number of tranche",
        "label": "Sale of Stock, Private Placement, Number of Tranche",
        "documentation": "Sale of Stock, Private Placement, Number of Tranche"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SaleOfStockRemainingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SaleOfStockRemainingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, remaining capacity",
        "label": "Sale Of Stock, Remaining Capacity",
        "documentation": "Sale Of Stock, Remaining Capacity"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SalesOfStockCommissionsPercentOfGrossProceeds": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SalesOfStockCommissionsPercentOfGrossProceeds",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commission, percent of gross proceeds from sale of common stock (as a percent)",
        "label": "Sales of Stock, Commissions, Percent Of Gross Proceeds",
        "documentation": "Sales of Stock, Commissions, Percent Of Gross Proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "vtl_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Shares Reserved for Future Issuance",
        "label": "Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]",
        "documentation": "Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense for Stock Awards Recognized",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r933",
      "r934"
     ]
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Assets and Prepaid Expenses",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r430"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://vitaltherapies.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r133",
      "r134",
      "r436",
      "r437",
      "r438",
      "r601",
      "r602",
      "r605"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Significant Expense",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r293",
      "r295",
      "r296",
      "r297",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r329"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r78"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Valuation Assumptions Used",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockCommonStockDetails",
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails",
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r75",
      "r76",
      "r77",
      "r107",
      "r108",
      "r109",
      "r166",
      "r260",
      "r261",
      "r262",
      "r264",
      "r267",
      "r272",
      "r274",
      "r369",
      "r538",
      "r539",
      "r540",
      "r541",
      "r705",
      "r842",
      "r864",
      "r866"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Table]",
        "label": "Variable Interest Entity [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r361",
      "r362",
      "r363",
      "r364",
      "r447",
      "r448",
      "r449"
     ]
    },
    "vtl_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Purchase Agreement",
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90",
      "r164",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r206",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r226",
      "r227",
      "r357",
      "r358",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r691",
      "r694",
      "r695",
      "r701",
      "r742",
      "r960",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r169",
      "r204",
      "r205",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r492",
      "r493",
      "r494",
      "r495",
      "r560",
      "r563",
      "r565",
      "r632",
      "r635",
      "r640",
      "r644",
      "r655",
      "r657",
      "r658",
      "r659",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r674",
      "r686",
      "r706",
      "r707",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r741",
      "r747",
      "r960",
      "r962",
      "r963",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Disclosures",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r164",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r189",
      "r191",
      "r192",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r206",
      "r690",
      "r692",
      "r693",
      "r694",
      "r696",
      "r697",
      "r698"
     ]
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative Expenses",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "vtl_SeriesAWarrantAndSeriesBWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SeriesAWarrantAndSeriesBWarrantMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Warrant and Series B Warrant",
        "label": "Series A Warrant and Series B Warrant [Member]",
        "documentation": "Series A Warrant and Series B Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SeriesAWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SeriesAWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Warrants",
        "label": "Series A Warrants [Member]",
        "documentation": "Series A Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_SeriesBWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "SeriesBWarrantsMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Warrants",
        "label": "Series B Warrants [Member]",
        "documentation": "Series B Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Total",
        "netLabel": "Non-cash stock compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment arrangement",
        "label": "Share-Based Payment Arrangement, Accelerated Cost",
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost."
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional shares authorized (as a percent)",
        "label": "Share-based Compensation Arrangement By Share-Based Payment Award, Additional Shares Authorized, Percent",
        "documentation": "Share-based Compensation Arrangement By Share-Based Payment Award, Additional Shares Authorized, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price of the stock, at discount from market price at purchase date (as a percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued under the ESPP (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected dividend yield (as a percent)",
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected volatility (as a percent)",
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Risk-free interest rate (as a percent)",
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r293",
      "r295",
      "r296",
      "r297",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r329"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares exercised from pre-funded warrants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Remaining Contractual Term and Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable, ending balance (in shares)",
        "verboseLabel": "Options exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable, ending balance (in usd per share)",
        "verboseLabel": "Options exercisable (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited or expired (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted in period, weighted-average grant date fair value (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r313"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, Aggregate Intrinsic Value, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in usd per share)",
        "periodEndLabel": "Outstanding, ending balance (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repricing modification (in shares)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Repricing Modification in Period",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Repricing Modification in Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in other share (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Other Share Increase (Decrease)",
        "documentation": "Other than shares newly issued, the number of additional shares issued (for example, a stock split) or canceled (for example, to correct a share issuance), during the period under the plan."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repricing cost during the period",
        "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost",
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Award [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in usd per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "vtl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repricing modifications (in usd per share)",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Repricing Modifications Price",
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Repricing Modifications Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in usd per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 1",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 3",
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 2",
        "verboseLabel": "Second tranche",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "vtl_ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options repriced (in shares)",
        "label": "Share-Based Compensation By Share-Based Payment Award, Options, Repriced, Number Of Shares",
        "documentation": "Share-Based Compensation By Share-Based Payment Award, Options, Repriced, Number Of Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r298",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339"
     ]
    },
    "vtl_ShareBasedPaymentArrangementPlanModificationOptionExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ShareBasedPaymentArrangementPlanModificationOptionExercisePrice",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation, exercise price (in usd per share)",
        "label": "Share-based Payment Arrangement, Plan Modification, Option, Exercise Price",
        "documentation": "Share-based Payment Arrangement, Plan Modification, Option, Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial exercise price per share of common stock (in usd per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofValuationAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected term of options (in years)",
        "terseLabel": "Expected term of options (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable, Aggregate Intrinsic Value, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable, Weighted-Average Remaining Contractual Term, Ending balance (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, Weighted-Average Remaining Contractual Term, Ending balance (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of stock (in usd per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shelf registration, termination, prior written notice (in days)",
        "label": "Shelf Registration, Termination, Prior Written Notice, Number of Days",
        "documentation": "Shelf Registration, Termination, Prior Written Notice, Number of Days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://vitaltherapies.com/role/SegmentDisclosuresScheduleofSignificantExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90",
      "r101",
      "r164",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r206",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r223",
      "r226",
      "r227",
      "r357",
      "r358",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r691",
      "r694",
      "r695",
      "r701",
      "r742",
      "r960",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r107",
      "r108",
      "r109",
      "r129",
      "r131",
      "r155",
      "r156",
      "r158",
      "r160",
      "r166",
      "r167",
      "r208",
      "r234",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r248",
      "r249",
      "r251",
      "r252",
      "r254",
      "r257",
      "r260",
      "r261",
      "r264",
      "r267",
      "r274",
      "r405",
      "r538",
      "r539",
      "r540",
      "r541",
      "r546",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r577",
      "r598",
      "r620",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r842",
      "r866",
      "r867",
      "r874"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r55",
      "r58",
      "r59",
      "r98",
      "r99",
      "r100",
      "r118",
      "r119",
      "r120",
      "r137",
      "r138",
      "r139",
      "r141",
      "r148",
      "r150",
      "r152",
      "r165",
      "r209",
      "r210",
      "r221",
      "r246",
      "r276",
      "r330",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r359",
      "r360",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r421",
      "r423",
      "r432",
      "r510",
      "r529",
      "r530",
      "r531",
      "r546",
      "r620"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/LeasesAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r169",
      "r204",
      "r205",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r492",
      "r493",
      "r494",
      "r495",
      "r560",
      "r563",
      "r565",
      "r632",
      "r635",
      "r640",
      "r644",
      "r655",
      "r657",
      "r658",
      "r659",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r674",
      "r686",
      "r706",
      "r707",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r741",
      "r747",
      "r960",
      "r962",
      "r963",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r165",
      "r248",
      "r249",
      "r251",
      "r254",
      "r423",
      "r453",
      "r536",
      "r547",
      "r558",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r599",
      "r600",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r620",
      "r683",
      "r684",
      "r748",
      "r993"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionLocationActivityCapitalizationAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Activity, Capitalization [Axis]",
        "label": "Statement of Financial Position Location, Activity, Capitalization [Axis]",
        "documentation": "Information by location in statement of financial position in which disaggregated capitalized activity is included."
       }
      }
     },
     "auth_ref": [
      "r924",
      "r925",
      "r945"
     ]
    },
    "us-gaap_StatementOfFinancialPositionLocationActivityCapitalizationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionLocationActivityCapitalizationDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Activity, Capitalization [Domain]",
        "label": "Statement of Financial Position Location, Activity, Capitalization [Domain]",
        "documentation": "Location in statement of financial position in which disaggregated capitalized activity is included."
       }
      }
     },
     "auth_ref": [
      "r924",
      "r925",
      "r945"
     ]
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r165",
      "r207",
      "r248",
      "r249",
      "r251",
      "r254",
      "r423",
      "r453",
      "r536",
      "r547",
      "r558",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r599",
      "r600",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r620",
      "r683",
      "r684",
      "r748",
      "r993"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r775",
      "r785",
      "r817"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://vitaltherapies.com/role/SubsequentEventsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of pre-funded warrants (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r34",
      "r55",
      "r58",
      "r77",
      "r245"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in connection with the Company's employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r54",
      "r55",
      "r77"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of pre-funded warrants and common stock (in shares)",
        "terseLabel": "Stock issued (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r54",
      "r55",
      "r77",
      "r538",
      "r620",
      "r650"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r54",
      "r55",
      "r77",
      "r304"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of pre-funded warrants",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r55",
      "r58",
      "r59",
      "r77"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in connection with the Company's employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r54",
      "r55",
      "r77"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of pre-funded warrants and common stock",
        "terseLabel": "Shares issued",
        "netLabel": "Aggregate proceeds from the offering",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r54",
      "r55",
      "r77",
      "r546",
      "r620",
      "r650",
      "r754"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockOptionMember",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options to purchase common stock",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r747",
      "r926"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r58",
      "r59",
      "r70",
      "r579",
      "r595",
      "r621",
      "r622",
      "r731",
      "r755",
      "r864",
      "r867",
      "r868",
      "r884",
      "r942",
      "r997"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r259",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r276",
      "r369",
      "r380",
      "r623",
      "r626",
      "r654"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and Tranche Rights",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r624"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r441"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r441"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r441"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r441"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r441"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r442"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockApril2025OfferingDetails",
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails",
      "http://vitaltherapies.com/role/CommonStockPrefundedWarrantsDetails",
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementofCashFlows",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Details",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TangibleAssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment losses",
        "label": "Tangible Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r71"
     ]
    },
    "vtl_ThresholdTradingDaysForAggregateTradingVolumeCalculation": {
     "xbrltype": "durationItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ThresholdTradingDaysForAggregateTradingVolumeCalculation",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Threshold trading days for aggregate trading volume calculation (in days)",
        "label": "Threshold Trading Days for Aggregate Trading Volume Calculation",
        "documentation": "Threshold Trading Days for Aggregate Trading Volume Calculation"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_ThresholdTradingDaysForWeightedAveragePriceCalculation": {
     "xbrltype": "durationItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "ThresholdTradingDaysForWeightedAveragePriceCalculation",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Threshold trading days for weighted average price calculation (in days)",
        "label": "Threshold Trading Days for Weighted Average Price Calculation",
        "documentation": "Threshold Trading Days for Weighted Average Price Calculation"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r881",
      "r948"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockBasedCompensationExpenseforStockAwardsRecognizedDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Relationship to Entity [Domain]",
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://vitaltherapies.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "vtl_TrancheRightFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "TrancheRightFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche right, fair value",
        "label": "Tranche Right, Fair Value Disclosure",
        "documentation": "Tranche Right, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_TrancheRightsLiabilityReceivedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "TrancheRightsLiabilityReceivedAmount",
     "crdr": "debit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche rights as a liability, received amount",
        "label": "Tranche Rights Liability, Received Amount",
        "documentation": "Tranche Rights Liability, Received Amount"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_TrancheRightsLiabilityRemainderAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "TrancheRightsLiabilityRemainderAmount",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche rights as a liability, remainder amount",
        "label": "Tranche Rights Liability, Remainder Amount",
        "documentation": "Tranche Rights Liability, Remainder Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "vtl_TwoThousandFourteenEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "TwoThousandFourteenEquityIncentivePlanMember",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2014 Equity Incentive Plan",
        "label": "Two Thousand Fourteen Equity Incentive Plan [Member]",
        "documentation": "Two Thousand Fourteen Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember",
     "presentation": [
      "http://vitaltherapies.com/role/StockBasedCompensationPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 Omnibus Equity Incentive Plan, Evergreen Provision",
        "label": "Two Thousand Nineteen Omnibus Equity Incentive Plan, Evergreen Provision [Member]",
        "documentation": "Two Thousand Nineteen Omnibus Equity Incentive Plan, Evergreen Provision"
       }
      }
     },
     "auth_ref": []
    },
    "vtl_TwoThousandNineteenOmnibusEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "TwoThousandNineteenOmnibusEquityIncentivePlanMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/StockBasedCompensationPlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 Omnibus Equity Incentive Plan",
        "label": "Two Thousand Nineteen Omnibus Equity Incentive Plan [Member]",
        "documentation": "Two Thousand Nineteen Omnibus Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://vitaltherapies.com/role/FairValueAdditionalInformationDetails",
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "vtl_UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration",
     "crdr": "credit",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsold securities to be sold under shelf registration",
        "label": "Unsold Securities Rolled Over To Be Sold Under New Shelf Registration",
        "documentation": "Unsold Securities Rolled Over To Be Sold Under New Shelf Registration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://vitaltherapies.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r168",
      "r170",
      "r171",
      "r172",
      "r492",
      "r494",
      "r687"
     ]
    },
    "us-gaap_ValueAddedTaxReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValueAddedTaxReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://vitaltherapies.com/role/BalanceSheetDetailsScheduleofOtherCurrentAssetsandPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VAT receivable",
        "label": "Value Added Tax Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://vitaltherapies.com/role/DescriptionofBusinessandBasisofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r447",
      "r448",
      "r449"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingAxis",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingDomain",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails",
      "http://vitaltherapies.com/role/CommonStockScheduleofSharesReservedforFutureIssuanceDetails",
      "http://vitaltherapies.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920"
     ]
    },
    "vtl_VolumeWeightageAveragePriceTargetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "VolumeWeightageAveragePriceTargetMember",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockMay2025EquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VWAP Target",
        "label": "Volume Weightage Average Price Target [Member]",
        "documentation": "Volume Weightage Average Price Target"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r160"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://vitaltherapies.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r160"
     ]
    },
    "vtl_WeightedAveragePriceOfLast10Days": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://vitaltherapies.com/20250630",
     "localname": "WeightedAveragePriceOfLast10Days",
     "presentation": [
      "http://vitaltherapies.com/role/CommonStockJanuary2024FinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average price (in usd per share)",
        "label": "Weighted Average Price of Last 10 Days",
        "documentation": "Weighted Average Price of Last 10 Days"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "850",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-10"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-5"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-6"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0001280776-25-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001280776-25-000012-xbrl.zip
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MABZ;0M'O\=S$+@Y,R1 =R+IGTHWA:/8H=G3X6]8KNRZC53FWJZ+C\S5$$XE
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MJH+7-VU5MPD<$'R##P.>KVN>#@[%.4#8*TTR.NB?1:]LKNJL4C5\ES3^]'_
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M"$G5JD2J18D6#D33RW![-#6O&TB. 5#<?Y-]54=8(-U?_$V8H>&%3!LS9MN
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MW_<\<'T^H?O[P$Q8!L#&P&*1534)*N0E[_&,B^\Q:59#6IL*9S;S>#$W-.6
M15B&1Z78AG;TR#MPTW502.P[Y1#Y[;P>'O8M5.)0Z";9&7F-$B]#80*!BT_H
M&1\?SRQ0L>D$6E6CL8<C8;0C ,?K];9Z[F0:+/0W5EWXNFOO>R=#'V44KA;
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M#Z,0ON@JA"^^BT+X8HM"^.>M]-L%-%V5H=].\%>$LU Z>TCA['ZYZ7]&.'L
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M3]44+=5'_L DSO'<PKE(W,"?-4(Y9:-)(5U4Z)_R4EEJ!P&[%G?4;;Y@>M;
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MOBOZ!/\<GA]_QG_?S=Z?_OI_ %!+ P04    " ! -P=;\?G@&/UC 0 \D@\
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M#+Z?NLY=X!H_^;-^^93YB@0:R4J.)H<&%0?YR#19I('8-\0R+YUS,L/D357
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MB(FC8_@YFK#1A%MJPZ[,&X##*Y[]Y!.#'>GPZVOZE_DTA%]=XIG7XR^61XW
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MUP>]GF1=R;J2=?==)U$FZVJ\:J*].H6V,JPK)V#("1B;0-Y9!,26$S &94S
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MA5;:V#"V\^$& JI"8<7D#\>C\/I_8Z8XFCAA1&V!RB.Q3F%"W>$EY?K^RM\
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M2-J!#..>*.%L,%TW$\YFJ=IIX0CV[F#UP*;JF[+"%HQPU>@O58& JQ'XK+;
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M?3'XT00>"<#*CV:[ ODP\8^E_NP/K/=_ EPZNSD![Y'7-HA\CHKK\46$B%O
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ME*;RA0)WX"04]@R?Y;]#O&*>$<7P-[ZYP89N<.FJ\(K!R,Z.B_!,'('XA!Z
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MVE]Y!">+7L!@!#YCHW$R%]X-C;P;&9]&&QA<L/;I S)-K%_ /QX7-BCLZ*[
MR>;:A/3[]0I7F89K.2(4N2Y:0?"#)\$#@\#S.WO4*^79I5&.WQ<K!$TM?,JO
M7NIUMZE>$B&( 3#!8_2>BR.B&;:%1\='$PX0R0&Y&>!?R7NA8L]1E#Z-AYV^
MWJM:^33J=_1NM8G9)2VE>[6-N1[W^MM4&3UWXLY+Q7"WK+:I-6_@O"/_YQ>[
MWY!^4\KDOPD-^CM#606,Z7;^V4;)^D\PS;,1_%ZWW[KJU38E^$2Z.KT@\0]V
M(OXFY?4 )/-QS;["BC\>F?/ OI!*F4<P _2U[5U.=%I-@%Z08(9U2\NM".;L
MNP+61# H57X\>GET,FQ=C1JY<B@R&35RY=C)!-U*>80R D(YD8;#+UC2=E35
M=*<E17/K19I:XZ;6^$BX8\6L\UYWC%GG9$L=>5'RF>L=-R)FW.@>VT+LXE#D
M]:<+0HXFA[+9IU^8%72]Q'_ED)/>!8LV6X3UYLATCU.7PM_28>\X%/%"LCF_
MS.:U2^[]H'*TG.?Y6_#DL1:]=34>C@]1'?;<4GR/@J^M(Z4;ZG)>6^'8H+AP
MK$)=E!G511U5M=GAJZKZ5:NJ/ENV_Q=*JX^@2CA>L/9SBJIZNI$IJH+/LD55
MN)I&R^U26"66S'F1T:J8)'$W7;#9VF&W\^B E'4;7+MJK^ OP-S@Q+-;]SO#
M/ W@(.^MP"YH_MK3S=-/G\#\5IX.@0D3<[PPKJTL;.#X_G3QI!$7#*(<OD1.
MX 13R)DU76A+ZU^>KTVMD-UC"8_(Q1!)J%$ZW-S&3!K,6J5,^B"32K\45X!)
MALINJ$[ EY>"Z35V<"2I&N..@>UFJZ5J]+N=T6A43X)%M],=5^L(6_SYJ*Y!
MXD>Z*6-#P]L7@E0Y)FS9I?;(E?-\!3"V^_4C:BB[6;S2D6+YI@G105G0P+J*
M6^V^BLM4C-@*W1N.^Z+YD84V4\^Y-S16/@_8_<$>F*/I#<RJPHPCG-$ ;C?
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M$2XL=Q,%C N0A5? R^A)P#-.ML/T@5 :"W+N>?I5F+4%A=(<:99<P8A(N4C
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M@<]6]5?<%QLGX^+"F'3,K1^A]DAC:>4],E&YOR+_%G.G+) ]II2WKB+O%Y?
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MJ2#TX?\S^6)!(!TXW6_9ST>##A@SN5]U.WKNYT5+Z7IG8(Y*E_J-ML:W!P!
M,%$7O633D[?&ZI>F)TULS*]+PX ?OT8<&6U"D2YO>8)YVA%9A;,=CL.9\<$/
ME.$A="!NN?-C>7/BG)P,$F?<<'<3:_KSWO? #+\4.YY.&9O/WU6\5. &!Z7Z
MKI(;R=UP"=J/B![^\7:+.R\$@Z!_8G:K4*.T?4T>2L*HBQ#:@E"R;YG3_]+
MUNA/HV/TCQ3PP#YU[=-RY7A/3$:NXFX&CN46@MRH!HRNEH-_I,8_.Q%N"8K*
M?I0*28DBKBGK!0J$>%7'2L]L70V[H[8^R%IL^4QR%_3M;GMCNY!-/H\Z>K)1
M?-DR_2+ET:Y"+CE .$-RV=3Y_OG)I5?FAZQ(,"6(^ZP$<Z)R)I[U8MWS,L\]
MZ.5UB)?^B],+&.3&R&R;9E'Y>"->G@=7;M5.6#P_A@?X&_%22"Y%I9N'(Q>,
M\O7;H[[9'G2+AI>>J'PY2BKA$"WZ;YXC*:^S4DX[LKF,2S?2J9#<AB].;L/6
M56_0'AC==K=7U)CF1 74"9+;%^L7I7D%+T5VKT/*O3S9C>HDNT;*/9.4BV:,
M?LOF9C52K9"\BF;8'(Z\L%DDD-< _[^WDZ*1:L]-7M%X^\8!N)&X*O1@>![B
MZG?K)*Y&=CVSRI@FLO>-!-M(9,,*'4&>B<CT1H*]7.Q<%@+%I4%* @WU,=PK
MB/Z*X^3Z4+MQ<5X'13%X<0 6GV,IZ0,-LV]BY<5LJ4);C&=B2P;9K49.=[V3
M9DFG0#EC[7;IVI-U4"/9O J5>;BIRNGYR0;[1X^!;HR]8X"-OKP1/WYX(:_+
M7L9E(F69L/L(')$/)S)<3;B)F;=&A4&><*N$N;.DNQ=/[.KW6E?F:-PV,;EK
M6%?TO;X;WYEN?Z/L:K5*0YF^EU^U45[TA@"SS?EX9 U,:SPS1KV184U&^M0:
M6<:P"T"<]X?_BUZU+9MN/"-NYA<0##L;QB"FL>^C'6##@+5H-A?5MG['\A4L
M=PW"(%/:&F1K [!1?JK?*GR&[TM6#!">7])BFOH^DMV9$8KUU#/F%XF([>5L
MVMBBL.$4:N23Z;B\MN2;3,=-Z$IG7BYZ*Z=W8Z\OA$IR)HLU T-7-/O?"#/M
MHO7I[MNWUIMH^B*6EN+@+#&53NF%R!LIBH84M/*U"TCH:%\8D\UK[M36B=0%
MR1/MR71>D*+SSEGXTGA@)P,8V\AMF=AJIK,M%5+"=KW5RO-#E%%4U!JE8R<;
MYB2?#46C16LZ72_7Q BTE?7D>]0&"LQ641#) 8#U,GRJGMK;?KKV?;1MY=P:
M]+GQ+E[P]1,]1 /UU#W)]\L!$9^RITP4<\JB]HE]:7' >F*,JVRJA/U'I@O/
M"ZBQ"#7<X,W<J840"P(^2Z90I+M43)%5I3<)]8]L#E@([-,-?;!5<%%$'N&D
MY%B@?DEM/\4AX:]3FJHC)#GPHXAE#5I7>C8;Z._B FULY45PF" XF>6[.-)6
M$R[0F^]W\GLQ@E("GBI;J888* 3($ $;3YY.-.U2[RNWIW)N-Q2.P\G)ALD)
MB':0NI,+^TW]][)S(P>4DS@R!\>)\192-&A=LH:/5LAR+PR[%11?6-2L1X!8
MP(5CM9R1%4$-ZY(O; !+X9."U4P8""Q7,)A2 N'WLA2^<PY595*NZ*]&\Z\4
MPP'[VH!J]J2M:1@3C=9"UHBLL+)5NBF3>_?>&XFY"M?2APGZ]._HNJRL1E,A
M?FF[ZJANN#;Y9FPEW[3:W[N=7+UVXW;K95RTZ.HW)27O??7747^R?2<;];$/
M^U9SC79IO3[<E&_ZLD00@V'0Q6DWQG: *-&,,NI*LFO7?P?:W0HVD525@CQ5
M*3$GH%,_)52DP%?83O='-/J%N:@B4DA#Z%\I 8$J ?;HH)N[7M_#*32=:[EB
MJG6,$=C_<<>65\--B6T[DU.FC=,M*KL_%I9H\Q00504W+F^26%7&#/3656^L
MMT?F."MC)%DY]IR!-7I)^D$,8#004G/,<.+4O4OC+RJ.UAHF1VN9:0!>RPEI
M^9#\Q =;53X^6-Z&D2]AJX\'&XY?Y PF7.$H_PS P^3(+Y_[5Z0I0M2A=(H%
M"XQQA:]TS!>8LX 1*SFEM.3Z*T%NU*T?<J6-70:]\O[XV1WJA]YA?\O6^#7?
M<"]SPV<N:G;JF,*9K_;-]^Y]:UG<"?(L(%0JC&_0>>1@JI,^;N>:Y<E9'5(]
MXQZJ3<'5MG81-U+CRXOFZ_0L_B1NMJZXQX2#K; 7%N_CWJ(O6F\BWY7HA_T0
MV\+<,4;:GC[FQFOT9AK;^1@W:^6#-I'G\J-8C]3+%<?-2G=2FYHLKYV0NDPB
M,0(M7\JOM5G<JXM,'=X*65K+.U@\H^=K-%FOL3M 1U.[OWDZT\8VN-1Y*YE
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MCS-IC8<'_J <^-7F3!R?7U'4+G./BR\FA9$/4$P8Q+\'Q,AG3$R G:)9C$.
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MDHCGJP +1G^K *6AE.?]51-'W^VLKP1>Q;TR&A1J4.CETCEX^?3X2)V!WUG
M+'^ZX 4P[($YWBI1;'A,$J"I<7_%->Y&MZL&%"ZWC"ALUW;'C!T_.-9WH+?A
MS$=2I=[00D,+&5K0#T(+V"JR9S2TT-#",=."<1!:H*Z2_7%##0TU'#4UF >A
MAB$83$ )_2.BAIIR-H[;7ON=N<RW'#+7K-G2=NT@]*G9T(E8;-OT#'\]HQ=S
M*;AW$ H>H3S3S5$=%'R$?>=?.0[U#X)#F!+9[O:Z#0Z=(PX-#H%#O2YJ$F9O
MW.#0.>+0\" XI",.#8SA$>'0JX@>4(+9B2B>>QC!5=JF[S##[*1-Z!IA<R8L
M;W00EF?0D)-Q+6*S]JL\4F=60\<-'6]/Q^.#T+%)=#RJTZW<T'%#QPT=2SK6
M#Y(VT.OAM)YQK\[$@8:.&SINZ#BBXX.D//2P%4Y[8)Z//-YBR,7I5;9=9T;E
M]:FKJL\V=^G,8E8R@:"?QJRM:@R_>B[V?64S*B8-R#.B?H]UAE^]\)\LC"L0
M(_P;Q/B':0;]G/IT#0#H4+M#5PNIKF_M*C5ZN85]A:,-VJ+AN+( =3:WHE:K
M40_:N*EQU9+I9P,;+]S\[/GB(_S=%M6Y/1RHU]$':?37J.R=^D/OACX;(NZB
M^I3-\B$@JF&KC@?LX5BR_.#=YIZMV3-LB#D^TQG&<(9>_AED.]&RPE6EAV](
M-4PE77R)%G@W4OR]SV1G4]N=.NL9+W.]+XRNTT=^0;*T0G!JV]B=$6I#\.YY
M+J/?;5WU![4AU(;@T3.=00?IG>\2JXI0&YI"'P*=TFV(=T>H#5&89[H,HW55
M<!<[X-,&K^HS'<%L717PV'KY4^]E^5-JO%8S\RR>>=9+P>989YYM,]TLH<<?
M'I85*7Y<KI772?&Q_MWO42/\ LM/ZN#5^9?1?9'3]/$TYH;3U"D9#\/(4I+Q
M9.:F%#3*62]AHS2RYM._USB0YL9%?H?00&LMT*@E$4!N[GM+[2]<F)BWM;)9
M<,(#/K %_M6?*T SQ#F'A0(;$6]^^'!P05DTGBUU[#;B4T>[:-'GK3<X#>@:
M4,W1=*--EFZ;/T(C1X?O OS,T*@ID<:G+_!!(!?X-OR1T7U'/\%/Z=_ZNS<Y
M:_3R+RF]3B^Q#B%R9JDAK#%;3ZE-SA:K*C].[E$,*N0X,GE21X]U-. LLJ=/
M9AX*$/:*$(QFR3 ;/2C:A#$7^<R<47\?ST>JLWTV PWTA)%-3I-!4/DEL]8"
M9,!!EH$_V[2UK]0_44P+":X?+-M!9]UGSZ<I)EG'!O#]1P_ND[DQHQ^TKMSL
M<#7-\>#E/LVZX^?2++D^M7WB@W02\W$XXF*/IK2'K;Y90CW2?@Y__;>N=L=6
M(4. $P&FZ7OBP87@P6> \-/0\P%@JY7O/8BQ?2D2!-);V""F4(<&9"!I*.17
M2$(01-U7>#AZ7T?[,X)U:JWJ&&D< T9N8T4-P2H?M(U^CADEL!(@GKP($ B@
M8W"]A/,WU G\!R9G)=+D&O8+5(J E !"9QPK\^\U(-[<AF_%G"P<X^A2VV_X
M)H ;\_B"..EQY;,'VUL'\'P\C@864JX?9];@ O*N<.:7;ULT#,<2+)7]-^I"
M(4T5C<;=T*]1=(G^:4MFX51X/.OW-=!??V#V+Z9O+GIOI,S[:@4SZ]_:'S:?
M'X:_"H#IUL=U7XKNJJG*Y@:\WD57+AU.V1]5W6+OX%L<5]UB_]!;''2K;G%P
M\"WJK:NO63&YPP>1882L'\,H/O)^Y$$T>8^4*BNKM6<\0O# EN/G2FV>4I>-
MRB6&G<$6?&(8,8D\5P0NC0"US?EX9 U,:SPS1KV184U&^M0:6<:P:X[&\_[P
M?]'^5%L[EJSXC#PIW^H:59WK]IT;MM\L/WQ2K)/@HQW@>-"UGS.T;6!DA[8-
MC.S0-K&V1HNKMD]0V$MV,U0+!J71^[-^MJ,SBS_]8M,U64(?%I8-% X&WCW0
M3"17M8]KRR6IN2B4D(5'*T+LK.OQF.R7V\C([1-[Z,9SIB.7#?QC:8<ABZ:+
MOI=*[<=(JQ'?R&F[>*H5HZ.!)H0Z$7L4JFRD_I(#EOMQ4/-Q52W'2MX++IUS
M>^IVVLKEM;4O']O:_\#_O[R_3EB\92B0,*U7:S]8HRD#6PO6Z#BB;5M.6_$+
M#-,@PZ/CTQ_]#FV$GY'4=N&]*ML GRA<BJ5H!DP<.UC0Y$-Y*@O!Y#CB "H<
MN1,=J'YAKT#Q@]N^A?M"XT%LWFQK-\LE2-5I&ST%G6C[,323A[B>X42.]5+C
M.KW6U[0MCD8S&W^%3,RCE8WB)9PB+5U%@6#3E9=B(+SP(YMR0\G4N2L1('"#
MKB'798H?*'ND=@J7ISXC1V9FNR1E'3X^6@LL!YUN\.**GMQ$,*TKI<1#Z+R]
MHR6OW=D_K'MV.Y_;4^9_X>]$Y85_7=5Z&IBM*]-HFX/LG%*N653<_NC V\?$
MR&Z^\7?!K6?A& [$V&Q 89^%.-78UU;64^2K0/./["=7O>_H<@6.^;R=]33D
MHT[Y3_/0\4T'Z>MZ?0_L73/&;:%D)<FK,GT-3H>^^EO2UV O^@+CE]38ZG0V
M/C"B@JYJFNWQ*"?W:A<Z.S2;&!2SB9>E,_) >^1:1D2/4+.40/A<<QYO L!5
M,7>JJ&[[F3=#,GE?SH095S5AN&I(7?D!_3X0!.^9.[59N14SS+%BAEDK1EF>
M&&?B!>6&3)&M0F_)>;>Q1;C[Z"P:A <2Y=IRM%O0"^\M8>*==E"E*!DW$AD+
MX _HFIU:[I3QX,-4 847@T*$(H A(F.*[8I #2O;\$\U* R:_KUO+0/B2 _V
MS)L#F[.7ZP"8G#.U09(A,MY\^?-RU!_PY%EB6F@B_++1GPLRJQ)W-\N#^<H]
MQ]=<-78_P 3/CEX>NV_3X Z ON#P ?FEIF'D)E]9]BR2P<*5-#CU@/DM"9,T
MMSDMBJIXY(^6#1=L:W>6^_/)BP7E"9QTDT/C?RQ@^J I9CP:R#K8+^9/;=0V
MD>KYI#)$;6\22OT@"@)ICY[OS![M&=.H)@)_AW$D7 %._A]+YA<(5M#1KD%C
MO9>ZR0*80L#?+MXC7RXC2<(VT*Y_YZDM^!**+R5O)U*55L!:4'5?K>"2^=L5
M-B9VT2:VQ>E7/3DH\LQ&QXN%D2K0$7'G%D[-02[*55+\_9^=NX[VC;_IOZSE
MZAVZ#V>@/OD_-:Y<(OU+.Z<+%YVG]>><.GD1Q$@L4 K990AWKZU7L -X)9R,
MN0'RTSEC65BH <\B'&ZGO\$104X )A*@JXW2 I85X-#FZQ!T%)7_HV/\?@U@
M]7SNS@'+ W 3\)0%(>P7E5OB$FW44Q\9YD. //&>+"<$O23G2CI-0F1Q0F3_
M!!(BM]40CYSSXY2?JS_6P-+N+[]8H*K8CFVYP>6?+N"5'V"ZT#D( CKFI_F<
MQ[92X2^%YR8<+Y;">5+NYW*(D=GJ*E*#KT-,1G"5M@8G6<]1@_-Y0J(J1A@J
MG+/UE+10GU@TK8F&L\US&5P Q])SP+Y%3D110: %,I5=MO8]VYT[UG+)6=8,
M>"V8_1CICWEE?*3RT]B4>&"'#F=@-7#)4U<._V#W8%-\\[TI8U@X>0K*X*:<
MM=CY%E#:RG3M^SQ68\&]8<B00C)/@,NAT(';\$,??V^'E/['U0<4Y,R=D7O'
MIQ T*@Z .^J#X<(*\;$)R%] ()"9WMJ918DO^%8B5E+))D!$+@M N(H9?["T
MSX*U@_)V;KN@K&"R#$X)M+G^Y7/?TQSG_W6T_^L]PCO\-BV&:38!I=& [;:P
MT.2!5_Z'9S7.??;O-5+$U+'L)=?YXVT+[Q:^/@"Z\VV2[>JQQ&- !I9/OY/J
M&:S#54!@+* =,&Z5 I'#@0"T0LTC-L"70((6/ #>8$UHXC!HD_ C<?:V')K(
M"3&I2BVM)S3-;/?!<QYXDMB#Y6,:DN80\JYBY!5Z'FI<Z%>VMW2%;>N_&KYH
M?+XB9>O=JOZN.W://.T[6WD^8F:IDVN<XV@:9YU<8DTM7FM'U]8XU[4U/E[%
MI=R0BZ@_X  **,UVQH 'H!%#*7TK$#1B(BB*8)3G*Q\-+&OBK4-A! 4,6!J0
M)@K&J<]"I!3N.B'HI5-8V8/E",B*U&>P)-A<84?H8PGP^Z7U$SD-YO<I'^%/
ML&Y_142+WQ!W6'B/Q%5%#A(2MK?VIPRY%*;V ,\C)L)\VAS89#P@K#J]BE,Z
M.8PR0],W)$3)Q$R.T @"@8W!5EG"PV[K"FX@&R#PH_7D[;T%QC:'?TUM%IU,
M_43^CH:^VD$8>?55QQQ\- 5,P;8$/$H/ZHG\M^2?4_B"1L8&4?94:HF\( 0R
M9U"V0O0;H+(5RK* Q!W$V:2E&*%=B,#\A]N/7Z*T CM0W_S?@?:!%HFC%B)R
M4ZPO%=9<G6;NR0\Q WA-3GUMY0'7%OIN6(0=R )D#(='B3PL)@*.ZMN3>+1P
M$%? !'!L&P"+R1PY;Q/W"Q<E:! VH)!@A$.YN^'U37#M+@/![05BM26HWVNN
M($7[AH5#FE7,28,_A@M/+(=>%"P8HZ@L;\:0F'W,GU:W*IA(H' 12J[).P+6
MER77@WW;J$UYTW40[R2#Y#RBEUA?<BJ5EH!V)D)GH2.OI_!SND9RL;GWGM#A
M\DNPD&<\D';5T;Z+M\D#(DE)VN+\G[-NH<!Y0/]60$.C*9#^BW115)#$=KGF
M)5(KD=&2HDN6#4+B]9 :/V]>%"44M7.$9ZC."S[JPQ6!'I&403P8$'!'*%<T
M>#H\P#5!:1'(21F.^"32B,*8\0(#QKCHY1:FQ0V,V0.B;I#'U<'(\-;W"S%A
MW+KG'".!4:19"[D0HHE!^VAKH$B+\$P;*)/]#!(VK,CP2COK#HP5!8F7N\RR
M3VNK-[':\_Y)?)G56X<Y6N10S^JMIX#VF M#V 6F)ZA?7"S  H$H/,T@K(9<
M]=[SN1\7<<-7$QAE+1SR8(G$(O&:7" %F==OLR960KO/,[FV0JS7YBL>G(*O
MF(BES$PS<@";IA2A/,O;HGY> &''6@7LK?S+.]F[VG8)6/30.V'@B2O&@Z5;
M>^,+^=?BS*-1IS\>X+%%AW'QXO)I[[U!9ZR/:QD<;W0[H]ZPEJ5@4Z-^?9LJ
M/]^6,[K/9(*Y.MA=VW]R^3-- 3ZJEH0G,#7YV.!5:6IRR;F.J5UG[,V2FO';
M?;!B6Y38%W.R[SF/Z_A0[#4J:,9Y%LUAS["+JUG0C1GSHN4M?^.7_"&ZXZI-
M7(<X'&'8'NH5.[@^3\ODDL[(#98>*986]!JN%TNQ]7^O/3:+<CR?"4O/0R1\
M\]EE23"A4%H;N0<]L[%;95P6 %>"PEDL[8&2=V@4W4$[>AWW6L*7JMYK'^Y5
M'S>LI_J5R<;6<(0@#"X+0R6OG =M&,O^AP5FS+4[$ZT/*G4X5-!X@*/_^N->
MPZ".XM(W]$*OZ=*'?&C2L.%>>W.OXDZ<KYQ];>B(7Q,F8Y%7NSLJ:M':L*_#
M7OJ&SOLU73J-S39[V4KMAGUMO,^O5$<:+$1K0+59\2MG6 >9<S;JBKFC#<,Z
MBDL_R%"LD2Z&5#8,J_I]?F28]FHGVJDWG*H,:56( ;L7SCW"VRQJ&JVK_Y^]
M-VUNX\H21/]*AL:>(>,E4=A(@E)41=!:7.JQ++4HM^-]ZD@ %V!:B4PX%U+L
M7S]GNTMN($!1)$"BNFT30"[WGGOV=;C7GK;C7&]A1AN=*W:]>F"C_FGPFT]I
M,L/:A"0&JVZF=$XG%3CI]&8=U-[SH57XZD+RG=H\P#,:DF^JOV=/VW'<M["G
M[S[N8SKNW@,?]]/@6C3XT<D\WX!#W9X-\Q21^1;>91*8Q$>Q.3:C8_UT<]?4
M>J?QX'SM>2+)+1SO^Y'D%)"D[X]Z&VIJ/PY)G@8W_"W)I/);.*+;T^KI<\*#
M[V2%6"@"?[6B^_MXDBP4 GECA!^U<L7#/4/< 5RI<<0?B"MGK<SQX7'E:?#%
M]]0!*,NQ@A%.Y1FQQ'M5#M_3S'7T!#!V:[ V(/%9%V>@;IC^M6=Y6X0+M^B
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MY7X,C%7D1<7827BE??0).E=5NFC@6SM&_BO(3100(*,\9V,WL 3A\(D9Z/Q
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M+&1UR#P4V'V1HKYE^SYBS@ Y5SP5@(5PHP(@P!#E*/YKF;.4 *'9.^EXYCT
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MDNA&+Z0&[](6 N,'UJ !>(3J2NED&?S)01/FW=Q-QG@)ZO*B$8 9Y6\$49:
M3I&'V>R&"UG&P&U-(Q?M-:N<MXXU!1IUT8<68;6;OM#7WEMRGV@ZDY6FP!$
M'3*36F1ZP1#]7.LSB-OC@,\MK^!L6_,*6GT9#PB=%F5JJC@U2;'VDDX=+S.F
M8Q=14$^=0FH-)R2 ! \[WK^E71.\H*8B(A7Y+A.@!E+4\,C:G6VIQY3YIM,<
M;0HI$\P$T_F81DJU<2V[)29*":C+Q&'0PA5JZR;')@C6 J]8!%^UDXV\X4#V
MO$"3#X8)"VJQ-.UWQ@INFJJJJX?>341L%D ^TQN7@5F=N,Q6?$]A*TJ*NZE
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MZ22@9Y2(DB*S:^*;=L]Z_?SVYW77\S+CHH[T0%C;!\!Z(4"6!2GUP>947]1
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MJ;K"*X$/VBN]-Q9[F"?CH*PY-H#%A+"*( _Y.9@X@_=C+UX7^]PJ+:. $&M
MPDL58#TFGME.O_8Y5"I#*@)R#;YB?"/\&P^V=VAJ<V), ,[5/$DU*8#F U\@
MO67!?(YY15JDN,^3TJVVQ?0/&];C/)'SG/\JTC";AI0\R  K 8O$1WC%0PYH
MB,Y2OB!>@GH2=AV;7^),5>=78%] VG8Q*DB1J4TEWPD>O<2IJSA_@=^:":)3
MCC5=Y^3Z!7&,S HE08)J/!8A 0QU?G2/U<U[4+_:4I7#Z3]?A(/9V2@X&01G
MT_YH..H'XU%O$HR"_FEW,#J;'9_^]^G@Q>TOOU.^]</SI/<@I5DE'G2\_RRP
MH7$>\-'"<<(7D?[L4)R(OP\TH<#['&9?=[SJ1+O5O,](9!?8*)^* 6[VV>R2
MS3[89[-_%P#_7*,W=JD;=E-2H"\:*O6VOU01<\[K)"7M5 ^6D8SF\G0>1!O.
M).>J,Y:IQ'BE6;ED9A>,OXU/T>JU5K=-6CDJCSA]&:4N6PW8O=U6NS:6'E,9
MJ5T+R@/=7QUM#GMW932&K8>#!V:78.P<X60 +\8,3-5!_8.*5$ECU16K#0_R
MO<ODFB<ST5P7L/T*SE W9:Z21VN7*:*6YE6+#(QN?*TOR.@?#1F>R6$'",WH
MT?I1.U^I)P73KW7!]-MO4FN^N4#8/GK]2",'0DHX;QU#[DR:0;L.K:."=$YM
M#G/!@AC(OP*2 K%8RZE2X#$EZXQM;4;Q$M72\"J9]F)]9GZS]DJMVO5@]"P'
MJPHI&0T.REQ'G-58ZI)LK0A>Z3--C=DYB["F0[8]5OFU4DS@Y"298B8QSSFM
M/(Q\#G:Q>,?;(DV,R^&\P&%DF/(N#]'<CB<O!%-,@D<OGO@ZROX&,7#=*8ZB
M%9,9GM X:Z>M0%N)_A<>)=9>B2.%-=4I8U(&OXR"."L?G4RYJT+V4DWG5$-@
MBWJ(88']C>/-D 4[\WN=B]BN7WEJH.I_99ZF#XLJ]O64%5*O.>L<GE3";H,S
M+IH[E9'P%#RT)8/5')EP:T)M 45T8\9OXA0!IV!#Y@.6)G/@$,<LG)JN%(A+
MN\Y":*I"$4_TW#=#!GKK^MQPE$@X#0.V"_%,+XUEA7(C2B:E^RN$3)*'1\O0
MU#*79,O4FL1FPIX&NY;$%58FSANQS0!3" .Y=HPZ8Q"N"EF%-!BO6!3,?G3=
M%1C=ZA)5:6MY'^ =A^3N"644BHS0DOH9&7[6\;QW5:1V:$!6X%"VP_JB))ZS
M0D \4\;TPM=$F=H'MPQN"+9:.:G/:F,?(L*9&3K77(D+XN MNTP/F1J9M=N#
MO$'+UQ)"&?_1/>MXCLT0(MB.3X W)ZOI"B_M=7_6BVWASDW<U3?#;:YH I+6
MTT( "O+0JMM6&R4TJM,Z1BUV[#Q5GFM'ABW/ ;!628Q$,94($B@UN&8.CVVC
MKD:PZ<,61"DQSS(#\!N>3'/O> E2K-845S!G%W!E6(L;NL)\*H2OZ5RK)8Y0
MSTHCEV6F46.LHU27B>RJR919#QP<5\3:^88N-0=3!=OG-D"51C01C?6JWW.(
MM:OCOV2L74URNFP.I:C/K9:<-F:P&X<J*_%%MT50&)?6+>NZ=L=(-9IXY)</
MO,N;)3)2]J4C\8L"Y#1T^KM(A$.O4MI<MN"T$E' '8#-OH_-%$'D-_BB2L>H
M6U3"]:8 ^;)QXD.,RB@IW!98XYLJ-)VF<JLVL>-VU%LKNM_'L\CZ4K_ =F>S
MG8\(_&GM#(GP ;V:\:=N1RD)2);] /,H&=-U AK7:F]V3(0E*!*RFF%LS$]:
M!6$S[R85"%0(K3@O.?<)]@$:@0KC5A>)U0!4+!A/@^S0L0*Z"I\O*^JK!;2S
M&([PP9*N@Q3TA;&$(3G.5\.5!S]M*REM87)"X?$X!HURXNQ;AT(QW$N*5X!;
M <4)QV8W4/6:SOF3]9WSC^)G'W:\UPG-DF39_ G[P4S1K;YF?'/4&1W7(YP/
MOZ6W')H65=:&!^ZZO6UG9.>QCL;CEC%^A;'_D.18[CM)!ED!Y'H59@(9A(()
M<%-CO4FX+"6/P*H"[D[@^B_PE]>7H9IY;[^I24$N@8\X;5JQ?P5__P2J&#XM
MTGV#X"^YQM>VM GND94AKW02/";N<2W-<7D'L$.M8 %W_EQ@PX#>(#CJ'1^H
M0[JZ=SR%3QY\/'3V?V$'9AN?X#DSA=[98.@3BU^PEG#P@DP5Y[(7A[XH1K1X
MW"C_*6%!'/R<<E"3N,5_%@!2A6''SY3YTO%^H5Z5.&L3NY38,_._%Z3,I3$"
MB_T7IF)-UI6X=2&,'-"&7LEKQ#Z=RT#L#B<,+#E!.C--'L^ *(R7G;-_T,\%
MED'$_5:*,=HQ]GQ*AX)XK,U<GQ<'FNK4E\&/0!]32=N0M"(QWJEW*%"6D8K4
MUF46,K(0&KQ];;IBI(0\XA5<K&]%/D*ZG(T[O&>?:Z09&L_^M5C!^ :DNB;C
M[G;6RTS9"F[W!74;PHXX<4P"Q.Q0PZ4T$]GUQ0I<&)&3">E!TPUZV=%].#)=
MZT/&[8N8B6&4S.9WH:'^%0T&RI2K7.]OMN*[JQUG+VIJU[XA6BF$/&P/(:\/
MYU'_Q>/&G1^<(7W"_L;OWWM'WL<O_W[[V7O_^[N/GS^<?WG_\??MY:)6W>UU
MO-_4'&CL$_<]!"+;>4WP3V6,%]?)B[H=<2'R-P-ESD7MB-& 1&X*]UT'G%/+
M!F6L0^_Y)>6"H:YE[_0"<G2#[*9<U7*.*SM4:@ROY%/VZ\/,_5)7-TGGI-Q.
M,]F9?=H 8W3)L2O[,L!$?L7J +;-1&V$,MJB(#0#V,VZK1*;65W0A8C<9EMI
M+0,*G9,21HYV9-G1_VOO2IO;1I+L7T%X=B?D'1'"R4/N\88LV]UJR[;6LJ=G
M/W44B:*(, BP = 2__UD9A4.@B!%2C)%$M4?W!2)HXZL][*R\@BX<%_-<]V*
M+.7RJ(H>,8R*VO"9G6]&)L?,BG"<F[+(L)]7F>_3P7X4_! J2^99')"T3@II
ME9ZRJ.N@V>DQF].NN^.;4_-,%Q_P#%][+]RK]WBY$K+_?S1%/Q%<+K!CX\-I
MD&5GS31B.C#-G,G]3+U'%1!&1H-!R;9-9\)#46A^N,5XC\[BIM'ZD!M"9YS%
M4JG)/6%M4V:'19V\M!L$%1D?\I'.7^5%;GXBGBV$BBLHK$?Q_O)FD90J/LAV
ME725T&I 8E-\J<RB]S'?:^;*.6[=ITF26<S.0%&:H><[/*=0=L]SK,!KOA2&
MLL^Y;8K>8+[*=U+WACR$F()/URX$&F8[/N'L[_%D$/O]PIEB;NB+2(6B;GUI
M$O-?\;N:9Q6S1DZK0<)O2=V='U^AN1[?AZAB6U,#JN+HK8\30] "4@<X.A:N
ML,5;6)!$I)C2H::T[+6"*"*OKM+02>LF09;L&;X:K6H42B4\&&J\_D5#I-]_
MB3%D"$!$]52D6:+8OZUH2<5&.Q>&P2CQX*K)JU\W0Y!"N&35\CE>,ET+)H ]
M0*SU3PE$33/F!]+=8XS)3C^QQ&-_Y4LX\QI"%DZD<)*Y0,S7H'SJ)*?7XT&1
MG5H<YHW'D3R5QP3U-TRXMVW%J+SAH4GI-)3L^G5](&$INI&;U'%]"#4!1S-F
M/HJ_/ /#]2O<*!=E:*U-W>Y1H'!G"\4.V^IDYW&EW*5H_^'^#Q'"@WE1<4 O
M>9IF44)"V!"NH3^5Q*>Y7DI.J:@2TTG.>()'N? <XCKY@$LI<&A*U%S'-8[8
MRR-3V/OH8#N #2W&+_F>G%8$AX5Y1:,$:,'1+=WT7Z9N&&B% HX7/ANYX.?8
M$C!0HFV#2#^S^^5^%QYL%45PPGS7">^\>6=7LVM@P"G'& :Z\5B<;J1^4(I[
M<?)!CDC%K1D1;!5L2/WQ=%SJ;JGM1(O%"=?B8_JSJH'T(O130=7Y15=DG,M5
M7G0JFLGSK#F9+^Z05E8LK).ER1=^JXO"H5=1R./H=^.'N7$;8)IT&'C]7QA*
M,%SOY70BYO$)]2TL/X5^(0"4CA#+44\&[E&(0NYV/)GV 6"0B-%[F@1&!M-A
M'+#(HETX7LUAJ!@%,<(Y<LI1$>)]+AVP15S$<3'1_&[ )X5J=L_,"Y9CVFV,
M<3,A+;L"X7!?%-*ST,5Z*KW%T$X_\.E\OF1E6SG((#_2]HQQTAC&1^X%8HDE
M<#'JEUBW  W"+)XM)]6-PVQV&RL7D6 DK*#^&'0W'[USN-QJB^E?P:-XR=="
M0GX5A]G7'#>V4DYT\L$@MZ][ +-K&D>#ET?VRZ.SE[2D!RRL 09_N 1,Z]H'
MVA/ &R8H3B62T@+-)90\SU;AYD58:.TY5BX%+>K<$AK 5B)>9[[T$[\(L5X)
M;]H1-GF%K),@%^M:#)[T^2?FFUMKPRR@35BO8<1*1@QDF)(#4:Y$-6IU9-1/
M6.21OS.3L1!HU?=32;NU(NB3/EI1TS &49[3(1KE(1.1C#U^%)&*HPQ<+'W4
M4"BH.:8GY =M68](*. J>ODC7BI,>G4/)Y*Y19T3KF04E%+[>$%&&;1D89.%
MOY5 "!UV5K-Y5;XN*?W<>)=4NK(%H;*GPVD")B\IRO5#<9]JM\1[OZZ5I9>Q
ME#*'4%2O")F!_>5Q%J(C0!<&V\/+96/1@QQ'B89+$#NE+BAO:N3]?IJLLP68
M>Y^88H0WD2JD*L481D7>F_DF*]MZ2*7#EZ6Z<H^G5%9?S)R:A?N3'XY$Z#UJ
M7#(TB\ZQ99]HT/'X"C66_!69_W<F'=6A+;M:"UTW$\H!.N:(0/^8RUF7XRT-
M#I6>$I@*B<O*66;"E*T>^1O9BH0<YY$K)2C-'0FAS=*54:8Q^('Y=T:\)7S0
MQ:\"DI,9/'FLS[LM;B;^TAB"JJK6CZ/O\"Z/@TH?2T.OS/7 ,MW1#_-B(K1L
M$\Z_2Z.]<&*3/L0RM$PJRBN;0+$^B*FR&5DJ'+3U^^E4>N.BKP"TBCS0L&%%
MN;@E[RC3%)J5 AW-+-+!7QR7)H6%/2D/W :KM+"$U=F\Q$& 7)H_B10W*3ZU
MIEV^N^-V>4O7OH6 P+BP\"C]FJIW@+B_HWB)LLL-SL W43!''KEM:,!_[C)M
M4?CP Y:>J8[A[SF&=Y<?PS?D1)T.=6P,%!XRLH]_FP!R7?,0MQ^EE;1GRR8M
M;7$>OH"<M1?0\\R;HVL?X1= P"$'X"MGI6CD?'5VG+E</8^<R\\Q-S.M;WUJ
MC@8OM4T*(D>:!]L^.G<4 $*:D-G&&G7D-OJ+?X=9Q#]-Q]"@ 9DM00*_\"%T
MI^6^ .UX##WC ^\4R ]W4*;1=\VS.#X3"7+>!^SFA2:&#X3B+CT=^G?<@XX'
M"7]!DC)L=6Q,2[/VFQ[^&D (F;CGEY.YU[VN_HW#\>"^?XW'8;INF]R'=GVC
MM[1?O,X,W&MT'G=7M!W&=[7,?#=7K5.(63/OO>X(='[.,!H>MHYT8%)RS1;
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MQG9.X7:JUPVA#--XOA V95W: >N2NSQ^+6>#BG<_44+!$$UFA*;:G1JXAVB
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M"USB4O\J58^-=%GB/A*I=D_."'^>8$ZVY%I;KJW1.=?)V$#AJ/:J=*;^*%8
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M4=(];5K,&GV6PXF[M4[K*QA=G3R]Y6QJZHE+C67'I*'==WTTO\V8?^<#+%B
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MSXF]FM5$[ZZIO@Q:.!,RQ5]^^C=02P,$%     @ 0#<'6QZ<C.TX%   ";L
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MXV2Y./^D,W)GX#L%6=EV>^W>').=EQ06#I"@=GZ+KY<TE0&-5,A :ZU(4YW
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M['!Q:NR9%F_B9/RIN^,.V6NGV[5)7^TT;I2_#G"Q0+P%,N>;9+T\P5&**?O
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M/A*02;J,"/1='%6*-\2XZM-WQWS]69"QA,N+64/$]S^[*=[QIS!L*>![']T
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M\T:[G#JUE3BT A^(Z[75WR8":ZRW7TA2GRX_+8&@M*GX6C:/K([ULY*<9!_
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MS&4\652?775':Q(.W/AIK<.$NRVWU_"A-AJ="K*V2)=DMF,$GPL"(W,>$\:
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M_\DD=NQR?#07:,/,_3L#CYQF*!4#+3R9N3P7<!(1I$,5N!/>8J=KGR<T<^T
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M79(-^D/X;.AX1(KNH:_]UBN;;_;S'[T9I0E6)Q<7_QUDJ8Q24D)B 6N$1Y.
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MTOX&L1ZB[*D,8KTWML8D@<Q[#9XE40>4<0BFQHR#PA*0F1A;+\]^7N.[#D+
MKO%=AVBB_XE.7:CYJXSO.D@SNT<['2/6_I6-R0=/1RA8)*]+Q4(.5ZA1".V]
M<KKN)^UKAM]4QG<UU/$ATFP\ONM,,.[W3I+RO++C+1A1RRTX.=GD57A@F:%&
M\KFU+WLL\<X/&WU$UT':F/4IRBE-*]JT3.WCQ>)?;^=8'5 DO_AZN4S-!!Z$
MR1(*8PX4Q@0A!PW6)9,BJL#59):+=67J"04N&MF[DX+)U-^#C4L%A0G%B.)
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M9'\8!LP:JWT,+L36-_TC(IZ+MD^3[F-UVV;J7D4VJE]Z3LSQH(L"Z6L8H\Y
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M87=@+^!NP1'#,<#QP\G :<"9P[G#!<+%P&7#E<*UP W!+<(=PL/#X\'3PO/
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M^]8J"LPQQ>(Q3+_TL]'<\,M3T.TJG#\\.,WH_,!=RJ,4-'7]7GAN/M3K=PG
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ML?9:K.6Z (+TUM4<Z*((739! _SP-@0<Y.Z_R/+?O]I)K)+THL7_XU>T_B]
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ME)SJU'ADOXE>#Y,QS]H1Z#YJBBCTQC>EUY)=IWN\<5H+]-B]_96E8?L47*=
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M)C/@ D:(^YJ?+\5%IDU];+$>W@+$WP#>@<W*R8$7K9^#19?&EZ]HJ@W.@Y<
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M4K$*3.0>VOXN!Q$N[@Q0 ;LNM/9HH9G# "8?-+X:(JPZNK#5O3Q""R@,H9D
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MC]-[I;0BH@F29N%9Q;=X9MATM$29';97?P!<O#^FOF^'$^^32;11]S%MAX+
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M1Q1D-VSX54HMKTT]J,NJ^,-KA)_4P(U/S*AQP%T<32*X"X_"S\AL)E"QI-L
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MH6M2Y0&)=K/&!]$]T*\GZ* M4B1I[412?XH(&OY1Q7!/8GWX;5#/C+)_ZXZ
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M&/<-]^J&K'YK2:#:!+;Q*NY57[ LO3H<_PFS6N"_FKV:<B?"G[T?MHU2*9S
M_5I79I7<*(;@TF;69[T;6QKN\" M0_*PH=**+;;C*\92?37=4+SY72^0P\*I
M9L+*=I2"/MW1IT<I;Z)*+UBKL,#;AG:JI=QHQ'TCV&%Z;_<R(Y9C-;T2M.]$
MD?0'T#_I2DF$9KN(NP<XQ.&'@\;'9(VXGCI4E(!\0D5#4';&IXH*2W78+=4D
ME$!%>YU[&GD'!\'FC\S$-L5Y$YX:(HWI4A-^GA]7%G?VI3R-/I0!3\OV2\;F
M]I1JA[__6Q"C6M/*'DPSN7@WI5)#*E9FW[4-G$;9G5[6U<!=5(VA(?/>/1JM
M=DPTG -8?ZU+L4DS6\J*L<X/?%U\A>->!5G08<_1ASKM.LI5>?+99 6>MRGE
MIK7:YHAC;D,TQ]8SZ-B$*FK)4W0]AA%"#'9Z$3Z+Q5!2$X]S4^/6@8CCK/-5
M'&LCD@;)(WL2/!<T=@$RHLY=CZ7(Z%E=KP(!1CT=45RUG3OA*3-XZ=RBN#4D
MIM'QDM_(3/??34,9.\4_RQ :]7G7EN4IV-"E GR/!G-VA8!0ZTO*DXC=HJT\
MJ&8IZ)4XQ;4_(/// "Z5+C5%=]+6Y!;52<%FV&M65>__#,!!X_"U_'.G_ DZ
M')NL0;5_N[LLYD>0T%-[ KMXLYHZ^< !K&<:[7$%'NJ7J:MVGH!-6 LR%AW
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M^?5.'H=Z# V2#R;.$%$ARVKCFP8OLK17ZH-UMJTF_YYXR)V\&AG[":JE&]@
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M5'2F1Z<_>^E.]6K:B'#M?^:I2JF9] K9*/?;H@YDG%F3A%C !+(,FZ9K+EP
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M1990]*VO_.T:<)ZMY0719LZ,M.GN!<\)O#[G\/JE?VQUGX9FE:JU6V*DN<]
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M\EC)GYC3(I AL(YMK@G3&9_&.Q$*/3;L GGEI!8G+4ZA* 9;RZF5QA6;.#W
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M[#VW_OS2]),Y4@ [6X:;B%*(:-L77D\B@/GAC^-S_R93/ 7<</@77&_&19A
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M.06L$DL*G7N=EKB%UJ+;J*]@G TXV)6"&KGRN;WXNW,E\=-N4:XA[$\K:]*
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MJ[G*@ .++FB,FC1^UF;1C+V7123NM#_TE;:2;JA<UY5=Z5]#!.;?,A>OSP?
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MK+W6]D"9?A->P,X^I7GD" 8.T8W?#JF3Q-*6%DED@F)F7%3.%.JD$WR)*K%
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M[$@(YHY=ZZ+YD\"<'O&S,F\=[-FG'3?.RU%&0(B*+MRF$29>\9S8D97^3NC
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MXLH=EX?CHH=0XTB7C.C;1J/[8V-E&+QD'_WB#E8!_MJQ2M2'V0=!,Q5.>8O
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M+._MA3Q>:(SF4C*UYFIUY:>U)@<VFW&N-)"YZ,8VD"^>,^>E",MJGG%IUDS
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M09BX]+^6=QONI*;JF7M8[5WZCEAS7_PTPQC8$9;<.9O[*S/C^#4)&)7_D/L
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MF:^Q<FHQ49RWV1@<6J?V#N:"<&#Z$WY>U"<5>/B,=#$",Q@YB1">K$@QZ8E
M-3UY1M<?"4G?;E#;Q?*#<HE%,^1<#Q(]CK;2A;62:T*+A)BEQZ-9,CN^3[F^
M:5XXR9)V+C PU$5/>I,G@F)ESF3NXB+!5\.Y]P N\6U^K(11Y^ 1RG4%<"W#
MLO"-84+LIH!1B'W@_/N7R6%X-E5HE.8CC49AAA,;+R#3D U)W\<:F!BZ!UK[
M63.:=:^W7R".J3OQA7!3![N]6/N[1+B"#-0Z[K*W];E<;I![@-R9R+0#?6YN
MWBU]Q[\=K35"E_%ZYT2R33O'//NUSA;BEDGFN7J)+AILRLY,8@6JZ9ZPN>A#
MBEGN:3K_IYDN\*=Y8HL]/-P#C!]59*.73PP-'KQYG@?WM/TQG55L?N(\FE$%
M=]DBZF)J<<6#A( %J,O'&^)M ?F34.*$Z?VW^-61\%D* >%JDZ\3;I\X:0-\
M0?8$4(D!-;'H+YXZ/L.$O"]*5.TI'G]XMJZI;S<0MK\TS.2PC_;0_EI(W:L5
ML<%KZ.#"TJ=J\YE-O1/6,>*EA8D0QH HN&=AV1%7+_&?.WA\B$K%2R98/%V$
M6M4C@E/#JP&&E.M?N/57P]-LUUR'G&D_9%0!4VU7X'6+N,R]F?0[C%Z=[C@:
M,>H@S_;RTFKQF3?5')3MQC3U7O!XH]$6_(M+T6'5;.S\-B0TFX;&S]B.N$Y?
M[Y,KL_QT3N@0"P0I*%\=? \@988(.]N>:!*$6.6:95IVFXO?GDI$5'%0QQ>I
MOC=4Q@^MWB&8]D7%4/7F)I3@$,WNN\_!@Q++>GE=#@2IF/C! $:.6)TO64S
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M)J_RS2]":[97WM"^X[:E?#@#^8#"+F"]<R:PGZYP0BEAV@J/9]2(+L[D/8;
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M_KN#/6F?*?'%@B77(CFBQ!/+T[_ $>"PI#A$F7^@ZUD2?SY(4>*(5>^KC.W
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MBV54#3@$^;/CXS?9ZX?^XFF#_NCD><F:W@1/YQO5%)8>B7&H*5W%5"O>C^&
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M@,\'VH$SX9?.HQZ*ONF;'ZE06%CY\F(G*9SP%#'@]TOQR7+R4DVF]5NF"?O
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M<SAZ]DI2L.&QEF4C TLTS9X!_Q1+B.-C\TG[W![&4JOPZ,&JI3O)%TUMX>9
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M=O0OA@SVNIVH? 26^;KK>E=9OK_L[@I SI3IX&F3DD:5$8OIIC$2/,6$EWU
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M!B!R=0FX@9<'XDVG@ODJ?T1-0B6B)(,+_\KO;OB[$K'@YI.;,^'<FV#8@BH
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M<89Y@,";-;V+DYCXWM:-UCC)O9:UKOKEV\1(E33BPTJ&_7:X2'56!Q&R8JJ
M^BRCYV@]^\JD5>5YD>I)ZU5>_^Y6%9L9"DA:=3/5G(4 %N0!VTU!/;L!>P@+
MO+,I"?U$ZHQ9"",K9K,<B"VU#H;:&).W:3/;-<U!\@;TB+NU!8]D8:$AZDE)
MTBH^MBUYKS,>/YXK;5X: H$]Z*2&;-56C[78N6!*CZF;<]4O.V!DT)C==IID
M(F70._4+HYH2N*5,M^QKR5)5D$*JGTN9A9H_];&^2P&HS#AXD$- 6\( ]D$9
M&[Y-T8!G11=W;"QES612,'\>=YSQ3%13/3X/2P5* )_HH#B8W\6QD]<@<%OM
M.')IL0!_HHK^-YJIRK:F&P*J/P9DU^TR9'UW],GX*VN(E#8*6OP 1"9G_E-E
M::\H^4E%<=JGJ\]MO>AY7EC;1@*858[6B4N9FQ>NM8OJZ0Q"[+/]ER.%=,\M
M#/\"H)8+,)D#Z3\OP^VEBFX._)D^!;HL>WU/.&?,_JWI=R:1VQ!JR?R=\=?[
MN:&T_A?^H^:Y" ^]Q*6"X%G<5RA[!++L%@"0N3Y_<KQ%?C5Q/B+'4YLGTE8G
MS$@N89(3?R!*^])0HGA9\?3KO)Z/FE$',L^<^#O]0]88Q$8VZB,P=FSLDIM2
MI9E:_'(0JVK[8'*,\K=T0@F#016N3+$8(  T>=80>E<F#K+H?=:! #I"40][
MYA6U9Y:7WL*-9VEI!#C*OK?^C/J\3?T+R+(F&'K>VYET"-@6..(W)GHH4TC2
M+\>C1<G=G1K&5$8X8CJ5\-W]:J:G!7-(V@OE1!ZMVPSN$#D>;5?XR_#4BPBB
M.>3 :NFY/:;WJWHN-\AA7"I3;+GV(Q?73+NNI<=S8FAL9F>!$!(ML11A@LJ<
M2_AG?$^P[^2AV[W714]CB74#KVY>;+ V8AF@TT95E725--:0 H>>3PM;^Q:L
M[FG6I1K C+8R_,!SU4"2@E<ASLQ+'B_>6.8SVX]<^L6(_3XMT?:I[?S%CR%V
M^RCWK"5N^!AUW0!%)B.>S[!.J:MKC)\LSBT^7"QW5'QV([?<0D1UES.03"&@
MX9G_O.5)8^#B>?XND_+,IO;99IA5DE1,XS$,6R"NQDU3^K+*2+RD'\GN/]53
MZ,1-1'4]P.GK)/O;;-B5BQKC/KN!X4P+?N:LV0QZ@^] 3R&)31_V]-0*]$<;
MM8_HL_X"LNV$'_,ZP]2B%?,3BV_N5'J;>1"=JJH8)52'[PC63W9;EU.B$DE
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M]VYR4":*&1P;$)2P7,L_4[41]$7LH6=0HG4LCU(UGD#)!$E+ L=H9J];J)5
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MLG0^6/^1A@%E"/,@T&3[GDJ]$M/^-^<,T/P:=M/HUF^RN= 0L\$/+<49;P4
MR^-OG9QT^CU;SR"UC9'+MS7C%]&Y95"P<3_P_R+K08>E;XS:!/CF?\%0QU]Q
MBQQ:=&;?C$N?5*"&1-P:O*)=UNY?JM[UB$5NS#1DO(103VN]#6[$*YK2 TT)
MZ<H6N?<X+];L?RL8M_V, 0\5J7_BMJC0GB"97%$":O7^Z_BQE_/>>W=")D.=
MR^K[1WR=WV.RLA1Q"MO2;>R*V,+/EZ,C7?WROZD.Y6:'+,2NAK4#;P#95Q3+
MM6YB&()8B)P82!4<Z)9AY&PE=G+F]M*M?8>5U.YF/1/__J<;!\_#],7E*]+*
M(!9%8,%;LWLMS7Z?;C)Q4]3UJ/*6 [ %M3'+\S%S9)7WLI'\F7EN9 ;^@:=1
MV4C7$*32-3"79[$S2^UW(-WA5\\*%J/QQGRC5X%YR3%CN)^O%&CFL]S*N#_^
M,NL_%KQ=Y&[DL,!?"RJ=&H'HN*)!Y6<"L^SID-?&$ 6SKYG5KZULZ31U=[:%
MC]1!GC(%<D8JM84.>".*OK^\P5=1U&^O\CDRR6(1N)J_)P5V8PK;];*SA:=%
M "1:P#1@&D$6OB>TD7EA-<,O'CE+*Z]_,GB$&?#$0"V#=7(MHAH$ 9?SQ[R4
M_9Z$"OCF?D[]7?E>N>/?A+BOTA4;5/@IY+BZ<N%0@2.>NPT=^WH@><D:11!K
M$-?2 (2]^U&@]2-LXW_!4Y@_%3X?3N:Y9PMG>@DC-J[2DD*BK(PFP*!=T*^%
MTC;?URV@&'8XS+-82C2J'\GQ]D*KU/4*:O[H@<FAV2&YUK?A=ZE<8L9[UP-K
M-XW]!Z&FB9%LWZO2?V%CT[%E8+T( ,3P/D!^SBYBV:IC<<TFI?6V:H(6;BF1
M6SG"C:'B+\!]C_A#RNK>R2<!A5\_)\[(O(FOL2J,RSOO_GS^@3JM_G'[QRTU
M_T')=&:ALYLHXQK? IA!Z;7^L[G[GSRQN^KF@)(SMOD%>V?/CNEV_L4DJ2[%
MJ7RF;$'Q$@B%2CA0,%M_4)PWXW'P2611ZG=A2(I\!5)EHHQ@QD!7>#+DLC+U
MV&.6F4;CXG6_*\DN KDK8UIO:?=\7-:+/+6*,I(DQB%'=V,P_%L\S]_\:PA<
MG]3.IR3__/%IAV[_%'N0T?F*>KC6YX56_@O0_"^'2#_.>#&+#9_"GP+'SF%O
MBI\LP%P&,>'-%]&OSG@OA%_T.O\%L/\/M]"FV[O2ZA0VVYJY^>TA3RBR/"G>
M2.]K#$CW?B6349@9D3]T]Z!CQ/Z+99?T2F[T%$$E&"TEGVVZAW\MJI[> JH/
M)( )F9T!:=]$?W1R&M_(2>BJYI$V/%NPAFK]C'UDY3*JXO*J"=_J%9 _<5B?
M+U'\<6.Y\4^Q/O+</=M<.=[[X//3^^UP;;L?@0:,6DA&(5M#&HG1;T]V++BR
MC,A]_P;Y\]3[FRFW?5;,//1L@^EAJ%4722\ZLG9D/IS$VKW#;6OVVR[6ILA[
M2!AB[8DIKHW. +M)$G<^!BHK>JR3BD_=R[/^)"U2G21_L,I_*FT!S]ZIW;<H
M3/UT!XA3C-C _-F=,<7BS&S]ZK;_ D#UFY;)4]^\C":&_%K;;RO4JM$X Z\K
ML!*]<(WZ@!7N;7CA[*$Q[..+UL&6Y-(!;JD)R7/Q8(YG6MB ^:P3'$&*J=2$
MAR>7]7#;KJFGT.K8U4SV2Z!>H0^5"%/2YIC%-7&4SZG86-,P8^;%-RO:V-.K
M9'[BOQPJI5'J0_RNJ9R'+7Y:;;/E37LBB8F1@U.D7KOUV8Y/R-@_,N+$\0D'
MPM URSZKKW.&ZW7RO[BI&09']VR>('/%R;V<3%.IOQ)H5(=^6<ZGK9PG2W8#
MIUT[-[^$I<\,I\39I@AE9VUK8<-O4Y'*'\'JQLN?ROAOMSA.V@QXIMR1R?8W
MD!2*$XD1PO9!)0*TYMMMWFD;D<4)1%V%]ZIQLV.^IG("1>-MUD<93\&ZV65:
MC(*#TLCH+B2. (:6=AJ!J_]@9IAO*]9H"S9=Y_(D=PMU%I!>\7+V39"FRHL8
M#?FV!(4T*L'RC'"]:QZ?0VV$\+>GV<8\K\\+;.F@.:PI+;'BF]7>F<:_X"G=
MNS'>HQTTV7>3ZRHMQB2N5X,FY)S+YT'9^=MP&$AW"R<=L?_D%F"CW5+A^\9O
ML=6U5=@;M;6L0_?P45AQ=WWCNHEXY2S@K#,0,SM6NQB&G4;I5MF-LU(PI^I8
MB2D.V8>"BG@N,Z\V1/NS\BH)D7<E\QZGXXF& SG:".F@[_0PW0E1)0:J:%OI
MZ"H*0C_9Y$+OL5&;OUEPHZEOV&:7CC<ZAXC;71#)ZI.Y<^P-9!]EI^8'>5C/
M1!]X)A[H:X;GW)A3*ELAL3Z6/%,/D^.UU\0?/%<C#</Q[>I0\[>F3#/5G5F=
MTS\H>?[<KW;;(.L"#TYH1;K^ L0DTW42$3A+BSV[/E/5F#G+?1>Z9JKW)QLC
M$G!\"#O-&X^?,$,;<]*!A#IH&_6=%?X"YEG0C50T=3?:B\71N K5(;W$,4[$
M,;C>+^_\8N"%%E<\.G0;GTD. M^1N;.4M71]4ZDK,+WN\A:$*+]AUF?Y."%<
MNN;1S< ;2=RZ?X[#@?S.K64$4GR- K\A/,ML%3Y#*O8THL4J69%4GJEXA%2W
M@S8L),Q[^ 9X/6*B?IW^>&'>ML%IG?=H)S&ZLIQ0<3/J=[]LRG*#>A5U]M5U
MOF#@HL_:O:_!8'\@9_TF3/BEMEL$$YRH@7?JIOG"7SK8X/'2(W>6NMLZ]5[^
M?F1%TD%S:>M<HY:5=F@]EK."$[%8X#?XY=JMA-DN::3KN\UM:-.(3K.O55")
M6&%Z>6]5>M4\ZG"F^,Z9T6JON;T2;PGM/ROC([H?Q,T",?;VW67FE-[FXRKW
M:I/'Q\D^8Y=#LC6Y I(\G!L8A"S-!WVQ4]P,UE-838A(#JE?/- _>=O.H7&S
M9OV5+E7AE;=4[7# MIL/ZK[QXS =N9]&;&I9$;F)PGBZP<]:C@-G"?N:8[^*
MP$]P/[5<@I4-+ [RN[M030&':L0^R]7$]\]$@B[J;B8$>VHP U4F>FRLK!/)
M'HS[-(*)R,KYZ$.2G_%]"38FU!>#IG?=P?#:ZQ8E) /,U*:Q4-O&5"2/(;0R
MJ"W 3&]L%B8"31,XNI53SEU<.E9IG>??6 +=QT ,S"^OTQ23%.2D02*<1I_.
M9&<ITRK7+[&MUH6:R!1FS7$_\SK&I8V@][EFLXM7I)NLI2UA.XK5D<X/$>,-
MK' GG(H0%8\<1#=#4LK49]L(@#J:SW^NS/+J*:A!WBADA&SX)/ /Y%3%\2E'
M>?GO*G_T%[VB]7*%FHBP!'T?R5==?!I+(G]?O3HB5X$K%B?JQBA2&. )4/U@
MA^A"SMEY(E8H9$7.ND166MSB>ZNPPDJY+8-E#,A@.?<8$&$HW#'PBWYJ8%&J
M-6F%1"D]? 4(]O!9LI343QZ#>G0*Z7!QXB-XN4J^WBFL$5Y(?L7L#^1R093S
M)C +M9 %?I<&"L<8FJF9FS+R)+A\SE/>AP7;&X]WK.&%5JI7=!K?NVZ+5A50
M6^J<E>&OT\PP$W64$AGI+U67OMW;E/ZIOL.?V/Z0B+O7[FJ-C60RO$=59AVW
M>E[F$\(23M\#&G+2)+]Z%GIY)M):_QX48=P5@]:)YE1J/J0L&MDUBH.UMMZ^
MA" ,?3J9%E$P W-Q5X--[<7*[M!^R1O-:J(V3_,O>GRVI='3(U,/*T1.9AOO
MNBW5B6DG8@80/BF<Z<^OS%!XW9[Q?[K7 (5)"$%14.T2=&4J78F]H6C 5(==
M$X&%.O<^.);7LN?Z- 1V\L3.+78AU917"ZP+=C,SU]0X* ^;85XATSW\!O#Y
MX5G C]U+Y\M#N^1PKQCX8CM2#R^6V8*0;M>_*8CQ#XFLIPS$R-GAAYP@^]_U
MR?2CVL6QULM(/G0I-T$Q9!O&.6]<[%<UQO/'-ZZL.;[1%AG((EPRR)GM!E^"
ME\5T(?%_C$1%Z7EVIR=-=I@4[PFI&/78[MWK$P#F:7MI&Y]M=B2 H*8,5'S*
MFR1K/'MR]HW/;(?;C>_BWRL2LQ]&&X0AI TT;)+OS 3R;I-G ]I:\.*9R$M:
ME\UGDW\MQ+<+7//&.W92A.]U5T@_;(O-@[%6(IM/\C692A-I+-,:J[J@>_S5
M?+X"W:U>B)$F:1A\?TQNT;]!\+Y%W)0KSQ/)R&QS4YA#A^-?P$N1OP"&J;^
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M6RK-OQ*7C!Y,__A_P2'0>1'V'QP"W?^)0S"E:B3BW_,%TR]""=\!PJVP]B"
M<N%DRSO=U-4UUF+[ OAG_C^69E(-N7$*;3=^E<DJG&+9G12DI'V0%-QJ&1Z
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M"<_WU=9[NZ7'E(CP7ZA,\]5*SMIAF4&&JBL> H,77#+H9-Y<PQ6@QMC(D<A
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MPNN!'FFSV7RJI:C*D2#(N'!<B8+AAVN3#U-$=W_\]]T^TU=^=<TBC!;]MB<
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MQFTY&:LC#'/[.$]==3W*E?75'%(?'WU0IE7; KHF+K%)W?,LQ[YZM 5RF;*
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MP(HL-O!\BN(&0",LEP8/)/8E1M3 TRT*X?J(+[GW-S5;PB8WK[UWP&@#1 ]
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MFJ6(,9*B:4*2\19#1FJ[2L4P!(O&1>5\VM.DPIO$!\3G4NM':L?WH@>:^U%
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MW^IMJA4=,IG,=\:H1U 82:G1B)W'MW 9-E0[I5!G8;#&2-Y+6%F(CSIL447
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MH$9X(*?%O+OF:>L+.1O7K'E,8P:6?S:-@7 RY<!R^"FTWCK)[6RW/-0/S6J
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M,/,-M[%-GIWD&6<N>36/J<2G:> _TVP-W8<D#7$)A+C2C)JAB&#]A+A:PXE
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MXXT:\E,8VX-3V(%XF);!P6Q9)][@\Q_D);X"'\=VJ4>? J)!7EE%]V"\!5^
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M[@B*?4&YDN U[8 B0;?^&\$%A98EDUMW-S@%8R9SDC8YIM<[</"XY5I)"D/
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M?30+N#%[[=40.NKFMA(R\P3,C.0WKP\*%ROPE]^>9?)KW$.-0D?Z*!]XN>?
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MG>1 79NV(LXRI'R7WW_16Z_QF.V4).3B)N\RG"4CJ7-'7P2!J$N/(LW[7W_
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MF!)$"0+ZA_!O]KGH?W=*@_31IT@.,4"+?D#L?AV_7+D6>[_0YWS]Z^[QV%_
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M7E7)9%ETM61KXTGJC?;0G^2HUT]'FRY8A/V\E9;L"B+VZC4L,0LA !%VYRD
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MH5^S/V]$%6>8.FNZ\SNK@O&@*6LS,;/3U)@>^OM2W3=Z-/H:/U-"V,,]\V$
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M*MZ _XKR&$"WVA5&>SY6]7RUU<Z4C6)XM#&0Q=?6G$6>NZ%QK<'N%;V4Q%\
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MVN0]?@]T#JO"]J/]F37Y9HEZXKU7WXJ(S!AR> ;3.R-X+5YY](45HN&DQ>J
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MFD@09<%RXT!DS4%X9CX^^F%C@O29TT>#B("F-\Z6M><Y B(_#!G)L2-%C#(
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M7?ZEX2=]\R^ Z7_ML<GW@O_+32W'G2)*QQ^? MBLAO^NQ#S:N=9[#EP:T5%
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M;-OP%[ U6<'YZ.U#@2\IEI"4E3JO)M:)12?)F9_Z"J.6RQ2"?D^Y1:.$^##
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MMDG)L5AR^XV; A6_&+?\!BE60!DQ>3TD,VX7_P#Q(X-<#O3B;-=!7DN^&>0
MP<*'VVJ4J/G$VBJ4/#K[*M @U?;#8%R2SQ$;*U?\F<UC[6?D#&9:_UDDJ"_M
M6KP_DD5))@7E]\L_)ZF=4RJ9O&J0ZZT6E=USH5\ZD%<C>/T5JU&@DN;1EN&"
MF(EQ2$)@^V?7@.5+TM4L ]05U,'E36FYJR9=Q9&:P_OT"/^EL&<3G;-%(:>Y
MYFO"&)SNO=R?]67]!.;;CU_F;U@?(%>V%H&SURS]=X([Z61!]:5/,UBH5EK+
MU'S^SYR17*\#M9NY=5L/'G\@@J7 ",W I0G]97NE^W\:M"H "J7Q$8IX@=8'
M2=4A^VMGK?2?,0T.CTJUT)]4*%<)_?1SML_%&EQY$9\LWJ4]N+%ZM=-T-MF!
M[)ANVJ70H@#W.5.AOIR\@%X"9^7 8A <0,]!5W-.^^:3[>.:LW).AU':L=>K
M_="94KEVVQ$,Q9PIM=C&F3PR-OE'#ZI1ULH]@:HLMUUZI]Y:<C:J;2V\0QXC
M3T+B?%(>?LN@XQ]@B=Q^1GBU1F+U9=](<-$'+QMCDV_ENT!J/B4U1%2*F$4$
MW=>_BJTZ[N1](R5:\=]B?KUC*^[(T(]-56MOF7-IXS#U73!T[I>JQ>L.@>OK
MK_\H%G3[^DQX0M0T^9823@29JSVUM*/<5G$LG4:EKH*'K[(D61RZS! 7K?=4
MO,=AWQRITW$1*6$1H.9HM.L0?VY@5OYN\E!JTF=/Q$.+^(\V3R@3&)";= M\
MO&)^?B[8 8)']#_ WH>%-/O)'V>TT%C&/V8IG:LONY@-[Z.5D["7K6Q^8O:.
M7B1FD'N;.E[");U>37W:CL1XDS*C^F*7B.:BY\@CD-XZA\>OJ!MK(?./*9JM
M0M/^+9NPJSC)*(D@=]PPB06W.H!+!)8ZG(,N!UM9C=8T?/^R5/&+/-XXF[\K
M?DZ(%^)0ZNUT^$4XP&*]N/(S0!4@^^6OFLE=BB'VW9R$B][@^U@PU9&6B#_?
MG9-3+ OS%<FWQWX6P+&WG3(W<Z[A[%%L2D5TS\GD+<GY2(1C9K$5!90Z\D-?
M?!):6KJ*5T*\_M(I:]4I(P<GO=1TGF+YQ$1@INJ7= N^Y%&7]2&E*.L028_$
MMT2LV$:"?/JV)6*8.99'B@=BX!<R7Y2'5]4WPBG@/BKT_O3XA<A([N9\^-PP
ML/F5M5%,JJ@4-0,P5L#86%\X$,)=^>2@W)ZAHPJ5Z#>6OC,-#6$.%7Z79!\-
M<<#PG"%*4Z+P;WY&'=OXYVG<V#[+6/$-#PE9.@%O+[WY7";8-N:=N?86&8;#
MS7/0C3.'CPQ#:XG>!U,7*[X902/+A*ZA[@PS=X$O*5R[&JI]0H^<(%1(U_VV
M1AP8M## TB?NRY?1F3K=]1#_-N7;;7O-X+J4,ZC^ 7.I_[BJ<8,EHY'B:L92
M2/>[$.F?9I8C]FN2QX%KOHJU'L@QCQX,V.4(2I_:+)C$FR3ZU5%CWXZM6OS1
M=.VT,*_1Q>M^A\_,GX&[(]1:8VX547A1*':XDZD%]%ZA-\'R@??OV)@F$-[@
M6+MCJM4QO1GSM.P_A;EGX13@F.@BQZ#*XGFX9"Q^H?&:*!GIP !^T,,9L>V
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ME_4\Z$V?6 Z[4Z7)[_1H8 OZ[N?'TMP5S'AL<$<;>S1MK.#33V11LK/0Q4J
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MXN+;E<%V2AR]+_H_+Q<2Y]ZJ7.:9D\GMD:OM+RJ_97^#QGK[?:<U-EJ*)A'
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M+G81JPXBPZM0 O+6#=6:(^3$"*9B/4#WR^V?' (?^@G?T2.8GBC&F/:JXY+
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MZJ.*WVL21S7_ $?7E"<WGV^D_^>!D%HGY\=X:-?F>8:]&&LG+F;GUX, ,5#
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M*F7;W1^88 #7BN3M-X8=/ROW/*R&>1Q8XBQ+=7S8[C%,>*%G8JB@I&K2>T@
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M<]MJA&0'(8;,S4NCVSBN5T7SQ/ _;FDA$?#\OLN]"/"KTLJE6V+7^KV:1A.
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M4NO#1VF;A^XG]%"_R!@Q>\VX!0.P,NPX4G<R7[%]22*MWB=\(-LKR@.[X?6
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M-A+NQ9<\*4WG"BUKAQ)TS36A!YL!3.1Q9_[[W$M<?$0S4/EUVX=EI6%B?R\
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M/':''S<G04WS]IO>ERB-!4=4\-?"]FS6A&V77HB8'2HM&&]3FDS4=HW]V/G
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M<VG$?1 WHHZ8-%%_"^,('O8:8#/&)J*KQ1*.5&ZW+#G^' %)I1V8+X2%KM:
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MV5]/91]&I1;IM;ME?6QS_IGKZN6C&4'\A;^MT SW[VHQXJ9&E=AO?3I?/''
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ME[N;YLZJYC;Q)\@/>%R<UF^-$D;H,W$P&<2G#+::V;M>FR%NL,:)HWCMO34
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M3;1S">1L;8BVM/$2NC-5UPD>[^>59GXUU]Y2&[[_%!<YKRXXO^G^T0-A_%Z
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M=*?IIEE_*I$,R5D?;CHZ@P%5/>)6[HR74C:UVC2:-)RIFDA&\=G8+]<_9CP
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M1G=X)%P>8;-!X)HG[^3G8^H[ANN1QD8OMG(QA&]^:$L2><!9D4FH]KZY43*
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MA8&?\@)L*@:>> DJQ=T?__7GG5".T%V^"F9+&[B^-'!M&;@"D@50\W %%!=
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MSBMV2OV15Q7G9Y;K._RB5NGJ,U?;3CFH6J\KN2O]&\?E(N"$<>(AZ#&IZ2A
M%&;"#V#B^U'L>S&)?&2B\_:L3&P2U*=DIO87H*IG%>;!RLQH-#Q=@:']Q'H%
M"*\O5*_ EKUF2Z$8!(I#=\;E<I0<V9X+&)G5-%T.V*'E<C"BF6%C/%_<%&LY
M^OM\R3]MFA/-R(LXBB/(6"9]%"\)((XR#)/82U&<,91$L8ZI.C7XQ,:G(0<4
M/= 0U#-%)W$8-BZ72F=F+@P$TU;\(0D&_'WY6J/%\B\[Y3TYV"SJ."1&IV"#
MS]CY M>,U5MPN1F7!OI#\18_Y6N\;,_&4Y%E,24I#&B80<1Q!%,>)S#!'D[B
M# N?!R;+_2"UJ;?:6]KU6@0_%* E;[;.#R.FMY0[P\%P"WX 0;Z%8/RZTG@A
MUI+1T5H[3&O6Y51+[,,54^\E.PW_\/B$\[(^>2O?Y=73JL++6_%Q)1?F_)FS
M:[E6KZLZ$N)E%Y'#L=S3^Y3"E$4)1(G(("&A@)SY%!.11%&4F2B^#1,3VX,=
M2\H75:S FA?0,&-F%*Q UK,54T-G9D+ZJ)6@X^<D@E=-:-0+^-;^.4E\U"7P
M.+(^5BS,:I0N >G05ETTEOF1_E=,-DM<JHL!^=<EWZF/YK'^V0$FMB\M7: (
M7X&:M/Z9_GFIQ\_UG0AL9A7ZLH)O-56WVJXEE]7I_OE19SOA'Q6L?\H__K"=
MF_")_]X+C"Q7A?PKK2_L6F4^7+VH1V(2<P23, T@PH1!DB*)+O)HE@D:<F:T
M-S!E8/([ 2I)+U_ AZK:R#4-%^QGN>)=L]63.B7O!0!_6<O?X9(9N@S&@.NY
M"U/":&84)"=[<=)[O,SC'-B"X<@Q,"8_JU-@"\ZA0V ]CN5^IJ"E.E%\QYL_
M/Q0M]>H.ORB+N" L3H-$1)#&H;J=Q 1FJ8\A9EZ"DR ,0\:,-B]C%*<^N6BI
M@:>&G.'69!0OS7V(2Q0,-QTM:?!31_R/("_ %I>[$5S,-Q6ZLKK:08S2FW>[
MH"O^T=Y ^T6+C4")5>6#Z[)\\_*A8+7SH[T'./'NU.Y_0Q)<JV#M^V[1(]*?
M*.H$S8WNN>-9V35V A>*;;@)&)>XW1NXVA ,B&>W%S@UX'S;@ %Q]G8 0\_9
MK:EOE[BJ;D6;67!;?E8U06XW:U490]%:>)3'(0MBZ*<LABC+U)+*&!0(LSCS
M(X^E1O?^8P0G5LXVD2EO7'LU#8!_YR7-Y1JS$N"IY%!L5.;Y-I&I3J&N4Z<K
MT]SI,6SUEE^7B)GI=4U9P=+25@=_-?4KT*/O,%E:4U)7B=)CY.9-DM84_BA!
M6O<].P-Q@\M"CK+-N7Z#JYPN:!2D@N($IC2D$'$_A82(!$8>2J+$)]A'6DOT
M()6)3<$GO@;+E?S M[41Y)JEZ%Y<-.$T9GK:?C$29BK>D>N70:A)NM/J08D<
MJ?)I&K/J[Z"8ATH[_+!%^#O[^]?5V]7C4QUKJAOVWG]I\COXOV^J=7U[M%X!
M190759TT\F>#>/<]*<>]8&L!S73HO&S. FC/2F,7U[XWTGSQ[*<$V(MC/_F
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M4:0I2C]B2/<5<Q.FXHWX_?U?N(IO?6GKI:3<D\M^$D,_C#*(O"B!.,E\2+.
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M./19QK34?H3.U'%SS:?<D08-;= 2-\T&.(W4L'X[E-],KRU%M\@+&!3L@MR
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MU+"@AZ[/R-.VZ6)<-;=4GE!1\>N"U4=N31OPKAZJ"$)"4N%#(9B *&,)S)*
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M0X0\#E/$I#X%L8B##*&$&:F2%M6)E:R7G=.KBF"F;'KHZ:FA<TS,%+0'QTJ
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M\H_^1Z5MQGKU3M?9+L(HD")/]5 4F6*2$(Y3*3U, Q&&$6?<RY/%JLZ]Y??
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M-X]THQ]=HLT:?19B@ZZ?GY=Z.)+2V+^+JBX%TM(53;%KTPU _>2;T.FJ>@W
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M4G]I]<9V?#JIK/K@ N#MU^5I0!MY1ND"N.<!?34V;0!TS'M3N$?)KD.%"[1
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MB*]"NR/JY^_6JWJ@[)8N[T7Y%"P\)DG (X%%SG0#)!I@*I3W$+ P])/(YW$
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M=0%.YJY>G$$(XPU>!S#><?0F6AY1P^3!Y]=OHG4*-*/HIO,F#KPV*7)O\28
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M+?ZK>%Z7FT5 ?8_GGH>].%8>490D.,U#AH7PB#JVI1[SC4YN?40FMGT[LNA
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MQ!,>SG,:8>91'D@_D=0##2"$LS"Q\>^FGBF?;,=?G6%0LW5<UKT?, &L9[6
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M)SC<]-5?+K40FEY 78-C?(*BAXOC:F.FDENMO%H$9EN+3<3MK\Y&[SF^9;;
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M0(1$ #'*4UC$(LN#-,L+QDSV(W[8]*SL!Z;!@>N;+JGJ!G3%TL /7?FT'V_
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M>5'MJ@[,U.UW]RVJ+BD1Z6)N]);UF1$W,R\M<Z#/0+W]N0'=/#0<'CU1U6V
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M ?MU&2S>MMNM/92;0E25')JL?A:B6D28T12C",H]6:@Z"&20D$CNU((P9D%
MXRS0.E@>(N#9<O;)@4+2JR] ;>HF[E5;J\^L;NP@4GH;M$OD-[."1Z(K4NZV
M8D-".-J!G0P_Z\9K2+BW^ZW!YV9.X^W:,==_K6Y?R'*EG&3I?M6^]R+/LIQ'
M/(%Y3BE$19% '" L?XB(<19&TH;,DKH[P:AO'ZJF"DA'%A2;$CS6NQ-UWE'5
M?[8)G_N8,X/@^95G8O;0>=O37;DHS8S>'LUH+< WD+^K"?&U<W:GV/P^\G0U
MP7:6FZM+[\)\W*;QF#J6QJJ@?Q$E,41IGD"2,0IYE!0XHBA)L%&9UN/A?5O=
M_;6LJ09D.E!HFD5K 0V-F;9L]KFU4TW5+DJHG;&UVKA@@ZFS+EJIW2MG_\-F
MO2]9UEW%JKW^113R+"L(@QR)'**D2&$>$0J+0OI,08H%SHTV../D/*M;31PL
MV]XO[<;FQ[I5AF&_FW'0B. DI2R#>4JD3<(\A5CD,0SB.(XPIAE-D5D>C3O8
MK')AS@/G%#,]X^4.!S-CU@#0)[QO(70WA89Y%R$M(5TU%!HG-F]O(2W!3]H,
MZ;UE9AZK<KOXVT8Z,_?%3\M2,#ECU;LGLBR?R;H];"JHH'%$0YBB1%TJB(G4
M\A"ISD(!"C -,Z$52Y\FY=DLUL35EF%/'G3T]51< ZQQ]78+@9EJCTCO\"1-
M7\(QO9:C]'1:_NN@SQH$9M%E?4$[/39X8^;8T7V3[U/O6JKWZX?ZXO+?A:KN
M*_BM7$G)HZC_J YP]YE""R82+!!+8)&J3HD)(S!G)(6(!"2B14&B<)[;X';\
M^W;"VHS,QT-=KN9&^ WXJV4-DH:W-@#%U?%XH8['7^KC<160VE6\OA!1!Z;F
MBDM9?A\\AZO\S_+L4:S[+N.S$4I]1Q[:[T@G&&@E.Y]"\0V$N"Z;EFM'OBRY
M_SX"8I=-C;,XV85L7)"O=LO_6=U]9:M'.>+'+Z6JC_<V/\4R;4U[9,^KS'$-
MR%Z!995%SE:[NMICDVW5SZIRDJBFC^[XRN ?6#/#;HFIJODR7Y::,4Z7):OI
MDYL_9\T8BK.I:^:CF&>PR1V[_!XM7T1W5:[.Y6CL8ZLJ.,J"($T2F&5% A%'
M(:1YCJ#*@R_D_VA*M3/7ILEYMDY[!IJ<M>Z6DGZBE09@X[;%/0QFMN2 0$>\
MK</1D+?H$*D!B7[.F5MH['+-+H;(*,5,7^*1U#*-069+*=,7J)]*9O"693""
M/0F^4_EJ_:M%8EO=KGG7,F@IJM\$J7:EX/<JB6U7JN)ITG]<5O7:^5E\W?Y-
MROF_"TH2D><XAAF+!$0B2&">4 9S^3,A(4Z%T.IN[H4[WX>G+:_'S0<:=NL\
MMA[#H.,8D.U1IOT:$+"7 =1"& 83G,ZG9JC@6K-D& CH3U"O=]K4%#6IM/TI
M:8^0@6(:U%R[/$WV@::K_;M3WN;=G?N ]63O[86(=7+POC/Z3X)NZT;H78MT
M58BN6N08A44<1Y!D7#JQTJ6%&(M4':ZG(4*"D\"HN=HT2?\)Q#4#0,V_U/.F
MZWM]HJZT?MFR4M< -<\@GH)3SUJZ!<G,!![CHZC?U W(5!7F#IMWH]C89!]K
MBNLN'WF*X-P9RIH G,E9UGW3LGNC="WY<E67T/^D+%%MG9K@B>"*K-I4[[9M
M4\FN[_&#*.L(8G,/<)$A0:,4(Q@7*B<GS7-(*(]A7L1I*DU(FD5&YTM.N/)M
M:#9;Y9>3U>H5=+R":L^L?9*RFRG1LT2S VUFK/KL@0-_H&.P,6(]%NN+JET;
M=546JV;SIKVOZK IHDO<7'4^=,+3O.T-7<)XTL/0Z>!VYG7O VJX?K^O-[02
MY8OR -^O)6-=K\5E4SB8K)CJ-*]ND6U6ZK:NBGHO1);&19ZFD""1091E"<11
MRF"2!(CD(D1Q:E3RUSO'GLUR?UNGN9>[ 7U!0"T).!;E!O2$ 7\J<4 KCV&&
MM/]OA)[E_Z;FV6Q5^(:FV'CAF UV1XN*?WYG77!F@__M8C0?8?-#^-O5ZI;_
M\_-&+8=FA^RG;WJV[I(@>-, O7^0JW\T?D;FZ:/OR\0U='W')75\6#TLF=5A
M])GA9CML'A:E?Y@\\I1YE?=;.45<3=//*_*X0$6!!4X(S-.00A32 N(D5/>_
M1,$I"VB@=P)R,K)OW>IH 45,OX+[L?3C6G213(8*I">.477VLZQ;E60_'FFV
M.NQG!>@77S__@.7!XJ$(QD.Y9*+;62V"2' <X1SF65K(/8M@$*.,PR CG,:(
MQ(%A(<$!0KZ/^XZK_*CN4N*0 GQY4O 0?)I'<@Y ,3Q=.RY%4U,]!&$<'H]-
M2.;JI&N(S+R'5A/"GIP_33U_W6H7N^W3IES^6_!%D"1QQ&@.@X FT@BD,<S#
M+(=QR(HLRY.$1<$URESL.?2]W.X)7;^>Q6%6-&W+-;$V-$H^*ECL^?X&LOJG
M(+UVWOX@?]]'9OX4O+YJ5)P2,D]B_6.SVCV+)G^?/(HV@;]>%CZ3\E%LVYTO
MBV):4!Q!AKE07180)#D.8)*$(J%1%A2%UH[%@*9GX_K'WV\?0$-//U]3%ZYQ
M&^D)!#.KUS  ]ASL[R8U3EG#A$5*JRY$^GFM'J"R2V[5@LQ-9JNAS"/IK;HC
MS9;C:BA:/]'5]%4[1_97455"W'<W\W]5[<BK0[IC$B <Q5$$PR25II#',<0!
M"6&>D"C.4LYB8M3A:YR<9RO84#-S*2?PT?,/W4EM9O8:NNJV9E<3HR$-_O22
MIZDGIB,';(+8K-Z4GN!O72/-M\P/,#Z77#I8JOG%<ET;_;J!I.89QMF7/2MF
MCYI!N\QA4:>/+BZ6TDP1/Y>DOGO7WV1I"VUT<C$JF-7AQ?D19SN_&!6H?X0Q
M_J#=ZOA!;-^1ZNFAW+PLN>!_>_U=[E+>K]O+#.O'6[9=OM2'EXL"(48*6L X
MB7.U:0@A)D4&(YYRFLC%,A#!8KO9DI7>2JE/VD@Y]PQH?W=5-BR3G( O+2LJ
M/%!T; "RY\-L836 5F^1]0.8F9XK!L!##Z<?%!-@N?X1[/D +2.O-ZI"57LI
M]Z=EI7J)+M<[^7B[)(R<WQHOS>;@.%JF#0C/NF2; _)V^;88P3QD\1MYE9"B
MV\^_M3M)BK,@37$"29)*,Q,$.:1Y3"&B,2I2S(.":YT5G1O<\RHOR0%%#TB"
M^EOL$P2FPPV7R&6F[WV1+,(')[+IQPDND=$N(* U?4;[_B$91C;X)Z_,MI,?
M8K:_91]\QMR'?]]T29!.S<-FM632BJB[#[=\\V4K>)U9H.G/3P[D6>M;^J!S
M@3LNZMN%]7T.OJL/$1J.]%W_:82FMP%.P3$S'8:X@#\5.X[2F[3%MMHP3(\^
MV^9!6]#^1D+_)=OU/'EX_W G)WY=*>]Y7_T@37 6%7D$DT*5I1,AA7E!8YC'
MF+ PX$61:6WCIPC-L\XG0!$'/>JF"^, 3+H.P.7"6SD#4F[P7O[_2'1KYV
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MI0#P#7U)_EM(BF!=H& FR0@5(7J"OHJ*)9F4M[%U,ODF%9W4<#2\M-I/P!U
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M&#:UHL>UR<E&C1^0I+B:KO$C+K].4QV@0G#^@&EQ--]\RJ:ST\2Z(+(V!73
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M^C51-2:;;KN#AWG>OI,[POF>E0/W?5K#('(G@AO9JDOKO;BVWFU)S<R=E5F
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M')]L+B!>8:% =3W)P11>9(#L,UE<'VMYC2<IT3D<%<D+3>N^# ]3->[5S1#
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MIC;F]AP"I^-6"*OIM%6V^%VJ+>[X^'&R0L.HOX4$Q^_I-<>C:_0C.FF8820
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M2##6NQA"<3RW;NKR]!=RSZ V<!]/97Q$=+ =+BJ W\SI4^GK3>/72/NX%&W
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MW\?YQ&=J92_FRKWZSQEPZ(4+ZT:RF!M_&R0##8@+F1!(2H$D=X1R8A4A;;I
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M!=K._C0Z3*@+VKL\3B$@+HT!,8DMXDY1, $"$>6[B5Y>!FLG=K?.8.U"^QI
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MCT4F!NQ8K_R@@&.;'F8^@'7<$VDL,E90Q!5H.RZ!>86#TLQ+3H@I72)WOOD
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M3JN$-&86Z<05U<PKD6+APUU*.*@+WSN-B^Y \@I>K_U# "-1-B5I4!3&YDF
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M7%Z3>7V$.*.'HA_+B,K%G'>OV8IU-=G31XA3:QO[][/%!(CY>6Y7(PSG\YR
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M4$L! A0#%     @ 0#<'6Q5:L:]3!   \Q$  !D              ( !"@P
M &EM=7@M-C,P,C5X97AH:6)I=#,R,BYH=&U02P$"% ,4    " ! -P=;*6HX
M0T4'  !8(   &P              @ &4$   :6UU>"TV>#,P>#(U>&5X:&EB
M:70S,3(N:'1M4$L! A0#%     @ 0#<'6^TL1PP[/0  CN(  !8
M     ( !$A@  '1A<F1I;V%G<F5E;65N=&$P,2YH=&U02P$"% ,4    " !
M-P=;\?G@&/UC 0 \D@\ $               @ &!50  =G1L+3(P,C4P-C,P
M+FAT;5!+ 0(4 Q0    ( $ W!UL_V.*%F1(  %?+   0              "
M :RY 0!V=&PM,C R-3 V,S N>'-D4$L! A0#%     @ 0#<'6QZ<C.TX%
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M,C4P-C,P7VQA8BYX;6Q02P$"% ,4    " ! -P=;;GKGC4B:   O- < %
M            @ &'^P8 =G1L+3(P,C4P-C,P7W!R92YX;6Q02P4&      P
,#  G P   98'

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>vtl-20250630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:vtl="http://vitaltherapies.com/20250630"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="vtl-20250630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025PIPETransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2025PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vtl:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vtl:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:NewYorkCityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:GrafelfingGermanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-07</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:GrafelfingGermanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:NewYorkCityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtl:PlaneggGermanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2024-01-08</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-08</startDate>
            <endDate>2024-01-08</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-08</startDate>
            <endDate>2024-01-08</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2024-01-08</startDate>
            <endDate>2024-01-08</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2022ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025AndMay2025FinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:April2025AndMay2025FinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2024ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2024ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:May2024ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:December2020ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-09</startDate>
            <endDate>2025-04-09</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-09</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PlacementAgencyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-09</startDate>
            <endDate>2025-04-09</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PlacementAgencyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-09</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:OfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-09</startDate>
            <endDate>2025-04-09</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-28</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-28</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-28</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesAWarrantAndSeriesBWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-28</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:VolumeWeightageAveragePriceTargetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-28</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-28</startDate>
            <endDate>2025-05-28</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-28</startDate>
            <endDate>2025-05-28</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PlacementAgencyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-28</startDate>
            <endDate>2025-05-28</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-04</startDate>
            <endDate>2024-01-04</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-04</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-04</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-08</startDate>
            <endDate>2024-01-08</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-08</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-04</startDate>
            <endDate>2024-01-04</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-04</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:AccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-04</startDate>
            <endDate>2024-01-04</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-08</startDate>
            <endDate>2024-01-08</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-04</startDate>
            <endDate>2024-01-04</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-04</startDate>
            <endDate>2024-01-04</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-08</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vtl:CommonStockAndPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:CommonStockAndPreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-08</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-03</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityCapitalizationAxis">us-gaap:EquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityCapitalizationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:May2025PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:May2025SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:May2025SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:EmployeeStockOptionsforFutureGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:EmployeeStockOptionsforFutureGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-25</startDate>
            <endDate>2021-04-25</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-25</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-01</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-28</startDate>
            <endDate>2023-06-28</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanEvergreenProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-04</startDate>
            <endDate>2025-06-04</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:IncentiveEmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:NonStatutoryEmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtl:NonStatutoryEmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandNineteenOmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">vtl:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2019OmnibusEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtl:A2017InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtl:DuaneNashMDJDMBAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vtl:ExecutiveChairmanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-17</startDate>
            <endDate>2023-10-17</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtl:DuaneNashMDJDMBAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vtl:ExecutiveChairmanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtl:DuaneNashMDJDMBAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vtl:ExecutiveChairmanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-29</startDate>
            <endDate>2024-08-29</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtl:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">vtl:January2024PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="employee">
        <measure>vtl:employee</measure>
    </unit>
    <unit id="program">
        <measure>vtl:program</measure>
    </unit>
    <unit id="financialinstitution">
        <measure>vtl:financialInstitution</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="lease">
        <measure>vtl:lease</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="tranche">
        <measure>vtl:tranche</measure>
    </unit>
    <unit id="vote">
        <measure>vtl:vote</measure>
    </unit>
    <unit id="segment">
        <measure>vtl:segment</measure>
    </unit>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-28">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-29">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-30">0001280776</dei:EntityCentralIndexKey>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-78" id="f-310">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-5" id="f-324">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</us-gaap:GovernmentAssistanceExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-6" id="f-329">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-7" id="f-330">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-331">http://fasb.org/us-gaap/2025#NonoperatingIncomeExpense</us-gaap:GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-385">http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-386">http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <vtl:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod contextRef="c-138" id="f-491">P5D</vtl:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod>
    <vtl:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod contextRef="c-138" id="f-492">P5D</vtl:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConsecutiveTradingDayPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-190" id="f-575">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36201</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Immunic, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">56-2358443</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">1200 Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">New York,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">10036</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">332</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">255-9818</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">IMUX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-19">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-21">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-22">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">98650590</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-31" unitRef="usd">55310000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-32" unitRef="usd">35668000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-33" unitRef="usd">4532000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-34" unitRef="usd">3664000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-35" unitRef="usd">59842000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-36" unitRef="usd">39332000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-37" unitRef="usd">612000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-38" unitRef="usd">545000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-39" unitRef="usd">975000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">991000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-41" unitRef="usd">61429000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">40868000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-43" unitRef="usd">7893000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">7846000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-45" unitRef="usd">18113000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">12913000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-47" unitRef="usd">1307000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">1416000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-49" unitRef="usd">27313000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">22175000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-51" unitRef="usd">205000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">264000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-53" unitRef="usd">205000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">264000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-55" unitRef="usd">27518000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">22439000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-57" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-58" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-59"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-60"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-61" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-62" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-63" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-64" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-65" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-66" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-3" id="f-67" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-69"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-70"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-71" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-72" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-73" unitRef="shares">98650590</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-74" unitRef="shares">98650590</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-75" unitRef="shares">90150869</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-76" unitRef="shares">90150869</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-77" unitRef="usd">9000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-79" unitRef="usd">595069000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">525611000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-81" unitRef="usd">2525000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">4209000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-83" unitRef="usd">-563692000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">-511399000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-85" unitRef="usd">33911000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">18429000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-87" unitRef="usd">61429000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">40868000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-89" unitRef="usd">21369000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-90" unitRef="usd">18323000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-91" unitRef="usd">42902000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-92" unitRef="usd">37059000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-93" unitRef="usd">5714000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-94" unitRef="usd">4491000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-95" unitRef="usd">11006000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-96" unitRef="usd">9636000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-3" id="f-97" unitRef="usd">27083000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-3" id="f-98" unitRef="usd">22814000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-99" unitRef="usd">53908000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-3" id="f-100" unitRef="usd">46695000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-101" unitRef="usd">-27083000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-102" unitRef="usd">-22814000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-103" unitRef="usd">-53908000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-3" id="f-104" unitRef="usd">-46695000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-5" decimals="-3" id="f-105" unitRef="usd">241000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-6" decimals="-3" id="f-106" unitRef="usd">998000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-107" unitRef="usd">424000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-7" decimals="-3" id="f-108" unitRef="usd">2185000</us-gaap:InvestmentIncomeInterest>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">0</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-6" decimals="-3" id="f-110" unitRef="usd">0</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-1" decimals="-3" id="f-111" unitRef="usd">0</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-7" decimals="-3" id="f-112" unitRef="usd">4796000</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-113" unitRef="usd">22000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-114" unitRef="usd">436000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-115" unitRef="usd">1191000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-116" unitRef="usd">-1658000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-117" unitRef="usd">263000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-118" unitRef="usd">1434000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-119" unitRef="usd">1615000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-120" unitRef="usd">-4269000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">-26820000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-122" unitRef="usd">-21380000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-123" unitRef="usd">-52293000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-124" unitRef="usd">-50964000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-125"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-126"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-127"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-128"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-129"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-130"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-131"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-132"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-133" unitRef="shares">132175202</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-134" unitRef="shares">132175202</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-135" unitRef="shares">101272580</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-136" unitRef="shares">101272580</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-137" unitRef="shares">116844985</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-138" unitRef="shares">116844985</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-139" unitRef="shares">99607158</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-140" unitRef="shares">99607158</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-141" unitRef="usd">-26820000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-142" unitRef="usd">-21380000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">-52293000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-144" unitRef="usd">-50964000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-145" unitRef="usd">-1399000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-146" unitRef="usd">-505000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">-1684000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-3" id="f-148" unitRef="usd">23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-149" unitRef="usd">-28219000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-150" unitRef="usd">-21885000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">-53977000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-152" unitRef="usd">-50941000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-153" unitRef="shares">90150869</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-154" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-155" unitRef="usd">525611000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-156" unitRef="usd">4209000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-157" unitRef="usd">-511399000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-158" unitRef="usd">18429000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-159" unitRef="usd">-25473000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-160" unitRef="usd">-25473000</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-161" unitRef="usd">2042000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-3" id="f-162" unitRef="usd">2042000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-15" decimals="-3" id="f-163" unitRef="usd">-285000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-13" decimals="-3" id="f-164" unitRef="usd">-285000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-16"
      decimals="INF"
      id="f-165"
      unitRef="shares">90150869</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-166" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-167" unitRef="usd">527653000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-168" unitRef="usd">3924000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-169" unitRef="usd">-536872000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-170" unitRef="usd">-5287000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-171" unitRef="usd">-26820000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-172" unitRef="usd">-26820000</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-22" decimals="-3" id="f-173" unitRef="usd">1899000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-174" unitRef="usd">1899000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-23" decimals="-3" id="f-175" unitRef="usd">-1399000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-176" unitRef="usd">-1399000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-24" decimals="-3" id="f-177" unitRef="usd">4332000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-25" decimals="-3" id="f-178" unitRef="usd">60661000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-24" decimals="-3" id="f-179" unitRef="usd">60661000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-26" decimals="-3" id="f-180" unitRef="usd">367000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-27"
      decimals="INF"
      id="f-181"
      unitRef="shares">5666667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-27" decimals="-3" id="f-182" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-28" decimals="-3" id="f-183" unitRef="usd">4733000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-26" decimals="-3" id="f-184" unitRef="usd">4734000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-29"
      decimals="INF"
      id="f-185"
      unitRef="shares">2613057</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-5" decimals="-5" id="f-186" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-29"
      decimals="INF"
      id="f-187"
      unitRef="shares">219997</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-22" decimals="-3" id="f-188" unitRef="usd">123000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-5" decimals="-3" id="f-189" unitRef="usd">123000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-30"
      decimals="INF"
      id="f-190"
      unitRef="shares">98650590</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-191" unitRef="usd">9000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-192" unitRef="usd">595069000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-193" unitRef="usd">2525000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-194" unitRef="usd">-563692000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-195" unitRef="usd">33911000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-34"
      decimals="INF"
      id="f-196"
      unitRef="shares">45177730</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-197" unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-198" unitRef="usd">436060000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-199" unitRef="usd">3759000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-200" unitRef="usd">-410892000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-201" unitRef="usd">28931000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-39" decimals="-3" id="f-202" unitRef="usd">-29584000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-40" decimals="-3" id="f-203" unitRef="usd">-29584000</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-41" decimals="-3" id="f-204" unitRef="usd">2750000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-40" decimals="-3" id="f-205" unitRef="usd">2750000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-42" decimals="-3" id="f-206" unitRef="usd">528000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-40" decimals="-3" id="f-207" unitRef="usd">528000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-43" decimals="-3" id="f-208" unitRef="usd">4037000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-44"
      decimals="INF"
      id="f-209"
      unitRef="shares">44751286</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-44" decimals="-3" id="f-210" unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-45" decimals="-3" id="f-211" unitRef="usd">52360000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-46" decimals="-3" id="f-212" unitRef="usd">52364000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <vtl:AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity contextRef="c-41" decimals="-3" id="f-213" unitRef="usd">28396000</vtl:AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity>
    <vtl:AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity contextRef="c-40" decimals="-3" id="f-214" unitRef="usd">28396000</vtl:AdjustmentsToAdditionalPaidInCapitalConversionOfTrancheRightsLiabilityToEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-47" decimals="-3" id="f-215" unitRef="usd">6000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-48"
      decimals="INF"
      id="f-216"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-49" decimals="-3" id="f-217" unitRef="usd">191000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-50" decimals="-3" id="f-218" unitRef="usd">191000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-51"
      decimals="INF"
      id="f-219"
      unitRef="shares">90079016</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-3" id="f-220" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-3" id="f-221" unitRef="usd">519757000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-3" id="f-222" unitRef="usd">4287000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-223" unitRef="usd">-440476000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-224" unitRef="usd">83576000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-56" decimals="-3" id="f-225" unitRef="usd">-21380000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-226" unitRef="usd">-21380000</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-57" decimals="-3" id="f-227" unitRef="usd">1882000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-228" unitRef="usd">1882000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-58" decimals="-3" id="f-229" unitRef="usd">-505000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-230" unitRef="usd">-505000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-59"
      decimals="INF"
      id="f-231"
      unitRef="shares">90079016</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-59" decimals="-3" id="f-232" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-60" decimals="-3" id="f-233" unitRef="usd">521639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-61" decimals="-3" id="f-234" unitRef="usd">3782000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-62" decimals="-3" id="f-235" unitRef="usd">-461856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-63" decimals="-3" id="f-236" unitRef="usd">63573000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">-52293000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-238" unitRef="usd">-50964000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">86000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-3" id="f-240" unitRef="usd">57000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-7" decimals="-3" id="f-242" unitRef="usd">147000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">3941000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-3" id="f-244" unitRef="usd">4632000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses contextRef="c-1" decimals="-3" id="f-245" unitRef="usd">108000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses contextRef="c-7" decimals="-3" id="f-246" unitRef="usd">342000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <vtl:GainLossFromChangeInFairValueOfTrancheRights contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">0</vtl:GainLossFromChangeInFairValueOfTrancheRights>
    <vtl:GainLossFromChangeInFairValueOfTrancheRights contextRef="c-7" decimals="-3" id="f-248" unitRef="usd">4796000</vtl:GainLossFromChangeInFairValueOfTrancheRights>
    <us-gaap:ManagementFeeExpense contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">0</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-7" decimals="-3" id="f-250" unitRef="usd">1690000</us-gaap:ManagementFeeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">429000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-3" id="f-252" unitRef="usd">-375000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">-896000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-7" decimals="-3" id="f-254" unitRef="usd">2977000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-3" id="f-255" unitRef="usd">3447000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-7" decimals="-3" id="f-256" unitRef="usd">-4420000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-257" unitRef="usd">-231000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-7" decimals="-3" id="f-258" unitRef="usd">4000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-259" unitRef="usd">-118000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-7" decimals="-3" id="f-260" unitRef="usd">-350000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-261" unitRef="usd">-46385000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-262" unitRef="usd">-41008000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-263" unitRef="usd">83000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-264" unitRef="usd">211000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-265" unitRef="usd">-83000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-266" unitRef="usd">-211000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-267" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-7" decimals="-3" id="f-268" unitRef="usd">191000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-64" decimals="-3" id="f-269" unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-65" decimals="-3" id="f-270" unitRef="usd">74273000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-1" decimals="-3" id="f-271" unitRef="usd">123000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-7" decimals="-3" id="f-272" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-66" decimals="-3" id="f-273" unitRef="usd">60661000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-67" decimals="-3" id="f-274" unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-68" decimals="-3" id="f-275" unitRef="usd">4734000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-69" decimals="-3" id="f-276" unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-277" unitRef="usd">65518000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-278" unitRef="usd">74464000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-279" unitRef="usd">592000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-280" unitRef="usd">-221000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-281" unitRef="usd">19642000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-282" unitRef="usd">33024000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-283" unitRef="usd">35668000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-38" decimals="-3" id="f-284" unitRef="usd">46674000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-285" unitRef="usd">55310000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-63" decimals="-3" id="f-286" unitRef="usd">79698000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <vtl:ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares contextRef="c-1" decimals="-3" id="f-287" unitRef="usd">0</vtl:ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares>
    <vtl:ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares contextRef="c-7" decimals="-3" id="f-288" unitRef="usd">28396000</vtl:ConversionOfTrancheRightsLiabilityToEquityUponIncreaseInAuthorizedShares>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c-1" id="f-289">Description of Business and Basis of Financial Statements&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immunic, Inc. ("Immunic" or the "Company") is a biotechnology company developing a clinical pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The Company is headquartered in New York City with its main operations in Gr&#xe4;felfing near Munich, Germany. The Company had approximately 90 employees as of July 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is pursuing clinical development of orally administered, small molecule programs, each of which has unique features intended to directly address the unmet needs of patients with serious chronic inflammatory and autoimmune diseases. These include the vidofludimus calcium (IMU-838) program, which is in Phase 3 clinical development for patients with relapsing multiple sclerosis (&#x201c;RMS&#x201d;), and which has shown therapeutic activity in Phase 2 clinical trials in patients suffering from relapsing-remitting MS ("RRMS"), progressive MS (&#x201c;PMS&#x201d;) and moderate-to-severe ulcerative colitis (&#x201c;UC&#x201d;); the IMU-856 program, which is targeted to regenerate bowel epithelium and restore intestinal barrier function, which could potentially be applicable in numerous gastrointestinal diseases, such as celiac disease, inflammatory bowel disease ("IBD"), Graft-versus-Host-Disease ("GvHD") and possibly weight management; and the IMU-381 program, which is a next generation molecule being developed to specifically address the needs of gastrointestinal diseases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s business, operating results, financial condition and growth prospects are subject to significant risks and uncertainties, including the failure of its clinical trials to meet their endpoints, failure to obtain regulatory approval and needing additional funding to continue and potentially complete the development and commercialization of the Company's three development programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Condition, Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immunic has no products approved for commercial sale and has not generated any revenue from product sales. It has never been profitable and has incurred operating losses in each year since inception in 2016.  The Company has an accumulated deficit of approximately $563.7&#160;million as of June 30, 2025 and $511.4 million as of December 31, 2024.  Substantially all of Immunic's operating losses resulted from expenses incurred in connection with its research and development programs and from general and administrative costs associated with its operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Immunic expects to incur significant expenses and increasing operating losses for the foreseeable future as it initiates and continues the development of its product candidates and adds personnel necessary to advance its pipeline of product candidates. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Immunic expects that its operating losses will fluctuate significantly from quarter-to-quarter and year-to-year due to timing of development programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From inception through June 30, 2025, Immunic has raised net cash of approximately $496.3 million from private and public offerings of preferred stock, common stock, pre-funded warrants and tranche rights. As of June 30, 2025, the Company had cash and cash equivalents of approximately $55.3 million. With these funds, the Company does not have adequate liquidity to fund its operations for at least twelve months from the issuance of these condensed consolidated financial statements included in this quarterly report without raising additional capital and such actions are not solely within the control of the Company. If the Company is unable to obtain additional capital, it would have a material adverse effect on the operations of the Company, its clinical development program, and the Company may have to cease operations altogether. These factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in conformity with United States generally accepted accounting principles ("U.S. GAAP") and include the accounts of Immunic and its wholly-owned subsidiaries, Immunic AG and Immunic Australia Pty Ltd.  All intercompany accounts and transactions have been eliminated in consolidation. Immunic manages its operations as a single reportable segment for the purposes of assessing performance and making operating decisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immunic has prepared the accompanying interim unaudited condensed consolidated financial statements in accordance with United States generally accepted accounting principles, (&#x201c;US GAAP&#x201d;), for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals which, in the opinion of management, are necessary to present fairly Immunic&#x2019;s consolidated financial position, consolidated results of operations, consolidated statement of stockholders&#x2019; equity (deficit) and consolidated cash flows for the periods and as of the dates presented. The Company&#x2019;s fiscal year ends on December 31. The condensed consolidated balance sheet as of December 31, 2024 was derived from audited consolidated financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto included on the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the"SEC") on March 31, 2025. The nature of Immunic&#x2019;s business is such that the results of any interim period may not be indicative of the results to be expected for the entire year or for corresponding interim periods in an any subsequent year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <dei:EntityNumberOfEmployees
      contextRef="c-70"
      decimals="-1"
      id="f-290"
      unitRef="employee">90</dei:EntityNumberOfEmployees>
    <vtl:NumberOfDevelopmentPrograms
      contextRef="c-3"
      decimals="INF"
      id="f-291"
      unitRef="program">3</vtl:NumberOfDevelopmentPrograms>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-292" unitRef="usd">-563700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-293" unitRef="usd">-511400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-71" decimals="-5" id="f-294" unitRef="usd">496300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-295" unitRef="usd">55300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-296">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in conformity with United States generally accepted accounting principles ("U.S. GAAP") and include the accounts of Immunic and its wholly-owned subsidiaries, Immunic AG and Immunic Australia Pty Ltd.  All intercompany accounts and transactions have been eliminated in consolidation. Immunic manages its operations as a single reportable segment for the purposes of assessing performance and making operating decisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immunic has prepared the accompanying interim unaudited condensed consolidated financial statements in accordance with United States generally accepted accounting principles, (&#x201c;US GAAP&#x201d;), for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals which, in the opinion of management, are necessary to present fairly Immunic&#x2019;s consolidated financial position, consolidated results of operations, consolidated statement of stockholders&#x2019; equity (deficit) and consolidated cash flows for the periods and as of the dates presented. The Company&#x2019;s fiscal year ends on December 31. The condensed consolidated balance sheet as of December 31, 2024 was derived from audited consolidated financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto included on the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the"SEC") on March 31, 2025. The nature of Immunic&#x2019;s business is such that the results of any interim period may not be indicative of the results to be expected for the entire year or for corresponding interim periods in an any subsequent year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-297">Summary of Significant Accounting Policies&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements. The most significant estimates in the Company&#x2019;s financial statements and accompanying notes relate to stock-based compensation and the valuation of the tranche rights. Management believes its estimates to be reasonable under the circumstances. Actual results could differ materially from those estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is United States (&#x201c;U.S.&#x201d;) dollars. Immunic AG is located in Germany with the Euro being its functional currency. Immunic Australia Pty Ltd.&#x2019;s functional currency is the Australian dollar. All amounts in the financial statements where the functional currency is not the U.S. dollar are translated into U.S. dollar equivalents at exchange rates as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%"&gt;&#x2022; assets and liabilities at reporting period-end rates;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%"&gt;&#x2022; income statement accounts at average exchange rates for the reporting period; and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%"&gt;&#x2022; components of equity at historical rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses from translation of the financial statements into U.S. dollars are recorded in stockholders&#x2019; equity (deficit) as a component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses resulting from foreign currency transactions denominated in currencies other than the functional currency are reflected as general and administrative expenses in the Consolidated Statements of Operations. Foreign currency transaction gains and losses related to long-term intercompany loans that are payable in the foreseeable future are recorded in Other Income (Expense). The Consolidated Statements of Cash Flows were prepared by using the average exchange rate in effect during the reporting period which reasonably approximates the timing of the cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash on hand and deposits in banks located in the U.S. of approximately $47.9&#160;million, Germany of approximately $7.3&#160;million and Australia of approximately $0.1&#160;million as of June 30, 2025. The Company maintains cash and cash equivalent balances denominated in Euro and U.S. dollars with major financial institutions in the U.S. and Germany in excess of the deposit limits insured by the government. Management periodically reviews the credit &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;standing of these financial institutions. The Company currently deposits its cash and cash equivalents with two large financial institutions. Cash and cash equivalents in the U.S. are held at JP Morgan and are primarily held in a U.S. Government money market fund account earning interest at a rate of 4.1% during the period ended June 30, 2025. Cash and cash equivalents in Germany are earning interest at a rate of 1.6% to 3.25% during the period ended June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Quoted prices in active markets for identical assets or liabilities. Level 1 assets consisted of money market funds for the periods presented. The Company had no Level 1 liabilities for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Inputs other than observable quoted prices for the asset or liability, either directly or indirectly; these include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. The Company had no Level 2 assets or liabilities for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The Company had no Level 3 assets or liabilities for the periods presented.  The Company did have tranche rights that were at level 3 during the first quarter of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents, other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximates fair value due to the short period of time to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at cost. Depreciation is computed using the straight-line method based on the estimated service lives of the assets, which range from &lt;span style="-sec-ix-hidden:f-310"&gt;three&lt;/span&gt; to thirteen years. Depreciation expense was $43,000 and $31,000 for the three months ended June 30, 2025 and 2024, respectively, and $86,000 and $57,000 for the six months ended June 30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records impairment losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets&#x2019; carrying amount. Impaired assets are then recorded at their estimated fair value. There were no impairment losses during the six months ended June 30, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;These costs primarily include external development expenses and internal personnel expenses for its development programs, vidofludimus calcium and IMU-856. Immunic has spent the majority of its research and development resources on vidofludimus calcium, the Company's lead development program, for clinical trials in MS and UC.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expenses consist of expenses incurred in research and development activities, which include clinical trials, contract research services, certain milestone payments, salaries and related employee benefits, allocated facility costs and other outsourced services. Research and development expenses are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into agreements with contract research organizations (&#x201c;CROs&#x201d;) to provide clinical trial services for individual studies and projects by executing individual work orders governed by a Master Service Arrangement (&#x201c;MSA&#x201d;). The MSAs and associated work orders provide for regular recurrent payments and payments upon the completion of certain milestones. The Company regularly assesses the timing of payments against actual costs incurred to ensure a proper accrual of related expenses in the appropriate accounting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain collaboration and license agreements may include payments to or from the Company of one or more of the following: non-refundable or partially refundable upfront or license fees; development, regulatory and commercial milestone payments; payment for manufacturing supply services; partial or complete reimbursement of research and development costs; and royalties on net sales of licensed products. The Company assesses whether such contracts are within the scope of Financial Accounting Standards Board (FASB) Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; and ASU No. 2018-18, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASU 2018-18"). ASU 2018-18, clarifies that certain elements of collaborative arrangements could qualify as transactions with customers in the scope of ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Daiichi Sankyo Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2018, the Company entered into an option and license agreement (the "Daiichi Sankyo Agreement") with Daiichi Sankyo Co., Ltd. ("Daiichi Sankyo") which granted the Company the right to license a group of compounds, designated by the Company as IMU-856, as a potential new oral treatment option for gastrointestinal diseases such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea and other barrier function associated diseases. During the option period, the Company performed agreed upon research and development activities for which it was reimbursed by Daiichi Sankyo up to a maximum agreed-upon limit. Such reimbursement was recorded as other income. There are no additional research and development reimbursements expected under this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#x2019;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp;amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%"&gt;Ludwig-Maximilians-University Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%"&gt;Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Government assistance&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government assistance relating to research and development performed by Immunic Australia is recorded as a component of other (income) expense. This government assistance is recognized at a rate of 43.5% of the qualified research and development expenditures which are incurred. We also receive government assistance from the German Government  for reimbursement of research and development expenses up to 3.5&#160;million Euros per year.  We had recognized &lt;span style="-sec-ix-hidden:f-324"&gt;expense&lt;/span&gt; of $7,000 and income of $3,000 for the three months ended June 30, 2025 and 2024, respectively and $1.0&#160;million and $39,000 of &lt;span style="-sec-ix-hidden:f-329"&gt;&lt;span style="-sec-ix-hidden:f-330"&gt;&lt;span style="-sec-ix-hidden:f-331"&gt;other income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; related to research activities performed during the six months ended June 30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative expenses consist primarily of salaries and related costs for personnel in executive, finance, business development and other support functions. Other general and administrative expenses include, but are not limited to, stock-based compensation, insurance costs, professional fees for legal, accounting and tax services, consulting, related facility costs and travel.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the cost of employee and non-employee services received in exchange for equity awards based on the grant-date fair value of the award recognized generally as an expense (i) on a straight-line basis over the requisite service period for those awards whose vesting is based upon a service condition, and (ii) on an accelerated method for awards whose &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;vesting is based upon a performance condition, but only to the extent it is probable that the performance condition will be met. Stock-based compensation is (i) estimated at the date of grant based on the award&#x2019;s fair value for equity classified awards and (ii) based on the final measurement date for liability classified awards. Forfeitures are recorded in the period in which they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the fair value of stock options using the Black-Scholes-Merton option-pricing model ("BSM"), which requires the use of estimates and subjective assumptions, including the risk-free interest rate, the expected dividend yield of the Company&#x2019;s common stock, the expected volatility of the price of the Company&#x2019;s common stock, and the expected term of the option. These estimates involve inherent uncertainties and the application of management&#x2019;s judgment. If factors change and different assumptions are used, the Company&#x2019;s stock-based compensation expense could be materially different in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company leases office space and office equipment. The underlying lease agreements have lease terms of less than 12 months and up to 60 months. Leases with terms of 12 months or less at inception are not included in the operating lease right of use asset and operating lease liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three existing leases for office and laboratory space. At inception of a lease agreement, the Company determines whether an agreement represents a lease and at commencement each lease agreement is assessed as to classification as an operating or financing lease. The Company's leases have been classified as operating leases and an operating lease right-of-use asset and an operating lease liability have been recorded on the Company&#x2019;s consolidated balance sheet. A right-of-use lease asset represents the Company&#x2019;s right to use the underlying asset for the lease term and the lease obligation represents its commitment to make the lease payments arising from the lease. Right-of-use lease assets and obligations are recognized at the commencement date based on the present value of remaining lease payments over the lease term. As the Company&#x2019;s leases do not provide an implicit rate, the Company has used an estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The right-of-use lease asset includes any lease payments made prior to commencement and excludes any lease incentives. The lease term used in estimating future lease payments may include options to extend when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or changes in expectations regarding the lease term. Variable lease costs such as common area costs and property taxes are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Accumulated other comprehensive income (loss) has been reflected as a separate component of stockholders&#x2019; equity in the accompanying Consolidated Balance Sheets and consists of foreign currency translation adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to corporate income tax laws and regulations in the U.S., Germany and Australia. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment in their application.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes the asset and liability method of accounting for income taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the audited consolidated financial statements. Deferred income tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. Deferred taxes are reduced by a valuation allowance when, in the opinion of management, it is more likely than not some portion or the entire deferred tax asset will not be realized.  As of June 30, 2025 and December 31, 2024, respectively, the Company maintained a full valuation allowance against the balance of deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is the Company&#x2019;s policy to provide for uncertain tax positions and the related interest and penalties based upon management&#x2019;s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense.  The Company is subject to U.S. federal, New York, California, Texas, German and Australian income taxes. The Company is subject to U.S. federal or state income tax examination by tax authorities for tax returns filed for the years 2003 and forward due to the carryforward of NOLs. Tax years 2019 through 2023 are subject to audit by German and Australian tax authorities. The Company is not currently under examination by any tax jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants and Tranche Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for issued financial instruments either as a liability or equity in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (&#x201c;ASC 480-10&#x201d;) or ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#x2019;s Own Stock (&#x201c;ASC 815-40&#x201d;). If financial instruments do not meet liability classification under ASC 480-10, the Company considers the requirements of ASC 815-40 to determine whether the financial instruments should be classified as a liability or as equity. Liability-classified financial instruments are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the financial instruments after the issuance date is recorded in the Consolidated Statements of Operations as a gain or loss. If financial instruments do not require liability classification under ASC 815-40, the instrument is classified in permanent equity. Equity-classified financial instruments are accounted for based on allocated proceeds on the issuance date with no subsequent measurement after the issuance date.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share attributable to common stockholders is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of common shares and, if dilutive, common stock equivalents outstanding for the period determined using the treasury-stock method. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#x2019;s net loss position. The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2025 includes 8,580,507 pre-funded warrants from the January 2024 Financing and 86,666,667 pre-funded warrants from the May 2025 Offering that remain unexercised as of June 30, 2025.  The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2024 includes 11,193,564 per-funded warrants from the January 2024 Financing that were unexercised as of June 30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive securities, which are not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.953%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.955%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,853,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,819,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Placement agent warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,136,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,819,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued and/or Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The new guidance is expected to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information by requiring 1) consistent categories and greater disaggregation of information in the rate reconciliation and 2) income taxes paid disaggregated by jurisdiction. The guidance is effective on a prospective basis, although retrospective application and early adoption is permitted. The standard was adopted by the Company for the annual period starting January 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2024, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures to improve the disclosures about a public entity&#x2019;s expenses and provide more detailed information about the types of expenses in commonly presented expense captions such as inventory purchases, employee compensation, depreciation and intangible asset &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amortization. The disclosure requirements must be applied retrospectively to all prior periods presented in the financial statements. The effective date for the standard is for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-298">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements. The most significant estimates in the Company&#x2019;s financial statements and accompanying notes relate to stock-based compensation and the valuation of the tranche rights. Management believes its estimates to be reasonable under the circumstances. Actual results could differ materially from those estimates and assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-299">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is United States (&#x201c;U.S.&#x201d;) dollars. Immunic AG is located in Germany with the Euro being its functional currency. Immunic Australia Pty Ltd.&#x2019;s functional currency is the Australian dollar. All amounts in the financial statements where the functional currency is not the U.S. dollar are translated into U.S. dollar equivalents at exchange rates as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%"&gt;&#x2022; assets and liabilities at reporting period-end rates;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%"&gt;&#x2022; income statement accounts at average exchange rates for the reporting period; and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:180%"&gt;&#x2022; components of equity at historical rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses from translation of the financial statements into U.S. dollars are recorded in stockholders&#x2019; equity (deficit) as a component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses resulting from foreign currency transactions denominated in currencies other than the functional currency are reflected as general and administrative expenses in the Consolidated Statements of Operations. Foreign currency transaction gains and losses related to long-term intercompany loans that are payable in the foreseeable future are recorded in Other Income (Expense). The Consolidated Statements of Cash Flows were prepared by using the average exchange rate in effect during the reporting period which reasonably approximates the timing of the cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-300">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash on hand and deposits in banks located in the U.S. of approximately $47.9&#160;million, Germany of approximately $7.3&#160;million and Australia of approximately $0.1&#160;million as of June 30, 2025. The Company maintains cash and cash equivalent balances denominated in Euro and U.S. dollars with major financial institutions in the U.S. and Germany in excess of the deposit limits insured by the government. Management periodically reviews the credit &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;standing of these financial institutions. The Company currently deposits its cash and cash equivalents with two large financial institutions. Cash and cash equivalents in the U.S. are held at JP Morgan and are primarily held in a U.S. Government money market fund account earning interest at a rate of 4.1% during the period ended June 30, 2025. Cash and cash equivalents in Germany are earning interest at a rate of 1.6% to 3.25% during the period ended June 30, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-72" decimals="-5" id="f-301" unitRef="usd">47900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-73" decimals="-5" id="f-302" unitRef="usd">7300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-74" decimals="-5" id="f-303" unitRef="usd">100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <vtl:NumberOfFinancialInstitutionsUsedForCashDeposits
      contextRef="c-3"
      decimals="INF"
      id="f-304"
      unitRef="financialinstitution">2</vtl:NumberOfFinancialInstitutionsUsedForCashDeposits>
    <us-gaap:InvestmentInterestRate contextRef="c-75" decimals="3" id="f-305" unitRef="number">0.041</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRate contextRef="c-76" decimals="3" id="f-306" unitRef="number">0.016</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRate contextRef="c-77" decimals="4" id="f-307" unitRef="number">0.0325</us-gaap:InvestmentInterestRate>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-308">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Quoted prices in active markets for identical assets or liabilities. Level 1 assets consisted of money market funds for the periods presented. The Company had no Level 1 liabilities for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Inputs other than observable quoted prices for the asset or liability, either directly or indirectly; these include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. The Company had no Level 2 assets or liabilities for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The Company had no Level 3 assets or liabilities for the periods presented.  The Company did have tranche rights that were at level 3 during the first quarter of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents, other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximates fair value due to the short period of time to maturity.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-309">&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;Property and equipment is stated at cost. Depreciation is computed using the straight-line method based on the estimated service lives of the assets, which range from &lt;span style="-sec-ix-hidden:f-310"&gt;three&lt;/span&gt; to thirteen years.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-79" id="f-311">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:DepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-312" unitRef="usd">43000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-3" id="f-313" unitRef="usd">31000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-314" unitRef="usd">86000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-3" id="f-315" unitRef="usd">57000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-316">&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;The Company records impairment losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets&#x2019; carrying amount. Impaired assets are then recorded at their estimated fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-7" decimals="INF" id="f-317" unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="INF" id="f-318" unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-319">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;These costs primarily include external development expenses and internal personnel expenses for its development programs, vidofludimus calcium and IMU-856. Immunic has spent the majority of its research and development resources on vidofludimus calcium, the Company's lead development program, for clinical trials in MS and UC.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expenses consist of expenses incurred in research and development activities, which include clinical trials, contract research services, certain milestone payments, salaries and related employee benefits, allocated facility costs and other outsourced services. Research and development expenses are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into agreements with contract research organizations (&#x201c;CROs&#x201d;) to provide clinical trial services for individual studies and projects by executing individual work orders governed by a Master Service Arrangement (&#x201c;MSA&#x201d;). The MSAs and associated work orders provide for regular recurrent payments and payments upon the completion of certain milestones. The Company regularly assesses the timing of payments against actual costs incurred to ensure a proper accrual of related expenses in the appropriate accounting period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CollaborativeArrangementAccountingPolicy contextRef="c-1" id="f-320">&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain collaboration and license agreements may include payments to or from the Company of one or more of the following: non-refundable or partially refundable upfront or license fees; development, regulatory and commercial milestone payments; payment for manufacturing supply services; partial or complete reimbursement of research and development costs; and royalties on net sales of licensed products. The Company assesses whether such contracts are within the scope of Financial Accounting Standards Board (FASB) Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; and ASU No. 2018-18, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASU 2018-18"). ASU 2018-18, clarifies that certain elements of collaborative arrangements could qualify as transactions with customers in the scope of ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Daiichi Sankyo Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2018, the Company entered into an option and license agreement (the "Daiichi Sankyo Agreement") with Daiichi Sankyo Co., Ltd. ("Daiichi Sankyo") which granted the Company the right to license a group of compounds, designated by the Company as IMU-856, as a potential new oral treatment option for gastrointestinal diseases such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea and other barrier function associated diseases. During the option period, the Company performed agreed upon research and development activities for which it was reimbursed by Daiichi Sankyo up to a maximum agreed-upon limit. Such reimbursement was recorded as other income. There are no additional research and development reimbursements expected under this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#x2019;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp;amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%"&gt;Ludwig-Maximilians-University Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%"&gt;Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:GovernmentAssistancePolicyTextBlock contextRef="c-1" id="f-321">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Government assistance&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government assistance relating to research and development performed by Immunic Australia is recorded as a component of other (income) expense. This government assistance is recognized at a rate of 43.5% of the qualified research and development expenditures which are incurred. We also receive government assistance from the German Government  for reimbursement of research and development expenses up to 3.5&#160;million Euros per year.  We had recognized &lt;span style="-sec-ix-hidden:f-324"&gt;expense&lt;/span&gt; of $7,000 and income of $3,000 for the three months ended June 30, 2025 and 2024, respectively and $1.0&#160;million and $39,000 of &lt;span style="-sec-ix-hidden:f-329"&gt;&lt;span style="-sec-ix-hidden:f-330"&gt;&lt;span style="-sec-ix-hidden:f-331"&gt;other income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; related to research activities performed during the six months ended June 30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GovernmentAssistancePolicyTextBlock>
    <vtl:GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent contextRef="c-80" decimals="3" id="f-322" unitRef="number">0.435</vtl:GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresPercent>
    <vtl:GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount contextRef="c-73" decimals="-5" id="f-323" unitRef="eur">3500000</vtl:GovernmentAssistanceQualifiedResearchAndDevelopmentExpendituresMaximumAmount>
    <us-gaap:GovernmentAssistanceExpense contextRef="c-5" decimals="-3" id="f-325" unitRef="usd">7000</us-gaap:GovernmentAssistanceExpense>
    <us-gaap:GovernmentAssistanceAmount contextRef="c-6" decimals="-3" id="f-326" unitRef="usd">3000</us-gaap:GovernmentAssistanceAmount>
    <us-gaap:GovernmentAssistanceAmount contextRef="c-1" decimals="-5" id="f-327" unitRef="usd">1000000</us-gaap:GovernmentAssistanceAmount>
    <us-gaap:GovernmentAssistanceAmount contextRef="c-7" decimals="-3" id="f-328" unitRef="usd">39000</us-gaap:GovernmentAssistanceAmount>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="c-1" id="f-332">&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative expenses consist primarily of salaries and related costs for personnel in executive, finance, business development and other support functions. Other general and administrative expenses include, but are not limited to, stock-based compensation, insurance costs, professional fees for legal, accounting and tax services, consulting, related facility costs and travel.&lt;/span&gt;&lt;/div&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-333">&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the cost of employee and non-employee services received in exchange for equity awards based on the grant-date fair value of the award recognized generally as an expense (i) on a straight-line basis over the requisite service period for those awards whose vesting is based upon a service condition, and (ii) on an accelerated method for awards whose &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;vesting is based upon a performance condition, but only to the extent it is probable that the performance condition will be met. Stock-based compensation is (i) estimated at the date of grant based on the award&#x2019;s fair value for equity classified awards and (ii) based on the final measurement date for liability classified awards. Forfeitures are recorded in the period in which they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the fair value of stock options using the Black-Scholes-Merton option-pricing model ("BSM"), which requires the use of estimates and subjective assumptions, including the risk-free interest rate, the expected dividend yield of the Company&#x2019;s common stock, the expected volatility of the price of the Company&#x2019;s common stock, and the expected term of the option. These estimates involve inherent uncertainties and the application of management&#x2019;s judgment. If factors change and different assumptions are used, the Company&#x2019;s stock-based compensation expense could be materially different in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-334">&lt;div style="margin-top:18pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company leases office space and office equipment. The underlying lease agreements have lease terms of less than 12 months and up to 60 months. Leases with terms of 12 months or less at inception are not included in the operating lease right of use asset and operating lease liability.&lt;/span&gt;&lt;/div&gt;The Company has three existing leases for office and laboratory space. At inception of a lease agreement, the Company determines whether an agreement represents a lease and at commencement each lease agreement is assessed as to classification as an operating or financing lease. The Company's leases have been classified as operating leases and an operating lease right-of-use asset and an operating lease liability have been recorded on the Company&#x2019;s consolidated balance sheet. A right-of-use lease asset represents the Company&#x2019;s right to use the underlying asset for the lease term and the lease obligation represents its commitment to make the lease payments arising from the lease. Right-of-use lease assets and obligations are recognized at the commencement date based on the present value of remaining lease payments over the lease term. As the Company&#x2019;s leases do not provide an implicit rate, the Company has used an estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The right-of-use lease asset includes any lease payments made prior to commencement and excludes any lease incentives. The lease term used in estimating future lease payments may include options to extend when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or changes in expectations regarding the lease term. Variable lease costs such as common area costs and property taxes are expensed as incurred.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-78" id="f-335">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-79" id="f-336">P60M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <vtl:LesseeOperatingLeasesNumberOfExistingLeases contextRef="c-3" decimals="INF" id="f-337" unitRef="lease">3</vtl:LesseeOperatingLeasesNumberOfExistingLeases>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-338">&lt;div style="margin-top:18pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Accumulated other comprehensive income (loss) has been reflected as a separate component of stockholders&#x2019; equity in the accompanying Consolidated Balance Sheets and consists of foreign currency translation adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-339">&lt;div style="margin-top:18pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to corporate income tax laws and regulations in the U.S., Germany and Australia. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment in their application.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes the asset and liability method of accounting for income taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the audited consolidated financial statements. Deferred income tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. Deferred taxes are reduced by a valuation allowance when, in the opinion of management, it is more likely than not some portion or the entire deferred tax asset will not be realized.  As of June 30, 2025 and December 31, 2024, respectively, the Company maintained a full valuation allowance against the balance of deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is the Company&#x2019;s policy to provide for uncertain tax positions and the related interest and penalties based upon management&#x2019;s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense.  The Company is subject to U.S. federal, New York, California, Texas, German and Australian income taxes. The Company is subject to U.S. federal or state income tax examination by tax authorities for tax returns filed for the years 2003 and forward due to the carryforward of NOLs. Tax years 2019 through 2023 are subject to audit by German and Australian tax authorities. The Company is not currently under examination by any tax jurisdictions.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="c-1" id="f-340">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants and Tranche Rights&lt;/span&gt;&lt;/div&gt;The Company accounts for issued financial instruments either as a liability or equity in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (&#x201c;ASC 480-10&#x201d;) or ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#x2019;s Own Stock (&#x201c;ASC 815-40&#x201d;). If financial instruments do not meet liability classification under ASC 480-10, the Company considers the requirements of ASC 815-40 to determine whether the financial instruments should be classified as a liability or as equity. Liability-classified financial instruments are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the financial instruments after the issuance date is recorded in the Consolidated Statements of Operations as a gain or loss. If financial instruments do not require liability classification under ASC 815-40, the instrument is classified in permanent equity. Equity-classified financial instruments are accounted for based on allocated proceeds on the issuance date with no subsequent measurement after the issuance date.</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-341">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share attributable to common stockholders is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of common shares and, if dilutive, common stock equivalents outstanding for the period determined using the treasury-stock method. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#x2019;s net loss position. The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2025 includes 8,580,507 pre-funded warrants from the January 2024 Financing and 86,666,667 pre-funded warrants from the May 2025 Offering that remain unexercised as of June 30, 2025.  The weighted average shares outstanding calculation for basic and diluted earnings per share for the three and six months ended June 30, 2024 includes 11,193,564 per-funded warrants from the January 2024 Financing that were unexercised as of June 30, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-81"
      decimals="INF"
      id="f-342"
      unitRef="shares">8580507</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-82"
      decimals="INF"
      id="f-343"
      unitRef="shares">86666667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-83"
      decimals="INF"
      id="f-344"
      unitRef="shares">11193564</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-345">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive securities, which are not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.953%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.955%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,853,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,819,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Placement agent warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,136,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,819,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-84" decimals="0" id="f-346" unitRef="shares">25853605</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-85" decimals="0" id="f-347" unitRef="shares">10819558</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-86" decimals="0" id="f-348" unitRef="shares">283334</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-87" decimals="0" id="f-349" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-350" unitRef="shares">26136939</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="0" id="f-351" unitRef="shares">10819558</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-352">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued and/or Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The new guidance is expected to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information by requiring 1) consistent categories and greater disaggregation of information in the rate reconciliation and 2) income taxes paid disaggregated by jurisdiction. The guidance is effective on a prospective basis, although retrospective application and early adoption is permitted. The standard was adopted by the Company for the annual period starting January 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2024, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures to improve the disclosures about a public entity&#x2019;s expenses and provide more detailed information about the types of expenses in commonly presented expense captions such as inventory purchases, employee compensation, depreciation and intangible asset &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amortization. The disclosure requirements must be applied retrospectively to all prior periods presented in the financial statements. The effective date for the standard is for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-353">Balance Sheet Details&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Assets and Prepaid Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Current Assets and Prepaid Expenses consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.419%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.255%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid clinical and related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts Payable consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.046%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.969%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and audit costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued clinical and related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued legal and audit costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Current Liabilities consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.740%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-385"&gt;&lt;span style="-sec-ix-hidden:f-386"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-354">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Current Assets and Prepaid Expenses consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.419%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.255%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid clinical and related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <vtl:PrepaidClinicalAndRelatedCostsCurrent contextRef="c-3" decimals="-3" id="f-355" unitRef="usd">2467000</vtl:PrepaidClinicalAndRelatedCostsCurrent>
    <vtl:PrepaidClinicalAndRelatedCostsCurrent contextRef="c-4" decimals="-3" id="f-356" unitRef="usd">1871000</vtl:PrepaidClinicalAndRelatedCostsCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="c-3" decimals="-3" id="f-357" unitRef="usd">594000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="c-4" decimals="-3" id="f-358" unitRef="usd">647000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:PrepaidInsurance contextRef="c-3" decimals="-3" id="f-359" unitRef="usd">610000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-4" decimals="-3" id="f-360" unitRef="usd">198000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-361" unitRef="usd">861000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-362" unitRef="usd">948000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-363" unitRef="usd">4532000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-364" unitRef="usd">3664000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-365">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts Payable consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.046%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.969%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and audit costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued clinical and related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued legal and audit costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <vtl:ClinicalCostsPayableCurrent contextRef="c-3" decimals="-3" id="f-366" unitRef="usd">7015000</vtl:ClinicalCostsPayableCurrent>
    <vtl:ClinicalCostsPayableCurrent contextRef="c-4" decimals="-3" id="f-367" unitRef="usd">7561000</vtl:ClinicalCostsPayableCurrent>
    <vtl:LegalAndAuditCostsPayableCurrent contextRef="c-3" decimals="-3" id="f-368" unitRef="usd">743000</vtl:LegalAndAuditCostsPayableCurrent>
    <vtl:LegalAndAuditCostsPayableCurrent contextRef="c-4" decimals="-3" id="f-369" unitRef="usd">31000</vtl:LegalAndAuditCostsPayableCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-3" decimals="-3" id="f-370" unitRef="usd">135000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-4" decimals="-3" id="f-371" unitRef="usd">254000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-372" unitRef="usd">7893000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-373" unitRef="usd">7846000</us-gaap:AccountsPayableCurrent>
    <vtl:AccruedClinicalCostsCurrent contextRef="c-3" decimals="-3" id="f-374" unitRef="usd">16227000</vtl:AccruedClinicalCostsCurrent>
    <vtl:AccruedClinicalCostsCurrent contextRef="c-4" decimals="-3" id="f-375" unitRef="usd">12456000</vtl:AccruedClinicalCostsCurrent>
    <vtl:AccruedLegalAndAuditCostsCurrent contextRef="c-3" decimals="-3" id="f-376" unitRef="usd">353000</vtl:AccruedLegalAndAuditCostsCurrent>
    <vtl:AccruedLegalAndAuditCostsCurrent contextRef="c-4" decimals="-3" id="f-377" unitRef="usd">72000</vtl:AccruedLegalAndAuditCostsCurrent>
    <vtl:AccruedCompensationCurrent contextRef="c-3" decimals="-3" id="f-378" unitRef="usd">1457000</vtl:AccruedCompensationCurrent>
    <vtl:AccruedCompensationCurrent contextRef="c-4" decimals="-3" id="f-379" unitRef="usd">354000</vtl:AccruedCompensationCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-380" unitRef="usd">76000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-381" unitRef="usd">31000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-382" unitRef="usd">18113000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-383" unitRef="usd">12913000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-384">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Current Liabilities consist of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.740%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-385"&gt;&lt;span style="-sec-ix-hidden:f-386"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-387" unitRef="usd">774000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-388" unitRef="usd">740000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-389" unitRef="usd">533000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-390" unitRef="usd">676000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-391" unitRef="usd">1307000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-392" unitRef="usd">1416000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-393">Leases&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain office space under non-cancelable operating leases. The leases terminate on July 31, 2026 for the New York City office, December 31, 2025 for the Gr&#xe4;felfing, Germany office and November 30, 2028 for the research laboratory in Planegg, Germany.  These agreements include both lease (e.g., fixed rent) and non-lease components (e.g., common-area and other maintenance costs). The non-lease components are deemed to be executory costs and are therefore excluded from the minimum lease payments used to determine the present value of the operating lease obligation and related right-of-use asset. The New York City lease was extended on November 8, 2024 for an additional 12 months resulting in the new lease termination date of July 31, 2026. The New York City lease has a renewal option, but this was not included in calculating the right of use asset and liabilities. On April 7, 2020, the Company signed a five year lease for its facility in Gr&#xe4;felfing, Germany. On March 1, 2021 and August 1, 2022 the Company added additional lease space at the Gr&#xe4;felfing, Germany office. The lease term has expired, however, the Company is currently operating on a one-year monthly rolling lease and the Company needs to provide one-years notice to terminate the lease. Renewal options were not included in calculating the right of use asset and liabilities for this facility. In February 2023, the Company leased space in Germany for a research laboratory. The leases do not have concessions, leasehold improvement incentives or other build-out clauses. Further, the leases do not contain contingent rent provisions. There were net additions of $448,000 related to the extension of the New York City lease and Gr&#xe4;felfing offices during the year ended December 31, 2024.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The leases do not provide an implicit rate and, due to the lack of a commercially salable product, the Company is generally considered unable to obtain commercial credit. Therefore, the Company estimated its incremental interest rate to be 6% for the original leases and 8% for the New York City extension and German laboratory, considering the quoted rates for the lowest investment-grade debt. Immunic used its estimated incremental borrowing rate and other information available at the lease commencement date in determining the present value of the lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Immunic&#x2019;s operating lease costs and variable lease costs were $312,000 and $270,000 for the three months ended June 30, 2025 and 2024, respectively and $591,000 and $527,000 for the six months ended June 30, 2025 and 2024, respectively. Variable lease costs consist primarily of common area maintenance costs, insurance and taxes which are paid based upon actual costs incurred by the lessor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the operating lease obligation are as follows as of June 30, 2025 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.106%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.945%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-88" id="f-394">P12M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-89" id="f-395">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <vtl:IncreaseDecreaseInOperatingLeaseRightOfUseAsset contextRef="c-90" decimals="-3" id="f-396" unitRef="usd">448000</vtl:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <vtl:IncreaseDecreaseInOperatingLeaseRightOfUseAsset contextRef="c-91" decimals="-3" id="f-397" unitRef="usd">448000</vtl:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <vtl:OperatingLeaseIncrementalBorrowingRate contextRef="c-88" decimals="2" id="f-398" unitRef="number">0.06</vtl:OperatingLeaseIncrementalBorrowingRate>
    <vtl:OperatingLeaseIncrementalBorrowingRate contextRef="c-92" decimals="2" id="f-399" unitRef="number">0.08</vtl:OperatingLeaseIncrementalBorrowingRate>
    <vtl:OperatingAndVariableLeasesCost contextRef="c-5" decimals="-3" id="f-400" unitRef="usd">312000</vtl:OperatingAndVariableLeasesCost>
    <vtl:OperatingAndVariableLeasesCost contextRef="c-6" decimals="-3" id="f-401" unitRef="usd">270000</vtl:OperatingAndVariableLeasesCost>
    <vtl:OperatingAndVariableLeasesCost contextRef="c-1" decimals="-3" id="f-402" unitRef="usd">591000</vtl:OperatingAndVariableLeasesCost>
    <vtl:OperatingAndVariableLeasesCost contextRef="c-7" decimals="-3" id="f-403" unitRef="usd">527000</vtl:OperatingAndVariableLeasesCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-404">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the operating lease obligation are as follows as of June 30, 2025 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.106%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.945%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-405" unitRef="usd">415000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-406" unitRef="usd">444000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-407" unitRef="usd">85000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-408" unitRef="usd">82000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-409" unitRef="usd">1026000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-410" unitRef="usd">47000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-411" unitRef="usd">979000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-412">Fair Value&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following fair value hierarchy tables present information about each major category of the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at Fair&#160;Value&#160;Measurement&#160;at&#160;December&#160;31,&#160;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between Level&#160;1, Level&#160;2 or Level&#160;3 assets during the periods presented.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s money market funds which are included as a component of cash and cash equivalents on the Consolidated Balance Sheet, realized gains and losses are included in interest income on the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our money market fund account is held in our bank in the U.S. and was earning interest at a rate of 4.1% in a U.S. Government money market fund.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has cash balances in banks in excess of the maximum amount insured by the FDIC and other international agencies as of June 30, 2025. The Company has not historically experienced any credit losses with balances in excess of FDIC limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded tranche rights of $23.6&#160;million at January 8, 2024 as a result of the January 2024 Financing (see note 6).  The fair value measurement of the tranche rights associated with the January 2024 Financing was classified as Level 3 under the fair value hierarchy.  The fair value of the tranche rights was determined using a Black Scholes Option Pricing Model. The inputs to this model included a risk-free rate range of 3.93%-4.36%, a stock price volatility range of 105-115%, an expected dividend rate of 0% and remaining term of 1.81-4.81 years.  This liability was revalued on March 4, 2024, upon stockholder approval to increase its authorized shares of common stock from 130&#160;million to 500&#160;million, which resulted in the reclassification of the tranche rights from a liability to equity.  This revaluation resulted in an increase in the tranche rights liability of $4.8&#160;million using a Black Scholes Option Pricing Model. The inputs to this model as of the date of the reclassification included a risk-free rate range of 4.16%-4.63%, a stock price volatility range of 90%-105%, an expected dividend rate of 0% and remaining term of 1.66-4.66 years. The inputs used in the determination of fair value of the liability are level 3 inputs. A rollforward of the fair value of the tranche rights is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.928%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of January 8, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value through March 4, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification to equity in March 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The carrying amounts of other current assets and prepaid expenses, accounts payable, accrued expenses, and other current liabilities approximate their fair values due to their short-term nature. The fair value and book value of the money market funds presented in the table above are the same.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-413">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following fair value hierarchy tables present information about each major category of the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at Fair&#160;Value&#160;Measurement&#160;at&#160;December&#160;31,&#160;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-93" decimals="-3" id="f-414" unitRef="usd">47190000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-94" decimals="-3" id="f-415" unitRef="usd">47190000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-95" decimals="-3" id="f-416" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-96" decimals="-3" id="f-417" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-97" decimals="-3" id="f-418" unitRef="usd">47190000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-98" decimals="-3" id="f-419" unitRef="usd">47190000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-99" decimals="-3" id="f-420" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-421" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-422" unitRef="usd">14751000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-423" unitRef="usd">14751000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-424" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-425" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-426" unitRef="usd">14751000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-427" unitRef="usd">14751000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-428" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-108" decimals="-3" id="f-429" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentInterestRate contextRef="c-72" decimals="3" id="f-430" unitRef="number">0.041</us-gaap:InvestmentInterestRate>
    <vtl:TrancheRightFairValueDisclosure contextRef="c-109" decimals="-5" id="f-431" unitRef="usd">23600000</vtl:TrancheRightFairValueDisclosure>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-110" decimals="4" id="f-432" unitRef="number">0.0393</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-111" decimals="4" id="f-433" unitRef="number">0.0436</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-110"
      decimals="INF"
      id="f-434"
      unitRef="number">1.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-111"
      decimals="INF"
      id="f-435"
      unitRef="number">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-112" decimals="4" id="f-436" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-110" id="f-437">P1Y9M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-111" id="f-438">P4Y9M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-109"
      decimals="-6"
      id="f-439"
      unitRef="shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-113"
      decimals="-6"
      id="f-440"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <vtl:FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement contextRef="c-113" decimals="-5" id="f-441" unitRef="usd">4800000</vtl:FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-114" decimals="4" id="f-442" unitRef="number">0.0416</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-115" decimals="4" id="f-443" unitRef="number">0.0463</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-114" decimals="2" id="f-444" unitRef="number">0.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-115" decimals="2" id="f-445" unitRef="number">1.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-116" decimals="4" id="f-446" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-114" id="f-447">P1Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-115" id="f-448">P4Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-449">A rollforward of the fair value of the tranche rights is as follows (in thousands):&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.928%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of January 8, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value through March 4, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification to equity in March 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-38" decimals="0" id="f-450" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <vtl:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag contextRef="c-117" id="f-451">Fair value as of January 8, 2024</vtl:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-117" decimals="0" id="f-452" unitRef="usd">23600</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="c-117" decimals="0" id="f-453" unitRef="usd">4796</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <vtl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity contextRef="c-117" decimals="0" id="f-454" unitRef="usd">-28396</vtl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassificationToEquity>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-4" decimals="0" id="f-455" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-456">Common Stock&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shelf Registration Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2020, the Company filed a Prospectus Supplement to the shelf registration statement on Form S-3 filed on November 13, 2020 and declared effective on November 24, 2020 (the "2020 Shelf Registration Statement") for the offering, issuance and sale of up to a maximum aggregate offering price of $50.0&#160;million of common stock that may be issued and sold under an at-the-market sales agreement with SVB Leerink LLC (now Leerink Partners LLC) as agent ("December 2020 ATM"). The Company used the net proceeds from the December 2020 ATM to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The December 2020 ATM terminated in May 2024.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2022, the Company filed a Prospectus Supplement to the 2020 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $80.0&#160;million of common stock to be issued and sold under another at-the-market sales agreement ("May 2022 ATM") with Leerink Partners LLC (formerly SVB Leerink LLC) as agent. The 2020 Shelf Registration Statement expired in November 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, the Company filed a shelf registration statement on Form S-3 (the "2023 Shelf Registration Statement").  The 2023 Shelf Registration Statement permits the offering, issuance and sale of up to $250.0&#160;million of common stock, preferred stock, warrants, debt securities, and/or units in one or more offerings and in any combination of the foregoing. This registration statement was declared effective on May 31, 2024.  Unsold securities from the expired 2020 Shelf Registration Statement can continue to be sold under the 2023 Shelf Registration Statement.  As a result of the April 2025 Offering and May 2025 Offering, the amount available under the 2023 Shelf Registration Statement was reduced by $70.1&#160;million to $342.2&#160;million as of June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2024, we filed a Prospectus Supplement to the 2023 Shelf Registration Statement for the offering, issuance and sale of up to a maximum aggregate offering price of $80.0&#160;million of common stock that may be issued and sold under an at-the-market sales agreement with Leerink Partners LLC as agent ("May 2024 ATM"), which rolls over the $80.0&#160;million of unsold common stock from the May 2022 ATM. We intend to use the net proceeds from the May 2024 ATM to continue to fund the ongoing clinical development of our product candidates and for other general corporate purposes, including funding existing and potential new clinical programs and product candidates. The May 2024 ATM will terminate upon the earlier of (i) the issuance and sale of all of the shares through Leerink Partners LLC on the terms and subject to the conditions set forth in the May 2024 ATM or (ii) termination of the May 2024 ATM as otherwise permitted thereby. The May 2024 ATM may be terminated at any time by either party upon ten days&#x2019; prior notice, or by Leerink Partners LLC at any time in certain circumstances, including the occurrence of a material adverse effect on us.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2025, $80.0&#160;million in capacity remains under the May 2024 ATM.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;The Company has agreed to pay Leerink Partners LLC a commission equal to 3.0% of the gross proceeds from the sales of common stock pursuant to the May 2024 ATM and has agreed to provide Leerink Partners LLC with customary indemnification and contribution rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any ATM activity during the three or six months ended June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended June 30, 2024, we raised gross proceeds of $0.2&#160;million pursuant to the December 2020 ATM through the sale of 150,000 shares of common stock at a weighted average price of $1.31 per share. The net proceeds from the December 2020 ATM were $0.2&#160;million after deducting sales agent commissions of $6,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;April 2025 Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 9, 2025, Immunic entered into a securities purchase agreement with certain institutional and accredited investors relating to the issuance and sale of an aggregate of 5,666,667 shares of the Company&#x2019;s common stock, par value $0.0001 per share. The purchase price per share was $0.90 for aggregate gross proceeds to the Company of approximately $5.1&#160;million. The offer and sale of the shares is referred to herein as the &#x201c;April 2025 Offering.&#x201d; The April 2025 Offering closed on April 10, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, on April 9, 2025, the Company entered into a placement agency agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (the &#x201c;Placement Agent&#x201d;), relating to the April 2025 Offering. Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the April 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;therewith. Additionally, upon the closing of the April 2025 Offering, the Company agreed to issue to the Placement Agent, or its designees, warrants to purchase up to an aggregate of 283,334 shares of common stock, representing 5.0% of the shares sold in the April 2025 Offering (the &#x201c;Placement Agent Warrants&#x201d;). The Placement Agent Warrants will be exercisable, in whole or in part, commencing 180 days from the date of the Placement Agency Agreement and expiring on the five year anniversary of the Placement Agency Agreement, at an initial exercise price per share of common stock of $1.125, which is equal to 125% of the price per share to investors in the April 2025 Offering. The Placement Agent Warrants and the shares of common stock underlying the Placement Agent Warrants were offered pursuant to the exemptions from registration provided in Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds to the Company from the April 2025 Offering, after deducting commissions and the Company&#x2019;s offering expenses, was approximately $4.7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The April 2025 Shares were registered under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), on the Company&#x2019;s Registration Statement on Form S-3 (Registration No. 333-275717), previously filed with the SEC, and declared effective on May 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;May 2025 Equity Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 28, 2025, Immunic entered into an underwriting agreement (the &#x201c;Underwriting Agreement&#x201d;) with Leerink Partners LLC, issuance and sale of (i) pre-funded warrants to purchase an aggregate of 86,666,667 shares of common stock, par value $0.0001 (&#x201c;Common Stock&#x201d;) of the Company (the &#x201c;Pre-Funded Warrants&#x201d;), (ii) accompanying series A warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#x201c;Series A Warrants&#x201d;), and (iii) accompanying series B warrants to purchase an aggregate of 86,666,667 shares of Common Stock of the Company (or Pre-Funded Warrants) (the &#x201c;Series B Warrants&#x201d;) (the &#x201c;May 2025 Offering&#x201d;). The price per Pre-Funded Warrant and accompanying Series A Warrant and Series B Warrant was $0.7499. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.0001 per share and will expire when exercised in full. Each Series A Warrant is immediately exercisable for one share of Common Stock at an exercise price of $0.75 per share and will expire on December 31, 2025. Each Series B Warrant is exercisable on the earlier of (i) October 1, 2025, (ii) the first day following any &lt;span style="-sec-ix-hidden:f-491"&gt;five&lt;/span&gt; trading days during which the volume weighted average price for the Common Stock of the Company during such &lt;span style="-sec-ix-hidden:f-492"&gt;five&lt;/span&gt; trading day period is $1.25 or greater (the &#x201c;VWAP Target&#x201d;), or (iii) immediately prior to the consummation of a Fundamental Transaction (as defined in the Series B Warrants) for one share of Common Stock at an exercise price of $0.75 per share and will expire five years from the date of issuance. Each Series A Warrant and Series B Warrant will immediately expire in proportion to the extent that the corresponding Pre-Funded Warrant is exercised prior to September 30, 2025; provided that this term will not apply to the Series B Warrants immediately as of the date of achievement of the VWAP Target. The holder of the Pre-Funded Warrants and Series B Warrants may also satisfy its obligation to pay the exercise price through a &#x201c;cashless exercise,&#x201d; in which the holder receives the net value of such warrant in shares of Common Stock determined according to the formula set forth in the applicable warrant. Holders of Series A Warrants may, provided there is no effective registration statement or prospectus available which covers the warrants and shares of Common Stock issuable upon exercise of the Series A Warrants, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Series A Warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is prohibited from effecting an exercise of any Pre-Funded Warrants, Series A Warrants or Series B Warrants to the extent that such exercise would result in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding 4.99% (or 9.99% at election of the holder) of the total number of shares of Common Stock outstanding immediately after giving effect to the exercise (the &#x201c;Beneficial Ownership Limitation&#x201d;), which percentage may be increased or decreased at the holder&#x2019;s election, not to exceed 19.99%. Any increase to the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. If a holder is not permitted to exercise a Series A Warrant or a Series B Warrant for Common Stock due to the Beneficial Ownership Limitation, then the holder may exercise such Series A Warrant or Series B Warrant for an equivalent number of Pre-Funded Warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The aggregate proceeds from the May 2025 Offering were approximately $65&#160;million before deducting underwriting discounts and commissions and offering expenses payable by the Company in connection with the May 2025 Offering. The Company may receive up to an aggregate of $130&#160;million of additional gross proceeds if the Series A Warrants and Series B Warrants are exercised in full for cash.  Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 6.0% of the gross proceeds from the May 2025 Offering raised from investors and to reimburse the Placement Agent for certain costs incurred in connection therewith. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The May 2025 Offering was made pursuant to an effective registration statement on Form S-3 (Registration Statement No. 333-275717), as amended, previously filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on November 22, 2023, and declared effective by the SEC on May 31, 2024, as supplemented by the preliminary prospectus supplement, dated May 28, 2025, and a final prospectus supplement (the &#x201c;Prospectus Supplement&#x201d;) filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), on May 30, 2025. The closing of the May 2025 Offering took place on  June 3, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Private Placement of up to $240&#160;million (the "January 2024 Financing")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2024, Immunic entered into a Securities Purchase Agreement with select accredited investors, pursuant to which the Company agreed to issue and sell to the Investors in a three-tranche private placement shares of the Company&#x2019;s common stock, $0.0001 par value per share or in lieu thereof, pre-funded warrants to purchase shares of Common Stock. The Pre-Funded Warrants are exercisable immediately for $0.0001 per share and until exercised in full.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The first tranche, which closed on January 8, 2024, resulted in the purchase by the Investors of an aggregate of $80&#160;million of Common Stock (or pre-funded warrants) from the Company at a price of $1.43 per share;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The second tranche is a conditional mandatory purchase by the Investors of an additional $80&#160;million of Common Stock (or pre-funded warrants) from the Company at a price of $1.716 per share, equal to 120% of the price paid in the first tranche and is subject to the satisfaction of three conditions:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;release by the Company of topline data from its Phase 2b clinical trial of vidofludimus calcium (IMU-838) in progressive multiple sclerosis, which data was announced on April 30, 2025;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;the 10-day volume-weighted average price of the Common Stock is at least $8.00 per share during the 6 months following the data release; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;aggregate trading volume during the same 10-day period is at least $100&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The third tranche must occur no later than three years after the second tranche and is conditioned on the same volume-weighted average share price and minimum trading volumes as the second tranche. The third tranche provides for the issuance of $80&#160;million of shares of common stock (or pre-funded warrants) at the same price per share as the second tranche, but permits investors to fund their purchase obligations on a &#x201c;cashless&#x201d; or net settlement basis, which would reduce the cash proceeds to be raised by the Company in the January 2024 Financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The volume-weighted average share price and minimum trading volume conditions of the second and third tranches have not&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;been satisfied as of June 30, 2025. Any of the conditions in the second or third tranches can be waived by holders of a majority of the outstanding securities (including the lead investor).  The fair value methodology used by the Company assumed the conditions will be waived if the trading price of the stock exceeds the purchase price.  Through June 30, 2025, the investors in&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the first tranche have not purchased any additional shares of common stock from the Company pursuant to the terms of the January 2024 Financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The January 2024 Financing resulted in gross proceeds to the Company of approximately $80&#160;million in the first tranche, and an additional $80&#160;million if and when the second tranche occurs. If the second tranche is completed and conditions for the third tranche are satisfied or waived, the Company could receive up to an additional $80&#160;million in the third tranche. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the closing date of the transaction of January 8, 2024, the Company did not have enough authorized shares to be able to issue the potential shares for tranche 2 and tranche 3 (collectively referred to hereafter as "the tranche rights").  Therefore, the Company recorded the value associated to the tranche rights as a liability of $23.6&#160;million and allocated the remainder of the $80&#160;million received (or $56.4&#160;million) with the common stock and pre-funded warrants to equity.  On March 4, 2024, the stockholders voted to increase the Company's authorized common stock from 130&#160;million to 500&#160;million shares.  As a result of the ability to issue shares in satisfaction of the tranche rights, the instrument was reclassified to stockholders' equity.  The Company allocated the transaction costs across the instruments on a relative fair value basis at the grant date. As a result $4.0&#160;million was netted against the equity proceeds and $1.7&#160;million was recorded in other expense in the Consolidated Statements of Operations for the six months ended June 30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company registered for resale by the investors in the January 2024 Financing up to 55,944,850 shares of common stock issued (or issuable upon exercise of pre-funded warrants) in the first tranche. The Company will not receive any proceeds from the sale of these shares of common stock. These shares are registered on a registration statement on Form S-3 (registration No. 333-277040).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 4, 2024, the stockholders of the Company voted to increase the authorized shares of the Company from 130,000,000 shares of common stock to 500,000,000 shares of common stock, par value of $0.0001 per share. The voting, dividend and liquidation rights of the holders of the Company&#x2019;s common stock are subject to and qualified by the rights, powers and preferences of any holders of preferred stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#x2019;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Board of Directors, if any. Through June 30, 2025, no cash dividends had been declared or paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Notice of Non-Compliance with Nasdaq Listing Rule 5450(a)(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2025, Immunic, Inc. received a written notification (the &#x201c;Notice Letter&#x201d;) from The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) notifying the Company that we were not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price for our common stock was below the $1.00 per share requirement for the last 30 consecutive business days. The Notice Letter stated that we have 180 calendar days, or until December 24, 2025 (the &#x201c;Initial Compliance Period&#x201d;), to regain compliance with the minimum bid price requirement. If we do not regain compliance by the end of the Initial Compliance Period, we may apply for an additional compliance period as provided for in the Notice Letter. Nasdaq&#x2019;s determination of whether we qualify for an additional compliance period will depend on whether we will meet the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and a written notice of our intention to cure the deficiency during the additional compliance period by effecting a reverse stock split, if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Notice Letter has no immediate effect on the listing of our common stock on The Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we can regain compliance if the closing bid price of our common stock is at least $1.00 for a minimum of 10 consecutive business days. In the event that we do not regain compliance with Listing Rule 5450(a)(1) prior to the expiration of the Initial Compliance Period (or additional compliance period, if applicable), we will receive written notification that our securities are subject to delisting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company intends to actively monitor the closing bid price of its common stock and is evaluating available options to regain compliance with the minimum bid price requirement. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or that the Company will otherwise remain in compliance with the other listing standards for the Nasdaq. If the Company&#x2019;s common stock is delisted from Nasdaq, it could have a material adverse effect on the trading price and liquidity of the common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pre-funded Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued 11,193,564 pre-funded warrants in connection with the January 2024 Financing, 2,613,057 of which were exercised in the quarter ended June 30, 2025 and 8,580,507 of which remain outstanding as of June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s certificate of incorporation, as amended and restated, authorizes the Company to issue 20 million shares of $0.0001 par value preferred stock, with such voting powers (if any), designations, powers, preferences, and relative, participating, optional or other rights, if any, and any qualifications, limitations or restrictions thereof, as shall be set by the Board of Directors. No preferred shares were issued or outstanding as of June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Reserved for Future Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares reserved for future issuance at June 30, 2025 are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock reserved for issuance for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-funded stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,580,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Placement agent warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,853,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Shares reserved for the second tranche of the January 2024 financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,620,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the second tranche of the January 2024 financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,620,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Pre-funded warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,666,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Series A warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,666,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the May 2025 Series B warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,666,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options available for future grant:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Inducement Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Omnibus Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total common shares reserved for future issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,308,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration contextRef="c-118" decimals="-5" id="f-457" unitRef="usd">50000000</vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration>
    <vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration contextRef="c-119" decimals="-5" id="f-458" unitRef="usd">80000000</vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration>
    <vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration contextRef="c-120" decimals="-5" id="f-459" unitRef="usd">250000000</vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration>
    <vtl:UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration contextRef="c-121" decimals="-5" id="f-460" unitRef="usd">70100000</vtl:UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration>
    <vtl:UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration contextRef="c-122" decimals="-5" id="f-461" unitRef="usd">342200000</vtl:UnsoldSecuritiesRolledOverToBeSoldUnderNewShelfRegistration>
    <vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration contextRef="c-123" decimals="-5" id="f-462" unitRef="usd">80000000</vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration>
    <vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration contextRef="c-119" decimals="-5" id="f-463" unitRef="usd">80000000</vtl:MaximumAggregateOfferingPriceOfSecuritiesUnderShelfRegistration>
    <vtl:ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays contextRef="c-124" decimals="INF" id="f-464" unitRef="d">10</vtl:ShelfRegistrationTerminationPriorWrittenNoticeNumberOfDays>
    <vtl:SaleOfStockRemainingCapacity contextRef="c-124" decimals="-5" id="f-465" unitRef="usd">80000000</vtl:SaleOfStockRemainingCapacity>
    <vtl:SalesOfStockCommissionsPercentOfGrossProceeds contextRef="c-125" decimals="3" id="f-466" unitRef="number">0.030</vtl:SalesOfStockCommissionsPercentOfGrossProceeds>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-126" decimals="-5" id="f-467" unitRef="usd">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-127" decimals="-5" id="f-468" unitRef="usd">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-127"
      decimals="INF"
      id="f-469"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-126"
      decimals="INF"
      id="f-470"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-128"
      decimals="2"
      id="f-471"
      unitRef="usdPerShare">1.31</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-126" decimals="-5" id="f-472" unitRef="usd">200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForCommissions contextRef="c-126" decimals="-3" id="f-473" unitRef="usd">6000</us-gaap:PaymentsForCommissions>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-129"
      decimals="INF"
      id="f-474"
      unitRef="shares">5666667</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-130"
      decimals="INF"
      id="f-475"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-130"
      decimals="INF"
      id="f-476"
      unitRef="usdPerShare">0.90</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-129" decimals="-5" id="f-477" unitRef="usd">5100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <vtl:PlacementAgentAgreementBrokerageFeePercent contextRef="c-131" decimals="3" id="f-478" unitRef="number">0.060</vtl:PlacementAgentAgreementBrokerageFeePercent>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-132"
      decimals="INF"
      id="f-479"
      unitRef="shares">283334</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction contextRef="c-131" decimals="3" id="f-480" unitRef="number">0.050</us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction>
    <us-gaap:SharePrice
      contextRef="c-132"
      decimals="3"
      id="f-481"
      unitRef="usdPerShare">1.125</us-gaap:SharePrice>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction contextRef="c-131" decimals="2" id="f-482" unitRef="number">1.25</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <vtl:ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses contextRef="c-133" decimals="-5" id="f-483" unitRef="usd">4700000</vtl:ProceedsFromIssuanceOfCommonStockNetOfOfferingExpenses>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-134"
      decimals="INF"
      id="f-484"
      unitRef="shares">86666667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-134"
      decimals="INF"
      id="f-485"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-135"
      decimals="INF"
      id="f-486"
      unitRef="shares">86666667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-136"
      decimals="INF"
      id="f-487"
      unitRef="shares">86666667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-137"
      decimals="4"
      id="f-488"
      unitRef="usdPerShare">0.7499</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-134"
      decimals="4"
      id="f-489"
      unitRef="usdPerShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-135"
      decimals="2"
      id="f-490"
      unitRef="usdPerShare">0.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-138"
      decimals="2"
      id="f-493"
      unitRef="usdPerShare">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-136"
      decimals="2"
      id="f-494"
      unitRef="usdPerShare">0.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <vtl:ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance contextRef="c-136" id="f-495">P5Y</vtl:ClassOfWarrantOrRightExpirationPeriodFromTheDateOfIssuance>
    <vtl:OwnershipLimitationPercentage contextRef="c-139" decimals="4" id="f-496" unitRef="number">0.0499</vtl:OwnershipLimitationPercentage>
    <vtl:OwnershipLimitationPercentageUponElectionOfTheHolder contextRef="c-139" decimals="4" id="f-497" unitRef="number">0.0999</vtl:OwnershipLimitationPercentageUponElectionOfTheHolder>
    <vtl:OwnershipLimitationPercentage contextRef="c-140" decimals="4" id="f-498" unitRef="number">0.1999</vtl:OwnershipLimitationPercentage>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-139" decimals="-6" id="f-499" unitRef="usd">65000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-139" decimals="-6" id="f-500" unitRef="usd">130000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <vtl:PlacementAgentAgreementBrokerageFeePercent contextRef="c-141" decimals="3" id="f-501" unitRef="number">0.060</vtl:PlacementAgentAgreementBrokerageFeePercent>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-142" decimals="-6" id="f-502" unitRef="usd">240000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <vtl:SaleOfStockPrivatePlacementNumberOfTranche
      contextRef="c-143"
      decimals="INF"
      id="f-503"
      unitRef="tranche">3</vtl:SaleOfStockPrivatePlacementNumberOfTranche>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-143"
      decimals="INF"
      id="f-504"
      unitRef="usdPerShare">0.0001</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-144"
      decimals="INF"
      id="f-505"
      unitRef="usdPerShare">0.0001</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-145" decimals="-6" id="f-506" unitRef="usd">80000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-146"
      decimals="2"
      id="f-507"
      unitRef="usdPerShare">1.43</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-147" decimals="-6" id="f-508" unitRef="usd">80000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-148"
      decimals="3"
      id="f-509"
      unitRef="usdPerShare">1.716</us-gaap:SaleOfStockPricePerShare>
    <vtl:SaleOfStockConsiderationReceivedPercentage contextRef="c-148" decimals="2" id="f-510" unitRef="number">1.20</vtl:SaleOfStockConsiderationReceivedPercentage>
    <vtl:SaleOfStockNumberOfTrancheConditions
      contextRef="c-148"
      decimals="INF"
      id="f-511"
      unitRef="tranche">3</vtl:SaleOfStockNumberOfTrancheConditions>
    <vtl:ThresholdTradingDaysForWeightedAveragePriceCalculation contextRef="c-147" id="f-512">P10D</vtl:ThresholdTradingDaysForWeightedAveragePriceCalculation>
    <vtl:WeightedAveragePriceOfLast10Days
      contextRef="c-147"
      decimals="2"
      id="f-513"
      unitRef="usdPerShare">8.00</vtl:WeightedAveragePriceOfLast10Days>
    <vtl:ThresholdTradingDaysForAggregateTradingVolumeCalculation contextRef="c-147" id="f-514">P10D</vtl:ThresholdTradingDaysForAggregateTradingVolumeCalculation>
    <vtl:SaleOfStockAggregateTradingVolumeOfLast10Days contextRef="c-147" decimals="-6" id="f-515" unitRef="usd">100000000</vtl:SaleOfStockAggregateTradingVolumeOfLast10Days>
    <vtl:SaleOfStockEquityOfferingsPeriod contextRef="c-149" id="f-516">P3Y</vtl:SaleOfStockEquityOfferingsPeriod>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-149" decimals="-6" id="f-517" unitRef="usd">80000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-150" decimals="-6" id="f-518" unitRef="usd">80000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-151" decimals="-6" id="f-519" unitRef="usd">80000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-152" decimals="-6" id="f-520" unitRef="usd">80000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <vtl:FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement contextRef="c-153" decimals="-5" id="f-521" unitRef="usd">23600000</vtl:FairValueReclassificationOfFutureTrancheRightLiabilityUponSettlement>
    <vtl:TrancheRightsLiabilityRemainderAmount contextRef="c-154" decimals="-6" id="f-522" unitRef="usd">80000000</vtl:TrancheRightsLiabilityRemainderAmount>
    <vtl:TrancheRightsLiabilityReceivedAmount contextRef="c-154" decimals="-5" id="f-523" unitRef="usd">56400000</vtl:TrancheRightsLiabilityReceivedAmount>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-155"
      decimals="-6"
      id="f-524"
      unitRef="shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-156"
      decimals="-6"
      id="f-525"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-157" decimals="-5" id="f-526" unitRef="usd">4000000</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-158" decimals="-5" id="f-527" unitRef="usd">1700000</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <vtl:CommonStockNumberOfSharesRegisteredForResale
      contextRef="c-146"
      decimals="INF"
      id="f-528"
      unitRef="shares">55944850</vtl:CommonStockNumberOfSharesRegisteredForResale>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-159"
      decimals="INF"
      id="f-529"
      unitRef="shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-160"
      decimals="INF"
      id="f-530"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-113"
      decimals="INF"
      id="f-531"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <vtl:NumberOfVotesPerEachShareOfCommonStock contextRef="c-3" decimals="INF" id="f-532" unitRef="vote">1</vtl:NumberOfVotesPerEachShareOfCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-533"
      unitRef="usdPerShare">0</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="INF"
      id="f-534"
      unitRef="usdPerShare">0</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-161"
      decimals="INF"
      id="f-535"
      unitRef="shares">11193564</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="c-162"
      decimals="INF"
      id="f-536"
      unitRef="shares">2613057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-161"
      decimals="INF"
      id="f-537"
      unitRef="shares">8580507</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-538" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-539"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-540" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-541" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <vtl:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock contextRef="c-1" id="f-542">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares reserved for future issuance at June 30, 2025 are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock reserved for issuance for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-funded stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,580,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Placement agent warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,853,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Shares reserved for the second tranche of the January 2024 financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,620,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the second tranche of the January 2024 financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,620,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Pre-funded warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,666,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Shares reserved for the May 2025 Series A warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,666,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Maximum shares reserved for the May 2025 Series B warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,666,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options available for future grant:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Inducement Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Omnibus Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total common shares reserved for future issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,308,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</vtl:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-163"
      decimals="INF"
      id="f-543"
      unitRef="shares">708161</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-164"
      decimals="INF"
      id="f-544"
      unitRef="shares">8580507</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-165"
      decimals="INF"
      id="f-545"
      unitRef="shares">283334</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-166"
      decimals="INF"
      id="f-546"
      unitRef="shares">25853605</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-167"
      decimals="INF"
      id="f-547"
      unitRef="shares">46620046</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-167"
      decimals="INF"
      id="f-548"
      unitRef="shares">46620046</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-168"
      decimals="INF"
      id="f-549"
      unitRef="shares">86666667</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-169"
      decimals="INF"
      id="f-550"
      unitRef="shares">86666667</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-170"
      decimals="INF"
      id="f-551"
      unitRef="shares">86666667</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-171"
      decimals="INF"
      id="f-552"
      unitRef="shares">46250</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-172"
      decimals="INF"
      id="f-553"
      unitRef="shares">596224</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-3" decimals="INF" id="f-554" unitRef="shares">389308174</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-555">Stock-Based Compensation Plans&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 25, 2021, the Company adopted the 2021 Employee Stock Purchase Plan ("ESPP"), which was approved by stockholder vote at the 2021 Annual Meeting of Stockholders held on June 10, 2021. The ESPP provides eligible employees of the Company with an opportunity to purchase common stock of the Company through accumulated payroll deductions, which are included in other current liabilities until they are used to purchase Company shares. Eligible employees participating in the bi-annual offering period can choose to have up to the lesser of 15% of their annual base earnings or the IRS annual share purchase limit of $25,000 in aggregate market value to purchase shares of the Company&#x2019;s common stock. The purchase price of the stock is the lesser of (i) 85% of the closing market price on the date of purchase and (ii) the closing market price at the beginning of the bi-annual offering period. The maximum number of shares initially reserved for delivery under the plan was 200,000 shares.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;An increase of 1&#160;million shares to 1.2&#160;million shares was approved by stockholders of the Company at the Company's Special Meeting of stockholders held on March 4, 2024. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The first enrollment period under the plan commenced on August 1, 2021 and the Company has issued 491,839  shares life-to-date under the ESPP.  The Company recognized  $22,000 and $48,000 of expense related to the plan during the three and six months ended June 30, 2025, respectively.  The Company recognized  no  expense related to the plan during the three and six months ended June 30, 2024, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Option Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Company&#x2019;s stockholders approved the 2019 Omnibus Equity Incentive Plan, (as amended, the &#x201c;2019 Plan&#x201d;), which was adopted by the Board of Directors (the "Board") with an effective date of June 14, 2019. The 2019 Plan allows for the grant of equity awards to employees, consultants and non-employee directors. An initial maximum of 1,500,000 shares of the Company&#x2019;s common stock were available for grant under the 2019 Plan. The 2019 Plan included an evergreen provision that allowed for the annual addition of up to 4% of the Company&#x2019;s fully-diluted outstanding stock, with a maximum allowable increase of 4,900,000 shares over the term of the 2019 Plan. In accordance with this provision, the shares available for grant were increased in 2020 through 2023 by a total of 4,408,871 shares. At the Company's Annual Stockholders meeting on June 28, 2023, stockholders voted to increase the allowable shares under the 2019 plan by 4,440,000 shares as well as to eliminate the evergreen provision.  On March 4, 2024, the stockholders voted at the Company's Special Meeting to increase the allowable shares under the 2019 plan by 9,100,000 shares.  On June 4, 2025, at the Company&#x2019;s 2025 Annual Meeting of Stockholders,  the Company&#x2019;s stockholders approved a proposal to amend the terms of the 2019 Plan to, among other things, increase the allowable shares under the 2019 plan by 7,000,000 shares. The 2019 Plan (as amended on June 28, 2023 and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 4, 2024) is currently administered by the Board, or, at the discretion of the Board, by a committee of the Board, which determines the exercise prices, vesting schedules and other restrictions of awards under the 2019 Plan at its discretion. Options to purchase stock may not have an exercise price that is less than the fair market value of underlying shares on the date of grant, and may not have a term greater than ten years. Incentive stock options granted to employees typically vest over four years. Non-statutory options granted to employees, officers, members of the Board, advisors, and consultants of the Company typically vest over &lt;span style="-sec-ix-hidden:f-575"&gt;three&lt;/span&gt; or four years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares that are expired, terminated, surrendered or canceled under the 2019 Plan without having been fully exercised will be available for future awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Option Repricing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 4, 2024, the Company's stockholders voted to approve the repricing of outstanding stock options having an exercise price above $3.00 per share to $1.72 per share.  All other terms of the grant remained the same. There were 3,317,596 stock options that were repriced to $1.72 per share.  The repricing resulted in $1.2&#160;million of stock compensation being recognized by the Company over the remaining term of the repriced grants.  $52,000 and $0.1&#160;million was recognized in the three months and six months ended June 30, 2025, respectively and $17,000 and $1.0&#160;million of this amount was recognized in the three months and six months ended June 30, 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Corporate Transaction Option Acceleration Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 4, 2025, the Company established a Corporate Transaction Option Acceleration Plan, pursuant to which in the case of a merger or consolidation of the Company with or into another corporation or a sale of substantially all of the stock of the Company each option award held by an eligible employee will become fully vested upon the occurrence of a Corporate Transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Movements during the year &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the six months ended June 30, 2025 and 2024, respectively, for the 2019 Plan:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.307%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.307%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.421%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&#160;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,136,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,937,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219,540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,853,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,042,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.04&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.020%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.561%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.561%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.858%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.561%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&#160;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,196,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,810,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repricing Modification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,819,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable as of June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,606,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used in the BSM option pricing model to determine the fair value of the employee and non-employee stock option grants relating to the 2019 Plan were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risk-free rate assumption is based on U.S. Treasury instruments with maturities similar to the expected term of the stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividend Yield&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company has not issued any dividends and does not expect to issue dividends over the life of the options. As a result, the Company has estimated the dividend yield to be zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates expected volatility based on the historical volatility of its own stock. The historical volatility data was computed using the daily closing prices during the equivalent period of the calculated expected term of the stock-based awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected term of options is estimated considering the vesting period at the grant date, the life of the option and the average length of time similar grants have remained outstanding in the past.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant date fair value of stock options granted under the 2019 Plan during the six months ended June 30, 2025 and 2024 was $0.67 and $0.98, respectively. The following are the underlying assumptions used in the Black-Scholes option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.812%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six  Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense for all stock awards recognized in the accompanying unaudited condensed consolidated statements of operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.115%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months&lt;br/&gt;&#160;Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months&lt;br/&gt;&#160;Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,138,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,627,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,632,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2025, there was $15.6 million in total unrecognized compensation expense relating to the 2019 Plan, to be recognized over a weighted average period of 3.16 years. There was $28,000 and $24,000 of stock-based compensation expense during the three months ended June 30, 2025 related to the repricing included in general and administrative and research and development expense respectively. There was $56,000 and $49,000 of stock-based compensation expense during the six months ended June 30, 2025 related to the repricing included in general and administrative and research and development expense, respectively.  There was $9,000 and $8,000 of stock-based compensation expense during the three months ended June 30, 2024 related to the repricing included in general and administrative and research and development expense respectively. There was &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.6&#160;million and $0.3&#160;million of stock-based compensation expense during the six months ended June 30, 2024 related to the repricing included in general and administrative and research and development expense, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Summary of Equity Incentive Plans Assumed from Vital Therapies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon completion of the Transaction with Vital Therapies, inc. ("Vital") on April 12, 2019, Vital&#x2019;s 2012 Stock Option Plan (the &#x201c;2012 Plan&#x201d;), Vital&#x2019;s 2014 Equity Incentive Plan (the &#x201c;2014 Plan&#x201d;) and Vital&#x2019;s 2017 Inducement Equity Incentive Plan (the &#x201c;Inducement Plan&#x201d;), were assumed by the Company. All awards granted under these plans have either been forfeited or expired.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no longer any shares available for grant under the 2014 Plan as of June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 2017, Vital&#x2019;s board of directors approved the Inducement Plan, which was amended and restated in November 2017. Under the Inducement Plan 46,250 shares of Vital&#x2019;s common stock were reserved to be used exclusively for non-qualified grants to individuals who were not previously employees or directors as an inducement material to a grantee's entry into employment within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No expense was recorded for the plans assumed from Vital during the three or six months ended June 30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="c-173"
      decimals="INF"
      id="f-556"
      unitRef="number">0.15</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="c-173"
      decimals="INF"
      id="f-557"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-174"
      decimals="INF"
      id="f-558"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-175"
      decimals="INF"
      id="f-559"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-176"
      decimals="INF"
      id="f-560"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-177"
      decimals="INF"
      id="f-561"
      unitRef="shares">491839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-178" decimals="-3" id="f-562" unitRef="usd">22000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-179" decimals="-3" id="f-563" unitRef="usd">48000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-180" decimals="-3" id="f-564" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-181" decimals="-3" id="f-565" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-182"
      decimals="INF"
      id="f-566"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <vtl:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent
      contextRef="c-183"
      decimals="INF"
      id="f-567"
      unitRef="number">0.04</vtl:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-183"
      decimals="INF"
      id="f-568"
      unitRef="shares">4900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-184"
      decimals="INF"
      id="f-569"
      unitRef="shares">4408871</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
      contextRef="c-185"
      decimals="INF"
      id="f-570"
      unitRef="shares">4440000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
      contextRef="c-186"
      decimals="INF"
      id="f-571"
      unitRef="shares">9100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
      contextRef="c-187"
      decimals="INF"
      id="f-572"
      unitRef="shares">7000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-188" id="f-573">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-189" id="f-574">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-191" id="f-576">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-115"
      decimals="2"
      id="f-577"
      unitRef="usdPerShare">3.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-114"
      decimals="2"
      id="f-578"
      unitRef="usdPerShare">1.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <vtl:ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares
      contextRef="c-116"
      decimals="INF"
      id="f-579"
      unitRef="shares">3317596</vtl:ShareBasedCompensationByShareBasedPaymentAwardOptionsRepricedNumberOfShares>
    <vtl:ShareBasedPaymentArrangementPlanModificationOptionExercisePrice
      contextRef="c-116"
      decimals="2"
      id="f-580"
      unitRef="usdPerShare">1.72</vtl:ShareBasedPaymentArrangementPlanModificationOptionExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost contextRef="c-1" decimals="-5" id="f-581" unitRef="usd">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="c-5" decimals="-3" id="f-582" unitRef="usd">52000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="c-1" decimals="-5" id="f-583" unitRef="usd">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="c-6" decimals="-3" id="f-584" unitRef="usd">17000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="c-7" decimals="-5" id="f-585" unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-586">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the six months ended June 30, 2025 and 2024, respectively, for the 2019 Plan:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.307%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.307%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.421%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&#160;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,136,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,937,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219,540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,853,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,042,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.04&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.020%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.561%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.561%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.858%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.561%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&#160;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,196,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,810,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repricing Modification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,819,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable as of June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,606,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-192"
      decimals="INF"
      id="f-587"
      unitRef="shares">16136045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-192"
      decimals="2"
      id="f-588"
      unitRef="usdPerShare">1.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-193"
      decimals="INF"
      id="f-589"
      unitRef="shares">9937100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-193"
      decimals="2"
      id="f-590"
      unitRef="usdPerShare">0.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-193"
      decimals="INF"
      id="f-591"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-193"
      decimals="2"
      id="f-592"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-193"
      decimals="INF"
      id="f-593"
      unitRef="shares">219540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-193"
      decimals="2"
      id="f-594"
      unitRef="usdPerShare">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-194"
      decimals="INF"
      id="f-595"
      unitRef="shares">25853605</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-194"
      decimals="2"
      id="f-596"
      unitRef="usdPerShare">1.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-193" id="f-597">P8Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-194" decimals="0" id="f-598" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-194"
      decimals="INF"
      id="f-599"
      unitRef="shares">7042889</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-194"
      decimals="2"
      id="f-600"
      unitRef="usdPerShare">1.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-193" id="f-601">P7Y14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-194" decimals="0" id="f-602" unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-195"
      decimals="INF"
      id="f-603"
      unitRef="shares">6196140</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-195"
      decimals="2"
      id="f-604"
      unitRef="usdPerShare">7.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-196"
      decimals="INF"
      id="f-605"
      unitRef="shares">4810349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-196"
      decimals="2"
      id="f-606"
      unitRef="usdPerShare">1.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-196"
      decimals="INF"
      id="f-607"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-196"
      decimals="2"
      id="f-608"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <vtl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod
      contextRef="c-196"
      decimals="INF"
      id="f-609"
      unitRef="shares">0</vtl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepricingModificationInPeriod>
    <vtl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice
      contextRef="c-196"
      decimals="2"
      id="f-610"
      unitRef="usdPerShare">9.55</vtl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRepricingModificationsPrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-196"
      decimals="INF"
      id="f-611"
      unitRef="shares">186931</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-196"
      decimals="2"
      id="f-612"
      unitRef="usdPerShare">2.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-197"
      decimals="INF"
      id="f-613"
      unitRef="shares">10819558</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-197"
      decimals="2"
      id="f-614"
      unitRef="usdPerShare">1.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-196" id="f-615">P8Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-197" decimals="0" id="f-616" unitRef="usd">1875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-197"
      decimals="INF"
      id="f-617"
      unitRef="shares">3606762</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-197"
      decimals="2"
      id="f-618"
      unitRef="usdPerShare">2.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-196" id="f-619">P6Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-197" decimals="0" id="f-620" unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="INF" id="f-621" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-198"
      decimals="2"
      id="f-622"
      unitRef="usdPerShare">0.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-199"
      decimals="2"
      id="f-623"
      unitRef="usdPerShare">0.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-624">The following are the underlying assumptions used in the Black-Scholes option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.812%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six  Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-198" decimals="4" id="f-625" unitRef="number">0.0414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-199" decimals="4" id="f-626" unitRef="number">0.0410</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-198"
      decimals="INF"
      id="f-627"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-199"
      decimals="INF"
      id="f-628"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-198" decimals="3" id="f-629" unitRef="number">1.160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-199" decimals="3" id="f-630" unitRef="number">0.996</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-198" id="f-631">P5Y10M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-199" id="f-632">P5Y11M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-633">&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense for all stock awards recognized in the accompanying unaudited condensed consolidated statements of operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.115%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months&lt;br/&gt;&#160;Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months&lt;br/&gt;&#160;Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,138,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,627,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,632,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation contextRef="c-200" decimals="-3" id="f-634" unitRef="usd">761000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-201" decimals="-3" id="f-635" unitRef="usd">842000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-202" decimals="-3" id="f-636" unitRef="usd">1592000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-203" decimals="-3" id="f-637" unitRef="usd">2005000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-204" decimals="-3" id="f-638" unitRef="usd">1138000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-205" decimals="-3" id="f-639" unitRef="usd">1040000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-206" decimals="-3" id="f-640" unitRef="usd">2349000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-207" decimals="-3" id="f-641" unitRef="usd">2627000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-208" decimals="-3" id="f-642" unitRef="usd">1899000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-209" decimals="-3" id="f-643" unitRef="usd">1882000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-210" decimals="-3" id="f-644" unitRef="usd">3941000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-211" decimals="-3" id="f-645" unitRef="usd">4632000000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-212" decimals="-5" id="f-646" unitRef="usd">15600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-198" id="f-647">P3Y1M28D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-213" decimals="-3" id="f-648" unitRef="usd">28000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-214" decimals="-3" id="f-649" unitRef="usd">24000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-215" decimals="-3" id="f-650" unitRef="usd">56000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-216" decimals="-3" id="f-651" unitRef="usd">49000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-217" decimals="-3" id="f-652" unitRef="usd">9000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-218" decimals="-3" id="f-653" unitRef="usd">8000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-219" decimals="-5" id="f-654" unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-220" decimals="-5" id="f-655" unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-221"
      decimals="INF"
      id="f-656"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-222"
      decimals="INF"
      id="f-657"
      unitRef="shares">46250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-223" decimals="INF" id="f-658" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-224" decimals="INF" id="f-659" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-225" decimals="INF" id="f-660" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-226" decimals="INF" id="f-661" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-662">Related Party Transactions&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Executive Chairman Agreement with Duane Nash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 15, 2020, the Compensation Committee of the Board of Directors of the Company independently reviewed and approved entering into an employment agreement with the Executive Chairman of the Board, Duane Nash, MD, JD, MBA (the &#x201c;Executive Chairman Agreement&#x201d;) and pursuant to such approval, on April 17, 2020, the Company and Dr. Nash entered into the Executive Chairman Agreement. The Executive Chairman Agreement establishes an &#x201c;at will&#x201d; employment relationship.  On October 17, 2023, Immunic, Inc. and Dr. Duane Nash entered into Addendum Number 5  to the Executive Chairman Agreement to extend the term of Dr. Nash&#x2019;s employment as Executive Chairman of the Board of Directors of the Company to December 31, 2024.  In connection with  Addendum Number 5, the Company increased Dr. Nash&#x2019;s monthly base salary to $32,368 from $30,250 (which includes the cash retainer payable for serving on the Company&#x2019;s Board or for acting as the Chairman of the Board). On August 29, 2024, Immunic, Inc.  and Dr. Duane Nash entered into Addendum Number 6  to the Executive Chairman Agreement to extend the term of Dr. Nash&#x2019;s employment as Executive Chairman of the Board of Directors of the Company to December 31, 2025.  In connection with  Addendum Number 6, the Company increased Dr. Nash&#x2019;s monthly base salary in 2025 to $33,986 from $32,368 (which includes the cash retainer payable for serving on the Company&#x2019;s Board or for acting as the Chairman of the Board) All other terms of the Executive Chairman Agreement remain the same.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <vtl:SalaryAndWageOfficerMonthlyBaseSalary contextRef="c-227" decimals="0" id="f-663" unitRef="usd">32368</vtl:SalaryAndWageOfficerMonthlyBaseSalary>
    <vtl:SalaryAndWageOfficerMonthlyBaseSalary contextRef="c-228" decimals="0" id="f-664" unitRef="usd">30250</vtl:SalaryAndWageOfficerMonthlyBaseSalary>
    <vtl:SalaryAndWageOfficerMonthlyBaseSalary contextRef="c-229" decimals="0" id="f-665" unitRef="usd">33986</vtl:SalaryAndWageOfficerMonthlyBaseSalary>
    <vtl:SalaryAndWageOfficerMonthlyBaseSalary contextRef="c-227" decimals="0" id="f-666" unitRef="usd">32368</vtl:SalaryAndWageOfficerMonthlyBaseSalary>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-667">Commitments and Contingencies&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contractual Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2025, the Company has non-cancelable contractual obligations under certain agreements related to its development programs for vidofludimus calcium and IMU-856 totaling approximately $2.1&#160;million, all of which is expected to be paid in 2025 and 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Commitments and Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Daiichi Sankyo Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 5, 2020, the Company exercised its option to obtain the exclusive worldwide right to commercialization of IMU-856. Among other things, the option exercise grants Immunic AG the rights to Daiichi Sankyo&#x2019;s patent application related to IMU-856, for which the Company received a notice of allowance from the U.S. Patent &amp;amp; Trademark Office in August 2022. In connection with the option exercise, the Company paid a one-time upfront licensing fee to Daiichi Sankyo. Under the Daiichi Sankyo Agreement, Daiichi Sankyo is also eligible to receive future development, regulatory and sales milestone payments, as well as royalties related to IMU-856. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:130%"&gt;Ludwig-Maximilians-University Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%"&gt;Effective June 30, 2025 Immunic AG entered into a licensing agreement with Ludwig-Maximilians-University for an exclusive license to develop, manufacture and commercialize products derived for a series of new molecules for treating neuroinflammatory diseases.  Under the agreement Ludwig-Maximilians-University is entitled to receive future development, regulatory and sales milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not currently a party to any litigation, nor is it aware of any pending or threatened litigation, that it believes would materially affect its business, operating results, financial condition or cash flows. However, its industry is characterized by frequent claims and litigation including securities litigation, claims regarding patent and other intellectual property rights and claims for product liability. As a result, in the future, the Company may be involved in various legal proceedings from time to time.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ContractualObligation contextRef="c-3" decimals="-5" id="f-668" unitRef="usd">2100000</us-gaap:ContractualObligation>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-669">Segment Disclosures&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision making group, in deciding how to allocate resources in assessing performance. The Company has one reportable segment: life science. The life science segment consists of the development of clinical and preclinical product candidates for the development of the Company&#x2019;s proprietary new therapies. The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) is the Company's Chief Executive Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the life science segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the life science segment based on net loss. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM allocates resources and assesses performance on a consolidated basis, focused on the Company&#x2019;s cash resources and an assessment of the probability of success of its ongoing research and development activities. Resource allocation decisions are informed by forecasted cash expenditures and actual expenses incurred to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To date, the Company has not generated any product revenue. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances product candidates through all stages of development and clinical trials and, ultimately, seeks regulatory approval. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the significant expense categories regularly reviewed by the CODM for the  three and six months ended June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.847%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.849%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs- research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs-general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs- research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs-general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of the tranche rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-670"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-671">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the significant expense categories regularly reviewed by the CODM for the  three and six months ended June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.847%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.849%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs- research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs-general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-clinical product candidates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs- research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee costs-general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of the tranche rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <vtl:ClinicalProductCandidates contextRef="c-230" decimals="-3" id="f-672" unitRef="usd">17710000</vtl:ClinicalProductCandidates>
    <vtl:ClinicalProductCandidates contextRef="c-231" decimals="-3" id="f-673" unitRef="usd">14931000</vtl:ClinicalProductCandidates>
    <vtl:PreClinicalProductCandidates contextRef="c-230" decimals="-3" id="f-674" unitRef="usd">231000</vtl:PreClinicalProductCandidates>
    <vtl:PreClinicalProductCandidates contextRef="c-231" decimals="-3" id="f-675" unitRef="usd">219000</vtl:PreClinicalProductCandidates>
    <us-gaap:LaborAndRelatedExpense contextRef="c-232" decimals="-3" id="f-676" unitRef="usd">2594000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-233" decimals="-3" id="f-677" unitRef="usd">1887000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-234" decimals="-3" id="f-678" unitRef="usd">2083000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-235" decimals="-3" id="f-679" unitRef="usd">1348000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-230" decimals="-3" id="f-680" unitRef="usd">1899000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-231" decimals="-3" id="f-681" unitRef="usd">1882000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationNonproduction contextRef="c-230" decimals="-3" id="f-682" unitRef="usd">43000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction contextRef="c-231" decimals="-3" id="f-683" unitRef="usd">34000</us-gaap:DepreciationNonproduction>
    <us-gaap:ProfessionalFees contextRef="c-230" decimals="-3" id="f-684" unitRef="usd">2523000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-231" decimals="-3" id="f-685" unitRef="usd">2513000</us-gaap:ProfessionalFees>
    <us-gaap:OperatingExpenses contextRef="c-230" decimals="-3" id="f-686" unitRef="usd">27083000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-231" decimals="-3" id="f-687" unitRef="usd">22814000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-230" decimals="-3" id="f-688" unitRef="usd">-27083000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-231" decimals="-3" id="f-689" unitRef="usd">-22814000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-230" decimals="-3" id="f-690" unitRef="usd">241000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-231" decimals="-3" id="f-691" unitRef="usd">998000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-230" decimals="-3" id="f-692" unitRef="usd">22000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-231" decimals="-3" id="f-693" unitRef="usd">436000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-230" decimals="-3" id="f-694" unitRef="usd">-26820000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-231" decimals="-3" id="f-695" unitRef="usd">-21380000</us-gaap:NetIncomeLoss>
    <vtl:ClinicalProductCandidates contextRef="c-236" decimals="-3" id="f-696" unitRef="usd">35491000</vtl:ClinicalProductCandidates>
    <vtl:ClinicalProductCandidates contextRef="c-237" decimals="-3" id="f-697" unitRef="usd">29882000</vtl:ClinicalProductCandidates>
    <vtl:PreClinicalProductCandidates contextRef="c-236" decimals="-3" id="f-698" unitRef="usd">345000</vtl:PreClinicalProductCandidates>
    <vtl:PreClinicalProductCandidates contextRef="c-237" decimals="-3" id="f-699" unitRef="usd">400000</vtl:PreClinicalProductCandidates>
    <us-gaap:LaborAndRelatedExpense contextRef="c-238" decimals="-3" id="f-700" unitRef="usd">4761000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-239" decimals="-3" id="f-701" unitRef="usd">3881000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-240" decimals="-3" id="f-702" unitRef="usd">3643000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-241" decimals="-3" id="f-703" unitRef="usd">2704000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-236" decimals="-3" id="f-704" unitRef="usd">3941000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-237" decimals="-3" id="f-705" unitRef="usd">4632000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationNonproduction contextRef="c-236" decimals="-3" id="f-706" unitRef="usd">86000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction contextRef="c-237" decimals="-3" id="f-707" unitRef="usd">57000</us-gaap:DepreciationNonproduction>
    <us-gaap:ProfessionalFees contextRef="c-236" decimals="-3" id="f-708" unitRef="usd">5641000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-237" decimals="-3" id="f-709" unitRef="usd">5139000</us-gaap:ProfessionalFees>
    <us-gaap:OperatingExpenses contextRef="c-236" decimals="-3" id="f-710" unitRef="usd">53908000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-237" decimals="-3" id="f-711" unitRef="usd">46695000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-236" decimals="-3" id="f-712" unitRef="usd">-53908000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-237" decimals="-3" id="f-713" unitRef="usd">-46695000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-236" decimals="-3" id="f-714" unitRef="usd">424000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-237" decimals="-3" id="f-715" unitRef="usd">2185000</us-gaap:InvestmentIncomeInterest>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-236" decimals="-3" id="f-716" unitRef="usd">0</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts contextRef="c-237" decimals="-3" id="f-717" unitRef="usd">4796000</vtl:FairValueChangeInFairValueOfTrancheRightsTransactionCosts>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-236" decimals="-3" id="f-718" unitRef="usd">1191000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-237" decimals="-3" id="f-719" unitRef="usd">-1658000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-236" decimals="-3" id="f-720" unitRef="usd">-52293000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-237" decimals="-3" id="f-721" unitRef="usd">-50964000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-722">Subsequent Events &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Appreciation Rights Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 7, 2025, the Board of Directors (the &#x201c;Board&#x201d;) of Immunic, Inc. (the &#x201c;Company&#x201d;) authorized grants, subject to the final approval of the Compensation Committee of the Board, of up to an aggregate of 35,000,000 stock appreciation rights (&#x201c;SARs&#x201d;) to the Company&#x2019;s employees and executive officers. This includes an aggregate of 22,015,000 SARs to the Company&#x2019;s executive officers. The SARs could be settled for cash, but it is the intention of the Company that these SARs will be settled for shares of the Company&#x2019;s common stock, par value $0.0001 per share (&#x201c;Common Stock&#x201d;) provided the Company obtains stockholder approval to amend the Company&#x2019;s 2019 Omnibus Equity Incentive Plan, as amended (the &#x201c;Plan&#x201d;), to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock. The Company intends to seek stockholder approval to increase the number of shares available under the Plan. The exercise price of each SAR is $0.77, the closing price of the Common Stock on July 7, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the 35,000,000 SARs, (i) 5,000,000 will be exercisable beginning August 1, 2026; (ii) up to 10,000,000 will be exercisable beginning August 1, 2026, subject to the exercise of the Company&#x2019;s Series A  warrants by the holders thereof; (iii) up to 10,000,000 will be exercisable beginning August 1, 2026, subject to the exercise of the Company&#x2019;s Series B warrants by the holders thereof; (iv) up to 5,000,000 will be exercisable beginning August 1, 2026, subject to the Company&#x2019;s issuance of Common Stock or pre-funded warrants to subscribers in connection with the second tranche of the Company&#x2019;s January 4, 2024 private placement (the &#x201c;January 2024 Offering&#x201d;); and (v) up to 5,000,000 will be exercisable beginning August 1, 2026, subject to the issuance of Common Stock or pre-funded warrants to subscribers in connection with the third tranche of the January 2024 Offering.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-242"
      decimals="INF"
      id="f-723"
      unitRef="shares">35000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-243"
      decimals="INF"
      id="f-724"
      unitRef="shares">22015000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-242"
      decimals="4"
      id="f-725"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-242"
      decimals="2"
      id="f-726"
      unitRef="usdPerShare">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-242"
      decimals="INF"
      id="f-727"
      unitRef="shares">35000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-244"
      decimals="INF"
      id="f-728"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-245"
      decimals="INF"
      id="f-729"
      unitRef="shares">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-246"
      decimals="INF"
      id="f-730"
      unitRef="shares">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-247"
      decimals="INF"
      id="f-731"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-248"
      decimals="INF"
      id="f-732"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-733">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-5" id="f-734">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-735">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-5" id="f-736">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
